{
  "experiment_metadata": {
    "model": "nemotron-nano-30b",
    "experiment": "e3_page_window_distract",
    "pattern": "qualitative_2hop_cross_year",
    "total_questions": 1000
  },
  "results": [
    {
      "question_id": 77,
      "question": "How did the gross benefit obligation and the actuarial losses for LMT's nonqualified defined benefit pension plans evolve between 2023 and 2024?",
      "original_answer": "In 2023, the gross benefit obligation for LMT's nonqualified defined benefit pension plans was $1.0 billion with actuarial losses totaling $347 million. By 2024, the gross benefit obligation decreased to $905 million, and the actuarial losses declined to $303 million. This indicates a reduction in both the liability and the associated actuarial losses over the period.",
      "llm_answer": "The gross benefit obligation for LMT’s nonqualified defined benefit pension plans declined slightly from $1.0 billion at the end of 2023 to $905 million at the end of 2024, while the related actuarial losses recorded in accumulated other comprehensive loss fell from $347 million to $303 million (pretax). This indicates a modest reduction in both the obligation and the unrecognized actuarial losses over the one‑year period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "LMT_10k_2023.pdf",
          "target_page": 88,
          "pages": [
            86,
            87,
            88,
            89,
            90
          ]
        },
        "hop_2_rel": {
          "source_file": "LMT_10k_2024.pdf",
          "target_page": 89,
          "pages": [
            87,
            88,
            89,
            90,
            91
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 49302,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 12545,
        "completion_tokens": 106,
        "total_tokens": 12652
      }
    },
    {
      "question_id": 2,
      "question": "How did General Motors' long-term rate of return assumptions on U.S. pension plan assets evolve between 2022 and 2024, and what does this indicate about the company's strategic asset mix adjustments?",
      "original_answer": "In 2022, General Motors reported that the weighted-average long-term rate of return on U.S. pension plan assets decreased from 5.6% at December 31, 2020, to 5.4% at December 31, 2021. By contrast, in 2024, the company indicated that the weighted-average long-term rate of return on U.S. pension plan assets increased from 6.3% at December 31, 2023, to 6.5% at December 31, 2024. This indicates a notable shift in the company's strategic asset mix, moving from a more conservative assumption in 2022 to a more optimistic projection in 2024, likely reflecting changes in capital market assumptions and investment strategies aimed at improving funded status.",
      "llm_answer": "Between 2022 and 2024, General Motors adjusted its long-term rate of return assumptions for U.S. pension plan assets from 5.6% to 6.5%, reflecting a strategic shift toward a more aggressive asset allocation—particularly increasing exposure to alternative investments like private equity, real estate, and hedge funds (from 23% to 29% of the portfolio). This change, driven by updated capital market assumptions and investment policy studies, aims to improve funded status and mitigate volatility while aligning with the company’s de-risking objectives. The increased expected return supports a more aggressive portfolio mix to better match long-term liability obligations.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "GM_10k_2022.pdf",
          "target_page": 86,
          "pages": [
            84,
            85,
            86,
            87,
            88
          ]
        },
        "hop_2_rel": {
          "source_file": "GM_10k_2024.pdf",
          "target_page": 88,
          "pages": [
            86,
            87,
            88,
            89,
            90
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 9,
        "total_chars": 63855,
        "num_window_pages": 9,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 16197,
        "completion_tokens": 168,
        "total_tokens": 16365
      }
    },
    {
      "question_id": 5,
      "question": "How has Chevron's relationship with PDC Energy evolved between 2023 and 2024, and what specific operational and financial impacts were attributed to this change?",
      "original_answer": "In 2023, Chevron acquired PDC Energy, and as a result, PDC was excluded from Chevron’s internal control assessment due to the business combination. By 2024, the integration had progressed to the point where Chevron reported a $2.2 billion increase in U.S. upstream earnings attributed to legacy PDC assets, and a 19% increase in net oil-equivalent production driven by the full-year contribution from PDC. This reflects a shift from acquisition to operational integration and performance contribution.",
      "llm_answer": "Chevron's relationship with PDC Energy evolved from a previously disclosed acquisition during 2023, which was explicitly excluded from the company's internal control assessment as of December 31, 2023, due to being acquired in a business combination. This integration likely contributed to operational changes and financial impacts reflected in Chevron's 2024 results, including higher upstream earnings from legacy PDC assets (notably a 19% increase in U.S. upstream production and $3.5 billion in increased earnings driven by higher volumes and absence of decommissioning charges) and adjustments to integration-related expenses. The document also references \"legacy PDC assets\" in the context of upstream performance, indicating that PDC's operations were fully absorbed into Chevron's upstream segment by 2024, though no specific financial impact of the relationship itself is detailed beyond this operational integration and its effect on production and earnings.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CVX_10k_2023.pdf",
          "target_page": 30,
          "pages": [
            28,
            29,
            30,
            31,
            32
          ]
        },
        "hop_2_rel": {
          "source_file": "CVX_10k_2024.pdf",
          "target_page": 44,
          "pages": [
            42,
            43,
            44,
            45,
            46
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 109716,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 27653,
        "completion_tokens": 242,
        "total_tokens": 27895
      }
    },
    {
      "question_id": 5,
      "question": "How did Southern Company's treatment and valuation of energy-related derivatives change between 2022 and 2024, particularly in terms of unrealized gains (losses) and their presentation in financial statements?",
      "original_answer": "In 2022, Southern Company reported the pre-tax effects of unrealized derivative gains (losses) from energy-related derivatives that were designated as regulatory hedging instruments and deferred, specifically as of December 31, 2021, and 2020. By 2024, the company shifted its disclosure focus to the fair value of energy-related derivatives, interest rate derivatives, and foreign currency derivatives, which were presented as either assets or liabilities in the balance sheets, typically under 'Other' or separately as 'Risk Management Activities'. This indicates a change in both the valuation approach and the presentation of these instruments in financial disclosures.",
      "llm_answer": "Between 2022 and 2024, Southern Company's treatment of energy-related derivatives shifted toward greater use of regulatory hedging frameworks, with increased recognition of unrealized gains and losses in the balance sheet under regulatory asset/liability accounts. In 2024, net amounts recognized for energy-related derivatives designated as hedging instruments totaled $28 million in assets and $84 million in liabilities (up from $21 million and $87 million in 2023), reflecting higher valuation of both current and non-current derivatives. Unrealized gains/losses from these derivatives were primarily recorded in AOCI for cash flow hedges and deferred in regulatory accounts for regulatory hedges, with minimal impact on income until realized. The 2024 filings also show expanded use of cash flow and fair value hedges for interest rate and foreign currency risks, though gains/losses remained immaterial for AOCI reclassifications in 2025. (Based on SO_10k_2024 pages 281-285 and comparative 2023 data.)",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "SO_10k_2022.pdf",
          "target_page": 324,
          "pages": [
            322,
            323,
            324,
            325,
            326
          ]
        },
        "hop_2_rel": {
          "source_file": "SO_10k_2024.pdf",
          "target_page": 283,
          "pages": [
            281,
            282,
            283,
            284,
            285
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 53912,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 13716,
        "completion_tokens": 252,
        "total_tokens": 13968
      }
    },
    {
      "question_id": 7,
      "question": "How did Chevron's financial relationship with Tengizchevroil evolve between 2022 and 2024, particularly in terms of its investment carrying value and equity earnings?",
      "original_answer": "In 2022, Chevron disclosed that its carrying value of its investment in Tengizchevroil (TCO) was about $100 higher than its underlying equity in TCO's net assets, with a significant portion of the investment tied to a $4,500 loan to fund the FGP/WPMP development. By 2024, Chevron's financial stake in Tengizchevroil had grown substantially, with its investment and advances reaching $27,368 million in 2024, compared to $26,954 million in 2023. Additionally, Chevron's equity in earnings from TCO declined from $4,386 million in 2022 to $3,033 million in 2024, indicating a reduction in profitability from the venture over this period.",
      "llm_answer": "Chevron's investment carrying value in Tengizchevroil increased from $23,727 million at the end of 2021 to $27,368 million by the end of 2024, reflecting a $3,641 million rise over the three‑year period.  Correspondingly, Chevron's equity earnings from Tengizchevroil grew from $1,238 million in 2021 to $3,375 million in 2024, indicating a substantial improvement in earnings from that equity affiliate.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CVX_10k_2022.pdf",
          "target_page": 78,
          "pages": [
            76,
            77,
            78,
            79,
            80
          ]
        },
        "hop_2_rel": {
          "source_file": "CVX_10k_2024.pdf",
          "target_page": 84,
          "pages": [
            82,
            83,
            84,
            85,
            86
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 58866,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 14942,
        "completion_tokens": 101,
        "total_tokens": 15043
      }
    },
    {
      "question_id": 10,
      "question": "How did Walmart's ownership stake in Alert Innovation evolve between fiscal 2023 and fiscal 2024, and what specific transaction occurred to change its relationship with the entity?",
      "original_answer": "In fiscal 2023, Walmart completed a $0.4 billion acquisition of Alert Innovation, which was previously consolidated as a variable interest entity, resulting in Walmart becoming a 100% owner. However, by fiscal 2024, Walmart had subsequently sold and deconsolidated Alert Innovation, indicating a complete exit from the entity. This marks a full transformation from full ownership to no ownership within a single fiscal year.",
      "llm_answer": "Based on the provided 10-K filings, Walmart's ownership stake in Alert Innovation underwent a specific transaction during fiscal 2023 that changed its relationship with the entity. \n\nAccording to Note 3 (Shareholders' Equity) in the 2023 10-K (page 65), Walmart completed a $0.4 billion acquisition of Alert Innovation during fiscal 2023, which resulted in the Company becoming a 100% owner. This entity was previously consolidated as a variable interest entity, and the acquisition marked the point at which Walmart gained full ownership. The entity was subsequently sold and deconsolidated in fiscal 2025, as noted in the same section.\n\nThus, the evolution was: Alert Innovation was initially consolidated as a variable interest entity, then fully acquired by Walmart in fiscal 2023 (increasing ownership from a non-100% stake to 100%), and later sold/deconsolidated in fiscal 2025. The specific transaction that changed the relationship was the $0.4 billion acquisition in fiscal 2023 that made Walmart the 100% owner.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "WMT_10k_2023.pdf",
          "target_page": 66,
          "pages": [
            64,
            65,
            66,
            67,
            68
          ]
        },
        "hop_2_rel": {
          "source_file": "WMT_10k_2024.pdf",
          "target_page": 65,
          "pages": [
            63,
            64,
            65,
            66,
            67
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 59308,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 15056,
        "completion_tokens": 255,
        "total_tokens": 15311
      }
    },
    {
      "question_id": 14,
      "question": "How did Starbucks' foreign currency - other derivative asset and liability positions change from fiscal year 2022 to 2023, and what does this indicate about the company's exposure management strategy?",
      "original_answer": "In fiscal year 2022, Starbucks reported a foreign currency - other derivative asset of $55.3 million in Accumulated Other Comprehensive Income (AOCI) with $32.5 million expected to be reclassified into earnings within 12 months. By fiscal year 2023, Starbucks had shifted its position significantly, reporting foreign currency - other derivative assets of $1.9 million in current assets and $1.7 million in long-term assets, while carrying derivative liabilities of $4.7 million in current liabilities and $4.1 million in long-term liabilities. This indicates a substantial reduction in overall foreign currency - other derivative exposure and a shift from unrealized gains in equity to more balanced short- and long-term asset and liability positions.",
      "llm_answer": "From fiscal 2022 to 2023, Starbucks' foreign currency derivative assets and liabilities decreased substantially, with derivative assets falling from $85.9 million to $46.8 million and derivative liabilities from $56.7 million to $43.2 million. This reduction reflects the company’s active management of foreign‑exchange exposure—using forwards, swaps and designated hedging instruments—to offset currency volatility in its international operations and to limit potential losses from fluctuating exchange rates. The decline indicates that Starbucks is tightening its hedging program, likely to stabilize earnings and protect cash flows against adverse currency movements.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "SBUX_10k_2022.pdf",
          "target_page": 66,
          "pages": [
            64,
            65,
            66,
            67,
            68
          ]
        },
        "hop_2_rel": {
          "source_file": "SBUX_10k_2023.pdf",
          "target_page": 72,
          "pages": [
            70,
            71,
            72,
            73,
            74
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 64541,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 16369,
        "completion_tokens": 167,
        "total_tokens": 16537
      }
    },
    {
      "question_id": 15,
      "question": "How did Medtronic's treatment of A Preferred Shares evolve between fiscal years 2022 and 2024, and what specific action was taken regarding these shares in 2022?",
      "original_answer": "In fiscal year 2022, Medtronic redeemed 1,872 A Preferred Shares for $0.075 million during the third quarter, and no A Preferred Shares were outstanding by April 29, 2022. By fiscal year 2024, no A Preferred Shares remained outstanding, indicating that the company did not reissue or reintroduce this class of shares after the redemption in 2022. This shows a discontinuation of the A Preferred Shares following their redemption.",
      "llm_answer": "Based on the provided SEC 10-K filings, Medtronic's treatment of A Preferred Shares evolved as follows between fiscal years 2022 and 2024:  \n\n1.  **In fiscal 2022**, the Company **redeemed all outstanding A Preferred Shares** (1,872 shares) for $0.075 million, resulting in **no A Preferred Shares being outstanding at the end of fiscal 2022** (as stated in Note 11 on page 81: \"During the third quarter of fiscal year 2022 the Company redeemed the previously outstanding 1,872 A Preferred Shares for $0.075 million. At April 29, 2022, no A Preferred Shares were outstanding\").  \n2.  **In fiscal 2024**, there were **no A Preferred Shares outstanding** (as confirmed in Note 11 on page 81: \"At April 26, 2024, no A Preferred Shares were outstanding\"), and the Company continued to have **no Preferred Shares or A Preferred Shares issued or outstanding** (as noted in Note 11 on page 82).  \n\nThus, the specific action taken regarding A Preferred Shares in 2022 was the **full redemption of all outstanding A Preferred Shares**, eliminating them from the Company's capital structure. This action was completed during fiscal 2022, and no A Preferred Shares remained outstanding in subsequent years (2023 and 2024).",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MDT_10k_2022.pdf",
          "target_page": 81,
          "pages": [
            79,
            80,
            81,
            82,
            83
          ]
        },
        "hop_2_rel": {
          "source_file": "MDT_10k_2024.pdf",
          "target_page": 81,
          "pages": [
            79,
            80,
            81,
            82,
            83
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 48394,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 12322,
        "completion_tokens": 302,
        "total_tokens": 12625
      }
    },
    {
      "question_id": 16,
      "question": "How did Comcast's financial relationship with Atairos evolve between 2022 and 2023, particularly in terms of equity income (losses) driven by fair value adjustments on underlying investments?",
      "original_answer": "In 2022, Comcast's equity in net income (losses) from investees, particularly Atairos, showed a loss of $(434) million due to fair value adjustments on its underlying investments. In contrast, by 2023, Atairos generated income of $1.1 billion for Comcast, reflecting a significant turnaround. This change indicates a substantial improvement in the performance of Atairos's underlying investments over the period.",
      "llm_answer": "Based on the provided SEC 10-K pages, Comcast's financial relationship with Atairos evolved such that equity income (losses) driven by fair value adjustments on underlying investments shifted from a significant positive contributor in 2021 ($1.8 billion income at Atairos) to a major negative driver in 2022 and 2023, with losses of $(434) million in 2022 and $(1.1 billion) in 2023. This is documented in the \"Consolidated Investment and Other Income (Loss), Net\" table on page 39 (2023) and page 48 (2021-2022), which explicitly states that the change in investment income was primarily due to fair value adjustments at Atairos, with income (loss) of $1.1 billion and $(434) million in 2023 and 2022, respectively. The 2023 equity income (losses) directly reflects these fair value adjustments, marking a continued deterioration in the relationship's contribution to Comcast's overall financial results compared to the prior year.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CMCSA_10k_2022.pdf",
          "target_page": 48,
          "pages": [
            46,
            47,
            48,
            49,
            50
          ]
        },
        "hop_2_rel": {
          "source_file": "CMCSA_10k_2023.pdf",
          "target_page": 39,
          "pages": [
            37,
            38,
            39,
            40,
            41
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 9,
        "total_chars": 40578,
        "num_window_pages": 9,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 10377,
        "completion_tokens": 233,
        "total_tokens": 10610
      }
    },
    {
      "question_id": 23,
      "question": "How has COP's natural gas reserves in the Asia Pacific/Middle East region evolved from 2023 to 2024, and what does this indicate about the company's strategic positioning in that geographic area?",
      "original_answer": "In 2023, COP reported 312 billion cubic feet of natural gas reserves in the Asia Pacific/Middle East region. By 2024, this figure slightly declined to 296 billion cubic feet. This minor decrease suggests limited growth or a strategic reallocation of resources in the region during that period.",
      "llm_answer": "COP's natural gas reserves in the Asia Pacific/Middle East region increased from 5,275 billion cubic feet (end‑2023) to 5,870 billion cubic feet (end‑2024), reflecting upward revisions, purchases (notably from the Marathon Oil acquisition) and extensions/discoveries in the region. This growth underscores the company’s strategic focus on expanding its presence and resource base in the Asia Pacific/Middle East, positioning it as a key hub for future gas production and revenue.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "COP_10k_2023.pdf",
          "target_page": 150,
          "pages": [
            148,
            149,
            150,
            151,
            152
          ]
        },
        "hop_2_rel": {
          "source_file": "COP_10k_2024.pdf",
          "target_page": 145,
          "pages": [
            143,
            144,
            145,
            146,
            147
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 75601,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 19135,
        "completion_tokens": 119,
        "total_tokens": 19255
      }
    },
    {
      "question_id": 24,
      "question": "How did the revenue performance of ENBREL in Canada evolve between 2022 and 2024, and what does this indicate about its market trajectory?",
      "original_answer": "In 2022, ENBREL in Canada generated $113 million in revenue, which declined to $47 million in 2023, and further dropped to $28 million in 2024. This indicates a consistent downward trend in revenue, suggesting a shrinking market presence or reduced demand for ENBREL in Canada over this period.",
      "llm_answer": "ENBREL sales in Canada declined from $73 million in 2022 to $47 million in 2023 (a 36% drop) and further to $28 million in 2024 (a 40% drop from the prior year). This consistent downward trend signals a weakening market position and suggests that ENBREL’s Canadian sales trajectory is moving toward continued erosion.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AMGN_10k_2023.pdf",
          "target_page": 72,
          "pages": [
            70,
            71,
            72,
            73,
            74
          ]
        },
        "hop_2_rel": {
          "source_file": "AMGN_10k_2024.pdf",
          "target_page": 71,
          "pages": [
            69,
            70,
            71,
            72,
            73
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 40248,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 10281,
        "completion_tokens": 79,
        "total_tokens": 10360
      }
    },
    {
      "question_id": 25,
      "question": "How has Qualcomm's approach to linking human capital advancements with executive compensation evolved from fiscal 2023 to fiscal 2024, and what specific performance modifier range was applied in fiscal 2024?",
      "original_answer": "In fiscal 2023, Qualcomm indicated that human capital advancements would be considered in determining executives' fiscal 2024 bonus. By fiscal 2024, this approach evolved into a more defined structure where progress toward human capital advancements served as a non-financial performance modifier that could adjust executives' bonus payouts by a multiplier ranging from 0.9 to 1.1. This represents a shift from a general consideration to a quantified performance modifier in executive compensation.",
      "llm_answer": "From fiscal 2023 to fiscal 2024, Qualcomm’s executive compensation began to tie human‑capital progress to bonus payouts, using a non‑financial performance modifier that can adjust the fiscal 2024 executive bonus by a multiplier of **0.9 to 1.1**. This represents the first time the company explicitly linked human‑capital advancements to executive pay, whereas in fiscal 2023 the approach was not quantified in this manner. The specific performance modifier range applied in fiscal 2024 is **0.9 – 1.1**.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "QCOM_10k_2023.pdf",
          "target_page": 16,
          "pages": [
            14,
            15,
            16,
            17,
            18
          ]
        },
        "hop_2_rel": {
          "source_file": "QCOM_10k_2024.pdf",
          "target_page": 16,
          "pages": [
            14,
            15,
            16,
            17,
            18
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 61237,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 15545,
        "completion_tokens": 126,
        "total_tokens": 15671
      }
    },
    {
      "question_id": 27,
      "question": "How has the therapeutic scope of Breyanzi evolved between 2022 and 2024, based on the specific indications and approvals documented in those years?",
      "original_answer": "In 2022, Breyanzi was associated with trials for 3L+ Chronic Lymphocytic Leukemia (TRANSCEND-CLL-004) and 3L+ Follicular Lymphoma (TRANSCEND-FL), both with expected timing in 2023/24. By 2024, Breyanzi received FDA accelerated approvals for two distinct indications: relapsed or refractory Follicular Lymphoma (FL) after at least two prior lines of therapy (approved in May 2024), and relapsed or refractory Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Lymphoma (SLL) after at least two prior lines of therapy, including a Bruton tyrosine kinase inhibitor and a B-cell lymphoma 2 inhibitor (approved in March 2024). This reflects a shift from being in late-stage trials to having concrete accelerated approvals in specific patient populations.",
      "llm_answer": "Based on the provided SEC 10-K filings, Breyanzi's therapeutic scope expanded significantly between 2022 and 2024 through multiple new approvals. In 2022, it was approved for relapsed/refractory DLBCL (as noted in the Phase III table on page 18), but by 2024 it received FDA accelerated approvals for three additional B-cell malignancies: relapsed/refractory CLL/SLL (page 45), relapsed/refractory FL (page 45), and relapsed/refractory MCL (page 44). This broadened its indication from a single DLBCL approval to a portfolio covering multiple hematologic cancers, with the 2024 approvals specifically extending its use to CLL/SLL, FL, and MCL after prior systemic therapies.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "BMY_10k_2022.pdf",
          "target_page": 20,
          "pages": [
            18,
            19,
            20,
            21,
            22
          ]
        },
        "hop_2_rel": {
          "source_file": "BMY_10k_2024.pdf",
          "target_page": 45,
          "pages": [
            43,
            44,
            45,
            46,
            47
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 9,
        "total_chars": 45273,
        "num_window_pages": 9,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 11539,
        "completion_tokens": 168,
        "total_tokens": 11707
      }
    },
    {
      "question_id": 28,
      "question": "How has the financial performance of Disney's Resorts and Vacations segment evolved from 2023 to 2024, and how does this compare to the overall revenue growth of the Parks & Experiences segment?",
      "original_answer": "The Resorts and Vacations segment saw an increase in revenue from $7,949 million in 2023 to $8,375 million in 2024, representing a 5% growth. This growth was slightly below the overall Parks & Experiences revenue growth of 5%, which increased from $32,549 million in 2023 to $34,151 million in 2024. The Resorts and Vacations segment remained a significant contributor to the overall Parks & Experiences division, maintaining a consistent proportion of total revenue despite the modest growth difference.",
      "llm_answer": "From 2023 to 2024, the Resorts and Vacations subsegment within Experiences grew revenue by 5% (from $7,949 M to $8,375 M), driven by higher cruise ticket prices, modest hotel rate increases, and increased occupancy, while overall Parks & Experiences revenue rose 5% to $34,151 M, reflecting broader park attendance and spending gains. This segment’s growth contributed to the Experiences segment’s operating income increasing 4% to $9,272 M, outpacing the modest 5% overall revenue growth of the segment.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "DIS_10k_2023.pdf",
          "target_page": 12,
          "pages": [
            10,
            11,
            12,
            13,
            14
          ]
        },
        "hop_2_rel": {
          "source_file": "DIS_10k_2024.pdf",
          "target_page": 47,
          "pages": [
            45,
            46,
            47,
            48,
            49
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 9,
        "total_chars": 35803,
        "num_window_pages": 9,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 9183,
        "completion_tokens": 126,
        "total_tokens": 9309
      }
    },
    {
      "question_id": 33,
      "question": "How has the structure and value of CVS's forward contracts associated with accelerated share repurchase (ASR) transactions evolved between 2023 and 2024?",
      "original_answer": "In 2023, CVS executed a $2.0 billion ASR with Citibank, N.A., which was accounted for as an initial treasury stock transaction of $1.6 billion and a forward contract of $0.4 billion. The forward contract was classified as an equity instrument and recorded within capital surplus, with the final 20% of shares received in February 2023. In 2024, CVS entered into a larger $3.0 billion ASR with Morgan Stanley, accounted for as an initial treasury stock transaction of $2.6 billion and a forward contract of $0.4 billion. The forward contract was similarly classified and recorded, but the remaining 15% of shares were received later, in March 2024. Despite the increase in the ASR size, the forward contract value remained constant at $0.4 billion, indicating a shift in the proportion of the ASR allocated to the forward contract component.",
      "llm_answer": "Between 2023 and 2024, CVS's forward contracts tied to accelerated share repurchase (ASR) transactions evolved from a $1.5 billion ASR with Barclays Bank PLC in January 2022 (accounted as a $1.2 billion treasury‑stock transaction and a $0.3 billion equity‑classified forward) to a $3.0 billion ASR with Morgan Stanley in January 2024 (initially recorded as a $2.6 billion treasury‑stock transaction and a $0.4 billion equity‑classified forward, later reclassified to treasury stock in March 2024). The company also executed a $2.0 billion ASR with Citibank in January 2023, similarly structured as an initial treasury‑stock entry with a forward equity component. These transactions progressively increased the notional amounts and share volumes repurchased, while the forward contracts remained classified as equity instruments initially recorded in capital surplus before being re‑classified to treasury stock upon final settlement.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CVS_10k_2023.pdf",
          "target_page": 75,
          "pages": [
            73,
            74,
            75,
            76,
            77
          ]
        },
        "hop_2_rel": {
          "source_file": "CVS_10k_2024.pdf",
          "target_page": 175,
          "pages": [
            173,
            174,
            175,
            176,
            177
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 39284,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 10044,
        "completion_tokens": 233,
        "total_tokens": 10277
      }
    },
    {
      "question_id": 37,
      "question": "How did Duke Energy's disclosure regarding the Master Retirement Trust's pension asset valuation methodology evolve from 2023 to 2024, particularly in terms of transparency around fair value categorization?",
      "original_answer": "In 2023, Duke Energy disclosed the allocation percentages of the Master Retirement Trust among its subsidiaries and noted that certain investments measured at fair value using the net asset value per share practical expedient were not categorized in the fair value hierarchy. In 2024, the company maintained the same allocation percentages but added a new disclosure element — a reconciliation of beginning and ending balances of the Master Retirement Trust's qualified pension and other post-retirement assets, specifically those valued using significant unobservable inputs (Level 3). This represents a significant increase in transparency regarding the fair value categorization of pension assets.",
      "llm_answer": "From 2023 to 2024, Duke Energy’s disclosure for the Master Retirement Trust became more transparent regarding fair value categorization. In 2023, the trust’s fair value hierarchy table clearly separated Level 1, Level 2, Level 3, and “Not Categorized” assets, with Level 3 assets explicitly defined as those measured using significant unobservable inputs. By 2024, the disclosure retained this structure but added clearer context in the accompanying narrative, specifying that certain investments measured using net asset value per share were excluded from the hierarchy (as noted in footnote (b)), and the reconciliation of Level 3 balances (from $62M to $76M) was explicitly detailed. This evolution improved clarity on how assets were classified, particularly for Level 3 items like partnership interests and hedge funds, while maintaining consistent categorization across periods.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "DUK_10k_2023.pdf",
          "target_page": 219,
          "pages": [
            217,
            218,
            219,
            220,
            221
          ]
        },
        "hop_2_rel": {
          "source_file": "DUK_10k_2024.pdf",
          "target_page": 228,
          "pages": [
            226,
            227,
            228,
            229,
            230
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 67776,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 17182,
        "completion_tokens": 221,
        "total_tokens": 17403
      }
    },
    {
      "question_id": 40,
      "question": "How did Pfizer's financial obligations and revenue recognition related to Paxlovid change between 2023 and 2024, particularly concerning the U.S. government's inventory return and the creation of the U.S. Strategic National Stockpile?",
      "original_answer": "In 2023, Pfizer recorded a non-cash revenue reversal of $3.5 billion related to the expected return of 6.5 million EUA-labeled Paxlovid treatment courses previously purchased by the U.S. government. In 2024, this estimate was adjusted based on the actual return of 5.1 million treatment courses, resulting in a favorable final adjustment of $771 million. Additionally, in 2024, Pfizer recognized $442 million of revenue in connection with the creation of the U.S. Strategic National Stockpile (SNS) of 1.0 million Paxlovid treatment courses for future pandemic preparedness. These developments reflect a shift from revenue reversal and inventory transition in 2023 to revenue recognition and strategic stockpile establishment in 2024.",
      "llm_answer": "Pfizer's revenue recognition for Paxlovid shifted significantly between 2023 and 2024 due to the U.S. government's inventory return and the creation of the U.S. Strategic National Stockpile. In 2023, Pfizer recorded a $3.5 billion non-cash revenue reversal related to the expected return of 6.5 million Paxlovid treatment courses from U.S. government inventory, which was partially offset by a $771 million favorable adjustment in early 2024 reflecting 5.1 million courses returned through February 2024. This reversal was tied to the transition from government distribution to commercial markets, culminating in the creation of the U.S. Strategic National Stockpile of 1.0 million treatment courses in 2024, which will be supplied at no cost to the government through 2028. Consequently, deferred revenue for Paxlovid decreased from $5.1 billion as of December 31, 2023, to $2.2 billion as of December 31, 2024, as amounts were recognized in revenue upon product delivery.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "PFE_10k_2023.pdf",
          "target_page": 110,
          "pages": [
            108,
            109,
            110,
            111,
            112
          ]
        },
        "hop_2_rel": {
          "source_file": "PFE_10k_2024.pdf",
          "target_page": 109,
          "pages": [
            107,
            108,
            109,
            110,
            111
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 98589,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 24892,
        "completion_tokens": 243,
        "total_tokens": 25135
      }
    },
    {
      "question_id": 47,
      "question": "How has the financial performance of ERLEADA evolved between 2022 and 2023, and what does this indicate about its role in J&J's oncology portfolio?",
      "original_answer": "ERLEADA's sales increased from $1,881 million in 2022 to $2,387 million in 2023, representing a 26.9% growth. This indicates that ERLEADA has become a more prominent contributor to J&J's oncology segment, which saw overall growth of 10.5% in 2023. The strong performance of ERLEADA contrasts with the decline in other key oncology products like IMBRUVICA and ZYTIGA, suggesting that ERLEADA is playing an increasingly important role in sustaining J&J's oncology revenue.",
      "llm_answer": "ERLEADA sales grew from $1,881 million in 2022 to $2,387 million in 2023—a 26.9% increase (27.5% operational growth, partially offset by a 0.6% currency impact). This strong performance underscores ERLEADA’s expanding role within J&J’s oncology portfolio, highlighting its rising contribution to overall oncology sales (which rose 10.5% to $17.7 billion in 2023).",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "JNJ_10k_2022.pdf",
          "target_page": 8,
          "pages": [
            6,
            7,
            8,
            9,
            10
          ]
        },
        "hop_2_rel": {
          "source_file": "JNJ_10k_2023.pdf",
          "target_page": 31,
          "pages": [
            29,
            30,
            31,
            32,
            33
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 42516,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 10848,
        "completion_tokens": 90,
        "total_tokens": 10939
      }
    },
    {
      "question_id": 49,
      "question": "How did the global sales performance of ERLEADA evolve from 2022 to 2023, and what does this indicate about its market trajectory?",
      "original_answer": "In 2022, ERLEADA reported worldwide sales of $1,291 million, with a significant growth rate of 70.0% compared to the previous year. By 2023, the product's global sales increased further to $2,387 million, reflecting a 26.9% growth from 2022. This indicates that ERLEADA continued to experience strong market adoption and revenue expansion, albeit at a slower growth rate compared to the prior year, suggesting a maturing growth phase in its lifecycle.",
      "llm_answer": "ERLEADA (apalutamide) sales grew sharply from $297 million in 2022 to $813 million in 2023 in the United States and from $35 million to $478 million internationally, driving worldwide sales up from $332 million to $1.291 billion—a 70 % increase in the U.S. and a 70 % rise globally. This rapid acceleration indicates that ERLEADA is gaining market share and expanding its footprint, suggesting a positive trajectory as it captures additional patients with metastatic castration‑resistant prostate cancer.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "JNJ_10k_2022.pdf",
          "target_page": 85,
          "pages": [
            83,
            84,
            85,
            86,
            87
          ]
        },
        "hop_2_rel": {
          "source_file": "JNJ_10k_2023.pdf",
          "target_page": 31,
          "pages": [
            29,
            30,
            31,
            32,
            33
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 38493,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 9839,
        "completion_tokens": 126,
        "total_tokens": 9965
      }
    },
    {
      "question_id": 51,
      "question": "How did NVDA's debt management strategy evolve regarding the 0.584% Notes Due 2024 between fiscal years 2023 and 2024?",
      "original_answer": "In fiscal year 2023, NVDA reported a balance of $1,250 million for the 0.584% Notes Due 2024, with an effective interest rate of 0.66%. By fiscal year 2024, NVDA disclosed in its 10-K filing that it repaid these notes in fiscal year 2025, resulting in no remaining balance for this instrument as of January 26, 2025. This indicates a shift in NVDA's debt management strategy, where it chose to retire the obligation before or shortly after the due date rather than rolling it over or extending it.",
      "llm_answer": "NVIDIA repaid the 0.584% Notes Due 2024 during fiscal year 2025, as indicated by the updated debt table showing a zero balance for that tranche in the Jan 26 2025 column and a note stating “In fiscal year 2025, we repaid the 0.584% Notes Due 2024.” This repayment reduced the short‑term portion of long‑term debt and left no outstanding balance for those notes as of the latest reporting date.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "NVDA_10k_2023.pdf",
          "target_page": 72,
          "pages": [
            70,
            71,
            72,
            73,
            74
          ]
        },
        "hop_2_rel": {
          "source_file": "NVDA_10k_2024.pdf",
          "target_page": 72,
          "pages": [
            70,
            71,
            72,
            73,
            74
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 41384,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 10560,
        "completion_tokens": 98,
        "total_tokens": 10658
      }
    },
    {
      "question_id": 53,
      "question": "How did Honeywell's investment in Mortgage/Asset-backed securities evolve between 2022 and 2023, and what was the magnitude of this change?",
      "original_answer": "In 2022, Honeywell reported $982 million invested in Mortgage/Asset-backed securities under U.S. Plans. By 2023, this amount had significantly decreased to $10 million under Non-U.S. Plans. This represents a reduction of $972 million, or over 98%, indicating a major shift in Honeywell's investment strategy concerning Mortgage/Asset-backed securities.",
      "llm_answer": "Based on the provided 10-K pages, Honeywell's investment in Mortgage/Asset-backed securities declined from **$31 million in 2022 to $10 million in 2023**, a reduction of **$21 million (approximately a 68% decrease)**. This change is reflected in the “Mortgage/Asset‑backed securities” line item under Fixed Income in the Level 2 and Level 3 tables for both years.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "HON_10k_2022.pdf",
          "target_page": 111,
          "pages": [
            109,
            110,
            111,
            112,
            113
          ]
        },
        "hop_2_rel": {
          "source_file": "HON_10k_2023.pdf",
          "target_page": 110,
          "pages": [
            108,
            109,
            110,
            111,
            112
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 57819,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 14676,
        "completion_tokens": 90,
        "total_tokens": 14766
      }
    },
    {
      "question_id": 68,
      "question": "How did Capital One's use of securitized debt obligations evolve between 2022 and 2023, particularly in terms of their role in the company's funding mix and their fair value classification?",
      "original_answer": "In 2022, securitized debt obligations were described as a key component of Capital One's diversified funding strategy, used alongside deposits, senior and subordinated notes, federal funds purchased, and FHLB advances to maintain access to wholesale funding sources. By 2023, the company disclosed that the carrying value of securitized debt obligations was $18,043 million, with an estimated fair value of $18,067 million, all classified under Level 2 of the fair value hierarchy. This indicates that while the company continued to rely on securitized debt obligations as a funding source, the 2023 data provides more specific transparency into their valuation and classification, showing a shift toward more detailed disclosure and potentially more structured risk management.",
      "llm_answer": "Between 2022 and 2023, Capital One’s use of securitized debt obligations shifted toward greater reliance on them within its long‑term funding mix, as evidenced by the increase in securitized debt issuances (from $1.25 billion in 2020 to $6.25 billion in 2021 and continued growth reflected in the 2023 disclosures) and the corresponding reduction in other long‑term debt maturities. These obligations are consistently classified as Level 3 in the fair‑value hierarchy, with fair‑value measurements relying on significant unobservable inputs such as discount rates, prepayment rates, and loss severity. Consequently, while securitized debt remains a key component of the company’s funding strategy, its fair‑value classification remains at Level 3, reflecting the use of internally derived valuation techniques rather than quoted market prices.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "COF_10k_2022.pdf",
          "target_page": 113,
          "pages": [
            111,
            112,
            113,
            114,
            115
          ]
        },
        "hop_2_rel": {
          "source_file": "COF_10k_2023.pdf",
          "target_page": 210,
          "pages": [
            208,
            209,
            210,
            211,
            212
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 48530,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 12366,
        "completion_tokens": 210,
        "total_tokens": 12577
      }
    },
    {
      "question_id": 78,
      "question": "How did JPMorgan's treatment of CECL capital transition provisions under U.S. capital rules evolve from 2023 to 2024, and what was the quantitative change in the CECL-related capital benefit during this period?",
      "original_answer": "In 2023, JPMorgan reported a $1.4 billion benefit from the CECL capital transition provisions included in its CET1 capital. By 2024, this benefit had decreased to $720 million, reflecting a phased reduction in the CECL-related capital benefit as the provisions were being phased in under U.S. capital rules. The capital metrics indicated that the CECL benefit was fully phased in by January 1, 2025.",
      "llm_answer": "From 2023 to 2024, JPMorgan’s CECL capital transition benefit declined from a $1.4 billion benefit reflected in CET1 capital at the end of 2023 to a $720 million benefit by the end of 2024. Consequently, the quantitative CECL‑related capital benefit fell by roughly $680 million over the one‑year period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "JPM_10k_2023.pdf",
          "target_page": 99,
          "pages": [
            97,
            98,
            99,
            100,
            101
          ]
        },
        "hop_2_rel": {
          "source_file": "JPM_10k_2024.pdf",
          "target_page": 104,
          "pages": [
            102,
            103,
            104,
            105,
            106
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 56862,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 14453,
        "completion_tokens": 76,
        "total_tokens": 14529
      }
    },
    {
      "question_id": 78,
      "question": "How did the terms and capacity of Salesforce's Revolving Loan Credit Agreement evolve between fiscal 2023 and fiscal 2024?",
      "original_answer": "In fiscal 2023, Salesforce had a $3.0 billion unsecured revolving credit facility under the Revolving Loan Credit Agreement, which was scheduled to mature in December 2025. By fiscal 2024, this agreement was replaced with a new $5.0 billion unsecured revolving credit facility that matures in October 2029. The increase in capacity and the extension of the maturity date reflect a strategic enhancement of the company’s credit resources.",
      "llm_answer": "The Revolving Loan Credit Agreement was expanded in fiscal 2024: the prior $3 billion facility (maturing December 2025) was replaced by a $5 billion unsecured revolving facility that now matures in October 2029, providing greater borrowing capacity and extending the maturity horizon. No borrowings were outstanding under either facility as of the respective fiscal‑year ends.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CRM_10k_2023.pdf",
          "target_page": 53,
          "pages": [
            51,
            52,
            53,
            54,
            55
          ]
        },
        "hop_2_rel": {
          "source_file": "CRM_10k_2024.pdf",
          "target_page": 51,
          "pages": [
            49,
            50,
            51,
            52,
            53
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 48626,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 12371,
        "completion_tokens": 94,
        "total_tokens": 12465
      }
    },
    {
      "question_id": 86,
      "question": "How did UPS's relationship with Coyote evolve between 2022 and 2024, and what financial impact did this change have on UPS in 2024?",
      "original_answer": "In 2022, UPS had an active business relationship with Coyote, operating it as a branded subsidiary that provided truckload brokerage services in the U.S. and Europe. Coyote was integrated into UPS’s broader supply chain offerings, leveraging the UPS fleet and third-party carrier networks to provide customized transportation solutions. However, by 2024, UPS had completed the divestiture of Coyote, recording a pre-tax gain of $156 million ($152 million after tax) as a result of the transaction. This change marks a full transition from a strategic business unit to a divested asset, reflecting a shift in UPS's supply chain strategy.",
      "llm_answer": "UPS's relationship with Coyote evolved from a strategic partnership to a divestiture. The company completed the sale of Coyote in the third quarter of 2024, recording a pre-tax gain of $156 million ($152 million after tax) from the transaction. This change impacted UPS's 2024 financial results by contributing to the overall gains and adjustments reflected in the non-GAAP financial measures reported in the 2024 10-K filing.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "UPS_10k_2022.pdf",
          "target_page": 7,
          "pages": [
            5,
            6,
            7,
            8,
            9
          ]
        },
        "hop_2_rel": {
          "source_file": "UPS_10k_2024.pdf",
          "target_page": 31,
          "pages": [
            29,
            30,
            31,
            32,
            33
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 44453,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 11328,
        "completion_tokens": 106,
        "total_tokens": 11435
      }
    },
    {
      "question_id": 100,
      "question": "How has Union Pacific's relationship with chassis evolved between 2023 and 2024, particularly in terms of total units and ownership structure?",
      "original_answer": "In 2023, Union Pacific had a total of 48,340 chassis units, with 30,635 owned and 17,705 leased. By 2024, the total number of chassis dropped significantly to 5,553 units, with only 4,356 owned and 1,197 leased. This represents a transformation in Union Pacific's relationship with chassis, shifting from a heavy reliance on both owned and leased chassis to a much smaller, still mixed but significantly reduced footprint. The drastic reduction in total chassis units indicates a strategic shift in how the company manages this asset class.",
      "llm_answer": "Between 2023 and 2024, Union Pacific’s chassis fleet declined from 48,340 total units (30,635 owned + 17,705 leased) in 2023 to 48,340 total units (30,635 owned + 17,705 leased) in 2024, with ownership remaining stable at 30,635 units and leased units unchanged at 17,705. The company maintained its chassis fleet size and structure, focusing on operational efficiency and buffer capacity for equipment needs without significant changes to ownership or leasing arrangements.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "UNP_10k_2023.pdf",
          "target_page": 19,
          "pages": [
            17,
            18,
            19,
            20,
            21
          ]
        },
        "hop_2_rel": {
          "source_file": "UNP_10k_2024.pdf",
          "target_page": 19,
          "pages": [
            17,
            18,
            19,
            20,
            21
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 35175,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 9013,
        "completion_tokens": 118,
        "total_tokens": 9131
      }
    },
    {
      "question_id": 114,
      "question": "How has Boeing's treatment and disclosure of aluminum agreements evolved between 2022 and 2024, particularly in terms of their classification as derivatives and the time horizon for these agreements?",
      "original_answer": "In 2022, Boeing disclosed that its aluminum agreements were classified as derivatives but were not designated for hedge accounting treatment, with changes in fair value recorded in earnings immediately. The agreements were described in the context of long-term strategic sourcing objectives and non-U.S. business requirements. By 2024, the disclosure evolved to indicate that these aluminum agreements were now part of a broader set of commodity contracts hedging forecasted transactions through 2028. This represents a shift from purely strategic sourcing to a more structured hedging strategy with a defined time horizon extending to 2028.",
      "llm_answer": "Between 2022 and 2024, Boeing's treatment of aluminum agreements evolved from being classified as derivatives not receiving hedge accounting treatment (as noted in 2022 disclosures) to continuing this classification in 2024, with no change in their hedge accounting status. The time horizon for these agreements remains tied to the contract terms, with the aluminum agreements and other non-hedge derivatives having notional amounts and maturities extending through 2028, as disclosed in the 2024 derivative disclosures.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "BA_10k_2022.pdf",
          "target_page": 80,
          "pages": [
            78,
            79,
            80,
            81,
            82
          ]
        },
        "hop_2_rel": {
          "source_file": "BA_10k_2024.pdf",
          "target_page": 111,
          "pages": [
            109,
            110,
            111,
            112,
            113
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 39908,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 10211,
        "completion_tokens": 130,
        "total_tokens": 10341
      }
    },
    {
      "question_id": 114,
      "question": "How has Procter & Gamble's exposure to currency rate risk evolved between the fiscal years ended June 30, 2023 and June 30, 2024, particularly in terms of its hedging instruments and confidence in mitigating near-term exchange rate fluctuations?",
      "original_answer": "Procter & Gamble's exposure to currency rate risk remained materially unchanged between the fiscal years ended June 30, 2023 and June 30, 2024. The company continued to use forward contracts and currency swaps with maturities of less than 18 months to manage exchange rate risk. Additionally, P&G maintained its assessment that, at a 95% confidence level based on historical currency rate movements, the impact of a near-term change in currency rates would not materially affect its financial statements in either reporting period.",
      "llm_answer": "Procter & Gamble's exposure to currency rate risk has remained stable between fiscal 2023 and 2024, with the company maintaining its hedging strategy of using forward contracts and currency swaps with maturities under 18 months to manage exchange rate volatility. The company continues to express confidence that near-term currency fluctuations will not materially impact its financial statements, as evidenced by its 95% confidence level assessments based on historical movements. While the company acknowledges currency devaluation as a potential risk factor for goodwill and intangible asset impairments (particularly for the Gillette indefinite-lived intangible asset), it has not altered its hedging instruments or reduced its confidence in mitigating near-term exchange rate risks.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "PG_10k_2023.pdf",
          "target_page": 31,
          "pages": [
            29,
            30,
            31,
            32,
            33
          ]
        },
        "hop_2_rel": {
          "source_file": "PG_10k_2024.pdf",
          "target_page": 31,
          "pages": [
            29,
            30,
            31,
            32,
            33
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 63320,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 16074,
        "completion_tokens": 196,
        "total_tokens": 16271
      }
    },
    {
      "question_id": 129,
      "question": "How has Adobe's positioning and integration of Frame.io evolved between 2022 and 2024, particularly in terms of its functional scope and integration with other Adobe products?",
      "original_answer": "In 2022, Frame.io was listed among Adobe's trademarks, indicating it was an established product within Adobe's portfolio but with no detailed description of its functionality or integration. By 2024, Frame.io was actively described as a 'cloud-native creative collaboration platform' with expanded capabilities such as real-time upload, review and approval, frame-accurate commenting, and Camera to Cloud functionality. It was also integrated with Adobe Premiere Pro, After Effects, Photoshop, Lightroom, and Workfront, and positioned as part of Adobe GenStudio for large-scale content production. This reflects a significant evolution from a trademarked asset to a core collaborative tool deeply embedded in Adobe's creative workflow.",
      "llm_answer": "Adobe has progressively expanded Frame.io’s functional scope and deepened its integration with other Adobe products between 2022 and 2024. Initially positioned as a cloud‑native collaboration platform for video and creative asset review, Frame.io is now tightly embedded within the Creative Cloud ecosystem, offering native frame‑accurate commenting and annotation workflows that are directly accessible from Adobe Premiere Pro, After Effects, Photoshop, Lightroom, and Adobe Express. The platform also supports Camera‑to‑Cloud uploads and integrates with Adobe Stock, Adobe Firefly Services, and Adobe GenStudio, enabling end‑to‑end content creation, editing, and publishing pipelines. This evolution reflects Adobe’s strategy of treating Frame.io as a core collaboration layer that unifies video, design, and generative AI workflows across its suite of Creative Cloud and Document Cloud offerings.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "ADBE_10k_2022.pdf",
          "target_page": 105,
          "pages": [
            95,
            96,
            97,
            98,
            99
          ]
        },
        "hop_2_rel": {
          "source_file": "ADBE_10k_2024.pdf",
          "target_page": 12,
          "pages": [
            10,
            11,
            12,
            13,
            14
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 9,
        "total_chars": 38910,
        "num_window_pages": 9,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 9955,
        "completion_tokens": 224,
        "total_tokens": 10180
      }
    },
    {
      "question_id": 133,
      "question": "How has AMD's financial relationship with the ATMP JV evolved between the 2022 and 2023 fiscal years, particularly in terms of the carrying value of its investment and the nature of its financial disclosures?",
      "original_answer": "In the 2022 filing, AMD disclosed that the carrying value of its investment in the ATMP JV was $69 million as of December 25, 2021, and $63 million as of December 26, 2020. Additionally, AMD provided detailed figures regarding purchases from and resales to the ATMP JV, including purchases of $1.1 billion in 2021 and $831 million in 2020. In contrast, the 2023 filing omits any mention of the carrying value of the investment and specific transaction figures, only reiterating the structural details of the relationship, such as AMD's 15% equity interest and the accounting method used. This indicates a reduction in the level of financial disclosure regarding the ATMP JV, even though the nature of the relationship and AMD's equity stake remained unchanged.",
      "llm_answer": "Between fiscal years 2022 and 2023, AMD's investment in the ATMP joint venture remained relatively stable, with the carrying value of its equity interest increasing from approximately $83 million to $99 million. The company continues to account for this investment using the equity method, recognizing gains from the JV (e.g., $16 million in 2023 and $14 million in 2022) and reporting related party balances such as payables of $363 million and receivables of $9 million as of December 30 2023. This consistent accounting treatment reflects AMD's unchanged 15 % ownership and lack of funding obligations.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AMD_10k_2022.pdf",
          "target_page": 64,
          "pages": [
            62,
            63,
            64,
            65,
            66
          ]
        },
        "hop_2_rel": {
          "source_file": "AMD_10k_2023.pdf",
          "target_page": 77,
          "pages": [
            75,
            76,
            77,
            78,
            79
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 43004,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 10987,
        "completion_tokens": 151,
        "total_tokens": 11138
      }
    },
    {
      "question_id": 139,
      "question": "How did Honeywell's revenue from Commercial Aviation Original Equipment evolve between 2023 and 2024, and what does this indicate about its position in the aerospace sector?",
      "original_answer": "Honeywell's revenue from Commercial Aviation Original Equipment decreased from $2,397 million in 2023 to $2,223 million in 2024. This decline suggests a contraction in this segment despite overall growth in the Aerospace Technologies division, indicating a potential weakening in original equipment demand or supply constraints in this specific product line.",
      "llm_answer": "Based on the provided financial data, Honeywell's revenue from Commercial Aviation Original Equipment decreased from $2,397 million in 2023 to $2,223 million in 2024. This decline indicates a reduction in the company's aerospace segment sales, suggesting a potential weakening in its position within the aerospace sector, possibly due to market dynamics or industry-specific challenges.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "HON_10k_2023.pdf",
          "target_page": 68,
          "pages": [
            66,
            67,
            68,
            69,
            70
          ]
        },
        "hop_2_rel": {
          "source_file": "HON_10k_2024.pdf",
          "target_page": 68,
          "pages": [
            66,
            67,
            68,
            69,
            70
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 52070,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 13244,
        "completion_tokens": 96,
        "total_tokens": 13341
      }
    },
    {
      "question_id": 140,
      "question": "How did the global revenue contribution from Heart Failure Devices evolve between 2023 and 2024, and what was the percentage change in this segment's total revenue?",
      "original_answer": "In 2023, the global revenue from Heart Failure Devices was $1,161 million, while in 2024, this figure increased to $1,279 million. This represents a 10.2% increase in total revenue for the Heart Failure Devices segment. The growth was consistent across both U.S. and international markets, with minimal impact from exchange rate fluctuations, indicating strong underlying demand and market expansion.",
      "llm_answer": "The global revenue contribution from Heart Failure Devices increased from $1,161 million in 2023 to $1,279 million in 2024, reflecting a 10.2 % total change (or 10.3 % when excluding exchange‑rate effects). This represents the percentage change in the segment’s total revenue for Heart Failure Devices between 2023 and 2024.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "ABT_10k_2023.pdf",
          "target_page": 53,
          "pages": [
            51,
            52,
            53,
            54,
            55
          ]
        },
        "hop_2_rel": {
          "source_file": "ABT_10k_2024.pdf",
          "target_page": 29,
          "pages": [
            27,
            28,
            29,
            30,
            31
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 47386,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 12071,
        "completion_tokens": 81,
        "total_tokens": 12152
      }
    },
    {
      "question_id": 151,
      "question": "How has IBM's treatment of the 0.300% Notes due 2028 evolved between the 2022 and 2023 filings?",
      "original_answer": "In the 2022 filing, the 0.300% Notes due 2028 were referenced as part of a list of debt instruments, with their rights defined in Exhibit 4.1 to Form 8-K filed February 10, 2020, and incorporated by reference. By 2023, the 0.300% Notes due 2028 were formally listed in the table of registered securities with a specific trading symbol (IBM 28B) and explicitly called out as a distinct class of notes registered on the New York Stock Exchange. This reflects a shift from general incorporation by reference to explicit disclosure and formal registration.",
      "llm_answer": "Based on the provided document pages, IBM's treatment of the 0.300% Notes due 2028 has evolved from being classified as a liability on the balance sheet in the 2022 filing (page 28 of IBM_10k_2022.pdf) to being explicitly disclosed as a registered debt security in the 2023 filing (page 1 of IBM_10k_2023.pdf), where it is listed among the company’s outstanding notes with its specific terms and maturity. This shift reflects a more prominent presentation of the notes in the 2023 Form 10‑K, highlighting the issuance details and market‑wide registration, whereas the 2022 filing only referenced the notes within the broader debt disclosures without the same level of explicit enumeration.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "IBM_10k_2022.pdf",
          "target_page": 35,
          "pages": [
            28,
            29,
            30,
            31,
            32
          ]
        },
        "hop_2_rel": {
          "source_file": "IBM_10k_2023.pdf",
          "target_page": 1,
          "pages": [
            1,
            2,
            3,
            4,
            5
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 8,
        "total_chars": 36086,
        "num_window_pages": 8,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 9228,
        "completion_tokens": 172,
        "total_tokens": 9400
      }
    },
    {
      "question_id": 158,
      "question": "How has Apple's financial performance in the Rest of Asia Pacific region evolved from 2022 to 2023, based on changes in net sales and operating income?",
      "original_answer": "In 2022, Apple's Rest of Asia Pacific segment reported net sales of $29,375 million and operating income of $11,569 million. In 2023, these figures increased to $29,615 million in net sales and $12,066 million in operating income. This represents a moderate growth in both metrics, with net sales rising by $240 million (0.8%) and operating income increasing by $497 million (4.3%).",
      "llm_answer": "Apple's financial performance in the Rest of Asia Pacific region improved from 2022 to 2023, with net sales increasing from $29.375 billion to $30.658 billion and operating income rising from $11.569 billion to $13.062 billion.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AAPL_10k_2022.pdf",
          "target_page": 40,
          "pages": [
            38,
            39,
            40,
            41,
            42
          ]
        },
        "hop_2_rel": {
          "source_file": "AAPL_10k_2023.pdf",
          "target_page": 50,
          "pages": [
            48,
            49,
            50,
            51,
            52
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 42869,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 10939,
        "completion_tokens": 56,
        "total_tokens": 10996
      }
    },
    {
      "question_id": 169,
      "question": "How has the vesting period for stock options issued under the 2007 Omnibus Incentive Plan evolved between grants made prior to 2022 and those made after December 31, 2021, based on disclosures in the 2022 and 2024 10-K filings?",
      "original_answer": "In the 2022 10-K filing, stock options granted prior to 2022 under the 2007 Omnibus Incentive Plan generally vested pro rata over a five-year period, while those granted after December 31, 2021, under the amended and restated plan, generally vested pro rata over a four-year period. The 2024 10-K confirms that stock options granted prior to 2022 continued to vest pro rata over a five-year period, and those granted after December 31, 2021, also continued to vest pro rata over a four-year period. This indicates a consistent reduction in the vesting period from five to four years for post-2021 grants, showing a structural change in the incentive plan's vesting terms over time.",
      "llm_answer": "Based on the disclosures in the 2022 and 2024 10-K filings, the vesting period for stock options issued under the 2007 Omnibus Incentive Plan changed from a five-year pro rata schedule (for grants prior to 2022) to a four-year pro rata schedule (for grants after December 31, 2021), as explicitly stated in the stock-based compensation notes in both filings. This change applies to options granted under the amended and restated 2007 Omnibus Incentive Plan after 2021, while executive officers and certain other employees may still have different vesting terms.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "DHR_10k_2022.pdf",
          "target_page": 116,
          "pages": [
            114,
            115,
            116,
            117,
            118
          ]
        },
        "hop_2_rel": {
          "source_file": "DHR_10k_2024.pdf",
          "target_page": 96,
          "pages": [
            94,
            95,
            96,
            97,
            98
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 61534,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 15625,
        "completion_tokens": 140,
        "total_tokens": 15765
      }
    },
    {
      "question_id": 170,
      "question": "How has CVS's approach to validating the fair value estimates for its Level 2 debt securities evolved from 2022 to 2023, particularly in terms of price adjustments and secondary source comparisons?",
      "original_answer": "In 2022, CVS obtained one price for each of its Level 2 debt securities and did not adjust any of those prices at December 31, 2021 or 2020. The company compared selected sample prices quarterly to secondary sources and reviewed variances over a specified threshold. In 2023, the company maintained the same validation methodology, obtaining one price per Level 2 debt security without any adjustments at December 31, 2023 or 2022, and continued to compare prices quarterly to secondary sources. Despite maintaining the same process, the emphasis on consistent internal validation by the investment team appears to have remained stable, indicating a sustained but unchanging approach to fair value estimation.",
      "llm_answer": "CVS Health's approach to validating fair value estimates for Level 2 debt securities remained consistent from 2022 to 2023, relying on observable market inputs such as quoted prices for similar assets and discounted cash flows. The company maintained its quarterly validation process, comparing Level 2 prices to secondary sources and internal estimates, and did not adjust any Level 2 prices during 2023 or 2022. However, Level 2 debt securities decreased significantly from $20,812 million in 2022 to $19,671 million in 2023, reflecting a net transfer out of Level 3 assets (50 million in 2023 vs. 29 million in 2022), though the validation methodology itself did not change.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CVS_10k_2022.pdf",
          "target_page": 148,
          "pages": [
            146,
            147,
            148,
            149,
            150
          ]
        },
        "hop_2_rel": {
          "source_file": "CVS_10k_2023.pdf",
          "target_page": 153,
          "pages": [
            151,
            152,
            153,
            154,
            155
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 49829,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 12693,
        "completion_tokens": 169,
        "total_tokens": 12862
      }
    },
    {
      "question_id": 172,
      "question": "How did CVS's classification and valuation methodology for privately-placed equity securities evolve between 2022 and 2023, particularly in terms of fair value determination and unobservable inputs?",
      "original_answer": "CVS maintained a consistent classification of privately-placed equity securities as Level 3 in both 2022 and 2023, indicating no active market for these securities. However, the company emphasized in both years that it uses an internal analysis of financial statements and cash flow projections to determine fair value. In 2022, the significant unobservable inputs included earnings and revenue multiples, discount for lack of marketability, and comparability adjustments. In 2023, the same unobservable inputs were referenced, but with an added emphasis on the potential impact of changes in these inputs on fair value measurements, suggesting a more detailed sensitivity analysis or increased scrutiny of these inputs in the valuation process.",
      "llm_answer": "Between 2022 and 2023, CVS Health’s classification and valuation methodology for privately-placed equity securities remained consistent, continuing to classify these securities as Level 3 due to the absence of an active market and reliance on internal valuation using unobservable inputs such as earnings multiples and discount rates for lack of marketability. The fair value determination for these securities was based on internal analysis of financial statements and cash flow projections, with no material changes observed in the methodology. Additionally, Level 3 financial assets, including privately placed equity securities, saw a net decrease of $50 million in transfers out of Level 3 during 2023, reflecting reduced holdings in such instruments.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CVS_10k_2022.pdf",
          "target_page": 148,
          "pages": [
            146,
            147,
            148,
            149,
            150
          ]
        },
        "hop_2_rel": {
          "source_file": "CVS_10k_2023.pdf",
          "target_page": 153,
          "pages": [
            151,
            152,
            153,
            154,
            155
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 49829,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 12693,
        "completion_tokens": 189,
        "total_tokens": 12882
      }
    },
    {
      "question_id": 184,
      "question": "How did the total net revenue from Alphagan/Combigan change between 2023 and 2024, and what was the trend in its international revenue during this period?",
      "original_answer": "The total net revenue from Alphagan/Combigan decreased from $272 million in 2023 to $248 million in 2024, reflecting an 8.8% decline. During the same period, its international revenue slightly increased from $151 million in 2023 to $153 million in 2024, representing a 1.5% growth.",
      "llm_answer": "Based on the provided financial data from both 2023 and 2024 Form 10-K filings:\n\n1.  **Total Net Revenue Change (Alphagan/Combigan):** The total net revenue for Alphagan/Combigan decreased by **21.4%** in 2024 compared to 2023 (from $272M in 2023 to $272M in 2024, with a 21.4% decline at actual currency rates and 19.1% at constant currency rates).\n\n2.  **International Revenue Trend:** International revenue for Alphagan/Combigan increased by **4.9%** in 2024 (from $144M in 2023 to $151M in 2024 at actual currency rates, and 10.4% at constant currency rates), showing growth internationally despite the overall decline.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "ABBV_10k_2023.pdf",
          "target_page": 43,
          "pages": [
            41,
            42,
            43,
            44,
            45
          ]
        },
        "hop_2_rel": {
          "source_file": "ABBV_10k_2024.pdf",
          "target_page": 43,
          "pages": [
            41,
            42,
            43,
            44,
            45
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 64480,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 16343,
        "completion_tokens": 155,
        "total_tokens": 16498
      }
    },
    {
      "question_id": 1,
      "question": "How has Chevron's relationship with PDC Energy evolved from 2023 to 2024, and what specific operational impact did this change have on Chevron's overall production performance?",
      "original_answer": "In 2023, Chevron acquired PDC Energy, Inc. (PDC), and as a result, PDC was excluded from Chevron's internal control assessment over financial reporting due to the timing of the acquisition. By 2024, Chevron's relationship with PDC had evolved from a newly acquired entity to an integral operational component, as evidenced by the 7% increase in Chevron's worldwide oil-equivalent production, which was attributed in part to the full-year contribution from legacy PDC operations. This indicates that PDC Energy transitioned from being a recent acquisition in 2023 to a key contributor to Chevron's production growth in 2024.",
      "llm_answer": "Chevron's relationship with PDC Energy shifted from a standalone entity in 2023 to a fully integrated subsidiary after Chevron's acquisition of PDC in 2023, which was completed during 2023 and became fully operational in 2024. This integration directly contributed to Chevron's 2024 production growth, as evidenced by the \"full-year of legacy PDC Energy, Inc. (PDC) production\" cited in the 2024 production summary (page 29), which drove a 7% increase in worldwide oil-equivalent production to 3.3 million barrels per day compared to 2023. The acquisition also expanded Chevron's operational footprint, particularly in the Permian Basin, where PDC's assets were incorporated into Chevron's development strategy.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CVX_10k_2023.pdf",
          "target_page": 30,
          "pages": [
            28,
            29,
            30,
            31,
            32
          ]
        },
        "hop_2_rel": {
          "source_file": "CVX_10k_2024.pdf",
          "target_page": 9,
          "pages": [
            7,
            8,
            9,
            10,
            11
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 61594,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 15625,
        "completion_tokens": 177,
        "total_tokens": 15803
      }
    },
    {
      "question_id": 1,
      "question": "How has UPS's investment in cold-chain logistics capabilities evolved from 2023 to 2024, and what specific acquisitions contributed to this change?",
      "original_answer": "In 2023, UPS expanded its cold-chain logistics capabilities through the acquisition of Bomi Group and MNX Global Logistics, aiming to enhance its healthcare logistics services. By 2024, this strategic focus intensified with the acquisition of Frigo-Trans and Biotech & Pharma Logistics in Germany for approximately $440 million, signaling a significant increase in international investment in complex cold-chain logistics. This represents a shift from general expansion to targeted, high-value international acquisitions in the cold-chain sector.",
      "llm_answer": "From 2023 to 2024, UPS expanded its cold‑chain logistics capabilities primarily through the acquisition of healthcare‑focused logistics firms. In 2023, it bought MNX Global Logistics and Happy Returns, both of which added temperature‑sensitive and returns‑management expertise to its Supply Chain Solutions segment. Building on that foundation, in January 2025 UPS completed the purchase of Frigo‑Trans and Biotech & Pharma Logistics—a leading European complex healthcare logistics provider—for roughly $440 million, further strengthening its international cold‑chain network. These acquisitions collectively broadened UPS’s specialized logistics offerings and reinforced its strategy to deepen cold‑chain capabilities worldwide.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "UPS_10k_2023.pdf",
          "target_page": 6,
          "pages": [
            4,
            5,
            6,
            7,
            8
          ]
        },
        "hop_2_rel": {
          "source_file": "UPS_10k_2024.pdf",
          "target_page": 103,
          "pages": [
            101,
            102,
            103,
            104,
            105
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 38980,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 9965,
        "completion_tokens": 182,
        "total_tokens": 10148
      }
    },
    {
      "question_id": 1,
      "question": "How has Linde plc's non-employee director restricted stock unit award program evolved between 2022 and 2024, particularly in terms of governance structure and long-term shareholder alignment mechanisms?",
      "original_answer": "In 2022, Linde plc introduced the Non-Employee Director Restricted Stock Unit Award under the 2021 Linde plc Long Term Incentive Plan, establishing a framework for equity-based compensation tied to long-term performance metrics. This initiative was part of a broader suite of incentive programs aimed at aligning director interests with those of shareholders. By 2024, the company expanded this framework by introducing the Linde plc Non-employee Director Deferral Program, adopted by the Board of Directors on July 30, 2024. This deferral program enhances governance by allowing directors to defer receipt of stock units, thereby reinforcing long-term alignment with shareholder value creation. The evolution from a basic restricted stock unit award to a more sophisticated deferral mechanism indicates Linde’s strategic emphasis on strengthening board accountability and promoting sustained corporate governance standards.",
      "llm_answer": "Between 2022 and 2024, Linde plc's non-employee director restricted stock unit (RSU) award program was updated through amendments to its 2021 Long-Term Incentive Plan, which introduced a dedicated RSU award form for directors and added performance-based metrics to align compensation with shareholder interests. The 2024 filing (Exhibit 10.16) confirms the adoption of a formal Director Deferral Program and updated RSU award terms, reinforcing governance by tying director equity to long-term performance metrics such as Return on Capital and Total Shareholder Return, thereby enhancing shareholder alignment.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "LIN_10k_2022.pdf",
          "target_page": 105,
          "pages": [
            103,
            104,
            105,
            106,
            107
          ]
        },
        "hop_2_rel": {
          "source_file": "LIN_10k_2024.pdf",
          "target_page": 96,
          "pages": [
            94,
            95,
            96,
            97,
            98
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 60742,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 15421,
        "completion_tokens": 152,
        "total_tokens": 15573
      }
    },
    {
      "question_id": 1,
      "question": "How did General Motors' financial and legal relationship with Stellantis evolve between 2022 and 2024, particularly regarding indemnification obligations and investment gains?",
      "original_answer": "In 2022, General Motors reported a gain of $0.2 billion related to Stellantis N.V. (Stellantis) warrants, indicating a positive financial relationship. However, by 2024, the relationship had evolved into a more complex and potentially costly one. GM had agreed to indemnify Stellantis for certain liabilities tied to pre-sale emissions claims, product liabilities, and recalls related to the 2017 sale of the Opel/Vauxhall business. Additionally, GM faced potential future liabilities from ongoing investigations into Opel’s historical conduct in Europe. Unlike the earlier gains, GM's 2024 disclosures highlighted contingent liabilities and legal risks rather than financial benefits from its relationship with Stellantis.",
      "llm_answer": "Between 2022 and 2024, General Motors’ financial and legal relationship with Stellantis remained anchored by the 2017 sale of Opel/Vauxhall, which included Stellantis’ indemnification of GM for certain post‑sale liabilities such as emissions claims, product liabilities and recalls, with those indemnification obligations extending through 2025‑2029 or until specific events occur.  While GM cannot quantify any material loss from these indemnities, the company notes that ongoing consumer lawsuits in Europe alleging emissions violations could trigger payments under the indemnity, though it presently considers such exposure remote.  Separately, GM’s 2024 financial disclosures highlight a $2.6 billion accrual and $1.6 billion receivable related to the Chevrolet Bolt recall and associated costs, reflecting the company’s estimate of recall expenses net of expected reimbursements from LG Energy Solution.  This recall matter is distinct from the Stellantis indemnity but illustrates how GM’s post‑sale financial exposures are being managed through accruals and receivables.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "GM_10k_2022.pdf",
          "target_page": 36,
          "pages": [
            34,
            35,
            36,
            37,
            38
          ]
        },
        "hop_2_rel": {
          "source_file": "GM_10k_2024.pdf",
          "target_page": 93,
          "pages": [
            91,
            92,
            93,
            94,
            95
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 60145,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 15263,
        "completion_tokens": 269,
        "total_tokens": 15532
      }
    },
    {
      "question_id": 1,
      "question": "How did Southern Company's treatment and disclosure of energy-related derivatives evolved from 2022 to 2024, particularly in terms of their financial presentation and categorization?",
      "original_answer": "In 2022, Southern Company reported the pre-tax effects of energy-related derivatives not designated as hedging instruments on the statements of income for prior years (2021, 2020, and 2019), indicating a focus on income statement impacts. By 2024, the company shifted its disclosure to emphasize the fair value of energy-related derivatives as either assets or liabilities on the balance sheets, specifically categorized under 'Other' or 'Risk Management Activities'. This represents a shift from income-focused reporting to balance sheet-oriented transparency.",
      "llm_answer": "Southern Company’s 2024 10‑K shows energy‑related derivatives now presented separately as “Risk Management Activities” with detailed line‑item balances for current and non‑current assets and liabilities, and they are categorized into regulatory hedges, cash‑flow hedges and non‑designated contracts; in contrast, the 2022 filing (pages 325‑329) only disclosed a summary table of “Energy‑related derivatives” without the same segment‑specific breakdown or explicit classification of cash‑flow versus fair‑value hedges. Consequently, the 2024 presentation provides a more granular, disaggregated view of derivative categorization and financial statement placement, while the 2022 filing relied on aggregated “Other” balances and less explicit hedge‑type labeling.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "SO_10k_2022.pdf",
          "target_page": 327,
          "pages": [
            325,
            326,
            327,
            328,
            329
          ]
        },
        "hop_2_rel": {
          "source_file": "SO_10k_2024.pdf",
          "target_page": 283,
          "pages": [
            281,
            282,
            283,
            284,
            285
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 52496,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 13355,
        "completion_tokens": 190,
        "total_tokens": 13545
      }
    },
    {
      "question_id": 1,
      "question": "How did GILD's strategic relationship with Arcus evolve between 2023 and 2024, particularly in terms of equity ownership and governance influence?",
      "original_answer": "In 2023, GILD owned approximately 19.9% of Arcus' issued and outstanding voting stock and had two designees on Arcus' board of directors. In January 2024, GILD made an additional $320 million equity investment in Arcus, increasing its ownership to 33%, and expanded its board representation to three designees. This represents a significant increase in both financial commitment and governance influence over Arcus within a year.",
      "llm_answer": "Between 2023 and 2024, Gilead’s strategic relationship with Arcus evolved through a series of amendments and equity actions that deepened Gilead’s ownership and governance influence. In May 2023 Gilead amended the Collaboration Agreement to add up to four new inflammatory‑disease targets, paid a $35 million upfront fee, and secured the right to license each program at two predetermined points; exercising the earlier option for the first two targets would make Arcus eligible for up to $420 million in option and milestone payments plus tiered royalties, while later exercises would involve shared development costs and U.S. profit‑sharing. In January 2024 Gilead made an additional $320 million equity investment in Arcus, raising its stake to roughly 33 % and increasing its board representation to three designees, thereby enhancing its governance role. These moves built on the 2021 option exercise that had already generated a $725 million collaboration payment and a $625 million in‑process R&D charge, and they set the stage for future cost‑sharing and profit‑sharing arrangements under the amended agreement.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "GILD_10k_2023.pdf",
          "target_page": 77,
          "pages": [
            75,
            76,
            77,
            78,
            79
          ]
        },
        "hop_2_rel": {
          "source_file": "GILD_10k_2024.pdf",
          "target_page": 31,
          "pages": [
            29,
            30,
            31,
            32,
            33
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 56650,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 14383,
        "completion_tokens": 279,
        "total_tokens": 14663
      }
    },
    {
      "question_id": 2,
      "question": "How has the maturity date and borrowing capacity of the 2021 Multicurrency Credit Facility evolved between 2022 and 2023?",
      "original_answer": "In 2022, the 2021 Multicurrency Credit Facility had a maximum borrowing capacity of $6.0 billion with a maturity date of June 30, 2025. By 2023, the borrowing capacity remained at $6.0 billion, but the maturity date was extended to July 1, 2026. This reflects a one-year extension of the facility’s term without any increase in the total commitment amount, indicating a strategic move to maintain financial flexibility over a longer horizon.",
      "llm_answer": "The maturity date of the 2021 Multicurrency Credit Facility was extended from June 28 2024 to July 1 2026 in the June 29 2023 amendment, and the borrowing capacity under that facility remained unchanged at $6.0 billion (subject to sublimits). Additionally, the facility’s interest‑rate benchmark was switched from LIBOR to SOFR.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AMT_10k_2022.pdf",
          "target_page": 49,
          "pages": [
            47,
            48,
            49,
            50,
            51
          ]
        },
        "hop_2_rel": {
          "source_file": "AMT_10k_2023.pdf",
          "target_page": 52,
          "pages": [
            50,
            51,
            52,
            53,
            54
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 9,
        "total_chars": 46322,
        "num_window_pages": 9,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 11794,
        "completion_tokens": 82,
        "total_tokens": 11876
      }
    },
    {
      "question_id": 2,
      "question": "How has Chevron's utilization of imported crude oil in U.S. refining operations evolved between 2023 and 2024, and what changes in refinery capacity utilization accompanied this trend?",
      "original_answer": "Chevron's reliance on imported crude oil in U.S. refining operations remained consistent at approximately 60% of refinery inputs in both 2023 and 2024. However, the utilization of U.S. refineries changed: in 2023, crude unit distillation capacity utilization averaged 90.8%, while in 2024 it decreased to 86.6%. This indicates that while the company's dependency on imported crude oil remained stable, the overall operational intensity of its U.S. refineries declined slightly in 2024.",
      "llm_answer": "Chevron’s U.S. refinery crude inputs were about 60 % imported in both 2023 and 2024, and the company continued to rely on that imported mix to run its refineries.  Refinery capacity utilization fell from roughly 90 % in 2023 to about 87 % in 2024, reflecting the lower utilization noted for 2024.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CVX_10k_2023.pdf",
          "target_page": 17,
          "pages": [
            15,
            16,
            17,
            18,
            19
          ]
        },
        "hop_2_rel": {
          "source_file": "CVX_10k_2024.pdf",
          "target_page": 18,
          "pages": [
            16,
            17,
            18,
            19,
            20
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 52679,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 13399,
        "completion_tokens": 74,
        "total_tokens": 13473
      }
    },
    {
      "question_id": 2,
      "question": "How did UPS's hedging position in British Pound Sterling evolve between 2023 and 2024, and what does this shift indicate about the company's currency risk management strategy?",
      "original_answer": "In 2023, UPS reported a British Pound Sterling (GBP) hedge position of 663 million units, which decreased to 536 million units in 2024. This represents a reduction of 127 million units, or approximately 19.15%. The decrease indicates a strategic move to reduce exposure to GBP, suggesting that UPS may have reassessed its currency risk related to the British Pound and opted for a more conservative hedging approach or a lower anticipated risk in that currency during the later year.",
      "llm_answer": "UPS reduced its notional exposure to British Pound Sterling hedging instruments from $856 million in 2022 to $663 million in 2023, and further to $536 million in 2024, reflecting a deliberate scaling back of its foreign‑currency hedge program. This contraction, coupled with the shift in AOCI gains from a $199 million gain on designated net‑investment hedges in 2022 to a $127 million gain in 2024, indicates that UPS is tightening its currency‑risk management—relying more on cash‑flow hedges and natural hedges rather than maintaining large designated investment hedges—while still using forward contracts to protect forecasted GBP‑denominated cash flows.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "UPS_10k_2023.pdf",
          "target_page": 130,
          "pages": [
            128,
            129,
            130,
            131,
            132
          ]
        },
        "hop_2_rel": {
          "source_file": "UPS_10k_2024.pdf",
          "target_page": 137,
          "pages": [
            135,
            136,
            137,
            138,
            139
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 47386,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 12076,
        "completion_tokens": 164,
        "total_tokens": 12241
      }
    },
    {
      "question_id": 2,
      "question": "How has the fair value of money market investments held by Bank of America evolved between 2023 and 2024, and what does this shift indicate about the company's short-term investment strategy?",
      "original_answer": "The fair value of money market investments held by Bank of America increased from $1.2 billion at December 31, 2023, to $1.3 billion at December 31, 2024. This indicates a modest growth in the company's short-term investment holdings, suggesting a slight expansion in liquidity management or short-term capital deployment strategies over the year.",
      "llm_answer": "Based on the provided 2023 and 2024 data, Bank of America's money market investments (classified as time deposits and other short-term investments) held at fair value increased slightly from **$1.2 billion at December 31, 2023, to $1.3 billion at December 31, 2024**. This modest shift indicates a relatively stable short-term investment strategy, with minimal reallocation between years, likely reflecting a conservative approach to preserve liquidity and capital preservation amid market conditions. The near-identical figures suggest the company maintained its short-term investment position without significant strategic adjustments during the transition from 2023 to 2024.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "BAC_10k_2023.pdf",
          "target_page": 113,
          "pages": [
            111,
            112,
            113,
            114,
            115
          ]
        },
        "hop_2_rel": {
          "source_file": "BAC_10k_2024.pdf",
          "target_page": 113,
          "pages": [
            111,
            112,
            113,
            114,
            115
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 94041,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 23744,
        "completion_tokens": 169,
        "total_tokens": 23913
      }
    },
    {
      "question_id": 2,
      "question": "How has the maximum expected volume of natural gas subject to physical supply contracts with sell-back options changed across Southern Company's subsidiaries between 2022 and 2024?",
      "original_answer": "In 2022, the maximum expected volume of natural gas subject to such contracts was 26 million mmBtu for Southern Company as a whole, with individual volumes of 6 million mmBtu for Alabama Power, 8 million mmBtu for Georgia Power, 4 million mmBtu for Mississippi Power, and 8 million mmBtu for Southern Power. By 2024, this volume had decreased to 15 million mmBtu company-wide, with corresponding reductions in each subsidiary's volume: 4 million mmBtu for Alabama Power, 6 million mmBtu for Georgia Power, 2 million mmBtu for Mississippi Power, and 3 million mmBtu for Southern Power. This represents a consistent reduction across all entities.",
      "llm_answer": "The maximum expected volume of natural gas subject to physical supply contracts with sell‑back options is 26 million mmBtu for Southern Company in 2021, which is broken down as 6 million mmBtu for Alabama Power, 8 million mmBtu for Georgia Power, 4 million mmBtu for Mississippi Power and 8 million mmBtu for Southern Power. In the 2024 filing, this figure is reduced to 15 million mmBtu for Southern Company, comprising 4 million mmBtu for Alabama Power, 6 million mmBtu for Georgia Power, 2 million mmBtu for Mississippi Power and 3 million mmBtu for Southern Power. Thus, the maximum expected sell‑back volume declined from 26 million mmBtu in 2021 to 15 million mmBtu in 2024.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "SO_10k_2022.pdf",
          "target_page": 319,
          "pages": [
            317,
            318,
            319,
            320,
            321
          ]
        },
        "hop_2_rel": {
          "source_file": "SO_10k_2024.pdf",
          "target_page": 281,
          "pages": [
            279,
            280,
            281,
            282,
            283
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 54919,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 13960,
        "completion_tokens": 170,
        "total_tokens": 14130
      }
    },
    {
      "question_id": 2,
      "question": "How has the integration and application of the Firefly Vector Model evolved across Adobe's product suite between 2023 and 2024?",
      "original_answer": "In 2023, the Firefly Vector Model was integrated into Adobe Express, enabling users to generate custom images and text effects from text prompts in over 100 languages. By 2024, the Firefly Vector Model had expanded its application beyond Adobe Express and was now also integrated into Adobe Illustrator, powering features like Generative Recolor, which allows users to create different color palettes using text prompts and apply them to vector graphics. This represents a significant expansion of the Firefly Vector Model’s functionality and reach within Adobe’s creative tools, moving from a single-app integration to becoming a core AI-driven feature across multiple professional-grade applications.",
      "llm_answer": "Between 2023 and 2024, Adobe integrated Firefly’s generative AI capabilities more deeply across its Creative Cloud suite, introducing features like Generative Fill, Expand, and Background in Photoshop, as well as Generative Recolor in Illustrator, all powered by the Firefly Vector Model for editable vector graphics. The Firefly web app and its AI-driven tools (including vector and design model APIs) became central to products like Express, Acrobat, and Stock, with paid Generative Credits and enterprise-focused Firefly Services/Custom Models expanding access for commercial use cases. This evolution emphasized native, commercially safe AI integration across Adobe’s ecosystem, from creative workflows to document management.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "ADBE_10k_2023.pdf",
          "target_page": 11,
          "pages": [
            9,
            10,
            11,
            12,
            13
          ]
        },
        "hop_2_rel": {
          "source_file": "ADBE_10k_2024.pdf",
          "target_page": 11,
          "pages": [
            9,
            10,
            11,
            12,
            13
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 44248,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 11277,
        "completion_tokens": 182,
        "total_tokens": 11460
      }
    },
    {
      "question_id": 2,
      "question": "How has the commercial significance of Biktarvy evolved for GILD from 2023 to 2024, and what implications does this have for the company's HIV business strategy?",
      "original_answer": "In 2023, Biktarvy was a major revenue driver for GILD, generating $11,850 million in total product sales globally, representing a growth from $10,390 million in 2022. By 2024, although Biktarvy remained central to GILD's HIV portfolio, the company highlighted increased risks around its reliance on HIV products, particularly those containing TAF like Biktarvy, due to potential shifts in treatment paradigms and growing generic competition. This indicates that while Biktarvy continued to be a key asset, GILD faced mounting pressure to diversify or innovate within its HIV pipeline to sustain revenue growth.",
      "llm_answer": "From 2023 to 2024, Biktarvy’s commercial significance has declined markedly within Gilead’s HIV portfolio. In 2023, Biktarvy generated $9.69 billion in U.S. sales (26 % of total revenue) and $1.25 billion in Europe, but by 2024 its share of total product revenue fell to roughly 21 % of U.S. sales and 19 % of European sales, reflecting growing competition and the impact of pricing pressures and reimbursement reforms. This erosion of Biktarvy’s contribution forces Gilead to accelerate the launch of newer HIV regimens and expand its oncology and cell‑therapy pipelines to offset the loss of revenue and maintain growth.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "GILD_10k_2023.pdf",
          "target_page": 65,
          "pages": [
            63,
            64,
            65,
            66,
            67
          ]
        },
        "hop_2_rel": {
          "source_file": "GILD_10k_2024.pdf",
          "target_page": 18,
          "pages": [
            16,
            17,
            18,
            19,
            20
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 74271,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 18792,
        "completion_tokens": 155,
        "total_tokens": 18948
      }
    },
    {
      "question_id": 3,
      "question": "How did the status and financial structure of the Series 2018-1A Securities evolve between 2022 and 2023, particularly in terms of outstanding principal and interest rate?",
      "original_answer": "In 2022, the Series 2018-1A Securities had an aggregate principal amount of $500.0 million and an interest rate of 3.652%. By 2023, the outstanding principal had slightly decreased to $496.8 million, while the interest rate remained unchanged at 3.652%. This indicates a minor reduction in the principal amount over the year without any modification to the interest rate.",
      "llm_answer": "Based on the provided document pages, the Series 2018-1A Securities (a specific tranche of the 2018 securitization) had an outstanding principal balance of $496.8 million as of December 31, 2023, compared to $496.1 million as of December 31, 2022. The interest rate for this tranche was 3.652% (as noted in the \"Series 2018-1A Securities (11)\" entry on page 108). This indicates minimal change in outstanding principal between the two years, with the interest rate remaining fixed at 3.652% for the tranche. The document does not specify any significant structural changes to the interest rate or principal repayment schedule between 2022 and 2023 for this particular series.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AMT_10k_2022.pdf",
          "target_page": 118,
          "pages": [
            116,
            117,
            118,
            119,
            120
          ]
        },
        "hop_2_rel": {
          "source_file": "AMT_10k_2023.pdf",
          "target_page": 108,
          "pages": [
            106,
            107,
            108,
            109,
            110
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 58705,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 14905,
        "completion_tokens": 168,
        "total_tokens": 15074
      }
    },
    {
      "question_id": 3,
      "question": "How did UPS's relationship with Coyote evolve from 2023 to 2024 in terms of financial impact and strategic direction?",
      "original_answer": "In 2023, UPS recorded a $111 million impairment charge related to the Coyote trade name due to declining market conditions and a strategic evaluation of the business. By 2024, this strategic evaluation culminated in the September 2024 divestiture of Coyote, which significantly impacted UPS's Supply Chain Solutions revenue, contributing to a decrease primarily driven by Coyote's exit. This marks a clear evolution from impairment and strategic review in 2023 to full divestiture in 2024.",
      "llm_answer": "From 2023 to 2024, UPS’s relationship with Coyote shifted from a core growth contributor to a divested asset, resulting in a $156 million gain on divestiture and a $111 million goodwill impairment charge in 2023 that was later reversed with an additional $108 million impairment in 2024. The exit reduced Supply Chain Solutions revenue by $806 million and lowered operating expenses, but the company expects modest revenue growth in 2025 from remaining Logistics and freight‑forwarding businesses. Strategically, UPS is refocusing on its core U.S. package network and expanding high‑margin logistics (e.g., MNX acquisition) while exiting the underperforming truckload brokerage segment.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "UPS_10k_2023.pdf",
          "target_page": 54,
          "pages": [
            52,
            53,
            54,
            55,
            56
          ]
        },
        "hop_2_rel": {
          "source_file": "UPS_10k_2024.pdf",
          "target_page": 42,
          "pages": [
            40,
            41,
            42,
            43,
            44
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 38614,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 9866,
        "completion_tokens": 171,
        "total_tokens": 10038
      }
    },
    {
      "question_id": 3,
      "question": "How did Linde plc's structure of Performance Share Unit Awards evolve between 2022 and 2024, particularly in terms of the performance metrics used for grants beginning in 2019?",
      "original_answer": "In 2022, Linde plc disclosed two forms of Performance Share Unit Awards under the Amended and Restated 2009 Praxair, Inc. Long Term Incentive Plan: one with Return on Capital performance metrics (Exhibit 10.11k) and another with Total Shareholder Return performance metrics (Exhibit 10.11l). By 2024, these same forms of Performance Share Unit Awards remained in place, as evidenced by Exhibits 10.10l and 10.10m, which correspond directly to the 2019 grants with the same performance metrics. This indicates that the company maintained the same dual structure for Performance Share Unit Awards tied to 2019 grants, without introducing new metrics or eliminating existing ones.",
      "llm_answer": "The Performance Share Unit Awards under Linde plc’s 2009 Long‑Term Incentive Plan were first introduced for grants beginning in 2019, with two distinct performance metrics used: Return on Capital (as set out in Exhibit 10.11k) and Total Shareholder Return (as set out in Exhibit 10.11l). Subsequent amendments—most recently the First Amendment effective January 29 2024 (Exhibit 10.03e)—updated the plan’s structure but did not change the 2019‑era performance‑metric framework.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "LIN_10k_2022.pdf",
          "target_page": 107,
          "pages": [
            104,
            105,
            106,
            107,
            108
          ]
        },
        "hop_2_rel": {
          "source_file": "LIN_10k_2024.pdf",
          "target_page": 96,
          "pages": [
            94,
            95,
            96,
            97,
            98
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 60502,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 15354,
        "completion_tokens": 119,
        "total_tokens": 15474
      }
    },
    {
      "question_id": 3,
      "question": "How has the regulatory status of Trodelvy evolved between 2023 and 2024, and what does this indicate about its development trajectory?",
      "original_answer": "In 2023, Trodelvy was indicated for the treatment of adult patients with unresectable locally advanced or metastatic triple-negative breast cancer, hormone receptor-positive/HER2-negative breast cancer, and urothelial cancer. By 2024, the FDA granted Trodelvy a Breakthrough Therapy designation for the treatment of extensive-stage small cell lung cancer in patients whose disease has progressed after platinum-based chemotherapy. This indicates a strategic expansion of Trodelvy’s development into new oncology indications with high unmet medical need.",
      "llm_answer": "Between 2023 and 2024, Trodelvy’s regulatory trajectory accelerated with two key milestones: it received FDA Breakthrough Therapy designation for extensive-stage small cell lung cancer (2023) and subsequently gained FDA approval for treating unresectable locally advanced or metastatic HR+/HER2- breast cancer (2024), followed by EU approval as monotherapy for the same indication. This progression—from designation to expanded approvals—demonstrates a clear development trajectory toward broader therapeutic applications, particularly in oncology, while reinforcing its strategic focus on high-unmet-need areas.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "GILD_10k_2023.pdf",
          "target_page": 5,
          "pages": [
            3,
            4,
            5,
            6,
            7
          ]
        },
        "hop_2_rel": {
          "source_file": "GILD_10k_2024.pdf",
          "target_page": 8,
          "pages": [
            6,
            7,
            8,
            9,
            10
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 59078,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 14985,
        "completion_tokens": 153,
        "total_tokens": 15138
      }
    },
    {
      "question_id": 4,
      "question": "How has the role of the Vertex AI platform within Google Cloud evolved from 2023 to 2024, particularly in terms of its capabilities and integration with generative AI models?",
      "original_answer": "In 2023, the Vertex AI platform was described as a tool that allowed developers to train, tune, augment, and deploy applications using generative AI models and services such as Enterprise Search and Conversations. By 2024, the platform had evolved to specifically support Gemini and other leading generative AI models, offering developers the ability to train, tune, augment, test, and deploy applications with additional services like vector search, grounding, and distillation to improve model cost and quality. This reflects a shift toward more advanced and optimized generative AI integration.",
      "llm_answer": "From 2023 to 2024, Vertex AI’s role within Google Cloud shifted from a primarily infrastructure‑focused platform for training and deploying custom models to a more integrated, generative‑AI‑centric hub. In 2023 the platform chiefly offered tools for training, tuning, and serving traditional AI models, but by 2024 it was expanded to host Gemini‑based generative models (e.g., Gemini 1.5/2.0) and pre‑packaged AI agents such as Duet AI for Cloud, enabling developers to more easily build, augment, and deploy multimodal generative applications directly on Google Cloud. This evolution reflects Google’s broader push to make Vertex AI the primary gateway for enterprises to leverage the company’s latest generative‑AI capabilities at scale.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "GOOGL_10k_2023.pdf",
          "target_page": 6,
          "pages": [
            4,
            5,
            6,
            7,
            8
          ]
        },
        "hop_2_rel": {
          "source_file": "GOOGL_10k_2024.pdf",
          "target_page": 8,
          "pages": [
            6,
            7,
            8,
            9,
            10
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 49671,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 12644,
        "completion_tokens": 184,
        "total_tokens": 12828
      }
    },
    {
      "question_id": 4,
      "question": "How has the treatment and valuation of weather derivatives changed in SO's financial disclosures from 2022 to 2024, particularly in terms of the amounts considered immaterial and excluded from derivative valuations?",
      "original_answer": "In 2022, SO disclosed that the premium and intrinsic value associated with weather derivatives were immaterial for all periods presented, but did not specify exact amounts. By 2024, SO continued to exclude the premium and intrinsic value of weather derivatives as immaterial, but also provided more specific context by disclosing that cash collateral held in broker margin accounts was $17 million and $62 million at the end of 2024 and 2023, respectively. This suggests a more detailed and structured approach to derivative disclosures over time, even though the weather derivative component remained immaterial.",
      "llm_answer": "From 2022 to 2024, the treatment of weather derivatives in Southern Company’s disclosures shifted from being treated as immaterial and excluded from derivative valuations (as noted in the 2022 discussion of “immaterial premium and intrinsic value associated with weather derivatives” on page 124) to being explicitly included in the fair‑value tables and regulatory‑hedge accounting disclosures for 2023‑2024 (pages 283‑287). The 2024 notes now present detailed balances of energy‑related derivatives—including weather‑related components—within regulatory assets and liabilities, showing amounts such as $‑61 million in current regulatory assets and $8 million in net derivative gains, whereas the 2022 filing only referenced weather derivatives in passing without quantifying them. Consequently, the amounts deemed immaterial and excluded from derivative valuations in 2022 are no longer treated as immaterial; they are now measured, disclosed, and incorporated into the Registrants’ risk‑management and regulatory frameworks.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "SO_10k_2022.pdf",
          "target_page": 122,
          "pages": [
            120,
            121,
            122,
            123,
            124
          ]
        },
        "hop_2_rel": {
          "source_file": "SO_10k_2024.pdf",
          "target_page": 285,
          "pages": [
            283,
            284,
            285,
            286,
            287
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 55373,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 14083,
        "completion_tokens": 256,
        "total_tokens": 14339
      }
    },
    {
      "question_id": 4,
      "question": "How has the regulatory and market positioning of Biktarvy evolved between 2023 and 2024 based on GILD's disclosures?",
      "original_answer": "In 2023, Biktarvy was listed with a U.S. patent expiration year of 2033, indicating long-term market exclusivity protection in the U.S. In 2024, Biktarvy received an expanded regulatory indication from the FDA to treat people with HIV who have suppressed viral loads with known or suspected M184V/I resistance, a common form of treatment resistance. Additionally, the FDA approved an updated label with data reinforcing Biktarvy's safety and efficacy for use in pregnant people with HIV-1. This represents a shift from primarily patent protection in 2023 to expanded therapeutic application and broader patient eligibility in 2024.",
      "llm_answer": "Based on GILD's 2023 and 2024 disclosures, Biktarvy's regulatory and market positioning evolved through an expanded HIV indication (FDA approval for patients with M184V/I resistance and use in pregnancy) and maintained strong patent protection through 2033 in both the U.S. and EU, with no generic competition anticipated before then. The company also reinforced its manufacturing strategy by expanding cell therapy capabilities and securing proprietary process patents, while regulatory exclusivity in the U.S. is projected to last until 2032.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "GILD_10k_2023.pdf",
          "target_page": 9,
          "pages": [
            7,
            8,
            9,
            10,
            11
          ]
        },
        "hop_2_rel": {
          "source_file": "GILD_10k_2024.pdf",
          "target_page": 8,
          "pages": [
            6,
            7,
            8,
            9,
            10
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 59106,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 14988,
        "completion_tokens": 136,
        "total_tokens": 15124
      }
    },
    {
      "question_id": 5,
      "question": "How did AMT's utilization of the 2021 Multicurrency Credit Facility change between 2022 and 2023, particularly in terms of borrowing amounts and facility amendments?",
      "original_answer": "In 2022, AMT made additional net borrowings of $850.0 million under the 2021 Multicurrency Credit Facility, which were used to repay existing indebtedness and for general corporate purposes. By 2023, the company borrowed an aggregate of $3.0 billion and repaid $6.1 billion under the same facility, including a significant repayment of 842.6 million EUR ($919.1 million). Additionally, the facility underwent amendments in 2023 that extended its maturity date to July 1, 2026, maintained a total commitment of $6.0 billion, and replaced the LIBOR pricing benchmark with SOFR. This reflects a significant transformation in the usage and structure of the facility.",
      "llm_answer": "Between 2022 and 2023, AMT's utilization of the 2021 Multicurrency Credit Facility shifted from net borrowing to net repayment. In 2022 (as of December 31, 2021), the facility had $1.6 billion available, and subsequent to that date, AMT borrowed an additional $850 million under the facility (as noted in the 2021 filing for 2021 usage). However, in 2023, AMT borrowed $3.0 billion under the facility but repaid $6.1 billion in aggregate, resulting in a net reduction of $3.1 billion in outstanding borrowings under the facility during the year ended December 31, 2023. This repayment was used to settle existing indebtedness, including the 2021 USD Two-Year Delayed Draw Term Loan. The facility was subsequently amended in June 2023 to extend its maturity to July 2026 and replace LIBOR with SOFR.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AMT_10k_2022.pdf",
          "target_page": 44,
          "pages": [
            42,
            43,
            44,
            45,
            46
          ]
        },
        "hop_2_rel": {
          "source_file": "AMT_10k_2023.pdf",
          "target_page": 52,
          "pages": [
            50,
            51,
            52,
            53,
            54
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 52247,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 13287,
        "completion_tokens": 199,
        "total_tokens": 13486
      }
    },
    {
      "question_id": 5,
      "question": "How has the role of Google Ad Manager in Alphabet's advertising revenue recognition strategy evolved between 2023 and 2024, particularly in terms of its integration with revenue reporting models?",
      "original_answer": "In 2023, Google Ad Manager was directly tied to Alphabet's advertising revenue recognition on a gross basis, with the company reporting the full amount billed to customers as revenue for ads placed on Google Network properties. By 2024, the language around Google Ad Manager shifted, emphasizing a more nuanced control-based evaluation where Alphabet asserts its role as principal by controlling advertising inventory before transfer to customers, being primarily responsible to them, and having discretion over pricing. This reflects a strategic evolution from a transactional reporting model to a more control-driven justification for gross revenue recognition, reinforcing the centrality of Google Ad Manager in revenue operations.",
      "llm_answer": "The role of Google Ad Manager in Alphabet’s advertising revenue recognition strategy has shifted from being treated as a distinct revenue stream to being integrated under broader advertising revenue categories. In 2023, Ad Manager’s revenue was included within \"Advertising revenues\" alongside Google Search, YouTube, and Google Network properties, with recognition occurring on a gross basis when Alphabet acts as the principal (i.e., controls ad inventory before transferring it to customers). By 2024, the strategy emphasized that advertising revenue from Ad Manager is recognized when control transfers to customers, with gross reporting for network inventory and variable consideration (e.g., incentives) estimated and reduced from revenue. This integration reflects a streamlined approach where Ad Manager’s revenue is no longer isolated but part of Alphabet’s consolidated advertising revenue model, consistent with its gross basis reporting for network placements.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "GOOGL_10k_2023.pdf",
          "target_page": 57,
          "pages": [
            55,
            56,
            57,
            58,
            59
          ]
        },
        "hop_2_rel": {
          "source_file": "GOOGL_10k_2024.pdf",
          "target_page": 58,
          "pages": [
            56,
            57,
            58,
            59,
            60
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 51786,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 13180,
        "completion_tokens": 243,
        "total_tokens": 13423
      }
    },
    {
      "question_id": 5,
      "question": "How has UPS's financial exposure and strategic positioning regarding Roadie evolved between 2023 and 2024, particularly in terms of goodwill impairment and risk assessment?",
      "original_answer": "In 2023, UPS recorded a $56 million goodwill impairment charge related to Roadie, indicating financial concerns about its value. By 2024, although no further impairment was recorded, Roadie was identified among the reporting units with limited excess of fair value over carrying value, signaling ongoing financial risk. This evolution reflects a shift from active impairment to a cautious monitoring stance due to Roadie's continued sensitivity to cost of capital and performance forecasts.",
      "llm_answer": "UPS recorded $56 million of goodwill impairment in 2023 related to the Roadie reporting unit and $61 million in 2022, but no goodwill impairments were recorded in 2024. The company’s 2024 goodwill testing identified Roadie, Global Freight Forwarding and Global Logistics and Distribution as units with limited excess fair value, indicating heightened risk of future impairment, yet the fair values still exceeded carrying amounts, so no impairment was recognized this year.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "UPS_10k_2023.pdf",
          "target_page": 102,
          "pages": [
            100,
            101,
            102,
            103,
            104
          ]
        },
        "hop_2_rel": {
          "source_file": "UPS_10k_2024.pdf",
          "target_page": 57,
          "pages": [
            55,
            56,
            57,
            58,
            59
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 35964,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 9219,
        "completion_tokens": 118,
        "total_tokens": 9337
      }
    },
    {
      "question_id": 5,
      "question": "How has Linde's relationship with helium evolved from 2022 to 2024, and what quantitative impact did this change have on the company's sales and operating profit?",
      "original_answer": "In 2022, helium was a supply component for Linde, indicating a positive or neutral role in operations. By 2024, helium had a negative impact on performance, with a 2% underlying sales decrease in the 'Other' segment primarily due to lower volumes in global helium and Linde Advanced Materials Technology (LAMT). Additionally, operating profit in the 'Other' segment saw increased costs related to helium, partially offset by an insurance recovery for LAMT. This reflects a shift from helium being a supply input to a source of cost pressure.",
      "llm_answer": "Linde's helium-related business, primarily within the \"Other\" segment (which includes global helium wholesale), underwent a strategic shift from 2022 to 2024, marked by a significant reduction in helium-related costs and a notable improvement in profitability. This change directly contributed to a $19 million (44%) increase in operating profit for the \"Other\" segment in 2024 compared to 2023, driven explicitly by \"insurance recovery for LAMT partially offset by higher costs due to helium\" (page 28). While the provided financial data (e.g., sales and operating profit figures for segments like APAC, Americas, and EMEA) does not quantify helium's standalone impact on total company sales or operating profit, the segment-level improvement confirms that the resolution of helium-related cost pressures positively affected the company's overall operating performance, with the \"Other\" segment's operating profit rising to $43 million in 2024 from $62 million in 2023 (though the segment's sales declined slightly by 2%). The document does not provide specific dollar figures for helium's contribution to total sales or operating profit, but the qualitative shift and segment-level profit increase indicate a positive evolution in Linde's helium strategy.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "LIN_10k_2022.pdf",
          "target_page": 72,
          "pages": [
            70,
            71,
            72,
            73,
            74
          ]
        },
        "hop_2_rel": {
          "source_file": "LIN_10k_2024.pdf",
          "target_page": 28,
          "pages": [
            26,
            27,
            28,
            29,
            30
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 38083,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 9745,
        "completion_tokens": 314,
        "total_tokens": 10059
      }
    },
    {
      "question_id": 5,
      "question": "How did the total value of loans covered under long-term credit protection agreements with FNMA and FHLMC evolve from 2023 to 2024, and what does this indicate about the Corporation's credit risk exposure on residential mortgage loans?",
      "original_answer": "In 2023, the Corporation had $8.7 billion in loans covered under credit protection agreements with FNMA and FHLMC, which decreased to $8.0 billion in 2024. This indicates a reduction in the Corporation's reliance on full credit protection for residential mortgage loans that become severely delinquent. Since these agreements provide full credit protection and the Corporation does not record an allowance for credit losses on these loans, the decline suggests a potential decrease in the volume of high-risk residential mortgage loans in their portfolio.",
      "llm_answer": "The total value of loans covered under long‑term credit protection agreements with FNMA and FHLMC rose from $8.0 billion at the end of 2023 to $8.7 billion at the end of 2024. This increase reflects a larger pool of residential‑mortgage loans that are fully insured and thus receive complete credit protection, indicating that the Corporation’s exposure to credit losses on its residential‑mortgage portfolio is limited – the insured loans are not subject to allowance for credit losses, so the growth in protected loans suggests the Corporation’s direct credit‑risk exposure on residential mortgages remains relatively low.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "BAC_10k_2023.pdf",
          "target_page": 117,
          "pages": [
            115,
            116,
            117,
            118,
            119
          ]
        },
        "hop_2_rel": {
          "source_file": "BAC_10k_2024.pdf",
          "target_page": 117,
          "pages": [
            115,
            116,
            117,
            118,
            119
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 112686,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 28416,
        "completion_tokens": 156,
        "total_tokens": 28572
      }
    },
    {
      "question_id": 5,
      "question": "How has Adobe's strategic positioning of Adobe Firefly evolved between 2023 and 2024, particularly in terms of competitive differentiation and associated regulatory risks?",
      "original_answer": "In 2023, Adobe positioned Adobe Firefly as a competitive differentiator by emphasizing its generative AI capabilities that are natively integrated into Adobe products and designed to be safe for commercial use. By 2024, Adobe continued to highlight Firefly's AI innovations but introduced new concerns around regulatory risks, particularly referencing the EU AI Act adopted in 2024, which could impose compliance costs, delay development, or require changes to AI development practices. This reflects a shift from purely competitive emphasis to a more risk-aware strategic positioning of the product.",
      "llm_answer": "Adobe's strategic positioning of Adobe Firefly has evolved from a standalone generative AI app (2023) to a deeply integrated, commercially safe AI capability embedded across Creative Cloud, Express, and Experience Cloud (2024), emphasizing native integration and enterprise indemnification to differentiate from competitors. However, this expansion introduces significant regulatory risks, as new AI-specific regulations like the EU AI Act (2024) could impose inconsistent compliance costs, liability exposure, and potential restrictions on AI development or deployment, directly threatening Adobe's monetization strategies and market position if regulatory frameworks conflict with its responsible AI approach.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "ADBE_10k_2023.pdf",
          "target_page": 9,
          "pages": [
            7,
            8,
            9,
            10,
            11
          ]
        },
        "hop_2_rel": {
          "source_file": "ADBE_10k_2024.pdf",
          "target_page": 23,
          "pages": [
            21,
            22,
            23,
            24,
            25
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 50590,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 12874,
        "completion_tokens": 177,
        "total_tokens": 13051
      }
    },
    {
      "question_id": 5,
      "question": "How did the financial performance and regulatory trajectory of Trodelvy evolve between 2023 and 2024?",
      "original_answer": "In 2023, Trodelvy generated total product sales of $1,063 million, reflecting a 56% increase compared to the previous year. By 2024, the regulatory landscape for Trodelvy advanced significantly with the FDA granting it a second Breakthrough Therapy designation, specifically for the treatment of adult patients with extensive-stage small cell lung cancer who have progressed after platinum-based chemotherapy. This indicates both strong financial growth and increased regulatory recognition of the drug's potential clinical impact.",
      "llm_answer": "Based on the provided SEC 10-K filings, Trodelvy's financial performance and regulatory trajectory between 2023 and 2024 show significant growth and regulatory expansion. Trodelvy product sales increased 56% year-over-year in 2023 to $1.063 billion, driven by higher demand across new and existing geographies, and received a second Breakthrough Therapy designation from the FDA in 2024 for treating adult patients with extensive-stage small cell lung cancer after platinum-based chemotherapy. Regulatory exclusivity for Trodelvy is projected to expire in 2028 (U.S.) and 2029 (EU), with pediatric exclusivity extending protection until 2031, while its patent expiration is listed as 2028 in the U.S. and 2029 in the EU. The drug also gained expanded FDA approval in 2023 for unresectable or metastatic HR+/HER2- breast cancer after prior endocrine therapy and systemic treatments, and received accelerated approval for liver cancer (Livdelzi) in 2024, further solidifying its oncology portfolio momentum.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "GILD_10k_2023.pdf",
          "target_page": 40,
          "pages": [
            38,
            39,
            40,
            41,
            42
          ]
        },
        "hop_2_rel": {
          "source_file": "GILD_10k_2024.pdf",
          "target_page": 8,
          "pages": [
            6,
            7,
            8,
            9,
            10
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 61855,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 15672,
        "completion_tokens": 251,
        "total_tokens": 15923
      }
    },
    {
      "question_id": 6,
      "question": "How has Chevron's financial involvement and strategic positioning in Angola LNG evolved from 2022 to 2024, based on specific disclosures regarding its equity investments and affiliate transactions?",
      "original_answer": "In 2022, Chevron reported improved income from equity affiliates, including upstream-related earnings from Angola LNG, which contributed to an overall increase in income from equity affiliates to $5,657 million. By 2024, Chevron's specific interest in Angola LNG Limited was disclosed as a 36.4% ownership stake, with Angola LNG Limited described as a key entity that processes and liquefies natural gas produced in Angola for delivery to international markets. This evolution reflects a continued strategic emphasis on LNG as part of Chevron’s broader upstream portfolio, with a clear quantification of its stake in 2024, suggesting a more defined and stable long-term positioning compared to the more general mention of earnings contribution in 2022.",
      "llm_answer": "From 2022 to 2024 Chevron’s stake in Angola LNG Limited remained a 36.4 % equity interest, but the company’s financial exposure grew through larger net loans to the project ($4.731 bn in 2024 versus $4.278 bn in 2022) and increased equity‑method accounting disclosures.  In its 2024 10‑K (pages 83‑87) Chevron reports $1.665 bn of Angola LNG Limited investments and notes that its share of equity‑affiliate earnings rose to $4.272 bn in 2023, reflecting stronger upstream realizations and the absence of prior impairments.  The 2022 filing (pages 40‑44) shows a $73 million carrying‑value premium on the Angola LNG investment and highlights that the project’s net loan balance was $4.494 bn at year‑end 2022, indicating a steady expansion of Chevron’s capital commitment and strategic positioning in the Angolan LNG value chain.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CVX_10k_2022.pdf",
          "target_page": 42,
          "pages": [
            40,
            41,
            42,
            43,
            44
          ]
        },
        "hop_2_rel": {
          "source_file": "CVX_10k_2024.pdf",
          "target_page": 85,
          "pages": [
            83,
            84,
            85,
            86,
            87
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 58256,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 14797,
        "completion_tokens": 207,
        "total_tokens": 15004
      }
    },
    {
      "question_id": 6,
      "question": "How did the value and issuance activity of META's Fixed-Rate Senior Unsecured Notes evolve from 2023 to 2024?",
      "original_answer": "In 2023, META issued $8.46 billion of net proceeds from Fixed-Rate Senior Unsecured Notes in May. By the end of 2024, the total value of these Notes had increased to $29.0 billion, up from $18.50 billion at the end of 2023, with an additional $10.50 billion issued in August 2024. This reflects both continued reliance on this form of debt financing and a significant increase in the total outstanding amount over the two-year period.",
      "llm_answer": "From 2023 to 2024, META’s Fixed-Rate Senior Unsecured Notes increased from $18.5 billion (as of Dec 31 2023) to $29.0 billion (as of Dec 31 2024), reflecting the issuance of $10.5 billion of new notes in August 2024 in addition to the existing $18.5 billion of outstanding notes. The Notes, which mature between 2027 and 2064 and carry stated rates of 3.50%–5.55%, now represent the company’s primary long‑term debt, with $28.8 billion recorded as long‑term debt on the balance sheet after adjusting for unamortized discounts.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "META_10k_2023.pdf",
          "target_page": 79,
          "pages": [
            77,
            78,
            79,
            80,
            81
          ]
        },
        "hop_2_rel": {
          "source_file": "META_10k_2024.pdf",
          "target_page": 110,
          "pages": [
            108,
            109,
            110,
            111,
            112
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 45691,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 11635,
        "completion_tokens": 131,
        "total_tokens": 11767
      }
    },
    {
      "question_id": 6,
      "question": "How did LIN's financial exposure to helium as a raw material change from 2023, when it was categorized as a supply, to 2024, when it became a dependency, based on specific cost or sourcing disclosures?",
      "original_answer": "In 2023, LIN categorized helium as a supply, indicating it was a standard input with manageable sourcing dynamics, and reported helium costs at 4.2% of total raw material expenses. By 2024, the relationship shifted to 'depends_on,' signaling increased strategic importance, and helium costs rose to 6.8% of raw material expenses, reflecting a more critical role in operations and a corresponding increase in cost exposure.",
      "llm_answer": "Based on the provided SEC 10-K filings, LIN's financial exposure to helium as a raw material shifted from being categorized as a \"supply\" in 2023 to a \"dependency\" in 2024, as evidenced by specific cost and sourcing disclosures in the documents. The 2024 filing (page 60) explicitly references helium in the context of \"cost reduction programs and other charges\" (Note 3), where helium-related costs were materially included in the $175 million accrued liability for such programs, and the company's reliance on helium as a critical raw material for its core industrial gas operations was underscored by its inclusion in the \"Other Current Liabilities\" line item. This transition reflects a strategic shift from treating helium as a manageable supply to recognizing it as a key dependency requiring close monitoring due to its impact on operational costs and supply chain resilience.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "LIN_10k_2023.pdf",
          "target_page": 72,
          "pages": [
            70,
            71,
            72,
            73,
            74
          ]
        },
        "hop_2_rel": {
          "source_file": "LIN_10k_2024.pdf",
          "target_page": 61,
          "pages": [
            59,
            60,
            61,
            62,
            63
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 29515,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 7613,
        "completion_tokens": 220,
        "total_tokens": 7833
      }
    },
    {
      "question_id": 6,
      "question": "How did PayPal's utilization of European customer balances for credit activities evolve between 2022 and 2023, and what was the percentage change in the amount approved for such activities?",
      "original_answer": "In 2022, PayPal had $3.8 billion approved to fund credit activities, representing approximately 37% of European customer balances available for corporate use. In 2023, the approved amount decreased to $3.0 billion, representing approximately 39% of European customer balances. This indicates a reduction in the absolute amount approved for credit activities, even though the percentage slightly increased, signaling a more conservative approach to utilizing customer balances for credit funding.",
      "llm_answer": "PayPal’s European customer balances were progressively expanded for credit use: the Luxembourg regulator allowed up to 35 % of European balances to be designated for credit in 2018, and by the end of 2021 the cumulative amount approved for credit had risen to $2.7 billion (≈27 % of European balances). In 2023 the company further increased the authorized pool, with management designating additional funds that brought the total approved for credit to $3.0 billion, representing roughly 39 % of European customer balances. Consequently, the amount approved for credit activities grew from $2.7 billion in 2021 to $3.0 billion in 2023, a $0.3 billion increase, which corresponds to an approximate 11 % rise.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "PYPL_10k_2022.pdf",
          "target_page": 75,
          "pages": [
            73,
            74,
            75,
            76,
            77
          ]
        },
        "hop_2_rel": {
          "source_file": "PYPL_10k_2023.pdf",
          "target_page": 49,
          "pages": [
            47,
            48,
            49,
            50,
            51
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 9,
        "total_chars": 44345,
        "num_window_pages": 9,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 11318,
        "completion_tokens": 176,
        "total_tokens": 11494
      }
    },
    {
      "question_id": 6,
      "question": "How did Starbucks' exposure to foreign currency - other instruments evolve between 2023 and 2024, particularly in terms of their fair value and the expected reclassification impact on earnings?",
      "original_answer": "In 2023, Starbucks reported a fair value of $1,164 million for foreign currency - other instruments, with a net gain of $39.6 million included in AOCI. By 2024, the fair value decreased to $920 million, and the net gain included in AOCI dropped to $11.5 million. Additionally, the amount expected to be reclassified from AOCI into earnings within 12 months declined from $55.3 million in 2023 to $9.5 million in 2024, indicating a reduced short-term earnings impact from these instruments.",
      "llm_answer": "Between 2023 and 2024, Starbucks' exposure to foreign currency derivatives designated as cash flow hedges shifted significantly: the fair value of foreign currency - other designated derivative assets decreased from $32.0 million (Oct 1 2023) to $1.9 million (Sep 29 2024), while the corresponding liability in accrued liabilities fell from $2.0 million to $2.5 million, reflecting a net reduction in the hedged foreign‑currency positions. This reduction is mirrored in the AOCI reclassification schedule, where the cumulative amount of gains/(losses) expected to be reclassified from AOCI to earnings within 12 months dropped from $9.5 million (Oct 1 2023) to $60.1 million (Sep 29 2024) for coffee‑related hedges and from $39.6 million to $11.5 million for other foreign‑currency hedges, indicating a smaller pool of gains to be recognized in earnings. Consequently, the expected reclassification impact on earnings from these foreign‑currency hedges is now lower, with the net gains/(losses) anticipated to be reclassified decreasing from $9.5 million to $60.1 million for coffee and from $39.6 million to $11.5 million for other foreign‑currency positions, resulting in a net reduction of approximately $30 million in earnings‑impacting gains compared with the prior year.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "SBUX_10k_2023.pdf",
          "target_page": 71,
          "pages": [
            69,
            70,
            71,
            72,
            73
          ]
        },
        "hop_2_rel": {
          "source_file": "SBUX_10k_2024.pdf",
          "target_page": 70,
          "pages": [
            68,
            69,
            70,
            71,
            72
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 9,
        "total_chars": 54970,
        "num_window_pages": 9,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 13975,
        "completion_tokens": 319,
        "total_tokens": 14294
      }
    },
    {
      "question_id": 6,
      "question": "How did the fair value of energy-related derivatives held by Alabama Power and Georgia Power evolve from 2022 to 2023, and what was the directional change in their asset versus liability positions?",
      "original_answer": "In 2022, Alabama Power reported energy-related derivatives with a fair value of $55 million in assets and $11 million in liabilities, while Georgia Power reported $75 million in assets and $8 million in liabilities. By 2023, Alabama Power's energy-related derivatives decreased to $15 million in assets but increased significantly to $110 million in liabilities. Similarly, Georgia Power's derivatives were valued at $13 million in assets and $124 million in liabilities in 2023. This indicates a substantial shift toward liability exposure for both entities over the period.",
      "llm_answer": "Based on the provided pages, the fair value of energy-related derivatives held by Alabama Power and Georgia Power increased from $15 million (assets) and $61 million (liabilities) at December 31 2022 to $15 million (assets) and $110 million (liabilities) at December 31 2023. This represents a directional shift from a net liability position in 2022 to a larger net liability position in 2023, with the liability amount more than doubling.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "SO_10k_2022.pdf",
          "target_page": 311,
          "pages": [
            309,
            310,
            311,
            312,
            313
          ]
        },
        "hop_2_rel": {
          "source_file": "SO_10k_2023.pdf",
          "target_page": 281,
          "pages": [
            279,
            280,
            281,
            282,
            283
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 83261,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 21050,
        "completion_tokens": 109,
        "total_tokens": 21160
      }
    },
    {
      "question_id": 6,
      "question": "How did the asset allocation strategy for the U.S. Retiree Health Care Plan evolve from 2022 to 2023, particularly in terms of the percentage distribution between fixed income securities and equity securities?",
      "original_answer": "In 2022, the U.S. Retiree Health Care Plan allocated 65% to fixed income securities and cash equivalents and 35% to equity securities. By 2023, the allocation to fixed income securities increased to 80%, while equity securities decreased to 20%. This represents a shift toward a more conservative investment strategy in 2023 compared to 2022.",
      "llm_answer": "Based on the provided 10-K filings, the U.S. Retiree Health Care Plan's asset allocation strategy evolved from 2022 to 2023 with fixed income securities increasing from 65% to 80% of total plan assets, while equity securities decreased from 35% to 20%. This shift aligns with the stated target allocation ranges (65%-80% fixed income, 20%-35% equity) and reflects a deliberate move toward greater fixed income exposure to better match liability sensitivity. The 2023 weighted average allocation shows 80% fixed income and 20% equity, compared to 65% fixed income and 35% equity in 2022.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "TXN_10k_2022.pdf",
          "target_page": 48,
          "pages": [
            46,
            47,
            48,
            49,
            50
          ]
        },
        "hop_2_rel": {
          "source_file": "TXN_10k_2023.pdf",
          "target_page": 49,
          "pages": [
            47,
            48,
            49,
            50,
            51
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 55092,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 14009,
        "completion_tokens": 146,
        "total_tokens": 14155
      }
    },
    {
      "question_id": 6,
      "question": "How has the regulatory approval status of Trodelvy evolved between 2022 and 2023, and what new indications were granted in 2023?",
      "original_answer": "In 2022, Trodelvy was indicated for the treatment of adult patients with unresectable locally advanced or metastatic triple-negative breast cancer (TNBC) who have received two or more prior systemic therapies and for metastatic urothelial cancer after platinum-based chemotherapy and a PD-1/PD-L1 inhibitor. By 2023, Trodelvy received additional approvals: it was granted EC approval and FDA approval for the treatment of adult patients with unresectable or metastatic hormone receptor-positive, HER2-negative (HR+/HER2-) breast cancer who have received endocrine-based therapy and at least two additional systemic therapies in the metastatic setting. This represents a significant expansion of the drug’s therapeutic applications.",
      "llm_answer": "Between 2022 and 2023, Trodelvy's regulatory approval expanded with a new indication granted by the European Commission for monotherapy treatment of adult patients with unresectable locally advanced or metastatic HR+/HER2- breast cancer who have previously received endocrine therapy and at least two systemic therapies. Additionally, the FDA approved Trodelvy for the same HR+/HER2- breast cancer indication, while earlier in 2023 the company noted that the Phase 3 EVOKE-01 trial of Trodelvy versus docetaxel in previously treated metastatic non-small cell lung cancer did not meet its primary survival endpoint, though it observed a potential trend in a subgroup of patients who were non-responsive to prior anti-PD-(L)1 immunotherapy.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "GILD_10k_2022.pdf",
          "target_page": 6,
          "pages": [
            4,
            5,
            6,
            7,
            8
          ]
        },
        "hop_2_rel": {
          "source_file": "GILD_10k_2023.pdf",
          "target_page": 39,
          "pages": [
            37,
            38,
            39,
            40,
            41
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 58566,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 14856,
        "completion_tokens": 184,
        "total_tokens": 15041
      }
    },
    {
      "question_id": 7,
      "question": "How did Meta's disclosure regarding user perception as a risk factor evolve between 2023 and 2024, particularly in terms of the nature of risks highlighted and their potential impact on business operations?",
      "original_answer": "In 2023, Meta emphasized user perception risks related to privacy, safety, content quality, and regulatory changes, specifically noting concerns around decreased user sentiment and engagement due to data practices and content policies. In 2024, while user perception was still acknowledged, the focus shifted toward broader operational and financial risks, such as integration challenges from acquisitions, tax liabilities, and investor sentiment. The explicit mention of user perception as a direct risk factor was notably reduced in 2024, indicating a strategic shift in how Meta communicated its risk profile.",
      "llm_answer": "Between 2023 and 2024, Meta’s disclosure regarding user perception as a risk factor evolved from a general warning about declining user engagement and platform trust (e.g., risks tied to user behavior changes, competition, and platform integrity in 2023 filings) to a more specific emphasis on how regulatory actions and data privacy laws directly undermine user trust and platform utility. In 2024, the focus shifted to concrete threats like the invalidation of EU-U.S. data transfer mechanisms (DPF), which could legally restrict data flows and force Meta to limit product availability in Europe—potentially reducing ad revenue and user engagement. Additionally, 2024 disclosures highlighted how evolving privacy regulations (e.g., GDPR, DMA, CCPA/CPRA) and proposed digital services taxes (e.g., \"digital advertising taxes\") could force Meta to alter its core advertising model, directly impacting its ability to monetize user data and deliver targeted ads. This marks a shift from broad user retention risks to legally driven, structural threats to Meta’s revenue model tied to global regulatory compliance.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "META_10k_2023.pdf",
          "target_page": 17,
          "pages": [
            15,
            16,
            17,
            18,
            19
          ]
        },
        "hop_2_rel": {
          "source_file": "META_10k_2024.pdf",
          "target_page": 35,
          "pages": [
            33,
            34,
            35,
            36,
            37
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 47394,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 12084,
        "completion_tokens": 277,
        "total_tokens": 12362
      }
    },
    {
      "question_id": 7,
      "question": "How has the notional amount of Lockheed Martin's variable interest rate swaps evolved from 2021 to 2024, and what does this indicate about the company's interest rate risk management strategy?",
      "original_answer": "In 2021, the notional amount of Lockheed Martin's variable interest rate swaps was $500 million, while by 2024, it had increased to $1.3 billion. This indicates a significant shift in the company's interest rate risk management strategy, with a growing emphasis on converting fixed-rate borrowings to variable-rate borrowings, likely in response to changes in the interest rate environment and the company's borrowing profile over the period.",
      "llm_answer": "Based on the provided 10-K disclosures, the notional amount of Lockheed Martin's variable interest rate swaps was $1.3 billion at both December 31 2024 and December 31 2023 (as disclosed in the \"ITEM 7A. Quantitative and Qualitative Disclosures About Market Risk\" section of the 2024 filing). This consistent notional level indicates that the company has maintained a stable hedge position for its variable‑rate debt over the 2021‑2024 period, reflecting a focused strategy to manage interest‑rate exposure without expanding the size of its swap portfolio.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "LMT_10k_2022.pdf",
          "target_page": 66,
          "pages": [
            64,
            65,
            66,
            67,
            68
          ]
        },
        "hop_2_rel": {
          "source_file": "LMT_10k_2024.pdf",
          "target_page": 52,
          "pages": [
            50,
            51,
            52,
            53,
            54
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 41759,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 10671,
        "completion_tokens": 139,
        "total_tokens": 10810
      }
    },
    {
      "question_id": 7,
      "question": "How did PayPal's approach to its Seller Protection Programs evolve between 2022 and 2023, particularly in terms of financial provisions for transaction losses?",
      "original_answer": "In 2022, PayPal acknowledged the risk of losses from its Seller Protection Programs and noted that historical loss rates ranged between 0.09% and 0.15% of TPV, with the potential for increased losses due to macroeconomic conditions such as the ongoing impacts of the COVID-19 pandemic. By 2023, PayPal provided more structured financial disclosures, showing that the allowance for transaction losses was $64 million (down from $66 million in 2022), indicating a slight decrease in expected losses. This shift reflects a more defined and quantified approach to managing seller protection risk in 2023 compared to the more qualitative risk assessment in 2022.",
      "llm_answer": "PayPal’s Seller Protection Programs have not changed materially between 2022 and 2023; the company continues to offer protection against unauthorized transactions and non-receipt of goods, recording a $64 million allowance for transaction losses in 2023 (up from $66 million in 2022) and recognizing $1.192 billion in provisions for those losses.  The only financial‑provision shift noted is the modest increase in the allowance and related expense, reflecting higher provisions ($1.192 billion in 2023 versus $1.170 billion in 2022) but essentially stable coverage for seller‑related transaction losses.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "PYPL_10k_2022.pdf",
          "target_page": 51,
          "pages": [
            49,
            50,
            51,
            52,
            53
          ]
        },
        "hop_2_rel": {
          "source_file": "PYPL_10k_2023.pdf",
          "target_page": 113,
          "pages": [
            111,
            112,
            113,
            114,
            115
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 50181,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 12770,
        "completion_tokens": 151,
        "total_tokens": 12921
      }
    },
    {
      "question_id": 7,
      "question": "How did Starbucks' derivative asset and liability positions in foreign currency - other change from fiscal year 2023 to fiscal year 2024, and what was the magnitude of this change on the balance sheet?",
      "original_answer": "In fiscal year 2023, Starbucks reported a derivative asset of $1,164 million under 'Foreign currency - other.' By fiscal year 2024, this amount significantly decreased to $1.9 million in derivative assets under the same category. Additionally, the derivative liability for 'Foreign currency - other' increased from $2.0 million in 2023 to $4.7 million in 2024. This indicates a major reduction in the company's foreign currency derivative assets and a moderate increase in liabilities tied to foreign currency over this period.",
      "llm_answer": "The foreign currency‑other derivative position in AOCI declined from $39.6 million (Oct 1 2023) to $11.5 million (Sep 29 2024), a $28.1 million decrease, and this change was reclassified into earnings as $28.2 million of gains during fiscal 2024. Consequently, the net impact on the balance sheet was an increase of $28.2 million in the amount reclassified from AOCI to earnings.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "SBUX_10k_2023.pdf",
          "target_page": 71,
          "pages": [
            69,
            70,
            71,
            72,
            73
          ]
        },
        "hop_2_rel": {
          "source_file": "SBUX_10k_2024.pdf",
          "target_page": 72,
          "pages": [
            70,
            71,
            72,
            73,
            74
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 9,
        "total_chars": 63210,
        "num_window_pages": 9,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 16037,
        "completion_tokens": 94,
        "total_tokens": 16132
      }
    },
    {
      "question_id": 7,
      "question": "How did the financial impact of energy-related derivatives on natural gas cost and revenue hedging positions evolve from 2022 to 2023?",
      "original_answer": "In 2022, energy-related derivatives had a negative impact of $117 million on natural gas revenues and a $27 million negative impact on the cost of natural gas. In 2023, the impact shifted positively with a $59 million gain on the cost of natural gas, while the revenue impact remained neutral at $0. This indicates a transformation in the role and effectiveness of these derivatives in managing natural gas exposure.",
      "llm_answer": "The financial impact of energy‑related derivatives on natural‑gas cost and revenue hedging positions shifted markedly from 2022 to 2023.  In 2022 the non‑designated hedges generated a $149 million gain (including $134 million in natural‑gas revenue and $15 million in cost), whereas in 2023 the same category produced a $59 million gain (with $‑11 million in revenue and $59 million in cost), reflecting a reversal of the prior‑year gains and a much smaller overall benefit.  Consequently, the net effect of these hedges on earnings declined substantially, moving from a $149 million positive impact in 2022 to only about $59 million in 2023.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "SO_10k_2022.pdf",
          "target_page": 327,
          "pages": [
            325,
            326,
            327,
            328,
            329
          ]
        },
        "hop_2_rel": {
          "source_file": "SO_10k_2023.pdf",
          "target_page": 295,
          "pages": [
            293,
            294,
            295,
            296,
            297
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 64328,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 16301,
        "completion_tokens": 160,
        "total_tokens": 16462
      }
    },
    {
      "question_id": 7,
      "question": "How did Walmart's treatment of its Deferred Compensation Matching Plan evolve between the 2023 and 2024 10-K filings, particularly in terms of its documentation status and effective date?",
      "original_answer": "In the 2023 10-K filing, the Deferred Compensation Matching Plan was newly introduced as 'Walmart Inc. Deferred Compensation Matching Plan, as amended and restated effective November 8, 2023.' By the 2024 10-K filing, the plan was no longer labeled as newly introduced but was instead referenced as being 'incorporated by reference' to the 2024 Annual Report on Form 10-K, indicating that it had become an established, ongoing plan. The effective date remained unchanged at November 8, 2023, suggesting no substantive changes to the plan’s implementation timeline, but its treatment shifted from being newly introduced to being formally integrated into the company's long-term compensation framework.",
      "llm_answer": "Based on the provided 10-K filings, Walmart's Deferred Compensation Matching Plan was amended and restated effective November 8, 2023, as disclosed in Exhibit 10.1 of the 2024 Form 10-K (filed March 15, 2024), confirming its updated documentation status and effective date. The plan remains part of the company's executive compensation structure, with no indication of changes to its effective date between the 2023 and 2024 filings.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "WMT_10k_2023.pdf",
          "target_page": 84,
          "pages": [
            81,
            82,
            83,
            84,
            85
          ]
        },
        "hop_2_rel": {
          "source_file": "WMT_10k_2024.pdf",
          "target_page": 84,
          "pages": [
            82,
            83,
            84,
            85,
            86
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 71125,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 18012,
        "completion_tokens": 108,
        "total_tokens": 18120
      }
    },
    {
      "question_id": 8,
      "question": "How has the disclosure and treatment of LTIP Units evolved between 2023 and 2024, particularly in terms of their dilutive effect and accrual policy?",
      "original_answer": "In 2023, LTIP Units were described as potentially dilutive securities that are convertible into units and exchangeable for common stock, with no material dilutive effect reported for the years 2023, 2022, and 2021. The company stated it does not adjust net income attributable to common stockholders or weighted average shares outstanding due to no dilutive impact. In 2024, the disclosure simplified, stating that LTIP Units are potentially dilutive but again noting no material dilutive effect for the years 2024, 2023, and 2022. Additionally, the accrual policy remained consistent, stating that distributions are accrued when declared. The treatment of LTIP Units remained stable with no significant change in dilutive impact or accrual policy.",
      "llm_answer": "Between 2023 and 2024, the dilutive effect and accrual policy of LTIP Units remained consistent with prior practice: no potentially dilutive securities, including LTIP Units, had a material dilutive impact on earnings per share or per unit for the years ended December 31 2023, 2022, or 2024, and LTIP Units were accrued only when declared, with no adjustment to net income attributable to common stockholders or unitholders required.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "SPG_10k_2023.pdf",
          "target_page": 111,
          "pages": [
            109,
            110,
            111,
            112,
            113
          ]
        },
        "hop_2_rel": {
          "source_file": "SPG_10k_2024.pdf",
          "target_page": 114,
          "pages": [
            112,
            113,
            114,
            115,
            116
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 49211,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 12526,
        "completion_tokens": 108,
        "total_tokens": 12634
      }
    },
    {
      "question_id": 8,
      "question": "How has Meta's compliance approach to the EU-U.S. Data Privacy Framework (EU-U.S. DPF) evolved between 2023 and 2024, particularly in response to regulatory actions and decisions?",
      "original_answer": "In 2023, Meta was in the process of implementing steps to comply with corrective orders from the Irish Data Protection Commission (IDPC) following a EUR €1.2 billion fine and a directive to suspend unlawful data transfers to the U.S. under Standard Contractual Clauses (SCCs). At that time, the EU-U.S. DPF had just been finalized, and Meta viewed its implementation as a key milestone to address data transfer compliance. By 2024, Meta had implemented compliance measures with the corrective orders and was actively engaging with regulators on new compliance models, such as the 'subscription for no ads' alternative introduced in November 2023. In 2024, the European Commission opened formal proceedings into the compliance of this model with the Digital Markets Act (DMA), issuing preliminary findings in July 2024 that suggested non-compliance. This reflects a shift from foundational compliance with the EU-U.S. DPF framework to navigating more complex regulatory scrutiny around specific business models under evolving EU laws.",
      "llm_answer": "Meta’s compliance approach to the EU-U.S. Data Privacy Framework (EU‑U.S. DPF) has shifted from reliance on prior adequacy frameworks to active implementation of the new DPF after its EU Commission adequacy decision in July 2023. The company has taken concrete steps to meet the DPF’s requirements—including adjusting data‑transfer mechanisms, engaging with the Irish Data Protection Commission, and aligning internal processes with the framework—while also preparing for potential CJEU challenges that could disrupt its European operations. At the same time, Meta continues to navigate related regulatory pressures, such as the GDPR, the Digital Markets Act, and the FTC’s ongoing enforcement actions, which collectively drive ongoing compliance‑cost investments and product‑design changes across its European business.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "META_10k_2023.pdf",
          "target_page": 10,
          "pages": [
            8,
            9,
            10,
            11,
            12
          ]
        },
        "hop_2_rel": {
          "source_file": "META_10k_2024.pdf",
          "target_page": 11,
          "pages": [
            9,
            10,
            11,
            12,
            13
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 56145,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 14264,
        "completion_tokens": 205,
        "total_tokens": 14469
      }
    },
    {
      "question_id": 8,
      "question": "How has Linde's approach to green hydrogen production evolved between 2023 and 2024, particularly in terms of production methods and emphasis on renewable energy sources?",
      "original_answer": "In 2023, Linde described green hydrogen as being produced primarily through electrolysis using renewable energy or from steam methane reforming of biomethane, and it was presented as one of the company's clean energy offerings alongside blue hydrogen. By 2024, the company had expanded its description to emphasize green hydrogen as 'renewable hydrogen' produced by electrolysis using renewable energy and water as feedstock, and it was clearly differentiated from low-carbon (blue) hydrogen. Additionally, in 2024, Linde placed more emphasis on the carbon intensity metric to differentiate production methods, indicating a more refined and strategic framing of green hydrogen within the broader context of clean energy solutions.",
      "llm_answer": "Between 2023 and 2024, Linde’s approach to green hydrogen production has shifted toward greater emphasis on renewable energy sources and expanded low-carbon hydrogen technologies. The 2024 report highlights that green hydrogen is produced via electrolysis powered by renewable energy, while blue hydrogen involves capturing and sequestering carbon emissions from fossil-based production. This reflects a strategic focus on advancing clean energy solutions through both renewable-powered electrolysis and carbon management in hydrogen manufacturing.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "LIN_10k_2023.pdf",
          "target_page": 4,
          "pages": [
            2,
            3,
            4,
            5,
            6
          ]
        },
        "hop_2_rel": {
          "source_file": "LIN_10k_2024.pdf",
          "target_page": 4,
          "pages": [
            2,
            3,
            4,
            5,
            6
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 45130,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 11506,
        "completion_tokens": 137,
        "total_tokens": 11643
      }
    },
    {
      "question_id": 8,
      "question": "How did Southern Company's relationship with Sequent evolve between 2022 and 2023, and what were the financial implications of this change?",
      "original_answer": "Southern Company's relationship with Sequent evolved from a business ownership relationship in 2022 to a completed divestiture in 2023. In 2022, Southern Company Gas completed the sale of Sequent to Williams Field Services Group for $159 million, recognizing a pre-tax gain of $121 million. Additionally, the sale resulted in $85 million of additional tax expense due to changes in state apportionment rates. By 2023, Sequent was no longer part of Southern Company's portfolio, and the financial impact of the sale was fully reflected in the company's financial statements, with the gain from the sale reported as a $121 million pre-tax benefit. This marked a complete transformation in the relationship, shifting from operational integration to full separation.",
      "llm_answer": "Southern Company sold its Sequent wholesale gas services business to Williams Field Services Group on July 1 2021 for $159 million, generating a pre‑tax gain of about $121 million (after‑tax $92 million). The transaction also triggered $85 million of additional tax expense due to changes in state apportionment rates, and the company recorded an $84 million pre‑tax impairment charge ($67 million after tax) on its PennEast Pipeline investment. Consequently, Southern Company Gas’s segment net income fell from $671 million in 2022 to $630 million in 2023, reflecting the loss of Sequent’s wholesale revenues and the associated tax and impairment impacts.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "SO_10k_2022.pdf",
          "target_page": 57,
          "pages": [
            55,
            56,
            57,
            58,
            59
          ]
        },
        "hop_2_rel": {
          "source_file": "SO_10k_2023.pdf",
          "target_page": 302,
          "pages": [
            300,
            301,
            302,
            303,
            304
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 40059,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 10234,
        "completion_tokens": 164,
        "total_tokens": 10398
      }
    },
    {
      "question_id": 8,
      "question": "How has Walmart's relationship with the Allswell brand evolved between 2023 and 2024, and what does this indicate about its strategic positioning within the company's private brand portfolio?",
      "original_answer": "In 2023, Walmart introduced the Allswell brand as part of its private brand offerings, indicating its initial entry into the market. By 2024, the brand was not only retained but explicitly listed among other mature private brands like 'bettergoods,' 'Equate,' and 'Great Value,' suggesting that Allswell has transitioned from a newly introduced brand to a more established part of Walmart's private label strategy. This evolution indicates that Allswell has likely gained traction and is being positioned as a core component of Walmart’s private brand portfolio.",
      "llm_answer": "Walmart’s relationship with the Allswell private‑brand label has shifted from a standalone brand to a more integrated component of its broader private‑brand portfolio. In fiscal 2025 the company highlighted Allswell as part of its “strategic merchandise units” and noted periodic revisions to how private‑brand categories are presented, indicating that Allswell’s assortment is being expanded and aligned with Walmart’s overall private‑brand strategy to drive value and maintain price competitiveness. This evolution reflects Walmart’s focus on consolidating and growing its own‑brand offerings—such as Allswell—across its U.S. segment to strengthen margin control and deepen customer loyalty within its omni‑channel ecosystem.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "WMT_10k_2023.pdf",
          "target_page": 7,
          "pages": [
            5,
            6,
            7,
            8,
            9
          ]
        },
        "hop_2_rel": {
          "source_file": "WMT_10k_2024.pdf",
          "target_page": 7,
          "pages": [
            5,
            6,
            7,
            8,
            9
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 48445,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 12340,
        "completion_tokens": 181,
        "total_tokens": 12522
      }
    },
    {
      "question_id": 8,
      "question": "How has the strategic importance of Embedded Processing products evolved from 2022 to 2023 based on TXN's revenue composition and strategic emphasis?",
      "original_answer": "In 2022, Embedded Processing products were described as one of two core segments, positioned alongside Analog as a key part of the business, though no specific revenue figures were disclosed. By 2023, Embedded Processing remained a strategic focus area, and notably, it partially offset a decline in Analog revenue, contributing to a $17.52 billion total revenue. This indicates that while Embedded Processing maintained its strategic importance, it also played a more pronounced compensatory role in the revenue mix during a year of overall revenue decline.",
      "llm_answer": "The strategic importance of Embedded Processing products increased from 2022 to 2023, as evidenced by its revenue growth (3% increase to $3.368 billion) and its role in offsetting declines in the Analog segment, which saw a 15% revenue drop. While Embedded Processing operating profit declined (20% decrease to $1.008 billion) due to higher manufacturing costs, its revenue growth and contribution to total revenue (from 16.2% in 2022 to 19.3% in 2023) underscore its rising strategic significance as a key growth driver amid broader segment challenges.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "TXN_10k_2022.pdf",
          "target_page": 32,
          "pages": [
            30,
            31,
            32,
            33,
            34
          ]
        },
        "hop_2_rel": {
          "source_file": "TXN_10k_2023.pdf",
          "target_page": 19,
          "pages": [
            17,
            18,
            19,
            20,
            21
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 42119,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 10751,
        "completion_tokens": 138,
        "total_tokens": 10889
      }
    },
    {
      "question_id": 9,
      "question": "How has Chevron's involvement in Angola LNG evolved from 2022 to 2024, and what does this indicate about its strategic positioning in the LNG market?",
      "original_answer": "In 2022, Chevron's involvement in Angola LNG was referenced in the context of its production volumes, indicating operational participation. By 2024, Chevron's stake in Angola LNG Limited was explicitly stated as a 36.4% interest, highlighting a more defined and structured investment approach. This evolution suggests a strategic shift toward securing a stable position in the LNG market through formalized equity stakes.",
      "llm_answer": "From 2022 to 2024, Chevron’s involvement in Angola LNG evolved from a 36.4 % equity stake in Angola LNG Limited (noted in the 2022 10‑K) to a continued 36.4 % interest reflected in the 2024 filings, with the investment balance decreasing slightly from $1,762 million in 2023 to $1,665 million in 2024 while equity earnings from the project also declined from $513 million (2023) to $405 million (2024). This reduction underscores a strategic shift toward higher‑margin, lower‑risk assets and a focus on core upstream and downstream operations, signaling Chevron’s intent to streamline its LNG portfolio and allocate capital to projects offering stronger returns.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CVX_10k_2022.pdf",
          "target_page": 8,
          "pages": [
            6,
            7,
            8,
            9,
            10
          ]
        },
        "hop_2_rel": {
          "source_file": "CVX_10k_2024.pdf",
          "target_page": 85,
          "pages": [
            83,
            84,
            85,
            86,
            87
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 63907,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 16197,
        "completion_tokens": 165,
        "total_tokens": 16362
      }
    },
    {
      "question_id": 9,
      "question": "How has the financial contribution and production status of the CH-53K program evolved between 2021 and 2024, and what does this indicate about its role within Lockheed Martin's RMS division?",
      "original_answer": "In 2021, the CH-53K program contributed to a $540 million increase in RMS net sales, driven by higher production volume alongside the Black Hawk and CRH programs. Additionally, it contributed to a $140 million increase in operating profit due to higher risk retirements and production volume. By 2024, the CH-53K program was described as being in a 'production ramp-up' phase, contributing $1.1 billion to higher product sales within RMS, indicating a shift from early-stage production and risk retirement to a more mature, high-volume production phase. This evolution shows that the CH-53K has transitioned from a developing program with growing financial impact to a key growth driver within RMS.",
      "llm_answer": "The CH‑53K heavy‑lift helicopter program has grown from a modest contribution in 2021 to a clearly defined revenue stream by 2024, with its sales and backlog now reported as a key part of Lockheed Martin’s Rotary and Mission Systems (RMS) segment.  In the 2024 filing the company notes “higher production volume on CH‑53K” and cites the program among the drivers of a 5 % rise in RMS product sales and a corresponding increase in RMS operating profit, underscoring that the CH‑53K has become a strategic, profit‑generating pillar within RMS and a major contributor to the division’s overall backlog and future earnings outlook.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "LMT_10k_2022.pdf",
          "target_page": 50,
          "pages": [
            48,
            49,
            50,
            51,
            52
          ]
        },
        "hop_2_rel": {
          "source_file": "LMT_10k_2024.pdf",
          "target_page": 34,
          "pages": [
            32,
            33,
            34,
            35,
            36
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 46467,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 11848,
        "completion_tokens": 156,
        "total_tokens": 12005
      }
    },
    {
      "question_id": 9,
      "question": "How did PayPal's use of macroeconomic factors in its loss curves for revolving consumer credit products evolve between 2022 and 2023?",
      "original_answer": "In 2022, PayPal applied macroeconomic factors such as forecasted trends in unemployment and benchmark credit card charge-off rates to its revolving consumer credit loss curves, using a single scenario deemed most appropriate for the economic conditions. By 2023, the company updated its expected credit loss models for revolving consumer receivables to include forecasted trends in household disposable income and retail e-commerce sales, replacing unemployment rates after the first quarter of 2023. This reflects a shift in the macroeconomic indicators used to inform loss curves for this segment.",
      "llm_answer": "Between 2022 and 2023, PayPal’s approach to incorporating macroeconomic factors into its loss curves for revolving consumer credit products evolved in two key ways: First, the forecast period for revolving products was extended from 2 years (in 2022) to approximately 5 years and 7 months (in 2023), reflecting a longer, more comprehensive outlook. Second, the macroeconomic inputs were updated to include household disposable income trends (in addition to unemployment and retail e‑commerce sales) and were sourced from a single external scenario, improving the alignment of loss‑rate projections with current economic conditions.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "PYPL_10k_2022.pdf",
          "target_page": 54,
          "pages": [
            52,
            53,
            54,
            55,
            56
          ]
        },
        "hop_2_rel": {
          "source_file": "PYPL_10k_2023.pdf",
          "target_page": 70,
          "pages": [
            68,
            69,
            70,
            71,
            72
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 9,
        "total_chars": 49526,
        "num_window_pages": 9,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 12599,
        "completion_tokens": 157,
        "total_tokens": 12757
      }
    },
    {
      "question_id": 9,
      "question": "How did Starbucks' foreign currency debt-related gains or losses included in AOCI change from 2023 to 2024, and what does this indicate about the company's exposure to foreign currency fluctuations?",
      "original_answer": "In 2023, Starbucks reported a foreign currency debt-related loss of $6.3 million included in OCI before reclassifications, while in 2024, the company reported a gain of $135.2 million in AOCI related to foreign currency debt. This indicates a significant shift from a loss to a substantial gain, suggesting a reversal in the company's exposure to foreign currency fluctuations over this period.",
      "llm_answer": "From the 2024 10‑K (pages 70‑71), the net pre‑tax gains/(losses) on cash‑flow hedges that remain in AOCI and are expected to be reclassified into earnings within the next 12 months total **$11.5 million** (foreign‑currency‑other) plus **$60.1 million** (coffee) plus **$2.0 million** (dairy) plus **$0.5 million** (cross‑currency swaps) = **≈ $74 million**.  \n\nIn the prior year (2023) the comparable amount was **$39.6 million** (foreign‑currency‑other) plus **$(78.1) million** (coffee) plus **$(1.8) million** (dairy) plus **$39.6 million** (foreign‑currency‑other) = **≈ $0 million** (essentially a net loss).  \n\nThus, the balance of gains/(losses) expected to be reclassified from AOCI into earnings **increased sharply** from near‑zero in 2023 to about **$74 million** in 2024. This jump signals that Starbucks’ foreign‑currency‑related hedges have become more effective at offsetting currency movements, and the company now expects a material amount of those hedging gains to flow into earnings over the next year, indicating heightened exposure to foreign‑currency fluctuations that is being actively managed through its hedging program.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "SBUX_10k_2023.pdf",
          "target_page": 70,
          "pages": [
            68,
            69,
            70,
            71,
            72
          ]
        },
        "hop_2_rel": {
          "source_file": "SBUX_10k_2024.pdf",
          "target_page": 70,
          "pages": [
            68,
            69,
            70,
            71,
            72
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 9,
        "total_chars": 50833,
        "num_window_pages": 9,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 12942,
        "completion_tokens": 286,
        "total_tokens": 13228
      }
    },
    {
      "question_id": 9,
      "question": "How did the fair value of energy-related derivatives for Alabama Power and Georgia Power change between 2022 and 2023, and what was the overall trend in their combined liabilities related to these derivatives?",
      "original_answer": "In 2022, Alabama Power reported a net liability of $144 million related to derivatives in non-designated hedging relationships, including energy-related derivatives. In 2023, Alabama Power had $15 million in assets and $110 million in liabilities related to energy-related derivatives, resulting in a net liability of $95 million. Georgia Power had $13 million in assets and $124 million in liabilities related to energy-related derivatives in 2023, yielding a net liability of $111 million. Therefore, the combined net liability for energy-related derivatives across both entities decreased from $255 million in 2022 to $206 million in 2023, indicating a reduction in exposure.",
      "llm_answer": "Based on the fair value measurements provided in the 2023 and 2022 financial statements, the fair value of energy-related derivatives for Alabama Power decreased from $110 million in 2022 to $15 million in 2023, while Georgia Power’s energy‑related derivative liability increased from $124 million in 2022 to $13 million in 2023. Consequently, the combined liabilities related to these derivatives declined overall, falling from $210 million (Alabama Power $178 million + Georgia Power $32 million) in 2022 to $28 million (Alabama Power $110 million + Georgia Power $13 million) in 2023.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "SO_10k_2022.pdf",
          "target_page": 327,
          "pages": [
            325,
            326,
            327,
            328,
            329
          ]
        },
        "hop_2_rel": {
          "source_file": "SO_10k_2023.pdf",
          "target_page": 281,
          "pages": [
            279,
            280,
            281,
            282,
            283
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 67770,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 17180,
        "completion_tokens": 146,
        "total_tokens": 17327
      }
    },
    {
      "question_id": 9,
      "question": "How did Walmart's financial relationship with Alert Innovation evolve between fiscal 2023 and fiscal 2024, particularly in terms of acquisition and subsequent disposition activities?",
      "original_answer": "In fiscal 2023, Walmart completed a $0.4 billion acquisition of Alert Innovation, bringing its ownership to approximately 100%. However, in fiscal 2024, Walmart sold and deconsolidated the Alert Innovation entity, signaling a complete exit from the investment. This represents a full evolution from acquisition to divestiture within a one-year span.",
      "llm_answer": "Between fiscal 2023 and fiscal 2024, Walmart moved from a 100 % stake in Alert Innovation to a full acquisition in fiscal 2023, then sold and de‑consolidated the entity in fiscal 2025. The 2024 fiscal year included a $3.5 billion payment to acquire Flipkart non‑controlling interests and settle PhonePe liabilities, while the 2023 fiscal year featured a $0.4 billion buyout of Massmart’s non‑controlling interest and the $0.4 billion purchase of Alert Innovation. Thus, the relationship evolved from acquiring a controlling interest in 2023 to holding a majority stake and later disposing of Alert Innovation by 2025, while simultaneously expanding its stake in other subsidiaries such as Flipkart.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "WMT_10k_2023.pdf",
          "target_page": 45,
          "pages": [
            43,
            44,
            45,
            46,
            47
          ]
        },
        "hop_2_rel": {
          "source_file": "WMT_10k_2024.pdf",
          "target_page": 44,
          "pages": [
            42,
            43,
            44,
            45,
            46
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 60204,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 15280,
        "completion_tokens": 174,
        "total_tokens": 15455
      }
    },
    {
      "question_id": 9,
      "question": "How did the regulatory approval status of Trodelvy evolve between 2022 and 2023, and what does this indicate about Gilead's oncology strategy?",
      "original_answer": "In 2022, Trodelvy was part of Gilead's marketed product portfolio and contributed to growth in the oncology franchise, though no specific regulatory updates were mentioned. By 2023, Trodelvy received both FDA and EC approvals for the treatment of adult patients with unresectable locally advanced or metastatic HR+/HER2- breast cancer who had received prior endocrine-based therapy and at least two additional systemic therapies. This regulatory progress indicates a strategic focus by Gilead on expanding the therapeutic applications of Trodelvy and strengthening its position in the oncology market, particularly in breast cancer treatment.",
      "llm_answer": "Between 2022 and 2023, the regulatory approval status of Trodelvy evolved from receiving U.S. FDA approval for a new indication in adult patients with unresectable locally advanced or metastatic HR+/HER2- breast cancer (approved in April 2023) and maintaining its existing approvals in metastatic triple-negative breast cancer (TNBC) and urothelial cancer, while also expanding its use in Europe and other regions. This indicates Gilead's oncology strategy is focused on broadening the therapeutic applications of Trodelvy across multiple solid tumor types, leveraging its antibody-drug conjugate platform to target Trop-2 expressing cancers, and using regulatory milestones to drive continued growth and market penetration in both hematologic and solid tumor oncology. The approvals underscore a strategic emphasis on expanding Trodelvy's clinical footprint to maximize revenue potential and address unmet needs in oncology.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "GILD_10k_2022.pdf",
          "target_page": 37,
          "pages": [
            35,
            36,
            37,
            38,
            39
          ]
        },
        "hop_2_rel": {
          "source_file": "GILD_10k_2023.pdf",
          "target_page": 39,
          "pages": [
            37,
            38,
            39,
            40,
            41
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 53076,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 13489,
        "completion_tokens": 231,
        "total_tokens": 13720
      }
    },
    {
      "question_id": 10,
      "question": "How has Simon Property Group's financial relationship with ABG evolved between 2023 and 2024, particularly in terms of capital transactions and strategic positioning?",
      "original_answer": "In 2023, Simon Property Group (SPG) engaged in multiple capital transactions with ABG, including recognizing a non-cash pre-tax gain of $36.4 million from a dilution of ownership in ABG during the second quarter and an additional $145.8 million gain in the third quarter due to further dilution from SPARC Group issuing equity. Additionally, SPG had a long-standing strategic partnership with ABG dating back to 2021, involving licensing ventures such as Forever 21, Brooks Brothers, and Eddie Bauer, which resulted in significant gains. In 2024, SPG no longer reported active capital transactions with ABG, such as gains from dilution or new equity investments. Instead, the 2024 filing only referenced historical transactions, such as the 2021 sale of a portion of SPG’s ABG interest for a pre-tax gain of $18.8 million and the 2022 acquisition of Reebok assets alongside a strategic partnership. This indicates a shift from active financial engagement and restructuring with ABG in 2023 to a more stable, historically referenced relationship in 2024.",
      "llm_answer": "Between 2023 and 2024, Simon Property Group's financial relationship with ABG shifted from active equity ownership to full exit. In Q1 2024, SPG sold its remaining stake in ABG for $1.2 billion in cash, realizing a $414.8 million pre-tax gain, and recorded $103.7 million in tax expense. This followed earlier partial sales in 2023 (including a $157.1 million gain in Q4 2023) and a capital transaction that diluted SPG's ownership from ~11.8% to ~9.6%, triggering a $10.3 million non-cash gain from deemed disposal. These transactions marked the complete exit from its ABG investment, with no remaining equity position after the Q1 2024 sale.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "SPG_10k_2023.pdf",
          "target_page": 72,
          "pages": [
            70,
            71,
            72,
            73,
            74
          ]
        },
        "hop_2_rel": {
          "source_file": "SPG_10k_2024.pdf",
          "target_page": 74,
          "pages": [
            72,
            73,
            74,
            75,
            76
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 50180,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 12770,
        "completion_tokens": 160,
        "total_tokens": 12931
      }
    },
    {
      "question_id": 10,
      "question": "How did Chevron's relationship with Chevron Phillips Chemical Company LLC evolve between 2022 and 2024, particularly in terms of financial reporting and investment value?",
      "original_answer": "In 2022, Chevron Phillips Chemical Company LLC was included in Chevron’s consolidated financial disclosures, specifically in Note 8 on page 70 of the 10-K filing, indicating it was a consolidated subsidiary. By 2024, the company was reported as an equity method investee under 'Downstream' in the Investments and Advances section, with a disclosed investment value of $8,571 million as of December 31, 2024, up from $7,765 million in 2023. This reflects a shift from full consolidation to an equity method investment, suggesting a structural or ownership change in Chevron’s relationship with the entity.",
      "llm_answer": "Between 2022 and 2024, Chevron's financial reporting reflects a strategic shift in how it accounts for and values its investments, particularly through its 50% ownership of Chevron Phillips Chemical Company LLC and other equity affiliates. In the 2024 consolidated financial statements, the company reports $8.571 billion in investments in downstream entities like Chevron Phillips Chemical, up from $7.765 billion in 2023, with a corresponding increase in equity in earnings to $608 million from $210 million in 2022—indicating stronger performance and valuation of these investments. Additionally, the company discloses that its investment in Chevron Phillips includes a $669 million loan to fund the Golden Triangle Polymers Project, underscoring the financial commitment and integration of these partnerships into its broader strategy. While the text does not explicitly detail the financial value of the Chevron Phillips relationship over the period, the growth in investment balance and equity earnings, alongside the strategic emphasis on lower-carbon ventures and planned capital allocation, suggests a continued and deepening integration of these partnerships into Chevron’s long-term value creation framework.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CVX_10k_2022.pdf",
          "target_page": 32,
          "pages": [
            30,
            31,
            32,
            33,
            34
          ]
        },
        "hop_2_rel": {
          "source_file": "CVX_10k_2024.pdf",
          "target_page": 84,
          "pages": [
            82,
            83,
            84,
            85,
            86
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 9,
        "total_chars": 48099,
        "num_window_pages": 9,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 12251,
        "completion_tokens": 304,
        "total_tokens": 12556
      }
    },
    {
      "question_id": 10,
      "question": "How did the status and financial impact of Meta's Facilities Consolidation Strategy evolve between the end of 2023 and the end of 2024?",
      "original_answer": "At the end of 2023, Meta had 'substantially completed' its facilities consolidation initiatives as part of the 2022 Restructuring, indicating the process was still ongoing. By the end of 2024, the company reported that it had 'completed the 2022 restructuring initiatives,' which included the facilities consolidation strategy, showing the process had reached full completion. Additionally, the 2024 disclosure included a financial summary of the 2022 Restructuring pre-tax charges across three years (2022–2024), indicating a retrospective quantification of the financial impact that was not explicitly detailed in 2023.",
      "llm_answer": "Between the end of 2023 and the end of 2024, Meta's Facilities Consolidation Strategy shifted from active implementation to completion, with the 2022 restructuring initiatives fully concluded by December 31, 2024. The company recorded $31 million in facilities consolidation charges during 2024 (all related to ongoing lease terminations), compared to $1.74 billion in 2023 and $4.10 billion in 2022, reflecting the strategy's wind-down phase. The financial impact diminished significantly as the company completed its office subleasing, early lease terminations, and facility abandonments, with no remaining accrued liabilities for these initiatives as of year-end 2024.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "META_10k_2023.pdf",
          "target_page": 104,
          "pages": [
            102,
            103,
            104,
            105,
            106
          ]
        },
        "hop_2_rel": {
          "source_file": "META_10k_2024.pdf",
          "target_page": 102,
          "pages": [
            100,
            101,
            102,
            103,
            104
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 40316,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 10299,
        "completion_tokens": 167,
        "total_tokens": 10467
      }
    },
    {
      "question_id": 10,
      "question": "How has Lockheed Martin's involvement in hypersonics programs evolved from 2022 to 2024, particularly in terms of strategic focus and program status?",
      "original_answer": "In 2022, Lockheed Martin's involvement in hypersonics programs was described as a key growth area that was dependent on U.S. Government authorization and funding, indicating that the programs were still in a development phase with uncertain future funding. By 2024, the company was actively producing hypersonic strike weapons under multiple programs with the U.S. Air Force and Army, showing a shift from a funding-dependent future initiative to an active production program. This evolution reflects a significant advancement in the maturity and strategic importance of hypersonics within Lockheed Martin's portfolio.",
      "llm_answer": "Lockheed Martin has steadily expanded its hypersonics portfolio from 2022 through 2024, integrating the effort across multiple business segments and linking it to its broader 21st Century Security strategy.  In the 2022 filing the company highlighted “advancing hypersonic capabilities” as part of its innovation pipeline, and by 2024 it was explicitly citing hypersonics among its key growth pillars—alongside AI/ML, autonomous systems, and CJADC2—while noting that the work is being pursued through both internal R&D and strategic partnerships.  Programmatically, the 2022 document referenced early‑stage development and technology demonstrations, whereas the 2024 filing reports that hypersonics projects are now moving toward production and fielding, with specific mentions of Army and Navy hypersonic strike weapons and the Transport Layer satellite constellation that supports proliferated hypersonic operations.  Thus, the company’s focus has shifted from exploratory R&D toward mature program development and eventual deployment, while maintaining a cross‑segment, partnership‑driven approach to accelerate fielding of hypersonic strike weapons.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "LMT_10k_2022.pdf",
          "target_page": 14,
          "pages": [
            12,
            13,
            14,
            15,
            16
          ]
        },
        "hop_2_rel": {
          "source_file": "LMT_10k_2024.pdf",
          "target_page": 4,
          "pages": [
            2,
            3,
            4,
            5,
            6
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 9,
        "total_chars": 49609,
        "num_window_pages": 9,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 12622,
        "completion_tokens": 288,
        "total_tokens": 12910
      }
    },
    {
      "question_id": 10,
      "question": "How did Southern Company's treatment and disclosure of energy-related derivatives evolve from 2022 to 2023, particularly in terms of their designation and financial impact?",
      "original_answer": "In 2022, Southern Company reported the pre-tax effects of unrealized derivative gains (losses) from energy-related derivatives that were designated as regulatory hedging instruments and deferred. By 2023, the company expanded its disclosure to include the pre-tax effects of energy-related derivatives not designated as hedging instruments on its statements of income, covering the years 2023, 2022, and 2021. This indicates a shift from focusing only on regulatory hedging instruments to providing a broader view of its energy-related derivative activities.",
      "llm_answer": "Based on the provided SEC 10-K pages, Southern Company's treatment of energy-related derivatives shifted significantly from 2022 to 2023 in terms of designation and financial impact. In 2023, the company designated specific energy derivatives as regulatory hedging instruments (with gains/losses recorded in regulatory assets/liabilities), while previously in 2022, such derivatives were primarily accounted for as non-designated hedging instruments (resulting in volatile pre-tax gains/losses recorded directly in income, such as the $59 million gain in natural gas revenues and $(65) million loss in cost of natural gas for 2022). This evolution reflects a move toward more structured regulatory accounting for hedges, reducing volatility in earnings and improving transparency of the financial impact, particularly in the balance sheet recognition of cumulative fair value adjustments (e.g., $235 million for Southern Company's long-term debt in 2023 versus $282 million in 2022). The shift also aligns with their enhanced disclosure of regulatory hedge accounting in the balance sheet, moving away from the material earnings volatility observed in 2022.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "SO_10k_2022.pdf",
          "target_page": 324,
          "pages": [
            322,
            323,
            324,
            325,
            326
          ]
        },
        "hop_2_rel": {
          "source_file": "SO_10k_2023.pdf",
          "target_page": 295,
          "pages": [
            293,
            294,
            295,
            296,
            297
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 65744,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 16665,
        "completion_tokens": 289,
        "total_tokens": 16954
      }
    },
    {
      "question_id": 10,
      "question": "How did Gilead's intellectual property strategy regarding Truvada evolve between 2022 and 2023, particularly in terms of patent disclosures?",
      "original_answer": "In 2022, Gilead highlighted the October 2020 loss of exclusivity of Truvada in the United States as a transitory headwind, indicating that the product was no longer protected under patent, which likely affected revenue. In 2023, Gilead provided structured disclosures regarding the patent expiration dates of its principal products, including Truvada, focusing on the actual or estimated expiration dates in the U.S. and the EU. This represents a shift from acknowledging a past loss of exclusivity to proactively disclosing future intellectual property timelines for key products.",
      "llm_answer": "Based on the provided SEC 10-K filings, Gilead's intellectual property strategy regarding Truvada (which contains tenofovir alafenamide [TAF]) evolved between 2022 and 2023 primarily through patent settlements and exclusivity extensions. In September 2022, Gilead settled U.S. patent litigation concerning TAF-protected products (Descovy, Vemlidy, Odefsey) with five generic manufacturers, securing agreements that likely extended market protection. Additionally, in January 2024 (referenced in the 2023 filing), the FDA granted pediatric exclusivity for Veklury, which extended all non-expired exclusivities by six months—though this pertains to Veklury, not Truvada. The 2022 and 2023 patent expiration tables show Truvada's U.S. patent term (as part of fixed-dose combinations) was set to expire in 2029 (with potential extensions noted in footnotes), but the key evolution was the 2022 settlement strategy to manage generic competition and maintain exclusivity through negotiated agreements rather than solely relying on patent term.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "GILD_10k_2022.pdf",
          "target_page": 37,
          "pages": [
            35,
            36,
            37,
            38,
            39
          ]
        },
        "hop_2_rel": {
          "source_file": "GILD_10k_2023.pdf",
          "target_page": 9,
          "pages": [
            7,
            8,
            9,
            10,
            11
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 53511,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 13596,
        "completion_tokens": 259,
        "total_tokens": 13855
      }
    },
    {
      "question_id": 11,
      "question": "How did SPG's use of the Supplemental Facility evolve between 2022 and 2024, particularly in terms of borrowing and repayment activities?",
      "original_answer": "In 2022, SPG borrowed $1.05 billion under the Supplemental Facility in January 2022, which was used to fund the early extinguishment of nine mortgages with a principal balance of $1.16 billion. This borrowing was repaid shortly after issuance. By 2024, SPG again utilized the Supplemental Facility, borrowing €750.0 million ($815.4 million U.S. dollar equivalent) in November 2023, which was repaid on November 17, 2023. Additionally, in 2024, SPG issued new senior unsecured notes to redeem other outstanding notes at maturity, indicating a shift in financing strategy. The evolution shows a continued reliance on the Supplemental Facility for short-term financing needs but with a more structured approach to repayment and refinancing.",
      "llm_answer": "Between 2022 and 2024, SPG’s use of the Supplemental Facility shifted from a borrowing tool to a repayment vehicle. In 2022, the Partnership drew $1.05 billion under the Supplemental Facility to refinance nine mortgages, then used proceeds from a $1.05 billion note issuance on January 12 2022 to fully repay that draw. Subsequent activity focused on retiring the Facility’s balances—most notably, the $1.0 billion, 2.00 % senior notes matured in September 2024 and the $900 million, 3.38 % notes were redeemed on October 1 2024—effectively eliminating outstanding borrowings under the Supplemental Facility by the end of 2024.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "SPG_10k_2022.pdf",
          "target_page": 73,
          "pages": [
            71,
            72,
            73,
            74,
            75
          ]
        },
        "hop_2_rel": {
          "source_file": "SPG_10k_2024.pdf",
          "target_page": 70,
          "pages": [
            68,
            69,
            70,
            71,
            72
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 51168,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 13010,
        "completion_tokens": 156,
        "total_tokens": 13167
      }
    },
    {
      "question_id": 11,
      "question": "How has the role of cash buffer needs in MetLife's capital management strategy evolved from 2022 to 2024, particularly in terms of liquidity levels and their impact on capital allocation decisions?",
      "original_answer": "In 2022, MetLife maintained a short-term liquidity position of $12.4 billion and a total liquid asset base of $223.0 billion, reflecting a strong buffer to meet business requirements under both normal and stress scenarios. The company emphasized its belief in having ample liquidity and highlighted active monitoring and adjustment of liquidity and capital plans. By 2024, the narrative shifted to a more cautious tone, noting that maintaining or increasing cash buffers could limit capital available for innovation, acquisitions, and shareholder returns. This indicates that while liquidity remained a strategic priority, the implications of holding larger cash buffers became more pronounced, potentially constraining other capital deployment opportunities.",
      "llm_answer": "From 2022 to 2024, MetLife’s capital management strategy has increasingly emphasized maintaining a robust cash buffer to ensure liquidity resilience amid heightened market volatility and regulatory scrutiny. While 2022 highlighted reliance on strong short-term liquidity ($12.4 billion) and liquid assets ($223 billion), the 2024 disclosures underscore a more conservative approach, with heightened focus on stress testing, collateral requirements, and the risks of forced asset sales or collateral calls under adverse market conditions. This evolution reflects a strategic shift toward prioritizing liquidity stability over aggressive capital allocation, ensuring sufficient buffers to meet obligations, support dividend payments, and sustain credit ratings despite evolving regulatory and market pressures.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MET_10k_2022.pdf",
          "target_page": 122,
          "pages": [
            120,
            121,
            122,
            123,
            124
          ]
        },
        "hop_2_rel": {
          "source_file": "MET_10k_2024.pdf",
          "target_page": 33,
          "pages": [
            31,
            32,
            33,
            34,
            35
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 52299,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 13309,
        "completion_tokens": 202,
        "total_tokens": 13511
      }
    },
    {
      "question_id": 11,
      "question": "How did Starbucks' exposure to 'Foreign currency - other' derivatives evolve between 2022 and 2023, particularly in terms of asset and liability classifications?",
      "original_answer": "In 2022, Starbucks reported 'Foreign currency - other' derivative liabilities of $0.3 million under accrued liabilities and no corresponding asset value. By 2023, the company had a derivative asset of $1.9 million under prepaid expenses and other current assets and a derivative liability of $4.7 million under accrued liabilities for the same category. This indicates a significant increase in exposure and a shift toward a more balanced treatment across asset and liability classifications.",
      "llm_answer": "Based on the provided SEC 10-K pages, Starbucks' exposure to \"Foreign currency - other\" derivatives evolved significantly between 2022 and 2023 in both asset and liability classifications. The fair value of the \"Foreign currency - other\" derivative asset decreased from $920 million (as of October 1, 2023) to $1,164 million (as of October 2, 2022) in the asset section, but the liability side also shifted: the derivative liability for \"Foreign currency - other\" decreased from $7.4 million (Oct 3, 2021) to $0.3 million (Oct 2, 2022) in the liability classifications, while in the most recent 2024 data (page 72), the derivative liability for \"Foreign currency - other\" was $4.7 million (accrued liabilities) and $2.5 million (other long-term liabilities) as of September 29, 2024. This indicates a reduction in liability exposure but a notable increase in the asset value from 2022 to 2023, with the asset peaking at $920 million in 2022 before declining slightly in 2023.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "SBUX_10k_2022.pdf",
          "target_page": 68,
          "pages": [
            66,
            67,
            68,
            69,
            70
          ]
        },
        "hop_2_rel": {
          "source_file": "SBUX_10k_2023.pdf",
          "target_page": 72,
          "pages": [
            70,
            71,
            72,
            73,
            74
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 71340,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 18059,
        "completion_tokens": 243,
        "total_tokens": 18303
      }
    },
    {
      "question_id": 11,
      "question": "How has The Coca-Cola Company's relationship with Coca-Cola FEMSA evolved from 2023 to 2024, particularly in terms of its strategic engagement and financial stake?",
      "original_answer": "In 2023, Coca-Cola FEMSA was one of The Coca-Cola Company's five largest independent bottling partners, operating in multiple countries including Mexico, Brazil, and Argentina, and collectively these top five bottlers accounted for 42% of Coca-Cola's worldwide unit case volume. By 2024, the relationship had evolved significantly, as Coca-Cola FEMSA transitioned from being a key bottler to becoming an equity method investee in which The Coca-Cola Company held a 28% ownership stake. This shift indicates a deeper financial commitment and alignment beyond the traditional bottler-concentrate supplier model.",
      "llm_answer": "From 2023 to 2024, The Coca-Cola Company’s strategic engagement with Coca-Cola FEMSA evolved through both equity investment and deeper operational integration. Coca-Cola FEMSA remains a key equity method investee, with the Company holding a 28% stake as of December 31, 2024, and continues to benefit from significant sales of beverage products to and through FEMSA, supporting its bottling operations globally. Financially, the Company’s involvement includes maintaining a strategic equity position and leveraging relationships that enhance system-wide efficiency, though no major structural changes in ownership or control were indicated during this period. Additionally, the Company’s use of financial instruments, including hedging strategies, reflects ongoing efforts to manage risks associated with its investments in bottling partners like FEMSA.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "KO_10k_2023.pdf",
          "target_page": 7,
          "pages": [
            5,
            6,
            7,
            8,
            9
          ]
        },
        "hop_2_rel": {
          "source_file": "KO_10k_2024.pdf",
          "target_page": 87,
          "pages": [
            85,
            86,
            87,
            88,
            89
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 55069,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 13990,
        "completion_tokens": 213,
        "total_tokens": 14203
      }
    },
    {
      "question_id": 11,
      "question": "How has Intel's strategic positioning of FPGAs evolved between 2022 and 2024, particularly in terms of their role within adjacent products and their broader production focus?",
      "original_answer": "In 2022, Intel positioned FPGAs as part of its 'adjacent products' within the Client Computing Group (CCG), Data Center Group (DCG), and Internet of Things Group (IOTG), indicating a supporting role within comprehensive platform solutions. By 2024, FPGAs were explicitly listed under direct product definitions, signaling a shift toward a more central production focus. This reflects a transformation in the strategic importance of FPGAs, moving from a supplementary role to a core product offering.",
      "llm_answer": "Intel's strategic positioning of FPGAs has evolved from being a standalone IP offering to a core component of its broader product portfolio and adjacent markets. By 2024, FPGAs are integrated into key platforms like the Infrastructure Processing Unit (IPU) and are critical to Intel's focus on AI, networking, and edge computing, supporting adjacent products such as Mobileye and NEX. This shift reflects a strategic pivot toward high-growth areas like AI and data center solutions, with FPGAs enabling flexible, programmable solutions that complement Intel's core CPU and accelerator offerings, while also being tied to initiatives like the CHIPS Act and Smart Capital investments.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "INTC_10k_2022.pdf",
          "target_page": 113,
          "pages": [
            111,
            112,
            113,
            114,
            115
          ]
        },
        "hop_2_rel": {
          "source_file": "INTC_10k_2024.pdf",
          "target_page": 102,
          "pages": [
            100,
            101,
            102,
            103,
            104
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 8,
        "total_chars": 70984,
        "num_window_pages": 8,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 17976,
        "completion_tokens": 170,
        "total_tokens": 18147
      }
    },
    {
      "question_id": 12,
      "question": "How did ConocoPhillips' financial activity related to the Lower 48 region evolve from 2022 to 2023, particularly in terms of asset acquisition and depreciation, depletion, and amortization expenses?",
      "original_answer": "In 2022, ConocoPhillips noted that purchases in the Lower 48 were driven by the Concho acquisition, indicating a strategic expansion in that region. The depreciation, depletion, amortization, and impairments expense for the Lower 48 was $4,854 million. In 2023, the company's expense for the same category in the Lower 48 increased to $5,729 million, showing a significant rise of $875 million. This increase suggests continued investment and asset utilization in the Lower 48 following the acquisition.",
      "llm_answer": "From 2022 to 2023, ConocoPhillips increased its Lower 48 proved reserves from 2,775 MMBOE to 2,775 MMBOE (essentially stable) and added significant extensions and discoveries, while depreciation, depletion and amortization (DD&A) expenses for the Lower 48 rose sharply—from $4,053 million in 2022 to $5,729 million in 2023—reflecting higher depletion of the added reserves and increased capital spending. This indicates that while reserve quantities held steady, the company’s DD&A expense for the region grew substantially due to both the added reserves and higher investment in development.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "COP_10k_2022.pdf",
          "target_page": 164,
          "pages": [
            162,
            163,
            164,
            165,
            166
          ]
        },
        "hop_2_rel": {
          "source_file": "COP_10k_2023.pdf",
          "target_page": 133,
          "pages": [
            131,
            132,
            133,
            134,
            135
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 84031,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 21243,
        "completion_tokens": 148,
        "total_tokens": 21391
      }
    },
    {
      "question_id": 12,
      "question": "How did Emerson's financial and strategic relationship with AspenTech evolve between 2022 and 2024, particularly in terms of ownership structure and financial impact on gross margins?",
      "original_answer": "In 2022, Emerson completed the acquisition of AspenTech, contributing approximately $6.0 billion in cash, paying $87.69 per share to Heritage AspenTech stockholders, and retaining $168 million in AspenTech's balance sheet. The acquisition positively impacted gross margins by 0.6 percentage points in 2023. By 2024, Emerson owned 55% of AspenTech on a fully diluted basis, and AspenTech continued to operate under its former name and ticker symbol 'AZPN.' The acquisition's financial impact persisted, contributing to a gross margin increase of 1.8 percentage points to 50.8% in 2024, despite a negative impact from acquisition-related inventory step-up amortization of $231 million, which reduced margins by 1.3 percentage points.",
      "llm_answer": "Between 2022 and 2024, Emerson’s ownership stake in AspenTech increased from 55% to approximately 57% following its 2022 acquisition of Heritage AspenTech, which created \"New AspenTech\" and gave Emerson a controlling interest. Financially, the integration of AspenTech (particularly the Test & Measurement acquisition) contributed to a 1.8 percentage point rise in gross margin in 2024, although this was partially offset by a $231 charge from acquisition-related inventory step-up amortization that negatively impacted margins by about 1.3 percentage points.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "EMR_10k_2022.pdf",
          "target_page": 57,
          "pages": [
            55,
            56,
            57,
            58,
            59
          ]
        },
        "hop_2_rel": {
          "source_file": "EMR_10k_2024.pdf",
          "target_page": 26,
          "pages": [
            24,
            25,
            26,
            27,
            28
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 41001,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 10480,
        "completion_tokens": 139,
        "total_tokens": 10619
      }
    },
    {
      "question_id": 12,
      "question": "How has the treatment and availability of shares under the 2015 Director Stock Plan evolved between 2022 and 2024, particularly in terms of share recovery and issuance mechanics?",
      "original_answer": "In 2022, the 2015 Director Stock Plan specified that each share issued under the plan reduced the number of shares remaining for issuance by one, and shares recovered from expired, forfeited, or cash-settled awards were again available for issuance. By 2024, the plan had a total of 35,395,894 shares authorized for issuance as of January 1, 2015, with 37,608,213 shares recovered for issuance between 2015 and 2024. However, 42,343,146 shares were covered by new awards and reinvested dividends since 2015, leaving 30,660,961 shares available for future issuance. This reflects a net reduction in available shares over time despite ongoing share recovery, indicating a shift in the balance between new issuances and recovered shares.",
      "llm_answer": "Between 2022 and 2024, the 2015 Director Stock Plan experienced a net increase in available shares due to recoveries, despite ongoing issuances. As detailed in the 2022 filing (page 334), \"Additional Shares recovered for issuance since January 1, 2015\" totaled 31,545,071, with 32,867,851 shares covered by new awards and reinvested dividends, leaving 34,073,114 shares remaining available for future issuance. By 2024, the 2024 equity compensation data (page 310) shows 30,660,961 shares remained available for future issuance under the plan, reflecting a reduction from the 2021 baseline due to new award grants and recoveries. Share recovery mechanisms—such as forfeited awards, cash settlements, or tendered shares for tax withholding—continued to replenish the pool, though issuance of new awards consistently utilized shares from this recovered reserve.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MET_10k_2022.pdf",
          "target_page": 335,
          "pages": [
            333,
            334,
            335,
            336,
            337
          ]
        },
        "hop_2_rel": {
          "source_file": "MET_10k_2024.pdf",
          "target_page": 311,
          "pages": [
            309,
            310,
            311,
            312,
            313
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 9,
        "total_chars": 41299,
        "num_window_pages": 9,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 10555,
        "completion_tokens": 214,
        "total_tokens": 10770
      }
    },
    {
      "question_id": 12,
      "question": "How has Starbucks' relationship with the Global Coffee Alliance evolved from fiscal year 2022 to fiscal year 2023 in terms of strategic emphasis and revenue contribution?",
      "original_answer": "In fiscal year 2022, the Global Coffee Alliance contributed to the growth of the Channel Development segment, which saw a $250 million increase in revenue driven by product sales and royalty income from the alliance. By fiscal year 2023, the strategic emphasis on the Global Coffee Alliance had evolved, with Starbucks explicitly highlighting its licensing relationship with Nestlé under the alliance as a core channel for product distribution, indicating a deeper integration and ongoing importance to Starbucks' global licensing and product expansion strategy. This evolution reflects a shift from viewing the alliance primarily as a revenue driver to positioning it as a strategic enabler of global product reach and brand extension.",
      "llm_answer": "From fiscal 2022 to fiscal 2023, Starbucks’ strategic emphasis shifted toward reinvesting in its partners and stores—evidenced by the temporary suspension of share repurchases in April 2022 to fund higher labor wages, expanded training, and technology initiatives—while maintaining its Global Coffee Alliance as a growing revenue stream. Although specific revenue contribution figures for the Alliance are not disclosed in the provided excerpts, the 2022 10‑K notes that “Other revenues” (which include royalty income and product sales from the Alliance) rose $216 million, underscoring its increasing importance to the company’s overall top line.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "SBUX_10k_2022.pdf",
          "target_page": 31,
          "pages": [
            29,
            30,
            31,
            32,
            33
          ]
        },
        "hop_2_rel": {
          "source_file": "SBUX_10k_2023.pdf",
          "target_page": 6,
          "pages": [
            4,
            5,
            6,
            7,
            8
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 9,
        "total_chars": 36951,
        "num_window_pages": 9,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 9463,
        "completion_tokens": 161,
        "total_tokens": 9625
      }
    },
    {
      "question_id": 12,
      "question": "How has NEE's financial stake and involvement in the Mountain Valley Pipeline evolved between 2022 and 2023, and what does this indicate about its investment strategy?",
      "original_answer": "In 2022, NEE's equity method investments totaled $6,159 million, and the Mountain Valley Pipeline was listed among key equity method investees alongside NEP OpCo, Sabal Trail, and Silver State South Solar, with NEE's interest ranging from approximately 32% to 55%. By 2023, NEE's total equity method investments were $6,156 million, with its interest in the principal entities, including the Mountain Valley Pipeline, ranging from approximately 32.8% to 52.6%. The shift from a broader range (32%–55%) in 2022 to a narrower range (32.8%–52.6%) in 2023 suggests a slight adjustment in ownership stakes, potentially reflecting a more refined or strategic investment posture. Additionally, in 2023, the Mountain Valley Pipeline was specifically noted in the context of Nonrecurring Fair Value Measurements, indicating a possible revaluation or change in financial treatment.",
      "llm_answer": "Between 2022 and 2023, NEE’s stake in the Mountain Valley Pipeline was fully written off, with an approximately $1.2 billion impairment charge recorded in 2023 that primarily reflects the write‑down of its investment in the pipeline. This impairment, disclosed in Note 4 (Nonrecurring Fair Value Measurements) and noted in the equity‑method investment summary, indicates that NEE has largely exited or de‑prioritized its investment in the project, shifting its capital focus toward renewable‑energy assets and away from the pipeline’s troubled expansion.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "NEE_10k_2022.pdf",
          "target_page": 96,
          "pages": [
            94,
            95,
            96,
            97,
            98
          ]
        },
        "hop_2_rel": {
          "source_file": "NEE_10k_2023.pdf",
          "target_page": 95,
          "pages": [
            93,
            94,
            95,
            96,
            97
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 62514,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 15854,
        "completion_tokens": 138,
        "total_tokens": 15992
      }
    },
    {
      "question_id": 12,
      "question": "How has Medtronic's InterStim Therapy product line evolved between 2022 and 2024 in terms of neurostimulator offerings and therapeutic indications?",
      "original_answer": "In 2022, InterStim therapy was described with a range of neurostimulators including InterStim II, InterStim Micro, and InterStim X, targeting symptoms of overactive bladder, urinary retention, and bowel incontinence. By 2024, the product line continued to include InterStim II and InterStim X, now specifically labeled as 'recharge-free' neurostimulators, and retained its focus on overactive bladder and urinary retention, but expanded its therapeutic scope to include 'chronic fecal incontinence.' This reflects a refinement in product positioning and a broadening of clinical applications over the two-year period.",
      "llm_answer": "Between 2022 and 2024, Medtronic's InterStim therapy product line evolved with the introduction of newer, more advanced neurostimulators, including the InterStim Micro (rechargeable) and InterStim X (recharge-free) systems, which expanded therapeutic indications to include chronic pain, Diabetic Peripheral Neuropathy (DPN), and overactive bladder. The company also advanced its closed-loop technology with the FDA approval of the Inceptiv SCS device in April 2024, enhancing treatment personalization for chronic pain. These innovations reflect a strategic shift toward integrated, AI-driven solutions within the Neuroscience segment, particularly under the AiBLE ecosystem, supporting broader adoption of neuromodulation therapies.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MDT_10k_2022.pdf",
          "target_page": 42,
          "pages": [
            40,
            41,
            42,
            43,
            44
          ]
        },
        "hop_2_rel": {
          "source_file": "MDT_10k_2024.pdf",
          "target_page": 39,
          "pages": [
            37,
            38,
            39,
            40,
            41
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 41100,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 10495,
        "completion_tokens": 183,
        "total_tokens": 10679
      }
    },
    {
      "question_id": 13,
      "question": "How did Simon Property Group's financial stake and strategic relationship with Authentic Brands Group (ABG) evolve from 2022 to 2024?",
      "original_answer": "In 2022, Simon Property Group held a 1.37% interest in ABG and had merged Forever 21 operations into SPARC Group after increasing its stake to 50% alongside ABG. By 2024, Simon sold a portion of its ABG stake, realizing a pre-tax gain of $18.8 million, and later acquired additional interests in ABG for $100 million in cash, indicating a dynamic evolution in their financial relationship.",
      "llm_answer": "From 2022 through 2024 Simon’s stake in Authentic Brands Group (ABG) was reduced via a series of capital transactions that generated multiple non‑cash gains. In 2022 the company sold a portion of its ABG interest for $65.5 million and later repurchased additional ABG equity for $100 million, while also recording a $159 million gain from exchanging its licensing‑venture interests for more ABG equity. In 2023 and early 2024 Simon sold further ABG holdings for $1.2 billion in cash, realizing a $414.8 million pretax gain, and its ownership fell to roughly 9.6 % after a dilution‑driven disposal that produced an additional $10.3 million non‑cash gain. By the end of 2024 Simon owned only about a 9 % non‑controlling interest in ABG, having previously held a larger stake, and the relationship shifted from a significant equity investment to a modest, passive holding.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "SPG_10k_2022.pdf",
          "target_page": 68,
          "pages": [
            66,
            67,
            68,
            69,
            70
          ]
        },
        "hop_2_rel": {
          "source_file": "SPG_10k_2024.pdf",
          "target_page": 74,
          "pages": [
            72,
            73,
            74,
            75,
            76
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 50280,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 12787,
        "completion_tokens": 217,
        "total_tokens": 13004
      }
    },
    {
      "question_id": 13,
      "question": "How has ConocoPhillips' investment activity in the Lower 48 region evolved from 2021 to 2023, particularly in terms of depreciation, depletion, and amortization expenses?",
      "original_answer": "ConocoPhillips' depreciation, depletion, and amortization (DD&A) expenses in the Lower 48 region increased from $4,067 million in 2021 to $5,729 million in 2023, indicating a significant rise in asset utilization or investment activity. This reflects a growing emphasis on the Lower 48 as a core operational area for the company.",
      "llm_answer": "ConocoPhillips' depreciation, depletion, and amortization (DD&A) expenses related to its Lower 48 operations have increased steadily from 2021 to 2023, reflecting higher capital investment and resource development in the region. According to the 2023 10-K (page 158), DD&A expenses for the Lower 48 segment were $5,729 million in 2023, up from $4,854 million in 2022 and $4,067 million in 2021. This upward trend aligns with increased capital expenditures in the Lower 48, which rose to $6,487 million in 2023 (page 135) from $3,129 million in 2021, driven by acquisitions and expanded drilling activities. The company's investments in the Lower 48, including the Concho and Shell Permian acquisitions, have directly contributed to higher DD&A expenses as it develops and produces natural gas liquids and other resources in the region.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "COP_10k_2022.pdf",
          "target_page": 158,
          "pages": [
            156,
            157,
            158,
            159,
            160
          ]
        },
        "hop_2_rel": {
          "source_file": "COP_10k_2023.pdf",
          "target_page": 133,
          "pages": [
            131,
            132,
            133,
            134,
            135
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 73297,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 18553,
        "completion_tokens": 208,
        "total_tokens": 18762
      }
    },
    {
      "question_id": 13,
      "question": "How has Verizon's (VZ) treatment and valuation approach for international bonds evolved from 2023 to 2024 based on their 10-K disclosures?",
      "original_answer": "In 2023, Verizon described that international bonds were valued using matrix prices with input from independent third-party valuation sources as part of the broader fixed income securities category. By 2024, international bonds were specifically itemized in a detailed table with a total value of $12 million, broken down into $10 million in Level 1 and $2 million in Level 2 inputs. This represents a shift from a general description in 2023 to a more transparent and segmented valuation approach in 2024, indicating a more refined disclosure strategy and possibly a more structured approach to valuing international bonds.",
      "llm_answer": "Verizon's treatment and valuation approach for international bonds in its pension and postretirement benefit plans remained consistent between 2023 and 2024, with no significant changes observed in the asset allocation or valuation methodology. In 2023, international bonds were valued using matrix prices with input from independent third-party valuation sources, and were classified as Level 2 assets. By 2024, the same valuation approach was maintained, with international bonds still classified as Level 2 assets, comprising $113 million in total international bond holdings at fair value as of December 31, 2024. The company continued to use independent third-party sources for valuation, and international bonds remained a minor component of the overall portfolio, representing approximately 2.7% of total pension plan assets ($113 million out of $4,146 million total investments at fair value). The allocation strategy emphasized liability hedging assets, but international bonds were not specifically highlighted as a separate category in the 2024 target allocation.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "VZ_10k_2023.pdf",
          "target_page": 93,
          "pages": [
            91,
            92,
            93,
            94,
            95
          ]
        },
        "hop_2_rel": {
          "source_file": "VZ_10k_2024.pdf",
          "target_page": 95,
          "pages": [
            93,
            94,
            95,
            96,
            97
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 51724,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 13149,
        "completion_tokens": 268,
        "total_tokens": 13417
      }
    },
    {
      "question_id": 13,
      "question": "How did Emerson's relationship with AspenTech evolve between 2022 and 2024, particularly in terms of financial stake and operational integration?",
      "original_answer": "In 2022, Emerson had a financial stake in AspenTech valued at $8,326 million, as shown in the balance sheet following acquisitions and currency adjustments. By 2024, Emerson's relationship had transformed significantly: it contributed the AspenTech Industrial Software Business along with $6.0 billion in cash to form 'New AspenTech,' retaining a 55% ownership stake in the newly structured company. This indicates a strategic restructuring rather than a simple financial investment, with increased operational integration and a formalized majority ownership.",
      "llm_answer": "Between 2022 and 2024, Emerson's relationship with AspenTech evolved from a 55% ownership stake (acquired in 2022) to a proposed full acquisition at $240 per share in November 2024, implying a $15.3 billion fully diluted market capitalization. Financially, Emerson's stake was valued at approximately $8.3 billion in goodwill and intangibles by 2022, with AspenTech contributing $7.3 billion in acquisition-related intangibles. Operationally, AspenTech's results were integrated into Emerson's segment reporting, with its software business (including the 2023 National Instruments acquisition) driving significant growth in Software and Control segment sales (+48% in 2024). The proposed acquisition would transition AspenTech from a partially owned subsidiary to a fully owned entity, though the deal remained subject to market conditions and regulatory review.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "EMR_10k_2022.pdf",
          "target_page": 61,
          "pages": [
            59,
            60,
            61,
            62,
            63
          ]
        },
        "hop_2_rel": {
          "source_file": "EMR_10k_2024.pdf",
          "target_page": 26,
          "pages": [
            24,
            25,
            26,
            27,
            28
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 39019,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 9975,
        "completion_tokens": 215,
        "total_tokens": 10190
      }
    },
    {
      "question_id": 13,
      "question": "How did Starbucks' position in interest rate swaps evolve between 2022 and 2023, particularly in terms of their classification and associated liabilities?",
      "original_answer": "In 2022, Starbucks had an interest rate swap classified as a long-term liability with a value of $34.0 million. By 2023, the company's interest rate swaps were categorized under both current and long-term liabilities, with $0.4 million listed under accrued liabilities (current) and $19.2 million under other long-term liabilities. This reflects a shift in the classification and a net decrease in the overall liability associated with interest rate swaps from $34.0 million in 2022 to $19.6 million in 2023.",
      "llm_answer": "Between 2022 and 2023, Starbucks' interest rate swap position evolved in classification and liability structure as reflected in the fair value disclosures. In the 2022 filing (page 66), interest rate swaps were disclosed as derivative liabilities under \"Other long-term liabilities\" with a cumulative fair value hedging adjustment of $(52.3) included in the carrying amount of the hedged long-term debt. By the 2023 filing (page 70), the same hedging relationship showed a revised carrying amount of the hedged item at $332.2 million (up from $1,047.7 million in 2022? Note: This appears to be a data inconsistency in the source, but the key evolution is in classification and reporting), with the cumulative fair value hedging adjustment now showing $(17.8) as of September 29, 2024 (previously $(52.3) as of October 2, 2022). The notional value of interest rate swaps designated in fair value hedging relationships increased significantly, with the 2023 filing (page 71) showing $350 million in fair value hedging instruments and $1,100 million in cross-currency swaps, while the 2022 filing (page 68) reported $22.7 million in interest rate swaps as of October 2, 2022. The liability classification remained under \"Other long-term liabilities\" for derivative liabilities, but the scale and specific components of the swaps shifted, including a notable increase in designated interest rate swaps tied to long-term debt hedging. No material transfers between fair value levels occurred, and the swaps continued to be classified as Level 2 inputs. The associated liabilities for these swaps were consistently reported in \"Other long-term liabilities\" with derivative liabilities of $43.2 million in 2023 (page 74) compared to $34.0 million in 2022 (page 69), reflecting growth in the swap portfolio. The evolution indicates a strategic expansion in the use of interest rate swaps for hedging long-term debt, with enhanced disclosure of fair value adjustments and reclassification impacts from AOCI to earnings.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "SBUX_10k_2022.pdf",
          "target_page": 68,
          "pages": [
            66,
            67,
            68,
            69,
            70
          ]
        },
        "hop_2_rel": {
          "source_file": "SBUX_10k_2023.pdf",
          "target_page": 72,
          "pages": [
            70,
            71,
            72,
            73,
            74
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 71340,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 18058,
        "completion_tokens": 502,
        "total_tokens": 18560
      }
    },
    {
      "question_id": 13,
      "question": "How did NextEra Energy Resources' financial commitment and involvement in the Mountain Valley Pipeline evolve from 2022 to 2023?",
      "original_answer": "In 2022, NextEra Energy Resources recorded an impairment charge of approximately $0.8 billion related to its equity method investment in the Mountain Valley Pipeline, which was fully written off due to the very low probability of pipeline completion. By 2023, despite the ongoing challenges, NEE's subsidiary NEER maintained a 32.8% equity investment in the joint venture and committed to a 20-year natural gas transportation agreement with an annual obligation of approximately $70 million, subject to the completion of construction.",
      "llm_answer": "From 2022 to 2023, NextEra Energy Resources’ involvement with the Mountain Valley Pipeline shifted from an active development participant to a largely withdrawn investor. In early 2022 the company recorded an approximately $0.8 billion (pre‑tax) impairment charge after determining that legal and regulatory hurdles made completion of the pipeline “very low probability,” effectively writing down its equity stake. By 2023 the company’s disclosures focus on contractual obligations and capital‑expenditure tables that reference the pipeline only as a minor, non‑core commitment (e.g., a $70 million‑per‑year gas‑transport agreement and a $1.065 billion joint‑venture liability), with no indication of further investment or development activity. In short, NEE’s financial commitment to the project was essentially frozen and its equity interest was fully impaired by 2022, leaving only limited, passive contractual obligations in 2023.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "NEE_10k_2022.pdf",
          "target_page": 92,
          "pages": [
            90,
            91,
            92,
            93,
            94
          ]
        },
        "hop_2_rel": {
          "source_file": "NEE_10k_2023.pdf",
          "target_page": 109,
          "pages": [
            107,
            108,
            109,
            110,
            111
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 69731,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 17650,
        "completion_tokens": 233,
        "total_tokens": 17883
      }
    },
    {
      "question_id": 13,
      "question": "How has The Coca-Cola Company's investment in equity and debt securities related to its captive insurance company reinsuring group annuity insurance contracts evolved between 2023 and 2024?",
      "original_answer": "In 2023, The Coca-Cola Company reported that its captive insurance company reinsuring group annuity insurance contracts held $1,643 million in equity and debt securities as part of its solvency capital funds. By 2024, this amount increased to $1,883 million, indicating a growth in the company's investment in these securities over the year.",
      "llm_answer": "The Company’s captive insurance subsidiary that reinsures group annuity contracts held $1.883 billion of equity securities and $1.643 billion of debt securities as of December 31 2024, compared with $1.643 billion of equity and $1.378 billion of debt securities at the end of 2023. This represents an increase in the captive’s solvency‑capital investment in marketable equity and debt securities between 2023 and 2024.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "KO_10k_2023.pdf",
          "target_page": 80,
          "pages": [
            78,
            79,
            80,
            81,
            82
          ]
        },
        "hop_2_rel": {
          "source_file": "KO_10k_2024.pdf",
          "target_page": 81,
          "pages": [
            79,
            80,
            81,
            82,
            83
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 56208,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 14282,
        "completion_tokens": 104,
        "total_tokens": 14387
      }
    },
    {
      "question_id": 13,
      "question": "How has Intel's approach to the Intel 4 process node evolved from 2022 to 2024, particularly in terms of production status and strategic positioning within Intel's product roadmap?",
      "original_answer": "In 2022, Intel was incurring higher period charges related to the ramp-up of Intel 4, indicating early-stage production challenges and investment. By 2024, Intel 4 had transitioned to high-volume manufacturing in Ireland and became the process node for the high-volume Intel Core Ultra processor, marking its strategic importance in Intel's product roadmap. This evolution shows a shift from initial investment and production ramp-up in 2022 to full-scale production and product integration by 2024.",
      "llm_answer": "Intel's Intel 4 node transitioned from limited 2023 client‑product shipments (Core Ultra Series 1) to high‑volume manufacturing in Ireland in 2024, positioning it as the foundation for upcoming 2025 products such as Panther Lake on Intel 18A. The company is leveraging Intel 4’s density and ~20% performance‑per‑watt gains to support its IDM 2.0 strategy and to fund further advances to Intel 3 and Intel 18A, while maintaining Intel 7 for the bulk of its 13th/14th‑gen Core processors. This evolution underscores Intel 4’s strategic role in bridging current revenue streams to the next generation of process‑technology leadership.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "INTC_10k_2022.pdf",
          "target_page": 24,
          "pages": [
            22,
            23,
            24,
            25,
            26
          ]
        },
        "hop_2_rel": {
          "source_file": "INTC_10k_2024.pdf",
          "target_page": 10,
          "pages": [
            8,
            9,
            10,
            11,
            12
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 43664,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 11145,
        "completion_tokens": 157,
        "total_tokens": 11302
      }
    },
    {
      "question_id": 14,
      "question": "How did Emerson's strategic relationship with AspenTech evolve between 2022 and 2024, particularly in terms of ownership structure and financial integration?",
      "original_answer": "In 2022, AspenTech was described as a strategic partner of Emerson, with no mention of ownership stakes or integration into Emerson's financials. By 2024, Emerson had merged its industrial software business with AspenTech, creating 'New AspenTech,' and retained a 55% ownership stake in the newly formed entity. This marked a significant shift from a partnership to a partially owned subsidiary structure. Additionally, AspenTech's financials were now integrated into Emerson's results, with the acquisition positively impacting gross margins by 0.6 percentage points in 2023 and influencing SG&A expenses in 2024 due to the deeper integration.",
      "llm_answer": "Between 2022 and 2024, Emerson's strategic relationship with AspenTech evolved from a 57% ownership stake (as noted in the 2022 filing) to a full acquisition proposal announced on November 5, 2024, offering $240 per share in cash for the remaining shares, valuing AspenTech at $15.3 billion fully diluted. This move followed Emerson's prior strategic investments, including the 2022 acquisition of Heritage AspenTech (which increased its stake to 55% at that time) and the 2023 divestiture of its majority stake in Climate Technologies (Copeland), which was later partially reversed through the June 2024 sale of its 40% non-controlling equity interest in Copeland to Blackstone for $1.5 billion, while retaining a note receivable. The 2024 proposal marks a shift from partial ownership to a full acquisition, integrating AspenTech entirely into Emerson's portfolio under a cash-and-debt financing structure.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "EMR_10k_2022.pdf",
          "target_page": 7,
          "pages": [
            5,
            6,
            7,
            8,
            9
          ]
        },
        "hop_2_rel": {
          "source_file": "EMR_10k_2024.pdf",
          "target_page": 26,
          "pages": [
            24,
            25,
            26,
            27,
            28
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 43284,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 11043,
        "completion_tokens": 227,
        "total_tokens": 11270
      }
    },
    {
      "question_id": 14,
      "question": "How has Intel's approach to the Intel 4 process node evolved from 2022 to 2024, particularly in terms of its manufacturing readiness and performance improvements?",
      "original_answer": "In 2022, Intel 4 was newly introduced as part of a restructured naming convention for manufacturing process nodes, signaling its position as a next-generation node following Intel 7. By 2024, Intel 4 had transitioned from a conceptual roadmap item to a fully realized product, with high-volume manufacturing ramped up in Ireland. Intel 4, as the company's first EUV lithography node, delivered a 20% performance-per-watt improvement over Intel 7 and was used in the production of the Intel Core Ultra processor, which began shipping in 2023. This represents a significant evolution from its initial naming in 2022 to full-scale production and performance quantification by 2024.",
      "llm_answer": "Intel's Intel 4 node has progressed from limited 2023 shipments of the Core Ultra Series 1 to high‑volume manufacturing in Ireland in 2024, delivering roughly 20 % better performance‑per‑watt versus Intel 7 and becoming a larger share of its 2025 product mix. The next‑generation Intel 18A (featuring RibbonFET and PowerVia) is slated for high‑volume production in 2025 with Panther Lake, promising further gains in performance and density over Intel 3, while Intel 3 remains in high‑volume use for Xeon 6 data‑center chips. This evolution reflects a shift from relying mainly on Intel 7 for most 2024 processors to leveraging Intel 4 for AI‑centric client CPUs and expanding EUV‑based nodes (Intel 4, Intel 3, and upcoming Intel 18A) to accelerate manufacturing readiness and performance improvements.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "INTC_10k_2022.pdf",
          "target_page": 115,
          "pages": [
            112,
            113,
            114,
            115,
            116
          ]
        },
        "hop_2_rel": {
          "source_file": "INTC_10k_2024.pdf",
          "target_page": 10,
          "pages": [
            8,
            9,
            10,
            11,
            12
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 58559,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 14865,
        "completion_tokens": 200,
        "total_tokens": 15066
      }
    },
    {
      "question_id": 14,
      "question": "How has the role and positioning of InterStim Micro evolved within MDT's Pelvic Health therapies between 2022 and 2024?",
      "original_answer": "In 2022, InterStim Micro was listed as one of several neurostimulators within MDT's Pelvic Health product portfolio, which also included InterStim X and InterStim II, used to treat overactive bladder, urinary retention, and fecal incontinence. By 2024, InterStim Micro was specifically highlighted as the rechargeable neurostimulator option, differentiated from the recharge-free InterStim X and InterStim II. This indicates a more defined strategic positioning of InterStim Micro as the rechargeable variant within the broader InterStim therapy lineup, with an emphasis on its continued global growth and adoption.",
      "llm_answer": "Between 2022 and 2024, InterStim Micro evolved from a niche, rechargeable neurostimulator within Medtronic’s Pelvic Health portfolio to a core growth driver highlighted in the company’s 2024 disclosures. It was explicitly positioned alongside InterStim X and InterStim II as a key platform for treating overactive bladder, urinary retention, and fecal incontinence, with explicit emphasis on “continued acceptance and growth” in the 2024 Neuroscience section (page 39). This marked a strategic shift from its 2022 focus (where it was listed as part of the broader Pelvic Health therapies without standalone emphasis) to a central, high-growth product within Medtronic’s neuromodulation ecosystem, directly tied to the expansion of the AiBLE integrated spine and pelvic health solutions.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MDT_10k_2022.pdf",
          "target_page": 10,
          "pages": [
            8,
            9,
            10,
            11,
            12
          ]
        },
        "hop_2_rel": {
          "source_file": "MDT_10k_2024.pdf",
          "target_page": 39,
          "pages": [
            37,
            38,
            39,
            40,
            41
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 39367,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 10055,
        "completion_tokens": 196,
        "total_tokens": 10251
      }
    },
    {
      "question_id": 15,
      "question": "How has the disclosure around the dilutive effect of LTIP Units evolved from 2022 to 2024, particularly in terms of material impact across reporting periods?",
      "original_answer": "In 2022, the disclosure stated that LTIP units were exchangeable for common stock and that no securities had a material dilutive effect for the years ended December 31, 2021, 2020, and 2019. By 2024, the disclosure simplified to state that no securities had a material dilutive effect for the years ended December 31, 2024, 2023, and 2022, without explicitly referencing the exchangeability of LTIP units into common stock. This indicates a reduction in the level of detail provided about LTIP units' conversion features, while maintaining the same conclusion regarding dilution impact.",
      "llm_answer": "The dilutive impact of LTIP Units was disclosed in the 2022 and 2024 10‑K filings as “potentially dilutive securities” that were examined for material effect, but in each year the filings concluded that “no securities had a material dilutive effect” and therefore no adjustments to earnings per share or per unit were required.  Consequently, the disclosure of LTIP Units as a potentially dilutive element remained consistent from 2022 through 2024, with no material impact reported in any of the comparative periods.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "SPG_10k_2022.pdf",
          "target_page": 115,
          "pages": [
            113,
            114,
            115,
            116,
            117
          ]
        },
        "hop_2_rel": {
          "source_file": "SPG_10k_2024.pdf",
          "target_page": 114,
          "pages": [
            112,
            113,
            114,
            115,
            116
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 51175,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 13019,
        "completion_tokens": 129,
        "total_tokens": 13148
      }
    },
    {
      "question_id": 15,
      "question": "How has MetLife's approach to managing cash buffer needs in relation to stock repurchases evolved from 2022 to 2024, particularly in terms of remaining repurchase authorization and liquidity considerations?",
      "original_answer": "In 2022, MetLife had $1.5 billion remaining under its $3.0 billion common stock repurchase authorization as of December 31, 2021, indicating a significant but partially utilized capacity for returning capital to shareholders. By 2024, the company emphasized increased caution around cash buffer needs, noting that maintaining or increasing liquidity buffers could limit capital available for repurchases, acquisitions, and innovation. This reflects a shift from a more active repurchase posture in 2022 to a more conservative liquidity strategy in 2024, influenced by regulatory, market, and internal capital considerations.",
      "llm_answer": "From 2022 through 2024 MetLife’s cash‑buffer strategy has shifted from a more aggressive share‑repurchase posture to a more conservative stance driven by heightened liquidity and regulatory constraints.  In 2022 the company still had roughly $1.5 billion of repurchase authorization remaining, but by 2024 it emphasized maintaining a larger cash buffer to meet debt‑service, dividend and regulatory capital needs, limiting further stock buy‑backs.  Consequently, the remaining authorization under its announced $3 billion program was largely exhausted, and the firm now prioritizes preserving liquidity over pursuing additional repurchases.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MET_10k_2022.pdf",
          "target_page": 50,
          "pages": [
            48,
            49,
            50,
            51,
            52
          ]
        },
        "hop_2_rel": {
          "source_file": "MET_10k_2024.pdf",
          "target_page": 33,
          "pages": [
            31,
            32,
            33,
            34,
            35
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 9,
        "total_chars": 39487,
        "num_window_pages": 9,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 10107,
        "completion_tokens": 160,
        "total_tokens": 10267
      }
    },
    {
      "question_id": 15,
      "question": "How did Starbucks' foreign currency - other derivative asset and liability positions evolve from fiscal year 2022 to 2023, and what specific changes occurred in their balance sheet classifications?",
      "original_answer": "In fiscal year 2022, Starbucks reported foreign currency - other derivative assets of $103.9 million recognized in OCI before reclassifications and $22.0 million reclassified from AOCI to earnings. By fiscal year 2023, the foreign currency - other derivative assets on the balance sheet were reported as $1.9 million in prepaid expenses and other current assets and $1.7 million in other long-term assets as of October 1, 2023, while derivative liabilities were $4.7 million in accrued liabilities and $4.1 million in other long-term liabilities. This represents a significant reduction in asset positions compared to the prior year, with a shift in balance sheet classification.",
      "llm_answer": "From fiscal 2022 to 2023, Starbucks’ foreign‑currency derivative assets shifted from $32.0 million (prepaid expenses) and $22.9 million (other long‑term assets) in 2022 to $1.9 million (prepaid) and $1.7 million (other long‑term) in 2023, while foreign‑currency derivative liabilities fell from $2.0 million (accrued) and $‑ million (other long‑term) to $2.5 million (accrued) and $0.1 million (other long‑term), reflecting a net reduction in both asset and liability balances. Additionally, the balance‑sheet classification of these derivatives remained within “prepaid expenses and other current assets” for assets and “accrued liabilities”/“other long‑term liabilities” for liabilities in both years.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "SBUX_10k_2022.pdf",
          "target_page": 67,
          "pages": [
            65,
            66,
            67,
            68,
            69
          ]
        },
        "hop_2_rel": {
          "source_file": "SBUX_10k_2023.pdf",
          "target_page": 72,
          "pages": [
            70,
            71,
            72,
            73,
            74
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 66863,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 16949,
        "completion_tokens": 175,
        "total_tokens": 17125
      }
    },
    {
      "question_id": 16,
      "question": "How has Procter & Gamble's global cash management strategy evolved in relation to its restructuring activities and corporate-level financial performance between fiscal 2022 and fiscal 2024?",
      "original_answer": "In fiscal 2022, Procter & Gamble incurred restructuring costs within its historical range of $250 to $500 million before tax, with $147 million in restructuring accruals as of June 30, 2022. Corporate net earnings improved by $872 million to $485 million, partly due to tax benefits and lower restructuring charges. By fiscal 2024, restructuring costs increased significantly to $659 million before tax, including $216 million in non-cash foreign currency translation losses. Corporate net earnings decreased by $1.0 billion, largely due to the $1.4 billion impairment charge of the Gillette intangible asset and incremental restructuring charges. This indicates a shift toward more aggressive restructuring actions, particularly in Enterprise Markets like Nigeria, which impacted both cash flow and earnings. The global cash management strategy remained focused on liquidity and tax considerations, but faced increased pressure from these restructuring activities and impairment charges.",
      "llm_answer": "Between fiscal 2022 and fiscal 2024, Procter & Gamble’s global cash‑management strategy has been closely tied to its restructuring and productivity initiatives, which have helped sustain strong cash generation despite shifting market dynamics.  The company’s cash flow trends show that operating cash flow rose sharply—from $16.7 billion in 2022 to $19.8 billion in 2024—driven by higher net earnings, improved working‑capital efficiency, and the benefits of extended payment terms and supply‑chain financing.  At the same time, restructuring costs of roughly $660 million were incurred in 2024 (including $216 million of non‑cash currency‑translation losses), reflecting ongoing portfolio rationalizations that support margin expansion and free cash flow growth, while debt levels remain manageable and credit ratings stay stable.  This integrated approach underpins the company’s solid liquidity and its ability to fund dividends, share repurchases and strategic investments.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "PG_10k_2022.pdf",
          "target_page": 29,
          "pages": [
            27,
            28,
            29,
            30,
            31
          ]
        },
        "hop_2_rel": {
          "source_file": "PG_10k_2024.pdf",
          "target_page": 26,
          "pages": [
            24,
            25,
            26,
            27,
            28
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 59603,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 15131,
        "completion_tokens": 244,
        "total_tokens": 15375
      }
    },
    {
      "question_id": 16,
      "question": "How has NVIDIA's positioning and application of Omniverse evolved between 2022 and 2023, particularly in terms of its integration with enterprise solutions and simulation technologies?",
      "original_answer": "In 2022, NVIDIA Omniverse was positioned primarily as a virtual world simulation and collaboration platform for 3D workflows, emphasizing its availability as a software subscription for enterprise use and free for individuals. It was highlighted in use cases such as virtual car showrooms, surgical training, and architectural walkthroughs, and was integrated with DRIVE Sim software for automotive simulation and validation. By 2023, Omniverse had evolved into a more robust development platform and operating system for building virtual world simulation applications. It was increasingly tied to industrial enterprises for digitalizing complex physical assets and processes, including digital twins of factories and real-time 3D product configurators. Additionally, it was more explicitly linked to NVIDIA's accelerated computing infrastructure both on-premises and in the cloud, indicating a broader integration with enterprise-grade simulation and AI workflows.",
      "llm_answer": "Between 2022 and 2023, NVIDIA deepened Omniverse’s integration into enterprise workflows by embedding it as a core platform for building digital twins and simulation-driven applications—highlighted by its adoption in automotive (e.g., DRIVE Sim for autonomous vehicle testing) and industrial digitalization. The company expanded Omniverse’s enterprise offering (subscription model) and strengthened its ecosystem through partnerships, enabling real-time 3D collaboration and simulation across industries like manufacturing, architecture, and automotive, while leveraging its AI and GPU acceleration stack to enhance virtual world capabilities. This positioned Omniverse as a strategic extension of NVIDIA’s broader platform strategy, linking simulation, AI, and enterprise computing.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "NVDA_10k_2022.pdf",
          "target_page": 9,
          "pages": [
            7,
            8,
            9,
            10,
            11
          ]
        },
        "hop_2_rel": {
          "source_file": "NVDA_10k_2023.pdf",
          "target_page": 6,
          "pages": [
            4,
            5,
            6,
            7,
            8
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 7,
        "total_chars": 40893,
        "num_window_pages": 7,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 10451,
        "completion_tokens": 195,
        "total_tokens": 10647
      }
    },
    {
      "question_id": 17,
      "question": "How did AMT's financial commitments related to communications sites evolve from 2023 to 2024, particularly in terms of anticipated spending and future obligations?",
      "original_answer": "In 2023, AMT anticipated spending approximately $450 million related to data center assets as part of its construction plans for 2,500 to 3,500 communications sites globally. By 2024, the company disclosed a much larger financial commitment, with an estimated undiscounted future cash outlay of $4.5 billion for asset retirement obligations tied to leased sites hosting communications infrastructure. This indicates a significant increase in long-term financial exposure related to communications sites, shifting from near-term capital allocation planning in 2023 to a more mature and substantial obligation structure in 2024.",
      "llm_answer": "From 2023 to 2024, AMT's financial commitments related to communications sites shifted toward reduced near-term borrowing and increased focus on debt repayment and contractual obligations. While the company maintained significant available liquidity under its credit facilities ($7.6B net available as of 2023), it repaid $3.1B of revolving indebtedness during 2024 and fully settled the 2021 EUR Three Year Delayed Draw Term Loan in May 2024. The company's capital expenditure plans remained stable at $1.5B–$1.65B annually, with $450M allocated to data center assets, but emphasized using cash flows to fund distributions ($3.2B expected in 2025), repay debt, and maintain REIT qualification rather than new infrastructure commitments. (Based on synthesis of pages 47–58, particularly liquidity disclosures, debt repayment activities, capital expenditure ranges, and cash flow allocations.)",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AMT_10k_2023.pdf",
          "target_page": 49,
          "pages": [
            47,
            48,
            49,
            50,
            51
          ]
        },
        "hop_2_rel": {
          "source_file": "AMT_10k_2024.pdf",
          "target_page": 56,
          "pages": [
            54,
            55,
            56,
            57,
            58
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 55460,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 14089,
        "completion_tokens": 223,
        "total_tokens": 14312
      }
    },
    {
      "question_id": 17,
      "question": "How has ExxonMobil's characterization of asset divestitures in relation to strategic objectives evolved between 2023 and 2024, particularly in terms of the language used to describe the proceeds from these transactions?",
      "original_answer": "In 2023, ExxonMobil described proceeds from asset sales as part of 'sales of subsidiaries, property, plant and equipment, and sales and returns of investments,' emphasizing a disciplined review process to ensure assets align with strategic goals. By 2024, the company refined its language, referring more broadly to 'proceeds from asset sales and returns of investments,' maintaining the same strategic alignment rationale but streamlining the description. This evolution indicates a more consolidated framing of divestiture proceeds without specific mention of subsidiaries or equipment sales, suggesting a possible shift toward a more generalized narrative around asset management.",
      "llm_answer": "ExxonMobil's language describing proceeds from asset divestitures has shifted from emphasizing \"proceeds associated with sales of subsidiaries, property, plant and equipment\" in 2023 (page 39) to framing them as part of \"Cash flow from operations and asset sales\" in 2024 (page 36), reflecting a strategic integration of divestment proceeds into broader cash flow metrics. The 2024 filing also explicitly links these proceeds to structural cost savings and capital efficiency, aligning with the company's updated earnings driver terminology that highlights \"Advantaged Volume Growth\" and \"Structural Cost Savings\" as key performance drivers.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "XOM_10k_2023.pdf",
          "target_page": 39,
          "pages": [
            37,
            38,
            39,
            40,
            41
          ]
        },
        "hop_2_rel": {
          "source_file": "XOM_10k_2024.pdf",
          "target_page": 36,
          "pages": [
            34,
            35,
            36,
            37,
            38
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 43866,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 11205,
        "completion_tokens": 160,
        "total_tokens": 11365
      }
    },
    {
      "question_id": 17,
      "question": "How has Comcast's financial exposure to Universal Beijing Resort evolved from 2022 to 2023, based on the changes in consolidated asset and liability amounts?",
      "original_answer": "In 2022, Comcast's consolidated balance sheet included $9.7 billion in assets and $8.1 billion in liabilities related to Universal Beijing Resort. By 2023, these figures had decreased to $7.8 billion in assets and $7.2 billion in liabilities. This indicates a reduction in both the scale of assets and liabilities associated with the Universal Beijing Resort, suggesting either asset depreciation, debt repayment, or a strategic reduction in the resort's financial footprint within Comcast's consolidated statements.",
      "llm_answer": "Based on the provided financial disclosures, Comcast's financial exposure to Universal Beijing Resort decreased from 2022 to 2023 as evidenced by the consolidation of its assets and liabilities. In the 2022 consolidated balance sheet (page 104), Universal Beijing Resort's assets and liabilities were reported at $9.7 billion and $8.1 billion, respectively. By 2023, these figures were reduced to $7.8 billion in assets and $7.2 billion in liabilities (page 87), reflecting the impact of debt repayments and operational changes. This reduction indicates a lower financial exposure, as the resort's consolidated liabilities decreased by approximately $900 million while assets declined by about $1.9 billion over the same period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CMCSA_10k_2022.pdf",
          "target_page": 104,
          "pages": [
            102,
            103,
            104,
            105,
            106
          ]
        },
        "hop_2_rel": {
          "source_file": "CMCSA_10k_2023.pdf",
          "target_page": 87,
          "pages": [
            85,
            86,
            87,
            88,
            89
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 9,
        "total_chars": 54094,
        "num_window_pages": 9,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 13749,
        "completion_tokens": 182,
        "total_tokens": 13931
      }
    },
    {
      "question_id": 17,
      "question": "How has the nature of Customer Demand Volatility as a risk factor for Caterpillar evolved between 2023 and 2024, particularly in relation to its impact on financial performance and supply chain stability?",
      "original_answer": "In 2023, Customer Demand Volatility was described as being primarily driven by economic uncertainties, including the lingering effects of a global pandemic, which led to inflationary pressures, supply chain disruptions, and labor inefficiencies, all of which limited Caterpillar's ability to meet customer demand. By 2024, while the risk remained, the focus shifted slightly to include broader commodity price changes, material price increases, and significant disruptions to supply chains or shortages of labor and material as key contributors to financial performance risks. This evolution indicates a broadening of the risk profile to include more systemic supply-side challenges alongside demand volatility.",
      "llm_answer": "The nature of Customer Demand Volatility as a risk factor has shifted from a general macroeconomic sensitivity in 2023 to a more pronounced, supply‑chain‑driven concern in 2024.  In the 2024 filing, Caterpillar explicitly links volatile demand to potential excess inventories, higher operating costs, and the need to adjust production schedules and supplier purchases quickly, underscoring that such volatility can directly impair financial performance and strain supply‑chain stability.  This evolution reflects a heightened awareness that abrupt shifts in customer orders now have a more immediate and material impact on both revenue and operational resilience.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CAT_10k_2023.pdf",
          "target_page": 13,
          "pages": [
            11,
            12,
            13,
            14,
            15
          ]
        },
        "hop_2_rel": {
          "source_file": "CAT_10k_2024.pdf",
          "target_page": 13,
          "pages": [
            11,
            12,
            13,
            14,
            15
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 49489,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 12607,
        "completion_tokens": 165,
        "total_tokens": 12773
      }
    },
    {
      "question_id": 17,
      "question": "How did the fair value and valuation methodology of Net derivative assets (liabilities) evolve from 2022 to 2024?",
      "original_answer": "In 2022, the fair value of Net derivative assets (liabilities) was $19 million as of December 31, 2021, with changes in value primarily tied to derivative activity such as issuances ($68 million), settlements ($-37 million), and transfers ($6 million). By 2024, the fair value had increased significantly to $58 million as of December 31, 2023. Additionally, the valuation methodology shifted from being primarily based on realized and unrealized gains/losses reported in net income to being assessed using discounted cash flows with a focus on observable inputs like swap rates (3-5%, weighted average of 4%). This indicates both a material increase in value and a methodological shift toward more transparent and observable valuation techniques.",
      "llm_answer": "The fair‑value hierarchy for net derivative assets (liabilities) shows a Level 3 balance of $58 million at the beginning of 2024, a $15 million loss recorded in net income, and a $2 million transfer out of Level 3, resulting in an ending Level 3 fair‑value balance of $69 million as of December 31, 2024. This reflects the evolution from $58 million (Level 3) in 2023 to $69 million (Level 3) in 2024.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "COF_10k_2022.pdf",
          "target_page": 220,
          "pages": [
            218,
            219,
            220,
            221,
            222
          ]
        },
        "hop_2_rel": {
          "source_file": "COF_10k_2024.pdf",
          "target_page": 217,
          "pages": [
            215,
            216,
            217,
            218,
            219
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 107446,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 27076,
        "completion_tokens": 100,
        "total_tokens": 27176
      }
    },
    {
      "question_id": 17,
      "question": "How has NVIDIA's GeForce NOW cloud gaming offering evolved from 2022 to 2023 in terms of its positioning within the company's broader GPU and cloud platform ecosystem?",
      "original_answer": "In 2022, GeForce NOW was positioned as a cloud platform enabling gamers to access interactive graphics applications from nearly any device, emphasizing its role in extending NVIDIA’s graphics leadership and ecosystem reach. It was mentioned alongside other cloud platforms like vGPU for enterprise use. By 2023, GeForce NOW was more specifically integrated into the broader NVIDIA accelerated computing platform narrative, and its positioning shifted to emphasize cloud gaming as part of a suite of GPU-driven services, including AI training platforms like NVIDIA DGX Cloud. This evolution reflects a more strategic alignment of GeForce NOW with NVIDIA’s expanding cloud infrastructure and software offerings, particularly in the context of gaming as a service.",
      "llm_answer": "From 2022 to 2023, NVIDIA evolved GeForce NOW from a niche cloud‑gaming service into a core pillar of its broader GPU‑and‑cloud ecosystem. The offering was positioned alongside the company’s full‑stack accelerated‑computing platform—leveraging the same RTX‑based graphics and AI technologies (e.g., DLSS, ray tracing) and the Omniverse/DRIVE software stack—so that cloud gaming could benefit from the company’s AI‑enhanced graphics pipeline, developer tools, and enterprise‑grade cloud infrastructure (DGX Cloud, vGPU, and partnerships with CSPs). This integration reinforced GeForce NOW’s role as a showcase for NVIDIA’s GPU and AI leadership while expanding its reach into new markets such as enterprise visualization and autonomous‑vehicle simulation.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "NVDA_10k_2022.pdf",
          "target_page": 11,
          "pages": [
            9,
            10,
            11,
            12,
            13
          ]
        },
        "hop_2_rel": {
          "source_file": "NVDA_10k_2023.pdf",
          "target_page": 6,
          "pages": [
            4,
            5,
            6,
            7,
            8
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 7,
        "total_chars": 40893,
        "num_window_pages": 7,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 10448,
        "completion_tokens": 188,
        "total_tokens": 10636
      }
    },
    {
      "question_id": 17,
      "question": "How did the revenue performance of Inlyta evolve between 2022 and 2023, and what factors influenced this change?",
      "original_answer": "In 2022, Inlyta had total global revenue of $1,003 million, while in 2023, its revenue increased to $1,036 million, representing a 3% growth. This growth was primarily driven by continued adoption of Inlyta in combination with immune checkpoint inhibitors for the first-line treatment of advanced renal cell carcinoma (RCC) in the U.S., and growth in emerging markets. However, this increase was partially offset by lower volumes and lower net prices in certain European markets.",
      "llm_answer": "Inlyta’s revenue grew modestly from $1,003 million in 2022 to $1,036 million in 2023, a 3% worldwide increase (4% in the U.S. and 7% internationally). This growth was driven by continued adoption of Inlyta combined with immune‑checkpoint inhibitors for first‑line treatment of advanced renal cell carcinoma, especially in emerging markets, while the upside was tempered by lower volumes and pricing pressure in certain European markets.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "PFE_10k_2022.pdf",
          "target_page": 15,
          "pages": [
            13,
            14,
            15,
            16,
            17
          ]
        },
        "hop_2_rel": {
          "source_file": "PFE_10k_2023.pdf",
          "target_page": 44,
          "pages": [
            42,
            43,
            44,
            45,
            46
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 9,
        "total_chars": 72873,
        "num_window_pages": 9,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 18430,
        "completion_tokens": 109,
        "total_tokens": 18539
      }
    },
    {
      "question_id": 18,
      "question": "How has the treatment and valuation of network location intangibles evolved from 2023 to 2024, particularly in terms of amortization assumptions and impairment review processes?",
      "original_answer": "In 2023, the company amortized network location intangibles on a straight-line basis over their estimated useful lives, with a weighted average amortization period of 15 years as of December 31, 2023. The focus was on the relationship between these intangibles and tower assets, particularly in terms of potential revenue growth from leasing excess capacity. By 2024, the company expanded its disclosures to include a more detailed impairment review process for network location intangibles, assessing impairment on an individual tower basis and identifying specific triggers such as lack of tenant leases or expenses exceeding revenues. Additionally, while amortization remained a key treatment, the company's broader discussion of asset retirement obligations in 2024, including a $470 million increase in liability due to revised settlement dates, indirectly impacts the valuation and useful life assumptions for these intangible assets.",
      "llm_answer": "From 2023 to 2024, American Tower revised its treatment of network location intangibles by extending the estimated useful lives of tower assets from 20 to 30 years and modifying depreciation/amortization schedules accordingly, which reduced depreciation and amortization expense by approximately $730 million for 2024. The company also updated its impairment review process for these intangibles, assessing recoverability on a tower‑by‑tower basis using projected undiscounted cash flows and fair‑value measurements, and recorded impairment charges when carrying amounts exceeded fair value.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AMT_10k_2023.pdf",
          "target_page": 103,
          "pages": [
            101,
            102,
            103,
            104,
            105
          ]
        },
        "hop_2_rel": {
          "source_file": "AMT_10k_2024.pdf",
          "target_page": 96,
          "pages": [
            94,
            95,
            96,
            97,
            98
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 51189,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 13026,
        "completion_tokens": 147,
        "total_tokens": 13174
      }
    },
    {
      "question_id": 18,
      "question": "How has ExxonMobil's strategic emphasis on Guyana evolved between 2023 and 2024, particularly in terms of its upstream growth portfolio and production capacity?",
      "original_answer": "In 2023, ExxonMobil highlighted Guyana as a key component of its upstream growth portfolio, noting four additional discoveries on the Stabroek Block and the startup of the Prosperity FPSO vessel, which brought production to nearly 440 kbd in the fourth quarter. By 2024, Guyana was formally categorized under 'Advantaged Assets' within the updated earnings drivers, reflecting its strategic elevation alongside the Permian and LNG projects as a core contributor to earnings through volume/mix growth. This shift indicates a transition from a discovery and early production phase in 2023 to a more mature, financially impactful asset in 2024.",
      "llm_answer": "ExxonMobil’s strategic focus on Guyana intensified through 2023‑2024, with the Stabroek Block delivering record‑breaking production—gross output rose to nearly 440 kbd in Q4 2023 and is projected to reach six FPSO vessels by the end of 2027, including the newly approved Whiptail project.  The company’s 2024 capital program explicitly highlights Guyana as a core growth pillar, allocating significant upstream investment and expecting the country’s oil‑equivalent production to continue expanding, while also leveraging the region’s advantaged volumes to offset declines elsewhere.  This emphasis is reflected in the 2024 earnings narrative, where Guyana‑related volume growth contributed positively to earnings despite lower realized prices, underscoring a strategic shift toward higher‑margin, deep‑water assets in the Americas.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "XOM_10k_2023.pdf",
          "target_page": 52,
          "pages": [
            50,
            51,
            52,
            53,
            54
          ]
        },
        "hop_2_rel": {
          "source_file": "XOM_10k_2024.pdf",
          "target_page": 37,
          "pages": [
            35,
            36,
            37,
            38,
            39
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 45988,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 11721,
        "completion_tokens": 207,
        "total_tokens": 11928
      }
    },
    {
      "question_id": 18,
      "question": "How has the X1 platform's integration with third-party streaming services evolved between 2022 and 2023, and what does this evolution indicate about Comcast's strategy in reducing cord-cutting and increasing average revenue per user (ARPU)?",
      "original_answer": "In 2022, the X1 platform integrated third-party streaming services such as Disney+ and Netflix, and provided access to Peacock's premium tier, with Comcast earning commission revenue from the sale of these services. By 2023, the X1 platform continued to support third-party integrations but now included Xumo Play, NBC, and Sky as part of the NOW TV service, which was specifically marketed to residential broadband customers. This expansion indicates a strategic pivot toward enhancing the value of broadband subscriptions and bundling streaming access to retain customers and potentially increase ARPU through deeper content integration and commission-generating partnerships.",
      "llm_answer": "The X1 platform’s integration with third‑party streaming services expanded markedly between 2022 and 2023, adding support for newer DTC services such as Peacock, Disney+, Netflix and the launch of the NOW streaming brand, and embedding these offerings directly into the X1 user experience (e.g., via the Flex/Xumo Stream Box and voice‑activated remote). This evolution reflects Comcast’s strategy to curb cord‑cutting by turning X1 into a unified entertainment hub that keeps subscribers engaged with a broader slate of streaming options, thereby driving higher engagement and increasing average revenue per user (ARPU) through added subscription commissions and upgraded service tiers.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CMCSA_10k_2022.pdf",
          "target_page": 7,
          "pages": [
            5,
            6,
            7,
            8,
            9
          ]
        },
        "hop_2_rel": {
          "source_file": "CMCSA_10k_2023.pdf",
          "target_page": 6,
          "pages": [
            4,
            5,
            6,
            7,
            8
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 44533,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 11375,
        "completion_tokens": 171,
        "total_tokens": 11547
      }
    },
    {
      "question_id": 18,
      "question": "How has Caterpillar's relationship with FG Wilson evolved between 2023 and 2024 in terms of its distribution network coverage for electric power generation systems?",
      "original_answer": "In 2023, FG Wilson's electric power generation systems were distributed through a network of 110 distributors covering 109 countries. By 2024, this distribution network had slightly contracted to 108 distributors, now covering 158 countries. This indicates a minor reduction in the number of distributors but an expansion in the geographic reach of the network. The change suggests a strategic shift toward optimizing distributor efficiency while broadening market access.",
      "llm_answer": "Based on the provided SEC 10-K filings, Caterpillar's relationship with FG Wilson has not evolved in terms of its distribution network coverage for electric power generation systems between 2023 and 2024. The documents indicate that FG Wilson branded electric power generation systems continue to be distributed through Caterpillar's established worldwide network of 110 distributors covering 158 countries, as stated in the \"Nature of operations\" section of both the 2023 and 2024 filings. There is no mention of any changes to this distribution structure or coverage expansion/contraction in the provided pages. The financial statements and notes focus on accounting policies, cash flow, and operational metrics rather than distribution network modifications.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CAT_10k_2023.pdf",
          "target_page": 65,
          "pages": [
            63,
            64,
            65,
            66,
            67
          ]
        },
        "hop_2_rel": {
          "source_file": "CAT_10k_2024.pdf",
          "target_page": 66,
          "pages": [
            64,
            65,
            66,
            67,
            68
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 58627,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 14881,
        "completion_tokens": 190,
        "total_tokens": 15072
      }
    },
    {
      "question_id": 18,
      "question": "How did Capital One's exposure to securitized debt obligations change between 2022 and 2024, particularly in terms of the carrying value and fair value of these obligations?",
      "original_answer": "In 2022, Capital One reported that the assets and liabilities of consolidated VIEs, including securitized debt obligations, were primarily composed of loan receivables and debt securities issued by the VIEs, with the liabilities reported under 'securitized debt obligations' on the consolidated balance sheets. By 2024, the carrying value of 'Securitized debt obligations' was $18,043 million, with a fair value of $18,067 million, all categorized under Level 2 of the fair value hierarchy. This indicates that Capital One maintained a significant exposure to securitized debt obligations, with a slight increase in fair value relative to carrying value, suggesting stable valuation and continued involvement in securitization activities.",
      "llm_answer": "Between 2022 and 2024, Capital One’s exposure to securitized debt obligations declined in carrying value from $14,264 million (as of Dec 31 2023) to $14,335 million (estimated fair value) in 2024, reflecting a modest increase in fair‑value estimates but essentially stable principal exposure. The company’s consolidated VIE tables show that retained interests and servicing obligations related to credit‑card and auto securitizations remained present, but the overall securitized‑debt balance has not grown materially, indicating a relatively flat exposure to securitized debt over this period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "COF_10k_2022.pdf",
          "target_page": 179,
          "pages": [
            177,
            178,
            179,
            180,
            181
          ]
        },
        "hop_2_rel": {
          "source_file": "COF_10k_2024.pdf",
          "target_page": 220,
          "pages": [
            218,
            219,
            220,
            221,
            222
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 51084,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 13000,
        "completion_tokens": 148,
        "total_tokens": 13149
      }
    },
    {
      "question_id": 18,
      "question": "How has McDonald's use of line of credit agreements evolved between 2023 and 2024 in relation to its financing activities and cash flow management?",
      "original_answer": "In 2023, McDonald's cash used for financing activities totaled $4.4 billion, a decrease of $2.2 billion compared to 2022, primarily due to increased bond issuances. The company's cash and equivalents balance was $4.6 billion at the end of 2023, reflecting sufficient liquidity supported by cash from operations and access to commercial paper borrowings and line of credit agreements. In 2024, cash used for financing activities increased to $7.5 billion, a rise of $3.1 billion compared to 2023, driven by decreased bond issuances. The company's cash and equivalents balance dropped to $1.1 billion at year-end 2024, with the prior year's higher balance attributed to the timing of debt issuances that funded 2024's required cash outflows. The company continued to rely on its line of credit agreements and commercial paper to meet short-term funding needs. This indicates a shift from surplus liquidity and bond financing in 2023 to a more cash-constrained environment in 2024, with greater reliance on existing credit facilities.",
      "llm_answer": "McDonald's reduced its share repurchase authorization in 2024, terminating its $15 billion 2020 program and replacing it with a new $15 billion 2025 program, while simultaneously increasing quarterly dividends to $1.77 per share (a 6% rise) to $6.78 annually. The company’s financing activities shifted toward higher cash outflows for dividends and share buybacks, reflecting stronger cash flow generation but a more conservative approach to debt issuance, as evidenced by a modest decline in total debt and a focus on maintaining ample liquidity via commercial paper and revolving credit facilities.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MCD_10k_2023.pdf",
          "target_page": 20,
          "pages": [
            18,
            19,
            20,
            21,
            22
          ]
        },
        "hop_2_rel": {
          "source_file": "MCD_10k_2024.pdf",
          "target_page": 21,
          "pages": [
            19,
            20,
            21,
            22,
            23
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 30842,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 7931,
        "completion_tokens": 150,
        "total_tokens": 8081
      }
    },
    {
      "question_id": 18,
      "question": "How has the role of the Worldwide Business Conduct Manual in reinforcing internal controls evolved between 2022 and 2024, and what does this indicate about Procter & Gamble's approach to governance?",
      "original_answer": "In 2022, the Worldwide Business Conduct Manual was described as reinforcing the company's commitment to conducting business with integrity and within the letter and spirit of the law, emphasizing its role in supporting internal controls through policies, segregation of duties, and employee development. In 2024, while the core description remained similar, the manual was more specifically tied to governance frameworks such as the oversight activities of the Global Leadership Council and the responsibilities of the Disclosure Committee in evaluating significant business activities. This indicates a shift toward emphasizing structured governance mechanisms alongside ethical conduct, suggesting a more integrated approach to internal control over time.",
      "llm_answer": "The Worldwide Business Conduct Manual has become an increasingly explicit component of Procter & Gamble’s governance narrative between 2022 and 2024, moving from a general statement of commitment to a more detailed articulation of how the Manual underpins internal control and ethical conduct. In the 2022 filing (page 38), the Manual is described as reinforcing “strong internal controls” and aligning with the company’s Purpose, Values and Principles, while the 2024 filing (page 34) reiterates that it “sets forth our commitment to conduct business with integrity, and within both the letter and the spirit of the law,” and ties it directly to the Board’s oversight and the Audit Committee’s review of control matters. Moreover, the 2024 Management Report on Internal Control (page 34) explicitly links the Manual to the Control Self‑Assessment Program and to the Global Leadership Council’s oversight of controls, indicating a more integrated, systematic use of the Manual to embed governance expectations across the organization. This evolution signals that P&G is tightening its governance framework—using the Manual not only as a cultural touchstone but also as a concrete control‑monitoring tool that supports the effectiveness of its internal control over financial reporting.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "PG_10k_2022.pdf",
          "target_page": 38,
          "pages": [
            36,
            37,
            38,
            39,
            40
          ]
        },
        "hop_2_rel": {
          "source_file": "PG_10k_2024.pdf",
          "target_page": 34,
          "pages": [
            32,
            33,
            34,
            35,
            36
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 45080,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 11503,
        "completion_tokens": 321,
        "total_tokens": 11824
      }
    },
    {
      "question_id": 19,
      "question": "How has Exxon's strategic positioning in Guyana evolved between 2023 and 2024, as reflected in its long-lived asset disclosures and earnings driver definitions?",
      "original_answer": "In 2023, Exxon disclosed $9,689 million in long-lived assets in Guyana, indicating it was already a significant contributor among non-U.S. assets. By 2024, Guyana was explicitly named as part of Exxon's 'Advantaged Assets' under the new 'Advantaged Volume Growth' earnings driver, which includes key growth projects like Guyana and LNG. This evolution shows that Guyana transitioned from being a quantitatively notable asset in 2023 to a strategically emphasized growth engine in 2024.",
      "llm_answer": "ExxonMobil's strategic positioning in Guyana has evolved from a focus on exploration and development to emphasizing long-term production and integration within its global portfolio. In 2023, Guyana contributed significantly to earnings through the Stabroek Project, with $17.1 billion in earnings from non-U.S. upstream operations, reflecting its status as a high-value, advantaged asset. By 2024, the company explicitly categorized Guyana as part of its \"Advantaged Assets\" under the new earnings driver framework, highlighting its role in driving volume growth through high-value, low-emission projects and integration into global operations, while structural cost savings and portfolio optimization further solidified its strategic importance.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "XOM_10k_2023.pdf",
          "target_page": 115,
          "pages": [
            113,
            114,
            115,
            116,
            117
          ]
        },
        "hop_2_rel": {
          "source_file": "XOM_10k_2024.pdf",
          "target_page": 37,
          "pages": [
            35,
            36,
            37,
            38,
            39
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 46982,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 11970,
        "completion_tokens": 186,
        "total_tokens": 12157
      }
    },
    {
      "question_id": 19,
      "question": "How has Capital One's reliance on securitized debt obligations as a funding source evolved from 2022 to 2024, based on the disclosed figures and descriptions?",
      "original_answer": "In 2022, Capital One identified securitized debt obligations as part of its diversified funding mix, which also included deposits, senior and subordinated notes, federal funds purchased, and FHLB advances. While no specific dollar value was disclosed in 2022, the company emphasized the strategic importance of securitized debt obligations in maintaining access to wholesale funding. By 2024, Capital One disclosed that its securitized debt obligations had a carrying value of $14,264 million and an estimated fair value of $14,335 million. This represents a concrete quantification of the instrument's role in the company's capital structure, showing an increased transparency and continued use of this funding source.",
      "llm_answer": "Capital One’s reliance on securitized debt as a funding source has grown markedly over the two‑year period.  In 2022 the company reported $6.25 billion of securitized‑debt issuances (Table 33), and by the 2024 filing that figure had risen to $18.04 billion of outstanding securitized obligations (Table 17.6), with $6.25 billion of new issuances recorded in 2024 alone.  This expansion reflects a strategic shift toward using securitizations—particularly for credit‑card and auto‑loan assets—to diversify and lower‑cost wholesale funding, a trend that is evident in the increasing proportion of securitized debt within its overall long‑term borrowing profile.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "COF_10k_2022.pdf",
          "target_page": 113,
          "pages": [
            111,
            112,
            113,
            114,
            115
          ]
        },
        "hop_2_rel": {
          "source_file": "COF_10k_2024.pdf",
          "target_page": 219,
          "pages": [
            217,
            218,
            219,
            220,
            221
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 52603,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 13376,
        "completion_tokens": 164,
        "total_tokens": 13541
      }
    },
    {
      "question_id": 19,
      "question": "How has NVIDIA's Omniverse platform evolved in terms of its positioning and enterprise adoption between fiscal years 2022 and 2023?",
      "original_answer": "In fiscal year 2022, Omniverse was described as 'real-time 3D design collaboration and virtual world simulation software' aimed at empowering creators to collaborate across leading design applications. By fiscal year 2023, Omniverse had evolved into a more robust enterprise-focused development platform and operating system for building virtual world simulation applications. It was made available as a software subscription for enterprise use and offered free for individual users, with industrial enterprises adopting its 3D and simulation technologies to digitalize complex physical assets and environments, including digital twins of factories and real-time 3D product configurators. This indicates a strategic shift from a creative collaboration tool to a broader enterprise simulation and digital twin platform.",
      "llm_answer": "Between fiscal years 2022 and 2023, NVIDIA’s Omniverse platform transitioned from a primarily enterprise‑focused, subscription‑based 3D collaboration and simulation tool to a broader, AI‑enhanced ecosystem that is now tightly integrated with its automotive and graphics strategies.  In the 2022 filing the company highlighted Omniverse as a real‑time 3D design collaboration platform for creators and noted its use in automotive digital‑twin and simulation workflows, while by 2023 it emphasized Omniverse Avatar Cloud Engine (ACE) for real‑time conversational AI avatars and positioned Omniverse as a core component of its end‑to‑end automotive solution stack (DRIVE Hyperion) for autonomous‑driving simulation and cockpit experiences, underscoring deeper enterprise adoption and cross‑industry integration.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "NVDA_10k_2022.pdf",
          "target_page": 11,
          "pages": [
            9,
            10,
            11,
            12,
            13
          ]
        },
        "hop_2_rel": {
          "source_file": "NVDA_10k_2023.pdf",
          "target_page": 6,
          "pages": [
            4,
            5,
            6,
            7,
            8
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 7,
        "total_chars": 40893,
        "num_window_pages": 7,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 10439,
        "completion_tokens": 202,
        "total_tokens": 10641
      }
    },
    {
      "question_id": 19,
      "question": "How has Pfizer's financial relationship with Viatris evolved between 2022 and 2023, particularly in terms of net amounts due under their various agreements?",
      "original_answer": "In 2022, the net amounts due to Viatris under the agreements were $94 million as of December 31, 2022. By 2023, this amount had decreased to $33 million as of December 31, 2023. This indicates a significant reduction in the net financial obligations between the two companies over the period, suggesting a winding down or stabilization of transitional financial arrangements established post-separation.",
      "llm_answer": "Between 2022 and 2023, Pfizer's net amounts due from Viatris under post‑spin‑off agreements declined sharply, from $401 million at the end of 2020 to $53 million by the end of 2021, reflecting the winding down of transitional services and manufacturing supply arrangements as Viatris became fully independent. Consequently, the company no longer records material balances or cash flows related to these Viatris‑related agreements in its consolidated results.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "PFE_10k_2022.pdf",
          "target_page": 75,
          "pages": [
            73,
            74,
            75,
            76,
            77
          ]
        },
        "hop_2_rel": {
          "source_file": "PFE_10k_2023.pdf",
          "target_page": 73,
          "pages": [
            71,
            72,
            73,
            74,
            75
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 71288,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 18045,
        "completion_tokens": 114,
        "total_tokens": 18159
      }
    },
    {
      "question_id": 20,
      "question": "How has ExxonMobil's strategic emphasis on Guyana evolved between 2023 and 2024, and what specific changes in project activity or classification reflect this evolution?",
      "original_answer": "In 2023, ExxonMobil's operations in Guyana were characterized by active exploration and development, with 12.6 net exploratory and development wells completed, and key projects such as Payara, Yellowtail, and Uaru underway. By 2024, Guyana was formally classified as part of ExxonMobil's 'Advantaged Assets' under the 'Advantaged Volume Growth' earnings driver, signaling a strategic elevation of its importance alongside the Permian Basin and LNG. This reclassification reflects a shift from operational reporting to strategic prioritization, indicating increased emphasis on Guyana as a core growth asset.",
      "llm_answer": "Between 2023 and 2024, ExxonMobil's strategic emphasis on Guyana evolved from early-stage development to active project execution and classification as a core advantaged growth area. In 2023, Guyana was highlighted as a key growth project within the \"Advantaged Assets\" category alongside Permian and LNG, with activities focused on the Payara development and Yellowtail project progress. By 2024, Guyana's role was reinforced as a central component of the company's strategy, with the Uaru project funded and continued development on Yellowtail, while the term \"Advantaged Projects\" explicitly included Guyana as a driver of \"Advantaged Volume Growth\" – reflecting its transition from exploration to production-focused investment. This shift is underscored by the reclassification of Guyana-related activities under \"Advantaged Projects\" (previously grouped under \"Advantaged Assets\") and its inclusion as a key contributor to earnings growth, signaling a strategic prioritization of Guyana's upstream potential as a near-term revenue and value driver.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "XOM_10k_2023.pdf",
          "target_page": 20,
          "pages": [
            18,
            19,
            20,
            21,
            22
          ]
        },
        "hop_2_rel": {
          "source_file": "XOM_10k_2024.pdf",
          "target_page": 37,
          "pages": [
            35,
            36,
            37,
            38,
            39
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 37314,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 9554,
        "completion_tokens": 263,
        "total_tokens": 9817
      }
    },
    {
      "question_id": 20,
      "question": "How did the weighted-average interest rate and face value of senior notes with maturities greater than 10 years evolve from 2022 to 2023?",
      "original_answer": "In 2022, the weighted-average interest rate for senior notes with maturities greater than 10 years was 3.67%, with a face value of $54.536 billion. In 2023, the interest rate remained unchanged at 3.8%, but the face value slightly decreased to $53.4 billion. This indicates a slight reduction in long-term debt in this category, while the interest rate stayed stable.",
      "llm_answer": "The weighted‑average interest rate on senior notes with maturities greater than 10 years held steady at roughly 3.8 % from 2022 to 2023, while the face‑value amount of those notes increased slightly from $52.8 billion in 2022 to $53.4 billion in 2023.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CMCSA_10k_2022.pdf",
          "target_page": 102,
          "pages": [
            100,
            101,
            102,
            103,
            104
          ]
        },
        "hop_2_rel": {
          "source_file": "CMCSA_10k_2023.pdf",
          "target_page": 82,
          "pages": [
            80,
            81,
            82,
            83,
            84
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 8,
        "total_chars": 45038,
        "num_window_pages": 8,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 11480,
        "completion_tokens": 62,
        "total_tokens": 11542
      }
    },
    {
      "question_id": 20,
      "question": "How did the nuclear decommissioning trusts managed by Alabama Power and Georgia Power shift their domestic equity investment allocations and valuation methodologies between 2023 and 2024, particularly in terms of Level 1 and Level 2 input classifications?",
      "original_answer": "In 2023, Alabama Power reported $396 million in domestic equity investments under Level 1 inputs and $169 million under Level 2 inputs, totaling $565 million. Georgia Power reported $255 million in Level 1 and $1 million in Level 2, totaling $256 million. By 2024, Alabama Power’s domestic equity investments increased to $443 million in Level 1 and $208 million in Level 2, totaling $651 million. Georgia Power saw its Level 1 domestic equity investments rise to $321 million while Level 2 remained at $1 million, totaling $322 million. This indicates a strategic shift toward higher allocations in domestic equities, particularly through more actively traded (Level 1) instruments, which may reflect a more transparent or liquid investment approach in line with evolving trust management strategies.",
      "llm_answer": "Between 2023 and 2024, Alabama Power and Georgia Power shifted their nuclear decommissioning trust investments toward greater use of Level 2 inputs, particularly in domestic equity and fixed-income securities, as reflected in the 2024 disclosures showing increased allocations to observable market inputs (e.g., domestic equity at $8 million and pooled fixed‑income funds at $7 million in 2024 versus $169 million private‑equity at Level 3 in 2023). Their valuation methodology remained consistent—using external pricing vendors and net asset value as a practical expedient—but the proportion of Level 1 inputs (quoted market prices) stayed minimal, while Level 2 inputs (other observable inputs) grew, and Level 3 measurements (significant unobservable inputs) were largely confined to private‑market investments and contingent consideration, which were excluded from the NAV‑based practical expedient.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "SO_10k_2023.pdf",
          "target_page": 284,
          "pages": [
            282,
            283,
            284,
            285,
            286
          ]
        },
        "hop_2_rel": {
          "source_file": "SO_10k_2024.pdf",
          "target_page": 277,
          "pages": [
            275,
            276,
            277,
            278,
            279
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 91761,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 23190,
        "completion_tokens": 225,
        "total_tokens": 23415
      }
    },
    {
      "question_id": 20,
      "question": "How has NVIDIA's strategic positioning of CUDA evolved from 2022 to 2023 in terms of its role within the company's full-stack computing platform and its integration across different end markets?",
      "original_answer": "In 2022, CUDA was positioned as a fundamental building block of NVIDIA's accelerated computing platform, supporting a variety of end markets such as Gaming, Data Center, Professional Visualization, and Automotive through a unified underlying architecture. It was described as essential for leveraging GPU capabilities across these markets. By 2023, CUDA's role had evolved into being the foundational programming model within NVIDIA's full-stack computing infrastructure, extending its integration beyond traditional markets into domain-specific verticals such as healthcare, telecom, automotive, and manufacturing. Additionally, in 2023, CUDA was positioned as the base layer supporting hundreds of domain-specific software libraries, SDKs, and APIs, which were not explicitly emphasized in 2022. This indicates a strategic shift from CUDA being a foundational component to becoming the core enabler of a broader, more vertically integrated software stack aimed at accelerating deployment across computationally intensive workloads.",
      "llm_answer": "From 2022 to 2023, NVIDIA's strategic positioning of CUDA evolved from being a foundational parallel computing platform to becoming the core software layer of a full-stack computing platform that spans data center, automotive, and professional visualization markets. The company deepened CUDA's integration across end markets by embedding it within end-to-end solutions like the NVIDIA DRIVE platform for autonomous driving (with Orin SoC enabling AI perception and planning), Omniverse for industrial digitalization, and AI Enterprise software for enterprise AI workloads. This integration allowed CUDA to serve as the unifying building block for diverse applications—from training AI models in data centers to powering real-time simulation in automotive and professional visualization—while leveraging the same underlying GPU architecture across all markets to deliver order-of-magnitude performance advantages.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "NVDA_10k_2022.pdf",
          "target_page": 9,
          "pages": [
            7,
            8,
            9,
            10,
            11
          ]
        },
        "hop_2_rel": {
          "source_file": "NVDA_10k_2023.pdf",
          "target_page": 4,
          "pages": [
            2,
            3,
            4,
            5,
            6
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 7,
        "total_chars": 36411,
        "num_window_pages": 7,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 9333,
        "completion_tokens": 228,
        "total_tokens": 9562
      }
    },
    {
      "question_id": 20,
      "question": "How did Pfizer's financial obligations and contractual relationships with Viatris evolve from 2022 to 2023, particularly in terms of transitional service agreements and net amounts owed?",
      "original_answer": "In 2022, Pfizer disclosed that amounts recorded under transitional service agreements (TSAs) and master services agreements (MSAs) with Viatris were not material to operations, and the TSA services were largely completed by the end of 2022. By 2023, services under the TSAs were fully completed as of December 31, 2023, and the net amounts due to Viatris under the agreements decreased from $94 million in 2022 to $33 million in 2023. This reflects a reduction in intercompany financial obligations and the winding down of transitional support following the 2020 spin-off of the Upjohn Business into Viatris.",
      "llm_answer": "From 2022 to 2023, Pfizer’s contractual relationships with Viatris under the interim TSAs and MSAs were largely completed by December 31 2023. Net amounts due to Viatris declined from $94 million as of December 31 2022 to $33 million as of December 31 2023, reflecting the winding down of those transitional service arrangements.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "PFE_10k_2022.pdf",
          "target_page": 113,
          "pages": [
            111,
            112,
            113,
            114,
            115
          ]
        },
        "hop_2_rel": {
          "source_file": "PFE_10k_2023.pdf",
          "target_page": 73,
          "pages": [
            71,
            72,
            73,
            74,
            75
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 83587,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 21128,
        "completion_tokens": 82,
        "total_tokens": 21210
      }
    },
    {
      "question_id": 21,
      "question": "How has the relationship between retail deregulation pressures and Duke Energy's environmental regulation compliance costs evolved from 2022 to 2023?",
      "original_answer": "In 2022, Duke Energy highlighted that retail deregulation could result in unrecovered costs, including those related to above-market purchased power commitments from qualifying facilities (QFs) under PURPA, which could hinder the recovery of environmental compliance costs through regulatory rate structures. By 2023, the company noted increased regulatory emphasis on environmental compliance, including EPA regulations on CO2 emissions and cooling water intake structures, as well as new state-level carbon reduction goals more aggressive than the company’s own plans. These developments suggest that deregulation pressures have compounded the challenge of recovering rising environmental compliance costs, as competitive market conditions limit the ability to pass on these expenses to customers.",
      "llm_answer": "From 2022 to 2023, Duke Energy’s environmental compliance costs—particularly those tied to coal ash (CCR) management—continued to rise, driven by expanded excavation, closure activities, and stricter EPA and state regulations. While the company seeks full cost recovery through regulated rate cases, the timing and extent of such recoveries remain uncertain, creating potential cash flow pressure. Concurrently, deregulation pressures in competitive electricity markets heightened exposure to unrecovered stranded costs and margin compression, especially where retail markets are restructured, further complicating the company’s ability to manage compliance costs amid evolving regulatory and market dynamics.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "DUK_10k_2022.pdf",
          "target_page": 28,
          "pages": [
            26,
            27,
            28,
            29,
            30
          ]
        },
        "hop_2_rel": {
          "source_file": "DUK_10k_2023.pdf",
          "target_page": 26,
          "pages": [
            24,
            25,
            26,
            27,
            28
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 69966,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 17712,
        "completion_tokens": 177,
        "total_tokens": 17890
      }
    },
    {
      "question_id": 21,
      "question": "How did the retail share of Skoal oral tobacco products change between 2023 and 2024, and how does this contrast with the pricing strategy applied to Skoal during 2023?",
      "original_answer": "The retail share of Skoal oral tobacco products decreased from 9.3% in 2023 to 7.6% in 2024, reflecting a decline in market presence. This contrasts with the pricing strategy in 2023, where multiple price increases were applied to Skoal products, including a $0.11 per can increase effective January 23, 2024 (announced in 2023), following earlier increases of $0.09, $0.09, and $0.08 per can in May, February, and January 2022, respectively. The cumulative effect of these increases may have impacted consumer demand, contributing to the drop in retail share.",
      "llm_answer": "The retail share of Skoal oral tobacco products declined from 9.3% in 2023 to 7.6% in 2024, a decrease of 1.7 percentage points, reflecting broader share losses in the MST category. This contrasts with the pricing strategy applied to Skoal in 2023, which involved multiple list price increases across its product portfolio (including a $0.10 per can increase effective January 24, 2023, and additional hikes in July and August 2023) to offset inflationary pressures, while the 2024 pricing actions continued this trend with further increases (e.g., $0.11 per can effective January 23, 2024, and $0.12 per can effective January 19, 2025).",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MO_10k_2023.pdf",
          "target_page": 47,
          "pages": [
            45,
            46,
            47,
            48,
            49
          ]
        },
        "hop_2_rel": {
          "source_file": "MO_10k_2024.pdf",
          "target_page": 48,
          "pages": [
            46,
            47,
            48,
            49,
            50
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 66177,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 16769,
        "completion_tokens": 159,
        "total_tokens": 16929
      }
    },
    {
      "question_id": 21,
      "question": "How did Amgen's investment in 'Other short-term interest-bearing securities' evolve between 2023 and 2024, and what does this indicate about the company's short-term investment strategy?",
      "original_answer": "Amgen's investment in 'Other short-term interest-bearing securities' remained unchanged at $138 million in both 2023 and 2024. This stability suggests that the company maintained a consistent approach to this segment of its short-term investment portfolio over the two-year period.",
      "llm_answer": "Amgen's \"Other short-term interest-bearing securities\" remained minimal and stable between 2023 and 2024, with amortized cost holding at $135 million in both years (as shown in the 2024 and 2023 available‑for‑sale investment tables). This consistency indicates that Amgen is maintaining a conservative short‑term investment strategy, focusing on preserving principal and liquidity rather than pursuing higher‑risk or higher‑return securities.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AMGN_10k_2023.pdf",
          "target_page": 133,
          "pages": [
            131,
            132,
            133,
            134,
            135
          ]
        },
        "hop_2_rel": {
          "source_file": "AMGN_10k_2024.pdf",
          "target_page": 133,
          "pages": [
            131,
            132,
            133,
            134,
            135
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 46717,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 11912,
        "completion_tokens": 110,
        "total_tokens": 12023
      }
    },
    {
      "question_id": 22,
      "question": "How has the nature of General Dynamics' involvement in Abrams Main Battle Tank Upgrades evolved from 2022 to 2024, particularly in terms of contract scope and value?",
      "original_answer": "In 2022, General Dynamics received a $360 million contract from the Army for Abrams main battle tank upgrades, mission control units, and systems technical support. By 2024, the company's involvement had evolved to include both production and support services, as evidenced by a $350 million contract for Abrams upgrades, engineering and logistics support, and system and sustainment technical support services. Additionally, a separate $285 million contract was awarded for producing Abrams tanks in the SEPv3 configuration for Romania. This indicates a shift from primarily upgrade-focused contracts to a broader scope that includes both upgrades and production of new configurations, with an increase in total contract value.",
      "llm_answer": "From 2022 to 2024, General Dynamics' involvement in Abrams main battle tank upgrades shifted from a $360 award in 2021 (page 40) to $350 in 2022 (page 44) and $350 again in 2023 (page 44), with the 2024 estimate showing a $350 contract for upgrades, engineering, and logistics support (page 44). The contract scope remained focused on upgrades and support services, but the value remained consistent around $350, indicating no significant expansion in scope or value over the period. The 2024 estimate also includes a $285 contract for SEPv3 configuration tanks for Romania (page 44), but the core Abrams upgrade funding stayed stable at approximately $350 annually.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "GD_10k_2022.pdf",
          "target_page": 42,
          "pages": [
            40,
            41,
            42,
            43,
            44
          ]
        },
        "hop_2_rel": {
          "source_file": "GD_10k_2024.pdf",
          "target_page": 44,
          "pages": [
            42,
            43,
            44,
            45,
            46
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 19534,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 5108,
        "completion_tokens": 166,
        "total_tokens": 5274
      }
    },
    {
      "question_id": 22,
      "question": "How did AIG's financial relationship with Corebridge evolve from 2023 to 2024, particularly in terms of borrowing arrangements and income recognition?",
      "original_answer": "In 2023, AIG disclosed that Corebridge had the ability to continue borrowing through February 25, 2025, indicating an ongoing financial arrangement. By 2024, AIG's relationship with Corebridge had transformed, as AIG began recognizing equity method income tied to Corebridge’s stock price changes and dividends received since June 9, 2024. This shift reflects a change from a borrowing-based relationship to one focused on equity-based returns.",
      "llm_answer": "From 2023 to 2024, AIG’s borrowing arrangements with Corebridge evolved significantly. In 2023, AIG provided a guarantee and collateral support for Corebridge’s debt (including CRBGLH notes and junior subordinated debt), with terms requiring AIG to reimburse any payments made on its behalf and to post collateral if Corebridge’s credit rating fell below certain thresholds. By 2024, Corebridge had issued $7.7 billion of senior unsecured notes and $1.5 billion of DDTL facility debt (not guaranteed by AIG), while AIG’s own general borrowings declined to $10.3 billion. The deconsolidation of Corebridge in June 2024 shifted AIG’s exposure from direct debt guarantees to an equity method investment, with income recognition now tied to dividends and fair value changes in Corebridge stock rather than direct debt obligations.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AIG_10k_2023.pdf",
          "target_page": 113,
          "pages": [
            111,
            112,
            113,
            114,
            115
          ]
        },
        "hop_2_rel": {
          "source_file": "AIG_10k_2024.pdf",
          "target_page": 109,
          "pages": [
            107,
            108,
            109,
            110,
            111
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 91678,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 23143,
        "completion_tokens": 206,
        "total_tokens": 23350
      }
    },
    {
      "question_id": 22,
      "question": "How has Tesla's approach to the Solar Roof product evolved between 2022 and 2024, particularly in terms of production challenges and strategic dependencies?",
      "original_answer": "In 2022, Tesla was actively selling the Solar Roof and improving installation efficiency through collaboration with real estate developers and builders. The company emphasized its engineering efforts to combine aesthetics, durability, and power generation. By 2024, however, Tesla's 10-K highlights that the future of the Solar Roof (alongside other products) 'depends in large part' on overcoming production ramp challenges, including bottlenecks, supplier risks, and cost control. This reflects a shift from product development and sales emphasis to a more complex production and dependency landscape.",
      "llm_answer": "Tesla’s Solar Roof strategy shifted from a broad retrofit focus in 2022 to a tighter integration with its energy‑storage and vehicle‑charging ecosystem by 2024, emphasizing streamlined installation through partnerships with builders and utilities. Production challenges persisted, with supply‑chain constraints and the need to scale proprietary battery‑cell manufacturing still limiting rollout speed, while the company increasingly depended on its own cell production and raw‑material availability to meet demand.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "TSLA_10k_2022.pdf",
          "target_page": 6,
          "pages": [
            4,
            5,
            6,
            7,
            8
          ]
        },
        "hop_2_rel": {
          "source_file": "TSLA_10k_2024.pdf",
          "target_page": 17,
          "pages": [
            15,
            16,
            17,
            18,
            19
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 45696,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 11646,
        "completion_tokens": 128,
        "total_tokens": 11774
      }
    },
    {
      "question_id": 22,
      "question": "How has the retail share of Skoal in the U.S. oral tobacco market changed between 2023 and 2024, and what does this indicate about its competitive positioning?",
      "original_answer": "In 2023, Skoal held a 9.3% retail share in the U.S. oral tobacco market, which decreased to 7.6% in 2024. This decline indicates a weakening in Skoal's competitive positioning within the oral tobacco segment over this period. The drop in market share for Skoal contrasts with the growth seen in other products like on!, which increased from 6.8% to 8.3% during the same timeframe.",
      "llm_answer": "Based on the provided document pages, the retail share of Skoal in the U.S. oral tobacco market declined from 9.3% in 2023 to 7.6% in 2024 (as shown in the oral tobacco products segment retail share table on page 48), contributing to a drop in the segment's total retail share from 42.5% to 37.5%. This share loss indicates a weakening competitive positioning for Skoal, as its market share eroded despite industry growth driven by oral nicotine pouches.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MO_10k_2023.pdf",
          "target_page": 22,
          "pages": [
            20,
            21,
            22,
            23,
            24
          ]
        },
        "hop_2_rel": {
          "source_file": "MO_10k_2024.pdf",
          "target_page": 48,
          "pages": [
            46,
            47,
            48,
            49,
            50
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 46916,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 11952,
        "completion_tokens": 113,
        "total_tokens": 12065
      }
    },
    {
      "question_id": 22,
      "question": "How has the risk associated with the concentration of device share among premium tier companies evolved between 2023 and 2024, particularly in terms of its potential impact on Qualcomm's pricing power and revenue stability?",
      "original_answer": "In 2023, Qualcomm highlighted that the concentration of device share among a few premium tier companies was contributing to a trend of deriving a significant portion of revenues from a small number of customers, particularly Chinese OEMs. This concentration was noted to potentially result in lower prices for Qualcomm's products due to the purchasing power of these companies. In 2024, the risk factor remained present, but the emphasis shifted slightly to underscore the broader implications of this concentration, including the potential for even greater pricing pressure and revenue fluctuation due to the timing and success of customer product introductions. The continued reliance on a small group of customers, especially those developing their own integrated circuits or using competitors, suggests that the risk has not only persisted but potentially intensified, increasing its impact on Qualcomm's pricing power and revenue stability.",
      "llm_answer": "The risk associated with concentration of device share among premium tier companies has intensified between 2023 and 2024, with heightened concerns about customers vertically integrating (e.g., Apple acquiring Intel's modem assets and developing its own modems, Chinese OEMs pursuing semiconductor self-sufficiency via the Made in China 2025 campaign) and government policies (U.S./China trade tensions, export restrictions like Huawei's license revocation) potentially accelerating shifts away from Qualcomm's integrated circuit products. This concentration directly threatens pricing power and revenue stability, as premium-tier sales—particularly from a few dominant customers—now carry greater volatility due to reduced purchasing power, potential price pressure, and the risk of customers replacing Qualcomm's components with in-house or competitor solutions, which could materially reduce revenues and margins.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "QCOM_10k_2023.pdf",
          "target_page": 18,
          "pages": [
            16,
            17,
            18,
            19,
            20
          ]
        },
        "hop_2_rel": {
          "source_file": "QCOM_10k_2024.pdf",
          "target_page": 18,
          "pages": [
            16,
            17,
            18,
            19,
            20
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 64467,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 16357,
        "completion_tokens": 229,
        "total_tokens": 16586
      }
    },
    {
      "question_id": 22,
      "question": "Given Amgen's approach to managing short-term liquidity, how did its allocation to money market mutual funds evolve between 2023 and 2024?",
      "original_answer": "Amgen's allocation to money market mutual funds remained unchanged at $10,266 million in both 2023 and 2024. The disclosed investment values for money market mutual funds under available-for-sale investments were identical in both years, indicating no shift in this portion of the company's short-term investment strategy.",
      "llm_answer": "Amgen’s short‑term liquidity is managed through a combination of cash, cash equivalents and highly liquid money‑market investments. In 2023 the company held $10,266 million of money‑market mutual funds, and by the end of 2024 that position grew to $10,354 million, reflecting a modest increase in its allocation to these funds. This evolution shows a slight expansion of Amgen’s short‑term liquidity buffer over the one‑year period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AMGN_10k_2023.pdf",
          "target_page": 133,
          "pages": [
            131,
            132,
            133,
            134,
            135
          ]
        },
        "hop_2_rel": {
          "source_file": "AMGN_10k_2024.pdf",
          "target_page": 133,
          "pages": [
            131,
            132,
            133,
            134,
            135
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 46717,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 11900,
        "completion_tokens": 108,
        "total_tokens": 12008
      }
    },
    {
      "question_id": 23,
      "question": "How has General Dynamics' participation in the Capital Construction Fund evolved between 2022 and 2024, particularly in terms of the amount of U.S. government accounts receivable pledged to the fund?",
      "original_answer": "In 2022, General Dynamics had U.S. government accounts receivable pledged to the Capital Construction Fund (CCF) of $295 million as of December 31, 2021. By 2024, the amounts pledged to the CCF had increased to $315 million on December 31, 2023, and $333 million on December 31, 2024. This indicates a steady increase in GD's participation in the CCF over the period, reflecting a growing utilization of the tax deferral benefits offered by the program.",
      "llm_answer": "Based on the provided SEC 10-K filings, General Dynamics' participation in the Capital Construction Fund (CCF) shows a clear evolution in the amount of U.S. government accounts receivable pledged to the fund between 2022 and 2024. In the 2022 filing (GD_10k_2022.pdf), the company reported U.S. government accounts receivable pledged to the CCF as $295 million on December 31, 2021 and 2020. However, in the 2024 filing (GD_10k_2024.pdf), this amount increased to $333 million on December 31, 2024 and $315 million on December 31, 2023. This represents a $38 million increase from the 2021/2020 level to the 2024 level, indicating that the pledged amount has grown over the three-year period, with the most recent data showing $333 million pledged as of December 31, 2024. The CCF participation remains a key component of the company's tax strategy, allowing deferral of federal and state income taxes on earnings from eligible programs as long as proceeds are deposited in the fund and used for qualified activities.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "GD_10k_2022.pdf",
          "target_page": 67,
          "pages": [
            65,
            66,
            67,
            68,
            69
          ]
        },
        "hop_2_rel": {
          "source_file": "GD_10k_2024.pdf",
          "target_page": 68,
          "pages": [
            66,
            67,
            68,
            69,
            70
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 34480,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 8853,
        "completion_tokens": 254,
        "total_tokens": 9107
      }
    },
    {
      "question_id": 23,
      "question": "How did AIG's financial relationship with Corebridge evolve between 2023 and 2024, particularly in terms of its tax implications and investment income following the IPO and subsequent deconsolidation?",
      "original_answer": "In 2023, AIG's ownership in Corebridge dropped below 80% after Corebridge's IPO on September 19, 2022, resulting in the tax deconsolidation of Corebridge from AIG’s U.S. federal income tax group. This deconsolidation had significant tax implications, including restrictions on future consolidated tax filings for five years and the retention of Corebridge's net operating losses and tax credit carryforwards by Corebridge entities. By 2024, AIG no longer consolidated Corebridge's financials, and instead, AIG reported its investment in Corebridge under the equity method, recognizing $X in equity method income for the period from June 10, 2024, to December 31, 2024, based on dividends received and changes in Corebridge's stock price. This marks a shift from a consolidated tax and financial reporting relationship to a more arms-length investment relationship.",
      "llm_answer": "Between 2023 and 2024, AIG's financial relationship with Corebridge underwent significant changes following its IPO and subsequent deconsolidation. After Corebridge's September 2022 IPO, AIG reduced its ownership below 80%, triggering tax deconsolidation, and on June 9, 2024, AIG met the requirements for deconsolidation by reducing its board representation and selling shares. This resulted in a $4.8 billion loss from deconsolidation, primarily due to recognizing $7.2 billion in accumulated comprehensive loss. Post-deconsolidation, AIG retained a 22.7% stake in Corebridge (down from 48.4%), elected the fair value option for its remaining interest, and recognized equity method income from dividends and stock price changes. The deconsolidation also created tax implications, as AIG's U.S. federal tax group could no longer include Corebridge in its consolidated tax return, affecting the utilization of Corebridge's tax attributes. AIG subsequently sold additional Corebridge shares in late 2024, generating a $282 million gain, but the deconsolidation fundamentally altered the financial relationship, shifting Corebridge from a consolidated subsidiary to an equity method investment with associated tax and accounting impacts.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AIG_10k_2023.pdf",
          "target_page": 255,
          "pages": [
            253,
            254,
            255,
            256,
            257
          ]
        },
        "hop_2_rel": {
          "source_file": "AIG_10k_2024.pdf",
          "target_page": 109,
          "pages": [
            107,
            108,
            109,
            110,
            111
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 104823,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 26442,
        "completion_tokens": 308,
        "total_tokens": 26751
      }
    },
    {
      "question_id": 23,
      "question": "How has Tesla's approach to Solar Roof production and its dependencies evolved from 2022 to 2024, particularly in terms of operational strategy and supply chain challenges?",
      "original_answer": "In 2022, Tesla emphasized improving Solar Roof installation capabilities by onboarding and training new installers and collaborating with real estate developers to reduce installation time and costs. The company also highlighted the need to maintain adequate battery cell supply and hire additional skilled electricians to support the ramp. By 2024, Tesla's focus had shifted to broader manufacturing and supply chain risks, with Solar Roof production now described as being dependent on the company's ability to manage global component procurement, avoid bottlenecks, and maintain cost-effective production amid potential supplier failures and inflationary pressures. The evolution reflects a shift from localized installer development to systemic supply chain and production scalability concerns.",
      "llm_answer": "From 2022 to 2024, Tesla shifted from a focus on scaling Solar Roof through installer training, developer partnerships, and simplified online ordering (2022) to a more constrained operational strategy driven by supply chain and labor challenges. By 2024, the company explicitly cited \"sensitivity to global component constraints\" and \"need to hire additional personnel, particularly skilled electricians\" to support Solar Roof ramp, while also acknowledging that \"production is sensitive to global component constraints\" and \"material price increases and supply chain challenges\" from the pandemic were forcing higher capital expenditures. This evolution reflects a move from aggressive deployment toward cautious, capacity-constrained growth reliant on internal battery cell production and supply chain stabilization.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "TSLA_10k_2022.pdf",
          "target_page": 34,
          "pages": [
            32,
            33,
            34,
            35,
            36
          ]
        },
        "hop_2_rel": {
          "source_file": "TSLA_10k_2024.pdf",
          "target_page": 17,
          "pages": [
            15,
            16,
            17,
            18,
            19
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 9,
        "total_chars": 49206,
        "num_window_pages": 9,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 12529,
        "completion_tokens": 204,
        "total_tokens": 12733
      }
    },
    {
      "question_id": 23,
      "question": "How has Duke Energy's estimated total cost to permanently close all coal ash basins in North Carolina and South Carolina evolved from 2022 to 2023, and what does this indicate about the company's progress under the Coal Ash Act?",
      "original_answer": "In 2022, Duke Energy estimated the total cost to permanently close all coal ash basins in North Carolina and South Carolina to be approximately $8 billion to $9 billion. By 2023, this estimate had decreased to approximately $7 billion to $8 billion, indicating a downward adjustment in projected costs. Additionally, the amount already spent on these closures increased from approximately $3.1 billion through 2021 (as reported in 2022) to approximately $4 billion through 2023. This evolution suggests that Duke Energy has made measurable progress in implementing closure plans under the Coal Ash Act, with more basins excavated and cost estimates refined over time.",
      "llm_answer": "From 2022 to 2023 Duke Energy’s estimated total cost to permanently close all coal‑ash basins in North Carolina and South Carolina fell from roughly $9.5 billion–$10.5 billion (as noted in the 2022 filing) to about $7 billion–$8 billion (as reflected in the 2023 filing), reflecting the impact of the 2019 settlement that reduced the projected excavation cost by about $1.5 billion. This reduction shows that, under the Coal Ash Act, the company has made measurable progress toward meeting the mandated closure deadlines—most basins have been excavated and closed, with only a few remaining sites to be completed over the next 10–20 years.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "DUK_10k_2022.pdf",
          "target_page": 71,
          "pages": [
            69,
            70,
            71,
            72,
            73
          ]
        },
        "hop_2_rel": {
          "source_file": "DUK_10k_2023.pdf",
          "target_page": 69,
          "pages": [
            67,
            68,
            69,
            70,
            71
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 68610,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 17393,
        "completion_tokens": 159,
        "total_tokens": 17553
      }
    },
    {
      "question_id": 23,
      "question": "How did the retail share of the 'on!' oral tobacco product evolved between 2023 and 2024, and what does this indicate about its market position relative to the overall oral tobacco product segment during this period?",
      "original_answer": "The retail share of the 'on!' oral tobacco product increased from 6.8% in 2023 to 8.3% in 2024. This indicates that 'on!' gained market share during this period. In contrast, the total oral tobacco product segment saw a decline in retail share, dropping from 42.5% in 2023 to 37.5% in 2024. This divergence suggests that 'on!' strengthened its position within the broader oral tobacco market between these years.",
      "llm_answer": "Between 2023 and 2024, the retail share of the “on!” oral tobacco product declined from 6.8% to 8.3% of the oral tobacco category, but its share of the broader nicotine‑pouch segment fell further—from 19.2% to 19.2% (a 2.6‑point drop).  Although “on!” still accounted for about 8 % of the oral‑tobacco market, its share slipped relative to the overall segment, indicating that the product’s market position is weakening within the faster‑growing nicotine‑pouch category.  This erosion of share suggests that “on!” is losing ground to competing pouch brands and to the overall growth of the oral‑tobacco segment.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MO_10k_2023.pdf",
          "target_page": 22,
          "pages": [
            20,
            21,
            22,
            23,
            24
          ]
        },
        "hop_2_rel": {
          "source_file": "MO_10k_2024.pdf",
          "target_page": 48,
          "pages": [
            46,
            47,
            48,
            49,
            50
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 46916,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 11966,
        "completion_tokens": 152,
        "total_tokens": 12119
      }
    },
    {
      "question_id": 23,
      "question": "How has Qualcomm's reliance on Chinese OEMs for revenue evolved from 2023 to 2024, and what implications does this have for its business stability?",
      "original_answer": "In 2023, Qualcomm derived a significant portion of its revenues from a small number of Chinese OEMs, highlighting its dependency on their device share growth in China and other regions. By 2024, this dependency persisted, with the company continuing to emphasize that it derives a significant portion of its revenues from these same OEMs. This ongoing reliance indicates that any political, economic, or market shifts affecting Chinese OEMs could continue to pose a risk to Qualcomm's revenue stability, particularly given the persistent U.S./China trade and national security tensions mentioned in both filings.",
      "llm_answer": "From 2023 to 2024, Qualcomm’s reliance on Chinese OEMs for revenue remained structurally significant but faced heightened risks. While the company continues to derive a substantial portion of its revenue from Chinese customers and licensees—particularly through premium-tier handset sales and licensing agreements—this concentration is increasingly vulnerable. Key risks include U.S./China trade tensions, potential U.S. export restrictions (e.g., the revocation of Huawei’s 4G/5G export license in May 2024), and China’s \"Made in China 2025\" policy, which incentivizes domestic semiconductor self-sufficiency. These factors could limit Qualcomm’s ability to sell integrated circuit products to Chinese OEMs, reduce payments from Chinese licensees, or accelerate customer-driven vertical integration (e.g., Apple and Samsung developing proprietary modem or application processor technologies). Consequently, while China remains a critical market, its evolving regulatory and geopolitical landscape poses material threats to revenue stability and long-term business resilience.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "QCOM_10k_2023.pdf",
          "target_page": 18,
          "pages": [
            16,
            17,
            18,
            19,
            20
          ]
        },
        "hop_2_rel": {
          "source_file": "QCOM_10k_2024.pdf",
          "target_page": 18,
          "pages": [
            16,
            17,
            18,
            19,
            20
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 64467,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 16338,
        "completion_tokens": 269,
        "total_tokens": 16607
      }
    },
    {
      "question_id": 23,
      "question": "How did Amgen's composition of total available-for-sale investments evolve between 2022 and 2023, particularly in terms of specific security types held?",
      "original_answer": "In 2022, Amgen reported total available-for-sale investments of $4,335 million, which included $1,676 million in marketable securities alongside $2,659 million in cash and cash equivalents. By 2023, Amgen no longer held any marketable securities or U.S. Treasury bills, and instead, the entire $10,404 million in total available-for-sale investments was composed of $10,266 million in money market mutual funds and $138 million in other short-term interest-bearing securities. This reflects a strategic shift toward more liquid and short-term interest-bearing instruments.",
      "llm_answer": "Between 2022 and 2023, Amgen’s available‑for‑sale investment portfolio remained essentially unchanged in composition, consisting solely of interest‑bearing securities (U.S. Treasury bills, money‑market mutual funds and short‑term interest‑bearing instruments). The amortized cost of these securities grew modestly from $10.4 billion at December 31 2023 to $11.5 billion at December 31 2024, but the types of securities held did not shift – Amgen continued to hold only Treasury bills, money‑market funds and short‑term interest‑bearing securities, maintaining its policy of limiting such investments to investment‑grade issuers with short maturities. No equity securities were included in the available‑for‑sale category during this period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AMGN_10k_2023.pdf",
          "target_page": 133,
          "pages": [
            131,
            132,
            133,
            134,
            135
          ]
        },
        "hop_2_rel": {
          "source_file": "AMGN_10k_2024.pdf",
          "target_page": 133,
          "pages": [
            131,
            132,
            133,
            134,
            135
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 46717,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 11904,
        "completion_tokens": 185,
        "total_tokens": 12089
      }
    },
    {
      "question_id": 24,
      "question": "How has the presence of Shake Shack as a tenant evolved across SPG's premium outlet properties between 2022 and 2023?",
      "original_answer": "In 2022, Shake Shack was listed as a tenant at Woodbury Common Premium Outlets in New York. By 2023, Shake Shack not only remained at Woodbury Common but also expanded its presence to Las Vegas Outlets North Premium in Nevada. This indicates a strategic expansion of Shake Shack’s footprint within SPG's portfolio of properties over the two years.",
      "llm_answer": "Between 2022 and 2023, Shake Shack’s presence across Simon Property Group’s premium outlet properties remained unchanged, with no indication of new tenant additions or removals in the provided data. The company’s footprint was consistent across both years, as evidenced by its recurring mention in tenant lists for properties like Sawgrass Mills (2022) and Woodbury Common Premium Outlets (2023), where it was listed alongside other major retailers without any noted changes in occupancy status. This suggests Shake Shack maintained its existing position within SPG’s premium outlet portfolio during this period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "SPG_10k_2022.pdf",
          "target_page": 35,
          "pages": [
            33,
            34,
            35,
            36,
            37
          ]
        },
        "hop_2_rel": {
          "source_file": "SPG_10k_2023.pdf",
          "target_page": 34,
          "pages": [
            32,
            33,
            34,
            35,
            36
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 69985,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 17709,
        "completion_tokens": 153,
        "total_tokens": 17862
      }
    },
    {
      "question_id": 24,
      "question": "How did the classification of retirement annuity contracts within the fair value hierarchy evolve between 2022 and 2024, and what does this indicate about GD's valuation methodology for these assets?",
      "original_answer": "In 2022, retirement annuity contracts were part of Level 3 assets, indicating that their fair value was determined using unobservable inputs. By 2024, these contracts remained in Level 3, but the disclosure noted that investments valued using net asset value (NAV) as a practical expedient were now included in the tables for reconciliation to total plan assets, which was not explicitly stated in 2022. This suggests a refinement in disclosure practices rather than a change in hierarchy classification, indicating that while the valuation methodology remained complex and less observable, GD improved transparency in how these assets are reported.",
      "llm_answer": "Between 2022 and 2024, the classification of retirement annuity contracts remained consistently in Level 3 of the fair value hierarchy across all disclosed years (2021–2024), with no movement to Level 1 or Level 2. This indicates that GD continues to value these contracts using significant unobservable inputs (e.g., internally developed models, discounted cash flows, or third-party appraisals), reflecting limited market transparency. Consequently, GD’s valuation methodology for these assets remains heavily reliant on internal estimates and proprietary assumptions, with no shift toward market-based pricing, underscoring persistent conservatism in fair value reporting for illiquid or non-traded retirement products.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "GD_10k_2022.pdf",
          "target_page": 93,
          "pages": [
            91,
            92,
            93,
            94,
            95
          ]
        },
        "hop_2_rel": {
          "source_file": "GD_10k_2024.pdf",
          "target_page": 93,
          "pages": [
            91,
            92,
            93,
            94,
            95
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 49520,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 12613,
        "completion_tokens": 180,
        "total_tokens": 12793
      }
    },
    {
      "question_id": 24,
      "question": "How did AIG's financial relationship with Corebridge evolve between 2023 and 2024, particularly in terms of potential equity dilution and income recognition?",
      "original_answer": "In 2023, AIG had a stake in Corebridge that included a potential equity dilution mechanism tied to Blackstone's right to exchange its ownership interest in Corebridge for AIG common shares, which would have introduced up to 24.1 million additional shares in 2022 (and 4.4 million in 2023) had the IPO not occurred before 2024. However, since the IPO occurred on September 19, 2022, this exchange right was terminated. By 2024, AIG's relationship with Corebridge had shifted from a stakeholding to an equity method investment, where AIG reported income based on dividends received and changes in Corebridge's stock price from June 9, 2024 onwards. This reflects a transformation from a potential equity dilution scenario to a post-divestiture equity income model.",
      "llm_answer": "Between 2023 and 2024, AIG’s financial relationship with Corebridge evolved from consolidation to deconsolidation, resulting in significant equity dilution and income recognition impacts. As AIG reduced its ownership stake through secondary offerings and ultimately sold a 21.6% stake to Nippon Life in December 2024, it recognized an $8.5 billion retained investment loss and reclassified $7.2 billion of accumulated other comprehensive loss, leading to a $4.75 billion after-tax loss from discontinued operations. This deconsolidation marked a strategic shift, with AIG retaining only a 22.7% equity interest as of December 31, 2024, while recognizing equity method income from Corebridge dividends and stock price changes.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AIG_10k_2023.pdf",
          "target_page": 242,
          "pages": [
            240,
            241,
            242,
            243,
            244
          ]
        },
        "hop_2_rel": {
          "source_file": "AIG_10k_2024.pdf",
          "target_page": 109,
          "pages": [
            107,
            108,
            109,
            110,
            111
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 130264,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 32791,
        "completion_tokens": 181,
        "total_tokens": 32973
      }
    },
    {
      "question_id": 25,
      "question": "How has Comcast's financial exposure to Universal Beijing Resort evolved from 2022 to 2024, based on its debt disclosures and consolidation treatment?",
      "original_answer": "In 2022, Comcast disclosed that Universal Beijing Resort had $3.6 billion in debt as of December 31, 2021, and $2.5 billion as of December 31, 2020. By 2024, Comcast clarified that Universal Beijing Resort had $3.4 billion in debt outstanding as of December 31, 2024, and $3.5 billion as of December 31, 2023. This indicates that the debt levels stabilized after earlier reductions, and Comcast now consolidates Universal Beijing Resort as a variable interest entity (VIE), with its assets and liabilities fully included in Comcast’s consolidated balance sheets at $7.3 billion in assets and $7.0 billion in liabilities as of 2024.",
      "llm_answer": "Comcast’s debt exposure to Universal Beijing Resort has declined modestly from 2022 to 2024. In the 2022 filing the resort’s debt was reported at $3.6 billion, and by the 2024 filing it had risen slightly to $3.4 billion (the amount of debt outstanding under the term loan fell from $3.1 billion in 2023 to $3.0 billion in 2024), while the consolidated balance‑sheet shows the resort’s total assets and liabilities falling from $7.8 billion/$7.2 billion in 2023 to $7.3 billion/$7.0 billion in 2024, reflecting a net reduction in the company’s direct financial exposure to the resort over the period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CMCSA_10k_2022.pdf",
          "target_page": 71,
          "pages": [
            69,
            70,
            71,
            72,
            73
          ]
        },
        "hop_2_rel": {
          "source_file": "CMCSA_10k_2024.pdf",
          "target_page": 86,
          "pages": [
            84,
            85,
            86,
            87,
            88
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 54244,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 13783,
        "completion_tokens": 150,
        "total_tokens": 13933
      }
    },
    {
      "question_id": 25,
      "question": "How has the structure of aircraft trade-in commitments changed between 2022 and 2023, particularly in terms of customer eligibility and risk exposure?",
      "original_answer": "In 2022, the Aerospace segment had outstanding options with 'some customers' to trade in aircraft as partial consideration for new aircraft purchases, indicating a broader or less-specific customer eligibility. By 2023, the eligibility was narrowed to 'some Gulfstream customers,' suggesting a more specific subset of customers was offered trade-in options. Additionally, while both years acknowledged the risk associated with adverse market changes affecting trade-in values, 2023 introduced a more specific framing by highlighting Gulfstream, a key business jet brand, which may indicate a strategic focus or increased risk concentration in that segment. Despite these structural changes, both years reported that the estimated change in fair market values from the commitment date was 'not material.'",
      "llm_answer": "The aircraft trade‑in commitments remained structured similarly in 2022 and 2023, but the 2023 filing shows a shift toward more formalized fair‑value assessments and greater emphasis on risk exposure: commitments are now generally set at fair market value ≤ 45 days before new‑aircraft delivery, with customers required to exercise or let the option expire, and any excess of the pre‑established trade‑in price over that fair market value is recorded as a reduction of new‑aircraft revenue. Earlier disclosures (2022) described the same mechanics but did not stress the “pre‑established trade‑in value” guarantees or the explicit revenue‑reduction treatment as prominently as the 2023 language. Consequently, while eligibility (options granted to Gulfstream customers) was unchanged, the 2023 commitments carry a clearer, more formal risk‑allocation framework that heightens exposure to market‑value fluctuations.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "GD_10k_2022.pdf",
          "target_page": 77,
          "pages": [
            75,
            76,
            77,
            78,
            79
          ]
        },
        "hop_2_rel": {
          "source_file": "GD_10k_2023.pdf",
          "target_page": 79,
          "pages": [
            77,
            78,
            79,
            80,
            81
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 38898,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 9945,
        "completion_tokens": 228,
        "total_tokens": 10173
      }
    },
    {
      "question_id": 25,
      "question": "How has Tesla's approach to the Tesla Semi evolved between 2022 and 2024, particularly in terms of its production status and strategic positioning within Tesla's product lineup?",
      "original_answer": "In 2022, Tesla had only announced the Tesla Semi as part of its planned electric vehicles, indicating it was in the conceptual and development phase. By 2024, Tesla had moved the Tesla Semi into 'pilot production' at its Nevada facility, signaling a significant advancement in its development and a step closer to commercialization. This evolution reflects Tesla's strategic shift from merely planning the vehicle to actively preparing it for market entry.",
      "llm_answer": "Between 2022 and 2024, Tesla's approach to the Semi evolved from pilot production to active development within its broader product strategy. The 2022 filing (page 5) lists the Semi among \"Future Consumer and Commercial Electric Vehicles\" alongside Cybertruck and next-gen Roadster, while the 2024 filing (page 37) confirms it remains in \"Pilot production\" at Nevada, alongside ongoing development of Cybercab. Crucially, the 2024 update (page 34) positions the Semi as part of Tesla's \"next generation vehicle platform\" and emphasizes its role in expanding manufacturing capacity for \"newer vehicle models\" to improve affordability and customer awareness, though it remains secondary to consumer vehicles like the updated Model Y in near-term rollout plans.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "TSLA_10k_2022.pdf",
          "target_page": 5,
          "pages": [
            3,
            4,
            5,
            6,
            7
          ]
        },
        "hop_2_rel": {
          "source_file": "TSLA_10k_2024.pdf",
          "target_page": 36,
          "pages": [
            34,
            35,
            36,
            37,
            38
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 38104,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 9753,
        "completion_tokens": 189,
        "total_tokens": 9942
      }
    },
    {
      "question_id": 25,
      "question": "How did the valuation allowance related to Altria's investment in Cronos evolve between 2022 and 2024, and what does this indicate about the company's expectations regarding the realizability of associated deferred tax assets?",
      "original_answer": "Between 2022 and 2024, the valuation allowance related to Altria's investment in Cronos increased from $379 million in 2022 to $402 million in 2024. This indicates that Altria continued to maintain significant uncertainty regarding the realizability of deferred tax assets associated with the Cronos investment, as the company still did not expect the temporary difference to reverse in the foreseeable future. The steady increase in the allowance suggests a cautious stance by Altria in recognizing the full value of these assets.",
      "llm_answer": "The valuation allowance related to Altria's investment in Cronos decreased from $397 million at the end of 2023 to $402 million at the end of 2024, reflecting a modest increase in the deferred tax asset for the Cronos investment but still leaving a significant allowance in place. This reduction signals that Altria now expects a greater likelihood of realizing the associated deferred tax assets, though it remains cautious and continues to maintain a valuation allowance to account for uncertainty regarding the ultimate realizability of those assets.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MO_10k_2023.pdf",
          "target_page": 30,
          "pages": [
            28,
            29,
            30,
            31,
            32
          ]
        },
        "hop_2_rel": {
          "source_file": "MO_10k_2024.pdf",
          "target_page": 84,
          "pages": [
            82,
            83,
            84,
            85,
            86
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 9,
        "total_chars": 49615,
        "num_window_pages": 9,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 12643,
        "completion_tokens": 138,
        "total_tokens": 12782
      }
    },
    {
      "question_id": 25,
      "question": "How did the financial treatment and valuation impact of Amgen's investment in BeiGene evolve between 2023 and 2024?",
      "original_answer": "In 2023, Amgen changed the accounting method for its investment in BeiGene from the equity method to fair value, resulting in gains recognized in connection with this revaluation. By 2024, the investment contributed net unrealized losses within Amgen's Other income (expense), net, reflecting a shift from gains in 2023 to losses in 2024 due to market or valuation changes. This evolution shows a reversal in the financial benefit derived from the BeiGene investment over the two years.",
      "llm_answer": "Between 2023 and 2024, Amgen’s financial treatment of its investment in BeiGene shifted from equity-method accounting to fair‑value measurement, with changes in fair value now recognized directly in earnings. This change, disclosed in the 2024 filing (page 77), caused other‑income/expense to swing from gains in 2023 (driven by fair‑value adjustments) to net unrealized losses in 2024, while also affecting related tax expense and the overall effective tax rate. Consequently, the valuation impact of the BeiGene stake became more volatile and was reflected directly in the company’s net income rather than being deferred through equity earnings.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AMGN_10k_2023.pdf",
          "target_page": 78,
          "pages": [
            76,
            77,
            78,
            79,
            80
          ]
        },
        "hop_2_rel": {
          "source_file": "AMGN_10k_2024.pdf",
          "target_page": 77,
          "pages": [
            75,
            76,
            77,
            78,
            79
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 52675,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 13382,
        "completion_tokens": 161,
        "total_tokens": 13543
      }
    },
    {
      "question_id": 26,
      "question": "How has the positioning and market strategy for Disney+ Hotstar evolved between 2023 and 2024, particularly in terms of its regional branding and service structure?",
      "original_answer": "In 2023, Disney+ Hotstar was described as a DTC service primarily in India that offered general entertainment, family, and sports programming. It was positioned as a distinct regional brand within Disney’s broader Direct-to-Consumer portfolio. By 2024, while still branded as Disney+ Hotstar in India and Southeast Asia, the company had merged its previously separate Star+ and Disney+ services in Latin America into a single Disney+ product offering by the end of June 2024. This indicates a strategic shift toward consolidating regional streaming services under the Disney+ brand umbrella, streamlining offerings, and possibly enhancing content integration across markets.",
      "llm_answer": "Between 2023 and 2024, Disney+ Hotstar’s positioning evolved from a distinct regional brand to a unified component of Disney’s broader direct-to-consumer (DTC) strategy. Previously described as a standalone service in India and Southeast Asia offering general entertainment, family, and sports content, it was rebranded and integrated into Disney’s global DTC portfolio, with its multi-product offerings (like Combo+) merged into a single Disney+ service by mid-2024. This shift reflects a strategic move to consolidate regional offerings under the Disney+ umbrella while maintaining localized branding (e.g., Disney+ Hotstar in India) to preserve market relevance, as evidenced by its inclusion in subscriber metrics and multi-product bundling data. The change underscores Disney’s focus on streamlining its DTC ecosystem, leveraging shared infrastructure and content, and aligning regional services with global operational frameworks to enhance scalability and reduce complexity.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "DIS_10k_2023.pdf",
          "target_page": 4,
          "pages": [
            2,
            3,
            4,
            5,
            6
          ]
        },
        "hop_2_rel": {
          "source_file": "DIS_10k_2024.pdf",
          "target_page": 57,
          "pages": [
            55,
            56,
            57,
            58,
            59
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 46862,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 11939,
        "completion_tokens": 245,
        "total_tokens": 12184
      }
    },
    {
      "question_id": 26,
      "question": "How did PayPal's approach to its Protection Programs evolve between 2023 and 2024, particularly in terms of risk exposure and loss recovery mechanisms?",
      "original_answer": "In 2023, PayPal disclosed that the costs associated with its protection programs were recorded in 'transaction and credit losses' during the period the payment transaction was completed, and it did not provide a separate service to customers under these programs. By 2024, PayPal introduced more detailed disclosures around its protection programs, highlighting that it incurs substantial losses from these programs due to customer disputes and faces challenges in recovering losses from merchants, especially in cases involving fraud or merchant insolvency. Additionally, PayPal noted that it may face increased exposure due to evolving fraud schemes and potential regulatory changes affecting chargeback requirements. This indicates a shift toward more explicit risk acknowledgment and a broader understanding of potential financial impact.",
      "llm_answer": "PayPal’s protection programs have not changed materially between 2023 and 2024 – the company continues to record associated costs as transaction and credit‑loss expenses and to estimate loss‑recovery through allowances and charge‑back recoveries.  However, the 2024 filing adds more explicit discussion of the risk that fraud‑related losses, charge‑backs and merchant defaults could increase the loss rate and strain earnings, and it highlights new regulatory uncertainties (e.g., the FDIC “valid‑when‑made” rule) that could affect how the company acquires and recovers loan receivables under its credit products.  In short, the core risk‑exposure and loss‑recovery mechanisms remain the same, but the 2024 disclosures draw greater attention to evolving fraud threats, regulatory changes, and the potential for higher charge‑off rates that could impact the company’s loss‑recovery outlook.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "PYPL_10k_2023.pdf",
          "target_page": 77,
          "pages": [
            75,
            76,
            77,
            78,
            79
          ]
        },
        "hop_2_rel": {
          "source_file": "PYPL_10k_2024.pdf",
          "target_page": 24,
          "pages": [
            22,
            23,
            24,
            25,
            26
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 55501,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 14097,
        "completion_tokens": 222,
        "total_tokens": 14319
      }
    },
    {
      "question_id": 26,
      "question": "How has NextEra Energy's relationship with solar generation facilities evolved from 2022 to 2024, particularly in terms of ownership structure and financial exposure?",
      "original_answer": "In 2022, NextEra Energy Resources was actively divesting ownership stakes in solar generation facilities, including the sale of a 100% ownership interest in a 100 MW solar facility in Arizona and the sale of a 90% ownership interest in a portfolio that included four solar facilities. These transactions resulted in significant cash proceeds and the recognition of gains. By 2024, the company's relationship had transformed into a more complex structure involving equity stakes and consolidated variable interest entities (VIEs). For example, NextEra consolidated eight VIEs owning solar generation facilities with approximately 765 MW of capacity and held a 10% direct ownership interest in additional solar facilities. This shift indicates a strategic move from outright ownership and divestiture to a more diversified and financially leveraged stake through VIEs, with increased financial exposure through guarantees and credit support.",
      "llm_answer": "From 2022 to 2024, NextEra Energy’s solar‑related assets have shifted from being primarily held through consolidated subsidiaries (e.g., NEER) to a structure that combines consolidated projects with a growing portfolio of jointly‑owned and variable‑interest entities.  The company has sold controlling stakes in several solar (and wind‑plus‑storage) portfolios to NextEra Energy Partners (NEP) and other third parties, recording noncontrolling interests and, in some cases, contract liabilities for future construction milestones.  This evolution reflects a move toward shared ownership and financing arrangements, while still maintaining operational control through service agreements and guarantees, and results in NEE’s financial exposure being split between its retained equity stakes and the variable‑interest entities it continues to consolidate.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "NEE_10k_2022.pdf",
          "target_page": 81,
          "pages": [
            79,
            80,
            81,
            82,
            83
          ]
        },
        "hop_2_rel": {
          "source_file": "NEE_10k_2024.pdf",
          "target_page": 97,
          "pages": [
            95,
            96,
            97,
            98,
            99
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 64775,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 16419,
        "completion_tokens": 213,
        "total_tokens": 16632
      }
    },
    {
      "question_id": 26,
      "question": "How did ACN's investment in Mutual Fund Debt Securities evolve from 2022 to 2023, and what was the change in valuation methodology as reflected in the fair value hierarchy levels?",
      "original_answer": "In 2022, ACN reported Mutual Fund Debt Securities valued at $379,989 with the entire amount categorized under Level 2 of the fair value hierarchy. In 2023, this investment decreased to $253,025, and the valuation remained entirely under Level 2. The decrease in value indicates a reduction in exposure to Mutual Fund Debt Securities over the year, while the valuation methodology remained consistent, relying on observable market data.",
      "llm_answer": "From 2022 to 2023, ACN’s investment in Mutual Fund Debt Securities declined from $379,989 million (Level 2) to $379,989 million (still Level 2) but the underlying fair‑value hierarchy remained Level 2, reflecting that the securities are quoted prices for similar instruments in active markets. The valuation methodology did not change; the assets continued to be classified as Level 2 in the fair‑value hierarchy, with no shift to Level 1 or Level 3.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "ACN_10k_2022.pdf",
          "target_page": 89,
          "pages": [
            87,
            88,
            89,
            90,
            91
          ]
        },
        "hop_2_rel": {
          "source_file": "ACN_10k_2023.pdf",
          "target_page": 96,
          "pages": [
            81,
            82,
            83,
            84,
            85
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 33412,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 8581,
        "completion_tokens": 112,
        "total_tokens": 8694
      }
    },
    {
      "question_id": 27,
      "question": "How has Chevron's financial stake and involvement in Tengizchevroil evolved between 2022 and 2023?",
      "original_answer": "In 2022, Chevron's carrying value of its investment in Tengizchevroil was $23,727 million with a reported equity in earnings of $1,238 million. By 2023, Chevron disclosed that its carrying value was approximately $80 million higher than its underlying equity in Tengizchevroil's net assets, indicating a more complex valuation approach. Additionally, Chevron highlighted that it provided a loan of $4,500 million to Tengizchevroil to fund the Future Growth Project and Wellhead Pressure Management Project (FGP/WPMP). This shows a significant deepening of Chevron's financial involvement and strategic commitment to the partnership in 2023 compared to 2022.",
      "llm_answer": "Chevron’s financial stake in the Tengizchevroil joint venture grew modestly from $26.5 billion at the end of 2022 to $26.95 billion at the end of 2023, while its share of the venture’s underlying equity remained roughly unchanged (about $3.38 billion in 2023 versus $2.83 billion in 2022).  The company also increased the carrying value of its investment in Tengizchevroil by roughly $400 million over the two‑year period, reflecting the loan it holds for the FGP/WPMP development project.  Overall, Chevron’s involvement in the Tengizchevroil upstream segment remained stable, with only a small rise in the reported investment balance and continued 50 % equity ownership.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CVX_10k_2022.pdf",
          "target_page": 78,
          "pages": [
            76,
            77,
            78,
            79,
            80
          ]
        },
        "hop_2_rel": {
          "source_file": "CVX_10k_2023.pdf",
          "target_page": 82,
          "pages": [
            80,
            81,
            82,
            83,
            84
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 56646,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 14370,
        "completion_tokens": 168,
        "total_tokens": 14538
      }
    },
    {
      "question_id": 27,
      "question": "How has Disney's relationship with ABC Network evolved between 2023 and 2024, particularly in terms of its strategic positioning within Disney's broader entertainment ecosystem?",
      "original_answer": "In 2023, ABC Network was positioned as a core component of Disney's 'Linear Networks' within the Entertainment segment, specifically highlighting its domestic footprint through eight owned ABC television stations and its role in content distribution. By 2024, ABC Network's role had evolved, with its programming becoming more integrated into Disney's direct-to-consumer platforms, such as Hulu and Disney+. Specifically, content from ABC Network was made available on Hulu's SVOD service one day after its linear airing. This shift indicates a strategic move toward digital integration and away from traditional linear distribution. Additionally, while ABC Network was still referenced in the context of affiliate fees in 2023, 2024 emphasized its contribution to streaming services rather than standalone linear revenue.",
      "llm_answer": "Disney's relationship with ABC Network has strengthened its strategic positioning within the broader entertainment ecosystem by integrating ABC's broadcast reach with Disney's direct-to-consumer platforms and sports content. The company leverages ABC's linear networks (including ESPN on ABC) to distribute sports programming and promote its DTC services like ESPN+, while using ABC's extensive distribution network to support subscriber growth for Disney+ and Hulu. This integration is further reinforced by the planned launch of an ESPN-branded tile on Disney+ in early fiscal 2025, which will enhance cross-platform synergy and reinforce Disney's unified entertainment strategy.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "DIS_10k_2023.pdf",
          "target_page": 78,
          "pages": [
            76,
            77,
            78,
            79,
            80
          ]
        },
        "hop_2_rel": {
          "source_file": "DIS_10k_2024.pdf",
          "target_page": 7,
          "pages": [
            5,
            6,
            7,
            8,
            9
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 42747,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 10913,
        "completion_tokens": 170,
        "total_tokens": 11084
      }
    },
    {
      "question_id": 27,
      "question": "How has General Dynamics' positioning of the ASCOD vehicle within its Land Systems portfolio evolved between 2022 and 2023, and what does this indicate about potential shifts in production focus or investment allocation?",
      "original_answer": "In 2022, General Dynamics explicitly stated it was 'producing and upgrading' the ASCOD vehicle, indicating active development and enhancement of the platform. By 2023, the company's disclosure shifted to simply 'offering' the ASCOD, without specific mention of production or upgrades. This change in language suggests a potential shift in focus away from active investment or development of the ASCOD platform, possibly reallocating resources to other vehicle programs like the Piranha 5 and AJAX, which are explicitly called out in both years with continued production and international deployments.",
      "llm_answer": "Between 2022 and 2023, General Dynamics' ASCOD vehicle positioning within its Land Systems portfolio shifted from being highlighted as one of several key tracked platforms (e.g., alongside Piranha, Duro, Eagle) to being explicitly emphasized as a core, versatile tracked combat vehicle offered by European Land Systems (ELS) for multiple international customers, including Spain (Pizarro) and Austria (Ulan). This evolution reflects a strategic focus on expanding ASCOD production and upgrades—evidenced by ELS producing and upgrading ASCOD variants for export markets—while simultaneously accelerating investment in next-generation platforms like the M1E3 Abrams and Stryker upgrades, suggesting a dual-track approach where ASCOD supports near-term export growth and modernization efforts, but is not the primary focus of domestic U.S. Army production shifts.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "GD_10k_2022.pdf",
          "target_page": 11,
          "pages": [
            9,
            10,
            11,
            12,
            13
          ]
        },
        "hop_2_rel": {
          "source_file": "GD_10k_2023.pdf",
          "target_page": 11,
          "pages": [
            9,
            10,
            11,
            12,
            13
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 24557,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 6377,
        "completion_tokens": 215,
        "total_tokens": 6592
      }
    },
    {
      "question_id": 27,
      "question": "How has PayPal's utilization of European customer balances for credit activities evolved between 2023 and 2024, and what does this shift indicate about the company's credit funding strategy?",
      "original_answer": "In 2023, PayPal had approved $3.0 billion of European customer balances for credit activities, representing approximately 39% of balances made available for corporate use. By 2024, the approved amount had decreased to $2.0 billion, or 26% of European customer balances. This indicates a strategic shift toward reducing reliance on customer balances for credit funding, potentially in favor of external financing sources, as evidenced by PayPal's multi-year agreement to sell consumer installment receivables, which saw $20.8 billion in loans sold in 2024 compared to $5.5 billion in 2023.",
      "llm_answer": "PayPal's utilization of European customer balances for credit activities declined from $3.0 billion (≈39% of European balances) in 2023 to $2.0 billion (≈26% of European balances) in 2024, reflecting a deliberate reduction in the proportion of those funds earmarked for credit funding. This shift indicates that the company is moving away from relying heavily on customer‑held balances to finance its credit products and is instead seeking external sources of capital to support its growing loan portfolio.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "PYPL_10k_2023.pdf",
          "target_page": 71,
          "pages": [
            69,
            70,
            71,
            72,
            73
          ]
        },
        "hop_2_rel": {
          "source_file": "PYPL_10k_2024.pdf",
          "target_page": 46,
          "pages": [
            44,
            45,
            46,
            47,
            48
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 51156,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 13021,
        "completion_tokens": 126,
        "total_tokens": 13147
      }
    },
    {
      "question_id": 27,
      "question": "How did the valuation and categorization of equity securities within NEE's Special Use Funds evolve between 2022 and 2024, and what does this indicate about changes in transparency or investment composition?",
      "original_answer": "In 2022, NEE's Special Use Funds reported equity securities at a carrying amount of $906 million (with an estimated fair value of $907 million) for NEE and $672 million (with an estimated fair value of $672 million) for FPL, without detailed categorization by valuation levels. By 2024, the equity securities in the Special Use Funds had grown significantly, with NEE holding $2,614 million in Level 1 equity securities and FPL holding $1,028 million in Level 1 equity securities, alongside more granular disclosures that included Level 2 and Level 3 valuations. This indicates a substantial increase in equity investments and a shift toward more transparent and detailed reporting of asset valuation methodologies.",
      "llm_answer": "Between 2022 and 2024, NEE’s Special Use Funds shifted from primarily Level 2 equity and debt holdings (with minimal Level 3 exposure) in 2021‑2022 to a higher proportion of Level 3 assets—particularly equity securities and certain debt securities—by 2024, as shown by the increasing Level 3 balances in the fair‑value hierarchy tables (e.g., $229 million of Level 3 equity for NEE and $204 million for FPL in 2024 versus virtually none in earlier years). This evolution reflects a more complex, less transparent investment composition, with greater reliance on unobservable inputs and private‑equity‑style assets, indicating reduced visibility into the underlying securities and heightened reliance on internal valuation techniques.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "NEE_10k_2022.pdf",
          "target_page": 90,
          "pages": [
            88,
            89,
            90,
            91,
            92
          ]
        },
        "hop_2_rel": {
          "source_file": "NEE_10k_2024.pdf",
          "target_page": 89,
          "pages": [
            87,
            88,
            89,
            90,
            91
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 70906,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 17962,
        "completion_tokens": 183,
        "total_tokens": 18145
      }
    },
    {
      "question_id": 27,
      "question": "How did the scope and utilization of Accenture's share purchase program evolve from fiscal 2022 to fiscal 2023, particularly in terms of shares acquired under the public program versus those acquired through employee-related transactions?",
      "original_answer": "In fiscal 2022, Accenture purchased 1,964,612 Class A ordinary shares under the publicly announced open-market share purchase program for an aggregate price of $576 million. Additionally, 97,251 shares were acquired through employee-related transactions, such as share withholding for payroll tax obligations, which do not affect the aggregate available authorization. In fiscal 2023, there is no mention of shares purchased under the public program, but the company continued acquiring shares through employee-related transactions under equity share plans. This indicates a shift where the public share purchase program saw reduced or no activity, while employee-related share acquisitions remained consistent.",
      "llm_answer": "From fiscal 2022 to fiscal 2023 the company’s share‑purchase activity shifted toward a larger share of the total purchases being made under the publicly announced open‑market program rather than through employee‑related transactions. In fiscal 2022, of the 2.06 million shares bought in the fourth quarter, 1.96 million (about 95 %) were acquired under the public program, with the remaining ~97 k shares coming from employee‑forfeiture transactions; by fiscal 2023 the proportion of shares purchased under the public program grew further, reflecting an increased authorization and larger dollar amount of shares authorized for repurchase, while employee‑related acquisitions remained a small, non‑material component of the overall program.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "ACN_10k_2022.pdf",
          "target_page": 33,
          "pages": [
            31,
            32,
            33,
            34,
            35
          ]
        },
        "hop_2_rel": {
          "source_file": "ACN_10k_2023.pdf",
          "target_page": 101,
          "pages": [
            81,
            82,
            83,
            84,
            85
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 29973,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 7736,
        "completion_tokens": 185,
        "total_tokens": 7921
      }
    },
    {
      "question_id": 28,
      "question": "How did Chevron's financial reporting relationship with Chevron Phillips Chemical Company LLC evolve between 2022 and 2023, particularly in terms of its consolidation status and investment accounting approach?",
      "original_answer": "In 2022, Chevron Phillips Chemical Company LLC was consolidated into Chevron’s financial statements, as indicated by the inclusion of 'Note 8: Summarized Financial Data - Chevron Phillips Chemical Company LLC' among other consolidated subsidiaries. However, in 2023, Chevron explicitly stated that its investment in Chevron Phillips Chemical Company LLC was accounted for using the equity method, and it was no longer consolidated under Chevron U.S.A. Inc.'s financial data. This reflects a significant structural change where Chevron transitioned from consolidating the entity to reporting its investment under the equity method, altering how its financial performance is reflected in Chevron’s consolidated results.",
      "llm_answer": "Between 2022 and 2023, Chevron's consolidation status for Chevron Phillips Chemical Company LLC (CPChem) remained unchanged – it continued to be accounted for using the equity method, as reflected in the \"Investments and Advances\" section of Note 15 in both 2022 and 2023 filings. The company did not record any material nonrecurring fair‑value adjustments to its investment in CPChem during this period, and the carrying value of the investment was reported as $14,683 million at the end of 2023 versus $13,569 million at the end of 2022. Consequently, there was no shift in consolidation treatment; Chevron maintained its equity‑method accounting approach for CPChem throughout 2022‑2023.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CVX_10k_2022.pdf",
          "target_page": 32,
          "pages": [
            30,
            31,
            32,
            33,
            34
          ]
        },
        "hop_2_rel": {
          "source_file": "CVX_10k_2023.pdf",
          "target_page": 75,
          "pages": [
            73,
            74,
            75,
            76,
            77
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 9,
        "total_chars": 50872,
        "num_window_pages": 9,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 12954,
        "completion_tokens": 172,
        "total_tokens": 13126
      }
    },
    {
      "question_id": 28,
      "question": "How has the role of Hydra-70 rockets in General Dynamics' Combat Systems segment evolved from 2022 to 2023, particularly in terms of contract involvement and production capacity expansion?",
      "original_answer": "In 2022, General Dynamics received a $175 million contract for the production of Hydra-70 rockets as part of its Combat Systems segment. By 2023, the company's role had evolved significantly, with OTS (Orbital Technologies Corporation, part of Combat Systems) maintaining a market-leading position in the supply of Hydra-70 rockets and expanding its production capacity. Specifically, OTS received awards to increase metal parts production capacity for munitions from 18,000 to 86,000 rounds per month by 2025, which includes Hydra-70 rockets as part of its broader munitions portfolio.",
      "llm_answer": "From 2022 to 2023, Hydra-70 rocket production was expanded under a $175 contract awarded to OTS (Ordnance and Tactical Systems) within the Combat Systems segment, reflecting increased demand and capacity investment to support U.S. Army artillery modernization. This production growth aligns with broader segment revenue growth, as Combat Systems revenue rose to $8.268 billion in 2023 (from $7.308 billion in 2022), driven by systems like the Stryker M-SHORAD and Abrams upgrades, with Hydra-70 rockets being a key component of these land warfare platforms.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "GD_10k_2022.pdf",
          "target_page": 42,
          "pages": [
            40,
            41,
            42,
            43,
            44
          ]
        },
        "hop_2_rel": {
          "source_file": "GD_10k_2023.pdf",
          "target_page": 12,
          "pages": [
            10,
            11,
            12,
            13,
            14
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 26143,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 6766,
        "completion_tokens": 139,
        "total_tokens": 6905
      }
    },
    {
      "question_id": 28,
      "question": "How has PayPal's treatment of the Global Restricted Stock Unit Award Grant Notice evolved between the 2023 and 2024 filings, particularly in terms of its documentation status and associated agreements?",
      "original_answer": "In the 2023 filing, the Global Restricted Stock Unit Award Grant Notice was listed as Exhibit 10.07+ and was associated with the PayPal Holdings, Inc. 2015 Equity Incentive Award Plan, with its form incorporated by reference from 10-12B/A filed on May 14, 2015. By 2024, the same form of the Global Restricted Stock Unit Award Grant Notice (Exhibit 10.07+) remained in place, still referencing the 2015 plan and incorporated by reference from the same 10-12B/A filing on May 14, 2015. However, in the 2024 filing, there was an updated form of the Global Performance Based Restricted Stock Unit Award Grant Notice (Exhibit 10.08+), which was now filed under the amended and restated plan and was linked to a more recent 10-Q filing on April 30, 2024. This indicates that while the base RSU grant notice remained unchanged, the performance-based variant saw active revision and documentation updates in 2024.",
      "llm_answer": "Based on the provided SEC 10-K filings, PayPal's treatment of the Global Restricted Stock Unit Award Grant Notice has evolved in documentation status and agreement references between 2023 and 2024. In the 2023 filing (page 124), the notice was referenced as part of the \"Form of Global Restricted Stock Unit Award Grant Notice and Restricted Stock Unit Award Agreement under the PayPal Holdings, Inc. 2015 Equity Incentive Award Plan\" (Exhibit 10.07+), which was originally filed in 2015 (10-12B/A). By the 2024 filing (page 123), this same exhibit is still listed but now appears under the updated \"PayPal Holdings, Inc. 2015 Equity Incentive Award Plan, as Amended and Restated\" (Exhibit 10.03+), with the notice specifically cited in the context of the amended plan. The documentation status remains consistent as a filed exhibit, but the agreement context is now explicitly tied to the plan's amended and restated version, reflecting updated governance under the current equity incentive framework.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "PYPL_10k_2023.pdf",
          "target_page": 124,
          "pages": [
            122,
            123,
            124,
            125,
            126
          ]
        },
        "hop_2_rel": {
          "source_file": "PYPL_10k_2024.pdf",
          "target_page": 121,
          "pages": [
            119,
            120,
            121,
            122,
            123
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 68426,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 17343,
        "completion_tokens": 250,
        "total_tokens": 17594
      }
    },
    {
      "question_id": 28,
      "question": "How has the role of Opdivo within Bristol-Myers Squibb's portfolio evolved from 2022 to 2024, based on its revenue performance and new regulatory approvals?",
      "original_answer": "In 2022, Opdivo generated $7,523 million in revenue, indicating it was a major contributor to Bristol-Myers Squibb's oncology portfolio. By 2024, Opdivo received a new FDA approval in March 2024 for use in combination with cisplatin and gemcitabine for the first-line treatment of adult patients with unresectable or metastatic urothelial carcinoma. This regulatory expansion demonstrates a strategic evolution in Opdivo’s therapeutic application and reinforces its continued importance in the company's oncology pipeline, despite not showing a significant revenue increase from earlier years.",
      "llm_answer": "From 2022 to 2024, Opdivo’s revenue grew steadily ($7,523 M in 2021 → $7,523 M in 2022 and $7,523 M in 2023, with a modest increase to $7,523 M in 2024), but its strategic importance rose sharply as new regulatory approvals expanded its use across multiple oncology indications—including accelerated FDA approvals for Breyanzi and Abecma, and a March 2024 approval for Opdivo in combination with cisplatin and gemcitabine for first‑line urothelial carcinoma. These approvals, together with ongoing launches such as Opdivo Qvantig (December 2024) and multiple label expansions in 2024, have strengthened Opdivo’s position as a core growth driver within BMS’s portfolio.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "BMY_10k_2022.pdf",
          "target_page": 110,
          "pages": [
            108,
            109,
            110,
            111,
            112
          ]
        },
        "hop_2_rel": {
          "source_file": "BMY_10k_2024.pdf",
          "target_page": 45,
          "pages": [
            43,
            44,
            45,
            46,
            47
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 8,
        "total_chars": 43734,
        "num_window_pages": 8,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 11157,
        "completion_tokens": 167,
        "total_tokens": 11324
      }
    },
    {
      "question_id": 29,
      "question": "How did Chevron's financial involvement and strategic support for Chevron Phillips Chemical Company LLC evolve between 2022 and 2023, particularly in terms of project funding and investment structure?",
      "original_answer": "In 2022, Chevron highlighted its 50% ownership in Chevron Phillips Chemical Company LLC (CPChem), emphasizing ongoing investments in global manufacturing facilities and expansion projects, such as the planned 1-hexene unit in Old Ocean, Texas, and a C3 splitter at Cedar Bayou, with targeted start-ups in 2023. By 2023, Chevron's involvement had evolved to include a direct loan of $387 million to fund a portion of the Golden Triangle Polymers Project in Orange, Texas, in which CPChem owns 51%. This indicates a shift from general equity ownership and project announcements in 2022 to more direct financial support and structured investment in specific projects in 2023.",
      "llm_answer": "Between 2022 and 2023, Chevron’s financial involvement and strategic support for Chevron Phillips Chemical Company LLC evolved through increased investment and project funding. In 2023, Chevron held a 50% equity stake in Chevron Phillips Chemical, with its share of affiliate net income rising to $5,485 (from $8,595 in 2022), reflecting stronger performance in downstream operations. The company also provided a $387 million loan to fund the Golden Triangle Polymers Project in Orange, Texas, and increased its investment in the affiliate from $6,843 (2022) to $7,765 (2023). This growth aligns with Chevron Phillips Chemical’s expansion plans, including new ethylene and propylene units, which were advancing toward 2023 start-up. The investment structure remained consistent as an equity method holding, but financial commitments and project funding intensified to support downstream petrochemical growth.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CVX_10k_2022.pdf",
          "target_page": 18,
          "pages": [
            16,
            17,
            18,
            19,
            20
          ]
        },
        "hop_2_rel": {
          "source_file": "CVX_10k_2023.pdf",
          "target_page": 82,
          "pages": [
            80,
            81,
            82,
            83,
            84
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 51816,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 13188,
        "completion_tokens": 227,
        "total_tokens": 13415
      }
    },
    {
      "question_id": 29,
      "question": "How did PayPal's protection programs evolve between 2023 and 2024 in terms of financial commitments and disclosures regarding transaction loss reserves?",
      "original_answer": "In 2023, PayPal disclosed that it estimated and recorded costs associated with protection programs in transaction and credit losses, but did not specify the exact amounts for the allowance for transaction losses or negative customer balances. In 2024, PayPal provided more detailed disclosures, including specific figures: the allowance for transaction losses increased from $64 million in 2023 to $86 million in 2024, and the allowance for negative customer balances rose from $218 million to $256 million. This indicates a significant increase in PayPal's financial commitments and potential risk exposure under its protection programs in 2024 compared to the prior year.",
      "llm_answer": "Between 2023 and 2024, PayPal’s transaction loss reserves grew from a $64 million allowance at the end of 2023 to $86 million by the end of 2024, reflecting an increase in provisions to $1.114 billion in 2024 (up from $1.192 billion in 2023) and resulting in an ending allowance of $342 million after accounting for realized losses and recoveries. This expansion of the protection‑program reserve was disclosed in the “Protection Programs” note (page 110) and is tied to the company’s ongoing need to cover potential consumer‑ and merchant‑losses under its assurance‑type warranty framework. The company continues to record these reserves as part of transaction and credit losses, with the allowance for transaction losses rising to $86 million and the allowance for negative customer balances increasing to $256 million in 2024.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "PYPL_10k_2023.pdf",
          "target_page": 77,
          "pages": [
            75,
            76,
            77,
            78,
            79
          ]
        },
        "hop_2_rel": {
          "source_file": "PYPL_10k_2024.pdf",
          "target_page": 110,
          "pages": [
            108,
            109,
            110,
            111,
            112
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 47806,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 12175,
        "completion_tokens": 207,
        "total_tokens": 12382
      }
    },
    {
      "question_id": 29,
      "question": "How has McDonald's strategic framing of its relationship with franchisees changed between 2022 and 2024, particularly in terms of franchising as a core business model and the role of franchisee co-investment?",
      "original_answer": "In 2022, McDonald's described its relationship with franchisees in neutral, structural terms, emphasizing the division of responsibilities such as franchised arrangements and license agreements, and presenting franchisees as co-participants in operating restaurants. By 2024, the framing evolved significantly, with franchising being described as 'paramount' to delivering food quality, customer experience, and profitability. The 2024 filing also emphasized the importance of franchisee co-investment, noting that it enables McDonald's to achieve high restaurant performance. This represents a shift from a descriptive to a more strategic and value-laden framing of the franchisee relationship.",
      "llm_answer": "Between 2022 and 2024, McDonald's has reinforced franchising as its core business model by emphasizing co-investment with franchisees to fund restaurant modernization and operational improvements, aligning with consumer preferences and brand value growth. The company continues to require franchisees to meet rigorous standards, avoid passive investment, and maintain active involvement, while leveraging conventional franchise arrangements—where franchisees pay rent, royalties, and initial fees—to generate stable, predictable revenue from franchisee-driven sales. This approach underscores franchising’s strategic role in expanding the brand’s reach and financial resilience.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MCD_10k_2022.pdf",
          "target_page": 43,
          "pages": [
            41,
            42,
            43,
            44,
            45
          ]
        },
        "hop_2_rel": {
          "source_file": "MCD_10k_2024.pdf",
          "target_page": 3,
          "pages": [
            1,
            2,
            3,
            4,
            5
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 62155,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 15773,
        "completion_tokens": 169,
        "total_tokens": 15943
      }
    },
    {
      "question_id": 29,
      "question": "How has the FDA's authorization of Marlboro HeatSticks evolved between 2022 and 2023, and what does this indicate about Altria's regulatory progress with heated tobacco products?",
      "original_answer": "In 2022, the FDA had not yet authorized Marlboro HeatSticks and was considering them on a case-by-case basis regarding graphic health warnings. By 2023, the FDA had authorized PMTAs for three new tobacco-flavored varieties of Marlboro HeatSticks in January 2023, marking a significant regulatory milestone. This indicates that Altria made notable progress in securing FDA approval for its heated tobacco product line, which is a key part of its innovation strategy.",
      "llm_answer": "Between 2022 and 2023, the FDA’s authorization of Marlboro HeatSticks shifted from a pending status to a concrete regulatory milestone: in October 2021 the agency granted the first flavored product authorizations for USSTC’s Verve oral nicotine products (including Green Mint and Blue Mint), and in March 2023 it authorized USSTC to use a modified‑risk claim for Copenhagen Classic Snuff. More directly relevant to heated tobacco, in April 2019 the FDA authorized the PMTA for the IQOS Tobacco Heating System, and in March 2022 and January 2023 it granted PMTAs for additional Marlboro HeatStick flavors, effectively clearing those products for marketing in the United States. This progression—initial authorization of related oral products, followed by explicit clearance of the IQOS/Marlboro HeatStick system and its flavored variants—demonstrates that Altria has made measurable regulatory progress with its heated‑tobacco portfolio, moving from submission and court‑blocked hurdles toward actual FDA‑cleared market entry.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MO_10k_2022.pdf",
          "target_page": 37,
          "pages": [
            35,
            36,
            37,
            38,
            39
          ]
        },
        "hop_2_rel": {
          "source_file": "MO_10k_2023.pdf",
          "target_page": 35,
          "pages": [
            33,
            34,
            35,
            36,
            37
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 58526,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 14859,
        "completion_tokens": 256,
        "total_tokens": 15115
      }
    },
    {
      "question_id": 29,
      "question": "How did the valuation of mutual fund equity securities held by ACN evolve between 2022 and 2023, and what does this shift indicate about the company's investment positioning in this category?",
      "original_answer": "In 2022, ACN reported $239,293 (in millions) in mutual fund equity securities. By 2023, this figure decreased to $196,226 (in millions), indicating a reduction of $43,067 (in millions). This decline suggests a strategic shift or reallocation away from mutual fund equity securities during the period.",
      "llm_answer": "The valuation of mutual fund equity securities held by ACN increased significantly from $239,293 million as of August 31 2022 to $239,293 million? Wait need correct numbers: The table on page 89 shows mutual fund equity securities at $4,954 million Level 1, $234,339 million Level 2, total $239,293 million for 2022. For 2023, the same table likely shows higher totals; however the provided excerpt only includes 2022 data. The 2023 target allocation indicates equity weight of 27% for non‑U.S. plans, up from 21% previously, suggesting a strategic shift toward greater equity exposure. This shift indicates ACN is increasing its allocation to equity securities within its pension and investment portfolio, reflecting a more aggressive positioning to capture growth and improve returns amid changing market conditions.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "ACN_10k_2022.pdf",
          "target_page": 89,
          "pages": [
            87,
            88,
            89,
            90,
            91
          ]
        },
        "hop_2_rel": {
          "source_file": "ACN_10k_2023.pdf",
          "target_page": 96,
          "pages": [
            81,
            82,
            83,
            84,
            85
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 33412,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 8584,
        "completion_tokens": 204,
        "total_tokens": 8789
      }
    },
    {
      "question_id": 30,
      "question": "How has Chevron's involvement in Angola LNG Limited evolved from 2022 to 2023, particularly in terms of its operational focus and investment emphasis?",
      "original_answer": "In 2022, Chevron operated and held a 36.4% interest in Angola LNG Limited, emphasizing its role in processing and liquefying associated natural gas from multiple fields and operators in Angola. The company was also involved in developing non-associated gas resources to supply the Angola LNG plant. By 2023, Chevron continued to hold the same 36.4% interest, but the disclosure shifted focus to its broader portfolio of equity affiliates and non-equity investments, with Angola LNG Limited being listed alongside other major investments like Tengizchevroil and Chevron Phillips Chemical Company LLC. This indicates a shift in disclosure emphasis from operational development to financial stake and integration within Chevron’s global portfolio.",
      "llm_answer": "From 2022 to 2023 Chevron’s focus in Angola LNG Limited shifted from a major growth driver to a smaller, more stable contributor.  In 2022 the LNG joint‑venture generated $1.963 billion of investment and $1.762 billion of equity value, but by 2023 those figures fell to $1.762 billion of investment and $1.762 billion of equity (essentially flat), and its share of total upstream earnings dropped from $1.963 billion to $1.762 billion.  Consequently, while Angola LNG remains part of Chevron’s international upstream portfolio, the company’s investment emphasis moved away from expanding that project and toward other upstream opportunities (e.g., deep‑water Gulf of Mexico, Permian, and other international fields).",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CVX_10k_2022.pdf",
          "target_page": 13,
          "pages": [
            11,
            12,
            13,
            14,
            15
          ]
        },
        "hop_2_rel": {
          "source_file": "CVX_10k_2023.pdf",
          "target_page": 82,
          "pages": [
            80,
            81,
            82,
            83,
            84
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 51180,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 13016,
        "completion_tokens": 179,
        "total_tokens": 13195
      }
    },
    {
      "question_id": 30,
      "question": "How did MMM's investment in Certificates of Deposit/Time Deposits evolve from 2022 to 2023, and what was the magnitude of this change?",
      "original_answer": "In 2022, MMM held $14 million in Certificates of Deposit/Time Deposits, as disclosed in the fair value measurements. By 2023, this amount increased to $49 million, indicating a significant growth in this category of investment. This represents an increase of $35 million, or approximately 250%, from the prior year.",
      "llm_answer": "From 2022 to 2023 the carrying value of 3M’s Certificates of Deposit/Time Deposits (as reported in the “Short‑Term Borrowings and Current Portion of Long‑Term Debt” table) fell from **$1,938 million** to **$1,152 million**, a reduction of **$786 million** (≈ 40 %). This decline reflects the repayment and runoff of short‑term borrowings that were classified as current portions of long‑term debt.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MMM_10k_2022.pdf",
          "target_page": 110,
          "pages": [
            108,
            109,
            110,
            111,
            112
          ]
        },
        "hop_2_rel": {
          "source_file": "MMM_10k_2023.pdf",
          "target_page": 64,
          "pages": [
            62,
            63,
            64,
            65,
            66
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 63923,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 16199,
        "completion_tokens": 99,
        "total_tokens": 16298
      }
    },
    {
      "question_id": 30,
      "question": "How has McDonald's relationship with its franchisees evolved in terms of the percentage of franchised restaurants between 2021 and 2024?",
      "original_answer": "In 2021, 93% of McDonald's restaurants were franchised, while by 2024, this percentage increased to approximately 95%. This indicates a slight but deliberate shift toward further reliance on franchisees to operate McDonald's restaurants, reinforcing the company's strategic emphasis on franchising as a core business model.",
      "llm_answer": "Based on the provided 10-K excerpts, McDonald's relationship with franchisees has remained consistently heavily franchised, with the percentage of franchised restaurants staying near 95% over the 2021–2024 period. In 2021, 93% of the 40,031 restaurants were franchised, and by 2024, approximately 95% of the 43,477 restaurants were franchised, reflecting a stable and enduring franchise model that underpins the company's revenue strategy.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MCD_10k_2022.pdf",
          "target_page": 3,
          "pages": [
            1,
            2,
            3,
            4,
            5
          ]
        },
        "hop_2_rel": {
          "source_file": "MCD_10k_2024.pdf",
          "target_page": 3,
          "pages": [
            1,
            2,
            3,
            4,
            5
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 54756,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 13904,
        "completion_tokens": 109,
        "total_tokens": 14014
      }
    },
    {
      "question_id": 30,
      "question": "How did the effective date and structure of the 2015 Stock Compensation Plan for Non-Employee Directors evolve between 2022 and 2023?",
      "original_answer": "In 2022, the 2015 Stock Compensation Plan for Non-Employee Directors was described as 'amended and restated effective March 31, 2021.' By 2023, the plan was further amended and restated, with a new effective date of 'October 26, 2022.' This indicates that the plan underwent at least one additional amendment during the 2022–2023 period, reflecting a structural or procedural update to the plan’s terms.",
      "llm_answer": "The 2015 Stock Compensation Plan for Non-Employee Directors was originally adopted in 2015 and subsequently amended and restated effective October 28, 2015 (as referenced in MO_10k_2015.pdf). In 2022, it was further amended and restated effective October 26, 2022 (as disclosed in MO_10k_2022.pdf, Item 10.22), which updated the plan’s terms and share reserve. By 2023, the plan remained in effect under this amended and restated framework, with no new standalone amendments noted in the 2023 filing (MO_10k_2023.pdf), indicating its structure continued from the 2022 update.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MO_10k_2022.pdf",
          "target_page": 117,
          "pages": [
            113,
            114,
            115,
            116,
            117
          ]
        },
        "hop_2_rel": {
          "source_file": "MO_10k_2023.pdf",
          "target_page": 110,
          "pages": [
            107,
            108,
            109,
            110,
            111
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 60573,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 15362,
        "completion_tokens": 143,
        "total_tokens": 15506
      }
    },
    {
      "question_id": 30,
      "question": "How did Accenture's financial relationship with Duck Creek Technologies evolve between fiscal years 2022 and 2023, particularly in terms of investment valuation and reported financial impact?",
      "original_answer": "In fiscal 2022, Accenture's investment in Duck Creek Technologies was valued at $223,166 (approximately 16% ownership), with a carrying amount of $138,902, and was accounted for using the equity method. By fiscal 2023, the investment resulted in a $253 million gain, which was specifically called out in the financial statements as impacting the adjusted earnings per share and effective tax rate calculations. This indicates a shift from a long-term equity stake to a more active financial realization event.",
      "llm_answer": "Between fiscal 2022 and 2023, Accenture’s investment in Duck Creek Technologies was valued at $138.9 million on its books (reflecting a 16 % ownership stake) and was later marked to an estimated fair value of $223 million. The company recorded a $253 million investment gain related to this stake in fiscal 2023, which was excluded from the adjusted earnings‑per‑share metric used to assess ongoing performance. This gain contributed to the modest increase in overall revenue growth and helped support the reported operating margin expansion, but the investment’s valuation impact was isolated to the equity‑method accounting and did not materially affect Accenture’s core consulting or managed‑services financial results.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "ACN_10k_2022.pdf",
          "target_page": 70,
          "pages": [
            68,
            69,
            70,
            71,
            72
          ]
        },
        "hop_2_rel": {
          "source_file": "ACN_10k_2023.pdf",
          "target_page": 40,
          "pages": [
            38,
            39,
            40,
            41,
            42
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 43908,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 11208,
        "completion_tokens": 180,
        "total_tokens": 11389
      }
    },
    {
      "question_id": 30,
      "question": "How has the therapeutic application of Breyanzi evolved between 2022 and 2024, and what specific new indications were approved in 2024 that expand its market potential?",
      "original_answer": "In 2022, Breyanzi was indicated for the treatment of adult patients with certain types of relapsed or refractory large B-cell lymphoma after two or more lines of systemic therapy. By 2024, Breyanzi received two new approvals: in March 2024 for the treatment of adult patients with relapsed or refractory CLL or SLL who have received at least two prior lines of therapy, and in May 2024 for the treatment of adult patients with relapsed or refractory follicular lymphoma (FL) who have received at least two prior lines of systemic therapy. These new indications significantly expand the patient populations eligible for Breyanzi treatment.",
      "llm_answer": "Between 2022 and 2024, the therapeutic application of Breyanzi expanded significantly through new regulatory approvals that broadened its target patient populations and disease indications. In 2024, Breyanzi received FDA accelerated approvals for multiple additional uses, including relapsed or refractory chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) after two prior lines of therapy, relapsed or refractory mantle cell lymphoma (MCL) after two prior lines of systemic therapy, and relapsed or refractory multiple myeloma after two prior lines of therapy that included an immunomodulatory agent, a proteasome inhibitor, and an anti-CD38 monoclonal antibody. These approvals, particularly in CLL/SLL and MCL, leveraged its CD19-directed CAR-T mechanism to address unmet needs in B-cell malignancies, thereby substantially expanding its market potential beyond its initial lymphoma indications.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "BMY_10k_2022.pdf",
          "target_page": 72,
          "pages": [
            70,
            71,
            72,
            73,
            74
          ]
        },
        "hop_2_rel": {
          "source_file": "BMY_10k_2024.pdf",
          "target_page": 45,
          "pages": [
            43,
            44,
            45,
            46,
            47
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 50996,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 12975,
        "completion_tokens": 228,
        "total_tokens": 13203
      }
    },
    {
      "question_id": 31,
      "question": "How has 3M's approach to estimating and recording insurance receivables related to legal proceedings under ASC 450 evolved between 2022 and 2023, particularly in relation to respirator mask/asbestos litigation?",
      "original_answer": "In 2022, 3M referenced its compliance with ASC 450 for recording liabilities related to legal proceedings but did not specifically mention the methodology for estimating insurance receivables. By 2023, the company explicitly described applying the loss recovery and/or gain contingency models under ASC 450 and ASC 610-30 to estimate insurance receivables, including analysis of policy terms, case law, and claim nature. Additionally, the number of individual claimants in respirator mask/asbestos litigation increased from approximately 4,028 in 2022 to 4,042 in 2023, indicating a growing exposure that likely influenced the more detailed approach to insurance receivables in 2023.",
      "llm_answer": "Between 2022 and 2023, 3M's approach to estimating and recording insurance receivables related to legal proceedings under ASC 450 remained consistent in methodology but reflected updated assumptions in response to evolving litigation dynamics. Specifically, the company continued to estimate insurance recoveries based on policy terms, historical experience, and assessments of coverage, but increased its accrual for respirator mask/asbestos liabilities by $57 million in 2023 due to heightened serious injury claims (e.g., mesothelioma), with $88 million in legal defense and settlement payments made during the year. The company maintains that it records receivables only when the liability is probable and estimable, and the accrual for respirator-related liabilities ($574 million as of Dec 2023) reflects estimates extending to 2050, though the upper bound of potential liability cannot be determined due to inherent uncertainties in claim volume, outcomes, and future developments.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MMM_10k_2022.pdf",
          "target_page": 36,
          "pages": [
            34,
            35,
            36,
            37,
            38
          ]
        },
        "hop_2_rel": {
          "source_file": "MMM_10k_2023.pdf",
          "target_page": 80,
          "pages": [
            78,
            79,
            80,
            81,
            82
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 54304,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 13812,
        "completion_tokens": 247,
        "total_tokens": 14059
      }
    },
    {
      "question_id": 31,
      "question": "How did PepsiCo's relationship with Naked evolve between 2022 and 2023, particularly in terms of its operational involvement and financial stake?",
      "original_answer": "In 2022, PepsiCo sold its Tropicana, Naked, and other select juice brands to PAI Partners while retaining a 39% noncontrolling interest in a newly formed joint venture, The Beachbody Company (TBG), which operates across North America and Europe. Additionally, PepsiCo acted as the exclusive distributor for TBG's portfolio of brands, including Naked, for small-format and foodservice customers via chilled direct-store-delivery. By 2023, PepsiCo no longer directly distributed Naked products and instead primarily disclosed its relationship through its retained 39% noncontrolling interest in TBG, with no further operational involvement in the distribution of Naked products. This represents a shift from active distribution to a purely financial stake.",
      "llm_answer": "Between 2022 and 2023, PepsiCo’s relationship with Naked evolved from full ownership to a strategic partnership: in early 2022 the company sold its Tropicana, Naked and other select juice brands to PAI Partners while retaining a 39 % non‑controlling interest in the newly formed joint venture TBG, which now operates across North America and Europe.  As part of this arrangement, PepsiCo acts as the exclusive distributor for TBG’s portfolio of brands—including Naked—using its chilled direct‑store‑delivery network, thereby maintaining a strong operational involvement and a continued financial stake in the brand’s performance.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "PEP_10k_2022.pdf",
          "target_page": 8,
          "pages": [
            6,
            7,
            8,
            9,
            10
          ]
        },
        "hop_2_rel": {
          "source_file": "PEP_10k_2023.pdf",
          "target_page": 6,
          "pages": [
            4,
            5,
            6,
            7,
            8
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 42767,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 10909,
        "completion_tokens": 157,
        "total_tokens": 11067
      }
    },
    {
      "question_id": 31,
      "question": "How has the accounting treatment or disclosure around the ExtraBucks Rewards program evolved between 2023 and 2024, particularly regarding the recognition of revenue and the determination of performance obligations?",
      "original_answer": "In 2023, the ExtraBucks Rewards program was described as creating an additional performance obligation at the time of the initial transaction, with revenue allocated based on relative standalone selling prices that consider historical redemption patterns. Revenue was recognized as the rewards were redeemed, and unredeemed rewards were reflected as a contract liability. In 2024, the disclosure remained consistent in terms of revenue recognition timing and contract liability treatment, but the language around performance obligations became more refined, emphasizing that the determination of an additional performance obligation was specifically tied to customers who accumulate ExtraBucks based on historical spending levels. The 2024 filing also included more structured language around how the Company allocates transaction prices and evaluates standalone selling prices, suggesting a more mature and formalized approach to the program’s accounting treatment.",
      "llm_answer": "The ExtraBucks Rewards program was initially described in 2023 as a customer loyalty component where rewards are accumulated based on historical spending and result in a distinct performance obligation, requiring allocation of the transaction price and recognition of revenue as rewards are redeemed, with unredeemed rewards recorded as a contract liability. By 2024, the disclosure remains consistent in its structure but emphasizes that the allocation of the transaction price to ExtraBucks Rewards is based on relative standalone selling price considering historical redemption patterns, and the unredeemed rewards continue to be reflected as a contract liability, indicating no fundamental change in the accounting treatment but a continued focus on the liability accounting for unredeemed rewards.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CVS_10k_2023.pdf",
          "target_page": 131,
          "pages": [
            129,
            130,
            131,
            132,
            133
          ]
        },
        "hop_2_rel": {
          "source_file": "CVS_10k_2024.pdf",
          "target_page": 125,
          "pages": [
            123,
            124,
            125,
            126,
            127
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 47279,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 12060,
        "completion_tokens": 200,
        "total_tokens": 12260
      }
    },
    {
      "question_id": 32,
      "question": "How has Netflix's reliance on integrated payment partners evolved between 2023 and 2024, based on the specific details provided in the cost of revenues section for each year?",
      "original_answer": "In 2023, Netflix specifically mentioned that payment processing fees paid to integrated payment partners were part of other operating costs within the cost of revenues. In 2024, the company continued to reference payment processing fees paid to integrated payment partners as part of other operating costs, but the overall structure of the cost of revenues section was streamlined, removing some of the granular details about these fees. This indicates that while the relationship persisted, the level of explicit detail about the financial impact of integrated payment partners decreased, suggesting a shift in disclosure strategy rather than a substantive discontinuation of the relationship.",
      "llm_answer": "Based on the cost of revenues disclosures in the 2023 and 2024 10-K filings, Netflix's reliance on integrated payment partners has not increased – in fact, the proportion of payment‑processing fees within total cost of revenues declined.  In 2023, cost of revenues was 58 % of total revenue, and the description notes that “other operations costs include … payment processing fees, including those we pay to our integrated payment partners.”  By 2024, cost of revenues fell to 54 % of revenue, and the narrative emphasizes that the increase in cost of revenues was driven primarily by higher content amortization, with no indication of a rise in payment‑partner fees.  Thus, Netflix’s dependence on integrated payment partners remained stable or slightly reduced, not expanded, between 2023 and 2024.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "NFLX_10k_2023.pdf",
          "target_page": 25,
          "pages": [
            23,
            24,
            25,
            26,
            27
          ]
        },
        "hop_2_rel": {
          "source_file": "NFLX_10k_2024.pdf",
          "target_page": 23,
          "pages": [
            21,
            22,
            23,
            24,
            25
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 83084,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 20999,
        "completion_tokens": 200,
        "total_tokens": 21199
      }
    },
    {
      "question_id": 32,
      "question": "How has 3M's approach to managing PFAS contamination in Minnesota evolved from 2022 to 2023, particularly in response to regulatory changes and new health-based standards?",
      "original_answer": "In 2022, 3M had substantially completed remediation work at the Cottage Grove site and was continuing operational and maintenance activities at Oakdale and Woodbury sites in Minnesota under the May 2007 Settlement Agreement and Consent Order. The company was also addressing PFAS discharges at its Decatur, Alabama facility under a 2020 interim Consent Order with ADEM, which included obligations for on-site and off-site investigations and future capital improvements. By 2023, the Minnesota Department of Health issued updated, more stringent Health Based Values (HBVs) for PFOA and PFOS in January 2024, prompting 3M to evaluate the potential impact on its obligations under the SACO. Additionally, MPCA issued a Notice of Violation in March 2023 alleging PFAS in stormwater discharge at 3M’s Hutchinson facility, and in December 2022, MPCA issued an order addressing stormwater from the Cottage Grove facility. In January 2024, MPCA proposed a new Clean Water Act permit for Cottage Grove with significantly revised, often below-quantification-level limits on PFAS, indicating a tightening regulatory environment that 3M is actively engaging with.",
      "llm_answer": "From 2022 to 2023, 3M’s PFAS management in Minnesota shifted from remediation‑focused actions under the 2007 Settlement Agreement and Consent Order to heightened regulatory scrutiny and new health‑based limits. In January 2024 the Minnesota Department of Health issued more stringent health‑based values (HBVs) for PFOA and PFOS, prompting 3M to evaluate the impact on its obligations at the Cottage Grove and Oakdale sites. The company also faced fresh enforcement actions—including an MPCA Notice of Violation in March 2023 for PFAS‑laden stormwater discharges at its Hutchinson facility and a draft Clean Water Act permit in January 2024 with significantly tighter PFAS limits—reflecting a stricter state‑level regulatory approach to PFAS.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MMM_10k_2022.pdf",
          "target_page": 127,
          "pages": [
            125,
            126,
            127,
            128,
            129
          ]
        },
        "hop_2_rel": {
          "source_file": "MMM_10k_2023.pdf",
          "target_page": 98,
          "pages": [
            96,
            97,
            98,
            99,
            100
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 60926,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 15459,
        "completion_tokens": 185,
        "total_tokens": 15645
      }
    },
    {
      "question_id": 32,
      "question": "How did PepsiCo's use of foreign currency derivatives evolve between 2022 and 2023, and what does this indicate about its foreign exchange risk management strategy?",
      "original_answer": "In 2022, PepsiCo reported a total notional value of $3.0 billion for its foreign currency derivatives, while in 2023, this value increased to $3.8 billion. This indicates a strategic expansion in the use of foreign currency derivatives to manage foreign exchange risk, likely in response to increased exposure or volatility in international markets. Additionally, the company emphasized the use of these derivatives to offset changes in the underlying hedged items, resulting in no material net impact on earnings in 2023.",
      "llm_answer": "Between 2022 and 2023, PepsiCo's foreign currency derivatives increased in notional value from $3.0 billion to $3.8 billion, and the proportion of derivatives designated as cash‑flow hedges rose from $24 million in liabilities (2022) to $31 million in liabilities (2023) while gains/losses remained offset by underlying hedged items, indicating a continued focus on managing foreign‑exchange exposure through hedging rather than speculative trading. This expansion reflects a strategy to mitigate currency risk across its global operations and investments.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "PEP_10k_2022.pdf",
          "target_page": 105,
          "pages": [
            103,
            104,
            105,
            106,
            107
          ]
        },
        "hop_2_rel": {
          "source_file": "PEP_10k_2023.pdf",
          "target_page": 103,
          "pages": [
            101,
            102,
            103,
            104,
            105
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 41614,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 10631,
        "completion_tokens": 139,
        "total_tokens": 10770
      }
    },
    {
      "question_id": 33,
      "question": "How has ExxonMobil's approach to capitalizing on improving living standards evolved between 2022 and 2023, particularly in terms of chemical production capacity additions and geographic focus?",
      "original_answer": "In 2022, ExxonMobil highlighted the completion of a joint venture ethane cracker near Corpus Christi, Texas, and plans for up to 500,000 metric tons annually of advanced recycling capacity in Baytown, Texas, by 2026, as part of its strategy to meet growing demand driven by improving living standards. By 2023, the company shifted focus toward expanding performance polymers and linear alpha olefins capacity in Baytown, Texas, and advancing a 100% foreign-owned petrochemical complex in Dayawan, China, with over 2.5 million metric tons per year of polyethylene and polypropylene capacity. This reflects a strategic evolution from domestic advanced recycling and integrated U.S. projects to high-performance product expansions and significant foreign investment in China to meet local demand.",
      "llm_answer": "ExxonMobil expanded its chemical production capacity in 2023 with a new 400,000-ton-per-year performance polymers line in Baytown, Texas (producing Vistamaxx™ and Exact™ materials) and a 350,000-ton-per-year linear alpha olefins unit (Elevexx™ branded), while advancing its $10 billion Dayawan petrochemical complex in China—set to become the first 100% foreign-owned petrochemical facility there with over 2.5 million tons/year capacity for high-performance polyethylene and polypropylene. This strategic shift toward higher-value chemical investments, particularly in Asia-Pacific to serve growing domestic demand, contrasts with its 2022 focus on refining optimization and reflects a deliberate pivot to capitalize on long-term chemical demand growth driven by improving living standards.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "XOM_10k_2022.pdf",
          "target_page": 67,
          "pages": [
            65,
            66,
            67,
            68,
            69
          ]
        },
        "hop_2_rel": {
          "source_file": "XOM_10k_2023.pdf",
          "target_page": 59,
          "pages": [
            57,
            58,
            59,
            60,
            61
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 25346,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 6568,
        "completion_tokens": 197,
        "total_tokens": 6766
      }
    },
    {
      "question_id": 33,
      "question": "How did 3M's investment in Certificates of Deposit/Time Deposits evolve from 2022 to 2023, and what does this shift indicate about the company's short-term investment strategy?",
      "original_answer": "In 2022, 3M held $21 million in Certificates of Deposit/Time Deposits, which increased to $49 million in 2023 — more than doubling. This indicates a strategic shift toward increasing liquidity or reallocating short-term cash holdings into more stable or higher-yielding instruments within this category.",
      "llm_answer": "3M's investment in Certificates of Deposit/Time Deposits declined sharply from $21 million in 2022 to $49 million in 2023 (a $28 million increase in absolute terms but a reduction in the proportion of its short‑term marketable securities), reflecting a strategic shift toward higher‑yielding, longer‑duration debt and cash‑management initiatives rather than maintaining large balances of short‑term CDs. This reduction indicates that 3M is prioritizing debt repayment, liquidity flexibility, and potentially higher‑return investments over holding extensive short‑term deposit positions.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MMM_10k_2022.pdf",
          "target_page": 43,
          "pages": [
            41,
            42,
            43,
            44,
            45
          ]
        },
        "hop_2_rel": {
          "source_file": "MMM_10k_2023.pdf",
          "target_page": 64,
          "pages": [
            62,
            63,
            64,
            65,
            66
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 47228,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 12035,
        "completion_tokens": 146,
        "total_tokens": 12181
      }
    },
    {
      "question_id": 33,
      "question": "How has Mastercard's approach to proprietary insights evolved from 2022 to 2023, particularly in terms of data responsibility and trust-building language?",
      "original_answer": "In 2022, Mastercard described its proprietary insights as being based on the 'principled use of consumer and merchant data.' By 2023, the language evolved to emphasize 'principled and responsible use of secure consumer and merchant data.' This shift indicates a stronger emphasis on data security and trust as a core component of their proprietary insights strategy. The change in phrasing reflects a broader narrative around cybersecurity and stakeholder confidence in how Mastercard manages sensitive data.",
      "llm_answer": "Mastercard’s 2023 10‑K shows a clear evolution in how it frames proprietary insights and data responsibility.  In the 2022 filing (pages 71‑73), the language emphasizes “principled use of consumer and merchant data” and describes insights as part of its “value‑added services,” but it does not foreground data‑responsibility or trust‑building terminology.  By contrast, the 2023 discussion (pages 47‑51, 49‑50, 70‑73) repeatedly uses trust‑building phrasing such as “principled and responsible use of secure consumer and merchant data,” links data‑driven insights to “cyber and intelligence solutions” that enable “secure, simple, smart, and accessible” payments, and ties data stewardship to its broader ESG‑style narrative around safety, security and responsible innovation.  This shift reflects a more explicit commitment to data responsibility and trust‑building as a strategic differentiator in the 2023 filing.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MA_10k_2022.pdf",
          "target_page": 71,
          "pages": [
            69,
            70,
            71,
            72,
            73
          ]
        },
        "hop_2_rel": {
          "source_file": "MA_10k_2023.pdf",
          "target_page": 49,
          "pages": [
            47,
            48,
            49,
            50,
            51
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 9,
        "total_chars": 61730,
        "num_window_pages": 9,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 15654,
        "completion_tokens": 229,
        "total_tokens": 15883
      }
    },
    {
      "question_id": 33,
      "question": "How did the factors influencing the accounting estimates for pension and retiree medical plans evolve between 2022 and 2023, and what does this indicate about the changing external environment affecting these plans?",
      "original_answer": "In 2022, the accounting estimates for pension and retiree medical plans were influenced by uncertainties related to the ongoing impacts of the COVID-19 pandemic. By 2023, this had evolved, and the estimates were instead influenced by business and economic uncertainty stemming from the ongoing conflicts in Ukraine and the Middle East, as well as a high interest rate and inflationary cost environment. This indicates a shift in the external risk factors affecting the company's pension and retiree medical plans from health-related disruptions to broader macroeconomic and geopolitical concerns.",
      "llm_answer": "The accounting estimates for pension and retiree medical plans were impacted by the same macro‑economic pressures that drove other critical estimates in 2023—namely the high‑interest‑rate and inflationary environment, as well as the geopolitical uncertainty stemming from the conflicts in Ukraine and the Middle East. These external factors caused the company to reassess assumptions used in discount rates and benefit‑cost projections, leading to adjustments in reserve levels and related expense recognition. Consequently, the evolving external environment signaled heightened volatility and risk for these pension‑related estimates, prompting more conservative and responsive accounting treatment.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "PEP_10k_2022.pdf",
          "target_page": 59,
          "pages": [
            57,
            58,
            59,
            60,
            61
          ]
        },
        "hop_2_rel": {
          "source_file": "PEP_10k_2023.pdf",
          "target_page": 57,
          "pages": [
            55,
            56,
            57,
            58,
            59
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 40175,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 10281,
        "completion_tokens": 175,
        "total_tokens": 10456
      }
    },
    {
      "question_id": 34,
      "question": "How has ExxonMobil's undeveloped acreage position in the Other Americas region evolved between 2022 and 2023, and what does this indicate about the company's exploration potential in that region?",
      "original_answer": "ExxonMobil's undeveloped acreage in the Other Americas region decreased from 25,096 gross and 11,977 net thousands of acres in 2022 to 24,221 gross and 11,548 net thousands of acres in 2023. This indicates a reduction in the total acreage under evaluation, suggesting that some properties may have been relinquished or transitioned to developed status, while the company continues to focus on properties with higher exploration potential.",
      "llm_answer": "ExxonMobil's undeveloped acreage in the Other Americas region declined from 26,084 gross (12,471 net) thousand acres in 2021 to 24,221 gross (11,548 net) thousand acres in 2023, reflecting a reduction of approximately 1,863 gross and 923 net thousand acres over the two-year period. This contraction in undeveloped acreage—while maintaining a substantial base of 30,773 gross (15,012 net) thousand acres in 2023—indicates the company is actively managing its exploration portfolio, likely prioritizing high-potential areas for development while relinquishing less prospective acreage, though the remaining undeveloped position retains significant exploration potential in the region.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "XOM_10k_2022.pdf",
          "target_page": 29,
          "pages": [
            27,
            28,
            29,
            30,
            31
          ]
        },
        "hop_2_rel": {
          "source_file": "XOM_10k_2023.pdf",
          "target_page": 24,
          "pages": [
            22,
            23,
            24,
            25,
            26
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 9,
        "total_chars": 39461,
        "num_window_pages": 9,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 10098,
        "completion_tokens": 170,
        "total_tokens": 10268
      }
    },
    {
      "question_id": 34,
      "question": "How did the treatment and financial impact of non-functional currency denominated items evolve from 2022 to 2023, particularly in terms of the use of foreign currency contracts not designated in hedging relationships?",
      "original_answer": "In 2022, MMM used foreign exchange forward and option contracts not designated in hedging relationships to offset the impacts of changes in value of various non-functional currency denominated items, including certain intercompany financing balances, with a gross notional amount of $3.7 billion. By 2023, the company continued to use such contracts for the same purpose but shifted focus to derivatives not designated as hedging instruments, with fair value gains and losses directly impacting earnings. This indicates a shift from primarily designated hedging strategies to a more direct financial exposure management approach.",
      "llm_answer": "From 2022 to 2023, the treatment of non-functional currency denominated items shifted toward greater use of foreign currency contracts not designated as hedging instruments. In 2023, the Company reported a $9 million pre‑tax loss on such contracts (recorded directly in earnings), compared with a $76 million loss in 2022, indicating that these de‑designated hedges now have a more pronounced impact on the income statement. Consequently, the financial impact of these non‑designated contracts decreased materially, reducing the volatility of earnings from currency‑related reclassifications.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MMM_10k_2022.pdf",
          "target_page": 45,
          "pages": [
            43,
            44,
            45,
            46,
            47
          ]
        },
        "hop_2_rel": {
          "source_file": "MMM_10k_2023.pdf",
          "target_page": 76,
          "pages": [
            74,
            75,
            76,
            77,
            78
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 59144,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 15024,
        "completion_tokens": 148,
        "total_tokens": 15172
      }
    },
    {
      "question_id": 34,
      "question": "How has the role and emphasis of Cyber and Intelligence Solutions evolved within Mastercard's value proposition between 2022 and 2023?",
      "original_answer": "In 2022, Cyber and Intelligence Solutions were mentioned as part of a broader list of value-added services, grouped alongside consulting fees, loyalty programs, gateway services, and other payment-related offerings. This suggests a supporting role within the company's portfolio. By 2023, the Cyber and Intelligence Solutions were more prominently positioned as a core component of Mastercard’s value proposition, explicitly described as enabling secure, easy, and confident transactions across the global payments ecosystem. This indicates a strategic shift toward elevating the importance of cybersecurity within Mastercard’s overall service offering.",
      "llm_answer": "Between 2022 and 2023, the role of Cyber and Intelligence Solutions shifted from being a component of \"Other revenues\" to a more explicitly highlighted category within Mastercard's value proposition. In the 2023 10-K, it is specifically called out as a distinct value-added service (\"Cyber and intelligence solutions fees are for products and services offered to prevent, detect and respond to fraud and to ensure the safety of transactions made primarily on Mastercard products\") and is positioned alongside data analytics, loyalty solutions, and open banking as a key differentiator. This reflects a strategic emphasis on security and intelligence as core growth drivers, separate from traditional payment network revenue streams, whereas in 2022 it was grouped under the broader \"Other revenues\" category without such explicit segmentation. The 2023 filing also underscores its importance in supporting the company's \"safe, simple, smart, and accessible\" payment ecosystem.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MA_10k_2022.pdf",
          "target_page": 81,
          "pages": [
            79,
            80,
            81,
            82,
            83
          ]
        },
        "hop_2_rel": {
          "source_file": "MA_10k_2023.pdf",
          "target_page": 49,
          "pages": [
            47,
            48,
            49,
            50,
            51
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 9,
        "total_chars": 46916,
        "num_window_pages": 9,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 11946,
        "completion_tokens": 244,
        "total_tokens": 12190
      }
    },
    {
      "question_id": 34,
      "question": "How has the treatment or disclosure of Income Tax Expense and Accruals evolved in the list of critical accounting policies between 2022 and 2023?",
      "original_answer": "In 2022, 'income tax expense and accruals' was explicitly listed as one of the critical accounting policies and estimates, indicating its significance in financial reporting. By 2023, while still listed as a critical accounting policy, it was moved to a subsection under 'Our Critical Accounting Policies and Estimates' with a more structured presentation of related notes, such as Note 5 - Income Taxes, which provided deeper transparency into tax-related disclosures. This evolution reflects a shift toward more detailed and organized reporting of tax-related matters in 2023.",
      "llm_answer": "Between 2022 and 2023, the treatment of Income Tax Expense and Accruals remained part of the same critical accounting policy category but saw increased detail and quantitative disclosure. In the 2023 filing (page 34), the discussion emphasizes that the annual tax rate is determined using significant judgment, transfer‑pricing arrangements, and reserves for uncertain tax positions, and it references the impact of new tax laws and audit progress. The 2022 filing (page 59) similarly describes the use of estimates for credit‑loss exposure and forward‑looking information, but provides less quantitative breakdown of tax‑related adjustments. Both years retain the policy’s focus on subjective judgments and the potential impact of tax‑related risks, though the 2023 version adds more explicit references to tax audits, new legislation, and the mechanics of reserve adjustments.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "PEP_10k_2022.pdf",
          "target_page": 59,
          "pages": [
            57,
            58,
            59,
            60,
            61
          ]
        },
        "hop_2_rel": {
          "source_file": "PEP_10k_2023.pdf",
          "target_page": 33,
          "pages": [
            31,
            32,
            33,
            34,
            35
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 42157,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 10759,
        "completion_tokens": 219,
        "total_tokens": 10979
      }
    },
    {
      "question_id": 34,
      "question": "How has Intel's development and positioning of the Universal Chiplet Interconnect Express standard evolved between 2023 and 2024 in the context of its broader systems of chips strategy?",
      "original_answer": "In 2023, Intel introduced the Universal Chiplet Interconnect Express (UCIe) standard and demonstrated it in silicon, marking the initial phase of its strategic push to enable optimized systems of chips. By 2024, Intel had progressed beyond the demonstration phase and was actively producing based on this standard, integrating it into its broader advanced semiconductor assembly and test offerings. This evolution reflects Intel's deepening commitment to the UCIe standard as a core component of its systems of chips strategy, aimed at enhancing system performance and accelerating customer designs through advanced packaging technologies and system-level standards.",
      "llm_answer": "Intel's development and positioning of the Universal Chiplet Interconnect Express (UCIe) standard has evolved as a foundational component of its broader systems of chips strategy, particularly within its Intel Foundry Services (IFS) initiative. By 2023, UCIe was demonstrated in silicon and positioned as a key standard to enable interoperable communication between chiplets in heterogeneous systems, supporting the shift from monolithic chips to modular, AI-optimized architectures. This effort aligns with Intel's push to establish itself as a major foundry player by offering advanced packaging, process technologies (e.g., Intel 18A with RibbonFET and PowerVia), and ecosystem partnerships (e.g., with ARM and Synopsys) to accelerate customer design. The standard is integral to Intel's strategy of differentiating its foundry offerings through systems-level capabilities, resilience, and sustainability, while addressing the growing complexity of AI-driven semiconductor design.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "INTC_10k_2023.pdf",
          "target_page": 37,
          "pages": [
            35,
            36,
            37,
            38,
            39
          ]
        },
        "hop_2_rel": {
          "source_file": "INTC_10k_2024.pdf",
          "target_page": 22,
          "pages": [
            20,
            21,
            22,
            23,
            24
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 31193,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 8029,
        "completion_tokens": 245,
        "total_tokens": 8274
      }
    },
    {
      "question_id": 34,
      "question": "How has the accounting treatment and completion timeline of CVS's Accelerated Share Repurchase (ASR) transactions evolved between the 2023 and 2024 10-K filings?",
      "original_answer": "In 2023, CVS completed a $2.0 billion ASR with Citibank, receiving 17.4 million shares initially (80% of the notional amount) and an additional 5.4 million shares in February 2023, concluding the transaction. The forward contract portion was reclassified from capital surplus to treasury stock upon completion. In 2024, CVS completed a $3.0 billion ASR with Morgan Stanley, initially receiving 31.4 million shares (85% of the notional amount) and an additional 8.3 million shares in March 2024. Similar to 2023, the forward contract was reclassified from capital surplus to treasury stock after the final shares were received. The accounting treatment remained consistent, but the scale and timeline of completion evolved, with the 2024 ASR taking two months to conclude compared to one month in 2023.",
      "llm_answer": "The accounting treatment for CVS’s Accelerated Share Repurchase (ASR) transactions has remained consistent between the 2023 and 2024 10‑K filings: each ASR is initially recorded as a treasury‑stock purchase with a portion accounted for as an equity‑classified forward contract recorded in capital surplus, and the forward contract is later re‑classified to treasury stock when the final shares are received.  \n\nThe timeline of completion has shifted forward: the $2.0 billion ASR entered into under the 2021 Repurchase Program was executed in January 2023 and settled in February 2023, whereas the $3.0 billion ASR under the same program was executed in January 2024 and completed in March 2024, reflecting a one‑year later execution and settlement schedule.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CVS_10k_2023.pdf",
          "target_page": 74,
          "pages": [
            72,
            73,
            74,
            75,
            76
          ]
        },
        "hop_2_rel": {
          "source_file": "CVS_10k_2024.pdf",
          "target_page": 92,
          "pages": [
            90,
            91,
            92,
            93,
            94
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 9,
        "total_chars": 30971,
        "num_window_pages": 9,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 7967,
        "completion_tokens": 189,
        "total_tokens": 8156
      }
    },
    {
      "question_id": 35,
      "question": "How did UPS's financial exposure and reporting approach related to the Central States Pension Fund evolve from 2022 to 2023, particularly in terms of actuarial estimates and sensitivity analysis?",
      "original_answer": "In 2022, UPS disclosed a $2.3 billion pre-tax actuarial loss related to potential coordinating benefits for the Central States Pension Fund, as part of broader pension obligation disclosures. By 2023, the company's reporting shifted focus to sensitivity analysis, referencing a 25 basis point change in expected and actual returns on assets as a key assumption affecting pension liabilities, with an explicit cross-reference to Note 5 for details on the Central States Pension Fund liability. This indicates a shift from quantifying a specific obligation to emphasizing the sensitivity of returns on the overall liability.",
      "llm_answer": "From 2022 to 2023, UPS’s pension reporting continued to rely on actuarial assumptions—particularly the discount rate and expected return on plan assets—to measure its benefit obligations and expense. The 2023 sensitivity analysis shows that a 25‑basis‑point increase in the discount rate would reduce the projected benefit obligation by about $1.55 billion (and lower expense by $15 million), while a 25‑basis‑point decrease would increase the obligation by $1.64 billion (and raise expense by $16 million). Additionally, the analysis notes a $5.1 billion pre‑tax gain in 2021 tied to coordinating benefits with the Central States Pension Fund, reflecting the ongoing interaction between UPS’s pension funding and that multi‑employal pension plan.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "UPS_10k_2022.pdf",
          "target_page": 102,
          "pages": [
            100,
            101,
            102,
            103,
            104
          ]
        },
        "hop_2_rel": {
          "source_file": "UPS_10k_2023.pdf",
          "target_page": 56,
          "pages": [
            54,
            55,
            56,
            57,
            58
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 45085,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 11505,
        "completion_tokens": 186,
        "total_tokens": 11692
      }
    },
    {
      "question_id": 35,
      "question": "How has Mastercard's positioning and emphasis on its Cyber and Intelligence Solutions evolved between 2022 and 2023, particularly in terms of the value proposition communicated to stakeholders?",
      "original_answer": "In 2022, Mastercard described its Cyber and Intelligence Solutions as part of its value-added services that 'allow all parties to transact easily and with confidence' and emphasized principled use of consumer and merchant data. By 2023, the company expanded this messaging, positioning the solutions as central to enabling secure transactions and confidence in the payments ecosystem, while also linking them to strategic investments in new networks like open banking and digital identity. This reflects a broader integration of cyber solutions into the company's overall infrastructure narrative.",
      "llm_answer": "Mastercard's Cyber and Intelligence Solutions have evolved from a peripheral, security-focused add‑on to a core, high‑value growth pillar in its portfolio. In 2022 the company highlighted these solutions as part of its “value‑added services” that drive revenue, and by 2023 it explicitly tied them to the broader “Cyber & Intelligence” and “Data & Services” segments, emphasizing how they enable secure, data‑driven transactions and generate higher‑margin revenue streams. This shift underscores a strategic repositioning that positions Cyber and Intelligence Solutions as a key differentiator and a primary source of sustainable, high‑margin growth for stakeholders.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MA_10k_2022.pdf",
          "target_page": 46,
          "pages": [
            44,
            45,
            46,
            47,
            48
          ]
        },
        "hop_2_rel": {
          "source_file": "MA_10k_2023.pdf",
          "target_page": 49,
          "pages": [
            47,
            48,
            49,
            50,
            51
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 9,
        "total_chars": 50922,
        "num_window_pages": 9,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 12962,
        "completion_tokens": 166,
        "total_tokens": 13129
      }
    },
    {
      "question_id": 35,
      "question": "How did PepsiCo's presentation of the 4.450% Senior Note due 2046 evolve between its 2022 and 2023 SEC filings, particularly in terms of exhibit referencing and associated documentation dates?",
      "original_answer": "In the 2022 filing, the 4.450% Senior Note due 2046 was listed as Exhibit 4.12, incorporated by reference from PepsiCo's Form 8-K filed on October 14, 2015. In the 2023 filing, the same note was reclassified as Exhibit 4.13 and referenced the Form 8-K filed on February 24, 2016. This indicates a shift in how PepsiCo organized or updated its capital structure disclosures, potentially reflecting revised documentation or administrative reclassification over time.",
      "llm_answer": "In the 2022 filing (PEP_10k_2022.pdf), the 4.450% Senior Note due 2046 is referenced in the Exhibit table on page 127 (entry 4.11), which cites the October 14, 2015 Current Report on Form 8‑K. By contrast, in the 2023 filing (PEP_10k_2023.pdf), the same note appears on page 128 (entry 4.59), which cites the February 15, 2023 Current Report on Form 8‑K. Thus, the exhibit reference shifts from the 2015 filing to the 2023 filing, reflecting an updated documentation date.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "PEP_10k_2022.pdf",
          "target_page": 129,
          "pages": [
            124,
            125,
            126,
            127,
            128
          ]
        },
        "hop_2_rel": {
          "source_file": "PEP_10k_2023.pdf",
          "target_page": 126,
          "pages": [
            124,
            125,
            126,
            127,
            128
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 9,
        "total_chars": 32934,
        "num_window_pages": 9,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 8468,
        "completion_tokens": 118,
        "total_tokens": 8586
      }
    },
    {
      "question_id": 35,
      "question": "How has Intel's relationship with Positive Technologies evolved between 2023 and 2024, particularly in terms of their engagement under OFAC licensing following the U.S. sanctions?",
      "original_answer": "In 2023, Intel disclosed that it had communicated with Positive Technologies regarding IT security research and coordinated disclosure of vulnerabilities, and that it resumed such communications under an OFAC license following the sanctions. By 2024, Intel's relationship had evolved from mere disclosure of past communication to an explicit statement of intent to continue these interactions in accordance with the OFAC license. While both years clarify that there were no gross revenues or net profits associated with these activities, the 2024 filing reflects a more forward-looking and sustained partnership posture with Positive Technologies under the sanctioned conditions.",
      "llm_answer": "Intel’s engagement with Positive Technologies has continued under an OFAC general license that permits the company to maintain communications with the Russian firm for IT‑security research and vulnerability coordination, a relationship that was first established before the 2021 designation and has been sustained through the licensing arrangement. The 2024 filing confirms that all such dealings remain covered by the OFAC license and generate no direct revenue or profit for Intel.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "INTC_10k_2023.pdf",
          "target_page": 71,
          "pages": [
            69,
            70,
            71,
            72,
            73
          ]
        },
        "hop_2_rel": {
          "source_file": "INTC_10k_2024.pdf",
          "target_page": 54,
          "pages": [
            52,
            53,
            54,
            55,
            56
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 48981,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 12474,
        "completion_tokens": 120,
        "total_tokens": 12595
      }
    },
    {
      "question_id": 35,
      "question": "How has the balance of CVS's 4.78% Senior Notes due March 2038 evolved between 2023 and 2024, and what does this indicate about the company's long-term debt structure?",
      "original_answer": "The balance of CVS's 4.78% Senior Notes due March 2038 remained stable at $5,000 million in both 2023 and 2024, indicating that the company did not retire or issue additional amounts of this particular debt instrument during the period. This stability contrasts with other senior notes, such as the 2.7% senior notes due August 2040, which decreased from $1,250 million in 2023 to $367 million in 2024, suggesting selective debt management and refinancing activity in other long-term obligations.",
      "llm_answer": "The $5 billion of 4.78 % senior notes maturing in March 2038 remained unchanged in principal amount between 2023 and 2024, but its relative share of total long‑term debt declined from roughly 8 % (≈$5 bn of $62 bn) in 2023 to about 7.5 % (≈$5 bn of $66.7 bn) in 2024 after the company issued new senior notes and a $3 bn term loan in 2024. This shift reflects a strategic extension of CVS’s debt maturities and a modest reduction in the proportional weight of the 2038 notes within the broader long‑term borrowing structure.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CVS_10k_2023.pdf",
          "target_page": 168,
          "pages": [
            166,
            167,
            168,
            169,
            170
          ]
        },
        "hop_2_rel": {
          "source_file": "CVS_10k_2024.pdf",
          "target_page": 161,
          "pages": [
            159,
            160,
            161,
            162,
            163
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 32417,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 8332,
        "completion_tokens": 131,
        "total_tokens": 8463
      }
    },
    {
      "question_id": 36,
      "question": "How has the status of the 0.835% Notes due 2032 evolved between the 2022 and 2024 SEC filings for Exxon Mobil Corporation?",
      "original_answer": "In the 2022 filing, the 0.835% Notes due 2032 were listed among other notes with distinct trading symbols, including the 0.142% Notes due 2024 (XOM24B), indicating a broader set of publicly traded debt instruments. By 2024, the 0.835% Notes due 2032 remained listed with the trading symbol XOM32, but the 0.142% Notes due 2024 no longer appeared in the 2024 filing, suggesting that the 2024 notes were either redeemed or no longer publicly traded. Therefore, while the 0.835% Notes due 2032 remained a consistent part of Exxon Mobil's publicly disclosed debt structure, the removal of the 2024 notes indicates a change in the company's short-to-intermediate term debt composition.",
      "llm_answer": "The 0.835% Notes due 2032 were listed in the securities tables of both the 2022 and 2024 Form 10‑K filings, confirming that the notes remained outstanding and unchanged in the company’s capital structure across those years. No subsequent amendment or redemption of the notes was disclosed in the provided pages.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "XOM_10k_2022.pdf",
          "target_page": 1,
          "pages": [
            1,
            2,
            3,
            4,
            5
          ]
        },
        "hop_2_rel": {
          "source_file": "XOM_10k_2024.pdf",
          "target_page": 1,
          "pages": [
            1,
            2,
            3,
            4,
            5
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 9,
        "total_chars": 48848,
        "num_window_pages": 9,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 12424,
        "completion_tokens": 77,
        "total_tokens": 12501
      }
    },
    {
      "question_id": 36,
      "question": "How has American Express's investment strategy toward U.S. Government treasury obligations evolved between 2022 and 2024, particularly in terms of fair value allocation and maturity distribution?",
      "original_answer": "In 2022, American Express held U.S. Government treasury obligations exclusively in short-term instruments with a fair value of $477 million and no long-term exposure. By 2024, the company shifted its strategy to include both short-term ($189 million) and intermediate-term ($98 million) treasury obligations, indicating a more diversified maturity profile. This reflects a transformation in the company's investment approach, expanding beyond less than 12-month instruments to include holdings maturing within 1 to 5 years.",
      "llm_answer": "Based on the provided SEC 10-K pages, American Express's investment strategy toward U.S. Government treasury obligations evolved significantly between 2022 and 2024 in terms of fair value allocation and maturity distribution. In 2022 (page 126), U.S. Government treasury obligations represented $287 million in fair value with a weighted average yield of 4.81% for maturities beyond 10 years, but this was part of a broader portfolio where treasury obligations were primarily held in longer maturities (832 due within 1 year, 862 due after 1-5 years, and 10 due after 5-10 years as of 2021). By 2024 (page 125), the fair value allocation shifted to $287 million in U.S. Government treasury obligations with a more concentrated maturity profile: $123 million due after 1-5 years and $10 million due after 5-10 years, reflecting a strategic shift toward shorter-duration holdings. The weighted average yield for these treasury obligations also declined to 2.73% for maturities beyond 10 years (compared to 4.81% in 2021), indicating a deliberate move toward lower-yielding, shorter-term Treasury securities to manage interest rate risk amid rising rates. This evolution shows a clear strategic pivot from longer-duration, higher-yield Treasury holdings toward shorter-maturity, lower-yielding instruments, as evidenced by the reduced emphasis on 10+ year maturities and the increased allocation to shorter-term Treasury securities within the AFS portfolio.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AXP_10k_2022.pdf",
          "target_page": 120,
          "pages": [
            118,
            119,
            120,
            121,
            122
          ]
        },
        "hop_2_rel": {
          "source_file": "AXP_10k_2024.pdf",
          "target_page": 126,
          "pages": [
            124,
            125,
            126,
            127,
            128
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 39660,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 10150,
        "completion_tokens": 363,
        "total_tokens": 10513
      }
    },
    {
      "question_id": 36,
      "question": "How did Amazon's introduction and subsequent treatment of the 2.500% Note due 2050 evolve between 2022 and 2024?",
      "original_answer": "In 2022, the 2.500% Note due 2050 was introduced as part of an Officers' Certificate dated June 3, 2020, and was listed alongside other notes in Exhibit 4.5. By 2024, the 2.500% Note due 2050 was reintroduced in Exhibit 4.6, which was an exact replication of Exhibit 4.5 from 2020, indicating that Amazon continued to maintain this long-term debt instrument without modification. The reintroduction in 2024 reaffirmed the note's role in Amazon's capital structure.",
      "llm_answer": "Amazon introduced its 2.500% Note due 2050 in its June 3 2020 Officers’ Certificate (page 72), which was later referenced again in the May 12 2021 certificate (page 73) alongside other long‑dated notes. By the 2022 filing (page 75), the company had issued new 4.7%–4.7% notes due 2024‑2032, but the 2.500% 2050 note remained part of the earlier 2020 issuance and continued to be described in subsequent certificates, indicating that its terms were unchanged through 2024. No subsequent amendments or retirements of the 2.500% Note due 2050 were disclosed in the provided 2022‑2024 documents.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AMZN_10k_2022.pdf",
          "target_page": 72,
          "pages": [
            69,
            70,
            71,
            72,
            73
          ]
        },
        "hop_2_rel": {
          "source_file": "AMZN_10k_2024.pdf",
          "target_page": 75,
          "pages": [
            72,
            73,
            74,
            75,
            76
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 9,
        "total_chars": 45117,
        "num_window_pages": 9,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 11491,
        "completion_tokens": 147,
        "total_tokens": 11639
      }
    },
    {
      "question_id": 36,
      "question": "How did the number of amendments to the Citibank, N.A. Co-Branded Credit Card Agreement evolve between 2022 and 2023?",
      "original_answer": "In 2022, the most recent amendment to the Citibank, N.A. Co-Branded Credit Card Agreement was the Eighth Amendment, filed on March 10, 2022. By 2023, the agreement had undergone further modifications, with the Twelfth Amendment being filed on October 11, 2023, indicating a total of four additional amendments during this period. This demonstrates a continued evolution and refinement of the agreement terms over the 12-month period.",
      "llm_answer": "The Citibank, N.A. Co-Branded Credit Card Agreement saw a progression of amendments between 2022 and 2023, with the Fourth through Eighth Amendments filed in 2018–2022 (Exhibits 10.8.4–10.8.8), followed by the Ninth and Tenth Amendments filed in November 2022 (Exhibits 10.8.9–10.8.10), and the Eleventh Amendment filed in February 2023 (Exhibit 10.8.11), with a Twelfth Amendment filed in October 2023 (Exhibit 10.8.12). This indicates a steady evolution of amendments, with two amendments filed in 2022 and one additional amendment filed in 2023.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "COST_10k_2022.pdf",
          "target_page": 68,
          "pages": [
            65,
            66,
            67,
            68,
            69
          ]
        },
        "hop_2_rel": {
          "source_file": "COST_10k_2023.pdf",
          "target_page": 68,
          "pages": [
            66,
            67,
            68,
            69,
            70
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 55000,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 13963,
        "completion_tokens": 137,
        "total_tokens": 14100
      }
    },
    {
      "question_id": 36,
      "question": "How has NVIDIA's approach to CUDA evolved between 2022 and 2024, particularly in terms of its integration with new computing architectures and software ecosystems?",
      "original_answer": "In 2022, NVIDIA emphasized CUDA as a foundational building block across its target markets, including Gaming, Data Center, Professional Visualization, and Automotive, highlighting its role in enabling accelerated computing and deep learning. CUDA was positioned as a core component of the company's unified architecture, supporting a wide range of applications through internal and third-party software stacks. By 2024, NVIDIA had significantly expanded the scope of CUDA's integration, describing it as part of a broader full-stack computing platform that includes the CUDA-X collection of acceleration libraries, APIs, SDKs, and domain-specific application frameworks. Additionally, CUDA was now explicitly tied to NVIDIA's expanded data center platform, which now includes CPUs (introduced in fiscal 2024) alongside GPUs and DPUs, showing a strategic evolution toward deeper integration with heterogeneous computing architectures and enterprise-grade AI ecosystems.",
      "llm_answer": "NVIDIA's CUDA approach has evolved from a foundational parallel computing model to a full-stack AI platform tightly integrated with new architectures. By 2024, it expanded to include DPUs and CPUs (e.g., Grace CPU, Blackwell architecture), enabling unified acceleration across GPUs, CPUs, and networking, while deepening software integration through AI-specific features like Tensor Cores, DLSS, and Omniverse for simulation. This integration supports end-to-end AI workflows—from training and inference to autonomous driving and generative AI—across data centers, gaming, and automotive ecosystems.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "NVDA_10k_2022.pdf",
          "target_page": 9,
          "pages": [
            7,
            8,
            9,
            10,
            11
          ]
        },
        "hop_2_rel": {
          "source_file": "NVDA_10k_2024.pdf",
          "target_page": 6,
          "pages": [
            4,
            5,
            6,
            7,
            8
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 7,
        "total_chars": 41217,
        "num_window_pages": 7,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 10527,
        "completion_tokens": 149,
        "total_tokens": 10677
      }
    },
    {
      "question_id": 36,
      "question": "How did Pfizer's financial relationship with Paxlovid evolve between 2023 and 2024, particularly in terms of revenue recognition and contractual obligations?",
      "original_answer": "In 2023, Paxlovid generated $1.279 billion in revenue, but this figure was significantly impacted by a non-cash revenue reversal of $3.5 billion due to the expected return of 6.5 million treatment courses of EUA-labeled U.S. government inventory. By 2024, this reversal was adjusted favorably by $771 million as only 5.1 million treatment courses were actually returned, and an additional $442 million in revenue was recorded in connection with the creation of the U.S. Strategic National Stockpile (SNS). Furthermore, as of December 31, 2024, Pfizer reported approximately $1 billion in remaining performance obligations related to Paxlovid supply contracts, indicating ongoing but reduced commercial activity compared to the prior year. This evolution reflects a shift from a high-volume, government-driven revenue model in 2023 to a more stable, contracted future delivery model in 2024.",
      "llm_answer": "Pfizer's financial relationship with Paxlovid shifted dramatically between 2023 and 2024 due to the resolution of pandemic-era government contracts and revenue reversals. In 2023, Paxlovid revenue plummeted 92% year-over-year to $1.279 billion, driven by a $3.5 billion non-cash revenue reversal in Q4 2023 related to the expected return of 6.5 million EUA-labeled government courses, partially offset by a $771 million favorable adjustment in Q1 2024 reflecting only 5.1 million courses returned (vs. 6.5 million estimated). By 2024, Paxlovid revenue further declined to $1.191 billion globally, with $1.279 billion in the U.S. and $2.568 billion internationally, as the company transitioned to commercial market sales and recognized $442 million in revenue from a U.S. Strategic National Stockpile supply agreement. Deferred revenue for Paxlovid and Comirnaty decreased from $5.1 billion (as of Dec 31, 2023) to $2.2 billion (as of Dec 31, 2024), reflecting revenue recognition as products were delivered under remaining performance obligations through 2028.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "PFE_10k_2023.pdf",
          "target_page": 44,
          "pages": [
            42,
            43,
            44,
            45,
            46
          ]
        },
        "hop_2_rel": {
          "source_file": "PFE_10k_2024.pdf",
          "target_page": 109,
          "pages": [
            107,
            108,
            109,
            110,
            111
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 89356,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 22563,
        "completion_tokens": 265,
        "total_tokens": 22828
      }
    },
    {
      "question_id": 37,
      "question": "How has the availability and structure of shares under the 2003 Incentive Program evolved between 2022 and 2024?",
      "original_answer": "In 2022, the 2003 Incentive Program had 65,754,069 shares available for award. By 2024, the total maximum number of shares that could be issued under the program was increased to 220 million, with 47 million remaining available for awards by the end of 2024. This indicates a significant expansion in the program's capacity, although actual usage had grown moderately over time, with restricted stock units granted increasing from 9,392 thousand in 2022 to 10,393 thousand in 2024.",
      "llm_answer": "Between 2022 and 2024, the availability of shares under the 2003 Incentive Program declined from an unspecified but larger pool to 47 million shares remaining at year‑end 2024, while the program continued to allow new awards until those shares are exhausted.  The structure of the program remained unchanged: awards may be stock options, SARs, restricted stock, or other forms, with a maximum life of 10 years for options/SARs and no set expiration for the program itself, and forfeited, expired, or cash‑settled awards do not reduce the 220 million‑share cap.  Additionally, the 2024 totals now incorporate Pioneer restricted‑stock units issued after the May 3, 2024 merger, with 760 thousand such awards granted, of which 67 thousand vested and 209 thousand were forfeited.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "XOM_10k_2022.pdf",
          "target_page": 43,
          "pages": [
            41,
            42,
            43,
            44,
            45
          ]
        },
        "hop_2_rel": {
          "source_file": "XOM_10k_2024.pdf",
          "target_page": 102,
          "pages": [
            100,
            101,
            102,
            103,
            104
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 45650,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 11625,
        "completion_tokens": 193,
        "total_tokens": 11819
      }
    },
    {
      "question_id": 37,
      "question": "How has AdSense's role within Google's advertising revenue streams evolved between 2022 and 2024, particularly in relation to the company's broader advertising technology portfolio?",
      "original_answer": "In 2022, AdSense was explicitly cited as a key growth driver within the Google Network, contributing to an $8.6 billion year-over-year revenue increase alongside AdMob and Google Ad Manager. By 2024, while AdSense remained part of the Google Network, it was no longer specifically quantified as a growth lever. Instead, newer AI-powered advertising products like Demand Gen and Performance Max were highlighted as central to advertiser success, suggesting a strategic shift where AdSense became a more foundational, mature offering within Google's broader advertising technology stack.",
      "llm_answer": "Between 2022 and 2024, AdSense’s role within Google’s advertising revenue streams has shifted from a standalone revenue source to a key component of Google’s broader advertising technology portfolio. In 2022, AdSense was primarily positioned as a platform for publishers to monetize content through contextual ads, contributing to Google’s overall advertising revenue, which was driven by Google Search, YouTube, and Google Network (including AdSense, AdMob, and Ad Manager). By 2023–2024, AdSense’s functionality was increasingly integrated into Google’s AI-driven advertising ecosystem, particularly through Gemini AI and tools like Performance Max and Demand Gen, which leverage AI to optimize ad targeting, creative generation, and campaign management across Google’s platforms. This evolution reflects Google’s broader strategy to consolidate its advertising technology stack under AI-powered solutions, enhancing efficiency and scalability while maintaining AdSense as a foundational channel for publishers within the larger Google Ads ecosystem.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "GOOGL_10k_2022.pdf",
          "target_page": 35,
          "pages": [
            33,
            34,
            35,
            36,
            37
          ]
        },
        "hop_2_rel": {
          "source_file": "GOOGL_10k_2024.pdf",
          "target_page": 8,
          "pages": [
            6,
            7,
            8,
            9,
            10
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 45293,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 11552,
        "completion_tokens": 263,
        "total_tokens": 11815
      }
    },
    {
      "question_id": 37,
      "question": "How did the UPS Retirement Plan's benefit accrual structure evolve between 2022 and 2023, and what specific changes were made to future benefit accruals for non-union participants?",
      "original_answer": "In 2022, the UPS Retirement Plan was described as noncontributory and covering substantially all eligible employees hired before July 1, 2016, who were not part of a collective bargaining unit or certain employees covered by a collective bargaining agreement. The plan provided retirement benefits based on average compensation and was subject to IRS limits. It was also disclosed that the plan would cease accruals of additional benefits for future service and compensation for non-union participants effective January 1, 2023. In 2023, this cessation of accruals was confirmed as effective, and the plan was described with the same eligibility and benefit structure but explicitly stated that no further accruals would occur for non-union participants. This marks a transformational change in the plan's structure, as the accrual freeze was implemented as planned, shifting the plan from an active benefit-accruing structure to a closed one for non-union employees. The change represents a significant strategic shift in UPS's retirement benefit policy.",
      "llm_answer": "The UPS Retirement Plan stopped accruing additional benefits for non‑union participants as of January 1 2023, and the UPS Excess Coordinating Benefit Plan made the same change effective that date. In 2023 the company began providing a new retirement contribution to the UPS 401(k) Savings Plan for non‑union employees—5 % to 8 % of eligible compensation (up from 3 % to 8 % before 2023)—and the related expense for these contributions was $380 million in 2023.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "UPS_10k_2022.pdf",
          "target_page": 92,
          "pages": [
            90,
            91,
            92,
            93,
            94
          ]
        },
        "hop_2_rel": {
          "source_file": "UPS_10k_2023.pdf",
          "target_page": 82,
          "pages": [
            80,
            81,
            82,
            83,
            84
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 9,
        "total_chars": 44324,
        "num_window_pages": 9,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 11310,
        "completion_tokens": 115,
        "total_tokens": 11425
      }
    },
    {
      "question_id": 37,
      "question": "How has Amazon's utilization and structure of its short-term credit facilities evolved between 2022 and 2024, particularly in terms of credit capacity, interest rate terms, and outstanding borrowings?",
      "original_answer": "In 2022, Amazon had a $7.0 billion unsecured revolving credit facility with an interest rate of benchmark rate plus 0.50% and a commitment fee of 0.04%, and no borrowings were outstanding under this facility. Additionally, Amazon had $7.2 billion in unused letters of credit as of December 31, 2021. By 2024, Amazon had significantly expanded its credit capacity by entering into a new $15.0 billion unsecured revolving credit facility with a lower interest rate of benchmark rate plus 0.45% and a reduced commitment fee of 0.03%. In addition, Amazon introduced a new $5.0 billion unsecured 364-day revolving credit facility in October 2024, which also carried a rate of SOFR plus 0.45% and a 0.03% commitment fee. Notably, there were still no borrowings outstanding under the main Credit Agreement or the Short-Term Credit Agreement as of December 31, 2024. However, Amazon had $147 million and $151 million in borrowings under other short-term credit facilities as of December 31, 2023 and 2024, respectively, which were included in 'Accrued expenses and other.' The company also increased its unused letters of credit to $8.3 billion by the end of 2024.",
      "llm_answer": "Amazon's short-term credit facilities evolved between 2022 and 2024 through the replacement of its prior 364-day revolving credit facility with a new $5.0 billion facility maturing in October 2025, which carries interest at the Secured Overnight Financing Rate plus 0.45% and includes a 0.03% commitment fee on undrawn amounts. The company also maintains a $15.0 billion unsecured revolving credit facility extending to November 2028, and utilizes other short-term facilities with $147 million and $151 million outstanding as of December 31, 2023 and 2024. No borrowings were outstanding under the Credit Agreement or Short-Term Credit Agreement as of December 31, 2023 and 2024, with the company relying on commercial paper programs (up to $20.0 billion total capacity) and these credit facilities for general corporate purposes.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AMZN_10k_2022.pdf",
          "target_page": 57,
          "pages": [
            55,
            56,
            57,
            58,
            59
          ]
        },
        "hop_2_rel": {
          "source_file": "AMZN_10k_2024.pdf",
          "target_page": 58,
          "pages": [
            56,
            57,
            58,
            59,
            60
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 56235,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 14293,
        "completion_tokens": 207,
        "total_tokens": 14500
      }
    },
    {
      "question_id": 37,
      "question": "How has Costco's use of variable-priced contracts for energy purchases evolved between 2022 and 2023, and what does this indicate about its commodity price risk management strategy?",
      "original_answer": "In 2022, Costco entered into variable-priced contracts for some purchases of electricity and natural gas, as well as fuel for its gas stations, on an index basis. These contracts met the definition of derivatives but generally qualified for the 'normal purchases and normal sales' exception, requiring no mark-to-market adjustment. By 2023, Costco continued this approach but specifically called out natural gas and fuel for gas stations as key components of its variable-priced contract usage. This indicates a continued reliance on variable-priced contracts as part of its commodity price risk management, with no significant shift away from index-based pricing mechanisms. The strategy remains consistent, showing stability in how Costco manages exposure to energy price fluctuations.",
      "llm_answer": "Costco's use of variable-priced contracts for energy purchases remained consistent between 2022 and 2023, as evidenced by its continued reliance on index-based agreements for natural gas and electricity purchases (noted in both 2022 and 2023 documents) that qualify for the \"normal purchases and normal sales\" exception and require no mark-to-market adjustments. This stability indicates a deliberate strategy to manage commodity price risk through partial hedging via fixed-price contracts for select facilities while accepting exposure to market fluctuations for other purchases, reflecting a pragmatic approach to balancing risk mitigation with operational flexibility.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "COST_10k_2022.pdf",
          "target_page": 31,
          "pages": [
            29,
            30,
            31,
            32,
            33
          ]
        },
        "hop_2_rel": {
          "source_file": "COST_10k_2023.pdf",
          "target_page": 47,
          "pages": [
            45,
            46,
            47,
            48,
            49
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 37668,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 9646,
        "completion_tokens": 168,
        "total_tokens": 9814
      }
    },
    {
      "question_id": 37,
      "question": "How has the strategic positioning and commercial role of NVIDIA AI Enterprise evolved within NVIDIA's data center offerings between 2022 and 2024?",
      "original_answer": "In 2022, NVIDIA AI Enterprise was introduced as part of the Compute & Networking segment, indicating its foundational role in NVIDIA's AI and accelerated computing strategy. By 2024, the product had evolved into a more prominent commercial offering, described as a 'comprehensive suite of enterprise-grade AI software' that is actively licensed and integrated into broader data center solutions. This shift reflects NVIDIA's move from positioning it as a strategic initiative to a key monetization vehicle within its full-stack data center platform, alongside offerings like NVIDIA DGX Cloud and the expansion into CPUs and DPUs.",
      "llm_answer": "Between 2022 and 2024, NVIDIA AI Enterprise evolved from a core enterprise AI software suite into a broader, full-stack AI and accelerated computing platform. Initially launched as a paid license for enterprise AI software and NVIDIA vGPU software, it expanded to include AI Enterprise tools like NIM (delivering 2.5x token throughput), NeMo for model curation/fine-tuning, and AI Blueprints for building AI agents. This evolution was reinforced by the 2023 launch of the Blackwell architecture, which integrated AI Enterprise software into a unified data center-scale infrastructure spanning GPUs, CPUs, DPUs, and networking. By 2024, AI Enterprise was positioned as the \"operating system for enterprise AI,\" tightly coupled with NVIDIA's hardware (including the Blackwell GPUs and CPUs) and software stack (CUDA, Tensor Cores), enabling end-to-end deployment of generative AI workloads across data centers. This strategic shift solidified its role as the central software layer for NVIDIA's data center offerings, moving beyond standalone software licenses to become an integrated component of its full-stack computing platform.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "NVDA_10k_2022.pdf",
          "target_page": 99,
          "pages": [
            78,
            79,
            80,
            81,
            82
          ]
        },
        "hop_2_rel": {
          "source_file": "NVDA_10k_2024.pdf",
          "target_page": 6,
          "pages": [
            4,
            5,
            6,
            7,
            8
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 49717,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 12649,
        "completion_tokens": 282,
        "total_tokens": 12931
      }
    },
    {
      "question_id": 37,
      "question": "How did Pfizer's contractual obligations related to Paxlovid evolve between 2023 and 2024, and what does this indicate about the company's future revenue expectations for the product?",
      "original_answer": "In 2023, Pfizer had a non-cash revenue reversal of $3.5 billion recorded in the fourth quarter related to the expected return of an estimated 6.5 million treatment courses of Paxlovid labeled under Emergency Use Authorization (EUA) from the U.S. government. This indicated uncertainty and potential decline in demand for Paxlovid. By 2024, however, remaining performance obligations for Paxlovid totaled approximately $1 billion as of December 31, 2024, signaling a stabilization and expectation of future revenue from existing contracts. This shift from a large revenue reversal to a defined forward-looking contractual obligation suggests improved demand forecasting and a more stable outlook for Paxlovid in 2024 compared to the uncertainty in 2023.",
      "llm_answer": "Pfizer’s contractual obligations for Paxlovid shifted markedly between 2023 and 2024. In 2023, the company recorded a $3.5 billion non‑cash revenue reversal related to expected returns of U.S. government‑stockpiled courses, followed by a $771 million favorable adjustment in early 2024 reflecting fewer returns than initially projected and the delivery of 1 million courses to the U.S. Strategic National Stockpile. By the end of 2024, deferred revenue linked to Paxlovid had fallen from $5.1 billion to $2.2 billion, with $1.4 billion classified as current (to be recognized within the next 12 months) and the remainder slated for recognition from 2025 through 2028. This decline signals that Pfizer expects substantially lower future Paxlovid sales and therefore anticipates only modest, back‑end revenue from the product in the coming years.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "PFE_10k_2023.pdf",
          "target_page": 66,
          "pages": [
            64,
            65,
            66,
            67,
            68
          ]
        },
        "hop_2_rel": {
          "source_file": "PFE_10k_2024.pdf",
          "target_page": 109,
          "pages": [
            107,
            108,
            109,
            110,
            111
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 78180,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 19776,
        "completion_tokens": 211,
        "total_tokens": 19987
      }
    },
    {
      "question_id": 38,
      "question": "Compare and contrast how Google's exposure to new regulatory costs in international markets evolved between 2022 and 2024, particularly in terms of the scope and nature of regulatory challenges described?",
      "original_answer": "In 2022, Google highlighted that an evolving foreign policy landscape could subject the company to 'new regulatory costs and challenges,' specifically mentioning data transfers between the EU and the UK, as well as new customer requirements. By 2024, the scope of regulatory challenges expanded significantly. The 2024 filing not only reiterated the exposure to 'new regulatory costs and challenges' but also introduced elements like 'uncertainty regarding regulatory outcomes' and the risk of 'other liabilities under local laws that may not offer due process or clear legal precedent.' This indicates a shift from primarily data-related regulatory concerns in 2022 to broader, more unpredictable regulatory risks in 2024, reflecting an increased complexity in Google's international regulatory environment.",
      "llm_answer": "Between 2022 and 2024, Google’s exposure to new regulatory costs in international markets shifted from a general focus on supply‑chain and operational risks to a more explicit articulation of direct regulatory and compliance expenses. In the 2022 filing (pages 12‑16), the company highlighted supply‑chain disruptions, component shortages, and the need to comply with foreign labor, environmental and export‑control rules as indirect cost drivers, but it did not isolate “regulatory costs” as a distinct line‑item. By the 2024 filing (pages 14‑18), Google explicitly lists sanctions, export controls, foreign‑ownership restrictions, data‑localization mandates, and new privacy‑related regulations as separate risk factors that could impose “new regulatory costs” in each jurisdiction, and it notes that these costs are “evolving” and may materially affect earnings. Thus, the scope broadened from indirect supply‑chain‑related compliance to direct, jurisdiction‑specific regulatory liabilities, and the nature of the challenges moved from generic operational risk to concrete legal and fiscal obligations tied to international law and policy changes.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "GOOGL_10k_2022.pdf",
          "target_page": 14,
          "pages": [
            12,
            13,
            14,
            15,
            16
          ]
        },
        "hop_2_rel": {
          "source_file": "GOOGL_10k_2024.pdf",
          "target_page": 16,
          "pages": [
            14,
            15,
            16,
            17,
            18
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 59699,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 15160,
        "completion_tokens": 287,
        "total_tokens": 15448
      }
    },
    {
      "question_id": 38,
      "question": "How has UPS's approach to funding postretirement medical benefits evolved between 2022 and 2023, particularly in terms of the sources used for expected benefit payments?",
      "original_answer": "In 2022, UPS indicated that expected benefit payments for postretirement medical benefits would be paid from both plan trusts and corporate assets. In 2023, the language remained unchanged, indicating continuity in the funding approach. Therefore, there was no change in the sources used for expected benefit payments for postretirement medical benefits between the two years.",
      "llm_answer": "Based on the provided 10-K filings, UPS's approach to funding postretirement medical benefits has remained consistent in its primary funding source: **expected benefit payments for postretirement medical benefits are paid from plan trusts and corporate assets** (as stated in both 2022 and 2023 filings, specifically on page 109 and reiterated in 2023 on page 94). There is no indication of a structural change in funding sources between 2022 and 2023—contributions continue to be made to plan trusts, with corporate assets supplementing payments for medical benefits, maintaining the same funding methodology as the prior year.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "UPS_10k_2022.pdf",
          "target_page": 109,
          "pages": [
            107,
            108,
            109,
            110,
            111
          ]
        },
        "hop_2_rel": {
          "source_file": "UPS_10k_2023.pdf",
          "target_page": 92,
          "pages": [
            90,
            91,
            92,
            93,
            94
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 9,
        "total_chars": 44050,
        "num_window_pages": 9,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 11240,
        "completion_tokens": 157,
        "total_tokens": 11397
      }
    },
    {
      "question_id": 38,
      "question": "How has the role and scope of NVIDIA AI Enterprise evolved from its introduction in 2022 to its broader supply and integration in 2024?",
      "original_answer": "In 2022, NVIDIA AI Enterprise was introduced as part of the Compute & Networking segment, described as a software suite aimed at simplifying the deployment of AI applications across data centers and enterprise environments. By 2024, the platform had evolved into a more comprehensive and integrated solution, including components such as NVIDIA NIM, NVIDIA NeMo, and AI Blueprints, with specific performance improvements like a 2.5x increase in token throughput. This reflects a shift from a foundational offering to a full-stack, production-grade generative AI platform with enhanced capabilities and broader deployment options.",
      "llm_answer": "From its launch in 2022, NVIDIA AI Enterprise began as a paid, enterprise‑grade AI software suite bundled with NVIDIA’s data‑center platform, offering AI‑accelerated libraries, NIM inference microservices, and tools such as NeMo for model fine‑tuning. By 2024 the offering had expanded into a broader, full‑stack AI infrastructure that now includes GPUs, CPUs, DPUs, and networking, and is tightly integrated with the Blackwell architecture, DGX Cloud, and Omniverse, enabling end‑to‑end AI workloads—from training to production—across data‑center, cloud, and edge environments.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "NVDA_10k_2022.pdf",
          "target_page": 6,
          "pages": [
            4,
            5,
            6,
            7,
            8
          ]
        },
        "hop_2_rel": {
          "source_file": "NVDA_10k_2024.pdf",
          "target_page": 7,
          "pages": [
            5,
            6,
            7,
            8,
            9
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 7,
        "total_chars": 39093,
        "num_window_pages": 7,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 9989,
        "completion_tokens": 144,
        "total_tokens": 10133
      }
    },
    {
      "question_id": 39,
      "question": "How has ExxonMobil's proved reserves through equity companies evolved from 2022 to 2024, and what does this indicate about its strategic positioning in different regions?",
      "original_answer": "In 2022, ExxonMobil's total proved reserves from equity companies amounted to 14 million barrels gross (1 million net) across the United States, Europe, Africa, and Asia. By 2024, these reserves had significantly increased to 467 million barrels of crude oil, 120 million barrels of natural gas liquids, and 5,367 billion cubic feet of natural gas, with the majority of this growth concentrated in Asia. This indicates a major strategic shift toward strengthening its upstream presence in the Asia region through equity companies.",
      "llm_answer": "From 2022 to 2024, ExxonMobil’s proved reserves through equity companies declined from 208 productive development wells (2022) to 20 at year-end 2024, with total equity‑company reserves falling from 208 wells to 20 net productive development wells and from 208 total wells (including dry) to 0 dry wells—indicating a strategic shift away from equity‑partnered development, especially in regions like the United States and Asia where reserves were previously sizable. This reduction, coupled with the heavy focus on consolidated subsidiary reserves (which grew from 686 total productive development wells in 2022 to 487 in 2024) and a substantial increase in undeveloped reserves (7.4 GOEB in 2024 versus 6.3 GOEB in 2023), shows that ExxonMobil is concentrating its capital and technical resources on its own operated assets, especially in high‑potential regions such as the U.S. Permian, Guyana, and the Asia‑Pacific, while scaling back involvement in equity‑joint ventures. Consequently, the company’s strategic positioning is increasingly centered on controlling and developing its proprietary reserve base in key basins and international projects, rather than relying on equity partnerships to add reserves.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "XOM_10k_2022.pdf",
          "target_page": 22,
          "pages": [
            20,
            21,
            22,
            23,
            24
          ]
        },
        "hop_2_rel": {
          "source_file": "XOM_10k_2024.pdf",
          "target_page": 10,
          "pages": [
            8,
            9,
            10,
            11,
            12
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 47054,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 11989,
        "completion_tokens": 302,
        "total_tokens": 12292
      }
    },
    {
      "question_id": 39,
      "question": "How has the financial relationship with Google Network Partners evolved between 2022 and 2024, particularly in terms of their role in revenue generation and cost structure?",
      "original_answer": "In 2022, Google Network Partners played a central role in the revenue generation process as Google acted as the principal for ads placed on Google Network properties, reporting advertising revenues on a gross basis, with payments to partners recorded as cost of revenues. By 2024, Google continued to pay Google Network partners, but the focus of the financial reporting shifted to emphasize the net cash flow impact, noting that payments to these partners were a primary use of cash from operating activities. This reflects a more cost-centric framing of the relationship in the later year.",
      "llm_answer": "Between 2022 and 2024, Google Network Partners transitioned from a gross revenue reporting model to a net basis for certain arrangements, though the provided 2024 documents confirm they remain primarily reported on a gross basis (i.e., revenues are recorded in full and payments to partners are classified as cost of revenues). The financial relationship evolved with increased reliance on Network Partners for ad inventory monetization, particularly through AdMob, AdSense, and Ad Manager, contributing to higher revenue streams. However, the cost structure shifted significantly, as payments to these partners (TAC) are now explicitly recorded as a direct cost of revenues, reducing net margins despite revenue growth. This is reflected in the 2024 financials where Google Services operating income rose due to revenue growth offsetting increases in TAC and content acquisition costs. The 2024 data shows no material change in the core gross reporting model, but the emphasis on Network Partners' role in driving revenue growth is now explicitly tied to their inclusion in cost of revenues, not as a revenue offset.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "GOOGL_10k_2022.pdf",
          "target_page": 55,
          "pages": [
            53,
            54,
            55,
            56,
            57
          ]
        },
        "hop_2_rel": {
          "source_file": "GOOGL_10k_2024.pdf",
          "target_page": 42,
          "pages": [
            40,
            41,
            42,
            43,
            44
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 52730,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 13410,
        "completion_tokens": 279,
        "total_tokens": 13689
      }
    },
    {
      "question_id": 39,
      "question": "How has UPS's foreign currency exchange risk management strategy evolved between 2022 and 2023, particularly in terms of the financial impact of undesignated foreign currency forward contracts on earnings volatility?",
      "original_answer": "In 2022, UPS disclosed that foreign currency exchange forward contracts were used to economically offset foreign currency remeasurement and settlement risk for certain balance sheet assets and liabilities, and that changes in their fair value affected earnings directly. For 2023, UPS expanded the disclosure to emphasize that undesignated derivative settlements are now explicitly linked to earnings volatility, with a specific focus on how these contracts impact income statement recognition. The 2023 filing also introduced a more structured presentation of fair value changes and settlements for these contracts, with amounts for both 2023 and 2022 now reported side-by-side in millions, indicating a more transparent and systematic approach to disclosing the financial effects of these instruments.",
      "llm_answer": "UPS’s foreign‑currency‑exchange‑risk management strategy remained focused on using over‑the‑counter forward contracts to hedge anticipated cash‑flow exposures, but the company’s earnings‑volatility profile shifted in 2023. In 2022, gains and losses on undesignated forward contracts were recorded directly in income, creating relatively large swings in earnings; by 2023, the amount of such gains/losses had been reduced to just $‑7 million (a small net loss) and was largely offset by the $213 million gain on designated fair‑value hedges, resulting in a much smoother earnings impact. Consequently, the volatility of earnings attributable to undesignated foreign‑currency forwards declined markedly between the two years.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "UPS_10k_2022.pdf",
          "target_page": 159,
          "pages": [
            136,
            137,
            138,
            139,
            140
          ]
        },
        "hop_2_rel": {
          "source_file": "UPS_10k_2023.pdf",
          "target_page": 132,
          "pages": [
            130,
            131,
            132,
            133,
            134
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 8,
        "total_chars": 38694,
        "num_window_pages": 8,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 9914,
        "completion_tokens": 180,
        "total_tokens": 10094
      }
    },
    {
      "question_id": 39,
      "question": "How has the role of the membership format in Costco's profitability strategy evolved between 2022 and 2023, particularly in terms of its impact on member loyalty and fee revenue?",
      "original_answer": "In 2022, the membership format was described as 'an integral part of our business and has a significant effect on our profitability,' with an emphasis on growth in the membership base, increasing Executive member penetration, and sustaining high renewal rates as key drivers of profitability. By 2023, the language evolved to underscore that the membership format 'is an integral part of our business and profitability,' indicating a more consolidated role in the company's financial model. Additionally, in 2023, Costco introduced a new concern about the potential adverse impact of lower renewal rates in newer markets on the worldwide renewal rate, which was not explicitly mentioned in 2022. This suggests that while the membership model remained central to profitability, the company faced emerging challenges in sustaining renewal rates as it expanded into newer markets.",
      "llm_answer": "Between 2022 and 2023, Costco’s membership format remained a core profitability driver, but its impact shifted subtly. While membership fee revenue grew 5% to $4,828 million in 2024 (up from $4,224 million in 2022), the company emphasized that growth in member sign‑ups and Executive upgrades—and sustained high renewal rates—directly boosted fee income and reinforced loyalty. However, the MD&A notes that the membership model’s contribution to profitability is now more intertwined with overall sales growth and cost‑control, as lower renewal rates in newer markets or openings in existing markets could dampen paid‑membership growth. Thus, the membership format continues to underpin fee revenue and loyalty, but its relative influence on profitability is increasingly mediated by broader sales dynamics and cost pressures.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "COST_10k_2022.pdf",
          "target_page": 23,
          "pages": [
            21,
            22,
            23,
            24,
            25
          ]
        },
        "hop_2_rel": {
          "source_file": "COST_10k_2023.pdf",
          "target_page": 24,
          "pages": [
            22,
            23,
            24,
            25,
            26
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 83535,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 21112,
        "completion_tokens": 206,
        "total_tokens": 21319
      }
    },
    {
      "question_id": 39,
      "question": "How has NVIDIA's approach to CUDA evolved between 2022 and 2024, particularly in terms of its integration within the broader data center platform and software ecosystem?",
      "original_answer": "In 2022, CUDA was primarily positioned as a key component of NVIDIA's AI ecosystem, with nearly 3 million developers using CUDA and other software tools to deploy AI and accelerated computing technologies. It was described as central to NVIDIA's partnerships and developer programs, including the Deep Learning Institute and Inception program. By 2024, CUDA had evolved into a more deeply integrated part of a full-stack computing platform, specifically within the data center. It was described as the foundation of the CUDA-X collection of acceleration libraries, APIs, SDKs, and domain-specific frameworks, emphasizing its role in enabling end-to-end optimized computing across GPUs, CPUs, and DPUs. This reflects a strategic shift from promoting CUDA as a developer-focused tool to positioning it as a core infrastructure layer for enterprise-scale computing solutions.",
      "llm_answer": "Between 2022 and 2024, NVIDIA deepened CUDA’s integration into its broader data center platform by expanding the software stack around it—launching AI Enterprise with tools like NIM and NeMo for generative AI, embedding CUDA‑X libraries and APIs across DGX Cloud, and extending the architecture with new hardware generations (Blackwell GPUs, Grace CPUs, DPUs) that are tightly coupled to the same CUDA ecosystem. This end‑to‑end approach ties CUDA to networking (Mellanox), storage, and automotive solutions, making it the central software layer that unifies training, inference, simulation, and over‑the‑air updates across data‑center, automotive, and professional visualization workloads.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "NVDA_10k_2022.pdf",
          "target_page": 11,
          "pages": [
            9,
            10,
            11,
            12,
            13
          ]
        },
        "hop_2_rel": {
          "source_file": "NVDA_10k_2024.pdf",
          "target_page": 6,
          "pages": [
            4,
            5,
            6,
            7,
            8
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 7,
        "total_chars": 41217,
        "num_window_pages": 7,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 10529,
        "completion_tokens": 172,
        "total_tokens": 10702
      }
    },
    {
      "question_id": 39,
      "question": "How has Pfizer's financial commitment and contractual obligations related to Paxlovid evolved from 2023 to 2024, particularly in terms of expected future revenue and product delivery timelines?",
      "original_answer": "In 2023, Pfizer had a non-cash revenue reversal of $3.5 billion recorded in the fourth quarter related to the expected return of an estimated 6.5 million treatment courses of EUA-labeled Paxlovid from U.S. government inventory. By the end of 2024, Pfizer reported remaining performance obligations for Paxlovid at approximately $1 billion, with expected product delivery and revenue realization scheduled from 2025 through 2028, indicating a shift from uncertain returns and revenue reversals to a more defined forward-looking revenue outlook based on firm contracts.",
      "llm_answer": "Pfizer's financial commitment to Paxlovid shifted from pandemic-driven government contracts to commercial market sales between 2023 and 2024. While 2023 saw $1.279 billion in Paxlovid revenue (primarily from government purchases under EUA), 2024 revenue dropped to $5.716 billion (including $442 million from a U.S. strategic national stockpile supply), with remaining performance obligations totaling approximately $1 billion in contracted revenue expected through 2028 as the company transitions to commercial pricing and delivery timelines.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "PFE_10k_2023.pdf",
          "target_page": 4,
          "pages": [
            2,
            3,
            4,
            5,
            6
          ]
        },
        "hop_2_rel": {
          "source_file": "PFE_10k_2024.pdf",
          "target_page": 109,
          "pages": [
            107,
            108,
            109,
            110,
            111
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 97822,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 24687,
        "completion_tokens": 135,
        "total_tokens": 24823
      }
    },
    {
      "question_id": 40,
      "question": "How has ExxonMobil's strategic emphasis on Guyana evolved between 2022 and 2024, based on its disclosures around reserves development and advantaged asset reporting?",
      "original_answer": "In 2022, ExxonMobil reported that Guyana was a key contributor to extensions and discoveries, adding approximately 1.3 billion oil-equivalent barrels (GOEB) of proved undeveloped reserves. By 2024, Guyana was explicitly listed as one of the core 'Advantaged Assets' in the company's updated earnings drivers, signaling a strategic shift to highlight Guyana's role in driving earnings through volume growth. This evolution reflects a transition from Guyana being primarily a reserves growth region to being a recognized source of advantaged production and earnings visibility.",
      "llm_answer": "ExxonMobil’s strategic emphasis on Guyana has intensified markedly between 2022 and 2024, as reflected in its disclosures of reserves development and advantaged asset reporting. In the 2022 filing, Guyana’s offshore resources were highlighted as a key growth area, with the company noting significant additions to proved reserves and ongoing development of the Stabroek block, though still framed within broader global reserve trends. By 2024, Guyana emerged as a central pillar of ExxonMobil’s “advantaged assets” strategy, explicitly cited alongside the Permian Basin and LNG as a driver of earnings through “Advantaged Volume Growth.” The 2024 10-K underscores that Guyana’s deepwater projects—particularly the Liza Phase 2 and subsequent developments—are now material contributors to production growth, with reserves development accelerating through major funding commitments and infrastructure investments. This shift is further evidenced by the company’s increased capital allocation to Guyana-related projects, which now feature prominently in its structural cost savings narrative and ROCE analysis, signaling a strategic pivot to prioritize high-value, low-development-cost resources in Guyana as a cornerstone of its future production and earnings growth.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "XOM_10k_2022.pdf",
          "target_page": 14,
          "pages": [
            12,
            13,
            14,
            15,
            16
          ]
        },
        "hop_2_rel": {
          "source_file": "XOM_10k_2024.pdf",
          "target_page": 37,
          "pages": [
            35,
            36,
            37,
            38,
            39
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 54768,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 13917,
        "completion_tokens": 316,
        "total_tokens": 14233
      }
    },
    {
      "question_id": 40,
      "question": "How did the planned utilization of the ATR 72-600F aircraft evolve from 2022 to 2024, and what does this indicate about its role in the company's fleet strategy?",
      "original_answer": "In 2022, the ATR 72-600F was projected to have a decreasing role in the company's fleet, with planned units dropping from 11 in 2023 to just 1 by 2026. By 2024, however, the company's projections showed a shift, with ATR 72-600F units remaining steady at 7 for 2025 and declining only slightly to 3 by 2026. This indicates that while the aircraft was initially expected to phase out more rapidly, it continued to play a more sustained, albeit reduced, role in the fleet strategy.",
      "llm_answer": "From 2022 to 2024 the company’s planned deliveries of the ATR 72‑600F fell from 11 aircraft in 2023 to 6 in 2024, and the 2024 10‑K shows only 7 ATR 72‑600Fs scheduled for delivery in 2025. This reduction reflects a shift toward larger, more fuel‑efficient jets (B767F/B777F) and indicates that the ATR 72‑600F is being phased out of FedEx’s fleet strategy in favor of newer freighter models.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "FDX_10k_2022.pdf",
          "target_page": 114,
          "pages": [
            112,
            113,
            114,
            115,
            116
          ]
        },
        "hop_2_rel": {
          "source_file": "FDX_10k_2024.pdf",
          "target_page": 117,
          "pages": [
            115,
            116,
            117,
            118,
            119
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 39648,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 10138,
        "completion_tokens": 98,
        "total_tokens": 10236
      }
    },
    {
      "question_id": 40,
      "question": "How has NVIDIA's approach to offering Omniverse evolved between 2022 and 2024, particularly in terms of its integration with other AI and simulation platforms?",
      "original_answer": "In 2022, NVIDIA Omniverse was primarily described as a virtual world simulation and collaboration platform for 3D workflows, available as a software subscription for enterprise use and free for individual use. It was highlighted as being integrated with VR and AR in enterprise applications such as virtual car showrooms and surgical training. By 2024, NVIDIA's offering of Omniverse had evolved into a more comprehensive development platform and operating system for building and running virtual world simulation applications. It was now emphasized as being used by industrial enterprises to digitalize complex physical assets and processes—such as building digital twins of factories and testing autonomous robots and vehicles—powered by NVIDIA's accelerated computing infrastructure both on-premises and in the cloud. This represents a shift from general 3D collaboration to a more specialized, enterprise-focused simulation and digital twin platform.",
      "llm_answer": "Between 2022 and 2024, NVIDIA's approach to Omniverse evolved from a real-time 3D design collaboration and simulation platform for industrial digitalization into a core component of its broader AI and simulation ecosystem. By 2024, Omniverse was deeply integrated with AI technologies—such as generative AI for digital avatars and synthetic data generation—and tightly coupled with NVIDIA’s AI infrastructure (e.g., Blackwell GPUs, AI Enterprise software, and Omniverse Cloud) to enable scalable, AI-powered virtual worlds and digital twin applications across industries. This integration allowed seamless interoperability with leading design tools and supported enterprise-scale simulation workflows, reinforcing its role as a foundational platform for AI-driven 3D computing.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "NVDA_10k_2022.pdf",
          "target_page": 9,
          "pages": [
            7,
            8,
            9,
            10,
            11
          ]
        },
        "hop_2_rel": {
          "source_file": "NVDA_10k_2024.pdf",
          "target_page": 6,
          "pages": [
            4,
            5,
            6,
            7,
            8
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 7,
        "total_chars": 41217,
        "num_window_pages": 7,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 10526,
        "completion_tokens": 194,
        "total_tokens": 10720
      }
    },
    {
      "question_id": 41,
      "question": "How has the role of Google Play in generating non-advertising revenue evolved between 2022 and 2023?",
      "original_answer": "In 2022, Google Play was introduced as part of the company's broader strategy to expand non-advertising revenues, specifically through the sales of apps, in-app purchases, and digital content. By 2023, Google Play had transitioned into a more defined revenue stream under 'platforms,' where it was explicitly tied to revenues from app sales and in-app purchases. This evolution indicates a strategic shift toward solidifying Google Play’s role as a key monetization platform rather than just a component of diversification. The change reflects a more structured categorization and likely a stronger contribution to revenue stability within the ecosystem.",
      "llm_answer": "Between 2022 and 2023, Google Play's contribution to non-advertising revenue grew as part of Alphabet's broader shift toward higher-margin diversification beyond advertising. While non-advertising revenues (including Google Play, Cloud, and hardware) increased 9% year-over-year to $307.4 billion in 2023, their margins remained lower than advertising revenues due to pricing pressures and higher costs—particularly for devices and content acquisition. This trend reflects Google Play's evolving role in monetizing non-advertising streams, though its growth was modest compared to faster-expanding segments like Google Cloud (26% growth). The company explicitly highlighted that \"revenues from non-advertising sources\" are increasing and \"may adversely affect margins,\" underscoring Google Play's expanding but margin-constrained contribution to overall revenue growth.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "GOOGL_10k_2022.pdf",
          "target_page": 30,
          "pages": [
            28,
            29,
            30,
            31,
            32
          ]
        },
        "hop_2_rel": {
          "source_file": "GOOGL_10k_2023.pdf",
          "target_page": 33,
          "pages": [
            31,
            32,
            33,
            34,
            35
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 37024,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 9466,
        "completion_tokens": 217,
        "total_tokens": 9683
      }
    },
    {
      "question_id": 41,
      "question": "How has AIG's use of expected loss ratio methods in workers' compensation reserving evolved between 2022 and 2023, particularly in relation to guaranteed cost and excess of deductible business?",
      "original_answer": "In 2022, AIG generally gave significant weight to expected loss ratio methods for guaranteed cost business only in the most recent accident year, while for excess of deductible business, these methods were given significant weight in the most recent five accident years. The company also noted that changes in claims strategy and loss mitigation efforts were accelerating settlements, increasing paid losses along the latest diagonals. In 2023, the reserving methodology remained broadly consistent, with AIG continuing to use a combination of loss development, frequency/severity, and expected loss ratio methods. However, the 2023 filing emphasized that incurred and paid losses were now presented net of reinsurance and undiscounted, which may reflect a refinement in reporting transparency rather than a change in reserving philosophy. Additionally, the increased proportion of large deductible business continued to slow the reporting pattern of claims in 2023, consistent with the trend noted in 2022.",
      "llm_answer": "Between 2022 and 2023, AIG’s reserving methodology for workers’ compensation remained consistent in its use of expected loss ratio methods for excess‑of‑deductible (large‑deductible) business, but the company continued to give significant weight to those methods only in the most recent five accident years.  The proportion of large‑deductible business has grown, slowing claim reporting and prompting AIG to segment the portfolio by deductible size and handling arrangement.  In 2023, AIG recognized only modest unfavorable prior‑year development ($51 million) in Excess Casualty, reflecting the impact of higher attachment points and the slower emergence of claims, while still applying expected loss ratios to recent accident years to project ultimate losses.  This evolution underscores a continued reliance on expected loss ratios for newer business, even as the mix toward higher‑deductible, longer‑tail exposures has increased.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AIG_10k_2022.pdf",
          "target_page": 260,
          "pages": [
            258,
            259,
            260,
            261,
            262
          ]
        },
        "hop_2_rel": {
          "source_file": "AIG_10k_2023.pdf",
          "target_page": 202,
          "pages": [
            200,
            201,
            202,
            203,
            204
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 268741,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 67420,
        "completion_tokens": 233,
        "total_tokens": 67653
      }
    },
    {
      "question_id": 41,
      "question": "How has Cisco's product category segmentation evolved between fiscal 2022 and fiscal 2024, particularly in relation to the Collaboration category?",
      "original_answer": "In fiscal 2022, Cisco introduced a product revenue segmentation that included 'Collaboration' as one of six distinct categories, which also included Secure, Agile Networks; Internet for the Future; End-to-End Security; Optimized Application Experiences; and Other Products. By fiscal 2024, Cisco restructured its product categories into four main areas, retaining 'Collaboration' but now grouping it alongside Networking, Security, and a new category called Observability. This indicates a consolidation and realignment of product offerings, with the introduction of Observability as a distinct area and the removal or reclassification of Optimized Application Experiences and Internet for the Future.",
      "llm_answer": "Cisco's product category segmentation has evolved significantly between fiscal 2022 and fiscal 2024, particularly regarding the Collaboration category. In fiscal 2022, Collaboration revenue declined 5% year-over-year due to decreases in Meetings, Collaboration Devices, Calling, and Contact Center offerings, partially offset by growth in CPaaS. By fiscal 2024, Collaboration revenue increased 2% year-over-year, driven by growth across the portfolio except for Meetings offerings, indicating a stabilization and modest recovery in this category after the prior downturn.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CSCO_10k_2022.pdf",
          "target_page": 44,
          "pages": [
            42,
            43,
            44,
            45,
            46
          ]
        },
        "hop_2_rel": {
          "source_file": "CSCO_10k_2024.pdf",
          "target_page": 41,
          "pages": [
            39,
            40,
            41,
            42,
            43
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 40770,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 10413,
        "completion_tokens": 142,
        "total_tokens": 10556
      }
    },
    {
      "question_id": 41,
      "question": "How has Amgen's disclosure regarding the 3.125% 2025 Notes evolved from 2022 to 2023 in terms of financial presentation and associated interest rate framework?",
      "original_answer": "In 2022, Amgen reported a carrying value of $1,000 million for the 3.125% 2025 Notes within its debt table, but no specific interest rate framework was disclosed. By 2023, Amgen included the 3.125% 2025 Notes in a new table that explicitly outlined the interest rate mechanism, identifying it as SOFR + 2.1%. This evolution reflects a shift from a purely quantitative disclosure in 2022 to a more detailed qualitative and quantitative presentation in 2023, including the interest rate benchmark and spread.",
      "llm_answer": "Amgen's disclosure of the 3.125% 2025 Notes shifted from a fixed 3.125% coupon rate in 2022 to a floating rate tied to SOFR plus 2.1% in 2023, reflecting a broader trend of converting fixed-rate debt to floating-rate structures via interest rate swaps. This change aligns with the company's strategy to manage interest rate risk, as evidenced by the 2023 interest rate swap disclosures showing the 3.125% 2025 Notes now carry an effective rate of SOFR + 2.1% (compared to the prior fixed 3.125% rate), while the 2022 filing still referenced the fixed coupon. The 2023 filing also details the swap's notional amount ($1.0 billion) and effective rate mechanism, marking a clear evolution in financial presentation from static coupon disclosure to dynamic hedging framework.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AMGN_10k_2022.pdf",
          "target_page": 130,
          "pages": [
            128,
            129,
            130,
            131,
            132
          ]
        },
        "hop_2_rel": {
          "source_file": "AMGN_10k_2023.pdf",
          "target_page": 144,
          "pages": [
            142,
            143,
            144,
            145,
            146
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 44007,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 11228,
        "completion_tokens": 192,
        "total_tokens": 11421
      }
    },
    {
      "question_id": 42,
      "question": "How has COP's natural gas reserves in the Asia Pacific/Middle East region evolved from 2022 to 2024, and what does this indicate about the company's strategic positioning in that geographic area?",
      "original_answer": "In 2022, COP reported 326 billion cubic feet of natural gas reserves in the Asia Pacific/Middle East region. By 2024, this figure had decreased to 296 billion cubic feet. This indicates a reduction in the company's natural gas holdings in the region over the two-year period, suggesting a potential strategic shift or divestment in that geographic area.",
      "llm_answer": "From 2022 to 2024, ConocoPhillips’ proved natural‑gas reserves in the Asia Pacific/Middle East region grew markedly—from about 33 billion cubic feet at the end of 2022 to roughly 62 billion cubic feet by the end of 2024 (as shown in the reserve tables for 2021‑2024). This increase reflects upward revisions, purchases (notably the Marathon Oil acquisition) and extensions/discoveries in the region, indicating that the company is actively expanding and strengthening its natural‑gas position in Asia Pacific/Middle East as a strategic growth area.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "COP_10k_2022.pdf",
          "target_page": 174,
          "pages": [
            172,
            173,
            174,
            175,
            176
          ]
        },
        "hop_2_rel": {
          "source_file": "COP_10k_2024.pdf",
          "target_page": 145,
          "pages": [
            143,
            144,
            145,
            146,
            147
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 77321,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 19565,
        "completion_tokens": 137,
        "total_tokens": 19702
      }
    },
    {
      "question_id": 42,
      "question": "How did the repurchase activity of Class C Capital Stock by Alphabet change between 2022 and 2023, and what does this indicate about the company's capital allocation strategy?",
      "original_answer": "In 2022, Alphabet repurchased $59.3 billion of Class A and Class C shares, while in 2023, the repurchase amount increased to $62.2 billion. Additionally, in April 2023, the Board authorized an additional $70.0 billion for share repurchases, with $36.3 billion remaining available as of December 31, 2023. This indicates a continued and expanding emphasis on returning capital to shareholders through share repurchases, with a notable increase in the scale of buybacks year-over-year.",
      "llm_answer": "Between 2022 and 2023, Alphabet’s repurchase activity for Class C Capital Stock increased substantially, with $52.9 billion of Class C shares repurchased in 2023 versus $59.3 billion total (including both Class A and C) repurchased in 2022; the company retired 450 million Class C shares for $52.9 billion in 2023, up from 469 million shares ($52.6 billion) in 2022. This heightened buyback reflects a more aggressive capital‑allocation strategy, signaling that Alphabet is deploying a larger portion of its cash to return capital to shareholders and to manage its equity structure amid market conditions.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "GOOGL_10k_2022.pdf",
          "target_page": 53,
          "pages": [
            51,
            52,
            53,
            54,
            55
          ]
        },
        "hop_2_rel": {
          "source_file": "GOOGL_10k_2023.pdf",
          "target_page": 81,
          "pages": [
            79,
            80,
            81,
            82,
            83
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 56665,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 14395,
        "completion_tokens": 151,
        "total_tokens": 14546
      }
    },
    {
      "question_id": 42,
      "question": "How has AIG's use of frequency/severity methods evolved between 2022 and 2023, particularly in terms of the lines of business where they are applied and the reasoning behind their usage?",
      "original_answer": "In 2022, AIG primarily used frequency/severity methods for short-tail classes such as U.S. Property, and explicitly avoided using them for aviation exposures due to the high severity and varying mix of claims year to year. By 2023, AIG expanded the application of frequency/severity methods to include U.S. Workers' Compensation, a long-tail line of business, as part of a combination of methods that also included loss development and expected loss ratio methods. This reflects a strategic shift toward using frequency/severity methods in more complex, long-tail environments, especially where risk-sharing features and large deductible business have increased.",
      "llm_answer": "AIG applied frequency/severity methods primarily to its long‑tail lines—U.S. Workers’ Compensation, U.S. Excess Casualty, U.S. Other Casualty, U.S. Financial Lines, U.S. Property & Special Risks, and U.S. Personal Insurance—while using expected‑loss‑ratio approaches for shorter‑tail or high‑severity lines such as aviation. In 2022 the company continued to segment these businesses (e.g., separating guaranteed‑cost and excess‑of‑deductible workers‑compensation, grouping by state/industry, and distinguishing AIG‑handled versus third‑party administered claims) and to adjust the proportion of large‑deductible exposure, which slowed claim reporting patterns. By 2023 the same frequency/severity framework was retained, but the methodology was refined to incorporate updated actuarial assumptions, the impact of the adverse‑development reinsurance agreement, and the increased use of ground‑up claim projections and Cape Cod weighting, especially for program‑business and excess‑casualty layers where loss development lags. Thus, the core frequency/severity approach persisted, but its application became more tailored to each line’s development characteristics and risk‑sharing structure.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AIG_10k_2022.pdf",
          "target_page": 273,
          "pages": [
            271,
            272,
            273,
            274,
            275
          ]
        },
        "hop_2_rel": {
          "source_file": "AIG_10k_2023.pdf",
          "target_page": 202,
          "pages": [
            200,
            201,
            202,
            203,
            204
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 298350,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 74820,
        "completion_tokens": 297,
        "total_tokens": 75118
      }
    },
    {
      "question_id": 42,
      "question": "How has Amgen's financial relationship with BeiGene evolved from 2022 to 2023, particularly in terms of cost recovery, product sales, and profit and loss sharing?",
      "original_answer": "In 2022, Amgen recovered $199 million in R&D costs from BeiGene, recorded product sales of $64 million, and recognized $53 million in profit and loss sharing expenses. In 2023, these figures changed to $109 million in cost recovery, $125 million in product sales, and $40 million in profit and loss sharing expenses. This indicates a decrease in cost recovery and profit-sharing expenses, but a significant increase in product sales to BeiGene. The shift suggests a maturation of the collaboration, with more product sales occurring in 2023, while the level of R&D cost sharing declined.",
      "llm_answer": "From 2022 to 2023 Amgen’s financial relationship with BeiGene shifted from a cost‑recovery model to a more balanced profit‑and‑loss sharing arrangement.  During 2023 the company recorded $109 million of net cost recoveries from BeiGene (down from $199 million in 2022 and $220 million in 2021), while product sales to BeiGene rose to $125 million (up from $64 million in 2022 and $72 million in 2021).  Profit‑and‑loss share expenses also declined to $40 million in 2023 (from $53 million in 2022 and $64 million in 2021), reflecting the transition to the post‑January‑1‑2022 arrangement in which Amgen no longer shares commercialization costs or pays milestones with BeiGene and instead receives only royalties on Chinese sales.  Overall, the partnership’s cash flows are now driven primarily by product sales and royalties rather than the earlier cost‑recovery and shared‑expense structure.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AMGN_10k_2022.pdf",
          "target_page": 124,
          "pages": [
            122,
            123,
            124,
            125,
            126
          ]
        },
        "hop_2_rel": {
          "source_file": "AMGN_10k_2023.pdf",
          "target_page": 131,
          "pages": [
            129,
            130,
            131,
            132,
            133
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 47371,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 12070,
        "completion_tokens": 223,
        "total_tokens": 12293
      }
    },
    {
      "question_id": 43,
      "question": "How has COP's natural gas reserves in the Asia Pacific/Middle East region evolved from 2022 to 2024, and what specific changes occurred in terms of revisions, production, and purchases during this period?",
      "original_answer": "In 2022, COP reported 326 billion cubic feet of natural gas reserves in the Asia Pacific/Middle East region. By 2024, this figure decreased slightly to 296 billion cubic feet. During this period, revisions in 2023 added 9 billion cubic feet, but production subtracted 25 billion cubic feet in 2024. Additionally, there were no purchases reported directly affecting this region in 2024, indicating a reduction in active reserve growth strategies compared to earlier years.",
      "llm_answer": "From 2022 to 2024, COP's natural gas reserves in the Asia Pacific/Middle East region increased from 434 billion cubic feet (BCF) at the end of 2022 to 457 BCF at the end of 2024. This growth reflects upward revisions driven by additional development drilling and technical updates, partially offset by downward revisions from price and infrastructure factors. The region also saw purchases from acquisitions (e.g., Marathon Oil) and extensions/discoveries in the Middle East, contributing to the net increase in proved reserves.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "COP_10k_2022.pdf",
          "target_page": 166,
          "pages": [
            164,
            165,
            166,
            167,
            168
          ]
        },
        "hop_2_rel": {
          "source_file": "COP_10k_2024.pdf",
          "target_page": 145,
          "pages": [
            143,
            144,
            145,
            146,
            147
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 83130,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 21020,
        "completion_tokens": 132,
        "total_tokens": 21152
      }
    },
    {
      "question_id": 43,
      "question": "How did FedEx's planned usage of the B767F aircraft evolve from 2022 to 2024, and what does this indicate about its strategic fleet planning?",
      "original_answer": "In 2022, FedEx projected using 14 B767F aircraft in both 2023 and 2024, with a planned reduction to 10 by 2025. By 2024, the projections had changed, showing a decrease to 11 B767F aircraft for 2025 and only 3 by 2026. This indicates a strategic shift toward a more accelerated reduction in the planned use of B767F aircraft, reducing reliance on this model over time.",
      "llm_answer": "From 2022 to 2024, FedEx's planned usage of the B767F aircraft evolved from a commitment to acquire 38 B767F aircraft (as disclosed in the 2022 10-K's aircraft purchase table) to a significantly larger commitment of 38 B767F aircraft for delivery through 2025 (with additional deliveries in 2026), as reflected in the 2024 10-K's updated purchase commitments table showing 14 B767F deliveries in 2025 and 3 in 2026. This expansion indicates a strategic shift toward accelerating fleet modernization with more fuel-efficient aircraft to replace older models, as emphasized in the 2024 10-K's note on aircraft modernization programs that states these purchases are \"necessary to achieve significant long-term operating savings and to replace older aircraft,\" demonstrating a deliberate, capital-intensive plan to upgrade its cargo fleet for operational efficiency.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "FDX_10k_2022.pdf",
          "target_page": 40,
          "pages": [
            38,
            39,
            40,
            41,
            42
          ]
        },
        "hop_2_rel": {
          "source_file": "FDX_10k_2024.pdf",
          "target_page": 117,
          "pages": [
            115,
            116,
            117,
            118,
            119
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 9,
        "total_chars": 40108,
        "num_window_pages": 9,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 10247,
        "completion_tokens": 215,
        "total_tokens": 10463
      }
    },
    {
      "question_id": 43,
      "question": "How did AIG's use of Expected Loss Ratio Methods evolve between 2022 and 2023, particularly in terms of the lines of business and the reasoning behind their application?",
      "original_answer": "In 2022, AIG used Expected Loss Ratio Methods primarily for the latest accident year and in combination with other methods like loss development for aviation exposures, due to the high severity nature of claims and varying mix across years. By 2023, AIG applied Expected Loss Ratio Methods more broadly, particularly in U.S. Workers' Compensation, a long-tail line of business, where they used a combination of methods including Expected Loss Ratio, to account for extended loss emergence periods and complex risk-sharing features in policies. This reflects a shift from a focus on short-term forecasting in high-severity contexts to a broader application in long-tail, structurally complex lines.",
      "llm_answer": "AIG's use of Expected Loss Ratio Methods evolved between 2022 and 2023 by incorporating them more prominently for newer accident years, particularly in long-tail lines like U.S. Workers' Compensation and U.S. Excess Casualty, where loss development patterns are inconsistent or slow-emerging. The methods were applied alongside other techniques (e.g., loss development and frequency/severity methods) to estimate ultimate losses, with recent accident years relying more heavily on projected ultimate loss ratios adjusted for rate changes, inflation, and market conditions. This evolution reflects a strategic weighting of the Expected Loss Ratio method in combination with other approaches, especially for complex or data-scarce lines, to improve reserve adequacy amid changing market conditions and emerging risks.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AIG_10k_2022.pdf",
          "target_page": 273,
          "pages": [
            271,
            272,
            273,
            274,
            275
          ]
        },
        "hop_2_rel": {
          "source_file": "AIG_10k_2023.pdf",
          "target_page": 202,
          "pages": [
            200,
            201,
            202,
            203,
            204
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 298350,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 74816,
        "completion_tokens": 203,
        "total_tokens": 75020
      }
    },
    {
      "question_id": 43,
      "question": "How has Cisco's positioning around Enterprise Data Center Transformation evolved between 2022 and 2024, particularly in relation to its strategic alliances and competitive landscape?",
      "original_answer": "In 2022, Cisco highlighted that the enterprise data center was undergoing a fundamental transformation due to the convergence of technologies like computing, networking, storage, and software, with strategic alliance partners sometimes acquiring or aligning with competitors, reducing business with Cisco. By 2024, Cisco continued to emphasize this transformation but expanded its focus on strategic alliances aimed at industry advancement and new market creation, while also updating its competitive landscape to include new entrants like Nvidia Corporation, signaling a shift in market dynamics and alliance strategies.",
      "llm_answer": "Cisco’s Enterprise Data Center Transformation positioning has shifted markedly from 2022 to 2024, moving from a broad, “build‑buy‑partner‑invest‑co‑develop” innovation model that emphasized strategic alliances with companies like Apple, Google and Equinix to a more focused, outcome‑driven narrative centered on its own architectural stack—particularly the convergence of networking, security, collaboration and observability (e.g., ThousandEyes, Splunk, AppDynamics).  In 2022 the company highlighted alliances that accelerated new markets, but by 2024 it stresses that competitors—including hyperscalers (AWS, Microsoft, Google) and specialist rivals (Arista, Palo Alto, Fortinet)—are intensifying price‑focused pressure, especially in Asia, and that strategic partners can also become competitors.  Consequently, Cisco now leverages its financing arrangements, channel‑partner ecosystem and acquisitions to reinforce a differentiated, end‑to‑end data‑center portfolio that directly competes with these hyperscalers while continuing to pursue alliances that expand its observability and security capabilities.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CSCO_10k_2022.pdf",
          "target_page": 11,
          "pages": [
            9,
            10,
            11,
            12,
            13
          ]
        },
        "hop_2_rel": {
          "source_file": "CSCO_10k_2024.pdf",
          "target_page": 8,
          "pages": [
            6,
            7,
            8,
            9,
            10
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 9,
        "total_chars": 47206,
        "num_window_pages": 9,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 12030,
        "completion_tokens": 277,
        "total_tokens": 12308
      }
    },
    {
      "question_id": 43,
      "question": "How did the effective interest rate and notional amount associated with the 3.125% 2025 Notes evolve between 2022 and 2023?",
      "original_answer": "In 2022, the 3.125% 2025 Notes were part of a $5.2 billion principal amount on which new interest rate swaps were entered into after the termination of previous swaps, indicating a dynamic hedging strategy due to low interest rates. By 2023, the notional amount of the 3.125% 2025 Notes under interest rate swaps had decreased to $1.0 billion, with an effective interest rate of SOFR + 2.1%. This reflects a reduction in the hedged notional exposure and a shift in the interest rate environment.",
      "llm_answer": "Based on the provided pages, the effective interest rate for the 3.125% 2025 Notes was SOFR + 2.1% with a notional amount of $1,000 million as of December 31 2023 (page 144). This represents the evolution of the rate and notional amount for that specific tranche between 2022 and 2023.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AMGN_10k_2022.pdf",
          "target_page": 132,
          "pages": [
            130,
            131,
            132,
            133,
            134
          ]
        },
        "hop_2_rel": {
          "source_file": "AMGN_10k_2023.pdf",
          "target_page": 144,
          "pages": [
            142,
            143,
            144,
            145,
            146
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 44959,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 11457,
        "completion_tokens": 71,
        "total_tokens": 11528
      }
    },
    {
      "question_id": 44,
      "question": "How has Cisco's strategic positioning of AppDynamics within its product portfolio evolved from 2022 to 2024, particularly in terms of its emphasis within observability offerings?",
      "original_answer": "In 2022, Cisco explicitly introduced AppDynamics as a key component of its full-stack observability strategy, positioning it alongside Intersight and ThousandEyes to provide application performance monitoring capabilities. However, by 2024, Cisco restructured its product revenue reporting to include a new category called 'Observability,' which subsumed offerings like AppDynamics. This shift indicates a more formalized and integrated strategic emphasis on observability as a standalone pillar within Cisco's broader portfolio.",
      "llm_answer": "From 2022 to 2024 Cisco’s strategic positioning of AppDynamics evolved from a standalone observability solution to a core component of its broader observability and Application Experience portfolio. In the 2022 “Reimagine Applications” section, Cisco highlighted adding AppDynamics to its full‑stack observability stack alongside Intersight, ThousandEyes and security innovations. By 2024, the company explicitly grouped AppDynamics under the “Observability” product category, reporting a 27 % revenue increase (driven by ThousandEyes and the Splunk‑derived Observability Suite) and emphasizing its role in delivering “greater insights that enable faster, better decision making.” This shows Cisco has deepened its emphasis on observability—particularly application performance monitoring—within its portfolio, integrating AppDynamics more tightly with its networking, security and collaboration offerings to support multicloud and hybrid‑work environments.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CSCO_10k_2022.pdf",
          "target_page": 5,
          "pages": [
            3,
            4,
            5,
            6,
            7
          ]
        },
        "hop_2_rel": {
          "source_file": "CSCO_10k_2024.pdf",
          "target_page": 41,
          "pages": [
            39,
            40,
            41,
            42,
            43
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 44521,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 11358,
        "completion_tokens": 239,
        "total_tokens": 11597
      }
    },
    {
      "question_id": 44,
      "question": "How did the effective interest rate and notional amount associated with the 4.663% 2051 Notes evolve from 2022 to 2023?",
      "original_answer": "In 2022, the 4.663% 2051 Notes were part of a $5.2 billion principal amount of notes that were hedged using interest rate swaps, with the swaps terminated and replaced at then-current interest rates. In 2023, the notional amount of the 4.663% 2051 Notes was $1.5 billion, and the effective interest rate was SOFR + 4.3%. This indicates a continuation of the hedging strategy but with updated interest rate terms and a more specific disclosure of the notional amount and rate for the 2051 Notes.",
      "llm_answer": "The effective interest rate for the 4.663% 2051 Notes was SOFR + 4.3% in both 2022 and 2023, and the associated notional amount remained $1,500 million throughout the period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AMGN_10k_2022.pdf",
          "target_page": 132,
          "pages": [
            130,
            131,
            132,
            133,
            134
          ]
        },
        "hop_2_rel": {
          "source_file": "AMGN_10k_2023.pdf",
          "target_page": 144,
          "pages": [
            142,
            143,
            144,
            145,
            146
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 44959,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 11456,
        "completion_tokens": 43,
        "total_tokens": 11500
      }
    },
    {
      "question_id": 45,
      "question": "How has AIG's use of expected loss ratio methods evolved between 2022 and 2023, particularly in terms of the lines of business and segmentation criteria applied?",
      "original_answer": "In 2022, AIG referenced the use of expected loss ratio methods in a general sensitivity analysis related to loss reserve assumptions, without specifying detailed segmentation or particular lines of business. By 2023, AIG explicitly applied expected loss ratio methods to U.S. Workers' Compensation, a long-tail line of business, and introduced more granular segmentation criteria such as risk-sharing features, state and industry subsets, deductible size, and claim handling entities. This indicates a more structured and detailed application of the method in 2023 compared to 2022.",
      "llm_answer": "Between 2022 and 2023, AIG’s reserving methodology for loss development remained consistent in its core approaches—using paid and incurred development methods, expected loss ratios, and Bornhuetter-Ferguson/Cape Cod hybrids—but the application refined segmentation and criteria. In 2023, the company continued to segment U.S. Excess Casualty by deductible size and whether claims were handled internally or by third parties, and expanded grouping by state and industry subset for Workers’ Compensation, while maintaining the use of expected loss ratio methods for long-tail lines like U.S. Excess Casualty and Workers’ Compensation. The 2023 tables show updated accident year development data through 2023, with prior year development excluding ADC impacts now reflecting more granular segmentation (e.g., separating guaranteed cost and excess of deductible business) and adjusted reporting patterns due to increased large deductible business. This evolution reflects a more detailed application of the same methods, particularly in how loss development factors and expected loss ratios are applied across refined business subsets and segmentation criteria.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AIG_10k_2022.pdf",
          "target_page": 68,
          "pages": [
            66,
            67,
            68,
            69,
            70
          ]
        },
        "hop_2_rel": {
          "source_file": "AIG_10k_2023.pdf",
          "target_page": 202,
          "pages": [
            200,
            201,
            202,
            203,
            204
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 167731,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 42158,
        "completion_tokens": 289,
        "total_tokens": 42447
      }
    },
    {
      "question_id": 45,
      "question": "How did PepsiCo's engagement with the 2.850% Senior Notes due 2026 evolve between 2023 and 2024, particularly in terms of its broader debt issuance strategy as reflected in the additional notes introduced in 2024?",
      "original_answer": "In 2023, PepsiCo referenced the 2.850% Senior Notes due 2026 as part of a broader set of debt instruments, including other senior notes with varying interest rates and maturity dates. By 2024, the company introduced a significantly expanded range of senior notes, including higher-yielding instruments such as the 7.00% Senior Notes due 2029 and the 5.50% Senior Notes due 2035, indicating a more diversified and long-term debt issuance strategy. This evolution suggests that PepsiCo not only maintained its commitment to the 2.850% Senior Notes due 2026 but also broadened its capital structure by incorporating a wider spectrum of debt instruments with different risk-return profiles.",
      "llm_answer": "Between 2023 and 2024, PepsiCo’s engagement with the 2.850% Senior Notes due 2026 shifted from being referenced as a floating‑rate note issuance in 2023 (Form 4.57) to being explicitly authorized as part of a broader 2024 debt issuance slate in the Board resolutions dated February 28, 2024 (Form 4.64). This reflects a strategic expansion of its senior note program, incorporating the 2.850% 2026 tranche alongside a suite of new notes (e.g., 3.600% 2024, 2.625% 2026, 4.250% 2044, etc.) to diversify maturities and funding costs.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "PEP_10k_2023.pdf",
          "target_page": 129,
          "pages": [
            127,
            128,
            129,
            130,
            131
          ]
        },
        "hop_2_rel": {
          "source_file": "PEP_10k_2024.pdf",
          "target_page": 130,
          "pages": [
            128,
            129,
            130,
            131,
            132
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 65856,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 16703,
        "completion_tokens": 132,
        "total_tokens": 16836
      }
    },
    {
      "question_id": 45,
      "question": "How has Cisco's exposure to channel partner financing guarantees evolved between fiscal years 2022 and 2024, and what does this indicate about the company's financial risk management strategy?",
      "original_answer": "In fiscal year 2022, Cisco disclosed that the volume of channel partner financing was $27.9 billion, with a balance of financing subject to guarantees amounting to $1.4 billion as of July 30, 2022. By fiscal year 2024, while the company continued to provide financing guarantees, the specific volume of channel partner financing and the balance subject to guarantees were no longer explicitly quantified in the disclosures. This shift indicates a potential strategic move toward reducing transparency around these financial commitments, which may reflect a broader risk management approach to limit visibility into contingent liabilities. However, the absence of updated figures prevents definitive conclusions about the actual change in exposure.",
      "llm_answer": "Cisco’s exposure to channel‑partner financing guarantees remained modest but grew slightly over the period.  In fiscal 2022 the maximum potential future payments under these guarantees were about $188 million (with $9 million of deferred revenue), and by fiscal 2024 the corresponding figures rose to roughly $188 million in potential payments and $0.9 million of deferred revenue – essentially unchanged in absolute terms but reflecting a small increase in the underlying exposure.  This limited growth indicates that Cisco’s risk‑management strategy continues to rely on modest guarantees while shifting most financing risk to the channel partners themselves, using hedging and contractual protections rather than large balance‑sheet commitments.  Consequently, the company’s overall financial‑risk profile remains low, with risk concentrated in its core product and service contracts rather than in extensive financing guarantees.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CSCO_10k_2022.pdf",
          "target_page": 94,
          "pages": [
            92,
            93,
            94,
            95,
            96
          ]
        },
        "hop_2_rel": {
          "source_file": "CSCO_10k_2024.pdf",
          "target_page": 52,
          "pages": [
            50,
            51,
            52,
            53,
            54
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 52651,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 13395,
        "completion_tokens": 233,
        "total_tokens": 13628
      }
    },
    {
      "question_id": 45,
      "question": "How has the status and interest rate structure of the 2.45% 2030 Notes evolved between 2022 and 2023?",
      "original_answer": "In 2022, Amgen disclosed that it had entered into interest rate swap contracts with an aggregate notional amount of $1.0 billion with respect to the 2.45% 2030 Notes, effectively converting the fixed-rate interest to a floating LIBOR-based coupon. By 2023, the 2.45% 2030 Notes remained outstanding with a notional amount of $1.0 billion, but the interest rate structure had transitioned from LIBOR to SOFR, now stated as SOFR + 1.3%. This reflects a continuation of the note's existence but with a modified floating-rate benchmark.",
      "llm_answer": "Between 2022 and 2023, the 2.45% 2030 Notes maintained a notional amount of $1,000 million, but their effective interest rate structure shifted from a LIBOR‑plus‑1.0% spread (as shown for 2021) to a SOFR‑plus‑1.3% spread (reflecting the 2023 table). This change reflects the transition from LIBOR‑based swaps to SOFR‑based swaps for that tranche.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AMGN_10k_2022.pdf",
          "target_page": 131,
          "pages": [
            129,
            130,
            131,
            132,
            133
          ]
        },
        "hop_2_rel": {
          "source_file": "AMGN_10k_2023.pdf",
          "target_page": 144,
          "pages": [
            142,
            143,
            144,
            145,
            146
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 45207,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 11514,
        "completion_tokens": 86,
        "total_tokens": 11600
      }
    },
    {
      "question_id": 46,
      "question": "How has FedEx's relationship with Pass-Through Certificates evolved between 2022 and 2023, particularly regarding its financial guarantees and obligations?",
      "original_answer": "In 2022, FedEx Express had issued $970 million of Pass-Through Certificates, Series 2020-1AA, which were fully and unconditionally guaranteed by FedEx. These certificates were secured by 19 Boeing aircraft with a net book value of $1.8 billion. However, in 2023, FedEx clarified that pass-through certificates associated with leveraged operating leases were not direct obligations of, nor guaranteed by, FedEx or FedEx Express. This indicates a shift from direct financial guarantees in 2022 to a position of no direct financial obligation in 2023.",
      "llm_answer": "Based on the provided 10-K filings, FedEx's relationship with Pass-Through Certificates remained consistent in structure but evolved in scale and context between 2022 and 2023. The company continues to fully and unconditionally guarantee the $970 million Series 2020-1AA Pass-Through Certificates issued by FedEx Express, which are secured by aircraft (net book value of $1.7 billion as of May 2024) and carry a fixed 1.875% interest rate due in February 2034. While the 2022 filing notes the certificates were issued to fund general corporate purposes, the 2023 filing confirms the same structure with updated aircraft valuations and no material changes to the guarantee obligation, though the company's overall debt profile shifted toward longer-term unsecured debt (e.g., $1.75 billion New Five-Year Credit Agreement replacing prior facilities).",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "FDX_10k_2022.pdf",
          "target_page": 94,
          "pages": [
            92,
            93,
            94,
            95,
            96
          ]
        },
        "hop_2_rel": {
          "source_file": "FDX_10k_2023.pdf",
          "target_page": 98,
          "pages": [
            96,
            97,
            98,
            99,
            100
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 46123,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 11753,
        "completion_tokens": 212,
        "total_tokens": 11965
      }
    },
    {
      "question_id": 46,
      "question": "How did Mastercard's use of risk mitigation arrangements to manage gross settlement exposure evolve from 2023 to 2024, and what does this indicate about the company's risk management strategy?",
      "original_answer": "In 2023, Mastercard had $75,023 million in gross settlement exposure, with $12,167 million covered by risk mitigation arrangements. By 2024, gross settlement exposure increased to $78,385 million, and the company applied $13,466 million in risk mitigation arrangements, reflecting an increase in both total exposure and the amount mitigated. This indicates that Mastercard's risk management strategy became more robust over time, as it increased its use of mitigation tools in response to growing settlement exposure.",
      "llm_answer": "Mastercard’s risk‑mitigation framework for settlement exposure has remained anchored in its rule‑based guarantee of customer settlement obligations, but the company has progressively refined how it quantifies and offsets that exposure.  In 2023 the firm recorded a gross settlement exposure of roughly $75 million and applied risk‑mitigation arrangements that reduced net exposure to about $63 million; by the end of 2024 the gross exposure had risen to roughly $78 million and net exposure to about $65 million, reflecting higher daily payment volumes and tighter collateral requirements.  This evolution shows that Mastercard is tightening its risk‑management methodology—updating exposure estimates, expanding collateral and credit‑enhancement requirements, and revising its methodology as market conditions change—while still relying on a disciplined, short‑term settlement‑risk model to protect against customer failures.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MA_10k_2023.pdf",
          "target_page": 112,
          "pages": [
            110,
            111,
            112,
            113,
            114
          ]
        },
        "hop_2_rel": {
          "source_file": "MA_10k_2024.pdf",
          "target_page": 105,
          "pages": [
            103,
            104,
            105,
            106,
            107
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 67965,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 17225,
        "completion_tokens": 231,
        "total_tokens": 17456
      }
    },
    {
      "question_id": 46,
      "question": "How did Nike's liabilities related to foreign exchange forwards and options designated as hedging instruments change between 2022 and 2024, and what does this indicate about the company's exposure or strategy?",
      "original_answer": "In 2022, Nike reported $37 million in liabilities for foreign exchange forwards and options designated as hedging instruments under accrued liabilities, and $11 million under deferred income taxes and other liabilities, totaling $48 million. By 2024, the liability under accrued liabilities for the same category increased to $110 million, while the amount under deferred income taxes and other liabilities decreased to $5 million, resulting in a total of $115 million. This represents a significant increase in total liabilities for designated hedging instruments related to foreign exchange forwards and options, indicating a potential increase in Nike's foreign exchange risk exposure or a strategic shift in hedging activity.",
      "llm_answer": "Between 2022 and 2024, Nike's liabilities related to foreign exchange forwards and options designated as hedging instruments decreased significantly—from $426 million in 2022 to $48 million in 2024—reflecting a reduction in the notional amount of outstanding cash‑flow hedges (from $18.2 billion to $16.2 billion) and the associated deferred gains in accumulated other comprehensive income. This decline indicates that Nike is either unwinding or scaling back its hedge program, shifting exposure management toward other mechanisms (e.g., internal netting or unhedged positions), and suggests a lower reliance on formal hedging of foreign‑currency cash‑flow risks during that period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "NKE_10k_2022.pdf",
          "target_page": 83,
          "pages": [
            81,
            82,
            83,
            84,
            85
          ]
        },
        "hop_2_rel": {
          "source_file": "NKE_10k_2024.pdf",
          "target_page": 83,
          "pages": [
            81,
            82,
            83,
            84,
            85
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 63678,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 16155,
        "completion_tokens": 170,
        "total_tokens": 16326
      }
    },
    {
      "question_id": 46,
      "question": "How did the representation of Bounty within P&G's Baby, Feminine & Family Care segment evolve between the 2022 and 2023 10-K filings, and what does this suggest about its brand visibility?",
      "original_answer": "In the 2022 10-K filing, Bounty was mentioned as part of P&G's Family Care business within the Baby, Feminine & Family Care segment, but it was not explicitly listed among the key brands. In contrast, the 2023 10-K filing explicitly included Bounty among the major brands under the Family Care category. This change suggests an increase in Bounty's brand visibility within P&G's portfolio, though the filings do not provide specific market share or sales figures to quantify this shift. The explicit mention in 2023 indicates a possible strategic move to highlight Bounty's role, though no direct strategic intent is stated in the evidence provided.",
      "llm_answer": "The representation of Bounty within P&G’s Baby, Feminine & Family Care segment remained consistent in both the 2022 and 2023 10‑K filings, continuing to be listed under the “Baby, Feminine & Family Care” reportable segment with its major brands highlighted as “Always, Always Discreet, Tampax Bounty, Charmin, Puffs.” The segment’s net‑sales and earnings percentages (24%/25% in 2022 and 25%/23% in 2023) show that Bounty’s business is still a core component of the segment, but the lack of any growth or specific mention of Bounty suggests its brand visibility has not materially increased; it remains a stable, though not expanding, contributor to the segment’s overall performance.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "PG_10k_2022.pdf",
          "target_page": 19,
          "pages": [
            17,
            18,
            19,
            20,
            21
          ]
        },
        "hop_2_rel": {
          "source_file": "PG_10k_2023.pdf",
          "target_page": 18,
          "pages": [
            16,
            17,
            18,
            19,
            20
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 9,
        "total_chars": 51030,
        "num_window_pages": 9,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 12988,
        "completion_tokens": 171,
        "total_tokens": 13159
      }
    },
    {
      "question_id": 46,
      "question": "How has Oracle's approach to its hardware business, particularly Oracle Engineered Systems, evolved between fiscal 2022 and fiscal 2023 in terms of revenue recognition and strategic emphasis?",
      "original_answer": "In fiscal 2022, Oracle's hardware business, which includes Oracle Engineered Systems, was described in terms of its contractual activities and revenue recognition, with an emphasis on the timing of revenue recognition for cloud and license contracts. By fiscal 2023, Oracle introduced a more detailed explanation of how hardware and related software are treated as a combined performance obligation, with revenue recognized at the point in time of delivery and ownership transfer. Additionally, in 2023, Oracle emphasized ongoing R&D investments to improve and develop new hardware products and services, which was not explicitly mentioned in 2022. This indicates a shift toward a more strategic focus on innovation and integration of hardware and software components within the hardware business.",
      "llm_answer": "Oracle’s hardware business revenue recognition remained unchanged between fiscal 2022 and fiscal 2023 – hardware products and support are recognized at the point of delivery when ownership transfers, and support services are recognized ratably over the contract term. However, the company’s strategic emphasis shifted markedly toward its cloud and license segment, with cloud services and license support revenues rising to $30.174 billion in fiscal 2022 (up from $28.700 billion in fiscal 2021) and now representing the majority of total revenue, while hardware’s share fell to 6 % of total revenue. This strategic shift is reflected in the increased focus on cloud‑based offerings and the corresponding growth in cloud services and license support margins.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "ORCL_10k_2022.pdf",
          "target_page": 105,
          "pages": [
            103,
            104,
            105,
            106,
            107
          ]
        },
        "hop_2_rel": {
          "source_file": "ORCL_10k_2023.pdf",
          "target_page": 43,
          "pages": [
            41,
            42,
            43,
            44,
            45
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 50112,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 12761,
        "completion_tokens": 189,
        "total_tokens": 12951
      }
    },
    {
      "question_id": 46,
      "question": "How did the sales performance of the product ERLEADA evolve between 2022 and 2023, and what does this indicate about its market trajectory?",
      "original_answer": "In 2022, ERLEADA generated $1,881 million in sales, and by 2023, its sales increased to $2,387 million, representing a 26.9% growth. This indicates a strong upward trajectory for ERLEADA in the market, suggesting increased adoption or improved commercial performance over the period.",
      "llm_answer": "Based on the provided SEC 10-K filings, ERLEADA (apalutamide) sales grew from $1,881 million in 2021 to $2,387 million in 2022, representing a 26.9% year-over-year increase (with operational growth of 27.5% and a minor currency impact of -0.6%). This growth continued into 2023, where ERLEADA sales reached $2,387 million (consistent with 2022 levels) but showed a 26.9% total change from 2022 (with operational growth of 27.5% and a -0.6% currency impact), indicating sustained market momentum and expansion in key regions like Europe and the U.S., despite broader oncology market pressures. This trajectory suggests ERLEADA is maintaining strong, growing market share in metastatic castration-resistant prostate cancer, driven by continued clinical adoption and competitive positioning.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "JNJ_10k_2022.pdf",
          "target_page": 30,
          "pages": [
            28,
            29,
            30,
            31,
            32
          ]
        },
        "hop_2_rel": {
          "source_file": "JNJ_10k_2023.pdf",
          "target_page": 31,
          "pages": [
            29,
            30,
            31,
            32,
            33
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 37972,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 9711,
        "completion_tokens": 197,
        "total_tokens": 9908
      }
    },
    {
      "question_id": 47,
      "question": "How has the nature of CMCSA's relationship with local broadcast television stations evolved from 2023 to 2024, particularly in terms of competitive positioning and dependency for content distribution?",
      "original_answer": "In 2023, CMCSA's Media segment directly competed with local broadcast television stations for viewers' attention and advertising revenue. By 2024, the relationship shifted to a more interdependent one, where CMCSA's linear television networks became reliant on local broadcast television stations for retransmission consent, which is necessary for distributing broadcast network programming to video service customers. This marks a shift from competition to dependency, reflecting a strategic and operational evolution in how CMCSA interacts with local broadcast stations.",
      "llm_answer": "From 2023 to 2024, CMCSA’s relationship with local broadcast television stations has shifted from a reliance on traditional affiliation agreements to a more competitive, market‑driven dynamic. While the company still depends on local stations to carry its broadcast networks and to secure carriage on multichannel video providers, it now faces heightened competition for audience share and advertising revenue as viewers fragment across DTC streaming and other platforms. This evolving landscape has increased the pressure on CMCSA to negotiate retransmission consent and affiliation terms that reflect the declining linear‑TV audience, making the company more vulnerable to the financial and distribution risks associated with these local station relationships.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CMCSA_10k_2023.pdf",
          "target_page": 14,
          "pages": [
            12,
            13,
            14,
            15,
            16
          ]
        },
        "hop_2_rel": {
          "source_file": "CMCSA_10k_2024.pdf",
          "target_page": 23,
          "pages": [
            21,
            22,
            23,
            24,
            25
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 56071,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 14252,
        "completion_tokens": 190,
        "total_tokens": 14443
      }
    },
    {
      "question_id": 47,
      "question": "How did the value of Held-to-Maturity (HTM) securities held by MA evolve between 2023 and 2024, and what does this shift indicate about the company's investment strategy?",
      "original_answer": "In 2023, MA held $306 million in HTM securities, but by 2024, this amount dropped significantly to $38 million. This indicates a major shift in MA's investment strategy, with a sharp reduction in long-term held securities, likely reflecting a move toward more liquid or short-term investment positions.",
      "llm_answer": "The value of MA's Held-to-Maturity (HTM) securities declined sharply from $306 million at the end of 2023 to $38 million at the end of 2024. This reduction reflects a strategic shift away from low‑yielding time‑deposit holdings toward higher‑return assets such as available‑for‑sale securities and equity investments, indicating that the company is reallocating its cash portfolio to improve earnings and manage interest‑rate risk.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MA_10k_2023.pdf",
          "target_page": 86,
          "pages": [
            84,
            85,
            86,
            87,
            88
          ]
        },
        "hop_2_rel": {
          "source_file": "MA_10k_2024.pdf",
          "target_page": 83,
          "pages": [
            81,
            82,
            83,
            84,
            85
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 56948,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 14463,
        "completion_tokens": 107,
        "total_tokens": 14570
      }
    },
    {
      "question_id": 47,
      "question": "How has the positioning of the Always brand within Procter & Gamble's Baby, Feminine & Family Care segment evolved between 2022 and 2023, particularly in terms of its product categorization and associated sub-categories?",
      "original_answer": "In 2022, Always was categorized under Feminine Care within the Baby, Feminine & Family Care segment, which included sub-categories like Adult Incontinence and Feminine Care. By 2023, the brand remained part of the same reportable segment but was more specifically aligned with 'Menstrual Care' under the updated Feminine Care sub-category, reflecting a more targeted positioning. This evolution indicates a strategic shift in how Always is being categorized to emphasize its core focus area.",
      "llm_answer": "Between 2022 and 2023, the Always brand remained within the Baby, Feminine & Family Care segment, continuing to be categorized under Feminine Care sub-categories alongside Tampax and other menstrual and incontinence products. The brand maintained its positioning in the feminine care space, with market share and strategic focus consistent with prior years, though specific changes in categorization or sub-category structure were not indicated. The segment as a whole showed stable net sales and earnings contributions, with no major restructuring or reclassification of Always mentioned in the provided disclosures.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "PG_10k_2022.pdf",
          "target_page": 19,
          "pages": [
            17,
            18,
            19,
            20,
            21
          ]
        },
        "hop_2_rel": {
          "source_file": "PG_10k_2023.pdf",
          "target_page": 18,
          "pages": [
            16,
            17,
            18,
            19,
            20
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 9,
        "total_chars": 51030,
        "num_window_pages": 9,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 12996,
        "completion_tokens": 154,
        "total_tokens": 13150
      }
    },
    {
      "question_id": 47,
      "question": "How has Oracle's positioning and financial contribution of Oracle Engineered Systems evolved between 2022 and 2023, particularly in terms of revenue recognition and strategic emphasis?",
      "original_answer": "In 2022, Oracle Engineered Systems were disclosed as part of hardware revenues, but no specific percentage of total revenue was provided. Revenue recognition for hardware products, including Engineered Systems, was described as occurring at the point in time when the product and related software were delivered. By 2023, Oracle explicitly stated that the hardware business, which includes Engineered Systems, represented 6% of total revenues in both fiscal 2023 and fiscal 2024, indicating a clearer and more consistent measurement of the product line's contribution. Additionally, in 2023, Oracle emphasized ongoing R&D investments to improve hardware offerings and introduced more detailed factors affecting hardware revenue predictability, such as manufacturing partner performance and competitive positioning against cloud infrastructure offerings. This reflects both quantitative and strategic evolution in how Oracle presents and manages the Engineered Systems product line.",
      "llm_answer": "Oracle's positioning of Engineered Systems shifted from a revenue driver to a lower-margin, strategic hardware component, with its revenue share declining from 6% of total revenue in fiscal 2023 to 6% in fiscal 2024, while the company emphasized cloud and license growth as the primary margin drivers. Financially, Engineered Systems revenue recognition follows standard hardware accounting (recognized at delivery), but its contribution to overall revenue and margins has diminished, reflecting a strategic pivot toward cloud services and license support as the core growth engines, with cloud services now representing 37% of total revenue (up from 25% in 2022). The company's financial disclosures highlight that Engineered Systems' revenue is increasingly less central to growth, with margin pressures and lower revenue share compared to the higher-margin cloud and license segments.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "ORCL_10k_2022.pdf",
          "target_page": 74,
          "pages": [
            72,
            73,
            74,
            75,
            76
          ]
        },
        "hop_2_rel": {
          "source_file": "ORCL_10k_2023.pdf",
          "target_page": 43,
          "pages": [
            41,
            42,
            43,
            44,
            45
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 48685,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 12401,
        "completion_tokens": 221,
        "total_tokens": 12623
      }
    },
    {
      "question_id": 48,
      "question": "How has Comcast's relationship with representation firms evolved in terms of advertising sales strategy between 2023 and 2024?",
      "original_answer": "In 2023, Comcast worked with representation firms as an extension of its sales force to sell a portion of the advertising units allocated to them, recording revenue net of agency commissions. By 2024, Comcast had evolved this relationship into formal representation agreements under which they sell advertising on behalf of third parties, indicating a deeper strategic alignment and expanded role for these firms. This reflects a shift from a co-selling model to a more formalized representation structure.",
      "llm_answer": "Comcast’s advertising‑sales strategy has remained anchored in using its own sales force and representation firms to sell ad inventory, but the 2024 filing shows a modest shift in how those relationships are structured.  The 2023 10‑K notes that “we also enter into representation agreements under which we sell advertising on behalf of third parties… we record the advertising that is sold in advertising revenue and the fees paid to the third parties in other operating and administrative expenses,” and that “in some cases, we work with representation firms as an extension of our sales force to sell a portion of the advertising units allocated to us and record the revenue net of agency commissions.”  By contrast, the 2024 10‑K (page 73) emphasizes that “we have determined that a contract exists for our advertising sales arrangements once all terms and conditions are agreed upon… Revenue from these arrangements is recognized in the period in which advertisements are aired or delivered,” with no substantive change to the role of external representation firms—only a clarification of the timing and accounting of the revenue.  Thus, between 2023 and 2024 the evolution is one of refined accounting language and tighter integration of representation‑firm commissions into expense reporting, rather than a strategic overhaul of the advertising‑sales model.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CMCSA_10k_2023.pdf",
          "target_page": 75,
          "pages": [
            73,
            74,
            75,
            76,
            77
          ]
        },
        "hop_2_rel": {
          "source_file": "CMCSA_10k_2024.pdf",
          "target_page": 74,
          "pages": [
            72,
            73,
            74,
            75,
            76
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 55440,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 14076,
        "completion_tokens": 340,
        "total_tokens": 14417
      }
    },
    {
      "question_id": 48,
      "question": "How has Oracle's approach to its industry-specific hardware offerings evolved between fiscal 2022 and fiscal 2023, particularly in terms of revenue recognition and strategic emphasis?",
      "original_answer": "In fiscal 2022, Oracle described its hardware business as including industry-specific hardware and recognized hardware revenues at the point in time when products and related software were delivered to customers. By fiscal 2023, Oracle introduced a more detailed explanation of revenue recognition for hardware, stating that revenues for combined performance obligations (hardware plus related software) are generally recognized at the point in time of delivery and ownership transfer. Additionally, in 2023, Oracle emphasized ongoing investments in R&D to improve existing hardware offerings and develop new products, signaling a more strategic focus on innovation in this area compared to 2022, where the description was more general and focused on the breadth of offerings.",
      "llm_answer": "Oracle’s industry‑specific hardware offerings continued to represent a small, relatively stable portion of total revenue (about 6 % in both fiscal 2023 and fiscal 2022), with modest revenue declines from $3.359 billion in 2022 to $3.183 billion in 2023 and corresponding margin pressure.  The company’s accounting treatment for hardware‑related revenue remains point‑in‑time recognition upon delivery, and the hardware segment’s operating margin fell from $1.878 billion (≈ 59 % of its revenue) in 2022 to $1.878 billion (≈ 59 % of its revenue) in 2023 after adjusting for fixed‑cost structure, indicating that strategic emphasis on hardware has not shifted dramatically between the two years.  Overall, the evolution is characterized more by modest revenue contraction and margin stability than by a fundamental change in how hardware revenue is recognized or reported.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "ORCL_10k_2022.pdf",
          "target_page": 105,
          "pages": [
            103,
            104,
            105,
            106,
            107
          ]
        },
        "hop_2_rel": {
          "source_file": "ORCL_10k_2023.pdf",
          "target_page": 43,
          "pages": [
            41,
            42,
            43,
            44,
            45
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 50112,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 12759,
        "completion_tokens": 217,
        "total_tokens": 12977
      }
    },
    {
      "question_id": 48,
      "question": "How did the sales performance of IMBRUVICA (ibrutinib) evolve between 2022 and 2023, and what factors contributed to this change?",
      "original_answer": "IMBRUVICA sales decreased from $3.784 billion in 2022 to $3.264 billion in 2023, a decline of 13.7%. In 2022, the growth of IMBRUVICA was already being offset by competitive pressures from novel oral agents and market dynamics related to the pandemic, such as delays in new patient starts. By 2023, this downward trend continued, with the product experiencing a significant drop in sales, reflecting sustained competitive pressures and likely increased market saturation or treatment shifts in the oncology space.",
      "llm_answer": "IMBRUVICA (ibrutinib) sales declined 13.7% from $3,784 million in 2022 to $3,264 million in 2023, with operational growth of 13.2% offset by a 0.5% negative currency impact. This decrease was primarily driven by global competitive pressures affecting the drug's market position.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "JNJ_10k_2022.pdf",
          "target_page": 31,
          "pages": [
            29,
            30,
            31,
            32,
            33
          ]
        },
        "hop_2_rel": {
          "source_file": "JNJ_10k_2023.pdf",
          "target_page": 31,
          "pages": [
            29,
            30,
            31,
            32,
            33
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 38934,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 9949,
        "completion_tokens": 69,
        "total_tokens": 10019
      }
    },
    {
      "question_id": 49,
      "question": "How has Comcast's involvement with Universal Beijing Resort evolved from 2023 to 2024 in terms of debt levels, ownership structure, and financial risk exposure?",
      "original_answer": "In 2023, Universal Beijing Resort had $3.5 billion of debt outstanding, including a $3.1 billion term loan, and was consolidated by Comcast, which owns a 30% interest. By 2024, the debt level slightly decreased to $3.4 billion, with the term loan principal reducing to $3.0 billion. Comcast continues to consolidate Universal Beijing Resort as a VIE, maintaining its 30% ownership stake. The maximum financial risk exposure for Comcast remains limited to its 30% equity interest, indicating a stable risk profile despite the slight reduction in debt. This evolution reflects a minor decrease in leverage but no change in ownership or governance structure.",
      "llm_answer": "Comcast's involvement with Universal Beijing Resort has evolved from 2023 to 2024 with no material change in debt levels or ownership structure, as the resort remains a consolidated VIE with $3.5 billion of debt outstanding as of December 31, 2024 (up slightly from $3.5 billion in 2023), and Comcast maintains its 30% equity interest without any new financing commitments or structural changes to its risk exposure. The company continues to report the resort's assets and liabilities on its balance sheet ($7.3 billion in assets and $7.0 billion in liabilities as of December 31, 2024), while its maximum financial risk remains limited to its 30% equity stake, with no additional guarantees or liquidity arrangements beyond its existing contractual obligations.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CMCSA_10k_2023.pdf",
          "target_page": 54,
          "pages": [
            52,
            53,
            54,
            55,
            56
          ]
        },
        "hop_2_rel": {
          "source_file": "CMCSA_10k_2024.pdf",
          "target_page": 86,
          "pages": [
            84,
            85,
            86,
            87,
            88
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 51941,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 13210,
        "completion_tokens": 190,
        "total_tokens": 13400
      }
    },
    {
      "question_id": 49,
      "question": "How did the financial commitment related to future lease payments for build-to-suit facilities and equipment evolve from 2022 to 2023, and what does this indicate about FedEx's leasing strategy?",
      "original_answer": "In 2022, FedEx disclosed future undiscounted payments of approximately $3.4 billion for build-to-suit facilities that had not yet commenced, with expected commencement dates from 2023 to 2024. By 2023, the company reported a significant reduction in these future commitments, with undiscounted payments dropping to approximately $0.9 billion for build-to-suit facilities and equipment, with commencement dates expected from 2025 to 2027. This indicates a strategic shift toward fewer long-term build-to-suit lease commitments and a more extended timeline for asset utilization.",
      "llm_answer": "The financial commitment related to future lease payments for build-to-suit facilities and equipment increased from approximately $3.4 billion in 2022 to about $0.9 billion in undiscounted future payments for 2024‑2027 commitments reported in 2023, and is projected to reach roughly $3.4 billion in undiscounted payments for 2025‑2027 as disclosed in the 2024 lease schedule. This growth indicates that FedEx is expanding its build‑to‑suit leasing strategy, adding significant new lease obligations as it secures additional facilities and equipment for future operations.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "FDX_10k_2022.pdf",
          "target_page": 96,
          "pages": [
            94,
            95,
            96,
            97,
            98
          ]
        },
        "hop_2_rel": {
          "source_file": "FDX_10k_2023.pdf",
          "target_page": 98,
          "pages": [
            96,
            97,
            98,
            99,
            100
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 47989,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 12230,
        "completion_tokens": 142,
        "total_tokens": 12372
      }
    },
    {
      "question_id": 49,
      "question": "How has Mastercard's relationship with Dynamic Yield LTD evolved between 2023 and 2024, and what does this indicate about the company's strategic focus during this period?",
      "original_answer": "In 2023, Mastercard disclosed that it had acquired Dynamic Yield LTD in April 2022 for $325 million, with $200 million of goodwill attributed to synergies expected after the acquisition. By 2024, the relationship is described as stable, with no new investments or acquisitions involving Dynamic Yield reported during the year. This indicates that the integration of Dynamic Yield was largely completed by 2023, and Mastercard shifted focus to newer acquisitions like Recorded Future in 2024, signaling a strategic pivot toward cybersecurity and threat intelligence.",
      "llm_answer": "Mastercard completed its acquisition of Dynamic Yield Ltd. in April 2022, finalizing the purchase accounting in 2023 and reporting $200 million of goodwill and $125 million of other intangible assets acquired. In 2024 the company expanded its strategic focus on digital identity and cyber‑security by acquiring Recorded Future for $2.7 billion, adding threat‑intelligence capabilities, and continued to invest in value‑added services. These moves signal Mastercard’s deliberate shift toward broadening its high‑margin, data‑driven solutions and strengthening its technology platform beyond core payment‑network revenues.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MA_10k_2023.pdf",
          "target_page": 82,
          "pages": [
            80,
            81,
            82,
            83,
            84
          ]
        },
        "hop_2_rel": {
          "source_file": "MA_10k_2024.pdf",
          "target_page": 79,
          "pages": [
            77,
            78,
            79,
            80,
            81
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 52033,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 13234,
        "completion_tokens": 155,
        "total_tokens": 13389
      }
    },
    {
      "question_id": 49,
      "question": "How has the Severance Plan for Senior Officers at Lowe's evolved between 2022 and 2024, particularly in terms of the most recent amendment dates and associated filings?",
      "original_answer": "In 2022, the Severance Plan for Senior Officers was described as 'amended and restated May 29, 2020' and was filed on August 26, 2020 (Exhibit 10.29). By 2024, the plan had been further amended and restated on May 26, 2022, with the updated version filed on November 27, 2024 (Exhibit 10.28). This indicates that Lowe's updated its Severance Plan for Senior Officers at least once between 2022 and 2024, with the most recent amendment occurring in mid-2022 and formally disclosed in late 2024.",
      "llm_answer": "The Severance Plan for Senior Officers was most recently amended and restated effective May 26 2022, as reflected in Exhibit 10.28 of Lowe’s 2022 Form 10‑Q (filed November 27 2024). This amendment supersedes the prior plan and is the latest version referenced in the company’s SEC filings.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "LOW_10k_2022.pdf",
          "target_page": 90,
          "pages": [
            79,
            80,
            81,
            82,
            83
          ]
        },
        "hop_2_rel": {
          "source_file": "LOW_10k_2024.pdf",
          "target_page": 79,
          "pages": [
            77,
            78,
            79,
            80,
            81
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 8,
        "total_chars": 36727,
        "num_window_pages": 8,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 9407,
        "completion_tokens": 72,
        "total_tokens": 9480
      }
    },
    {
      "question_id": 50,
      "question": "How did the fair value of Netflix's 6.375% Senior Notes change between December 31, 2021, and December 31, 2023, and what does this evolution indicate about market perceptions of the company's debt over this period?",
      "original_answer": "The fair value of Netflix's 6.375% Senior Notes increased from $999 million as of December 31, 2021, to $872 million as of December 31, 2023. This indicates a decrease in the fair value of the notes over the two-year period, suggesting a potential decline in market confidence or an increase in required yields for this debt instrument.",
      "llm_answer": "The fair value of Netflix's 6.375% Senior Notes increased from $830 million at the end of 2022 to $872 million at the end of 2023, reflecting a modest rise in market perception of the company's debt value over that period. This upward shift suggests that investors’ expectations of the company’s creditworthiness and the notes’ attractiveness improved slightly between 2022 and 2023.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "NFLX_10k_2022.pdf",
          "target_page": 56,
          "pages": [
            54,
            55,
            56,
            57,
            58
          ]
        },
        "hop_2_rel": {
          "source_file": "NFLX_10k_2023.pdf",
          "target_page": 56,
          "pages": [
            54,
            55,
            56,
            57,
            58
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 44329,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 11320,
        "completion_tokens": 95,
        "total_tokens": 11416
      }
    },
    {
      "question_id": 50,
      "question": "How did the sales performance of IMBRUVICA evolve between 2022 and 2023, and what does this indicate about its market position in the oncology segment?",
      "original_answer": "IMBRUVICA's sales decreased from $4,369 million in 2022 to $3,264 million in 2023, representing a decline of 25.2%. This indicates a weakening market position for IMBRUVICA within the oncology segment, especially as other products like DARZALEX and ERLEADA experienced significant growth during the same period.",
      "llm_answer": "IMBRUVICA sales declined 13.7% from $3.784 billion in 2022 to $3.264 billion in 2023, reflecting global competitive pressures and loss of exclusivity, which signals a weakening market position for the drug within J&J’s oncology portfolio despite overall oncology segment growth of 10.5%.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "JNJ_10k_2022.pdf",
          "target_page": 30,
          "pages": [
            28,
            29,
            30,
            31,
            32
          ]
        },
        "hop_2_rel": {
          "source_file": "JNJ_10k_2023.pdf",
          "target_page": 31,
          "pages": [
            29,
            30,
            31,
            32,
            33
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 37972,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 9714,
        "completion_tokens": 71,
        "total_tokens": 9786
      }
    },
    {
      "question_id": 51,
      "question": "How did LOW's inventory shrink reserve and LCNRV reserve evolve between 2022 and 2024, and what were the implications for net earnings?",
      "original_answer": "Between 2022 and 2024, LOW's inventory shrink reserve increased from $414 million to $427 million, while the LCNRV reserve increased from $168 million to $222 million. In 2024, a 10% change in either the amount of inventory subject to markdown or the weighted average estimated loss rate used in the LCNRV reserve calculation would have affected net earnings by approximately $17 million, and a 10% change in the estimated shrinkage rate would have impacted net earnings by approximately $32 million. These changes indicate a growing need for reserves, particularly for shrinkage, and highlight the increasing sensitivity of net earnings to inventory valuation assumptions.",
      "llm_answer": "LOW's inventory reserves declined modestly from 2022 to 2024, with the LCNRV reserve falling from $222 million to $222 million (essentially stable) and the shrink reserve rising from $414 million to $427 million; however, a 10 % shift in either reserve would alter net earnings by roughly $17–$32 million, meaning the reserves have a limited but material impact on earnings volatility. The company’s overall earnings were primarily driven by share‑repurchase spending and dividend increases rather than inventory reserve adjustments.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "LOW_10k_2022.pdf",
          "target_page": 33,
          "pages": [
            31,
            32,
            33,
            34,
            35
          ]
        },
        "hop_2_rel": {
          "source_file": "LOW_10k_2024.pdf",
          "target_page": 34,
          "pages": [
            32,
            33,
            34,
            35,
            36
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 9,
        "total_chars": 37123,
        "num_window_pages": 9,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 9498,
        "completion_tokens": 133,
        "total_tokens": 9631
      }
    },
    {
      "question_id": 51,
      "question": "How did Qulipta's status and financial contribution evolve from 2022 to 2023, particularly in terms of its development and commercialization progress?",
      "original_answer": "In 2022, Qulipta was among the products that contributed to the reclassification of $1.0 billion of indefinite-lived research and development intangible assets to developed product rights upon receiving regulatory approvals. By 2023, Qulipta had transitioned from development to commercialization, generating $405 million in revenue in the United States and $3 million internationally, indicating a significant shift from a developmental asset to a revenue-generating product.",
      "llm_answer": "From 2022 to 2023, Qulipta evolved from a newly launched product to a commercially established asset, with its net revenues increasing by more than 100% in 2023, driven by strong market share uptake, market growth, and regulatory approvals for chronic migraine prevention in both the U.S. (April 2023) and Europe (August 2023). This growth contributed to AbbVie’s overall net revenue expansion and was highlighted as a key driver in the company’s neuroscience portfolio performance.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "ABBV_10k_2022.pdf",
          "target_page": 100,
          "pages": [
            98,
            99,
            100,
            101,
            102
          ]
        },
        "hop_2_rel": {
          "source_file": "ABBV_10k_2023.pdf",
          "target_page": 42,
          "pages": [
            40,
            41,
            42,
            43,
            44
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 48563,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 12363,
        "completion_tokens": 120,
        "total_tokens": 12484
      }
    },
    {
      "question_id": 52,
      "question": "How has Honeywell's financial dependency on the Resideo subsidiary for environmental liabilities evolved between 2022 and 2023, and what does this indicate about the company's risk exposure?",
      "original_answer": "Honeywell's financial dependency on the Resideo subsidiary for environmental liabilities remained consistent between 2022 and 2023, with Resideo's subsidiary still obligated to pay 90% of Honeywell's annual net spending on environmental matters at specified sites, up to a maximum of $140 million per year. This ongoing arrangement indicates that Honeywell continues to rely on Resideo's payments to offset a significant portion of its environmental costs, suggesting that the risk mitigation strategy through this indemnification agreement has not changed over the two years.",
      "llm_answer": "Between 2022 and 2023 Honeywell’s environmental‑liability exposure shifted markedly from being largely dependent on Resideo’s reimbursements to a more self‑contained funding model.  In 2022 the company recorded a $140 million receivable from Resideo for 90 % of its environmental costs, and the indemnification agreement capped annual payments at $140 million with a 2043 expiry.  By 2023 the same $140 million quarterly reimbursement was still being collected, but the company’s own accrued environmental liability had risen to $641 million (up from $615 million in 2022), reflecting higher accruals and payments, while the Resideo receivable remained unchanged at $140 million.  This indicates that Honeywell’s risk exposure is now primarily borne by its own balance‑sheet provisions rather than by external reimbursements, increasing its direct financial risk for future environmental remediation.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "HON_10k_2022.pdf",
          "target_page": 98,
          "pages": [
            96,
            97,
            98,
            99,
            100
          ]
        },
        "hop_2_rel": {
          "source_file": "HON_10k_2023.pdf",
          "target_page": 97,
          "pages": [
            95,
            96,
            97,
            98,
            99
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 84693,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 21405,
        "completion_tokens": 225,
        "total_tokens": 21630
      }
    },
    {
      "question_id": 52,
      "question": "How has Target's definition or treatment of 'original maturity' for cash equivalents evolved between 2022 and 2024, and what does this indicate about potential changes in their cash management strategy?",
      "original_answer": "In 2022, Target defined cash equivalents as highly liquid investments with an original maturity of three months or less, with no additional context or clarification. By 2024, the company maintained the same three-month threshold for original maturity but added a broader discussion around fair value measurements for other short-term assets and liabilities, suggesting a more comprehensive approach to short-term financial instruments. This evolution indicates a potential refinement in how Target evaluates and manages its cash and near-cash assets within a broader financial framework.",
      "llm_answer": "Target's definition of \"original maturity\" for cash equivalents has remained consistent across both filings, specifying \"highly liquid investments with an original maturity of three months or less from the time of purchase\" (2022 Form 10-K, page 49; 2024 Form 10-K, page 52). However, the 2024 filing explicitly includes \"short-term investments\" within cash and cash equivalents (page 52), whereas the 2022 filing treated these as a separate line item under cash equivalents (page 49). This evolution indicates a strategic shift toward consolidating short-term investments into the cash equivalent category for presentation simplicity, not a change in the underlying maturity definition. The core criterion—original maturity of three months or less—remains unchanged, reflecting stable cash management practices with no material shift in risk profile or liquidity strategy.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "TGT_10k_2022.pdf",
          "target_page": 48,
          "pages": [
            46,
            47,
            48,
            49,
            50
          ]
        },
        "hop_2_rel": {
          "source_file": "TGT_10k_2024.pdf",
          "target_page": 52,
          "pages": [
            50,
            51,
            52,
            53,
            54
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 43152,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 11022,
        "completion_tokens": 218,
        "total_tokens": 11240
      }
    },
    {
      "question_id": 52,
      "question": "How did the valuation and classification of NVDA's 3.50% Notes Due 2040 evolve between 2023 and 2024, and what does this indicate about the company's long-term debt strategy?",
      "original_answer": "In 2023, the 3.50% Notes Due 2040 were listed under liabilities with a carrying value of $851 million as of January 28, 2024, and were categorized as Level 2 in the pricing hierarchy. By 2024, the valuation of the same notes increased to $1,000 million as of January 26, 2025, with a more detailed breakdown including an effective interest rate of 3.54% and a remaining term of 15.2 years. This indicates a strategic emphasis on long-term financing with stable interest rate structures.",
      "llm_answer": "Between 2023 and 2024, NVIDIA reclassified its 3.50% Notes Due 2040 from a Level 2 liability (carrying amount $870 million) in 2023 to a Level 2 liability with a slightly lower carrying amount of $851 million in 2024, reflecting routine fair‑value adjustments and the amortization of discount and issuance costs. This modest change indicates that the company’s long‑term debt strategy remains focused on maintaining a stable ladder of senior unsecured notes with staggered maturities, while continuing to manage debt at relatively low yields and preserving flexibility for future capital needs.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "NVDA_10k_2023.pdf",
          "target_page": 67,
          "pages": [
            65,
            66,
            67,
            68,
            69
          ]
        },
        "hop_2_rel": {
          "source_file": "NVDA_10k_2024.pdf",
          "target_page": 72,
          "pages": [
            70,
            71,
            72,
            73,
            74
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 41288,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 10550,
        "completion_tokens": 148,
        "total_tokens": 10698
      }
    },
    {
      "question_id": 52,
      "question": "How did the financial performance of Venclexta evolve between 2022 and 2023, particularly in terms of total global revenue and the growth rate?",
      "original_answer": "In 2022, Venclexta generated a total global revenue of $2,009 million, with a growth rate of 10.4%. In 2023, the total global revenue from Venclexta increased to $2,288 million, representing a growth rate of 13.9%. This indicates an upward trend in both absolute revenue and growth rate year-over-year.",
      "llm_answer": "Based on the provided financial data, Venclexta's total global revenue increased by 13.9% in 2023 compared to 2022 (from $2,009 million to $2,288 million), with the growth rate reported as 13.9% at actual currency rates and 15.0% at constant currency rates. This represents a clear acceleration in revenue growth from the prior year, driven by continued market share gains and favorable pricing across key markets.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "ABBV_10k_2022.pdf",
          "target_page": 99,
          "pages": [
            97,
            98,
            99,
            100,
            101
          ]
        },
        "hop_2_rel": {
          "source_file": "ABBV_10k_2023.pdf",
          "target_page": 42,
          "pages": [
            40,
            41,
            42,
            43,
            44
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 9,
        "total_chars": 45207,
        "num_window_pages": 9,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 11522,
        "completion_tokens": 103,
        "total_tokens": 11626
      }
    },
    {
      "question_id": 53,
      "question": "How has Netflix's approach to executive severance and retention incentives evolved between the 2022 and 2023 SEC filings, particularly in terms of plan amendments and their effective dates?",
      "original_answer": "In 2022, the filing referenced the 'Amended and Restated Executive Severance and Retention Incentive Plan' with a filing date of September 10, 2021, indicating that the plan had undergone revisions by that date. By 2023, the filing showed further evolution, introducing the 'Executive Severance and Retention Incentive Plan as Amended and Restated effective January 1, 2024,' with a filing date of December 8, 2023. This demonstrates Netflix’s ongoing adjustments to executive compensation frameworks, with a forward-looking amendment effective in 2024.",
      "llm_answer": "Netflix amended its Executive Severance and Retention Incentive Plan in September 2021 (effective September 10, 2021) and, in December 2023, replaced it with an amended and restated version that took effect on January 1, 2024. The 2023 filing (Exhibit 10.16† in the 2023 10‑K) details this amendment and its January 1, 2024 effective date, marking the evolution of the plan between the 2022 and 2023 SEC filings.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "NFLX_10k_2022.pdf",
          "target_page": 66,
          "pages": [
            63,
            64,
            65,
            66,
            67
          ]
        },
        "hop_2_rel": {
          "source_file": "NFLX_10k_2023.pdf",
          "target_page": 68,
          "pages": [
            66,
            67,
            68,
            69,
            70
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 46537,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 11866,
        "completion_tokens": 103,
        "total_tokens": 11969
      }
    },
    {
      "question_id": 53,
      "question": "How did Lowe's documentation and structure of its Benefit Restoration Plan evolve from 2022 to 2024, and what does this indicate about the company's approach to employee retirement benefits?",
      "original_answer": "In 2022, Lowe's maintained the Benefit Restoration Plan as part of its defined contribution retirement offerings, supplementing benefits under the 401(k) Plan for employees affected by IRS limitations. The plan included both employee salary deferrals and employer contributions in the form of a Company Match. By 2024, the company formally introduced an updated and restated version of the Benefit Restoration Plan, effective January 1, 2025, as evidenced by the new exhibit filing (10.3) in the 2024 10-K. This indicates a deliberate effort to formalize and likely enhance the structure of the plan, signaling a more strategic and forward-looking approach to managing executive and high-earner compensation through improved documentation and alignment with long-term benefit policies.",
      "llm_answer": "The Benefit Restoration Plan’s documentation and structure remained consistent between 2022 and 2024, with no substantive changes to its design or provisions noted in the filings. The company continued to use the plan to supplement 401(k) benefits for employees affected by IRS contribution limits, maintaining the same eligibility rules and employer matching structure. This consistency suggests Lowe’s takes a stable, long-term approach to retirement benefits, prioritizing continuity and predictability for participants rather than frequent revisions.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "LOW_10k_2022.pdf",
          "target_page": 68,
          "pages": [
            66,
            67,
            68,
            69,
            70
          ]
        },
        "hop_2_rel": {
          "source_file": "LOW_10k_2024.pdf",
          "target_page": 78,
          "pages": [
            76,
            77,
            78,
            79,
            80
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 47355,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 12070,
        "completion_tokens": 138,
        "total_tokens": 12208
      }
    },
    {
      "question_id": 53,
      "question": "How did NVDA's financial obligations related to the 0.584% Notes Due 2024 evolve between fiscal years 2023 and 2024?",
      "original_answer": "In fiscal year 2023, NVDA reported a liability of $1,185 million for the 0.584% Notes Due 2024. By fiscal year 2024, this obligation was fully repaid, as stated in the 2024 10-K filing. This indicates a complete resolution of this specific debt obligation over the two-year period.",
      "llm_answer": "Between fiscal years 2023 and 2024, the outstanding balance of NVDA’s 0.584% Notes Due 2024 fell from $1,250 million to $‑ (reflecting the full repayment of the issue in fiscal 2025), while the total long‑term debt net carrying amount declined from $8,459 million to $8,463 million (the slight increase is attributable to the unamortized discount and issuance costs being removed after repayment). In short, the company retired the 0.584% Notes Due 2024 during FY 2025, eliminating that $1.25 billion liability from its long‑term obligations.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "NVDA_10k_2023.pdf",
          "target_page": 67,
          "pages": [
            65,
            66,
            67,
            68,
            69
          ]
        },
        "hop_2_rel": {
          "source_file": "NVDA_10k_2024.pdf",
          "target_page": 72,
          "pages": [
            70,
            71,
            72,
            73,
            74
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 41288,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 10535,
        "completion_tokens": 135,
        "total_tokens": 10671
      }
    },
    {
      "question_id": 53,
      "question": "How did the global revenue performance of Mavyret evolve between 2022 and 2023, and what were the trends in its United States and international markets during this period?",
      "original_answer": "In 2022, Mavyret generated total global revenue of $1,541 million, with $755 million from the United States and $786 million from international markets. By 2023, total revenue from Mavyret decreased to $1,430 million, driven by a decline in both U.S. and international markets. Specifically, U.S. revenue dropped to $659 million, a decrease of 12.7%, while international revenue slightly declined to $771 million, a marginal decrease of 1.9%. This indicates a contraction in Mavyret's market performance across both regions, with a more pronounced decline in the U.S. market.",
      "llm_answer": "Between 2022 and 2023, Mavyret’s global net revenue declined by 7.2% at constant currency, driven by a 12.7% drop in the United States and a 1.9% decrease internationally. In the U.S., sales fell to $659 million from $755 million in 2022, while international revenues slipped to $771 million from $786 million, reflecting ongoing competition and market pressures.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "ABBV_10k_2022.pdf",
          "target_page": 11,
          "pages": [
            9,
            10,
            11,
            12,
            13
          ]
        },
        "hop_2_rel": {
          "source_file": "ABBV_10k_2023.pdf",
          "target_page": 43,
          "pages": [
            41,
            42,
            43,
            44,
            45
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 8,
        "total_chars": 45465,
        "num_window_pages": 8,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 11593,
        "completion_tokens": 90,
        "total_tokens": 11684
      }
    },
    {
      "question_id": 54,
      "question": "How did Netflix's compliance with covenant limitations related to its Senior Notes evolve between 2022 and 2024, particularly in terms of repayment obligations and the scope of restrictions?",
      "original_answer": "In 2022, Netflix was in compliance with all covenant limitations tied to its Senior Notes, which included restrictions on creating liens, entering into sale and lease-back transactions, incurring additional indebtedness by certain subsidiaries, and merging or transferring substantial assets. These notes included various euro-denominated tranches with principal amounts totaling €5,170 million. By 2024, Netflix remained in compliance with these covenants, but the scope of limitations had slightly evolved—specifically, certain Senior Notes no longer referenced restrictions on sale and lease-back transactions, suggesting a narrowing of covenant scope for some notes. Additionally, in 2024, Netflix repaid $400 million of its 5.750% Senior Notes upon maturity, indicating active debt management and a shift in its debt composition.",
      "llm_answer": "Between 2022 and 2024, Netflix’s covenant limitations under its senior notes remained consistent in scope—restricting liens, sale‑lease‑back transactions, additional subsidiary indebtedness, and the consolidation or merger of substantially all assets—but the company’s repayment obligations evolved. In 2022 it still had $400 million of 5.750% notes maturing in March 2024; by 2024 those notes had been fully repaid upon maturity, and the company added newer long‑dated issues (e.g., $1 billion 4.900% notes due 2034 and $800 million 5.400% notes due 2054). Consequently, while the covenant framework did not change materially, the composition of outstanding notes shifted toward later‑maturity debt, reducing near‑term repayment pressure and maintaining compliance with all covenants through 2024.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "NFLX_10k_2022.pdf",
          "target_page": 56,
          "pages": [
            54,
            55,
            56,
            57,
            58
          ]
        },
        "hop_2_rel": {
          "source_file": "NFLX_10k_2024.pdf",
          "target_page": 54,
          "pages": [
            52,
            53,
            54,
            55,
            56
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 44769,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 11424,
        "completion_tokens": 199,
        "total_tokens": 11623
      }
    },
    {
      "question_id": 54,
      "question": "How did Honeywell's approach to the Safety and Retail product line evolve between 2022 and 2023, and what structural change was introduced in 2023 that reflects this evolution?",
      "original_answer": "In 2022, Honeywell reported the Safety and Retail business unit as a standalone component under the Safety and Productivity Solutions segment, generating $2,387 million in revenue. By 2023, the company had realigned its organizational structure, merging the Safety and Retail unit with the Advanced Sensing Technologies unit to form a new business unit called Sensing and Safety Technologies. This structural change, introduced in July 2022 but reported in the 2023 filing, reflects a strategic shift toward integrating sensing capabilities with safety solutions to enhance technological offerings and streamline operations.",
      "llm_answer": "Between 2022 and 2023, Honeywell’s Safety and Productivity Solutions segment underwent a structural reorganization that combined the Safety and Retail business unit with the Advanced Sensing Technologies unit to form the new Sensing and Safety Technologies unit. This realignment was reflected in the 2023 financial disclosures, where the segment’s revenue declined to $5,489 million (down from $6,907 million in 2022), and the company explicitly noted the recasting of historical periods to reflect the new structure. The evolution culminated in a strategic acquisition in 2023: Honeywell agreed to acquire Carrier Global’s Global Access Solutions business for $5.0 billion, which will be reported within the Honeywell Building Technologies segment, signaling a shift toward expanding its building technologies portfolio through targeted acquisitions.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "HON_10k_2022.pdf",
          "target_page": 69,
          "pages": [
            67,
            68,
            69,
            70,
            71
          ]
        },
        "hop_2_rel": {
          "source_file": "HON_10k_2023.pdf",
          "target_page": 68,
          "pages": [
            66,
            67,
            68,
            69,
            70
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 52263,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 13293,
        "completion_tokens": 213,
        "total_tokens": 13506
      }
    },
    {
      "question_id": 54,
      "question": "How has the status and role of Class B-2 Common Stock evolved between 2023 and 2024, particularly in terms of its convertibility and impact on corporate governance?",
      "original_answer": "In 2023, Class B-2 Common Stock was described as part of a structure that would become convertible into Class A Common Stock, with potential dilutive effects on voting power and market price. It also played a role in approving significant corporate actions, indicating a governance influence. By 2024, no shares of Class B-2 Common Stock were outstanding prior to the Class B-1 Common Stock exchange offer, suggesting a strategic shift in equity structure. This indicates a transformation in the role of Class B-2 Common Stock, moving from an active governance and conversion position to a non-outstanding status, reducing its influence on corporate decisions.",
      "llm_answer": "Between 2023 and 2024, Class B‑2 common stock transitioned from having no outstanding shares to being issued (49 million shares) and began participating in the company’s capital structure, while its conversion rights were aligned with those of Class B‑1 and the broader series A convertible preferred stock. The conversion of Class B‑1, B‑2 and C common stock (and the series A, B and C preferred stock) into Class A common stock would increase the number of Class A shares outstanding, leading to voting dilution and potentially pressuring the market price of the existing Class A shares. Moreover, holders of these non‑Class A securities have limited but distinct voting rights on certain corporate actions, which can create divergent interests from Class A shareholders and affect governance dynamics.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "V_10k_2023.pdf",
          "target_page": 34,
          "pages": [
            32,
            33,
            34,
            35,
            36
          ]
        },
        "hop_2_rel": {
          "source_file": "V_10k_2024.pdf",
          "target_page": 59,
          "pages": [
            57,
            58,
            59,
            60,
            61
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 57820,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 14679,
        "completion_tokens": 201,
        "total_tokens": 14880
      }
    },
    {
      "question_id": 54,
      "question": "How has The Home Depot's approach to enhancing the ease of shopping experience evolved between 2023 and 2024, particularly in terms of digital and in-store capabilities?",
      "original_answer": "In 2023, The Home Depot focused on improving the ease of shopping experience by investing in mobile app-enabled store navigation, electronic shelf labels, reconfigured service desks, and enhanced self-checkout options. These efforts were aimed at improving store navigation, convenience, and checkout speed. By 2024, the company expanded its focus to include more personalized digital experiences, such as customer product review summaries and enhanced product content, while continuing to invest in digital platforms to improve navigation and 'shopability.' The 2024 strategy placed greater emphasis on leveraging customer data to meet personalized expectations, indicating a shift toward deeper integration of data-driven insights into the shopping journey.",
      "llm_answer": "The Home Depot has evolved its shopping experience between 2023 and 2024 by deepening its interconnected digital and in-store capabilities. It expanded omnichannel fulfillment (BOPIS, BODFS, BORIS, curbside pickup, and same-day/next-day delivery) and enhanced store navigation tools, mobile app features, and electronic shelf labels to streamline the customer journey. Simultaneously, it invested in associate productivity—through AI-powered inventory tools like Sidekick and Computer Vision, upgraded hdPhone devices, and labor optimization—to improve in-store service speed and product availability. These efforts collectively aim to create a seamless, personalized experience across all touchpoints, from online research to in-store checkout and delivery.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "HD_10k_2023.pdf",
          "target_page": 8,
          "pages": [
            6,
            7,
            8,
            9,
            10
          ]
        },
        "hop_2_rel": {
          "source_file": "HD_10k_2024.pdf",
          "target_page": 8,
          "pages": [
            6,
            7,
            8,
            9,
            10
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 52527,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 13355,
        "completion_tokens": 189,
        "total_tokens": 13545
      }
    },
    {
      "question_id": 54,
      "question": "How has the structure of the Target Corporation Long-Term Incentive Plan evolved from 2022 to 2024, particularly in terms of the specific forms of equity awards included under the plan?",
      "original_answer": "In 2022, the Long-Term Incentive Plan included forms such as Non-Qualified Stock Options, Restricted Stock Units, Performance-Based Restricted Stock Units, Performance Share Units, Price-Vested Stock Options, Non-Employee Director Non-Qualified Stock Options, and Non-Employee Director Restricted Stock Units. By 2024, the plan introduced new forms of equity awards, including the Cliff-Vested Restricted Stock Unit Agreement and the Performance Award Performance Share Unit Agreement, indicating an expansion in the types of equity compensation vehicles available under the plan.",
      "llm_answer": "From 2022 to 2024, the Target Corporation Long-Term Incentive Plan expanded its equity award types to include performance share units, performance-based restricted stock units, and cliff-vested restricted stock unit agreements, reflecting an evolution in the specific forms of equity compensation offered under the plan.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "TGT_10k_2022.pdf",
          "target_page": 68,
          "pages": [
            65,
            66,
            67,
            68,
            69
          ]
        },
        "hop_2_rel": {
          "source_file": "TGT_10k_2024.pdf",
          "target_page": 73,
          "pages": [
            71,
            72,
            73,
            74,
            75
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 9,
        "total_chars": 45916,
        "num_window_pages": 9,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 11709,
        "completion_tokens": 80,
        "total_tokens": 11789
      }
    },
    {
      "question_id": 54,
      "question": "How did Qulipta's commercial performance evolve from its FDA approval in 2021 through 2023, based on AbbVie's financial disclosures?",
      "original_answer": "Qulipta was approved by the FDA in September 2021 for the preventive treatment of episodic migraine in adults, marking its entry into the market. By 2023, Qulipta had generated $405 million in U.S. revenue and $3 million internationally, totaling $408 million. This indicates a significant commercial trajectory following its approval, especially considering it had no revenue in 2021 and only $158 million in U.S. revenue in 2022. The product demonstrated strong growth, suggesting robust market adoption and positioning within AbbVie's portfolio.",
      "llm_answer": "Based on AbbVie's financial disclosures in the provided 10-K filings, Qulipta's commercial performance evolved as follows from its 2021 FDA approval through 2023:  \n- **2021**: Qulipta generated no revenue (as indicated by \"$ -\" in the 2021 column for both U.S. and total net revenues).  \n- **2022**: U.S. net revenues surged to $158 million (>100% growth from 2021), with international revenues reaching $158 million (also >100% growth), reflecting strong market uptake following its 2021 approval for chronic migraine prevention.  \n- **2023**: Total net revenues exploded to over $100 million (exceeding 100% growth from 2022), driven by continued market share expansion, favorable pricing, and regulatory approvals in additional regions (e.g., EU approval in August 2023). This growth was explicitly cited as \"greater than 100%\" in AbbVie's 2023 financial disclosures, underscoring accelerating adoption post-launch.  \n\nThus, Qulipta transitioned from zero revenue in 2021 to becoming a rapidly growing, high-performing product within AbbVie's portfolio by 2023.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "ABBV_10k_2022.pdf",
          "target_page": 60,
          "pages": [
            58,
            59,
            60,
            61,
            62
          ]
        },
        "hop_2_rel": {
          "source_file": "ABBV_10k_2023.pdf",
          "target_page": 42,
          "pages": [
            40,
            41,
            42,
            43,
            44
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 9,
        "total_chars": 43072,
        "num_window_pages": 9,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 10985,
        "completion_tokens": 266,
        "total_tokens": 11251
      }
    },
    {
      "question_id": 55,
      "question": "How has Netflix's treatment and disclosure of the 2020 Stock Plan evolved between the 2022 and 2024 SEC filings, particularly in terms of its structural description and associated equity compensation activities?",
      "original_answer": "In 2022, the 2020 Stock Plan was referenced primarily through its inclusion in the exhibit list as a filed document (Def 14A, filed April 22, 2020), with no detailed description of its provisions or activities. In contrast, by 2024, the 2020 Stock Plan was not only explicitly described in detail but also linked to specific equity compensation activities, including the granting of incentive stock options, nonstatutory stock options, and restricted stock units (RSUs) with defined vesting schedules and performance-based criteria. This represents a significant shift from mere documentation to a more comprehensive disclosure of the plan's operational role in equity compensation.",
      "llm_answer": "Netflix’s equity compensation disclosures show a clear evolution between the 2022 and 2024 filings. The 2022 filing (2020 Stock Plan) described stock option and RSU grants under the plan, but the 2024 filing expands this to detail both RSU and performance‑based PSU awards, outlines the specific vesting conditions, and provides a more granular schedule of option activity, exercises, and remaining contractual terms. Additionally, the 2024 filing includes updated tables on granted options, vested shares, and the intrinsic value of exercised options, reflecting a more comprehensive disclosure of the equity compensation activities and the plan’s structural changes.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "NFLX_10k_2022.pdf",
          "target_page": 66,
          "pages": [
            63,
            64,
            65,
            66,
            67
          ]
        },
        "hop_2_rel": {
          "source_file": "NFLX_10k_2024.pdf",
          "target_page": 60,
          "pages": [
            58,
            59,
            60,
            61,
            62
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 51484,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 13108,
        "completion_tokens": 167,
        "total_tokens": 13275
      }
    },
    {
      "question_id": 55,
      "question": "How did the company's approach to aluminum purchase agreements evolve between 2022 and 2023, particularly in terms of their classification and strategic use of derivative instruments?",
      "original_answer": "In 2022, the company described its aluminum purchase agreements as derivative instruments entered into for long-term strategic sourcing objectives and non-U.S. business requirements. By 2023, the company continued to use these agreements but provided additional clarity that the quantities of aluminum in these contracts offset each other and are priced at prevailing market prices. This evolution indicates a more refined strategy around market pricing alignment and potentially reduced exposure through offsetting positions.",
      "llm_answer": "Between 2022 and 2023, the company's approach to aluminum purchase agreements remained consistent in that these agreements are classified as derivative instruments not receiving hedge accounting treatment, as explicitly stated in Note 19 and reiterated in Note 121. While the company continued to use aluminum derivative contracts for strategic sourcing and non-U.S. business requirements, the classification and accounting treatment did not change—these instruments were still not designated as hedges and were recorded at fair value through earnings, with no hedge accounting applied in either period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "BA_10k_2022.pdf",
          "target_page": 121,
          "pages": [
            119,
            120,
            121,
            122,
            123
          ]
        },
        "hop_2_rel": {
          "source_file": "BA_10k_2023.pdf",
          "target_page": 103,
          "pages": [
            101,
            102,
            103,
            104,
            105
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 43113,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 11010,
        "completion_tokens": 150,
        "total_tokens": 11160
      }
    },
    {
      "question_id": 55,
      "question": "How has the disclosure or treatment of the Directors' Code of Conduct evolved between 2023 and 2024, particularly in terms of its accessibility and scope?",
      "original_answer": "In 2023, the Directors' Code of Conduct was explicitly referenced and posted on the company's website at a specific URL: https://www.bnymellon.com/content/dam/bnymellon/documents/pdf/inv relations/directors-code-of-conduct.pdf. In 2024, the URL for the Directors' Code of Conduct changed to https://www.bny.com/content/dam/bnymellon/documents/pdf/investor-relations/directors-code-ofconduct.pdf, indicating a shift in how the document is categorized or accessed. Additionally, in 2024, the company introduced a new section titled 'INSIDER TRADING POLICIES AND PROCEDURES,' which was not present in 2023, suggesting an expanded focus on compliance mechanisms beyond the Code itself. These changes reflect a transformation in the presentation and accessibility of the Directors' Code of Conduct, as well as an increased emphasis on insider trading compliance.",
      "llm_answer": "The Directors' Code of Conduct was accessible via a dedicated URL on the company's website in both 2023 and 2024, with no indication of removal or relocation. However, the 2024 filing (page 13) explicitly states it will disclose amendments or waivers to the Directors' Code of Conduct on its website, whereas the 2023 filing (page 13) only mentioned such disclosures for the Code of Conduct relating to executive officers, not specifically for the Directors' Code of Conduct. The scope of the Directors' Code of Conduct remained consistent, applying to all directors, but its accessibility details were slightly more explicit in the 2024 filing regarding future disclosure practices.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "BK_10k_2023.pdf",
          "target_page": 13,
          "pages": [
            11,
            12,
            13,
            14,
            15
          ]
        },
        "hop_2_rel": {
          "source_file": "BK_10k_2024.pdf",
          "target_page": 13,
          "pages": [
            11,
            12,
            13,
            14,
            15
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 34739,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 8906,
        "completion_tokens": 170,
        "total_tokens": 9077
      }
    },
    {
      "question_id": 55,
      "question": "How has the structure and value of HD's 4.95% Senior Notes evolved between 2023 and 2024, and what does this indicate about the company's long-term debt strategy?",
      "original_answer": "In 2023, HD issued $750 million of 4.95% senior notes due September 30, 2026, at a discount of $1.6 million. By 2024, the carrying amount of these 4.95% senior notes due September 2026 was $747 million as of February 2, 2025, and the company also reported $980 million in 4.95% senior notes due September 2052. This indicates that while the original 2026 notes remained outstanding with only a slight reduction in carrying value, HD expanded its 4.95% senior note structure to a much longer maturity in 2052, suggesting a strategy of extending debt maturities and potentially locking in fixed interest rates over a longer horizon.",
      "llm_answer": "Between 2023 and 2024, the company issued a new tranche of 4.95% senior notes due June 25 2034 (the “2034 notes”) as part of its June 2024 debt issuance, adding $1.75 billion of long‑term debt at that fixed rate. This addition, together with the broader 2024 issuance of nine senior‑note tranches (including floating‑rate and longer‑dated fixed‑rate notes), reflects a strategic shift toward a more diversified and longer‑dated debt profile, extending maturities out to 2064 and reducing reliance on near‑term borrowings. Consequently, the company’s long‑term debt balance grew from $44.1 billion at the end of 2023 to $53.1 billion at the end of 2024, indicating a deliberate move to fund growth initiatives—such as the SRS acquisition—while managing interest‑rate risk through a mix of floating and fixed‑rate securities.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "HD_10k_2023.pdf",
          "target_page": 60,
          "pages": [
            58,
            59,
            60,
            61,
            62
          ]
        },
        "hop_2_rel": {
          "source_file": "HD_10k_2024.pdf",
          "target_page": 62,
          "pages": [
            60,
            61,
            62,
            63,
            64
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 52423,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 13329,
        "completion_tokens": 205,
        "total_tokens": 13535
      }
    },
    {
      "question_id": 55,
      "question": "How did Intel's financial treatment and valuation of its investment in Beijing Unisoc Technology Ltd. evolve between 2021 and 2023, particularly in terms of observable price adjustments and net book value?",
      "original_answer": "In 2021, Intel recognized $471 million in observable price adjustments in its investment in Beijing Unisoc Technology Ltd. By the end of 2023, Intel was accounting for its interest in Unisoc as a non-marketable equity security, with a net book value of $1.1 billion as of December 30, 2023 (the same as December 31, 2022). This indicates that while Intel continued to hold the investment without marketability, the valuation remained stable over the two-year period despite the earlier price adjustment.",
      "llm_answer": "Based on the provided SEC 10-K pages, Intel's investment in Beijing Unisoc Technology Ltd. (Unisoc) was accounted for as a non-marketable equity security. In 2021, Intel recognized $471 million in observable price adjustments to its investment in Unisoc, and as of December 30, 2023, the net book value of this investment was $1.1 billion (matching the $1.1 billion reported as of December 31, 2022). The document confirms no significant changes in the investment's valuation between 2022 and 2023, with the net book value remaining stable at $1.1 billion despite ongoing market conditions.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "INTC_10k_2022.pdf",
          "target_page": 43,
          "pages": [
            41,
            42,
            43,
            44,
            45
          ]
        },
        "hop_2_rel": {
          "source_file": "INTC_10k_2023.pdf",
          "target_page": 96,
          "pages": [
            94,
            95,
            96,
            97,
            98
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 42308,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 10812,
        "completion_tokens": 147,
        "total_tokens": 10960
      }
    },
    {
      "question_id": 55,
      "question": "How did AbbVie's engagement with Qulipta evolve from 2022 to 2023, particularly in terms of its regulatory and commercial development status?",
      "original_answer": "In 2022, Qulipta was part of a group of products that received regulatory approvals, leading to the reclassification of $1.0 billion of indefinite-lived research and development intangible assets to developed product rights. By 2023, AbbVie had introduced Qulipta with specific regulatory milestones: it received FDA approval in April 2023 for the preventive treatment of chronic migraine in adults and EC approval in August 2023 for the preventive treatment of migraine in adults with four or more migraine days per month. This evolution reflects a shift from asset reclassification to active regulatory and commercial advancement.",
      "llm_answer": "AbbVie’s engagement with Qulipta evolved from a regulatory milestone in 2023 to commercial launch later that year. In April 2023 the FDA approved Qulipta for the preventive treatment of chronic migraine, and by August 2023 the EC followed with a similar approval; the product then entered the market in January 2024 after the company submitted a Complete Response Resubmission for its NDA in December 2023. This progression reflects a shift from seeking regulatory clearance to actively commercializing Qulipta.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "ABBV_10k_2022.pdf",
          "target_page": 100,
          "pages": [
            98,
            99,
            100,
            101,
            102
          ]
        },
        "hop_2_rel": {
          "source_file": "ABBV_10k_2023.pdf",
          "target_page": 40,
          "pages": [
            38,
            39,
            40,
            41,
            42
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 43192,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 11018,
        "completion_tokens": 127,
        "total_tokens": 11146
      }
    },
    {
      "question_id": 56,
      "question": "How has Boeing's framing and strategic emphasis on 'upgrades and conversions' within the Global Services segment evolved between 2022 and 2023, based on the language used in the 10-K filings?",
      "original_answer": "In 2022, 'upgrades and conversions' were listed as part of a broader set of services under the Global Services segment, grouped alongside supply chain logistics, engineering, maintenance, spare parts, training systems, technical documents, and digital services. The description was general and lacked strategic framing. In 2023, while the service was still included, the context shifted subtly: it was now positioned within a more structured narrative that emphasized the full spectrum of sustaining aerospace platforms and systems, indicating a more integrated and strategic role within the segment. This evolution suggests a more deliberate positioning of 'upgrades and conversions' as a core capability rather than a general service offering.",
      "llm_answer": "Between 2022 and 2023, Boeing’s framing of “upgrades and conversions” within Global Services shifted from a general acknowledgment of its role in sustaining platforms to a more strategic emphasis on leveraging these capabilities to drive market share growth amid heightened competition. In the 2022 filing, the segment was described as providing services including “upgrades and conversions” as part of a broader service portfolio, while the 2023 filing explicitly tied these activities to competitive differentiation, stating BGS intends to “grow market share by leveraging a high level of customer satisfaction and productivity” through such offerings. This evolution reflects a deliberate strategic emphasis on upgrades and conversions as a key growth lever within Global Services, moving from operational description to a core competitive strategy.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "BA_10k_2022.pdf",
          "target_page": 5,
          "pages": [
            3,
            4,
            5,
            6,
            7
          ]
        },
        "hop_2_rel": {
          "source_file": "BA_10k_2023.pdf",
          "target_page": 3,
          "pages": [
            1,
            2,
            3,
            4,
            5
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 39812,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 10181,
        "completion_tokens": 213,
        "total_tokens": 10394
      }
    },
    {
      "question_id": 56,
      "question": "How did Intel's financial relationship with Beijing Unisoc Technology Ltd. evolve between 2021 and 2023, particularly in terms of the valuation and recognition of this investment?",
      "original_answer": "Intel's financial relationship with Beijing Unisoc Technology Ltd. remained consistent in terms of total net book value, which stayed at $1.1 billion as of both December 25, 2021 (from the 2022 filing) and December 30, 2023 (from the 2023 filing). However, in 2021, Intel recognized $471 million in observable price adjustments related to its investment in Unisoc, indicating a revaluation event during that year. This type of valuation adjustment was not explicitly mentioned in the 2023 filing, suggesting a stabilization of the investment's value over time or a lack of significant observable price changes in 2023 compared to 2021.",
      "llm_answer": "Between 2021 and 2023, Intel’s investment in Beijing Unisoc Technology Ltd. remained classified as a non‑marketable equity security. In 2021 the company recorded a $471 million observable price adjustment to the investment, and by the end of 2023 the net book value of the holding was $1.1 billion (up from $1.1 billion as of Dec 31 2022, having been $658 million as of Dec 26 2020). The investment is accounted for under the cost method, with no market‑based valuation adjustments reported beyond the initial price adjustment; consequently, its valuation is reflected only through the carrying amount on Intel’s balance sheet, which remained at $1.1 billion throughout 2023.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "INTC_10k_2022.pdf",
          "target_page": 52,
          "pages": [
            50,
            51,
            52,
            53,
            54
          ]
        },
        "hop_2_rel": {
          "source_file": "INTC_10k_2023.pdf",
          "target_page": 96,
          "pages": [
            94,
            95,
            96,
            97,
            98
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 54211,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 13782,
        "completion_tokens": 168,
        "total_tokens": 13950
      }
    },
    {
      "question_id": 57,
      "question": "How has the role of Self-Service Lockers evolved within Home Depot's interconnected shopping experience between 2023 and 2024?",
      "original_answer": "In 2023, Self-Service Lockers were described as part of Home Depot's investments to improve the customer shopping experience, specifically to enable convenient online order pickup options alongside other features like wayfinding signage and electronic shelf labels. By 2024, Self-Service Lockers were positioned more strategically as part of the company's broader fulfillment network, specifically referenced in the context of leveraging stores as 'convenient customer pickup, return, and delivery fulfillment locations' under interconnected retail programs such as BOSS, BOPIS, BODFS, and BORIS. Additionally, in 2024, approximately 50% of U.S. online orders were fulfilled through a store, highlighting a more integrated and operationally significant role for Self-Service Lockers in the fulfillment process. This reflects a shift from a convenience-focused feature to a core component of the omnichannel delivery strategy.",
      "llm_answer": "Between 2023 and 2024, Self-Service Lockers evolved from a convenience feature into a core component of Home Depot’s interconnected shopping experience, enabling seamless online order pickup and curbside service that bridges digital and physical channels. This integration supports the company’s broader strategy of unifying in-store, online, and job-site interactions—enhancing customer satisfaction, driving sales growth, and reinforcing the frictionless journey from inspiration to post-purchase support.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "HD_10k_2023.pdf",
          "target_page": 8,
          "pages": [
            6,
            7,
            8,
            9,
            10
          ]
        },
        "hop_2_rel": {
          "source_file": "HD_10k_2024.pdf",
          "target_page": 10,
          "pages": [
            8,
            9,
            10,
            11,
            12
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 50562,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 12854,
        "completion_tokens": 126,
        "total_tokens": 12980
      }
    },
    {
      "question_id": 57,
      "question": "How has the level of detail and specificity in Costco's disclosure regarding the estimation methods for Insurance/Self-insurance Liabilities evolved from 2023 to 2024?",
      "original_answer": "In 2023, Costco provided a general description of its self-insurance practices and risk management mechanisms, including the use of a captive insurance subsidiary and a reinsurance program, but did not specify the factors used in estimating liabilities. In 2024, the company significantly expanded its disclosure, detailing that liabilities are estimated using historical claims experience, demographic factors, severity factors, and other actuarial assumptions. Additionally, 2024's disclosure included a discussion of the unpredictability of claim costs and the potential for significant differences between actual and recorded liabilities, which was not present in 2023. This represents a meaningful increase in transparency and specificity.",
      "llm_answer": "The level of detail and specificity in Costco’s disclosures regarding estimation methods for Insurance/Self‑insurance Liabilities remained essentially consistent between 2023 and 2024. Both years describe the use of historical claims experience, demographic and severity factors, and other actuarial assumptions to estimate retained risk, noting that adjustments have historically been immaterial and that the methodology has not changed materially.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "COST_10k_2023.pdf",
          "target_page": 46,
          "pages": [
            44,
            45,
            46,
            47,
            48
          ]
        },
        "hop_2_rel": {
          "source_file": "COST_10k_2024.pdf",
          "target_page": 31,
          "pages": [
            29,
            30,
            31,
            32,
            33
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 36650,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 9388,
        "completion_tokens": 112,
        "total_tokens": 9501
      }
    },
    {
      "question_id": 57,
      "question": "How did the financial impact of the Aldevron acquisition on inventory-related costs evolve from 2022 to 2023?",
      "original_answer": "In 2022, the Aldevron acquisition contributed to a $59 million increase in cost of sales due to fair value adjustments to inventory. By 2023, this specific acquisition-related cost associated with Aldevron was no longer present; instead, a new $87 million charge emerged in the second quarter, primarily related to excess inventory in the Biotechnology segment due to reduced demand. This indicates a shift from acquisition-driven inventory adjustments to operational inventory challenges.",
      "llm_answer": "The financial impact of the Aldevron acquisition on inventory‑related costs shifted from a $59 million increase in cost of sales in 2021 (driven by fair‑value adjustments to inventory) to an $87 million charge in 2023 related to excess inventory, while the 2022 cost of sales rose primarily due to higher volumes and incremental acquisition‑related expenses. Consequently, inventory‑related cost pressures eased in 2023 compared with the prior two years.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "DHR_10k_2022.pdf",
          "target_page": 82,
          "pages": [
            80,
            81,
            82,
            83,
            84
          ]
        },
        "hop_2_rel": {
          "source_file": "DHR_10k_2023.pdf",
          "target_page": 46,
          "pages": [
            44,
            45,
            46,
            47,
            48
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 51391,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 13059,
        "completion_tokens": 113,
        "total_tokens": 13172
      }
    },
    {
      "question_id": 58,
      "question": "How has the treatment and recognition of shop card liabilities evolved between 2023 and 2024, and what does this indicate about Costco's approach to unclaimed balances?",
      "original_answer": "In both 2023 and 2024, Costco recognized revenue from shop cards upon redemption and accounted for outstanding balances as a liability, net of estimated breakage based on redemption data. However, the specific mention of 'estimated breakage' and the methodology tied to redemption data became more emphasized in 2024, indicating a more refined or formalized approach to tracking and accounting for unclaimed shop card balances. This evolution suggests Costco improved its estimation techniques for unclaimed balances, aligning its liability reporting more closely with actual redemption behavior over time.",
      "llm_answer": "The treatment of shop card liabilities remained consistent between 2023 and 2024, with the Company continuing to record outstanding shop card balances as a liability net of estimated breakage in other current liabilities. This consistent approach reflects Costco's disciplined accounting for unclaimed balances, recognizing revenue only upon redemption while systematically estimating and accounting for breakage based on historical redemption patterns. The lack of material changes indicates a stable, conservative approach to handling unclaimed shop card balances that aligns with their overall conservative financial reporting practices.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "COST_10k_2023.pdf",
          "target_page": 48,
          "pages": [
            46,
            47,
            48,
            49,
            50
          ]
        },
        "hop_2_rel": {
          "source_file": "COST_10k_2024.pdf",
          "target_page": 48,
          "pages": [
            46,
            47,
            48,
            49,
            50
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 42643,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 10887,
        "completion_tokens": 160,
        "total_tokens": 11047
      }
    },
    {
      "question_id": 58,
      "question": "How has Intel's Foundry Services offering evolved from 2022 to 2023 in terms of strategic partnerships and customer engagement, based on the specific initiatives and agreements mentioned in those years?",
      "original_answer": "In 2022, Intel introduced its Foundry Services as part of the IDM 2.0 strategy, emphasizing plans to build a world-class foundry business with differentiated offerings, including leading-edge packaging and process technology, committed capacity in the US and Europe, and a strong IP portfolio. By 2023, Intel had significantly advanced this offering by securing four design wins on Intel 18A, including a major high-performance computing customer, and five new design wins in advanced packaging, particularly for AI-related designs. Additionally, Intel expanded its IFS Accelerator Ecosystem Alliance program to over 40 strategic agreements and entered into multigenerational agreements with ARM and Synopsys to enable optimized SoC design on Intel 18A. These developments indicate a shift from strategic intent in 2022 to concrete customer engagements and ecosystem partnerships in 2023.",
      "llm_answer": "From 2022 to 2023, Intel's Foundry Services (IFS) evolved from a nascent offering into a strategically scaled business, marked by significant customer commitments and expanded partnerships. In 2022, IFS secured foundational agreements like the ARM and Synopsys collaborations and expanded its RAMP-C program with DoD, while 2023 saw accelerated momentum with four design wins on Intel 18A (including a major high-performance computing customer), five new advanced packaging design wins, and the commercial agreement with Tower for New Mexico analog manufacturing. This growth was underpinned by a doubling of the IFS Accelerator Ecosystem to over 40 partners and the culmination of its first phase of the RAMP-C program, positioning IFS as a differentiated foundry provider focused on advanced packaging and US/European capacity.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "INTC_10k_2022.pdf",
          "target_page": 9,
          "pages": [
            7,
            8,
            9,
            10,
            11
          ]
        },
        "hop_2_rel": {
          "source_file": "INTC_10k_2023.pdf",
          "target_page": 36,
          "pages": [
            34,
            35,
            36,
            37,
            38
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 34237,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 8793,
        "completion_tokens": 207,
        "total_tokens": 9000
      }
    },
    {
      "question_id": 58,
      "question": "How did the financial impact of DHR's relationship with Aldevron evolve between 2022 and 2023, particularly in terms of goodwill and net cash consideration?",
      "original_answer": "In 2022, DHR preliminarily recorded approximately $6.1 billion of goodwill related to the Aldevron Acquisition. By 2023, the net cash consideration for Aldevron increased to $9.561 billion, indicating a more detailed or revised financial assessment of the acquisition. This evolution shows a significant increase in the financial commitment to the Aldevron relationship, particularly in terms of cash outlay, beyond the initial goodwill estimate provided in 2022.",
      "llm_answer": "Based on the provided document pages, the financial impact of DHR's relationship with Aldevron evolved as follows:  \n- In 2023, DHR recorded approximately $6.1 billion of goodwill related to the Aldevron Acquisition (Page 83), with net cash consideration of $5.61 billion (Page 83).  \n- This contrasts with 2021, where DHR recorded $6.1 billion of goodwill and $9.56 billion of net cash consideration for the Aldevron Acquisition (Page 83), indicating a significant increase in both goodwill and cash outlay in 2023 compared to the 2021 transaction.  \n- The 2023 goodwill ($6.1 billion) and net cash consideration ($5.61 billion) reflect the acquisition's scale, though the 2023 transaction was financed primarily through cash on hand (Page 73), while the 2021 transaction utilized a mix of cash, debt, and equity (Page 73).  \n\n(Note: The document does not explicitly detail a *change* in the relationship between 2022 and 2023 beyond the 2023 acquisition activity, but the 2023 goodwill and cash consideration figures are directly contrasted with the 2021 data for context.)",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "DHR_10k_2022.pdf",
          "target_page": 83,
          "pages": [
            81,
            82,
            83,
            84,
            85
          ]
        },
        "hop_2_rel": {
          "source_file": "DHR_10k_2023.pdf",
          "target_page": 74,
          "pages": [
            72,
            73,
            74,
            75,
            76
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 50740,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 12908,
        "completion_tokens": 268,
        "total_tokens": 13176
      }
    },
    {
      "question_id": 59,
      "question": "How has the maturity date of the AT&T Inc. 1.800% Global Notes changed between the 2022 and 2024 SEC filings, and what does this indicate about the company's debt structure evolution?",
      "original_answer": "In the 2022 SEC filing, the AT&T Inc. 1.800% Global Notes were due on September 5, 2026. In the 2024 filing, the same class of notes is listed with a maturity date of September 14, 2039. This indicates a significant shift in the company's debt structure, extending the maturity of this particular note by over 13 years.",
      "llm_answer": "The maturity date of AT&T's 1.800% Global Notes shifted from September 5, 2026 in the 2022 filing to September 14, 2039 in the 2024 filing, reflecting a longer‑dated debt issuance. This extension indicates AT&T is deliberately lengthening the average maturity of its outstanding notes to better match financing needs and reduce near‑term refinancing pressure.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "T_10k_2022.pdf",
          "target_page": 2,
          "pages": [
            1,
            2,
            3,
            4,
            5
          ]
        },
        "hop_2_rel": {
          "source_file": "T_10k_2024.pdf",
          "target_page": 2,
          "pages": [
            1,
            2,
            3,
            4,
            5
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 42322,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 10806,
        "completion_tokens": 89,
        "total_tokens": 10896
      }
    },
    {
      "question_id": 59,
      "question": "How has Target's compliance with its debt leverage covenant evolved between 2023 and 2024, and what changes in credit facility structure may have influenced this compliance?",
      "original_answer": "In 2023, Target stated that it was, and expected to remain, in compliance with its debt leverage covenant, which was part of a $1.0 billion 364-day credit facility that would expire in October 2024, along with a $3.0 billion five-year facility expiring in October 2028. By 2024, Target had renewed its 364-day credit facility, extending its expiration to October 2025, while maintaining the same $3.0 billion five-year facility. The company continued to assert compliance with the debt leverage covenant. The renewal of the 364-day facility likely provided continued flexibility, supporting Target’s ability to remain compliant with the covenant.",
      "llm_answer": "Target's compliance with its debt‑leverage covenant remained strong throughout 2023‑2024, and the company continued to meet the covenant without triggering any breach.  The only structural change that could affect future compliance is the replacement of the prior 364‑day revolving credit facility with a new $1.0 billion facility (expiring October 2025) and the retention of the $3.0 billion facility expiring in October 2028; these facilities provide a liquidity backstop for the commercial‑paper program and support the company’s overall debt‑management strategy.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "TGT_10k_2023.pdf",
          "target_page": 54,
          "pages": [
            52,
            53,
            54,
            55,
            56
          ]
        },
        "hop_2_rel": {
          "source_file": "TGT_10k_2024.pdf",
          "target_page": 35,
          "pages": [
            33,
            34,
            35,
            36,
            37
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 38337,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 9811,
        "completion_tokens": 141,
        "total_tokens": 9953
      }
    },
    {
      "question_id": 59,
      "question": "How has Intel's approach to expanding digital readiness for global populations evolved from 2022 to 2023, particularly in relation to its RISE strategy and external collaboration initiatives?",
      "original_answer": "In 2022, Intel committed to expanding digital readiness through its RISE strategy, focusing on collaborative initiatives with other technology companies via the Alliance for Global Inclusion to create an Inclusion Index with unified goals and metrics. By 2023, this effort had matured into the publication of the third global inclusion index survey, which transitioned into an index system where organizations scoring 50% or higher were formally recognized. Intel was among the 18 recognized organizations out of 27 respondents, indicating a more structured and outcome-focused approach to digital readiness and inclusion. This evolution reflects a shift from establishing collaborative frameworks to measuring and recognizing performance against defined benchmarks.",
      "llm_answer": "From 2022 to 2023 Intel’s RISE strategy evolved from a broad sustainability framework into a more targeted, measurable agenda that explicitly ties digital‑readiness initiatives to its RISE goals.  The 2022 filing highlighted the expansion of supplier engagement and responsible‑minerals collaboration as part of RISE, while the 2023 report shows a concrete scaling‑up of those efforts—e.g., a larger supplier‑audit and capacity‑building program, new spending targets for women‑ and minority‑owned suppliers, and the launch of the Intel RISE Technology Initiative that funds projects on inclusive technology, carbon‑neutral computing, and AI‑driven health‑and‑safety solutions.  This progression reflects a shift from describing RISE as a strategic pillar to operationalizing it through expanded external collaborations (such as the Alliance for Global Inclusion and green‑bond funding) and linking its milestones to specific performance metrics like renewable‑energy use, Scope 3 emissions reductions, and digital‑readiness volunteer hour targets.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "INTC_10k_2022.pdf",
          "target_page": 15,
          "pages": [
            13,
            14,
            15,
            16,
            17
          ]
        },
        "hop_2_rel": {
          "source_file": "INTC_10k_2023.pdf",
          "target_page": 18,
          "pages": [
            16,
            17,
            18,
            19,
            20
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 51538,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 13116,
        "completion_tokens": 261,
        "total_tokens": 13378
      }
    },
    {
      "question_id": 60,
      "question": "How did Emerson's relationship with Micromine evolve between 2023 and 2024, and what financial implications were associated with this change?",
      "original_answer": "In 2023, Emerson (via its AspenTech subsidiary) entered into an agreement to acquire Micromine for AU$900 (approximately $623 USD), but later terminated the agreement due to uncertainty around Russian regulatory approval. This led to a mark-to-market gain of $24 in 2023 related to foreign currency forward contracts tied to the Micromine acquisition. By 2024, AspenTech had terminated all outstanding foreign currency forward contracts associated with the Micromine deal. The termination of the Micromine acquisition represented a shift from a strategic expansion effort in 2023 to a full withdrawal from the transaction, with no further financial commitments or exposures to Micromine reported in 2024.",
      "llm_answer": "Emerson sold its 40 % non‑controlling equity stake in Copeland to Blackstone for $1.5 billion in August 2024, generating a $539 pre‑tax gain ($435 after‑tax) that is reported in discontinued operations. The transaction also included the sale of the $2.25 billion note receivable for $1.9 billion, providing additional cash proceeds and eliminating the equity‑method losses that had been recorded in Other deductions. This divestiture marked the final exit from the Climate Technologies business and resulted in a substantial one‑time gain and cash inflow for the company.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "EMR_10k_2023.pdf",
          "target_page": 52,
          "pages": [
            50,
            51,
            52,
            53,
            54
          ]
        },
        "hop_2_rel": {
          "source_file": "EMR_10k_2024.pdf",
          "target_page": 55,
          "pages": [
            53,
            54,
            55,
            56,
            57
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 39265,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 10035,
        "completion_tokens": 142,
        "total_tokens": 10178
      }
    },
    {
      "question_id": 60,
      "question": "How did the availability of shares under The Home Depot's U.S. Employee Stock Purchase Plan (ESPP) and the average purchase price of shares during the fiscal year change from 2022 to 2023?",
      "original_answer": "In 2022, there were approximately 17 million shares available under the U.S. ESPP, and associates purchased approximately one million shares at an average price of $305.14. In 2023, the number of shares available under the U.S. ESPP decreased to 15 million, and associates again purchased approximately one million shares, but at a lower average price of $277.19. This indicates a reduction in share availability and a notable decrease in the average purchase price during the fiscal year.",
      "llm_answer": "The Home Depot's U.S. Employee Stock Purchase Plan (ESPP) had approximately 15 million shares available at the end of fiscal 2023, compared with about 17 million shares available at the end of fiscal 2022.  During fiscal 2023, roughly 1 million shares were purchased under the ESPP at an average price of $277.19, whereas in fiscal 2022 the company reported about 1 million shares purchased at an average price of $305.14.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "HD_10k_2022.pdf",
          "target_page": 70,
          "pages": [
            68,
            69,
            70,
            71,
            72
          ]
        },
        "hop_2_rel": {
          "source_file": "HD_10k_2023.pdf",
          "target_page": 68,
          "pages": [
            66,
            67,
            68,
            69,
            70
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 43115,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 11009,
        "completion_tokens": 105,
        "total_tokens": 11114
      }
    },
    {
      "question_id": 60,
      "question": "How has the pattern of impairment triggers and associated charges across DHR's business segments evolved between the 2022 and 2023 filings, and what does this indicate about shifting risks in its intangible asset portfolio?",
      "original_answer": "In the 2022 filing, DHR reported impairment triggers only in the Diagnostics segment during the first quarter of 2021, resulting in a $10 million impairment charge. In contrast, the 2023 filing identified impairment triggers in multiple segments: the Biotechnology segment in the second quarter of 2023, the Diagnostics and Biotechnology segments in the fourth quarter of 2023, and again in the Diagnostics segment in the first quarter of 2021 (which was included for comparative purposes). The impairment charges increased significantly, from $10 million in 2021 (reported in the 2022 filing) to $77 million in 2023 (reported in the 2023 filing). This indicates a notable expansion in both the scope and magnitude of impairment activity, particularly affecting the Biotechnology segment in 2023, which was not previously a focus of impairment events. This evolution suggests growing risks in DHR’s intangible asset portfolio, especially in its Biotechnology segment.",
      "llm_answer": "The pattern of impairment triggers and associated charges shifted notably between 2022 and 2023, reflecting evolving risks in Danaher’s intangible asset portfolio. In 2022, impairment charges totaled $77 million, primarily triggered in the second quarter of 2023 across the Biotechnology, Diagnostics and Biotechnology segments, whereas in 2021 the Company recorded only $10 million of impairment charges, linked to triggers in the first quarter of 2021 within the Diagnostics segment. This increase indicates a heightened risk of asset overvaluation, especially in finite‑lived intangibles such as technology and customer relationships, prompting more frequent testing and larger write‑downs as market conditions and segment performance changed.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "DHR_10k_2022.pdf",
          "target_page": 100,
          "pages": [
            98,
            99,
            100,
            101,
            102
          ]
        },
        "hop_2_rel": {
          "source_file": "DHR_10k_2023.pdf",
          "target_page": 89,
          "pages": [
            87,
            88,
            89,
            90,
            91
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 54732,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 13923,
        "completion_tokens": 186,
        "total_tokens": 14110
      }
    },
    {
      "question_id": 61,
      "question": "How did the value of outstanding letters of credit related to trade contracts change between 2022 and 2023, and what does this indicate about the company's involvement in business transactions tied to trade contracts?",
      "original_answer": "The value of outstanding letters of credit related to trade contracts increased from $362 million in 2022 to $598 million in 2023. This significant increase indicates a growing involvement or expansion in business activities tied to trade contracts during this period.",
      "llm_answer": "The outstanding letters of credit related to trade contracts decreased from $362 million in 2022 to $598 million in 2023, reflecting an increase in the company’s exposure to trade‑related commitments. This rise suggests that Home Depot is becoming more involved in business transactions tied to trade contracts, likely to support its expanded supply‑chain and distribution activities.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "HD_10k_2022.pdf",
          "target_page": 70,
          "pages": [
            68,
            69,
            70,
            71,
            72
          ]
        },
        "hop_2_rel": {
          "source_file": "HD_10k_2023.pdf",
          "target_page": 69,
          "pages": [
            67,
            68,
            69,
            70,
            71
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 43447,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 11099,
        "completion_tokens": 96,
        "total_tokens": 11195
      }
    },
    {
      "question_id": 61,
      "question": "How has the status of the 0.300% Notes due 2028 evolved between the 2023 and 2024 SEC filings, and what does this indicate about IBM's financial instruments disclosures?",
      "original_answer": "In the 2023 filing, the 0.300% Notes due 2028 were disclosed as part of IBM's instruments defining the rights of holders, with specific reference to Exhibit 4.1, filed on February 10, 2020. In the 2024 filing, the 0.300% Notes due 2028 are listed as actively issued financial instruments under the trading symbol IBM28B, registered on the New York Stock Exchange. This indicates a shift from merely disclosing the existence of the instrument in 2023 to formally recognizing it as an actively traded financial instrument in 2024, suggesting increased market engagement or liquidity for this instrument.",
      "llm_answer": "The 0.300% Notes due 2028 were listed among IBM’s outstanding debt securities in both the 2023 and 2024 Form 10‑K filings, confirming that the issue remains part of IBM’s capital structure and continues to be disclosed in the company’s periodic reports. This consistent inclusion indicates that IBM maintains transparent, ongoing disclosures of its long‑term debt instruments across filing periods.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "IBM_10k_2023.pdf",
          "target_page": 20,
          "pages": [
            18,
            19,
            20,
            21,
            22
          ]
        },
        "hop_2_rel": {
          "source_file": "IBM_10k_2024.pdf",
          "target_page": 1,
          "pages": [
            1,
            2,
            3,
            4,
            5
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 56209,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 14277,
        "completion_tokens": 99,
        "total_tokens": 14376
      }
    },
    {
      "question_id": 62,
      "question": "How has IBM's treatment of the 1.750% Notes due 2031 evolved between 2023 and 2024, particularly in terms of disclosure and registration on stock exchanges?",
      "original_answer": "In 2023, IBM disclosed the 1.750% Notes due 2031 in its 10-K filing, indicating that the instrument defining the rights of the holders was incorporated by reference as part of an exhibit filed on January 30, 2019. By 2024, the 1.750% Notes due 2031 were not only still referenced but also explicitly registered under a trading symbol (IBM31) on the New York Stock Exchange, reflecting a shift from mere disclosure to formal recognition and active listing on a financial market platform.",
      "llm_answer": "Between 2023 and 2024 IBM’s disclosure and registration of the 1.750% Notes due 2031 shifted from being referenced only in the 2023 10‑K’s “Exhibits” section (where the 1.750% Notes due 2031 were listed among the debt instruments incorporated by reference in 2022‑2023 filings) to being explicitly included in the 2024 registration table of securities on page 1 of the 2024 10‑K, where it appears alongside other IBM notes with their ticker symbols (e.g., IBM31 for the 1.750% Notes due 2031) and is identified as being listed on the New York Stock Exchange. This change reflects a more prominent disclosure of the 2031 notes in the 2024 filing, moving them from a generic exhibit reference to a specific, exchange‑listed security.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "IBM_10k_2023.pdf",
          "target_page": 20,
          "pages": [
            18,
            19,
            20,
            21,
            22
          ]
        },
        "hop_2_rel": {
          "source_file": "IBM_10k_2024.pdf",
          "target_page": 1,
          "pages": [
            1,
            2,
            3,
            4,
            5
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 56209,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 14274,
        "completion_tokens": 182,
        "total_tokens": 14456
      }
    },
    {
      "question_id": 62,
      "question": "How did Eli Lilly's financial relationship with Zyprexa evolve between 2023 and 2024, particularly in terms of revenue recognition and business model approach?",
      "original_answer": "In 2023, Eli Lilly generated $1.45 billion from the sale of the rights for the olanzapine portfolio, including Zyprexa, outside the U.S., indicating a direct revenue stream from product sales. By 2024, the company no longer reported Zyprexa as part of product sales; instead, revenue from the 2023 sale of rights was included in collaboration and other arrangements revenue, signaling a shift from direct product sales to revenue recognition through licensing and collaboration agreements. This change reflects a transformation in the financial relationship from active product sales to post-sale royalty or profit-sharing arrangements.",
      "llm_answer": "Based on the provided SEC 10-K filings, Eli Lilly's financial relationship with Zyprexa (an olanzapine-based product) evolved significantly between 2023 and 2024, particularly concerning revenue recognition and business model shifts. In 2023, revenue from Zyprexa was primarily driven by the sale of the olanzapine portfolio rights (including Zyprexa) to a third party, resulting in a one-time revenue recognition of $1.69 billion outside the U.S. (page 47), which was explicitly noted as part of collaboration and other revenue. This transaction, along with the sale of rights to other products like Baqsimi, contributed to a 23% increase in gross margin in 2023, as the absence of COVID-19 antibody revenue and the olanzapine rights sale improved realized pricing and margin structure (page 49). By 2024, Zyprexa itself no longer generated revenue as a product; instead, its revenue was fully replaced by the one-time gain from the portfolio rights sale in 2023, and subsequent revenue recognition for related products (like Olumiant, which includes baricitinib sales under the olanzapine portfolio framework) was reported under \"Other products\" with no specific Zyprexa revenue line item. The company's revenue model shifted from recognizing product sales of Zyprexa to recognizing one-time gains from intellectual property asset sales, with no ongoing product revenue from Zyprexa itself. Revenue recognition for such collaborations and IP sales was governed by the company's policy of recognizing revenue when control transfers or when the product has no alternative use, and the 2023 rights sale was treated as a collaboration arrangement revenue component (page 63). Thus, the financial relationship with Zyprexa transitioned from ongoing product sales to a one-time revenue event, with no material revenue from Zyprexa in 2024, and the business model moved toward leveraging IP rights sales as a strategic revenue source rather than product sales.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "LLY_10k_2023.pdf",
          "target_page": 47,
          "pages": [
            45,
            46,
            47,
            48,
            49
          ]
        },
        "hop_2_rel": {
          "source_file": "LLY_10k_2024.pdf",
          "target_page": 64,
          "pages": [
            62,
            63,
            64,
            65,
            66
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 48167,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 12265,
        "completion_tokens": 488,
        "total_tokens": 12754
      }
    },
    {
      "question_id": 63,
      "question": "How did the treatment and financial impact of the Mobility Preferred Interests evolve from 2023 to 2024, particularly in terms of redemption obligations and their effect on earnings per share calculations?",
      "original_answer": "In 2023, AT&T reclassified the Mobility Preferred Interests from equity to a liability due to the certainty of redemption, recording $2,670 in current liabilities and $2,670 in noncurrent liabilities. The company ultimately repurchased all remaining interests in April 2023 for $5,414, including accrued distributions. By 2024, the Mobility Preferred Interests were fully retired, and the focus shifted to their impact on earnings per share calculations, where under ASU 2020-06, the ability to settle these interests in stock was reflected in the diluted earnings per share computation for periods prior to the repurchase. This indicates a shift from active financial obligations to retrospective accounting treatment.",
      "llm_answer": "The Mobility Preferred Interests were fully repurchased in April 2023, eliminating any outstanding redemption obligations; consequently, no liability for these interests remained on the balance sheet at December 31 2023, and they had no impact on earnings‑per‑share calculations thereafter. Prior to the repurchase, the interests were re‑classified from equity to a liability at fair value, with the redemption price paid in cash (or AT&T stock) and recorded as a current liability, and the difference between fair value and carrying value was charged to additional paid‑in capital, which affected diluted EPS only while the interests were outstanding.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "T_10k_2023.pdf",
          "target_page": 90,
          "pages": [
            88,
            89,
            90,
            91,
            92
          ]
        },
        "hop_2_rel": {
          "source_file": "T_10k_2024.pdf",
          "target_page": 53,
          "pages": [
            51,
            52,
            53,
            54,
            55
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 67381,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 17079,
        "completion_tokens": 163,
        "total_tokens": 17242
      }
    },
    {
      "question_id": 63,
      "question": "How has IBM's treatment and disclosure of the 0.875% Notes due 2030 evolved between 2023 and 2024, particularly in terms of its listing and registration status?",
      "original_answer": "In 2023, the 0.875% Notes due 2030 were disclosed as part of a list of instruments incorporated by reference to Exhibit 4.1 to Form 8-K filed on February 8, 2022. By 2024, the 0.875% Notes due 2030 were explicitly listed in the table of registered securities with a trading symbol (IBM30A) and registered on the New York Stock Exchange. This indicates a shift from a referenced disclosure to a fully listed and registered financial instrument.",
      "llm_answer": "Based on the provided SEC filing excerpts, IBM's treatment and disclosure of the 0.875% Notes due 2030 shows a consistent pattern of listing and registration across multiple filings. The notes are explicitly identified in the 2024 Form 10-K (page 1) as part of the \"Securities registered pursuant to Section 12(b) of the Act\" table, where they are listed as \"0.875% Notes due 2030\" with the trading symbol \"IBM30A\" on the New York Stock Exchange. This confirms their active listing and registration status. The 2023 filing (page 21) references the \"instruments defining the rights of the holders of the 0.875% Notes due 2030\" as part of a February 8, 2022 Form 8-K filing, indicating the registration was previously established and remains referenced in ongoing disclosures. Thus, there is no evidence of a change in listing status or registration between 2023 and 2024; the notes have been consistently listed and registered as part of IBM's long-term debt instruments.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "IBM_10k_2023.pdf",
          "target_page": 20,
          "pages": [
            18,
            19,
            20,
            21,
            22
          ]
        },
        "hop_2_rel": {
          "source_file": "IBM_10k_2024.pdf",
          "target_page": 1,
          "pages": [
            1,
            2,
            3,
            4,
            5
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 56209,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 14275,
        "completion_tokens": 242,
        "total_tokens": 14517
      }
    },
    {
      "question_id": 64,
      "question": "How did the structure and distribution terms of the Telco Preferred Interests evolve from 2023 to 2024, and what does this indicate about AT&T's approach to financing through preferred equity instruments?",
      "original_answer": "In 2023, the Telco Preferred Interests consisted of $2,000 of Class A-1 preferred interests issued in September 2020, paying a 4.25% annual distribution, and $5,250 of Class A-2 and A-3 preferred interests issued in April 2023, paying a 6.85% annual distribution. By 2024, the total Telco Preferred Interests had grown to $7,250, with the Class A-1 preferred interests still at 4.25% and the Class A-2 and A-3 interests remaining at 6.85%, both subject to reset every seven years. Additionally, in 2024, AT&T clarified that failure to pay distributions would not restrict cash movements or its ability to pay dividends or repurchase shares. The structure remained consistent in terms of redemption rights and noncontrolling interest classification, but the expansion of the instrument in 2024 suggests a continued reliance on preferred equity as a financing strategy.",
      "llm_answer": "The Telco LLC preferred interests evolved from a 2020 issuance of $2 billion of cumulative preferred equity (Telco Class A‑1) that paid a 4.25 % distribution and reset every seven years, to a 2023 expansion adding $5.25 billion of Class A‑2 and A‑3 interests at a 6.85 % rate with a reset in 2027, and then in October 2024 AT&T authorized an additional $2.25 billion of Class A‑4 interests paying a higher 5.94 % distribution that resets in 2028. This progression shows AT&T’s strategy of layering preferred equity with escalating distribution rates and staggered reset periods to fund subsidiary growth while retaining flexibility to call or redeem the securities, indicating a deliberate use of preferred equity as a financing tool that can be adjusted to market conditions and capital‑allocation priorities.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "T_10k_2023.pdf",
          "target_page": 91,
          "pages": [
            89,
            90,
            91,
            92,
            93
          ]
        },
        "hop_2_rel": {
          "source_file": "T_10k_2024.pdf",
          "target_page": 87,
          "pages": [
            85,
            86,
            87,
            88,
            89
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 69569,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 17626,
        "completion_tokens": 202,
        "total_tokens": 17828
      }
    },
    {
      "question_id": 64,
      "question": "How has Capital One's involvement in multifamily commercial real estate loans evolved between 2022 and 2023, particularly in terms of risk exposure under loss sharing agreements with government-sponsored enterprises?",
      "original_answer": "In 2022, Capital One originated multifamily commercial real estate loans with the intent to sell them to GSEs, entering into loss sharing agreements, which resulted in a liability of $82 million. By 2023, the company continued this practice but the liability recognized on the consolidated balance sheets for these loss sharing agreements increased to $137 million, indicating a significant increase in risk exposure. This evolution reflects a growing involvement in these types of loans and a corresponding rise in the financial obligations tied to their loss sharing agreements.",
      "llm_answer": "Capital One’s exposure to multifamily commercial real‑estate loans is managed through loss‑sharing agreements with government‑sponsored enterprises (GSEs).  Under these agreements the company originated multifamily loans that it subsequently sells to GSEs and shares any credit losses that may arise.  In 2022 the company recorded a liability of $82 million related to these loss‑sharing arrangements, and by the end of 2023 that liability had increased to $137 million, reflecting higher expected losses and the adoption of a fair‑value option for new loss‑sharing agreements entered into after January 1 2020.  The liability is recognized in other non‑interest income (or amortized into income as risk is released), and the amount of exposure has grown modestly from 2022 to 2023.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "COF_10k_2022.pdf",
          "target_page": 98,
          "pages": [
            96,
            97,
            98,
            99,
            100
          ]
        },
        "hop_2_rel": {
          "source_file": "COF_10k_2023.pdf",
          "target_page": 217,
          "pages": [
            215,
            216,
            217,
            218,
            219
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 48829,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 12446,
        "completion_tokens": 195,
        "total_tokens": 12642
      }
    },
    {
      "question_id": 64,
      "question": "How did Amazon's co-branded credit card programs shift in strategic significance and associated regulatory risks from 2022 to 2023, particularly in terms of new compliance obligations and their potential impact on operating results?",
      "original_answer": "In 2022, Amazon introduced co-branded credit card programs as part of its payment offerings, highlighting the risk that renewal on less favorable terms or termination could adversely affect operating results. The regulatory risks at that time included compliance with payment card association rules such as data security and certification requirements. By 2023, Amazon expanded its offerings and emphasized additional compliance obligations, including data localization rules, which were not mentioned in 2022. This indicates that the co-branded credit card programs became subject to a broader set of regulatory risks, particularly in international jurisdictions, which could increase compliance costs and operational complexity. The potential impact on operating results grew as Amazon now faced risks not only from traditional payment regulations but also from evolving data governance laws, particularly regarding cross-border data transfers tied to these credit card programs.",
      "llm_answer": "From 2022 to 2023 Amazon’s co‑branded credit‑card programs moved from a peripheral revenue stream to a more strategically significant source of payment‑related income, but this shift also introduced heightened regulatory exposure.  In the 2023 filing the company explicitly warns that renewal or continuation of these programs on less‑favorable terms—or their termination—could “adversely affect our operating results,” and it highlights new compliance obligations tied to payment‑card rules, data‑security standards, and evolving tax‑collection requirements for marketplace sellers.  Consequently, the programs now carry material compliance costs and potential liabilities that could materially dent Amazon’s earnings if regulatory pressures or contract renegotiations force unfavorable changes.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AMZN_10k_2022.pdf",
          "target_page": 13,
          "pages": [
            11,
            12,
            13,
            14,
            15
          ]
        },
        "hop_2_rel": {
          "source_file": "AMZN_10k_2023.pdf",
          "target_page": 14,
          "pages": [
            12,
            13,
            14,
            15,
            16
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 55026,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 13999,
        "completion_tokens": 199,
        "total_tokens": 14198
      }
    },
    {
      "question_id": 64,
      "question": "How has PM's financial relationship with RBH evolved between 2022 and 2024, particularly regarding the consolidation status and valuation considerations of RBH within PM's financial statements?",
      "original_answer": "In 2022, RBH was deconsolidated from PM's financial statements due to CCAA proceedings initiated in 2019, with its financial results excluded since that time. Additionally, PM faced potential material impacts from unresolved Canadian tobacco litigation, including a CAD 3.1 billion allocation of compensatory damages against RBH. By 2024, PM's relationship with RBH had evolved into holding an equity investment, which required impairment analysis. The audit process emphasized significant judgment around the fair value estimate of the investment, including assumptions on discount rates, sales volumes, operating margins, and the tax treatment of a potential global settlement. This reflects a shift from a deconsolidated subsidiary to a valued equity stake requiring ongoing impairment evaluation.",
      "llm_answer": "Between 2022 and 2024, PMI's financial relationship with RBH shifted from consolidation to deconsolidation following RBH's entry into Court‑Protection under Canada's Companies' Creditors Arrangement Act (CCAA) in March 2019, with RBH's results removed from PMI's consolidated balance sheets thereafter. The 2024 10‑K confirms that RBH remains under CCAA protection, its financial statements are no longer consolidated, and PMI recorded a $2.3 billion impairment charge on its equity investment in RBH after a court‑ordered objection to the proposed restructuring plan indicated potential impairment, reflecting the deconsolidated and uncertain valuation of RBH in PMI's financial statements.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "PM_10k_2022.pdf",
          "target_page": 113,
          "pages": [
            111,
            112,
            113,
            114,
            115
          ]
        },
        "hop_2_rel": {
          "source_file": "PM_10k_2024.pdf",
          "target_page": 148,
          "pages": [
            146,
            147,
            148,
            149,
            150
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 50540,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 12869,
        "completion_tokens": 172,
        "total_tokens": 13042
      }
    },
    {
      "question_id": 64,
      "question": "How did the financial performance and strategic positioning of Baqsimi evolve between 2023 and 2024, particularly in terms of revenue contribution and its role within LLY's product portfolio?",
      "original_answer": "In 2023, Baqsimi contributed $677.6 million in total revenue, with $645.7 million from the U.S. and $31.9 million from outside the U.S., indicating it was still a growing product within LLY's portfolio. By 2024, Baqsimi was no longer reported as a direct revenue contributor through product sales; instead, it was disclosed as part of a collaboration and other arrangements, specifically under the 2023 sale of rights. This shift suggests that LLY transitioned Baqsimi from an internally commercialized product to a divested asset, impacting its strategic focus and revenue model. The absence of Baqsimi from direct product revenue in 2024 reflects a significant change in its role and contribution to LLY's financials.",
      "llm_answer": "Between 2023 and 2024, Baqsimi’s revenue grew from $677.6 million (total) in 2023 to $645.7 million in U.S. sales plus $31.9 million outside the U.S. in 2023, reflecting its contribution as part of Lilly’s broader portfolio expansion; however, its standalone revenue share remains modest relative to blockbuster products such as Jardiance, Verzenio, and Mounjaro. Strategically, Baqsimi is positioned as a niche, high‑margin respiratory asset that bolsters Lilly’s diversified product mix, supporting overall revenue growth while complementing the company’s focus on high‑value, high‑impact therapies within its portfolio.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "LLY_10k_2023.pdf",
          "target_page": 48,
          "pages": [
            46,
            47,
            48,
            49,
            50
          ]
        },
        "hop_2_rel": {
          "source_file": "LLY_10k_2024.pdf",
          "target_page": 64,
          "pages": [
            62,
            63,
            64,
            65,
            66
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 47033,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 11990,
        "completion_tokens": 155,
        "total_tokens": 12145
      }
    },
    {
      "question_id": 65,
      "question": "How has the composition of Union Pacific's Total Highway Revenue Equipment changed from 2022 to 2024, particularly in terms of the ratio of owned versus leased containers and chassis?",
      "original_answer": "In 2022, Union Pacific owned 78,837 units and leased 16,004 units of Total Highway Revenue Equipment, with containers making up the majority of owned assets and chassis being heavily leased. By 2024, the company significantly reduced both owned and leased equipment, with owned units dropping to 50,731 and leased units to 1,485. The most notable change was in leased containers, which fell from 1,856 in 2022 to just 288 in 2024, and owned chassis decreased from 29,875 to 4,356. This indicates a strategic shift toward owning fewer assets and leasing even fewer, especially in chassis.",
      "llm_answer": "From 2022 to 2024, Union Pacific’s Total Highway Revenue Equipment composition shifted toward greater ownership of containers and chassis. In 2022, owned containers were 48,962 and leased were 1,856 (≈96% owned); by 2024, owned containers rose to 46,375 and leased dropped to 288 (≈99% owned), while owned chassis increased from 29,875 to 4,356 and leased fell from 14,148 to 1,197 (≈78% owned). This indicates a clear trend of increasing ownership and decreasing reliance on leased equipment across both container and chassis categories.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "UNP_10k_2022.pdf",
          "target_page": 24,
          "pages": [
            22,
            23,
            24,
            25,
            26
          ]
        },
        "hop_2_rel": {
          "source_file": "UNP_10k_2024.pdf",
          "target_page": 19,
          "pages": [
            17,
            18,
            19,
            20,
            21
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 9,
        "total_chars": 31391,
        "num_window_pages": 9,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 8077,
        "completion_tokens": 134,
        "total_tokens": 8212
      }
    },
    {
      "question_id": 65,
      "question": "How did Capital One's use of securitized debt obligations evolve between 2022 and 2023, particularly in terms of their role within the company's overall funding structure?",
      "original_answer": "In 2022, securitized debt obligations were explicitly described as one of the company's key funding sources alongside deposits, senior and subordinated notes, federal funds purchased, and FHLB advances. By 2023, while still present in the funding structure at $18.043 billion in carrying value, securitized debt obligations were categorized under Level 2 in the fair value hierarchy, indicating a shift toward more standardized valuation methods. This evolution suggests a more structured and possibly less volatile role for securitized debt obligations in Capital One's funding strategy.",
      "llm_answer": "Capital One’s use of securitized debt obligations grew modestly from 2022 to 2023, with the carrying value of securitized debt rising from $16.9 billion to $18.0 billion and its share of total funding increasing from roughly 4% to 5% of overall funding. This reflects continued reliance on securitizations as a source of liquidity, but the proportion remains small relative to the company’s dominant deposit base, which still provides the majority of funding.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "COF_10k_2022.pdf",
          "target_page": 67,
          "pages": [
            65,
            66,
            67,
            68,
            69
          ]
        },
        "hop_2_rel": {
          "source_file": "COF_10k_2023.pdf",
          "target_page": 210,
          "pages": [
            208,
            209,
            210,
            211,
            212
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 47982,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 12223,
        "completion_tokens": 114,
        "total_tokens": 12338
      }
    },
    {
      "question_id": 65,
      "question": "How did the nature of LLY's revenue from Zyprexa evolve between 2023 and 2024, particularly in terms of the source and recognition method of that revenue?",
      "original_answer": "In 2023, Zyprexa revenue was primarily derived from the sale of the rights for the olanzapine portfolio. By 2024, the revenue associated with Zyprexa was recognized as part of collaboration and other arrangements, specifically stemming from the 2023 sale of rights for the olanzapine portfolio, and was included in collaboration revenue rather than product sales. This reflects a shift in how Zyprexa-related revenue was categorized and recognized in 2024 compared to 2023.",
      "llm_answer": "The nature of LLY's revenue from Zyprexa evolved such that in 2023 it was included under \"collaboration and other revenue\" as part of the sale of the olanzapine portfolio rights, and by 2024 it was reclassified into \"net product revenue\" as part of the broader product sales, reflecting a shift from being treated as a one-time portfolio sale to ongoing product revenue. This transition is documented in Note 2 of the 2024 10-K, which states that revenue from Zyprexa (referenced as \"sale of the rights for the olanzapine portfolio\") was initially recorded in collaboration and other revenue in 2023, but by 2024 it was integrated into net product revenue as part of regular product sales. The revenue recognition method remained consistent as point-in-time sales at shipment, with no material changes to the underlying accounting policy.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "LLY_10k_2023.pdf",
          "target_page": 67,
          "pages": [
            65,
            66,
            67,
            68,
            69
          ]
        },
        "hop_2_rel": {
          "source_file": "LLY_10k_2024.pdf",
          "target_page": 64,
          "pages": [
            62,
            63,
            64,
            65,
            66
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 46486,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 11844,
        "completion_tokens": 209,
        "total_tokens": 12053
      }
    },
    {
      "question_id": 66,
      "question": "How has the valuation methodology and classification of Federal Government Securities in the pension plan evolved from 2022 to 2024?",
      "original_answer": "In 2022, Federal Government Securities were valued under the 'Significant Other Observable Inputs (Level 2)' category and totaled $742 million. By 2024, the company clarified that these securities are valued using a bid evaluation process with bid data from independent pricing sources and are explicitly classified as Level 2 investments. This reflects a continuation in classification but adds specificity in methodology explanation.",
      "llm_answer": "The valuation methodology for Federal Government Securities remained consistent as Level 2 fair‑value measurements using a bid‑evaluation process with independent pricing sources, but the classification and target allocation shifted as the plan’s overall strategy evolved. In 2022 the plan targeted a 45%–55% split between equity and debt, with debt representing about 42% of assets and Federal Government Securities held at roughly 742 million (Level 2). By 2024 the target allocation moved to a 70%–80% debt weighting, and the debt portfolio’s average credit rating improved to AA‑ while the expected long‑term return on assets was lowered from 6.25% to 5.25%, reflecting a more conservative, de‑risking approach that increased the relative importance of Federal Government Securities within the plan.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "UNP_10k_2022.pdf",
          "target_page": 72,
          "pages": [
            70,
            71,
            72,
            73,
            74
          ]
        },
        "hop_2_rel": {
          "source_file": "UNP_10k_2024.pdf",
          "target_page": 56,
          "pages": [
            54,
            55,
            56,
            57,
            58
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 9,
        "total_chars": 42472,
        "num_window_pages": 9,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 10835,
        "completion_tokens": 200,
        "total_tokens": 11035
      }
    },
    {
      "question_id": 66,
      "question": "How did Capital One's credit score data utilization for product segmentation decisions evolve from 2022 to 2023, and what does this indicate about their credit risk modeling strategy?",
      "original_answer": "In 2022, Capital One used credit score data for product segmentation decisions based on historical credit score distributions from 2020 to 2021, as shown in Table 21. In 2023, the company updated its data to reflect credit score distributions from 2022 to 2023 in the same table. This shift indicates a more current and dynamic credit risk modeling strategy, with product segmentation decisions being informed by the most recent borrower behavior and risk profiles, suggesting a proactive approach to managing credit risk in evolving economic conditions.",
      "llm_answer": "From 2022 to 2023 Capital One shifted from using refreshed FICO scores (69% > 660 in 2022) to a slightly lower share of high‑score cards (68% > 660 in 2023), while the proportion of sub‑prime (≤ 660) balances rose modestly (31 → 32%). The company continues to leverage credit‑score data for subprime classification, benchmarking and product segmentation, indicating that its credit‑risk modeling still relies on borrower credit scores as a key input for segmentation and risk assessment, but with a marginally higher emphasis on lower‑score segments in 2023.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "COF_10k_2022.pdf",
          "target_page": 103,
          "pages": [
            101,
            102,
            103,
            104,
            105
          ]
        },
        "hop_2_rel": {
          "source_file": "COF_10k_2023.pdf",
          "target_page": 95,
          "pages": [
            93,
            94,
            95,
            96,
            97
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 46819,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 11935,
        "completion_tokens": 139,
        "total_tokens": 12075
      }
    },
    {
      "question_id": 66,
      "question": "How has Amazon's strategic positioning of AWS evolved from 2022 to 2023 in terms of its role within the company's broader business segments and investment priorities?",
      "original_answer": "In 2022, AWS was positioned primarily as a key area of investment within Amazon's broader technology and content spending, with an emphasis on supporting geographic expansion, new product categories, and internal operational efficiencies. The document highlighted that Amazon was investing in AWS alongside initiatives to build and deploy innovative software and electronic devices, indicating a strategic alignment with internal growth and infrastructure enhancement. By 2023, AWS had evolved into one of Amazon's three core business segments—alongside North America and International—reflecting its elevated strategic importance. The 2023 filing explicitly states that AWS serves developers and enterprises by offering a broad set of on-demand technology services, including compute, storage, database, analytics, and machine learning, and is now a distinct and central pillar of Amazon’s business model. This shift demonstrates a transformation in AWS's role from a strategic investment area to a standalone, mission-critical business segment.",
      "llm_answer": "From 2022 to 2023, AWS transitioned from being described primarily as a technology‑infrastructure investment that supports the broader retail and consumer businesses to a distinct, strategic growth pillar within Amazon’s portfolio. The 2023 filing explicitly positions AWS as a separate segment with its own leadership (CEO Adam Selipsky) and highlights continued heavy capital spending on AWS‑related technology infrastructure, while earlier 2022 commentary framed AWS mainly as a cost‑saving, efficiency‑driving service for the company’s overall operations. Consequently, investment priorities shifted toward expanding AWS’s service breadth (compute, storage, database, analytics, machine‑learning) and scaling global data‑center capacity, reflecting a deliberate focus on growing AWS as a standalone revenue and profit driver rather than a supporting function.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AMZN_10k_2022.pdf",
          "target_page": 19,
          "pages": [
            17,
            18,
            19,
            20,
            21
          ]
        },
        "hop_2_rel": {
          "source_file": "AMZN_10k_2023.pdf",
          "target_page": 3,
          "pages": [
            1,
            2,
            3,
            4,
            5
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 46450,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 11837,
        "completion_tokens": 215,
        "total_tokens": 12053
      }
    },
    {
      "question_id": 66,
      "question": "How has Philip Morris International's financial relationship with Rothmans, Benson & Hedges Inc. (RBH) evolved between 2022 and 2024, particularly in terms of its accounting treatment and potential financial exposure?",
      "original_answer": "In 2022, RBH was deconsolidated from Philip Morris International’s financial statements due to its CCAA restructuring, and its financial results were no longer included in PMI’s consolidated financials. At that time, there was a comprehensive stay of Canadian tobacco litigation until March 31, 2022, and no loss accruals were made due to the inability to estimate potential losses. By 2024, PMI’s relationship with RBH had shifted from deconsolidation to an equity investment model. A proposed settlement of CAD 32.5 billion in the Canadian tobacco litigation emerged, prompting PMI to assess its investment in RBH for impairment. As a result, PMI recorded a non-cash impairment charge of $2,316 million in 2024, reflecting a decline in the estimated fair value of its investment. This marks a significant evolution from a deconsolidated entity with uncertain liabilities to a recognized equity investment with a quantified impairment.",
      "llm_answer": "Between 2022 and 2024, PMI’s financial relationship with Rothmans, Benson & Hedges Inc. (RBH) underwent a material transformation due to the ongoing CCAA restructuring and the resolution of long-standing Canadian tobacco litigation. Following RBH’s entry into CCAA protection in March 2019, its financial results were deconsolidated from PMI’s consolidated statements, and a comprehensive stay of all Canadian tobacco-related litigation—including the $15.5 billion class action judgment against RBH—was in effect until March 2022. Although the stay expired, the legal exposure remained unresolved until PMI recorded a $2.3 billion non-cash impairment charge in December 2024 related to its equity investment in RBH, reflecting uncertainty over the allocation of a proposed CAD 32.5 billion settlement. This impairment, tied to the CCAA-mediated resolution process, underscores the material financial risk PMI faces from its historical association with RBH, despite no accrued liabilities being recorded in its consolidated financial statements for the pending cases.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "PM_10k_2022.pdf",
          "target_page": 113,
          "pages": [
            111,
            112,
            113,
            114,
            115
          ]
        },
        "hop_2_rel": {
          "source_file": "PM_10k_2024.pdf",
          "target_page": 30,
          "pages": [
            28,
            29,
            30,
            31,
            32
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 9,
        "total_chars": 40277,
        "num_window_pages": 9,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 10308,
        "completion_tokens": 266,
        "total_tokens": 10574
      }
    },
    {
      "question_id": 66,
      "question": "How has the commercial significance of Biktarvy evolved for GILD from 2022 to 2024, considering both its revenue contribution and associated product risks?",
      "original_answer": "In 2022, Biktarvy was a major revenue driver for GILD, generating $8,624 million in total product sales globally, indicating its strong market position in the HIV treatment segment. By 2024, while specific revenue figures are not provided, the company's risk disclosures highlight Biktarvy's ongoing importance but also emphasize heightened risks related to the HIV product class, particularly concerning the reliance on TAF-based therapies and potential shifts in treatment paradigms. This evolution suggests that although Biktarvy remains central to GILD's revenue, its commercial outlook has become more vulnerable to competitive and regulatory pressures.",
      "llm_answer": "From 2022 to 2024, Biktarvy’s commercial significance for GILD declined markedly. In 2022, it generated $8.6 billion in total revenue (≈ $7.0 billion in the U.S.), but by 2024 its sales had fallen to $5.57 billion overall ($3.64 billion in the U.S.), reflecting reduced market share and heightened competition. This revenue drop is compounded by product‑specific risks: Biktarvy relies on tenofovir alafenamide, a nucleoside backbone that could lose relevance if HIV treatment paradigms shift, and it faces intensified pricing pressure and reimbursement constraints from government programs such as the Inflation Reduction Act. Consequently, while still a major contributor to HIV sales, Biktarvy’s growth prospects are now limited by both market saturation and evolving clinical and regulatory risks.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "GILD_10k_2022.pdf",
          "target_page": 70,
          "pages": [
            68,
            69,
            70,
            71,
            72
          ]
        },
        "hop_2_rel": {
          "source_file": "GILD_10k_2024.pdf",
          "target_page": 18,
          "pages": [
            16,
            17,
            18,
            19,
            20
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 80533,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 20356,
        "completion_tokens": 200,
        "total_tokens": 20556
      }
    },
    {
      "question_id": 67,
      "question": "How has Union Pacific Railroad's financial stake and operational relationship with TTX evolved from 2022 to 2024, particularly in terms of investment value and car hire expenses?",
      "original_answer": "Union Pacific Railroad's financial stake in TTX increased from $1.6 billion in 2021 (referenced in the 2022 filing) to $1.9 billion in 2024. Additionally, UPRR's car hire expenses rose from $375 million in 2021 to $432 million in 2024. These increases indicate a growing financial and operational involvement with TTX over the period.",
      "llm_answer": "From 2022 to 2024 Union Pacific’s stake in TTX remained roughly constant at about a 36‑37 % economic and voting interest, and it continues to account for the investment in TTX under the equity‑method.  Consequently, the value of that investment (reported as $1.9 billion in 2024 and $1.8 billion in 2023) has been essentially unchanged, and the associated car‑hire expense—recorded in equipment and other rents—has risen modestly, from $375 million in 2021 to $432 million in 2024.  This reflects the ongoing operational relationship with TTX but does not indicate a material change in Union Pacific’s financial stake.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "UNP_10k_2022.pdf",
          "target_page": 89,
          "pages": [
            86,
            87,
            88,
            89,
            90
          ]
        },
        "hop_2_rel": {
          "source_file": "UNP_10k_2024.pdf",
          "target_page": 68,
          "pages": [
            66,
            67,
            68,
            69,
            70
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 40027,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 10235,
        "completion_tokens": 154,
        "total_tokens": 10389
      }
    },
    {
      "question_id": 67,
      "question": "How did Tesla's approach to scaling Solar Roof production change from 2022 to 2023, particularly regarding installer training initiatives and supply chain risk management?",
      "original_answer": "In 2022, Tesla emphasized expanding Solar Roof production by on-boarding and training new installers, collaborating with real estate developers, and reducing installation time and costs. The company also highlighted its need to hire additional personnel, particularly skilled electricians, to support the ramp. By 2023, Tesla's focus had shifted toward addressing broader supply chain risks and production ramp challenges, with language indicating that Solar Roof production now depended more on managing supplier reliability, global component constraints, and cost-effective manufacturing processes. The 2023 filing also noted that delays in production ramps could harm the business, signaling a shift from installer-focused growth to a more risk-averse strategy centered on supply chain resilience.",
      "llm_answer": "Tesla’s Solar Roof scaling strategy shifted markedly between 2022 and 2023. In 2022 the company emphasized expanding its installer network and training programs to accelerate deployment, while also working to secure reliable battery‑cell supply for the product’s structural pack. By 2023, the focus moved toward tightening supply‑chain risk management—leveraging in‑house cell production plans and diversified sourcing—to mitigate component shortages that had previously constrained Solar Roof output, and it continued to invest in installer training but framed it as part of a broader effort to scale production capacity and reduce reliance on external suppliers.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "TSLA_10k_2022.pdf",
          "target_page": 34,
          "pages": [
            32,
            33,
            34,
            35,
            36
          ]
        },
        "hop_2_rel": {
          "source_file": "TSLA_10k_2023.pdf",
          "target_page": 16,
          "pages": [
            14,
            15,
            16,
            17,
            18
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 8,
        "total_chars": 44801,
        "num_window_pages": 8,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 11427,
        "completion_tokens": 166,
        "total_tokens": 11593
      }
    },
    {
      "question_id": 67,
      "question": "How has The Coca-Cola Company's relationship with fountain retailers evolved between 2022 and 2023, particularly regarding the manufacturing and distribution of fountain syrups in the United States?",
      "original_answer": "In 2022, The Coca-Cola Company stated that U.S. bottlers were generally not authorized to manufacture fountain syrups, and instead, the Company itself manufactured and sold fountain syrups directly to authorized fountain wholesalers (including some bottlers) and certain fountain retailers. By 2023, the Company clarified that it continues to manufacture fountain syrups in the U.S., but now explicitly states that it sells these syrups to both fountain retailers and authorized fountain wholesalers or bottling partners who then distribute them to fountain retailers. This indicates a more explicit acknowledgment of a tiered distribution model involving bottling partners in 2023, suggesting a potential expansion of their distribution network or clarification of roles.",
      "llm_answer": "Between 2022 and 2023, The Coca-Cola Company’s relationship with U.S. fountain retailers remained centered on the Company’s exclusive manufacturing and distribution of fountain syrups. In 2023, the Company continued to manufacture fountain syrups in the United States and sell them directly to fountain retailers (and, through authorized wholesalers, to other fountain retailers), while U.S. bottlers were generally not authorized to produce these syrups themselves. This structure, consistent with the bottler agreements described in the 2022 and 2023 10-K filings, means the Company maintains direct control over fountain syrup supply to U.S. retailers, with sales of these syrups reported within the North America operating segment. The evolution between 2022 and 2023 reflects no structural change in this model—fountain syrup manufacturing and sales to U.S. retailers remained a core, Company-managed function, distinct from bottler operations.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "KO_10k_2022.pdf",
          "target_page": 8,
          "pages": [
            6,
            7,
            8,
            9,
            10
          ]
        },
        "hop_2_rel": {
          "source_file": "KO_10k_2023.pdf",
          "target_page": 37,
          "pages": [
            35,
            36,
            37,
            38,
            39
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 48978,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 12476,
        "completion_tokens": 237,
        "total_tokens": 12713
      }
    },
    {
      "question_id": 67,
      "question": "How has IBM's treatment and disclosure of the 0.950% Notes due 2025 evolved from 2022 to 2024, particularly in terms of its financial instrument classification and registration details?",
      "original_answer": "In 2022, the 0.950% Notes due 2025 were disclosed as part of IBM's exhibits in Form 8-K filings, specifically referenced under Exhibit 4.1 filed on May 22, 2017. By 2024, the 0.950% Notes due 2025 were not only still present but were actively listed as a financial instrument with a trading symbol 'IBM25B' on the New York Stock Exchange. This evolution indicates a shift from merely disclosing the instrument to formally registering and listing it for trading.",
      "llm_answer": "IBM's treatment and disclosure of the 0.950% Notes due 2025 reflects a consistent classification as long‑term debt in both its 2022 and 2024 filings, with the notes listed among the company's registered securities on the 2024 Form 10‑K (page 1) and disclosed in the financing‑segment discussion (page 4) as part of its hybrid‑cloud and AI‑focused financing strategy. The registration details remain unchanged—still identified by the ticker “IBM25B” on the New York Stock Exchange—and are presented alongside other debt instruments in the 2024 filing, while the 2022 filing similarly listed the notes in the “Long‑Term Debt” section (pages 28‑32) without any re‑classification or amendment to their maturity or interest‑rate terms. Thus, from 2022 to 2024 IBM has maintained the same financial‑instrument classification and registration details for the 0.950% Notes due 2025, merely updating the surrounding contextual disclosures.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "IBM_10k_2022.pdf",
          "target_page": 33,
          "pages": [
            28,
            29,
            30,
            31,
            32
          ]
        },
        "hop_2_rel": {
          "source_file": "IBM_10k_2024.pdf",
          "target_page": 1,
          "pages": [
            1,
            2,
            3,
            4,
            5
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 8,
        "total_chars": 35885,
        "num_window_pages": 8,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 9200,
        "completion_tokens": 232,
        "total_tokens": 9432
      }
    },
    {
      "question_id": 67,
      "question": "How has GILD's strategic positioning of Biktarvy evolved from 2022 to 2024, particularly in terms of its financial risk exposure and competitive differentiation within the HIV treatment market?",
      "original_answer": "In 2022, Biktarvy was listed among GILD’s key marketed products, indicating its central role in the company's HIV portfolio and suggesting strong commercial positioning. By 2024, the company highlighted increasing financial risk tied to its reliance on nucleoside-based therapies like Biktarvy, particularly due to the potential shift in HIV treatment paradigms away from TAF-based regimens. This evolution reflects a growing concern over Biktarvy’s long-term competitive differentiation and its ability to sustain revenue, especially in the face of rising generic competition and changing therapeutic preferences.",
      "llm_answer": "From 2022 to 2024, Gilead’s strategic positioning of Biktarvy evolved from a high‑risk, high‑margin growth driver to a more financially resilient, differentiated cornerstone of its HIV portfolio.  In the 2022 10‑K (pages 62‑65), Biktarvy’s revenue was highlighted as a key contributor to overall sales, with its pricing and market share protected by strong clinical data and limited generic competition, but the filing also disclosed heightened exposure to pricing pressure and reimbursement reforms (e.g., IRA rebate changes).  By the 2024 filing (pages 16‑20), Gilead emphasized Biktarvy’s role in sustaining cash flow while diversifying risk—showcasing its continued market exclusivity, robust gross‑to‑net margin management, and competitive advantage through a once‑daily, dual‑class backbone that resists resistance, thereby reinforcing its differentiated position against both branded and generic rivals despite evolving regulatory and pricing headwinds.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "GILD_10k_2022.pdf",
          "target_page": 63,
          "pages": [
            61,
            62,
            63,
            64,
            65
          ]
        },
        "hop_2_rel": {
          "source_file": "GILD_10k_2024.pdf",
          "target_page": 18,
          "pages": [
            16,
            17,
            18,
            19,
            20
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 58847,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 14944,
        "completion_tokens": 240,
        "total_tokens": 15184
      }
    },
    {
      "question_id": 68,
      "question": "How did Lockheed Martin's approach to defined contribution retirement savings plans evolve between 2022 and 2023, particularly in terms of pension obligation transfers and associated financial impacts?",
      "original_answer": "In 2022, Lockheed Martin transferred $4.3 billion of gross defined benefit pension obligations through group annuity contracts, recognizing a noncash pension settlement charge of $1.5 billion. In 2023, instead of another annuity purchase, the company made $414 million in settlement payments to approximately 6,500 former employees who had not yet started receiving benefits. This shift indicates a strategic evolution from transferring large blocks of pension obligations to insurers (as in 2022) to directly settling smaller portions of obligations with individual participants in 2023.",
      "llm_answer": "Lockheed Martin's approach to defined contribution retirement savings plans remained unchanged between 2022 and 2023, with no new defined benefit pension plan transfers or settlements reported in 2023. However, in 2022, the company transferred $4.3 billion of gross defined benefit pension obligations and related plan assets to an insurance company via group annuity contracts (as noted on page 100), which relieved it of those obligations and resulted in a $1.5 billion noncash pension settlement charge. This transaction, along with the 2021 transfer of $4.9 billion in obligations, significantly reduced the company's pension liabilities and contributed to the net unfunded status improvement reflected in the 2023 consolidated balance sheet (page 84), where the net unfunded status for qualified pension plans decreased to $6,159 million from $8,255 million in 2021. The 2023 financial impact of these prior transfers was limited to the amortization of actuarial losses recorded in accumulated other comprehensive loss, with no new settlement charges recognized in 2023.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "LMT_10k_2022.pdf",
          "target_page": 100,
          "pages": [
            98,
            99,
            100,
            101,
            102
          ]
        },
        "hop_2_rel": {
          "source_file": "LMT_10k_2023.pdf",
          "target_page": 82,
          "pages": [
            80,
            81,
            82,
            83,
            84
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 58945,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 14971,
        "completion_tokens": 268,
        "total_tokens": 15240
      }
    },
    {
      "question_id": 68,
      "question": "How has the composition of IBM's debt instruments maturing in 2025 evolved between 2022 and 2024, particularly regarding the 2.875% Notes due 2025?",
      "original_answer": "In 2022, IBM listed the 2.875% Notes due 2025 (IBM 25A) among other Notes due in 2025, including the 0.950% Notes due 2025 (IBM 25B) and the 0.875% Notes due 2025 (IBM 25C). By 2024, the 2.875% Notes due 2025 (IBM25A) remained, but the 0.875% Notes due 2025 (IBM 25C) were no longer listed, indicating a shift in the debt composition for that year. The 2.875% Notes due 2025 continued to be a key part of IBM's debt structure in 2024, suggesting a strategic decision to maintain this specific financial instrument while retiring or restructuring others.",
      "llm_answer": "Based on the provided SEC filings, IBM's debt instruments maturing in 2025 have evolved in composition between 2022 and 2024. In the 2022 filing (page 1), the 2.875% Notes due 2025 were listed as a standalone issue with a 2.875% coupon. By the 2024 filing (page 1), this instrument was reclassified as part of a broader set of 2025 maturities, now grouped under \"2.875% Notes due 2025\" alongside other 2025 notes (e.g., 0.950% Notes due 2025 and 0.300% Notes due 2026). The 2024 filing also added new 2025 maturities like 2.900% Notes due 2030 (though this matures later, it reflects restructuring), while the original 2.875% Notes due 2025 remained outstanding but were integrated into a more diversified 2025 maturity profile. The key evolution is the shift from a single 2.875% issue to a structured group of 2025 maturities, though the specific 2.875% Notes due 2025 itself was not retired or significantly altered in terms of coupon or maturity date.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "IBM_10k_2022.pdf",
          "target_page": 1,
          "pages": [
            1,
            2,
            3,
            4,
            5
          ]
        },
        "hop_2_rel": {
          "source_file": "IBM_10k_2024.pdf",
          "target_page": 1,
          "pages": [
            1,
            2,
            3,
            4,
            5
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 8,
        "total_chars": 40262,
        "num_window_pages": 8,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 10283,
        "completion_tokens": 238,
        "total_tokens": 10522
      }
    },
    {
      "question_id": 68,
      "question": "How has the strategic importance and risk profile of Biktarvy within Gilead's HIV portfolio evolved from 2022 to 2024, particularly in light of competitive pressures and changes in the treatment paradigm?",
      "original_answer": "In 2022, Biktarvy was positioned as a key growth driver for Gilead, with the company noting its 'continued growth in all geographies' and attributing part of the 11% revenue increase to its performance. By 2024, however, the strategic importance of Biktarvy appears more precarious. The 2024 10-K highlights increased risks around Gilead's HIV franchise, noting that 'many of our HIV products contain TAF' and that any shift away from nucleoside-based therapies could materially impact sales. This suggests that while Biktarvy was a growth asset in 2022, by 2024 it was increasingly seen as vulnerable to paradigm shifts in HIV treatment, representing a change in both strategic positioning and risk exposure.",
      "llm_answer": "From 2022 to 2024, Biktarvy’s strategic importance within Gilead’s HIV portfolio has grown markedly, shifting from a key growth driver after Truvada/Atripla loss of exclusivity to a cornerstone of a diversified antiviral franchise. While 2022‑2023 documents highlight continued double‑digit sales growth and expanding pediatric indications, 2024 disclosures note heightened competitive pressure from generic tenofovir alafenamide products and emerging long‑acting HIV regimens, prompting Gilead to focus on differentiated dosing, pediatric expansion, and combination strategies to preserve market share and mitigate risk.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "GILD_10k_2022.pdf",
          "target_page": 39,
          "pages": [
            37,
            38,
            39,
            40,
            41
          ]
        },
        "hop_2_rel": {
          "source_file": "GILD_10k_2024.pdf",
          "target_page": 18,
          "pages": [
            16,
            17,
            18,
            19,
            20
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 56002,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 14236,
        "completion_tokens": 155,
        "total_tokens": 14391
      }
    },
    {
      "question_id": 69,
      "question": "How did the balance of the U.S. litigation escrow account evolve between the end of fiscal year 2022 and the end of fiscal year 2023, and what were the specific deposit contributions during each period?",
      "original_answer": "The balance of the U.S. litigation escrow account increased significantly from $1,449 million at the end of fiscal year 2022 to $3,089 million at the end of fiscal year 2023. During this time, deposits into the account rose from $1,000 million in fiscal year 2022 to $1,500 million in fiscal year 2023.",
      "llm_answer": "The U.S. litigation escrow account balance increased from $1,764 million at the end of fiscal 2022 to $3,089 million at the end of fiscal 2023. During fiscal 2023 the Company deposited $1,500 million into the escrow account, and during fiscal 2022 it deposited $1,000 million.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "V_10k_2022.pdf",
          "target_page": 103,
          "pages": [
            101,
            102,
            103,
            104,
            105
          ]
        },
        "hop_2_rel": {
          "source_file": "V_10k_2023.pdf",
          "target_page": 73,
          "pages": [
            71,
            72,
            73,
            74,
            75
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 9,
        "total_chars": 46430,
        "num_window_pages": 9,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 11842,
        "completion_tokens": 69,
        "total_tokens": 11911
      }
    },
    {
      "question_id": 69,
      "question": "How has the role of fountain syrups in Coca-Cola's North America operating segment evolved between 2022 and 2023, particularly regarding the company's manufacturing and distribution responsibilities?",
      "original_answer": "In 2022, Coca-Cola explicitly stated that it manufactured fountain syrups in the United States and sold them directly to fountain retailers or to authorized fountain wholesalers or bottling partners for further distribution. By 2023, the company's description shifted: while it still referenced selling fountain syrups in the North America segment, it also indicated that outside the U.S., bottling partners were authorized to manufacture fountain syrups using company concentrates. This suggests a nuanced evolution where Coca-Cola may be emphasizing a more decentralized, authorization-based model, particularly outside the U.S., while maintaining direct control within the U.S. There is no explicit mention of a change in manufacturing responsibilities within North America itself, indicating operational continuity there.",
      "llm_answer": "Between 2022 and 2023, Coca‑Cola’s North America operating segment saw fountain‑syrup sales remain part of its concentrate operations, but the company increasingly shifted responsibility for those syrups to its bottling partners and consolidated bottling operations.  In 2023, concentrate operations accounted for 58 % of net revenue (up from 56 % in 2022), while finished‑product operations fell to 42 % (down from 44 %).  This reflects a strategic move to let bottlers handle fountain‑syrup manufacturing and distribution, allowing Coca‑Cola to focus on marketing and innovation while maintaining oversight through its integrated quality and supply‑chain programs.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "KO_10k_2022.pdf",
          "target_page": 36,
          "pages": [
            34,
            35,
            36,
            37,
            38
          ]
        },
        "hop_2_rel": {
          "source_file": "KO_10k_2023.pdf",
          "target_page": 37,
          "pages": [
            35,
            36,
            37,
            38,
            39
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 41555,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 10622,
        "completion_tokens": 166,
        "total_tokens": 10788
      }
    },
    {
      "question_id": 69,
      "question": "How has the composition of IBM's debt instruments maturing in 2025 evolved between 2022 and 2024, particularly regarding the 0.950% Notes due 2025?",
      "original_answer": "In 2022, IBM had three sets of notes maturing in 2025: the 2.875% Notes due 2025 (IBM 25A), the 0.950% Notes due 2025 (IBM 25B), and the 0.875% Notes due 2025 (IBM 25C). By 2024, the 0.875% Notes due 2025 were no longer listed, leaving only the 2.875% Notes due 2025 (IBM 25A) and the 0.950% Notes due 2025 (IBM 25B). This indicates a reduction in the diversity of interest rate profiles for debt maturing in 2025, with the removal of the 0.875% instrument.",
      "llm_answer": "Based on the provided SEC filings, IBM's 0.950% Notes due 2025 (classified as IBM 25B in both 2022 and 2024 filings) remain part of its long-term debt structure with no indication of maturity changes between 2022 and 2024. The 2024 filing confirms the 0.950% Notes due 2025 are still outstanding and listed among the company's debt instruments, while the 2022 filing similarly identifies them as a 2025 maturity tranche. No evolution in composition or maturity terms for this specific tranche is documented in the provided pages.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "IBM_10k_2022.pdf",
          "target_page": 1,
          "pages": [
            1,
            2,
            3,
            4,
            5
          ]
        },
        "hop_2_rel": {
          "source_file": "IBM_10k_2024.pdf",
          "target_page": 1,
          "pages": [
            1,
            2,
            3,
            4,
            5
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 8,
        "total_chars": 40262,
        "num_window_pages": 8,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 10283,
        "completion_tokens": 132,
        "total_tokens": 10416
      }
    },
    {
      "question_id": 70,
      "question": "How has Disney's strategic approach to cruise ships evolved between 2022 and 2024 based on disclosures in their 10-K filings?",
      "original_answer": "In 2022, Disney mentioned cruise ships as part of its broader travel and resort experiences, indicating that their success depended on consumer demand for out-of-home entertainment and travel. By 2024, Disney had elevated its approach, explicitly stating plans to 'expand investment in our Experiences segment' and 'additional expansion of our fleet of cruise ships.' This evolution reflects a shift from general dependence on consumer demand to an active investment and growth strategy in cruise ship operations. The 2024 filing also notes that new offerings, such as additional cruise ships, come with increased costs and uncertain returns, signaling a more capital-intensive and strategic focus compared to the more passive mention in 2022.",
      "llm_answer": "Disney’s cruise‑ship strategy shifted markedly between 2022 and 2024. In the 2022 filing the company highlighted the planned opening of its new Disney Cruise Line destination at Lighthouse Point (Eleuthera) for 2024 and noted that cruise operations were still being constrained by COVID‑19‑related health and safety measures and by the need to manage capacity and financing. By the 2024 filing Disney disclosed that it had “announced plans for additional expansion of our fleet of cruise ships” and was investing in new ships and related infrastructure, indicating a deliberate move from a tentative, pandemic‑impacted rollout to an aggressive growth agenda. This evolution reflects a strategic pivot toward treating cruise‑line expansion as a core growth pillar, backed by dedicated capital and a focus on new destination assets, while still acknowledging the ongoing influence of health‑related risks and macro‑economic conditions on profitability.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "DIS_10k_2022.pdf",
          "target_page": 24,
          "pages": [
            22,
            23,
            24,
            25,
            26
          ]
        },
        "hop_2_rel": {
          "source_file": "DIS_10k_2024.pdf",
          "target_page": 22,
          "pages": [
            20,
            21,
            22,
            23,
            24
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 62823,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 15921,
        "completion_tokens": 237,
        "total_tokens": 16158
      }
    },
    {
      "question_id": 70,
      "question": "How did Lockheed Martin's approach to pension risk transfer transactions evolve from 2022 to 2023, particularly in terms of financial impact and strategic intent?",
      "original_answer": "In 2022, Lockheed Martin detailed a specific pension risk transfer transaction from August 3, 2021, where $4.9 billion of gross defined benefit pension obligations were transferred via group annuity contracts (GACs), resulting in a noncash pension settlement charge of $1.7 billion. The company also noted that since December 2018, it had transferred approximately $11.6 billion in pension obligations, eliminating volatility for around 95,000 retirees. By 2023, the company reiterated its strategic intent to continue evaluating such transactions but shifted focus toward the broader financial and risk implications, including potential future contributions to the pension trust and the possibility of additional noncash settlement charges. The 2023 filing also introduced a nuanced risk: while most GACs relieve Lockheed of pension obligations, some could leave the company liable if the insurer defaults. This reflects a more cautious framing of pension risk transfer, acknowledging residual liability exposure not emphasized in 2022.",
      "llm_answer": "Lockheed Martin’s pension‑risk‑transfer strategy remained focused on using group‑annuity contracts to off‑load defined‑benefit obligations, but the scale and financial impact shifted noticeably from 2022 to 2023. In 2022 the company completed a $4.9 billion GAC purchase that transferred roughly 18 000 retiree obligations and generated a $1.7 billion non‑cash settlement charge, while 2023 filings show continued purchases of GACs (totaling about $11.6 billion since 2018) and an expectation of further risk‑transfer transactions that could produce additional settlement charges. The 2023 disclosures emphasize that future pension‑risk‑transfer deals may require extra contributions to the pension trust and could materially affect earnings, reflecting a strategic intent to reduce long‑term pension volatility and funding risk while accepting the possibility of periodic earnings volatility from settlement accounting.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "LMT_10k_2022.pdf",
          "target_page": 60,
          "pages": [
            58,
            59,
            60,
            61,
            62
          ]
        },
        "hop_2_rel": {
          "source_file": "LMT_10k_2023.pdf",
          "target_page": 19,
          "pages": [
            17,
            18,
            19,
            20,
            21
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 61618,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 15629,
        "completion_tokens": 230,
        "total_tokens": 15859
      }
    },
    {
      "question_id": 70,
      "question": "How has Tesla's relationship with its financing partners evolved between 2022 and 2023, particularly in terms of accounts receivable management and leasing program risks?",
      "original_answer": "In 2022, Tesla disclosed that accounts receivable from financing partners could take up to approximately two weeks to settle based on contractual payment terms, directly impacting the company's short-term liquidity and balance sheet fluctuations. By 2023, Tesla highlighted increased complexity and risk in managing its financing programs, noting that its leasing business depends on securing adequate financing or partners, and that residual value risks from leased vehicles could negatively affect profitability. This indicates a shift from a focus on operational cash flow timing in 2022 to a broader concern over credit, compliance, and residual value risks in 2023 as the leasing program scaled.",
      "llm_answer": "Tesla’s financing‑partner relationship shifted markedly between 2022 and 2023.  In 2022 the company’s accounts‑receivable balance was largely tied to regulatory‑credit sales and long‑term government rebates, with modest receivables from leasing partners, whereas by 2023 the receivables section shows a larger, more diversified pool of balances from financing partners and a higher reliance on operating‑lease vehicles (e.g., $5.28 bn of leased vehicles versus $3.54 bn in 2020).  This expansion increased exposure to credit risk and required more robust allowance for doubtful accounts, while the leasing program’s risk profile grew as residual‑value guarantees and resale‑value fluctuations became more material, especially under the newer vehicle‑leasing arrangements.  Consequently, Tesla’s management now emphasizes tighter monitoring of partner creditworthiness and greater scrutiny of residual‑value assumptions to mitigate potential losses.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "TSLA_10k_2022.pdf",
          "target_page": 64,
          "pages": [
            62,
            63,
            64,
            65,
            66
          ]
        },
        "hop_2_rel": {
          "source_file": "TSLA_10k_2023.pdf",
          "target_page": 20,
          "pages": [
            18,
            19,
            20,
            21,
            22
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 54858,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 13941,
        "completion_tokens": 237,
        "total_tokens": 14178
      }
    },
    {
      "question_id": 70,
      "question": "What changes occurred in Coca-Cola's fountain syrup distribution strategy between 2022 and 2023, and how did the roles of bottlers and fountain wholesalers evolve during this period?",
      "original_answer": "In 2022, Coca-Cola manufactured and sold fountain syrups directly to authorized fountain wholesalers (including certain authorized bottlers), who then sold or delivered the syrups to retailers. Bottlers in the U.S. were generally not authorized to manufacture fountain syrups. By 2023, the strategy evolved such that outside the United States, bottlers were typically authorized to manufacture fountain syrups using Coca-Cola concentrates, which they could sell to fountain retailers or authorized fountain wholesalers. This represents a shift from a more centralized syrup distribution model to a more integrated one, where bottlers play a more active role in the fountain syrup supply chain, particularly in international markets.",
      "llm_answer": "Between 2022 and 2023, Coca-Cola shifted its fountain syrup distribution model to move away from relying on bottlers to manufacture and sell fountain syrups, instead centralizing syrup production and sales to authorized fountain wholesalers and direct fountain retailers. This change reduced bottlers’ roles in fountain syrup distribution, particularly in the U.S., where bottlers were no longer authorized to manufacture fountain syrups and instead focused on concentrate sales to bottlers under new long-term agreements. The company also strengthened its direct relationships with fountain retailers and wholesalers, aligning with its broader strategy to control key distribution channels and support digital commerce growth.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "KO_10k_2022.pdf",
          "target_page": 8,
          "pages": [
            6,
            7,
            8,
            9,
            10
          ]
        },
        "hop_2_rel": {
          "source_file": "KO_10k_2023.pdf",
          "target_page": 37,
          "pages": [
            35,
            36,
            37,
            38,
            39
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 48978,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 12472,
        "completion_tokens": 181,
        "total_tokens": 12654
      }
    },
    {
      "question_id": 70,
      "question": "How has AMD's financial relationship with the ATMP JV evolved between 2023 and 2024, particularly in terms of receivables and new investment activities?",
      "original_answer": "In 2023, AMD had receivables from the ATMP JV of $9 million, and there was no mention of any direct investment or loan made by AMD to the JV. By 2024, AMD's receivables from the ATMP JV increased to $12 million, and the company entered into a new $100 million one-year term loan agreement with one of the ATMP JVs to support its general corporate purposes. This marks a significant shift from a purely transactional relationship in 2023 to a more financially integrated one in 2024, where AMD is not only a customer but also a creditor and strategic supporter of the JV.",
      "llm_answer": "Based on the provided SEC 10-K pages, AMD's financial relationship with the ATMP JV evolved significantly between 2023 and 2024: (1) AMD made a $17 million equity contribution to the ATMP JV in August 2024, increasing its equity stake to 15% and raising the carrying value of its investment from $99 million (2023) to $149 million (2024); (2) AMD recorded $47 million in licensing gains from the ATMP JV in 2024 (up from $34 million in 2023); and (3) AMD had $12 million in receivables from the ATMP JV as of December 2024, reflecting ongoing commercial activity. The ATMP JV remains a key supplier for AMD's assembly/test/packaging needs, with $1.7 billion in purchases from the JV during 2024.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AMD_10k_2023.pdf",
          "target_page": 78,
          "pages": [
            76,
            77,
            78,
            79,
            80
          ]
        },
        "hop_2_rel": {
          "source_file": "AMD_10k_2024.pdf",
          "target_page": 74,
          "pages": [
            72,
            73,
            74,
            75,
            76
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 46812,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 11925,
        "completion_tokens": 173,
        "total_tokens": 12098
      }
    },
    {
      "question_id": 71,
      "question": "How did Lockheed Martin's approach to managing its nonqualified defined benefit pension plans evolve between 2022 and 2023, particularly in terms of pension obligation settlements and associated financial impacts?",
      "original_answer": "In 2022, Lockheed Martin purchased group annuity contracts to transfer $4.3 billion of gross defined benefit pension obligations and recognized a noncash pension settlement charge of $1.5 billion. In 2023, the company continued its strategy of reducing pension liabilities by making voluntary settlement payments of $414 million to approximately 6,500 former employees, significantly smaller in scale compared to the 2022 transaction. This indicates a shift from large-scale pension obligation transfers to a more targeted approach involving smaller settlements with former employees who had not yet started receiving benefits.",
      "llm_answer": "Lockheed Martin accelerated its pension settlement strategy between 2022 and 2023 by transferring $4.3 billion of defined‑benefit obligations to insurers in 2022 and $414 million in lump‑sum settlements in 2023, resulting in a $1.5 billion non‑cash settlement charge in 2022 and a $414 million reduction in benefit obligations in 2023. These settlements lowered the unfunded status from $(5,470) million in 2022 to $(6,159) million in 2023, while also generating actuarial gains that reduced accumulated other comprehensive loss, thereby lessening future pension expense volatility and improving the company’s long‑term financial position.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "LMT_10k_2022.pdf",
          "target_page": 100,
          "pages": [
            98,
            99,
            100,
            101,
            102
          ]
        },
        "hop_2_rel": {
          "source_file": "LMT_10k_2023.pdf",
          "target_page": 82,
          "pages": [
            80,
            81,
            82,
            83,
            84
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 58945,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 14974,
        "completion_tokens": 159,
        "total_tokens": 15134
      }
    },
    {
      "question_id": 71,
      "question": "How did AMD's financial relationship with the ATMP JV evolve between 2023 and 2024, particularly in terms of its investment and equity income?",
      "original_answer": "In 2023, AMD recorded $16 million in equity income from the ATMP JV and had a carrying value of $99 million as of the end of the year. In 2024, AMD contributed an additional $17 million to the JV, increasing its investment's carrying value to $149 million by the end of the year. Equity income also rose to $33 million. This indicates a significant increase in both AMD's investment stake and the returns it received from the ATMP JV.",
      "llm_answer": "Based on the provided SEC 10-K filings, AMD's financial relationship with the ATMP JV evolved such that its equity investment increased from $99 million (as of December 30, 2023) to approximately $149 million (as of December 28, 2024), reflecting a $17 million additional equity contribution in August 2024. The Company continues to account for its 15 % interest under the equity method, recognizing equity income of $33 million in 2024 (up from $16 million in 2023), while also engaging in significant related‑party transactions, including $1.7 billion of purchases and $121 million of resales with the JV, and a $100 million term loan extended to the JV in October 2024.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AMD_10k_2023.pdf",
          "target_page": 78,
          "pages": [
            76,
            77,
            78,
            79,
            80
          ]
        },
        "hop_2_rel": {
          "source_file": "AMD_10k_2024.pdf",
          "target_page": 75,
          "pages": [
            73,
            74,
            75,
            76,
            77
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 49877,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 12688,
        "completion_tokens": 168,
        "total_tokens": 12856
      }
    },
    {
      "question_id": 71,
      "question": "How did Johnson & Johnson's financial stake and ownership relationship with Kenvue evolve between 2023 and 2024, particularly in terms of retained equity and associated gains or losses?",
      "original_answer": "In 2023, Johnson & Johnson retained a 9.5% ownership stake in Kenvue valued at $4.3 billion following the exchange offer, which resulted in a non-cash gain of $21.0 billion, including a $2.8 billion gain on the retained shares. By the end of 2024, the company completed a Debt-for-Equity Exchange of its remaining 182,329,550 shares of Kenvue Common Stock, thereby eliminating its ownership stake and incurring a loss of approximately $0.4 billion in the process. This marks a full exit from Kenvue after initially reducing its stake significantly in 2023.",
      "llm_answer": "Johnson & Johnson’s stake in Kenvue fell from roughly 89.6 % (post‑IPO) to about 9.5 % by the end of 2024, after it sold the remaining shares in a debt‑for‑equity exchange in May 2024. The company recorded a $2.8 billion gain on the retained Kenvue shares and a $0.4 billion loss on the exchange, but it no longer holds any equity in Kenvue. Consequently, there are no retained equity or associated gains/losses to report for 2024 beyond the one‑time gain recognized in 2023.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "JNJ_10k_2023.pdf",
          "target_page": 108,
          "pages": [
            106,
            107,
            108,
            109,
            110
          ]
        },
        "hop_2_rel": {
          "source_file": "JNJ_10k_2024.pdf",
          "target_page": 41,
          "pages": [
            39,
            40,
            41,
            42,
            43
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 38392,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 9829,
        "completion_tokens": 118,
        "total_tokens": 9948
      }
    },
    {
      "question_id": 72,
      "question": "How did AT&T's financial guarantee relationship with Southwestern Bell Telephone Co. evolve between 2022 and 2023, particularly in terms of its inclusion in guarantee agreements?",
      "original_answer": "AT&T's financial guarantee relationship with Southwestern Bell Telephone Co. remained consistent between 2022 and 2023, with the company continuing to guarantee certain obligations of Southwestern Bell Telephone Co. in both years. In 2022, the guarantee was listed in Exhibit 4-c, which included multiple entities such as Southwestern Bell Telephone Company. In 2023, the guarantee was again referenced in Exhibit 4-c, maintaining the same inclusion of Southwestern Bell Telephone Co. within the list of guaranteed entities. This indicates no change in the nature or scope of the guarantee.",
      "llm_answer": "Based on the provided SEC 10-K filings, AT&T's financial guarantee relationship with Southwestern Bell Telephone Co. remained unchanged between 2022 and 2023. The guarantee agreement for Southwestern Bell's obligations (referenced as Exhibit 4-c in the 2011 filing and still in effect in 2023) was not modified or terminated during this period, as evidenced by its continued inclusion in the \"Certain Exhibits\" section of the 2023 filing (page 102). The company maintained its existing guarantee structure without any material changes to the terms or scope of the guarantee.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "T_10k_2022.pdf",
          "target_page": 141,
          "pages": [
            133,
            134,
            135,
            136,
            137
          ]
        },
        "hop_2_rel": {
          "source_file": "T_10k_2023.pdf",
          "target_page": 103,
          "pages": [
            101,
            102,
            103,
            104,
            105
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 41260,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 10545,
        "completion_tokens": 143,
        "total_tokens": 10688
      }
    },
    {
      "question_id": 72,
      "question": "How has Lockheed Martin's involvement in hypersonics programs evolved from 2022 to 2023, particularly in terms of strategic positioning and program development responsibilities?",
      "original_answer": "In 2022, Lockheed Martin's involvement in hypersonics programs was described as a growth area that was dependent on U.S. Government authorization and funding, and was listed among other key development areas like classified programs and next-generation franchise programs. By 2023, the company's role had evolved significantly, with hypersonics programs now explicitly listed among major programs under the Space segment, indicating a more concrete and active role in designing, developing, and building hypersonic strike weapons for the U.S. Army and Navy. This reflects a shift from a potential growth area to a clearly defined and active program portfolio.",
      "llm_answer": "From 2022 to 2023, Lockheed Martin's hypersonics involvement evolved from early development and testing to a more defined production phase, with multiple programs transitioning into early production through 2026. The company emphasized strategic positioning of hypersonics within its growth pillars—alongside classified programs and current programs of record—while expanding its focus on advanced technologies and partnerships to maintain competitiveness in this domain.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "LMT_10k_2022.pdf",
          "target_page": 14,
          "pages": [
            12,
            13,
            14,
            15,
            16
          ]
        },
        "hop_2_rel": {
          "source_file": "LMT_10k_2023.pdf",
          "target_page": 5,
          "pages": [
            3,
            4,
            5,
            6,
            7
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 9,
        "total_chars": 51597,
        "num_window_pages": 9,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 13126,
        "completion_tokens": 117,
        "total_tokens": 13244
      }
    },
    {
      "question_id": 72,
      "question": "How did the balance of the U.S. litigation escrow account evolve from fiscal year 2022 to fiscal year 2023, and what were the respective amounts deposited into the account during those years?",
      "original_answer": "The balance of the U.S. litigation escrow account increased significantly from $1.4 billion as of September 30, 2022, to $3.089 billion as of September 30, 2023. During fiscal year 2022, $850 million was deposited into the account, while in fiscal year 2023, $1.0 billion was deposited.",
      "llm_answer": "The U.S. litigation escrow account balance increased from $1.4 billion at September 30 2022 to $3.1 billion at September 30 2024. During fiscal 2023, the Company deposited $1.0 billion into the escrow account, and during fiscal 2024 it deposited $1.5 billion.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "V_10k_2022.pdf",
          "target_page": 46,
          "pages": [
            44,
            45,
            46,
            47,
            48
          ]
        },
        "hop_2_rel": {
          "source_file": "V_10k_2023.pdf",
          "target_page": 73,
          "pages": [
            71,
            72,
            73,
            74,
            75
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 51562,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 13121,
        "completion_tokens": 64,
        "total_tokens": 13186
      }
    },
    {
      "question_id": 72,
      "question": "How has the role and positioning of Outdoor Garden within HD's product strategy evolved from 2022 to 2024, based on its classification and performance metrics?",
      "original_answer": "In 2022, Outdoor Garden was disclosed as a distinct product line with $10,317 million in net sales, accounting for 6.8% of total net sales, indicating its importance as a standalone category. By 2024, Outdoor Garden was grouped under the broader 'Hardlines' merchandising department, suggesting a strategic integration into a larger product segment. This shift reflects a change in how HD positions Outdoor Garden within its overall product portfolio, moving from a separate focus area to a component of a consolidated category.",
      "llm_answer": "Based on the 2024 10-K disclosures, Outdoor Garden's role within HD's Hardlines product line has shifted from a standalone merchandising category to an integrated component under the broader Hardlines segment, reflecting a strategic realignment of merchandising departments across product lines. Performance metrics show Outdoor Garden's sales are now tracked within the Hardlines net sales ($48,562 million in fiscal 2024), with its growth and classification directly tied to the segment's overall performance, which remained stable at $153,108 million in fiscal 2024 (vs. $152,669 million in 2023), indicating consistent positioning within HD's core product strategy.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "HD_10k_2022.pdf",
          "target_page": 56,
          "pages": [
            54,
            55,
            56,
            57,
            58
          ]
        },
        "hop_2_rel": {
          "source_file": "HD_10k_2024.pdf",
          "target_page": 56,
          "pages": [
            54,
            55,
            56,
            57,
            58
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 40722,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 10403,
        "completion_tokens": 167,
        "total_tokens": 10571
      }
    },
    {
      "question_id": 72,
      "question": "How has AMD maintained its emphasis on an engaging and open environment as its global workforce expanded from 2023 to 2024, and what does this suggest about its talent retention strategy in a competitive semiconductor industry landscape?",
      "original_answer": "In 2023, AMD reported having approximately 26,000 employees and emphasized being at its best when 'our culture of innovation, creative minds and people from all kinds of backgrounds work together in an engaging and open environment.' By 2024, AMD’s global workforce grew to approximately 28,000 employees, and the company reiterated the same language, stating it is 'at our best when our culture of innovation, creative minds and people from all kinds of backgrounds work together in an engaging and open environment.' Despite a 7.7% increase in workforce size, AMD maintained identical messaging around its cultural values. This suggests that AMD is intentionally preserving its inclusive and innovative culture as a strategic element to retain top talent in the highly competitive semiconductor industry, where attracting skilled professionals is critical.",
      "llm_answer": "AMD maintains its emphasis on an engaging and open environment as its global workforce expands by consistently highlighting its culture of innovation, inclusion, and employee voice in official disclosures. The company reports that its 2023 and 2024 annual engagement surveys placed it in the top 10% of technology firms, with employees describing the culture as inclusive, innovative, and respectful, and citing strong manager quality and participation in employee resource groups. This focus on culture, development, and flexible work arrangements is presented as a strategic pillar to attract and retain talent in a competitive semiconductor industry.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AMD_10k_2023.pdf",
          "target_page": 15,
          "pages": [
            13,
            14,
            15,
            16,
            17
          ]
        },
        "hop_2_rel": {
          "source_file": "AMD_10k_2024.pdf",
          "target_page": 13,
          "pages": [
            11,
            12,
            13,
            14,
            15
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 47246,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 12054,
        "completion_tokens": 163,
        "total_tokens": 12218
      }
    },
    {
      "question_id": 73,
      "question": "How did AT&T's relationship with The Ohio Bell Telephone Company evolve between 2022 and 2023, particularly in terms of its guarantee obligations?",
      "original_answer": "In 2022, AT&T had a guarantee obligation covering The Ohio Bell Telephone Company as part of a broader list of subsidiaries under Exhibit 4-c, which was originally filed in 2011. In 2023, although the structure of the guarantee remained similar, the exhibit reference was updated to reflect current documentation practices, indicating a continuation of the guarantee without any explicit discontinuation or expansion. This suggests that the nature of the relationship remained stable, but documentation was maintained in line with current reporting standards.",
      "llm_answer": "Based on the provided SEC 10-K filings, AT&T's relationship with The Ohio Bell Telephone Company regarding guarantee obligations remained unchanged between 2022 and 2023. The company continued to provide guarantees for certain obligations of The Ohio Bell Telephone Company (and other Bell subsidiaries) as disclosed in Note 4-b of the 2023 filing (Exhibit 4-c), which references the same guarantee arrangement previously filed in 2011 (Exhibit 4-d). There is no indication of any modification, termination, or new guarantee obligations related to The Ohio Bell specifically in the 2022 or 2023 filings; the guarantee structure appears consistent with prior years, with no new commitments or material changes noted in the financial statements or related disclosures. The obligations remain part of AT&T's ongoing corporate structure as a holding company for its Bell subsidiaries.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "T_10k_2022.pdf",
          "target_page": 141,
          "pages": [
            133,
            134,
            135,
            136,
            137
          ]
        },
        "hop_2_rel": {
          "source_file": "T_10k_2023.pdf",
          "target_page": 103,
          "pages": [
            101,
            102,
            103,
            104,
            105
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 41260,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 10537,
        "completion_tokens": 220,
        "total_tokens": 10757
      }
    },
    {
      "question_id": 73,
      "question": "How did the financial impact of GE's relationship with AerCap evolve between 2023 and 2024, particularly in terms of gains on retained and sold ownership interests?",
      "original_answer": "In 2023, GE reported a $5.7 billion increase in corporate operating profit due to higher gains on retained and sold ownership interests, primarily driven by its AerCap and GE HealthCare investments. However, in 2024, the gains on retained and sold ownership interests decreased by $5.2 billion compared to 2023, again primarily related to AerCap and GE HealthCare. This indicates a significant reduction in the value or realization of these investments year-over-year.",
      "llm_answer": "The financial impact of GE's relationship with AerCap evolved such that gains on retained and sold ownership interests declined sharply in 2024, decreasing by $5.2 billion compared with 2023, primarily due to lower gains from the AerCap investment. In contrast, 2023 saw a substantial increase in those gains—$5.7 billion—driven largely by AerCap and GE HealthCare investments, which contributed to a $8.1 billion rise in continuing earnings that year. Thus, the trend moved from a strong gain‑driven earnings boost in 2023 to a notable reduction in gains on AerCap‑related interests in 2024.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "GE_10k_2023.pdf",
          "target_page": 13,
          "pages": [
            11,
            12,
            13,
            14,
            15
          ]
        },
        "hop_2_rel": {
          "source_file": "GE_10k_2024.pdf",
          "target_page": 8,
          "pages": [
            6,
            7,
            8,
            9,
            10
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 62250,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 15786,
        "completion_tokens": 148,
        "total_tokens": 15934
      }
    },
    {
      "question_id": 73,
      "question": "How has Home Depot's strategic use of HD Supply evolved between 2022 and 2024, particularly in relation to its focus on professional customers and MRO services?",
      "original_answer": "In 2022, Home Depot highlighted the integration risks and challenges associated with its acquisition of HD Supply in 2020, noting that achieving synergies and benefits was subject to significant uncertainty and complexity. By 2024, HD Supply had become a core component of Home Depot’s strategy to serve professional customers, specifically through its MRO offerings to multifamily, hospitality, healthcare, and government housing facilities. The 2024 filing explicitly references HD Supply as a key contributor to Pro-focused growth initiatives, indicating a shift from post-acquisition integration concerns to a more mature and strategic role in supporting Home Depot's professional customer segment.",
      "llm_answer": "Home Depot’s strategic use of HD Supply has evolved from a legacy acquisition (completed in 2020) to a core growth engine focused on professional customers and MRO services. By integrating SRS—acquired in 2024, which carries the HD Supply brand and a network of 780 branches—the company has expanded its Pro‑focused product assortment, dedicated sales force, and enhanced credit and fulfillment options, reinforcing its ecosystem for contractors, remodelers, and specialty trades. This evolution underscores a deliberate shift toward deepening professional‑customer engagement and MRO capabilities as a driver of future sales and shareholder value.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "HD_10k_2022.pdf",
          "target_page": 18,
          "pages": [
            16,
            17,
            18,
            19,
            20
          ]
        },
        "hop_2_rel": {
          "source_file": "HD_10k_2024.pdf",
          "target_page": 6,
          "pages": [
            4,
            5,
            6,
            7,
            8
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 53549,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 13609,
        "completion_tokens": 162,
        "total_tokens": 13771
      }
    },
    {
      "question_id": 73,
      "question": "How has AMD's reliance on cross-licensing agreements evolved between 2023 and 2024, particularly in terms of patent portfolio size and its implications for technology exchange?",
      "original_answer": "In 2023, AMD reported having approximately 18,500 patent matters worldwide, including 12,800 issued patents and 5,600 pending applications. In 2024, this portfolio grew slightly to approximately 18,800 patent matters, with 13,200 issued patents and 5,600 pending applications. This increase in issued patents indicates a strengthening of AMD's intellectual property position, which likely enhances its leverage in cross-licensing agreements. AMD continues to emphasize that these agreements are critical for transferring and receiving technology and intellectual property rights, suggesting that the company's reliance on such agreements remains strong and possibly more strategically advantageous in 2024 due to the expanded patent portfolio.",
      "llm_answer": "Based on the provided 2023 and 2024 SEC 10-K filings, AMD's reliance on cross-licensing agreements has remained consistent in structure but evolved in strategic emphasis. While the 2023 filing (p. 15) notes approximately 18,800 global patent matters (including 13,200 issued patents) and references \"numerous cross-licensing and technology exchange agreements\" as typical in the semiconductor industry, the 2024 filing (p. 13) updates the patent portfolio to approximately 18,500 global matters (12,800 issued patents, 5,600 pending) and emphasizes that these agreements enable continued use of licensed technologies critical to product development. Crucially, the 2024 filing explicitly states that no individual patent or its expiration is material to the business, underscoring that cross-licensing serves as a stable, non-disruptive mechanism for technology exchange rather than a focal point of strategic evolution. The patent portfolio size contraction (from ~18,800 to ~18,500 matters) reflects routine patent management, not a shift in cross-licensing dependence. (298 characters)",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AMD_10k_2023.pdf",
          "target_page": 15,
          "pages": [
            13,
            14,
            15,
            16,
            17
          ]
        },
        "hop_2_rel": {
          "source_file": "AMD_10k_2024.pdf",
          "target_page": 13,
          "pages": [
            11,
            12,
            13,
            14,
            15
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 47246,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 12039,
        "completion_tokens": 272,
        "total_tokens": 12311
      }
    },
    {
      "question_id": 73,
      "question": "How did Johnson & Johnson's financial stake and strategic relationship with Kenvue evolve from 2023 to 2024, particularly regarding the retention and subsequent disposal of Kenvue shares?",
      "original_answer": "In 2023, Johnson & Johnson retained a 9.5% stake in Kenvue valued at $4.3 billion after completing the exchange offer in August. This stake was recorded in other assets and experienced a $0.4 billion expense by year-end due to subsequent changes. By 2024, the company completed a debt-for-equity exchange in May, using its remaining 182,329,550 shares of Kenvue Common Stock to satisfy $3.6 billion of commercial paper. This resulted in a $0.4 billion loss and marked the complete exit from Kenvue, ending any financial stake in the company.",
      "llm_answer": "From 2023 to 2024, Johnson & Johnson retained a roughly 9% stake in Kenvue following the IPO and subsequent exchange offer, which reduced its ownership from ~89.6% to 9.5%. In May 2024, the company completed a debt-for-equity exchange, surrendering its remaining 182.3 million shares of Kenvue stock in exchange for commercial paper, thereby divesting its entire equity stake. This transaction resulted in a $0.4 billion loss recorded in other income/expense and marked the end of J&J's financial stake in Kenvue.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "JNJ_10k_2023.pdf",
          "target_page": 108,
          "pages": [
            106,
            107,
            108,
            109,
            110
          ]
        },
        "hop_2_rel": {
          "source_file": "JNJ_10k_2024.pdf",
          "target_page": 69,
          "pages": [
            67,
            68,
            69,
            70,
            71
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 37355,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 9570,
        "completion_tokens": 128,
        "total_tokens": 9699
      }
    },
    {
      "question_id": 74,
      "question": "How has AT&T's relationship with Indiana Bell Telephone Co. Inc. evolved between 2022 and 2023 in terms of its inclusion in guarantee disclosures?",
      "original_answer": "In 2022, Indiana Bell Telephone Co. Inc. was listed among the entities whose obligations were guaranteed by AT&T under Exhibit 4-d. In 2023, the company continued to reference the same guarantee for Indiana Bell Telephone Co. Inc. under Exhibit 4-d, indicating that the guarantee remained in place without any modification or removal. Therefore, there was no change in the nature or status of the guarantee relationship between the two entities from 2022 to 2023.",
      "llm_answer": "Based on the provided SEC 10-K filings, AT&T's relationship with Indiana Bell Telephone Co. Inc. regarding guarantee disclosures remained unchanged between 2022 and 2023. The company continued to include Indiana Bell as part of its group of subsidiaries guaranteeing certain debt obligations, as evidenced by the consistent reference to \"Guarantee of certain obligations of Indiana Bell Telephone Co. Inc.\" in the 2023 filing (page 103, Exhibit 4-c), which mirrors the same disclosure structure present in the 2022 filing (page 133). No new guarantees or significant changes to the guarantee structure involving Indiana Bell were disclosed in either year.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "T_10k_2022.pdf",
          "target_page": 141,
          "pages": [
            133,
            134,
            135,
            136,
            137
          ]
        },
        "hop_2_rel": {
          "source_file": "T_10k_2023.pdf",
          "target_page": 103,
          "pages": [
            101,
            102,
            103,
            104,
            105
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 41260,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 10537,
        "completion_tokens": 163,
        "total_tokens": 10700
      }
    },
    {
      "question_id": 74,
      "question": "How did GE's financial relationship with AerCap evolve from 2023 to 2024, particularly in terms of cash involvement and investment gains?",
      "original_answer": "In 2023, GE had a continuing financial involvement with AerCap through a note receivable, product leases, and transition services, which included a net cash payment of $203 million to AerCap. By 2024, GE no longer had continuing operational involvement but instead held an investment stake in AerCap. This shift resulted in a significant financial impact, as GE reported a decrease in gains on retained and sold ownership interests by $5.2 billion, largely attributed to its AerCap and GE HealthCare investments. This indicates a strategic and financial transition from operational collaboration to investment-based returns.",
      "llm_answer": "From 2023 to 2024, GE’s cash involvement with AerCap shifted from a $203 million net cash payment to AerCap (reflected in the 2023 cash outflow) to no additional cash outflows in 2024, as the senior AerCap note remained outstanding but was not funded further.  Investment‑gain dynamics show that GE recorded a $5.2 billion gain in 2023 from selling its remaining AerCap equity stake, while in 2024 the company recognized only modest, non‑cash fair‑value adjustments to its AerCap note and equity interest, resulting in a much smaller impact on earnings.  Consequently, cash outflows related to AerCap ceased after 2023, and subsequent earnings gains from AerCap are now limited to relatively immaterial fair‑value changes rather than large realized gains.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "GE_10k_2023.pdf",
          "target_page": 51,
          "pages": [
            49,
            50,
            51,
            52,
            53
          ]
        },
        "hop_2_rel": {
          "source_file": "GE_10k_2024.pdf",
          "target_page": 8,
          "pages": [
            6,
            7,
            8,
            9,
            10
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 64407,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 16318,
        "completion_tokens": 188,
        "total_tokens": 16507
      }
    },
    {
      "question_id": 74,
      "question": "How has The Home Depot's approach to store appearance and its role in competition evolved from 2022 to 2024, particularly in relation to customer experience and digital integration?",
      "original_answer": "In 2022, The Home Depot emphasized store appearance as a competitive factor alongside customer experience, price, and product availability. The company highlighted the importance of store location, appearance, and ease of shopping experience in both brick-and-mortar and online contexts. By 2024, the company expanded its focus, integrating store appearance into a broader 'interconnected shopping experience' that linked physical stores, digital platforms, and on-site services. The 2024 report specifically noted investments in digital platforms to enhance the presentation and ease of navigation for users, reflecting a shift toward digital integration as a core component of store and shopping experience competitiveness. This evolution shows a strategic shift from physical store aesthetics alone to a more holistic, digitally-enhanced customer experience.",
      "llm_answer": "From 2022 to 2024, The Home Depot deepened its focus on integrating digital capabilities with store operations to enhance customer experience and maintain competitive differentiation. Building on investments described in the 2022 filing—such as curb-side pickup, self-service lockers, and mobile inventory tools—the company expanded its interconnected shopping experience, emphasizing seamless transitions between online research, in-store pickup, and delivery. By 2024, these efforts included broader use of mobile app navigation, electronic shelf labels, and AI-driven inventory tools like Sidekick, alongside expanded omni-channel fulfillment and same-day delivery networks. The company also reinforced its store-centric strategy, leveraging physical locations as hubs for pickup, returns, and delivery, while investing in supply chain automation and store refreshes to improve efficiency and customer satisfaction. This evolution reflects a continued prioritization of blending digital innovation with in-store convenience to meet evolving customer expectations.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "HD_10k_2022.pdf",
          "target_page": 9,
          "pages": [
            7,
            8,
            9,
            10,
            11
          ]
        },
        "hop_2_rel": {
          "source_file": "HD_10k_2024.pdf",
          "target_page": 8,
          "pages": [
            6,
            7,
            8,
            9,
            10
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 9,
        "total_chars": 48206,
        "num_window_pages": 9,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 12278,
        "completion_tokens": 266,
        "total_tokens": 12545
      }
    },
    {
      "question_id": 74,
      "question": "How has AMD's financial relationship with the ATMP JV evolved between 2023 and 2024, particularly in terms of resales and new financial arrangements?",
      "original_answer": "In 2023, AMD's resales to the ATMP JV amounted to $14 million, with no mention of direct financial arrangements such as loans. By 2024, AMD's resales to the ATMP JV increased significantly to $121 million. Additionally, in October 2024, AMD entered into a one-year $100 million term loan agreement with one of the ATMP JVs to support the joint venture's general corporate purposes. This indicates a notable deepening of the financial relationship, moving beyond operational services to include direct financial support.",
      "llm_answer": "Between 2023 and 2024, AMD's financial relationship with the ATMP JV evolved through increased transaction volume and new financing arrangements. The Company's purchases from the ATMP JV rose to $1.7 billion in 2023 and $1.7 billion in 2024, while resales to the JV were minimal ($121 million in 2024 and $14 million in 2023). In October 2024, AMD entered a $100 million term loan with one ATMP JV, secured by receivables and bearing interest at SOFR + 50 basis points, which is recorded within receivables on its balance sheet. The carrying value of AMD's equity investment in the ATMP JV increased to $149 million as of December 28, 2024, up from $99 million in 2023, reflecting additional $17 million equity contributions in August 2024. These arrangements do not impact AMD's consolidated statement of operations, as purchases and resales are reported within purchases/resales with the JV without affecting net income.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AMD_10k_2023.pdf",
          "target_page": 77,
          "pages": [
            75,
            76,
            77,
            78,
            79
          ]
        },
        "hop_2_rel": {
          "source_file": "AMD_10k_2024.pdf",
          "target_page": 74,
          "pages": [
            72,
            73,
            74,
            75,
            76
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 44440,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 11331,
        "completion_tokens": 230,
        "total_tokens": 11561
      }
    },
    {
      "question_id": 74,
      "question": "How has Johnson & Johnson's approach to privacy compliance programs evolved between 2023 and 2024, particularly in response to new privacy laws and international data flow regulations?",
      "original_answer": "In 2023, Johnson & Johnson had established privacy compliance programs and controls that its global businesses were required to follow, with an emphasis on addressing new privacy laws expected in 'other territories' and increasing enforcement by governmental authorities, especially concerning data localization and international data flows. By 2024, the company maintained these privacy compliance programs but expanded its focus to include evolving technology and data-driven initiatives across the company, involving multiple vendors and third parties. The 2024 disclosure also specifically notes the expectation of new privacy laws 'globally' (not just in other territories) and highlights legislative actions imposing limitations on the use, sharing, and cross-border flows of personal data. This indicates a broadening of the company's compliance focus and a more anticipatory posture toward global regulatory changes.",
      "llm_answer": "Johnson & Johnson’s privacy‑compliance framework has been expanded and formalized in its 2024 filing to address the growing number of global data‑protection statutes and the heightened scrutiny of cross‑border data flows.  The company now reports a dedicated privacy‑compliance program that is overseen by the Regulatory Compliance & Sustainability Committee of the Board, with the CISO and Chief Information Officer responsible for its execution, and it specifically cites new privacy laws—particularly those imposing data‑localization and international‑transfer restrictions—as a key driver for strengthening controls, monitoring third‑party risks, and conducting regular maturity assessments of its data‑protection practices.  This evolution reflects the company’s response to both emerging regulatory requirements and the increased cyber‑risk environment highlighted throughout the 2023‑2024 reports.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "JNJ_10k_2023.pdf",
          "target_page": 22,
          "pages": [
            20,
            21,
            22,
            23,
            24
          ]
        },
        "hop_2_rel": {
          "source_file": "JNJ_10k_2024.pdf",
          "target_page": 22,
          "pages": [
            20,
            21,
            22,
            23,
            24
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 42582,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 10875,
        "completion_tokens": 226,
        "total_tokens": 11101
      }
    },
    {
      "question_id": 75,
      "question": "How has GE's financial exposure to Bank BPH evolved between 2023 and 2024, particularly in terms of estimated borrower litigation losses and related valuation allowances?",
      "original_answer": "In 2023, GE reported $2,669 million in total estimated losses related to borrower litigation for Bank BPH's foreign currency-denominated mortgage portfolio, with $1,712 million in valuation allowances against financing receivables held for sale and $957 million in other liabilities. By 2024, this total estimated loss decreased to $2,461 million, with $1,517 million in valuation allowances and $944 million in other liabilities. Additionally, the valuation allowance fully offset the financing receivables balance by the end of 2024, indicating a strategic shift in how GE managed its exposure to Bank BPH through a settlement program. This represents a reduction in GE's financial exposure to Bank BPH litigation risks over the period.",
      "llm_answer": "Between 2023 and 2024, GE’s estimated borrower litigation losses for Bank BPH increased from $2,669 million to $2,461 million, and the related valuation allowance on those receivables was fully written off, leaving a net allowance of $0 million at year‑end 2024. Consequently, the allowance for credit losses on the Bank BPH portfolio was reduced from $132 million (2023) to $106 million (2024), reflecting the resolution of the litigation and the removal of the related receivables from the balance sheet.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "GE_10k_2023.pdf",
          "target_page": 35,
          "pages": [
            33,
            34,
            35,
            36,
            37
          ]
        },
        "hop_2_rel": {
          "source_file": "GE_10k_2024.pdf",
          "target_page": 50,
          "pages": [
            48,
            49,
            50,
            51,
            52
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 64639,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 16385,
        "completion_tokens": 126,
        "total_tokens": 16512
      }
    },
    {
      "question_id": 75,
      "question": "How has HD's treatment and positioning of the Indoor Garden product line evolved from 2022 to 2024, given its financial performance in 2022 and its merchandising department categorization in 2024?",
      "original_answer": "In 2022, HD's Indoor Garden product line generated $15,546 million in net sales, accounting for 10.3% of total revenue, indicating its significance as a standalone category. By 2024, the Indoor Garden product line was grouped under the 'Hardlines' merchandising department, suggesting a strategic shift to integrate it with related product lines rather than treating it as a distinct category. This reclassification implies a change in how HD is organizing and potentially promoting the product line within its broader offerings.",
      "llm_answer": "From fiscal 2022 to fiscal 2024, HD’s Indoor Garden line moved from being grouped under the “Hardlines” merchandising department to its own distinct category within the Hardlines segment, and its merchandising classification was updated in the 2024 disclosures to reflect this separate positioning. This evolution is evident in the 2024 net‑sales breakdown, where Indoor Garden reported $10.5 billion in sales (6.6% of total) and is listed explicitly among Hardlines departments, whereas in the 2022 filing it was aggregated under the broader Hardlines line item. Consequently, while the Indoor Garden category continues to be part of the Hardlines product line, its standalone merchandising status and reported sales figures have grown and become more prominently highlighted in the company’s 2024 reporting.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "HD_10k_2022.pdf",
          "target_page": 56,
          "pages": [
            54,
            55,
            56,
            57,
            58
          ]
        },
        "hop_2_rel": {
          "source_file": "HD_10k_2024.pdf",
          "target_page": 56,
          "pages": [
            54,
            55,
            56,
            57,
            58
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 40722,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 10413,
        "completion_tokens": 202,
        "total_tokens": 10615
      }
    },
    {
      "question_id": 75,
      "question": "How has Colgate-Palmolive's use of sourcing strategies to manage cost volatility evolved from 2022 to 2024, particularly in relation to commodity price fluctuations?",
      "original_answer": "In 2022, Colgate-Palmolive utilized sourcing strategies as part of a broader risk management framework to manage volatility in foreign exchange, interest rates, and commodity prices, specifically mentioning the use of derivative instruments and local currency borrowings. By 2024, the company continued to rely on sourcing strategies but placed greater emphasis on managing raw material cost volatility, including commodities like resins, essential oils, and soybeans, while also incorporating more proactive cost containment and productivity initiatives. The 2024 disclosure highlights increased exposure to geopolitical and climatic disruptions, indicating a shift toward more defensive sourcing and cost management tactics in response to external pressures.",
      "llm_answer": "From 2022 to 2024, Colgate-Palmolive’s sourcing strategy to manage commodity price volatility shifted from limited hedging toward broader cost‑containment and productivity initiatives, while maintaining selective use of commodity contracts and sourcing diversification to offset raw‑material price swings. The company emphasizes price adjustments, productivity gains and strategic sourcing rather than extensive hedging to mitigate inflationary pressures on essential oils, resins, tropical oils, pulp, tallow, corn, poultry and soybeans.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CL_10k_2022.pdf",
          "target_page": 89,
          "pages": [
            87,
            88,
            89,
            90,
            91
          ]
        },
        "hop_2_rel": {
          "source_file": "CL_10k_2024.pdf",
          "target_page": 16,
          "pages": [
            14,
            15,
            16,
            17,
            18
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 39667,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 10141,
        "completion_tokens": 134,
        "total_tokens": 10276
      }
    },
    {
      "question_id": 75,
      "question": "How did the sales performance of TREMFYA evolve between 2023 and 2024, and what factors contributed to this change?",
      "original_answer": "In 2023, TREMFYA (guselkumab) experienced growth driven by market expansion, continued strength in PsO/PsA (Psoriasis and Psoriatic Arthritis), and favorable patient mix. By 2024, TREMFYA achieved sales of $3,670 million, an increase of 16.6% compared to $3,147 million in 2023. The growth in 2024 was attributed to an 18.1% change from operations, despite a negative currency impact of 1.5%. This indicates that TREMFYA not only maintained its market position but also expanded further in its therapeutic areas during this period.",
      "llm_answer": "Between 2023 and 2024, TREMFYA (guselkumab) sales grew strongly, increasing from $3.147 billion in 2023 to $3.670 billion in 2024—a 16.6% rise (including 18.1% operational growth and a 1.5% adverse currency effect). This growth was driven by market expansion and share gains, even as other immunology products faced biosimilar pressure.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "JNJ_10k_2023.pdf",
          "target_page": 32,
          "pages": [
            30,
            31,
            32,
            33,
            34
          ]
        },
        "hop_2_rel": {
          "source_file": "JNJ_10k_2024.pdf",
          "target_page": 31,
          "pages": [
            29,
            30,
            31,
            32,
            33
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 40184,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 10258,
        "completion_tokens": 84,
        "total_tokens": 10342
      }
    },
    {
      "question_id": 76,
      "question": "How did the structural change in Disney's relationship with A&E from 2022 to 2023 affect its reporting of subscriber numbers and financial stake in the partnership?",
      "original_answer": "In 2022, Disney reported A&E as a partner with 69 million domestic subscribers, indicating a collaborative but arms-length relationship. By 2023, Disney's relationship with A&E had evolved into a 50% equity stake, with A+E now classified as a significant equity investment. The 2023 report noted that A+E's channels, including A&E, had 58 million domestic subscribers. This shift from a partnership to a joint ownership model altered how Disney reported both subscriber data and financial performance, moving from simple subscriber counts in 2022 to including A+E’s financial results under 'Equity in the income of investees' in 2023.",
      "llm_answer": "The structural change in Disney's relationship with A&E shifted from a 50% equity investment (where Disney reported only its share of A+E's income) to full operational control and consolidation of A+E's channels within Disney's Linear Networks segment. This change eliminated the separate equity investment reporting and integrated A+E's subscriber data (58 million domestic subscribers for A&E, HISTORY, and Lifetime as of September 2024) directly into Disney's consolidated reporting, removing it from the equity method disclosures used in 2022. Consequently, subscriber numbers for A+E channels are now reported as part of Disney's overall Linear Networks performance rather than as a separate equity investment stake.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "DIS_10k_2022.pdf",
          "target_page": 12,
          "pages": [
            10,
            11,
            12,
            13,
            14
          ]
        },
        "hop_2_rel": {
          "source_file": "DIS_10k_2023.pdf",
          "target_page": 6,
          "pages": [
            4,
            5,
            6,
            7,
            8
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 9,
        "total_chars": 34637,
        "num_window_pages": 9,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 8883,
        "completion_tokens": 180,
        "total_tokens": 9063
      }
    },
    {
      "question_id": 76,
      "question": "How did the financial impact of GE's relationship with AerCap evolve between 2023 and 2024, particularly in terms of realized and unrealized gains or losses?",
      "original_answer": "In 2023, GE reported an unrealized gain of $129 million from its investment in and note with AerCap. However, in 2024, the relationship had evolved such that GE recognized a significant decrease in gains on retained and sold ownership interests, which dropped by $5.2 billion compared to 2023, with AerCap being one of the primary contributors to this decline. This indicates a negative shift in the financial performance of the AerCap investment from a gain in 2023 to a loss or significantly reduced gain in 2024.",
      "llm_answer": "The financial impact of GE's relationship with AerCap shifted from a $865 million unrealized loss in 2022 to a $129 million realized and unrealized gain in 2023, reflecting the full monetization of the AerCap investment during 2023. Consequently, the realized/unrealized gains recorded under “Investment in and note with AerCap” in Note 19 rose sharply to $129 million in 2023, while the prior year showed a $865 million loss.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "GE_10k_2023.pdf",
          "target_page": 72,
          "pages": [
            70,
            71,
            72,
            73,
            74
          ]
        },
        "hop_2_rel": {
          "source_file": "GE_10k_2024.pdf",
          "target_page": 8,
          "pages": [
            6,
            7,
            8,
            9,
            10
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 63693,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 16145,
        "completion_tokens": 106,
        "total_tokens": 16251
      }
    },
    {
      "question_id": 76,
      "question": "How has Mastercard's multi-layered security approach evolved between 2022 and 2024, particularly in terms of addressing risks associated with third-party service providers, and what does this evolution indicate about the company's strategic response to emerging cybersecurity threats?",
      "original_answer": "In 2022, Mastercard's multi-layered security approach included a robust program to protect its network from cyber and information security threats, with multiple layers of protection and third-party assessments. However, there was no explicit mention of addressing risks related to third-party service providers. By 2024, Mastercard explicitly integrated third-party provider risk management into its security framework, noting that it works with experts across the organization and through public-private partnerships to monitor and respond to threats associated with the use of services provided by third-party providers. This indicates a strategic shift toward strengthening the ecosystem-wide resilience of its security architecture, particularly in response to the growing complexity and interconnectedness of the payments landscape.",
      "llm_answer": "Mastercard’s multi-layered security approach has evolved from a primarily network‑centric model in 2022 to a more proactive, ecosystem‑wide strategy by 2024, explicitly incorporating safeguards for third‑party service providers.  The 2024 disclosures highlight new security‑focused initiatives such as the Alias‑Based Remittances and Payouts platform, expanded integration of Mastercard In Control™ virtual‑card controls, and tighter technical standards developed with issuers, acquirers and fintech partners to protect cross‑border and B2B payment flows.  This progression signals a strategic shift toward embedding security into every layer of the payments ecosystem—particularly at the interfaces with external providers—to stay ahead of emerging cyber threats and maintain trust in its global network.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MA_10k_2022.pdf",
          "target_page": 11,
          "pages": [
            9,
            10,
            11,
            12,
            13
          ]
        },
        "hop_2_rel": {
          "source_file": "MA_10k_2024.pdf",
          "target_page": 11,
          "pages": [
            9,
            10,
            11,
            12,
            13
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 43063,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 11019,
        "completion_tokens": 201,
        "total_tokens": 11221
      }
    },
    {
      "question_id": 76,
      "question": "How has Target Corporation's compliance with its debt leverage covenant evolved between 2022 and 2023, particularly in light of changes to its credit facilities?",
      "original_answer": "In 2022, Target Corporation stated that it was in compliance with its debt leverage covenant and expected to remain so, with a $3.0 billion unsecured revolving credit facility set to expire in October 2026. By 2023, Target had obtained a new $1.0 billion 364-day unsecured revolving credit facility (expiring in October 2024) and extended the expiration of its five-year $3.0 billion facility to October 2028. Despite these structural changes to its credit facilities, Target continued to assert compliance with the debt leverage covenant in 2023, indicating consistent adherence to regulatory requirements even as its financing arrangements evolved.",
      "llm_answer": "Between 2022 and 2023, Target Corporation’s debt leverage covenant compliance remained intact, supported by its investment-grade credit ratings (A from S&P, A2 from Moody’s, and A from Fitch) and the replacement of its prior $2.5 billion revolving credit facility with a new $3.0 billion facility expiring in October 2028 (later extended to 2028). The company maintained compliance with the debt‑leverage covenant throughout 2021–2023, and no credit‑rating downgrade triggered any mandatory repayment provisions. Consequently, the evolution of compliance reflects continued adherence to covenant requirements despite the credit‑facility restructuring.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "TGT_10k_2022.pdf",
          "target_page": 30,
          "pages": [
            28,
            29,
            30,
            31,
            32
          ]
        },
        "hop_2_rel": {
          "source_file": "TGT_10k_2023.pdf",
          "target_page": 33,
          "pages": [
            31,
            32,
            33,
            34,
            35
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 35370,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 9066,
        "completion_tokens": 162,
        "total_tokens": 9229
      }
    },
    {
      "question_id": 76,
      "question": "How has the nature of the risks associated with Salesforce's AI offerings, including generative AI such as Agentforce, evolved from 2023 to 2024?",
      "original_answer": "In 2023, Salesforce's primary risk related to third-party integrations and applications centered on potential claims or liabilities stemming from customer expectations for warranties, despite the company not developing or selling these third-party offerings. By 2024, the risk profile expanded significantly with the increased integration of AI into Salesforce's offerings, particularly generative and agentic AI like Agentforce. The 2024 disclosures highlight new risks such as ethical concerns, regulatory scrutiny, and potential legal liabilities from AI-generated content that may be inaccurate, biased, or infringe on copyright. Additionally, the company now anticipates increased costs related to AI governance, compliance, and testing, which were not specifically tied to AI in 2023.",
      "llm_answer": "The risks tied to Salesforce’s AI offerings—especially generative AI such as Agentforce—have shifted from a general focus on technology‑leadership and brand reputation in 2023 to a more specific set of concerns in 2024 about ethical and regulatory exposure, accuracy and bias in AI‑generated content, and heightened scrutiny from evolving AI‑related laws and standards. In 2023 the disclosures emphasized the need to keep pace with rapid AI innovation and the potential reputational damage of controversial AI use; by 2024 the filing explicitly calls out the “emerging ethical issues” of generative AI, the risk of inaccurate or copyrighted outputs, increased compliance costs, and the possibility of government or regulatory actions that could limit adoption and harm the brand.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CRM_10k_2023.pdf",
          "target_page": 23,
          "pages": [
            21,
            22,
            23,
            24,
            25
          ]
        },
        "hop_2_rel": {
          "source_file": "CRM_10k_2024.pdf",
          "target_page": 22,
          "pages": [
            20,
            21,
            22,
            23,
            24
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 63348,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 16057,
        "completion_tokens": 194,
        "total_tokens": 16252
      }
    },
    {
      "question_id": 77,
      "question": "How has Lowe's delivery capability for parcel-eligible items evolved between fiscal years 2023 and 2024, and what specific improvements were made?",
      "original_answer": "In fiscal year 2023, most parcel-eligible items could be delivered within two business days at standard shipping rates. By fiscal year 2024, Lowe's improved this capability, enabling delivery of most parcel-eligible items within two business days or less. Additionally, in 2024, Lowe's expanded its delivery capabilities to include next-day delivery for major appliances in nearly every zip code in the United States. This represents a refinement and expansion of their delivery speed and geographic coverage.",
      "llm_answer": "Between fiscal 2023 and 2024, Lowe’s delivery capability for parcel‑eligible items accelerated markedly.  In fiscal 2023 the company could ship most parcel‑eligible products within two business days, and by fiscal 2024 it had expanded same‑day delivery via its gig‑network and next‑day delivery of major appliances to nearly every U.S. ZIP code.  These improvements were driven by the rollout of a market‑based delivery model, expanded fulfillment‑center capacity, and broader use of its gig‑provider network, enabling faster, more reliable home delivery of online orders.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "LOW_10k_2023.pdf",
          "target_page": 6,
          "pages": [
            4,
            5,
            6,
            7,
            8
          ]
        },
        "hop_2_rel": {
          "source_file": "LOW_10k_2024.pdf",
          "target_page": 6,
          "pages": [
            4,
            5,
            6,
            7,
            8
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 46526,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 11849,
        "completion_tokens": 143,
        "total_tokens": 11992
      }
    },
    {
      "question_id": 77,
      "question": "How has the financial impact of the Dermstore LLC sale evolved from 2022 to 2023 in terms of Target's consolidated revenues and operating income?",
      "original_answer": "The financial impact of the Dermstore LLC sale remained minimal in both years, as Dermstore represented less than 1 percent of Target's consolidated revenues, operating income, and net assets in both 2022 and 2023. The sale, which occurred in February 2021, resulted in a $335 million pretax gain included in Net Other (Income)/Expense, and no significant post-sale financial contribution or change was observed in either year.",
      "llm_answer": "From 2022 to 2023, Target's consolidated revenues declined modestly by 1.6% (from $109.1 billion in 2022 to $107.4 billion in 2023), while operating income rose sharply by 48.3% (from $3.85 billion in 2022 to $5.71 billion in 2023), reflecting improved profitability despite lower sales.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "TGT_10k_2022.pdf",
          "target_page": 21,
          "pages": [
            19,
            20,
            21,
            22,
            23
          ]
        },
        "hop_2_rel": {
          "source_file": "TGT_10k_2023.pdf",
          "target_page": 24,
          "pages": [
            22,
            23,
            24,
            25,
            26
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 33016,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 8474,
        "completion_tokens": 71,
        "total_tokens": 8546
      }
    },
    {
      "question_id": 77,
      "question": "How has the strategic positioning of Data Cloud evolved between 2023 and 2024, particularly in terms of its role within Salesforce's broader service offerings and competitive landscape?",
      "original_answer": "In 2023, Data Cloud was described as a 'hyperscale, trusted data engine native to Salesforce' that unified enterprise data to deliver a 360-degree view of customers, emphasizing its integration across Salesforce's offerings like Marketing and Analytics. By 2024, Data Cloud was positioned within a broader context of competitive risk, with the filing noting that markets for offerings like Data Cloud are 'relatively new and uncertain,' and that Salesforce faces increasing competition as AI and data platforms evolve. Additionally, in 2024, Salesforce acknowledged limited experience in pricing consumption-based models like that of Data Cloud, signaling a shift from product-centric messaging to one that includes strategic risk and monetization challenges.",
      "llm_answer": "Between 2023 and 2024, Data Cloud’s strategic positioning shifted from being a foundational data engine to a central, AI‑enabled hub within Salesforce’s broader Customer 360 platform. The 2024 disclosures emphasize Data Cloud’s role in unifying disparate enterprise data, powering AI‑driven automation across Sales, Service, Marketing and Commerce, and serving as the backbone for new consumption‑based offerings such as Agentforce. This evolution places Data Cloud at the core of Salesforce’s growth strategy—driving deeper penetration with enterprise and international customers, expanding industry‑specific clouds, and differentiating Salesforce from competitors that lack an integrated, hyperscale data layer. Consequently, Data Cloud now functions not just as a data store but as a strategic differentiator that reinforces Salesforce’s end‑to‑end service ecosystem and intensifies the competitive battle in the enterprise cloud market.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CRM_10k_2023.pdf",
          "target_page": 7,
          "pages": [
            5,
            6,
            7,
            8,
            9
          ]
        },
        "hop_2_rel": {
          "source_file": "CRM_10k_2024.pdf",
          "target_page": 20,
          "pages": [
            18,
            19,
            20,
            21,
            22
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 53833,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 13687,
        "completion_tokens": 235,
        "total_tokens": 13922
      }
    },
    {
      "question_id": 78,
      "question": "How has LOW's treatment and accounting of forward interest rate swap contracts evolved between 2023 and 2024, particularly in terms of hedge designation and financial impact?",
      "original_answer": "In 2023, LOW disclosed forward interest rate swap contracts related to its March 2023 Notes with a notional amount of $2.0 billion, from which it received $247 million upon settlement. These contracts were designated as cash flow hedges and their (loss)/gain was recorded in other comprehensive (loss)/income and earnings. By 2024, the company clarified that its fixed-to-floating interest rate swap agreements are accounted for as fair value hedges using the shortcut method, under which the hedges are assumed perfectly effective. This resulted in no net impact on the consolidated statements of earnings from the fair value of the derivatives, indicating a shift in both hedge designation and accounting treatment compared to the prior year.",
      "llm_answer": "LOW's treatment of forward interest rate swap contracts as cash flow hedges remained consistent between 2023 and 2024, with no change in hedge designation methodology. The company continued to use the shortcut method for fair value hedges on its $850 million fixed-to-floating interest rate swaps, while cash flow hedges (including matured swaps from 2022-2023 note issuances) continued to be recorded in other comprehensive income before reclassification to earnings. The financial impact remained unchanged: matured swaps from 2023 note issuances generated a $247 million cash receipt, and the resulting gains/losses on cash flow hedges were still reported net of tax in OCI, with no material difference in accounting treatment between fiscal years.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "LOW_10k_2023.pdf",
          "target_page": 60,
          "pages": [
            58,
            59,
            60,
            61,
            62
          ]
        },
        "hop_2_rel": {
          "source_file": "LOW_10k_2024.pdf",
          "target_page": 58,
          "pages": [
            56,
            57,
            58,
            59,
            60
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 43558,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 11117,
        "completion_tokens": 187,
        "total_tokens": 11304
      }
    },
    {
      "question_id": 78,
      "question": "How has Target's strategy around its owned brands evolved from 2022 to 2023, particularly in terms of portfolio emphasis and strategic objectives?",
      "original_answer": "In 2022, Target highlighted a significant portion of sales coming from its owned brands, listing over 40 such brands across multiple categories, indicating a strong but descriptive presence in the market. By 2023, the company elevated its focus by strategically positioning owned brands as a core element of its overall strategy to 'delight with newness, style, and value,' explicitly aiming to strengthen the portfolio as part of broader efforts to drive traffic, sales, and market share growth. This shift reflects a move from simply showcasing owned brands to actively leveraging them as a strategic differentiator.",
      "llm_answer": "Target’s owned‑brand strategy remained focused on expanding and deepening its portfolio of exclusive labels—such as A New Day, Goodfellow & Co, and Universal Thread—while using these brands to drive traffic, increase market share, and differentiate the shopping experience. In 2023 the company emphasized growing the breadth and depth of its owned‑brand assortment and leveraging partnerships (e.g., exclusive design collaborations) to enhance relevance and value for guests, continuing the same strategic pillars introduced in 2021 but with a stronger emphasis on owned‑brand growth as a core driver of sales and differentiation.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "TGT_10k_2022.pdf",
          "target_page": 5,
          "pages": [
            3,
            4,
            5,
            6,
            7
          ]
        },
        "hop_2_rel": {
          "source_file": "TGT_10k_2023.pdf",
          "target_page": 3,
          "pages": [
            1,
            2,
            3,
            4,
            5
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 9,
        "total_chars": 25468,
        "num_window_pages": 9,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 6585,
        "completion_tokens": 157,
        "total_tokens": 6742
      }
    },
    {
      "question_id": 79,
      "question": "How has GM's approach to software-enabled services evolved from 2022 to 2023, particularly in terms of service offerings and platform deployment, and what does this indicate about the company's investment in scalable digital solutions?",
      "original_answer": "In 2022, GM described its software-enabled services in general terms as part of its broader operations, noting that it 'provides software-enabled services worldwide' and integrates them into its automotive business alongside investments in AV technology and automotive financing. By 2023, GM's approach had evolved significantly, with specific details on its end-to-end software platform that enables over-the-air updates for features like Super Cruise, active safety, infotainment, and EV ownership experience. The 2023 filing highlights that select 2024 models, such as the Cadillac LYRIQ and Chevrolet Silverado EV, were already using this platform, indicating a strategic shift toward scalable, software-defined vehicles. This evolution shows a transition from general involvement in digital services to concrete platform deployment across product lines, reflecting increased investment and operational maturity in software-enabled offerings.",
      "llm_answer": "From 2022 to 2023, GM significantly expanded its software-enabled services and platform deployment, shifting from foundational connectivity (e.g., OnStar) to a broader, scalable ecosystem of subscription-based features and over-the-air updates. This included launching an end-to-end software platform for vehicle performance, safety, and infotainment (e.g., Super Cruise, climate controls), integrating with Tesla Superchargers, and expanding its Ultium EV architecture to enable rapid software updates across models. These efforts reflect a strategic pivot toward monetizing software-defined vehicles, with GM Financial and Cruise (its AV subsidiary) further embedding digital services into core operations—evidenced by $9.9 billion in R&D spending in 2023 and dedicated EV manufacturing investments—to build a sustainable, scalable digital revenue stream beyond traditional automotive sales.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "GM_10k_2022.pdf",
          "target_page": 60,
          "pages": [
            58,
            59,
            60,
            61,
            62
          ]
        },
        "hop_2_rel": {
          "source_file": "GM_10k_2023.pdf",
          "target_page": 5,
          "pages": [
            3,
            4,
            5,
            6,
            7
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 55420,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 14096,
        "completion_tokens": 223,
        "total_tokens": 14319
      }
    },
    {
      "question_id": 79,
      "question": "How has the revenue contribution from ThousandEyes within the Optimized Application Experiences/Observability product category evolved between fiscal years 2022 and 2023?",
      "original_answer": "In fiscal year 2022, the Optimized Application Experiences category, which included ThousandEyes, saw revenue growth of $75 million (11%), driven by ThousandEyes and Intersight. By fiscal year 2023, the Observability category (which includes ThousandEyes) experienced a revenue increase of $80 million (14%), specifically attributed to growth in ThousandEyes and monitoring and analytics offerings. This shows a continued upward trend in ThousandEyes' revenue contribution, with both absolute and percentage growth increasing from 2022 to 2023.",
      "llm_answer": "The revenue contribution from ThousandEyes within the Optimized Application Experiences/Observability product category grew from $661 million in fiscal 2023 to $837 million in fiscal 2024, reflecting a 27% increase. This growth was driven by expansion of the ThousandEyes offering and contributions from the broader Observability suite.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CSCO_10k_2022.pdf",
          "target_page": 45,
          "pages": [
            43,
            44,
            45,
            46,
            47
          ]
        },
        "hop_2_rel": {
          "source_file": "CSCO_10k_2023.pdf",
          "target_page": 42,
          "pages": [
            40,
            41,
            42,
            43,
            44
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 41825,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 10683,
        "completion_tokens": 84,
        "total_tokens": 10767
      }
    },
    {
      "question_id": 80,
      "question": "How did the treatment of Amendment No. 4 to the Lockheed Martin Executive Severance Plan evolve between the 2023 and 2024 10-K filings, and what does this indicate about its inclusion in the company's disclosure strategy?",
      "original_answer": "In the 2023 10-K filing, Amendment No. 4 to the Executive Severance Plan was disclosed as part of the exhibit list (Exhibit 10.34) and referenced as being incorporated from the September 2022 10-Q filing. However, in the 2024 10-K filing, Amendment No. 4 is no longer listed as a standalone exhibit but appears instead as part of a sequence that includes earlier amendments (Nos. 2, 3, 4, and 5), with Amendment No. 4 specifically incorporated from the same September 2022 10-Q filing. This indicates that while the amendment itself remained relevant, its treatment shifted from a highlighted disclosure in 2023 to a more integrated part of the broader severance plan history in 2024, suggesting a more consolidated and retrospective approach to disclosure.",
      "llm_answer": "The treatment of Amendment No. 4 to the Lockheed Martin Executive Severance Plan shows it was first referenced in the 2023 10-K (page 104) as \"Amendment No. 4\" to the plan, but by the 2024 filing (page 104), it was formally listed as \"Amendment No. 4\" with a specific quarterly report citation (September 25, 2022). This evolution indicates Lockheed Martin strategically delayed explicit disclosure of the amendment until it was material enough to warrant formal inclusion in the executive compensation documentation, reflecting a deliberate disclosure strategy to manage regulatory visibility while maintaining transparency about plan modifications.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "LMT_10k_2023.pdf",
          "target_page": 104,
          "pages": [
            100,
            101,
            102,
            103,
            104
          ]
        },
        "hop_2_rel": {
          "source_file": "LMT_10k_2024.pdf",
          "target_page": 105,
          "pages": [
            102,
            103,
            104,
            105,
            106
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 55683,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 14162,
        "completion_tokens": 162,
        "total_tokens": 14325
      }
    },
    {
      "question_id": 80,
      "question": "How did JPMorgan's compliance with capital ratio requirements evolve from 2023 to 2024, particularly in terms of its Tier 1 leverage ratio and Standardized CET1 capital ratio?",
      "original_answer": "In 2023, JPMorgan's Standardized CET1 capital ratio was 15.0%, exceeding the requirement of 11.4%. In 2024, the Tier 1 leverage ratio was 7.2%, which was above the requirement of 4.0%. This indicates that JPMorgan maintained compliance with capital ratio requirements across both years, with consistent capital strength relative to evolving regulatory expectations.",
      "llm_answer": "From 2023 to 2024, JPMorgan's CET1 capital ratio increased from 15.0% to 15.7% (and 15.8% under the Advanced approach), while its Tier 1 capital ratio rose from 16.6% to 16.8% (16.9% under the Advanced approach). The leverage‑based Tier 1 leverage ratio remained steady at 7.2% in both years, with the regulatory minimum unchanged at 4.0%. Thus, the firm’s capital ratios improved modestly, especially the CET1 ratio, while maintaining comfortable leverage coverage.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "JPM_10k_2023.pdf",
          "target_page": 98,
          "pages": [
            96,
            97,
            98,
            99,
            100
          ]
        },
        "hop_2_rel": {
          "source_file": "JPM_10k_2024.pdf",
          "target_page": 104,
          "pages": [
            102,
            103,
            104,
            105,
            106
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 54351,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 13817,
        "completion_tokens": 116,
        "total_tokens": 13933
      }
    },
    {
      "question_id": 80,
      "question": "How has the role of GM Financial in General Motors' operations evolved between 2022 and 2023, particularly in terms of its integration and financial presentation within the consolidated financial statements?",
      "original_answer": "In 2022, GM Financial was described as a segment through which General Motors provides automotive financing services, with its financials adjusted to reflect the impact of consolidated tax returns and intercompany transactions. By 2023, the description of GM Financial became more detailed, emphasizing that the amounts presented for GM Financial are adjusted for the impact on deferred tax positions and the provision for income taxes due to its inclusion in the consolidated tax return, and that these amounts differ from those presented on a stand-alone basis. This evolution reflects a more explicit focus on the integration and financial alignment of GM Financial with the broader corporate structure.",
      "llm_answer": "Between 2022 and 2023, GM Financial’s role evolved from being presented as a distinct segment within the consolidated financial statements to a more integrated component of GM’s overall operations. In 2023, GM Financial’s revenue and earnings were included in the consolidated totals under \"Total consolidated\" in the segment reporting tables, and its financial results were no longer separately identified as a distinct segment in the notes. Instead, its revenue and earnings were aggregated within the broader \"Automotive\" and \"Total consolidated\" figures, reflecting a tighter integration into GM’s core financial presentation. This is evident in the 2023 consolidated income statement where GM Financial’s $13,831 million revenue and $2,702 million earnings before interest and taxes are now part of the total $122,485 million revenue and $9,710 million earnings before interest and taxes, without separate segment disclosure. Additionally, the 2023 cash flow statement shows GM Financial’s financing activities (e.g., $50,963 million in debt proceeds and $44,675 million in debt payments) are now reported as part of the consolidated financing cash flows, rather than being isolated in a separate segment. This shift underscores a move toward consolidating GM Financial’s financial impact within GM’s overall consolidated results, rather than presenting it as a standalone segment.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "GM_10k_2022.pdf",
          "target_page": 99,
          "pages": [
            97,
            98,
            99,
            100,
            101
          ]
        },
        "hop_2_rel": {
          "source_file": "GM_10k_2023.pdf",
          "target_page": 63,
          "pages": [
            61,
            62,
            63,
            64,
            65
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 83723,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 21166,
        "completion_tokens": 346,
        "total_tokens": 21513
      }
    },
    {
      "question_id": 80,
      "question": "How has the treatment and disclosure of step-rent provisions in lease accounting evolved between 2022 and 2024, particularly regarding the recognition of periodic rent increases based on price indices or sales volume?",
      "original_answer": "In 2022, the company disclosed that certain leases provided for periodic rent increases based on price indices or the greater of minimum guaranteed amounts or sales volume, and these were accounted for on a straight-line basis. By 2024, the company clarified that such increases, based on price indices or the greater of minimum guaranteed amounts or sales volume, are now recognized as variable lease payments rather than being straight-lined, indicating a shift in accounting treatment. This reflects a more dynamic approach to recognizing lease costs that fluctuate with external factors.",
      "llm_answer": "The treatment of step‑rent provisions in lease accounting has remained consistent between 2022 and 2024: periodic rent increases tied to price indices or sales volume are recognized as variable lease payments on a straight‑line basis over the lease term (including any renewal options that are reasonably certain to be exercised). Both the 2022 and 2024 filings disclose that such step‑rent provisions are accounted for as variable lease payments and are not recognized as separate lease components, with no material impact on the financial statements.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "COST_10k_2022.pdf",
          "target_page": 45,
          "pages": [
            43,
            44,
            45,
            46,
            47
          ]
        },
        "hop_2_rel": {
          "source_file": "COST_10k_2024.pdf",
          "target_page": 45,
          "pages": [
            43,
            44,
            45,
            46,
            47
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 43614,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 11142,
        "completion_tokens": 138,
        "total_tokens": 11280
      }
    },
    {
      "question_id": 81,
      "question": "How did the projected funding obligations for Lockheed Martin's qualified defined benefit pension plans evolve from 2023 to 2024, particularly in terms of the amounts expected to be paid out in 2025 and over the long-term period from 2029 to 2033?",
      "original_answer": "In 2023, Lockheed Martin projected $1,860 million in payments for qualified defined benefit pension plans in 2025 and $10,020 million over the period from 2029 to 2033. By 2024, the projected payment for 2025 increased slightly to $1,860 million, while the long-term projection from 2030 to 2034 decreased to $9,990 million. This indicates a marginal reduction in long-term pension obligations.",
      "llm_answer": "Based on the provided document pages, the projected funding obligations for Lockheed Martin's qualified defined benefit pension plans show the following evolution from 2023 to 2024:\n\n1.  **2025 Payment:** The estimated benefit payment for 2025 increased slightly from **$1,860 million (2023)** to **$1,860 million (2024)** in the most recent table (page 88, 2024 data), indicating stability in the near-term payment amount.\n2.  **Long-Term (2029-2033):** The projected payments over the long-term period (2029-2033) increased significantly from **$10,020 million (2023)** to **$9,990 million (2024)**. This reflects a slight decrease in the total long-term projection ($10,020M vs. $9,990M), but the key point is the *increase in the 2025 payment* relative to the prior year's 2025 figure ($1,860M), with the long-term total remaining substantial at approximately $10 billion.\n\n**In summary:** The projected 2025 payment remained flat at $1,860 million from 2023 to 2024, while the long-term funding obligation (2029-2033) remained very large, totaling approximately $10 billion (specifically $9,990 million in the 2024 projection). The document confirms no expected required contributions to qualified pension plans in 2024 or 2025, with payments expected to be funded from plan assets.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "LMT_10k_2023.pdf",
          "target_page": 88,
          "pages": [
            86,
            87,
            88,
            89,
            90
          ]
        },
        "hop_2_rel": {
          "source_file": "LMT_10k_2024.pdf",
          "target_page": 89,
          "pages": [
            87,
            88,
            89,
            90,
            91
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 49302,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 12571,
        "completion_tokens": 321,
        "total_tokens": 12893
      }
    },
    {
      "question_id": 81,
      "question": "How did JPMorgan Chase's disclosures about its resolution plan obligations evolve between 2023 and 2024, particularly in terms of its described liquidity risk management strategies and funding cost considerations?",
      "original_answer": "In 2023, JPMorgan Chase emphasized that its resolution plan obligations could lead to higher funding costs and constrained liquidity due to the need to satisfy liquidity coverage ratio and net stable funding ratio requirements, as well as regulatory demands outside the U.S. regarding liquidity pre-positioning in subsidiaries. The firm highlighted the potential need to rely on more expensive or limited alternative funding sources if traditional ones like deposits or Federal Home Loan Bank borrowings were reduced. In 2024, the firm expanded its disclosures to include how resolution plan obligations interacted with dynamic regulatory expectations and systemic events, noting that changes in laws, rules, and regulations—especially in response to economic effects of systemic events—could further impact liquidity and capital requirements. This reflects a shift toward framing resolution-related liquidity risks within a broader context of regulatory evolution and macroeconomic uncertainty.",
      "llm_answer": "Between 2023 and 2024, JPMorgan Chase’s disclosures reveal a more explicit articulation of its liquidity risk management and funding cost considerations. In the 2023 filing, the firm highlighted that liquidity could be constrained by external shocks—such as market stress, loss of depositor confidence, or sudden outflows—that are largely outside its control, and it noted that funding cost pressures could arise from the need to meet coverage ratios, resolution‑plan obligations, or foreign regulatory liquidity requirements. By the 2024 filing, the discussion expands to stress the interdependence of its holding‑company structure on subsidiary dividends and intercompany lending, emphasizing that any inability to obtain those cash flows would impair its capacity to service debt, pay dividends, or repurchase securities. Consequently, the 2024 text underscores that funding‑cost increases may stem not only from market‑wide illiquidity but also from regulatory mandates tied to its resolution plan and from heightened reliance on alternative, potentially more expensive, funding sources if stable, lower‑cost deposits or Federal Home Loan Bank borrowings become less accessible. This evolution reflects a deeper focus on how resolution‑plan obligations and associated liquidity pre‑positioning requirements directly influence the firm’s funding cost trajectory.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "JPM_10k_2023.pdf",
          "target_page": 21,
          "pages": [
            19,
            20,
            21,
            22,
            23
          ]
        },
        "hop_2_rel": {
          "source_file": "JPM_10k_2024.pdf",
          "target_page": 22,
          "pages": [
            20,
            21,
            22,
            23,
            24
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 53595,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 13636,
        "completion_tokens": 341,
        "total_tokens": 13977
      }
    },
    {
      "question_id": 81,
      "question": "How has the financial structure of Optum Rx's pharmacy care services evolved between 2022 and 2023, particularly in terms of revenue recognition and accounts receivable?",
      "original_answer": "In 2022, Optum Rx's pharmacy care services were characterized by a gross revenue reporting model due to the Company's primary obligation to pay network pharmacy providers regardless of payment collection, with revenue recognized at the point of prescription dispensing. By 2023, the financial structure remained aligned with this model but showed an increase in accounts receivable related to products and services, rising from $7.1 billion in 2022 to $8.6 billion in 2023. This indicates a growth in the value of receivables tied to pharmacy care services, suggesting either increased transaction volume or changes in payment timing.",
      "llm_answer": "Between 2022 and 2023, the financial structure of Optum Rx’s pharmacy care services evolved primarily through changes in revenue recognition and accounts receivable related to pharmaceutical manufacturer rebates. As disclosed in the 2023 10-K (page 48), total pharmaceutical manufacturer rebates receivable in other current receivables increased to $11.0 billion from $8.2 billion in 2022, reflecting growth in rebate accruals tied to client usage of manufacturer products. Revenue from pharmacy care services is recognized upon dispensing of prescriptions (page 45), with rebates recorded as a reduction to product revenue and accrued as rebates receivable when earned monthly under contract terms. The Company generally collects rebates two to five months after billing, which impacts the timing of accounts receivable recognition. This evolution underscores a shift toward more structured accrual-based revenue recognition and increased reliance on rebate-driven reimbursement models within Optum Rx’s operations.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "UNH_10k_2022.pdf",
          "target_page": 6,
          "pages": [
            4,
            5,
            6,
            7,
            8
          ]
        },
        "hop_2_rel": {
          "source_file": "UNH_10k_2023.pdf",
          "target_page": 46,
          "pages": [
            44,
            45,
            46,
            47,
            48
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 56881,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 14445,
        "completion_tokens": 254,
        "total_tokens": 14699
      }
    },
    {
      "question_id": 82,
      "question": "How has UPS's quantitative exposure and strategic approach to managing interest rate risk through Floating to Fixed Interest Rate Swaps evolved between 2022 and 2024?",
      "original_answer": "In 2022, UPS disclosed a $28 million notional amount for Floating to Fixed Interest Rate Swaps, indicating limited use of this instrument at that time. By 2024, UPS articulated a broader strategy to 'manage the fixed and floating interest rate mix of its total debt portfolio and related overall cost of borrowing,' suggesting a more intentional and strategic deployment of these swaps. This evolution reflects a shift from a minor, quantitative hedge in 2022 to a more comprehensive interest rate risk management approach in 2024.",
      "llm_answer": "Between 2022 and 2024, UPS's quantitative exposure to interest rate risk through Floating-to-Fixed Interest Rate Swaps evolved as follows:  \n\n1.  **Quantitative Disclosure Shift**: While 2022 and 2023 10-Ks (pages 136-138 of 2022 and 134-138 of 2024) detailed interest rate swap activity within \"Note 17. Derivative Instruments and Risk Management,\" specifically under \"Interest Rate Risk Management,\" the 2024 filing (page 136) explicitly states that interest rate swaps converting *fixed-rate to floating-rate* are designated as **fair value hedges** of associated debt instruments. This represents a clearer articulation of the *purpose* and *accounting treatment* of these swaps compared to prior years, where the focus was more on the *existence* of swaps rather than their specific hedge designation.  \n\n2.  **Strategic Focus on Fixed-Rate Debt Hedging**: The 2024 document (page 136) emphasizes that these swaps are used to manage the *fixed and floating interest rate mix* of the *total debt portfolio*, with specific examples like hedging fixed-coupon interest payments via forward-starting swaps. This strategic focus on *proactively managing the overall debt structure* (including hedging anticipated debt offerings) is more pronounced in the 2024 filing than in the 2022/2023 disclosures, which primarily described swap activity without explicitly linking it to portfolio-wide debt strategy.  \n\n3.  **Quantitative Exposure Context**: The 2024 filing (page 137) shows no outstanding *commodity* hedges, but details *foreign currency* hedges (e.g., Euro, GBP, CAD) as the primary derivative exposure. While interest rate swaps are mentioned in the risk management policies (page 136), the *quantitative exposure* (notional amounts, fair value impacts) for interest rate swaps is *not explicitly quantified* in the provided 2024 pages (unlike foreign currency swaps, which have disclosed notional values). This contrasts with the 2022 filing (page 137), which listed specific interest rate swap notional amounts ($1,200M floating-to-fixed as of 2022), indicating a *more transparent quantitative disclosure* of swap exposure in prior years.  \n\n**In summary**: UPS shifted from a more descriptive approach to interest rate swaps in 2022/2023 to a clearer strategic articulation of using *fixed-to-floating swaps as fair value hedges* for debt portfolio management in 2024, though quantitative exposure details (like notional amounts) were less emphasized in the 2024 excerpt provided compared to 2022. The core strategy of using swaps to manage interest rate risk remained consistent, but the *framing* of the hedge purpose and accounting designation became more precise in 2024.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "UPS_10k_2022.pdf",
          "target_page": 155,
          "pages": [
            136,
            137,
            138,
            139,
            140
          ]
        },
        "hop_2_rel": {
          "source_file": "UPS_10k_2024.pdf",
          "target_page": 136,
          "pages": [
            134,
            135,
            136,
            137,
            138
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 8,
        "total_chars": 39945,
        "num_window_pages": 8,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 10214,
        "completion_tokens": 671,
        "total_tokens": 10886
      }
    },
    {
      "question_id": 82,
      "question": "How has GM's financial relationship with LG Energy Solution evolved between 2022 and 2023, particularly in terms of joint venture activities and recall-related costs?",
      "original_answer": "In 2022, GM highlighted its joint venture, Ultium Cells LLC, with LG Energy Solution, as a key part of its EV strategy to mass-produce battery cells across three U.S. plants. By 2023, the relationship had shifted toward financial liabilities, as GM accrued $2.6 billion related to the Chevrolet Bolt EV battery recall, with $1.6 billion recognized as receivables from LG. This marks a transition from strategic collaboration to a more transactional and cost-driven dynamic due to product defects.",
      "llm_answer": "Between 2022 and 2023, GM's financial relationship with LG Energy Solution evolved significantly through its joint venture **Ultium Cells LLC**, which is equally owned by GM and LG Energy Solution. During this period, GM expanded Ultium battery production capacity to support its EV rollout, including new plants in Lordstown, Ohio, Spring Hill, Tennessee, and Lansing, Michigan, with a fourth U.S. plant planned by mid-decade. The collaboration intensified as GM scaled production of Ultium-based vehicles like the GMC HUMMER EV, Chevrolet Silverado EV, and BrightDrop EV600/EV410, while also integrating LG's battery technology into its EV strategy. \n\nRegarding recall-related costs, GM expanded its 2021 Chevrolet Bolt EV/EUV recall in August 2021 to include all 2017–2022 model years after determining battery cell defects were not confined to the initial population. LG Energy Solution agreed to reimburse GM for certain recall costs and resolved commercial matters related to the joint venture. By December 31, 2023, GM had accrued a total of **$2.6 billion** for recall-related expenses and recognized **$1.6 billion in receivables** from LG, with a remaining accrual of **$600 million** at year-end. This reflects GM's current best estimate of recall remedy costs, which could vary materially. The partnership also involved broader commercial negotiations tied to the Ultium joint venture, though specific financial impacts beyond the recall accruals were not detailed in the provided disclosures.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "GM_10k_2022.pdf",
          "target_page": 4,
          "pages": [
            2,
            3,
            4,
            5,
            6
          ]
        },
        "hop_2_rel": {
          "source_file": "GM_10k_2023.pdf",
          "target_page": 92,
          "pages": [
            90,
            91,
            92,
            93,
            94
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 58939,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 14958,
        "completion_tokens": 376,
        "total_tokens": 15334
      }
    },
    {
      "question_id": 82,
      "question": "How has the revenue contribution from ThousandEyes within the Observability product category evolved from fiscal 2022 to fiscal 2023?",
      "original_answer": "In fiscal 2022, revenue in the Observability product category increased by $80 million, driven in part by growth in ThousandEyes and monitoring and analytics offerings. By fiscal 2023, the Observability product category saw a 27% revenue increase, or $176 million, with ThousandEyes and the newly included Splunk offering (Observability Suite) being key contributors. Excluding Splunk, product revenue from Observability still grew by 15%, indicating strong organic growth primarily from ThousandEyes.",
      "llm_answer": "Based on the document pages, the revenue contribution from ThousandEyes within the Observability product category increased from fiscal 2022 to fiscal 2023. Specifically, revenue in the Observability product category grew by 14% in fiscal 2023 compared to fiscal 2022, driven by growth in the ThousandEyes offering and monitoring and analytics offerings, with product revenue in the category increasing 15% (not including Splunk's contribution). The document explicitly states that revenue in the Observability product category increased by 14% in fiscal 2023 versus fiscal 2022, driven by growth in ThousandEyes and monitoring and analytics offerings.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CSCO_10k_2022.pdf",
          "target_page": 8,
          "pages": [
            6,
            7,
            8,
            9,
            10
          ]
        },
        "hop_2_rel": {
          "source_file": "CSCO_10k_2023.pdf",
          "target_page": 42,
          "pages": [
            40,
            41,
            42,
            43,
            44
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 46034,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 11725,
        "completion_tokens": 163,
        "total_tokens": 11888
      }
    },
    {
      "question_id": 83,
      "question": "How has UPS's relationship with the 7.620% Debentures evolved between 2022 and 2024 in terms of their redemption terms and interest payment structure?",
      "original_answer": "In 2022, the 7.620% Debentures had a principal amount of $276 million with a maturity date of April 1, 2030, and were listed with a carrying value of $280 million. By 2024, UPS clarified that these debentures are redeemable at any time at the company's option, with a redemption price equal to the greater of the principal amount plus accrued interest or the present value of remaining scheduled payments discounted at a benchmark treasury yield plus five basis points, plus accrued interest. Additionally, the interest payment structure was specified as semi-annual, payable in April and October. This evolution reflects a shift from a general description of the debentures in 2022 to a more detailed explanation of their redemption flexibility and interest payment schedule in 2024.",
      "llm_answer": "UPS's 7.620% debentures, with a $276 million principal and maturity in 2030, saw their interest rate reduced from 8.375% to 7.620% effective April 1 2020 for the remaining term. The debentures are callable at any time, with redemption priced as the greater of principal plus accrued interest or the present value of remaining payments discounted at a benchmark Treasury yield plus five basis points, plus accrued interest; interest is paid semi‑annually in April and October. No material changes to these terms occurred between 2022 and 2024.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "UPS_10k_2022.pdf",
          "target_page": 118,
          "pages": [
            116,
            117,
            118,
            119,
            120
          ]
        },
        "hop_2_rel": {
          "source_file": "UPS_10k_2024.pdf",
          "target_page": 108,
          "pages": [
            106,
            107,
            108,
            109,
            110
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 9,
        "total_chars": 32898,
        "num_window_pages": 9,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 8448,
        "completion_tokens": 135,
        "total_tokens": 8584
      }
    },
    {
      "question_id": 83,
      "question": "How did the composition and total fair value of Fixed Maturity Securities AFS held by MET evolve from 2022 to 2023, particularly in terms of U.S. government bonds and corporate securities?",
      "original_answer": "In 2022, MET reported a carrying amount of $2,164 million for Fixed Maturity Securities AFS as of December 31, 2021. By 2023, the total estimated fair value of Fixed Maturity Securities AFS had increased significantly to $6,714 million. Specifically, the fair value of corporate securities rose to $3,083 million, with $3,029 million categorized under Level 2, while U.S. government bonds increased to $1,575 million, with $1,537 million under Level 1. This reflects a substantial transformation in both the size and breakdown of these investments over the year.",
      "llm_answer": "From 2022 to 2023, the fair value of Fixed Maturity Securities AFS in MET’s portfolio declined slightly from $6,802 million to $6,714 million, with the proportion allocated to U.S. government bonds falling from 23 % to 23 % (essentially stable) and corporate securities decreasing from 45 % to 54 % of the total AFS allocation. The share of foreign bonds rose modestly from 11 % to 12 % of the AFS mix, while the overall composition remained heavily weighted toward high‑quality government and corporate debt, with corporate securities comprising the largest single segment of the portfolio.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MET_10k_2022.pdf",
          "target_page": 250,
          "pages": [
            248,
            249,
            250,
            251,
            252
          ]
        },
        "hop_2_rel": {
          "source_file": "MET_10k_2023.pdf",
          "target_page": 308,
          "pages": [
            306,
            307,
            308,
            309,
            310
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 81593,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 20631,
        "completion_tokens": 147,
        "total_tokens": 20779
      }
    },
    {
      "question_id": 83,
      "question": "How has General Motors' relationship with Ultium Cells LLC evolved from 2022 to 2023, particularly in terms of financial involvement and regulatory implications?",
      "original_answer": "In 2022, General Motors reported a direct financial investment of $0.5 billion in Ultium Cells LLC as part of its investing activities. By 2023, the nature of GM's relationship with Ultium Cells LLC had evolved from a primarily investment-based relationship to a more operationally integrated partnership, evidenced by GM's involvement in regulatory violations related to the joint venture. Specifically, in February 2023, GM self-disclosed potential violations of the Toxic Substances Control Act (TSCA) related to Ultium Cells LLC to the EPA, which resulted in a November 2023 settlement involving joint civil penalties estimated at approximately $5.1 million. This indicates a shift from a passive investment to a more active and operationally entangled partnership with associated regulatory responsibilities.",
      "llm_answer": "From 2022 to 2023, GM’s financial involvement with Ultium Cells LLC shifted from an initial capital investment of $1.0 billion in 2021 to a $0.5 billion cash outflow in 2021 (reflected in the 2021 investing activities table) and continued through 2023 as part of ongoing joint‑venture funding.  The most significant regulatory development was a 2023 EPA settlement of potential TSCA violations tied to the Ultium Cells joint venture, which required GM and Ultium Cells to pay civil penalties estimated at about $5.1 million (subject to growth) and incorporated the matter into GM’s legal disclosures.  This settlement marked the first major regulatory action directly involving Ultium Cells during the 2022‑2023 period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "GM_10k_2022.pdf",
          "target_page": 42,
          "pages": [
            40,
            41,
            42,
            43,
            44
          ]
        },
        "hop_2_rel": {
          "source_file": "GM_10k_2023.pdf",
          "target_page": 28,
          "pages": [
            26,
            27,
            28,
            29,
            30
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 45937,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 11708,
        "completion_tokens": 179,
        "total_tokens": 11887
      }
    },
    {
      "question_id": 83,
      "question": "How has the company's use of variable-priced contracts for natural gas and fuel purchases evolved between 2022 and 2024?",
      "original_answer": "In 2022, the company entered into variable-priced contracts for some purchases of natural gas and fuel for its gas stations on an index basis, though the specific volume or value of these contracts was not disclosed. By 2024, the company continued using variable-priced contracts for similar purchases and explicitly noted that these contracts met the characteristics of derivative instruments but generally qualified for the 'normal purchases and normal sales' exception, requiring no mark-to-market adjustment. This indicates a more formalized or strategic use of variable-priced contracts by 2024, aligning them with accounting frameworks for derivatives, suggesting a shift in how these contracts are managed or accounted for.",
      "llm_answer": "Based on the provided SEC 10-K excerpts, the company's use of variable-priced contracts for natural gas and fuel purchases has remained consistent in structure but expanded in scope between 2022 and 2024. The company continues to enter into variable-priced contracts on an index basis for natural gas purchases (including for its gas stations) and for fuel at certain warehouses, primarily in the U.S. and Canada, as noted in the 2022 and 2024 documents. While the core mechanism (index-based variable pricing) has not changed, the 2024 filing specifically references these contracts as part of its strategy to \"partially mitigate\" energy price fluctuations, indicating ongoing reliance on this approach. The documents confirm no shift away from variable pricing, with the 2024 context showing continued use of index-based agreements for natural gas and fuel purchases, though the scale of such contracts appears to have grown slightly (e.g., reference to \"some purchases\" in 2022 vs. explicit mention of \"some purchases of natural gas\" in 2024). No evidence suggests a strategic pivot to fixed pricing; the evolution is one of continued, stable use of variable-priced contracts within the same risk management framework.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "COST_10k_2022.pdf",
          "target_page": 46,
          "pages": [
            44,
            45,
            46,
            47,
            48
          ]
        },
        "hop_2_rel": {
          "source_file": "COST_10k_2024.pdf",
          "target_page": 47,
          "pages": [
            45,
            46,
            47,
            48,
            49
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 43779,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 11159,
        "completion_tokens": 305,
        "total_tokens": 11464
      }
    },
    {
      "question_id": 83,
      "question": "How has Cisco's financial reporting approach for the APJC segment evolved between fiscal 2022 and fiscal 2023, particularly in terms of the expense categories excluded from segment performance measurement?",
      "original_answer": "Cisco's financial reporting for the APJC segment maintained a consistent exclusion of key expense categories from segment performance measurement in both fiscal 2022 and fiscal 2023. In fiscal 2022, the company explicitly excluded research and development, sales and marketing, and general and administrative expenses from segment financial decisions and resource allocations. This approach remained unchanged in fiscal 2023, with the same categories of expenses—along with amortization and impairment of acquisition-related intangible assets, share-based compensation expense, significant litigation settlements, and charges related to asset impairments and restructurings—not being allocated to the gross margin for each segment. The consistency in exclusions indicates no change in how APJC's performance was internally measured across the two fiscal years.",
      "llm_answer": "Between fiscal 2022 and fiscal 2023, Cisco’s APJC segment reporting remained consistent in its methodology, continuing to exclude certain expenses from segment performance measurement—specifically, it does not allocate research and development, sales and marketing, general and administrative expenses, amortization of acquisition-related intangibles, share-based compensation, significant litigation settlements, contingencies, asset impairment and restructuring charges, or other discrete charges to its segment gross margin. This approach was unchanged from prior periods, indicating no evolution in how the APJC segment excludes expense categories during that timeframe.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CSCO_10k_2022.pdf",
          "target_page": 105,
          "pages": [
            103,
            104,
            105,
            106,
            107
          ]
        },
        "hop_2_rel": {
          "source_file": "CSCO_10k_2023.pdf",
          "target_page": 104,
          "pages": [
            102,
            103,
            104,
            105,
            106
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 35699,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 9163,
        "completion_tokens": 168,
        "total_tokens": 9331
      }
    },
    {
      "question_id": 83,
      "question": "How has UNH's approach to managing medical cost trends evolved from 2022 to 2023, particularly in terms of strategies to address rising outpatient procedure costs for seniors?",
      "original_answer": "In 2022, UNH expressed concern over increased medical care costs due to deferred care during the pandemic and the potential for higher demand for services, especially among individuals with chronic conditions. The company emphasized the importance of accurate cost prediction and effective management under risk-based arrangements. By 2023, UNH specifically identified rising outpatient procedure costs for seniors as a persistent trend, expecting it to continue into 2024 and beyond. In response, the company shifted toward more proactive strategies, such as engaging physicians and consumers with data-driven insights to guide clinical decisions and promote affordable, high-quality care. This represents a shift from general concern in 2022 to targeted intervention in 2023.",
      "llm_answer": "UNH's approach to managing medical cost trends evolved from 2022 to 2023 by intensifying focus on outpatient care for seniors, as evidenced by the 2023 MCR increase driven by \"elevated care activity, primarily relating to outpatient care for seniors\" (page 27), while continuing to leverage data analytics and care coordination to address rising costs. The company specifically cited efforts to \"engage physicians and consumers with information and help them make clinically sound choices\" to achieve \"high-quality, affordable care\" amid persistent outpatient procedure cost pressures for seniors.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "UNH_10k_2022.pdf",
          "target_page": 16,
          "pages": [
            14,
            15,
            16,
            17,
            18
          ]
        },
        "hop_2_rel": {
          "source_file": "UNH_10k_2023.pdf",
          "target_page": 27,
          "pages": [
            25,
            26,
            27,
            28,
            29
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 9,
        "total_chars": 49684,
        "num_window_pages": 9,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 12648,
        "completion_tokens": 149,
        "total_tokens": 12798
      }
    },
    {
      "question_id": 84,
      "question": "How has UPS's approach to time-definite delivery services evolved between 2022 and 2024, particularly in terms of service scope and network integration?",
      "original_answer": "In 2022, UPS emphasized its integrated global air and ground network as the foundation for time-definite delivery services, highlighting its ability to combine all packages within a single network for operational efficiency. By 2024, UPS expanded its time-definite delivery offerings by insourcing the final delivery of non-urgent, lightweight residential shipments previously handled by the USPS through UPS SurePost, giving it greater control over service quality. Additionally, in 2024, UPS offered same-day pickup seven days a week and expanded returns services across approximately 150 countries, reflecting a broader and more customer-centric service scope compared to 2022.",
      "llm_answer": "Between 2022 and 2024, UPS expanded the scope of its time‑definite delivery services and deepened network integration.  In its U.S. Domestic Package segment it continued to offer guaranteed air services—including same‑day, next‑day, two‑day and three‑day options—while growing its ground network to handle over 17 million packages per day, most delivered within one to three business days.  Internationally, UPS broadened guaranteed day‑ and time‑definite options across Europe, Asia‑Pacific and the ISMEA region, adding more express services and improving transit times through new direct flights and regional hub investments.  The company also integrated these services into its broader Supply Chain Solutions portfolio, leveraging technology and automation to streamline pick‑up, processing and final delivery across its global network.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "UPS_10k_2022.pdf",
          "target_page": 5,
          "pages": [
            3,
            4,
            5,
            6,
            7
          ]
        },
        "hop_2_rel": {
          "source_file": "UPS_10k_2024.pdf",
          "target_page": 5,
          "pages": [
            3,
            4,
            5,
            6,
            7
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 47350,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 12057,
        "completion_tokens": 209,
        "total_tokens": 12266
      }
    },
    {
      "question_id": 84,
      "question": "How did Lowe's Companies, Inc.'s treatment or recognition of its 2.50% Notes maturing in April 2026 evolve between the 2022 and 2023 annual filings?",
      "original_answer": "In the 2022 filing, the 2.50% Notes maturing in April 2026 were referenced as part of the Thirteenth Supplemental Indenture dated April 20, 2016, but were described in the context of historical documentation. By the 2023 filing, these same notes were explicitly recognized as issued instruments under the same indenture, indicating a shift in disclosure treatment. This reflects a procedural or administrative transition from planning or documentation phase in 2022 to a more active recognition of the notes as part of the company's outstanding debt structure in 2023, even though the core terms (interest rate of 2.50%, maturity in April 2026) remained unchanged.",
      "llm_answer": "Based on the provided SEC 10-K filing pages, Lowe's treatment of its 2.50% Notes maturing in April 2026 evolved as follows:  \n- In the **2022 filing** (page 72), the 2.50% Notes were included as part of the **Twentieth Supplemental Indenture** (dated March 24, 2022), which established them with a maturity date of April 1, 2027 (not 2026).  \n- In the **2023 filing** (page 74), the same notes were reclassified under the **Twenty-Second Supplemental Indenture** (dated March 30, 2023), which explicitly listed them as **\"4.800% Notes due April 1, 2026\"**—correcting the maturity date to 2026 and reflecting updated terms.  \n\nThus, the 2023 filing updated the notes' maturity date and reclassified them within the indenture structure, while the 2022 filing had previously referenced them as part of a 2027 maturity tranche.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "LOW_10k_2022.pdf",
          "target_page": 82,
          "pages": [
            79,
            80,
            81,
            82,
            83
          ]
        },
        "hop_2_rel": {
          "source_file": "LOW_10k_2023.pdf",
          "target_page": 76,
          "pages": [
            74,
            75,
            76,
            77,
            78
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 8,
        "total_chars": 41419,
        "num_window_pages": 8,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 10575,
        "completion_tokens": 205,
        "total_tokens": 10781
      }
    },
    {
      "question_id": 84,
      "question": "How has the impact of sovereign debt crises on Costco's merchandise sourcing and cost structure evolved from 2022 to 2024?",
      "original_answer": "In 2022, sovereign debt crises were mentioned as part of a broader set of macroeconomic factors that could adversely affect demand for Costco's products and services, influence the cost or ability to purchase inventory, and require a change in product mix. The document highlighted that the degree of exposure depended on the type of goods, tariff rates, and timing, with the potential for higher tariffs to impact results. By 2024, the framing had shifted, with sovereign debt crises now explicitly stated to 'negatively impact' Costco's business, financial condition, and results of operations. The 2024 filing emphasized a broader set of supply chain risks, including supplier adherence to standards, supply constraints, and geopolitical instability, suggesting a heightened concern over the cascading effects of sovereign debt crises on both sourcing and cost predictability.",
      "llm_answer": "From 2022 to 2024, Costco’s exposure to sovereign debt crises shifted from a general risk factor in 2022—highlighting potential impacts on demand, product mix, and inventory costs—to a more specific focus on international operations in 2024. By 2024, the company explicitly tied sovereign debt and macroeconomic instability to foreign exchange volatility and tariff-related cost pressures in markets like Canada, directly threatening its international revenue and margin growth. While tariffs and commodity inflation remained relevant in both years, the 2024 filing emphasizes sovereign debt’s role in exacerbating currency risks and supply chain disruptions abroad, making these crises a more targeted threat to Costco’s global sourcing and cost structure.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "COST_10k_2022.pdf",
          "target_page": 14,
          "pages": [
            12,
            13,
            14,
            15,
            16
          ]
        },
        "hop_2_rel": {
          "source_file": "COST_10k_2024.pdf",
          "target_page": 15,
          "pages": [
            13,
            14,
            15,
            16,
            17
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 43870,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 11182,
        "completion_tokens": 189,
        "total_tokens": 11371
      }
    },
    {
      "question_id": 84,
      "question": "How has the number of shares available for future grants under the 2020 Stock Incentive Plan changed between 2021 and 2023, and what does this indicate about UnitedHealth Group's capacity for issuing new share-based awards?",
      "original_answer": "In 2021, UnitedHealth Group had 64 million shares available for future grants under the 2020 Stock Incentive Plan. By 2023, this number had decreased to 53 million shares. This indicates a reduction in the company's available capacity to issue new share-based awards over this period.",
      "llm_answer": "Between 2021 and 2023, the number of shares available for future grants under the 2020 Stock Incentive Plan increased from 64 million to 70 million, indicating that UnitedHealth Group has expanded its capacity to issue new share-based awards. This growth reflects the addition of 15 million shares approved under the Employee Stock Purchase Plan in 2021 and ongoing replenishment of shares for future grants.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "UNH_10k_2022.pdf",
          "target_page": 67,
          "pages": [
            65,
            66,
            67,
            68,
            69
          ]
        },
        "hop_2_rel": {
          "source_file": "UNH_10k_2023.pdf",
          "target_page": 72,
          "pages": [
            70,
            71,
            72,
            73,
            74
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 50047,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 12751,
        "completion_tokens": 102,
        "total_tokens": 12853
      }
    },
    {
      "question_id": 85,
      "question": "How did the expiration date and contribution significance of the IAM National Pension Fund / National Pension Plan relationship with UPS evolve between 2022 and 2024?",
      "original_answer": "In 2022, the IAM National Pension Fund / National Pension Plan had a collective bargaining agreement expiration date of July 31, 2024, and UPS had contributed more than 5% of the total plan contributions from all employers for the years 2019 through 2021. By 2024, the expiration date for this specific plan was extended to July 31, 2029, and UPS continued to be a significant contributor, providing more than 5% of total contributions for the plan years 2022 through 2024. This indicates a notable extension in the contractual relationship and sustained significance of UPS's contributions over time.",
      "llm_answer": "The IAM National Pension Fund / National Pension Plan’s collective bargaining agreement was extended from a July 31, 2023 expiration to July 31, 2024, while the related withdrawal‑liability agreement with the IAM Fund was reached in 2024 and the associated liability was recorded in current liabilities. Consequently, between 2022 and 2024 the plan’s expiration date moved forward by one year and its contribution significance grew, reflected in higher UPS contributions (rising from $48 million in 2022 to $53 million in 2024) and the recognition of a $19 million withdrawal‑liability liability in 2024.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "UPS_10k_2022.pdf",
          "target_page": 112,
          "pages": [
            110,
            111,
            112,
            113,
            114
          ]
        },
        "hop_2_rel": {
          "source_file": "UPS_10k_2024.pdf",
          "target_page": 98,
          "pages": [
            96,
            97,
            98,
            99,
            100
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 9,
        "total_chars": 56891,
        "num_window_pages": 9,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 14449,
        "completion_tokens": 151,
        "total_tokens": 14600
      }
    },
    {
      "question_id": 85,
      "question": "How did the terms and availability under LOW's 2020 Credit Agreement evolve between fiscal years 2022 and 2023?",
      "original_answer": "In fiscal year 2022, the 2020 Credit Agreement had a maturity date of March 2025 and provided $2.0 billion in availability. By fiscal year 2023, the 2020 Credit Agreement was amended and restated in September 2023 into the 2023 Credit Agreement, which extended the maturity date to September 2028 while maintaining the same $2.0 billion availability. Additionally, in 2023, the combined availability under both the 2023 Credit Agreement and the Third Amended and Restated Credit Agreement remained at $4.0 billion, consistent with the total availability reported in 2022.",
      "llm_answer": "The Company's 2020 Credit Agreement was amended and restated in December 2021 to extend the maturity to December 2026 and increase total availability to $2 billion, and then further amended in September 2023 (the 2023 Credit Agreement) to extend the maturity to September 2028 while maintaining a $2 billion revolving commitment.  Both agreements support the commercial‑paper program and can be expanded by an additional $1 billion subject to lender approval, with the combined availability remaining at $4 billion as of February 2 2024.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "LOW_10k_2022.pdf",
          "target_page": 60,
          "pages": [
            58,
            59,
            60,
            61,
            62
          ]
        },
        "hop_2_rel": {
          "source_file": "LOW_10k_2023.pdf",
          "target_page": 58,
          "pages": [
            56,
            57,
            58,
            59,
            60
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 45327,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 11543,
        "completion_tokens": 134,
        "total_tokens": 11677
      }
    },
    {
      "question_id": 85,
      "question": "How did MDLZ's use of Net Investment Hedge Derivative Contracts evolve between 2022 and 2024, particularly in terms of their notional amounts?",
      "original_answer": "In 2022, MDLZ reported a notional amount of $3,915 million for Net Investment Hedge Derivative Contracts as of December 31, 2021, and $4,551 million as of December 31, 2020. By 2024, the notional amount for these contracts had increased significantly to $8,647 million as of December 31, 2024, up from $7,456 million in 2023. This indicates a growing reliance on such contracts over the two-year period.",
      "llm_answer": "Between 2022 and 2024, MDLZ's net investment hedge derivative contracts decreased significantly in notional amount from $8,647 million (as of Dec 31 2024) to $3,915 million (as of Dec 31 2021), reflecting a reduction in the aggregate notional value of cross‑currency interest‑rate swaps and forwards used to hedge non‑U.S. dollar‑denominated net investments. This decline indicates a contraction in the scale of its net‑investment hedge program over the period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MDLZ_10k_2022.pdf",
          "target_page": 113,
          "pages": [
            111,
            112,
            113,
            114,
            115
          ]
        },
        "hop_2_rel": {
          "source_file": "MDLZ_10k_2024.pdf",
          "target_page": 96,
          "pages": [
            94,
            95,
            96,
            97,
            98
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 53679,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 13641,
        "completion_tokens": 115,
        "total_tokens": 13756
      }
    },
    {
      "question_id": 86,
      "question": "How has Microsoft 365's integration with AI technologies evolved between 2022 and 2024, and what specific new capabilities were introduced in 2024 to enhance its role in productivity and collaboration?",
      "original_answer": "In 2022, Microsoft 365 was described as integrating Office 365, Windows, and Enterprise Mobility + Security with AI-backed tools to empower employees, focusing on creativity, collaboration, and innovation. By 2024, Microsoft 365 had evolved into an 'AI first platform,' introducing Copilot for Microsoft 365, which combines AI with business data from the Microsoft Graph and Microsoft 365 applications. Additionally, role-specific extensions such as Copilot for Sales, Copilot for Service, and Copilot for Finance were introduced to streamline business processes. These developments reflect a significant enhancement in AI integration aimed at delivering more personalized and intelligent productivity tools.",
      "llm_answer": "Microsoft 365's AI integration evolved significantly between 2022 and 2024, transitioning from foundational AI capabilities to deeply embedded, role-specific AI assistants within the Microsoft 365 ecosystem. By 2024, the company introduced **Copilot for Microsoft 365** as a core productivity engine, integrating AI directly into Office applications (Word, Excel, PowerPoint, Outlook) and Teams to automate tasks, generate content, and provide contextual insights using business data from Microsoft Graph. This was complemented by **Copilot Studio**, enabling customers to customize Copilot for specific workflows, and **Copilot Pro**, a consumer subscription offering enhanced AI features. These capabilities collectively enhanced productivity and collaboration by making AI a seamless, proactive partner in daily work, moving beyond basic AI tools to a unified, intelligent layer across the Microsoft 365 platform.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MSFT_10k_2022.pdf",
          "target_page": 4,
          "pages": [
            2,
            3,
            4,
            5,
            6
          ]
        },
        "hop_2_rel": {
          "source_file": "MSFT_10k_2024.pdf",
          "target_page": 4,
          "pages": [
            2,
            3,
            4,
            5,
            6
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 9,
        "total_chars": 40100,
        "num_window_pages": 9,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 10257,
        "completion_tokens": 229,
        "total_tokens": 10486
      }
    },
    {
      "question_id": 87,
      "question": "How has 3M's approach to PFAS discharge characterization in its wastewater permits evolved between its Decatur, Alabama facility disclosures in 2022 and 2024?",
      "original_answer": "In 2022, 3M disclosed that it had not fully characterized its PFAS discharge in its NPDES permit for the Decatur facility and had submitted an application to ADEM to add additional PFAS to the permit. By 2024, the Company had installed and was upgrading wastewater treatment controls specifically designed to address PFAS at the Decatur facility, and the controls were being optimized, though ADEM had not yet acted on the permit modification request. This evolution shows a shift from identifying the issue and initiating corrective actions to implementing and refining treatment solutions while awaiting regulatory approval.",
      "llm_answer": "3M’s PFAS discharge characterization in its wastewater permits has evolved from an initial failure to fully identify all PFAS compounds in its NPDES permits at the Decatur, Alabama and Cottage Grove, Minnesota facilities (disclosed in 2019‑2020) to a more proactive approach that now includes submitting applications to add the missing PFAS to those permits, installing dedicated PFAS‑treatment systems, and entering into administrative consent orders (e.g., the 2022 SDWA order for Cordova, Illinois and the 2024 MPCA draft permit revisions for Cottage Grove) that require ongoing monitoring, sampling of nearby wells, and treatment upgrades. This represents a shift from merely acknowledging incomplete characterization to actively working with regulators to incorporate and manage PFAS discharges under updated permit limits and remediation obligations.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MMM_10k_2022.pdf",
          "target_page": 127,
          "pages": [
            125,
            126,
            127,
            128,
            129
          ]
        },
        "hop_2_rel": {
          "source_file": "MMM_10k_2024.pdf",
          "target_page": 101,
          "pages": [
            99,
            100,
            101,
            102,
            103
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 59398,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 15075,
        "completion_tokens": 214,
        "total_tokens": 15289
      }
    },
    {
      "question_id": 87,
      "question": "How did Lowe's Companies, Inc.'s issuance of the 4.550% Notes evolve between 2022 and 2023?",
      "original_answer": "In 2022, the 4.550% Notes were first introduced in the Fifteenth Supplemental Indenture dated April 5, 2019, and were due April 5, 2049. In 2023, the same 4.550% Notes continued to be referenced under the same Fifteenth Supplemental Indenture, with no changes to the terms or maturity date. Therefore, while the 4.550% Notes were still in effect in 2023, there was no modification or new issuance related to this specific instrument during that year.",
      "llm_answer": "Based on the provided SEC filing exhibits, Lowe's issued a series of supplemental indentures to its long-term debt agreements between 2020 and 2023. The most recent evolution of its 4.550% Notes specifically occurred through the **Twenty-First Supplemental Indenture dated September 8, 2022** (Exhibit 4.22 in the 2022 filing), which included a form of **4.550% Notes due April 15, 2033** among other tranches. This was later superseded by the **Twenty-Second Supplemental Indenture dated March 30, 2023** (Exhibit 4.23 in the 2023 filing), which refinanced portions of the debt but did not explicitly reference the 4.550% tranche—though it introduced new notes with maturities in 2026, 2033, 2053, and 2063. The 4.550% Notes from the 2022 indenture thus represent the culmination of this evolution, with the 2023 filing marking a transition to newer debt structures.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "LOW_10k_2022.pdf",
          "target_page": 82,
          "pages": [
            79,
            80,
            81,
            82,
            83
          ]
        },
        "hop_2_rel": {
          "source_file": "LOW_10k_2023.pdf",
          "target_page": 76,
          "pages": [
            74,
            75,
            76,
            77,
            78
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 8,
        "total_chars": 41419,
        "num_window_pages": 8,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 10561,
        "completion_tokens": 216,
        "total_tokens": 10778
      }
    },
    {
      "question_id": 87,
      "question": "How did MDLZ's financial relationship with KDP evolve between 2022 and 2024, particularly in terms of gains recognized from changes in accounting for the investment?",
      "original_answer": "In 2022, MDLZ recognized a pre-tax gain of $71 million (or $54 million after-tax) during the first quarter related to the sale of KDP shares, which reduced its ownership interest. By 2024, the company recorded a significantly larger pre-tax gain of $493 million ($368 million after-tax) due to a change in accounting for its investment in KDP. This indicates a substantial evolution in the financial impact of MDLZ's relationship with KDP over the two-year period.",
      "llm_answer": "Between 2022 and 2024, MDLZ’s financial relationship with KDP shifted from equity method accounting to marketable securities accounting after its ownership fell below 5% in 2023, triggering a change in accounting treatment. This transition allowed MDLZ to recognize pre-tax gains of $493 million in 2023 (from equity method transactions) and later realize $606 million in total gains on marketable securities sales in 2023, including the $593 million gain from selling the remaining KDP shares. The 2024 exit from JDE Peet's (via full sale of shares) generated a $332 million pre-tax gain, reflecting the final resolution of its investment in the KDP/JDE ecosystem.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MDLZ_10k_2022.pdf",
          "target_page": 104,
          "pages": [
            102,
            103,
            104,
            105,
            106
          ]
        },
        "hop_2_rel": {
          "source_file": "MDLZ_10k_2024.pdf",
          "target_page": 89,
          "pages": [
            87,
            88,
            89,
            90,
            91
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 9,
        "total_chars": 42748,
        "num_window_pages": 9,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 10914,
        "completion_tokens": 166,
        "total_tokens": 11080
      }
    },
    {
      "question_id": 87,
      "question": "How has the scale and positioning of Xbox Game Pass evolved between 2022 and 2024, based on the number of titles available and Microsoft's strategic emphasis?",
      "original_answer": "In 2022, Xbox Game Pass offered access to a curated library of over 100 first- and third-party titles, and was positioned as a key part of Microsoft's broader gaming strategy focused on content, community, and cloud services. By 2024, the service had expanded significantly, offering access to over 400 first- and third-party titles, and was described as the 'cornerstone' of Microsoft's gaming platform, reflecting a stronger strategic emphasis on subscriptions and community growth. This indicates a significant transformation in both scale and strategic importance.",
      "llm_answer": "Between 2022 and 2024, Xbox Game Pass expanded from a library of roughly 100 titles to over 400 first- and third-party games, reflecting Microsoft’s strategic shift toward a subscription-based gaming ecosystem. This growth was underscored by Microsoft’s $68.7 billion acquisition of Activision Blizzard, which bolstered its content pipeline and reinforced its ambition to lead in personal computing and cloud gaming.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MSFT_10k_2022.pdf",
          "target_page": 6,
          "pages": [
            4,
            5,
            6,
            7,
            8
          ]
        },
        "hop_2_rel": {
          "source_file": "MSFT_10k_2024.pdf",
          "target_page": 13,
          "pages": [
            11,
            12,
            13,
            14,
            15
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 8,
        "total_chars": 35178,
        "num_window_pages": 8,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 9017,
        "completion_tokens": 104,
        "total_tokens": 9121
      }
    },
    {
      "question_id": 88,
      "question": "How has the structure or disclosure of Deferred Stock Unit Award Agreements for non-employee directors under the 3M Company 2016 Long-Term Incentive Plan evolved from 2022 to 2024, based on the referenced filings?",
      "original_answer": "The Deferred Stock Unit Award Agreement for non-employee directors was first referenced in the 2022 10-K filing as part of the 3M Company 2016 Long-Term Incentive Plan, applicable to grants on or after January 1, 2019. By 2024, the agreement continued to be disclosed in the 10-K filing, still referencing grants on or after January 1, 2019, indicating no change in the effective date or structure of the agreement over this period. However, the 2024 disclosure reflects an updated incorporation by reference from the 2023 10-K, showing the ongoing maintenance of the plan through amendments as of May 8, 2023.",
      "llm_answer": "Based on the referenced filings, the structure and disclosure of Deferred Stock Unit Award Agreements for non‑employee directors under the 3M Company 2016 Long‑Term Incentive Plan have remained consistent in form and incorporation by reference. The agreement was first incorporated in the 2018 Form 10‑K (Amended and Restated 3M Compensation Plan for Non‑Employee Directors as of January 1 2019) and continues to be disclosed in the same manner in subsequent filings, including the 2022 Form 10‑K (Form 10‑K for the year ended December 31 2022) and the 2024 Form 10‑K (Item 10.27* and related exhibits). No substantive changes to the agreement’s terms or disclosure requirements are indicated between 2022 and 2024.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MMM_10k_2022.pdf",
          "target_page": 144,
          "pages": [
            129,
            130,
            131,
            132,
            133
          ]
        },
        "hop_2_rel": {
          "source_file": "MMM_10k_2024.pdf",
          "target_page": 117,
          "pages": [
            115,
            116,
            117,
            118,
            119
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 51706,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 13166,
        "completion_tokens": 178,
        "total_tokens": 13345
      }
    },
    {
      "question_id": 88,
      "question": "How has the composition of Charles Schwab Bank's First Mortgages and HELOCs portfolio evolved between 2023 and 2024, particularly in terms of origination costs and geographic concentration in California?",
      "original_answer": "In 2023, the First Mortgages and HELOCs portfolio included $100 million in unamortized premiums, discounts, and direct origination costs, with 43% of the portfolio concentrated in California. By 2024, these costs increased to $112 million, while the California concentration slightly decreased to 42%. This indicates a slight shift in geographic risk exposure and an increase in loan origination activity or associated costs over the year.",
      "llm_answer": "Based on the provided 10-K filings, the composition of Charles Schwab Bank's First Mortgages and HELOCs portfolio shows the following evolution between 2023 and 2024:\n\n1.  **Origination Costs:** Direct origination costs for First Mortgages and HELOCs increased from $100 million at December 31, 2023, to $112 million at December 31, 2024, indicating higher costs associated with new loan production during this period.\n\n2.  **Geographic Concentration in California:** The portfolio remained heavily concentrated in California, with 42% of the First Mortgage and HELOC portfolios located in California at December 31, 2024, compared to 43% at December 31, 2023. This indicates a slight decrease in the relative concentration within the portfolio, though California remains the dominant geographic market. The text explicitly states that these loans \"have performed in a manner consistent with the portfolio as a whole.\"",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "SCHW_10k_2023.pdf",
          "target_page": 90,
          "pages": [
            88,
            89,
            90,
            91,
            92
          ]
        },
        "hop_2_rel": {
          "source_file": "SCHW_10k_2024.pdf",
          "target_page": 88,
          "pages": [
            86,
            87,
            88,
            89,
            90
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 61053,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 15498,
        "completion_tokens": 229,
        "total_tokens": 15728
      }
    },
    {
      "question_id": 88,
      "question": "How has Nike's strategic emphasis on the Dri-FIT technology evolved between fiscal 2023 and fiscal 2024, based on the language in Nike's product research and development sections?",
      "original_answer": "Nike's strategic emphasis on the Dri-FIT technology remained stable between fiscal 2023 and fiscal 2024. In both years, Dri-FIT was listed among key technologies such as Nike Air, Zoom, Free, Flyknit, FlyEase, ZoomX, Air Max, and React, indicating consistent strategic importance. The exact same language was used in both the 2023 and 2024 10-K filings, showing no change in the description or emphasis of Dri-FIT's role in Nike’s innovation strategy.",
      "llm_answer": "Nike's strategic emphasis on Dri-FIT technology has evolved from a general innovation focus in fiscal 2023 to a more explicit integration of Dri-FIT within its product‑research and development narrative in fiscal 2024. In the 2024 filing, Nike highlights the proliferation of technologies—including Dri‑FIT—across its product categories, noting that design teams leverage market intelligence to apply such technologies to meet consumer preferences and enhance performance, comfort and environmental impact. This reflects a deliberate, technology‑driven expansion of Dri‑FIT as a core attribute of Nike’s innovative apparel offerings.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "NKE_10k_2023.pdf",
          "target_page": 6,
          "pages": [
            4,
            5,
            6,
            7,
            8
          ]
        },
        "hop_2_rel": {
          "source_file": "NKE_10k_2024.pdf",
          "target_page": 6,
          "pages": [
            4,
            5,
            6,
            7,
            8
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 48537,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 12360,
        "completion_tokens": 158,
        "total_tokens": 12518
      }
    },
    {
      "question_id": 88,
      "question": "How has Mondelez International's investment in backup and disaster recovery evolved from 2022 to 2024, particularly in response to increasing cybersecurity threats?",
      "original_answer": "In 2022, Mondelez was on heightened alert regarding cybersecurity risks, dedicating focused resources to backup and disaster recovery as part of its response to increased global cybersecurity threats, especially during the pandemic. By 2024, the company significantly expanded its efforts, explicitly stating that it continues to invest and augment its cybersecurity program with enhanced backup and disaster recovery solutions, among other measures, to address increasingly sophisticated threats including those from state-sponsored actors and emerging technologies like artificial intelligence.",
      "llm_answer": "Mondelez International has progressively strengthened its backup and disaster recovery capabilities in response to rising cyber threats, particularly through targeted investments in cybersecurity infrastructure and resilience measures. In its 2024 disclosures, the company emphasized enhanced identity and access management, multi-factor authentication, network security, and 24/7 security operations to protect critical systems, while explicitly noting that backup and disaster recovery are integral components of its broader cyber risk mitigation strategy. This evolution builds on earlier efforts highlighted in 2022, where the company detailed investments in backup and disaster recovery as part of its response to \"increasing cybersecurity threats,\" including heightened focus on safeguarding manufacturing environments and operational technologies amid remote work and evolving attack vectors. The 2024 filing further underscores that these measures are designed to ensure business continuity amid escalating risks like ransomware, supply chain disruptions, and geopolitical instability, reflecting a maturation from foundational investments to more sophisticated, integrated resilience planning.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MDLZ_10k_2022.pdf",
          "target_page": 45,
          "pages": [
            43,
            44,
            45,
            46,
            47
          ]
        },
        "hop_2_rel": {
          "source_file": "MDLZ_10k_2024.pdf",
          "target_page": 20,
          "pages": [
            18,
            19,
            20,
            21,
            22
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 8,
        "total_chars": 44400,
        "num_window_pages": 8,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 11325,
        "completion_tokens": 300,
        "total_tokens": 11626
      }
    },
    {
      "question_id": 88,
      "question": "How has Microsoft's financial commitment and engagement with Black and African American-owned suppliers evolved from fiscal year 2022 to fiscal year 2024?",
      "original_answer": "In fiscal year 2022, Microsoft reported that it had enriched its supplier pipeline, reaching more than 90% of its goal to spend $500 million with double the number of Black and African American-owned suppliers. By fiscal year 2024, Microsoft had not only achieved its $500 million spending goal but also expanded its financial commitments by allocating $150 million to Minority Depository Institutions and funds supporting Black and African American-owned small businesses. This evolution indicates a deepening of Microsoft's strategic focus on supplier diversity and community economic development over time.",
      "llm_answer": "Microsoft’s financial commitment and engagement with Black‑ and African‑American‑owned suppliers grew markedly from FY 2022 to FY 2024. In FY 2022 the company reported it was “double‑the‑number” of Black‑owned suppliers toward a $500 million spending goal and had already exceeded its target for transaction volumes with Black‑owned financial institutions. By FY 2024 it announced that it had **met its $500 million supplier‑spending goal with twice as many Black‑ and African‑American‑owned suppliers** and had **reached more than 90 % of that goal**, while also increasing deposits with Black‑owned minority depository institutions and expanding the Black Partner Growth Initiative. These actions reflect a continued and deepening investment in minority‑owned suppliers over the two‑year period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MSFT_10k_2022.pdf",
          "target_page": 7,
          "pages": [
            5,
            6,
            7,
            8,
            9
          ]
        },
        "hop_2_rel": {
          "source_file": "MSFT_10k_2024.pdf",
          "target_page": 7,
          "pages": [
            5,
            6,
            7,
            8,
            9
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 9,
        "total_chars": 40242,
        "num_window_pages": 9,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 10281,
        "completion_tokens": 199,
        "total_tokens": 10480
      }
    },
    {
      "question_id": 88,
      "question": "How has the availability of common shares for future issuance under the Abbott Laboratories Employee Stock Purchase Plan for Non-U.S. Employees evolved from 2022 to 2023, and what does this indicate about Abbott's stock-based incentive strategy?",
      "original_answer": "In 2022, as of December 31, 2021, an aggregate of 10,638,639 common shares were available for future issuance under the Employee Stock Purchase Plan. In 2023, as of December 31, 2023, this number had decreased to 8,565,087 common shares. This indicates a reduction in the number of shares available for future issuance, suggesting a potential tightening or adjustment in Abbott's stock-based incentive strategy for non-U.S. employees.",
      "llm_answer": "From 2022 to 2023, the number of common shares available for future issuance under the Abbott Laboratories Employee Stock Purchase Plan for Non-U.S. Employees declined from **10,638,639** (as reported for December 31 2021 in the 2022 filing) to **8,565,087** (as reported for December 31 2023 in the 2023 filing). This reduction indicates that Abbott is reserving fewer shares for future employee purchases, suggesting a more conservative use of its equity pool for stock‑based incentives and a possible shift toward other compensation or capital‑allocation priorities.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "ABT_10k_2022.pdf",
          "target_page": 83,
          "pages": [
            81,
            82,
            83,
            84,
            85
          ]
        },
        "hop_2_rel": {
          "source_file": "ABT_10k_2023.pdf",
          "target_page": 84,
          "pages": [
            82,
            83,
            84,
            85,
            86
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 45602,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 11645,
        "completion_tokens": 142,
        "total_tokens": 11788
      }
    },
    {
      "question_id": 89,
      "question": "How has Nike's treatment of Nike Air technology evolved in its product development strategy between fiscal years 2023 and 2024?",
      "original_answer": "In fiscal 2023, Nike Air was described as part of a list of technologies that 'typifies our dedication to designing innovative products,' indicating it was still being actively proliferated across product lines. By fiscal 2024, Nike Air was again listed among key technologies, but now embedded alongside mature technologies like Zoom, Free, and React, suggesting that Nike Air had become a standard component of Nike’s broader innovation platform rather than a distinct growth driver. This reflects a strategic shift from emphasizing Nike Air as an emerging innovation to treating it as an integrated, foundational offering within Nike’s product development framework.",
      "llm_answer": "Nike’s product development strategy has increasingly centered on integrating advanced air‑based cushioning technologies—such as Nike Air, Zoom X, and React—into its footwear and apparel lines, emphasizing innovation, performance enhancement, and sustainability. Across both fiscal 2023 and 2024, the company highlighted the proliferation of these air‑centric technologies as a core driver of design, leveraging market intelligence and cross‑functional research teams to respond to consumer preferences and maintain its competitive edge in the global athletic market.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "NKE_10k_2023.pdf",
          "target_page": 6,
          "pages": [
            4,
            5,
            6,
            7,
            8
          ]
        },
        "hop_2_rel": {
          "source_file": "NKE_10k_2024.pdf",
          "target_page": 6,
          "pages": [
            4,
            5,
            6,
            7,
            8
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 48537,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 12347,
        "completion_tokens": 141,
        "total_tokens": 12489
      }
    },
    {
      "question_id": 89,
      "question": "How has Abbott's positioning of Osmolite within its Nutritional Products segment evolved between 2022 and 2023, particularly in terms of its enteral feeding portfolio and associated product line strategy?",
      "original_answer": "In 2022, Osmolite was listed among Abbott's enteral feeding products used in healthcare institutions, alongside Jevity®, Glucerna® 1.2 Cal, Glucerna® 1.5 Cal, Oxepa®, Freego™, Nepro®, and Vital®. By 2023, Osmolite continued to be included in the enteral feeding portfolio, but Abbott's product listing in this category remained largely consistent, indicating a stable strategic positioning of Osmolite within the institutional enteral nutrition segment. There is no indication of Osmolite being newly introduced, discontinued, or significantly repositioned relative to other products in this category during this period.",
      "llm_answer": "Abbott’s Nutritional Products segment has shifted focus toward enteral feeding solutions, emphasizing Osmolite as a key product within its portfolio of enteral formulas. The company continues to leverage its broad nutritional product line—including Osmolite, Jevity, and Glucerna—to serve institutional and clinical settings, maintaining a strategy centered on scientific innovation, formulation differentiation, and global distribution through both direct and third-party channels. This aligns with its broader emphasis on ingredient innovation and competition in the medical nutrition space.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "ABT_10k_2022.pdf",
          "target_page": 3,
          "pages": [
            1,
            2,
            3,
            4,
            5
          ]
        },
        "hop_2_rel": {
          "source_file": "ABT_10k_2023.pdf",
          "target_page": 4,
          "pages": [
            2,
            3,
            4,
            5,
            6
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 45040,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 11492,
        "completion_tokens": 148,
        "total_tokens": 11640
      }
    },
    {
      "question_id": 90,
      "question": "How has 3M's regulatory engagement and remediation obligations related to PFAS discharge evolved between 2022 and 2024, particularly in Minnesota and Alabama?",
      "original_answer": "In 2022, 3M was actively working under a 2007 Settlement Agreement and Consent Order with the MPCA to address PFAS contamination in Minnesota, with remediation substantially completed at the Cottage Grove site and ongoing operational and maintenance activities at multiple locations. In Alabama, the Company had entered into a July 2020 Interim Consent Order with ADEM, which included obligations for PFAS-related wastewater discharges and air emissions, and had completed installation of a multilayer cap at the Decatur facility. By 2024, regulatory scrutiny had intensified. In Minnesota, MPCA issued a draft Clean Water Act permit for the Cottage Grove facility with significantly revised effluent limits for certain PFAS compounds, some below current quantification levels, and the Company submitted public comments in August 2024. Additionally, in 2024, MPCA published a revised draft permit in December after considering stakeholder input, which could have a significant adverse impact on the Cottage Grove facility's operations. In Alabama, while the 2020 Interim Consent Order remained in effect, the Company's obligations under ongoing investigations and potential future remediation were still expected to involve additional operating costs and capital expenditures over multiple years. The regulatory landscape evolved to include more stringent standards, such as updated HBVs from MDH in January 2024 and proposed HRLs in October 2024, further complicating 3M's compliance path.",
      "llm_answer": "Between 2022 and 2024, 3M’s regulatory engagement and remediation obligations tied to PFAS have intensified in both states. In Minnesota, the company continued implementing the 2007 Settlement Agreement and Consent Order, upgraded wastewater treatment, responded to a 2024 MPCA draft permit that proposes stricter PFAS effluent limits for the Cottage Grove plant, and addressed a 2023 notice of violation for storm‑water PFAS discharges at Hutchinson. In Alabama, 3M remained under the 2020 interim Consent Order and 2009 TSCA consent order for its Decatur facility, maintained ongoing groundwater‑sampling and treatment obligations, and faced a 2024 grand‑jury subpoena and EPA/Alabama investigations into historic releases to the Tennessee River. Across both states, the company’s remediation work now includes expanded monitoring, treatment system upgrades, and compliance‑driven reporting requirements, with the regulatory scrutiny and associated compliance costs expected to persist through 2024 and beyond.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MMM_10k_2022.pdf",
          "target_page": 127,
          "pages": [
            125,
            126,
            127,
            128,
            129
          ]
        },
        "hop_2_rel": {
          "source_file": "MMM_10k_2024.pdf",
          "target_page": 102,
          "pages": [
            100,
            101,
            102,
            103,
            104
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 58892,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 14949,
        "completion_tokens": 253,
        "total_tokens": 15202
      }
    },
    {
      "question_id": 90,
      "question": "How has The Coca-Cola Company's financial relationship with Coca-Cola HBC AG evolved between 2022 and 2024, particularly in terms of investment classification and stake percentage?",
      "original_answer": "In 2022, Coca-Cola HBC AG was among the listed equity method investees, though the specific ownership percentage was not disclosed in the provided evidence. By 2024, Coca-Cola HBC AG remained an equity method investee, and the company explicitly stated a 22% ownership stake as of December 31, 2024. This indicates a formalization and quantification of the relationship, with Coca-Cola now specifying the exact percentage of ownership, which was absent in the 2022 disclosures.",
      "llm_answer": "The Coca-Cola Company's financial relationship with Coca-Cola HBC AG has evolved such that its investment in the company is now classified as an equity method investment, with the stake percentage held at 19% as of December 31, 2024, reflecting a continued strategic partnership without a change in classification between 2022 and 2024.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "KO_10k_2022.pdf",
          "target_page": 118,
          "pages": [
            116,
            117,
            118,
            119,
            120
          ]
        },
        "hop_2_rel": {
          "source_file": "KO_10k_2024.pdf",
          "target_page": 87,
          "pages": [
            85,
            86,
            87,
            88,
            89
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 54282,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 13800,
        "completion_tokens": 84,
        "total_tokens": 13884
      }
    },
    {
      "question_id": 90,
      "question": "How has Oracle's strategic emphasis on hybrid deployments evolved between fiscal 2022 and fiscal 2024, particularly in terms of product development investment and deployment model integration?",
      "original_answer": "In fiscal 2022, Oracle emphasized hybrid deployments as part of its broader deployment model strategy, investing $7.2 billion in research and development to enhance existing offerings and develop new technologies, including hybrid solutions like Oracle Cloud@Customer. By fiscal 2024, Oracle further integrated hybrid deployments into its core offerings, positioning them as a standard deployment choice alongside on-premise and cloud-based models, and reinforcing its commitment to interoperability and customer choice. This reflects a strategic evolution from a development-focused approach to a more mature, integrated deployment model.",
      "llm_answer": "Oracle's strategic emphasis on hybrid deployments has intensified through fiscal 2022–2024, marked by significant investment in cloud and hybrid-ready product development and deeper integration of deployment models across its portfolio. The company increasingly prioritizes cloud services (including SaaS and OCI) and license support revenues, which now represent 71% of total revenue, while actively promoting hybrid cloud solutions like Oracle Cloud@Customer and migration pathways for on-premise workloads. This shift is underscored by R&D investments of $7.2B in fiscal 2022, the expansion of cloud license support contracts, and explicit strategic focus on enabling flexible, interoperable hybrid and cloud deployments to meet evolving customer needs relative to competitors.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "ORCL_10k_2022.pdf",
          "target_page": 6,
          "pages": [
            4,
            5,
            6,
            7,
            8
          ]
        },
        "hop_2_rel": {
          "source_file": "ORCL_10k_2024.pdf",
          "target_page": 72,
          "pages": [
            70,
            71,
            72,
            73,
            74
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 48939,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 12466,
        "completion_tokens": 195,
        "total_tokens": 12661
      }
    },
    {
      "question_id": 91,
      "question": "How has the filing status of the Mandatory Clawback Policy evolved between the 2023 and 2024 SEC 10-K disclosures for Wells Fargo & Company?",
      "original_answer": "In 2023, the Mandatory Clawback Policy was filed directly as part of the 10-K filing under Exhibit 97. In 2024, instead of being filed directly, it was incorporated by reference to Exhibit 97 from the previous year's 10-K filing. This indicates a procedural change in how the policy is disclosed rather than a substantive change to the policy itself.",
      "llm_answer": "The Mandatory Clawback Policy was first introduced in the 2023 SEC 10-K filing, where it was designated as Exhibit 97 and described as “Wells Fargo & Company Mandatory Clawback Policy, effective as of October 2, 2023.” In the 2024 filing, the same policy remains listed as Exhibit 97 and is again identified as “Wells Fargo & Company Mandatory Clawback Policy, effective as of October 2, 2023,” confirming that its status and effective date have not changed between the two filings.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "WFC_10k_2023.pdf",
          "target_page": 18,
          "pages": [
            15,
            16,
            17,
            18,
            19
          ]
        },
        "hop_2_rel": {
          "source_file": "WFC_10k_2024.pdf",
          "target_page": 21,
          "pages": [
            18,
            19,
            20,
            21,
            22
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 61917,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 15698,
        "completion_tokens": 120,
        "total_tokens": 15818
      }
    },
    {
      "question_id": 91,
      "question": "How did Thermo Fisher's relationship with CorEvitas, LLC evolve between 2023 and 2024, and what specific financial implications were associated with this change?",
      "original_answer": "In 2023, Thermo Fisher invested $0.91 billion to acquire CorEvitas, LLC, a U.S.-based provider of regulatory-grade, real-world evidence for medical treatments. By 2024, this relationship had evolved from an investment into a full acquisition, as CorEvitas was integrated into the Laboratory Products and Biopharma Services segment. The acquisition in 2023 was part of a broader strategy that included significant capital expenditures and financing activities, such as issuing $5.94 billion in senior notes and repurchasing $3.00 billion of company stock. In 2024, the company began amortizing the definite-lived intangible assets from CorEvitas over a weighted average period of 18 years, reflecting the long-term strategic value of the acquisition.",
      "llm_answer": "Thermo Fisher’s relationship with CorEvitas, LLC evolved from a 2023 acquisition (within the Laboratory Products and Biopharma Services segment) to a continued presence in 2024, where it remained part of the same segment and contributed to segment income. The 2023 acquisition required a cash outlay of $910 million (including $730 million cash paid and $184 million debt settled), resulting in $627 million of goodwill and $260 million of definite‑lived intangible assets (customer relationships, product technology, backlog). The amortization of these intangibles (weighted‑average 13‑year life for backlog, 18‑year for customer relationships, etc.) contributed to the $2.34 billion amortization expense reported in 2023 and $2.38 billion in 2024, directly affecting operating income and the adjusted operating margin. Consequently, the acquisition added to the company’s investing cash outflow ($0.91 billion in 2023) and influenced free cash flow, while the associated goodwill and intangibles are non‑tax‑deductible, affecting the tax rate and earnings per share.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "TMO_10k_2023.pdf",
          "target_page": 24,
          "pages": [
            22,
            23,
            24,
            25,
            26
          ]
        },
        "hop_2_rel": {
          "source_file": "TMO_10k_2024.pdf",
          "target_page": 65,
          "pages": [
            63,
            64,
            65,
            66,
            67
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 51724,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 13155,
        "completion_tokens": 267,
        "total_tokens": 13422
      }
    },
    {
      "question_id": 92,
      "question": "How did RTX's flight hour payment obligations under its 2012 agreement with Rolls-Royce evolve between 2022 and 2023, particularly in terms of the timing and capitalization treatment of these payments?",
      "original_answer": "In 2022, RTX disclosed that flight hour payments to Rolls-Royce were contingent upon each hour flown through June 2027 by V2500-powered aircraft in service as of the acquisition date, and these payments were considered in 'Other commercial aerospace commitments' and capitalized as collaboration intangible assets as payments were made. In 2023, RTX reiterated the same contingent payment structure tied to flight hours through June 2027 and maintained that these payments would continue to be capitalized as collaboration intangible assets. There was no indication of a change in the magnitude or timing of these obligations between the two years, suggesting a stable commitment structure.",
      "llm_answer": "Between 2022 and 2023, RTX’s flight‑hour payment obligations under its 2012 Rolls‑Royce acquisition agreement remained contingent on the number of flight hours flown by V2500‑powered aircraft through June 2027. The company continues to accrue and capitalize these payments as “collaboration intangible assets” when they are made, treating them as part of the intangible assets associated with the acquisition. The timing of the payments is therefore driven by actual flight‑hour usage, and the amounts are capitalized as incurred rather than expensed when the obligation arises.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "RTX_10k_2022.pdf",
          "target_page": 112,
          "pages": [
            110,
            111,
            112,
            113,
            114
          ]
        },
        "hop_2_rel": {
          "source_file": "RTX_10k_2023.pdf",
          "target_page": 101,
          "pages": [
            99,
            100,
            101,
            102,
            103
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 58865,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 14952,
        "completion_tokens": 144,
        "total_tokens": 15097
      }
    },
    {
      "question_id": 92,
      "question": "How has The Coca-Cola Company's financial relationship with fairlife evolved from 2022 to 2024, particularly regarding contingent payments tied to performance milestones?",
      "original_answer": "In 2022, Coca-Cola's acquisition-related disclosures referenced the 2020 acquisition of the remaining ownership interest in fairlife, with no mention of ongoing contingent payments. By 2024, the company disclosed that there was a remaining milestone payment related to the 2020 acquisition of fairlife, contingent on fairlife achieving certain financial targets through 2024, with the payment scheduled for 2025. This indicates that Coca-Cola's relationship with fairlife has evolved from a completed acquisition in 2020 to one where a performance-linked financial obligation remains active through 2024.",
      "llm_answer": "From 2022 to 2024, The Coca-Cola Company's contingent consideration liability related to its 2020 acquisition of fairlife was remeasured quarterly at fair value, with changes recorded in income until the final milestone payment is made. The liability, representing the remaining milestone payment contingent on fairlife achieving 2024 financial targets and payable in 2025, was valued using a Monte Carlo model (Level 3 inputs) and decreased from $6,126 million (as of Dec 31, 2024) to $3,017 million (as of Dec 31, 2023), reflecting the remeasurement adjustments tied to performance milestones.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "KO_10k_2022.pdf",
          "target_page": 55,
          "pages": [
            53,
            54,
            55,
            56,
            57
          ]
        },
        "hop_2_rel": {
          "source_file": "KO_10k_2024.pdf",
          "target_page": 111,
          "pages": [
            109,
            110,
            111,
            112,
            113
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 52608,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 13379,
        "completion_tokens": 148,
        "total_tokens": 13528
      }
    },
    {
      "question_id": 92,
      "question": "How has Oracle's strategic positioning of Oracle Cloud Services evolved between 2022 and 2024, particularly in terms of integration with enterprise applications and infrastructure technologies?",
      "original_answer": "In 2022, Oracle emphasized the transformational potential of Oracle Cloud Services, particularly highlighting the Oracle Autonomous Database as a key OCI offering that utilized machine learning to enable leaner business processes and automation. The focus was on flexibility, interoperability, and customer choice across deployment models, including cloud-based, hybrid, and on-premise environments. By 2024, Oracle expanded this positioning by describing Oracle Cloud Services (including SaaS and OCI) as comprehensive and integrated offerings that provide customers with a full suite of applications and infrastructure services. The 2024 filing explicitly frames Oracle Cloud Services as enabling customers to 'choose the best option that meets their specific business needs,' indicating a more mature and customer-centric strategic approach. This evolution reflects a shift from promoting individual innovations (e.g., Autonomous Database) to positioning Oracle Cloud Services as a holistic, integrated platform for enterprise IT transformation.",
      "llm_answer": "Oracle's strategic positioning of Oracle Cloud Services has evolved from a focus on standalone cloud applications toward deeper integration with enterprise applications and infrastructure technologies. The company emphasizes seamless migration paths for existing on-premise workloads to the Oracle Cloud, leveraging hybrid and multi-cloud deployment models to enhance interoperability, reduce customer complexity, and expand its SaaS and infrastructure offerings across core business functions. This shift underscores a strategy to unify cloud services with traditional license and hardware businesses, enabling customers to modernize IT environments through flexible, cost-effective, and scalable solutions.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "ORCL_10k_2022.pdf",
          "target_page": 7,
          "pages": [
            5,
            6,
            7,
            8,
            9
          ]
        },
        "hop_2_rel": {
          "source_file": "ORCL_10k_2024.pdf",
          "target_page": 72,
          "pages": [
            70,
            71,
            72,
            73,
            74
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 49133,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 12514,
        "completion_tokens": 177,
        "total_tokens": 12691
      }
    },
    {
      "question_id": 93,
      "question": "How has the treatment or status of the Key/Specified Employee Policy evolved between the 2023 and 2024 SEC filings, particularly in terms of its documentation and incorporation by reference?",
      "original_answer": "In the 2023 filing, the Key/Specified Employee Policy was introduced as part of the company's disclosures, specifically incorporated by reference to Exhibit 10(v) from the Annual Report on Form 10-K for the year ended December 31, 2018. By 2024, the policy was no longer newly introduced but was instead announced as a continuing policy, still relying on the same Exhibit 10(v) from the 2018 filing. This indicates that while the policy remained in place, there were no new amendments or updates to its documentation during this period.",
      "llm_answer": "The Key/Specified Employee Policy was first incorporated by reference in the 2018 filing (Exhibit 10(r) to the 2018 Form 10‑K) and remained unchanged in the 2023 filing, where it continued to be cited as “Key/Specified Employee Policy” incorporated by reference to Exhibit 10(v) of the 2023 Form 10‑K. Thus, the policy’s documentation and incorporation by reference have remained consistent between the 2023 and 2024 SEC filings.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "WFC_10k_2023.pdf",
          "target_page": 17,
          "pages": [
            15,
            16,
            17,
            18,
            19
          ]
        },
        "hop_2_rel": {
          "source_file": "WFC_10k_2024.pdf",
          "target_page": 20,
          "pages": [
            18,
            19,
            20,
            21,
            22
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 61917,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 15710,
        "completion_tokens": 107,
        "total_tokens": 15818
      }
    },
    {
      "question_id": 94,
      "question": "How did the aggregate principal balance of the 6.700% notes due 2028 evolve between 2022 and 2023, and what does this indicate about RTX's debt management strategy?",
      "original_answer": "In 2022, the aggregate principal balance of the 6.700% notes due 2028 was $115 million. By 2023, this amount increased significantly to $285 million. This indicates that RTX increased its outstanding debt related to this particular note, suggesting a strategic decision to retain or expand exposure to this fixed-rate debt instrument.",
      "llm_answer": "The aggregate principal balance of the 6.700% notes due 2028 remained unchanged at $285 million from 2022 to 2023. This stability reflects RTX’s focus on maintaining a consistent debt profile while it refinanced other maturing obligations and pursued targeted debt issuances, indicating a strategy of preserving existing low‑cost long‑term financing rather than altering the composition of its maturing debt.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "RTX_10k_2022.pdf",
          "target_page": 94,
          "pages": [
            92,
            93,
            94,
            95,
            96
          ]
        },
        "hop_2_rel": {
          "source_file": "RTX_10k_2023.pdf",
          "target_page": 84,
          "pages": [
            82,
            83,
            84,
            85,
            86
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 43217,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 11029,
        "completion_tokens": 102,
        "total_tokens": 11131
      }
    },
    {
      "question_id": 94,
      "question": "How did the carrying value and effective interest rate of TMO's 1.95% 12-Year Senior Notes evolve between 2023 and 2024?",
      "original_answer": "In 2023, the carrying value of the 1.95% 12-Year Senior Notes was $773 million with an effective interest rate of 2.08%. In 2024, the carrying value decreased to $725 million, and the effective interest rate slightly declined to 2.07%. This indicates a reduction in the financial liability associated with these notes and a marginal improvement in the effective borrowing cost.",
      "llm_answer": "Based on the provided pages, the carrying value of TMO's 1.95% 12-Year Senior Notes remained at $773 million as of both December 31 2023 and December 31 2024. The effective interest rate associated with these notes was 2.07 % at the end of 2023 and increased slightly to 2.08 % at the end of 2024.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "TMO_10k_2023.pdf",
          "target_page": 62,
          "pages": [
            60,
            61,
            62,
            63,
            64
          ]
        },
        "hop_2_rel": {
          "source_file": "TMO_10k_2024.pdf",
          "target_page": 47,
          "pages": [
            45,
            46,
            47,
            48,
            49
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 56701,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 14389,
        "completion_tokens": 74,
        "total_tokens": 14463
      }
    },
    {
      "question_id": 95,
      "question": "What are the corporate governance implications of the change in how BNY Mellon presents its Directors' Code of Conduct between its 2022 and 2024 SEC filings?",
      "original_answer": "In 2022, BNY Mellon explicitly detailed the availability of the Directors' Code of Conduct on its website with a direct URL link, and it was referenced within the broader context of corporate governance disclosures and ethics policies. By 2024, the Code was listed among other governance materials—such as committee charters and by-laws—without a direct link or specific mention of updates or amendments. This shift in presentation may signal a more streamlined or consolidated approach to governance disclosures, potentially reducing the visibility of the Code as a standalone document. While the Code remains accessible, the change could affect transparency and stakeholder engagement with the specific ethical expectations for directors, which may influence perceptions of governance accountability.",
      "llm_answer": "The 2024 filing explicitly references the Directors' Code of Conduct in its governance materials (page 11), while the 2022 filing does not include a separate Directors' Code of Conduct in the provided excerpt. This shift indicates a more formalized governance disclosure in 2024, with the code now posted on the company’s website and subject to public amendment notices.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "BK_10k_2022.pdf",
          "target_page": 11,
          "pages": [
            9,
            10,
            11,
            12,
            13
          ]
        },
        "hop_2_rel": {
          "source_file": "BK_10k_2024.pdf",
          "target_page": 3,
          "pages": [
            1,
            2,
            3,
            4,
            5
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 36713,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 9399,
        "completion_tokens": 92,
        "total_tokens": 9492
      }
    },
    {
      "question_id": 95,
      "question": "How has Amazon's Short-Term Credit Agreement evolved between 2023 and 2024, particularly in terms of facility size, maturity date, and the timing of its establishment?",
      "original_answer": "In 2023, Amazon entered into a $5.0 billion unsecured 364-day revolving credit facility (Short-Term Credit Agreement) in November, replacing the prior agreement from November 2022, with a maturity date in October 2024. In 2024, Amazon again entered into a new $5.0 billion unsecured 364-day revolving credit facility in October, replacing the 2023 agreement, with a maturity date in October 2025. The facility size remained the same at $5.0 billion, but the establishment date shifted from November to October, and the maturity date moved forward by one year, indicating a procedural renewal rather than a substantive change in the credit structure.",
      "llm_answer": "Amazon's Short-Term Credit Agreement was established in **October 2024** as a new $5 billion unsecured 364‑day revolving facility that replaced the prior 364‑day revolving agreement entered into in **November 2023**. The agreement matures in **October 2025** (with a one‑year extension possible) and carries an interest rate of SOFR + 0.45% plus a 0.03% commitment fee. Its facility size ($5 billion) and maturity date (October 2025) therefore represent an evolution from the earlier $15 billion revolving credit facility (Credit Agreement) that extends to **November 2028**, while the Short‑Term Credit Agreement’s maturity is earlier (2025 vs. 2028) and its size is smaller.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AMZN_10k_2023.pdf",
          "target_page": 59,
          "pages": [
            57,
            58,
            59,
            60,
            61
          ]
        },
        "hop_2_rel": {
          "source_file": "AMZN_10k_2024.pdf",
          "target_page": 58,
          "pages": [
            56,
            57,
            58,
            59,
            60
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 53240,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 13536,
        "completion_tokens": 169,
        "total_tokens": 13705
      }
    },
    {
      "question_id": 95,
      "question": "How has AMD's APU strategy evolved from 2022 to 2024 in terms of product integration and target markets, and what implications does this shift have for its revenue potential in the AI PC segment?",
      "original_answer": "In 2022, AMD emphasized external GPU-based solutions for AI and HPC workloads, particularly through the Instinct MI200 series and Radeon PRO V620 GPUs, focusing on data center and cloud applications. By 2024, AMD had shifted toward integrating dedicated AI acceleration directly into client devices, becoming the first company to include a dedicated neural processing unit (NPU) on the same SoC as an x86 CPU for AI PCs. This strategic pivot toward integrated APUs with NPU cores indicates a move to capture revenue growth in the emerging AI PC market, where on-device AI processing is becoming critical. This evolution likely enhances AMD's revenue potential by positioning it as a differentiated player in the AI PC segment, moving beyond traditional CPU-GPU combinations.",
      "llm_answer": "From 2022 through 2024 AMD’s APU strategy shifted from a primarily consumer‑focused, integrated CPU‑GPU product for mainstream PCs toward a broader, AI‑centric portfolio that tightly couples CPUs, GPUs and dedicated NPUs for both client and data‑center markets.  In 2022 the emphasis was on Ryzen and Ryzen PRO APUs for desktops and notebooks, while by 2024 AMD had expanded the APU line to include AI‑optimized processors (e.g., Ryzen AI 300 series with an on‑chip NPU) and was leveraging APU‑derived silicon in data‑center AI accelerators and semi‑custom solutions (e.g., Instinct MI300X GPUs, ZT Systems acquisition).  This integration across segments and the push into AI‑heavy workloads position AMD to capture higher‑margin revenue from AI‑PC and hyperscale deployments, driving growth in its Data Center and Client segments and expanding its addressable market in the emerging AI PC segment.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AMD_10k_2022.pdf",
          "target_page": 9,
          "pages": [
            7,
            8,
            9,
            10,
            11
          ]
        },
        "hop_2_rel": {
          "source_file": "AMD_10k_2024.pdf",
          "target_page": 5,
          "pages": [
            3,
            4,
            5,
            6,
            7
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 48242,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 12291,
        "completion_tokens": 224,
        "total_tokens": 12515
      }
    },
    {
      "question_id": 95,
      "question": "How has the treatment of Irish income tax liability for U.S. shareholders receiving dividends from Medtronic evolved between 2023 and 2024, particularly in relation to the Irish dividend withholding tax?",
      "original_answer": "In both 2023 and 2024, dividends paid by Medtronic were generally subject to Irish dividend withholding tax at a rate of 25 percent unless an exemption applied. For U.S. residents, exemptions were available based on residency documentation, such as a valid U.S. Certification of Residence (Form 6166) or Irish Non-Resident Form V2. In both years, a U.S. resident who met the exemption criteria and did not hold shares through an Irish branch generally had no Irish income tax liability. Additionally, if a U.S. shareholder was subject to the 25% withholding tax, the payment discharged any Irish income tax liability, provided the shareholder submitted the required statement to the Irish Revenue authorities. There was no change in the tax rate or in the conditions for exemption between the years, indicating a stable regulatory framework.",
      "llm_answer": "The treatment of Irish income tax liability for U.S. shareholders receiving Medtronic dividends has not changed materially between 2023 and 2024.  Irish dividend withholding tax remains generally at 25 % on dividends paid to non‑resident shareholders, but U.S. residents who hold shares through a qualified intermediary (e.g., DTC) or who provide a valid U.S. certification of residence (Form 6166) or Irish Non‑Resident Form V2 are exempt from that withholding.  Consequently, U.S. shareholders who meet these exemption requirements continue to incur no Irish income‑tax liability on Medtronic dividends, and the withholding payment (if any) fully satisfies any Irish tax obligation.  No new statutory changes or additional exemptions were disclosed in the 2024 filing.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MDT_10k_2023.pdf",
          "target_page": 31,
          "pages": [
            29,
            30,
            31,
            32,
            33
          ]
        },
        "hop_2_rel": {
          "source_file": "MDT_10k_2024.pdf",
          "target_page": 31,
          "pages": [
            29,
            30,
            31,
            32,
            33
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 34561,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 8875,
        "completion_tokens": 192,
        "total_tokens": 9067
      }
    },
    {
      "question_id": 96,
      "question": "How has the risk disclosure around new products and services evolved between 2022 and 2024, particularly regarding the company's platforms operating model initiative?",
      "original_answer": "In 2022, BNY Mellon highlighted that new lines of business, new products and services, or transformational or strategic project initiatives subject the company to new or additional risks. By 2024, this risk disclosure evolved to specifically include the 'transition to a platforms operating model' as a new source of uncertainty. The 2024 filing explicitly states that the company 'may not realize some or all of the expected benefits of our transition to a platforms operating model,' indicating a more focused risk related to this specific strategic initiative. This evolution shows a shift from general strategic risk language to a more concrete acknowledgment of platform-specific implementation risks.",
      "llm_answer": "The risk disclosures for new products and services have evolved to explicitly highlight the risks associated with the company's platforms operating model initiative, particularly in 2024. In the 2024 filing, the risk factor \"we may not realize some or all of the expected benefits of our transition to a platforms operating model\" appears directly in the risk factors section (page 5), whereas earlier disclosures in 2022 (page 4) only referenced \"new lines of business, new products and services or transformational or strategic project initiatives subject us to new or additional risks\" without specifically naming the platforms operating model. This represents a more targeted and explicit disclosure of the specific risk tied to the platforms operating model transition in the 2024 filing.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "BK_10k_2022.pdf",
          "target_page": 4,
          "pages": [
            2,
            3,
            4,
            5,
            6
          ]
        },
        "hop_2_rel": {
          "source_file": "BK_10k_2024.pdf",
          "target_page": 5,
          "pages": [
            3,
            4,
            5,
            6,
            7
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 41015,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 10476,
        "completion_tokens": 198,
        "total_tokens": 10674
      }
    },
    {
      "question_id": 96,
      "question": "How has Amazon's relationship with the 3.600% Note due 2032 evolved between 2023 and 2024, particularly in terms of its debt instrument disclosures?",
      "original_answer": "In 2023, the 3.600% Note due 2032 was disclosed as part of a Supplemental Indenture dated April 13, 2022, among Amazon.com, Inc., Wells Fargo Bank, National Association (as prior trustee), and Computershare Trust Company, National Association (as successor trustee). In 2024, the same note was referenced under the same Supplemental Indenture, but the trustee structure now only referenced Computershare Trust Company, National Association, as successor trustee, indicating a formal transition away from Wells Fargo Bank. This reflects a procedural evolution in the administration of the note, with no changes to the note’s terms or interest rate, but a shift in the trustee relationship.",
      "llm_answer": "Based on the provided 10-K filings, Amazon's relationship with the 3.600% Note due 2032 has remained consistent in its disclosure approach but evolved in timing and context. The note was first established under the May 12, 2021 Officers' Certificate (referenced in both 2023 and 2024 filings as part of the 2021 debt issuance), and its terms were reaffirmed in the December 1, 2022 Certificate (page 75, 4.8), which explicitly listed the 3.600% Note due 2032 among other 2024–2032 maturities. While the 2023 filing (AMZN_10k_2023.pdf) references the 2021 Certificate and includes the note in its debt disclosures (page 75, 4.8), the 2024 filing (AMZN_10k_2024.pdf) continues to reference the same 2022 Certificate (page 75, 4.8) without introducing new terms, indicating no material change in the instrument itself—only ongoing periodic reporting of existing debt covenants.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AMZN_10k_2023.pdf",
          "target_page": 75,
          "pages": [
            73,
            74,
            75,
            76,
            77
          ]
        },
        "hop_2_rel": {
          "source_file": "AMZN_10k_2024.pdf",
          "target_page": 74,
          "pages": [
            72,
            73,
            74,
            75,
            76
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 9,
        "total_chars": 43686,
        "num_window_pages": 9,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 11143,
        "completion_tokens": 218,
        "total_tokens": 11361
      }
    },
    {
      "question_id": 96,
      "question": "How did MDLZ's treatment and disclosure of net investment hedge derivative contracts evolve from 2023 to 2024, particularly in terms of their financial impact and presentation within the financial statements?",
      "original_answer": "In 2023, MDLZ disclosed the fair value of derivative assets and liabilities associated with net investment hedge contracts, with $1,347 million and $377 million in other current assets and $250 million and $413 million in other assets as of December 31, 2023 and 2022, respectively. By 2024, the focus shifted to the income statement impact, where the company noted that 'Other income, net' included amounts excluded from the assessment of hedge effectiveness related to these contracts, indicating a change in emphasis from balance sheet valuation to income volatility effects.",
      "llm_answer": "From 2023 to 2024, MDLZ’s net investment hedge derivative contracts shifted from a $219 million liability (recorded as a negative fair‑value in 2023) to a $255 million asset (positive fair‑value in 2024), reflecting a $474 million swing in fair‑value. This change is disclosed in the “Net investment hedge contracts” line of the fair‑value tables (page 96/97) and is also reflected in the interest‑and‑other expense line where the loss on debt extinguishment was removed in 2024, resulting in a lower overall interest expense ($508 million in 2024 vs. $550 million in 2023). Consequently, the hedge’s financial impact moved from a drag on earnings to a modest gain, and its presentation shifted from a liability to an asset within other current assets on the balance sheet.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MDLZ_10k_2023.pdf",
          "target_page": 95,
          "pages": [
            93,
            94,
            95,
            96,
            97
          ]
        },
        "hop_2_rel": {
          "source_file": "MDLZ_10k_2024.pdf",
          "target_page": 93,
          "pages": [
            91,
            92,
            93,
            94,
            95
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 45523,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 11617,
        "completion_tokens": 193,
        "total_tokens": 11810
      }
    },
    {
      "question_id": 97,
      "question": "How has the Abrams Main Battle Tank's modernization strategy evolved from 2023 to 2024, particularly in terms of technological development and international demand?",
      "original_answer": "In 2023, General Dynamics was focused on delivering the System Enhancement Package version 3 (SEPv3) for the Abrams tank, which included upgrades in communications, power generation, fuel efficiency, optics, and armor. Additionally, GD announced the development of the M1E3 Abrams, a more significant engineering change aimed at future threats, featuring the latest systems architecture for quicker upgrades and reduced sustainment footprint. By 2024, the company emphasized continued capability enhancement of the Abrams to counter current and potential threats, with increased international demand reflected in a growing installed base across Europe, the Middle East, North Africa, and the Indo-Pacific. While 2023 focused on the technical roadmap (SEPv3 and M1E3), 2024 highlighted the global strategic relevance and procurement momentum of the Abrams platform.",
      "llm_answer": "From 2023 to 2024, General Dynamics’ Abrams tank modernization strategy remained anchored in incremental upgrades rather than a new platform, with a strong focus on enhancing the existing M1A2 SEPv3 configuration and advancing the next‑generation M1E3 Abrams tank.  The company emphasized next‑generation lethality, survivability and mobility through upgrades such as SEPv3’s improved communications, power generation, fuel efficiency and armor, while also accelerating development of the M1E3 to meet future threat requirements.  Internationally, demand for Abrams tanks and related upgrades stayed robust, supported by ongoing export sales to NATO allies and partners in Europe, the Middle East, North Africa and the Indo‑Pacific, ensuring a growing installed base and sustained market leadership for the Abrams platform worldwide.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "GD_10k_2023.pdf",
          "target_page": 10,
          "pages": [
            8,
            9,
            10,
            11,
            12
          ]
        },
        "hop_2_rel": {
          "source_file": "GD_10k_2024.pdf",
          "target_page": 9,
          "pages": [
            7,
            8,
            9,
            10,
            11
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 26962,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 6963,
        "completion_tokens": 208,
        "total_tokens": 7172
      }
    },
    {
      "question_id": 97,
      "question": "How has AMD's role in the development and positioning of APUs evolved between 2022 and 2024, particularly in terms of their market segmentation and strategic emphasis?",
      "original_answer": "In 2022, APUs were discussed as part of AMD's broader Enterprise, Embedded and Semi-Custom product portfolio, which included CPUs, GPUs, and customized SoC products. They were described in general terms without specific market segmentation or strategic emphasis. By 2024, APUs were explicitly included in two of AMD's four reportable segments: the Data Center segment and the Client segment. In the Data Center segment, APUs were listed alongside AI accelerators, CPUs, GPUs, and DPUs, indicating a strategic shift to position APUs as part of data center solutions. In the Client segment, APUs were specifically tied to desktop and notebook CPUs and chipsets, showing a more defined and segmented approach to their market positioning. This evolution reflects a more structured and strategic integration of APUs into AMD's core business segments.",
      "llm_answer": "Between 2022 and 2024, AMD's APU strategy evolved from a primarily consumer-focused, value-and-mainstream positioning toward a more segmented, strategic emphasis on both client and enterprise markets. In 2022, APUs were positioned as integrated CPU+GPU solutions for mainstream desktops and notebooks, with Ryzen and Athlon mobile APUs built on Zen 3 architecture targeting gamers, creators, and commercial users. By 2024, AMD expanded APU adoption into the commercial and embedded segments, leveraging Ryzen PRO and embedded variants for enterprise durability, security, and manageability, while maintaining its role in semi-custom solutions like the Steam Deck. This shift reflects a strategic move to segment APUs across client (consumer and commercial), enterprise (via AMD PRO), and embedded markets, emphasizing performance-per-watt, security, and platform longevity rather than just cost-effective integrated graphics. The 2024 fiscal year also saw APUs integrated into data center and AI workloads through Instinct accelerators and semi-custom SoCs, underscoring a broader strategic emphasis on heterogeneous computing across all segments.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AMD_10k_2022.pdf",
          "target_page": 9,
          "pages": [
            7,
            8,
            9,
            10,
            11
          ]
        },
        "hop_2_rel": {
          "source_file": "AMD_10k_2024.pdf",
          "target_page": 69,
          "pages": [
            67,
            68,
            69,
            70,
            71
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 43335,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 11058,
        "completion_tokens": 286,
        "total_tokens": 11345
      }
    },
    {
      "question_id": 97,
      "question": "How has Medtronic's disclosure regarding the implications of the Financial Transfers Act 1992 on financial transfers between Ireland and third countries evolved from 2023 to 2024?",
      "original_answer": "In 2023, Medtronic disclosed that the Financial Transfers Act 1992 allowed the Irish Minister for Finance to impose restrictions on financial transfers with certain third countries, and that the list of such countries was subject to ongoing change. By 2024, the company continued to disclose the same regulatory framework but no longer emphasized the dynamic nature of the list of restricted countries, suggesting a potential shift in focus or a stabilization in the regulatory environment affecting these transfers.",
      "llm_answer": "Based on the provided document pages, Medtronic's disclosure regarding the Financial Transfers Act 1992 has remained consistent between 2023 and 2024. The company continues to state that the Irish Minister for Finance can restrict financial transfers between Ireland and third countries under the Act, and that such transfers may be subject to sanctions-related restrictions. However, there is no indication of any significant change or evolution in this disclosure between the fiscal years 2023 and 2024. The relevant information appears on page 31 of both the 2023 and 2024 filings, where the company describes the Act's provisions and current restrictions without noting any new developments or changes from the prior year.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MDT_10k_2023.pdf",
          "target_page": 31,
          "pages": [
            29,
            30,
            31,
            32,
            33
          ]
        },
        "hop_2_rel": {
          "source_file": "MDT_10k_2024.pdf",
          "target_page": 31,
          "pages": [
            29,
            30,
            31,
            32,
            33
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 34561,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 8869,
        "completion_tokens": 181,
        "total_tokens": 9050
      }
    },
    {
      "question_id": 98,
      "question": "How did the status and production outlook of the G700 aircraft evolve from 2023 to 2024 based on GD's disclosures?",
      "original_answer": "In 2023, the G700 was described as the next model to join the Gulfstream lineup, with expectations for it to enter service following FAA certification in early 2024. By 2024, the G700 had begun deliveries in the second quarter, indicating that it successfully completed certification and transitioned from development to active production and customer delivery. This marks a clear evolution from a future product to a realized and delivered aircraft model.",
      "llm_answer": "Based on the disclosures, the G700 aircraft transitioned from development to delivery between 2023 and 2024. In the 2023 10-K (pages 3, 4, 5), Gulfstream highlighted the G700 as an \"ultra-long-range, ultra-large-cabin\" aircraft in final certification stages, with FAA certification expected in \"early 2024\" and production ramping to support \"deliveries in the second quarter of 2024\" (page 5). By the 2024 10-K (pages 68-72), the aircraft had entered service, as evidenced by the inventory increase tied to \"new Gulfstream aircraft models, including the G700 that began deliveries in the second quarter of 2024\" (page 70), and the production ramp was reflected in the company's capital investments and manufacturing capacity expansions noted in the Aerospace segment overview (pages 3, 4, 6). The G700's inclusion in the product lineup and delivery schedule marked a key evolution from prototype to operational aircraft, directly contributing to the 2024 inventory growth and revenue from new aircraft sales.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "GD_10k_2023.pdf",
          "target_page": 5,
          "pages": [
            3,
            4,
            5,
            6,
            7
          ]
        },
        "hop_2_rel": {
          "source_file": "GD_10k_2024.pdf",
          "target_page": 70,
          "pages": [
            68,
            69,
            70,
            71,
            72
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 32646,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 8372,
        "completion_tokens": 252,
        "total_tokens": 8624
      }
    },
    {
      "question_id": 98,
      "question": "How has the nature of PMI's relationship with KT&G evolved from 2023 to 2024, particularly in terms of strategic dependency and product commercialization?",
      "original_answer": "In 2023, PMI announced a long-term collaboration with KT&G to commercialize KT&G's smoke-free devices and consumables on an exclusive, worldwide basis (excluding South Korea), under a 15-year agreement running through January 29, 2038. This partnership granted PMI exclusive access to KT&G's smoke-free brands and product pipeline, including offerings for low- and middle-income markets. By 2024, this relationship had evolved into a more integrated dependency, as KT&G's heat-not-burn products were explicitly referenced as part of PMI's heat-not-burn product portfolio, indicating a shift from exclusive distribution to inclusion within PMI's broader smoke-free product strategy. This evolution reflects a deeper strategic alignment and operational integration of KT&G's offerings into PMI's product ecosystem.",
      "llm_answer": "From 2023 to 2024, PMI’s relationship with KT&G deepened into a long‑term, exclusive global partnership that secures PMI continued access to KT&G’s smoke‑free product pipeline and innovation, while KT&G gains a stable, high‑volume distribution channel and co‑development of new reduced‑risk products. This strategic dependency is now embedded in a 15‑year agreement (through 2038) with performance‑based volume reviews, making KT&G a core supplier for PMI’s heated‑tobacco and other smoke‑free offerings outside South Korea. At the same time, the collaboration has accelerated product commercialization, with PMI launching and expanding KT&G‑licensed heated‑tobacco units (e.g., Fiit, Miix, and licensed HEETS variants) across multiple regions, driving a notable rise in smoke‑free net revenues and market share.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "PM_10k_2023.pdf",
          "target_page": 59,
          "pages": [
            57,
            58,
            59,
            60,
            61
          ]
        },
        "hop_2_rel": {
          "source_file": "PM_10k_2024.pdf",
          "target_page": 40,
          "pages": [
            38,
            39,
            40,
            41,
            42
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 44855,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 11435,
        "completion_tokens": 203,
        "total_tokens": 11638
      }
    },
    {
      "question_id": 98,
      "question": "How has AMD's approach to semi-custom SoC products evolved from 2022 to 2024, particularly in terms of their strategic positioning and integration with broader product ecosystems?",
      "original_answer": "In 2022, AMD's semi-custom SoC products were described as being dependent on third-party product success, with revenue tied to both non-recurring engineering fees and the incorporation of AMD's SoCs into customer devices. There was a clear emphasis on the risks associated with this dependency, including the lack of control over third-party marketing and the uncertainty of revenue realization. By 2024, AMD's approach had evolved significantly, with semi-custom SoCs being positioned as core components of a broader, more integrated product ecosystem that includes AI accelerators, CPUs, GPUs, and APUs. The 2024 filing highlights strategic integration with AI capabilities, such as the inclusion of a dedicated neural processing unit (NPU) on the same SoC as an x86 CPU for AI PCs, and the use of semi-custom SoCs in gaming, cloud services, and embedded systems across multiple industries. This reflects a shift from a dependency model to a more proactive, integrated product leadership strategy.",
      "llm_answer": "From 2022 through 2024 AMD’s semi‑custom SoC strategy shifted from a broad, diversified portfolio of custom‑design silicon for console, handheld and automotive platforms toward a more focused, AI‑centric positioning within its broader product ecosystem.  Early‑2022 disclosures highlighted the company’s reliance on long‑term wafer‑purchase agreements and joint‑venture ATMP capacity to support its semi‑custom designs, while emphasizing that revenue from these products depended on third‑party adoption and design wins.  By 2024 AMD was integrating its semi‑custom SoCs more tightly with its AI hardware roadmap—leveraging the same chiplet and Infinity Architecture platforms that power its Instinct accelerators and EPYC CPUs—and using acquisitions such as Silo AI and the pending ZT Systems transaction to accelerate AI‑software stacks (ROCm) and data‑center‑scale solutions.  This evolution reflects a strategic pivot to align semi‑custom offerings with AMD’s broader goal of becoming an end‑to‑end AI leader, embedding these SoCs in both data‑center AI accelerators and emerging AI‑PC client products.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AMD_10k_2022.pdf",
          "target_page": 25,
          "pages": [
            23,
            24,
            25,
            26,
            27
          ]
        },
        "hop_2_rel": {
          "source_file": "AMD_10k_2024.pdf",
          "target_page": 5,
          "pages": [
            3,
            4,
            5,
            6,
            7
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 48777,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 12421,
        "completion_tokens": 276,
        "total_tokens": 12698
      }
    },
    {
      "question_id": 98,
      "question": "How has the treatment of Irish income tax on dividends paid to U.S. residents evolved between 2023 and 2024, particularly regarding exemptions and withholding tax obligations?",
      "original_answer": "In 2023, Medtronic noted that U.S. residents who are exempt from Irish dividend withholding tax generally would not be subject to Irish income tax on dividends unless they had a connection to Ireland beyond shareholding. Additionally, non-residents subject to withholding tax typically had no further Irish income tax liability. In 2024, the company clarified that U.S. residents who qualify for a withholding tax exemption and do not hold shares through an Irish branch generally will not have Irish income tax liability, and those subject to withholding can discharge any further liability by furnishing a statement to Irish Revenue. The 25% withholding tax rate remained unchanged, but the 2024 disclosure provided more structured conditions for exemption and clarified post-withholding tax procedures.",
      "llm_answer": "Between 2023 and 2024, the treatment of Irish income tax on dividends paid to U.S. residents remained unchanged in its core exemption framework: U.S. shareholders who hold shares through DTC with properly recorded U.S. addresses (and have the information relayed to Medtronic’s qualifying intermediary) are exempt from Irish dividend withholding tax (currently at 25%), and such exempted dividends also incur no additional Irish income tax liability unless the shareholder has other Irish connections (e.g., residency). The 2024 filing confirms this exemption applies to U.S. residents holding shares via DTC, while other shareholders may still face withholding tax, and explicitly states that U.S. residents exempt from withholding tax generally have no further Irish income tax obligation on those dividends. No new exemptions or changes to this treatment were introduced in the 2024 filing.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MDT_10k_2023.pdf",
          "target_page": 26,
          "pages": [
            24,
            25,
            26,
            27,
            28
          ]
        },
        "hop_2_rel": {
          "source_file": "MDT_10k_2024.pdf",
          "target_page": 31,
          "pages": [
            29,
            30,
            31,
            32,
            33
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 47506,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 12104,
        "completion_tokens": 223,
        "total_tokens": 12327
      }
    },
    {
      "question_id": 99,
      "question": "How did General Dynamics' financial performance and strategic focus in ship construction change from 2023 to 2024, particularly regarding cost pressures on the Virginia-class and DDG-51 programs and the revenue outlook for the Columbia-class submarine initiative?",
      "original_answer": "In 2023, General Dynamics' Marine Systems segment experienced a 110 basis point decline in operating margin due to supply chain disruptions affecting the Virginia-class submarine schedule and cost overruns on the DDG-51 guided-missile destroyer program. Despite these challenges, revenue from U.S. Navy ship construction rose, driven by increased activity on the Columbia-class submarine program. By 2024, the company projected revenue for the Marine Systems segment to rise to $12.8–12.9 billion with an expected operating margin of approximately 7.6%, suggesting a strategic effort to stabilize and improve profitability. This indicates a shift from cost-driven margin pressure in 2023 to a more optimistic outlook in 2024, likely supported by improved program execution and growth in the Columbia-class program.",
      "llm_answer": "General Dynamics' financial performance and strategic focus in ship construction shifted from 2023 to 2024, with the Marine Systems segment's revenue outlook increasing to $12.8–12.9 billion for 2024 (up from $12.461 billion in 2023), driven by higher volume on the Columbia-class submarine program. However, operating margin pressure persisted in 2023 due to supply chain costs affecting the Virginia-class submarine and DDG-51 program, though the 2024 outlook anticipates improved margin (~7.6%) as the Columbia-class initiative advances.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "GD_10k_2023.pdf",
          "target_page": 37,
          "pages": [
            35,
            36,
            37,
            38,
            39
          ]
        },
        "hop_2_rel": {
          "source_file": "GD_10k_2024.pdf",
          "target_page": 59,
          "pages": [
            57,
            58,
            59,
            60,
            61
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 32423,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 8355,
        "completion_tokens": 135,
        "total_tokens": 8490
      }
    },
    {
      "question_id": 99,
      "question": "How has BKNG's financial dependency on Booking.com evolved between 2022 and 2023 based on the proportion of revenue derived from accommodation reservations?",
      "original_answer": "BKNG's financial dependency on Booking.com has remained high but slightly increased between 2022 and 2023. In 2022, Booking.com's accommodation reservations contributed 89% of BKNG's total revenues. This percentage remained unchanged in 2023, indicating BKNG continues to heavily rely on Booking.com for its revenue base. The consistent 89% contribution in both years shows a sustained and concentrated dependency on Booking.com's core service offering.",
      "llm_answer": "Based on the provided 10-K pages, BKNG's financial dependency on Booking.com for accommodation revenue remained heavily concentrated but showed a slight reduction in proportion between 2022 and 2023. In 2022, approximately 89% of the company's total revenue was derived from online accommodation reservation services, with Booking.com being the primary driver of this segment (as stated in BKNG_10k_2022.pdf page 5: \"The majority of the Company's merchant revenues and substantially all of its agency revenues are from Booking.com's accommodation reservations\"). By 2023, this proportion decreased to approximately 87% of total revenue (as noted in BKNG_10k_2023.pdf page 86: \"Approximately 89%, 89%, and 87% of the Company's revenues for the years ended December 31, 2023, 2022, and 2021, respectively, relate to online accommodation reservation services\"). This indicates a modest diversification of revenue streams, though Booking.com continues to be the dominant source of accommodation-related revenue, with the share declining slightly from 89% to 87% over the two-year period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "BKNG_10k_2022.pdf",
          "target_page": 4,
          "pages": [
            2,
            3,
            4,
            5,
            6
          ]
        },
        "hop_2_rel": {
          "source_file": "BKNG_10k_2023.pdf",
          "target_page": 87,
          "pages": [
            85,
            86,
            87,
            88,
            89
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 9,
        "total_chars": 41471,
        "num_window_pages": 9,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 10590,
        "completion_tokens": 270,
        "total_tokens": 10860
      }
    },
    {
      "question_id": 99,
      "question": "How did the company's position with respect to its Swiss Franc note evolve between 2023 and 2024, and what does this indicate about its foreign currency obligations?",
      "original_answer": "In 2023, the company disclosed a Swiss Franc note obligation of $299 million, which was completely removed by the end of 2024. This indicates that the company either repaid or restructured this foreign currency obligation over the year, reflecting a strategic shift in managing its Swiss Franc exposure.",
      "llm_answer": "Between 2023 and 2024, PMI's position regarding its Swiss Franc note shifted from having an outstanding balance of $299 million (as disclosed in the 2023 long‑term debt schedule) to $0 million by the end of 2024, indicating that the company fully repaid or otherwise removed that specific Swiss franc‑denominated obligation. This reduction reflects a deliberate de‑leveraging of foreign‑currency exposure, suggesting that PMI is actively managing its foreign‑currency obligations and may be seeking to minimize currency risk or simplify its debt profile.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "PM_10k_2023.pdf",
          "target_page": 105,
          "pages": [
            103,
            104,
            105,
            106,
            107
          ]
        },
        "hop_2_rel": {
          "source_file": "PM_10k_2024.pdf",
          "target_page": 102,
          "pages": [
            100,
            101,
            102,
            103,
            104
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 44147,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 11264,
        "completion_tokens": 138,
        "total_tokens": 11402
      }
    },
    {
      "question_id": 100,
      "question": "How did Goldman Sachs' treatment of Non-Employee Director RSU Award Agreements evolve between the 2023 and 2024 10-K filings, particularly in terms of introduced or modified agreements?",
      "original_answer": "In the 2023 10-K filing, Goldman Sachs referenced the 'Form of Non-Employee Director RSU Award Agreement (pre-2015)' as Exhibit 10.8, indicating that the existing documentation pertained to agreements prior to 2015. In the 2024 filing, the company not only retained the reference to the pre-2015 RSU Award Agreement but also introduced a new exhibit titled 'Amendments to Certain Non-Employee Director Equity Award Agreements' as Exhibit 10.18, which was not present in the 2023 filing. This indicates that Goldman Sachs expanded its disclosures to include amendments to these agreements, suggesting a more comprehensive or updated treatment of non-employee director equity arrangements in 2024.",
      "llm_answer": "Based on the provided 10-K filings, the treatment of Non-Employee Director RSU Award Agreements remained consistent between 2023 and 2024, with no new agreements introduced or modified. The 2024 filing (page 247) references the same pre-2015 forms (e.g., Exhibit 10.31 and 10.32) that were originally incorporated in the 2014 10-K (page 5, item 10.8), indicating no substantive changes to the agreement terms or structure during this period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "GS_10k_2023.pdf",
          "target_page": 5,
          "pages": [
            3,
            4,
            5,
            6,
            7
          ]
        },
        "hop_2_rel": {
          "source_file": "GS_10k_2024.pdf",
          "target_page": 246,
          "pages": [
            243,
            244,
            245,
            246,
            247
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 9,
        "total_chars": 41486,
        "num_window_pages": 9,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 10601,
        "completion_tokens": 110,
        "total_tokens": 10711
      }
    },
    {
      "question_id": 100,
      "question": "How did PM's financial relationship with Swedish Match AB evolve between 2023 and 2024, particularly in terms of long-term debt obligations tied to the acquisition?",
      "original_answer": "In 2023, the long-term debt obligations related to the Swedish Match AB acquisition totaled $6,121 million, while in 2024, this amount decreased to $2,610 million. This indicates a significant reduction in the debt tied to the acquisition, suggesting that PM made substantial repayments or refinanced during the period. The decrease supports the idea that PM's financial dependency or exposure linked to the Swedish Match acquisition lessened over time.",
      "llm_answer": "Between 2023 and 2024, PMI’s financial relationship with Swedish Match AB evolved primarily through the repayment of debt used to finance the acquisition. PMI recorded a $2.57 billion reduction to goodwill tied to Swedish Match due to measurement‑period adjustments, and it prepaid approximately €3 billion (about $3.2 billion) of the three‑year tranche of the €5.5 billion senior unsecured term loan that was taken out in 2022 to fund the Swedish Match purchase. The remaining €2.5 billion (≈$2.6 billion) of that term loan was still outstanding at year‑end 2024, reflecting the ongoing long‑term debt obligations linked to the acquisition.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "PM_10k_2023.pdf",
          "target_page": 100,
          "pages": [
            98,
            99,
            100,
            101,
            102
          ]
        },
        "hop_2_rel": {
          "source_file": "PM_10k_2024.pdf",
          "target_page": 102,
          "pages": [
            100,
            101,
            102,
            103,
            104
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 44505,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 11352,
        "completion_tokens": 160,
        "total_tokens": 11513
      }
    },
    {
      "question_id": 100,
      "question": "How did BMY's strategic positioning around KRAS inhibition evolve from 2023 to 2024, particularly in relation to the acquisition of Mirati and the development trajectory of Krazati?",
      "original_answer": "In 2023, BMY had not yet acquired Mirati, and Krazati was not part of its portfolio. However, by 2024, BMY completed the acquisition of Mirati for $4.8 billion, gaining full rights to Krazati, a KRAS G12C inhibitor. Krazati had already received FDA approval for second-line NSCLC and was in clinical development for first-line NSCLC in combination with a PD-1 inhibitor. Additionally, in 2024, Krazati was also FDA approved for advanced or metastatic KRAS-mutated colorectal cancer with cetuximab, expanding its therapeutic footprint. This acquisition marked a significant evolution in BMY’s oncology strategy, positioning it more strongly in the KRAS inhibition space.",
      "llm_answer": "From 2023 to 2024, BMS’s strategic positioning around KRAS inhibition shifted decisively with the **$4.8 billion acquisition of Mirati Therapeutics** (completed in January 2024). This transaction gave BMS full commercial rights to **Krazati (adagrasib)**, a best‑in‑class KRAS G12C inhibitor already approved for second‑line NSCLC and KRAS‑mutated colorectal cancer, and added the clinical‑stage **MRTX1719 (PRMT5 inhibitor)** to its pipeline. The acquisition was structured as a business combination, allocating roughly $640 million to acquired marketed product rights (Krazati) and $3.5 billion to indefinite‑lived IPRD covering future KRAS‑targeted programs. BMS now leverages Mirati’s commercial infrastructure and its own development capabilities to advance Krazati in first‑line NSCLC combinations and to expand the KRAS‑inhibitor portfolio, marking a clear evolution from a licensing‑focused approach to an integrated, acquisition‑driven strategy for KRAS‑targeted oncology.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "BMY_10k_2023.pdf",
          "target_page": 87,
          "pages": [
            85,
            86,
            87,
            88,
            89
          ]
        },
        "hop_2_rel": {
          "source_file": "BMY_10k_2024.pdf",
          "target_page": 93,
          "pages": [
            91,
            92,
            93,
            94,
            95
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 40866,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 10445,
        "completion_tokens": 245,
        "total_tokens": 10691
      }
    },
    {
      "question_id": 101,
      "question": "How has Goldman Sachs' disclosure and positioning of the Restricted Partner Compensation Plan evolved between 2023 and 2024, particularly in relation to newer compensation governance policies introduced during this period?",
      "original_answer": "In 2023, the Restricted Partner Compensation Plan was listed as Exhibit 10.3 and appeared early in the exhibit list, indicating a prominent position among compensation-related disclosures. By 2024, while the plan itself (still referenced as Exhibit 10.4) remained substantively unchanged, its relative placement shifted later in the exhibit list. Notably, in 2024, the firm introduced the Clawback Policy (Exhibit 10.1), signaling a new emphasis on compensation accountability and governance reforms. This suggests a strategic repositioning of compensation-related disclosures to prioritize risk mitigation and regulatory alignment alongside traditional partner compensation frameworks.",
      "llm_answer": "Between 2023 and 2024, Goldman Sachs updated its Restricted Partner Compensation Plan (RPCP) to reflect new governance standards. The 2023 filing (Item 10.4) references the “Amended and Restated Restricted Partner Compensation Plan” originally incorporated in 2006, while the 2024 filing (Item 10.4) explicitly includes the “Amended and Restated Restricted Partner Compensation Plan” as a current governance document, indicating a formal revision and re‑positioning of the RPCP alongside the newly adopted Clawback Policy (effective December 1 2023) and other governance‑related compensation disclosures. This evolution shows a deliberate alignment of the RPCP with the firm’s newer compensation governance policies introduced during this period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "GS_10k_2023.pdf",
          "target_page": 5,
          "pages": [
            3,
            4,
            5,
            6,
            7
          ]
        },
        "hop_2_rel": {
          "source_file": "GS_10k_2024.pdf",
          "target_page": 246,
          "pages": [
            243,
            244,
            245,
            246,
            247
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 9,
        "total_chars": 41486,
        "num_window_pages": 9,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 10610,
        "completion_tokens": 186,
        "total_tokens": 10797
      }
    },
    {
      "question_id": 101,
      "question": "How has Philip Morris International's approach to heat-not-burn products evolved from 2022 to 2023, particularly in terms of product categorization and business integration?",
      "original_answer": "In 2022, Philip Morris described its heat-not-burn products as part of its Reduced-Risk Products (RRPs) portfolio, emphasizing their role in a smoke-free future and highlighting the IQOS Platform 1 device and various heated tobacco units (HTUs) such as HEETS and Marlboro HeatSticks. These products were positioned as a key part of the company's long-term strategy to replace traditional cigarettes. By 2023, the categorization had evolved, with heat-not-burn products now explicitly grouped under 'smoke-free products' alongside e-vapor and oral nicotine products, as well as wellness and healthcare offerings. Additionally, in 2023, PMI explicitly stated that its heat-not-burn products include licensed KT&G heat-not-burn products, indicating a broader integration and expansion of the product line beyond internally developed offerings.",
      "llm_answer": "From 2022 to 2023, PMI’s heat-not-burn products shifted from being reported solely under “Heated Tobacco Units” in the shipment volume table to being explicitly categorized as “smoke-free products” within its net revenue breakdown, reflecting greater strategic emphasis on this segment. Additionally, the company integrated its smoke-free portfolio more closely with its broader business structure, as evidenced by the inclusion of Swedish Match’s revenue (including its smoke-free products like oral nicotine products) in the consolidated results and the reclassification of Swedish Match’s revenue under both “combustible tobacco” and “smoke-free products” categories, indicating deeper integration of its acquisitions into core operations.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "PM_10k_2022.pdf",
          "target_page": 5,
          "pages": [
            3,
            4,
            5,
            6,
            7
          ]
        },
        "hop_2_rel": {
          "source_file": "PM_10k_2023.pdf",
          "target_page": 39,
          "pages": [
            37,
            38,
            39,
            40,
            41
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 41122,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 10506,
        "completion_tokens": 185,
        "total_tokens": 10691
      }
    },
    {
      "question_id": 101,
      "question": "How did Bristol-Myers Squibb's approach to business risk governance evolve between 2023 and 2024 in relation to SEC Consent Order compliance, particularly regarding the role of the business risk and disclosure group?",
      "original_answer": "In 2023, Bristol-Myers Squibb established the business risk and disclosure group specifically to comply with the SEC Consent Order. This included implementing a formal review and certification process for SEC filings, retaining an outside consultant to re-engineer accounting and financial reporting processes, and introducing a governance mechanism to escalate and resolve compliance-related questions. By 2024, the company had fully integrated this group into its ongoing compliance framework, with no indication of modifications or reductions in scope, suggesting that the group remained a central component of financial governance under the Consent. The continued reference to the group in 2024 filings indicates that the company maintained its enhanced risk governance structure without significant changes.",
      "llm_answer": "Based on the provided SEC Consent Order disclosures in both 2023 and 2024 10-K filings, Bristol-Myers Squibb's business risk and disclosure group was formally established as part of its compliance measures under the Consent (specifically item (b) of the agreed measures), and the company maintained a company-wide policy with a formal governance process to monitor and resolve compliance questions regarding sales to direct customers. The 2024 filing confirms this governance structure remains in place, with the business risk and disclosure group continuing to play a key role in ensuring adherence to the Consent's requirements for limiting sales based on expected demand and preventing undisclosed inventory practices.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "BMY_10k_2023.pdf",
          "target_page": 63,
          "pages": [
            61,
            62,
            63,
            64,
            65
          ]
        },
        "hop_2_rel": {
          "source_file": "BMY_10k_2024.pdf",
          "target_page": 65,
          "pages": [
            63,
            64,
            65,
            66,
            67
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 46844,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 11949,
        "completion_tokens": 180,
        "total_tokens": 12129
      }
    },
    {
      "question_id": 102,
      "question": "How has UNP's treatment of the relationship between its pension plan's expected return and its asset allocation mix evolved between 2023 and 2024?",
      "original_answer": "In 2023, UNP explicitly stated that the expected return on plan assets was based on the asset allocation mix, historical returns, and market conditions, and included a specific actual return of 6% for that year. By 2024, the language shifted to indicating that the expected return 'depends on' the asset allocation mix, with no explicit mention of historical returns or market conditions, and no disclosure of the actual return for 2024. This represents a shift from a more comprehensive explanation of factors influencing returns to a narrower focus on the asset allocation mix alone.",
      "llm_answer": "UNP’s pension expense methodology—specifically the expected return on plan assets—has remained consistent between 2023 and 2024, with the expected return rate held steady at 5.25% in both years. However, the actual return on plan assets shifted significantly, moving from an actual return of approximately 6% in 2023 to a loss of about 18% in 2022 (though the 2024 actual return is not explicitly stated, the pattern of using a long-term expected return of 5.25% to smooth volatility remains unchanged). The company continues to apply this expected return over a five-year period to reduce year-to-year volatility in pension expense, deferring differences between actual and expected returns to accumulated other comprehensive income. This practice and the 5.25% assumption have not changed materially between 2023 and 2024.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "UNP_10k_2023.pdf",
          "target_page": 55,
          "pages": [
            53,
            54,
            55,
            56,
            57
          ]
        },
        "hop_2_rel": {
          "source_file": "UNP_10k_2024.pdf",
          "target_page": 54,
          "pages": [
            52,
            53,
            54,
            55,
            56
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 36797,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 9419,
        "completion_tokens": 206,
        "total_tokens": 9625
      }
    },
    {
      "question_id": 102,
      "question": "How did BNY Mellon's disclosure approach to the Directors' Code of Conduct evolve between 2022 and 2023, particularly in terms of its accessibility and integration within corporate governance reporting?",
      "original_answer": "In 2022, BNY Mellon explicitly stated that the Directors' Code of Conduct was posted on its website and outlined its applicability to all directors. The document was referenced in the context of broader corporate governance disclosures, including Board Meetings and Committee Information. By 2023, the Directors' Code of Conduct was no longer just referenced but was specifically listed among the governance materials 'available on our website,' alongside key governance documents like the Corporate Governance Guidelines and committee charters. This evolution indicates a more structured and centralized approach to governance disclosures, with the Code being more directly tied to the company's overall governance framework in the 2023 filing.",
      "llm_answer": "Between 2022 and 2023, BNY Mellon’s disclosure approach to the Directors’ Code of Conduct shifted from a general reference to a more explicit, publicly accessible format. In the 2022 filing, the code was mentioned only in passing within the “Available Information” section, directing readers to a PDF on the company’s website. By 2023, the filing specifically highlighted the Directors’ Code of Conduct in its own subsection under “Available Information,” provided a direct link to the PDF, and added a clear statement that any amendments or waivers to the code would be disclosed on the website. This change made the code more readily findable and integrated it into the broader corporate‑governance disclosures, improving both accessibility and transparency.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "BK_10k_2022.pdf",
          "target_page": 11,
          "pages": [
            9,
            10,
            11,
            12,
            13
          ]
        },
        "hop_2_rel": {
          "source_file": "BK_10k_2023.pdf",
          "target_page": 3,
          "pages": [
            1,
            2,
            3,
            4,
            5
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 36153,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 9270,
        "completion_tokens": 190,
        "total_tokens": 9460
      }
    },
    {
      "question_id": 102,
      "question": "How has Oracle's strategic positioning of Oracle Database evolved between 2023 and 2024 in terms of deployment flexibility and integration with engineered systems, and what does this indicate about the company's approach to cloud migration and hybrid IT environments?",
      "original_answer": "In 2023, Oracle emphasized the flexibility of running Oracle Database across multiple deployment models, including on-premise, Oracle Cloud, and multicloud environments, with specific offerings like Oracle Exadata Cloud@Customer and Oracle Roving Edge Infrastructure. These options were framed around enabling customers to securely run Oracle Database behind their firewalls while being managed by Oracle. By 2024, Oracle shifted toward deeper integration of Oracle Database within Oracle Engineered Systems, such as the Oracle Exadata Database Machine, which combines database, storage, operating system, and networking hardware into a single optimized platform. This system was highlighted as being available across on-premise, OCI cloud, and hybrid deployments. The evolution from flexible deployment of standalone database services to tightly integrated engineered systems suggests a strategic shift toward offering more holistic, performance-optimized solutions that align with enterprise needs for scalability, security, and simplified maintenance. This indicates a maturation of Oracle's cloud migration strategy, focusing not only on deployment flexibility but also on delivering comprehensive, high-performance infrastructure packages.",
      "llm_answer": "Oracle has expanded its deployment flexibility by offering OCI services in customer data centers through solutions such as Exadata Cloud@Customer, OCI Dedicated Region, OCI Sovereign Cloud, and Oracle Roving Edge Infrastructure, enabling hybrid and multicloud architectures. This strategy underscores Oracle’s focus on facilitating cloud migration while supporting hybrid IT environments, as evidenced by its investments in simplifying workload migration, expanding OCI’s global footprint, and integrating database and middleware services across on-premise, cloud, and edge deployments.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "ORCL_10k_2023.pdf",
          "target_page": 11,
          "pages": [
            9,
            10,
            11,
            12,
            13
          ]
        },
        "hop_2_rel": {
          "source_file": "ORCL_10k_2024.pdf",
          "target_page": 13,
          "pages": [
            11,
            12,
            13,
            14,
            15
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 44160,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 11291,
        "completion_tokens": 146,
        "total_tokens": 11437
      }
    },
    {
      "question_id": 102,
      "question": "How has the implementation of the formal review and certification process of annual and quarterly SEC reports evolved between 2023 and 2024, particularly in terms of compliance monitoring and governance procedures?",
      "original_answer": "In 2023, the company established a formal review and certification process of SEC filings as part of the Consent agreement, which included governance procedures to escalate potential compliance concerns to appropriate management levels and regular monitoring of compliance. By 2024, the company continued to emphasize the implementation of these governance procedures, noting that compliance with the policy was consistently monitored and that the process was integrated into company-wide sales policies to ensure adherence to inventory and sales limitations. The evolution reflects a shift from initial implementation in 2023 to sustained enforcement and integration into broader operational frameworks in 2024.",
      "llm_answer": "The formal review and certification process of annual and quarterly SEC reports was first established as part of the 2004 Consent Order with the SEC, and the company reaffirmed its continued use of that process in its 2023 and 2024 filings.  In the 2023 10‑K (page 61) and the 2024 10‑K (page 64), the company describes that the process includes a company‑wide policy, a governance structure to escalate compliance questions, regular monitoring of compliance, and documentation of the budgeting process—procedures that have remained essentially unchanged from 2023 to 2024.  No substantive evolution in the process is indicated; the focus in 2024 is on maintaining and documenting the existing governance and certification controls.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "BMY_10k_2023.pdf",
          "target_page": 63,
          "pages": [
            61,
            62,
            63,
            64,
            65
          ]
        },
        "hop_2_rel": {
          "source_file": "BMY_10k_2024.pdf",
          "target_page": 65,
          "pages": [
            63,
            64,
            65,
            66,
            67
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 46844,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 11948,
        "completion_tokens": 183,
        "total_tokens": 12131
      }
    },
    {
      "question_id": 103,
      "question": "How has Philip Morris International's approach to heat-not-burn products evolved from 2022 to 2023, particularly in terms of their market positioning and product categorization?",
      "original_answer": "In 2022, Philip Morris International (PMI) positioned heat-not-burn products as part of its broader Reduced-Risk Products (RRPs) portfolio, emphasizing their potential to present less harm to smokers who switch from traditional cigarettes. These products, including the Platform 1 device and its consumables, were described as being in various stages of development, scientific assessment, and commercialization. By 2023, PMI had refined its categorization, explicitly including heat-not-burn products within the smoke-free product segment, alongside e-vapor and oral nicotine products. Additionally, PMI began including licensed KT&amp;G heat-not-burn products in its portfolio, indicating a broader market approach and potential expansion of partnerships or offerings. This evolution shows a strategic shift from internal development focus to a more integrated and commercialized product positioning.",
      "llm_answer": "From 2022 to 2023, Philip Morris International expanded its heat-not-burn (HNB) portfolio within its broader smoke-free product strategy, positioning it as a distinct growth category separate from traditional combustible tobacco and oral products. In 2023, HNB products—including brands like HEETS, Marlboro HeatSticks, and TEREA—generated $5.561 billion in net revenue (up from $5.175 billion in 2022), reflecting strong growth in Europe (17.6%) and Japan (14.5%), while adjusted in-market sales rose 14.8%. This growth was driven by increased shipment volumes (+14.7% for HTUs), with HNB now categorized as a core segment under PMI’s \"smoke-free products\" division, distinct from oral nicotine products (e.g., Swedish Match’s nicotine pouches, which grew 100% due to acquisition). PMI explicitly separates HNB performance in its segment reporting, emphasizing its strategic focus on HTUs as a key growth driver amid declining cigarette volumes.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "PM_10k_2022.pdf",
          "target_page": 76,
          "pages": [
            74,
            75,
            76,
            77,
            78
          ]
        },
        "hop_2_rel": {
          "source_file": "PM_10k_2023.pdf",
          "target_page": 39,
          "pages": [
            37,
            38,
            39,
            40,
            41
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 45849,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 11690,
        "completion_tokens": 236,
        "total_tokens": 11926
      }
    },
    {
      "question_id": 103,
      "question": "How has Oracle's strategic positioning of Oracle Database evolved between 2023 and 2024 in terms of deployment flexibility and integration with other Oracle technologies?",
      "original_answer": "In 2023, Oracle emphasized the deployment flexibility of Oracle Database across cloud-based, on-premise, or other IT environments, highlighting its perpetual licensing model and the company's strategy to provide customer choice. By 2024, Oracle Database's role had evolved to become a foundational component within broader engineered systems, such as Oracle Exadata Database Machine, which integrates the database with storage, operating system software, and hardware components for optimized performance. This shift indicates a move toward deeper integration with Oracle's infrastructure technologies, positioning Oracle Database not just as a standalone product but as a core element of Oracle Engineered Systems, available in on-premise, cloud (OCI), and hybrid cloud deployments.",
      "llm_answer": "Oracle has expanded the flexibility of Oracle Database deployment through cloud-native options like Autonomous Database, which automates administration and enables consumption-based pricing, while deepening integration with its cloud platform (OCI), middleware (e.g., Java, Middleware), and engineered systems. This positions the database as a core component of Oracle's broader cloud strategy, emphasizing hybrid and multicloud deployment models (e.g., Exadata Cloud@Customer, Dedicated Region) to meet diverse customer needs.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "ORCL_10k_2023.pdf",
          "target_page": 42,
          "pages": [
            40,
            41,
            42,
            43,
            44
          ]
        },
        "hop_2_rel": {
          "source_file": "ORCL_10k_2024.pdf",
          "target_page": 13,
          "pages": [
            11,
            12,
            13,
            14,
            15
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 42380,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 10822,
        "completion_tokens": 131,
        "total_tokens": 10953
      }
    },
    {
      "question_id": 103,
      "question": "How has BMY's strategic relationship with Krazati evolved from 2023 to 2024, and what specific financial commitments were made in 2024 that reflect this evolution?",
      "original_answer": "In 2023, Krazati was mentioned as part of BMY's oncology portfolio, demonstrating a strategic fit into their offerings. By 2024, BMY had acquired Mirati for $4.8 billion, obtaining the rights to Krazati, which had received FDA and EMA approvals for second-line NSCLC and was in clinical development for first-line NSCLC. Additionally, BMY committed $1.0 billion in contingent value rights tied to the development of PRMT5 Inhibitor, further signaling long-term investment in the acquired assets.",
      "llm_answer": "From 2023 to 2024, BMS’s strategic relationship with Krazati evolved from a co-development and profit-sharing arrangement with 2seventy bio (originally covering BCMA-targeted therapies) to a fully licensed, BMS‑controlled commercialization. In 2024, BMS paid a $100 million upfront acquisition fee for the Orum ORM‑6151 program and, more significantly, completed the $4.8 billion acquisition of Mirati, which granted BMS exclusive rights to Krazati (a KRAS inhibitor). This transaction included a $100 million upfront payment plus up to $80 million in contingent milestones, and it was accounted for as an asset acquisition, with $12.1 billion expensed to acquired IPRD, reflecting BMS’s shift toward sole ownership and development of Krazati.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "BMY_10k_2023.pdf",
          "target_page": 43,
          "pages": [
            41,
            42,
            43,
            44,
            45
          ]
        },
        "hop_2_rel": {
          "source_file": "BMY_10k_2024.pdf",
          "target_page": 93,
          "pages": [
            91,
            92,
            93,
            94,
            95
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 39330,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 10057,
        "completion_tokens": 185,
        "total_tokens": 10243
      }
    },
    {
      "question_id": 104,
      "question": "How has the treatment or status of the 6.244% Fixed-to-Floating Rate Normal Preferred Capital Securities of Mellon Capital IV evolved between 2022 and 2023 based on BK's SEC filings?",
      "original_answer": "In 2022, the 6.244% Fixed-to-Floating Rate Normal Preferred Capital Securities of Mellon Capital IV were introduced as securities registered under Section 12(b) of the Act and were listed on the New York Stock Exchange under the trading symbol BK/P, fully and unconditionally guaranteed by The Bank of New York Mellon Corporation. In 2023, the same securities remained registered under Section 12(b) of the Act, retained the same trading symbol BK/P, and continued to be listed on the New York Stock Exchange with the same guarantee structure. Therefore, there was no change in the treatment or status of these securities between the two years.",
      "llm_answer": "Based on the 2022 and 2023 Form 10-K filings, the treatment of the 6.244% Fixed-to-Floating Rate Normal Preferred Capital Securities of Mellon Capital IV (trading as BK/P) remained unchanged in terms of its structure and listing. The securities continued to be fully and unconditionally guaranteed by The Bank of New York Mellon Corporation and were listed on the New York Stock Exchange under the symbol BK/P in both years. No material changes to their terms or status were disclosed in the provided documents.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "BK_10k_2022.pdf",
          "target_page": 1,
          "pages": [
            1,
            2,
            3,
            4,
            5
          ]
        },
        "hop_2_rel": {
          "source_file": "BK_10k_2023.pdf",
          "target_page": 1,
          "pages": [
            1,
            2,
            3,
            4,
            5
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 37406,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 9578,
        "completion_tokens": 127,
        "total_tokens": 9705
      }
    },
    {
      "question_id": 104,
      "question": "How has the capacity and utilization of PMI's short-term credit arrangements changed from 2022 to 2023, and what does this shift suggest about their near-term liquidity posture?",
      "original_answer": "The capacity of PMI's short-term credit arrangements increased from $1.9 billion at the end of 2022 to $2.7 billion at the end of 2023, while the actual utilization decreased slightly from $295 million to $283 million. This indicates that PMI has expanded its available liquidity buffer without increasing its drawdown, suggesting a more conservative approach to short-term financing and working capital management.",
      "llm_answer": "Based on the provided financial disclosures, PMI's short-term credit arrangements experienced a significant shift in capacity and utilization between 2022 and 2023. The company's committed credit facilities remained stable at $6.3 billion, but borrowings under these facilities increased from $295 million at December 31, 2022, to $283 million at December 31, 2023, while the available capacity decreased as the company utilized more of its existing commitments. This shift suggests a more conservative near-term liquidity posture, as PMI appears to be actively managing its short-term borrowing needs amid potential market uncertainties, though the overall credit capacity remains substantial. The utilization trend indicates a deliberate reduction in available liquidity buffers, potentially signaling a strategic shift toward more disciplined capital allocation.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "PM_10k_2022.pdf",
          "target_page": 88,
          "pages": [
            86,
            87,
            88,
            89,
            90
          ]
        },
        "hop_2_rel": {
          "source_file": "PM_10k_2023.pdf",
          "target_page": 108,
          "pages": [
            106,
            107,
            108,
            109,
            110
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 9,
        "total_chars": 37338,
        "num_window_pages": 9,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 9563,
        "completion_tokens": 216,
        "total_tokens": 9779
      }
    },
    {
      "question_id": 104,
      "question": "How has Oracle's positioning of the Autonomous Database evolved between 2023 and 2024, particularly in terms of integration with other cloud services and automation capabilities?",
      "original_answer": "In 2023, Oracle positioned the Autonomous Database as part of its broader Oracle Cloud Infrastructure (OCI) offerings, emphasizing its automated database operations and the ability to run in cloud, on-premise, or hybrid environments. It was described as a service that Oracle runs, manages, upgrades, and supports on behalf of the customer, with a focus on reducing IT process time and resources. By 2024, Oracle expanded its positioning to highlight deeper integration with other Oracle Cloud services, such as Java Cloud and Oracle APEX low-code service, and emphasized open interfaces and native machine learning capabilities. The 2024 filing also introduced a stronger focus on automation powered by machine learning, including diagnostics, fault prediction, error handling, and automatic threat detection. Additionally, 2024 emphasized the Autonomous Database's role in enabling modern cloud-native application development and analytics, including data lake houses and real-time analysis of transactional data.",
      "llm_answer": "Between 2023 and 2024, Oracle’s Autonomous Database has deepened its integration with the broader Oracle Cloud ecosystem and expanded its automation capabilities. The 2024 filing emphasizes tighter coupling with OCI services such as Java Cloud, OCI AI, and OCI networking/edge offerings, enabling customers to run Autonomous Database workloads across hybrid, multicloud, and sovereign cloud environments while leveraging OCI’s elastic compute, storage, and AI infrastructure. Automation has been broadened to include self‑driving database administration (patching, scaling, security, backup), machine‑learning‑driven fault prediction, and consumption‑based, on‑demand scaling, all designed to reduce labor costs and simplify deployment both on OCI and on‑premise via Exadata Cloud@Customer and OCI Dedicated Region.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "ORCL_10k_2023.pdf",
          "target_page": 10,
          "pages": [
            8,
            9,
            10,
            11,
            12
          ]
        },
        "hop_2_rel": {
          "source_file": "ORCL_10k_2024.pdf",
          "target_page": 12,
          "pages": [
            10,
            11,
            12,
            13,
            14
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 44411,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 11331,
        "completion_tokens": 203,
        "total_tokens": 11535
      }
    },
    {
      "question_id": 105,
      "question": "How did GM's financial relationship with Ultium Cells Holdings LLC evolve between 2023 and 2024, particularly in terms of its capital involvement and strategic positioning?",
      "original_answer": "In 2023, GM's relationship with Ultium Cells Holdings LLC was characterized by contingent capital commitments, with a committed contribution of $0.8 billion, and the entity was classified as a variable interest entity (VIE) where GM lacked voting control. By 2024, GM's involvement evolved into a more direct investment of $0.7 billion, indicating a shift from a potential future obligation to a realized investment stake. This transformation suggests a strategic realignment, providing GM with potentially greater influence over Ultium Cells' operations while stabilizing its financial exposure.",
      "llm_answer": "Based on the provided financial disclosures, GM's financial relationship with Ultium Cells Holdings LLC evolved significantly between 2023 and 2024, particularly regarding capital involvement and strategic positioning. In 2023, GM held a noncontrolling interest in Ultium Cells through its $1.6 billion investment (including $0.7 billion in 2023 alone), with $0.8 billion in committed capital contributions disclosed at year-end 2023. By 2024, GM increased its investment to $0.7 billion (as noted in the cash flow statement under \"Investment in UltiumCells Holdings LLC\"), reflecting continued strategic commitment to the joint venture despite broader industry shifts. However, GM's capital involvement remained secondary to its broader EV strategy, as evidenced by its 2024 decision to terminate funding for Cruise (a separate but related EV entity) while maintaining Ultium Cells investments, underscoring a focused pivot toward scalable battery manufacturing partnerships rather than expansive capital outlays. GM's maximum exposure to loss related to Ultium Cells was capped at $3.5 billion (including $0.8 billion in committed capital), but the company emphasized that its variable interests did not grant control over the entity's key economic activities.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "GM_10k_2023.pdf",
          "target_page": 80,
          "pages": [
            78,
            79,
            80,
            81,
            82
          ]
        },
        "hop_2_rel": {
          "source_file": "GM_10k_2024.pdf",
          "target_page": 40,
          "pages": [
            38,
            39,
            40,
            41,
            42
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 51359,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 13066,
        "completion_tokens": 315,
        "total_tokens": 13381
      }
    },
    {
      "question_id": 106,
      "question": "How has the financial impact of the Litigation Management Deed evolved between 2022 and 2024, particularly in terms of the amount of as-converted value released and the number of series A preferred shares issued during the anniversary releases?",
      "original_answer": "In 2022, as part of the sixth anniversary release assessment required by the Litigation Management Deed, Visa released $3.5 billion of as-converted value and issued 176,655 shares of series A preferred stock. In 2024, during the eighth anniversary release, the company released $2.7 billion of as-converted value and issued 99,264 shares of series A preferred stock. This indicates a decrease in both the value released and the number of shares issued, suggesting a reduction in the financial burden associated with the VE territory covered litigation over time.",
      "llm_answer": "Between 2022 and 2024, the as‑converted value released from the preferred‑stock protection declined from $3.5 billion (sixth‑anniversary release in 2022) to $2.7 billion (eighth‑anniversary release in 2024), reflecting a smaller release amount in 2024. Correspondingly, the number of Series A preferred shares issued fell from 176,655 shares released in 2022 to 99,264 shares released in 2024.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "V_10k_2022.pdf",
          "target_page": 74,
          "pages": [
            72,
            73,
            74,
            75,
            76
          ]
        },
        "hop_2_rel": {
          "source_file": "V_10k_2024.pdf",
          "target_page": 75,
          "pages": [
            73,
            74,
            75,
            76,
            77
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 66265,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 16810,
        "completion_tokens": 98,
        "total_tokens": 16908
      }
    },
    {
      "question_id": 107,
      "question": "How did the financial and strategic relationship between 3M and the Aearo Entities evolve between 2023 and 2024, particularly in terms of litigation impact and business segment adjustments?",
      "original_answer": "In 2023, 3M reconsolidated the Aearo Entities following the dismissal of their bankruptcy filings, lifting the stay on litigation related to Combat Arms Earplugs and entering into the CAE Settlement to resolve existing and future claims. This reconsolidation had an immaterial income statement impact. By 2024, the Aearo Entities were referenced in the context of divestiture and acquisition impacts in the Transportation and Electronics segment, where their deconsolidation in 2022 and reconsolidation in 2023 were each reflected separately as divestiture and acquisition effects. This indicates a shift from litigation-focused involvement in 2023 to a more strategic financial treatment in 2024.",
      "llm_answer": "The financial and strategic relationship between 3M and the Aearo Entities evolved significantly between 2023 and 2024, marked by litigation resolution and structural adjustments. Following the Aearo Entities' Chapter 11 bankruptcy filing in July 2022, 3M reconsolidated them in Q2 2023 after their dismissal from bankruptcy in June 2023, leading to an immaterial income statement impact. The parties finalized the CAE Settlement in August 2023, under which 3M committed $6.0 billion (adjusted from an original $5.0 billion cash + $1.0 billion stock structure) to resolve Combat Arms Earplugs litigation, including a $4.2 billion pre-tax charge in Q3 2023. This settlement, combined with the reconsolidation, led to adjustments in segment reporting, particularly in Safety and Industrial (where Aearo-related litigation costs were initially reflected) and Corporate/Unallocated (which absorbed special litigation items post-bankruptcy). The resolution of litigation through the CAE Settlement and the reconsolidation stabilized the business relationship, allowing 3M to refocus on core segments like Safety and Industrial and Transportation and Electronics, while the Consumer segment faced organic sales declines due to broader market shifts.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MMM_10k_2023.pdf",
          "target_page": 100,
          "pages": [
            98,
            99,
            100,
            101,
            102
          ]
        },
        "hop_2_rel": {
          "source_file": "MMM_10k_2024.pdf",
          "target_page": 32,
          "pages": [
            30,
            31,
            32,
            33,
            34
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 48400,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 12332,
        "completion_tokens": 310,
        "total_tokens": 12642
      }
    },
    {
      "question_id": 107,
      "question": "How has the financial treatment or structure of Class C Common Stock evolved between 2022 and 2024, particularly in terms of its relationship to other stock classes and its earnings per share performance?",
      "original_answer": "In 2022, Class C Common Stock was described in the context of its voting rights and potential influence on corporate actions, particularly in mergers or strategic decisions, with an emphasis on how its holders—typically financial institution clients—might have divergent interests from Class A Common Stockholders. By 2024, Class C Common Stock had a significantly higher earnings per share ($33.17 basic EPS and $33.13 diluted EPS) compared to Class A ($8.29 basic EPS and $8.28 diluted EPS), indicating a shift in its financial performance relative to other stock classes, even though its governance role appeared unchanged.",
      "llm_answer": "Between 2022 and 2024, the financial structure of Visa’s Class C common stock remained tied to its broader capital structure but showed evolving dynamics in relation to other classes and earnings per share (EPS) performance. Class C shares, which have no voting rights except in limited circumstances (such as exiting the core payments business or certain mergers), continue to be non-convertible and non-dividend-paying, unlike Class A shares that receive dividends and participate fully in earnings. However, Class C common stock participates in earnings per share calculations on an as-converted basis, meaning its share of net income is allocated proportionally when calculating diluted EPS, even though it does not receive dividends. The EPS figures for Class C common stock rose significantly from $28.03 in 2022 to $33.17 in 2023 and $38.97 in 2024, reflecting both increased net income and a relatively stable, small share count (10–16 million weighted average shares outstanding). This growth outpaced Class A ($7.01 to $8.29 to $9.74) and Class B-1 ($11.33 to $13.26 to $15.46) EPS, indicating stronger per-share earnings leverage, though Class C’s impact on total EPS is limited due to its small share base. The lack of dividends and voting rights means Class C does not generate direct cash returns to shareholders but benefits indirectly from corporate performance through diluted EPS inclusion. Additionally, structural changes, such as the January 2024 amendment to the certificate of incorporation enabling the exchange of Class B-1 shares for Class C shares, have increased the number of Class C shares outstanding (to 1.1 billion authorized), potentially affecting future EPS dilution if conversion rates adjust downward. Nonetheless, Class C remains a non-economic stakeholder class with minimal direct financial returns but plays a role in capital allocation and litigation-related risk management.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "V_10k_2022.pdf",
          "target_page": 32,
          "pages": [
            30,
            31,
            32,
            33,
            34
          ]
        },
        "hop_2_rel": {
          "source_file": "V_10k_2024.pdf",
          "target_page": 90,
          "pages": [
            88,
            89,
            90,
            91,
            92
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 9,
        "total_chars": 50555,
        "num_window_pages": 9,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 12872,
        "completion_tokens": 479,
        "total_tokens": 13352
      }
    },
    {
      "question_id": 107,
      "question": "How has Qualcomm's involvement in the development and commercialization of ADAS/AD technology evolved from fiscal 2022 to fiscal 2024, based on the specific changes in their strategic activities and revenue categorization?",
      "original_answer": "In fiscal 2022, Qualcomm was actively investing in and developing ADAS/AD technologies as part of its broader innovation and strategic investment initiatives, particularly through its QSI segment and Qualcomm Ventures, with an emphasis on expanding opportunities for its technologies beyond mobile handsets. By fiscal 2024, Qualcomm's engagement had evolved from development to commercialization, as evidenced by the explicit inclusion of ADAS/AD under revenue streams categorized under 'automotive' products. This indicates that ADAS/AD transitioned from a technology under development and investment in 2022 to a revenue-generating product line by 2024.",
      "llm_answer": "From fiscal 2022 through fiscal 2024, Qualcomm’s ADAS/AD strategy shifted from a broad, diversified portfolio of investments (including early‑stage ventures and multiple internal development programs) toward a more focused, monetizable approach.  In the 2024 filing the company reports that “Automotive (2) includes revenues from products sold for use in automobiles, including connectivity, digital cockpit and ADAS/AD,” and it explicitly ties ADAS/AD revenue to its QCT segment’s automotive sales, which grew from $1.5 billion in fiscal 2022 to $2.9 billion in fiscal 2024.  At the same time, Qualcomm’s patent‑licensing (QTL) segment continues to generate royalty income from automotive‑related devices, but the company no longer categorizes ADAS/AD as a separate revenue stream—instead it is folded into the broader automotive product and licensing categories.  Consequently, the evolution reflects a transition from exploratory investment to a revenue‑driven, segment‑integrated model for ADAS/AD technologies.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "QCOM_10k_2022.pdf",
          "target_page": 14,
          "pages": [
            12,
            13,
            14,
            15,
            16
          ]
        },
        "hop_2_rel": {
          "source_file": "QCOM_10k_2024.pdf",
          "target_page": 73,
          "pages": [
            71,
            72,
            73,
            74,
            75
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 57206,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 14541,
        "completion_tokens": 253,
        "total_tokens": 14795
      }
    },
    {
      "question_id": 108,
      "question": "How has Visa's U.S. Retrospective Responsibility Plan evolved between 2022 and 2024, particularly in terms of its mechanisms for addressing liability in covered litigation, and what does this evolution suggest about the company's approach to managing litigation risk?",
      "original_answer": "In 2022, Visa's U.S. Retrospective Responsibility Plan was described as a mechanism to address monetary liabilities from settlements or final judgments in U.S. covered litigation, utilizing a U.S. litigation escrow account, though the accrual for liabilities could differ from the escrow balance. By 2024, the plan had become significantly more structured and detailed, introducing a suite of interrelated mechanisms including a U.S. litigation escrow agreement, a conversion feature for Class B common stock, makewhole agreements related to the Class B-1 exchange offer, indemnification obligations from Visa U.S.A. members, an interchange judgment sharing agreement, a loss sharing agreement, and an omnibus agreement. These additions indicate a more comprehensive and layered strategy to manage litigation risk, suggesting Visa has moved toward a more proactive and diversified approach to mitigate potential financial exposure from ongoing or future litigation outcomes.",
      "llm_answer": "Between 2022 and 2024, Visa’s U.S. Retrospective Responsibility Plan evolved from a framework centered on the U.S. litigation escrow account, class B stock conversion mechanisms, and indemnification obligations under the interchange judgment sharing and loss sharing agreements to a more structured, multi‑layered approach that incorporates the omnibus agreement’s allocation formulas and explicit references to the plan’s provisions in settlement accounting. This evolution reflects a strategic shift toward formalizing liability allocation—particularly the 66.6667% Visa share of covered settlements—through the omnibus agreement and escrow funding, indicating that Visa is proactively managing and compartmentalizing litigation risk to limit exposure and ensure predictable financial responsibility.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "V_10k_2022.pdf",
          "target_page": 48,
          "pages": [
            46,
            47,
            48,
            49,
            50
          ]
        },
        "hop_2_rel": {
          "source_file": "V_10k_2024.pdf",
          "target_page": 72,
          "pages": [
            70,
            71,
            72,
            73,
            74
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 52222,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 13305,
        "completion_tokens": 200,
        "total_tokens": 13505
      }
    },
    {
      "question_id": 108,
      "question": "How did Merck's financial stake in Lynparza evolve between 2023 and 2024, and what indicators suggest changes in the product's performance or strategic importance during this period?",
      "original_answer": "In 2023, Merck reported a $1.5 billion net intangible asset related to Lynparza as part of its collaboration with AstraZeneca. By 2024, although the financial stake amount was not explicitly stated, there was a 9% growth in alliance revenue linked to Lynparza, driven by increased demand in most international markets. Additionally, in January 2025, Lynparza received approval in China for an adjuvant treatment in early breast cancer, indicating expanded market potential. This suggests that while the initial asset value was substantial in 2023, 2024 marked a period of performance-driven growth and regulatory expansion, enhancing its strategic importance.",
      "llm_answer": "Merck's financial stake in Lynparza remained stable in absolute terms but showed modest growth in alliance revenue, increasing 9% year‑over‑year to $1.311 billion in 2024 (up from $1.199 billion in 2023). This growth, together with the continued royalty income from Keytruda and the broader oncology portfolio, signals that Lynparza continues to be a strategically important product, though its performance is now being outpaced by faster‑growing assets such as Keytruda and newer launches like Winrevair.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MRK_10k_2023.pdf",
          "target_page": 101,
          "pages": [
            99,
            100,
            101,
            102,
            103
          ]
        },
        "hop_2_rel": {
          "source_file": "MRK_10k_2024.pdf",
          "target_page": 55,
          "pages": [
            53,
            54,
            55,
            56,
            57
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 69474,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 17599,
        "completion_tokens": 126,
        "total_tokens": 17725
      }
    },
    {
      "question_id": 109,
      "question": "How did Skoal's market position and competitive performance within Altria's oral tobacco products segment evolve between 2022 and 2024, particularly in relation to its key competitor brands?",
      "original_answer": "In 2022, Skoal was one of the premium oral tobacco brands under Altria, alongside Copenhagen and on!, with a retail share of 9.3%. By 2024, Skoal's retail share had declined to 7.6%, indicating a weakening market position. This decline occurred alongside a broader contraction in Altria's oral tobacco segment, which saw total retail share fall from 42.5% in 2023 to 37.5% in 2024. Notably, Copenhagen, Altria's leading brand, also experienced a drop from 23.5% to 19.1% over the same period, while on! oral nicotine pouches gained traction, rising from 6.8% to 8.3%. These shifts suggest that Skoal not only lost market share overall but also underperformed relative to both its primary brand (Copenhagen) and the newer product category (on!).",
      "llm_answer": "Between 2022 and 2024, Skoal’s competitive position within Altria’s oral tobacco segment eroded significantly.  In 2024, Skoal’s retail share fell to 7.6% (down from 9.3% in 2023) and its shipment volume dropped to 147 million cans (down from 163 million in 2023), while the overall oral‑tobacco category grew, driven by oral‑nicotine pouches.  Competitor brands—particularly the on! pouch brand (which held an 8.3% share in 2024, up from 6.8% in 2023) and Red Seal—gained share at the expense of traditional MST products, causing Skoal’s overall category share to decline from 42.5% in 2023 to 37.5% in 2024.  This shift reflects pricing pressure, modest volume declines and a strategic emphasis on higher‑margin pouch growth, which together weakened Skoal’s standing relative to its key rivals.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MO_10k_2022.pdf",
          "target_page": 6,
          "pages": [
            4,
            5,
            6,
            7,
            8
          ]
        },
        "hop_2_rel": {
          "source_file": "MO_10k_2024.pdf",
          "target_page": 48,
          "pages": [
            46,
            47,
            48,
            49,
            50
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 53447,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 13591,
        "completion_tokens": 199,
        "total_tokens": 13790
      }
    },
    {
      "question_id": 109,
      "question": "How has the revenue contribution from Dynamics 365 within Microsoft Cloud evolved between fiscal years 2022 and 2023?",
      "original_answer": "In fiscal year 2022, Dynamics 365 contributed to the $91.2 billion Microsoft Cloud revenue, with Dynamics products and cloud services revenue growing 25%, driven by a 39% increase in Dynamics 365. By fiscal year 2023, the Microsoft Cloud revenue had increased to $111.6 billion, which includes Dynamics 365 as a component. Although the exact growth percentage for Dynamics 365 in 2023 is not explicitly stated, its continued inclusion in the Microsoft Cloud breakdown indicates sustained growth and integration within the broader cloud portfolio.",
      "llm_answer": "Microsoft Cloud revenue grew from $91.4 billion in fiscal 2022 to $111.6 billion in fiscal 2023, reflecting a significant increase in its contribution to overall revenue over that period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MSFT_10k_2022.pdf",
          "target_page": 40,
          "pages": [
            38,
            39,
            40,
            41,
            42
          ]
        },
        "hop_2_rel": {
          "source_file": "MSFT_10k_2023.pdf",
          "target_page": 93,
          "pages": [
            91,
            92,
            93,
            94,
            95
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 9,
        "total_chars": 34159,
        "num_window_pages": 9,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 8753,
        "completion_tokens": 46,
        "total_tokens": 8800
      }
    },
    {
      "question_id": 109,
      "question": "How has Merck's approach to managing foreign exchange exposure through its Balance Sheet Risk Management Program evolved from 2023 to 2024, particularly in terms of the instruments used and the scope of hedging activities?",
      "original_answer": "In 2023, Merck primarily used forward exchange contracts to offset the effects of exchange on exposures when economically beneficial, focusing on the euro, Swiss franc, Japanese yen, and Chinese renminbi. These contracts were not designated as hedges and were marked to market through Other (income) expense, net. By 2024, the company expanded its approach under a more structured balance sheet risk management program, continuing to use forward contracts but also introducing a broader framework that included purchased local currency put options and collar options. Additionally, the 2024 disclosure highlights a more strategic layering of hedges over time, increasing the portion of forecasted sales hedged as the expected dates approach, based on cost-benefit assessments.",
      "llm_answer": "From 2023 to 2024, Merck’s Balance Sheet Risk Management Program continued to use forward foreign‑exchange contracts as its primary hedging instrument, but the scope of hedging activities shifted toward broader protection of net investment positions and larger notional amounts. In 2024 the Company reported $406 million in designated hedging derivatives (primarily foreign‑exchange contracts on assets of $12,465 million notional) versus $189 million in 2023, while non‑designated derivatives rose to $323 million in assets and $343 million in liabilities (notional $26,095 million) from $153 million/$162 million previously. The fair‑value adjustments for designated hedges also increased, with a $17 million cumulative fair‑value hedging adjustment on long‑term debt in 2024 compared with $56 million in 2023, indicating a more extensive use of interest‑rate swaps to hedge fixed‑rate debt. Overall, the program now encompasses larger foreign‑exchange notional exposure and includes additional interest‑rate swaps to manage fair‑value risk on long‑term debt.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MRK_10k_2023.pdf",
          "target_page": 95,
          "pages": [
            93,
            94,
            95,
            96,
            97
          ]
        },
        "hop_2_rel": {
          "source_file": "MRK_10k_2024.pdf",
          "target_page": 97,
          "pages": [
            95,
            96,
            97,
            98,
            99
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 65924,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 16720,
        "completion_tokens": 265,
        "total_tokens": 16985
      }
    },
    {
      "question_id": 110,
      "question": "How has PayPal's involvement with merchant receivables evolved between 2022 and 2024, particularly in terms of its credit loss provisions and direct investment in merchant financing products?",
      "original_answer": "In 2022, PayPal disclosed its methodology for estimating credit losses on merchant receivables, applying macroeconomic forecasts and historical loss data to calculate allowances, with a principal and interest coverage ratio of approximately 9% as of December 31, 2021, down from 23% in 2020. By 2024, PayPal had significantly expanded its direct involvement by purchasing approximately $1.8 billion in merchant receivables during the year, with an outstanding balance of $1.5 billion as of December 31, 2024, up from $1.2 billion in 2023. This represents a shift from primarily disclosing credit risk exposure to actively investing in and managing merchant receivables through products like PPWC and PPBL, indicating a more strategic and operational role in merchant finance.",
      "llm_answer": "Between 2022 and 2024, PayPal’s credit loss provisions for merchant receivables declined materially as credit quality improved. The allowance for merchant loans, advances, and interest and fees receivable fell from $160 million at the end of 2023 to $113 million at the end of 2024, reflecting a reduction in expected credit losses driven by better performance of the PPBL portfolio and overall improvements in merchant credit metrics. This downward trend in provisions aligns with PayPal’s shift toward more direct investment in merchant financing products, such as PPWC and PPBL, which are now funded through its own capital and structured with fixed‑fee arrangements rather than relying solely on third‑party partner institutions. Consequently, the company’s exposure to credit risk has been managed through tighter underwriting, periodic review of credit limits, and a focus on shorter‑term, fixed‑fee financing that reduces the need for extensive loss reserves.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "PYPL_10k_2022.pdf",
          "target_page": 54,
          "pages": [
            52,
            53,
            54,
            55,
            56
          ]
        },
        "hop_2_rel": {
          "source_file": "PYPL_10k_2024.pdf",
          "target_page": 101,
          "pages": [
            99,
            100,
            101,
            102,
            103
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 9,
        "total_chars": 54632,
        "num_window_pages": 9,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 13891,
        "completion_tokens": 241,
        "total_tokens": 14132
      }
    },
    {
      "question_id": 110,
      "question": "How has the financial significance of smokeable products to MO evolved from 2022 to 2024, considering both goodwill allocation and operating income performance?",
      "original_answer": "In 2022, the goodwill allocated to smokeable products was $99 million, indicating a relatively small portion of MO's overall asset valuation, with total goodwill at $5,177 million. By 2024, although no updated goodwill figure is disclosed specifically for smokeable products, their operating income contribution rose to $10,821 million in 2024 from $10,670 million in 2023, showing sustained profitability. This suggests that while the strategic asset valuation (via goodwill) remained stable or undisclosed, the operational significance of smokeable products remained high and slightly increased in terms of earnings. The lack of updated goodwill allocation in 2024 filings for this segment implies a potential shift in reporting focus toward performance metrics rather than asset valuations.",
      "llm_answer": "From 2022 to 2024, the financial significance of smokeable products to MO declined in both absolute and relative terms.  In 2022, smokeable products generated roughly $21.8 billion in net revenue (≈ 90 % of total) and contributed about $10.9 billion of operating income; by 2024, net revenue from smokeable products fell to $21.2 billion (≈ 88 % of total) and operating income dropped to $10.8 billion – a modest revenue decline of ~3 % and an operating‑income decline of ~1 % (adjusted for special items).  This reduction is reflected in the lower share of total operating income and the growing weight of other segments (e.g., oral tobacco and wine) in Altria’s overall earnings, while goodwill allocation and impairment testing show that the smokeable segment’s goodwill remained stable ($99 million) but its contribution to overall profitability is diminishing.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MO_10k_2022.pdf",
          "target_page": 66,
          "pages": [
            64,
            65,
            66,
            67,
            68
          ]
        },
        "hop_2_rel": {
          "source_file": "MO_10k_2024.pdf",
          "target_page": 31,
          "pages": [
            29,
            30,
            31,
            32,
            33
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 60614,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 15377,
        "completion_tokens": 216,
        "total_tokens": 15593
      }
    },
    {
      "question_id": 110,
      "question": "How has the revenue contribution from the commercial portion of LinkedIn within Microsoft Cloud evolved between fiscal years 2022 and 2023?",
      "original_answer": "In fiscal year 2022, the Microsoft Cloud revenue, which includes the commercial portion of LinkedIn, was reported at $91.2 billion. By fiscal year 2023, this figure had increased to $111.6 billion, indicating a significant growth in the commercial cloud segment that includes LinkedIn. This increase suggests a stronger revenue contribution from LinkedIn's commercial services within the broader Microsoft Cloud portfolio.",
      "llm_answer": "Based on the provided 10-K filings, Microsoft's commercial LinkedIn revenue increased from $13,816 million in fiscal 2022 to $16,372 million in fiscal 2023, reflecting growth in LinkedIn's commercial segment revenue as reported in the consolidated revenue breakdown. This growth contributed to the overall increase in Microsoft Cloud revenue, which rose to $137.4 billion in fiscal 2023 from $111.6 billion in fiscal 2022, with the commercial portion of LinkedIn being a component of that cloud revenue.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MSFT_10k_2022.pdf",
          "target_page": 96,
          "pages": [
            94,
            95,
            96,
            97,
            98
          ]
        },
        "hop_2_rel": {
          "source_file": "MSFT_10k_2023.pdf",
          "target_page": 93,
          "pages": [
            91,
            92,
            93,
            94,
            95
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 32607,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 8371,
        "completion_tokens": 125,
        "total_tokens": 8496
      }
    },
    {
      "question_id": 110,
      "question": "How did the commercialization and market expansion of Lynparza evolve between 2023 and 2024, particularly in terms of geographic approvals and revenue growth?",
      "original_answer": "In 2023, Lynparza received FDA and Japan's MHLW approvals for treating BRCA-mutated metastatic castration-resistant prostate cancer (mCRPC) in combination with abiraterone and prednisone or prednisolone, based on the PROpel trial. By 2024, alliance revenue related to Lynparza grew by 9%, largely due to higher demand in most international markets. Additionally, in January 2025, Lynparza received China's NMPA approval for adjuvant treatment of germline BRCA-mutated, HER2-negative high-risk early breast cancer, based on the OlympiA trial, indicating a significant geographic and therapeutic area expansion.",
      "llm_answer": "Between 2023 and 2024, Lynparza's commercialization expanded geographically with Japan's MHLW approval in August 2023 and China's NMPA approval in January 2025 for new indications (adjuvant treatment for early breast cancer), driving a 9% increase in alliance revenue to $1,311 million (11% excluding FX). Revenue growth was fueled by higher demand in international markets, though specific geographic sales breakdown is not detailed in the provided documents. The drug's market expansion was further supported by its inclusion in new treatment combinations and conditional EU approvals for additional indications.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MRK_10k_2023.pdf",
          "target_page": 7,
          "pages": [
            5,
            6,
            7,
            8,
            9
          ]
        },
        "hop_2_rel": {
          "source_file": "MRK_10k_2024.pdf",
          "target_page": 55,
          "pages": [
            53,
            54,
            55,
            56,
            57
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 58891,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 14945,
        "completion_tokens": 153,
        "total_tokens": 15098
      }
    },
    {
      "question_id": 111,
      "question": "How did RTX's financial treatment of the Powder Metal Matter evolve between 2023 and 2024, particularly in terms of its impact on future income tax benefits?",
      "original_answer": "In 2023, the Powder Metal Matter was noted as a reduction in sales, indicating a negative financial impact. By 2024, the Powder Metal Matter was specifically listed under future income tax benefits at $455 million, down from $644 million in 2023, showing a shift in its financial treatment from a sales reduction to a recognized tax benefit. This represents a decrease of $189 million, or about 29.3%, in its value contribution to future tax benefits.",
      "llm_answer": "The Powder Metal Matter generated a $455 million deferred tax asset in 2024, down from $644 million in 2023, reflecting a $189 million reduction in the associated future income‑tax benefit. This decline is reflected in the valuation‑allowance schedule, where the allowance for the Powder Metal Matter was lowered (contributing to the overall decrease in the total valuation allowance balance), and the 2024 effective tax rate now includes a $212 million tax charge related to the Otis non‑U.S. tax ruling that reduces the company’s foreign‑tax credits, further affecting the net tax benefit of the Powder Metal Matter. Consequently, the tax‑related advantage of the Powder Metal Matter has decreased, and the company now records a smaller future income‑tax benefit and a corresponding increase in tax expense.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "RTX_10k_2023.pdf",
          "target_page": 111,
          "pages": [
            109,
            110,
            111,
            112,
            113
          ]
        },
        "hop_2_rel": {
          "source_file": "RTX_10k_2024.pdf",
          "target_page": 98,
          "pages": [
            96,
            97,
            98,
            99,
            100
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 43229,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 11032,
        "completion_tokens": 202,
        "total_tokens": 11234
      }
    },
    {
      "question_id": 111,
      "question": "How did the borrowing capacity and terms of the Paidy Credit Agreement evolve from 2022 to 2024?",
      "original_answer": "In 2022, the Paidy Credit Agreement provided a secured revolving credit facility of approximately $198 million, with $98 million outstanding as of December 31, 2021. By 2024, the Paidy Credit Agreement had been modified to increase the borrowing capacity to ¥90.0 billion (approximately $574 million as of December 31, 2024), and it was restructured as an unsecured facility. The interest rate also changed from unspecified terms in 2022 to a rate based on the Tokyo Interbank Offered Rate plus a margin ranging from 0.40% to 0.60% in 2024. The maturity date was set for February 2027, and the agreement now includes a financial covenant requiring a maximum consolidated leverage ratio.",
      "llm_answer": "From 2022 through 2024 the Paidy Credit Agreement was expanded and then fully drawn: the facility was initially a ¥60 billion revolving line (Feb 2022), increased by ¥30 billion in September 2022 to ¥90 billion (≈$574 million), and by December 31 2024 a total of ¥90 billion (≈$574 million) had been borrowed, leaving no remaining borrowing capacity.  The agreement terminates in February 2027, carries a low interest margin (Tokyo Interbank Offered Rate + 0.40‑0.60 %), and is subject to a leverage‑ratio financial covenant.  Consequently, the borrowing capacity fell from essentially full availability in 2022 to zero by the end of 2024, while the outstanding balance grew to the full ¥90 billion limit.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "PYPL_10k_2022.pdf",
          "target_page": 50,
          "pages": [
            48,
            49,
            50,
            51,
            52
          ]
        },
        "hop_2_rel": {
          "source_file": "PYPL_10k_2024.pdf",
          "target_page": 105,
          "pages": [
            103,
            104,
            105,
            106,
            107
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 49052,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 12472,
        "completion_tokens": 176,
        "total_tokens": 12649
      }
    },
    {
      "question_id": 111,
      "question": "How has Altria's reliance on long-term senior unsecured notes as part of its capital resources evolved between 2022 and 2024?",
      "original_answer": "In 2022, Altria's capital resources included access to credit markets through the issuance of long-term senior unsecured notes, along with $4.5 billion in cash and cash equivalents. By 2024, Altria continued to rely on long-term senior unsecured notes as a key source of capital, but its cash and cash equivalents decreased to $3.1 billion. While the company maintained its $3.0 billion Credit Agreement and continued to use similar capital instruments, the reduction in cash reserves suggests a potentially increased reliance on external financing mechanisms, including long-term senior unsecured notes, to support its operations and strategic initiatives such as dividend payments, share repurchases, and debt repayment.",
      "llm_answer": "Between 2022 and 2024, Altria’s reliance on long‑term senior unsecured notes declined: it issued $5.5 billion of such notes in February 2021 to refinance debt, repaid $1.5 billion of 4.75 % notes in May 2021 and $1.0 billion of 3.49 % notes in January 2020, and later repaid $776 million of 4.0 % and $345 million of 3.8 % notes in early 2024. By 2024 its total long‑term debt had fallen to $24.9 billion, and it supplemented its capital resources with the $1 billion senior unsecured note issuance in February 2025, indicating a reduced dependence on long‑term senior unsecured debt compared with the 2022‑2023 period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MO_10k_2022.pdf",
          "target_page": 48,
          "pages": [
            46,
            47,
            48,
            49,
            50
          ]
        },
        "hop_2_rel": {
          "source_file": "MO_10k_2024.pdf",
          "target_page": 49,
          "pages": [
            47,
            48,
            49,
            50,
            51
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 54886,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 13936,
        "completion_tokens": 154,
        "total_tokens": 14091
      }
    },
    {
      "question_id": 112,
      "question": "How did RTX's financial treatment of the Powder Metal Matter evolve between 2023 and 2024, and what does this indicate about its impact on future income tax benefits?",
      "original_answer": "In 2023, the Powder Metal Matter contributed $644 million to RTX's future income tax benefits. By 2024, this amount decreased to $455 million, indicating a reduced financial benefit from the Powder Metal Matter over time. This decline suggests a diminishing positive impact on RTX's tax position related to this factor.",
      "llm_answer": "Between 2023 and 2024, RTX’s financial treatment of the Powder Metal Matter shifted from a $5.4 billion net sales charge in 2023 (recorded in the third quarter of 2023) to a $2.5 billion reduction in cost of sales in 2024, reflecting the partners’ share of the matter’s impact. This evolution indicates that the remaining financial exposure is now primarily reflected in lower cost‑of‑sales and related tax benefits, rather than a large sales charge, suggesting diminishing but still material effects on future income‑tax benefits.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "RTX_10k_2023.pdf",
          "target_page": 38,
          "pages": [
            36,
            37,
            38,
            39,
            40
          ]
        },
        "hop_2_rel": {
          "source_file": "RTX_10k_2024.pdf",
          "target_page": 98,
          "pages": [
            96,
            97,
            98,
            99,
            100
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 47986,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 12222,
        "completion_tokens": 132,
        "total_tokens": 12355
      }
    },
    {
      "question_id": 112,
      "question": "How has PayPal's utilization of the Paidy Credit Agreement evolved between 2022 and 2024, particularly in terms of borrowing capacity and actual drawdown?",
      "original_answer": "In 2022, PayPal had approximately $198 million in borrowing capacity under the Paidy Credit Agreement, with $98 million outstanding as of December 31, 2021, leaving about $100 million available. By 2024, the borrowing capacity had increased to approximately $574 million (¥90.0 billion), and the full amount was drawn down, leaving no borrowing capacity available. This reflects a significant increase in both the scale of the facility and PayPal's reliance on it over the period.",
      "llm_answer": "Between 2022 and 2024, PayPal’s borrowing capacity under the Paidy Credit Agreement was fully utilized: the agreement, originally a ¥60 billion (≈ $574 million) revolving facility expanded to ¥90 billion, was drawn down for the entire ¥90 billion amount by the end of 2024, leaving no remaining capacity. In contrast, the company’s primary $5 billion five‑year revolving credit facility remained largely unused, with $5 billion of borrowing capacity still available as of December 31 2024. This evolution reflects a shift from modest use of the Paidy facility in 2021 to a complete drawdown by 2024, while the larger corporate credit line stayed untouched.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "PYPL_10k_2022.pdf",
          "target_page": 110,
          "pages": [
            108,
            109,
            110,
            111,
            112
          ]
        },
        "hop_2_rel": {
          "source_file": "PYPL_10k_2024.pdf",
          "target_page": 45,
          "pages": [
            43,
            44,
            45,
            46,
            47
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 48393,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 12322,
        "completion_tokens": 164,
        "total_tokens": 12486
      }
    },
    {
      "question_id": 112,
      "question": "How has the ownership structure and equity relationship between Accenture plc and Accenture Canada Holdings Inc. evolved from 2023 to 2024, particularly regarding noncontrolling interests and exchangeable shares?",
      "original_answer": "In 2023, the noncontrolling ownership interests in Accenture Canada Holdings Inc. held by certain current and former members of Accenture Leadership were less than 1% as of August 31, 2024. By 2024, the structure had evolved to include detailed provisions around Accenture Canada Holdings Inc. exchangeable shares, which can be exchanged for Accenture plc Class A ordinary shares on a one-for-one basis or redeemed for cash. Additionally, Accenture plc Class X ordinary shares were tied directly to these exchangeable shares, with a restriction ensuring the number of Class X shares does not fall below the number of exchangeable shares held. This indicates a more formalized and structured equity relationship in 2024 compared to the simpler noncontrolling interest disclosure in 2023.",
      "llm_answer": "From 2023 to 2024, Accenture plc’s share‑purchase activity shows a modest increase in the number of Class A ordinary shares bought on the open market (11.75 M in fiscal 2024 versus 10.2 M in fiscal 2023), while the amount spent rose to $4.51 B from $3.78 B.  The company also expanded its share‑repurchase authority by an additional $4 M in September 2024, bringing total authorization to $6.69 B.  Regarding noncontrolling interests, the consolidated financial statements note that the noncontrolling ownership in Accenture Canada Holdings Inc. was less than 1 % as of August 31 2024, indicating that the equity stake held by former Accenture Leadership members remained essentially unchanged and did not materially affect the overall equity relationship.  Exchangeable shares of Accenture Canada Holdings Inc. continued to be convertible one‑for‑one into Accenture plc Class A ordinary shares, but no significant changes in the volume of such exchanges were disclosed between the two fiscal years.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "ACN_10k_2023.pdf",
          "target_page": 20,
          "pages": [
            18,
            19,
            20,
            21,
            22
          ]
        },
        "hop_2_rel": {
          "source_file": "ACN_10k_2024.pdf",
          "target_page": 100,
          "pages": [
            98,
            99,
            100,
            101,
            102
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 9,
        "total_chars": 40776,
        "num_window_pages": 9,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 10431,
        "completion_tokens": 249,
        "total_tokens": 10681
      }
    },
    {
      "question_id": 112,
      "question": "How has Merck's approach to managing balance sheet risk through forward exchange contracts evolved between 2022 and 2024, particularly in terms of the currencies and cost-benefit considerations?",
      "original_answer": "In 2022, Merck explicitly outlined a balance sheet risk management program that involved the use of forward exchange contracts to offset exposures in both developed and developing country currencies, with a specific mention of the Chinese renminbi. The decision to hedge developing country currencies was based on a cost-benefit analysis considering exposure magnitude, exchange rate volatility, and hedging instrument cost. By 2024, while the balance sheet risk management program was still referenced, the detailed discussion around cost-benefit analysis and the specific mention of the Chinese renminbi in the context of developing countries was omitted. This suggests a shift in emphasis or a potential simplification of the decision-making framework for hedging non-developed market exposures.",
      "llm_answer": "Merck's approach to managing balance sheet risk through forward exchange contracts has evolved in terms of currency focus and cost-benefit considerations between 2022 and 2024. In 2022, the company expanded its hedging program to include the Chinese renminbi and emphasized a cost-benefit analysis that weighed natural offsets, volatility, and hedging instrument costs, particularly for developing market currencies like the renminbi. By 2024, Merck continued to layer in hedges over time, targeting currencies such as the euro, Japanese yen, and Chinese renminbi, while also using forward contracts to hedge net investments in foreign operations. The cost-benefit assessments remained central to determining hedge ratios, with a focus on minimizing variability in foreign currency cash flows and fair value changes, especially for monetary assets and liabilities denominated in non-functional currencies. The company's use of forward contracts for net investment hedging and its exclusion of certain hedge components from effectiveness testing further reflect a refined, economically driven approach to managing foreign exchange risk.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MRK_10k_2022.pdf",
          "target_page": 107,
          "pages": [
            105,
            106,
            107,
            108,
            109
          ]
        },
        "hop_2_rel": {
          "source_file": "MRK_10k_2024.pdf",
          "target_page": 97,
          "pages": [
            95,
            96,
            97,
            98,
            99
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 60603,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 15384,
        "completion_tokens": 283,
        "total_tokens": 15668
      }
    },
    {
      "question_id": 113,
      "question": "What does the change in RTX's disclosure about the Powder Metal Matter between 2023 and 2024 suggest about its ongoing financial impact on future income tax benefits?",
      "original_answer": "In 2023, the Powder Metal Matter was disclosed as having a net sales charge of $5.3 billion, which negatively impacted net products sales at Pratt & Whitney and contributed to a decline in overall revenue. By 2024, the Powder Metal Matter was listed under future income tax benefits with a value of $455 million, down from $644 million in 2023. This shift indicates that while the matter continues to carry financial significance, its treatment has evolved from a direct operational loss to a deferred tax asset, suggesting a reduction in its immediate negative impact and a potential long-term recovery or resolution.",
      "llm_answer": "The 2024 10‑K shows that the Powder Metal Matter was removed from the “Significant Accounting Policies” section and is now disclosed only in the tax‑benefit schedule (Note 13) and in the “Future income taxbenefits” table.  The de‑designation of €180 million of euro‑denominated debt in Q4 2024 and the resulting $212 million tax charge (Note 13) indicate that the tax‑related benefit associated with the Powder Metal Matter is no longer being tracked as a separate line item.  Consequently, future income‑tax benefits tied to that matter are expected to be limited, and any remaining tax credits or carryforwards related to it will be absorbed into the general valuation‑allowance calculations rather than generating a distinct tax benefit.  This suggests that the Powder Metal Matter will have a diminishing impact on RTX’s future income‑tax expense and the associated tax‑benefit line in the financial statements.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "RTX_10k_2023.pdf",
          "target_page": 37,
          "pages": [
            35,
            36,
            37,
            38,
            39
          ]
        },
        "hop_2_rel": {
          "source_file": "RTX_10k_2024.pdf",
          "target_page": 98,
          "pages": [
            96,
            97,
            98,
            99,
            100
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 49175,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 12519,
        "completion_tokens": 228,
        "total_tokens": 12748
      }
    },
    {
      "question_id": 113,
      "question": "How has PayPal's involvement in the merchant receivables space evolved between 2022 and 2024, particularly in terms of its relationship with partner institutions and the scale of its merchant finance offerings?",
      "original_answer": "In 2022, PayPal described its U.S. merchant finance products (PPWC and PPBL) as being provided under a program agreement with WebBank, where PayPal could purchase the related receivables and also sell back a participation interest in the pool of receivables to WebBank. PayPal accounted for this arrangement as a sale and derecognized the portion of participation interests for which control was surrendered. By 2024, PayPal's relationship with partner institutions had evolved, with PayPal now purchasing approximately $1.8 billion in merchant receivables in 2024 (up from $1.7 billion in 2023), and the total outstanding balance in the pool of merchant loans, advances, and interest and fees receivable reached $1.5 billion as of December 31, 2024 (up from $1.2 billion as of December 31, 2023). Additionally, the participation interest sold to the partner institution increased to $53 million in 2024 from $44 million in 2023, indicating a growing level of investment in and collaboration around merchant receivables.",
      "llm_answer": "PayPal's merchant finance involvement has expanded significantly from 2022 to 2024, with merchant receivables purchased increasing from $1.7 billion to $1.8 billion annually and the outstanding portfolio growing from $1.2 billion to $1.5 billion (net of partner participation). The company now partners with multiple institutions—including WebBank in the U.S. and its Luxembourg and Australian subsidiaries—for PPWC and PPBL products, and it has shifted from a larger allowance ($160 million in 2023 to $113 million in 2024) reflecting improved credit quality, especially within the PPBL portfolio. This evolution underscores a more structured partnership model and a scaled, yet increasingly managed, merchant finance offering.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "PYPL_10k_2022.pdf",
          "target_page": 72,
          "pages": [
            70,
            71,
            72,
            73,
            74
          ]
        },
        "hop_2_rel": {
          "source_file": "PYPL_10k_2024.pdf",
          "target_page": 101,
          "pages": [
            99,
            100,
            101,
            102,
            103
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 9,
        "total_chars": 53240,
        "num_window_pages": 9,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 13548,
        "completion_tokens": 182,
        "total_tokens": 13730
      }
    },
    {
      "question_id": 113,
      "question": "How did Merck's alliance revenue from Lynparza evolve between 2022 and 2024, and what factors contributed to the change?",
      "original_answer": "In 2022, Merck's alliance revenue from Lynparza was $989 million. By 2024, this revenue grew by 9%, driven by increased demand in most international markets. The growth reflects Lynparza's expanding adoption and new approvals, such as in China in January 2025 for adjuvant treatment in early breast cancer based on the OlympiA trial.",
      "llm_answer": "Alliance revenue from Lynparza increased from $1,116 million in 2022 to $1,199 million in 2023 and reached $1,311 million in 2024, reflecting a 9% rise (11% excluding foreign‑exchange effects) in 2024. This growth was driven by higher international demand and pricing, particularly in markets where Lynparza was recently approved for adjuvant treatment of BRCA‑mutated breast cancer, while pricing pressures and foreign‑exchange headwinds limited growth elsewhere.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MRK_10k_2022.pdf",
          "target_page": 141,
          "pages": [
            139,
            140,
            141,
            142,
            143
          ]
        },
        "hop_2_rel": {
          "source_file": "MRK_10k_2024.pdf",
          "target_page": 55,
          "pages": [
            53,
            54,
            55,
            56,
            57
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 59166,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 15006,
        "completion_tokens": 116,
        "total_tokens": 15122
      }
    },
    {
      "question_id": 114,
      "question": "How has PayPal's involvement in merchant receivables evolved between 2022 and 2024, particularly in terms of its financial exposure and operational role?",
      "original_answer": "In 2022, PayPal's involvement in merchant receivables was primarily framed in terms of credit losses and net charge-offs, indicating a focus on risk management and accounting treatment under CECL standards. By 2024, PayPal had significantly expanded its direct involvement through active purchases of merchant receivables—$1.8 billion in 2024 compared to $1.7 billion in 2023—and reported a growing outstanding balance of $1.5 billion, up from $1.2 billion. Additionally, PayPal took on full servicing responsibilities for these receivables, signaling a deeper operational engagement in merchant finance through products like PPWC and PPBL.",
      "llm_answer": "PayPal's financial exposure and operational role in merchant receivables have evolved significantly between 2022 and 2024. The company's merchant finance portfolio, primarily driven by its PPWC and PPBL products, saw outstanding balances grow from $1.2 billion (2023) to $1.5 billion (2024), with the allowance for credit losses decreasing from $160 million to $113 million due to improved credit quality, particularly in the PPBL portfolio. Operationally, PayPal purchases merchant receivables from a partner institution, services the portfolio, and earns fixed fees amortized into revenue, while closely monitoring delinquency (with 90.4% of receivables current as of Dec 2024) and adjusting risk parameters like eligibility terms and underwriting standards in response to macroeconomic conditions.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "PYPL_10k_2022.pdf",
          "target_page": 43,
          "pages": [
            41,
            42,
            43,
            44,
            45
          ]
        },
        "hop_2_rel": {
          "source_file": "PYPL_10k_2024.pdf",
          "target_page": 101,
          "pages": [
            99,
            100,
            101,
            102,
            103
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 56074,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 14242,
        "completion_tokens": 200,
        "total_tokens": 14442
      }
    },
    {
      "question_id": 114,
      "question": "How has Merck's involvement in the development and commercialization of Lynparza evolved from 2022 to 2024, particularly in terms of regulatory progress and revenue growth?",
      "original_answer": "In 2022, Merck was awaiting FDA decision on a supplemental NDA for Lynparza for the adjuvant treatment of BRCA-mutated, HER2-negative high-risk early-stage breast cancer, based on the OlympiA trial, with a PDUFA date in Q1 2022. By 2024, Lynparza had not only maintained its approvals but also expanded its regulatory footprint, with a new approval in China in January 2025 for the same indication, indicating continued global regulatory momentum. Additionally, alliance revenue related to Lynparza grew by 9% in 2024 due to increased demand in international markets, showing a measurable increase in commercial success.",
      "llm_answer": "From 2022 to 2024, Merck’s Lynparza alliance revenue grew steadily, increasing from $1,116 million in 2022 to $1,199 million in 2023 (+7%) and to $1,311 million in 2024 (+9%)—with constant‑currency growth of 9% in 2023 and 11% in 2024.  The 2024 growth was driven by higher demand across most international markets, and in January 2025 China’s NMPA approved Lynparza for adjuvant treatment of BRCA‑mutated, HER2‑negative high‑risk early breast cancer, further expanding its commercial footprint.  Regulatory progress for Lynparza remained positive, with ongoing EU reviews for additional indications and continued collaboration with AstraZeneca.  Overall, Lynparza’s contribution to Merck’s oncology portfolio demonstrated consistent revenue expansion and broadening regulatory approvals through 2024.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MRK_10k_2022.pdf",
          "target_page": 22,
          "pages": [
            20,
            21,
            22,
            23,
            24
          ]
        },
        "hop_2_rel": {
          "source_file": "MRK_10k_2024.pdf",
          "target_page": 55,
          "pages": [
            53,
            54,
            55,
            56,
            57
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 54897,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 13951,
        "completion_tokens": 200,
        "total_tokens": 14151
      }
    },
    {
      "question_id": 115,
      "question": "How has Boeing's strategy with commodity purchase contracts evolved between 2022 and 2024, particularly in terms of risk management horizon and financial exposure?",
      "original_answer": "In 2022, Boeing disclosed that a 10% change in commodity prices would impact unrealized losses by $46 million, and the company used commodity swaps and purchase contracts to hedge against price volatility, neutralizing material market risk. By 2024, Boeing extended the scope of its hedging strategy, indicating the use of commodity purchase contracts and derivatives to manage exposure through 2031. This represents a shift toward longer-term risk management aligned with extended production planning cycles. The expansion from a general hedging approach in 2022 to a multi-decade horizon in 2024 suggests Boeing is proactively securing cost predictability for strategic business stability.",
      "llm_answer": "Between 2022 and 2024, Boeing's commodity purchase contracts strategy shifted from a shorter hedge horizon to a longer-term approach, explicitly extending hedges \"through 2028\" as noted in the 2024 filing. This evolution reflects a more deliberate risk management framework, where commodity derivatives (including swaps and purchase contracts) are now structured to hedge forecasted transactions over a multi-year horizon, reducing near-term exposure to price volatility. The company also refined its hedge accounting treatment, with a clearer distinction between designated hedging instruments (e.g., foreign exchange and commodity contracts offsetting forecasted transactions) and those not receiving hedge accounting, while maintaining a focus on minimizing unrealized gains/losses through offsetting positions. This strategy enhances financial exposure management by aligning hedges with long-term operational planning rather than short-term market fluctuations.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "BA_10k_2022.pdf",
          "target_page": 60,
          "pages": [
            58,
            59,
            60,
            61,
            62
          ]
        },
        "hop_2_rel": {
          "source_file": "BA_10k_2024.pdf",
          "target_page": 110,
          "pages": [
            108,
            109,
            110,
            111,
            112
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 34919,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 8955,
        "completion_tokens": 241,
        "total_tokens": 9196
      }
    },
    {
      "question_id": 115,
      "question": "How did Schwab's exposure to PALs and the associated credit risk evolve between 2021 and 2024, particularly in terms of collateralization and allowance for credit losses?",
      "original_answer": "In 2021, all PALs were fully collateralized by securities with fair values exceeding borrowings, and therefore no allowance for credit losses was required. In contrast, by 2024, although PALs experienced slight growth overall, Schwab observed a decrease in the allowance for credit losses due to lower projected loss rates and improved credit quality metrics. This reflects a shift from a focus on full collateralization as the primary risk mitigant to a broader assessment of credit quality and loss projections.",
      "llm_answer": "Between 2021 and 2024, Schwab's exposure to PALs (Pledged Asset Lines) remained fully collateralized with securities having fair values exceeding the borrowed amounts, requiring no allowance for credit losses throughout this period. The credit risk profile of the underlying residential real estate portfolio (including First Mortgages and HELOCs) showed stable delinquency metrics, with nonaccrual loans remaining minimal (0.12% for First Mortgages and 1.39% for HELOCs as of 2021), and the allowance for credit losses on total bank loans decreased from $30 million in 2020 to $18 million in 2021, reflecting improved credit quality and lower modeled loss rates in the subsequent years.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "SCHW_10k_2022.pdf",
          "target_page": 91,
          "pages": [
            89,
            90,
            91,
            92,
            93
          ]
        },
        "hop_2_rel": {
          "source_file": "SCHW_10k_2024.pdf",
          "target_page": 142,
          "pages": [
            137,
            138,
            139,
            140,
            141
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 52248,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 13290,
        "completion_tokens": 171,
        "total_tokens": 13462
      }
    },
    {
      "question_id": 116,
      "question": "How did Boeing's financial treatment and strategic positioning of the 777X program evolve between 2022 and 2024, given the changes in cost impacts and research & development investments?",
      "original_answer": "In 2022, the 777X program negatively impacted Boeing's financials, contributing to higher charges and a cost of sales increase, partly due to a 'reach-forward loss' on the program. By 2024, the program had transitioned to being a strategic investment priority, as evidenced by a $435 million increase in R&D spending in 2024 compared to 2023, following a $525 million increase in 2023 over 2022, indicating a shift from a cost burden to a focal point for future product development.",
      "llm_answer": "Between 2022 and 2024 Boeing’s 777X program shifted from early‑stage development to a more mature, cost‑intensive phase, reflected in a sharp rise in research‑and‑development spending—R&D for Commercial Airplanes climbed from $1.51 bn in 2022 to $2.39 bn in 2024—while cost‑of‑sales pressures mounted, with the 777X and 767 reach‑forward losses driving cost‑of‑sales as a share of revenue up to 103 % in 2024.  Consequently, the company recorded substantial forward‑looking losses on the 777X (and related programs) that reduced margins, even as backlog remained robust; however, the growing R&D outlays and heightened cost‑of‑sales percentages signaled a strategic positioning of the 777X as a high‑investment, high‑risk growth engine for Boeing’s commercial aircraft portfolio through 2024.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "BA_10k_2022.pdf",
          "target_page": 34,
          "pages": [
            32,
            33,
            34,
            35,
            36
          ]
        },
        "hop_2_rel": {
          "source_file": "BA_10k_2024.pdf",
          "target_page": 32,
          "pages": [
            30,
            31,
            32,
            33,
            34
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 33091,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 8502,
        "completion_tokens": 198,
        "total_tokens": 8700
      }
    },
    {
      "question_id": 116,
      "question": "How has Schwab's exposure to and risk management of Portfolio Against Loans (PALs) evolved between 2022 and 2024, particularly in terms of credit loss allowance methodology and portfolio growth?",
      "original_answer": "In 2022, Schwab applied the practical expedient for PALs due to their collateralized nature and over-collateralization requirements, which limited inherent credit loss. The company monitored collateral daily and maintained strict maintenance levels based on the type of security pledged. By 2024, PALs had contributed to the growth of the average loan portfolio, although there was a slight decrease in 2023. The overall decrease in the allowance for credit losses as a ratio to year-end loans in 2024 was attributed to improved credit quality metrics and lower projected loss rates, indicating a reduced risk profile for PALs despite portfolio growth.",
      "llm_answer": "Schwab's exposure to Portfolio Against Loans (PALs) has grown significantly, with the total PAL portfolio increasing from $45.2 billion at December 31, 2023 to $45.2 billion at December 31, 2024 (as shown in the maturity schedule on page 141), though the portfolio composition remains heavily weighted toward pledged asset lines ($16.7 billion) and other commitments. The credit loss allowance methodology for PALs has evolved to utilize a practical expedient based on collateral maintenance provisions, recognizing that credit losses are limited due to over-collateralization and daily collateral monitoring, while the allowance for the broader residential real estate portfolio (including First Mortgages and HELOCs) relies on statistical models forecasting losses using delinquency roll rates, loss severity, housing prices, interest rates, and unemployment—factors that have influenced the $660 million allowance for credit losses on the $42.3 billion bank loan portfolio (page 78). This represents a shift toward more sophisticated, model-based forecasting for the broader loan portfolio, while PALs maintain a simpler, collateral-focused approach to credit loss estimation.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "SCHW_10k_2022.pdf",
          "target_page": 78,
          "pages": [
            76,
            77,
            78,
            79,
            80
          ]
        },
        "hop_2_rel": {
          "source_file": "SCHW_10k_2024.pdf",
          "target_page": 142,
          "pages": [
            137,
            138,
            139,
            140,
            141
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 9,
        "total_chars": 45664,
        "num_window_pages": 9,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 11650,
        "completion_tokens": 294,
        "total_tokens": 11945
      }
    },
    {
      "question_id": 116,
      "question": "How did MDLZ's value of British pound sterling notes change from 2022 to 2023, and what does this shift indicate about the company's foreign exchange risk management strategy?",
      "original_answer": "In 2022, MDLZ reported a value of $3 million for British pound sterling notes. By 2023, this value had increased significantly to $45 million. This shift indicates a substantial change in MDLZ's foreign exchange risk management strategy, suggesting an increased exposure to the British pound sterling, which could reflect either a strategic decision to hedge more in this currency or an increase in operational activities tied to the UK market.",
      "llm_answer": "Based on the MDLZ 10-K disclosures, the notional value of British pound sterling notes designated as net investment hedges decreased from **$356 million in 2022 to $356 million in 2023** (though the 2022 figure is listed as $360 million in some tables, the 2023 value explicitly states $356 million). This shift reflects a deliberate reduction in exposure to British pound-denominated debt as part of MDLZ's foreign exchange risk management strategy, which uses cross-currency swaps and debt designations to hedge net investments in international operations. The decline indicates a strategic adjustment to mitigate currency volatility, particularly in the UK market, by reducing the notional amount of pound-denominated debt used for hedging purposes.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MDLZ_10k_2022.pdf",
          "target_page": 114,
          "pages": [
            112,
            113,
            114,
            115,
            116
          ]
        },
        "hop_2_rel": {
          "source_file": "MDLZ_10k_2023.pdf",
          "target_page": 98,
          "pages": [
            96,
            97,
            98,
            99,
            100
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 52649,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 13392,
        "completion_tokens": 188,
        "total_tokens": 13580
      }
    },
    {
      "question_id": 116,
      "question": "Compare the interest rate disclosures for Amgen's 3.125% 2025 Notes in the 2022 and 2024 filings, and explain what this reveals about the company's approach to debt financing for this instrument.",
      "original_answer": "In the 2022 filing, Amgen disclosed a fixed interest rate of 3.125% for the 2025 Notes with no mention of variable rate terms. However, by the 2024 filing, Amgen disclosed that the interest rate for the same 3.125% 2025 Notes was tied to SOFR (Secured Overnight Financing Rate) plus 2.1%. This indicates a shift from a purely fixed-rate structure to a floating-rate mechanism, suggesting Amgen may have refinanced or repriced the notes to adapt to changing market conditions and interest rate environments.",
      "llm_answer": "The 3.125% 2025 Notes carry the same 1,000 million carrying amount in both the 2022 and 2024 filings, but the 2024 filing notes that the effective interest rate on these notes is now SOFR + 2.1% (a floating rate), whereas the 2022 filing only disclosed the fixed 3.125% coupon. This shift reveals that Amgen has moved to a floating‑rate structure for this tranche, using interest‑rate swaps to convert the fixed coupon into a SOFR‑based cost, reflecting a more dynamic debt‑management approach that aligns financing costs with current market rates.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AMGN_10k_2022.pdf",
          "target_page": 130,
          "pages": [
            128,
            129,
            130,
            131,
            132
          ]
        },
        "hop_2_rel": {
          "source_file": "AMGN_10k_2024.pdf",
          "target_page": 149,
          "pages": [
            147,
            148,
            149,
            150,
            151
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 49057,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 12500,
        "completion_tokens": 137,
        "total_tokens": 12637
      }
    },
    {
      "question_id": 117,
      "question": "How has Schwab's reliance on its Commercial Paper Issuance Program evolved between 2022 and 2024 in response to market disruptions and rising interest rates?",
      "original_answer": "In 2022, Schwab introduced its Commercial Paper Issuance Program as one of several potential sources of external financing, alongside unsecured bank credit lines and a universal shelf registration, to address liquidity needs during market disruptions. The company emphasized that while these tools were available, access to financing could still be constrained due to credit market volatility and potential credit rating downgrades. By 2024, Schwab's reliance on the program had increased as a complement to other funding mechanisms like FHLB advances and repurchase agreements, particularly in response to rising short-term interest rates in 2022 and 2023, which led to higher client cash outflows. The company noted that these outflows, outpacing cash generated from maturities and paydowns, required supplemental funding sources, including the commercial paper program, to manage liquidity under more costly and constrained conditions.",
      "llm_answer": "Schwab’s reliance on its Commercial Paper Issuance Program has declined markedly from 2022 to 2024 as market disruptions and sharply higher interest rates forced the firm to turn to more expensive, short‑term funding sources such as FHLB advances, brokered CDs and other wholesale borrowings.  In its 2022 filing the company highlighted the CP program as a key liquidity source, but by 2024 it emphasized that rapid rate hikes had driven large client cash outflows, required supplemental funding, and limited the usefulness of the CP market, leading Schwab to depend less on commercial paper and more on alternative liquidity measures.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "SCHW_10k_2022.pdf",
          "target_page": 23,
          "pages": [
            21,
            22,
            23,
            24,
            25
          ]
        },
        "hop_2_rel": {
          "source_file": "SCHW_10k_2024.pdf",
          "target_page": 16,
          "pages": [
            14,
            15,
            16,
            17,
            18
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 55240,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 14033,
        "completion_tokens": 158,
        "total_tokens": 14192
      }
    },
    {
      "question_id": 117,
      "question": "How has the status and interest rate structure of the 3.625% Notes evolved from 2022 to 2024, and what does this indicate about the company's debt management strategy?",
      "original_answer": "In 2022, the 3.625% 2024 Notes had a carrying value of $1,400 million with a fixed interest rate of 3.625%. By 2024, these notes were fully paid off, as indicated by the $0 notional amount, and were replaced with floating interest rates tied to SOFR (Secured Overnight Financing Rate). This shift from fixed to floating rate debt indicates a strategic change in Amgen's debt management, aligning with broader market conditions and potentially reducing interest costs in a declining rate environment.",
      "llm_answer": "From 2022 through 2024 the company’s 3.625% notes due 2024 remained outstanding with a constant carrying value of $1.4 billion, but in 2022 the notes were partially retired (the $750 million aggregate principal of the 3.625% 2022 notes was redeemed) and the related interest‑rate swap contracts were terminated, resulting in a $24 million make‑whole charge. By 2024 the company had swapped the fixed‑rate exposure of the 3.625% 2024 notes into floating‑rate SOFR‑plus‑3.4% swaps (notional $1.4 billion) and later, in 2024, swapped portions of the 3.625% 2024 notes into new SOFR‑plus‑1.8% swaps tied to the newly issued 5.25% 2033 notes. These actions show a strategic shift toward managing interest‑rate risk and reducing reliance on fixed‑rate debt, using swaps and cross‑currency hedges to lower overall borrowing costs and improve flexibility in the company’s debt‑management strategy.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AMGN_10k_2022.pdf",
          "target_page": 130,
          "pages": [
            128,
            129,
            130,
            131,
            132
          ]
        },
        "hop_2_rel": {
          "source_file": "AMGN_10k_2024.pdf",
          "target_page": 149,
          "pages": [
            147,
            148,
            149,
            150,
            151
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 49057,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 12493,
        "completion_tokens": 222,
        "total_tokens": 12715
      }
    },
    {
      "question_id": 118,
      "question": "How has Schwab's approach to providing financial or other support to variable interest entities (VIEs) evolved between 2022 and 2024, particularly in terms of intent and conditions for funding commitments?",
      "original_answer": "In 2022, Schwab explicitly stated that it did not provide or intend to provide financial or other support to VIEs that it was not contractually required to provide. By 2024, Schwab's disclosures indicate a shift, as the company now acknowledges that while it has no contractual obligation, it may choose to provide credit, liquidity, or other support to its proprietary funds in response to significant declines in valuation or redemption activity. This reflects a more proactive stance in supporting funds under certain market conditions, even though it is not mandated.",
      "llm_answer": "Schwab’s funding commitments to VIEs have shifted from a general, non‑contractual stance in 2022 to a more explicit, conditional approach by 2024. In the 2022 filing (page 99), Schwab notes that it “did not provide or intend to provide financial or other support to the VIEs that it was not contractually required to provide,” indicating limited, obligation‑only support. By 2024 (page 17), the language emphasizes that any additional funding would occur only if specific conditions are met and that such funding is expected to be paid “substantially all … between 2022 and 2025,” reflecting a clearer intent to fund only when contractual triggers occur. Thus, the evolution shows a move from minimal, discretionary support toward a defined, condition‑based funding commitment.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "SCHW_10k_2022.pdf",
          "target_page": 98,
          "pages": [
            96,
            97,
            98,
            99,
            100
          ]
        },
        "hop_2_rel": {
          "source_file": "SCHW_10k_2024.pdf",
          "target_page": 19,
          "pages": [
            17,
            18,
            19,
            20,
            21
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 49888,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 12708,
        "completion_tokens": 194,
        "total_tokens": 12902
      }
    },
    {
      "question_id": 118,
      "question": "How has MDLZ's financial relationship with JDE Peet's evolved between 2022 and 2023, particularly in terms of how the investment impacts MDLZ's liquidity and capital structure?",
      "original_answer": "In 2022, MDLZ's relationship with JDE Peet's was characterized as a 'Has_Stake_In' arrangement, where MDLZ reported its proportionate share of significant operating and non-operating items from JDE Peet's including restructuring and acquisition-related costs. By 2023, the relationship was reclassified to 'Invests_In', and the investment in JDE Peet's was described as providing additional financial flexibility within MDLZ's liquidity and capital resources framework. This shift indicates a more strategic and stable investment posture, aligning JDE Peet's more closely with MDLZ's long-term capital planning and funding sources.",
      "llm_answer": "Between 2022 and 2023, MDLZ's investment in JDE Peet's strengthened its liquidity and capital flexibility, as noted in the 2023 10-K where the company states the investment \"provides us additional flexibility\" and that it \"do[es] not expect negative effects to our funding sources.\" While the investment itself is not directly tied to debt issuance, MDLZ's overall capital structure remained stable with a reduced debt-to-capitalization ratio (0.41 in 2023 vs. 0.46 in 2022), and the company continued to fund operations and strategic initiatives, including capital expenditures, through cash from operations and debt financing. The investment did not materially impact liquidity, as evidenced by robust operating cash flow ($4,714 million in 2023) and the company's ability to increase dividends and repurchase shares while maintaining a strong balance sheet.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MDLZ_10k_2022.pdf",
          "target_page": 46,
          "pages": [
            44,
            45,
            46,
            47,
            48
          ]
        },
        "hop_2_rel": {
          "source_file": "MDLZ_10k_2023.pdf",
          "target_page": 54,
          "pages": [
            52,
            53,
            54,
            55,
            56
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 39835,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 10187,
        "completion_tokens": 215,
        "total_tokens": 10402
      }
    },
    {
      "question_id": 119,
      "question": "How did the interest rate hedging strategy for the 3.125% 2025 Notes evolve between 2022 and 2024, particularly in terms of the interest rate applied under the swap agreements?",
      "original_answer": "In 2022, the company had terminated interest rate swaps for portions of the 3.125% 2025 Notes and reentered into new swap agreements at then-current interest rates, though the exact rate for the 3.125% 2025 Notes was not disclosed. By 2024, the interest rate applied under the swap agreement for the 3.125% 2025 Notes was explicitly stated as SOFR+2.1%, with a consistent notional amount of $1,000 million as of December 31, 2024, compared to December 31, 2023.",
      "llm_answer": "Between 2022 and 2024, the interest rate hedging strategy for the 3.125% 2025 Notes evolved from a fixed‑rate structure to a floating‑rate swap tied to SOFR. In 2022 the notes carried a fixed 3.125% coupon; by 2024 they were hedged with interest‑rate swaps that convert the fixed rate to a floating rate of **SOFR + 2.1%**, and the notional amount of these swaps remained at $1 billion. The swaps now qualify as fair‑value hedges, and any gains or losses on the hedged item are recorded in interest expense.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AMGN_10k_2022.pdf",
          "target_page": 132,
          "pages": [
            130,
            131,
            132,
            133,
            134
          ]
        },
        "hop_2_rel": {
          "source_file": "AMGN_10k_2024.pdf",
          "target_page": 149,
          "pages": [
            147,
            148,
            149,
            150,
            151
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 50009,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 12733,
        "completion_tokens": 126,
        "total_tokens": 12860
      }
    },
    {
      "question_id": 120,
      "question": "How did Walmart's fair value of equity investments measured using Level 2 inputs evolve from fiscal year 2022 to fiscal year 2023, and what was the magnitude of this change?",
      "original_answer": "Walmart's fair value of equity investments measured using Level 2 inputs decreased from $5,819 million in fiscal year 2022 to $5,570 million in fiscal year 2023, representing a moderate decline of $249 million over the period.",
      "llm_answer": "Based on the provided document pages, Walmart's fair value of equity investments measured using Level 2 inputs **decreased by $2,086 million** from fiscal year 2022 to fiscal year 2023, declining from **$7,905 million** (as of January 31, 2022) to **$5,819 million** (as of January 31, 2023). This represents a **magnitude of change of $2,086 million**.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "WMT_10k_2022.pdf",
          "target_page": 72,
          "pages": [
            70,
            71,
            72,
            73,
            74
          ]
        },
        "hop_2_rel": {
          "source_file": "WMT_10k_2023.pdf",
          "target_page": 71,
          "pages": [
            69,
            70,
            71,
            72,
            73
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 56046,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 14238,
        "completion_tokens": 88,
        "total_tokens": 14327
      }
    },
    {
      "question_id": 120,
      "question": "How has Apple's characterization of its reliance on marketing abilities evolved between its 2023 and 2024 10-K filings?",
      "original_answer": "In the 2023 10-K filing, Apple stated that while it believes ownership of intellectual property rights is an important factor in differentiating its business, it 'relies primarily' on the innovative skills, technical competence, and marketing abilities of its personnel. In the 2024 filing, Apple shifted its language, stating that it 'depends heavily' on these same three factors—innovative skills, technical competence, and marketing abilities—tying them directly to ensuring a continual and timely flow of competitive products, services, and technologies to the marketplace. This evolution reflects a stronger emphasis on the strategic importance of marketing abilities in maintaining competitiveness, particularly as the company faces increasing pressure from rivals imitating its features and offering lower-priced alternatives.",
      "llm_answer": "The 2024 10‑K continues Apple’s long‑standing emphasis on marketing as a core competitive advantage, describing it as essential to “ensuring the continuing and timely introduction of innovative new products, services and technologies” and highlighting the company’s “marketing and distribution capability” alongside product quality and design innovation.  While earlier filings framed marketing primarily as a driver of brand awareness and product adoption, the 2024 filing expands this view to include marketing’s role in supporting the full ecosystem of services, supply‑chain coordination, and talent development, underscoring a more integrated and strategic characterization of Apple’s reliance on its marketing abilities.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AAPL_10k_2023.pdf",
          "target_page": 6,
          "pages": [
            4,
            5,
            6,
            7,
            8
          ]
        },
        "hop_2_rel": {
          "source_file": "AAPL_10k_2024.pdf",
          "target_page": 6,
          "pages": [
            4,
            5,
            6,
            7,
            8
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 43282,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 11032,
        "completion_tokens": 181,
        "total_tokens": 11213
      }
    },
    {
      "question_id": 120,
      "question": "How did the notional amount and interest rate structure for the 3.625% 2024 Notes change between 2022 and 2024, and what does this indicate about Amgen's hedging strategy?",
      "original_answer": "In 2022, Amgen terminated interest rate swaps with a notional amount of $5.2 billion that hedged several notes, including the 3.625% 2024 Notes, and reentered into new interest rate swap agreements at then-current rates on the same principal amount. By 2024, the notional amount for the 3.625% 2024 Notes had dropped to $0 as of December 31, 2024, compared to $1,400 million in December 2023, with the interest rate tied to SOFR+3.4% in 2023. This indicates that Amgen fully unwound its hedging position for the 3.625% 2024 Notes by the end of 2024, likely as the notes approached maturity.",
      "llm_answer": "Between 2022 and 2024, the notional amount of the 3.625% 2024 Notes remained at $1.4 billion, but the interest‑rate structure shifted from a LIBOR‑plus‑3.2% floating rate (as shown for 2021‑2022) to a SOFR‑plus‑3.4% floating rate in the 2024 disclosures. This change reflects Amgen’s move to replace LIBOR with the newer SOFR benchmark in its interest‑rate swap agreements, indicating an active hedging strategy to maintain a desired mix of fixed‑ and floating‑rate debt while adapting to evolving market reference rates.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AMGN_10k_2022.pdf",
          "target_page": 132,
          "pages": [
            130,
            131,
            132,
            133,
            134
          ]
        },
        "hop_2_rel": {
          "source_file": "AMGN_10k_2024.pdf",
          "target_page": 149,
          "pages": [
            147,
            148,
            149,
            150,
            151
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 50009,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 12732,
        "completion_tokens": 130,
        "total_tokens": 12862
      }
    },
    {
      "question_id": 121,
      "question": "How did Schwab's integration of the iRebal portfolio rebalancing solution evolve from 2022 to 2023, and what does this indicate about its competitive positioning in the RIA market?",
      "original_answer": "In 2022, Schwab stated that it was retaining TD Ameritrade Institutional's customizable portfolio rebalancing solution, iRebal, as part of its offering for independent advisor clients. This indicated that Schwab acknowledged the value of iRebal but had not yet fully integrated or emphasized it within its broader platform. By 2023, Schwab had incorporated iRebal as a core part of its offerings for independent advisors, signaling a deeper integration and a strategic move to enhance its competitive positioning in the RIA market. This evolution reflects Schwab's broader integration progress, including the transition of over $1.6 trillion in client assets and more than 15 million client accounts from TD Ameritrade to the Schwab platform by 2023. The inclusion of iRebal as a central feature for RIAs suggests that Schwab is leveraging the solution to differentiate its service offerings and strengthen its appeal to independent advisors, aligning with its competitive advantage of introducing new products credibly through its strong brand and corporate reputation.",
      "llm_answer": "From 2022 to 2023, Schwab’s integration of the iRebal portfolio rebalancing solution evolved from being retained as a TD Ameritrade Institutional offering for independent advisors to being fully incorporated into Schwab’s own platform—highlighted by the launch of “Schwab Trading Powered by Ameritrade” and the broader migration of TD Ameritrade client assets onto Schwab systems. This progression underscores Schwab’s ability to leverage TD Ameritrade’s technology while unifying its product suite, reinforcing its competitive positioning in the RIA market by offering a seamless, scalable, and fully Schwab‑branded rebalancing solution that enhances its appeal to independent advisors.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "SCHW_10k_2022.pdf",
          "target_page": 6,
          "pages": [
            4,
            5,
            6,
            7,
            8
          ]
        },
        "hop_2_rel": {
          "source_file": "SCHW_10k_2023.pdf",
          "target_page": 4,
          "pages": [
            2,
            3,
            4,
            5,
            6
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 52330,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 13309,
        "completion_tokens": 171,
        "total_tokens": 13481
      }
    },
    {
      "question_id": 121,
      "question": "How has Apple's approach to the iMac product line evolved between 2023 and 2024, based on the company's disclosures in its 10-K filings?",
      "original_answer": "In 2023, Apple described the iMac as part of its Mac product line, indicating it was actively manufacturing and marketing the desktop computer as part of its standard offerings. By 2024, Apple elevated the iMac to the level of a significant product announcement, listing it among other key launches like the MacBook Pro and iPad Pro in the MD&A section of its 2024 10-K. This shift suggests that the iMac gained strategic importance in 2024, likely reflecting a product refresh or redesign that warranted special mention as part of the company's innovation cycle.",
      "llm_answer": "Apple's approach to the iMac product line evolved between 2023 and 2024 as reflected in its 10-K filings. In fiscal year 2024, the company highlighted the iMac as part of its product announcements, specifically noting the release of new iMac models during the first quarter of 2024, continuing its tradition of introducing updated desktop hardware. Additionally, while iMac net sales declined slightly year-over-year due to broader iPad and Wearables softness, the product remained part of Apple's diversified hardware portfolio, with segment performance indicating ongoing investment in desktop offerings despite macroeconomic pressures.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AAPL_10k_2023.pdf",
          "target_page": 4,
          "pages": [
            2,
            3,
            4,
            5,
            6
          ]
        },
        "hop_2_rel": {
          "source_file": "AAPL_10k_2024.pdf",
          "target_page": 24,
          "pages": [
            22,
            23,
            24,
            25,
            26
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 29664,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 7633,
        "completion_tokens": 159,
        "total_tokens": 7792
      }
    },
    {
      "question_id": 122,
      "question": "How has RTX's relationship with the 2.820% Notes Due 2051 evolved between 2022 and 2024, and what does this indicate about the company's long-term debt structure?",
      "original_answer": "In 2022, RTX introduced the 2.820% Notes Due 2051 with an aggregate principal balance of $1,000 million. By 2024, this debt instrument remained on the books with the same principal balance of $1,000 million, indicating no repayment or additional issuance occurred during this period. However, the broader long-term debt structure expanded significantly, with total principal long-term debt increasing from an implied $40,078 million in 2022 (based on the 2024 presentation format) to $41,146 million in 2024. This suggests that while the 2.820% Notes Due 2051 remained unchanged, RTX increased its overall debt burden through other issuances, maintaining the 2051 notes as a stable component within a growing long-term debt portfolio.",
      "llm_answer": "RTX retired the $1,000 million 2.820% Notes Due 2051 in 2023 and had no outstanding balance for that issue as of 2024, indicating that the company has eliminated this long‑term debt from its capital structure. This reduction reflects a strategic shift toward repaying maturing obligations and optimizing the debt mix, while the remaining long‑term debt schedule shows a continued reliance on higher‑maturity instruments (e.g., 2051‑2054 notes) to fund future financing needs.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "RTX_10k_2022.pdf",
          "target_page": 93,
          "pages": [
            91,
            92,
            93,
            94,
            95
          ]
        },
        "hop_2_rel": {
          "source_file": "RTX_10k_2024.pdf",
          "target_page": 89,
          "pages": [
            87,
            88,
            89,
            90,
            91
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 43685,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 11145,
        "completion_tokens": 118,
        "total_tokens": 11264
      }
    },
    {
      "question_id": 122,
      "question": "How did the terms of Schwab's IDA agreement evolve between 2022 and 2023, particularly regarding service fees and reference rate adjustments?",
      "original_answer": "In 2022, Schwab disclosed that the IDA agreement had been amended to reduce the service fee on client cash deposits held at the TD Depository Institutions to 15 basis points from 25 basis points. By 2023, the company reported that its IDA agreement had transitioned reference rates previously tied to LIBOR to other appropriate benchmarks as part of its broader LIBOR phase-out preparation. This evolution reflects a shift from adjustments in fee structure to modifications in financial reference mechanisms, aligning the agreement with post-LIBOR regulatory and market standards.",
      "llm_answer": "The IDA agreement terms evolved between 2022 and 2023 with a reduction in the service fee on client cash deposits held at the TD Depository Institutions from 25 basis points to 15 basis points, as noted in the pro forma financial information footnote describing the USAA-IMCO acquisition adjustments. Additionally, Schwab transitioned its IDA agreement and related intercompany lending agreements away from LIBOR to alternative reference rates, completing the transition prior to the June 30, 2023 LIBOR cessation, though monitoring of legacy loan transitions continued.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "SCHW_10k_2022.pdf",
          "target_page": 85,
          "pages": [
            83,
            84,
            85,
            86,
            87
          ]
        },
        "hop_2_rel": {
          "source_file": "SCHW_10k_2023.pdf",
          "target_page": 54,
          "pages": [
            52,
            53,
            54,
            55,
            56
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 46331,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 11802,
        "completion_tokens": 142,
        "total_tokens": 11945
      }
    },
    {
      "question_id": 122,
      "question": "What does the change in Filorga's financial treatment from 2023 (when it had $221 million in goodwill as a standalone reporting unit) to 2024 (when it was listed among other trademarks within broader segments) suggest about its strategic importance and valuation approach by the company?",
      "original_answer": "In 2023, Filorga was treated as a standalone reporting unit within the Europe segment with a clearly disclosed goodwill carrying value of $221 million, indicating its distinct financial significance and the company’s detailed impairment analysis for this brand. By 2024, Filorga was listed among other global and regional trademarks within broader product segments, without separate goodwill or valuation figures. This suggests that Filorga may have been integrated into a larger reporting structure, reducing its visibility as a standalone asset, which could signal a shift in strategic focus or a consolidation of brand management. This change affects how Filorga’s valuation and performance are assessed, potentially influencing future strategic decisions such as divestiture, investment, or brand prioritization.",
      "llm_answer": "The shift from treating Filorga as a standalone reporting unit with $221 million of goodwill in 2023 to aggregating it within broader trademark categories in 2024 indicates that management no longer views Filorga as a distinct driver of future cash flows. Instead, its value is now considered part of the overall brand portfolio, reflecting a more consolidated valuation approach that emphasizes the collective strength of the trademark suite rather than the individual reporting unit’s performance.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CL_10k_2023.pdf",
          "target_page": 59,
          "pages": [
            57,
            58,
            59,
            60,
            61
          ]
        },
        "hop_2_rel": {
          "source_file": "CL_10k_2024.pdf",
          "target_page": 79,
          "pages": [
            77,
            78,
            79,
            80,
            81
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 43051,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 11018,
        "completion_tokens": 124,
        "total_tokens": 11142
      }
    },
    {
      "question_id": 122,
      "question": "How does the change in Apple's disclosure about the iPhone 16 Pro between the 2023 and 2024 10-K filings reflect an evolution in its product development and reporting strategy?",
      "original_answer": "In the 2023 10-K filing, Apple announced the iPhone 16 Pro as part of its Fourth Quarter 2024 product lineup, indicating it was still in the planning and launch phase. By contrast, in the 2024 10-K filing, the iPhone 16 Pro is listed among existing product lines like the iPhone 15 and iPhone 14, suggesting it has transitioned into an active and established product within Apple's portfolio. This shift reflects a movement from forward-looking product planning in 2023 to retrospective inclusion in 2024, aligning with the product's lifecycle stage and indicating a more mature reporting posture around the iPhone 16 Pro.",
      "llm_answer": "The 2024 10‑K shows Apple now explicitly lists the iPhone 16 Pro (and its Pro Max variant) among its “Products” and highlights it as a new launch in the fiscal‑2024 product announcements, whereas the 2023 filing only referenced the iPhone 15 family and did not single out a “Pro” tier. This change reflects a more focused product‑development strategy that emphasizes the premium iPhone 16 Pro line as a key growth driver, and a reporting shift that treats the Pro model as a distinct, market‑significant offering rather than merely a variant within the broader iPhone lineup.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AAPL_10k_2023.pdf",
          "target_page": 24,
          "pages": [
            22,
            23,
            24,
            25,
            26
          ]
        },
        "hop_2_rel": {
          "source_file": "AAPL_10k_2024.pdf",
          "target_page": 4,
          "pages": [
            2,
            3,
            4,
            5,
            6
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 29812,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 7680,
        "completion_tokens": 143,
        "total_tokens": 7824
      }
    },
    {
      "question_id": 123,
      "question": "How has the company's use of Economic Value of Equity (EVE) simulations evolved in assessing interest rate risk, particularly in terms of modeling assumptions and balance sheet dynamics, between 2022 and 2023?",
      "original_answer": "In 2022, the company used EVE simulations to measure long-term interest rate risk, with key assumptions including non-negative investment yields, prepayment speeds of mortgage-related investments, and non-maturity deposit behavior. The EVE analysis was described as highly dependent on asset and liability assumptions based on historical behaviors and expectations of the economic environment. By 2023, the company expanded the role of EVE simulations to specifically capture the impact of client cash allocation changes on the balance sheet, which was not included in the earlier modeling approach. Additionally, in 2023, the company actively updated deposit beta assumptions in a declining interest rate environment for its net interest revenue simulation model, indicating a more dynamic approach to modeling interest rate sensitivity.",
      "llm_answer": "Between 2022 and 2023, Schwab’s EVE simulations evolved in two key ways: (1) modeling assumptions were refined to improve accuracy in capturing interest rate risk, particularly through updated deposit beta assumptions in a declining rate environment and more robust treatment of non-maturity client cash behavior; and (2) the Company enhanced its balance sheet dynamics analysis by incorporating updated prepayment speed models, rate floor assumptions, and third-party term structure inputs, while also transitioning away from LIBOR-based references to alternative benchmark rates. These updates resulted in more pronounced EVE sensitivities to interest rate shifts—evidenced by larger projected impacts on net interest revenue under rate changes—reflecting a shortened liability duration relative to asset duration amid rising rates, and a more dynamic representation of client cash reallocation and funding mix changes.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "SCHW_10k_2022.pdf",
          "target_page": 54,
          "pages": [
            52,
            53,
            54,
            55,
            56
          ]
        },
        "hop_2_rel": {
          "source_file": "SCHW_10k_2023.pdf",
          "target_page": 52,
          "pages": [
            50,
            51,
            52,
            53,
            54
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 49140,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 12521,
        "completion_tokens": 230,
        "total_tokens": 12752
      }
    },
    {
      "question_id": 123,
      "question": "How did Qualcomm's strategic shift from enabling wireless access point technologies in 2022 to directly producing them in 2023 affect its competitive positioning and product portfolio breadth in the broader networking market?",
      "original_answer": "In 2022, Qualcomm's involvement with wireless access points was limited to enabling the technology through its foundational wireless innovations and chipset solutions, as noted in its discussion of edge networking growth driven by 5G and Wi-Fi 6 adoption. However, by 2023, Qualcomm had evolved its strategy to directly producing wireless access points as part of its broader networking product suite, which included Wi-Fi chips, routers, and network processors. This shift reflects an expansion of Qualcomm's product portfolio and a more direct role in the networking ecosystem, positioning the company to compete more directly with players like Broadcom and Intel by offering full-system solutions rather than just underlying components.",
      "llm_answer": "Qualcomm’s 2022‑2023 shift—from merely enabling wireless access‑point technologies to actually producing them—expanded its footprint in the networking market and broadened its product portfolio. By moving into direct hardware manufacturing (e.g., Wi‑Fi 6/7 access points, integrated RF front‑end modules, and AI‑enabled networking chips), the company deepened its competitive positioning against traditional networking vendors and opened new revenue streams beyond licensing, while leveraging its existing strengths in 5G, positioning, and multimedia to offer end‑to‑end solutions across automotive, IoT and edge‑computing segments.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "QCOM_10k_2022.pdf",
          "target_page": 8,
          "pages": [
            6,
            7,
            8,
            9,
            10
          ]
        },
        "hop_2_rel": {
          "source_file": "QCOM_10k_2023.pdf",
          "target_page": 11,
          "pages": [
            9,
            10,
            11,
            12,
            13
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 64702,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 16415,
        "completion_tokens": 158,
        "total_tokens": 16573
      }
    },
    {
      "question_id": 124,
      "question": "How has the interest-only payment structure of Schwab's HELOC product evolved from 2022 to 2023, based on the percentage of adjustable-rate mortgages with interest-only terms and the portion not scheduled to reset for three or more years?",
      "original_answer": "In 2022, 28% of adjustable-rate mortgages were interest-only loans, with 89% of those not scheduled to reset for three or more years. In 2023, this shifted slightly to 27% of adjustable-rate mortgages being interest-only, with 86% of those not scheduled to reset for three or more years. This reflects a minor decrease in both metrics, suggesting a slight tightening or evolution in the interest-only structure of the HELOC product.",
      "llm_answer": "Based on the provided document pages, Schwab's HELOC interest-only payment structure has remained largely unchanged from 2022 to 2023. The percentage of adjustable-rate mortgages with interest-only terms held steady at approximately 27% in both years, and the portion of interest-only loans not scheduled to reset for three or more years remained consistently high—reported as \"approximately 86%\" in the 2023 disclosure (page 93) and similarly noted for 2022 (page 94), indicating no significant structural evolution in the interest-only feature during this period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "SCHW_10k_2022.pdf",
          "target_page": 94,
          "pages": [
            92,
            93,
            94,
            95,
            96
          ]
        },
        "hop_2_rel": {
          "source_file": "SCHW_10k_2023.pdf",
          "target_page": 93,
          "pages": [
            91,
            92,
            93,
            94,
            95
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 53329,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 13576,
        "completion_tokens": 141,
        "total_tokens": 13717
      }
    },
    {
      "question_id": 124,
      "question": "How has Qualcomm's involvement in the XR market evolved from 2022 to 2023, based on their strategic investments and product revenue disclosures?",
      "original_answer": "In 2022, Qualcomm's involvement in XR was primarily through strategic investments made via Qualcomm Ventures, targeting early-stage companies in areas including XR to expand opportunities for their technologies. By 2023, this involvement evolved into direct revenue generation, as XR was explicitly listed among the industries and applications for which Qualcomm sold products, indicating a shift from investment to commercialization. This transition reflects a significant change in Qualcomm's engagement with XR, moving from supporting external innovation to deriving tangible revenue from XR-related product sales.",
      "llm_answer": "From fiscal 2022 through fiscal 2023 Qualcomm’s XR‑related activity shifted from a focus on early‑stage strategic investments (via Qualcomm Ventures) toward more tangible product revenue and licensing exposure.  In the 2022 filing the company highlighted its XR investments as part of a broader “IoT and emerging‑technology” portfolio, but by 2023 the segment‑revenue tables show a clear increase in XR‑related sales—handset‑related revenue rose to $24.9 B and automotive/IoT (including XR devices) grew to $5.4 B—while the company also disclosed a $1.5 B gain from the sale of Veoneer’s safety business, underscoring a strategic pivot from pure investment to commercializing XR‑enabled chips and licensing.  Consequently, Qualcomm’s involvement in the XR market evolved from speculative funding to a revenue‑generating component of its QCT segment, driven by both product sales and licensing of XR‑relevant patents.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "QCOM_10k_2022.pdf",
          "target_page": 14,
          "pages": [
            12,
            13,
            14,
            15,
            16
          ]
        },
        "hop_2_rel": {
          "source_file": "QCOM_10k_2023.pdf",
          "target_page": 73,
          "pages": [
            71,
            72,
            73,
            74,
            75
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 57165,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 14511,
        "completion_tokens": 229,
        "total_tokens": 14740
      }
    },
    {
      "question_id": 125,
      "question": "How has the aggregate principal balance of the 3.030% Notes Due 2052 evolved between 2022 and 2024, and what does this indicate about RTX's long-term debt structure?",
      "original_answer": "The aggregate principal balance of the 3.030% Notes Due 2052 remained stable at $1,100 million in both 2022 and 2024. This indicates that RTX has maintained its long-term commitment to this particular debt instrument without any repayments or additional issuances during this period. Despite overall changes in other long-term debt components, the 3.030% Notes Due 2052 remained unchanged, suggesting strategic consistency in managing this portion of its capital structure.",
      "llm_answer": "The aggregate principal balance of the 3.030% Notes Due 2052 remained unchanged at $1,100 million from 2022 through 2024, indicating that RTX has not increased or decreased this specific long‑term debt issuance over the period. This stability suggests that the company’s long‑term debt structure is being maintained without new issuances or retirements of this particular tranche, relying instead on other debt maturities and repayments to manage its overall leverage.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "RTX_10k_2022.pdf",
          "target_page": 93,
          "pages": [
            91,
            92,
            93,
            94,
            95
          ]
        },
        "hop_2_rel": {
          "source_file": "RTX_10k_2024.pdf",
          "target_page": 89,
          "pages": [
            87,
            88,
            89,
            90,
            91
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 43685,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 11146,
        "completion_tokens": 117,
        "total_tokens": 11263
      }
    },
    {
      "question_id": 125,
      "question": "How has AXP's focus on Corporate Card solutions evolved between 2023 and 2024, and what does this shift suggest about its broader commercial payments strategy?",
      "original_answer": "In 2023, AXP emphasized evolving its card value propositions and differentiating its corporate card and accounts payable expense management solutions as part of a broader push to strengthen its position in commercial payments. By 2024, while the focus on commercial payments remained, AXP shifted toward designing 'innovative products and features, including financing, banking and payment solutions for our business customers,' indicating a more integrated and solution-oriented approach. This evolution suggests that AXP is expanding beyond just product differentiation to embedding the Corporate Card into a wider suite of business financial services, aligning it more closely with holistic commercial needs.",
      "llm_answer": "AXP's corporate card and commercial payments focus has intensified between 2023 and 2024, with the 2024 10-K highlighting expanded investments in \"evolving our card value propositions, further differentiating our corporate card and accounts payable expense management solutions, and designing innovative products and features, including financing, banking and payment solutions for our business customers\" (p. 8, Business Strategies). This shift is reinforced by structural leadership changes, including the elevation of Anna Marrs to Group President of Global Merchant and Network Services (p. 10, Executive Officers) and the continued oversight of the Commercial Services division by leaders like Douglas Buckminster (Vice Chairman) and Ray Joabar (Group President, Global Commercial Services, p. 9). The emphasis on corporate solutions—evident in the expanded description of commercial payment offerings and partnerships—signals a strategic pivot toward monetizing higher-value business customer relationships, aligning with AXP's broader goal to \"build on our strong position in commercial payments\" (p. 8) and leverage its global network to capture more transaction volume from business clients. This focus complements its premium consumer strategy but underscores a deliberate acceleration in targeting enterprise-scale payment needs.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AXP_10k_2023.pdf",
          "target_page": 8,
          "pages": [
            6,
            7,
            8,
            9,
            10
          ]
        },
        "hop_2_rel": {
          "source_file": "AXP_10k_2024.pdf",
          "target_page": 8,
          "pages": [
            6,
            7,
            8,
            9,
            10
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 30883,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 7942,
        "completion_tokens": 335,
        "total_tokens": 8277
      }
    },
    {
      "question_id": 125,
      "question": "How has the strategic positioning of PCA SKIN within Colgate-Palmolive's Oral, Personal and Home Care segment evolved between 2023 and 2024, particularly in terms of its distribution channels?",
      "original_answer": "In 2023, PCA SKIN was listed among Colgate-Palmolive’s principal global and regional trademarks and was included in the broader category of products sold primarily to traditional and eCommerce retailers, wholesalers, distributors, and dentists. By 2024, PCA SKIN remained a listed principal trademark, but the filing specifically expanded the distribution channels to include sales to skin health professionals in some geographies. This indicates a refinement in positioning PCA SKIN within more specialized skincare distribution channels, though no change in production or brand status is indicated.",
      "llm_answer": "Between 2023 and 2024, PCA SKIN’s distribution shifted from being primarily sold through specialty skin‑health professionals and select retailers to a broader, direct‑to‑consumer and e‑commerce focus within the Oral, Personal and Home Care segment. This expansion leverages Colgate‑Palmolive’s global retail and online channels, increasing shelf and digital availability across both traditional and direct‑to‑consumer touchpoints.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CL_10k_2023.pdf",
          "target_page": 79,
          "pages": [
            77,
            78,
            79,
            80,
            81
          ]
        },
        "hop_2_rel": {
          "source_file": "CL_10k_2024.pdf",
          "target_page": 79,
          "pages": [
            77,
            78,
            79,
            80,
            81
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 48316,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 12310,
        "completion_tokens": 107,
        "total_tokens": 12418
      }
    },
    {
      "question_id": 125,
      "question": "How has the strategic focus and commercial positioning of Opdivo evolved between 2022 and 2023, particularly in terms of new tumor indications and combination therapies, and what implications does this have for its revenue growth trajectory?",
      "original_answer": "In 2022, Opdivo was approved for several anti-cancer indications including bladder, blood, CRC, head and neck, RCC, HCC, lung, melanoma, MPM, and stomach cancers, with the Opdivo + Yervoy regimen approved in multiple markets for NSCLC, melanoma, MPM, RCC, CRC, and gastric/esophageal cancers. It reported U.S. revenue growth driven by combinations in NSCLC, kidney cancer, and gastric/esophageal cancers. By 2023, Opdivo's strategic focus expanded into new tumor types and earlier lines of therapy, with an emphasis on broadening its use both as a monotherapy and in combination with Yervoy and other agents. The company also highlighted the potential of a subcutaneous formulation to enhance patient benefits and drive long-term adoption. This evolution indicates a strategic push to sustain revenue growth by diversifying indications and optimizing delivery mechanisms, despite increasing market competition.",
      "llm_answer": "Between 2022 and 2023, Opdivo’s strategic focus shifted toward expanding its tumor indication portfolio and advancing combination therapies. In 2023, the FDA approved Opdivo for adjuvant treatment of melanoma (including pediatric patients), EC approval was granted for Opdivo plus chemotherapy in neoadjuvant NSCLC, and Japan approved Opdivo plus chemotherapy for resectable NSCLC. Additionally, Opdivo’s combination with Yervoy and other agents (e.g., CABOMETYX in kidney cancer) was emphasized to drive adoption, alongside ongoing registrational studies in earlier therapy lines and new tumor types. This expansion aligns with the company’s broader oncology strategy to diversify beyond IO and accelerate pipeline growth.  \n\nThe implications for revenue growth are significant: while Opdivo’s U.S. revenues grew 7% in 2021 (driven by combination therapies and higher demand), its 2023 revenue trajectory faces headwinds from generic erosion of key products like Revlimid and Eliquis, as well as pricing pressures from U.S. healthcare reforms (e.g., IRA). However, Opdivo’s expanding indications and combination strategies are positioned to offset these declines, supporting sustained growth in its new product portfolio and contributing to overall revenue resilience despite a 2% consolidated revenue decline in 2023.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "BMY_10k_2022.pdf",
          "target_page": 71,
          "pages": [
            69,
            70,
            71,
            72,
            73
          ]
        },
        "hop_2_rel": {
          "source_file": "BMY_10k_2023.pdf",
          "target_page": 43,
          "pages": [
            41,
            42,
            43,
            44,
            45
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 9,
        "total_chars": 39524,
        "num_window_pages": 9,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 10125,
        "completion_tokens": 329,
        "total_tokens": 10455
      }
    },
    {
      "question_id": 126,
      "question": "How did American Express's investment in foreign government bonds and obligations evolve between 2023 and 2024 in terms of fair value and maturity distribution?",
      "original_answer": "In 2023, American Express held $549 million in foreign government bonds and obligations with all of it maturing in 12 months or more and a gross unrealized loss of $1 million. By 2024, the fair value of these investments increased significantly to $765 million, with $764 million maturing within one year and only $1 million maturing after one year but within five years. This indicates a substantial increase in exposure to foreign government bonds, primarily in short-term maturities.",
      "llm_answer": "Based on the provided pages, American Express's investment in foreign government bonds and obligations is detailed in Note 4 (Investment Securities) and related tables. As of December 31, 2024, the company held $765 million in cost and $765 million in estimated fair value for foreign government bonds and obligations, with no gross unrealized gains or losses reported. This represents a decrease from $770 million in cost and $770 million in fair value as of December 31, 2023. The securities are categorized under \"Foreign government bonds and obligations\" in the investment securities tables, with maturities distributed across various time horizons (e.g., due within 1 year, after 1 year but within 5 years, etc.), though specific maturity distribution details for 2024 are not explicitly detailed beyond the general categorization in Table 4.4. The fair value is primarily influenced by interest rate changes, as noted in the context of unrealized losses across the AFS portfolio. \n\n(Word count: 198)",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AXP_10k_2023.pdf",
          "target_page": 120,
          "pages": [
            118,
            119,
            120,
            121,
            122
          ]
        },
        "hop_2_rel": {
          "source_file": "AXP_10k_2024.pdf",
          "target_page": 126,
          "pages": [
            124,
            125,
            126,
            127,
            128
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 46390,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 11824,
        "completion_tokens": 251,
        "total_tokens": 12075
      }
    },
    {
      "question_id": 126,
      "question": "How has Walmart's use of intercompany financing arrangements evolved between 2022 and 2024, particularly regarding the amount of cash not freely transferable to the U.S. and the conditions under which such transfers occur?",
      "original_answer": "In 2022, Walmart reported $4.3 billion in cash and cash equivalents that may not be freely transferable to the U.S., with $2.2 billion of that amount subject to approval by Flipkart minority shareholders. By 2024, the amount of cash not freely transferable decreased slightly to $3.3 billion, and the language indicates that these transfers are now generally subject to approval from noncontrolling interest shareholders, rather than specifically tied to Flipkart. This reflects a slight reduction in the magnitude of restricted cash and a broader framing of the conditions under which such transfers occur, suggesting a shift in the structure or focus of intercompany financing arrangements.",
      "llm_answer": "Walmart's intercompany financing arrangements have evolved to increase the availability of cash in foreign markets, particularly in India (Flipkart) and other jurisdictions, while maintaining flexibility for repatriation. As of January 31, 2022, approximately $4.3 billion of cash held outside the U.S. was not freely transferable due to local restrictions, with $2.2 billion accessible only through dividends or intercompany financing requiring Flipkart minority shareholder approval. By fiscal 2024–2025, the company continued to rely on these arrangements to support global operations, with $3.3–3.5 billion of foreign cash still subject to similar restrictions, though no material impact on overall liquidity was anticipated. The company's ability to repatriate earnings remains largely unrestricted under current U.S. tax law, but local legal or regulatory barriers continue to govern the transferability of cash in specific jurisdictions.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "WMT_10k_2022.pdf",
          "target_page": 60,
          "pages": [
            58,
            59,
            60,
            61,
            62
          ]
        },
        "hop_2_rel": {
          "source_file": "WMT_10k_2024.pdf",
          "target_page": 43,
          "pages": [
            41,
            42,
            43,
            44,
            45
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 59965,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 15230,
        "completion_tokens": 236,
        "total_tokens": 15466
      }
    },
    {
      "question_id": 126,
      "question": "How did the composition of Texas Instruments' U.S. Retiree Health Care Plan assets evolve between the 2023 and 2024 filings, particularly in terms of fixed income securities and equity securities allocation?",
      "original_answer": "The composition of Texas Instruments' U.S. Retiree Health Care Plan assets remained completely unchanged between the 2023 and 2024 filings. In both years, the plan held $210 million in fixed income securities and cash equivalents, and $54 million in equity securities, resulting in a total of $264 million in plan assets. The fixed income allocation represented approximately 79.5% of the total plan assets, while equity securities represented approximately 20.5% in both years. The identical figures across both filings indicate no evolution in the asset allocation strategy for this plan during the reported period.",
      "llm_answer": "Based on the 2024 filing (page 46), the U.S. Retiree Health Care plan held $198 million in fixed‑income securities and cash equivalents and $50 million in equity securities, up from $210 million and $54 million respectively in the 2023 filing (page 45). This shift reflects a modest increase in the plan’s fixed‑income allocation and a corresponding reduction in equity exposure. The 2024 filing also shows the overall asset mix moving to 80 % fixed income and 20 % equity, compared with 80 % fixed income and 20 % equity in 2023, indicating a stable but slightly more weighted allocation toward fixed‑income securities.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "TXN_10k_2023.pdf",
          "target_page": 47,
          "pages": [
            45,
            46,
            47,
            48,
            49
          ]
        },
        "hop_2_rel": {
          "source_file": "TXN_10k_2024.pdf",
          "target_page": 47,
          "pages": [
            45,
            46,
            47,
            48,
            49
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 57207,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 14537,
        "completion_tokens": 155,
        "total_tokens": 14692
      }
    },
    {
      "question_id": 127,
      "question": "How did Honeywell's 2006 Stock Plan for Non-Employee Directors evolve between 2022 and 2024 in terms of the specific forms of award agreements offered, and what might this suggest about changes in the company's non-employee director compensation structure?",
      "original_answer": "In 2022, Honeywell's 10-K filing listed both the 'Form of Option Agreement' (Exhibit 10.30) and the 'Form of Restricted Unit Agreement' (Exhibit 10.32) as part of the 2006 Stock Plan for Non-Employee Directors. By 2024, while the 'Form of Option Agreement' was still referenced (Exhibit 10.29), the 'Form of Restricted Unit Agreement' was no longer explicitly mentioned in the exhibit list. This suggests a shift in the types of equity awards offered to non-employee directors, potentially signaling a strategic move toward emphasizing stock options over restricted units in director compensation.",
      "llm_answer": "Between 2022 and 2024 Honeywell’s non‑employee director compensation shifted from a mix of stock options and restricted‑stock‑unit awards under the 2006 Stock Plan for Non‑Employee Directors to a single form of award—restricted‑stock‑unit agreements—under the 2016 Stock Plan for Non‑Employee Directors (as reflected in Exhibits 10.52‑10.53 and the 2023 amendment in Exhibit 10.54). This change suggests Honeywell is consolidating director compensation into a simpler, performance‑oriented RSU structure, likely to align director equity incentives more closely with long‑term shareholder interests and reduce the administrative complexity of managing multiple award types.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "HON_10k_2022.pdf",
          "target_page": 126,
          "pages": [
            121,
            122,
            123,
            124,
            125
          ]
        },
        "hop_2_rel": {
          "source_file": "HON_10k_2024.pdf",
          "target_page": 123,
          "pages": [
            121,
            122,
            123,
            124,
            125
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 78056,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 19764,
        "completion_tokens": 168,
        "total_tokens": 19932
      }
    },
    {
      "question_id": 127,
      "question": "How did Walmart's strategic position regarding its ownership stake in Flipkart evolve between 2022 and 2024, particularly in terms of financial implications and potential exposure to regulatory risks?",
      "original_answer": "In 2022, Walmart received $3.2 billion in equity funding related to Flipkart, which reduced its ownership stake from 83% to 75%. This signaled a partial financial exit while maintaining majority control. By 2024, however, Walmart disclosed ongoing regulatory scrutiny in India, including a show cause notice issued in July 2021 and subsequent information requests related to alleged violations of India's Foreign Direct Investment rules during the period 2009–2015—prior to Walmart's acquisition of Flipkart in 2018. Despite the reduced ownership stake, Walmart remained exposed to potential regulatory consequences, including share ownership restrictions, and noted its inability to reasonably estimate potential losses or indemnification proceeds from prior shareholders. The evolution reflects a shift from active financial participation to managing legacy risks tied to Flipkart's pre-acquisition history.",
      "llm_answer": "Walmart's strategic position regarding its ownership stake in Flipkart evolved significantly between 2022 and 2024, with the company reducing its stake from approximately 83% to 75% through a $3.2 billion equity funding in fiscal 2022 (Note 3). This reduction occurred amid ongoing regulatory challenges in India, where Flipkart faces a foreign direct investment (FDI) investigation by India's Directorate of Enforcement regarding alleged violations of FDI rules from 2009–2015 (prior to Walmart's 2018 acquisition). The Notice from Indian authorities could lead to monetary penalties, share ownership restrictions, or other relief if violations are confirmed, though the Company cannot estimate potential losses or outcomes (Page 76). \n\nSimultaneously, Walmart's subsidiary Flipkart remains under scrutiny in India's antitrust case, with the Competition Commission of India (CCI) having issued a non-confidential investigation report alleging competition law violations, though no final order has been issued (Page 77). The Company maintains that it cannot predict the scope or outcome of these proceedings, which could materially affect its financial position or cash flows. While Walmart's stake reduction may have mitigated some exposure, the ongoing regulatory risks in India—particularly the FDI investigation and antitrust matter—represent persistent financial and operational uncertainties that could impact Walmart's investment in Flipkart.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "WMT_10k_2022.pdf",
          "target_page": 66,
          "pages": [
            64,
            65,
            66,
            67,
            68
          ]
        },
        "hop_2_rel": {
          "source_file": "WMT_10k_2024.pdf",
          "target_page": 76,
          "pages": [
            74,
            75,
            76,
            77,
            78
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 53902,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 13709,
        "completion_tokens": 362,
        "total_tokens": 14071
      }
    },
    {
      "question_id": 128,
      "question": "How did the composition and strategic emphasis of HON's U.S. cash balances evolve between 2022 and 2024, particularly in terms of total cash holdings and geographic distribution of funds?",
      "original_answer": "In 2022, HON reported holding $11.5 billion of cash and cash equivalents as of December 31, 2021, with an emphasis on safety of principal and diversification among counterparties. By 2024, the company held $11.0 billion in total cash and equivalents as of December 31, 2024, but specifically noted that $8.0 billion of that amount was held in non-U.S. subsidiaries. This represents a shift in geographic distribution, with a larger portion of liquidity positioned outside the U.S., while maintaining the same strategic emphasis on safety and diversification.",
      "llm_answer": "Between 2022 and 2024, Honeywell’s U.S. cash balances declined from $11.5 billion (2021) to $11.0 billion (2024), reflecting a shift in emphasis toward funding acquisitions, capital expenditures and shareholder returns rather than holding large cash reserves. The company’s liquidity strategy increasingly relies on operating cash flow, commercial‑paper issuance and long‑term debt to meet cash‑requirement needs, while maintaining only modest U.S. cash balances.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "HON_10k_2022.pdf",
          "target_page": 41,
          "pages": [
            39,
            40,
            41,
            42,
            43
          ]
        },
        "hop_2_rel": {
          "source_file": "HON_10k_2024.pdf",
          "target_page": 39,
          "pages": [
            37,
            38,
            39,
            40,
            41
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 42059,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 10745,
        "completion_tokens": 115,
        "total_tokens": 10861
      }
    },
    {
      "question_id": 128,
      "question": "How did the financial treatment and liability estimation methodology for the Membership Rewards program evolve from 2023 to 2024, particularly in terms of deferred fees and liability modeling assumptions?",
      "original_answer": "In 2023, the company recognized deferred fees related to Membership Rewards program participants, indicating a focus on the deferral aspect of fee revenue associated with the program. By 2024, the disclosures provided a much more detailed explanation of the liability estimation methodology, including the use of the Ultimate Redemption Rate (URR) and the weighted average cost (WAC) per point. The 2024 filing also quantified the sensitivity of the liability to changes in assumptions, noting that a 25 basis point increase in URR would raise the liability by $197 million, and a 1 basis point increase in WAC per point would increase it by $220 million. This reflects a shift from a simpler mention of deferred fees to a comprehensive, model-driven approach to estimating future redemption liabilities.",
      "llm_answer": "The Membership Rewards liability increased from $13,742 million in 2023 to $13,742 million in 2024 (reflecting the 2023 balance as the latest disclosed figure), and the methodology for estimating it remained anchored in the same key assumptions—weighted‑average cost per point (WAC) and Ultimate Redemption Rate (URR)—with the WAC derived from recent redemptions and adjusted for cost changes, and the URR estimated via statistical and actuarial models using redemption trends, card product, tenure, spend and credit attributes; the 2024 disclosures note that a 25‑basis‑point rise in URR would add roughly $197 million to the liability and a 1‑basis‑point rise in WAC would add about $220 million, indicating the same modeling approach was applied but with updated sensitivity figures.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AXP_10k_2023.pdf",
          "target_page": 128,
          "pages": [
            126,
            127,
            128,
            129,
            130
          ]
        },
        "hop_2_rel": {
          "source_file": "AXP_10k_2024.pdf",
          "target_page": 86,
          "pages": [
            84,
            85,
            86,
            87,
            88
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 45143,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 11522,
        "completion_tokens": 196,
        "total_tokens": 11718
      }
    },
    {
      "question_id": 128,
      "question": "How has Adobe's strategic positioning and integration of Frame.io evolved between 2022 and 2024, particularly in terms of its alignment with Adobe's broader product ecosystem?",
      "original_answer": "In 2022, Adobe described the integration of Frame.io as part of its Digital Media reportable segment, emphasizing its role as a cloud-based video collaboration platform acquired for $1.18 billion, with integration efforts just beginning. By 2024, Frame.io had transitioned from being a newly acquired integration to being positioned as a core component of Adobe's creative collaboration suite, directly integrated with key applications such as Adobe Premiere Pro, After Effects, Photoshop, and Workfront. Additionally, in 2024, Frame.io was included as part of Adobe GenStudio, indicating a deeper strategic alignment with Adobe's broader content production and collaboration ecosystem. This evolution reflects a shift from initial integration to full ecosystem incorporation.",
      "llm_answer": "Adobe's strategic positioning of Frame.io has evolved from a standalone acquisition in late 2021 to an integrated component of its Digital Media ecosystem, where it now serves as the cloud‑native collaboration backbone for video workflows and is tightly coupled with Creative Cloud applications such as Premiere Pro, After Effects and Photoshop. By embedding Frame.io’s real‑time review, frame‑accurate commenting and Camera‑to‑Cloud ingestion directly into these Creative Cloud tools—and by offering it within Adobe Express and Adobe Firefly Services—Adobe aligns Frame.io with its broader product strategy of unifying creative, document and experience clouds into a single, AI‑enhanced workflow platform that drives recurring revenue and strengthens the end‑to‑end creative process.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "ADBE_10k_2022.pdf",
          "target_page": 41,
          "pages": [
            39,
            40,
            41,
            42,
            43
          ]
        },
        "hop_2_rel": {
          "source_file": "ADBE_10k_2024.pdf",
          "target_page": 12,
          "pages": [
            10,
            11,
            12,
            13,
            14
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 9,
        "total_chars": 43210,
        "num_window_pages": 9,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 11030,
        "completion_tokens": 196,
        "total_tokens": 11226
      }
    },
    {
      "question_id": 129,
      "question": "How did the composition of private alternative investments, specifically equity-like funds, evolve between 2022 and 2023 in terms of fair value measurements using significant unobservable inputs (Level 3)?",
      "original_answer": "In 2022, equity-like funds under private alternative investments had a fair value of $5.5 million measured using significant unobservable inputs (Level 3). In 2023, this value increased significantly to $25.4 million. This indicates a fivefold increase in the portion of equity-like funds valued using Level 3 inputs, suggesting a shift toward more opaque or complex valuation methodologies for these investments.",
      "llm_answer": "Between 2022 and 2023, the fair value of private alternative investments classified as Level 3 (significant unobservable inputs) for equity‑like funds increased modestly, from $5.5 million (2022) to $25.1 million (2023) in the pension plan and from $0.5 million to $2.4 million in the retiree health plan, while the overall Level 3 balance remained relatively stable at about $25 million versus $15.4 million previously, indicating only limited growth in the use of unobservable inputs for those assets.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "LLY_10k_2022.pdf",
          "target_page": 99,
          "pages": [
            97,
            98,
            99,
            100,
            101
          ]
        },
        "hop_2_rel": {
          "source_file": "LLY_10k_2023.pdf",
          "target_page": 99,
          "pages": [
            97,
            98,
            99,
            100,
            101
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 65129,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 16518,
        "completion_tokens": 125,
        "total_tokens": 16644
      }
    },
    {
      "question_id": 130,
      "question": "How has Adobe's integration and positioning of Frame.io within its Digital Media offerings evolved between 2022 and 2024?",
      "original_answer": "In 2022, Adobe had just acquired Frame.io in October 2021 and was beginning to integrate it into the Digital Media segment as a cloud-based video collaboration platform. By 2024, Frame.io had become a core part of Adobe’s creative collaboration tools, being directly integrated with Adobe Premiere Pro, After Effects, Photoshop, Lightroom, and Workfront, and was also included in Adobe GenStudio for scalable content production. This reflects a strategic evolution from initial integration to deeper ecosystem embedding.",
      "llm_answer": "Adobe's integration of Frame.io evolved from a standalone creative‑collaboration platform to a core component of its Digital Media portfolio. In the 2022 filing, Frame.io was described as a “cloud‑native creative collaboration platform” that streamlines asset production and is directly integrated with Adobe Premiere Pro, After Effects, Photoshop, Lightroom and Workfront, and its Camera‑to‑Cloud feature enables automated upload of on‑set footage. By 2024, Adobe positioned Frame.io within its broader Digital Experience and Digital Media offerings, emphasizing its role in accelerating content creation workflows, supporting enterprise‑scale production through Adobe GenStudio, and complementing generative‑AI services such as Firefly. The acquisition, initially noted in fiscal 2021, is now presented as part of Adobe’s strategy to connect content creation with digital‑experience delivery, personalization, and optimization across channels.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "ADBE_10k_2022.pdf",
          "target_page": 42,
          "pages": [
            40,
            41,
            42,
            43,
            44
          ]
        },
        "hop_2_rel": {
          "source_file": "ADBE_10k_2024.pdf",
          "target_page": 12,
          "pages": [
            10,
            11,
            12,
            13,
            14
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 9,
        "total_chars": 43552,
        "num_window_pages": 9,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 11102,
        "completion_tokens": 236,
        "total_tokens": 11339
      }
    },
    {
      "question_id": 130,
      "question": "How has CVS's approach to Medication Management evolved between 2022 and 2024, particularly in terms of clinical programs and digital tools aimed at improving medication adherence and cost efficiency?",
      "original_answer": "In 2022, CVS emphasized formulary management through its National Pharmacy and Therapeutics Committee, promoting the use of generic drugs and offering real-time benefit information to guide members toward lower-cost alternatives. The company also operated mail order and specialty pharmacies, and provided clinical programs focused on medication adherence and utilization management, including an industry-leading approach to limit opioid prescriptions to seven-day supplies for acute cases. By 2024, CVS had expanded its Medication Management offerings with the introduction of digital tools like the NovoLogix preauthorization platform and enhanced analytics for identifying lower-cost drug alternatives. The company also launched the CVS Weight Management program, integrating GLP-1 medication optimization with lifestyle coaching, and expanded its value-based care initiatives through Oak Street Health, operating 239 primary care centers across 27 states to better manage chronic conditions and medication use. These developments reflect a shift from primarily cost-containment strategies to a more integrated, digitally enabled, and clinically proactive model of medication support.",
      "llm_answer": "Between 2022 and 2024, CVS Health expanded its medication adherence and cost-efficiency initiatives through integrated clinical programs and digital tools, particularly within its Health Services segment. The company enhanced its formulary management and utilization management strategies, including the use of the NovoLogix preauthorization tool to promote clinically appropriate use of specialty drugs and reduce costs. Digital connectivity was strengthened to provide patients with expanded visibility into lower-cost alternatives via enhanced analytics and data sharing. Additionally, CVS advanced its value-based care model through platforms like Canopy, which uses AI and machine learning to personalize care plans and improve outcomes, while expanding services like Signify Health’s in-home evaluations and Oak Street Health’s primary care centers to support chronic disease management and medication adherence. These efforts reflect a strategic evolution toward more personalized, data-driven, and cost-conscious medication management.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CVS_10k_2022.pdf",
          "target_page": 12,
          "pages": [
            10,
            11,
            12,
            13,
            14
          ]
        },
        "hop_2_rel": {
          "source_file": "CVS_10k_2024.pdf",
          "target_page": 11,
          "pages": [
            9,
            10,
            11,
            12,
            13
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 53306,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 13560,
        "completion_tokens": 260,
        "total_tokens": 13821
      }
    },
    {
      "question_id": 131,
      "question": "How has Adobe's integration and positioning of Frame.io within its Creative Cloud ecosystem evolved from 2022 to 2024, and what specific enhancements were made to its collaboration features during this period?",
      "original_answer": "In 2022, Adobe acquired Frame.io and began integrating its cloud-based video collaboration platform into Adobe Creative Cloud, with initial enhancements focused on deeper integration into Premiere Pro and After Effects to deliver native collaborative workflows for video editing. By 2024, Frame.io had evolved into a more comprehensive cloud-native creative collaboration platform, offering real-time upload, review, and approval features not only for video but also for still images, design files, and PDFs. It expanded its integration across Adobe Photoshop, Lightroom, and Workfront, and introduced Camera to Cloud functionality, enabling automatic upload of footage directly into Frame.io from cameras on set. These enhancements reflect a strategic shift from a video-specific collaboration tool to a broader creative asset production and review platform within Adobe’s ecosystem.",
      "llm_answer": "From 2022 to 2024, Adobe has progressively deepened Frame.io’s integration within Creative Cloud, positioning it as a core collaborative hub across video, design, and marketing workflows. Key enhancements include tighter native integration with Premiere Pro, After Effects, Photoshop, and Lightroom for frame-accurate commenting and approvals, expanded Camera to Cloud functionality for direct on-set uploads, and broader availability within Adobe Express and Firefly-powered workflows. These improvements have streamlined end-to-end content production, enabling real-time collaboration, automated asset management, and seamless handoffs across creative teams—solidifying Frame.io’s role in Adobe’s vision for unified, AI-enhanced creative collaboration.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "ADBE_10k_2022.pdf",
          "target_page": 6,
          "pages": [
            4,
            5,
            6,
            7,
            8
          ]
        },
        "hop_2_rel": {
          "source_file": "ADBE_10k_2024.pdf",
          "target_page": 12,
          "pages": [
            10,
            11,
            12,
            13,
            14
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 9,
        "total_chars": 48218,
        "num_window_pages": 9,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 12290,
        "completion_tokens": 188,
        "total_tokens": 12478
      }
    },
    {
      "question_id": 132,
      "question": "How has the use of recently executed transactions in the valuation of loans and other assets evolved from 2023 to 2024, particularly in terms of their role in fair value determination?",
      "original_answer": "In 2023, recently executed transactions were a key input for determining the fair value of corporate loans and contingent lending commitments, often used alongside market price quotations, implied yields, and proprietary valuation models. By 2024, the role of recently executed transactions remained significant but was more specifically tied to the held-for-sale category of loans and lending commitments, and also extended to the valuation of other assets such as other investments, where they were used in conjunction with discounted cash flow models and comparable company multiples. This reflects a more targeted application of transaction data in valuation practices.",
      "llm_answer": "The use of recently executed transactions in fair‑value measurement has shifted from a primary Level 1 input toward a Level 2 approach. In 2023 the tables listed “recently executed transactions” as a direct source for Level 1 valuations of securities such as U.S. Treasury and agency issues, but by 2024 those same transactions are described as “comparable‑transaction” inputs that feed observable market data used in Level 2 classifications (e.g., benchmarking to comparable bonds or loans when quoted prices are unavailable). Consequently, the role of recent trades has moved from being quoted market prices that define fair value outright to being a supporting observable input that informs valuations classified at a higher level of the hierarchy.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MS_10k_2023.pdf",
          "target_page": 99,
          "pages": [
            97,
            98,
            99,
            100,
            101
          ]
        },
        "hop_2_rel": {
          "source_file": "MS_10k_2024.pdf",
          "target_page": 103,
          "pages": [
            101,
            102,
            103,
            104,
            105
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 109543,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 27617,
        "completion_tokens": 187,
        "total_tokens": 27804
      }
    },
    {
      "question_id": 132,
      "question": "How has Adobe's approach to the Substance 3D Stager product evolved between 2022 and 2024, particularly in terms of its positioning within the broader Substance 3D ecosystem?",
      "original_answer": "In 2022, Substance 3D Stager was listed among Adobe's trademarks, indicating it was an established product within the company's portfolio but without detailed information about its functionality or strategic positioning. By 2024, Adobe introduced a more comprehensive view of Substance 3D as an ecosystem, where Stager is specifically described as a tool for building and assembling 3D scenes. This evolution reflects a strategic shift from simply offering the product to integrating it into a broader suite of 3D tools, including Painter, Sampler, Designer, and Modeler, emphasizing its role in enabling end-to-end 3D content creation workflows.",
      "llm_answer": "Adobe's Substance 3D Stager has evolved from a standalone desktop tool into a tightly integrated component of the broader Substance 3D ecosystem, now bundled with Substance 3D Painter, Sampler, Designer and Modeler and offered as part of the Adobe Substance 3D Collection subscription. The product is positioned as the central hub for assembling and previewing 3D scenes, with seamless connectivity to Adobe Firefly’s generative AI services and Adobe Express for scalable content creation, reinforcing its role as the entry point for end‑to‑end 3D workflows within Adobe’s Creative Cloud suite.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "ADBE_10k_2022.pdf",
          "target_page": 105,
          "pages": [
            95,
            96,
            97,
            98,
            99
          ]
        },
        "hop_2_rel": {
          "source_file": "ADBE_10k_2024.pdf",
          "target_page": 12,
          "pages": [
            10,
            11,
            12,
            13,
            14
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 9,
        "total_chars": 38910,
        "num_window_pages": 9,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 9955,
        "completion_tokens": 148,
        "total_tokens": 10104
      }
    },
    {
      "question_id": 133,
      "question": "How did GE's strategic positioning regarding grid-scale batteries evolve from 2022 to 2023, particularly in terms of their role in the company's energy transition strategy and level of strategic reliance?",
      "original_answer": "In 2022, GE mentioned grid-scale batteries as part of a broader set of emerging technologies that 'may become more important over time' in achieving deep decarbonization goals, indicating GE was considering them as a potential future investment. By 2023, GE explicitly listed grid-scale batteries as one of the key technologies 'that may become more important over time' and integrated them into the company’s strategic narrative as a dependency, noting that achieving decarbonization goals would 'depend in part' on such technologies. This reflects a shift from viewing grid-scale batteries as a speculative investment to a more central component of GE's energy transition strategy.",
      "llm_answer": "From 2022 to 2023, GE’s strategic positioning on grid‑scale batteries shifted from a peripheral, risk‑aware mention in its 2022 outlook to a more explicit, forward‑looking component of its energy‑transition narrative in the 2023 filing. While both years stress that deep decarbonization will depend on emerging storage technologies—including grid‑scale batteries—2023 expands the discussion to highlight the need for significant investment, policy incentives, and the uncertainty around timing and commercial viability, signaling a higher strategic reliance on such technologies as a core pillar of GE’s future growth.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "GE_10k_2022.pdf",
          "target_page": 64,
          "pages": [
            62,
            63,
            64,
            65,
            66
          ]
        },
        "hop_2_rel": {
          "source_file": "GE_10k_2023.pdf",
          "target_page": 29,
          "pages": [
            27,
            28,
            29,
            30,
            31
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 9,
        "total_chars": 73035,
        "num_window_pages": 9,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 18493,
        "completion_tokens": 154,
        "total_tokens": 18647
      }
    },
    {
      "question_id": 133,
      "question": "How has CVS's disclosure regarding the use of broker quoted debt securities in its fair value measurements evolved between 2022 and 2024, particularly in terms of its presence or impact on financial reporting?",
      "original_answer": "In 2022, CVS explicitly stated that it did not have any broker quoted debt securities for the years ended December 31, 2021, and 2020, and that it only used internal pricing for certain private placements. By 2024, the company continued to disclose that it had no broker quoted debt securities for the years ended December 31, 2024 and 2023, indicating a consistent absence of such securities in its portfolio. However, the 2024 disclosure no longer mentions any negative impact or specific review process related to broker quoted debt securities, suggesting a reduced emphasis or relevance of this topic in the company's fair value measurement disclosures over time.",
      "llm_answer": "CVS Health's disclosure regarding the use of broker-quoted debt securities in fair value measurements has remained consistent between 2022 and 2024, with no broker-quoted securities reported in Level 3 valuations during these years. The company continues to rely on internal pricing models and observable market data (Level 2 inputs) for most debt securities, with Level 3 assets now primarily consisting of private placement securities priced using internal analyses or broker quotes without active market pricing, though no specific broker-quoted securities were identified in the 2024 or 2023 filings. This approach has maintained stability in its fair value hierarchy classification, with Level 3 assets showing minimal net transfers out of the category in recent years.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CVS_10k_2022.pdf",
          "target_page": 148,
          "pages": [
            146,
            147,
            148,
            149,
            150
          ]
        },
        "hop_2_rel": {
          "source_file": "CVS_10k_2024.pdf",
          "target_page": 146,
          "pages": [
            144,
            145,
            146,
            147,
            148
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 48100,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 12263,
        "completion_tokens": 193,
        "total_tokens": 12457
      }
    },
    {
      "question_id": 134,
      "question": "How did the composition of BlackRock's Equity Securities at FVTNI change between 2023 and 2024, particularly in terms of equity securities/mutual funds and equity method investments?",
      "original_answer": "In 2023, BlackRock reported $1,211 million in equity securities/mutual funds under Equity Securities at FVTNI, while equity method investments totaled $1,895 million. By 2024, the value of equity securities/mutual funds increased to $1,950 million, and equity method investments rose to $2,783 million. This reflects a significant increase in both categories, indicating a strategic expansion in these investment areas.",
      "llm_answer": "Between 2023 and 2024, BlackRock's equity securities at FVTNI increased from $1,059 million to $1,179 million, reflecting higher holdings in equity securities/mutual funds and related investments, while equity method investments rose from $2,510 million to $2,330 million in the consolidated VIE/VRE exposure table. The net interest in these consolidated VIEs also grew, with BlackRock's net interest increasing from $1,479 million (2023) to $1,460 million (2024) in the VIE column and from $716 million to $512 million in the VRE column, indicating a shift toward greater exposure through VIEs rather than VREs. Overall, the composition moved toward larger stakes in equity securities/mutual funds and a relative reduction in equity method investments compared with the prior year.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "BLK_10k_2023.pdf",
          "target_page": 88,
          "pages": [
            86,
            87,
            88,
            89,
            90
          ]
        },
        "hop_2_rel": {
          "source_file": "BLK_10k_2024.pdf",
          "target_page": 94,
          "pages": [
            92,
            93,
            94,
            95,
            96
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 97613,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 24632,
        "completion_tokens": 195,
        "total_tokens": 24828
      }
    },
    {
      "question_id": 134,
      "question": "How did UnitedHealth Group's evaluation and treatment of credit-related impairments for available-for-sale debt securities evolve from 2022 to 2024, particularly in terms of unrealized losses and the allowance for credit losses?",
      "original_answer": "In 2022, UnitedHealth Group reported that unrealized losses in its available-for-sale debt securities were primarily driven by interest rate increases and not credit deterioration, with no significant credit deterioration observed since purchase. The allowance for credit losses was noted to be not material as of December 31, 2021. By 2024, the company's evaluation methodology remained consistent in terms of assessing present value of expected cash flows, issuer credit condition, and fair value relative to amortized cost. However, the allowance for credit losses is now explicitly described as being recorded as a separate component through an allowance account, with credit-related impairments impacting investment and other income, indicating a more structured recognition of credit risk. This evolution shows a shift from a qualitative, low-risk assessment to a more formalized impairment accounting framework.",
      "llm_answer": "UnitedHealth Group's evaluation of credit-related impairments for available-for-sale debt securities remained consistent from 2022 to 2024, with no material allowance for credit losses recorded in any period. The company continued to assess securities for impairment based on fair value declines below amortized cost, credit quality of issuers, and intent to sell, concluding that unrealized losses were primarily driven by interest rate changes rather than credit deterioration. As of December 31, 2024, the allowance for credit losses on available-for-sale debt securities was still not material, reflecting no significant change in approach or material impairment recognition over the three-year period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "UNH_10k_2022.pdf",
          "target_page": 57,
          "pages": [
            55,
            56,
            57,
            58,
            59
          ]
        },
        "hop_2_rel": {
          "source_file": "UNH_10k_2024.pdf",
          "target_page": 49,
          "pages": [
            47,
            48,
            49,
            50,
            51
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 54066,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 13757,
        "completion_tokens": 176,
        "total_tokens": 13934
      }
    },
    {
      "question_id": 135,
      "question": "How has AMD's financial relationship with the ATMP JV evolved between 2022 and 2023, particularly in terms of investment value and equity income?",
      "original_answer": "In 2022, AMD's carrying value of its investment in the ATMP JV was $83 million, and it recorded $14 million in equity income from the JV. By 2023, the carrying value increased to $99 million, and equity income rose to $16 million. This indicates a growing financial stake and increased profitability from the joint venture over the two-year period.",
      "llm_answer": "Based on the provided SEC 10-K filings, AMD's financial relationship with the ATMP JV evolved significantly between 2022 and 2023 in terms of investment value and equity income. The Company's equity investment in the ATMP JV increased from $69 million as of December 25, 2021 (reported in 2022 filing) to $99 million as of December 30, 2023 (reported in 2023 filing), reflecting growth in the investment value. Additionally, equity income recognized from the ATMP JV rose from $6 million in 2020 to $16 million in 2023, with the 2023 filing specifically noting $16 million in gains for fiscal year 2023 (compared to $14 million in 2022 and $6 million in 2021), demonstrating a clear upward trend in equity income from this relationship.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AMD_10k_2022.pdf",
          "target_page": 64,
          "pages": [
            62,
            63,
            64,
            65,
            66
          ]
        },
        "hop_2_rel": {
          "source_file": "AMD_10k_2023.pdf",
          "target_page": 78,
          "pages": [
            76,
            77,
            78,
            79,
            80
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 45376,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 11564,
        "completion_tokens": 184,
        "total_tokens": 11748
      }
    },
    {
      "question_id": 135,
      "question": "How has UnitedHealth Group's exposure to tort claims evolved between 2022 and 2024, particularly in terms of the nature of the claims and the potential financial impact?",
      "original_answer": "In 2022, UnitedHealth Group specifically highlighted self-insured liabilities related to medical malpractice claims against affiliated physicians and the potential for actual losses to significantly exceed recorded liabilities. The document emphasized increasing legal actions alleging medical malpractice and general professional liabilities, with litigants seeking recoveries under new theories of liability that might not be subject to damage caps. By 2024, while tort claims remained a concern, the focus shifted slightly to broader legal risks tied to the delivery of health care services, including claims related to clinical quality and patient safety standards. The 2024 filing also emphasized the potential for reputational harm and adverse effects on business relationships, indicating a broader and more systemic risk profile compared to the more narrowly defined exposure in 2022.",
      "llm_answer": "Between 2022 and 2024, UnitedHealth Group’s exposure to tort claims remained significant, particularly through its affiliated physicians and health‑care provider networks, where medical‑malpractice and related liability claims continue to be self‑insured and can generate losses that exceed recorded reserves. The company also faces ongoing litigation involving out‑of‑network provider payment disputes, antitrust investigations, and whistleblower actions, all of which could result in monetary damages, regulatory penalties, or adverse publicity that materially affect its financial position. While the nature of the claims has not fundamentally changed, the volume of data‑driven services and the complexity of integrated health‑care operations have increased the potential financial impact of these tort and related legal exposures.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "UNH_10k_2022.pdf",
          "target_page": 20,
          "pages": [
            18,
            19,
            20,
            21,
            22
          ]
        },
        "hop_2_rel": {
          "source_file": "UNH_10k_2024.pdf",
          "target_page": 15,
          "pages": [
            13,
            14,
            15,
            16,
            17
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 9,
        "total_chars": 56829,
        "num_window_pages": 9,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 14433,
        "completion_tokens": 208,
        "total_tokens": 14642
      }
    },
    {
      "question_id": 136,
      "question": "How has the structure and capacity of Boeing's three-year revolving credit agreement evolved between 2023 and 2024, and what does this indicate about the company's liquidity strategy?",
      "original_answer": "In 2023, Boeing had a legacy three-year revolving credit agreement expiring in August 2025 with $3.0 billion of total commitments. In 2024, this agreement remained in effect, but Boeing also entered into a new $4.0 billion five-year revolving credit agreement expiring in May 2029 while terminating two other credit facilities. This evolution indicates a strategic shift to enhance liquidity capacity and extend maturity timelines, reinforcing Boeing's financial flexibility and commitment to managing corporate borrowing needs.",
      "llm_answer": "Between 2023 and 2024, Boeing’s revolving credit capacity evolved from a $3.0 billion three‑year facility and a $3.2 billion five‑year facility (both expiring in 2024) plus a $0.8 billion 364‑day line that expired in August 2024, to a new $4.0 billion five‑year revolving credit agreement (maturing May 2029) and the continued existence of the $3.0 billion three‑year line (now maturing August 2025) and the $3.0 billion five‑year line (maturing August 2028). This shift increased total available borrowing to $10 billion and extended the longest maturity to 2029, indicating a strategy to bolster liquidity, preserve cash for operations and large financing commitments, and maintain flexibility amid ongoing cash‑flow volatility.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "BA_10k_2023.pdf",
          "target_page": 43,
          "pages": [
            41,
            42,
            43,
            44,
            45
          ]
        },
        "hop_2_rel": {
          "source_file": "BA_10k_2024.pdf",
          "target_page": 94,
          "pages": [
            92,
            93,
            94,
            95,
            96
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 36750,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 9416,
        "completion_tokens": 182,
        "total_tokens": 9599
      }
    },
    {
      "question_id": 136,
      "question": "How did the financial impact of the 2017 Performance-based Options evolve between 2023 and 2024, particularly in terms of the fair value of options vested and the intrinsic value of options exercised?",
      "original_answer": "In 2023, the fair value of the 2017 Performance-based Options that vested was $56 million, and the intrinsic value of options exercised was $44 million. By 2024, the fair value of the options vested decreased slightly to $52 million, but the intrinsic value of options exercised saw a significant increase to $373 million. This indicates that while the value of options vesting declined slightly in 2024, the actual financial benefit realized from exercised options increased substantially compared to the prior year.",
      "llm_answer": "Based on the provided SEC 10‑K excerpts, the 2017 performance‑based options that were outstanding at the end of 2023 were fully exercised during 2024, generating an intrinsic value of **$373 million** on the date of exercise.  The fair‑value of the options that vested in 2024 was **$52 million**.  Consequently, the financial impact of the 2017 performance‑based options declined from a $52 million fair‑value of vested options in 2023 to $373 million of intrinsic value realized upon exercise in 2024, with no remaining outstanding performance‑based options after year‑end 2024.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "BLK_10k_2023.pdf",
          "target_page": 101,
          "pages": [
            99,
            100,
            101,
            102,
            103
          ]
        },
        "hop_2_rel": {
          "source_file": "BLK_10k_2024.pdf",
          "target_page": 109,
          "pages": [
            107,
            108,
            109,
            110,
            111
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 89842,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 22696,
        "completion_tokens": 145,
        "total_tokens": 22841
      }
    },
    {
      "question_id": 136,
      "question": "How did AMD's approach to estimating adjustments for product return rights evolve between 2022 and 2023, and what specific changes were made in the methodology used for these estimates?",
      "original_answer": "In 2022, AMD estimated adjustments for product return rights using trended actual historical product return rate information, adjusted for known information or events. By 2023, AMD maintained the use of historical data but placed additional emphasis on 'rights of return and rebates' as part of variable consideration under ASC 606-10-32-8 through 14, explicitly stating that these estimates were based on the 'most likely amount' of consideration expected after adjustments for returns, rebates, and price protection. This reflects a more structured and codified approach to estimating returns, aligning more closely with specific accounting standards.",
      "llm_answer": "Between 2022 and 2023, AMD refined its methodology for estimating adjustments to revenue related to product return rights and variable consideration. In 2022, the company used trended historical return rates adjusted for known events to estimate returns for OEMs and distributors. By 2023, it continued this approach but emphasized the use of \"relevant, trended actual historical product return rate information\" adjusted for current conditions, while maintaining that these estimates had been \"materially consistent with actual results.\" The core methodology remained stable, but the 2023 disclosures highlighted more explicit reliance on recent historical data and market analysis to inform adjustments for returns, rebates, and price protection, particularly for distributor incentives and OEM programs. No fundamental change in the estimation technique occurred—only incremental refinement in data utilization.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AMD_10k_2022.pdf",
          "target_page": 45,
          "pages": [
            43,
            44,
            45,
            46,
            47
          ]
        },
        "hop_2_rel": {
          "source_file": "AMD_10k_2023.pdf",
          "target_page": 49,
          "pages": [
            47,
            48,
            49,
            50,
            51
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 49125,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 12511,
        "completion_tokens": 228,
        "total_tokens": 12740
      }
    },
    {
      "question_id": 137,
      "question": "How did the number of shares under option for the 2017 Performance-based Options evolve from 2023 to 2024, and what does this indicate about the exercise and forfeiture trends of these options?",
      "original_answer": "The number of shares under option for the 2017 Performance-based Options decreased significantly from 1,549,080 shares at the end of 2023 to 625,825 shares at the end of 2024. This indicates that a large portion of these options were exercised (905,219 shares) and some were forfeited (18,036 shares) during 2024, showing a trend of completion in the lifecycle of these options as they approached their final vesting date.",
      "llm_answer": "The 2017 Performance‑based Options declined from **1,549,080 shares outstanding at 12/31/23 to 625,825 shares outstanding at 12/31/24** (a loss of roughly 923,255 shares). This reduction reflects both **exercises of 905,219 options during 2024** and **forfeitures of 18,036 shares**, indicating that a substantial portion of the original performance‑based grants were either exercised or cancelled rather than continuing to remain outstanding. Consequently, the downward trend signals that many of the performance‑based awards reached the end of their vesting/ exercise horizon and were either realized or lost through employee departure before full vesting.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "BLK_10k_2023.pdf",
          "target_page": 101,
          "pages": [
            99,
            100,
            101,
            102,
            103
          ]
        },
        "hop_2_rel": {
          "source_file": "BLK_10k_2024.pdf",
          "target_page": 108,
          "pages": [
            106,
            107,
            108,
            109,
            110
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 86033,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 21742,
        "completion_tokens": 164,
        "total_tokens": 21907
      }
    },
    {
      "question_id": 137,
      "question": "How has the role and scope of Optum Rx's Pharmacy Care Services evolved between 2022 and 2024, particularly in terms of its service offerings and strategic positioning within UnitedHealth Group's broader health care ecosystem?",
      "original_answer": "In 2022, Optum Rx was described as managing $112 billion in pharmaceutical spending, including $45 billion in specialty pharmaceutical spending, and was positioned as a provider of pharmacy care services through a network of over 67,000 retail pharmacies, home delivery, specialty pharmacies, and infusion services. It emphasized clinical programs, digital tools, and medication management to help clients reduce costs and improve health outcomes. By 2024, Optum Rx was more strategically integrated into Optum’s broader vision of creating a 'value-oriented and more connected approach to health care,' with an emphasis on leveraging 'data and analytics, pharmacy care services, health care operations, population health and health financial services' to improve the overall health system performance. While specific spending figures were not provided in 2024, the service was elevated as a core component of Optum’s mission to enhance affordability, quality, and patient experience across the health care continuum.",
      "llm_answer": "Between 2022 and 2024, Optum Rx's Pharmacy Care Services expanded its role within UnitedHealth Group's ecosystem by deepening integration with medical and behavioral care, scaling specialty and home-delivery capabilities, and embedding pharmacists into broader care teams. Strategically, it evolved from a standalone pharmacy benefits manager into a core engine for cost management and outcomes improvement across UnitedHealthcare's Medicare Advantage, Employer & Individual, and Optum Health segments, reinforcing the company's value-based care and holistic health model. This expansion was underscored by Optum Rx managing $178 billion in pharmaceutical spending in 2024, including $74 billion in specialty drugs, and serving as a critical link in coordinating medical, pharmacy, and behavioral care.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "UNH_10k_2022.pdf",
          "target_page": 6,
          "pages": [
            4,
            5,
            6,
            7,
            8
          ]
        },
        "hop_2_rel": {
          "source_file": "UNH_10k_2024.pdf",
          "target_page": 3,
          "pages": [
            1,
            2,
            3,
            4,
            5
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 50532,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 12871,
        "completion_tokens": 200,
        "total_tokens": 13071
      }
    },
    {
      "question_id": 138,
      "question": "How did the composition and valuation of BlackRock's Equity Securities at FVTNI change between 2023 and 2024, particularly in terms of investments held for deferred cash compensation plans?",
      "original_answer": "In 2023, BlackRock reported $9 million invested in Equity Securities at FVTNI as part of the investments held to economically hedge deferred cash compensation plans. By 2024, this specific category was no longer listed under Equity Securities at FVTNI but instead appeared under 'Investments related to deferred cash compensation plans' within the Equity Method section with a value of $173 million. This indicates a reclassification or realignment of how these investments were categorized and reported in the financial statements, reflecting a significant change in the composition of Equity Securities at FVTNI.",
      "llm_answer": "Based on the provided SEC 10-K pages, BlackRock's Equity Securities at FVTNI (Fair Value Through Net Income) held for deferred cash compensation plans decreased slightly from $241 million at December 31 2023 to $173 million at December 31 2024, as reflected in the “Investments related to deferred cash compensation plans” line item within the equity‑method investments section of the fair‑value hierarchy tables. This reduction indicates a modest decline in the fair‑value measurement of those deferred‑compensation investments over the one‑year period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "BLK_10k_2023.pdf",
          "target_page": 85,
          "pages": [
            83,
            84,
            85,
            86,
            87
          ]
        },
        "hop_2_rel": {
          "source_file": "BLK_10k_2024.pdf",
          "target_page": 94,
          "pages": [
            92,
            93,
            94,
            95,
            96
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 87301,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 22056,
        "completion_tokens": 138,
        "total_tokens": 22195
      }
    },
    {
      "question_id": 138,
      "question": "How has the aggregate available authorization for Accenture's open-market share purchase program changed between 2022 and 2024, and what does this indicate about the company's capital allocation strategy?",
      "original_answer": "The aggregate available authorization for Accenture's open-market share purchase program decreased from $3,129,296 in 2022 to $2,694,281 in 2024. This indicates a reduction in the company's capital allocated for share repurchases over this period, suggesting a more conservative approach to capital deployment or a strategic shift in how the company is managing its equity structure.",
      "llm_answer": "Between fiscal 2022 and fiscal 2024 Accenture’s publicly announced open‑market share‑purchase authorization grew from roughly **$3.13 billion** (as of August 31 2022) to **$6.69 billion** (as of September 25 2024). This expansion reflects the company’s intent to increase capital flexibility, signaling a strategy of using share repurchases to deploy excess cash, support the stock price, and offset dilution from employee equity programs.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "ACN_10k_2022.pdf",
          "target_page": 93,
          "pages": [
            91,
            92,
            93,
            94,
            95
          ]
        },
        "hop_2_rel": {
          "source_file": "ACN_10k_2024.pdf",
          "target_page": 100,
          "pages": [
            98,
            99,
            100,
            101,
            102
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 40798,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 10435,
        "completion_tokens": 109,
        "total_tokens": 10545
      }
    },
    {
      "question_id": 139,
      "question": "How has the treatment and disclosure around Accenture Canada Holdings Inc. Exchangeable Shares evolved between 2022 and 2024, particularly in terms of share repurchase activity and shareholder rights?",
      "original_answer": "In 2022, Accenture disclosed its intention to use a significant portion of cash generated from operations for share repurchases during fiscal 2023, including purchases and redemptions of Accenture Canada Holdings Inc. exchangeable shares. The company noted that the number of shares repurchased would depend on various factors such as share price and market conditions. By 2024, the disclosures had evolved to include more detailed descriptions of the rights associated with Accenture Canada Holdings Inc. exchangeable shares, particularly their exchangeability on a one-for-one basis for Accenture plc Class A ordinary shares, and the company's commitment to align the number of Class X ordinary shares with outstanding exchangeable shares. Additionally, as of August 31, 2024, the company had a specific remaining authorization of $2,694,281 for share repurchase programs, indicating a more structured and quantified approach compared to the more general intentions expressed in 2022.",
      "llm_answer": "Between 2022 and 2024, Accenture’s treatment and disclosure of Accenture Canada Holdings Inc. Exchangeable Shares shifted from describing them primarily as a redemption mechanism tied to Class X ordinary shares in 2022 (with a note that redemption would not reduce the holder’s exchangeable share count below its current level) to a more detailed equity‑share‑holder perspective in 2024 that emphasizes the exchange ratio (one‑for‑one), the option to settle exchanges in cash, and the fact that these shares receive the same dividend entitlements as Class A ordinary shares.  \n\nThe company’s share‑repurchase activity also evolved: in 2022 it disclosed a broad open‑market program for Class A shares and mentioned that purchases of exchangeable shares could be made “by other means,” but it did not quantify any specific exchange‑share repurchases. By 2024, the 10‑K provides a detailed table of share‑purchase activity that explicitly separates Accenture plc Class A ordinary‑share purchases from Accenture Canada Holdings Inc. exchangeable‑share purchases, showing 47,752 exchangeable shares repurchased for $15,254 and a total of $4.5 billion spent on all share‑ purchase activity. This granular disclosure reflects a more transparent, program‑level approach to managing both ordinary‑share and exchangeable‑share redemptions.  \n\nFinally, shareholder rights associated with the exchangeable shares remained consistent—holders can exchange them for Class A ordinary shares on a one‑for‑one basis and receive dividend equivalents—but the 2024 filing clarifies that these shares are now treated as part of the company’s publicly announced share‑ purchase authorizations, with an additional $4 billion of repurchase authority approved in September 2024, underscoring a stronger commitment to returning capital to shareholders through both ordinary‑share and exchangeable‑share repurchases.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "ACN_10k_2022.pdf",
          "target_page": 43,
          "pages": [
            41,
            42,
            43,
            44,
            45
          ]
        },
        "hop_2_rel": {
          "source_file": "ACN_10k_2024.pdf",
          "target_page": 100,
          "pages": [
            98,
            99,
            100,
            101,
            102
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 39486,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 10106,
        "completion_tokens": 472,
        "total_tokens": 10578
      }
    },
    {
      "question_id": 139,
      "question": "How did the global revenue from Electrophysiology Devices evolve between 2023 and 2024, and what was the percentage change in this revenue, excluding the impact of foreign exchange fluctuations?",
      "original_answer": "In 2023, the global revenue from Electrophysiology Devices was $2,195 million, which increased to $2,467 million in 2024. This represents a total change of 12.3%, with the change excluding the impact of foreign exchange fluctuations being 14.4%.",
      "llm_answer": "Based on the provided financial data, the global revenue from Electrophysiology Devices increased by 12.4% in 2024 compared to 2023, and by 14.1% in 2023 compared to 2022. Excluding the impact of foreign exchange fluctuations, the percentage change in revenue for Electrophysiology Devices was 14.4% in 2024 (compared to 15.9% in 2023), reflecting growth driven by higher procedure volumes and increased demand for catheters and cardiac mapping products.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "ABT_10k_2023.pdf",
          "target_page": 53,
          "pages": [
            51,
            52,
            53,
            54,
            55
          ]
        },
        "hop_2_rel": {
          "source_file": "ABT_10k_2024.pdf",
          "target_page": 29,
          "pages": [
            27,
            28,
            29,
            30,
            31
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 47386,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 12079,
        "completion_tokens": 113,
        "total_tokens": 12192
      }
    },
    {
      "question_id": 140,
      "question": "How has Accenture's financial relationship with Duck Creek Technologies evolved between fiscal 2022 and fiscal 2024, particularly in terms of investment valuation and its impact on financial performance?",
      "original_answer": "In fiscal 2022, Accenture's investment in Duck Creek Technologies was valued at $223,166 (approximately 16% ownership), with the investment accounted for under the equity method. By fiscal 2024, this investment resulted in a $253 million gain, indicating a significant increase in value and a shift in how the investment contributed to Accenture's financial performance. This demonstrates both a quantitative increase in the investment's value and a qualitative change in its impact on Accenture's earnings.",
      "llm_answer": "Based on the provided document pages, Accenture's investment in Duck Creek Technologies (recorded as a $253 million gain in fiscal 2023) was excluded from adjusted financial metrics in fiscal 2024, but there is no indication of a subsequent investment valuation change or its impact on financial performance between fiscal 2022 and 2024. The document confirms the investment was held as an equity method investment (16% ownership, $138,902 carrying value as of August 31, 2022) and was not referenced in fiscal 2024 financial results beyond the prior-year gain adjustment.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "ACN_10k_2022.pdf",
          "target_page": 70,
          "pages": [
            68,
            69,
            70,
            71,
            72
          ]
        },
        "hop_2_rel": {
          "source_file": "ACN_10k_2024.pdf",
          "target_page": 40,
          "pages": [
            38,
            39,
            40,
            41,
            42
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 45440,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 11594,
        "completion_tokens": 143,
        "total_tokens": 11737
      }
    },
    {
      "question_id": 141,
      "question": "How has the composition and scale of Union Pacific's retention share and unit awards changed between 2022 and 2023, and what does this indicate about the company's executive compensation strategy?",
      "original_answer": "In 2022, Union Pacific disclosed that 389,207 retention shares were outstanding under the 2021 Stock Incentive Plan as of December 31, 2021. By 2023, the company disclosed that 954,405 retention shares had been issued and were outstanding, along with 366,046 retention units that do not have an exercise price. This represents a significant increase in the number of outstanding retention instruments, indicating a shift toward greater use of retention-based compensation. The introduction of retention units in 2023 suggests a possible expansion or refinement of the company's long-term incentive strategy for executives.",
      "llm_answer": "Between 2022 and 2023, Union Pacific’s retention awards shifted dramatically toward larger, performance‑linked equity grants: the February 2023 performance stock‑unit awards (subject to ROIC and three‑year OIG targets) were granted at a higher weighted‑average fair value of $204–$205 per share, compared with the 2021 awards that had a fair value of $148–$173 and a smaller pool of 227 k shares granted.  At the same time, the company’s overall equity‑compensation pool grew modestly, with 2.44 million options and awards outstanding in 2023 versus roughly 2.5 million in 2021, indicating a strategic move to tie a greater share of executive pay to measurable performance metrics while maintaining a relatively stable overall award size.  This reflects a compensation strategy that emphasizes performance‑driven equity incentives and reduces reliance on cash‑based or purely time‑vested awards.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "UNP_10k_2022.pdf",
          "target_page": 65,
          "pages": [
            63,
            64,
            65,
            66,
            67
          ]
        },
        "hop_2_rel": {
          "source_file": "UNP_10k_2023.pdf",
          "target_page": 75,
          "pages": [
            73,
            74,
            75,
            76,
            77
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 51239,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 13042,
        "completion_tokens": 223,
        "total_tokens": 13266
      }
    },
    {
      "question_id": 141,
      "question": "How has MetLife's application of GAAP guidance for adjusted earnings evolved between 2023 and 2024, particularly in terms of the exclusions related to market volatility and asymmetrical accounting adjustments?",
      "original_answer": "In 2023, MetLife updated its calculation of adjusted earnings due to the adoption of LDTI, which led to the exclusion of certain adjustments related to the amortization of DAC, VOBA, and related intangibles, as well as changes in measurement of certain guarantees. Adjusted earnings excluded changes in fair value associated with MRBs, discount rate changes on annuitization guarantees, and asymmetrical accounting from in-force reinsurance. By 2024, MetLife continued to refine these exclusions, particularly expanding the scope of policyholder liability remeasurement gains (losses) to exclude asymmetrical accounting associated with in-force reinsurance. Additionally, in 2024, net investment income exclusions were expanded to include adjustments relating to joint ventures under the equity method, which was not explicitly mentioned in 2023. This reflects a more detailed and structured application of GAAP guidance over time.",
      "llm_answer": "Between 2023 and 2024, MetLife’s application of GAAP guidance for adjusted earnings remained consistent in its core exclusions—market volatility (e.g., net investment gains/losses, derivative gains/losses, MRB remeasurement, goodwill impairments) and asymmetrical accounting adjustments (e.g., amortization of basis adjustments, inflation-indexed benefit adjustments, in-force reinsurance asymmetries, non-economic contract inception losses). However, the 2024 reporting reflects a refined presentation under updated segment accounting policies, particularly following the adoption of ASU 2023-07 (Segment Reporting), which enhanced disclosure requirements but did not alter the fundamental exclusions. The 2024 adjusted earnings calculation also incorporates LDTI-related updates, such as reclassification of embedded derivatives to MRBs and adjustments to DAC/VOBA amortization, yet the exclusions for market volatility and asymmetrical accounting remain unchanged in substance. The key evolution lies in greater transparency and structural alignment with new reporting standards, not in the scope of adjustments.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MET_10k_2023.pdf",
          "target_page": 170,
          "pages": [
            168,
            169,
            170,
            171,
            172
          ]
        },
        "hop_2_rel": {
          "source_file": "MET_10k_2024.pdf",
          "target_page": 150,
          "pages": [
            148,
            149,
            150,
            151,
            152
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 60970,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 15481,
        "completion_tokens": 278,
        "total_tokens": 15760
      }
    },
    {
      "question_id": 141,
      "question": "How has Accenture's approach to achieving compressed transformations evolved from 2022 to 2024, particularly in terms of the technologies leveraged and the scope of transformation services offered?",
      "original_answer": "In 2022, Accenture focused on using technologies like digital twins, AI, IoT, cloud/Edge, 5G, advanced robotics, and metaverse to help clients achieve compressed transformations by redefining product design, engineering, sourcing, manufacturing, and servicing. By 2024, the company expanded its technological toolkit to include generative AI, artificial reality / virtual reality, and advanced robotics, while also enhancing its own development of automation equipment and commercial hardware to support client operations. Additionally, the scope of transformation broadened to include digitally transforming capital projects such as plant and asset construction, public infrastructure, power grids, and data centers. This reflects a more integrated and advanced technological approach to compressed transformations over the two-year period.",
      "llm_answer": "From 2022 to 2024, Accenture's approach to compressed transformations has evolved from emphasizing broad industry-specific reinvention and foundational technology adoption (e.g., cloud, AI, IoT) to a more integrated, AI-driven strategy centered on generative AI and ecosystem partnerships. By 2024, the scope expanded to include deeper integration of AI across all transformation areas—such as redefining product design and engineering via Industry X, leveraging SynOps for intelligent operations, and embedding AI into customer experiences (via \"Song\")—while maintaining its focus on 360° value through talent, sustainability, and cross-industry expertise. This shift reflects a strategic pivot toward AI as a core enabler of speed and scale in transformation, supported by investments in R&D, strategic acquisitions, and partnerships with tech leaders like AWS, Microsoft, and Google.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "ACN_10k_2022.pdf",
          "target_page": 7,
          "pages": [
            5,
            6,
            7,
            8,
            9
          ]
        },
        "hop_2_rel": {
          "source_file": "ACN_10k_2024.pdf",
          "target_page": 8,
          "pages": [
            6,
            7,
            8,
            9,
            10
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 33289,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 8553,
        "completion_tokens": 221,
        "total_tokens": 8774
      }
    },
    {
      "question_id": 141,
      "question": "How did Abbott's use of interest rate hedge contracts evolve between 2023 and 2024 in managing exposure to changes in the fair value of fixed-rate debt?",
      "original_answer": "In 2023, Abbott had interest rate hedge contracts totaling approximately $2.2 billion at December 31, 2023, to manage exposure to changes in the fair value of fixed-rate debt due to long-term benchmark interest rate fluctuations. These contracts were designated as fair value hedges, effectively converting fixed-rate debt to variable-rate debt. In 2024, Abbott continued to maintain interest rate hedge contracts with notional values totaling $2.2 billion, indicating a consistent strategy in hedging interest rate risk. However, the average interest rate on long-term debt increased from 3.6% in 2023 to 3.8% in 2024, suggesting a shift in the underlying debt structure or market interest rate conditions despite the stable hedge notional amount.",
      "llm_answer": "Abbott’s interest‑rate hedge contracts remained in place through 2024, but their notional amount and fair‑value exposure declined modestly from 2023 to 2024.  In the 2023 10‑K (Note 12), the “Interest Rate Hedge Contracts” column shows a fair‑value liability of $95 million at both December 2023 and December 2022, and the accompanying discussion notes that the decrease from 2022 was due to the maturity of $700 million of hedge contracts in 2023.  The 2024 filing (pages 38‑40) confirms that the company continues to use fair‑value hedges of fixed‑rate debt, but the hedge coverage has been reduced – the 2024 balance sheet reflects a lower fair‑value liability for these swaps (the 2024 table shows a $95 million liability, the same as 2023, but the footnote indicates that $2.9 billion of hedge contracts matured in 2023, leaving a smaller pool of active contracts).  Consequently, while the mechanism (fair‑value hedges that convert fixed‑rate debt to variable‑rate exposure) stayed the same, the extent of the hedging program contracted slightly, with fewer contracts outstanding in 2024 than in 2023.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "ABT_10k_2023.pdf",
          "target_page": 64,
          "pages": [
            62,
            63,
            64,
            65,
            66
          ]
        },
        "hop_2_rel": {
          "source_file": "ABT_10k_2024.pdf",
          "target_page": 40,
          "pages": [
            38,
            39,
            40,
            41,
            42
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 44758,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 11411,
        "completion_tokens": 276,
        "total_tokens": 11688
      }
    },
    {
      "question_id": 142,
      "question": "How has MetLife's treatment and definition of Adjusted Earnings evolved between 2023 and 2024, particularly in relation to GAAP guidance and segment performance measurement?",
      "original_answer": "In 2023, MetLife updated its calculation of Adjusted Earnings due to the adoption of LDTI, removing certain adjustments related to the amortization of DAC, VOBA, and related intangibles, and instead adjusted for changes in measurement of certain guarantees. Adjusted Earnings in 2023 excluded changes in fair value associated with MRBs, discount rate changes on annuitization guarantees, and asymmetrical accounting from in-force reinsurance. By 2024, Adjusted Earnings remained the GAAP measure of segment performance, but the exclusions were more clearly delineated to include market volatility impacts, asymmetrical and non-economic accounting adjustments, revenues and costs from divested businesses, and results from discontinued operations. Specifically, 2024 Adjusted Earnings excluded net investment gains/losses, derivative gains/losses, MRB remeasurement gains/losses, and goodwill impairments, with more structured exclusions such as inflation-indexed benefit adjustments and non-economic losses from single premium annuity contracts. This represents a refinement and expansion of the exclusions introduced in 2023.",
      "llm_answer": "Between 2023 and 2024, MetLife's definition of Adjusted Earnings remained consistent with its GAAP-aligned segment performance framework, as detailed in the 2023 and 2024 10-K filings. Adjusted Earnings, defined as adjusted revenues less adjusted expenses (net of income tax), continues to exclude non-recurring items and market volatility impacts (e.g., net investment gains/losses, derivative gains/losses, MRB remeasurement), and is used by management to evaluate segment performance and allocate resources. The 2024 filing (page 152) confirms this methodology, which aligns with the updated LDTI accounting framework adopted in 2023, ensuring consistency in measuring segment profitability and capital allocation across all segments, including Group Benefits, RIS, Asia, Latin America, EMEA, and Corporate & Other.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MET_10k_2023.pdf",
          "target_page": 119,
          "pages": [
            117,
            118,
            119,
            120,
            121
          ]
        },
        "hop_2_rel": {
          "source_file": "MET_10k_2024.pdf",
          "target_page": 150,
          "pages": [
            148,
            149,
            150,
            151,
            152
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 55771,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 14172,
        "completion_tokens": 204,
        "total_tokens": 14377
      }
    },
    {
      "question_id": 142,
      "question": "How has the funding and utilization of Accenture's share purchase program evolved from 2022 to 2024, particularly in terms of available authorization and share acquisition methods?",
      "original_answer": "In 2022, Accenture reported an aggregate available authorization of $3,129,296 for its publicly announced open-market share purchase program and other related share purchase programs. This included acquisitions of Accenture plc Class A ordinary shares and Accenture Canada Holdings Inc. exchangeable shares held by current and former members of Accenture Leadership. By 2024, the company clarified that its open-market share purchase program applied specifically to Accenture plc Class A ordinary shares, which were held as treasury shares for employee benefits, such as equity awards. Additionally, in fiscal 2024, Accenture acquired Class A ordinary shares primarily through share withholding for payroll tax obligations tied to employee equity plans. These purchases did not impact the aggregate available authorization for the public share purchase programs, indicating a shift in acquisition methods while maintaining a focus on funding levels.",
      "llm_answer": "From fiscal 2022 through fiscal 2024, Accenture’s publicly announced open‑market share‑purchase authorization has been expanded twice: the board added $3 million of authority in September 2022 (raising the total to $6.13 million) and $4 million in September 2024 (bringing the total to $6.69 million).  The company continues to fund these purchases through treasury shares, which are used for employee equity awards and other benefit programs.  In addition, Accenture acquires shares via employee‑share‑withholding programs for payroll‑tax obligations, which do not affect the aggregate open‑market authorization.  The share‑purchase activity shows a modest increase in volume and spending in 2024 compared with 2022, reflecting the higher authorization and continued use of both open‑market purchases and other employee‑share programs.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "ACN_10k_2022.pdf",
          "target_page": 93,
          "pages": [
            91,
            92,
            93,
            94,
            95
          ]
        },
        "hop_2_rel": {
          "source_file": "ACN_10k_2024.pdf",
          "target_page": 101,
          "pages": [
            99,
            100,
            101,
            102,
            103
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 37882,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 9700,
        "completion_tokens": 209,
        "total_tokens": 9909
      }
    },
    {
      "question_id": 143,
      "question": "How did MetLife's treatment and valuation methodology for Unit-linked Securities evolve from 2023 to 2024, particularly in terms of cost basis and fair value sensitivity?",
      "original_answer": "In 2023, MetLife described the cost basis for Unit-linked and FVO securities as primarily equity and fixed maturity securities, with cost representing original cost for equities and amortized cost for fixed maturities. By 2024, Unit-linked securities were included in Level 3 fair value measurements and subjected to valuation techniques involving significant unobservable inputs such as mortality rates, lapse rates, and equity volatility. Additionally, the 2024 disclosures emphasized sensitivity of fair value to changes in these inputs, indicating a more dynamic and assumption-driven valuation approach compared to the more static cost-based method described in 2023.",
      "llm_answer": "MetLife’s valuation methodology for Unit-linked Securities remained consistent between 2023 and 2024, still relying on significant unobservable inputs (Level 3) with no disclosed change in cost basis. The key evolution lies in the sensitivity analysis: the 2024 table (page 252) shows a reduced impact of input changes on estimated fair value for certain embedded derivatives (e.g., nonperformance risk spread decreased from 0.38% to 0.11% in 2023 to 0.38% to 0.11% in 2024, with a corresponding decrease in impact on estimated fair value), while the underlying valuation techniques and inputs for embedded derivatives (including mortality, lapse, utilization, and equity volatility assumptions) remained unchanged. The 2024 data also reflects a shift in the sensitivity of gains/losses for certain inputs, such as a smaller decrease in unrealized gains/losses in AOCI for nonperformance risk spread ($1,371 in 2023 vs. $1,189 in 2024).",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MET_10k_2023.pdf",
          "target_page": 320,
          "pages": [
            318,
            319,
            320,
            321,
            322
          ]
        },
        "hop_2_rel": {
          "source_file": "MET_10k_2024.pdf",
          "target_page": 250,
          "pages": [
            248,
            249,
            250,
            251,
            252
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 77630,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 19636,
        "completion_tokens": 234,
        "total_tokens": 19870
      }
    },
    {
      "question_id": 143,
      "question": "How has the structure and vesting timeline of market-based RSUs evolved between fiscal years 2022 and 2023?",
      "original_answer": "In fiscal year 2022, market-based RSUs generally vested over four years and grantees could receive between 0% and 300% of the original grant based on total stockholder return (TSR) relative to an index group. By fiscal year 2023, while four-year vesting remained common, the company also introduced market-based RSUs that vested over five years, with vesting contingent on achieving stock price performance milestones. This indicates an expansion in the types of market-based RSUs offered, adding a new vesting structure based on specific stock price targets.",
      "llm_answer": "The market-based RSU structure remained consistent between fiscal years 2022 and 2023, with both years featuring RSUs that include service and market conditions, vesting over four years (subject to market performance milestones in 2023), and fair value determined using a volatility of 32-38%, dividend yield of 1.7-3.3%, and risk-free rates of 1.4-4.2%. In fiscal 2023, the company increased the authorized shares under the 2012 Plan by 250 million and granted 124 million market-based RSUs at $51.98 weighted-average fair value, while fiscal 2022 included 27 million granted at $52.77. The total unrecognized compensation cost for unvested awards was $11,259 million as of November 3, 2024, expected to be recognized over a 3.0-year weighted-average period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AVGO_10k_2022.pdf",
          "target_page": 117,
          "pages": [
            101,
            102,
            103,
            104,
            105
          ]
        },
        "hop_2_rel": {
          "source_file": "AVGO_10k_2023.pdf",
          "target_page": 84,
          "pages": [
            82,
            83,
            84,
            85,
            86
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 41639,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 10622,
        "completion_tokens": 189,
        "total_tokens": 10812
      }
    },
    {
      "question_id": 145,
      "question": "How did the phase-in treatment of the CECL standard's ongoing impact on regulatory capital evolve between 2023 and 2024, and what specific regulatory capital treatment applied during the phase-in period?",
      "original_answer": "In 2023, the CECL Transition Election allowed for the cumulative 'day 2' ongoing impact to be phased into regulatory capital at 25% per year from January 1, 2022, through December 31, 2024. By 2024, this phase-in treatment remained consistent, with the ongoing impact continuing to be phased in at 25% annually, indicating that the regulatory capital treatment under the CECL Transition Rule was applied uniformly across both years as part of the multi-year transition framework.",
      "llm_answer": "Between 2023 and 2024, the phase‑in treatment of CECL’s impact on regulatory capital shifted from a 75 % phase‑in of the delayed “day‑2” impact as of December 31 2023 to a full 100 % phase‑in beginning January 1 2025, meaning that by the end of 2024 the company was carrying the remaining 25 % of the delayed amount ($600 million) that will be fully phased in next year. During the phase‑in period (2020‑2024), the Federal Banking Agencies allowed a 25 % scaling factor for the ongoing “day‑2” impact, so Capital One added back $2.4 billion of capital in 2021 and has been phasing in that amount at 25 % per year, reaching 75 % ($1.8 billion) by end‑2023 and the final 25 % ($600 million) scheduled for 2025. Consequently, the regulatory capital treatment that applied during the phase‑in was to exclude the full CECL transition impact initially and then gradually reinstate it at 25 % per year, resulting in a CET1 ratio of 13.5 % on a fully phased‑in basis as of December 31 2024.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "COF_10k_2023.pdf",
          "target_page": 80,
          "pages": [
            78,
            79,
            80,
            81,
            82
          ]
        },
        "hop_2_rel": {
          "source_file": "COF_10k_2024.pdf",
          "target_page": 202,
          "pages": [
            200,
            201,
            202,
            203,
            204
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 51169,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 13028,
        "completion_tokens": 245,
        "total_tokens": 13273
      }
    },
    {
      "question_id": 146,
      "question": "How has Broadcom's relationship with Wilmington Trust, National Association evolved between 2022 and 2023 in terms of the types and terms of senior notes issued under their indentures?",
      "original_answer": "In 2022, Broadcom had an ongoing relationship with Wilmington Trust, National Association as trustee under indentures governing senior notes issued in January 2021, which included notes with interest rates as low as 1.950% (due 2028) and as high as 3.750% (due 2051). By 2023, the relationship had evolved to include new indentures dated April 18, 2022, and July 12, 2024, under which Broadcom issued higher-yielding senior notes, including a 4.926% note due 2037 and later, in October 2024, notes ranging from 4.150% (due 2028) to 4.800% (due 2034). This reflects a shift toward issuing longer-term debt with higher interest rates over time.",
      "llm_answer": "Between 2022 and 2023, Broadcom's relationship with Wilmington Trust, National Association evolved from issuing senior notes under the April 2022 indenture (4.15% 2032, 4.926% 2037) to issuing new notes under subsequent indentures, including a July 2024 indenture with 5.050% 2027, 5.050% 2029 and 5.150% 2031 notes, and an October 2024 supplemental indenture adding 4.150% 2028, 4.350% 2030, 4.550% 2032 and 4.800% 2034 notes. This reflects a progression of new senior note issuances with varying terms and maturities under separate indentures rather than a continuation of the original 2022 indenture.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AVGO_10k_2022.pdf",
          "target_page": 134,
          "pages": [
            101,
            102,
            103,
            104,
            105
          ]
        },
        "hop_2_rel": {
          "source_file": "AVGO_10k_2023.pdf",
          "target_page": 100,
          "pages": [
            98,
            99,
            100,
            101,
            102
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 56553,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 14370,
        "completion_tokens": 150,
        "total_tokens": 14521
      }
    },
    {
      "question_id": 147,
      "question": "How did Capital One's regulatory capital add-back under the CECL Transition Rule evolve from 2023 to 2024, and what was the specific phase-in progression during this period?",
      "original_answer": "In 2023, Capital One had already added back $2.4 billion to its regulatory capital under the CECL Transition Rule, with a phase-in of 50% as of January 1, 2023. By January 1, 2024, the phase-in had progressed to 75%, indicating a 25 percentage point increase over the year. This reflects the structured five-year phase-in process under the CECL Transition Rule, where 25% of the cumulative impact was phased in annually after 2021.",
      "llm_answer": "From 2023 to 2024 Capital One phased in the CECL Transition Rule impact at a 75 % rate, adding back $2.4 billion of capital in 2021 and applying 75 % of that amount by January 1 2024. The company’s CET1 ratio rose to 13.5 % on a fully phased‑in basis in 2024 (up from 12.9 % in 2023), reflecting the 75 % phase‑in of the delayed CECL impact.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "COF_10k_2023.pdf",
          "target_page": 10,
          "pages": [
            8,
            9,
            10,
            11,
            12
          ]
        },
        "hop_2_rel": {
          "source_file": "COF_10k_2024.pdf",
          "target_page": 202,
          "pages": [
            200,
            201,
            202,
            203,
            204
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 51527,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 13109,
        "completion_tokens": 85,
        "total_tokens": 13195
      }
    },
    {
      "question_id": 147,
      "question": "How did the treatment of VMware stock options for non-employee directors evolve between 2022 and 2023 following the Broadcom acquisition?",
      "original_answer": "In 2022, the 10-K filing stated that all outstanding in-the-money VMware stock options and RSU awards held by non-employee directors would be accelerated and converted into the right to receive cash and shares of Broadcom common stock, in equal parts, upon the completion of the acquisition. By 2023, this provision had been realized, with the statement confirming that these awards were indeed accelerated and converted into the right to receive cash and Broadcom shares. This reflects a transition from a planned conversion to an actualized event following the completion of the acquisition.",
      "llm_answer": "Based on the provided SEC filings, the treatment of VMware stock options for non-employee directors evolved significantly following the Broadcom acquisition. In the pre-acquisition VMware filings (reflected in the 2022 10-K pages), non-employee director stock options were typically granted with a cash settlement feature upon merger, but the key change occurred at the time of the VMware merger closing in November 2023. \n\nSpecifically, as detailed on page 67 of the Broadcom 2023 10-K (which covers the VMware Merger completion), all outstanding \"in-the-money VMware stock options and RSU awards held by non-employee directors were accelerated and converted into the right to receive cash and shares of Broadcom common stock, in equal parts.\" This replaced any prior VMware-specific director option plans, meaning non-employee directors no longer received VMware stock options post-acquisition—instead, their vested VMware options were cashed out or converted into Broadcom equity as part of the merger settlement. Prior to the merger, VMware's director compensation (as implied by standard practice in the filings) likely involved stock options or restricted stock, but the merger agreement terminated these and replaced them with Broadcom's post-merger equity structure. \n\n(298 characters)",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AVGO_10k_2022.pdf",
          "target_page": 97,
          "pages": [
            95,
            96,
            97,
            98,
            99
          ]
        },
        "hop_2_rel": {
          "source_file": "AVGO_10k_2023.pdf",
          "target_page": 66,
          "pages": [
            64,
            65,
            66,
            67,
            68
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 44283,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 11289,
        "completion_tokens": 323,
        "total_tokens": 11612
      }
    },
    {
      "question_id": 147,
      "question": "How has the therapeutic positioning of Vraylar evolved from 2022 to 2024 based on AbbVie's disclosures?",
      "original_answer": "In 2022, Vraylar was described as being evaluated in Phase 3 clinical trials as an adjunctive treatment for major depressive disorder (MDD), with one trial meeting its primary endpoint and the other showing numerical but not statistically significant improvement. By 2024, Vraylar was disclosed as being indicated for a broader range of psychiatric conditions, including acute and maintenance treatment of schizophrenia, acute treatment of manic or mixed episodes associated with bipolar disorder, acute treatment of depressive episodes associated with bipolar I disorder, and as an adjunctive treatment in major depressive disorder. This reflects a clear expansion and solidification of its therapeutic positioning over time.",
      "llm_answer": "Based on AbbVie's disclosures in the 2022 and 2024 10-K filings, the therapeutic positioning of Vraylar has evolved to include its approval as an adjunctive treatment for major depressive disorder (MDD), in addition to its established indications for schizophrenia and bipolar disorder. The 2021 FDA approval of Vraylar as an adjunctive therapy for MDD (supported by Phase 3 trials showing statistically significant efficacy in one study and numerical improvement in another) marked a key expansion of its use beyond psychosis and mood episodes, solidifying its role in treating a broader range of neuropsychiatric conditions by 2024.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "ABBV_10k_2022.pdf",
          "target_page": 60,
          "pages": [
            58,
            59,
            60,
            61,
            62
          ]
        },
        "hop_2_rel": {
          "source_file": "ABBV_10k_2024.pdf",
          "target_page": 6,
          "pages": [
            4,
            5,
            6,
            7,
            8
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 9,
        "total_chars": 42233,
        "num_window_pages": 9,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 10767,
        "completion_tokens": 158,
        "total_tokens": 10925
      }
    },
    {
      "question_id": 148,
      "question": "How has GE's accounting policy for long-term services agreements evolved from 2022 to 2024, particularly in terms of revenue recognition method and contract billing estimates?",
      "original_answer": "In 2022, GE recognized revenue for long-term services agreements on a straight-line basis, primarily in the Healthcare and Renewable Energy segments, with periodic invoicing as services were provided. By 2024, GE shifted to using the percentage of completion method for revenue recognition, predominantly within the CES segment, based on costs incurred relative to total expected costs. Additionally, in 2024, GE reported a long-term services agreements net liability balance of $6.6 billion, representing approximately 4.1% of total estimated life of contract billings of $162 billion, indicating a more detailed and forward-looking estimation process involving asset utilization and cost improvements, which was not explicitly mentioned in 2022.",
      "llm_answer": "From 2022 to 2024, GE’s accounting for long‑term services agreements remained consistent: revenue is recognized over time using the percentage‑of‑completion method based on costs incurred to date versus the total estimated cost of the contract.  The company updates its estimates of future billings, utilization and costs whenever new information becomes available, revising revenue and related contract assets or liabilities on a cumulative‑catch‑up basis.  This approach is described in the 2022 filing (pages 83‑86) and reiterated in the 2024 filing (pages 15‑19).",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "GE_10k_2022.pdf",
          "target_page": 85,
          "pages": [
            83,
            84,
            85,
            86,
            87
          ]
        },
        "hop_2_rel": {
          "source_file": "GE_10k_2024.pdf",
          "target_page": 17,
          "pages": [
            15,
            16,
            17,
            18,
            19
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 8,
        "total_chars": 51931,
        "num_window_pages": 8,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 13210,
        "completion_tokens": 141,
        "total_tokens": 13351
      }
    },
    {
      "question_id": 148,
      "question": "How has IBM's disclosure of the 1.250% Notes due 2027 evolved between the 2022 and 2023 10-K filings?",
      "original_answer": "In the 2022 10-K filing, IBM disclosed the 1.250% Notes due 2027 as part of a list of instruments defining the rights of holders, with Exhibit 4.3 to Form 8-K filed on January 30, 2019, referenced for the notes. In the 2023 10-K filing, the 1.250% Notes due 2027 are listed under registered securities with the trading symbol IBM 27B on the New York Stock Exchange. This evolution reflects a shift from referencing the instrument defining the rights to identifying the notes as a registered class of securities.",
      "llm_answer": "The 1.250% Notes due 2027 are listed in both the 2022 and 2023 10‑K filings under “Notes due 2027” (2022 10‑K, page 29; 2023 10‑K, page 1). No substantive change to the terms or description of these notes is evident between the two filings—they continue to be identified simply as “1.250% Notes due 2027” with the same maturity and coupon. Consequently, IBM’s disclosure of the 1.250% Notes due 2027 remained essentially unchanged from the 2022 to the 2023 filing.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "IBM_10k_2022.pdf",
          "target_page": 33,
          "pages": [
            28,
            29,
            30,
            31,
            32
          ]
        },
        "hop_2_rel": {
          "source_file": "IBM_10k_2023.pdf",
          "target_page": 1,
          "pages": [
            1,
            2,
            3,
            4,
            5
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 8,
        "total_chars": 36086,
        "num_window_pages": 8,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 9229,
        "completion_tokens": 116,
        "total_tokens": 9345
      }
    },
    {
      "question_id": 148,
      "question": "How has the structure and performance criteria of AbbVie's performance-vested RSUs evolved between 2022 and 2024, particularly in terms of vesting increments and performance metrics?",
      "original_answer": "In 2022, performance-vested RSUs had the potential to vest in one-third increments over a three-year performance period, with performance measured based on AbbVie's return on invested capital (ROIC) relative to a defined peer group of pharmaceutical, biotech, and life science companies for awards granted in 2021 and 2020. By 2024, the vesting structure remained similar—allowing for one-third increments over a three-year period—but the description of performance metrics was streamlined, focusing primarily on ROIC performance against the same peer group, without mention of specific years tied to tranches as seen in 2022. This indicates a simplification or standardization of the performance criteria over time.",
      "llm_answer": "AbbVie's performance-vested RSUs have evolved from a structure with multi-year performance metrics tied to ROIC and total stockholder return (TSR) relative to a peer group in 2022 to a more streamlined framework by 2024, where vesting increments are now based on a combination of ROIC performance and TSR relative to a defined peer group, with vesting occurring in one-third increments over a three-year performance period. The company maintains its focus on aligning executive compensation with long-term value creation, though specific performance metrics and thresholds have been refined to reflect evolving strategic priorities.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "ABBV_10k_2022.pdf",
          "target_page": 123,
          "pages": [
            111,
            112,
            113,
            114,
            115
          ]
        },
        "hop_2_rel": {
          "source_file": "ABBV_10k_2024.pdf",
          "target_page": 92,
          "pages": [
            90,
            91,
            92,
            93,
            94
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 9,
        "total_chars": 52399,
        "num_window_pages": 9,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 13331,
        "completion_tokens": 158,
        "total_tokens": 13489
      }
    },
    {
      "question_id": 149,
      "question": "How did GE's financial relationship with AerCap evolve from 2022 to 2024, based on the realized and unrealized gains or losses associated with its investment?",
      "original_answer": "In 2022, GE reported an unrealized loss of $865 million related to its investment in and note with AerCap, indicating a negative valuation impact during that year. By 2024, this position had shifted to a realized and unrealized gain of $38 million, suggesting that GE had either exited part of its position or the value of the remaining investment had improved. This represents a significant turnaround in the financial performance of the AerCap investment over the two-year period.",
      "llm_answer": "From 2022 through 2024 GE’s investment in AerCap generated a net gain of $38 million in 2024 (up from a $865 million loss in 2022), reflecting the turnaround in the value of its AerCap stake.  The company also recognized a $480 million gain on its GE HealthCare investment in 2024, but the key point is that the realized/unrealized gains on the AerCap holding shifted from a large loss in 2022 to a modest gain in 2024, indicating an improving financial relationship with AerCap over that period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "GE_10k_2022.pdf",
          "target_page": 4,
          "pages": [
            2,
            3,
            4,
            5,
            6
          ]
        },
        "hop_2_rel": {
          "source_file": "GE_10k_2024.pdf",
          "target_page": 68,
          "pages": [
            66,
            67,
            68,
            69,
            70
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 9,
        "total_chars": 54355,
        "num_window_pages": 9,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 13810,
        "completion_tokens": 124,
        "total_tokens": 13934
      }
    },
    {
      "question_id": 149,
      "question": "How has IBM's treatment of the 0.300% Notes due 2026 evolved between the 2022 and 2023 SEC filings, particularly in terms of its disclosure status and visibility in financial instruments?",
      "original_answer": "In 2022, the 0.300% Notes due 2026 were disclosed as part of IBM's exhibits under Exhibit 4 to Form 8-K filed November 1, 2016, indicating it was referenced in the context of legal instruments defining holder rights. By 2023, the 0.300% Notes due 2026 were no longer just referenced in exhibits but were explicitly listed as a titled class of notes registered on the New York Stock Exchange under the trading symbol IBM 26B, showing increased visibility and formal recognition in the company's capital structure.",
      "llm_answer": "Based on the provided SEC filing excerpts, IBM's 0.300% Notes due 2026 (listed as \"0.300% Notes due 2026\" under \"Notes due 2026\" in the 2023 Form 10-K securities table on page 1) remained a disclosed debt instrument in both 2022 and 2023 filings. However, its visibility and prominence in financial instrument disclosures evolved: in the 2022 filing (page 28), it was referenced only within the broader context of the company's debt structure without specific emphasis, while in the 2023 filing (page 1), it was explicitly named and listed alongside other debt securities in the \"Securities registered pursuant to Section 12(b)\" table, confirming its continued formal disclosure but without increased prominence relative to other notes. The 2023 filing also included updated risk factor language about innovation and market competition that contextualizes the debt within IBM's broader strategic narrative, but the note itself was not highlighted as a distinct or newly emphasized financial instrument.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "IBM_10k_2022.pdf",
          "target_page": 33,
          "pages": [
            28,
            29,
            30,
            31,
            32
          ]
        },
        "hop_2_rel": {
          "source_file": "IBM_10k_2023.pdf",
          "target_page": 1,
          "pages": [
            1,
            2,
            3,
            4,
            5
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 8,
        "total_chars": 36086,
        "num_window_pages": 8,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 9251,
        "completion_tokens": 250,
        "total_tokens": 9501
      }
    },
    {
      "question_id": 150,
      "question": "How has GE's approach to the RISE Program evolved between 2022 and 2024, particularly in terms of its strategic emphasis and investment focus?",
      "original_answer": "In 2022, GE announced the RISE Program as a collaborative technology development initiative with Safran, targeting a reduction of more than 20% in fuel consumption and CO2 emissions compared to current engines. This marked the initial phase of the program as a forward-looking announcement aimed at shaping the future of sustainable aviation. By 2024, GE's engagement with the RISE Program had evolved into a more concrete investment strategy, with the company making 'significant investments' in the RISE program suite of technologies. This shift indicates a transition from conceptual development to active, funded R&D aimed at enabling a sustainable future of flight. The change reflects a deepening strategic commitment to sustainability and technological leadership in aviation.",
      "llm_answer": "GE's approach to the RISE Program has shifted from a focus on R&D investment and technology development (highlighted in 2022 as part of its sustainable flight strategy) to a more explicit commercial and strategic emphasis by 2024, where RISE is positioned as a core suite of technologies—including Open Fan, compact core, and hybrid electric systems—underpinning its sustainable aviation agenda and tied to tangible outcomes like the completion of over 250 tests on a full-scale Open Fan engine. This evolution reflects a deeper integration of RISE into GE Aerospace's core business strategy, with increased investment ($1.286B in 2024) and alignment with market demands for decarbonization, as evidenced by its role in the CFM International partnership and its focus on enabling next-generation engine platforms for both commercial and military applications.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "GE_10k_2022.pdf",
          "target_page": 18,
          "pages": [
            16,
            17,
            18,
            19,
            20
          ]
        },
        "hop_2_rel": {
          "source_file": "GE_10k_2024.pdf",
          "target_page": 6,
          "pages": [
            4,
            5,
            6,
            7,
            8
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 8,
        "total_chars": 52523,
        "num_window_pages": 8,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 13348,
        "completion_tokens": 214,
        "total_tokens": 13563
      }
    },
    {
      "question_id": 150,
      "question": "How has the role and emphasis on asset securitizations within American Express's funding strategy evolved from 2022 to 2023, based on the specific disclosures in the respective 10-K filings?",
      "original_answer": "In 2022, American Express defined asset securitizations in a glossary entry, describing the mechanics of transferring loans to trusts that issue asset-backed securities, and noted that securitized loans and receivables were reported as assets while the securities were reported as liabilities. This definition was part of a broader explanation of financial terminology rather than a strategic focus. By 2023, asset securitizations were explicitly positioned as a core component of the company's funding strategy, listed alongside deposits and unsecured debt as key funding sources. The 2023 filing emphasized the importance of diversity in funding sources, with securitizations playing a role in mitigating disruptions in any single funding channel. This represents a shift from a definitional disclosure in 2022 to a strategic emphasis in 2023.",
      "llm_answer": "From 2022 to 2023, American Express’s funding strategy shifted markedly toward greater reliance on asset‑backed securitizations and unsecured term‑debt issuances. In 2023 the company issued roughly $13.5 billion of new debt (including $7.4 billion of fixed‑to‑floating senior notes and $0.5 billion of subordinated notes) and transferred $3.5 billion of securitized loan balances into its Asset‑Backed Securities program, expanding the proportion of funding sourced from securitizations. This expansion complemented a continued growth in retail deposits (up to $129.1 billion) and a modest increase in long‑term debt, but the share of funding derived from securitizations rose substantially, reflecting a strategic emphasis on diversifying and cost‑effectively financing its loan portfolio through capital‑market assets.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AXP_10k_2022.pdf",
          "target_page": 88,
          "pages": [
            86,
            87,
            88,
            89,
            90
          ]
        },
        "hop_2_rel": {
          "source_file": "AXP_10k_2023.pdf",
          "target_page": 68,
          "pages": [
            66,
            67,
            68,
            69,
            70
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 9,
        "total_chars": 42230,
        "num_window_pages": 9,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 10789,
        "completion_tokens": 205,
        "total_tokens": 10994
      }
    },
    {
      "question_id": 151,
      "question": "How did Emerson's financial and strategic relationship with AspenTech evolve from 2022 to 2023, particularly in terms of investment returns and operational integration?",
      "original_answer": "In 2022, Emerson's relationship with AspenTech was characterized by a minority investment, with AspenTech contributing $656 in sales and a $12 earnings gain, while holding total assets of $14,484. By 2023, Emerson significantly deepened its involvement by acquiring Heritage AspenTech, gaining a 55% ownership stake in the newly formed AspenTech. This acquisition positively impacted gross margins by 0.6 percentage points in 2023 and marked a strategic shift from a passive investment to an active controlling interest, indicating a transformation in the nature of the relationship.",
      "llm_answer": "From 2022 to 2023, Emerson’s financial relationship with AspenTech shifted from a minority equity stake to full operational integration after acquiring the remaining shares in May 2022.  The 2022 acquisition added AspenTech’s $656 million in sales and contributed $12 million of earnings (loss) to the Automation Solutions segment, while 2023 saw AspenTech’s sales surge to $656 million (up from $319 million in 2022) and earnings improve to $12 million, reflecting the full consolidation of its asset‑optimization software business.  Operationally, the combined entity leveraged AspenTech’s software within Emerson’s Automation Solutions portfolio, driving higher segment earnings before interest and taxes and enabling the company to report adjusted EBITA growth of 22 % in 2024 versus 2023.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "EMR_10k_2022.pdf",
          "target_page": 77,
          "pages": [
            75,
            76,
            77,
            78,
            79
          ]
        },
        "hop_2_rel": {
          "source_file": "EMR_10k_2023.pdf",
          "target_page": 26,
          "pages": [
            24,
            25,
            26,
            27,
            28
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 44948,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 11463,
        "completion_tokens": 198,
        "total_tokens": 11661
      }
    },
    {
      "question_id": 152,
      "question": "How did Emerson's financial relationship with AspenTech evolve between 2022 and 2023, particularly in terms of noncontrolling interest accounting and acquisition-related impacts on equity and expenses?",
      "original_answer": "In 2022, Emerson completed the creation of New AspenTech by contributing its industrial software business and $6.0 billion in cash, resulting in a 55% ownership stake. A noncontrolling interest of $5.9 billion was recorded, with a decrease to additional paid-in capital of $550 million. By 2023, the AspenTech acquisition positively impacted gross margins by 0.6 percentage points and contributed to increased SG&A expenses, which rose by $572 million compared to 2022, partly due to the AspenTech transaction and higher stock compensation expenses. This shows that while the initial accounting impact was significant in 2022, by 2023, the focus had shifted to operational integration and financial performance effects.",
      "llm_answer": "Between 2022 and 2023, Emerson's financial relationship with AspenTech underwent a significant transformation. In 2022, Emerson acquired a controlling stake (55% ownership) in AspenTech through a transaction that included a $11.188 billion purchase consideration, resulting in the recognition of a $7.225 billion goodwill asset and a $4.39 billion intangible asset valuation, while recording a $5.9 billion noncontrolling interest for the remaining 45% stake. This acquisition, completed on May 16, 2022, fundamentally changed the accounting treatment, as Emerson began consolidating AspenTech's results and recognizing noncontrolling interest. By 2023, Emerson further refined its stake, ultimately selling its 40% noncontrolling interest in Copeland (a subsidiary of AspenTech formed after the 2022 acquisition) for $1.5 billion in cash and $1.9 billion note receivable in August 2024, though this sale occurred after the 2023 fiscal year. The 2023 financial statements reflect the ongoing impact of the acquisition, including $678 million in amortization of intangibles (including $97 related to Heritage AspenTech), $84 million in acquisition-related costs, and the reclassification of equity method losses from AspenTech to discontinued operations. The acquisition also drove significant non-cash charges, such as $231 million in acquisition-related inventory step-up amortization in 2024, which negatively impacted gross margins by 1.3 percentage points. Overall, the relationship evolved from a strategic acquisition in 2022 to a partial divestiture of its AspenTech stake by 2024, with the 2023 financials reflecting the initial consolidation and ongoing integration impacts.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "EMR_10k_2022.pdf",
          "target_page": 56,
          "pages": [
            54,
            55,
            56,
            57,
            58
          ]
        },
        "hop_2_rel": {
          "source_file": "EMR_10k_2023.pdf",
          "target_page": 26,
          "pages": [
            24,
            25,
            26,
            27,
            28
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 41810,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 10686,
        "completion_tokens": 420,
        "total_tokens": 11107
      }
    },
    {
      "question_id": 152,
      "question": "How has IBM's treatment and disclosure of the 6.22% Debentures due 2027 evolved between the 2022 and 2023 SEC filings?",
      "original_answer": "In 2022, IBM disclosed the 6.22% Debentures due 2027 by referencing the instrument defining the rights of its holders, which was filed as Exhibit 3 to Form 8-K on August 1, 1997. In contrast, the 2023 filing introduces a more structured and visible disclosure by listing the 6.22% Debentures due 2027 with its respective trading symbol (IBM 27) and explicitly identifying it among other registered securities on the New York Stock Exchange. This evolution reflects a shift from a purely historical reference to a more transparent and current market-oriented presentation.",
      "llm_answer": "The 6.22% Debentures due 2027 were first disclosed in IBM’s 2022 Form 10‑K (Item 7A, Table of Contents) and continued to appear in the 2023 filing (Item 7A, Table of Contents) as part of the list of registered securities. The only change is that the 2023 filing adds a reference to the “Report of the Audit Committee of the Board of Directors” and “Audit and Non‑Audit Fees” in the Proxy Statement, but the debenture itself remains listed in the same format and with identical terms. Thus, IBM’s treatment and disclosure of the 6.22% Debentures due 2027 is essentially unchanged between the 2022 and 2023 SEC filings.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "IBM_10k_2022.pdf",
          "target_page": 31,
          "pages": [
            28,
            29,
            30,
            31,
            32
          ]
        },
        "hop_2_rel": {
          "source_file": "IBM_10k_2023.pdf",
          "target_page": 1,
          "pages": [
            1,
            2,
            3,
            4,
            5
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 8,
        "total_chars": 36086,
        "num_window_pages": 8,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 9233,
        "completion_tokens": 154,
        "total_tokens": 9388
      }
    },
    {
      "question_id": 152,
      "question": "How has UnitedHealth Group's exposure to financial risk through risk-based arrangements with healthcare providers evolved from 2023 to 2024, and what implications does this have on its cost estimation and service delivery responsibilities?",
      "original_answer": "In 2023, UnitedHealth Group assumed economic risk under risk-based arrangements where it was responsible for funding healthcare costs, and it recognized premium revenues based on estimated premiums earned, net of projected rebates. The company also highlighted its involvement in value-based arrangements where it received per-patient-per-month premiums and recognized revenue as services were made available. By 2024, the company's exposure expanded as it noted increased responsibility for unpaid healthcare claims if risk-based providers faced financial difficulties or failed to meet their obligations. Additionally, the 2024 disclosures emphasized greater operational risk tied to providers' ability to manage costs, maintain solvency, and provide necessary data for cost estimation, indicating a broader and more complex financial exposure compared to 2023.",
      "llm_answer": "UnitedHealth Group’s exposure to financial risk through risk‑based arrangements with health‑care providers has grown more pronounced in 2024.  The 2024 filing notes that “risk‑based arrangements with some physicians, hospitals and other health‑care providers limit our exposure to the risk of increasing medical costs, but expose us to risk related to the adequacy of the financial and medical‑care resources of the health‑care providers,” and that “if a risk‑based health‑care provider organization faces financial difficulties … we may be held responsible for unpaid health‑care claims which should have been the responsibility of the provider.”  Consequently, the company’s cost‑estimation and service‑delivery responsibilities now carry a greater liability for provider solvency and claim payments, requiring more robust monitoring and contingency planning to manage the heightened financial risk.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "UNH_10k_2023.pdf",
          "target_page": 45,
          "pages": [
            43,
            44,
            45,
            46,
            47
          ]
        },
        "hop_2_rel": {
          "source_file": "UNH_10k_2024.pdf",
          "target_page": 14,
          "pages": [
            12,
            13,
            14,
            15,
            16
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 67880,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 17213,
        "completion_tokens": 225,
        "total_tokens": 17439
      }
    },
    {
      "question_id": 153,
      "question": "How did Emerson's financial relationship with AspenTech evolve between 2022 and 2023, particularly in terms of investment magnitude and strategic involvement?",
      "original_answer": "In 2022, Emerson's relationship with AspenTech was primarily financial, as shown by its investment reflected in the Automation Solutions segment, where Emerson reported $362 million invested in AspenTech in 2022. By 2023, the relationship evolved into a strategic partnership following the introduction of a major transaction where Emerson contributed its Industrial Software Business along with approximately $6.0 billion in cash to Heritage AspenTech stockholders, creating 'New AspenTech.' Emerson gained 55% ownership of AspenTech's outstanding shares, marking a significant shift from a minority investment to a controlling stake.",
      "llm_answer": "Between 2022 and 2023, Emerson's financial relationship with AspenTech shifted from a significant equity investment to active divestiture. In 2022, Emerson held approximately 55% of AspenTech's shares following the acquisition of Heritage AspenTech, and recognized a $56 million mark-to-market gain on its equity investment. By 2023, Emerson had fully divested its stake in AspenTech through the sale of its 40% non-controlling interest in Copeland (which included AspenTech's equity interest) for $1.5 billion in cash, while also selling the associated $1.9 billion note receivable. This marked a strategic exit from its AspenTech investment, transitioning from ownership to complete divestiture.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "EMR_10k_2022.pdf",
          "target_page": 78,
          "pages": [
            76,
            77,
            78,
            79,
            80
          ]
        },
        "hop_2_rel": {
          "source_file": "EMR_10k_2023.pdf",
          "target_page": 26,
          "pages": [
            24,
            25,
            26,
            27,
            28
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 41990,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 10721,
        "completion_tokens": 174,
        "total_tokens": 10895
      }
    },
    {
      "question_id": 153,
      "question": "How has Adobe Target's role within Adobe's customer journey solutions evolved from fiscal 2022 to fiscal 2023, and what does this evolution indicate about Adobe's strategic direction in AI-driven personalization?",
      "original_answer": "In fiscal 2022, Adobe Target was described as part of a broader set of customer journey solutions, specifically noted alongside Marketo Engage, Adobe Campaign, and Journey Optimizer. It was characterized as a tool for testing, targeting, and personalizing content across channels. By fiscal 2023, Adobe Target was elevated in prominence and described specifically as an 'AI- and machine learning-driven personalization engine' with capabilities for omnichannel personalization and large-scale A/B and multivariate testing through AI-powered automation. This evolution indicates Adobe is placing greater strategic emphasis on AI-driven personalization as a core capability within its customer journey offerings, aligning with its broader push toward AI-powered solutions.",
      "llm_answer": "From fiscal 2022 to fiscal 2023 Adobe shifted Adobe Target from a standalone personalization engine within the broader Experience Cloud portfolio to a core component of the AI‑driven “Customer Journey” and “Journey Optimizer” suite, embedding it more tightly with Adobe Experience Platform, Real‑Time Customer Data Platform and Journey Optimizer to enable near‑real‑time, AI‑powered personalization across all channels. This evolution reflects Adobe’s strategic focus on unifying data, AI and activation tools—leveraging Adobe Sensei and generative AI—to deliver end‑to‑end, hyper‑personalized customer experiences as a central pillar of its growth strategy.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "ADBE_10k_2022.pdf",
          "target_page": 43,
          "pages": [
            41,
            42,
            43,
            44,
            45
          ]
        },
        "hop_2_rel": {
          "source_file": "ADBE_10k_2023.pdf",
          "target_page": 15,
          "pages": [
            13,
            14,
            15,
            16,
            17
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 47028,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 11994,
        "completion_tokens": 164,
        "total_tokens": 12159
      }
    },
    {
      "question_id": 155,
      "question": "How did Emerson's relationship with AspenTech evolve from 2022 to 2023, particularly in terms of its financial stake and post-acquisition integration activities?",
      "original_answer": "In 2022, Emerson reported a balance of $8,326 million related to AspenTech as part of its acquisitions, indicating a significant financial stake following the acquisition of Heritage AspenTech. By 2023, the relationship had evolved into a more integrated structure, with AspenTech operating as a separate publicly traded company under Emerson's acquisition framework. This included the continuation of AspenTech's stock-based compensation plans, such as stock options and restricted stock units, which were now aligned with AspenTech's own equity structure. Additionally, Emerson was actively managing performance stock units tied to predefined goals like annual contract value and free cash flows, showing a shift from a purely financial stake to a more operationally integrated and incentive-driven relationship.",
      "llm_answer": "From 2022 to 2023, Emerson's financial stake in AspenTech remained indirect—it held no equity but acquired the company in Q3 2022 and integrated its operations. Post‑acquisition, Emerson converted outstanding Heritage AspenTech stock options and unvested restricted stock units into new AspenTech options and RSUs on the same terms, and it began recognizing AspenTech’s stock‑based compensation expense (e.g., $32 million in 2022, rising to $82 million in 2023) alongside the related tax benefits. Integration activities included reallocating the purchase‑price fair‑value of share‑based awards between pre‑ and post‑combination service periods, and Emerson’s stock‑compensation expense from AspenTech grew substantially as part of its broader compensation framework.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "EMR_10k_2022.pdf",
          "target_page": 61,
          "pages": [
            59,
            60,
            61,
            62,
            63
          ]
        },
        "hop_2_rel": {
          "source_file": "EMR_10k_2023.pdf",
          "target_page": 70,
          "pages": [
            68,
            69,
            70,
            71,
            72
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 40539,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 10359,
        "completion_tokens": 191,
        "total_tokens": 10550
      }
    },
    {
      "question_id": 155,
      "question": "How has Adobe Experience Platform's role within Adobe's customer journey solutions evolved from 2022 to 2023, particularly in terms of its integration with AI-powered tools and cross-channel campaign orchestration?",
      "original_answer": "In 2022, Adobe Experience Platform was described as the foundational infrastructure for Adobe Experience Cloud, enabling data standardization and integration with Adobe Sensei to provide AI-powered services such as automated insights, sentiment analysis, and enhanced anomaly detection. It was central to Adobe's differentiation, supporting applications like Adobe Analytics and Adobe Audience Manager. By 2023, Adobe Experience Platform's role had evolved to become the underlying engine for cross-channel campaign orchestration, particularly through its integration with Adobe Journey Optimizer. This app allowed brands to deliver personalized, connected customer journeys across any channel, using real-time data profiles and cloud-native scalability. Additionally, Adobe Mix Modeler, introduced in 2023 and powered by Adobe Sensei, leveraged cross-channel datasets in Adobe Experience Platform to provide machine learning-driven insights for optimizing marketing investments. This indicates a shift from a general AI-enhanced infrastructure role to a more specialized and actionable function in campaign planning and customer journey orchestration.",
      "llm_answer": "From 2022 to 2023, Adobe Experience Platform’s role within Adobe’s customer journey solutions evolved from being a foundational data and audience infrastructure to a more tightly integrated, AI-powered orchestration engine. The 2023 filing emphasizes that Experience Platform now serves as the central hub that connects Adobe’s Experience Cloud applications—such as Journey Optimizer, Marketo Engage, and Campaign—enabling real‑time, cross‑channel campaign orchestration and hyper‑personalized customer journeys through AI services like Adobe Sensei and Generative AI. This deeper integration allows brands to activate unified customer profiles instantly, delivering seamless, data‑driven experiences across every touchpoint.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "ADBE_10k_2022.pdf",
          "target_page": 8,
          "pages": [
            6,
            7,
            8,
            9,
            10
          ]
        },
        "hop_2_rel": {
          "source_file": "ADBE_10k_2023.pdf",
          "target_page": 15,
          "pages": [
            13,
            14,
            15,
            16,
            17
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 9,
        "total_chars": 48117,
        "num_window_pages": 9,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 12266,
        "completion_tokens": 181,
        "total_tokens": 12447
      }
    },
    {
      "question_id": 155,
      "question": "How did UnitedHealth Group's approach to care delivery models evolve from 2023 to 2024 in response to Medicare Advantage funding pressures?",
      "original_answer": "In 2023, UnitedHealth Group emphasized accelerating the transition to value-based care delivery models, investing in clinical engagement, integrated care coordination technology, and new delivery channels like in-home and virtual care. The company viewed these innovations as key to future growth despite initial costs. However, by 2024, the company faced significant funding pressures in the Medicare Advantage program, including reduced benchmarks and risk adjustment changes, which led to operational adjustments. These included selective changes to provider networks, benefit structures, and county-level decisions about plan offerings, indicating a shift from expansion-focused investment to cost containment and strategic retrenchment in response to external financial constraints.",
      "llm_answer": "UnitedHealth Group responded to Medicare Advantage funding pressures by accelerating its shift toward value-based care models, expanding integrated care delivery (including in-clinic, in-home, behavioral and virtual care), and intensifying medical and operating cost management—such as adjusting network composition, member benefits, and premiums—while continuing to grow enrollment in Medicare Advantage and Medicaid to offset revenue pressures.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "UNH_10k_2023.pdf",
          "target_page": 27,
          "pages": [
            25,
            26,
            27,
            28,
            29
          ]
        },
        "hop_2_rel": {
          "source_file": "UNH_10k_2024.pdf",
          "target_page": 20,
          "pages": [
            18,
            19,
            20,
            21,
            22
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 54660,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 13883,
        "completion_tokens": 111,
        "total_tokens": 13995
      }
    },
    {
      "question_id": 157,
      "question": "How has the composition of TMO's debt instruments evolved between 2022 and 2023, particularly regarding the 1.950% Notes due 2029?",
      "original_answer": "In 2022, the 1.950% Notes due 2029 were listed among TMO's outstanding debt instruments with the trading symbol TMO 29. In 2023, the 1.950% Notes due 2029 remained present with the same trading symbol TMO 29, indicating continuity in this debt instrument. However, TMO introduced new debt instruments in 2023, such as the 3.200% Notes due 2026 and the 3.650% Notes due 2034, suggesting a broader shift in financing strategy. The continued presence of the 1.950% Notes due 2029 indicates no change in this specific liability, even as TMO expanded its debt portfolio.",
      "llm_answer": "Between 2022 and 2023, Thermo Fisher issued new debt instruments while retiring older ones, but the 1.950% Notes due 2029 remained outstanding throughout both years. The company's debt profile in the 2023 10-K (page 1) explicitly lists \"1.950% Notes due 2029\" among its registered securities, confirming the instrument was still active. However, the provided documents do not detail specific changes to the composition of TMO's debt instruments during this period, such as new issuances, redemptions, or refinancing activities related to the 2029 notes. The 2022 and 2023 10-Ks only disclose the existence of the 1.950% Notes due 2029 as part of the company's long-term debt structure without describing evolution in its composition.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "TMO_10k_2022.pdf",
          "target_page": 1,
          "pages": [
            1,
            2,
            3,
            4,
            5
          ]
        },
        "hop_2_rel": {
          "source_file": "TMO_10k_2023.pdf",
          "target_page": 1,
          "pages": [
            1,
            2,
            3,
            4,
            5
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 47998,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 12213,
        "completion_tokens": 183,
        "total_tokens": 12396
      }
    },
    {
      "question_id": 159,
      "question": "How has the composition of TMO's debt instruments evolved between 2022 and 2023, particularly regarding the 0.500% Notes due 2028 and the introduction of new note categories?",
      "original_answer": "In 2022, TMO listed the 0.500% Notes due 2028 alongside other debt instruments, including the 1.375% Notes due 2028. By 2023, TMO continued to list the 0.500% Notes due 2028, but introduced new debt categories such as the 3.200% Notes due 2026 and the 3.650% Notes due 2034, while maintaining similar categories like the 1.375% Notes due 2028. This indicates a strategic shift toward diversifying TMO's debt portfolio with new interest rate structures and maturity timelines.",
      "llm_answer": "Between 2022 and 2023, Thermo Fisher added new note categories to its capital structure, including 0.500% Notes due 2028 (TMO 28A) and 1.375% Notes due 2028 (TMO 28), while retaining previously issued series such as the 0.750% Notes due 2024, 0.125% Notes due 2025, 2.000% Notes due 2025, 3.200% Notes due 2026, 1.400% Notes due 2026, 1.450% Notes due 2027, 1.750% Notes due 2027, 1.950% Notes due 2029, 0.875% Notes due 2031, 2.375% Notes due 2032, 3.650% Notes due 2034, 2.875% Notes due 2037, 1.500% Notes due 2039, and 1.875% Notes due 2049. The 0.500% Notes due 2028 represent a newly introduced tranche in the 2028 maturity year, expanding the company’s long‑term debt profile.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "TMO_10k_2022.pdf",
          "target_page": 1,
          "pages": [
            1,
            2,
            3,
            4,
            5
          ]
        },
        "hop_2_rel": {
          "source_file": "TMO_10k_2023.pdf",
          "target_page": 1,
          "pages": [
            1,
            2,
            3,
            4,
            5
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 47998,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 12224,
        "completion_tokens": 170,
        "total_tokens": 12395
      }
    },
    {
      "question_id": 160,
      "question": "How has the range of excess fair value over carrying value for DHR's reporting units changed between the 2023 and 2024 annual goodwill impairment analyses?",
      "original_answer": "In 2023, the excess of the estimated fair value over carrying value for DHR's reporting units ranged from approximately 140% to 495%. In 2024, this range decreased to between approximately 70% and 450%. This indicates a reduction in the lowest excess fair value percentage, suggesting a decline in the overall cushion before potential impairment.",
      "llm_answer": "The excess fair value over carrying value for DHR's reporting units was approximately 140% to 495% of carrying value in the 2023 annual goodwill impairment analysis, and ranged from approximately 115% to 435% of carrying value in the 2024 analysis after applying a hypothetical 10% decrease to fair values. This represents a decrease in the excess percentage across all reporting units compared to the 2023 results.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "DHR_10k_2023.pdf",
          "target_page": 56,
          "pages": [
            54,
            55,
            56,
            57,
            58
          ]
        },
        "hop_2_rel": {
          "source_file": "DHR_10k_2024.pdf",
          "target_page": 52,
          "pages": [
            50,
            51,
            52,
            53,
            54
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 51218,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 13027,
        "completion_tokens": 103,
        "total_tokens": 13131
      }
    },
    {
      "question_id": 161,
      "question": "How did the treatment of canceled RSUs and tax-withheld shares under the 2022 Employee Stock Plan evolve from 2022 to 2023 in terms of their impact on the available share pool?",
      "original_answer": "In 2022, the 2022 Employee Stock Plan specified that canceled RSUs and shares withheld to satisfy tax withholding obligations would increase the number of shares available for grant under the plan by a factor of two times the number of RSUs canceled or shares withheld. However, in 2023, this specific language regarding the factor of two times for RSUs canceled or shares withheld was omitted, indicating a change in how these events were accounted for in the share pool calculation.",
      "llm_answer": "The 2022 Employee Stock Plan reduced the available share pool by counting each RSU as two shares toward the plan’s authorization limit, while the 2023 plan eliminated that double‑counting rule, effectively freeing up additional shares for future equity awards. Consequently, the net available shares for issuance increased from 2022 to 2023 because RSUs no longer consumed two shares each under the updated plan.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AAPL_10k_2022.pdf",
          "target_page": 49,
          "pages": [
            47,
            48,
            49,
            50,
            51
          ]
        },
        "hop_2_rel": {
          "source_file": "AAPL_10k_2023.pdf",
          "target_page": 47,
          "pages": [
            45,
            46,
            47,
            48,
            49
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 43250,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 11041,
        "completion_tokens": 103,
        "total_tokens": 11144
      }
    },
    {
      "question_id": 162,
      "question": "How has Danaher's strategic relationship with Aldevron evolved between 2023 and 2024, particularly in terms of its financial stake and integration into Danaher's business segments?",
      "original_answer": "In 2023, Danaher had a significant financial stake in Aldevron, as evidenced by the $9,561 million in net cash consideration allocated to Aldevron in the acquisition table, indicating a direct ownership interest. By 2024, Aldevron was no longer listed as a separately accounted stake but had been integrated into the Life Sciences segment as part of Danaher's broader portfolio of acquisitions, including Beckman Coulter, Pall, and IDT. This reflects a strategic shift from holding a standalone stake to full operational integration, aligning Aldevron's capabilities in biopharma research and manufacturing with Danaher’s broader life sciences offerings.",
      "llm_answer": "Danaher's strategic relationship with Aldevron has evolved significantly between 2023 and 2024, particularly in terms of financial stake and integration. In 2023, Danaher acquired Aldevron in a $9.6 billion cash transaction (completed August 30, 2021), which positioned Aldevron as a key part of its Life Sciences segment. By 2023, Aldevron contributed approximately $300 million in annual revenue (2020 figure) and was integrated into Danaher's Life Sciences business, which also includes Abcam (acquired in 2023 for $5.6 billion). The acquisition strengthened Danaher's position in genomic medicines and custom nucleic acid products, with Aldevron's plasmid DNA, mRNA, and protein manufacturing capabilities complementing Danaher's broader Life Sciences portfolio. Financially, the acquisition was funded through cash on hand and commercial paper, resulting in $6.1 billion of goodwill recorded. By 2024, Aldevron's operations were fully integrated into Danaher's Life Sciences segment, contributing to the segment's $24.3 billion in sales (2023 unaudited pro forma), though specific financial details for 2024 are not detailed in the provided documents beyond its role within the segment. The integration reflects Danaher's strategy to expand its life sciences footprint through strategic acquisitions, with Aldevron serving as a foundational asset in this expansion.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "DHR_10k_2023.pdf",
          "target_page": 74,
          "pages": [
            72,
            73,
            74,
            75,
            76
          ]
        },
        "hop_2_rel": {
          "source_file": "DHR_10k_2024.pdf",
          "target_page": 8,
          "pages": [
            6,
            7,
            8,
            9,
            10
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 49059,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 12492,
        "completion_tokens": 342,
        "total_tokens": 12835
      }
    },
    {
      "question_id": 163,
      "question": "How has Microsoft's strategic positioning of Microsoft 365 evolved between 2023 and 2024, particularly in terms of its integration with AI technologies and its role in the company's commercial business metrics?",
      "original_answer": "In 2023, Microsoft 365 was described as an 'AI first' platform integrating Office, Windows, Copilot, and Enterprise Mobility + Security, with Copilot for Microsoft 365 combining AI with business data to enhance productivity. By 2024, Microsoft had expanded the Microsoft 365 Consumer subscribers metric to include Microsoft 365 Basic subscribers, aligning with internal business management practices and signaling a broader consumer focus. This evolution reflects a strategic shift toward enhancing AI integration and expanding the product's market reach, particularly within the commercial segment.",
      "llm_answer": "Microsoft's strategic positioning of Microsoft 365 has evolved significantly between 2023 and 2024 by embedding AI deeply into its core productivity suite, transitioning from a traditional office productivity platform to an AI-first operating environment. This is exemplified by the integration of Copilot across Microsoft 365 applications (Word, Excel, PowerPoint, Outlook, Teams), where AI assists with content creation, data analysis, and workflow automation, directly driving revenue growth in the \"Productivity and Business Processes\" segment (up 14% in FY2024, fueled by Office 365 Commercial and Microsoft 365 Consumer subscriptions). Concurrently, Microsoft Cloud revenue grew 23% to $137.4 billion, with Azure AI infrastructure (including custom silicon like Maia and Cobalt) and enterprise AI solutions (e.g., Dynamics 365, LinkedIn, and security tools like Copilot for Security) forming the backbone of its commercial business metrics, directly contributing to the 16% overall revenue increase and 24% operating income growth reported in FY2024.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MSFT_10k_2023.pdf",
          "target_page": 4,
          "pages": [
            2,
            3,
            4,
            5,
            6
          ]
        },
        "hop_2_rel": {
          "source_file": "MSFT_10k_2024.pdf",
          "target_page": 41,
          "pages": [
            39,
            40,
            41,
            42,
            43
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 40810,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 10438,
        "completion_tokens": 264,
        "total_tokens": 10702
      }
    },
    {
      "question_id": 164,
      "question": "How has Microsoft's positioning and emphasis on Copilot Pro evolved between 2023 and 2024, particularly in terms of its role within Microsoft 365 apps and web-based AI assistance?",
      "original_answer": "In 2023, Copilot Pro was introduced as a consumer subscription service that offered 'faster and more powerful AI assistance in Microsoft 365 apps and on the web.' By 2024, while the core definition remained consistent, the emphasis on Copilot Pro's differentiation and innovation appeared more pronounced, with language such as 'faster and more powerful AI assistance' retained but now embedded within a broader narrative of AI-driven transformation across Microsoft's ecosystem. This suggests a strategic evolution where Copilot Pro is not only a standalone offering but increasingly integrated into the broader AI-first positioning of Microsoft's productivity suite.",
      "llm_answer": "Between 2023 and 2024, Microsoft shifted Copilot Pro from a broad AI assistant to a tightly integrated, subscription‑based feature embedded in Microsoft 365 apps and the web. In the 2023 filing, Copilot was presented as a consumer‑focused AI tool for navigating the web and creating content, while the 2024 filing emphasizes its role within Microsoft 365 (e.g., Copilot for Sales, Service, Finance, and Copilot Studio) and its availability in Windows 11 and Edge, highlighting faster, more powerful AI assistance directly inside the productivity suite and across Microsoft’s cloud services.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MSFT_10k_2023.pdf",
          "target_page": 4,
          "pages": [
            2,
            3,
            4,
            5,
            6
          ]
        },
        "hop_2_rel": {
          "source_file": "MSFT_10k_2024.pdf",
          "target_page": 4,
          "pages": [
            2,
            3,
            4,
            5,
            6
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 43066,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 10993,
        "completion_tokens": 147,
        "total_tokens": 11140
      }
    },
    {
      "question_id": 164,
      "question": "How has the structure and availability of the 2007 Omnibus Incentive Plan evolved between 2023 and 2024, particularly in terms of remaining shares available for issuance?",
      "original_answer": "In 2023, the 2007 Omnibus Incentive Plan was described in the context of PSU and RSU awards, vesting conditions, and valuation methods, but no specific figure was provided regarding the remaining shares available for issuance. In contrast, by 2024, the plan explicitly stated that approximately 47 million shares of Danaher common stock remained available for issuance under the plan as of December 31, 2024 (excluding shares underlying outstanding awards). This indicates a more transparent disclosure and potential depletion or tracking of the share pool since the plan's inception, showing a shift in how the company communicates the availability of shares under the plan.",
      "llm_answer": "Based on the provided SEC 10-K filings, the 2007 Omnibus Incentive Plan (which authorizes up to 135 million shares for stock-based awards) had approximately 47 million shares remaining available for issuance as of December 31, 2024. This represents a decrease from prior years due to ongoing share issuances for equity compensation, though the plan itself remains active without an expiration date. The company continues to use new shares from its authorized but unissued pool to cover option exercises and award vestings.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "DHR_10k_2023.pdf",
          "target_page": 103,
          "pages": [
            101,
            102,
            103,
            104,
            105
          ]
        },
        "hop_2_rel": {
          "source_file": "DHR_10k_2024.pdf",
          "target_page": 96,
          "pages": [
            94,
            95,
            96,
            97,
            98
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 58934,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 14961,
        "completion_tokens": 130,
        "total_tokens": 15091
      }
    },
    {
      "question_id": 165,
      "question": "How did Microsoft's accounting policy regarding the estimated useful lives of server and network equipment evolve between fiscal years 2023 and 2024, and what factors influenced this change?",
      "original_answer": "In fiscal year 2023, Microsoft increased the estimated useful lives of server and network equipment from four years to six years, effective beginning fiscal year 2023. This change was driven by investments in software that improved operational efficiencies and advances in technology. In fiscal year 2024, the policy remained consistent with the updated six-year estimate, indicating that the initial change was sustained and likely integrated into ongoing asset management practices. The continued focus on cloud and AI infrastructure investments further supported the rationale behind extending the useful lives of these assets.",
      "llm_answer": "Microsoft increased the estimated useful lives of its server and network equipment from four to six years, effective in fiscal year 2023, as a result of efficiency‑enhancing software investments and technological advances that reduced the rate of equipment obsolescence. This accounting estimate change lowered depreciation expense and reflected the longer operational lifespan of the hardware.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MSFT_10k_2023.pdf",
          "target_page": 40,
          "pages": [
            38,
            39,
            40,
            41,
            42
          ]
        },
        "hop_2_rel": {
          "source_file": "MSFT_10k_2024.pdf",
          "target_page": 40,
          "pages": [
            38,
            39,
            40,
            41,
            42
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 8,
        "total_chars": 30595,
        "num_window_pages": 8,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 7880,
        "completion_tokens": 98,
        "total_tokens": 7979
      }
    },
    {
      "question_id": 165,
      "question": "How did MDT's exposure to auction rate securities evolve from 2022 to 2023 in terms of fair value and classification within the balance sheet?",
      "original_answer": "In 2022, MDT reported auction rate securities with a fair value of $33 million and classified them under 'Total' in the investment portfolio without specifying a separate balance sheet classification. By 2023, the fair value of auction rate securities remained at $33 million, but they were explicitly classified under 'Other Assets' instead of being included in the broader investment category. This indicates a shift in how MDT categorized these securities on its balance sheet, moving from a general investment classification to a more distinct reporting under other assets.",
      "llm_answer": "From the 2022 and 2023 10‑K pages, MDT’s auction‑rate securities are classified as Level 3 in the fair‑value hierarchy and are recorded in “Other assets” on the balance sheet.  The fair‑value of these securities was $33 million at both April 29 2022 and April 28 2023, reflecting a slight decline from $36 million cost (with a $3 million unrealized loss) in 2022 to $33 million fair value (with a $3 million unrealized loss) in 2023.  Thus, MDT’s exposure to auction‑rate securities remained minimal, staying at $33 million fair value and continuing to be reported as a Level 3 asset within other assets.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MDT_10k_2022.pdf",
          "target_page": 71,
          "pages": [
            69,
            70,
            71,
            72,
            73
          ]
        },
        "hop_2_rel": {
          "source_file": "MDT_10k_2023.pdf",
          "target_page": 71,
          "pages": [
            69,
            70,
            71,
            72,
            73
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 51525,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 13100,
        "completion_tokens": 151,
        "total_tokens": 13251
      }
    },
    {
      "question_id": 167,
      "question": "How did the net gains or losses from Cisco's available-for-sale debt investments change between fiscal years 2023 and 2024, and what does this indicate about the company's investment performance in this category?",
      "original_answer": "In fiscal year 2023, Cisco reported a net loss of $21 million from its available-for-sale debt investments, while in fiscal year 2024, this loss increased to $67 million. This indicates a significant worsening in investment performance related to this category year-over-year.",
      "llm_answer": "The net gains or losses from Cisco's available‑for‑sale debt investments shifted from a $21 million gain in fiscal 2023 to a $67 million loss in fiscal 2024, indicating a deterioration in the company's investment performance for this category.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CSCO_10k_2023.pdf",
          "target_page": 53,
          "pages": [
            51,
            52,
            53,
            54,
            55
          ]
        },
        "hop_2_rel": {
          "source_file": "CSCO_10k_2024.pdf",
          "target_page": 46,
          "pages": [
            44,
            45,
            46,
            47,
            48
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 50464,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 12853,
        "completion_tokens": 60,
        "total_tokens": 12914
      }
    },
    {
      "question_id": 170,
      "question": "How did Cisco's approach to the APJC region evolve between 2023 and 2024 in terms of operational structure versus financial investment, and what implications does this have for its revenue model in that region?",
      "original_answer": "In 2023, Cisco directly operated in the APJC region as one of its three geographic segments, indicating a strong operational presence focused on delivering products and services. By 2024, Cisco's relationship with APJC evolved to include financial investments, specifically through equity instruments categorized as marketable equity securities, non-marketable equity securities, and equity method investments. While the 2023 filing emphasized operational delivery and customer engagement in APJC, the 2024 financial statements suggest a parallel strategy of capital participation, potentially signaling a shift toward leveraging local market growth through investment rather than solely through direct sales. This dual approach could indicate a broader revenue model incorporating both operational income and investment returns, though the filings do not quantify the specific financial impact of these investments on Cisco's APJC revenue.",
      "llm_answer": "Cisco’s APJC operations shifted from a more capital‑intensive, hardware‑centric model in 2023 to a greater emphasis on software‑as‑a‑service and subscription‑based revenue streams in 2024, reflected in increased investment in cloud‑managed networking and security offerings. This strategic pivot reduces reliance on traditional product sales and drives a more recurring‑revenue model in the region.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CSCO_10k_2023.pdf",
          "target_page": 3,
          "pages": [
            1,
            2,
            3,
            4,
            5
          ]
        },
        "hop_2_rel": {
          "source_file": "CSCO_10k_2024.pdf",
          "target_page": 65,
          "pages": [
            63,
            64,
            65,
            66,
            67
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 58841,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 14946,
        "completion_tokens": 99,
        "total_tokens": 15045
      }
    },
    {
      "question_id": 172,
      "question": "How has Apple's approach to App Store commissions and regulatory compliance evolved between 2022 and 2024, particularly in response to legal and market pressures?",
      "original_answer": "In 2022, Apple acknowledged that changes to the App Store, including those in response to legal and market conditions, could reduce the volume of sales and the commission it earns on those sales, potentially affecting its financial condition. By 2024, Apple had implemented specific changes, particularly in the U.S. and the European Union, to address legal pressures such as the Digital Markets Act (DMA). These changes included new business terms, alternative fee structures, alternative app distribution methods, and additional developer tools and APIs. These adjustments reflect a shift from a more general acknowledgment of potential changes to concrete actions taken in response to regulatory demands, which could significantly affect App Store revenue and commission structures.",
      "llm_answer": "Between 2022 and 2024, Apple’s App Store commission structure and regulatory compliance evolved in direct response to mounting legal and market pressures. In 2022, Apple maintained its standard 15–30% commission model but began preemptively adjusting its policies ahead of anticipated regulatory scrutiny, particularly in the EU and under U.S. antitrust investigations. By 2024, following rulings such as the *Epic Games v. Apple* case and the implementation of the EU’s Digital Markets Act (DMA), Apple was compelled to allow alternative payment systems and app distribution channels in the EU, while in the U.S., it introduced changes to how developers communicate with users about off‑App purchases, though it retained its core commission rates. These adjustments reflect a shift from a rigid, uniform fee structure to a more nuanced, region‑specific approach that balances compliance with ongoing revenue goals. Additionally, Apple has increasingly emphasized its role as a platform provider, highlighting the importance of third‑party developer support and digital content availability, while also investing in robust compliance mechanisms to mitigate litigation and regulatory risks.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AAPL_10k_2022.pdf",
          "target_page": 13,
          "pages": [
            11,
            12,
            13,
            14,
            15
          ]
        },
        "hop_2_rel": {
          "source_file": "AAPL_10k_2024.pdf",
          "target_page": 13,
          "pages": [
            11,
            12,
            13,
            14,
            15
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 59091,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 14997,
        "completion_tokens": 297,
        "total_tokens": 15295
      }
    },
    {
      "question_id": 175,
      "question": "How did the allocation strategy for Texas Instruments' U.S. Retiree Health Care Plan evolve between fixed income securities and equity securities from 2022 to 2024?",
      "original_answer": "In 2022, the U.S. Retiree Health Care Plan had a diversified mix of fixed income securities and equity securities, with fixed income and cash equivalents totaling $248 million and equity securities at $137 million. By 2024, the allocation strategy showed a significant shift toward a more conservative posture, with fixed income securities and cash equivalents comprising 80% of the portfolio, while equity securities made up only 20%. This reflects a notable increase in emphasis on fixed income securities compared to equities, even though the relative proportions remained the same between 2023 and 2024, suggesting a strategic decision to prioritize capital preservation.",
      "llm_answer": "The allocation strategy for Texas Instruments' U.S. Retiree Health Care Plan shifted toward a higher proportion of fixed‑income securities over the period. In 2022 the plan’s assets were roughly 65% fixed income and 35% equity, while by 2024 the fixed‑income share rose to about 80% (with equity falling to roughly 20%), reflecting a deliberate move to align assets more closely with liability‑driven, interest‑rate sensitivity. This evolution is evident in the disclosed target ranges (fixed‑income 65‑80% and equity 20‑35% for the U.S. retiree health plan) and the actual weighted‑average allocations reported for 2024.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "TXN_10k_2022.pdf",
          "target_page": 48,
          "pages": [
            46,
            47,
            48,
            49,
            50
          ]
        },
        "hop_2_rel": {
          "source_file": "TXN_10k_2024.pdf",
          "target_page": 48,
          "pages": [
            46,
            47,
            48,
            49,
            50
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 55698,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 14149,
        "completion_tokens": 155,
        "total_tokens": 14304
      }
    },
    {
      "question_id": 177,
      "question": "How has Texas Instruments' strategic emphasis on Embedded Processing Products evolved from 2022 to 2024, particularly in terms of its contribution to the company's competitive advantages and segment reporting structure?",
      "original_answer": "In 2022, Texas Instruments described Embedded Processing as one of its core product lines within a broader business model that emphasized four competitive advantages: manufacturing and technology strength, a broad product portfolio, strong market channels, and product diversity and longevity. Embedded Processing was positioned as part of this integrated strategy but was not highlighted as a standalone reportable segment. By 2024, Embedded Processing was elevated to a reportable segment alongside Analog, indicating a strategic shift where the company explicitly called out Embedded Processing as a key driver of value. This change suggests that Embedded Processing has become more central to TI's competitive positioning, particularly in terms of enabling optimized performance, power, and cost across a range of customer applications. The elevation to a reportable segment also implies greater operational and financial focus, aligning with the company’s long-term objective of strengthening its competitive advantages and driving free cash flow growth.",
      "llm_answer": "From 2022 to 2024, Texas Instruments has maintained its strategic focus on analog and embedded processing products as core growth drivers, leveraging these segments to reinforce its competitive advantages in manufacturing efficiency, broad product portfolios, and supply chain control. In its 2024 segment reporting, the Analog segment generated $12.161 billion in revenue (38% of total) with a strong operating profit of $4.608 billion (38% margin), while Embedded Processing contributed $2.533 billion in revenue (16% of total) with $352 million in operating profit (14% margin)—both showing improved profitability versus prior years, underscoring how these segments continue to drive margin expansion and cash flow generation that underpin TI’s overall financial strength.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "TXN_10k_2022.pdf",
          "target_page": 20,
          "pages": [
            18,
            19,
            20,
            21,
            22
          ]
        },
        "hop_2_rel": {
          "source_file": "TXN_10k_2024.pdf",
          "target_page": 30,
          "pages": [
            28,
            29,
            30,
            31,
            32
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 45536,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 11622,
        "completion_tokens": 193,
        "total_tokens": 11816
      }
    },
    {
      "question_id": 177,
      "question": "How did TMO's issuance and valuation of its 2.00% 10-Year Senior Notes evolve between 2022 and 2024?",
      "original_answer": "In 2022, TMO reported $1,200 million in 2.00% 10-Year Senior Notes due on October 15, 2031, with an effective interest rate of 2.23%. By 2024, the same category of 2.00% 10-Year Senior Notes showed no change in the principal amount at $1,200 million, and the effective interest rate remained at 2.23%. This indicates that TMO maintained a consistent position on this specific debt instrument over the two-year period, with no new issuances or repayments affecting this line item.",
      "llm_answer": "Between 2022 and 2024, Thermo Fisher’s 2.00% 10‑Year Senior Notes due 2025 evolved from a €782 million issuance in 2022 (reflecting a 2.10 % effective rate) to a €663 million balance by the end of 2024, with the effective interest rate rising slightly to 2.07 % as shown in the 2024 debt tables. This evolution reflects both the remaining principal outstanding and the modest increase in the noted effective rate over the period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "TMO_10k_2022.pdf",
          "target_page": 88,
          "pages": [
            86,
            87,
            88,
            89,
            90
          ]
        },
        "hop_2_rel": {
          "source_file": "TMO_10k_2024.pdf",
          "target_page": 47,
          "pages": [
            45,
            46,
            47,
            48,
            49
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 48456,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 12323,
        "completion_tokens": 107,
        "total_tokens": 12430
      }
    },
    {
      "question_id": 178,
      "question": "How has the financial performance of REMICADE evolved between 2022 and 2024, and what does this indicate about its role in Johnson & Johnson's Pharmaceutical segment?",
      "original_answer": "In 2022, REMICADE was listed as a key product in Johnson & Johnson's Pharmaceutical segment, specifically within the Immunology therapeutic area, indicating its importance in treating immune-mediated inflammatory diseases. By 2024, REMICADE's sales had declined significantly, from $1,839 million in 2023 to $1,605 million in 2024, representing a 12.8% decrease. This decline suggests a diminishing contribution of REMICADE to the company's Immunology revenue, potentially due to market saturation, increased competition, or the emergence of newer biologics within the segment.",
      "llm_answer": "Between 2022 and 2024, REMICADE’s sales declined sharply from $1,839 million in 2023 to $1,605 million in 2024 (a 12.8 % drop), reflecting ongoing biosimilar competition and reduced market share. This downturn underscores that REMICADE’s contribution to Johnson & Johnson’s Pharmaceutical segment is diminishing, with growth now driven by newer immunology agents such as TREMFYA and DARZALEX and by oncology products. Consequently, REMICADE is becoming a less central revenue driver within the company’s pharmaceutical portfolio.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "JNJ_10k_2022.pdf",
          "target_page": 7,
          "pages": [
            5,
            6,
            7,
            8,
            9
          ]
        },
        "hop_2_rel": {
          "source_file": "JNJ_10k_2024.pdf",
          "target_page": 31,
          "pages": [
            29,
            30,
            31,
            32,
            33
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 44050,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 11236,
        "completion_tokens": 132,
        "total_tokens": 11369
      }
    },
    {
      "question_id": 179,
      "question": "How did the sales performance of REMICADE evolve from 2022 to 2024, and what does this indicate about its market position within JNJ's Immunology portfolio?",
      "original_answer": "In 2022, REMICADE had sales of $3,190 million, showing a decline of 14.9% compared to 2020. By 2024, its sales had further decreased to $1,605 million, representing a 12.8% drop from 2023. This consistent decline indicates a weakening market position of REMICADE within JNJ's Immunology portfolio over time.",
      "llm_answer": "From 2022 to 2024, REMICADE sales declined sharply from $1,839 million (2022) to $1,605 million (2023) and further to $1,605 million (2024), with a 12.8% drop in 2024 (down 11.4% operationally). This reflects ongoing biosimilar competition eroding its market position within J&J's Immunology portfolio, where it now represents a small fraction of total Immunology sales ($17.8 billion in 2024). While STELARA and TREMFYA drove Immunology growth, REMICADE's sustained decline underscores its weakening competitive standing as biosimilars gain market share.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "JNJ_10k_2022.pdf",
          "target_page": 30,
          "pages": [
            28,
            29,
            30,
            31,
            32
          ]
        },
        "hop_2_rel": {
          "source_file": "JNJ_10k_2024.pdf",
          "target_page": 31,
          "pages": [
            29,
            30,
            31,
            32,
            33
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 40385,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 10319,
        "completion_tokens": 138,
        "total_tokens": 10458
      }
    },
    {
      "question_id": 180,
      "question": "How has the sales performance of REMICADE evolved between 2021 and 2024, and what factors contributed to this change?",
      "original_answer": "REMICADE's sales declined significantly from $16.8 billion in 2021 (as part of total Immunology sales) to $1,605 million in 2024, reflecting a 12.8% decrease from 2023 to 2024 alone. This decline was primarily driven by biosimilar competition in the U.S. and other global markets, which intensified over time and led to a continued reduction in REMICADE sales.",
      "llm_answer": "The sales of REMICADE declined 12.8% from 2023 to $1,605 million in 2024, driven by ongoing biosimilar competition that has reduced its market share. This decline contributed to a 1.2% overall decrease in Immunology segment sales ($17,828 million in 2024 vs. $18,052 million in 2023), as noted on page 31. Additionally, the document states that \"Continued infliximab biosimimal competition will result in a further reduction in sales of REMICADE\" (page 32), confirming that biosimilar entry has been a persistent factor in its sales decline.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "JNJ_10k_2022.pdf",
          "target_page": 31,
          "pages": [
            29,
            30,
            31,
            32,
            33
          ]
        },
        "hop_2_rel": {
          "source_file": "JNJ_10k_2024.pdf",
          "target_page": 31,
          "pages": [
            29,
            30,
            31,
            32,
            33
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 41347,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 10550,
        "completion_tokens": 135,
        "total_tokens": 10685
      }
    },
    {
      "question_id": 181,
      "question": "How did the status and commercial performance of STELARA (ustekinumab) evolve between 2022 and 2024?",
      "original_answer": "In 2022, STELARA was in the filing stage for the treatment of pediatric patients with juvenile psoriatic arthritis in the U.S., indicating it was under regulatory review but not yet approved. By 2024, STELARA had achieved significant commercial success, generating $10,361 million in sales, a decrease from $10,858 million in 2023, representing a 4.6% decline in total sales. This reflects that STELARA had transitioned from a product in active regulatory development to a mature, high-revenue-generating drug facing slight sales decline, suggesting market saturation or increased competition.",
      "llm_answer": "Based on the provided SEC 10-K filing data, STELARA (ustekinumab) experienced a significant decline in commercial performance between 2022 and 2024. In 2024, sales of STELARA in the United States were approximately $6.7 billion, representing a 4.6% decrease from $10.858 billion in 2023 (page 31). This decline was primarily driven by biosimilar competition in Europe, where third parties had filed abbreviated applications seeking approval for biosimilar versions, with the Company expecting continued biosimilar launches in both Europe and the U.S. in 2025 (page 32). The patent protecting STELARA in the U.S. expired in September 2023, further contributing to the sales reduction as biosimilars entered the market.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "JNJ_10k_2022.pdf",
          "target_page": 32,
          "pages": [
            30,
            31,
            32,
            33,
            34
          ]
        },
        "hop_2_rel": {
          "source_file": "JNJ_10k_2024.pdf",
          "target_page": 31,
          "pages": [
            29,
            30,
            31,
            32,
            33
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 39262,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 10024,
        "completion_tokens": 179,
        "total_tokens": 10203
      }
    },
    {
      "question_id": 182,
      "question": "How did the total net revenue from Restasis in the United States change between 2023 and 2024, and what was the percentage decrease in each year?",
      "original_answer": "In 2023, the United States net revenue from Restasis was $382 million, which decreased to $172 million in 2024. This represents a 38.5% decrease in 2023 compared to 2022, and a further 55.2% decrease in 2024 compared to 2023.",
      "llm_answer": "The total net revenue from Restasis in the United States decreased by 55.2% in 2024 compared to 2023, and by 38.5% in 2023 compared to 2022.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "ABBV_10k_2023.pdf",
          "target_page": 43,
          "pages": [
            41,
            42,
            43,
            44,
            45
          ]
        },
        "hop_2_rel": {
          "source_file": "ABBV_10k_2024.pdf",
          "target_page": 43,
          "pages": [
            41,
            42,
            43,
            44,
            45
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 64480,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 16340,
        "completion_tokens": 35,
        "total_tokens": 16375
      }
    },
    {
      "question_id": 1,
      "question": "How has the role and strategic importance of Master Lease Agreements evolved between 2022 and 2023 in supporting AMT's international growth and tenant relationships?",
      "original_answer": "In 2022, AMT emphasized that master lease agreements were comprehensive in nature and instrumental in building strong strategic partnerships with tenants, significantly reducing colocation cycle times and enabling rapid deployment of equipment across its international portfolio of approximately 177,000 communications sites. By 2023, AMT reiterated the importance of these agreements in providing consistent, long-term revenue and reducing non-contractual churn, while operating an expanded international portfolio of approximately 182,000 communications sites. The evolution reflects a continued strategic focus on leveraging master lease agreements to support international growth and tenant retention, with an emphasis on mitigating risks such as customer consolidation and regulatory changes.",
      "llm_answer": "Master Lease Agreements have become increasingly strategic between 2022 and 2023 as a mechanism to secure long‑term, predictable revenue streams that underpin AMT’s international expansion.  The agreements—often comprehensive and multi‑year—reduce churn, lock in escalation clauses (typically 3% annually in the U.S. and inflation‑linked abroad), and enable rapid colocation of new tenant equipment, thereby accelerating site utilization and supporting the company’s growth in emerging markets such as India, Africa and Latin America.  This structure not only cushions AMT against carrier consolidation and churn risks but also provides the stable, recurring cash flow needed to fund its aggressive site‑acquisition and development program across its 182,000‑site global portfolio.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AMT_10k_2022.pdf",
          "target_page": 34,
          "pages": [
            32,
            33,
            34,
            35,
            36
          ]
        },
        "hop_2_rel": {
          "source_file": "AMT_10k_2023.pdf",
          "target_page": 37,
          "pages": [
            35,
            36,
            37,
            38,
            39
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 52835,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 13434,
        "completion_tokens": 195,
        "total_tokens": 13629
      }
    },
    {
      "question_id": 1,
      "question": "How has the role of Google Marketing Platform in the company's advertising revenue generation evolved between 2023 and 2024, particularly in relation to how advertising revenues are recognized and managed across Google Network properties?",
      "original_answer": "In 2023, Google Marketing Platform was directly involved in the recognition of advertising revenues on a gross basis for Google Network properties, meaning the full amount billed to customers was recorded as revenue. By 2024, the platform's role evolved to include a more nuanced evaluation of its principal versus agent status, with an emphasis on its control over advertising inventory before transfer to customers, further supporting the gross revenue reporting. Additionally, 2024 introduced a more detailed explanation of the platform's role in managing advertising across Google Network properties, highlighting its central function in both performance and brand advertising delivery.",
      "llm_answer": "The role of Google Marketing Platform in Alphabet’s advertising revenue has expanded significantly between 2023 and 2024, now serving as a key channel for delivering both performance and brand advertising across Google Network properties. Advertising revenues from this platform are recognized on a gross basis when we act as principal, with revenue recorded at the amount billed to customers and partner payments reported as cost of revenues. This structure allows Alphabet to capture full market pricing while managing recognition across its broader Google Network ecosystem.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "GOOGL_10k_2023.pdf",
          "target_page": 57,
          "pages": [
            55,
            56,
            57,
            58,
            59
          ]
        },
        "hop_2_rel": {
          "source_file": "GOOGL_10k_2024.pdf",
          "target_page": 58,
          "pages": [
            56,
            57,
            58,
            59,
            60
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 51786,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 13191,
        "completion_tokens": 144,
        "total_tokens": 13335
      }
    },
    {
      "question_id": 1,
      "question": "How did the volume and fair value of Federal Funds Purchased & Sec Loaned change between 2023 and 2024, and what does this indicate about BAC's short-term funding strategies?",
      "original_answer": "In 2023, the volume of Federal Funds Purchased & Sec Loaned showed a net change of $16,466 million, indicating a significant increase in short-term funding liabilities. By 2024, the fair value of this category was reported at $192,859 million, a substantial increase from the prior year. This suggests that BAC significantly expanded its reliance on short-term secured funding mechanisms in 2024, likely to support its trading and liquidity management activities.",
      "llm_answer": "Between 2023 and 2024, Federal Funds Purchased decreased from $14,804 million to $178,609 million (a modest decline), while Securities Loaned fell from $3,645 million to $192,859 million (a substantial drop). These declines indicate that Bank of America reduced its reliance on short‑term wholesale funding, shifting toward more stable funding sources such as deposits and retained earnings to support its short‑term liquidity needs.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "BAC_10k_2023.pdf",
          "target_page": 35,
          "pages": [
            33,
            34,
            35,
            36,
            37
          ]
        },
        "hop_2_rel": {
          "source_file": "BAC_10k_2024.pdf",
          "target_page": 155,
          "pages": [
            153,
            154,
            155,
            156,
            157
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 115139,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 29013,
        "completion_tokens": 108,
        "total_tokens": 29121
      }
    },
    {
      "question_id": 1,
      "question": "How has PepsiCo's disclosure regarding the sensitivity of pension and retiree medical plan liabilities to market fluctuations evolved between 2022 and 2024?",
      "original_answer": "In 2022, PepsiCo mentioned that the exposure of pension and retiree medical plan assets and liabilities to risks related to market fluctuations was discussed in 'Our Critical Accounting Policies and Estimates.' By 2024, the company expanded this disclosure, explicitly linking the sensitivity of these liabilities not only to market fluctuations but also to inflationary, deflationary, and recessionary conditions. This broader context indicates a more detailed characterization of the macroeconomic risks affecting these obligations, beyond just market volatility.",
      "llm_answer": "Between 2022 and 2024, PepsiCo's disclosures regarding pension and retiree medical plan liabilities shifted from a general discussion of market risks (e.g., interest rate and inflation impacts on pension assets/liabilities in 2022) to explicit quantification of sensitivity in 2024. In the 2024 filing (page 43), it states that a 1-percentage-point increase in interest rates would decrease net interest expense by $32 million due to higher cash balances, and notes that pension plan assets/liabilities are exposed to market fluctuations (referenced in \"Our Critical Accounting Policies and Estimates\"). The 2022 filing (page 39) only broadly mentions market risks affecting pension liabilities without specific sensitivity metrics, while the 2024 filing provides concrete, quantifiable exposure to interest rate changes.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "PEP_10k_2022.pdf",
          "target_page": 40,
          "pages": [
            38,
            39,
            40,
            41,
            42
          ]
        },
        "hop_2_rel": {
          "source_file": "PEP_10k_2024.pdf",
          "target_page": 42,
          "pages": [
            40,
            41,
            42,
            43,
            44
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 8,
        "total_chars": 31832,
        "num_window_pages": 8,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 8181,
        "completion_tokens": 205,
        "total_tokens": 8386
      }
    },
    {
      "question_id": 1,
      "question": "How has Adobe's approach to Adobe Scan evolved between 2023 and 2024, particularly in terms of its positioning within Adobe's broader document management ecosystem?",
      "original_answer": "In 2023, Adobe Scan was positioned as a free mobile scanning tool that converts paper documents into editable, searchable PDFs via Adobe Document Cloud services, emphasizing its utility for individual users. By 2024, Adobe Scan remained part of Adobe Document Cloud, but the broader ecosystem placed increased emphasis on integration with cloud-based productivity tools and AI-driven features like Content Credentials and Firefly-powered generative AI workflows, indicating a shift toward deeper integration within enterprise document workflows and enhanced digital trust mechanisms.",
      "llm_answer": "Adobe Scan remains positioned as a free, mobile-first scanning tool that transforms paper documents into editable PDFs via Adobe Document Cloud, maintaining its core functionality while being integrated into the broader Adobe Experience Cloud ecosystem. The 2024 context emphasizes its role within Adobe's AI-driven document workflows (e.g., Acrobat AI Assistant, Firefly integration), though its standalone positioning as a free mobile app for basic scanning has not changed significantly year-over-year.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "ADBE_10k_2023.pdf",
          "target_page": 13,
          "pages": [
            11,
            12,
            13,
            14,
            15
          ]
        },
        "hop_2_rel": {
          "source_file": "ADBE_10k_2024.pdf",
          "target_page": 12,
          "pages": [
            10,
            11,
            12,
            13,
            14
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 9,
        "total_chars": 44545,
        "num_window_pages": 9,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 11361,
        "completion_tokens": 126,
        "total_tokens": 11488
      }
    },
    {
      "question_id": 2,
      "question": "How has Gemini's role and integration across Google's products evolved from its initial launch in 2023 to 2024, and what specific advancements were made in its multimodal capabilities?",
      "original_answer": "In 2023, Gemini was introduced as a multimodal AI model capable of understanding and operating across different types of information, including text, code, audio, images, and video. It was intended to be leveraged across Alphabet to enhance product experiences. By 2024, Gemini had evolved significantly, with the launch of Gemini 2.0, which became the most capable model yet. It was integrated into all seven of Google's two billion-user products—Android, Chrome, Gmail, Maps, Play Store, Search, and YouTube—powering AI features across these platforms. Additionally, in 2024, Gemini was used in experimental research prototypes such as Project Astra and Project Mariner, showcasing broader and more advanced applications than in 2023.",
      "llm_answer": "From its 2023 launch, Gemini was introduced as Google’s first natively multimodal model, enabling it to understand and combine text, images, audio and video in a single system. By 2024, Gemini 2.0 was released as the most capable version yet, powering AI features across all of Google’s major products—including Search, Android, Chrome, Gmail, Maps, Play Store and YouTube—while also being integrated into Google Cloud’s Vertex AI platform for developers. This evolution transformed Gemini from a research breakthrough into a core, multimodal engine that drives search enhancements, generative AI experiences, and new assistant capabilities such as Project Astra and Project Mariner.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "GOOGL_10k_2023.pdf",
          "target_page": 6,
          "pages": [
            4,
            5,
            6,
            7,
            8
          ]
        },
        "hop_2_rel": {
          "source_file": "GOOGL_10k_2024.pdf",
          "target_page": 6,
          "pages": [
            4,
            5,
            6,
            7,
            8
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 9,
        "total_chars": 45224,
        "num_window_pages": 9,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 11534,
        "completion_tokens": 170,
        "total_tokens": 11705
      }
    },
    {
      "question_id": 2,
      "question": "How has Linde's relationship with helium evolved between 2022 and 2024, particularly in terms of its impact on sales and operating profit?",
      "original_answer": "In 2022, helium was listed as a supply for Linde, indicating a positive or neutral relationship. However, by 2024, the relationship had evolved, and helium was reported to negatively impact the company. Specifically, in 2024, lower volumes in global helium contributed to a 2% decrease in sales for the 'Other' segment, which includes global helium wholesale. Additionally, higher costs due to helium partially offset an insurance recovery for Linde Advanced Materials Technology (LAMT), limiting the operating profit growth in that segment despite a 44% overall increase in operating profit for 'Other'.",
      "llm_answer": "Linde's helium-related sales and operating profit trends are embedded within the \"Other\" segment, which includes global helium wholesale and LAMT. In 2024, sales for \"Other\" decreased 2% due to lower volumes in global helium, while operating profit increased 44% driven by insurance recoveries for LAMT partially offset by higher helium-related costs. This indicates helium's impact on profitability improved year-over-year despite modest sales declines. The document does not provide standalone helium sales figures but links helium's performance to the broader \"Other\" segment dynamics.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "LIN_10k_2022.pdf",
          "target_page": 29,
          "pages": [
            27,
            28,
            29,
            30,
            31
          ]
        },
        "hop_2_rel": {
          "source_file": "LIN_10k_2024.pdf",
          "target_page": 28,
          "pages": [
            26,
            27,
            28,
            29,
            30
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 34935,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 8952,
        "completion_tokens": 147,
        "total_tokens": 9099
      }
    },
    {
      "question_id": 2,
      "question": "How did the net value of acquired franchise rights evolve from 2022 to 2024, and what was the magnitude of this change?",
      "original_answer": "In 2022, the net value of acquired franchise rights was $789 million, while in 2024 it decreased to $598 million. This represents a significant decline in value over the two-year period.",
      "llm_answer": "The net value of acquired franchise rights declined slightly from $1,891 million in 2022 to $1,858 million in 2024, a decrease of $33 million over the two‑year period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "PEP_10k_2022.pdf",
          "target_page": 81,
          "pages": [
            79,
            80,
            81,
            82,
            83
          ]
        },
        "hop_2_rel": {
          "source_file": "PEP_10k_2024.pdf",
          "target_page": 83,
          "pages": [
            81,
            82,
            83,
            84,
            85
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 44339,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 11298,
        "completion_tokens": 41,
        "total_tokens": 11340
      }
    },
    {
      "question_id": 3,
      "question": "How did Chevron's natural gas delivery commitments and production volumes related to Tengizchevroil evolve from 2023 to 2024?",
      "original_answer": "In 2023, Chevron reported that its natural gas volumes included 596 million cubic feet per day consumed in operations and 7,148 million cubic feet per day as sold, which included its share from Tengizchevroil in Kazakhstan. By 2024, these figures increased to 609 million cubic feet per day consumed and 7,569 million cubic feet per day as sold, indicating a growth in both operational consumption and market delivery. This reflects an increase in Chevron’s involvement and dependency on Tengizchevroil for natural gas production and delivery commitments.",
      "llm_answer": "Chevron’s natural‑gas delivery commitments and Tengizchevroil production volumes are not detailed in the provided 2023‑2024 SEC 10‑K excerpts. The filings disclose general gas‑sales contracts (e.g., 2.9 trillion cubic feet of gas to be delivered from Australia and Israel through 2026) and worldwide gas production figures, but they do not specify the evolution of any specific Tengizchevroil delivery commitment or its production volume trajectory from 2023 to 2024. Consequently, the requested evolution cannot be determined from the supplied pages.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CVX_10k_2023.pdf",
          "target_page": 9,
          "pages": [
            7,
            8,
            9,
            10,
            11
          ]
        },
        "hop_2_rel": {
          "source_file": "CVX_10k_2024.pdf",
          "target_page": 9,
          "pages": [
            7,
            8,
            9,
            10,
            11
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 71399,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 18063,
        "completion_tokens": 137,
        "total_tokens": 18201
      }
    },
    {
      "question_id": 3,
      "question": "How has the role of Google Network partners in Google's advertising revenue model evolved between 2023 and 2024, based on changes in the way payments to these partners are described?",
      "original_answer": "In 2023, Google Network partners were described as part of the primary uses of cash from operating activities, specifically noting payments made to these partners as a standard operating expense. By 2024, the description evolved to categorize payments to Google Network partners under Traffic Acquisition Costs (TAC), explicitly linking them to ads displayed on partner properties and tying them directly to revenue generation. This shift indicates a more strategic and performance-based dependency on these partners within the advertising ecosystem.",
      "llm_answer": "The role of Google Network partners in Google's advertising revenue model has shifted from being treated as a cost of revenue (where payments to partners were recorded as cost of revenues) to being recognized as a revenue share that is now disclosed as part of the company's advertising revenue structure, with the 2024 filing showing that payments to Google Network partners are now accounted for as a reduction in revenue (i.e., reported on a gross basis with partner payments as cost of revenue) rather than as a separate expense line, reflecting a more integrated integration of network partner revenue into the core advertising revenue model.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "GOOGL_10k_2023.pdf",
          "target_page": 42,
          "pages": [
            40,
            41,
            42,
            43,
            44
          ]
        },
        "hop_2_rel": {
          "source_file": "GOOGL_10k_2024.pdf",
          "target_page": 59,
          "pages": [
            57,
            58,
            59,
            60,
            61
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 48509,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 12357,
        "completion_tokens": 161,
        "total_tokens": 12519
      }
    },
    {
      "question_id": 3,
      "question": "How has the impact of public policies on Bank of America's climate-related regulatory requirements evolved from 2023 to 2024, particularly in terms of jurisdictional divergence and compliance risks?",
      "original_answer": "In 2023, Bank of America highlighted increasing global regulatory focus on climate change, noting that new or heightened regulatory requirements across state, federal, and non-U.S. jurisdictions were expected to increase legal, compliance, and public disclosure risks and costs. The company specifically mentioned jurisdictional divergence as a challenge. By 2024, this concern intensified, with the company noting that existing and pending disclosure requirements in various jurisdictions, along with jurisdictional divergence, were now actively impacting legal, compliance, and public disclosure risks and costs. This indicates a shift from anticipation of increased risk to experiencing tangible impacts due to evolving public policies.",
      "llm_answer": "From 2023 to 2024, the impact of public policies on Bank of America’s climate‑related regulatory requirements shifted from a focus on evolving disclosure and reporting obligations (e.g., SEC climate‑related rules and global benchmark reforms) to heightened, divergent jurisdictional mandates—such as the OECD 15 % global minimum tax, stricter U.K. tax‑asset assessments, and expanding climate‑related reporting and emissions‑target requirements—raising compliance complexity and creating new cross‑border legal risks. This evolution has amplified the company’s exposure to differing regulatory expectations across the U.S., U.K., EU and other jurisdictions, increasing potential penalties, litigation and reputational exposure tied to climate‑related disclosures and actions.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "BAC_10k_2023.pdf",
          "target_page": 24,
          "pages": [
            22,
            23,
            24,
            25,
            26
          ]
        },
        "hop_2_rel": {
          "source_file": "BAC_10k_2024.pdf",
          "target_page": 24,
          "pages": [
            22,
            23,
            24,
            25,
            26
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 64713,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 16411,
        "completion_tokens": 193,
        "total_tokens": 16605
      }
    },
    {
      "question_id": 3,
      "question": "How has General Motors' strategic emphasis on full-size pickup trucks evolved from 2022 to 2024, and what quantitative indicators in 2024 suggest a shift toward stronger performance and market positioning for this product line?",
      "original_answer": "In 2022, General Motors identified the success of its full-size SUVs and full-size pickup trucks as a key risk factor, indicating that their performance was critical to the company's competitive position and financial health. By 2024, this strategic emphasis had evolved into a demonstrated strength, as evidenced by a significant increase in net wholesale volumes driven by higher sales of full-size pickup trucks. Additionally, the 2024 report highlights that full-size pickup trucks contributed favorably to the company's EBIT-adjusted results, with a variable profit of approximately 160% for trucks on a weighted-average basis, reflecting improved profitability and market demand for this product line.",
      "llm_answer": "From 2022 to 2024 GM’s strategy has shifted to double‑down on its full‑size pickup and mid‑size truck lines, using higher wholesale volumes and a more profitable mix to lift GMNA net sales (+11.4% in 2024) and EBIT‑adjusted (+18.1% in 2024).  In 2024 the company reports a $12.8 billion volume‑driven increase in GMNA net sales, with full‑size pickups accounting for the bulk of that growth, and notes that trucks now represent roughly 23.7 % of residual‑value units and generate higher variable profit, signaling a stronger market position for this product line.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "GM_10k_2022.pdf",
          "target_page": 48,
          "pages": [
            46,
            47,
            48,
            49,
            50
          ]
        },
        "hop_2_rel": {
          "source_file": "GM_10k_2024.pdf",
          "target_page": 34,
          "pages": [
            32,
            33,
            34,
            35,
            36
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 59763,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 15181,
        "completion_tokens": 140,
        "total_tokens": 15321
      }
    },
    {
      "question_id": 3,
      "question": "How did the allocation to U.S. Treasury and government agency securities within the nuclear decommissioning trusts evolve from 2022 to 2024, and what does this shift indicate about the company's investment strategy?",
      "original_answer": "In 2022, the allocation to U.S. Treasury and government agency securities was $21 million for Alabama Power and $293 million for Georgia Power. By 2024, this allocation decreased slightly to $20 million for Alabama Power but increased significantly to $349 million for Georgia Power. The overall trend shows a shift in focus toward Georgia Power’s portfolio, indicating a possible reallocation of safer, fixed-income assets to that subsidiary.",
      "llm_answer": "From 2022 to 2024, the allocation to U.S. Treasury and government agency securities within the nuclear decommissioning trusts declined modestly—from $9 million at the end of 2022 to $9 million at the end of 2023, and then to $9 million again by the end of 2024—indicating a relatively stable but small position. This shift suggests the company is maintaining a conservative, liquid investment posture for its decommissioning funds, while gradually emphasizing higher‑yielding or alternative assets (e.g., private‑equity, real‑estate, and corporate bonds) to enhance returns without significantly altering the overall risk profile.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "SO_10k_2022.pdf",
          "target_page": 311,
          "pages": [
            309,
            310,
            311,
            312,
            313
          ]
        },
        "hop_2_rel": {
          "source_file": "SO_10k_2024.pdf",
          "target_page": 277,
          "pages": [
            275,
            276,
            277,
            278,
            279
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 88448,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 22351,
        "completion_tokens": 157,
        "total_tokens": 22509
      }
    },
    {
      "question_id": 3,
      "question": "How has PepsiCo's relationship with independent bottlers evolved from 2022 to 2024 in terms of financial incentives and strategic dependency?",
      "original_answer": "In 2022, PepsiCo provided sales incentives and discounts to independent bottlers primarily through funding of advertising and other marketing activities, with accruals based on annual targets and historical experience. By 2024, the company's relationship had evolved into a more structured dependency, with bottler funding negotiated annually and specifically allocated across trade and consumer programs such as advertising support, new product launches, and vending equipment placement. Additionally, in 2024, sales through independent bottlers contributed to a significant portion of revenue, with Walmart alone accounting for approximately 14% of consolidated net revenue, highlighting increased strategic dependency on these bottlers.",
      "llm_answer": "From 2022 to 2024, PepsiCo’s relationship with independent bottlers shifted toward greater financial incentives and deeper strategic dependency. The company expanded bottler funding—annual, performance-based payments supporting advertising, consumer promotions, new product launches, and equipment placement—while maintaining exclusive territorial rights and perpetual franchise agreements that lock in long-term supply relationships. This increased reliance on bottler funding, coupled with the absence of any contractual limits on franchise rights, reinforces strategic dependency, as these rights are treated as indefinite-lived assets and are critical to PepsiCo’s global distribution model.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "PEP_10k_2022.pdf",
          "target_page": 60,
          "pages": [
            58,
            59,
            60,
            61,
            62
          ]
        },
        "hop_2_rel": {
          "source_file": "PEP_10k_2024.pdf",
          "target_page": 9,
          "pages": [
            7,
            8,
            9,
            10,
            11
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 9,
        "total_chars": 37551,
        "num_window_pages": 9,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 9606,
        "completion_tokens": 173,
        "total_tokens": 9780
      }
    },
    {
      "question_id": 3,
      "question": "How has Adobe Firefly's role within Adobe's product innovation strategy evolved from 2023 to 2024, based on its positioning in the company's trademark listings and risk disclosures?",
      "original_answer": "In 2023, Adobe Firefly was listed among Adobe's trademarks, indicating it was an established product within the company's portfolio. By 2024, Adobe Firefly was specifically highlighted in the risk factors section as a newly released generative AI product, reflecting its strategic importance in Adobe's innovation efforts. This evolution shows a shift from being a registered brand to becoming a central part of Adobe's forward-looking product development and AI strategy, with explicit mention of its role in addressing market demands for generative AI capabilities.",
      "llm_answer": "Adobe Firefly’s role in the company’s innovation strategy has shifted from a nascent, experimental capability in 2023 to a core, strategically‑integrated AI platform by 2024, as reflected in its expanded trademark coverage and heightened risk disclosures that emphasize both the growth potential and the regulatory, competitive and reputational risks associated with its AI investments.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "ADBE_10k_2023.pdf",
          "target_page": 99,
          "pages": [
            94,
            95,
            96,
            97,
            98
          ]
        },
        "hop_2_rel": {
          "source_file": "ADBE_10k_2024.pdf",
          "target_page": 23,
          "pages": [
            21,
            22,
            23,
            24,
            25
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 52229,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 13287,
        "completion_tokens": 96,
        "total_tokens": 13383
      }
    },
    {
      "question_id": 4,
      "question": "How has the role of contractual rent escalations in driving tenant billing growth changed between 2022 and 2023, particularly in light of the increased churn and lease cancellations in 2023?",
      "original_answer": "In 2022, contractual rent escalations were highlighted as a key factor contributing to tenant billing growth, listed alongside new colocation activity and lease amendments. By 2023, while contractual rent escalations remained a stated driver of growth, the context shifted due to an elevated churn rate of approximately 3%, primarily in the U.S. & Canada segment. This churn, expected to remain elevated through 2025 due to T-Mobile's lease cancellations, introduced a countervailing force against the positive impact of rent escalations, suggesting a more challenging environment for maintaining organic revenue growth solely through escalations.",
      "llm_answer": "The role of contractual rent escalations in driving tenant‑billing growth shifted markedly from 2022 to 2023. In 2022, escalations contributed to growth but churn remained modest (≈4 % in 2021 and ≈3 % in 2023), so rent increases were the primary growth lever. By 2023, however, churn rose to about 3 % of tenant billings—driven largely by cancellations and non‑renewals in the U.S. & Canada segment, especially T‑Mobile’s legacy Sprint leases—causing the net effect of rent escalations to be partially offset by the loss of revenue from churned tenants. Consequently, while escalations still add to billing growth, their contribution is now tempered by higher churn that erodes the incremental rent that would otherwise be realized.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AMT_10k_2022.pdf",
          "target_page": 33,
          "pages": [
            31,
            32,
            33,
            34,
            35
          ]
        },
        "hop_2_rel": {
          "source_file": "AMT_10k_2023.pdf",
          "target_page": 35,
          "pages": [
            33,
            34,
            35,
            36,
            37
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 56374,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 14325,
        "completion_tokens": 183,
        "total_tokens": 14508
      }
    },
    {
      "question_id": 4,
      "question": "How has Chevron's (CVX) relationship with Tengizchevroil evolved between 2023 and 2024 in terms of capital expenditure commitments and production involvement?",
      "original_answer": "In 2023, Chevron indicated that nearly half of its Affiliate Capex, which was expected to be $3 billion in 2024, was allocated to Tengizchevroil's FGP/WPMP Project in Kazakhstan. By 2024, Chevron continued to highlight its production involvement with Tengizchevroil, noting that production volumes included Chevron's share from affiliates such as Tengizchevroil in Kazakhstan. While 2023 focused on capital commitments for project development, 2024 emphasized ongoing production contributions from the same entity, indicating a shift from investment to operational phase.",
      "llm_answer": "Chevron's capital expenditure commitments to Tengizchevroil have remained focused on the $1.5 billion allocated to the FGP/WPMP project in Kazakhstan, which is part of the company's broader $16 billion 2024 capex plan and includes roughly one‑third of its affiliate‑level spending. While Chevron continues to be involved in the upstream operations of Tengizchevroil through its equity stake, there is no indication of any new, significant increase in capital commitments between 2023 and 2024; the company's disclosed capex for the joint venture remains around $1.5 billion, consistent with its prior‑year allocation.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CVX_10k_2023.pdf",
          "target_page": 50,
          "pages": [
            48,
            49,
            50,
            51,
            52
          ]
        },
        "hop_2_rel": {
          "source_file": "CVX_10k_2024.pdf",
          "target_page": 9,
          "pages": [
            7,
            8,
            9,
            10,
            11
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 60454,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 15336,
        "completion_tokens": 154,
        "total_tokens": 15490
      }
    },
    {
      "question_id": 4,
      "question": "How has the specificity of UPS's bond matching approach evolved in determining the discount rate for U.S. pension and postretirement benefit plans between 2023 and 2024?",
      "original_answer": "In 2023, UPS described using a bond matching approach to select specific bonds that would satisfy projected benefit payments, emphasizing its belief that this method reflects the process they would employ to settle pension and postretirement obligations. By 2024, the language evolved to place stronger emphasis on the bond matching approach as a guide for selecting bonds that align with projected benefit cash flows, without any material change in the mechanics of the method. However, the 2024 disclosure included a more precise statement indicating that the approach 'guides' the selection process, suggesting a subtle shift in how the policy is framed operationally, even though the underlying practice remained consistent.",
      "llm_answer": "The specificity of UPS’s bond‑matching approach for determining the discount rate for its U.S. pension and postretirement benefit plans has remained consistent between 2023 and 2024 – the company continues to select individual bonds that match the timing of projected benefit payments to establish the discount rate, rather than relying on a generic yield‑curve assumption. However, the actual discount rates applied shifted slightly: the 2024 U.S. pension discount rate was 5.88 % (up from 5.42 % in 2023), and the 2024 postretirement medical discount rate was 6.18 % (up from 5.80 % in 2023), reflecting the updated bond‑matching calculations.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "UPS_10k_2023.pdf",
          "target_page": 84,
          "pages": [
            82,
            83,
            84,
            85,
            86
          ]
        },
        "hop_2_rel": {
          "source_file": "UPS_10k_2024.pdf",
          "target_page": 88,
          "pages": [
            86,
            87,
            88,
            89,
            90
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 58718,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 14905,
        "completion_tokens": 161,
        "total_tokens": 15067
      }
    },
    {
      "question_id": 4,
      "question": "How has Linde's relationship with helium evolved from 2022 to 2024, and what financial impact did this change have on the company's sales and operating profit during this period?",
      "original_answer": "In 2022, helium was a supply input for Linde, indicating a supportive role in operations. By 2024, helium had a negative impact on operations, with a $32 million, or 2%, decrease in sales for the Other segment primarily due to lower volumes in global helium and LAMT. Additionally, helium-related costs contributed to downward pressure on operating profit, partially offset by an insurance recovery for LAMT. This reflects a shift from a neutral or positive relationship to one that posed operational challenges.",
      "llm_answer": "From 2022 to 2024, Linde’s helium business shifted from being a major growth driver to a smaller, more stable part of its portfolio, with helium sales declining slightly (‑2% in 2024 versus 2023) due to lower volumes and pricing pressure, while the company offset this by focusing on higher‑margin projects and cost‑pass‑through mechanisms. This evolution contributed to a modest rise in overall sales for the “Other” category (which includes global helium wholesale) of $32 million (‑2%) in 2024, but operating profit in that category actually increased $19 million (44%) because insurance recoveries and productivity gains outweighed the higher helium‑related costs. Consequently, the net financial impact was limited: sales grew only modestly and operating profit improved slightly, reflecting the transition of helium from a high‑growth to a more mature, profit‑contributing line item.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "LIN_10k_2022.pdf",
          "target_page": 70,
          "pages": [
            68,
            69,
            70,
            71,
            72
          ]
        },
        "hop_2_rel": {
          "source_file": "LIN_10k_2024.pdf",
          "target_page": 28,
          "pages": [
            26,
            27,
            28,
            29,
            30
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 32473,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 8346,
        "completion_tokens": 222,
        "total_tokens": 8569
      }
    },
    {
      "question_id": 4,
      "question": "How did Bank of America's unfunded capital contributions for renewable energy investments evolve between 2023 and 2024, and what was the corresponding change in recognized tax credits related to these investments?",
      "original_answer": "In 2023, Bank of America had unfunded capital contributions for renewable energy investments of $6.2 billion, and it recognized tax credits and other tax benefits of $4.0 billion. By 2024, the unfunded capital contributions decreased to $4.6 billion, and the recognized tax credits slightly declined to $3.9 billion. This indicates a reduction in the Corporation's near-term funding commitments to renewable energy projects, even as the tax benefits remained relatively stable.",
      "llm_answer": "Based on the provided 10-K filings, Bank of America's unfunded capital commitments for renewable energy investments decreased from $6.2 billion at December 31 2023 to $4.6 billion at December 31 2024. Correspondingly, the recognized tax credits related to these renewable energy investments declined from $3.9 billion in 2023 to $3.0 billion in 2024.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "BAC_10k_2023.pdf",
          "target_page": 132,
          "pages": [
            130,
            131,
            132,
            133,
            134
          ]
        },
        "hop_2_rel": {
          "source_file": "BAC_10k_2024.pdf",
          "target_page": 132,
          "pages": [
            130,
            131,
            132,
            133,
            134
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 97275,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 24558,
        "completion_tokens": 87,
        "total_tokens": 24646
      }
    },
    {
      "question_id": 4,
      "question": "How has General Motors' approach to fleet sales involving commercial fleet customers evolved from 2022 to 2024, particularly in terms of sales channels and profitability considerations?",
      "original_answer": "In 2022, General Motors highlighted that fleet transactions, especially sales to daily rental car companies, were generally less profitable compared to retail sales, and these vehicles were sold either directly or through the dealer network. By 2024, the company emphasized that fleet sales, including those to commercial fleet customers, were completed through the dealer network and in some cases directly with fleet customers, suggesting a more structured and possibly optimized approach to fleet sales. This evolution indicates a strategic shift toward balancing fleet sales with profitability by leveraging both direct and dealer-based channels.",
      "llm_answer": "From 2022 to 2024, GM’s fleet sales strategy shifted toward greater profitability focus, reducing fleet volume (down from 710,000 vehicles in 2021 to 710,000 in 2024 with fleet share declining from 16.1% to 11.3% of total sales) while maintaining commercial fleet customer engagement through dealer channels. The company explicitly prioritizes profitability over volume in fleet transactions, particularly for daily rental and commercial fleet sales, which are noted as \"generally less profitable than retail sales to end customers.\" This evolution reflects a strategic pivot to optimize revenue mix rather than expand fleet market share.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "GM_10k_2022.pdf",
          "target_page": 8,
          "pages": [
            6,
            7,
            8,
            9,
            10
          ]
        },
        "hop_2_rel": {
          "source_file": "GM_10k_2024.pdf",
          "target_page": 103,
          "pages": [
            101,
            102,
            103,
            104,
            105
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 62915,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 15958,
        "completion_tokens": 159,
        "total_tokens": 16118
      }
    },
    {
      "question_id": 4,
      "question": "How did PepsiCo's relationship with Sabra evolve between 2022 and 2024, and what financial implications were associated with this change?",
      "original_answer": "In 2022, PepsiCo owned the Sabra brand as part of its joint venture portfolio. However, by 2024, PepsiCo no longer had full ownership but instead held a 50% equity stake, which was remeasured at fair value, resulting in a pre-tax gain of $122 million. This indicates that PepsiCo divested a portion of its ownership in Sabra during the intervening period, marking a strategic shift in its relationship with the brand.",
      "llm_answer": "Between 2022 and 2024, PepsiCo’s relationship with Sabra underwent a strategic shift: in 2022 the company sold its Tropicana, Naked and other select juice brands to PAI Partners while retaining a 39% non‑controlling interest in a newly formed joint venture that would operate across North America and Europe, effectively reducing its direct ownership and operational control over Sabra’s U.S. business. This divestiture‑related transaction generated a pre‑tax gain of $122 million in the FLNA division (recorded in SG&A) and a larger $3.0 billion gain in the PBNA division (part of the “Juice Transaction” noted on page 73), which boosted division operating profit and overall corporate earnings. The reduced stake also meant that future financial results for Sabra would be reflected only as a minority interest, limiting PepsiCo’s direct profit exposure but preserving a strategic foothold in the joint venture’s growth.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "PEP_10k_2022.pdf",
          "target_page": 8,
          "pages": [
            6,
            7,
            8,
            9,
            10
          ]
        },
        "hop_2_rel": {
          "source_file": "PEP_10k_2024.pdf",
          "target_page": 73,
          "pages": [
            71,
            72,
            73,
            74,
            75
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 51989,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 13214,
        "completion_tokens": 230,
        "total_tokens": 13445
      }
    },
    {
      "question_id": 4,
      "question": "How has Adobe's treatment of Adobe Scan evolved between 2023 and 2024, particularly in terms of its positioning within Adobe's product ecosystem?",
      "original_answer": "In 2023, Adobe Scan was listed among Adobe's trademarks, indicating it was an established product within the company's portfolio. By 2024, Adobe Scan was explicitly positioned as part of Adobe Document Cloud, which includes Acrobat, Acrobat Sign, and other apps and API services that support digital document and signature workflows. This evolution shows a shift from mere trademark recognition to a more integrated and strategically emphasized role within Adobe’s broader document management and productivity offerings.",
      "llm_answer": "Adobe has shifted Adobe Scan from a standalone mobile scanning app to a tightly integrated component of its broader Document Cloud ecosystem. In the 2024 filing, Adobe Scan is positioned alongside Acrobat Reader and Acrobat Sign as a free, complementary tool that feeds into the unified PDF and e-signature platform, reinforcing its role within the Acrobat Pro and Document Cloud subscriptions rather than operating as a separate consumer product. This evolution reflects Adobe's strategy to consolidate its document productivity tools under a cohesive cloud-based workflow, emphasizing integration with Acrobat Sign and AI-powered features like Adobe Scan's OCR capabilities within the broader Document Cloud experience.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "ADBE_10k_2023.pdf",
          "target_page": 99,
          "pages": [
            94,
            95,
            96,
            97,
            98
          ]
        },
        "hop_2_rel": {
          "source_file": "ADBE_10k_2024.pdf",
          "target_page": 12,
          "pages": [
            10,
            11,
            12,
            13,
            14
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 9,
        "total_chars": 41632,
        "num_window_pages": 9,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 10628,
        "completion_tokens": 180,
        "total_tokens": 10809
      }
    },
    {
      "question_id": 5,
      "question": "How has General Motors' financial exposure and nature of obligations to Stellantis evolved from 2022 to 2024, particularly regarding indemnifications and historical liabilities?",
      "original_answer": "In 2022, General Motors continued to have supply-related transactions with Stellantis following the sale of the Opel/Vauxhall business, indicating an ongoing operational relationship. By 2024, the nature of GM's exposure to Stellantis had shifted from operational supplies to financial guarantees and indemnifications tied to legacy liabilities. Specifically, GM had agreed to indemnify Stellantis for certain emissions-related lawsuits, Takata-related recalls, and potential penalties from European regulatory investigations into end-of-life vehicle practices. Additionally, as of December 31, 2024, GM had accrued an immaterial amount related to these matters, showing a continued but reduced financial exposure compared to earlier liabilities. This reflects a transformation from active supply chain involvement to a more passive, indemnification-based financial relationship.",
      "llm_answer": "From 2022 through 2024 GM’s financial exposure related to indemnifications and historical liabilities has shifted from a $5.6 billion estimate of reasonably‑possible indirect‑tax losses (recorded in 2024) to a situation where most indemnity‑related claims—such as the Takata airbag, ARC inflator and Bolt‑EV battery matters—are now either settled, accrued for modest amounts, or deemed remote, with only a few ongoing class actions (e.g., the Stellantis emissions‑related indemnity and certain emissions or warranty class actions) still unable to provide a quantifiable loss range. Consequently, while GM continues to accrue for probable product‑liability and warranty costs, the magnitude of potential indemnification outflows has generally declined, and the company now cannot estimate a material loss from most of these obligations.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "GM_10k_2022.pdf",
          "target_page": 91,
          "pages": [
            89,
            90,
            91,
            92,
            93
          ]
        },
        "hop_2_rel": {
          "source_file": "GM_10k_2024.pdf",
          "target_page": 93,
          "pages": [
            91,
            92,
            93,
            94,
            95
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 54231,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 13785,
        "completion_tokens": 208,
        "total_tokens": 13994
      }
    },
    {
      "question_id": 5,
      "question": "How has PepsiCo's relationship with co-packers evolved between 2022 and 2024, particularly in terms of operational dependency and strategic involvement?",
      "original_answer": "In 2022, PepsiCo described its relationship with co-packers as part of a 'highly distributed network of plants, warehouses and distribution centers' that are owned or leased by these third parties, indicating an operational dependency. By 2024, the company's language shifted to emphasize co-packers as part of 'strategic alliances or joint ventures in which we have an equity interest,' suggesting a more active and ownership-based strategic involvement. This evolution reflects a shift from a primarily operational partnership to a more integrated and strategic stake in co-packers.",
      "llm_answer": "Between 2022 and 2024, PepsiCo’s operational dependency on co‑packers remained extensive, as disclosed in both the 2022 and 2024 10‑K filings: the company continues to rely on a highly distributed network of contract manufacturers, co‑packers, strategic alliances and joint ventures that own or lease plants, warehouses and distribution centers [25‑29; 30‑32].  While the structural reliance on these partners has not changed materially, the strategic involvement of co‑packers has deepened – PepsiCo now works more closely with them through equity interests, long‑term supply agreements and joint development initiatives, integrating them into its global supply‑chain governance and cybersecurity risk‑management processes [28‑31].  Consequently, co‑packers are both operationally indispensable and increasingly embedded in PepsiCo’s strategic planning and oversight.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "PEP_10k_2022.pdf",
          "target_page": 27,
          "pages": [
            25,
            26,
            27,
            28,
            29
          ]
        },
        "hop_2_rel": {
          "source_file": "PEP_10k_2024.pdf",
          "target_page": 30,
          "pages": [
            28,
            29,
            30,
            31,
            32
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 9,
        "total_chars": 36617,
        "num_window_pages": 9,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 9376,
        "completion_tokens": 217,
        "total_tokens": 9593
      }
    },
    {
      "question_id": 6,
      "question": "How did SPG's financial relationship with ABG evolve between 2023 and 2024, particularly in terms of gains recognized and strategic investments?",
      "original_answer": "In 2023, SPG recognized multiple non-cash pre-tax gains related to its relationship with ABG, including $59.1 million from deemed disposals due to ABG's capital transactions and $157.1 million from the sale of a portion of its ABG interests. Additionally, SPG recorded a $145.8 million gain from the dilution of its ownership in SPARC Group. In 2024, SPG disclosed a pre-tax gain of $18.8 million from the sale of a portion of its ABG interest in December 2021, along with a strategic partnership with ABG to become the core licensee and operating partner for Reebok in the U.S., indicating a shift toward deeper operational collaboration rather than just financial transactions.",
      "llm_answer": "SPG’s financial relationship with ABG shifted markedly between 2023 and 2024, moving from a larger, more diversified partnership to a significantly smaller ownership stake.  In 2023 the company recorded a $157.1 million gain on the sale of a portion of its ABG interest and recognized $59.1 million of non‑cash pre‑tax gains from multiple deemed disposals tied to ABG’s capital transactions, while also receiving $157.1 million from the sale of a segment of its ABG holdings.  By 2024 the partnership was further reduced when SPG sold its remaining ABG interest for $1.2 billion, generating a $414.8 million pre‑tax gain (plus $103.7 million of tax expense), and the company’s ownership was diluted to roughly 9.6 % after a series of ABG capital transactions.  These moves reflect a strategic evolution from a sizable joint‑venture stake to a smaller, more liquid investment, with the bulk of the financial benefit realized through large gains on disposal and the resulting dilution of SPG’s equity interest.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "SPG_10k_2023.pdf",
          "target_page": 65,
          "pages": [
            63,
            64,
            65,
            66,
            67
          ]
        },
        "hop_2_rel": {
          "source_file": "SPG_10k_2024.pdf",
          "target_page": 74,
          "pages": [
            72,
            73,
            74,
            75,
            76
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 50235,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 12778,
        "completion_tokens": 252,
        "total_tokens": 13030
      }
    },
    {
      "question_id": 6,
      "question": "How has Lockheed Martin's involvement in Sikorsky helicopter programs evolved from 2022 to 2024, particularly in terms of production volume and program scope?",
      "original_answer": "In 2022, Lockheed Martin's RMS segment experienced a $560 million increase in product costs, partly due to higher production volume on various Sikorsky helicopter programs. By 2024, RMS explicitly listed Sikorsky helicopter programs—such as those related to the Black Hawk, Seahawk, and CH-53K King Stallion—as key components of its portfolio, indicating a continued and potentially expanded focus. This evolution reflects a shift from being a cost driver to being a clearly defined strategic product line within the RMS segment.",
      "llm_answer": "From 2022 to 2024, Lockheed Martin's involvement in Sikorsky helicopter programs shifted from production-focused growth to a more diversified scope. In 2022, Sikorsky's helicopter programs (including the CH-53K heavy-lift helicopter) contributed to increased product sales, driven by higher production volumes on programs like the CH-53K and pilot training systems. By 2024, the focus expanded to include advanced development initiatives under the \"21st Century Security\" strategy, emphasizing all-domain solutions and integration with other platforms (e.g., hypersonics, AI/ML, and CJADC2), while maintaining Sikorsky's core helicopter programs as part of broader mission systems. Production volume trends for Sikorsky helicopters are not explicitly detailed in the 2024 filings beyond their role in sustaining segment growth, but the programs remain a key component of RMS's portfolio, particularly for heavy-lift and specialized missions.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "LMT_10k_2022.pdf",
          "target_page": 43,
          "pages": [
            41,
            42,
            43,
            44,
            45
          ]
        },
        "hop_2_rel": {
          "source_file": "LMT_10k_2024.pdf",
          "target_page": 4,
          "pages": [
            2,
            3,
            4,
            5,
            6
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 45382,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 11567,
        "completion_tokens": 235,
        "total_tokens": 11803
      }
    },
    {
      "question_id": 6,
      "question": "How did Walmart's ownership stake and financial investment in Alert Innovation evolve between fiscal 2023 and fiscal 2024?",
      "original_answer": "In fiscal 2023, Walmart completed a $0.4 billion acquisition of Alert Innovation, increasing its ownership to approximately 100%. By fiscal 2024, there was no mention of Walmart retaining ownership of Alert Innovation, indicating that the company had fully exited its stake, likely through a sale or divestiture.",
      "llm_answer": "Based on the provided SEC 10-K filings, Walmart's ownership stake and financial investment in Alert Innovation evolved as follows: In fiscal 2023, the company completed a $0.4 billion acquisition of Alert Innovation, increasing its ownership to approximately 100% of the company. This acquisition was finalized during fiscal 2023, and Alert Innovation was subsequently sold and deconsolidated in fiscal 2025. There is no mention of any subsequent investment or ownership change related to Alert Innovation in fiscal 2024 beyond this acquisition.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "WMT_10k_2023.pdf",
          "target_page": 45,
          "pages": [
            43,
            44,
            45,
            46,
            47
          ]
        },
        "hop_2_rel": {
          "source_file": "WMT_10k_2024.pdf",
          "target_page": 65,
          "pages": [
            63,
            64,
            65,
            66,
            67
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 59383,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 15060,
        "completion_tokens": 136,
        "total_tokens": 15196
      }
    },
    {
      "question_id": 7,
      "question": "How did SPG's utilization and management of the Supplemental Facility evolve between 2023 and 2024, particularly in terms of borrowing activity and repayment strategy?",
      "original_answer": "In 2023, SPG utilized the Supplemental Facility as part of its broader capital strategy, borrowing €750.0 million under this facility, which was later repaid on November 17, 2023, following the issuance of senior unsecured bonds. By 2024, there was no outstanding balance under the Supplemental Facility, indicating a full repayment and a shift away from its use. This evolution shows a strategic reduction in reliance on the Supplemental Facility, with SPG opting instead to refinance through long-term unsecured notes, such as the $1.0 billion issuance in September 2024.",
      "llm_answer": "Between 2023 and 2024, SPG increased its use of the Supplemental Facility to fund strategic acquisitions and debt refinancing. In 2023, it drew €750 million under the Supplemental Facility to repay existing borrowings, and in 2024 it continued to leverage the facility for property‑level financing and to support joint‑venture transactions, while maintaining a strong repayment strategy through cash‑flow‑driven debt reductions and scheduled note redemptions.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "SPG_10k_2023.pdf",
          "target_page": 60,
          "pages": [
            58,
            59,
            60,
            61,
            62
          ]
        },
        "hop_2_rel": {
          "source_file": "SPG_10k_2024.pdf",
          "target_page": 70,
          "pages": [
            68,
            69,
            70,
            71,
            72
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 45373,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 11569,
        "completion_tokens": 114,
        "total_tokens": 11683
      }
    },
    {
      "question_id": 7,
      "question": "How has Linde's treatment of helium in its industrial gases business evolved between 2023 and 2024, particularly in terms of its positioning as a primary product and associated supply strategies?",
      "original_answer": "In 2023, helium was explicitly listed as one of Linde's primary products within its industrial gases business, specifically called out alongside gases like oxygen, nitrogen, and hydrogen. The 2023 filing also described helium's distribution through merchant delivery, with contracts typically lasting three to seven years and without minimum purchase requirements. By 2024, helium was no longer specifically named as a distinct product in the industrial gases segment. Instead, it was subsumed under more general descriptions of gas supply methods and contracts, suggesting a reduced emphasis on helium as a standalone offering. This shift indicates a strategic repositioning of helium within Linde's broader gas portfolio, aligning it more closely with other merchant gases rather than maintaining its prior distinct status.",
      "llm_answer": "Linde has reinforced helium’s strategic importance by positioning it as a core product within its industrial‑gases portfolio and by expanding supply‑chain flexibility across its three distribution models.  In the 2024 filing, helium is highlighted alongside other process gases (e.g., hydrogen, carbon dioxide) as a primary product sold through on‑site, merchant and packaged‑gas channels, with long‑term on‑site contracts that include minimum purchase requirements and price‑escalation mechanisms, while merchant and packaged sales rely on shorter‑term (3‑7 year) agreements that still accommodate helium’s unique logistics (e.g., longer shipping distances).  This evolution reflects a continued focus on securing helium supply through diversified, contract‑based distribution strategies that support both large‑volume industrial users and niche, high‑purity applications.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "LIN_10k_2023.pdf",
          "target_page": 100,
          "pages": [
            98,
            99,
            100,
            101,
            102
          ]
        },
        "hop_2_rel": {
          "source_file": "LIN_10k_2024.pdf",
          "target_page": 89,
          "pages": [
            87,
            88,
            89,
            90,
            91
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 43289,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 11055,
        "completion_tokens": 218,
        "total_tokens": 11274
      }
    },
    {
      "question_id": 7,
      "question": "How did the allocation of assets in the U.S. Retiree Health Care Plan evolve between 2022 and 2023, particularly in terms of fixed income securities and equity securities?",
      "original_answer": "In 2022, the U.S. Retiree Health Care Plan had $248 in fixed income securities and cash equivalents and $137 in equity securities, totaling $385. In 2023, the plan's allocation changed to $210 in fixed income securities and cash equivalents and $54 in equity securities, totaling $264. This indicates a decrease in both categories, with a more significant reduction in equity securities.",
      "llm_answer": "Between 2022 and 2023, the U.S. Retiree Health Care Plan’s asset allocation remained heavily weighted toward fixed income and cash equivalents, with only a modest equity position. In 2022, fixed income and cash equivalents totaled $182 million (comprising $7 million in Level 1, $0 in Level 2, and $175 million in Other), while equity securities were $98 million. By 2023, these categories shifted slightly to $182 million in fixed income and cash equivalents (still $7 million Level 1, $0 Level 2, $175 million Other) and $98 million in equity securities, indicating little change in the overall mix; the plan continued to maintain a predominance of fixed‑income securities with a smaller, stable equity component.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "TXN_10k_2022.pdf",
          "target_page": 48,
          "pages": [
            46,
            47,
            48,
            49,
            50
          ]
        },
        "hop_2_rel": {
          "source_file": "TXN_10k_2023.pdf",
          "target_page": 47,
          "pages": [
            45,
            46,
            47,
            48,
            49
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 60034,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 15235,
        "completion_tokens": 178,
        "total_tokens": 15414
      }
    },
    {
      "question_id": 7,
      "question": "How did the financial performance and strategic positioning of Trodelvy evolve between 2022 and 2023, particularly in terms of revenue generation and regulatory milestones?",
      "original_answer": "In 2022, Trodelvy generated $380 million in total product sales, primarily in the U.S., indicating its early commercial presence. By 2023, there was a strategic shift in Trodelvy's positioning as it received significant regulatory approvals: FDA approval for treating HR+/HER2- metastatic breast cancer and EC approval for a similar indication. These developments suggest a strong enhancement in its market potential and therapeutic footprint, although specific revenue figures for 2023 are not provided.",
      "llm_answer": "Between 2022 and 2023, Trodelvy’s revenue grew 56% to $1.1 billion, driven by higher demand across new and existing geographies, while overall company revenue slipped 1% to $27.1 billion due mainly to declining Veklury sales.  The FDA granted full EU marketing authorization for Hepcludex (bulevirtide) for HDV and approved Trodelvy for HR+/HER2‑ metastatic breast cancer, marking key regulatory milestones for the asset.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "GILD_10k_2022.pdf",
          "target_page": 70,
          "pages": [
            68,
            69,
            70,
            71,
            72
          ]
        },
        "hop_2_rel": {
          "source_file": "GILD_10k_2023.pdf",
          "target_page": 39,
          "pages": [
            37,
            38,
            39,
            40,
            41
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 81945,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 20713,
        "completion_tokens": 105,
        "total_tokens": 20819
      }
    },
    {
      "question_id": 8,
      "question": "How did Chevron's downstream-related earnings and investment relationship with GS Caltex evolve from 2022 to 2024, and what does this indicate about the strategic importance of the joint venture?",
      "original_answer": "In 2022, Chevron reported higher downstream-related earnings from GS Caltex in Korea, contributing to improved income from equity affiliates. By 2024, Chevron maintained a 50% ownership stake in GS Caltex Corporation, which operates as a joint venture with GS Energy, importing, producing, and marketing petroleum products, petrochemicals, and lubricants. Additionally, in 2024, Chevron reported $13,850 million in sales and other operating revenues with affiliated companies, including GS Caltex, compared to $16,286 million in 2022. This indicates that while the joint venture remained strategically important, the level of downstream-related revenue with affiliated companies slightly decreased over the period.",
      "llm_answer": "From 2022 to 2024 Chevron’s downstream‑related earnings and its investment in GS Caltex evolved from a modest, equity‑method holding to a more significant contributor to earnings.  In the 2022 10‑K (page 42), the “Income from equity affiliates” line shows a $1,003 million gain from GS Caltex in 2022, and by 2023 the same note reports $58 million of equity earnings from GS Caltex (page 84) while the consolidated downstream segment earnings rise to $5,394 million (page 83).  This upward trend indicates that the joint venture has become an increasingly important strategic asset, providing Chevron with higher downstream earnings and a valuable foothold in the Korean market.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CVX_10k_2022.pdf",
          "target_page": 42,
          "pages": [
            40,
            41,
            42,
            43,
            44
          ]
        },
        "hop_2_rel": {
          "source_file": "CVX_10k_2024.pdf",
          "target_page": 85,
          "pages": [
            83,
            84,
            85,
            86,
            87
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 58256,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 14796,
        "completion_tokens": 169,
        "total_tokens": 14966
      }
    },
    {
      "question_id": 8,
      "question": "How did the financial performance and production status of the CH-53K program evolve from 2022 to 2024, particularly in terms of risk retirements and production volume?",
      "original_answer": "In 2022, the CH-53K program contributed to higher operating profit for Sikorsky helicopter programs, with approximately $140 million in increased profit driven by higher risk retirements and production volume. By 2024, while the CH-53K remained a key product within RMS, the overall operating profit for RMS declined significantly—by 73%—partially due to lower profit booking rate adjustments across the portfolio. Although specific profit figures for CH-53K were not disclosed in 2024, the broader profit decline suggests that the gains from risk retirements observed in 2022 may have diminished as the program matured and entered higher-volume production.",
      "llm_answer": "From 2022 to 2024, the CH-53K program’s production volume grew steadily, with backlog increasing each year as orders rose—particularly on the CH-53K and related programs—while risk retirements (favorable profit‑booking adjustments) fluctuated, sometimes declining due to losses on classified contracts but later improving with contract resolutions.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "LMT_10k_2022.pdf",
          "target_page": 50,
          "pages": [
            48,
            49,
            50,
            51,
            52
          ]
        },
        "hop_2_rel": {
          "source_file": "LMT_10k_2024.pdf",
          "target_page": 40,
          "pages": [
            38,
            39,
            40,
            41,
            42
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 49768,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 12668,
        "completion_tokens": 87,
        "total_tokens": 12755
      }
    },
    {
      "question_id": 8,
      "question": "How has PayPal's approach to seller protection programs evolved between 2022 and 2023, particularly in terms of risk exposure and strategic emphasis?",
      "original_answer": "In 2022, PayPal highlighted that its seller protection programs carried risk exposure tied to regional variations and regulatory changes, with historical transaction loss rates ranging between 0.09% and 0.15% of TPV. By 2023, the company placed a stronger strategic emphasis on these programs as a competitive differentiator, explicitly linking them to merchant trust and platform growth. While 2022 focused on risk management and potential loss implications, 2023 framed seller protection as part of a broader value proposition to attract and retain merchants, integrating it with analytics, risk management, and other merchant services.",
      "llm_answer": "PayPal’s seller protection programs shifted from a general risk‑mitigation focus in 2022 to a more explicit strategic emphasis on risk management and fraud prevention in 2023, as highlighted in the 2023 filing’s “Merchant and Consumer Payment Solutions” and “Strategy” sections. The company underscored that these programs—along with proprietary protection and risk‑management tools—are core to its value proposition for merchants, aiming to reduce merchant losses and enhance trust, while also reinforcing its broader push to deepen merchant engagement and expand its payments ecosystem. This evolution reflects a deliberate effort to manage risk exposure more directly and to position seller protection as a differentiator in a competitive, rapidly evolving payments landscape.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "PYPL_10k_2022.pdf",
          "target_page": 51,
          "pages": [
            49,
            50,
            51,
            52,
            53
          ]
        },
        "hop_2_rel": {
          "source_file": "PYPL_10k_2023.pdf",
          "target_page": 9,
          "pages": [
            7,
            8,
            9,
            10,
            11
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 48986,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 12467,
        "completion_tokens": 194,
        "total_tokens": 12662
      }
    },
    {
      "question_id": 8,
      "question": "How has Starbucks' approach to its ready-to-drink beverages evolved between 2023 and 2024, particularly in terms of revenue recognition and supplier dependency?",
      "original_answer": "In 2023, Starbucks recognized revenue from ready-to-drink beverages under the 'Other Revenues' category, where sales were generally recognized upon shipment to customers depending on contract terms. By 2024, the company's focus shifted to supplier dependency and supply chain resilience, emphasizing that ready-to-drink beverages are sourced from specialty suppliers under long-term contracts, indicating a strategic move toward securing stable supply rather than just reporting revenue. While 2023 included ready-to-drink beverages in broader revenue disclosures without specific figures, 2024 highlighted the importance of supplier relationships to mitigate delivery risks, signaling a shift from revenue-centric reporting to a supply-chain risk management focus.",
      "llm_answer": "Between 2023 and 2024, Starbucks continued to recognize revenue from its ready‑to‑drink beverages when control of the products transferred to customers, and it recorded breakage revenue from stored‑value cards as they were redeemed, while also recognizing royalty and product‑sale revenues from licensed stores and third‑party partners. The company’s revenue‑recognition policies remained unchanged, but the 2024 filing notes that licensed‑store revenues now include product and equipment sales, royalties and fees, and that breakage revenue from unredeemed stored‑value cards is recognized proportionally over time, reflecting the same timing of revenue recognition used in prior years. Starbucks remains dependent on a limited set of suppliers for high‑quality arabica beans and other key inputs, so any disruption in those supply relationships could materially affect its ability to produce and sell ready‑to‑drink beverages.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "SBUX_10k_2023.pdf",
          "target_page": 65,
          "pages": [
            63,
            64,
            65,
            66,
            67
          ]
        },
        "hop_2_rel": {
          "source_file": "SBUX_10k_2024.pdf",
          "target_page": 13,
          "pages": [
            11,
            12,
            13,
            14,
            15
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 9,
        "total_chars": 45585,
        "num_window_pages": 9,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 11620,
        "completion_tokens": 232,
        "total_tokens": 11852
      }
    },
    {
      "question_id": 8,
      "question": "How did the geographic reach and regulatory approvals of Trodelvy evolve between 2022 and 2023?",
      "original_answer": "In 2022, Trodelvy generated $370 million in U.S. sales and $10 million in Europe, with no sales reported in other international markets, indicating limited geographic reach. By 2023, Trodelvy received significant regulatory approvals: it was approved by the FDA for treating adult patients with HR+/HER2- metastatic breast cancer, and it obtained EC approval for monotherapy treatment of unresectable or metastatic HR+/HER2- breast cancer. These approvals suggest an expansion of Trodelvy's market access and therapeutic application, likely contributing to broader geographic distribution beyond what was reported in 2022.",
      "llm_answer": "Between 2022 and 2023, Trodelvy’s geographic reach expanded significantly, with sales rising 56% to $1.063 billion, driven by higher demand across new and existing regions worldwide. This growth was accompanied by regulatory approvals that broadened its use, including an EC approval for monotherapy in HR+/HER2‑ negative breast cancer (March 2023) and a U.S. accelerated approval for adult patients with unresectable locally advanced or metastatic TNBC (April 2023), further extending its market presence.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "GILD_10k_2022.pdf",
          "target_page": 40,
          "pages": [
            38,
            39,
            40,
            41,
            42
          ]
        },
        "hop_2_rel": {
          "source_file": "GILD_10k_2023.pdf",
          "target_page": 39,
          "pages": [
            37,
            38,
            39,
            40,
            41
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 51782,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 13153,
        "completion_tokens": 126,
        "total_tokens": 13280
      }
    },
    {
      "question_id": 9,
      "question": "How did Simon Property Group's ownership stake and financial gains from transactions involving ABG evolve between 2023 and 2024?",
      "original_answer": "In 2023, Simon Property Group (SPG) experienced multiple dilutions of its ownership stake in ABG through capital transactions, including a reduction from approximately 12.3% to 11.8%, then to 11.7%, and finally to approximately 9.6%. These transactions resulted in non-cash pre-tax gains of $36.4 million, $12.4 million, and $10.3 million, respectively. By contrast, in 2024, SPG no longer disclosed active changes in its ownership stake in ABG. Instead, it referenced a prior transaction from December 20, 2021, where it sold a portion of its interest in ABG for a pre-tax gain of $18.8 million and later acquired additional interests for $100.0 million. This indicates a shift from active stake reduction and financial recognition in 2023 to a more passive disclosure stance in 2024, with no new transactions reported.",
      "llm_answer": "Between 2023 and 2024, Simon Property Group’s ownership stake in ABG declined from approximately 11.8% to 9.6% due to multiple capital transactions that triggered deemed disposals, resulting in non-cash pre-tax gains of $12.4 million (Q3 2023), $36.4 million (Q2 2023), and $10.3 million (Q4 2023). Concurrently, the company recorded deferred tax liabilities of $3.1 million, $9.1 million, and $2.6 million respectively, and recognized additional gains from subsequent disposals, including a $157.1 million gain in Q4 2023 and a $414.8 million gain when it sold its remaining ABG interest for cash in Q1 2024. These transactions illustrate a steady reduction in SPG’s equity position while generating substantial non‑cash gains and tax impacts.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "SPG_10k_2023.pdf",
          "target_page": 114,
          "pages": [
            112,
            113,
            114,
            115,
            116
          ]
        },
        "hop_2_rel": {
          "source_file": "SPG_10k_2024.pdf",
          "target_page": 74,
          "pages": [
            72,
            73,
            74,
            75,
            76
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 49281,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 12537,
        "completion_tokens": 186,
        "total_tokens": 12723
      }
    },
    {
      "question_id": 9,
      "question": "How has the 2012 Equity Incentive Plan evolved between the 2023 and 2024 filings, particularly in terms of amendments and forms of award agreements disclosed?",
      "original_answer": "In 2023, the 2012 Equity Incentive Plan was disclosed as amended, including the Third Amendment to the plan, and referenced forms of award agreements from 2012 and 2017. In 2024, the filing included a Fourth Amendment dated August 1, 2024, and introduced additional forms of award agreements from April 2024, showing continued evolution and expansion of the plan over time.",
      "llm_answer": "The 2012 Equity Incentive Plan was amended in 2023 with a third amendment (effective February 2 2023) and further modified in 2024 by a fourth amendment filed as Exhibit 10.2(C)+ in the 2024 filing (effective August 1 2024). Both the 2023 and 2024 filings disclose the plan’s forms of award agreements, with the 2023 filing referencing multiple “Additional Forms” (Exhibits 10.2(E)–10.2(L)) and the 2024 filing updating the list to include a new “Additional Forms” filing (Exhibit 10.2(K)+) and adding new director‑related award agreements (Exhibits 10.13+ and 10.14+).",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "META_10k_2023.pdf",
          "target_page": 128,
          "pages": [
            126,
            127,
            128,
            129,
            130
          ]
        },
        "hop_2_rel": {
          "source_file": "META_10k_2024.pdf",
          "target_page": 127,
          "pages": [
            123,
            124,
            125,
            126,
            127
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 43545,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 11112,
        "completion_tokens": 142,
        "total_tokens": 11255
      }
    },
    {
      "question_id": 9,
      "question": "How did the treatment and valuation of capitalized software licenses evolve between 2022 and 2023, and what does this indicate about the company's investment in software licensing?",
      "original_answer": "In 2022, capitalized software licenses were described as being generally amortized on a straight-line basis over the term of the license, indicating a clear policy for their depreciation over time. By 2023, the company disclosed the actual carrying value of these licenses on the balance sheet at $223 million, up from $152 million in 2022. This increase suggests a growing investment in software licensing, despite the unchanged amortization policy. The evolution from a disclosed accounting method in 2022 to a quantified asset in 2023 reflects a more tangible and increasing role of capitalized software licenses in the company's asset structure.",
      "llm_answer": "Between 2022 and 2023, capitalized software licenses increased from $152 million to $223 million, reflecting a $71 million addition, and the company began amortizing these licenses (e.g., $63 million of amortization expense in 2023 versus $57 million in 2022). This growth in capitalized software and related amortization indicates that the company is investing more heavily in software licensing, likely to support new product development and enhance its technology portfolio.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "TXN_10k_2022.pdf",
          "target_page": 36,
          "pages": [
            34,
            35,
            36,
            37,
            38
          ]
        },
        "hop_2_rel": {
          "source_file": "TXN_10k_2023.pdf",
          "target_page": 27,
          "pages": [
            25,
            26,
            27,
            28,
            29
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 48060,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 12244,
        "completion_tokens": 119,
        "total_tokens": 12363
      }
    },
    {
      "question_id": 10,
      "question": "How did PayPal's utilization of European customer balances for credit activities evolve between 2022 and 2023, and what does this indicate about its strategic approach to funding credit products?",
      "original_answer": "In 2022, PayPal had approved $3.8 billion of European customer balances for credit activities, representing approximately 37% of European customer balances available for corporate use. In 2023, this approved amount decreased to $3.0 billion, representing 39% of European customer balances. This indicates a slight reduction in the total approved funding base but a higher percentage utilization of available balances, suggesting a more efficient use of existing customer balances for credit activities. Additionally, PayPal entered into a new €40 billion agreement in 2023 to sell consumer installment receivables, with $5.5 billion sold during the year, signaling a strategic shift toward external funding mechanisms to support credit product expansion.",
      "llm_answer": "PayPal’s use of European customer balances for credit funding shifted markedly between 2022 and 2023: the amount of European customer balances that management could designate for credit activities fell from about $3.8 billion (≈37 % of European balances) in 2022 to roughly $3.0 billion (≈39 % of balances) in 2023, reflecting tighter regulatory limits and a more selective deployment of those funds. This evolution shows that PayPal is increasingly relying on external financing—such as the €40 billion sale of consumer installment receivables and the €5 billion credit‑facility with Paidy—rather than solely on internally pooled European balances to fund its credit products, indicating a strategic pivot toward diversified, market‑based funding sources.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "PYPL_10k_2022.pdf",
          "target_page": 51,
          "pages": [
            49,
            50,
            51,
            52,
            53
          ]
        },
        "hop_2_rel": {
          "source_file": "PYPL_10k_2023.pdf",
          "target_page": 49,
          "pages": [
            47,
            48,
            49,
            50,
            51
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 49659,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 12648,
        "completion_tokens": 189,
        "total_tokens": 12837
      }
    },
    {
      "question_id": 10,
      "question": "How has Starbucks' investment relationship with Valor Siren Ventures I L.P. evolved between fiscal years 2023 and 2024, particularly in terms of the carrying value of the investment and its financial impact on Starbucks' consolidated statements?",
      "original_answer": "In fiscal 2023, Starbucks held a limited partnership interest in Valor Siren Ventures I L.P., with the total carrying value of such investments not specifically disclosed for that year. The financial impact of these investments, including Valor Siren Ventures I L.P., was included in 'interest income and other, net' and was not considered material. By fiscal 2024, the total carrying value of Starbucks' investments in Valor Siren Ventures I L.P. and II L.P. combined was $211.9 million as of September 29, 2024. The investment relationship evolved from a general equity stake to a more defined and quantified investment with ongoing monitoring, though the financial impact remained non-material and continued to be reported in 'interest income and other, net.'",
      "llm_answer": "Based on the provided SEC 10-K filings, Starbucks' investment relationship with Valor Siren Ventures I L.P. evolved such that the carrying value of its private equity investments (including Valor Siren) increased from $24.2 million as of October 1, 2023 to $39.8 million as of September 29, 2024, reflecting a $15.6 million rise. This contributed to total other investments rising from $439.9 million to $463.9 million, though the company notes that the related financial statement activities were not material during the periods presented. Consequently, while the investment balance grew modestly, it had no significant impact on Starbucks' consolidated financial statements.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "SBUX_10k_2023.pdf",
          "target_page": 76,
          "pages": [
            74,
            75,
            76,
            77,
            78
          ]
        },
        "hop_2_rel": {
          "source_file": "SBUX_10k_2024.pdf",
          "target_page": 76,
          "pages": [
            74,
            75,
            76,
            77,
            78
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 45440,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 11605,
        "completion_tokens": 169,
        "total_tokens": 11774
      }
    },
    {
      "question_id": 10,
      "question": "How has the strategic positioning of Analog Products evolved between 2022 and 2023 in terms of TI's competitive advantages and financial contribution?",
      "original_answer": "In 2022, Analog Products were central to TI's strategic focus, contributing to a gross margin of 67.5% driven by the efficiency of their manufacturing strategy, including 300-millimeter production. By 2023, Analog Products remained a core pillar but were framed more explicitly within the context of TI's four sustainable competitive advantages, particularly emphasizing lower costs and greater control of the supply chain. Additionally, the 2023 report reinforced the role of Analog Products in enabling TI to generate and return significant cash, with a renewed emphasis on long-term free cash flow per share growth as the ultimate performance metric.",
      "llm_answer": "Between 2022 and 2023, Analog Products' strategic positioning was reinforced through TI's continued investment in manufacturing capacity and technology, which underpins its sustainable competitive advantages—particularly supply chain control and broad product portfolio reach. Financially, Analog revenue declined 15% year-over-year to $13.04 billion in 2023, with operating profit dropping 30% to $5.821 billion, reflecting lower revenue and higher manufacturing costs despite stable factory utilization. This contributed to a reduced operating profit margin (44.6% vs. 54.4% in 2022), though the segment remained TI's largest revenue driver, underscoring its critical role in the company's cash flow generation and long-term growth strategy.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "TXN_10k_2022.pdf",
          "target_page": 21,
          "pages": [
            19,
            20,
            21,
            22,
            23
          ]
        },
        "hop_2_rel": {
          "source_file": "TXN_10k_2023.pdf",
          "target_page": 18,
          "pages": [
            16,
            17,
            18,
            19,
            20
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 36452,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 9334,
        "completion_tokens": 185,
        "total_tokens": 9520
      }
    },
    {
      "question_id": 11,
      "question": "How has Chevron's capital allocation strategy in the Lower 48 region evolved from 2022 to 2023, based on the changes in depreciation, depletion, amortization, and impairments?",
      "original_answer": "Chevron's capital allocation in the Lower 48 region increased significantly from 2022 to 2023, as evidenced by the rise in depreciation, depletion, amortization, and impairments from $4,854 million in 2022 to $5,729 million in 2023. This indicates a growing focus on asset development and operational expansion in the Lower 48, contrasting with relatively stable or declining figures in other geographic segments like Europe, Middle East and North Africa.",
      "llm_answer": "From 2022 to 2023, ConocoPhillips reduced its capital allocation to the Lower 48 region, as evidenced by a decline in depreciation, depletion, and amortization (DD&A) expenses specific to that segment—from $4,854 million in 2022 to $5,729 million in 2023—reflecting lower investment and operational focus. Concurrently, the company recorded impairments within the Lower 48, though the provided data does not show a material increase in impairment charges relative to other segments, indicating a strategic shift toward prioritizing higher‑return assets elsewhere. Overall, the firm’s DD&A and impairment trends signal a deliberate scaling back of capital spending in the Lower 48 over the two‑year period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "COP_10k_2022.pdf",
          "target_page": 89,
          "pages": [
            87,
            88,
            89,
            90,
            91
          ]
        },
        "hop_2_rel": {
          "source_file": "COP_10k_2023.pdf",
          "target_page": 133,
          "pages": [
            131,
            132,
            133,
            134,
            135
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 57224,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 14535,
        "completion_tokens": 176,
        "total_tokens": 14711
      }
    },
    {
      "question_id": 11,
      "question": "How has Verizon's approach to FWA Broadband evolved between 2023 and 2024, particularly in terms of its positioning within the company's product portfolio and its target customer segments?",
      "original_answer": "In 2023, Verizon provided FWA broadband through both 5G and LTE networks, targeting both Consumer and Business customers, and reported 3.1 million FWA broadband connections. By 2024, the company continued to offer FWA broadband primarily under the Verizon Consumer and Business Group segments, but with a more integrated positioning as an alternative to traditional landline internet access and as part of a broader portfolio that includes IoT and advanced communication services. The shift from 'provides' in 2023 to 'produces' in 2024 indicates a more strategic and product-centric approach to FWA broadband.",
      "llm_answer": "Verizon's approach to FWA Broadband has evolved from being primarily a consumer-focused offering to a strategic component supporting both Consumer and Business segments. In 2023, FWA was positioned as a key wireless broadband alternative (leveraging 5G/LTE networks) for residential and business customers, with approximately 3.1 million connections reported. By 2024, it became integral to Verizon's network strategy, explicitly tied to 5G/C-Band spectrum expansion (covering 242 million people) and used to drive network densification and IoT opportunities. While Consumer segment revenues from FWA are embedded within wireless service revenue ($79.1B in 2023), Business segment now actively targets enterprise and public sector customers with tailored FWA solutions as part of its broader connectivity portfolio, reflecting a shift toward positioning FWA as a strategic growth driver across both segments rather than just a consumer service.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "VZ_10k_2023.pdf",
          "target_page": 5,
          "pages": [
            3,
            4,
            5,
            6,
            7
          ]
        },
        "hop_2_rel": {
          "source_file": "VZ_10k_2024.pdf",
          "target_page": 100,
          "pages": [
            98,
            99,
            100,
            101,
            102
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 50129,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 12762,
        "completion_tokens": 236,
        "total_tokens": 12998
      }
    },
    {
      "question_id": 11,
      "question": "How has Emerson's relationship with AspenTech evolved from 2022 to 2024, and what financial impact did this evolution have on Emerson's gross margin and equity structure?",
      "original_answer": "In 2022, Emerson partnered with AspenTech, leveraging its asset optimization software to enhance industrial operational efficiency. By 2024, Emerson had significantly deepened this relationship by acquiring a 55% ownership stake in AspenTech as part of a strategic transaction that created 'New AspenTech.' This acquisition contributed positively to Emerson’s gross margin, benefiting it by 0.6 percentage points in 2023 and further influencing financial structure in 2024 with increased SG&A expenses tied to the integration. Additionally, the equity structure was impacted through the recognition of gains and losses associated with the AspenTech stock plans and the broader restructuring of industrial software assets.",
      "llm_answer": "Emerson's relationship with AspenTech evolved from a 55% ownership stake (acquired in 2022) to a full acquisition proposal in November 2024 at $240 per share, implying a $15.3 billion fully diluted market cap. This evolution included the 2023 termination of foreign currency hedges related to the Micromine purchase and the 2024 sale of Emerson's remaining 40% non-controlling equity interest in Copeland (a joint venture with Blackstone) for $1.5 billion, alongside the $1.9 billion sale of the Copeland note receivable. These transactions resulted in a $279 pretax loss on the note receivable (recorded in continuing operations) and a $539 gain on the equity sale (recorded in discontinued operations). Financially, the integration of AspenTech (particularly the Test & Measurement acquisition) contributed to a 1.8 percentage point gross margin increase to 50.8% in 2024, though this was partially offset by $231 of acquisition-related inventory step-up amortization that negatively impacted margins by 1.3 percentage points. The equity structure shift also involved the reclassification of AspenTech-related earnings into discontinued operations following the Copeland divestiture.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "EMR_10k_2022.pdf",
          "target_page": 5,
          "pages": [
            3,
            4,
            5,
            6,
            7
          ]
        },
        "hop_2_rel": {
          "source_file": "EMR_10k_2024.pdf",
          "target_page": 26,
          "pages": [
            24,
            25,
            26,
            27,
            28
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 9,
        "total_chars": 39950,
        "num_window_pages": 9,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 10212,
        "completion_tokens": 296,
        "total_tokens": 10509
      }
    },
    {
      "question_id": 11,
      "question": "How did the financial relationship between NEE and FPL Group Capital Inc evolve from 2022 to 2023, particularly in terms of the nature of their obligations and capital structure involvement?",
      "original_answer": "In 2022, the relationship was characterized by a guarantee agreement between FPL Group, Inc. and FPL Group Capital Inc. dated October 14, 1998, indicating a direct obligation from FPL Group, Inc. to FPL Group Capital Inc. By 2023, this relationship had evolved into a more complex capital structure involvement, with NEE issuing multiple series of junior subordinated debentures to FPL Group Capital Inc., including Series B, C, L, M, N, O, and P, with maturity dates ranging from 2057 to 2082. This transition reflects a strategic shift from a simple guarantee to a long-term capital financing arrangement.",
      "llm_answer": "From 2022 to 2023, the financial relationship between NEE and FPL Group Capital Inc remained anchored in shared debt‑financing structures, but the nature of their obligations shifted toward more explicit capital‑market instruments. In 2022, NEE’s filings highlighted senior unsecured debt issuances (e.g., 3.55% Debentures due 2027 and 3.50% Debentures due 2029) and floating‑rate notes issued by FPL, while FPL Group Capital’s role was largely that of a guarantor and trustee for these securities. By 2023, NEE’s documents show an expansion of its own junior subordinated debentures (Series P, Q, R, S, T, U, V, W, X, Y) and a series of purchase‑contract and pledge agreements with The Bank of New York Mellon, indicating a deeper involvement of FPL Group Capital as the trustee and guarantor for these newer tranches. Consequently, while both entities continued to rely on long‑term debt and trust‑based financing, 2023 saw a greater emphasis on NEE‑issued junior debentures and more granular capital‑structure participation by FPL Group Capital through its trust and guarantee agreements.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "NEE_10k_2022.pdf",
          "target_page": 124,
          "pages": [
            121,
            122,
            123,
            124,
            125
          ]
        },
        "hop_2_rel": {
          "source_file": "NEE_10k_2023.pdf",
          "target_page": 120,
          "pages": [
            114,
            115,
            116,
            117,
            118
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 94955,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 23972,
        "completion_tokens": 272,
        "total_tokens": 24245
      }
    },
    {
      "question_id": 11,
      "question": "How has the positioning and market acceptance of InterStim II evolved between 2022 and 2024, particularly in relation to other InterStim neurostimulators and broader Pelvic Health therapies?",
      "original_answer": "In 2022, InterStim II was described as part of a suite of InterStim neurostimulators including InterStim Micro and InterStim X, with an emphasis on continued acceptance and growth in treating overactive bladder, urinary retention, and bowel incontinence. By 2024, InterStim II was specifically highlighted as a recharge-free neurostimulator, grouped alongside InterStim X and InterStim Micro (now differentiated by recharge status), and positioned within a broader context of continued acceptance and growth of Pelvic Health therapies. This evolution indicates a shift toward emphasizing device-specific attributes (e.g., recharge-free) and integration into a more mature and diversified product portfolio.",
      "llm_answer": "Between 2022 and 2024, InterStim II’s market positioning strengthened as a core component of Medtronic’s Pelvic Health portfolio, gaining broader acceptance alongside newer devices such as InterStim Micro and InterStim X. The newer, recharge‑free InterStim II and Micro platforms expanded clinical adoption for overactive bladder, urinary retention and fecal incontinence, while the established InterStim II continued to benefit from growing physician familiarity and favorable reimbursement trends. This evolution placed InterStim II in direct competition with other neuromodulation solutions—particularly other InterStim models and emerging Sacral Neuromodulation devices—while also integrating more closely with Medtronic’s broader portfolio of Pelvic Health therapies, reinforcing its role alongside solutions like the Solitaire and Pipeline embolic devices and the evolving suite of spinal cord stimulation offerings.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MDT_10k_2022.pdf",
          "target_page": 42,
          "pages": [
            40,
            41,
            42,
            43,
            44
          ]
        },
        "hop_2_rel": {
          "source_file": "MDT_10k_2024.pdf",
          "target_page": 39,
          "pages": [
            37,
            38,
            39,
            40,
            41
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 41100,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 10506,
        "completion_tokens": 230,
        "total_tokens": 10737
      }
    },
    {
      "question_id": 12,
      "question": "How has Simon Property Group's utilization and management of the Supplemental Facility evolved between 2022 and 2024, particularly in terms of borrowing capacity, interest rate strategies, and repayment actions?",
      "original_answer": "In 2022, the Supplemental Facility had an initial borrowing capacity of $3.5 billion, which could be increased to $4.5 billion, with a maturity date of January 31, 2026. Borrowings under the facility bore interest based on SOFR or similar rates, with a margin determined by the company's credit rating. By 2024, SPG had borrowed €750.0 million under the Supplemental Facility, which was repaid on November 17, 2023, following the issuance of exchangeable bonds. Additionally, interest rate swaps were used in 2023 to fix the rate on these borrowings at 3.81%. This indicates a shift from passive availability in 2022 to active utilization and strategic interest rate management in 2024.",
      "llm_answer": "Between 2022 and 2024, Simon Property Group’s Supplemental Facility borrowing capacity remained robust, expanding from a $3.5–$4.5 billion range to support larger, longer‑dated issuances. The company shifted toward lower‑cost, fixed‑rate debt, issuing $1 billion of 4.75% senior notes due 2034 (Sept 2024) and earlier retirements of higher‑coupon floating‑rate notes (e.g., 2.75% notes in June 2023, 3.75% notes in Feb 2024, and 2% notes in Sept 2024). These actions reduced average interest expense (weighted‑average facility rate fell to 5.29% in 2024) and extended maturities, with the Supplemental Facility now maturing in 2029 and extendable to 2030, providing ample refinancing flexibility.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "SPG_10k_2022.pdf",
          "target_page": 6,
          "pages": [
            4,
            5,
            6,
            7,
            8
          ]
        },
        "hop_2_rel": {
          "source_file": "SPG_10k_2024.pdf",
          "target_page": 70,
          "pages": [
            68,
            69,
            70,
            71,
            72
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 51360,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 13075,
        "completion_tokens": 174,
        "total_tokens": 13249
      }
    },
    {
      "question_id": 12,
      "question": "How has Verizon's approach to device payment plans evolved from 2023 to 2024, particularly in terms of customer financing structure and promotional incentives?",
      "original_answer": "In 2023, Verizon permitted customers to acquire equipment using device payment plans that allowed installment payments over time, with no mention of structured promotional incentives or trade-in rights. By 2024, Verizon formalized the device payment plan structure, describing it as a non-interest-bearing installment note typically repaid over a 36-month term, and introduced a defined promotional feature that allows customers to upgrade to a new device after paying a specified portion of their plan and trading in their current device in good working order. This represents a shift from a general financing mechanism to a more structured and incentive-driven model.",
      "llm_answer": "Verizon's device payment plans have remained structurally consistent from 2023 to 2024, continuing to offer non-interest-bearing installment notes over 36-month terms with potential billing credits tied to service retention. However, the company has refined its promotional incentives, introducing more targeted trade-in guarantees and usage-based upgrade options for Business customers while maintaining its focus on postpaid device subsidies for Business segments, as evidenced by the continued emphasis on fixed-term plans and device payment structures in both 2023 and 2024 disclosures.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "VZ_10k_2023.pdf",
          "target_page": 5,
          "pages": [
            3,
            4,
            5,
            6,
            7
          ]
        },
        "hop_2_rel": {
          "source_file": "VZ_10k_2024.pdf",
          "target_page": 60,
          "pages": [
            58,
            59,
            60,
            61,
            62
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 52366,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 13313,
        "completion_tokens": 147,
        "total_tokens": 13461
      }
    },
    {
      "question_id": 12,
      "question": "How has The Coca-Cola Company's legal relationship with Aqua-Chem evolved between 2023 and 2024, particularly in terms of its stance on liability for Aqua-Chem's asbestos-related claims?",
      "original_answer": "In 2023, Coca-Cola maintained that it had no obligation to Aqua-Chem for any liabilities or expenses related to claims or lawsuits against Aqua-Chem, as outlined in the Georgia Case. By 2024, while the litigation status remained largely unchanged, Coca-Cola's disclosure now includes a more detailed description of the insurance policies issued during its ownership of Aqua-Chem, particularly highlighting the involvement of multiple insurers and the ongoing coverage litigation. This indicates a shift in emphasis from outright denial of liability to a more nuanced stance centered on insurance coverage and shared responsibility among insurers.",
      "llm_answer": "Between 2023 and 2024, The Coca-Cola Company’s legal relationship with Aqua-Chem has remained unchanged in terms of liability for Aqua-Chem’s asbestos-related claims. The Wisconsin insurance coverage litigation was fully resolved by 2014, with the Wisconsin Court of Appeals affirming summary judgment in favor of the Company and Aqua-Chem, and the Supreme Court of Wisconsin denying review. The Georgia case remains subject to the 2004 stay agreement, and no new legal developments regarding Aqua-Chem’s liability were reported in the 2023 or 2024 filings. The Company continues to pursue coverage agreements with insurers but holds no ongoing legal obligation to Aqua-Chem beyond the settled insurance matters.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "KO_10k_2023.pdf",
          "target_page": 30,
          "pages": [
            28,
            29,
            30,
            31,
            32
          ]
        },
        "hop_2_rel": {
          "source_file": "KO_10k_2024.pdf",
          "target_page": 30,
          "pages": [
            28,
            29,
            30,
            31,
            32
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 75773,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 19173,
        "completion_tokens": 178,
        "total_tokens": 19351
      }
    },
    {
      "question_id": 12,
      "question": "How did Intel's utilization of non-US tax credits impact its long-term income tax liabilities in 2024 compared to 2022, and what does this indicate about the company's international tax strategy?",
      "original_answer": "In 2022, Intel reported long-term income taxes payable of $4.3 billion, which included the transition tax from Tax Reform and uncertain tax positions, reduced by non-US tax credits. By 2024, this figure had decreased to $1.6 billion, indicating that the company's utilization of non-US tax credits had a stronger offsetting effect over time. This suggests a strategic shift or increased effectiveness in leveraging international tax credits to reduce overall tax liabilities.",
      "llm_answer": "Intel's utilization of non-US tax credits and reduced foreign tax rates contributed to a significant decline in its effective tax rate from 71.6% in 2024 to (119.8)% in 2023, and further to 8.5% in 2021, indicating a strategic shift toward leveraging international tax incentives to minimize global tax liabilities. This trend reflects a deliberate focus on optimizing its international tax structure, particularly through operations in low-tax jurisdictions like Ireland and Israel, where statutory rates range from 12.5% to 24.0%, and through the use of R&D tax credits and tax holidays, which provided $67 million in benefits in 2024 (down from $129 million in 2023 and $220 million in 2022). The company's international tax strategy is further reinforced by its efforts to restructure foreign subsidiaries and capitalize on favorable tax regimes, as evidenced by the $2.7 billion in tax benefits from non-US income taxed at different rates in 2024, despite the overall increase in its effective tax rate due to a valuation allowance on US deferred tax assets.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "INTC_10k_2022.pdf",
          "target_page": 92,
          "pages": [
            90,
            91,
            92,
            93,
            94
          ]
        },
        "hop_2_rel": {
          "source_file": "INTC_10k_2024.pdf",
          "target_page": 83,
          "pages": [
            81,
            82,
            83,
            84,
            85
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 40174,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 10276,
        "completion_tokens": 265,
        "total_tokens": 10542
      }
    },
    {
      "question_id": 13,
      "question": "How has the treatment and risk exposure of pension risk transfers evolved between 2022 and 2024, particularly in terms of interest rate sensitivity and regulatory influence?",
      "original_answer": "In 2022, pension risk transfers were part of the Retirement and Income Solutions business, which was described as containing both short- and long-duration products, and was subject to interest rate scenarios that could impact asset-liability management (ALM) strategies. By 2024, regulatory changes, particularly around defined benefit pension plan funding, were found to potentially reduce the likelihood or delay corporate plan sponsors from terminating their plans or transferring pension obligations. This regulatory evolution increased the potential for a shift in the mix of pension risk transfers toward non-guaranteed funding products, indicating a strategic and regulatory-driven change in exposure.",
      "llm_answer": "Between 2022 and 2024, pension risk transfers have become more sensitive to interest rate movements, with declining rates creating unfavorable impacts on derivative gains and adjusted earnings, while rising rates generate favorable effects through higher reinvestment yields and lower liability valuations. Regulatory influences—particularly evolving solvency standards, reserve financing rules, and pension funding regulations—continue to shape the structure and timing of these transfers, affecting capital requirements and the mix of guaranteed and non-guaranteed funding products. The interplay of interest rate scenarios and regulatory changes has made pension risk transfers more volatile and strategically sensitive.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MET_10k_2022.pdf",
          "target_page": 61,
          "pages": [
            59,
            60,
            61,
            62,
            63
          ]
        },
        "hop_2_rel": {
          "source_file": "MET_10k_2024.pdf",
          "target_page": 32,
          "pages": [
            30,
            31,
            32,
            33,
            34
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 51473,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 13095,
        "completion_tokens": 180,
        "total_tokens": 13276
      }
    },
    {
      "question_id": 13,
      "question": "How has Medtronic's positioning and product strategy around the InterStim Micro neurostimulator evolved between 2022 and 2024?",
      "original_answer": "In 2022, Medtronic positioned the InterStim Micro as part of its broader InterStim therapy offering for treating overactive bladder, urinary retention, and bowel incontinence, alongside InterStim II and InterStim X neurostimulators. It was described as part of a growing and accepted product line within the Pelvic Health therapies under the Specialty Therapies division. By 2024, Medtronic specifically highlighted the InterStim Micro as a 'rechargeable neurostimulator' while emphasizing the continued acceptance and growth of InterStim therapy, particularly in the U.S., and distinguishing it from the recharge-free InterStim X and InterStim II models. This indicates a more targeted marketing and differentiation strategy for the InterStim Micro within the evolving Pelvic Health product portfolio.",
      "llm_answer": "Between 2022 and 2024, Medtronic’s positioning and product strategy for the InterStim Micro neurostimulator shifted from early-stage market entry toward broader clinical adoption and integration within its Pelvic Health portfolio. The 2022 10‑K notes the launch of InterStim Micro as a recharge‑free device for overactive bladder, urinary retention and fecal incontinence, and emphasizes its role in expanding less‑invasive therapies for women’s health. By 2024, the company highlighted continued acceptance and growth of InterStim Micro alongside other InterStim platforms (InterStim II, InterStim X) and underscored its inclusion in the “Pelvic Health” growth agenda, indicating that the Micro device has moved from a niche launch to a key driver of overall pelvic‑health sales, supported by AI‑enabled surgical navigation (StealthStation) and robotics (Mazor) to accelerate adoption.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MDT_10k_2022.pdf",
          "target_page": 42,
          "pages": [
            40,
            41,
            42,
            43,
            44
          ]
        },
        "hop_2_rel": {
          "source_file": "MDT_10k_2024.pdf",
          "target_page": 39,
          "pages": [
            37,
            38,
            39,
            40,
            41
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 41100,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 10490,
        "completion_tokens": 221,
        "total_tokens": 10712
      }
    },
    {
      "question_id": 14,
      "question": "How has Simon Property Group's use of the Supplemental Facility evolved between 2022 and 2024, particularly in terms of outstanding borrowings and repayment actions?",
      "original_answer": "In 2022, Simon Property Group had a weighted average outstanding balance under the Credit Facilities (including the Supplemental Facility) of $519.9 million, with a maximum aggregate outstanding balance of $2.1 billion during the year. By 2024, the weighted average outstanding balance under the Facilities had decreased to $311.1 million, and the company had repaid a significant portion of its borrowings, including €750.0 million ($815.4 million U.S. dollar equivalent) under the Supplemental Facility on November 17, 2023. This indicates a strategic reduction and refinancing of debt drawn from the Supplemental Facility over the two-year period.",
      "llm_answer": "Between 2022 and 2024, Simon Property Group’s Supplemental Facility usage declined significantly. Outstanding borrowings under the Supplemental Facility fell from $1.05 billion at the end of 2021 to $323.7 million by December 31, 2024, reflecting active repayments and strategic reductions. The company consistently used the facility to refinance maturing debt—most notably redeploying proceeds to retire $1.16 billion of mortgages in December 2021 and to fund the $808 million bond issuance in November 2023 that repaid the same amount under the Supplemental Facility. Consequently, the facility’s balance was largely retired by 2024, with only modest remaining capacity.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "SPG_10k_2022.pdf",
          "target_page": 124,
          "pages": [
            122,
            123,
            124,
            125,
            126
          ]
        },
        "hop_2_rel": {
          "source_file": "SPG_10k_2024.pdf",
          "target_page": 70,
          "pages": [
            68,
            69,
            70,
            71,
            72
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 50061,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 12741,
        "completion_tokens": 168,
        "total_tokens": 12909
      }
    },
    {
      "question_id": 14,
      "question": "How did COP's investment activity in the Lower 48 region evolve from 2022 to 2023, based on the changes in depreciation, depletion, amortization, and impairments expenses?",
      "original_answer": "In 2022, COP reported $4,854 million in depreciation, depletion, amortization, and impairments expenses for the Lower 48 region, which increased to $5,729 million in 2023. This indicates a significant increase in investment activity or asset utilization in the Lower 48 region over that period.",
      "llm_answer": "Based on the depreciation, depletion, and amortization (DDA) expense figures in the consolidated financial statements, COP's DDA expense increased from $7,492 million in 2022 to $8,284 million in 2023. This rise reflects higher DDA costs in the Lower 48 region (up from $4,854 million to $5,729 million) and other segments, indicating that the company's investment activity in the Lower 48 expanded during 2023, driving the increased DDA expense. Consequently, the growth in DDA expense signals an acceleration in capital investment and related activity within the Lower 48 area from 2022 to 2023.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "COP_10k_2022.pdf",
          "target_page": 172,
          "pages": [
            170,
            171,
            172,
            173,
            174
          ]
        },
        "hop_2_rel": {
          "source_file": "COP_10k_2023.pdf",
          "target_page": 133,
          "pages": [
            131,
            132,
            133,
            134,
            135
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 56823,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 14435,
        "completion_tokens": 149,
        "total_tokens": 14584
      }
    },
    {
      "question_id": 14,
      "question": "How has Verizon's approach to corporate networking solutions evolved from 2023 to 2024, particularly in terms of service description and business segment emphasis?",
      "original_answer": "In 2023, Verizon's Business segment explicitly described offering a broad portfolio of network connectivity products, including private networking services, private cloud connectivity services, and software-defined networking services, with Enterprise and Public Sector revenues reaching $15.1 billion, or approximately 50% of Business's total revenues. By 2024, the Business segment's description became more streamlined, focusing on wireless and wireline communications services and products, including corporate networking solutions, without specifying the same level of detail in offerings or segment revenue. This indicates a shift toward a more generalized presentation of services, potentially signaling a strategic consolidation or simplification of messaging around corporate networking solutions.",
      "llm_answer": "Verizon's corporate networking solutions have evolved from 2023 to 2024 by shifting emphasis from a standalone \"Business Markets and Other\" segment to integrating networking services more deeply within the Business Group's broader portfolio. In 2024, the Business segment explicitly highlights \"corporate networking solutions\" as a core offering under its wireless and wireline services, alongside security, managed network services, and IoT connectivity, reflecting a strategic focus on enterprise-grade network infrastructure. This evolution is underscored by the 2024 segment data showing $14.2 billion in Enterprise and Public Sector revenues (up from $15.1 billion in 2023, though the segment's revenue share decreased slightly), with corporate networking positioned as a key driver for business market growth and innovation, particularly through 5G and intelligent edge network deployments.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "VZ_10k_2023.pdf",
          "target_page": 5,
          "pages": [
            3,
            4,
            5,
            6,
            7
          ]
        },
        "hop_2_rel": {
          "source_file": "VZ_10k_2024.pdf",
          "target_page": 100,
          "pages": [
            98,
            99,
            100,
            101,
            102
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 50129,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 12756,
        "completion_tokens": 224,
        "total_tokens": 12980
      }
    },
    {
      "question_id": 14,
      "question": "How did MetLife's valuation approach and sensitivity to fair value changes for FVO securities evolve from 2022 to 2024, particularly in terms of the impact of U.S. dollar appreciation?",
      "original_answer": "In 2022, MetLife reported that FVO securities had an estimated fair value of $1.6 billion and were sensitive to changes in the U.S. dollar, with a 10% appreciation leading to a $54 million decrease in value. By 2024, while no direct fair value figure for FVO securities is provided, the company emphasized a broader sensitivity framework where nonperformance risk spreads and unobservable inputs varied by duration and currency, indicating a more nuanced and dynamic valuation methodology. This evolution shows a shift from a static sensitivity model to a more complex, duration- and currency-dependent approach.",
      "llm_answer": "From 2022 to 2024, MetLife’s valuation of FVO securities and other Level‑3 assets was driven by observable market inputs (e.g., quoted prices, market‑pricing techniques) and significant unobservable inputs such as mortality, lapse, utilization, withdrawal, equity‑volatility and non‑performance‑risk spreads.  The company’s sensitivity analysis shows that a 10 % appreciation of the U.S. dollar would have reduced the estimated fair value of its interest‑rate‑ and foreign‑currency‑sensitive assets by roughly $11.8 billion, while the embedded‑derivative liabilities tied to those exposures would partially offset that impact.  Consequently, the net effect of U.S.‑dollar appreciation on the fair‑value hierarchy shifted the overall sensitivity from $7.2 billion of potential loss in 2021 to a smaller net exposure by 2024, reflecting both the higher observable market data and the offsetting liabilities.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MET_10k_2022.pdf",
          "target_page": 151,
          "pages": [
            149,
            150,
            151,
            152,
            153
          ]
        },
        "hop_2_rel": {
          "source_file": "MET_10k_2024.pdf",
          "target_page": 250,
          "pages": [
            248,
            249,
            250,
            251,
            252
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 84360,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 21322,
        "completion_tokens": 226,
        "total_tokens": 21548
      }
    },
    {
      "question_id": 14,
      "question": "How has NextEra Energy's engagement in power marketing activities evolved between 2022 and 2023, particularly in terms of its energy trading services and associated financial performance?",
      "original_answer": "In 2022, NextEra Energy (NEE) was actively engaged in power and fuel marketing and trading activities, primarily providing full energy and capacity requirements services to distribution utilities, including load-following and ancillary services, while also optimizing the value of electricity and fuel contracts and generation assets. By 2023, NEE's subsidiary NEER had expanded its role in power marketing and trading, contributing to a significant increase in net income, which rose from $285 million in 2022 to $3,558 million in 2023. This indicates a substantial evolution and growth in the scale or profitability of NEE’s power marketing and trading activities over the period.",
      "llm_answer": "Between 2022 and 2023, NextEra Energy's power marketing activities expanded through NEER, with energy trading revenues rising $5,952 million—driven by favorable non‑qualifying commodity hedges and new wind/solar/battery projects—while operating expenses increased $566 million due to higher O&M and depreciation costs. This growth contributed to a $3,273 million jump in NEER's net income (after noncontrolling interests), reflecting stronger earnings from new clean‑energy investments and improved trading gains, even as the company faced higher interest expenses and occasional impairment charges.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "NEE_10k_2022.pdf",
          "target_page": 77,
          "pages": [
            75,
            76,
            77,
            78,
            79
          ]
        },
        "hop_2_rel": {
          "source_file": "NEE_10k_2023.pdf",
          "target_page": 40,
          "pages": [
            38,
            39,
            40,
            41,
            42
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 9,
        "total_chars": 57890,
        "num_window_pages": 9,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 14703,
        "completion_tokens": 149,
        "total_tokens": 14853
      }
    },
    {
      "question_id": 14,
      "question": "How has The Coca-Cola Company's financial relationship with Coca-Cola FEMSA evolved between 2023 and 2024, particularly in terms of its stake ownership and implications for equity income?",
      "original_answer": "In 2023, Coca-Cola FEMSA was referenced as one of the key bottlers whose financial performance could influence The Coca-Cola Company's credit ratings, indicating an indirect financial dependency. By 2024, The Coca-Cola Company held a 28% ownership stake in Coca-Cola FEMSA, which was accounted for under the equity method. This shift from a dependency-based relationship to a direct ownership stake suggests a strategic evolution, where Coca-Cola now has a more direct financial interest in FEMSA's performance, which will directly impact its equity income (loss) - net line item.",
      "llm_answer": "\nBased on the provided document, The Coca-Cola Company maintained a 28% ownership stake in Coca-Cola FEMSA from 2023 to 2024, as indicated in Note 6 where it states \"As of December 31, 2024, we owned 28% of Coca-Cola FEMSA, S.A.B. de C.V.\" The Company's equity income (loss)-net from equity method investees increased from $1,691 million in 2023 to $1,770 million in 2024, reflecting improved performance of its equity method investments including Coca-Cola FEMSA. This increase in equity income is consistent with the overall rise in net income of the equity method investees, which grew from $7,657 million in 2023 to $8,439 million in 2024, as shown in the consolidated financial information. The Company's carrying value of its investment in Coca-Cola FEMSA was $1,786 million as of December 31, 2024, though the document does not provide the specific 2023 carrying value for this investment. The equity income increase demonstrates how the Company's stake in Coca-Cola FEMSA contributes to its overall equity income, which is a key component of its consolidated financial results.",
      "llm_thought": "The Coca-Cola Company's equity method investment in Coca-Cola FEMSA decreased from 28% ownership as of December 31, 2023 to 28% as of December 31, 2024 (noting the percentage remained unchanged year-over-year), but the Company's carrying value of this investment increased significantly from $1,786 million to $1,786 million? Wait, no - the carrying value was $1,786 million as of December 31, 2024 compared to $1,786 million? Let me check the data.\n\nLooking at the document, in Note 6 (Equity Method Investments), it states: \"As of December 31, 2024, we owned 28% of Coca-Cola FEMSA, S.A.B. de C.V.\" and the table shows \"Coca-Cola FEMSA, S.A.B. de C.V.\" with Fair Value $4,544 million and Carrying Value $1,786 million. The document also shows that the Company's equity income (loss)-net from equity method investees was $1,770 million for 2024, which includes its share of Coca-Cola FEMSA's net income.\n\nThe key evolution is that the Company's stake in Coca-Cola FEMSA remained at 28% from 2023 to 2024 (as stated in the document: \"As of December 31, 2024, we owned 28% of these companies' outstanding shares\" - referring to Coca-Cola FEMSA specifically), but the carrying value of the investment increased from $1,786 million to $1,786 million? Wait, the document shows the carrying value as $1,786 million for 2024, but doesn't explicitly state the 2023 carrying value for Coca-Cola FEMSA specifically. However, the total carrying value of all equity method investments decreased from $19,671 million (as of December 31, 2023) to $18,087 million (as of December 31, 2024), which suggests the Company's overall equity method investment portfolio decreased slightly.\n\nThe document also states: \"As of December 31, 2024, our investments in our equity method investees in the aggregate exceeded our proportionate share of the net assets of these equity method investees by $7,791 million. This difference is not amortized.\" This indicates that the Company's equity method investments are recorded at a value higher than its proportionate share of the investees' net assets, which is typical for equity method accounting.\n\nFor the equity income implication, the document shows that the Company's equity income (loss)-net from equity method investees was $1,770 million for 2024, compared to $1,691 million for 2023, indicating a slight increase in equity income from these investments. This increase is consistent with the overall increase in net income of the equity method investees from $8,439 million (2024) to $7,657 million (2023) - wait, no, the net income of the equity method investees was $8,439 million in 2024 compared to $7,657 million in 2023, so the Company's share of that income would be a portion of that amount.\n\nThe document also shows that the Company's proportionate share of the net income of its equity method investees includes items that can significantly impact the equity income (loss)-net, and that the carrying values of the investments are impacted by the investees' other comprehensive income (OCI) items.\n\nSo to answer the question: The Coca-Cola Company's stake ownership in Coca-Cola FEMSA remained at 28% between 2023 and 2024 (no change in ownership percentage), but the Company's carrying value of this investment and its equity income from this investment both increased during this period. The equity income increased from $1,691 million in 2023 to $1,770 million in 2024, reflecting the improved performance of Coca-Cola FEMSA and other equity method investees.\n\nWait, I need to be precise. The question asks about \"The Coca-Cola Company's financial relationship with Coca-Cola FEMSA evolved between 2023 and 2024, particularly in terms of its stake ownership and implications for equity income.\"\n\nFrom the document:\n- Stake ownership: The Company owned 28% of Coca-Cola FEMSA as of December 31, 2024, and also owned 28% as of December 31, 2023 (the document states \"As of December 31, 2024, we owned 19%, 21%, 20%, 28%, 22% and 19%, respectively, of these companies' outstanding shares\" - the 28% corresponds to Coca-Cola FEMSA).\n- Implications for equity income: The Company's equity income (loss)-net from equity method investees increased from $1,691 million in 2023 to $1,770 million in 2024, which includes its share of Coca-Cola FEMSA's net income. The document also shows that Coca-Cola FEMSA's net income attributable to common shareowners was $8,341 million in 2024 compared to $7,582 million in 2023, so the Company's share of that would be a portion of that amount.\n\nThe document also shows that the Company's carrying value of its investment in Coca-Cola FEMSA was $1,786 million as of December 31, 2024, but it doesn't explicitly state the 2023 carrying value for Coca-Cola FEMSA specifically. However, the total carrying value of all equity method investments decreased from $19,671 million (2023) to $18,087 million (2024), which suggests that the Company's investment in Coca-Cola FEMSA may have been a significant portion of that decrease.\n\nBut the key point is that the stake ownership remained at 28% for Coca-Cola FEMSA, and the equity income from this investment (and other equity method investees) increased during the period.\n\nSo the answer should be: The Coca-Cola Company maintained a 28% ownership stake in Coca-Cola FEMSA from 2023 to 2024, and its equity income from this investment increased from $1,691 million in 2023 to $1,770 million in 2024, reflecting the improved performance of Coca-Cola FEMSA and other equity method investees.\n\nLet me double-check the document to make sure I'm not missing anything.\n\nIn the document, under \"Equity Method Investments\" in Note 6, it states: \"As of December 31, 2024, we owned 19%, 21%, 20%, 28%, 22% and 19%, respectively, of these companies' outstanding shares.\" The 28% corresponds to Coca-Cola FEMSA, S.A.B. de C.V. The document also shows that the Company's equity income (loss)-net was $1,770 million for 2024, compared to $1,691 million for 2023.\n\nSo the stake ownership remained at 28% for Coca-Cola FEMSA, and the equity income increased from $1,691 million to $1,770 million.\n\nThe question asks about \"the Company's stake ownership and implications for equity income.\" So the answer should focus on the fact that the stake ownership remained the same (28%), but the equity income increased.\n\nI should also note that the document mentions that the Company's proportionate share of the net income or loss of its equity method investees includes significant operating and nonoperating items, and that these items can have a significant impact on the amount of equity income (loss)-net.\n\nSo the answer should be: The Coca-Cola Company maintained a 28% ownership stake in Coca-Cola FEMSA from 2023 to 2024, and its equity income from this investment increased from $1,691 million in 2023 to $1,770 million in 2024, reflecting the improved performance of Coca-Cola FEMSA and other equity method investees.\n\nWait, I need to be careful. The $1,770 million and $1,691 million are the total equity income (loss)-net for all equity method investees, not specifically for Coca-Cola FEMSA. The document doesn't break down the equity income by individual investee, only by the aggregate.\n\nSo I should say: The Coca-Cola Company maintained a 28% ownership stake in Coca-Cola FEMSA from 2023 to 2024, and its overall equity income (loss)-net from all equity method investees increased from $1,691 million in 2023 to $1,770 million in 2024, which includes its share of Coca-Cola FEMSA's net income.\n\nBut the question specifically asks about \"its stake ownership and implications for equity income\" in relation to Coca-Cola FEMSA. So I should focus on the fact that the stake ownership remained at 28%, and that the equity income from this investment (as part of the overall equity income) increased.\n\nThe document doesn't provide a specific figure for Coca-Cola FEMSA's contribution to the equity income, only the aggregate. So I should be careful not to attribute the entire $1,770 million to Coca-Cola FEMSA.\n\nThe safest answer is: The Coca-Cola Company maintained a 28% ownership stake in Coca-Cola FEMSA from 2023 to 2024, and its equity income (loss)-net from equity method investees increased from $1,691 million in 2023 to $1,770 million in 2024, reflecting improved performance of its equity method investees including Coca-Cola FEMSA.\n\nLet me check if there's any other information about Coca-Cola FEMSA specifically in the document.\n\nIn the table of \"Difference between calculated fair value, based on quoted closing prices of publicly traded shares, and our Company's carrying value in investments in publicly traded companies accounted for under the equity method,\" it shows that for Coca-Cola FEMSA, the fair value was $4,544 million and the carrying value was $1,786 million. This suggests that the Company's carrying value of its investment in Coca-Cola FEMSA was $1,786 million as of December 31, 2024, but it doesn't provide the 2023 carrying value for Coca-Cola FEMSA specifically.\n\nThe document also shows that the Company's investments in equity method investees in the aggregate exceeded its proportionate share of the net assets of these investees by $7,791 million as of December 31, 2024, but it doesn't provide the 2023 figure for this difference.\n\nSo, to answer the question accurately, I should say that the stake ownership in Coca-Cola FEMSA remained at 28% from 2023 to 2024, and the Company's equity income (loss)-net from equity method investees increased from $1,691 million in 2023 to $1,770 million in 2024, which includes its share of Coca-Cola FEMSA's net income.\n\nI think that's the most accurate answer based on the document.\n",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "KO_10k_2023.pdf",
          "target_page": 56,
          "pages": [
            54,
            55,
            56,
            57,
            58
          ]
        },
        "hop_2_rel": {
          "source_file": "KO_10k_2024.pdf",
          "target_page": 87,
          "pages": [
            85,
            86,
            87,
            88,
            89
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 52142,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 13265,
        "completion_tokens": 2688,
        "total_tokens": 15954
      }
    },
    {
      "question_id": 15,
      "question": "How has the financial investment and operational focus on the Lower 48 region evolved between 2022 and 2023 based on production volumes and depreciation expenses?",
      "original_answer": "In 2022, the Lower 48 region showed strong production volumes, particularly in crude oil (447 thousand barrels daily) and natural gas (1,340 million cubic feet daily), indicating a significant operational focus. In 2023, the financial emphasis on the Lower 48 increased further, as evidenced by a rise in depreciation, depletion, amortization, and impairments expenses from $4,854 million in 2022 to $5,729 million in 2023. This reflects a growing financial investment in the region despite stable or moderate production levels in the prior year.",
      "llm_answer": "Based on the provided financial data, the Lower 48 region's operational focus shifted significantly between 2022 and 2023, with production volumes increasing substantially while depreciation expenses also rose. Specifically, Lower 48 production volumes rose from 213 thousand barrels daily in 2022 to 447 thousand barrels daily in 2021 (and further to 584 thousand barrels daily in Delaware Basin alone by 2021), and depreciation expenses for the region increased from $4,854 million in 2022 to $5,729 million in 2023, reflecting both higher operational activity and asset base expansion.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "COP_10k_2022.pdf",
          "target_page": 169,
          "pages": [
            167,
            168,
            169,
            170,
            171
          ]
        },
        "hop_2_rel": {
          "source_file": "COP_10k_2023.pdf",
          "target_page": 133,
          "pages": [
            131,
            132,
            133,
            134,
            135
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 61873,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 15695,
        "completion_tokens": 147,
        "total_tokens": 15842
      }
    },
    {
      "question_id": 15,
      "question": "How has Verizon's strategic relationship with its 4G LTE network evolved between 2023 and 2024 in terms of its role within the company's network infrastructure and growth initiatives?",
      "original_answer": "In 2023, Verizon's 4G LTE network was positioned primarily as a foundational component of its wireless services, specifically highlighted as a means to provide FWA broadband as an alternative to traditional landline internet access. By 2024, the strategic role of the 4G LTE network had evolved into being part of a broader integrated network vision that includes C-Band spectrum, millimeter wave spectrum, and fiber infrastructure, aimed at driving innovative products and services and fueling growth. This shift indicates a move from viewing 4G LTE in a service delivery context to a more strategic asset within a multi-technology ecosystem.",
      "llm_answer": "Verizon's 4G LTE network has evolved from a foundational connectivity platform to a strategic growth driver within its broader network infrastructure and monetization strategy. While the company continues to invest in expanding and densifying its 4G LTE coverage to support Fixed Wireless Access (FWA) broadband and enhance network reliability, its primary strategic focus has shifted toward 5G deployment and leveraging the combined capabilities of its 4G LTE and 5G networks to deliver advanced services and fuel future growth, as highlighted in the 2024 10-K's emphasis on 5G evolution and fiber expansion.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "VZ_10k_2023.pdf",
          "target_page": 97,
          "pages": [
            95,
            96,
            97,
            98,
            99
          ]
        },
        "hop_2_rel": {
          "source_file": "VZ_10k_2024.pdf",
          "target_page": 23,
          "pages": [
            21,
            22,
            23,
            24,
            25
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 44344,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 11315,
        "completion_tokens": 152,
        "total_tokens": 11467
      }
    },
    {
      "question_id": 15,
      "question": "How did Emerson's financial and strategic relationship with AspenTech evolve from 2022 to 2024, particularly in terms of stake value, ownership structure, and the impact on financial metrics such as backlog and gross margin?",
      "original_answer": "In 2022, Emerson held a stake in AspenTech with a backlog value of $1,042 million, indicating a strategic business relationship. By 2024, this relationship evolved significantly as Emerson completed a transaction that resulted in the creation of 'New AspenTech,' where Emerson owned 55% of the outstanding shares. This acquisition had a measurable impact on financial metrics: gross margin in 2023 increased by 3.3 percentage points, partly due to the AspenTech acquisition, and backlog in 2024 reached $8,053 million, up from $6,533 million in 2021, showing the influence of the AspenTech integration.",
      "llm_answer": "From 2022 through 2024, Emerson’s financial relationship with AspenTech evolved from a 55% equity stake (after the 2022 Heritage AspenTech acquisition) to full ownership via a proposed $240‑per‑share cash acquisition announced in November 2024, while the company also explored divesting its Safety & Productivity segment.  The stake’s value grew as AspenTech’s backlog rose from $328 million in 2021 to $1,042 million in 2022, supporting higher segment earnings, and the integration of AspenTech contributed to gross‑margin expansion (50.8% in 2024) despite inventory‑step‑up amortization.  However, the later sale of Emerson’s remaining 40% non‑controlling interest in Copeland (a key AspenTech‑related asset) generated a $279 million pretax loss on the note receivable and a $539 million gain on the equity sale, underscoring the financial impact of the evolving AspenTech relationship on backlog, margins and overall earnings.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "EMR_10k_2022.pdf",
          "target_page": 10,
          "pages": [
            8,
            9,
            10,
            11,
            12
          ]
        },
        "hop_2_rel": {
          "source_file": "EMR_10k_2024.pdf",
          "target_page": 26,
          "pages": [
            24,
            25,
            26,
            27,
            28
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 9,
        "total_chars": 38458,
        "num_window_pages": 9,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 9854,
        "completion_tokens": 232,
        "total_tokens": 10086
      }
    },
    {
      "question_id": 15,
      "question": "How has NEE's financial commitment to the Mountain Valley Pipeline evolved between 2022 and 2023, and what does this indicate about its investment strategy?",
      "original_answer": "In 2022, NEE's involvement in the Mountain Valley Pipeline was described as part of its equity method investments, with an ownership stake ranging between 32% and 55%. By 2023, NEE, through its subsidiary NEER, had a more defined 32.8% equity investment in the Mountain Valley Pipeline, which was accompanied by a 20-year natural gas transportation agreement valued at approximately $70 million per year. This indicates a strategic deepening of NEE's commitment to the pipeline, moving from a general equity investment toward a more structured, long-term contractual relationship tied to infrastructure development.",
      "llm_answer": "Between 2022 and 2023, NEE’s financial commitment to the Mountain Valley Pipeline shifted from active investment to complete exit. In 2022, NEE recorded a $1.5 billion impairment charge related to its investment in the pipeline (page 97), and by the first quarter of 2022 it had fully written off that investment (page 97). By 2023, NEE reported no remaining investment in the project and disclosed only $11 million of equity method investees, indicating the pipeline was fully divested (page 111). This abandonment signals a strategic pivot away from gas‑pipeline ventures toward renewable and regulated transmission projects, emphasizing capital allocation to wind, solar, and transmission infrastructure instead.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "NEE_10k_2022.pdf",
          "target_page": 96,
          "pages": [
            94,
            95,
            96,
            97,
            98
          ]
        },
        "hop_2_rel": {
          "source_file": "NEE_10k_2023.pdf",
          "target_page": 109,
          "pages": [
            107,
            108,
            109,
            110,
            111
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 70184,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 17770,
        "completion_tokens": 178,
        "total_tokens": 17949
      }
    },
    {
      "question_id": 15,
      "question": "How has Coca-Cola's relationship with Costa Limited evolved from 2023 to 2024 in terms of its operational integration and strategic positioning within the Global Ventures segment?",
      "original_answer": "In 2023, Costa Limited was referenced as part of Coca-Cola's direct retail operations, specifically through retail stores operated by Costa, and was included within the Global Ventures operating segment. By 2024, Costa Limited was more strategically embedded within the Global Ventures segment, which now also included the results of innocent and doğadan businesses, as well as fees earned under distribution coordination agreements. This indicates a deeper integration and broader strategic role for Costa within Coca-Cola’s diversified beverage portfolio.",
      "llm_answer": "From 2023 to 2024, Coca-Cola's relationship with Costa Limited has deepened its operational integration and strategic positioning within the Global Ventures segment. Costa Limited's sales are now explicitly included in the Global Ventures operating segment, reflecting its expanded role beyond bottling to include direct consumer sales through its retail stores. This integration supports Coca-Cola's broader strategy of leveraging Costa's established market presence and brand portfolio to drive growth in emerging beverage categories and enhance its global beverage portfolio diversification. The 2024 annual impairment testing for indefinite-lived intangible assets, including goodwill tied to Global Ventures, underscores the strategic importance of this segment to Coca-Cola's long-term value creation.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "KO_10k_2023.pdf",
          "target_page": 6,
          "pages": [
            4,
            5,
            6,
            7,
            8
          ]
        },
        "hop_2_rel": {
          "source_file": "KO_10k_2024.pdf",
          "target_page": 73,
          "pages": [
            71,
            72,
            73,
            74,
            75
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 51873,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 13195,
        "completion_tokens": 201,
        "total_tokens": 13397
      }
    },
    {
      "question_id": 15,
      "question": "How has Intel's investment in financial institution instruments evolved between 2022 and 2024, particularly in terms of the fair value of economically hedged marketable debt investments?",
      "original_answer": "In 2022, Intel recorded net losses of $748 million on economically hedged marketable debt investments. By 2024, the fair value of these hedged investments had decreased to $13.5 billion from $17.1 billion in 2023, with Intel recording net losses of $464 million in 2024. This indicates a reduction in both the size of the hedged investment portfolio and the magnitude of losses compared to two years prior.",
      "llm_answer": "Based on the provided SEC 10-K filings, Intel's investment in economically hedged marketable debt instruments experienced a significant decline in fair value between 2022 and 2024. As explicitly stated in the 2024 filing (page 80), the fair value of these hedged investments was $13.5 billion as of December 28, 2024, compared to $17.1 billion as of December 30, 2023, reflecting a net loss of $464 million in 2024 (after prior net gains of $534 million in 2023 and $748 million in 2022). This deterioration was primarily attributed to the uncertainty surrounding the realizability of US deferred tax assets, which led to a $10.9 billion increase in the valuation allowance for deferred tax assets during 2024. Consequently, the fair value of Intel's economically hedged marketable debt investments decreased substantially over the two-year period, with the 2024 fair value being notably lower than both 2023 and 2022 levels.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "INTC_10k_2022.pdf",
          "target_page": 80,
          "pages": [
            78,
            79,
            80,
            81,
            82
          ]
        },
        "hop_2_rel": {
          "source_file": "INTC_10k_2024.pdf",
          "target_page": 83,
          "pages": [
            81,
            82,
            83,
            84,
            85
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 54525,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 13862,
        "completion_tokens": 231,
        "total_tokens": 14093
      }
    },
    {
      "question_id": 16,
      "question": "How did AMT's financial focus regarding communications sites evolve from 2023 to 2024, particularly in terms of recurring revenue generation and asset retirement liabilities?",
      "original_answer": "In 2023, AMT emphasized recurring revenue generation from communications sites, noting that 99% of total revenues came from property operations, which included leasing space on communications sites. By 2024, the focus expanded to include significant liabilities tied to these assets, with an estimated $4.5 billion in undiscounted future cash outlay for asset retirement obligations as of December 31, 2024. This reflects a shift from primarily highlighting revenue streams to also addressing the long-term financial responsibilities associated with site decommissioning.",
      "llm_answer": "From 2023 to 2024, AMT’s communications‑site portfolio continued to generate recurring lease revenue that is largely non‑cancellable and escalates on a fixed or inflation‑linked basis, providing a stable cash‑flow base.  However, the company recorded significant asset‑retirement obligations ($4.5 billion undiscounted) and, under its securitization and loan agreements, excess cash flow is subject to DSCR‑based cash‑trap and amortization conditions that can restrict distributions and limit the use of cash for capital projects or debt repayment.  Consequently, while recurring revenue remained robust, the ability to fully deploy cash from operations was increasingly constrained by these covenant‑driven cash‑flow restrictions and the need to fund asset‑retirement liabilities.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AMT_10k_2023.pdf",
          "target_page": 32,
          "pages": [
            30,
            31,
            32,
            33,
            34
          ]
        },
        "hop_2_rel": {
          "source_file": "AMT_10k_2024.pdf",
          "target_page": 56,
          "pages": [
            54,
            55,
            56,
            57,
            58
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 48174,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 12271,
        "completion_tokens": 195,
        "total_tokens": 12466
      }
    },
    {
      "question_id": 16,
      "question": "How has XOM's strategic positioning in Guyana evolved between 2023 and 2024, particularly in terms of its legal operating framework and business growth emphasis?",
      "original_answer": "In 2023, XOM's operations in Guyana were governed by the Petroleum Activities Act 2023, which allowed for an exploration period typically up to 10 years and a production period of 20 years for oil fields with a renewal period of up to 10 years. By 2024, Guyana was specifically highlighted as one of XOM's 'Advantaged Assets' under the 'Advantaged Volume Growth' earnings driver, indicating a strategic shift to emphasize Guyana as a key contributor to earnings through volume growth and integration. This evolution shows that Guyana transitioned from being a jurisdiction with defined exploration and production terms to being a core growth asset within XOM's portfolio.",
      "llm_answer": "XOM's strategic positioning in Guyana has evolved significantly between 2023 and 2024, with the legal operating framework transitioning from the Petroleum Activities Act 2023 to a more stable regulatory environment that supports long-term development. The company has emphasized Guyana as a core growth area, particularly through its Pioneer acquisition and expanding upstream investments, which are now categorized under \"Advantaged Assets\" in its earnings drivers. This strategic focus reflects a deliberate shift toward high-value, long-cycle projects in Guyana to drive future growth, supported by the country's newly established legal structure for petroleum agreements.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "XOM_10k_2023.pdf",
          "target_page": 25,
          "pages": [
            23,
            24,
            25,
            26,
            27
          ]
        },
        "hop_2_rel": {
          "source_file": "XOM_10k_2024.pdf",
          "target_page": 37,
          "pages": [
            35,
            36,
            37,
            38,
            39
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 45634,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 11632,
        "completion_tokens": 168,
        "total_tokens": 11801
      }
    },
    {
      "question_id": 16,
      "question": "How has Caterpillar's involvement in the diesel-electric locomotives business evolved between 2023 and 2024, particularly in terms of its strategic positioning and operational responsibilities?",
      "original_answer": "In 2023, Caterpillar's involvement in diesel-electric locomotives was described as part of its broader Machinery, Energy & Transportation (ME&T) segment, which included responsibilities such as remanufacturing Caterpillar reciprocating engines and components, as well as product support for on-highway vocational trucks in North America. By 2024, Caterpillar's positioning had evolved, with diesel-electric locomotives and related components being explicitly tied to integrated systems and solutions for industries like electric power generation, marine, oil and gas, and industrial sectors. Additionally, 2024 emphasized the development of electrified powertrains and zero-emission power sources, signaling a strategic shift toward more advanced and environmentally focused technologies in the locomotive space.",
      "llm_answer": "Caterpillar’s diesel‑electric locomotives remain part of its Energy & Transportation segment, but the company’s strategic focus and operational responsibilities have shifted.  While the segment continues to design, manufacture and support diesel‑electric locomotives and related components (including remanufacturing and leasing), the 2024 disclosures show that the segment’s profit growth was driven primarily by favorable price realization rather than volume changes, and that operational responsibilities are now integrated with the broader Machinery, Energy & Transportation (ME&T) business.  Consequently, Caterpillar’s involvement in diesel‑electric locomotives is positioned within the ME&T portfolio, with responsibilities spanning product design, manufacturing, marketing, sales and product support across the segment’s overall line‑of‑business strategy.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CAT_10k_2023.pdf",
          "target_page": 116,
          "pages": [
            114,
            115,
            116,
            117,
            118
          ]
        },
        "hop_2_rel": {
          "source_file": "CAT_10k_2024.pdf",
          "target_page": 39,
          "pages": [
            37,
            38,
            39,
            40,
            41
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 9,
        "total_chars": 39763,
        "num_window_pages": 9,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 10174,
        "completion_tokens": 215,
        "total_tokens": 10390
      }
    },
    {
      "question_id": 16,
      "question": "How has the company's reliance on securitized debt obligations as a funding source evolved from 2022 to 2024, and what does this indicate about its funding strategy?",
      "original_answer": "In 2022, the company disclosed that it raised funding through the issuance of securitized debt obligations, among other instruments, though the exact amount was not provided. By 2024, the company reported a carrying value of $14,264 million for securitized debt obligations, indicating a concrete quantification of this funding source. This evolution suggests a more defined and potentially increased reliance on securitized debt obligations, aligning with a broader strategic emphasis on structured financing.",
      "llm_answer": "From 2022 to 2024, Capital One’s reliance on securitized debt obligations as a funding source grew modestly but remained a relatively small portion of total funding. In the 2023 balance sheet (page 220), securitized debt obligations were reported at $18,067 million, up from $18,043 million in 2022, and represented about 4 % of total liabilities. By the 2024 filing (page 218), the carrying value of securitized debt fell slightly to $14,335 million, still accounting for roughly 4 % of total liabilities. This indicates that while the company continues to use securitizations to diversify funding, it is not a dominant or rapidly expanding component of its overall financing strategy.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "COF_10k_2022.pdf",
          "target_page": 67,
          "pages": [
            65,
            66,
            67,
            68,
            69
          ]
        },
        "hop_2_rel": {
          "source_file": "COF_10k_2024.pdf",
          "target_page": 219,
          "pages": [
            217,
            218,
            219,
            220,
            221
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 52055,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 13240,
        "completion_tokens": 171,
        "total_tokens": 13411
      }
    },
    {
      "question_id": 16,
      "question": "How has McDonald's treatment of developmental licensees evolved between 2023 and 2024, particularly in terms of financial reporting and relationship management?",
      "original_answer": "In 2023, McDonald's disclosed that developmental licensees paid royalties based on a percentage of sales and generally paid initial fees, and the company allocated consideration among lease and non-lease components using historical methods. By 2024, the company emphasized its ongoing evaluation of business relationships, including those with developmental licensees, to identify potential variable interest entities, although it concluded that consolidation of such entities was not appropriate. Additionally, in 2024, McDonald's updated its rounding presentation to the nearest whole number for reported amounts, which affected how financial figures were presented, though the company clarified that these changes were not significant.",
      "llm_answer": "Between 2023 and 2024, McDonald's treatment of developmental licensees evolved primarily through enhanced financial reporting and relationship management practices. The company refined its assumptions regarding renewal options in lease accounting (noting that renewal options were now considered \"reasonably certain\" of being exercised under its new \"Restaurant Development\" growth pillar), which increased lease right-of-use assets and liabilities. Additionally, the 2024 adoption of ASU 2023-07 expanded segment reporting disclosures, providing greater detail on reportable segment expenses that directly impacts how developmental licensee performance is disclosed. While the core franchise/license fee structure remained unchanged (royalties based on sales, initial fees recognized over the 20-year term), the company refined its estimates for renewal probabilities and lease liability valuations specifically tied to developmental licensee operations, reflecting a more structured approach to managing these relationships within its International Developmental Licensed Markets & Corporate segment.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MCD_10k_2023.pdf",
          "target_page": 50,
          "pages": [
            48,
            49,
            50,
            51,
            52
          ]
        },
        "hop_2_rel": {
          "source_file": "MCD_10k_2024.pdf",
          "target_page": 45,
          "pages": [
            43,
            44,
            45,
            46,
            47
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 53100,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 13499,
        "completion_tokens": 275,
        "total_tokens": 13774
      }
    },
    {
      "question_id": 16,
      "question": "How has Southern Company's approach to its Equity and Incentive Compensation Plan evolved between 2023 and 2024, particularly in terms of share availability and executive award disclosures?",
      "original_answer": "In 2023, Southern Company had 26.9 million shares available for awards under the Equity and Incentive Compensation Plan, indicating a reserve for future compensation initiatives. By 2024, the company increased transparency around executive compensation by disclosing specific terms for Named Executive Officer equity awards granted under the 2021 Equity and Incentive Compensation Plan, which was effective May 26, 2021. This evolution shows a shift from internal planning and reserve allocation in 2023 to more detailed public disclosure of executive-level compensation mechanisms in 2024, suggesting a more formalized and transparent governance approach for top-level incentives.",
      "llm_answer": "Southern Company’s Equity and Incentive Compensation Plan saw a modest increase in reserved shares for future awards, with 26.9 million shares still available at year‑end 2023 (up from prior years’ reserves). Executive award disclosures in the 2024 filing (page 317) continue to reference the 2021 Plan’s terms, but the company now explicitly notes that any remaining shares under the plan are limited to those reserved for the plan, reflecting a tighter share pool for future grants.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "SO_10k_2023.pdf",
          "target_page": 232,
          "pages": [
            230,
            231,
            232,
            233,
            234
          ]
        },
        "hop_2_rel": {
          "source_file": "SO_10k_2024.pdf",
          "target_page": 316,
          "pages": [
            314,
            315,
            316,
            317,
            318
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 81142,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 20518,
        "completion_tokens": 121,
        "total_tokens": 20639
      }
    },
    {
      "question_id": 16,
      "question": "How did the revenue performance of Inlyta evolve between 2022 and 2023, and what factors contributed to the change in its growth trajectory?",
      "original_answer": "In 2022, Inlyta contributed to Pfizer's operational growth, specifically mentioned among products like Comirnaty, Eliquis, and Vyndaqel that drove growth in the U.S. and international markets. By 2023, Inlyta's global revenue reached $1,036 million, reflecting a 3% total increase and a 5% operational growth. The growth was primarily attributed to the adoption of immune checkpoint inhibitor combinations with Inlyta for first-line treatment of advanced RCC in the U.S., despite lower volumes and net price in certain European markets. This indicates a continuation of growth, albeit at a more moderate pace compared to the broader portfolio dynamics in 2022.",
      "llm_answer": "Inlyta's revenue growth accelerated from 26% in 2022 to 5% in 2023, but this represented a slowdown from the prior year's robust expansion. The change was driven by adoption of Inlyta in combination with immune checkpoint inhibitors for first-line advanced RCC treatment in the U.S., partially offset by lower volumes and net price declines in certain European markets. The document notes that Inlyta's growth trajectory showed a deceleration, with the 2023 growth rate (5%) being significantly lower than the 26% growth recorded in 2022.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "PFE_10k_2022.pdf",
          "target_page": 41,
          "pages": [
            39,
            40,
            41,
            42,
            43
          ]
        },
        "hop_2_rel": {
          "source_file": "PFE_10k_2023.pdf",
          "target_page": 44,
          "pages": [
            42,
            43,
            44,
            45,
            46
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 98970,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 24961,
        "completion_tokens": 134,
        "total_tokens": 25096
      }
    },
    {
      "question_id": 17,
      "question": "How has McDonald's relationship with its franchisees evolved from 2023 to 2024 in terms of financial structure and dependency, particularly regarding revenue recognition and cost-sharing for technology platforms?",
      "original_answer": "In 2023, McDonald's described its relationship with franchisees as a collaborative partnership focused on consistency, quality, and revenue generation through rent, royalties based on a percent of sales, and initial fees. The business model was designed to generate stable and predictable revenue largely tied to franchisee sales. By 2024, the relationship evolved to reflect a stronger dependency on franchisees, particularly in the context of technology platforms. McDonald's began recognizing revenue from franchisees for technology services on a gross basis, with related expenses recorded in 'Other restaurant expenses,' indicating a more integrated and cost-sharing approach. This shift reflects a transformation in the nature of the relationship, with franchisees becoming more operationally interdependent with the company through shared technology infrastructure.",
      "llm_answer": "From 2023 to 2024, McDonald's financial structure with franchisees remained largely unchanged in terms of revenue recognition methodology, but the company continued to collect rent and royalty fees from franchised locations based on a percentage of sales, with initial fees recognized over the 20-year franchise term. The 2024 10-K shows no material change in the core franchise revenue model, though the company did acquire 228 restaurants from franchisees in Israel (page 47), recording $240 million of goodwill related to these acquisitions. The franchise model continues to rely on franchisees bearing occupancy costs (including property taxes, insurance, and site maintenance) while the company retains real estate ownership for company-operated locations. Technology platform fees paid by franchisees to recover costs are recognized on a gross basis as revenue when services are delivered, but this revenue recognition approach remained consistent year-over-year. The company's capitalized software amortization increased to $907 million in 2024 (from $836 million in 2023), reflecting ongoing investment in technology platforms that franchisees help fund.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MCD_10k_2023.pdf",
          "target_page": 4,
          "pages": [
            2,
            3,
            4,
            5,
            6
          ]
        },
        "hop_2_rel": {
          "source_file": "MCD_10k_2024.pdf",
          "target_page": 46,
          "pages": [
            44,
            45,
            46,
            47,
            48
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 62590,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 15883,
        "completion_tokens": 290,
        "total_tokens": 16173
      }
    },
    {
      "question_id": 17,
      "question": "How did the fair value of energy-related derivatives held by Southern Company's subsidiaries evolve from 2022 to 2023, and what does this indicate about the company's exposure to energy market fluctuations?",
      "original_answer": "In 2022, Southern Company's subsidiaries reported a net fair value of $101 million for energy-related derivatives (Mississippi Power: $59 assets, $32 liabilities; Southern Power: $8 assets, $12 liabilities; Southern Company Gas: $28 assets, $65 liabilities). In 2023, the subsidiaries showed a shift with Alabama Power reporting $15 in assets and $110 in liabilities, and Georgia Power reporting $13 in assets and $124 in liabilities for energy-related derivatives. This indicates a significant increase in net liability exposure, rising from a net liability of $54 million in 2022 to a net liability of $219 million in 2023, suggesting a greater exposure to energy market fluctuations.",
      "llm_answer": "The fair value of energy-related derivatives held by Southern Company's subsidiaries increased from $101 million at December 31 2022 to $161 million at December 31 2023, indicating that the company’s exposure to energy market fluctuations grew modestly over that period. This rise reflects higher valuations of natural‑gas and power derivatives, suggesting greater sensitivity to changes in energy prices and market conditions.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "SO_10k_2023.pdf",
          "target_page": 285,
          "pages": [
            283,
            284,
            285,
            286,
            287
          ]
        },
        "hop_2_rel": {
          "source_file": "SO_10k_2024.pdf",
          "target_page": 277,
          "pages": [
            275,
            276,
            277,
            278,
            279
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 84269,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 21304,
        "completion_tokens": 106,
        "total_tokens": 21411
      }
    },
    {
      "question_id": 17,
      "question": "How has the treatment and significance of the Procter & Gamble 2019 Stock and Incentive Compensation Plan evolved from 2022 to 2024, based on its disclosure context in the 10-K filings?",
      "original_answer": "In 2022, the 2019 Stock and Incentive Compensation Plan was introduced with detailed references to its adoption by shareholders on October 8, 2019, and its additional terms and conditions, indicating its formal establishment and integration into the company's compensation framework. By 2024, the plan was listed among other equity compensation plans as part of the company's broader disclosure on stock ownership and equity compensation, showing that it had become a standard and active component of the company's long-term incentive structure. This evolution reflects the plan's transition from a newly introduced policy to an established part of PG's equity compensation offerings.",
      "llm_answer": "The 2019 Stock and Incentive Compensation Plan (the “2019 Plan”) was adopted by shareholders in October 2019 and its detailed terms were first incorporated by reference in the 2021 Form 10‑K (Exhibit 10‑28). Subsequent filings—including the 2022 and 2024 Form 10‑Ks—re‑state the plan’s key provisions (e.g., the 187 million share reserve, one‑for‑one counting of options/SARs and five‑for‑one counting of full‑value awards) and note that the plan remains the only P&G equity plan that permits future grants, with about 77 million shares still available for issuance as of 2024. Thus, from 2022 through 2024 the plan’s disclosure context has remained consistent, focusing on its share reserve, award‑counting methodology, and continued status as the sole plan allowing future equity grants.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "PG_10k_2022.pdf",
          "target_page": 72,
          "pages": [
            69,
            70,
            71,
            72,
            73
          ]
        },
        "hop_2_rel": {
          "source_file": "PG_10k_2024.pdf",
          "target_page": 68,
          "pages": [
            66,
            67,
            68,
            69,
            70
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 68747,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 17416,
        "completion_tokens": 197,
        "total_tokens": 17613
      }
    },
    {
      "question_id": 18,
      "question": "How has Southern Company's approach to managing the risk of large losses in its pension plan assets evolved from 2023 to 2024, and what specific changes in risk management emphasis can be observed?",
      "original_answer": "In 2023, Southern Company emphasized a formal rebalancing program and external investment manager oversight as key components of managing the risk of large losses, with a strong focus on long-term investment expectations for return and risk. In 2024, while maintaining a diversified asset strategy and rebalancing program, the emphasis on external manager oversight was reduced, and the risk of large losses was more directly linked to the broader market volatility and interest rate fluctuations. This indicates a subtle shift in risk management emphasis from active oversight to market-driven risk exposure.",
      "llm_answer": "Southern Company's approach to managing the risk of large losses in its pension plan assets has evolved from 2023 to 2024 by shifting emphasis from diversification alone to a more structured, proactive risk management framework. In 2024, the company explicitly highlighted the use of formal rebalancing programs and external manager guidelines to manage asset class exposures relative to target allocations, alongside diversification as a primary risk mitigation strategy. This represents a more defined operationalization of its long-term investment strategy, which previously was described more generally in 2023. The 2024 disclosures also show a more detailed breakdown of asset allocations and fair value measurements, reinforcing a systematic approach to risk control.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "SO_10k_2023.pdf",
          "target_page": 263,
          "pages": [
            261,
            262,
            263,
            264,
            265
          ]
        },
        "hop_2_rel": {
          "source_file": "SO_10k_2024.pdf",
          "target_page": 255,
          "pages": [
            253,
            254,
            255,
            256,
            257
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 62529,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 15867,
        "completion_tokens": 193,
        "total_tokens": 16060
      }
    },
    {
      "question_id": 18,
      "question": "How has NVIDIA's role in the development and supply of the CUDA platform evolved between 2022 and 2023, and what does this shift indicate about the company's strategic focus?",
      "original_answer": "In 2022, NVIDIA's relationship with the CUDA platform was primarily as a supplier, providing the platform as part of its accelerated computing offerings. By 2023, NVIDIA's role had evolved into that of a developer, emphasizing a more active and strategic engagement in the platform's expansion and integration within its broader software ecosystem, including CUDA-X libraries, APIs, and domain-specific frameworks. This shift indicates a strategic move toward strengthening its full-stack computing platform to deliver more comprehensive data center-scale solutions.",
      "llm_answer": "Between 2022 and 2023, NVIDIA’s role in the CUDA platform shifted from being primarily a foundational programming layer for its GPUs to a more integrated, full‑stack offering that is tightly coupled with its broader data‑center and AI software ecosystem. The 2023 filing highlights expanded use of CUDA‑X libraries, AI‑specific extensions (e.g., Tensor Cores, AI Enterprise software), and new services such as DGX Cloud, indicating that NVIDIA is leveraging CUDA not just to accelerate compute but to lock customers into its end‑to‑end AI platform. This strategic focus underscores a move toward dominating enterprise AI workloads and reinforcing its leadership across data‑center, automotive, and professional visualization markets.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "NVDA_10k_2022.pdf",
          "target_page": 86,
          "pages": [
            78,
            79,
            80,
            81,
            82
          ]
        },
        "hop_2_rel": {
          "source_file": "NVDA_10k_2023.pdf",
          "target_page": 6,
          "pages": [
            4,
            5,
            6,
            7,
            8
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 49393,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 12575,
        "completion_tokens": 183,
        "total_tokens": 12758
      }
    },
    {
      "question_id": 18,
      "question": "How did Pfizer's financial relationship with Viatris evolve between 2022 and 2023, particularly in terms of supply agreements and outstanding balances?",
      "original_answer": "In 2022, Pfizer reported $780 million in revenue growth from PC1, primarily reflecting manufacturing of legacy Upjohn products for Viatris under supply agreements. By 2023, the financial relationship had evolved, as indicated by the net amounts due to Viatris under various agreements, which decreased from $94 million as of December 31, 2022, to $33 million as of December 31, 2023. Additionally, most transitional services under the TSAs were completed by the end of 2023, signaling a reduction in operational interdependence.",
      "llm_answer": "Based on the provided 10-K filings, Pfizer's financial relationship with Viatris evolved significantly between 2022 and 2023 through the termination of their post-separation agreements. In 2022, Pfizer recorded $33 million due to Viatris as of December 31, 2023 (down from $94 million as of December 31, 2022), reflecting the winding down of transitional services and manufacturing agreements. The $277 million payment to Viatris in 2021 (reported in Other financing activities) was a one-time settlement related to the separation agreement, after which the indemnification of GSK's guarantee was terminated. By 2023, these arrangements were largely completed, with no material amounts recorded under the interim TSAs or MSAs, indicating the financial relationship had been fully resolved.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "PFE_10k_2022.pdf",
          "target_page": 41,
          "pages": [
            39,
            40,
            41,
            42,
            43
          ]
        },
        "hop_2_rel": {
          "source_file": "PFE_10k_2023.pdf",
          "target_page": 73,
          "pages": [
            71,
            72,
            73,
            74,
            75
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 90107,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 22748,
        "completion_tokens": 197,
        "total_tokens": 22945
      }
    },
    {
      "question_id": 19,
      "question": "How has the treatment and disclosure of communications sites in relation to debt obligations evolved between 2023 and 2024?",
      "original_answer": "In 2023, communications sites were explicitly referenced as collateral securing debt obligations, such as the 3,343 communications sites securing the Series 2015-2 Notes and the repayment of $1.3 billion in Series 2013-2A Notes funded by the 2023 Securitization. In 2024, while there was no explicit mention of specific communications sites securing debt, the company disclosed broader financial commitments, such as $4.5 billion in estimated undiscounted future cash outlay for asset retirement obligations as of December 31, 2024. This shift indicates a move from site-specific debt disclosures to more general obligations, suggesting a change in how communications sites are framed in relation to financial liabilities.",
      "llm_answer": "The treatment of communications sites under debt obligations has shifted from the 2023 disclosures, which emphasized asset‑retirement obligations and the material cash requirements tied to lease‑related payments, to the 2024 filing, which integrates these sites into detailed securitization structures (e.g., the 2015, 2018 and 2023 Trust Securitizations). In 2024 the company explicitly links cash‑flow from the sites to debt‑service coverage tests, cash‑trap reserve accounts, and amortization periods, and it discloses how covenant compliance directly affects the ability to distribute excess cash. Thus, the evolution reflects a move from a general discussion of lease‑related cash needs to a precise, covenant‑driven framework that governs the sites’ cash flows and their role in meeting debt obligations.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AMT_10k_2023.pdf",
          "target_page": 112,
          "pages": [
            110,
            111,
            112,
            113,
            114
          ]
        },
        "hop_2_rel": {
          "source_file": "AMT_10k_2024.pdf",
          "target_page": 56,
          "pages": [
            54,
            55,
            56,
            57,
            58
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 61896,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 15690,
        "completion_tokens": 202,
        "total_tokens": 15892
      }
    },
    {
      "question_id": 19,
      "question": "How has Comcast's approach to retransmission consent agreements evolved between 2022 and 2023, particularly in terms of revenue recognition and distribution models?",
      "original_answer": "In 2022, Comcast recognized revenue from retransmission consent agreements on a monthly basis as programming was provided, with fees tied to the number of subscribers and generally collected within 60 days. By 2023, the company's Media segment emphasized a combined linear and streaming distribution model, with retransmission fees now explicitly including both traditional and virtual multichannel video providers. The 2023 filing also highlighted a broader integration of Peacock into the distribution ecosystem, suggesting a strategic shift toward hybrid distribution models that blend traditional and streaming services.",
      "llm_answer": "Comcast's approach to retransmission consent agreements remained consistent in structure but evolved in key ways between 2022 and 2023. Revenue from these agreements continues to be recognized as monthly fees under multi-year contracts based on subscriber counts, with payments generally collected within 60 days. However, the 2023 filing emphasizes that fees from NBC and Telemundo retransmission consent agreements—including those tied to streaming rights on Peacock—are now explicitly accounted for as licenses of functional intellectual property, with revenue recognized monthly as programming is delivered. This reflects a shift toward integrating streaming distribution models into traditional retransmission frameworks, though the core revenue recognition timing (monthly, post-delivery) and contractual structure (multi-year, subscriber-based) remained unchanged. The 2023 document also notes that while fixed fees apply to some networks, most revenue still derives from per-subscriber charges under these agreements.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CMCSA_10k_2022.pdf",
          "target_page": 94,
          "pages": [
            92,
            93,
            94,
            95,
            96
          ]
        },
        "hop_2_rel": {
          "source_file": "CMCSA_10k_2023.pdf",
          "target_page": 10,
          "pages": [
            8,
            9,
            10,
            11,
            12
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 42205,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 10776,
        "completion_tokens": 256,
        "total_tokens": 11033
      }
    },
    {
      "question_id": 19,
      "question": "How has Caterpillar's involvement in the production and strategic positioning of diesel-electric locomotives evolved from 2023 to 2024?",
      "original_answer": "In 2023, Caterpillar's involvement in diesel-electric locomotives was described as part of its broader ME&T segment, which included responsibilities such as remanufacturing Caterpillar reciprocating engines and components, as well as providing product support for on-highway vocational trucks in North America. By 2024, Caterpillar's engagement had evolved into a more defined production role under the Energy & Transportation segment, which explicitly stated that Caterpillar 'produces' diesel-electric locomotives and components, signaling a more direct and strategic emphasis on this product line. Additionally, in 2024, Caterpillar highlighted competitive pressures in rail-related businesses, naming companies like Wabtec Corp and Siemens Mobility A/S, which was not present in 2023. This indicates a shift from a general operational inclusion to a more prominent and competitive product focus.",
      "llm_answer": "From 2023 to 2024, Caterpillar's involvement in diesel-electric locomotives remained strategically focused but did not show significant expansion. The Energy & Transportation segment, which includes diesel-electric locomotives and related rail products, reported $11,982 million in sales for 2023 and $9,175 million for 2022, with no indication of new product launches or major strategic shifts in this area. The segment continues to face competitive pressures from firms like Wabtec Corp and Siemens Mobility, while maintaining its core offerings in remanufacturing, components, and rail-related services as part of its broader Energy & Transportation portfolio.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CAT_10k_2023.pdf",
          "target_page": 116,
          "pages": [
            114,
            115,
            116,
            117,
            118
          ]
        },
        "hop_2_rel": {
          "source_file": "CAT_10k_2024.pdf",
          "target_page": 6,
          "pages": [
            4,
            5,
            6,
            7,
            8
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 9,
        "total_chars": 39520,
        "num_window_pages": 9,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 10097,
        "completion_tokens": 165,
        "total_tokens": 10263
      }
    },
    {
      "question_id": 19,
      "question": "How has McDonald's relationship with its franchisees evolved in terms of revenue recognition and cost-sharing arrangements between 2023 and 2024?",
      "original_answer": "In 2023, McDonald's revenue from franchisees primarily included rent and royalties based on a percentage of sales with minimum rent payments, and initial fees. The company also mentioned that all restaurants were either operated by McDonald's or by franchisees under franchised arrangements. By 2024, the revenue recognition model remained consistent, but the company provided more detailed disclosures on how it recognizes revenue from franchisees, including the treatment of technology platform fees, which are now presented on a gross basis on the Consolidated Statement of Income. Additionally, in 2024, McDonald's clarified its cost-sharing arrangements for restaurant improvements, where it may fund certain projects and allocate costs between Property and Equipment and Accounts Receivable during the project, finalizing the allocation upon completion. This level of detail on cost-sharing was not present in the 2023 filing, indicating a more nuanced and transparent approach to franchisee financial interactions in 2024.",
      "llm_answer": "Between 2023 and 2024, McDonald's revenue recognition and cost-sharing arrangements with franchisees remained consistent with prior practice: royalties and rent continue to be based on a percentage of sales, with minimum rent payments recognized straight-line over the franchise term and variable rent recognized at the time of sale. Initial fees are recognized over the 20-year franchise term as performance obligations are satisfied. The Company generally acts as the principal in technology platform arrangements, recognizing gross revenue when services are transferred to franchisees, while cost allocations for restaurant improvements are finalized post-project and may result in immaterial adjustments to property and equipment or accounts receivable. No material changes to these core revenue recognition or cost-sharing practices were disclosed in the 2024 filings.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MCD_10k_2023.pdf",
          "target_page": 43,
          "pages": [
            41,
            42,
            43,
            44,
            45
          ]
        },
        "hop_2_rel": {
          "source_file": "MCD_10k_2024.pdf",
          "target_page": 46,
          "pages": [
            44,
            45,
            46,
            47,
            48
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 66231,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 16778,
        "completion_tokens": 218,
        "total_tokens": 16996
      }
    },
    {
      "question_id": 19,
      "question": "How has Southern Company's approach to executive equity compensation evolved between 2023 and 2024, particularly regarding plan documentation and award terms?",
      "original_answer": "In 2023, Southern Company disclosed that stock-based compensation, primarily in the form of performance share units (PSUs) and restricted stock units (RSUs), was granted under the Equity and Incentive Compensation Plan to employees ranging from line management to executives. By 2024, the company formalized the terms for Named Executive Officer equity awards under the same plan, indicating a more structured approach to executive compensation. Additionally, the 2024 filing included detailed documentation practices, such as the designation of specific exhibits for equity award terms, which was not present in the 2023 filing. This reflects a shift toward greater specificity and transparency in executive equity compensation documentation.",
      "llm_answer": "Southern Company's executive equity compensation approach remained consistent between 2023 and 2024, continuing to utilize its 2021 Equity and Incentive Compensation Plan for granting performance share units (PSUs) and restricted stock units (RSUs) to executives, with no significant changes to plan documentation or award terms observed in the provided filings. The company maintained its established vesting schedules (including immediate vesting upon change-in-control for unvested PSUs/RSUs) and performance-based award structures, as evidenced by the consistent descriptions of PSU/RSU terms, vesting periods, and plan amendments (e.g., the 2021 Plan's terms and the 2022 amendment to the Executive Change in Control Severance Plan) appearing in the 2023 and 2024 filings.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "SO_10k_2023.pdf",
          "target_page": 276,
          "pages": [
            274,
            275,
            276,
            277,
            278
          ]
        },
        "hop_2_rel": {
          "source_file": "SO_10k_2024.pdf",
          "target_page": 316,
          "pages": [
            314,
            315,
            316,
            317,
            318
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 9,
        "total_chars": 87358,
        "num_window_pages": 9,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 22065,
        "completion_tokens": 194,
        "total_tokens": 22259
      }
    },
    {
      "question_id": 19,
      "question": "How has Procter & Gamble's strategic reliance on membership club stores evolved from 2022 to 2024, and what does this shift indicate about the company's broader retail channel strategy?",
      "original_answer": "In 2022, Procter & Gamble identified membership club stores as one of its key retail channels, listing them among a broad set of distribution partners such as mass merchandisers, grocery stores, and e-commerce platforms. However, by 2024, the company's language shifted to emphasize dependency on these membership club stores, indicating a deeper strategic alignment or increased reliance on this channel. This evolution suggests that membership club stores have become more central to P&G's distribution and retail execution strategy, likely reflecting growth in this channel's importance to consumer purchasing behavior and overall market dynamics.",
      "llm_answer": "Procter & Gamble's strategic reliance on membership club stores has diminished from 2022 to 2024, as evidenced by its reduced emphasis on this channel in recent disclosures. The 2024 filing (pages 5-9) no longer highlights membership club stores as a key customer segment in the same strategic context as 2022 (pages 2-6), instead listing them generically among other retail channels without specific strategic focus. This shift indicates a broader strategic pivot toward diversified retail channels—including e-commerce and direct-to-consumer—while deprioritizing dependence on any single wholesale channel, including membership clubs, to mitigate concentration risks and align with evolving consumer shopping behaviors.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "PG_10k_2022.pdf",
          "target_page": 4,
          "pages": [
            2,
            3,
            4,
            5,
            6
          ]
        },
        "hop_2_rel": {
          "source_file": "PG_10k_2024.pdf",
          "target_page": 7,
          "pages": [
            5,
            6,
            7,
            8,
            9
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 9,
        "total_chars": 59827,
        "num_window_pages": 9,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 15184,
        "completion_tokens": 180,
        "total_tokens": 15364
      }
    },
    {
      "question_id": 20,
      "question": "How did AMT's involvement with Nigeria Letters of Credit evolve between 2023 and 2024, and what does this indicate about its financial obligations related to this instrument?",
      "original_answer": "In 2023, AMT had a $3.4 million obligation under the Nigeria Letters of Credit as part of its variable rate debt portfolio. However, by 2024, this obligation was no longer present, as indicated by the $0 carrying value in both denominated currency and USD. This indicates that AMT fully settled or otherwise exited its financial obligations tied to Nigeria Letters of Credit within this period.",
      "llm_answer": "Based on the provided 10-K pages, AMT's involvement with the Nigeria Letters of Credit remained unchanged between 2023 and 2024, with $3.4 million in letters of credit outstanding as of December 31, 2023 (page 118). The document indicates these were drawn during 2023 and 2024 but does not describe any structural evolution or new commitments related to them in 2024. The only relevant context is that they were part of the Company's \"other subsidiary debt\" with no prepayment considerations specified for the 2023 Securities (which relate to the Nigeria Letters of Credit structure), and the Company maintained compliance with related covenants as of December 2024 (page 115). This suggests the financial obligations tied to these instruments remained static without significant evolution during the period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AMT_10k_2023.pdf",
          "target_page": 60,
          "pages": [
            58,
            59,
            60,
            61,
            62
          ]
        },
        "hop_2_rel": {
          "source_file": "AMT_10k_2024.pdf",
          "target_page": 117,
          "pages": [
            115,
            116,
            117,
            118,
            119
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 49820,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 12683,
        "completion_tokens": 202,
        "total_tokens": 12885
      }
    },
    {
      "question_id": 20,
      "question": "How did the valuation methodology and composition of GD's Retirement Annuity Contracts change between 2022 and 2024, and what does this indicate about the company's approach to reporting these assets?",
      "original_answer": "In 2022, GD reported Retirement Annuity Contracts as part of Level 3 assets with a fair value of $35 million as of December 31, 2021, and this value remained relatively stable through December 31, 2020 at $38 million. The contracts were disclosed within a detailed table showing actual returns, unrealized gains and losses, and net purchases or sales. By 2024, Retirement Annuity Contracts were still categorized under Level 3 assets but were now described as being valued using NAV (net asset value) as a practical expedient, excluded from the formal fair value hierarchy. This indicates a shift in GD's reporting methodology from detailed fair value disclosures to a more simplified NAV-based approach, aligning with broader changes in how these contracts are categorized and disclosed.",
      "llm_answer": "Between 2022 and 2024, the composition of GD's Retirement Annuity Contracts shifted from being reported solely within Level 3 (with no Level 3 investments noted in 2023 or 2024) to being explicitly categorized under Level 3 assets in the fair value hierarchy, alongside other investments like insurance deposits and real estate funds. The valuation methodology remained consistent—reporting at fair value using observable inputs where possible, with Level 3 assets measured using significant unobservable inputs—but the explicit disclosure of Retirement Annuity Contracts as Level 3 assets (previously grouped under \"Other investments\" or not separately detailed in earlier years) indicates a more transparent breakdown of asset categories. This change reflects a refined approach to reporting, emphasizing the distinction between Level 2 and Level 3 investments to enhance clarity for stakeholders regarding the valuation inputs used for these assets.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "GD_10k_2022.pdf",
          "target_page": 96,
          "pages": [
            94,
            95,
            96,
            97,
            98
          ]
        },
        "hop_2_rel": {
          "source_file": "GD_10k_2024.pdf",
          "target_page": 93,
          "pages": [
            91,
            92,
            93,
            94,
            95
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 44577,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 11377,
        "completion_tokens": 238,
        "total_tokens": 11615
      }
    },
    {
      "question_id": 20,
      "question": "How has the composition and value of restricted cash for securitization investors changed between 2022 and 2024, particularly in terms of its fair value hierarchy classification?",
      "original_answer": "In 2022, the company reported restricted cash for securitization investors as part of consolidated VIEs, with the assets and liabilities presented on the consolidated balance sheets. By 2024, the restricted cash for securitization investors was valued at $441 million, with the entire amount classified under Level 1 of the estimated fair value hierarchy, indicating a shift toward more transparent or market-based valuation methods. This reflects a more defined and standardized valuation approach in 2024 compared to 2022, where the fair value hierarchy was not explicitly detailed for this category.",
      "llm_answer": "Based on the provided 2022 and 2024 10-K pages, the composition and value of restricted cash for securitization investors remained consistently classified at **Level 3** in both years (as shown in Table 17.6 of the 2024 filing and corroborated by the 2022 table on page 178, which lists \"Restricted cash for securitization investors\" under Level 3 with a carrying/fair value of $458 million in 2023 and $441 million in 2024). The fair value hierarchy classification did not change between 2022 and 2024, remaining Level 3, with no indication of reclassification to Level 1 or 2. The value decreased slightly from $458 million (2023) to $441 million (2024), but the classification remained unchanged.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "COF_10k_2022.pdf",
          "target_page": 179,
          "pages": [
            177,
            178,
            179,
            180,
            181
          ]
        },
        "hop_2_rel": {
          "source_file": "COF_10k_2024.pdf",
          "target_page": 219,
          "pages": [
            217,
            218,
            219,
            220,
            221
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 55397,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 14080,
        "completion_tokens": 174,
        "total_tokens": 14255
      }
    },
    {
      "question_id": 20,
      "question": "How has McDonald's relationship with its franchisees evolved in terms of financial recognition and asset management between 2023 and 2024?",
      "original_answer": "In 2023, McDonald's relationship with franchisees was primarily characterized by the acquisition of restaurants from franchisees, resulting in goodwill that was either fully or partially written off depending on the time of sale relative to acquisition. The Company used a discounted cash flow methodology to determine the fair value of acquired restaurants. By 2024, the relationship had transformed into a more dependency-based model, particularly in the area of technology platform services. McDonald's now provides distinct technology-related goods and services to franchisees, recognizing revenue on a gross basis and corresponding expenses within 'Other restaurant expenses.' This marks a shift from asset acquisition and goodwill management toward ongoing service-based financial interactions with franchisees.",
      "llm_answer": "Between 2023 and 2024, McDonald's financial relationship with its franchisees evolved through more structured asset management and goodwill accounting practices. The company recorded goodwill adjustments when acquiring franchise restaurants, with new acquisitions in 2024 resulting in approximately $240 million of goodwill, and it continues to write off goodwill entirely if a company‑operated restaurant is sold within 24 months of acquisition. Additionally, the company’s franchisees now incur significant advertising contributions based on a percent of sales, and the company’s consolidation conclusions about these cooperatives remain unchanged, indicating that franchisee‑related financial interactions are primarily through royalty, rent and advertising fee structures rather than direct equity ownership.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MCD_10k_2023.pdf",
          "target_page": 45,
          "pages": [
            43,
            44,
            45,
            46,
            47
          ]
        },
        "hop_2_rel": {
          "source_file": "MCD_10k_2024.pdf",
          "target_page": 46,
          "pages": [
            44,
            45,
            46,
            47,
            48
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 69131,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 17501,
        "completion_tokens": 203,
        "total_tokens": 17704
      }
    },
    {
      "question_id": 20,
      "question": "How has the treatment of the 2019 Stock and Incentive Compensation Plan evolved between 2022 and 2024 in Procter & Gamble's disclosures, particularly regarding its relationship with other compensation plans and its role in equity compensation?",
      "original_answer": "In 2022, the 2019 Stock and Incentive Compensation Plan was disclosed as part of a broader set of compensation plans, with specific reference to its adoption by shareholders in 2019 and its regulation in conjunction with other plans like the 2014 Stock and Incentive Compensation Plan. By 2024, the 2019 Plan was still included in the list of active equity compensation plans, but it was now referenced in the context of security ownership and the total shares available for issuance, indicating a shift from adoption and governance details to its role in the company's overall equity compensation structure. This reflects a transformation in how the plan is positioned within the company's disclosures, moving from procedural governance to a more strategic ownership framework.",
      "llm_answer": "Between 2022 and 2024, the 2019 Stock and Incentive Compensation Plan (the \"2019 Plan\") remained the sole equity compensation plan permitting future grants, with its maximum share reserve unchanged at 187 million shares. While the 2019 Plan continued to be counted alongside legacy plans (e.g., 2001, 2009, 2014) in disclosure tables, its future issuance capacity was explicitly highlighted as the only plan allowing new grants, with shares reserved for future issuance declining from 119 million (2022) to 77 million (2024) due to the \"one-for-one\" counting of options/SARs versus \"five-for-one\" for full-value awards (RSUs/PSUs). The plan’s role in equity compensation was consistently framed as the successor to prior plans, with its terms and governance oversight detailed in proxy statements, but no structural changes to its reserve or governance were disclosed between 2022 and 2024.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "PG_10k_2022.pdf",
          "target_page": 75,
          "pages": [
            69,
            70,
            71,
            72,
            73
          ]
        },
        "hop_2_rel": {
          "source_file": "PG_10k_2024.pdf",
          "target_page": 68,
          "pages": [
            66,
            67,
            68,
            69,
            70
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 68747,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 17431,
        "completion_tokens": 222,
        "total_tokens": 17653
      }
    },
    {
      "question_id": 21,
      "question": "How has Salvatore Ferragamo's presence in Simon Property Group's international outlet locations evolved between 2022 and 2023?",
      "original_answer": "In 2022, Salvatore Ferragamo was listed as a tenant in three of Simon Property Group's international outlet locations in Japan: Gotemba Premium Outlets, Kobe-Sanda Premium Outlets, and Sano Premium Outlets. By 2023, Salvatore Ferragamo appeared in only one of SPG's outlet locations, specifically Las Vegas Outlets North in Nevada, USA. This indicates a significant reduction in Salvatore Ferragamo's presence across SPG's outlet portfolio, shifting from multiple locations in Japan to a single location in the U.S.",
      "llm_answer": "Salvatore Ferragamo's presence in Simon Property Group's international outlet locations remained consistent between 2022 and 2023, with the brand continuing to operate in multiple international Premium Outlet locations across Japan, Mexico, South Korea, Malaysia, Thailand, and Canada. In 2022, Ferragamo was listed among the selected tenants at key international sites including Gotemba Premium Outlets (Japan), Yeoju Premium Outlets (South Korea), Johor Premium Outlets (Malaysia), and Punta Norte Premium Outlets (Mexico), and this presence continued into 2023 as evidenced by its inclusion in the 2023 international outlet listings such as at Yeoju, Paju, and Jeju in South Korea, and at Johor in Malaysia. The brand was not noted as having opened new international outlet locations during this period but maintained its existing foothold in these jointly operated properties.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "SPG_10k_2022.pdf",
          "target_page": 42,
          "pages": [
            40,
            41,
            42,
            43,
            44
          ]
        },
        "hop_2_rel": {
          "source_file": "SPG_10k_2023.pdf",
          "target_page": 34,
          "pages": [
            32,
            33,
            34,
            35,
            36
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 9,
        "total_chars": 50165,
        "num_window_pages": 9,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 12756,
        "completion_tokens": 220,
        "total_tokens": 12976
      }
    },
    {
      "question_id": 21,
      "question": "How has COP's natural gas position in the Asia Pacific/Middle East region evolved from 2023 to 2024, and what does this indicate about its operational focus in the region?",
      "original_answer": "In 2023, COP reported 312 billion cubic feet of natural gas in the Asia Pacific/Middle East region, while in 2024, this figure slightly decreased to 296 billion cubic feet. This indicates a minor reduction in natural gas reserves in the region, suggesting a potential shift or stabilization in operational focus rather than aggressive growth.",
      "llm_answer": "From 2023 to 2024, ConocoPhillips’ proved natural gas reserves in the Asia Pacific/Middle East region grew from 296 billion cubic feet to 296 billion cubic feet (stable), while total consolidated reserves rose from 8,443 billion to 9,771 billion cubic feet, driven by upward revisions and purchases in the Lower 48 and Alaska. This expansion reflects a strategic shift toward increasing natural‑gas production in North America, while maintaining a modest presence in the Asia‑Pacific/Middle East, underscoring the company’s focus on leveraging U.S. unconventional gas resources to bolster overall operational growth in the region.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "COP_10k_2023.pdf",
          "target_page": 155,
          "pages": [
            153,
            154,
            155,
            156,
            157
          ]
        },
        "hop_2_rel": {
          "source_file": "COP_10k_2024.pdf",
          "target_page": 145,
          "pages": [
            143,
            144,
            145,
            146,
            147
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 74347,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 18816,
        "completion_tokens": 157,
        "total_tokens": 18973
      }
    },
    {
      "question_id": 21,
      "question": "How has Comcast's approach to wireless gateways evolved from 2022 to 2024, particularly in terms of strategic emphasis and investment?",
      "original_answer": "In 2022, Comcast offered wireless gateways as part of its broadband services, combining modem and Wi-Fi router capabilities to enhance in-and-out-of-home coverage. The focus was on customer-facing features like the xFi whole-home application and advanced security. By 2024, the company elevated its strategic emphasis by shifting from merely offering wireless gateways to actively investing in their deployment as part of its broader network infrastructure upgrades. This included plans to increase capacity and deliver multigigabit symmetrical speeds, signaling a deeper integration of wireless gateways into its long-term network strategy.",
      "llm_answer": "From 2022 to 2024, Comcast’s capital‑expenditure focus shifted toward its Connectivity & Platforms business, emphasizing scalable infrastructure, line extensions, and the rollout of next‑generation wireless gateways to enable multigigabit symmetrical speeds and expanded home‑and‑business coverage.  Investment in customer‑premise equipment and support capital declined, while spending on network upgrades and new attractions at Universal theme parks remained a strategic priority.  This evolution reflects a continued emphasis on enhancing broadband capacity and delivering advanced gateway solutions across its cable operations.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CMCSA_10k_2022.pdf",
          "target_page": 7,
          "pages": [
            5,
            6,
            7,
            8,
            9
          ]
        },
        "hop_2_rel": {
          "source_file": "CMCSA_10k_2024.pdf",
          "target_page": 51,
          "pages": [
            49,
            50,
            51,
            52,
            53
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 46842,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 11927,
        "completion_tokens": 157,
        "total_tokens": 12085
      }
    },
    {
      "question_id": 21,
      "question": "How has the G600's market presence and production evolution changed between 2022 and 2024, particularly in terms of cumulative deliveries and its role within Gulfstream's product lineup?",
      "original_answer": "In 2022, the G500 and G600 had cumulative deliveries totaling almost 150 by year-end 2021, and were described as replacements for the G450 and G550 models with improvements in speed, fuel efficiency, cabin volume, and flight controls. By 2024, cumulative deliveries of the G500 and G600 had more than doubled to over 300 by year-end 2024. Additionally, the G600 was no longer described in the context of being a new product introduction, indicating it had become a more established part of Gulfstream's lineup, while the focus shifted to newer models like the G800 and G400.",
      "llm_answer": "Between 2022 and 2024, Gulfstream’s market presence evolved with the introduction of the ultra‑long‑range G800 (expected service in 2023) and the clean‑sheet G400 (target entry in 2025), expanding its lineup beyond the existing G500/G600 family. Cumulative deliveries of the G500 and G600 rose to over 300 aircraft by year‑end 2024, underscoring their growing role as the core of Gulfstream’s product portfolio while the new G800 and G400 models broaden the company’s reach into longer‑range and previously untapped market segments.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "GD_10k_2022.pdf",
          "target_page": 6,
          "pages": [
            4,
            5,
            6,
            7,
            8
          ]
        },
        "hop_2_rel": {
          "source_file": "GD_10k_2024.pdf",
          "target_page": 5,
          "pages": [
            3,
            4,
            5,
            6,
            7
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 31511,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 8105,
        "completion_tokens": 133,
        "total_tokens": 8238
      }
    },
    {
      "question_id": 21,
      "question": "How has AIG's financial relationship with Corebridge evolved between 2023 and 2024, particularly in terms of equity ownership and income recognition?",
      "original_answer": "In 2023, AIG held 52.2% of Corebridge common stock and was in the process of selling down its stake, with the intention to fully divest over time. By 2024, AIG had transitioned to accounting for its remaining interest in Corebridge using the equity method, recognizing pre-tax income based on dividends received and changes in Corebridge's stock price from June 9, 2024. This represents a shift from direct ownership control to a more passive investment approach, indicating a significant change in the nature of AIG's financial relationship with Corebridge.",
      "llm_answer": "Between 2023 and 2024, AIG's relationship with Corebridge shifted from majority ownership to a significantly reduced stake, culminating in the deconsolidation of Corebridge in June 2024. Following this, AIG retained a 22.7% ownership interest and began accounting for its remaining stake as an equity method investment, recognizing income from dividends and changes in Corebridge's stock price. The document details that AIG sold approximately 43 million shares between August and November 2024 and completed a $3.8 billion sale of 120 million shares to Nippon in December 2024, reducing its ownership from 48.4% to 22.7%. While AIG previously recognized gains from Corebridge's stock appreciation and received dividends, the deconsolidation resulted in a $4.8 billion loss, and subsequent equity method accounting now reflects only modest income from the retained investment.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AIG_10k_2023.pdf",
          "target_page": 27,
          "pages": [
            25,
            26,
            27,
            28,
            29
          ]
        },
        "hop_2_rel": {
          "source_file": "AIG_10k_2024.pdf",
          "target_page": 109,
          "pages": [
            107,
            108,
            109,
            110,
            111
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 96902,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 24448,
        "completion_tokens": 219,
        "total_tokens": 24667
      }
    },
    {
      "question_id": 21,
      "question": "How has Tesla's production strategy for the Solar Roof evolved between 2022 and 2024, particularly in terms of manufacturing dependencies and operational challenges?",
      "original_answer": "In 2022, Tesla was actively producing the Solar Roof at Gigafactory New York, which was specifically highlighted as a dedicated facility for the development and production of Solar Roof and other solar products. The company offered financing options tied to the Solar Roof, indicating a strategic push to integrate the product into its broader energy ecosystem. By 2024, Tesla's disclosures shifted to emphasize increased complexity and risk in ramping production of the Solar Roof, with explicit mention of 'delays in launching and/or ramping production of our energy storage products and Solar Roof.' The 2024 filing also highlighted broader operational dependencies, including the need to achieve 'design tolerances, high quality and output rates' across its manufacturing facilities, and noted potential disruptions due to supply chain coordination, localized procurement challenges, and the need for cost-effective scaling. This indicates a transition from a focused production setup in 2022 to a more complex and risk-laden ramp-up phase in 2024.",
      "llm_answer": "Between 2022 and 2024, Tesla’s Solar Roof production strategy shifted from a highly integrated, roof‑by‑roof installation model toward a more modular, factory‑built approach that relies on standardized tiles and streamlined on‑site assembly. This evolution reduced its direct manufacturing dependency on custom‑roof‑specific components but introduced new operational challenges, including supply‑chain constraints for specialized glass and solar cells, and the need to coordinate complex installation logistics across multiple regions. Consequently, Tesla had to invest heavily in training installers, expand its service network, and manage fluctuating raw‑material costs to maintain production ramps and meet demand.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "TSLA_10k_2022.pdf",
          "target_page": 9,
          "pages": [
            7,
            8,
            9,
            10,
            11
          ]
        },
        "hop_2_rel": {
          "source_file": "TSLA_10k_2024.pdf",
          "target_page": 17,
          "pages": [
            15,
            16,
            17,
            18,
            19
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 50178,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 12769,
        "completion_tokens": 179,
        "total_tokens": 12948
      }
    },
    {
      "question_id": 21,
      "question": "How has Qualcomm's strategic involvement with on-device artificial intelligence (AI) evolved from 2023 to 2024, particularly in terms of its business focus and investment approach?",
      "original_answer": "In 2023, Qualcomm was actively producing on-device AI technologies as part of its broader portfolio of foundational technologies, including wireless connectivity and low-power computing. The company positioned on-device AI as a key innovation driver across industries beyond mobile handsets, such as automotive and IoT. By 2024, Qualcomm's focus on on-device AI had evolved from being a core product offering to a more investment-centric strategy. The company continued to invest heavily in advancing on-device AI through research and development, acquisitions, and strategic transactions, signaling a shift toward long-term growth and ecosystem development rather than immediate product commercialization. This transition reflects a deeper commitment to enabling third-party integration of its AI technologies rather than solely selling AI-based products directly.",
      "llm_answer": "From 2023 to 2024, Qualcomm’s strategic focus on on‑device AI shifted from a broad, cross‑industry investment to a more targeted, partnership‑driven approach.  In the 2023 filing the company highlighted its intent to expand AI capabilities across automotive, IoT and other sectors, but by 2024 it emphasized tighter integration with key customers—especially smartphone OEMs—and noted that Apple’s move to develop its own modem and AI‑related chips, plus Chinese OEMs’ push for in‑house solutions, would constrain the market for Qualcomm’s integrated modem and AI‑enabled silicon.  Consequently, Qualcomm’s investment approach became more defensive, concentrating resources on core 5G/AI platforms that can be leveraged in high‑margin, premium‑tier handsets while seeking new growth in automotive and IoT only where it can secure clear commercial pathways.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "QCOM_10k_2023.pdf",
          "target_page": 65,
          "pages": [
            63,
            64,
            65,
            66,
            67
          ]
        },
        "hop_2_rel": {
          "source_file": "QCOM_10k_2024.pdf",
          "target_page": 20,
          "pages": [
            18,
            19,
            20,
            21,
            22
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 65559,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 16619,
        "completion_tokens": 213,
        "total_tokens": 16833
      }
    },
    {
      "question_id": 22,
      "question": "How has the presence of Dolce & Gabbana in SPG-operated properties evolved between 2022 and 2023, and what does this indicate about SPG's brand positioning strategy in its premium outlet locations?",
      "original_answer": "In 2022, Dolce & Gabbana was listed as a tenant in multiple SPG-operated premium outlets in Japan, including Gotemba Premium Outlets, Kobe-Sanda Premium Outlets, and Rinku Premium Outlets. By 2023, Dolce & Gabbana was only listed at Las Vegas Outlets North Premium NV in the U.S. This indicates a strategic shift from a multi-location presence in Japan to a more exclusive, flagship-style positioning in a key U.S. market, suggesting a reevaluation of brand placement and target demographics.",
      "llm_answer": "Between 2022 and 2023, Dolce & Gabbana's presence in SPG-operated properties remained consistent across international outlets, appearing in key locations such as Yeoju (South Korea), Paju (South Korea), Jeju (South Korea), and multiple European and Canadian premium outlets. This stability reflects SPG's strategic focus on maintaining high-end luxury tenant mix in its premium outlet portfolio, reinforcing brand positioning through curated, globally recognized luxury brands in high-traffic outlet destinations. The consistent inclusion of Dolce & Gabbana across multiple international properties underscores SPG's deliberate curation of premium luxury tenants to enhance the prestige and attractiveness of its outlet centers.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "SPG_10k_2022.pdf",
          "target_page": 42,
          "pages": [
            40,
            41,
            42,
            43,
            44
          ]
        },
        "hop_2_rel": {
          "source_file": "SPG_10k_2023.pdf",
          "target_page": 34,
          "pages": [
            32,
            33,
            34,
            35,
            36
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 9,
        "total_chars": 50165,
        "num_window_pages": 9,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 12774,
        "completion_tokens": 182,
        "total_tokens": 12956
      }
    },
    {
      "question_id": 22,
      "question": "How did COP's investment in exploration activities in the Asia Pacific/Middle East region evolve between 2023 and 2024, and what does this indicate about the company's strategic focus in that region?",
      "original_answer": "In 2023, COP reported $49 million in exploration expenditures in the Asia Pacific/Middle East region, while in 2024, the company disclosed a total of $0 in new exploration activities in that region. This indicates a complete withdrawal or pause in exploration efforts in the Asia Pacific/Middle East, suggesting a strategic shift away from that region in favor of other geographic areas.",
      "llm_answer": "Between 2023 and 2024, ConocoPhillips increased its investment in exploration and development activities in the Asia Pacific/Middle East region, particularly through equity affiliates. In 2023, the company reported $462 million in exploration and development spending for equity affiliates in this region (including $416 million in development costs), and in 2024, this expanded to $462 million in exploration and $416 million in development for affiliates, with notable discoveries in the Middle East. This indicates a strategic focus on growing its presence in the Asia Pacific/Middle East through targeted investments in equity partnerships, especially in resource-rich areas like the Middle East, to enhance long-term reserve growth and production.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "COP_10k_2023.pdf",
          "target_page": 156,
          "pages": [
            154,
            155,
            156,
            157,
            158
          ]
        },
        "hop_2_rel": {
          "source_file": "COP_10k_2024.pdf",
          "target_page": 145,
          "pages": [
            143,
            144,
            145,
            146,
            147
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 77217,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 19540,
        "completion_tokens": 188,
        "total_tokens": 19728
      }
    },
    {
      "question_id": 22,
      "question": "How has Comcast's financial stake and debt involvement in Universal Beijing Resort evolved from 2022 to 2024?",
      "original_answer": "In 2022, Universal Beijing Resort was introduced as a new entity in Comcast's disclosures, noting its opening in September 2021 and highlighting the increased depreciation and amortization expenses across the company, though no specific financial stake or debt figures were provided at that time. By 2024, Comcast explicitly stated its 30% ownership interest in Universal Beijing Resort and detailed the debt financing structure, including $3.4 billion of debt outstanding as of December 31, 2024, down from $3.5 billion in 2023. Additionally, the assets and liabilities of Universal Beijing Resort were reported as $7.3 billion and $7.0 billion respectively in 2024, compared to $7.8 billion and $7.2 billion in 2023.",
      "llm_answer": "From 2022 to 2024, Comcast’s financial stake and debt involvement in Universal Beijing Resort evolved as follows: In 2022, Comcast held a 30% interest in the resort and had consolidated its financials, including $3.5 billion of debt (primarily a term loan) tied to the project. By 2023, the resort’s debt had risen to $3.5 billion, with $3.1 billion of term loan outstanding, and Comcast’s consolidated balance sheet reflected $7.8 billion in assets and $7.2 billion in liabilities for the resort. By the end of 2024, the resort’s debt decreased slightly to $3.4 billion (including $3.0 billion term loan), while Comcast’s consolidated exposure remained substantial, with $7.3 billion in assets and $7.0 billion in liabilities, underscoring continued leverage and risk tied to its 30% ownership stake.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CMCSA_10k_2022.pdf",
          "target_page": 48,
          "pages": [
            46,
            47,
            48,
            49,
            50
          ]
        },
        "hop_2_rel": {
          "source_file": "CMCSA_10k_2024.pdf",
          "target_page": 86,
          "pages": [
            84,
            85,
            86,
            87,
            88
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 9,
        "total_chars": 43249,
        "num_window_pages": 9,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 11024,
        "completion_tokens": 200,
        "total_tokens": 11224
      }
    },
    {
      "question_id": 22,
      "question": "How did Duke Energy's net derivatives balance and associated settlement activity evolve from 2022 to 2023, and what does this indicate about the company's exposure or management of derivative instruments?",
      "original_answer": "In 2022, Duke Energy's net derivatives balance at the end of the year was $29 million, with settlements totaling $32 million. In 2023, the net derivatives balance decreased to $13 million, while settlements increased significantly to $68 million. This indicates a shift in the company's management of derivative instruments, with a larger reduction in the net balance despite higher settlement activity in 2023.",
      "llm_answer": "From 2022 to 2023 Duke Energy’s net derivatives balance declined modestly, moving from a net liability of $168 million at the end of 2022 to a net liability of $146 million at the end of 2023 (a reduction of roughly $22 million). This improvement was driven by a combination of purchases, settlements and realized gains/losses that offset one another, as shown in the “Derivatives (net) Years Ended December 31” tables for 2022 and 2023. The downward shift indicates that the company is actively managing its derivative positions—entering new contracts and settling existing ones in a way that reduces overall exposure, although the remaining net liability still reflects ongoing market‑based hedging and risk‑management activities.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "DUK_10k_2022.pdf",
          "target_page": 199,
          "pages": [
            197,
            198,
            199,
            200,
            201
          ]
        },
        "hop_2_rel": {
          "source_file": "DUK_10k_2023.pdf",
          "target_page": 192,
          "pages": [
            190,
            191,
            192,
            193,
            194
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 63356,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 16076,
        "completion_tokens": 183,
        "total_tokens": 16259
      }
    },
    {
      "question_id": 23,
      "question": "How did SPG's treatment and disclosure of LTIP Units evolve from 2022 to 2023, particularly in terms of their dilutive effect and valuation modeling?",
      "original_answer": "In 2022, SPG disclosed that LTIP units were part of potentially dilutive securities but had no material dilutive effect for the years 2021, 2020, and 2019. By 2023, SPG provided more detailed disclosures, including the use of a Monte Carlo model to estimate the grant-date fair values of market-based LTIP units and confirmed that these units are treated as participating securities under the two-class method of computing earnings per share. This reflects a shift from a general statement about dilution to a more granular and valuation-focused disclosure in 2023.",
      "llm_answer": "From 2022 to 2023, SPG’s LTIP units continued to be granted under its 2019 Stock Incentive Plan, but the 2023 LTI Program introduced a new performance‑based component with a higher potential fair‑value ($23.6 million for 2023 awards) and required a three‑year performance period before vesting on January 1, 2026. Earlier programs (2019‑2022) also used LTIP units with performance conditions tied to FFO and TSR, but their grant‑date fair values were lower ($12.2 million for 2021, $13.7 million for 2022) and they vested on January 1, 2023 for the 2019 awards. The dilutive effect of LTIP units is reflected in the two‑class earnings‑per‑share calculations, where earned LTIP units are treated as participating securities; however, the filings note that no securities had a material dilutive impact for the years examined. Valuation modeling shifted to Monte Carlo simulations for market‑based LTIP awards, and expense recognition now follows the performance‑period schedule, with the 2023 awards’ $7.9 million fair value being amortized over the three‑year vesting period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "SPG_10k_2022.pdf",
          "target_page": 115,
          "pages": [
            113,
            114,
            115,
            116,
            117
          ]
        },
        "hop_2_rel": {
          "source_file": "SPG_10k_2023.pdf",
          "target_page": 127,
          "pages": [
            125,
            126,
            127,
            128,
            129
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 51742,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 13159,
        "completion_tokens": 268,
        "total_tokens": 13427
      }
    },
    {
      "question_id": 23,
      "question": "How has Comcast's financial commitment and involvement in Atairos Group, Inc. evolved between 2022 and 2024, particularly in terms of capital funding and management fee commitments?",
      "original_answer": "Comcast's involvement in Atairos Group, Inc. evolved significantly between 2022 and 2024. In 2022, Comcast was the sole third-party investor with a commitment to fund up to $5 billion in aggregate capital to Atairos. By 2024, this commitment had decreased to up to $4.5 billion, with an additional specific commitment of $40 million annually for a management fee. The reduction in capital commitment and the introduction of a dedicated management fee structure indicate a recalibration of Comcast's financial involvement and strategic oversight of Atairos.",
      "llm_answer": "Comcast's financial commitment to Atairos Group, Inc. has decreased over time, with its capital commitment reduced from up to $5 billion to $4.5 billion in 2020 and further to $1.5 billion (as of 2021) in subsequent updates, while it also committed to fund $40–$45 million annually for management fees. The company accounts for its investment in Atairos as an equity‑method holding, recognizing its share of gains and losses, making capital contributions ($73 million in 2024, $145 million in 2023, $52 million in 2022), and maintaining an unfunded commitment of about $1.4–$1.5 billion, which represents its maximum financial risk. This involvement reflects a shift from larger early‑stage funding to a more limited, fee‑based and capital‑call‑driven engagement by 2024.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CMCSA_10k_2022.pdf",
          "target_page": 105,
          "pages": [
            103,
            104,
            105,
            106,
            107
          ]
        },
        "hop_2_rel": {
          "source_file": "CMCSA_10k_2024.pdf",
          "target_page": 84,
          "pages": [
            82,
            83,
            84,
            85,
            86
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 9,
        "total_chars": 44101,
        "num_window_pages": 9,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 11256,
        "completion_tokens": 192,
        "total_tokens": 11449
      }
    },
    {
      "question_id": 24,
      "question": "How has COP's natural gas reserves in the Asia Pacific/Middle East region evolved from 2023 to 2024, and what does this indicate about the company's operational focus in that geographic area?",
      "original_answer": "In 2023, COP reported 312 billion cubic feet of natural gas reserves in the Asia Pacific/Middle East region, while in 2024, this figure slightly decreased to 296 billion cubic feet. This indicates a modest reduction in reserves over the year, suggesting a potential shift in operational focus or resource allocation in the region.",
      "llm_answer": "ConocoPhillips' natural gas reserves in the Asia Pacific/Middle East region increased from 312 billion cubic feet at the end of 2023 to 296 billion cubic feet at the end of 2024, reflecting upward revisions and additions in the region despite a slight decline in total proved reserves. This growth indicates the company is maintaining and modestly expanding its focus on natural gas resources in the Asia Pacific/Middle East, even as overall reserve levels fluctuate.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "COP_10k_2023.pdf",
          "target_page": 137,
          "pages": [
            135,
            136,
            137,
            138,
            139
          ]
        },
        "hop_2_rel": {
          "source_file": "COP_10k_2024.pdf",
          "target_page": 145,
          "pages": [
            143,
            144,
            145,
            146,
            147
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 69057,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 17498,
        "completion_tokens": 116,
        "total_tokens": 17615
      }
    },
    {
      "question_id": 24,
      "question": "Compare Comcast's wireless gateway procurement strategy in 2022 with its network deployment investment focus in 2024.",
      "original_answer": "In 2022, Comcast's relationship with wireless gateways was primarily centered on procurement, as the company purchased a significant amount of customer premise equipment, including wireless gateways, from a limited number of suppliers to provide services to residential and business customers. By 2024, the company's approach had evolved into a more strategic investment focus, with wireless gateways being a key component of its planned capital expenditures. Specifically, in 2024, Comcast emphasized deploying wireless gateways as part of its broader network upgrades aimed at delivering multigigabit symmetrical speeds. This shift indicates a move from passive procurement to active integration of wireless gateways into its infrastructure strategy, aligning with its goals for network scalability and capacity expansion.",
      "llm_answer": "In 2022, Comcast’s wireless gateway procurement strategy was centered on acquiring a significant volume of customer‑premise equipment—including wireless gateways and set‑top boxes—from a limited pool of suppliers to support its expanding broadband and bundled services. By 2024, the company’s network‑deployment investment focus shifted toward upgrading its infrastructure, particularly by expanding scalable infrastructure and line‑extension projects to enable multigigabit symmetrical speeds via DOCSIS 4.0, while continuing to invest in next‑generation platforms such as xFi and cloud‑based services.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CMCSA_10k_2022.pdf",
          "target_page": 8,
          "pages": [
            6,
            7,
            8,
            9,
            10
          ]
        },
        "hop_2_rel": {
          "source_file": "CMCSA_10k_2024.pdf",
          "target_page": 51,
          "pages": [
            49,
            50,
            51,
            52,
            53
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 47802,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 12163,
        "completion_tokens": 150,
        "total_tokens": 12314
      }
    },
    {
      "question_id": 24,
      "question": "How has Tesla's approach to the Solar Roof product evolved between 2022 and 2024, particularly in terms of its strategic importance and production challenges?",
      "original_answer": "In 2022, Tesla highlighted the Solar Roof as a key contributor to the growth in Energy generation and storage revenue, indicating it was being actively deployed alongside products like Megapack and Powerwall. By 2024, Tesla's framing had shifted, with the Solar Roof now positioned as a product facing potential production ramp delays similar to past vehicle and energy storage product launches. This evolution reflects a shift from emphasizing deployment success to cautioning about the operational and manufacturing risks associated with scaling the product.",
      "llm_answer": "Tesla’s Solar Roof strategy shifted decisively between 2022 and 2024 from a peripheral, niche offering to a core, mass‑market growth lever. By 2024 the company was actively expanding its production capacity and integrating Solar Roof into its broader energy‑generation and storage segment, emphasizing higher‑volume manufacturing at new factories (e.g., Berlin, Texas) and leveraging localized supply chains to reduce unit costs. However, the product still faces significant production challenges, including scaling manufacturing processes, managing raw‑material constraints for photovoltaic cells, and achieving the cost efficiencies needed to compete with traditional solar solutions. Consequently, while Solar Roof’s strategic importance has risen, its rollout remains contingent on overcoming these technical and supply‑chain hurdles.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "TSLA_10k_2022.pdf",
          "target_page": 39,
          "pages": [
            37,
            38,
            39,
            40,
            41
          ]
        },
        "hop_2_rel": {
          "source_file": "TSLA_10k_2024.pdf",
          "target_page": 17,
          "pages": [
            15,
            16,
            17,
            18,
            19
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 57424,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 14580,
        "completion_tokens": 209,
        "total_tokens": 14789
      }
    },
    {
      "question_id": 24,
      "question": "How did Duke Energy's investment in Net Pending Transactions and Other Investments change from 2022 to 2023, and what does this indicate about the company's strategic positioning in this category?",
      "original_answer": "Duke Energy's investment in Net Pending Transactions and Other Investments decreased from $53 million in 2022 to $14 million in 2023. This indicates a significant reduction in exposure or involvement in pending transactions and other investments, suggesting a strategic shift or completion of certain initiatives during this period.",
      "llm_answer": "From 2022 to 2023, Duke Energy’s investment in “Net pending transactions and other investments” within its post‑retirement assets increased from $53 million to $54 million—a modest rise of $1 million (about 2%). This small growth suggests the company is maintaining a stable, low‑profile position in this category, likely reflecting a cautious or neutral strategic stance rather than an aggressive expansion.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "DUK_10k_2022.pdf",
          "target_page": 226,
          "pages": [
            224,
            225,
            226,
            227,
            228
          ]
        },
        "hop_2_rel": {
          "source_file": "DUK_10k_2023.pdf",
          "target_page": 219,
          "pages": [
            217,
            218,
            219,
            220,
            221
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 61772,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 15678,
        "completion_tokens": 102,
        "total_tokens": 15780
      }
    },
    {
      "question_id": 24,
      "question": "How has the company's implementation of its liability-driven investment framework evolved between 2023 and 2024, particularly in terms of defined contribution plan expenses and the disclosure of plan asset composition?",
      "original_answer": "In 2023, the company disclosed that amounts charged to expense for defined contribution plans totaled $109 million, and the liability-driven investment framework included a 20%/80% equity/fixed income target allocation for pension assets. By 2024, defined contribution plan expenses increased to $112 million, and while the same 20%/80% allocation was maintained, the 2024 filing added a new disclosure indicating that the actual composition of plan assets at year-end would be characterized, suggesting a more detailed transparency in reporting the implementation of the investment framework.",
      "llm_answer": "The company’s liability‑driven investment framework remained focused on aligning plan assets with liabilities, but the target equity/fixed‑income mix shifted slightly: pension assets moved from a 20% equity / 80% fixed‑income split to roughly 21% equity and 63% corporate bonds (with the remainder in government securities and other investments), while postretirement assets stayed near the 55% equity / 45% fixed‑income target but showed a higher equity share (about 57% equity, 30% corporate bonds, 13% government/other). Consequently, defined‑contribution plan expense rose to $112 million in 2024 (up from $109 million in 2023), and the disclosed composition of plan assets now reflects a larger allocation to equities and a modest increase in corporate‑bond holdings, with the fair‑value hierarchy showing more Level 2 inputs and a continued immaterial Level 3 presence.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MO_10k_2023.pdf",
          "target_page": 85,
          "pages": [
            83,
            84,
            85,
            86,
            87
          ]
        },
        "hop_2_rel": {
          "source_file": "MO_10k_2024.pdf",
          "target_page": 89,
          "pages": [
            87,
            88,
            89,
            90,
            91
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 51411,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 13090,
        "completion_tokens": 218,
        "total_tokens": 13309
      }
    },
    {
      "question_id": 24,
      "question": "How has Qualcomm's strategic focus on On-Device AI evolved between fiscal 2023 and fiscal 2024, and what specific investments or changes in direction were highlighted in the company's disclosures?",
      "original_answer": "In fiscal 2023, Qualcomm emphasized that On-Device AI, combined with 5G and high-performance, low-power computing, would drive adoption of smartphone technologies into industries beyond mobile, such as automotive and IoT. The company positioned itself as a leader in 5G and integrated circuit products to sustain long-term growth. By fiscal 2024, Qualcomm's focus on On-Device AI had evolved into a more investment-driven strategy, with the company explicitly stating it is investing in new product areas and industries beyond mobile handsets, including automotive and IoT, by leveraging its technical expertise and pursuing acquisitions or strategic transactions. This represents a shift from strategic vision to active investment and expansion.",
      "llm_answer": "Between fiscal 2023 and fiscal 2024, Qualcomm’s strategic focus on On-Device AI remained centered on advancing foundational technologies—particularly 5G, high‑performance low‑power computing, and AI‑enabled chipsets—for use across mobile handsets, automotive, and IoT. The company highlighted continued investment in AI‑centric R&D (e.g., on‑device AI capabilities within Snapdragon platforms) and expanded its AI‑related licensing and patent portfolio, while also emphasizing the transition to new process nodes and the integration of AI into its automotive cockpit and connectivity solutions. No major strategic pivot away from on‑device AI was disclosed; instead, the emphasis was on scaling existing AI‑driven product lines and leveraging them in new growth areas.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "QCOM_10k_2023.pdf",
          "target_page": 45,
          "pages": [
            43,
            44,
            45,
            46,
            47
          ]
        },
        "hop_2_rel": {
          "source_file": "QCOM_10k_2024.pdf",
          "target_page": 20,
          "pages": [
            18,
            19,
            20,
            21,
            22
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 56022,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 14239,
        "completion_tokens": 192,
        "total_tokens": 14431
      }
    },
    {
      "question_id": 25,
      "question": "How has the classification and presentation of the Voting Trust Agreement between Melvin Simon & Associates, Inc. and the Simon family members evolved between the 2022 and 2023 10-K filings, and what does this indicate about the governance structure's stability?",
      "original_answer": "In the 2022 10-K filing, the Voting Trust Agreement was described as 'Second Amended and Restated' as of March 1, 2004, indicating a formal update to the governance arrangement. In contrast, the 2023 10-K filing refers to the same agreement without the 'Second Amended and Restated' modifier, simply listing it as the Voting Trust Agreement dated March 1, 2004. This shift in presentation suggests that no further amendments were made in the intervening period, signaling stability in the governance structure and a continuation of the same voting trust framework without modification.",
      "llm_answer": "The Voting Trust Agreement between Melvin Simon & Associates, Inc. and the Simon family members is listed as Exhibit 9.1 in both the 2022 and 2023 10‑K filings, and it remains the “Second Amended and Restated Voting Trust Agreement, Voting Agreement and Proxy dated as of March 1, 2004.” No new amendment or replacement of this exhibit appears in the 2023 filing, indicating that the governance structure governed by this voting trust has remained unchanged and therefore stable between the two years.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "SPG_10k_2022.pdf",
          "target_page": 144,
          "pages": [
            142,
            143,
            144,
            145,
            146
          ]
        },
        "hop_2_rel": {
          "source_file": "SPG_10k_2023.pdf",
          "target_page": 140,
          "pages": [
            138,
            139,
            140,
            141,
            142
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 51517,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 13131,
        "completion_tokens": 125,
        "total_tokens": 13256
      }
    },
    {
      "question_id": 25,
      "question": "How did COP's natural gas reserves in the Asia Pacific/Middle East region evolve between 2023 and 2024, and what does this indicate about the region's changing strategic importance to COP's global reserves portfolio?",
      "original_answer": "In 2023, COP reported 312 billion cubic feet of natural gas reserves in the Asia Pacific/Middle East region, while in 2024, this figure decreased slightly to 296 billion cubic feet. This represents a reduction of 16 billion cubic feet, or about 5.1%. Despite this decline, the Asia Pacific/Middle East remained a notable contributor to COP's global reserves, especially when considering equity affiliates, which held an additional 5,870 billion cubic feet in 2024. The slight decrease may suggest a shift in emphasis or extraction focus in favor of other regions, indicating a potential reevaluation of the region's role in COP's long-term production strategy.",
      "llm_answer": "Between 2023 and 2024, ConocoPhillips' natural gas reserves in the Asia Pacific/Middle East region grew from 48 billion cubic feet (BCF) at the end of 2023 to 62 BCF at the end of 2024, reflecting upward revisions (including 55 BCF of technical revisions and 17 BCF from extensions/discoveries) that more than offset modest downward adjustments. This increase signals that the region is becoming a progressively more strategic component of COP’s global reserves portfolio, contributing a larger share of both proved gas and equity‑affiliated reserves.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "COP_10k_2023.pdf",
          "target_page": 154,
          "pages": [
            152,
            153,
            154,
            155,
            156
          ]
        },
        "hop_2_rel": {
          "source_file": "COP_10k_2024.pdf",
          "target_page": 145,
          "pages": [
            143,
            144,
            145,
            146,
            147
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 69792,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 17688,
        "completion_tokens": 137,
        "total_tokens": 17826
      }
    },
    {
      "question_id": 25,
      "question": "How did AIG's financial relationship with Corebridge evolve between 2023 and 2024, particularly in terms of debt structure and equity method income?",
      "original_answer": "In 2023, AIG had a direct financial stake in Corebridge, which was reflected in the $9,368 million total Corebridge debt on AIG's balance sheet, including $6,452 million in senior unsecured notes and $989 million in junior subordinated debt, both not guaranteed by AIG. By 2024, AIG no longer consolidated Corebridge as a subsidiary; instead, it reported Corebridge under the equity method as part of discontinued operations. During the second half of 2024, AIG reported equity method income from Corebridge, which included dividends received and changes in its stock price since June 9, 2024. This marks a significant transformation from a consolidated debt relationship to a minority equity investment with associated income reporting.",
      "llm_answer": "Between 2023 and 2024, AIG's relationship with Corebridge shifted from consolidation to deconsolidation, resulting in a $4.8 billion loss on deconsolidation and a retained equity‑method investment. Post‑deconsolidation, AIG reports equity‑method income from Corebridge—primarily dividends and changes in the stock’s fair value—reflected in net investment income, while Corebridge’s own debt structure remained largely unchanged, featuring a $250 million DDTL facility and $9.37 billion of total Corebridge debt outstanding.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AIG_10k_2023.pdf",
          "target_page": 112,
          "pages": [
            110,
            111,
            112,
            113,
            114
          ]
        },
        "hop_2_rel": {
          "source_file": "AIG_10k_2024.pdf",
          "target_page": 109,
          "pages": [
            107,
            108,
            109,
            110,
            111
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 91585,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 23119,
        "completion_tokens": 130,
        "total_tokens": 23250
      }
    },
    {
      "question_id": 25,
      "question": "How has NextEra Energy's investment strategy in Special Use Funds evolved from 2022 to 2024, particularly in terms of its allocation between fixed income and equity securities, and what does this suggest about its risk appetite or liquidity strategy?",
      "original_answer": "In 2022, NEE's Special Use Funds were entirely composed of fixed income securities, with a carrying amount of $2,505 million. By 2024, the composition had significantly transformed: NEE's Special Use Funds included $6,164 million in equity securities, $722 million in U.S. Government and municipal bonds, $685 million in corporate debt, and $873 million in asset-backed securities. This indicates a strategic shift from a purely fixed income allocation to a more diversified and equity-heavy portfolio, suggesting an increased risk appetite and a potential long-term growth orientation in its investment strategy.",
      "llm_answer": "From 2022 to 2024, NextEra Energy’s Special Use Funds allocation shifted markedly toward fixed‑income securities: the fair‑value of fixed‑income holdings rose from roughly $2.5 billion (2021) to $3.7 billion (2024) for NEE and from $1.9 billion to about $2.0 billion for FPL, while equity holdings remained a smaller, relatively stable share of the fund. This increased fixed‑income weighting—especially longer‑dated debt securities with average maturities of eight to nine years—reflects a more conservative risk posture and a focus on preserving liquidity, as the funds must meet potentially urgent storm‑damage or nuclear‑decommissioning cash needs. Consequently, the company appears to be prioritizing stable, lower‑volatility assets to safeguard cash availability rather than pursuing higher‑risk equity exposure.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "NEE_10k_2022.pdf",
          "target_page": 55,
          "pages": [
            53,
            54,
            55,
            56,
            57
          ]
        },
        "hop_2_rel": {
          "source_file": "NEE_10k_2024.pdf",
          "target_page": 89,
          "pages": [
            87,
            88,
            89,
            90,
            91
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 61295,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 15570,
        "completion_tokens": 204,
        "total_tokens": 15774
      }
    },
    {
      "question_id": 26,
      "question": "How has the nature and magnitude of the risk associated with site infrastructure sharing evolved between 2022 and 2024, particularly in relation to 5G technology adoption and its impact on new lease activity?",
      "original_answer": "In 2022, AMT identified site infrastructure sharing as a risk factor that could slow new lease activity or lead to decommissioning of equipment on existing sites, particularly due to the rise of 5G technology. By 2024, this risk evolved into a more specific concern around RAN (Radio Access Network) sharing, roaming, or resale arrangements, which were explicitly tied to the lack of compensation to AMT when carriers opted for shared infrastructure instead of deploying new equipment. The 2024 filing indicates a stronger emphasis on the financial impact of this trend, suggesting a more mature and impactful shift in carrier behavior driven by 5G deployment. This represents a significant evolution in the risk's specificity and perceived threat level.",
      "llm_answer": "The risk associated with site infrastructure sharing has evolved from a general competitive concern in 2022 to a more pronounced challenge by 2024, particularly due to 5G adoption and network sharing trends. By 2024, American Tower explicitly highlighted that extensive site infrastructure sharing—such as RAN sharing, roaming, or resale arrangements among wireless providers—could reduce new lease activity, as carriers might utilize shared equipment instead of deploying new equipment or decommission redundant network assets, directly threatening revenue from leasing agreements. This shift reflects a more specific and material risk to growth, as noted in the 2024 filing’s discussion of 5G-related technologies potentially diminishing demand for tower-based infrastructure.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AMT_10k_2022.pdf",
          "target_page": 16,
          "pages": [
            14,
            15,
            16,
            17,
            18
          ]
        },
        "hop_2_rel": {
          "source_file": "AMT_10k_2024.pdf",
          "target_page": 15,
          "pages": [
            13,
            14,
            15,
            16,
            17
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 56322,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 14316,
        "completion_tokens": 194,
        "total_tokens": 14511
      }
    },
    {
      "question_id": 26,
      "question": "How has Chevron's financial relationship with Angola LNG Limited evolved between 2022 and 2023, particularly in terms of its investment structure and equity method accounting?",
      "original_answer": "Chevron's relationship with Angola LNG Limited evolved from a dependency-based structure in 2022 to a more direct investment model in 2023. In 2022, Chevron reported a 36.4% interest in Angola LNG Limited, but the relationship was categorized under 'Depends_On', indicating a more passive or structurally dependent investment. By 2023, the relationship was reclassified as 'Invests_In', suggesting a more active or strategic financial posture. Additionally, while both years maintained the same ownership percentage (36.4%), the reclassification indicates a shift in how Chevron views or manages its investment, possibly reflecting changes in operational involvement or strategic alignment.",
      "llm_answer": "Chevron’s equity investment in Angola LNG Limited grew from $336 million at the end of 2019 to $2,180 million by the end of 2021, and its share of the affiliate’s net equity rose from $38,851 million to $40,153 million, reflecting an increase in both the size of the investment and the underlying affiliate’s equity base.  In the 2023 10‑K, the company reports that its “Investments and Advances” in Angola LNG Limited were $1,762 million at the end of 2023 (up from $1,963 million in 2022 and $336 million in 2021), and that its share of Angola LNG’s net equity was $45,823 million in 2023 (up from $40,153 million in 2021), indicating a continued expansion of its ownership stake and equity‑method exposure.  The 2023 filing also notes that Chevron records its share of Angola LNG’s earnings using the equity method, and that the investment is accounted for at a value higher than underlying equity (e.g., about $80 million excess at year‑end 2023), confirming that the investment structure remains an equity‑method affiliate with a growing carrying value.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CVX_10k_2022.pdf",
          "target_page": 78,
          "pages": [
            76,
            77,
            78,
            79,
            80
          ]
        },
        "hop_2_rel": {
          "source_file": "CVX_10k_2023.pdf",
          "target_page": 82,
          "pages": [
            80,
            81,
            82,
            83,
            84
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 56646,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 14389,
        "completion_tokens": 264,
        "total_tokens": 14653
      }
    },
    {
      "question_id": 26,
      "question": "How has the G600 aircraft's role in Gulfstream's product lineup evolved from 2022 to 2023, particularly in terms of its performance metrics and production status?",
      "original_answer": "In 2022, the G600 was described as a recent addition to the Gulfstream fleet, having entered service in 2019, and was positioned as a clean-sheet aircraft replacing the G550. By 2023, the G600 was no longer characterized as 'new' but rather as a mature product within the lineup, with over 250 cumulative deliveries by year-end 2023. Additionally, in 2023, the G600's advanced technologies, such as the Symmetry Flight Deck, were highlighted as foundational features being extended to newer models like the G700, G800, and G400. This indicates a shift from product introduction to integration within the broader Gulfstream platform.",
      "llm_answer": "From 2022 to 2023, the G600 remained in active production and service, with cumulative deliveries exceeding 250 aircraft by year-end 2023, reflecting steady production growth. While specific 2023 performance metrics aren't detailed in the provided pages, the G600—like its sister G500—was noted for being faster, more fuel-efficient, and offering greater cabin volume and range than the models it replaced, holding multiple city-pair speed records as part of Gulfstream's record-setting product line.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "GD_10k_2022.pdf",
          "target_page": 5,
          "pages": [
            3,
            4,
            5,
            6,
            7
          ]
        },
        "hop_2_rel": {
          "source_file": "GD_10k_2023.pdf",
          "target_page": 5,
          "pages": [
            3,
            4,
            5,
            6,
            7
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 30951,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 7959,
        "completion_tokens": 125,
        "total_tokens": 8084
      }
    },
    {
      "question_id": 26,
      "question": "How has McDonald's relationship with its franchisees evolved in terms of financial involvement and strategic collaboration between 2022 and 2024?",
      "original_answer": "In 2022, McDonald's relationship with franchisees was primarily framed around franchised arrangements and license agreements, with franchisees contributing revenue through rent, royalties, and initial fees, while the company did not typically invest in restaurant capital under developmental licenses. By 2024, the company had introduced a more active investment role, co-investing with franchisees to fund restaurant improvements and operating system upgrades. These co-investments were aimed at catering to consumer preferences, improving local performance, and enhancing the brand through modernization. This marks a strategic shift from a largely passive franchising model to a more collaborative and financially engaged partnership.",
      "llm_answer": "Between 2022 and 2024, McDonald's relationship with its franchisees evolved from a focus on financial co-investment and operational support to a deeper strategic collaboration centered on shared values and long-term sustainability. The company increasingly partnered with franchisees to fund restaurant modernization and technology upgrades, emphasizing joint investments in brand standards, supply chain innovation, and community engagement—while maintaining a franchising model that prioritizes franchisee autonomy in day-to-day operations but aligns on global priorities like equal pay, human rights, and inclusive growth. This shift reflects a move from purely transactional financial arrangements to a more integrated partnership focused on mutual success and stakeholder impact.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MCD_10k_2022.pdf",
          "target_page": 43,
          "pages": [
            41,
            42,
            43,
            44,
            45
          ]
        },
        "hop_2_rel": {
          "source_file": "MCD_10k_2024.pdf",
          "target_page": 4,
          "pages": [
            2,
            3,
            4,
            5,
            6
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 64236,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 16278,
        "completion_tokens": 196,
        "total_tokens": 16474
      }
    },
    {
      "question_id": 26,
      "question": "How did the financial performance of smokeable products evolve from 2022 to 2023, particularly in terms of net revenues and operating income?",
      "original_answer": "In 2022, smokeable products generated $22,476 million in net revenues and contributed $10,688 million to operating income. In 2023, net revenues from smokeable products decreased slightly to $21,756 million, and operating income from this segment also declined marginally to $10,670 million. This reflects a small decrease in both revenue and profitability year-over-year.",
      "llm_answer": "From 2022 to 2023, net revenues from smokeable products declined $720 million (from $22,476 million to $21,756 million), and operating income in that segment fell $18 million (from $10,688 million to $10,670 million). Overall, Altria’s reported operating income dropped $372 million (from $11,919 million in 2022 to $11,547 million in 2023), driven primarily by higher general corporate expenses and amortization of intangibles, despite gains in oral tobacco products.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MO_10k_2022.pdf",
          "target_page": 66,
          "pages": [
            64,
            65,
            66,
            67,
            68
          ]
        },
        "hop_2_rel": {
          "source_file": "MO_10k_2023.pdf",
          "target_page": 29,
          "pages": [
            27,
            28,
            29,
            30,
            31
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 58565,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 14860,
        "completion_tokens": 117,
        "total_tokens": 14977
      }
    },
    {
      "question_id": 26,
      "question": "How has the role of Opdivo within BMY's product development and commercialization strategy evolved from 2022 to 2024, particularly in terms of its collaborative framework and new therapeutic approvals?",
      "original_answer": "In 2022, Opdivo was primarily positioned within a joint development and commercialization framework with Ono, where profits, losses, and development costs were shared—either equally for combination therapies or under an 80-20 split for single-party compounds. Additionally, Opdivo was part of a broader alliance that included other products like Yervoy and Orencia, with structured co-promotion and supply responsibilities. By 2024, Opdivo's role had evolved significantly, marked by a new FDA approval in March 2024 for use in combination with cisplatin and gemcitabine for the first-line treatment of unresectable or metastatic urothelial carcinoma. This reflects a shift from a co-development focus to a more independent product introduction strategy, with BMY taking the lead in expanding Opdivo’s therapeutic applications in key oncology markets.",
      "llm_answer": "From 2022 to 2024, Opdivo's role in BMY's strategy evolved from a core IO product to a broader commercial and collaborative asset. It expanded through new approvals (e.g., Opdivo Qvantig, Opdivo plus Yervoy for colorectal cancer, and neoadjuvant NSCLC), entered new markets (e.g., Japan), and deepened its partnership framework—particularly with Ono in Japan and Nektar for NKTR-214 combinations—while maintaining its central role in BMY's oncology portfolio and generating significant alliance revenues.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "BMY_10k_2022.pdf",
          "target_page": 113,
          "pages": [
            111,
            112,
            113,
            114,
            115
          ]
        },
        "hop_2_rel": {
          "source_file": "BMY_10k_2024.pdf",
          "target_page": 45,
          "pages": [
            43,
            44,
            45,
            46,
            47
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 8,
        "total_chars": 44576,
        "num_window_pages": 8,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 11379,
        "completion_tokens": 126,
        "total_tokens": 11505
      }
    },
    {
      "question_id": 27,
      "question": "How has AMT's disclosure regarding interest rate benchmarks for debt instruments evolved between 2022 and 2024, particularly in terms of referenced rates and associated covenants?",
      "original_answer": "In 2022, AMT's debt instruments referenced LIBOR, EURIBOR, and a defined base rate for USD and EUR denominated borrowings, with the 2021 credit facilities tied to debt ratings and commitment fees ranging from 0.080% to 0.300%. By 2024, AMT disclosed that new drawings under letters of credit in Nigeria bore interest at SOFR (Secured Overnight Financing Rate) plus a spread, indicating a shift away from LIBOR-based instruments. Additionally, while 2022 disclosures detailed specific covenants and optional renewal periods for various credit facilities, the 2024 disclosure focused on the consequences of covenant non-compliance without specifying interest rate structures or renewal terms, suggesting a simplification or evolution in the presentation of covenant-related disclosures.",
      "llm_answer": "Between 2022 and 2024, American Tower’s disclosures regarding interest rate benchmarks for debt instruments shifted from referencing LIBOR-based rates in its 2022 filings (e.g., 2021 Credit Facility with LIBOR or EURIBOR borrowing rates ranging from 0.875%–1.750%) to explicitly adopting alternative benchmarks in its 2024 securitization structures. By 2024, the Company’s debt agreements (including the 2023 Securitization and related Loan Agreement) referenced specific fixed interest rates for tranches (e.g., 5.490% for Series 2023-1A Securities and 5.735% for Series 2023-1R Securities) and eliminated direct LIBOR/EURIBOR dependencies, instead tying rates to defined contractual terms and incorporating amortization triggers tied to debt service coverage ratios (DSCR). This evolution reflects a move toward more stable, predetermined rates and reduced reliance on floating benchmarks, particularly in securitized debt instruments, while maintaining covenants tied to financial performance metrics like DSCR thresholds.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AMT_10k_2022.pdf",
          "target_page": 52,
          "pages": [
            50,
            51,
            52,
            53,
            54
          ]
        },
        "hop_2_rel": {
          "source_file": "AMT_10k_2024.pdf",
          "target_page": 117,
          "pages": [
            115,
            116,
            117,
            118,
            119
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 9,
        "total_chars": 50514,
        "num_window_pages": 9,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 12858,
        "completion_tokens": 256,
        "total_tokens": 13114
      }
    },
    {
      "question_id": 27,
      "question": "How has McDonald's relationship with franchisees evolved in terms of real estate ownership and co-investment strategy between 2022 and 2024?",
      "original_answer": "In 2022, McDonald's emphasized Systemwide coordination and alignment to manage ESG initiatives, including environmental sustainability and responsible sourcing, which required franchisee cooperation. However, the specific role of franchisees in real estate ownership was not detailed. By 2024, the company explicitly outlined its conventional franchise model, where it typically owns or secures long-term leases on land and buildings, while franchisees invest in equipment, signs, seating, and décor. This co-investment model was described as enabling McDonald's to achieve high restaurant performance levels. The shift from a general emphasis on franchisee collaboration in 2022 to a clearly defined real estate and co-investment strategy in 2024 reflects a more structured and strategic approach to franchise relationships.",
      "llm_answer": "Between 2022 and 2024, McDonald's deepened its co‑investment strategy with franchisees, shifting toward greater real‑estate ownership by the company while still relying on franchisees to fund restaurant upgrades; the firm increasingly uses long‑term leases and ownership of land and buildings to support performance, and it partners with franchisees on capital projects to modernize stores and boost revenue.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MCD_10k_2022.pdf",
          "target_page": 34,
          "pages": [
            32,
            33,
            34,
            35,
            36
          ]
        },
        "hop_2_rel": {
          "source_file": "MCD_10k_2024.pdf",
          "target_page": 3,
          "pages": [
            1,
            2,
            3,
            4,
            5
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 53615,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 13621,
        "completion_tokens": 102,
        "total_tokens": 13723
      }
    },
    {
      "question_id": 27,
      "question": "How did the status and documentation of the 2015 Stock Compensation Plan for Non-Employee Directors change between 2022 and 2023, and what does this evolution indicate about Altria's governance approach to director compensation?",
      "original_answer": "In 2022, the 2015 Stock Compensation Plan for Non-Employee Directors was disclosed with 703,256 shares available for issuance under the plan. By 2023, the plan was formally amended and restated effective October 26, 2022, and was incorporated by reference from Altria's September 30, 2022, Form 10-Q filing. This indicates a formal update to the plan’s structure and governance, suggesting Altria refined its director compensation framework mid-cycle, potentially to align with evolving governance standards or internal compensation strategies.",
      "llm_answer": "Between 2022 and 2023, the 2015 Stock Compensation Plan for Non-Employee Directors was formally amended and restated effective October 26 2022 (as disclosed in the 2022 Form 10‑K and incorporated by reference to the 2022 10‑Q), and the same plan continued to be referenced in the 2023 filing (page 109 of the 2023 10‑K) with updated share‑availability figures. This evolution reflects Altria’s ongoing effort to align director compensation with shareholder interests while maintaining a structured, equity‑based framework that is regularly updated to reflect governance best practices and evolving compensation strategies.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MO_10k_2022.pdf",
          "target_page": 114,
          "pages": [
            112,
            113,
            114,
            115,
            116
          ]
        },
        "hop_2_rel": {
          "source_file": "MO_10k_2023.pdf",
          "target_page": 110,
          "pages": [
            107,
            108,
            109,
            110,
            111
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 54851,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 13955,
        "completion_tokens": 155,
        "total_tokens": 14111
      }
    },
    {
      "question_id": 28,
      "question": "How has the impact of roaming and resale arrangements among wireless service providers on AMT's leasing activity evolved from 2022 to 2024, and what does this indicate about the competitive pressures affecting new lease growth?",
      "original_answer": "In 2022, AMT noted that roaming or resale arrangements among wireless service providers, particularly with the rise of 5G technology, could slow new lease activity if carriers opted to share infrastructure rather than deploy new equipment. By 2024, this concern evolved into a broader risk involving RAN sharing and resale arrangements, which not only threatened new lease activity but also led to potential decommissioning of existing equipment due to redundancy. This indicates a growing competitive pressure where infrastructure sharing is becoming a more viable and widespread alternative to leasing, directly impacting AMT’s revenue growth prospects.",
      "llm_answer": "From 2022 to 2024, the impact of roaming and resale arrangements among wireless service providers has intensified competitive pressure on American Tower’s leasing activity, leading to slower new lease growth. This is evident from the 2024 filing noting that extensive sharing of site infrastructure—such as roaming, resale, and RAN sharing enabled by advanced technologies like 5G—may cause carriers to utilize shared equipment instead of deploying new equipment, potentially reducing demand for tower space and pressuring lease rates downward. The company explicitly states that such practices \"may cause new lease activity to slow\" and could result in \"decommissioning of equipment on certain existing sites,\" directly linking these dynamics to reduced lease growth and heightened competitive pressures.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AMT_10k_2022.pdf",
          "target_page": 16,
          "pages": [
            14,
            15,
            16,
            17,
            18
          ]
        },
        "hop_2_rel": {
          "source_file": "AMT_10k_2024.pdf",
          "target_page": 15,
          "pages": [
            13,
            14,
            15,
            16,
            17
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 56322,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 14321,
        "completion_tokens": 201,
        "total_tokens": 14522
      }
    },
    {
      "question_id": 28,
      "question": "How has McDonald's relationship with its franchisees evolved between 2022 and 2024, particularly in terms of strategic investment and operational expectations?",
      "original_answer": "In 2022, McDonald's highlighted the impact of the COVID-19 pandemic on franchise operations, emphasizing risks related to labor availability, supply chain disruptions, and the importance of executing its 'Accelerating the Arches' strategy to maintain growth. The focus was on franchisees' ability to adapt to changing consumer behavior and operational restrictions. By 2024, McDonald's had shifted toward a more active investment role, co-investing with franchisees to modernize restaurants and improve local performance. The company emphasized franchisee reinvestment in their businesses and introduced structured co-investment initiatives designed to increase the value of the McDonald's brand through restaurant modernization and enhanced consumer appeal. This marks a shift from pandemic-driven operational challenges to a more strategic, investment-backed growth approach.",
      "llm_answer": "Between 2022 and 2024, McDonald's franchisee relationship has shifted toward deeper strategic co-investment and tighter operational alignment. The company increasingly expects franchisees to fund major reinvestment initiatives—such as modernized restaurant builds, technology upgrades, and sustainability projects—often through co-investment partnerships, while simultaneously tightening standards around brand consistency, food safety, and customer experience execution. This reflects a move from pure royalty-based revenue dependence toward a model where franchisee financial commitment to capital projects is seen as essential to maintaining the brand's global competitiveness and accelerating growth under the \"Accelerating the Arches\" strategy. The 2024 filing emphasizes that franchisee willingness to invest at \"reasonable interest rates\" is now a critical factor for future growth, with the company actively collaborating on initiatives that cater to local consumer preferences while strengthening the overall system's value proposition.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MCD_10k_2022.pdf",
          "target_page": 28,
          "pages": [
            26,
            27,
            28,
            29,
            30
          ]
        },
        "hop_2_rel": {
          "source_file": "MCD_10k_2024.pdf",
          "target_page": 4,
          "pages": [
            2,
            3,
            4,
            5,
            6
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 55393,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 14070,
        "completion_tokens": 261,
        "total_tokens": 14332
      }
    },
    {
      "question_id": 28,
      "question": "How did NextEra Energy's investment strategy in equity securities within its Special Use Funds evolve from 2022 to 2024?",
      "original_answer": "In 2022, NextEra Energy held $8,922 million in Special Use Funds, with no explicit breakdown of equity securities provided in the filing. By 2024, the company disclosed a more detailed composition, with $6,164 million specifically allocated to equity securities under Special Use Funds. This evolution suggests a strategic shift toward transparency and a potentially greater emphasis on equity investments within these funds. While the total amount in Special Use Funds decreased, the explicit allocation to equities in 2024 indicates a more defined and possibly more aggressive investment posture compared to 2022.",
      "llm_answer": "Based on the provided SEC 10-K filings, NextEra Energy's investment strategy for equity securities within its Special Use Funds evolved significantly from 2022 to 2024. In 2022, the fund held $2,349 million in Level 1 equity securities and $199 million in Level 3 equity securities, with a total equity securities value of $5,290 million. By 2024, the fund's equity securities increased substantially to $2,614 million in Level 1, $3,321 million in Level 2, and $229 million in Level 3, totaling $6,164 million. This growth reflects a strategic shift toward higher allocations in Level 2 securities (commingled funds with underlying Level 1 assets) and a continued presence in Level 3, indicating a more diversified and potentially higher-yielding investment approach within the Special Use Funds. The fund also expanded its fixed-income holdings, with corporate debt securities rising from $5 million to $685 million and asset-backed securities from $0 to $873 million, suggesting a deliberate move to enhance portfolio stability and income generation amid changing market conditions.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "NEE_10k_2022.pdf",
          "target_page": 63,
          "pages": [
            61,
            62,
            63,
            64,
            65
          ]
        },
        "hop_2_rel": {
          "source_file": "NEE_10k_2024.pdf",
          "target_page": 89,
          "pages": [
            87,
            88,
            89,
            90,
            91
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 75982,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 19209,
        "completion_tokens": 271,
        "total_tokens": 19480
      }
    },
    {
      "question_id": 28,
      "question": "How did the financial performance of smokeable products evolve from 2022 to 2023, particularly in terms of net revenues and operating income?",
      "original_answer": "In 2022, smokeable products generated $22,476 million in net revenues and contributed $10,688 million to operating income. In 2023, net revenues from smokeable products decreased slightly to $21,756 million, and operating income from this segment also declined to $10,670 million. This indicates a marginal decrease in both revenue and profitability year-over-year.",
      "llm_answer": "From 2022 to 2023, net revenues from smokeable products declined modestly from $22,476 million to $21,756 million, while operating income for that segment fell slightly from $10,688 million to $10,670 million. Overall operating income for the company also slipped from $11,919 million in 2022 to $11,547 million in 2023, reflecting higher general corporate expenses and amortization, partially offset by improved results in the oral tobacco segment.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MO_10k_2022.pdf",
          "target_page": 67,
          "pages": [
            65,
            66,
            67,
            68,
            69
          ]
        },
        "hop_2_rel": {
          "source_file": "MO_10k_2023.pdf",
          "target_page": 29,
          "pages": [
            27,
            28,
            29,
            30,
            31
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 58343,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 14804,
        "completion_tokens": 112,
        "total_tokens": 14916
      }
    },
    {
      "question_id": 28,
      "question": "How has the utilization of Accenture plc Class A Ordinary Shares evolved between 2022 and 2023, particularly in terms of share purchase programs and their intended usage?",
      "original_answer": "In 2022, Accenture disclosed an aggregate available authorization of $3,129,296 for publicly announced open-market share purchase programs and other share purchase programs involving Accenture plc Class A Ordinary Shares and Accenture Canada Holdings Inc. exchangeable shares. By 2023, the company clarified that Class A Ordinary Shares acquired through these programs were being held as treasury shares and intended for employee benefits, such as equity awards. Additionally, in fiscal 2024, shares were acquired via share withholding for payroll tax obligations under employee equity share plans, which were separate from the publicly announced share purchase authorization. This indicates a shift in focus toward internal employee compensation mechanisms while maintaining a formal buyback program.",
      "llm_answer": "Between fiscal 2022 and 2023, Accenture’s utilization of its Class A ordinary shares shifted from a larger open‑market purchase program to a more focused share‑repurchase effort. In fiscal 2022 the company bought 12.18 million Class A shares for $4.11 billion (including $959 million of other share‑purchase activity), whereas by the end of fiscal 2023 it had authorized an additional $3 billion of repurchase authority and was actively repurchasing shares under that program, indicating a continued but more targeted deployment of its share‑purchase authority. The shares acquired are held as treasury stock and are intended for employee‑benefit uses such as equity awards and ESPP purchases.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "ACN_10k_2022.pdf",
          "target_page": 93,
          "pages": [
            91,
            92,
            93,
            94,
            95
          ]
        },
        "hop_2_rel": {
          "source_file": "ACN_10k_2023.pdf",
          "target_page": 101,
          "pages": [
            81,
            82,
            83,
            84,
            85
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 33235,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 8535,
        "completion_tokens": 173,
        "total_tokens": 8708
      }
    },
    {
      "question_id": 29,
      "question": "How has the nature and structure of AMT's operating covenants evolved between 2022 and 2024, particularly in terms of the types of debt instruments involved and associated interest rate benchmarks?",
      "original_answer": "In 2022, AMT's operating covenants were tied to a variety of credit facilities and loans that referenced LIBOR and EURIBOR as the interest rate benchmarks. These included the 2021 Multicurrency Credit Facility, the 2021 Credit Facility, and several term loans. By 2024, AMT's disclosures indicate a shift in the interest rate benchmark to SOFR, specifically for letters of credit drawn in Nigeria, which were subject to a rate equal to SOFR at the time of drawing plus a spread. This reflects a transition away from LIBOR-based covenants toward SOFR-based structures, signaling a strategic and regulatory evolution in how AMT manages its debt obligations and associated covenants.",
      "llm_answer": "Between 2022 and 2024, AMT's operating covenants evolved to include newer debt instruments with lower coupon rates and extended maturities, reflecting a strategic shift toward cheaper, longer-term financing. The company issued 0.400% and 0.950% senior unsecured notes in 2021 (with maturities in 2027 and 2030), followed by 0.450%, 0.875%, and 1.250% notes in 2021 (maturing in 2027, 2029, and 2033), and later 1.450%, 2.300%, and 2.950% notes in 2021 (maturing in 2026, 2031, and 2050). These offerings replaced higher-rate legacy debt (e.g., 4.70% notes redeemed in 2021) and reduced reliance on LIBOR/EURIBOR-based borrowings, with interest rates now anchored to fixed percentages (e.g., 0.400%–2.950%) and adjusted via credit rating-based margins (1.125% above EURIBOR/LIBOR for credit facilities). The structure shifted from variable-rate facility-based debt to a portfolio dominated by fixed-rate senior notes with longer maturities, reducing refinancing risk and enhancing financial flexibility.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AMT_10k_2022.pdf",
          "target_page": 114,
          "pages": [
            112,
            113,
            114,
            115,
            116
          ]
        },
        "hop_2_rel": {
          "source_file": "AMT_10k_2024.pdf",
          "target_page": 117,
          "pages": [
            115,
            116,
            117,
            118,
            119
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 9,
        "total_chars": 48548,
        "num_window_pages": 9,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 12372,
        "completion_tokens": 250,
        "total_tokens": 12623
      }
    },
    {
      "question_id": 29,
      "question": "How did Disney+ Hotstar's subscriber base evolve between the 2023 and 2024 SEC filings, and what impact did the consolidation of Star+ into Disney+ in Latin America have on Disney's international streaming strategy?",
      "original_answer": "In the 2023 SEC filing, Disney+ Hotstar reported approximately 36 million paid subscribers as of September 28, 2024. The 2024 filing noted that in certain Latin American countries prior to July 2024, Disney offered both Disney+ and Star+ as separate services, but these were merged into a single Disney+ product offering by the end of June 2024. This consolidation suggests a strategic shift toward streamlining international service offerings, potentially aligning with the model used for Disney+ Hotstar by integrating diverse content into a unified brand to enhance user experience and operational efficiency.",
      "llm_answer": "The 2024 filing shows Disney+ had approximately 123 million paid subscribers worldwide as of September 28, 2024, up from about 36 million Disney+ Hotstar subscribers (reported separately) and roughly 52 million Hulu subscribers; the 2023 filing does not provide a comparable Disney+ subscriber figure, but it does list 66 million total subscribers across its linear networks, indicating growth in the DTC segment.  \n\nThe consolidation of Star+ into Disney+ in Latin America eliminated the standalone Star+ offering and integrated its sports and general‑entertainment content into a single Disney+ product, strengthening Disney’s international streaming strategy by creating a unified, larger‑scale platform that can leverage a broader content library, improve subscriber retention, and support future multi‑product bundles (e.g., Disney+ + ESPN+ in the U.S.). This move is expected to boost Disney’s international subscriber base and increase average revenue per user across the region.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "DIS_10k_2023.pdf",
          "target_page": 7,
          "pages": [
            5,
            6,
            7,
            8,
            9
          ]
        },
        "hop_2_rel": {
          "source_file": "DIS_10k_2024.pdf",
          "target_page": 57,
          "pages": [
            55,
            56,
            57,
            58,
            59
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 46819,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 11941,
        "completion_tokens": 246,
        "total_tokens": 12187
      }
    },
    {
      "question_id": 29,
      "question": "How has the number of employees covered under collective labor agreements changed from 2022 to 2023, and what does this indicate about the company's labor agreement strategy?",
      "original_answer": "In 2022, the company expected to negotiate agreements covering approximately 3,000 employees in the following year. In 2023, the company projected negotiations covering 2,100 employees for the upcoming year. This indicates a reduction in the number of employees involved in labor renegotiations, suggesting a shift in the company's labor agreement strategy, possibly due to fewer expiring agreements or proactive resolution of collective bargaining terms.",
      "llm_answer": "The number of employees covered under collective labor agreements increased from approximately 3,000 in 2022 to approximately 2,100 in 2023 (covering about one-fifth of subsidiaries' employees), indicating the company's strategy of proactively renegotiating expiring agreements without material disruption to operations.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "GD_10k_2022.pdf",
          "target_page": 77,
          "pages": [
            75,
            76,
            77,
            78,
            79
          ]
        },
        "hop_2_rel": {
          "source_file": "GD_10k_2023.pdf",
          "target_page": 79,
          "pages": [
            77,
            78,
            79,
            80,
            81
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 38898,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 9951,
        "completion_tokens": 80,
        "total_tokens": 10031
      }
    },
    {
      "question_id": 29,
      "question": "How did NextEra Energy's investment in U.S. Government and municipal bonds evolve from 2022 to 2024, and what was the change in total value across these years?",
      "original_answer": "In 2022, NextEra Energy's investment in U.S. Government and municipal bonds totaled $137 million. By 2024, this investment had increased significantly to $161 million under 'Other investments' for NEE. This represents a growth of $24 million, or approximately 17.5%, indicating a strategic increase in this asset class over the two-year period.",
      "llm_answer": "Based on the provided SEC 10-K filings, NextEra Energy's investment in U.S. Government and municipal bonds was $131 million at the end of 2022 (as shown in the fair value hierarchy table on page 101 of the 2022 filing) and increased to $137 million at the end of 2023 (shown in the same table structure for 2023 on page 87 of the 2024 filing). This represents a $6 million increase in total value across these years. The investment remained relatively stable, with the 2024 filing showing $137 million compared to $131 million in 2022.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "NEE_10k_2022.pdf",
          "target_page": 101,
          "pages": [
            99,
            100,
            101,
            102,
            103
          ]
        },
        "hop_2_rel": {
          "source_file": "NEE_10k_2024.pdf",
          "target_page": 89,
          "pages": [
            87,
            88,
            89,
            90,
            91
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 61041,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 15485,
        "completion_tokens": 133,
        "total_tokens": 15618
      }
    },
    {
      "question_id": 29,
      "question": "How has the role of Opdivo in Bristol-Myers Squibb's product portfolio evolved between 2022 and 2024, particularly in terms of its manufacturing strategy and therapeutic approvals?",
      "original_answer": "In 2022, Opdivo was referenced as a product with both internal manufacturing capability and reliance on third-party manufacturers to meet demand, highlighting its strategic importance in BMY's supply chain. By 2024, Opdivo received a new FDA approval in March for combination therapy with cisplatin and gemcitabine for first-line treatment of unresectable or metastatic urothelial carcinoma, indicating an expansion of its therapeutic applications. This evolution reflects both continued manufacturing investment and increased clinical positioning of Opdivo within BMY's oncology portfolio.",
      "llm_answer": "Between 2022 and 2024, Opdivo's role in BMS's portfolio evolved from a mature oncology product to a strategically expanded asset with new combination and formulation approvals. Manufacturing strategy remained anchored in internal capability (e.g., maintaining an approved internal source for Opdivo) while expanding third-party partnerships to support demand, consistent with BMS's broader flexible manufacturing network approach. Therapeutic approvals accelerated with multiple 2024 FDA and EC authorizations: Opdivo received FDA approval for first-line metastatic urothelial carcinoma (Dec 2024), EC approval for Opdivo+Yervoy in colorectal cancer (Dec 2024), and expanded use in neoadjuvant NSCLC (Oct 2024), alongside the launch of Opdivo Qvantig (subcutaneous formulation) in December 2024. These developments reinforced Opdivo's position as a cornerstone IO therapy, supported by ongoing manufacturing investments to scale production for new indications.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "BMY_10k_2022.pdf",
          "target_page": 27,
          "pages": [
            25,
            26,
            27,
            28,
            29
          ]
        },
        "hop_2_rel": {
          "source_file": "BMY_10k_2024.pdf",
          "target_page": 45,
          "pages": [
            43,
            44,
            45,
            46,
            47
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 57864,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 14695,
        "completion_tokens": 240,
        "total_tokens": 14935
      }
    },
    {
      "question_id": 30,
      "question": "How has Disney's relationship with National Geographic magazine evolved between 2023 and 2024 in terms of its business structure and strategic positioning within the company's portfolio?",
      "original_answer": "In 2023, National Geographic magazine was explicitly described as part of the Entertainment segment under Content Sales/Licensing, and was noted as being 73% owned by Disney. By 2024, the magazine was still reported under Content Sales/Licensing, but the emphasis on its ownership percentage was removed, and it was described more as a publication 'published' by the company rather than a business in which Disney has a direct equity stake. This shift indicates a more operational rather than ownership-focused relationship in 2024 compared to 2023.",
      "llm_answer": "Disney's relationship with National Geographic magazine has remained within the broader Entertainment segment's content licensing and publishing activities, with National Geographic magazine reported as part of Content Sales/Licensing in the 2024 10-K. The company continues to leverage National Geographic's IP through its linear channels (including National Geographic Channels) and DTC platforms, though no structural changes to its business relationship with the magazine are noted between 2023 and 2024. The magazine's revenue is included in the Content Sales/Licensing revenue stream, which also encompasses TV/VOD distribution, home entertainment, and other licensing activities.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "DIS_10k_2023.pdf",
          "target_page": 78,
          "pages": [
            76,
            77,
            78,
            79,
            80
          ]
        },
        "hop_2_rel": {
          "source_file": "DIS_10k_2024.pdf",
          "target_page": 7,
          "pages": [
            5,
            6,
            7,
            8,
            9
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 42747,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 10916,
        "completion_tokens": 171,
        "total_tokens": 11087
      }
    },
    {
      "question_id": 30,
      "question": "How has PayPal's description of its transaction management databases' capabilities evolved between 2023 and 2024, particularly in relation to global payment processing in different currencies?",
      "original_answer": "In 2023, PayPal described its transaction management databases as part of a platform that allowed consumers to withdraw funds in 56 currencies. By 2024, the company updated this figure to 57 currencies, indicating a slight expansion in the global reach of its transaction processing capabilities. Additionally, while both years emphasize the role of these databases in enabling customers to utilize PayPal's suite of products, the 2024 filing introduced a more consumer-centric framing, placing 'consumers' ahead of 'merchants' in describing the ecosystem served by the platform. These changes suggest a refinement in how PayPal positions its transaction management systems within its broader global payments infrastructure.",
      "llm_answer": "PayPal’s 2024 filing expands its global payment capabilities by highlighting the ability to process transactions in “approximately 150 currencies” and to enable consumers to “send payments in approximately 200 markets,” a notable increase from the 2023 description that referenced “approximately 140 currencies” and “approximately 200 markets.”  The 2024 text also emphasizes broader currency‑holding options (“hold balances in their eligible PayPal accounts in 24 currencies”) and more explicit linkage of these capabilities to the company’s strategy for expanding offline engagement and cross‑border commerce.  Thus, between 2023 and 2024 the company’s language shifted from a general reference to multi‑currency support to a more detailed articulation of a larger number of supported currencies and markets, underscoring its ambition to process global payments in many different currencies.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "PYPL_10k_2023.pdf",
          "target_page": 10,
          "pages": [
            8,
            9,
            10,
            11,
            12
          ]
        },
        "hop_2_rel": {
          "source_file": "PYPL_10k_2024.pdf",
          "target_page": 9,
          "pages": [
            7,
            8,
            9,
            10,
            11
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 53847,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 13693,
        "completion_tokens": 223,
        "total_tokens": 13916
      }
    },
    {
      "question_id": 30,
      "question": "How did the interest rate terms associated with the Series K Debentures evolve between 2023 and 2024, and what does this indicate about NEE's financing strategy?",
      "original_answer": "In 2023, the Series K Debentures had their interest rate reset to 6.051% per year as part of a remarketing completed in March 2023. By 2024, the terms of the Series K Debentures were further updated through a letter dated March 1, 2023, which set forth certain terms effective March 1, 2023, indicating a continuation of the updated rate and terms from the 2023 remarketing. This suggests that NEE adjusted its financing strategy in response to market conditions, locking in a higher interest rate to secure funding.",
      "llm_answer": "The Series K Debentures issued in February 2020 carried a 4.60 % fixed rate, but in March 2023 NEECH completed a remarketing that reset the interest rate to 6.051 % per annum (payable semi‑annually beginning September 1, 2023). This rate increase reflects a more expensive refinancing environment and indicates that NEE is leveraging higher‑cost debt to fund its growth and equity‑unit programs, while still maintaining a strategy of issuing long‑dated, largely fixed‑rate securities to manage its capital structure.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "NEE_10k_2023.pdf",
          "target_page": 104,
          "pages": [
            102,
            103,
            104,
            105,
            106
          ]
        },
        "hop_2_rel": {
          "source_file": "NEE_10k_2024.pdf",
          "target_page": 120,
          "pages": [
            118,
            119,
            120,
            121,
            122
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 101500,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 25601,
        "completion_tokens": 129,
        "total_tokens": 25730
      }
    },
    {
      "question_id": 31,
      "question": "How has ExxonMobil's application of the Unit-of-Production Depreciation method evolved between 2022 and 2023, particularly in response to changes in proved reserves and asset life assumptions?",
      "original_answer": "In 2022, ExxonMobil applied the Unit-of-Production Depreciation method based on proved reserves or proved developed reserves, switching to straight-line depreciation when asset life did not correlate with reserves, and using SEC price-based reserves only when proved reserves were substantially de-booked. By 2023, the company maintained the same core methodology but placed greater emphasis on using the most recent SEC price to determine reserves for depreciation in cases where reserves had been significantly reduced, ensuring a more meaningful allocation of asset costs over the expected life of the asset. This reflects a refinement in the company's approach to align depreciation with updated economic conditions and production realities.",
      "llm_answer": "Between 2022 and 2023, ExxonMobil’s use of the unit‑of‑production depreciation method remained tied to its proved reserve base, but the company adjusted the underlying reserve estimates to reflect market‑driven price changes and reserve revisions. The 2023 filing notes that depreciation is calculated using the most recent SEC‑price‑based proved reserves, and that assets are re‑depreciated when proved reserves are “substantially de‑booked” or when reserve volumes shift enough to alter the unit‑of‑production rate. Consequently, any evolution in the method is driven by revised reserve volumes and price assumptions rather than a change in the depreciation principle itself.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "XOM_10k_2022.pdf",
          "target_page": 77,
          "pages": [
            75,
            76,
            77,
            78,
            79
          ]
        },
        "hop_2_rel": {
          "source_file": "XOM_10k_2023.pdf",
          "target_page": 73,
          "pages": [
            71,
            72,
            73,
            74,
            75
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 9,
        "total_chars": 48592,
        "num_window_pages": 9,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 12380,
        "completion_tokens": 169,
        "total_tokens": 12549
      }
    },
    {
      "question_id": 31,
      "question": "How has Netflix's strategic emphasis on original programming evolved between 2023 and 2024, particularly in terms of its reliance on third-party production partners versus internal studio scaling?",
      "original_answer": "In 2023, Netflix emphasized its investments in original programming and highlighted the risks associated with third-party production partners, including potential liability and loss due to legal violations, insolvency, or fraud. It also noted its acquisitions like Scanline and Animal Logic as part of scaling internal studio operations. By 2024, the company shifted its language to focus on the growing complexity of managing original content production and placed greater emphasis on the need to improve internal systems, corporate culture, and operational practices related to content creation. The explicit mention of third-party risks present in 2023 was omitted in 2024, suggesting a reduced dependency on external partners and a stronger strategic move toward internal control and scaling.",
      "llm_answer": "Netflix’s 2024 filing shows a clear shift toward deeper internal studio capacity, with the company explicitly describing the scaling of its own production operations—including recent acquisitions such as Scanline and Animal Logic—to create original programming in‑house. While it continues to work with third‑party partners for certain content and distribution, the emphasis on “building out expertise” and “scaling our own studio operations” signals a reduced reliance on external production partners compared with the 2023 filing, which placed greater focus on strategic acquisitions and external licensing as growth levers. This evolution reflects a move from a primarily partnership‑driven model toward greater vertical integration of its content creation pipeline.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "NFLX_10k_2023.pdf",
          "target_page": 7,
          "pages": [
            5,
            6,
            7,
            8,
            9
          ]
        },
        "hop_2_rel": {
          "source_file": "NFLX_10k_2024.pdf",
          "target_page": 7,
          "pages": [
            5,
            6,
            7,
            8,
            9
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 55193,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 14029,
        "completion_tokens": 192,
        "total_tokens": 14221
      }
    },
    {
      "question_id": 31,
      "question": "How has the strategic positioning of Mastercard's Cyber and Intelligence Solutions evolved between 2022 and 2023?",
      "original_answer": "In 2022, Cyber and Intelligence Solutions were positioned as part of 'Other revenues' and primarily described as products and services offered to prevent, detect, and respond to fraud, ensuring the safety of transactions made on Mastercard products. By 2023, the Cyber and Intelligence Solutions were elevated in strategic importance, being explicitly described as a value-added service that enables secure, easy, and confident transactions across the entire payments ecosystem, indicating a broader role in supporting Mastercard’s core operations and new network investments.",
      "llm_answer": "Based on the provided pages, Mastercard's strategic positioning of Cyber and Intelligence Solutions evolved from being positioned as a distinct growth area in 2022 to being integrated within broader value-added services and operational initiatives in 2023. The 2023 document (page 49) explicitly references \"cyber and intelligence solutions\" as part of its value-added products and services, highlighting their role in enabling secure transactions, but does not isolate them as a standalone strategic pillar like in prior years. Instead, the focus shifted toward operational efficiency and growth in core segments (e.g., 13% net revenue growth in 2023 driven by payment network and value-added services), with cyber and intelligence solutions embedded as a key enabler within the company's broader payments ecosystem, rather than a separate strategic category. The 2022 document (page 79) similarly contextualizes these solutions as part of Mastercard's \"family of well-known and trusted brands\" supporting secure payments, but the 2023 reporting reflects a more integrated, less emphasized positioning within overall financial results.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MA_10k_2022.pdf",
          "target_page": 80,
          "pages": [
            78,
            79,
            80,
            81,
            82
          ]
        },
        "hop_2_rel": {
          "source_file": "MA_10k_2023.pdf",
          "target_page": 49,
          "pages": [
            47,
            48,
            49,
            50,
            51
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 9,
        "total_chars": 45592,
        "num_window_pages": 9,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 11609,
        "completion_tokens": 284,
        "total_tokens": 11893
      }
    },
    {
      "question_id": 31,
      "question": "How has Tesla's approach to energy storage products evolved from 2023 to 2024, particularly in terms of production challenges and strategic dependencies?",
      "original_answer": "In 2023, Tesla emphasized its modular design and in-house expertise in power electronics and software to optimize the manufacturing and performance of its energy storage products like Megapack. By 2024, Tesla's focus shifted to addressing production ramps and supply chain dependencies, citing potential bottlenecks and the need for efficient, cost-effective manufacturing capabilities. The company also highlighted risks related to supplier reliability and the challenges of scaling production to meet planned output rates and quality standards for energy storage products.",
      "llm_answer": "From 2023 to 2024, Tesla’s energy storage product strategy shifted toward greater vertical integration and modular design to improve manufacturing efficiency and scalability, while explicitly acknowledging production risks tied to new factory ramp-ups and battery cell supply constraints. The company emphasized expanding its Megapack and Powerwall production at facilities like Gigafactory Texas and Nevada, but highlighted dependencies on proprietary battery cell development and raw material availability (e.g., lithium, nickel) to meet demand, with delays in cell production or supply chain disruptions posing significant operational risks.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "TSLA_10k_2023.pdf",
          "target_page": 7,
          "pages": [
            5,
            6,
            7,
            8,
            9
          ]
        },
        "hop_2_rel": {
          "source_file": "TSLA_10k_2024.pdf",
          "target_page": 17,
          "pages": [
            15,
            16,
            17,
            18,
            19
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 46089,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 11743,
        "completion_tokens": 161,
        "total_tokens": 11904
      }
    },
    {
      "question_id": 31,
      "question": "How did NextEra Energy Capital Holdings' issuance strategy for floating rate debentures evolve from 2023 to 2024, particularly in terms of the principal amount and maturity structure?",
      "original_answer": "In 2023, NextEra Energy Capital Holdings disclosed the sale of $600 million in floating rate debentures due in 2026. By 2024, the company formalized this issuance through an Officer's Certificate dated January 31, 2024, specifying the Floating Rate Debentures, Series due January 29, 2026. While the principal amount was not explicitly updated in 2024, the maturity structure remained consistent with the 2026 horizon, indicating a focused strategy on short-to-medium-term floating rate debt. This reflects a continuation of the prior year's approach without significant expansion or restructuring of the floating rate debenture program.",
      "llm_answer": "From 2023 to 2024, NextEra Energy Capital Holdings expanded its floating‑rate debenture program with a focus on shorter‑to‑mid‑term maturities and a larger principal footprint. In January 2024 it issued $3.8 billion of fixed‑rate debentures (4.90%–5.55%) maturing 2026‑2054, and concurrently issued $600 million of floating‑rate debentures due 2026. Subsequent 2024 filings added a $4.85% debenture series due 2028 and a floating‑rate series also due 2028, while the 2025‑2029 series (4.85%–5.45%) and the 2029‑2034 series (5.25%–5.55%) were rolled out through mid‑2024. Overall, the strategy shifted toward issuing more floating‑rate notes with maturities clustered around 2026‑2029 and extending longer‑dated fixed‑rate series to 2034‑2054, increasing total outstanding floating‑rate principal to roughly $600 million plus additional floating‑rate tranches in 2024.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "NEE_10k_2023.pdf",
          "target_page": 105,
          "pages": [
            103,
            104,
            105,
            106,
            107
          ]
        },
        "hop_2_rel": {
          "source_file": "NEE_10k_2024.pdf",
          "target_page": 121,
          "pages": [
            119,
            120,
            121,
            122,
            123
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 120951,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 30470,
        "completion_tokens": 216,
        "total_tokens": 30686
      }
    },
    {
      "question_id": 31,
      "question": "How has Intel's approach to industry initiatives related to supply chain responsibility evolved from 2023 to 2024, particularly in terms of collaboration focus and supplier engagement scope?",
      "original_answer": "In 2023, Intel announced a significant expansion of its supplier engagement activities under its RISE strategy, aiming to increase the number of suppliers covered in sustainability and compliance programs, and set a goal to achieve net-zero upstream Scope 3 greenhouse gas emissions by 2050. By 2024, Intel's approach evolved to emphasize broader collaboration on responsible minerals sourcing and transparency around climate and water impacts, with a continued focus on capability-building programs for suppliers but without explicit mention of expanding the number of suppliers engaged. The shift indicates a move from announcing strategic expansions to reinforcing and deepening existing industry partnerships.",
      "llm_answer": "From 2023 to 2024, Intel’s supply chain responsibility focus shifted from broad industry coalition-building toward more targeted supplier engagement and expanded diversity commitments. While continuing its RISE strategy collaborations (e.g., Alliances for Global Inclusion), the company significantly broadened its supplier diversity goals—aiming for $2 billion in annual spending with diverse suppliers by 2030—and deepened efforts to address forced‑labor risks, human‑rights oversight, and responsible minerals sourcing across its global supply chain. This evolution reflects a tighter integration of inclusion metrics into supplier programs and a more structured, accountable approach to managing upstream environmental and social impacts.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "INTC_10k_2023.pdf",
          "target_page": 20,
          "pages": [
            18,
            19,
            20,
            21,
            22
          ]
        },
        "hop_2_rel": {
          "source_file": "INTC_10k_2024.pdf",
          "target_page": 13,
          "pages": [
            11,
            12,
            13,
            14,
            15
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 50242,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 12792,
        "completion_tokens": 185,
        "total_tokens": 12978
      }
    },
    {
      "question_id": 32,
      "question": "How has the characterization of the assumptions underlying the standardized measure of discounted future cash flows evolved between XOM's 2022 and 2023 disclosures, particularly regarding the company's framing of its dependency on first-day-of-the-month average prices?",
      "original_answer": "In XOM's 2022 filing, the standardized measure of discounted future cash flows was described as being 'prepared on the basis of certain prescribed assumptions,' which included first-day-of-the-month average prices. This framing emphasized that the assumptions were foundational to the calculation but did not explicitly highlight the degree of dependency on them. In contrast, the 2023 filing reflects a shift in tone by emphasizing that the standardized measure 'depends on' these prescribed assumptions, particularly first-day-of-the-month average prices, which are described as discrete points in time that 'may cause significant variability in cash flows from year to year as prices change.' This indicates a more explicit acknowledgment of the sensitivity and dependency of the measure on these assumptions, even though the actual calculation methodology remained unchanged, using the same 10 percent discount factor, year-end costs, and legislated tax rates.",
      "llm_answer": "The characterization of the assumptions underlying the standardized measure of discounted future cash flows has evolved from emphasizing first‑day‑of‑the‑month average prices and year‑end costs in 2022 to explicitly noting that such discrete price points can cause significant year‑to‑year variability in cash‑flow estimates in 2023, while still applying the same 10 % discount factor and net‑proved‑reserve basis. Consequently, ExxonMobil’s 2023 disclosure underscores the potential for greater cash‑flow volatility due to changing average prices, whereas the 2022 filing presented the standardized measure without highlighting this source of variability.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "XOM_10k_2022.pdf",
          "target_page": 141,
          "pages": [
            128,
            129,
            130,
            131,
            132
          ]
        },
        "hop_2_rel": {
          "source_file": "XOM_10k_2023.pdf",
          "target_page": 133,
          "pages": [
            131,
            132,
            133,
            134,
            135
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 85652,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 21666,
        "completion_tokens": 164,
        "total_tokens": 21830
      }
    },
    {
      "question_id": 32,
      "question": "How has MA's digital identity solutions evolved between 2022 and 2023, particularly in terms of their integration with open banking capabilities and reach across financial institutions?",
      "original_answer": "In 2022, MA introduced its digital identity solutions as part of an open banking platform that enabled data providers and third parties to access consumer data on a permissioned basis, aiming to improve customer experience and financial inclusion. The platform leveraged data principles such as consumer protection and consent management, and it focused on identity verification across people, devices, and transactions. In 2023, MA expanded its open banking capabilities, achieving connectivity to over 95% of deposit accounts in the U.S. and approximately 3,000 banks across Europe, which significantly enhanced the reach and application of its digital identity solutions. Additionally, in 2023, MA partnered with leading financial institutions to launch an ACH payment solution using its open banking infrastructure, indicating a deeper integration of digital identity within broader financial services.",
      "llm_answer": "Between 2022 and 2023, Mastercard expanded its open banking platform to connect over 95% of U.S. deposit accounts and roughly 3,000 European banks, embedding it within its broader digital identity and data infrastructure. This integration enabled seamless, secure consumer data sharing and enhanced payment experiences, while its digital identity solutions—leveraging Ekata’s acquisition and AI-driven verification—strengthened authentication across people, devices, and transactions, supporting financial inclusion and fraud prevention. The company also deepened its DEI focus, tying executive compensation to gender pay equity metrics and expanding initiatives like its neurodiversity hiring program.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MA_10k_2022.pdf",
          "target_page": 17,
          "pages": [
            15,
            16,
            17,
            18,
            19
          ]
        },
        "hop_2_rel": {
          "source_file": "MA_10k_2023.pdf",
          "target_page": 17,
          "pages": [
            15,
            16,
            17,
            18,
            19
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 9,
        "total_chars": 34705,
        "num_window_pages": 9,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 8906,
        "completion_tokens": 175,
        "total_tokens": 9081
      }
    },
    {
      "question_id": 32,
      "question": "How has Tesla's approach to the Solar Roof product evolved between 2023 and 2024, particularly in terms of production challenges and strategic dependencies?",
      "original_answer": "In 2023, Tesla emphasized the engineering and design maturity of the Solar Roof, highlighting its aesthetic appeal, durability, and integration with Powerwall. The company positioned Solar Roof as a customized solution within its broader energy product suite. However, by 2024, Tesla acknowledged that the production ramp of Solar Roof faced delays similar to those experienced with other products. The 2024 filing also noted that the company's future success 'depends in large part' on scaling mass-market vehicle production, which indirectly signals a potential strategic prioritization shift that could affect Solar Roof's development and deployment timelines.",
      "llm_answer": "Tesla’s Solar Roof strategy shifted from a standalone residential product to an integrated offering tightly coupled with its energy storage and vehicle charging ecosystem. Production challenges persist due to complex glass‑tile manufacturing and supply‑chain constraints, while the company increasingly depends on its proprietary battery‑cell development and local manufacturing (e.g., new Gigafactories in Mexico and Europe) to meet cost and volume goals. Consequently, Solar Roof’s growth is now closely tied to Tesla’s broader battery‑cell supply strategy and its ability to scale new factories without disrupting vehicle or energy‑storage production.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "TSLA_10k_2023.pdf",
          "target_page": 7,
          "pages": [
            5,
            6,
            7,
            8,
            9
          ]
        },
        "hop_2_rel": {
          "source_file": "TSLA_10k_2024.pdf",
          "target_page": 17,
          "pages": [
            15,
            16,
            17,
            18,
            19
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 46089,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 11744,
        "completion_tokens": 163,
        "total_tokens": 11908
      }
    },
    {
      "question_id": 32,
      "question": "How has NextEra Energy, Inc.'s use of Pledge Agreements evolved between 2023 and 2024, particularly in terms of the dates and counterparties involved?",
      "original_answer": "In 2023, NextEra Energy, Inc. disclosed a Pledge Agreement dated September 1, 2022, involving Deutsche Bank Trust Company Americas and The Bank of New York Mellon. By 2024, the company introduced two new Pledge Agreements dated June 1, 2024, and October 1, 2024, with the same counterparties. This indicates an evolution in the structure and timing of these agreements, expanding their use over time.",
      "llm_answer": "Based on the provided document pages, NextEra Energy, Inc.'s use of Pledge Agreements has evolved with new agreements executed in 2024, specifically on **June 1, 2024**, and **October 1, 2024**. The June 1, 2024 Pledge Agreement involves **The Bank of New York Mellon** as the Purchase Contract Agent, while the October 1, 2024 Pledge Agreement involves the same agent and **Deutsche Bank Trust Company Americas** as Collateral Agent, Custodial Agent, and Securities Intermediary. These agreements are referenced in the 2024 filings (Form 10-Q for the quarter ended June 30, 2024, and Form 10-K for the year ended December 31, 2024), indicating a continuation and expansion of the Pledge Agreement structure with new counterparties and dates.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "NEE_10k_2023.pdf",
          "target_page": 121,
          "pages": [
            114,
            115,
            116,
            117,
            118
          ]
        },
        "hop_2_rel": {
          "source_file": "NEE_10k_2024.pdf",
          "target_page": 123,
          "pages": [
            121,
            122,
            123,
            124,
            125
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 102733,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 25907,
        "completion_tokens": 185,
        "total_tokens": 26092
      }
    },
    {
      "question_id": 32,
      "question": "How has Intel's strategic positioning in Edge AI evolved from 2023 to 2024, particularly in terms of its software platform offerings and ecosystem partnerships?",
      "original_answer": "In 2023, Intel emphasized its edge-native software platform with modular building blocks, premium services, and support offerings, aiming to enable developers to build, deploy, run, manage, connect, and secure distributed edge infrastructure and Edge AI across multiple verticals. The platform was described as a horizontal approach to scaling infrastructure for intelligent edge and hybrid AI, supporting diverse architectures and avoiding vendor lock-in. By 2024, Intel's strategy had evolved under its NEX initiative, which aimed to transform networks and edge compute systems from fixed-function hardware to general-purpose compute, acceleration, and networking devices running cloud-native software on programmable hardware. Intel highlighted broader ecosystem partnerships and a focus on rapid digital transformation from cloud to edge, leveraging core strengths in compute, connectivity, software, and large-scale manufacturing. This shift indicates a more integrated and scalable approach to Edge AI, with a stronger emphasis on cloud-native programmability and collaboration with partners to drive automation and secure data integrity at the edge.",
      "llm_answer": "From 2023 to 2024, Intel’s Edge AI strategy evolved through expanded software platforms and ecosystem partnerships. In 2024, the company emphasized AI-enabled compute and connectivity at the edge, launching updated processors (e.g., 4th Gen Xeon with vRAN Boost, Xeon D-1800/2800 series) and software tools like OpenVINO 2023.1 to accelerate edge AI deployment across industries. This included deeper collaboration with ecosystem partners (e.g., Ericsson, Nokia, Cisco, Dell, Microsoft) to drive software-defined networking and edge infrastructure adoption, while also advancing AI-specific hardware like the Intel Gaudi 3 AI accelerators and Jaguar Shores GPU accelerator. The focus shifted toward enabling developers to build, deploy, and manage distributed edge AI workloads through integrated hardware-software solutions, positioning Intel as a key player in the cloud-to-edge infrastructure transformation.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "INTC_10k_2023.pdf",
          "target_page": 31,
          "pages": [
            29,
            30,
            31,
            32,
            33
          ]
        },
        "hop_2_rel": {
          "source_file": "INTC_10k_2024.pdf",
          "target_page": 18,
          "pages": [
            16,
            17,
            18,
            19,
            20
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 44515,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 11353,
        "completion_tokens": 227,
        "total_tokens": 11581
      }
    },
    {
      "question_id": 32,
      "question": "How did the composition and value of CVS's long-term debt related to senior notes due in 2030 evolve between 2023 and 2024, particularly regarding the 1.75% senior notes due August 2030?",
      "original_answer": "In 2023, the 1.75% senior notes due August 2030 had a value of $1,250 million. In 2024, this value remained unchanged at $1,250 million. However, other senior notes due in 2030, such as the 3.75% senior notes due April 2030, decreased from $1,500 million in 2023 to $1,500 million in 2024, indicating stability in some areas of long-term debt but no change in the 1.75% notes specifically.",
      "llm_answer": "Based on the provided pages, CVS's long-term debt related to the 1.75% senior notes due August 2030 remained unchanged at $1,250 million during both 2023 and 2024, as shown in the 2023 and 2024 borrowings tables (page 168 and page 162). The company continued to hold this specific tranche of debt without any reported issuance, repayment, or modification between these years.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CVS_10k_2023.pdf",
          "target_page": 168,
          "pages": [
            166,
            167,
            168,
            169,
            170
          ]
        },
        "hop_2_rel": {
          "source_file": "CVS_10k_2024.pdf",
          "target_page": 161,
          "pages": [
            159,
            160,
            161,
            162,
            163
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 32417,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 8337,
        "completion_tokens": 93,
        "total_tokens": 8431
      }
    },
    {
      "question_id": 33,
      "question": "How did Netflix's ad-supported subscription plan evolve between 2023 and 2024 in terms of its role within the company's pricing strategy and membership growth objectives?",
      "original_answer": "In 2023, Netflix introduced the ad-supported subscription plan as a new, lower-priced option aimed at expanding its membership base and addressing competitive pressures by offering a more accessible entry point. This was part of broader efforts to adjust pricing models and membership plans to improve value perception. By 2024, the ad-supported plan had become a core component of Netflix's pricing strategy, explicitly included in a range of plans designed to meet varied consumer needs, indicating its integration into the company's long-term growth framework. This evolution reflects a shift from experimental pricing to a strategic offering intended to support sustained membership growth across different market segments.",
      "llm_answer": "Between 2023 and 2024, Netflix’s ad-supported subscription plan transitioned from a nascent offering to a core component of its pricing strategy, explicitly positioned to accelerate membership growth and broaden market reach. The company highlighted that the plan’s lower price point directly supports its objective of increasing subscriber additions, particularly in price-sensitive markets, while maintaining profitability through targeted advertising revenue. This strategy aligns with its broader goal of driving seasonal membership growth—especially in Q4—and reinforcing its competitive position against rivals by offering a differentiated, affordable option that expands its addressable audience without cannibalizing higher-tier plans. (Based on strategic emphasis in 2024 filings and prior-year context of testing the model.)",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "NFLX_10k_2023.pdf",
          "target_page": 6,
          "pages": [
            4,
            5,
            6,
            7,
            8
          ]
        },
        "hop_2_rel": {
          "source_file": "NFLX_10k_2024.pdf",
          "target_page": 3,
          "pages": [
            1,
            2,
            3,
            4,
            5
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 49773,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 12667,
        "completion_tokens": 208,
        "total_tokens": 12876
      }
    },
    {
      "question_id": 33,
      "question": "How has Tesla's approach to the Tesla Semi evolved between 2023 and 2024, based on its production status and strategic positioning?",
      "original_answer": "In 2023, Tesla stated that it had begun early production and deliveries of the Tesla Semi, indicating initial market introduction and limited availability. By 2024, Tesla's production status for the Tesla Semi had advanced to 'pilot production' at its Nevada facility, suggesting a more structured and expanded phase of manufacturing, though not yet full-scale commercial production. This evolution reflects Tesla's strategic progression from initial rollout to a more mature testing and scaling phase for the commercial electric vehicle.",
      "llm_answer": "Based on the provided 10-K filings, Tesla's approach to the Semi has evolved from pilot production (noted in the 2023 filing as \"Nevada: Tesla Semi – Pilot production\") to active development and integration into its broader strategy, as evidenced by its inclusion in 2024 production planning (\"Nevada: Tesla Semi – Pilot production\" remains active) and emphasis on new vehicle launches like the Cybercab and next-generation platforms. The company continues to advance the Semi's development alongside other new models, leveraging its manufacturing expansion and battery technology improvements to support production ramp-ups, though specific production milestones or revenue contributions from the Semi are not detailed in the provided excerpts.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "TSLA_10k_2023.pdf",
          "target_page": 5,
          "pages": [
            3,
            4,
            5,
            6,
            7
          ]
        },
        "hop_2_rel": {
          "source_file": "TSLA_10k_2024.pdf",
          "target_page": 36,
          "pages": [
            34,
            35,
            36,
            37,
            38
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 36694,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 9389,
        "completion_tokens": 186,
        "total_tokens": 9575
      }
    },
    {
      "question_id": 33,
      "question": "What does the expansion of NextEra Energy's Executive Retention Employment Agreements from 2023 to 2024 suggest about the company's approach to leadership continuity and its strategic emphasis on executive talent retention?",
      "original_answer": "In 2023, NextEra Energy had active Executive Retention Employment Agreements with executives including Mark Lemasney (signed January 1, 2023) and Armando Pimentel, Jr. (signed February 15, 2023), indicating a focus on retaining key leadership at that time. By 2024, the company not only maintained those agreements but also introduced a new agreement with Brian Bolster, dated May 6, 2024, showing an expansion in the number of covered executives. This evolution suggests that NextEra Energy has placed increasing strategic importance on securing leadership continuity and minimizing executive turnover risk, particularly during periods of potential transition or uncertainty. The addition of new executives under retention agreements implies a proactive approach to talent management, which could signal confidence in leadership or a response to external pressures affecting executive mobility.",
      "llm_answer": "The expansion of NextEra Energy's Executive Retention Employment Agreements from 2023 to 2024—evidenced by the addition of new agreements with executives like Brian Bolster (May 2024) and the inclusion of updated retention terms in the 2024 proxy filing—demonstrates the company’s deliberate focus on securing leadership continuity. By extending and broadening these agreements, NextEra underscores its strategic emphasis on retaining key executive talent to sustain its growth trajectory and oversee the execution of its long‑term capital projects and regulatory initiatives.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "NEE_10k_2023.pdf",
          "target_page": 123,
          "pages": [
            114,
            115,
            116,
            117,
            118
          ]
        },
        "hop_2_rel": {
          "source_file": "NEE_10k_2024.pdf",
          "target_page": 125,
          "pages": [
            123,
            124,
            125,
            126,
            127
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 94595,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 23891,
        "completion_tokens": 144,
        "total_tokens": 24035
      }
    },
    {
      "question_id": 33,
      "question": "How has Intel's approach to xPU products evolved from 2023 to 2024, particularly in terms of strategic focus and product development priorities?",
      "original_answer": "In 2023, Intel's focus on xPU products was part of a broader R&D strategy that included process and packaging technology, AI, and software, with $16.0 billion spent on R&D. The company faced challenges in timely product development and manufacturing process introductions, which had previously caused delays and cost overruns. By 2024, Intel had evolved its approach by embedding xPU products more deeply into its strategic priorities, specifically under the theme of 'product competitiveness.' The company announced the creation of an advisory group to expand the x86 ecosystem and emphasized the xPU family of products—including client and data center GPUs, IPUs, FPGAs, and other accelerators—as a way to meet diverse computing needs. This represents a shift from a general R&D focus to a more structured and strategic product development initiative.",
      "llm_answer": "From 2023 to 2024, Intel’s xPU strategy shifted from broad product expansion toward tighter integration with its IDM 2.0 foundry model and open‑platform initiatives. In 2023 the company emphasized a diversified xPU portfolio (GPUs, IPUs, FPGAs) to capture growth in AI, edge and networking, while 2024 focused on leveraging its internal foundry capacity, advancing the x86 ecosystem via an advisory group, and using Smart Capital to fund capacity and R&D, underscoring a strategic pivot to scale xPU offerings through its own manufacturing and ecosystem partnerships.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "INTC_10k_2023.pdf",
          "target_page": 51,
          "pages": [
            49,
            50,
            51,
            52,
            53
          ]
        },
        "hop_2_rel": {
          "source_file": "INTC_10k_2024.pdf",
          "target_page": 5,
          "pages": [
            3,
            4,
            5,
            6,
            7
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 9,
        "total_chars": 53033,
        "num_window_pages": 9,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 13477,
        "completion_tokens": 141,
        "total_tokens": 13619
      }
    },
    {
      "question_id": 34,
      "question": "How has Netflix's approach to advertising technology evolved between 2023 and 2024, particularly in terms of organizational development and infrastructure investment?",
      "original_answer": "In 2023, Netflix emphasized its limited experience with advertising and outlined several dependencies, particularly on third-party service providers for ad management and the need to attract and retain advertisers. The company also highlighted risks related to developing the necessary advertising technology infrastructure. By 2024, Netflix shifted toward a more proactive stance, emphasizing its ability to 'develop and expand an advertising sales and advertising technology organization team' and 'develop the technology and related infrastructure to support advertising and drive value to advertisers.' This indicates a strategic evolution from reliance on external providers to internal development and investment in ad tech capabilities.",
      "llm_answer": "Netflix’s advertising technology strategy has shifted from a nascent, risk‑laden pilot in 2023 to a more structured, infrastructure‑focused initiative by 2024.  In the 2023 filing the company highlighted “limited experience” and a host of uncertainties around ad‑sales organization, measurement tools, and member acceptance, warning that any failure could impair revenue growth.  By 2024 the same risk section emphasizes the need to “develop and expand an advertising sales and advertising technology organization team” and to build the “technology and related infrastructure to support advertising,” indicating that the firm has moved beyond early‑stage experimentation and is now investing in dedicated ad‑tech platforms, data‑analytics capabilities, and partner integrations to scale its ad business.  This evolution reflects a deliberate organizational development—creating a dedicated ad‑sales team and associated tech stack—paired with capital investment in scalable, secure infrastructure (e.g., cloud, CDN, and recommendation systems) to support a growing ad‑supported subscription tier.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "NFLX_10k_2023.pdf",
          "target_page": 10,
          "pages": [
            8,
            9,
            10,
            11,
            12
          ]
        },
        "hop_2_rel": {
          "source_file": "NFLX_10k_2024.pdf",
          "target_page": 10,
          "pages": [
            8,
            9,
            10,
            11,
            12
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 62892,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 15948,
        "completion_tokens": 273,
        "total_tokens": 16221
      }
    },
    {
      "question_id": 34,
      "question": "How has Tesla's approach to free Supercharging programs evolved between 2023 and 2024, particularly in terms of revenue recognition and program structure?",
      "original_answer": "In 2023, Tesla's free Supercharging programs were included under Automotive Sales Revenue as part of the revenue associated with new vehicle deliveries, indicating they were bundled with vehicle sales and recognized over time. By 2024, Tesla began deferring revenue related to features such as FSD (Supervised), internet connectivity, and free Supercharging, recognizing these as liabilities to be amortized over time rather than immediately upon vehicle delivery. This structural shift reflects a more formalized and segmented approach to monetizing these features, including free Supercharging, which allows Tesla to better align revenue recognition with service delivery.",
      "llm_answer": "Tesla’s approach to free Supercharging has shifted from recognizing revenue over the expected vehicle ownership period (as disclosed in 2023) to recognizing it based on actual usage or expiration, whichever occurs first, and only when the performance obligation is satisfied. In 2024, the company explicitly states that other limited free Supercharging incentives are recognized based on actual usage or expiration, reflecting a more usage-driven revenue model rather than straight-line recognition over the vehicle’s life. This change aligns with updated ASC 606 guidance and impacts how revenue from these programs is measured and recognized in the financial statements.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "TSLA_10k_2023.pdf",
          "target_page": 39,
          "pages": [
            37,
            38,
            39,
            40,
            41
          ]
        },
        "hop_2_rel": {
          "source_file": "TSLA_10k_2024.pdf",
          "target_page": 58,
          "pages": [
            56,
            57,
            58,
            59,
            60
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 50799,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 12922,
        "completion_tokens": 168,
        "total_tokens": 13090
      }
    },
    {
      "question_id": 34,
      "question": "How has NextEra Energy's approach to issuing Series O Junior Subordinated Debentures evolved between 2023 and 2024, particularly in terms of coupon structure and maturity dates, and what might this shift indicate about their financing strategy?",
      "original_answer": "In 2023, NextEra Energy issued the Series O Junior Subordinated Debentures due on May 1, 2079, with no explicit coupon rate disclosed in the filing. This indicates a potentially fixed or deferred interest structure typical for long-dated junior subordinated instruments. By 2024, the Series O Debentures were issued with a defined coupon rate of 5.55% and a significantly shorter maturity date of November 1, 2029. This represents a strategic shift toward issuing more conventional debt instruments with shorter durations and clearly defined interest costs. This evolution suggests a possible recalibration of NextEra’s capital structure strategy, favoring shorter-term, more predictable financing over long-dated, potentially lower-yielding instruments.",
      "llm_answer": "NextEra Energy's recent debt issuances show a clear shift toward longer‑dated, fixed‑rate subordinated securities. In 2023 the company issued 4.45% Notes due 2026 and Floating Rate Notes due 2073, and in early 2024 it launched the Series O Junior Subordinated Debentures due 2029 with a 4.85% coupon and a floating‑rate tranche due 2028. These moves extend maturity horizons (many series now run to 2030‑2055) and lock in relatively stable coupon rates, reflecting a strategy to diversify funding sources, reduce reliance on short‑term floating‑rate markets, and secure low‑cost capital for growth projects while maintaining a strong balance sheet.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "NEE_10k_2023.pdf",
          "target_page": 120,
          "pages": [
            114,
            115,
            116,
            117,
            118
          ]
        },
        "hop_2_rel": {
          "source_file": "NEE_10k_2024.pdf",
          "target_page": 121,
          "pages": [
            119,
            120,
            121,
            122,
            123
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 137893,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 34720,
        "completion_tokens": 162,
        "total_tokens": 34882
      }
    },
    {
      "question_id": 35,
      "question": "How has ExxonMobil's consideration of OPEC investment activities evolved in its impairment assessment framework from 2022 to 2023, particularly in relation to long-term oil supply dynamics?",
      "original_answer": "In 2022, ExxonMobil explicitly stated that OPEC investment activities and production policies had an impact on world oil supplies and were considered in the context of impairment assessments. By 2023, while the company still acknowledged OPEC's influence on global oil supply, the discussion of OPEC was embedded more broadly within a comprehensive cash flow assessment framework that included forward-looking variables such as greenhouse gas emission costs and net-zero targets. This indicates a shift from a direct focus on OPEC's role to a more integrated view of macroeconomic and environmental factors affecting long-term asset valuation.",
      "llm_answer": "ExxonMobil’s impairment assessment framework has evolved from a 2022 focus on monitoring long‑term oil‑price and margin trends, reserve volumes, and development plans to a 2023 approach that explicitly incorporates the Corporation’s Energy Outlook and greenhouse‑gas emission‑reduction targets into cash‑flow projections, while still relying on unit‑of‑production depreciation and straight‑line methods when reserve volumes or asset lives diverge from economic expectations. This shift reflects a more integrated view of long‑term supply dynamics, including OPEC policy impacts and climate‑related cost assumptions, in evaluating potential asset impairments.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "XOM_10k_2022.pdf",
          "target_page": 94,
          "pages": [
            92,
            93,
            94,
            95,
            96
          ]
        },
        "hop_2_rel": {
          "source_file": "XOM_10k_2023.pdf",
          "target_page": 88,
          "pages": [
            86,
            87,
            88,
            89,
            90
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 8,
        "total_chars": 41520,
        "num_window_pages": 8,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 10611,
        "completion_tokens": 164,
        "total_tokens": 10775
      }
    },
    {
      "question_id": 35,
      "question": "How has Netflix's approach to its ad-supported subscription plan evolved from 2023 to 2024, based on the level of detail and strategic emphasis provided in the filings?",
      "original_answer": "In 2023, Netflix's ad-supported subscription plan was mentioned in the context of uncertainty and risk, particularly around consumer adoption and the lack of operating history with such offerings, which could lead to discrepancies between forecasts and actual results. By 2024, the ad-supported plan was presented as part of the company's broader pricing strategy, explicitly included in the description of plans offered to meet a variety of consumer needs. This shift indicates a move from a risk-focused perspective to a more confident, strategic positioning of the ad-supported plan as a core part of Netflix's business model.",
      "llm_answer": "From 2023 to 2024, Netflix’s ad‑supported subscription plan has been positioned as a core growth lever within its broader strategy to expand pricing flexibility and attract price‑sensitive viewers.  The 2023 filing emphasizes the plan’s role in “offering a range of pricing plans, including our ad‑supported subscription plan, to meet a variety of consumer needs,” while the 2024 filing expands this focus, describing the ad tier as a “key driver of membership growth” and highlighting ongoing efforts to refine its pricing, ad inventory and user experience to further boost adoption.  Consequently, the company has shifted from merely acknowledging the ad‑supported tier to treating it as a strategic priority with more detailed operational and financial emphasis.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "NFLX_10k_2023.pdf",
          "target_page": 18,
          "pages": [
            16,
            17,
            18,
            19,
            20
          ]
        },
        "hop_2_rel": {
          "source_file": "NFLX_10k_2024.pdf",
          "target_page": 3,
          "pages": [
            1,
            2,
            3,
            4,
            5
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 40414,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 10328,
        "completion_tokens": 191,
        "total_tokens": 10520
      }
    },
    {
      "question_id": 35,
      "question": "How has Amazon's approach to shipping offers evolved between 2022 and 2024, particularly in terms of cost drivers and strategic focus on fulfillment efficiency?",
      "original_answer": "In 2022, Amazon highlighted that shipping costs were expected to increase as customers increasingly adopted its shipping offers, used faster delivery methods, and as the company expanded its fulfillment network. Shipping costs in 2021 were $76.7 billion, and the company anticipated continued growth in these costs. The strategic emphasis was on mitigating these increases through higher sales volumes, network optimization, supplier negotiations, and operational efficiencies. By 2024, the focus had shifted: while the company still invested in expanding its fulfillment network, it emphasized fulfillment network efficiencies as a key cost offset. The 2024 report notes that increased sales and network investments drove up fulfillment costs, but these were partially offset by efficiency gains. This marks a strategic evolution from a customer-driven cost increase in 2022 to a more operations-centric efficiency focus by 2024.",
      "llm_answer": "Amazon’s shipping-related costs have risen steadily, but the company has focused on improving fulfillment efficiency to offset those pressures. In 2022, fulfillment expenses grew 28% year‑over‑year, driven by higher wages, carrier rates, and network inefficiencies, while by 2024 the growth slowed to 9% and the fulfillment cost‑to‑sales ratio actually declined slightly (from 15.2% to 15.4% of net sales). This reflects Amazon’s strategic shift toward scaling its fulfillment network and leveraging economies of scale—such as higher sales volumes, optimized routing, and better supplier terms—to keep shipping costs from eroding margins, even as it continues to offer fast, low‑price shipping options.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AMZN_10k_2022.pdf",
          "target_page": 25,
          "pages": [
            23,
            24,
            25,
            26,
            27
          ]
        },
        "hop_2_rel": {
          "source_file": "AMZN_10k_2024.pdf",
          "target_page": 26,
          "pages": [
            24,
            25,
            26,
            27,
            28
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 48616,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 12378,
        "completion_tokens": 175,
        "total_tokens": 12554
      }
    },
    {
      "question_id": 35,
      "question": "How did Duke Energy's utilization and reporting of the Master Retirement Trust evolve between 2023 and 2024, particularly in terms of asset allocation and disclosure practices?",
      "original_answer": "In 2023, Duke Energy's Master Retirement Trust was described in terms of its investment objective, focusing on achieving sufficient returns for plan benefits, with specific mention of VEBA trusts and their target and actual asset allocations. By 2024, the reporting evolved to include a more detailed breakdown of how different subsidiaries were allocated portions of the trust, such as Duke Energy Progress at 15% and Duke Energy Florida at 18%. Additionally, 2024 introduced a reconciliation of beginning and ending balances for pension and post-retirement assets, including Level 3 fair value disclosures, which was not present in 2023. This reflects a shift toward more granular and transparent reporting on trust assets and their valuation methodologies.",
      "llm_answer": "Between 2023 and 2024, Duke Energy's Master Retirement Trust saw a shift in asset allocation and disclosure practices. The 2024 target allocation increased equity exposure to 45% (from 45% in 2023) and slightly reduced debt securities to 33% (from 35%), while maintaining similar hedge fund and real estate allocations. Disclosure practices remained consistent, with the same 27%/33%/15%/18%/5%/7%/3% subsidiary allocation percentages used for both years, and Level 3 assets (primarily partnership interests and hedge funds) continuing to be reported separately in the fair value hierarchy. The 2024 reconciliation shows a decrease in Level 3 assets from $76M to $68M, reflecting net losses and transfers.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "DUK_10k_2023.pdf",
          "target_page": 218,
          "pages": [
            216,
            217,
            218,
            219,
            220
          ]
        },
        "hop_2_rel": {
          "source_file": "DUK_10k_2024.pdf",
          "target_page": 228,
          "pages": [
            226,
            227,
            228,
            229,
            230
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 66639,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 16890,
        "completion_tokens": 176,
        "total_tokens": 17066
      }
    },
    {
      "question_id": 36,
      "question": "How has Google's financial relationship with Google Network Partners evolved between 2022 and 2024, particularly in terms of the cost structure and payment obligations?",
      "original_answer": "In 2022, Google's cost of revenues included significant Traffic Acquisition Costs (TAC) paid to Google Network partners, primarily for ads displayed on their properties, with a noted higher cost percentage compared to Google Search properties due to the substantial share of advertiser revenues paid out as TAC. By 2024, Google Network partners were referenced in the context of operating cash outflows, indicating that payments to these partners had become a primary use of operating cash. This shift suggests a transformation in the nature of the financial relationship, from a cost-of-revenue model to a more direct operational cash flow obligation, reflecting a potential increase in the scale or structure of Google's dependency on these partners.",
      "llm_answer": "Between 2022 and 2024, Google's financial relationship with Google Network Partners remained characterized by the same cost structure and payment obligations described in the 2022 and 2024 10-K filings. The company continues to pay Network Partners a significant portion of advertising revenue—specifically, amounts paid to Google Network partners are included in cost of revenues and are presented as financing activities in the cash flow statement. While the 2024 filing notes increased share repurchases and dividend payments, it does not indicate any structural change to the Network Partner payment model; the cost of these payments continues to be reported as part of cost of revenues, with no shift in the underlying contractual obligations or payment percentages relative to prior years. The company's cash flow from operations, which funds these payments, grew from $101.7B (2023) to $125.3B (2024), supporting ongoing Network Partner payments without altering the fundamental cost structure.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "GOOGL_10k_2022.pdf",
          "target_page": 32,
          "pages": [
            30,
            31,
            32,
            33,
            34
          ]
        },
        "hop_2_rel": {
          "source_file": "GOOGL_10k_2024.pdf",
          "target_page": 42,
          "pages": [
            40,
            41,
            42,
            43,
            44
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 44557,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 11366,
        "completion_tokens": 250,
        "total_tokens": 11616
      }
    },
    {
      "question_id": 36,
      "question": "How did the treatment and financial impact of offsetting swap positions evolve between 2022 and 2023, particularly in terms of fair value changes and settlements reported in the consolidated income?",
      "original_answer": "In 2022, UPS reported fair value changes and settlements of interest rate swaps, foreign currency exchange forwards, and investment market price forward contracts not designated as hedges, with specific figures for 2021 and 2020 provided (e.g., $163M net gain in 2021 and $124M net gain in 2020). In 2023, the company continued to report these derivatives at fair value with unrealized gains and losses in earnings, but the disclosure now included data for 2023 and 2022, showing a shift in focus to more recent periods. The explicit mention of terminating contracts or entering into offsetting swap positions remained consistent, but the financial impact in 2023 was not quantified in the excerpt, indicating a change in transparency around current-year derivative impacts.",
      "llm_answer": "Between 2022 and 2023, the treatment of offsetting swap positions evolved in terms of accounting recognition and financial impact as follows:\n\n1.  **Fair Value Hedge Accounting**: For designated interest rate swaps used as fair value hedges, the gain or loss on the hedged item (e.g., long-term debt) and the gain or loss on the derivative (e.g., interest rate contracts) are recorded in the same line item of the income statement (e.g., interest expense). In 2023, the gain on the hedged item was $0, while the derivative gain was $(11) million, resulting in a net gain of $(11) million in interest expense. This contrasts with 2022, where the hedged item had a gain of $11 million and the derivative had a loss of $(11) million, resulting in a net gain of $0 in interest expense. This indicates that the offsetting gains and losses were fully recognized in income but shifted in timing and presentation between years.\n\n2.  **Cash Flow Hedge Accounting**: For designated cash flow hedges (e.g., foreign currency exchange contracts), the gain or loss reclassified from AOCI to income is recognized in the same period as the hedged forecasted transaction. In 2023, $213 million was reclassified from AOCI to revenue and $(10) million to interest expense, compared to $304 million and $(10) million in 2022, respectively. This reflects a decrease in the amount reclassified, likely due to changes in the effectiveness of the hedges or the termination of certain hedge relationships. The actual amount reclassified over the next 12 months is expected to be approximately $62 million pre-tax, but will vary with market conditions.\n\n3.  **Non-Designated Derivatives**: For derivatives not designated as hedges (e.g., foreign currency exchange contracts), the gain or loss from fair value changes is recognized directly in income. In 2023, a loss of $7 million was recognized in investment income and other, compared to a loss of $69 million in 2022. This significant reduction in loss indicates that the company may have reduced its exposure to non-designated derivatives or that market movements caused smaller losses in 2023. The settlement of these derivatives (e.g., cash flows from termination) is also reflected in the consolidated statement of cash flows.\n\nOverall, the financial impact of these swap positions evolved from a more favorable net gain position in 2022 (for fair value hedges) and a larger loss in non-designated derivatives (2022) to a less favorable net loss position in 2023 (for fair value hedges) and a significantly smaller loss in non-designated derivatives (2023), reflecting changes in hedge designation, effectiveness, and market conditions. The settlements and fair value changes were consistently reported in the consolidated income statement as part of the respective line items (interest expense, revenue, or investment income and other), with the net effect impacting the bottom line.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "UPS_10k_2022.pdf",
          "target_page": 159,
          "pages": [
            136,
            137,
            138,
            139,
            140
          ]
        },
        "hop_2_rel": {
          "source_file": "UPS_10k_2023.pdf",
          "target_page": 132,
          "pages": [
            130,
            131,
            132,
            133,
            134
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 8,
        "total_chars": 38694,
        "num_window_pages": 8,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 9909,
        "completion_tokens": 728,
        "total_tokens": 10638
      }
    },
    {
      "question_id": 36,
      "question": "What does the increased prominence of the Directors' Savings Plan in Duke Energy's 2024 disclosures indicate about the company's director compensation strategy compared to 2023?",
      "original_answer": "In 2023, the Directors' Savings Plan was referenced primarily through historical amendments listed in exhibit references (e.g., Exhibit 10.12), with no detailed description of its structure or strategic role in compensation. In contrast, the 2024 filing provides a substantive description of the plan, explaining how outside directors may defer annual compensation, the phantom investment options available, and how balances are adjusted accordingly. This increased prominence indicates a shift toward emphasizing the plan as a core component of director compensation and deferral flexibility, suggesting a more strategic and transparent approach to director-level financial incentives in 2024.",
      "llm_answer": "The 2024 filing shows a markedly higher focus on the Directors' Savings Plan than in 2023, with the plan now explicitly highlighted in Item 11 (Executive Compensation) and detailed in the “Director and Officer Trading Arrangements” and “Equity Compensation Plan Information” sections. This increased prominence signals that Duke Energy is giving the Directors' Savings Plan a more central role in its director‑compensation strategy, using it to align director interests with shareholders and to provide a structured, defer‑and‑match mechanism that was less emphasized in the prior year’s disclosures.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "DUK_10k_2023.pdf",
          "target_page": 245,
          "pages": [
            243,
            244,
            245,
            246,
            247
          ]
        },
        "hop_2_rel": {
          "source_file": "DUK_10k_2024.pdf",
          "target_page": 239,
          "pages": [
            237,
            238,
            239,
            240,
            241
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 113498,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 28605,
        "completion_tokens": 150,
        "total_tokens": 28755
      }
    },
    {
      "question_id": 37,
      "question": "How has American Express's approach to developing value propositions evolved between 2022 and 2024, particularly in response to competitive pressures and changing customer behaviors?",
      "original_answer": "In 2022, American Express highlighted the challenge of developing compelling value propositions in the face of growing competition, particularly from alternative payment providers and digital wallets, which threatened to fragment customer spending and reduce the competitiveness of its offerings. The company emphasized the need to evolve its value propositions to retain relevance and attract customers amid rising Card Member rewards costs and shifting consumer preferences, especially in mobile and online payments. By 2024, the company's strategy had evolved to focus on expanding leadership in premium consumer and commercial payments, particularly targeting Millennial and Gen-Z consumers, and enhancing digital capabilities through investments in AI, automation, and the Amex app. It also emphasized the importance of strategic partnerships, dining platform expansion (including Tock and Rooam), and global merchant coverage growth as key enablers of its value proposition strategy. This represents a shift from a reactive stance on competition to a more proactive, innovation-driven approach.",
      "llm_answer": "American Express has shifted from a largely static, fee‑based value proposition to a more dynamic, partnership‑driven model that emphasizes expanding premium benefits, digital‑first experiences and broader merchant coverage.  Between 2022 and 2024 the company increasingly tied cobrand renewals and partner incentives to competitive pressures—raising reward and payment‑partner fees to secure or replace relationships—and responded to changing consumer habits (e.g., greater demand for travel, dining and digital‑wallet integration) by investing in new card product refreshes, expanded lounge and dining platforms, and AI‑enabled service tools.  This evolution is aimed at preserving its differentiated “premium consumer” positioning against rivals such as Visa and Mastercard, while mitigating the risk of losing key partner arrangements that could erode network volume and loan balances.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AXP_10k_2022.pdf",
          "target_page": 26,
          "pages": [
            24,
            25,
            26,
            27,
            28
          ]
        },
        "hop_2_rel": {
          "source_file": "AXP_10k_2024.pdf",
          "target_page": 93,
          "pages": [
            91,
            92,
            93,
            94,
            95
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 51948,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 13216,
        "completion_tokens": 222,
        "total_tokens": 13438
      }
    },
    {
      "question_id": 38,
      "question": "How has Exxon Mobil's approach to long-term debt financing evolved between 2022 and 2024, particularly regarding the composition of its long-term notes?",
      "original_answer": "In 2022, Exxon Mobil disclosed a broader range of debt instruments, including the 0.142% Notes due 2024, 0.524% Notes due 2028, 0.835% Notes due 2032, and the 1.408% Notes due 2039. By 2024, the company no longer listed the 0.142% Notes due 2024, indicating that those obligations had matured or been repaid. However, the 1.408% Notes due 2039 remained in the disclosure, suggesting a continued emphasis on long-term financing instruments with distant maturity dates. This shift reflects a strategic evolution in the company's capital structure, focusing more heavily on extended-term debt while retiring shorter-duration obligations.",
      "llm_answer": "Exxon Mobil's long-term debt financing strategy has remained consistent through 2022–2024, with its long-term notes continuing to be issued primarily through the New York Stock Exchange under the same naming conventions (e.g., 0.524% Notes due 2028, 0.835% Notes due 2032, 1.408% Notes due 2039). The company maintained a stable approach to debt maturity structure and issuance volumes, reflecting its focus on long-term financial stability rather than structural shifts in financing composition.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "XOM_10k_2022.pdf",
          "target_page": 1,
          "pages": [
            1,
            2,
            3,
            4,
            5
          ]
        },
        "hop_2_rel": {
          "source_file": "XOM_10k_2024.pdf",
          "target_page": 1,
          "pages": [
            1,
            2,
            3,
            4,
            5
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 9,
        "total_chars": 48848,
        "num_window_pages": 9,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 12431,
        "completion_tokens": 124,
        "total_tokens": 12555
      }
    },
    {
      "question_id": 38,
      "question": "How has American Express's approach to corporate card solutions evolved between 2022 and 2024, particularly in terms of strategic emphasis and product differentiation?",
      "original_answer": "In 2022, American Express emphasized evolving card value propositions and differentiating corporate card and accounts payable expense management solutions as part of its broader commercial payments strategy. By 2024, the company continued to focus on commercial payments but introduced a more integrated global network approach, aiming to increase merchant acceptance and provide enhanced fraud protection and marketing insights. This shift indicates a move from internal product development focus in 2022 to a more externally integrated ecosystem strategy by 2024.",
      "llm_answer": "Between 2022 and 2024, American Express deepened its strategic emphasis on corporate card solutions by positioning them as a core growth pillar within its broader commercial payments agenda. The company increasingly differentiated its corporate offerings through enhanced value propositions, expanded financing and expense management capabilities, and targeted innovations—such as integrated banking and payment solutions—designed to meet the evolving needs of business customers. This evolution reflects a sustained commitment to scaling high-value commercial relationships, particularly through product differentiation in corporate cards and accounts payable services, reinforcing American Express’s role as a strategic financial partner for enterprises.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AXP_10k_2022.pdf",
          "target_page": 8,
          "pages": [
            6,
            7,
            8,
            9,
            10
          ]
        },
        "hop_2_rel": {
          "source_file": "AXP_10k_2024.pdf",
          "target_page": 8,
          "pages": [
            6,
            7,
            8,
            9,
            10
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 30737,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 7908,
        "completion_tokens": 189,
        "total_tokens": 8097
      }
    },
    {
      "question_id": 38,
      "question": "How has Amazon's financial relationship with AWS Services evolved between 2022 and 2024, particularly in terms of cash flow generation and strategic emphasis?",
      "original_answer": "In 2022, AWS Services were primarily discussed in the context of competitive pressures and risks, with an emphasis on the challenges of operating in a rapidly evolving and intensely competitive market. By 2024, AWS had transitioned into a key financial contributor, with Amazon reporting $115.9 billion in operating cash flow for that year, up from $84.9 billion in 2023, driven in part by AWS and other enterprise services. This reflects a shift from viewing AWS as a risk-laden venture to a core revenue generator funding broader corporate initiatives.",
      "llm_answer": "Amazon's financial relationship with AWS Services has evolved to become a critical strategic driver of cash flow and investment focus between 2022 and 2024. AWS net sales grew 19% year-over-year in 2024 (reaching $107.6 billion), contributing significantly to consolidated sales growth (11%) and operating cash flow ($115.9 billion in 2024), while directly driving capital expenditures ($77.7 billion in 2024) primarily for AWS infrastructure. This strategic emphasis is underscored by substantial ongoing investments, including $2.75 billion in a Q1 2024 convertible note to Anthropic and plans for $2.7 billion additional AWS-related investments by Q4 2025, reflecting AWS's central role in Amazon's long-term growth and capital allocation strategy.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AMZN_10k_2022.pdf",
          "target_page": 6,
          "pages": [
            4,
            5,
            6,
            7,
            8
          ]
        },
        "hop_2_rel": {
          "source_file": "AMZN_10k_2024.pdf",
          "target_page": 22,
          "pages": [
            20,
            21,
            22,
            23,
            24
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 56707,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 14399,
        "completion_tokens": 187,
        "total_tokens": 14587
      }
    },
    {
      "question_id": 38,
      "question": "How did the scope or focus of trend analyses used in evaluating the historical consistency of regulatory asset balances evolve between 2023 and 2024?",
      "original_answer": "In 2023, trend analyses were used to evaluate the historical consistency of regulatory asset balances in general, without specific reference to asset retirement obligations. By 2024, the scope of the trend analyses remained focused on regulatory asset balances, but the audit procedures expanded to include a specific evaluation of the ongoing regulatory recoverability of asset retirement obligations related to coal ash, indicating a shift in focus toward more specialized regulatory compliance areas.",
      "llm_answer": "The trend analyses used to evaluate historical consistency of regulatory asset balances shifted focus between 2023 and 2024 from assessing historical consistency through management inquiries and independent expectation comparisons (2023) to incorporating more detailed external regulatory precedent analysis and specific storm/fuel cost recovery assessments in 2024, while maintaining the core approach of comparing recorded balances to independently developed expectations and evaluating commission-approved amortization patterns.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "DUK_10k_2023.pdf",
          "target_page": 102,
          "pages": [
            100,
            101,
            102,
            103,
            104
          ]
        },
        "hop_2_rel": {
          "source_file": "DUK_10k_2024.pdf",
          "target_page": 81,
          "pages": [
            79,
            80,
            81,
            82,
            83
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 54932,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 13955,
        "completion_tokens": 132,
        "total_tokens": 14088
      }
    },
    {
      "question_id": 38,
      "question": "How did Costco's strategy regarding the penetration of private-label items evolve between 2022 and 2023 in response to cost and pricing pressures?",
      "original_answer": "In 2022, Costco responded to higher-than-recent inflation in merchandise costs by employing several strategies, including absorbing some cost increases internally, purchasing earlier and in larger volumes, and selectively passing on cost increases to members, all of which were aimed at maintaining pricing authority while managing gross margin pressures. In 2023, Costco continued to emphasize increasing the penetration of its private-label items as part of its broader merchandising and pricing strategy to adapt to ongoing cost increases and competitive pressures. This indicates a shift from a more reactive approach in 2022 to a more strategic and sustained emphasis on private-label offerings in 2023 to maintain competitive pricing and member value.",
      "llm_answer": "Based on the 2022 and 2023 10‑K excerpts, Costco’s private‑label penetration grew as a deliberate response to heightened cost pressures.  In 2022 the company noted that “merchandise costs in 2022 were impacted by inflation higher than what we have experienced in recent years” and that its pricing strategy—including “increasing the penetration of our private‑label items”—was used to offset those cost increases while trying to keep overall price hikes minimal.  By 2023 the same discussion of “adjustments to our pricing and merchandise mix, including increasing the penetration of our private‑label items” continued, showing that the expansion of private‑label offerings was maintained and reinforced to mitigate ongoing inflationary cost pressures.  Thus, between 2022 and 2023 Costco deepened its reliance on private‑label products to sustain competitive pricing and protect margins amid rising costs.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "COST_10k_2022.pdf",
          "target_page": 22,
          "pages": [
            20,
            21,
            22,
            23,
            24
          ]
        },
        "hop_2_rel": {
          "source_file": "COST_10k_2023.pdf",
          "target_page": 23,
          "pages": [
            21,
            22,
            23,
            24,
            25
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 83157,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 21010,
        "completion_tokens": 226,
        "total_tokens": 21236
      }
    },
    {
      "question_id": 38,
      "question": "How has the financial outlook for Paxlovid evolved between 2023 and 2024 based on Pfizer's remaining performance obligations?",
      "original_answer": "In 2023, Pfizer did not disclose specific remaining performance obligations for Paxlovid. However, by the end of 2024, Pfizer reported that remaining performance obligations for Paxlovid totaled approximately $1 billion as of December 31, 2024, indicating a clear financial commitment from customers for future delivery of the product. This evolution suggests increased contractual certainty and forward-looking revenue expectations for Paxlovid between the two years.",
      "llm_answer": "Based on the financial disclosures in the 2023 and 2024 Form 10-K filings, Pfizer's outlook for Paxlovid shifted significantly from 2023 to 2024 as the company transitioned from government procurement to commercial market sales. In 2023, Paxlovid generated $18.9 billion in revenue, but by 2024, revenue dropped to $5.7 billion as the U.S. government discontinued free distribution and commercial pricing took effect, with only $1.3 billion in 2023 revenue attributed to government contracts. The company recorded a $3.5 billion non-cash revenue reversal in Q4 2023 due to expected returns of government inventory, followed by a $771 million favorable adjustment in Q1 2024 for returned courses, and recognized $442 million in revenue from a U.S. government stockpile supply through 2028. Remaining performance obligations for Paxlovid totaled approximately $1 billion in contracted revenue as of December 2024, with deliveries expected through 2028 under new commercial agreements.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "PFE_10k_2023.pdf",
          "target_page": 5,
          "pages": [
            3,
            4,
            5,
            6,
            7
          ]
        },
        "hop_2_rel": {
          "source_file": "PFE_10k_2024.pdf",
          "target_page": 109,
          "pages": [
            107,
            108,
            109,
            110,
            111
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 98857,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 24929,
        "completion_tokens": 245,
        "total_tokens": 25175
      }
    },
    {
      "question_id": 39,
      "question": "How has American Express's use and assumptions around the Reasonable and Supportable (R&S) Period evolved between 2022 and 2024 in estimating credit loss reserves, and what does this indicate about the company's approach to financial risk management?",
      "original_answer": "In 2022, American Express explicitly described its use of the R&S Period as a key component in estimating reserves for credit losses on Card Member loans, incorporating historical loss experience and current/future economic conditions over that period. The reserves stood at $3.3 billion as of December 31, 2021, and the R&S Period was a central assumption in modeling expected credit losses. By 2024, while the R&S Period was still referenced, it was no longer introduced as a newly explained concept and instead appeared embedded within a more mature and established process, indicating it had become a standard part of the company's financial risk modeling framework. This evolution suggests a shift from introducing the methodology (2022) to relying on it as a foundational element in credit loss estimation (2024).",
      "llm_answer": "American Express has extended its Reasonable and Supportable (R&S) Period from 2022 through 2024, reflecting a more forward-looking approach to estimating credit loss reserves by incorporating current and reasonably supportable economic conditions and longer-term loss rate assumptions. This evolution indicates a more sophisticated and risk-aware financial risk management strategy, as the company increasingly relies on statistical and actuarial models with greater discretion in determining the R&S Period and associated loss rates to reflect changing portfolio dynamics and macroeconomic trends.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AXP_10k_2022.pdf",
          "target_page": 95,
          "pages": [
            93,
            94,
            95,
            96,
            97
          ]
        },
        "hop_2_rel": {
          "source_file": "AXP_10k_2024.pdf",
          "target_page": 98,
          "pages": [
            96,
            97,
            98,
            99,
            100
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 42279,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 10816,
        "completion_tokens": 149,
        "total_tokens": 10966
      }
    },
    {
      "question_id": 39,
      "question": "How has Amazon's approach to debt financing evolved between 2022 and 2024, particularly with respect to the 0.800% Note due 2025?",
      "original_answer": "In 2022, Amazon's filings referenced the 0.800% Note due 2025 as part of its broader debt structure, originally introduced in the Officers' Certificate dated June 3, 2020. By 2024, Amazon not only continued to reference the 0.800% Note due 2025 in its filings but also introduced new debt instruments with different interest rates and maturity dates, such as the 4.600% Note due 2025. This indicates a shift in Amazon's debt financing strategy, incorporating a wider range of interest rates and maturities to potentially manage cash flow and interest rate risk more effectively.",
      "llm_answer": "Amazon’s debt financing strategy has remained focused on issuing long‑dated fixed‑rate notes, but the composition of its most recent tranche shifted in 2024.  In the 2022 filing (pages 71‑73) the company disclosed its 0.800 % senior unsecured notes due 2025 as part of the June 3 2020 “2020 Notes” shelf, describing them as a low‑cost, long‑term funding source.  By the 2024 filing (pages 72‑76), the same 0.800 % 2025 notes appear among a broader set of 2022‑2023 debt certificates, and the company added newer supplemental indentures (e.g., the April 13 2022 supplemental indenture) that introduced additional 2025‑dated securities with slightly higher coupons (3.000 % and 3.300 %).  Thus, while the 0.800 % 2025 note continues to exist, Amazon’s approach has evolved from a single‑issue, ultra‑low‑rate tranche to a more diversified portfolio of 2025‑dated notes with varied coupon structures, reflecting a strategic shift toward managing interest‑rate exposure and capital‑raising flexibility.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AMZN_10k_2022.pdf",
          "target_page": 72,
          "pages": [
            69,
            70,
            71,
            72,
            73
          ]
        },
        "hop_2_rel": {
          "source_file": "AMZN_10k_2024.pdf",
          "target_page": 75,
          "pages": [
            72,
            73,
            74,
            75,
            76
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 9,
        "total_chars": 45117,
        "num_window_pages": 9,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 11496,
        "completion_tokens": 249,
        "total_tokens": 11745
      }
    },
    {
      "question_id": 39,
      "question": "How has the treatment or disclosure of the Twenty-third Supplemental Indenture evolved between the 2022 and 2024 SEC filings, and what does this indicate about its ongoing relevance or status?",
      "original_answer": "In the 2022 filing (DUK_10k_2022.pdf), the Twenty-third Supplemental Indenture was explicitly listed and dated June 1, 1978, incorporated by reference to Exhibit 2(c), File No. 2-61611. However, in the 2024 filing (DUK_10k_2024.pdf), there is no direct mention or continued reference to the Twenty-third Supplemental Indenture. Instead, the focus shifts to more recent supplemental indentures, such as the Forty-ninth Supplemental Indenture dated March 14, 2024. This indicates that the Twenty-third Supplemental Indenture was not reaffirmed or highlighted in the most recent disclosure, suggesting it may have diminished in operational or reporting significance over time.",
      "llm_answer": "The treatment of the Twenty-third Supplemental Indenture has remained consistent in both the 2022 and 2024 SEC filings, where it is still listed as a current and active indenture (e.g., in 2022 filings it appears as part of the series of supplemental indentures under Item 4.1.23, and in 2024 filings it continues to be referenced as an ongoing indenture, such as the “Sixty‑second Supplemental Indenture, dated as of April 1, 2024”). This repeated disclosure indicates that the indenture remains relevant and in force, with no evidence of retirement, amendment, or discontinuation, underscoring its continued legal and financial significance in Duke Energy’s debt structure.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "DUK_10k_2022.pdf",
          "target_page": 249,
          "pages": [
            247,
            248,
            249,
            250,
            251
          ]
        },
        "hop_2_rel": {
          "source_file": "DUK_10k_2024.pdf",
          "target_page": 252,
          "pages": [
            250,
            251,
            252,
            253,
            254
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 9,
        "total_chars": 78426,
        "num_window_pages": 9,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 19841,
        "completion_tokens": 168,
        "total_tokens": 20009
      }
    },
    {
      "question_id": 40,
      "question": "How did the repurchase activity for Class C Capital Stock evolve from 2022 to 2024, and what was the total value of shares repurchased in each year?",
      "original_answer": "In 2022, Alphabet repurchased $59.3 billion of Class A and Class C shares, while in 2023 the amount increased to $62.2 billion, and in 2024 it remained high at $62.0 billion. This demonstrates a consistent and significant level of share repurchase activity over the three-year period, with a slight peak in 2023 followed by a minor decline in 2024.",
      "llm_answer": "From the 2022 10‑K (pages 51‑55) we see that Alphabet repurchased $59.3 billion of its Class A and Class C shares during fiscal 2022. The 2023 10‑K (page 83) reports $62.2 billion of repurchases for fiscal 2023, and the 2024 10‑K (page 84) shows $62.0 billion of repurchases for fiscal 2024. Thus, the total value of shares repurchased was approximately $59.3 billion in 2022, $62.2 billion in 2023, and $62.0 billion in 2024.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "GOOGL_10k_2022.pdf",
          "target_page": 53,
          "pages": [
            51,
            52,
            53,
            54,
            55
          ]
        },
        "hop_2_rel": {
          "source_file": "GOOGL_10k_2024.pdf",
          "target_page": 82,
          "pages": [
            80,
            81,
            82,
            83,
            84
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 58675,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 14890,
        "completion_tokens": 106,
        "total_tokens": 14997
      }
    },
    {
      "question_id": 40,
      "question": "What changes occurred in the treatment and documentation of the American Express Company Salary/Bonus Deferral Plan between the 2022 and 2024 SEC filings?",
      "original_answer": "In the 2022 filing, the Salary/Bonus Deferral Plan was referenced through historical amendments, including Exhibit 10.16 (1988 plan) and Exhibit 10.17 (1994 amendment). The 2024 filing reintroduces the plan through Exhibit 10.13, referencing the same 1988 plan, and also includes Exhibit 10.14, which references the 1994 amendment. Notably, the 2024 filing adds Exhibit 10.16, which incorporates the 1997 amendments to the plan. This indicates that while the foundational documentation remained consistent, the 2024 filing expanded the disclosure to include a broader historical record of amendments, providing more context on the plan's evolution.",
      "llm_answer": "The American Express Company Salary/Bonus Deferral Plan was first incorporated by reference in the 1988 10‑K (Exhibit 10.20) and has been amended over time. In the 2022 filing, the plan was restated as part of the “Twelfth Amendment and Restatement of the American Express Retirement Restoration Plan” (Exhibit 10.17), and the 2024 filing updates the plan’s documentation to reflect the “American Express Company 2016 Incentive Compensation Plan (as amended and restated effective May 6, 2024)” (Exhibit 10.23), which now governs the deferral provisions. Thus, between the 2022 and 2024 SEC filings, the plan’s documentation was revised to incorporate the 2024 restated 2016 Incentive Compensation Plan and related amendments.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AXP_10k_2022.pdf",
          "target_page": 165,
          "pages": [
            163,
            164,
            165,
            166,
            167
          ]
        },
        "hop_2_rel": {
          "source_file": "AXP_10k_2024.pdf",
          "target_page": 171,
          "pages": [
            169,
            170,
            171,
            172,
            173
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 9,
        "total_chars": 42705,
        "num_window_pages": 9,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 10901,
        "completion_tokens": 181,
        "total_tokens": 11082
      }
    },
    {
      "question_id": 40,
      "question": "How has Starbucks' exposure to interest rate swaps evolved between 2022 and 2024, particularly in terms of their balance sheet classification and magnitude of liability?",
      "original_answer": "In 2022, Starbucks reported an interest rate swap liability of $34.0 million under 'Other long-term liabilities'. By 2024, the company's interest rate swap position had shifted significantly, with a liability of $19.2 million under 'Other long-term liabilities' and an additional $41.4 million liability from interest rate swaps reported for the prior year (2023), indicating a decrease in liability from the previous year but a continued significant exposure. This reflects a transformation in the company's interest rate swap position, with a shift in balance sheet classification and a notable reduction in total swap liability.",
      "llm_answer": "Between 2022 and 2024, Starbucks' interest rate swap liability shifted from a $34.0 million long‑term liability (recorded in “Other long‑term liabilities”) in 2022 to $19.2 million in long‑term liabilities and $3.6 million in accrued liabilities in 2024, reflecting a substantial reduction in the swap’s balance‑sheet exposure. Concurrently, the fair‑value hedging adjustment on the hedged long‑term debt declined from a $52.3 million cumulative fair‑value hedge loss in 2022 to a $17.8 million loss in 2024, indicating that the magnitude of the liability related to its interest‑rate swaps has decreased significantly over the two‑year period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "SBUX_10k_2022.pdf",
          "target_page": 68,
          "pages": [
            66,
            67,
            68,
            69,
            70
          ]
        },
        "hop_2_rel": {
          "source_file": "SBUX_10k_2024.pdf",
          "target_page": 72,
          "pages": [
            70,
            71,
            72,
            73,
            74
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 74231,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 18784,
        "completion_tokens": 161,
        "total_tokens": 18945
      }
    },
    {
      "question_id": 40,
      "question": "How has the treatment of the Directors' Savings Plan evolved between 2022 and 2024, and what does this suggest about Duke Energy's approach to director compensation governance and deferral mechanisms?",
      "original_answer": "In 2022, the Directors' Savings Plan was formally introduced in the 10-K filing with a specific amendment dated December 16, 2021, indicating active documentation and policy updates around director deferrals. By 2024, the plan is referenced in the context of phantom investment options and deferred compensation mechanics, with an emphasis on unfunded accounts tied to the Duke Energy Common Stock Fund. This evolution suggests a shift from policy establishment to operational transparency, highlighting how deferrals are structured and invested, which may reflect a broader governance strategy to align director compensation with long-term shareholder interests and company stock performance.",
      "llm_answer": "Between 2022 and 2024, Duke Energy’s Directors’ Savings Plan was amended twice: an amendment effective December 16 2021 (referenced in the 2022 filing) and a further amendment that took effect in 2024, which updated the plan’s deferral and matching contribution provisions and clarified how phantom‑stock earnings are credited. These changes reflect a more structured, transparent approach to director compensation, emphasizing formal deferral mechanisms and aligning director pay with the company’s broader equity‑based compensation policies while maintaining a clear, board‑approved framework for governance.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "DUK_10k_2022.pdf",
          "target_page": 258,
          "pages": [
            256,
            257,
            258,
            259,
            260
          ]
        },
        "hop_2_rel": {
          "source_file": "DUK_10k_2024.pdf",
          "target_page": 239,
          "pages": [
            237,
            238,
            239,
            240,
            241
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 72655,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 18400,
        "completion_tokens": 152,
        "total_tokens": 18552
      }
    },
    {
      "question_id": 40,
      "question": "How has the positioning and associated risk profile of Costco's Kirkland Signature brand evolved between 2022 and 2023?",
      "original_answer": "In 2022, Costco emphasized the Kirkland Signature brand as a strategic asset, highlighting its high quality, competitive pricing, and contribution to higher margins. The company planned to continue increasing the sales penetration of these private-label items. However, by 2023, the risk disclosures included broader mentions of how supply chain disruptions, foreign exchange fluctuations, and catastrophic events could negatively impact the business—including private-label brands like Kirkland Signature. While the 2022 filing focused on growth and brand strength, the 2023 filing introduced a more risk-focused lens, indicating that the brand's expansion and reliance could expose Costco to greater operational and financial volatility.",
      "llm_answer": "Between 2022 and 2023 Costco’s Kirkland Signature brand shifted from a primarily price‑driven, value‑oriented positioning to a more differentiated, higher‑margin offering that is explicitly linked to the company’s sustainability and ESG commitments.  While the brand continues to emphasize low‑price quality, the 2023 filing highlights an increased focus on meeting ESG expectations—such as clean‑energy sourcing, carbon‑reduction goals, and transparent sustainability reporting—reflecting a strategic evolution toward a broader, socially responsible positioning that also raises regulatory and reputational risk.  This evolution is underscored by Costco’s public sustainability targets and its growing reliance on clean‑energy and emissions‑control initiatives, which now play a material role in the brand’s risk profile.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "COST_10k_2022.pdf",
          "target_page": 7,
          "pages": [
            5,
            6,
            7,
            8,
            9
          ]
        },
        "hop_2_rel": {
          "source_file": "COST_10k_2023.pdf",
          "target_page": 16,
          "pages": [
            14,
            15,
            16,
            17,
            18
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 45085,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 11484,
        "completion_tokens": 205,
        "total_tokens": 11689
      }
    },
    {
      "question_id": 41,
      "question": "How did COP's natural gas reserves in the Asia Pacific/Middle East region evolve from 2022 to 2024, and what were the key changes in terms of volume and sources of additions?",
      "original_answer": "In 2022, COP reported 326 billion cubic feet of natural gas reserves in the Asia Pacific/Middle East region. By 2024, this figure decreased slightly to 296 billion cubic feet. Over this period, the company experienced revisions and production activities that impacted reserves, with minimal extensions and discoveries contributing to the region. In 2024, there were no sales or significant reserve additions in this region, indicating a reduction in focus or activity compared to earlier years.",
      "llm_answer": "From 2022 to 2024, ConocoPhillips’ proved natural‑gas reserves in the Asia Pacific/Middle East region grew from **50 billion cubic feet (BCF) at the end of 2022 to 62 BCF at the end of 2024**.  The increase was driven by upward revisions (≈ 126 BCF in 2024), purchases (≈ 1 BCF in 2024), and extensions/discoveries (≈ 18 BCF in 2024), while sales were negligible.  Overall, the region’s gas reserve base expanded by roughly **12 BCF**, reflecting both organic additions and acquisitions.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "COP_10k_2022.pdf",
          "target_page": 167,
          "pages": [
            165,
            166,
            167,
            168,
            169
          ]
        },
        "hop_2_rel": {
          "source_file": "COP_10k_2024.pdf",
          "target_page": 145,
          "pages": [
            143,
            144,
            145,
            146,
            147
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 79259,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 20044,
        "completion_tokens": 121,
        "total_tokens": 20166
      }
    },
    {
      "question_id": 41,
      "question": "How has FedEx's strategic relationship with the Boeing 767F evolved between 2022 and 2024, particularly in terms of fleet ownership and modernization focus?",
      "original_answer": "In 2022, FedEx directly owned 114 Boeing 767F aircraft, indicating a significant owned asset position in its fleet strategy. By 2024, while no updated ownership figures were disclosed, FedEx emphasized the Boeing 767-300 Freighter (B767F) as a key component of its aircraft modernization programs. The company described these aircraft as significantly more fuel-efficient per unit than older models and noted that expenditures for these aircraft are necessary for long-term operating savings and fleet replacement, with limited flexibility to delay purchases without incurring significant costs.",
      "llm_answer": "Between 2022 and 2024, FedEx's strategic relationship with the Boeing 767F evolved through a clear shift from leasing to owning the aircraft type. As disclosed in the 2022 10-K (page 40), FedEx Express operated **114 Boeing 767F aircraft**, all leased, with no owned 767Fs. By 2024, the company had transitioned to **owning 14 B767F aircraft** (as shown in the 2024 10-K's aircraft purchase commitments on page 117), with additional commitments for 11 more deliveries through 2025–2026. This reflects a strategic modernization focus on replacing older, less fuel-efficient aircraft (like the MD-11 and 757) with newer, more efficient 767F and 777F models to achieve long-term operating savings, as noted in the 2022 10-K (page 40) and 2024 10-K (page 117). The 767F now serves as a key component of FedEx's fleet modernization, with planned deliveries aligning with its fuel efficiency and capacity goals.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "FDX_10k_2022.pdf",
          "target_page": 40,
          "pages": [
            38,
            39,
            40,
            41,
            42
          ]
        },
        "hop_2_rel": {
          "source_file": "FDX_10k_2024.pdf",
          "target_page": 116,
          "pages": [
            114,
            115,
            116,
            117,
            118
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 9,
        "total_chars": 40801,
        "num_window_pages": 9,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 10424,
        "completion_tokens": 226,
        "total_tokens": 10650
      }
    },
    {
      "question_id": 41,
      "question": "How did Starbucks' involvement with roasted coffee evolve from 2022 to 2024 in terms of inventory value and production infrastructure?",
      "original_answer": "In 2022, Starbucks reported an inventory value of roasted coffee at $310.3 million, reflecting its role in holding roasted coffee as part of its merchandise. By 2024, the company had expanded its infrastructure dedicated to roasting, with facilities in York, PA; Minden, NV (Carson Valley); Kunshan, China; and Kent, WA, indicating a significant increase in its direct involvement in the roasting process. This represents a shift from primarily holding roasted coffee inventory to actively producing and distributing it at scale.",
      "llm_answer": "From 2022 to 2024, Starbucks’ involvement with roasted coffee evolved through a strategic shift in its supply‑chain infrastructure and inventory management. While the company’s total inventory (including roasted coffee) grew from $2.18 billion in fiscal 2022 to $2.18 billion in fiscal 2023 and then to $2.18 billion in fiscal 2024 (reflecting continued investment in roasting capacity and warehouse space), the valuation of its equity‑method investments in joint ventures such as the North American Coffee Partnership remained relatively stable, hovering around $283 million in 2022 and $216 million in 2021, indicating a consistent but modest contribution to overall earnings. This suggests that Starbucks has been expanding its owned roasting and distribution facilities—evidenced by the listed owned roasting sites and growing PP&E—while maintaining a steady, non‑material equity stake in its key coffee‑production partnerships.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "SBUX_10k_2022.pdf",
          "target_page": 71,
          "pages": [
            69,
            70,
            71,
            72,
            73
          ]
        },
        "hop_2_rel": {
          "source_file": "SBUX_10k_2024.pdf",
          "target_page": 33,
          "pages": [
            31,
            32,
            33,
            34,
            35
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 42777,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 10912,
        "completion_tokens": 233,
        "total_tokens": 11145
      }
    },
    {
      "question_id": 41,
      "question": "How has PepsiCo's utilization of the 2.750% Senior Notes due 2025 evolved between 2023 and 2024, based on the specific debt instruments referenced in the filings?",
      "original_answer": "In 2023, the 2.750% Senior Notes due 2025 were listed among other notes in a Board of Directors Resolutions document that authorized officers to establish terms for several senior notes, including the 2.750% Senior Notes due 2025. By 2024, PepsiCo not only retained the 2.750% Senior Notes due 2025 in its list of authorized instruments but also introduced a new 2.750% Senior Notes due 2030. This indicates that PepsiCo extended its debt strategy involving this interest rate to a longer-term horizon, signaling a strategic evolution in its financing approach.",
      "llm_answer": "Based on the provided SEC filing pages, PepsiCo's utilization of the 2.750% Senior Notes due 2025 is documented as follows:  \n- The 2.750% Senior Notes due 2025 were first authorized in the Board of Directors' resolutions referenced on **page 129 of the 2023 10-K filing** (specifically listed among multiple senior note authorizations).  \n- The same resolution was reiterated in the **2024 10-K filing on page 130**, where it appears in the list of notes authorized for issuance (including \"2.750% Senior Notes due 2025\" alongside other senior debt instruments).  \n- No evidence of redemption, refinancing, or changes to the terms of the 2.750% Senior Notes due 2025 is indicated in the provided pages; the filings only confirm the ongoing authorization of these notes as part of PepsiCo's debt management strategy.  \n\nThus, the utilization of the 2.750% Senior Notes due 2025 remained consistent between 2023 and 2024, with no evolution in terms or usage disclosed in the referenced filings.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "PEP_10k_2023.pdf",
          "target_page": 129,
          "pages": [
            127,
            128,
            129,
            130,
            131
          ]
        },
        "hop_2_rel": {
          "source_file": "PEP_10k_2024.pdf",
          "target_page": 130,
          "pages": [
            128,
            129,
            130,
            131,
            132
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 65856,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 16691,
        "completion_tokens": 248,
        "total_tokens": 16939
      }
    },
    {
      "question_id": 42,
      "question": "How did FedEx's planned utilization of the B777F aircraft change from 2022 to 2024, and what does this indicate about its strategic role in the fleet?",
      "original_answer": "In 2022, FedEx planned to operate 4 B777F aircraft in 2024 and 2 in 2025. By 2024, the updated plan showed 2 B777F aircraft operating in 2025, with no further plans beyond that year. This indicates a reduction in the strategic emphasis on the B777F fleet, moving from a gradually decreasing role to a complete phase-out, suggesting a shift in aircraft preference or operational strategy.",
      "llm_answer": "From 2022 to 2024 FedEx’s planned utilization of the B777F aircraft shifted from a larger, multi‑year commitment (11 B777Fs slated for delivery in 2023‑2026 in the 2022 filing) to a much smaller, near‑term schedule of only two B777Fs planned for delivery in 2025, as shown in the 2024 “Aircraft purchase commitments” table. This reduction indicates that FedEx is scaling back its long‑term fleet expansion and is instead focusing on shorter‑term, more flexible aircraft acquisitions to meet near‑term capacity needs.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "FDX_10k_2022.pdf",
          "target_page": 114,
          "pages": [
            112,
            113,
            114,
            115,
            116
          ]
        },
        "hop_2_rel": {
          "source_file": "FDX_10k_2024.pdf",
          "target_page": 117,
          "pages": [
            115,
            116,
            117,
            118,
            119
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 39648,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 10136,
        "completion_tokens": 129,
        "total_tokens": 10265
      }
    },
    {
      "question_id": 42,
      "question": "How did Starbucks' foreign currency - other derivative liabilities and their impact on net gains/(losses) included in AOCI evolve from 2022 to 2024, and what does this indicate about the company's exposure to foreign currency fluctuations?",
      "original_answer": "In 2022, Starbucks reported foreign currency - other derivative liabilities of $0.3 million under accrued liabilities, while in 2024, the net gains included in AOCI related to foreign currency - other were $11.5 million. This indicates a significant shift from a minimal liability position in 2022 to a more substantial unrealized gain in 2024, suggesting increased exposure to or hedging of foreign currency fluctuations.",
      "llm_answer": "From 2022 to 2024, Starbucks' foreign currency-other derivative liabilities in AOCI declined significantly from $55.3 million to $11.5 million, reflecting reduced exposure to foreign exchange fluctuations. This decrease indicates the company is actively managing and reducing its sensitivity to currency movements, though some foreign currency risk remains through other derivative positions and hedging activities.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "SBUX_10k_2022.pdf",
          "target_page": 68,
          "pages": [
            66,
            67,
            68,
            69,
            70
          ]
        },
        "hop_2_rel": {
          "source_file": "SBUX_10k_2024.pdf",
          "target_page": 70,
          "pages": [
            68,
            69,
            70,
            71,
            72
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 65991,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 16742,
        "completion_tokens": 103,
        "total_tokens": 16845
      }
    },
    {
      "question_id": 42,
      "question": "How has PepsiCo's engagement with the 2.625% Senior Notes due 2026 evolved between 2023 and 2024, particularly in terms of its broader debt instrument disclosures?",
      "original_answer": "In 2023, the 2.625% Senior Notes due 2026 were listed among other notes in a section that included Board of Directors Resolutions authorizing officers to establish terms for various senior notes. By 2024, PepsiCo not only retained the 2.625% Senior Notes due 2026 in its disclosures but also introduced a significantly expanded list of senior notes, including newer maturities such as the 3.000% Senior Notes due 2027 and the 2.625% Senior Notes due 2029. This indicates a broader and more diversified set of debt instruments, suggesting an active capital markets strategy involving the issuance of notes with different maturities and rates.",
      "llm_answer": "PepsiCo’s 2.625% Senior Notes due 2026 were first established in 2019 (via the July 29, 2019 2.625% Senior Note due 2029 filing) and have since been referenced in multiple subsequent disclosures, including the February 15, 2023 filing of a Floating Rate Note due 2026 and the November 13, 2023 5.125% Senior Note due 2026 filing, which also included board resolutions authorizing the terms of the 2.625% 2026 notes. In the 2024 filings (July 17, 2024 and February 12, 2024), the company again disclosed board resolutions that specifically authorized the terms of the 2.625% Senior Notes due 2026 as part of its broader suite of senior note issuances, underscoring the continued use and formal authorization of this debt instrument in its capital‑raising strategy.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "PEP_10k_2023.pdf",
          "target_page": 129,
          "pages": [
            127,
            128,
            129,
            130,
            131
          ]
        },
        "hop_2_rel": {
          "source_file": "PEP_10k_2024.pdf",
          "target_page": 130,
          "pages": [
            128,
            129,
            130,
            131,
            132
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 65856,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 16691,
        "completion_tokens": 190,
        "total_tokens": 16882
      }
    },
    {
      "question_id": 42,
      "question": "How has Cisco's exposure to and reliance on overcoming technical hurdles evolved from 2022 to 2024, particularly in relation to its strategic investments and product development timelines?",
      "original_answer": "In 2022, Cisco acknowledged facing technical hurdles that could delay successful execution of its vision, especially in areas like product planning, timing, and resource allocation, which could lead to loss of market share and earnings. By 2024, the company's exposure to technical hurdles had transformed into a more specific dependency on overcoming these challenges in a timely manner to maintain competitive advantage, particularly in delivering complex software subscription offerings and introducing new technologies such as those related to artificial intelligence, security, observability, and cloud. The 2024 disclosures emphasize that failure to overcome these hurdles could not only result in loss of market share but also reputational damage, legal liability, and reduced customer retention. This represents a shift from internal execution risk to a broader operational and strategic dependency.",
      "llm_answer": "From 2022 to 2024, Cisco’s exposure to technical hurdles has intensified as it accelerates investments in strategic priority areas such as AI, cloud, cybersecurity, and network programmability. The company repeatedly emphasizes that developing new products—especially programmable, software‑defined networking and security solutions—requires overcoming complex technical challenges, and that delays or mis‑steps in these efforts could erode market share and profitability. Consequently, Cisco’s strategic investments and product development timelines are now more tightly linked to its ability to surmount these technical obstacles.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CSCO_10k_2022.pdf",
          "target_page": 25,
          "pages": [
            23,
            24,
            25,
            26,
            27
          ]
        },
        "hop_2_rel": {
          "source_file": "CSCO_10k_2024.pdf",
          "target_page": 20,
          "pages": [
            18,
            19,
            20,
            21,
            22
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 9,
        "total_chars": 55658,
        "num_window_pages": 9,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 14146,
        "completion_tokens": 158,
        "total_tokens": 14304
      }
    },
    {
      "question_id": 43,
      "question": "How did the role of Google Ad Manager in driving Google Network revenues change between 2022 and 2023, based on the specific mentions of its performance and positioning across those years?",
      "original_answer": "In 2022, Google Ad Manager was explicitly cited as one of the key drivers behind the $8.6 billion year-over-year increase in Google Network revenues, alongside AdMob and AdSense. By 2023, while Google Ad Manager remained a core advertising platform used by customers, it was listed among several platforms (including Google Ads, Display & Video 360, and the Marketing Platform) without specific attribution to revenue growth. This indicates a shift from being a standout growth contributor in 2022 to being part of a broader suite of advertising tools in 2023, suggesting a more integrated but less singularly emphasized role.",
      "llm_answer": "Based on the provided SEC 10-K filings, Google Ad Manager's role in driving Google Network revenues grew significantly between 2022 and 2023, as evidenced by its explicit positioning and performance metrics in the 2023 filing. In 2023, Google Network revenues were specifically tied to Ad Manager's ecosystem, with the filing stating that \"amounts paid to Google Network partners primarily for ads displayed on their properties\" are recorded as cost of revenues, and that Google Network partners are key to monetizing advertising inventory. This reflects a strategic shift where Ad Manager's platform (including AdMob, AdSense, and Ad Manager) became a more central driver of Google Network revenue growth, as highlighted by the 2023 document's emphasis on \"Google Network partners\" and the platform's role in delivering ads across third-party properties. The 2022 filing similarly noted Google Network revenue growth driven by \"strength in AdMob, Google Ad Manager, and AdSense,\" but the 2023 context shows deeper integration and reliance on Ad Manager's infrastructure for network revenue generation.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "GOOGL_10k_2022.pdf",
          "target_page": 35,
          "pages": [
            33,
            34,
            35,
            36,
            37
          ]
        },
        "hop_2_rel": {
          "source_file": "GOOGL_10k_2023.pdf",
          "target_page": 57,
          "pages": [
            55,
            56,
            57,
            58,
            59
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 45061,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 11497,
        "completion_tokens": 275,
        "total_tokens": 11772
      }
    },
    {
      "question_id": 43,
      "question": "How did Starbucks' derivative liabilities related to foreign currency - other evolve from 2022 to 2024, and what was the magnitude of change?",
      "original_answer": "In 2022, Starbucks reported derivative liabilities related to foreign currency - other at $0.3 million under accrued liabilities. By 2024, this amount had increased to $4.7 million under the same category. This indicates a significant increase in the company's liabilities tied to foreign currency derivatives over the two-year period.",
      "llm_answer": "From 2022 to 2024, Starbucks’ foreign currency‑other derivative liability in AOCI declined from $55.3 million to $11.5 million, a reduction of $43.8 million (approximately 79%). This represents the magnitude of change in those derivative liabilities over the two‑year period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "SBUX_10k_2022.pdf",
          "target_page": 68,
          "pages": [
            66,
            67,
            68,
            69,
            70
          ]
        },
        "hop_2_rel": {
          "source_file": "SBUX_10k_2024.pdf",
          "target_page": 72,
          "pages": [
            70,
            71,
            72,
            73,
            74
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 74231,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 18777,
        "completion_tokens": 68,
        "total_tokens": 18846
      }
    },
    {
      "question_id": 43,
      "question": "How has PepsiCo's issuance of the 4.600% Senior Notes due 2045 evolved between 2023 and 2024, and what does this indicate about the company's debt structure strategy?",
      "original_answer": "In 2023, the 4.600% Senior Notes due 2045 were listed among other senior notes in the Board of Directors Resolutions that authorized PepsiCo's officers to establish terms for various notes, including the 4.600% Senior Notes due 2045. By 2024, the 4.600% Senior Notes due 2045 remained part of the company's debt structure, but were now referenced alongside a broader range of newly introduced senior notes, such as the 4.000% Senior Notes due 2047 and Floating Rate Notes due 2026. This indicates that while the 4.600% Senior Notes due 2045 remained a part of PepsiCo's long-term debt strategy, the company expanded its debt portfolio with additional instruments, suggesting a more diversified approach to long-term financing in 2024.",
      "llm_answer": "Between 2023 and 2024, PepsiCo issued new senior notes with maturities spanning 2025 to 2054, including a notable 4.600% Senior Notes due 2045 referenced in its 2024 filings. This expansion of long-dated debt, alongside shorter-term notes like the 2024 floating-rate issue, reflects a strategic shift toward extending debt maturities and diversifying funding sources, aligning with a broader trend of managing liquidity and interest rate risk through staggered obligations. The 2024 indenture also formalized terms for multiple new tranches, underscoring a structured approach to capital structure optimization.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "PEP_10k_2023.pdf",
          "target_page": 129,
          "pages": [
            127,
            128,
            129,
            130,
            131
          ]
        },
        "hop_2_rel": {
          "source_file": "PEP_10k_2024.pdf",
          "target_page": 130,
          "pages": [
            128,
            129,
            130,
            131,
            132
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 65856,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 16692,
        "completion_tokens": 152,
        "total_tokens": 16844
      }
    },
    {
      "question_id": 44,
      "question": "How has COP's natural gas position in the Asia Pacific/Middle East region evolved between 2022 and 2024, and what does this indicate about its strategic focus in the region?",
      "original_answer": "In 2022, COP reported 326 billion cubic feet of natural gas in the Asia Pacific/Middle East region. By 2024, this figure had decreased slightly to 296 billion cubic feet. This indicates a minor reduction in natural gas reserves in the region over the two-year period. The decline, although modest, suggests a potential shift in strategic focus, possibly due to market dynamics or operational adjustments in the region.",
      "llm_answer": "COP has significantly expanded its natural gas reserves in the Asia Pacific/Middle East region, growing from 38 billion cubic feet (BCF) of productive gas (gross) at year-end 2021 to 296 BCF by end-2024, while also increasing undeveloped reserves from 38 BCF to 468 BCF. This growth, driven by strategic acquisitions (including Marathon Oil in 2024), extensions/discoveries in the Permian Basin and Montney, and upward revisions from price and technical improvements, reflects a clear strategic pivot toward expanding its gas footprint in high-growth international markets, particularly in the Asia Pacific/Middle East region where it now holds the majority of its equity affiliate reserves.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "COP_10k_2022.pdf",
          "target_page": 173,
          "pages": [
            171,
            172,
            173,
            174,
            175
          ]
        },
        "hop_2_rel": {
          "source_file": "COP_10k_2024.pdf",
          "target_page": 145,
          "pages": [
            143,
            144,
            145,
            146,
            147
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 74435,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 18838,
        "completion_tokens": 172,
        "total_tokens": 19011
      }
    },
    {
      "question_id": 44,
      "question": "How has Google Play's role in Google's non-advertising revenue strategy evolved from 2022 to 2023, based on the specific revenue sources mentioned in the filings?",
      "original_answer": "In 2022, Google Play was specifically mentioned as generating revenues from 'sales of apps and in-app purchases and digital content sold in the Google Play store.' By 2023, Google Play's revenue focus had evolved to be more narrowly described as primarily coming from 'apps and in-app purchases,' and it was grouped under the broader category of 'platforms' within non-advertising revenue sources. This indicates a shift in emphasis toward core app-based monetization within Google's strategic narrative around Play.",
      "llm_answer": "From 2022 to 2023, Google Play's role in Google's non-advertising revenue strategy expanded significantly as part of the company's broader effort to diversify beyond advertising. In 2022, Google highlighted Google Play as a key source of revenue from \"platforms\" that generate income through app and in-app purchase sales, alongside hardware and YouTube non-advertising services like subscriptions. By 2023, this diversification was explicitly reinforced in the \"How We Make Money\" section, where Google Play was listed alongside hardware and YouTube Premium/TV as a distinct non-advertising revenue stream, indicating a strategic emphasis on growing its platform-based revenues. This evolution reflects Google's long-term investment in the Google Play ecosystem to monetize digital content and services beyond traditional ad revenue.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "GOOGL_10k_2022.pdf",
          "target_page": 7,
          "pages": [
            5,
            6,
            7,
            8,
            9
          ]
        },
        "hop_2_rel": {
          "source_file": "GOOGL_10k_2023.pdf",
          "target_page": 8,
          "pages": [
            6,
            7,
            8,
            9,
            10
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 49258,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 12537,
        "completion_tokens": 208,
        "total_tokens": 12746
      }
    },
    {
      "question_id": 44,
      "question": "How has the projected utilization of the Cessna SkyCourier 408 evolved from 2022 to 2024, and what does this indicate about FedEx's strategic reliance on this aircraft model?",
      "original_answer": "In 2022, FedEx projected the Cessna SkyCourier 408 to have a total of 49 aircraft in operation across the years 2023 to thereafter. By 2024, this projection was reduced to a total of 31 aircraft for the years 2025 through 2029. However, in the 2024 report, the relationship to the Cessna SkyCourier 408 shifted from 'Increases' to 'Depends_On', indicating a change in strategic importance. This suggests a moderated but still significant reliance on the aircraft model over time.",
      "llm_answer": "From 2022 to 2024, FedEx's projected utilization of the Cessna SkyCourier 408 increased from 11 aircraft in 2023 (as shown in the 2022 10-K) to 12 aircraft in 2024 (as shown in the 2024 10-K), reflecting a strategic expansion of its regional delivery fleet to support growing package volume. This upward trend indicates FedEx's increasing reliance on the SkyCourier model to enhance its last-mile delivery capabilities and meet evolving e-commerce demands.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "FDX_10k_2022.pdf",
          "target_page": 114,
          "pages": [
            112,
            113,
            114,
            115,
            116
          ]
        },
        "hop_2_rel": {
          "source_file": "FDX_10k_2024.pdf",
          "target_page": 117,
          "pages": [
            115,
            116,
            117,
            118,
            119
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 39648,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 10142,
        "completion_tokens": 114,
        "total_tokens": 10256
      }
    },
    {
      "question_id": 44,
      "question": "How has AIG's use of expected loss ratio methods evolved between 2022 and 2023, particularly in terms of segmentation and the types of casualty lines analyzed?",
      "original_answer": "In 2022, AIG used expected loss ratio methods primarily for the three latest accident years in the U.S. Excess Casualty line, segmenting analysis by attachment point and further differentiating between automobile and non-automobile claims, including special treatment for latent exposures like construction defects and mass torts. In 2023, AIG continued to apply expected loss ratio methods but shifted focus to U.S. Workers' Compensation, where the company grouped business by risk-sharing features such as high deductibles and retrospective rating, and analyzed separately by state, industry, and claim handling entity. The increase in large deductible business also affected the reporting pattern of claims, indicating a broader application context for the method. This reflects a strategic evolution in where and how expected loss ratio methods are applied across different casualty lines.",
      "llm_answer": "Between 2022 and 2023 the company’s expected‑loss‑ratio methodology remained anchored in the same segmentation approach it has used for excess‑casualty lines: losses are split into automobile‑related claims and non‑automobile claims, with the latter further divided into latent exposures such as construction defects and mass‑tort claims.  For the most recent accident years the firm relies on expected‑loss‑ratio estimates (augmented by inflation and market‑trend adjustments) while older years are modeled with loss‑development techniques.  The 2023 tables continue to show this structure, reflecting the same attachment‑point segmentation and the separate treatment of large‑deductible and third‑party‑administered excess‑casualty business.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AIG_10k_2022.pdf",
          "target_page": 263,
          "pages": [
            261,
            262,
            263,
            264,
            265
          ]
        },
        "hop_2_rel": {
          "source_file": "AIG_10k_2023.pdf",
          "target_page": 202,
          "pages": [
            200,
            201,
            202,
            203,
            204
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 260515,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 65355,
        "completion_tokens": 185,
        "total_tokens": 65540
      }
    },
    {
      "question_id": 44,
      "question": "How did the classification and reporting of unallocated products evolve between fiscal years 2022 and 2024, particularly in terms of how they are categorized within Nike's consumer construct?",
      "original_answer": "In fiscal year 2022, unisex products were classified within Men's, and certain products not allocated to Men's, Women's, NIKE Kids', and Jordan Brand were included in 'Others' with adjustments not allocated by consumer. By fiscal year 2024, 'Others' continued to include products not allocated to Men's, Women's, Kids', and Jordan Brand, but there was no specific mention of unisex product classification within Men's, suggesting a potential shift or integration of unisex products within broader categories.",
      "llm_answer": "Between fiscal 2022 and 2024, Nike evolved its classification of unallocated products within its consumer construct by shifting from a geographic segmentation (e.g., Greater China, North America, EMEA) toward a consumer‑focused segmentation of Men’s, Women’s, and Kids’ (with Jordan Brand treated separately). This re‑organization, introduced with the Consumer Direct Acceleration strategy in fiscal 2022 and fully reflected in fiscal 2023‑24 disclosures, re‑allocates previously “unallocated” or corporate‑level revenues and costs into these consumer categories, improving visibility into product‑level performance and aligning reporting with the new consumer construct. Consequently, wholesale‑equivalent revenues and margin drivers are now presented alongside Nike Direct sales, and the company no longer reports unallocated products as a distinct segment.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "NKE_10k_2022.pdf",
          "target_page": 35,
          "pages": [
            33,
            34,
            35,
            36,
            37
          ]
        },
        "hop_2_rel": {
          "source_file": "NKE_10k_2024.pdf",
          "target_page": 37,
          "pages": [
            35,
            36,
            37,
            38,
            39
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 43463,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 11097,
        "completion_tokens": 214,
        "total_tokens": 11312
      }
    },
    {
      "question_id": 44,
      "question": "How did PepsiCo's engagement with the 3.500% Senior Notes due 2025 evolve between 2023 and 2024, and what does this indicate about the company's debt management strategy?",
      "original_answer": "In 2023, PepsiCo's 3.500% Senior Notes due 2025 were listed among other notes, indicating they were part of the company's existing debt structure. By 2024, the 3.500% Senior Notes due 2025 were still present, but they were now accompanied by a broader range of new notes, including longer-term instruments such as the 3.500% Senior Notes due 2040 and the 3.550% Senior Notes due 2034. This suggests that PepsiCo expanded its debt portfolio in 2024, introducing more long-term financing options while maintaining its commitment to the 3.500% Senior Notes due 2025. The addition of new notes indicates a strategic shift toward diversifying its debt maturity structure.",
      "llm_answer": "Between 2023 and 2024, PepsiCo issued new 3.500% Senior Notes due 2025 in November 2023 (Form 8‑K filing on Nov 13, 2023) and again in July 2024 (Form 8‑K filing on July 17, 2024), indicating a continued strategy of refinancing and extending its debt maturities through targeted senior note issuances. This pattern reflects a deliberate debt‑management approach focused on maintaining a diversified maturity profile and capitalizing on favorable market conditions to manage overall leverage.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "PEP_10k_2023.pdf",
          "target_page": 129,
          "pages": [
            127,
            128,
            129,
            130,
            131
          ]
        },
        "hop_2_rel": {
          "source_file": "PEP_10k_2024.pdf",
          "target_page": 130,
          "pages": [
            128,
            129,
            130,
            131,
            132
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 65856,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 16693,
        "completion_tokens": 122,
        "total_tokens": 16815
      }
    },
    {
      "question_id": 45,
      "question": "How did COP's financial disclosures regarding the Lower 48 region evolve between 2022 and 2024, particularly in terms of capital expenditures and future cash inflow revisions?",
      "original_answer": "In 2022, COP reported capital expenditures for the Lower 48 region at $3,129 million, indicating significant active investment in the area. By 2024, the company disclosed that certain amounts in the Lower 48 had been revised to reflect additional future cash inflows and future production costs, although no new capital expenditure figure was provided. This shift suggests a transition from active investment to a focus on revising financial projections based on updated expectations for production and cost dynamics in the region.",
      "llm_answer": "Between 2022 and 2024, ConocoPhillips' financial disclosures for the Lower 48 region show a significant shift in capital allocation and reserve valuation. In 2022, capital expenditures for the Lower 48 were $1,881 million, rising to $3,129 million in 2023 and $3,900 million in 2024, reflecting increased investment in the region. Concurrently, the discounted future net cash flows for the Lower 48 segment declined from $55,912 million (2023) to $38,693 million (2024), indicating revised downward expectations for future cash inflows. This reduction aligns with the \"Changes in estimated future development costs\" and \"Revisions of previous quantity estimates\" noted in the standardized measure disclosures, which were driven by lower commodity prices and updated reserve valuations. The 2024 disclosures also show a revised capital expenditure of $3,900 million (implied from the $3,203 million for 2024 in Note 23, with $1,297 million allocated to Lower 48 development), alongside a 31% drop in discounted future net cash flows for the region. These adjustments reflect a strategic pivot toward capital efficiency and reserve quality over volume growth.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "COP_10k_2022.pdf",
          "target_page": 149,
          "pages": [
            147,
            148,
            149,
            150,
            151
          ]
        },
        "hop_2_rel": {
          "source_file": "COP_10k_2024.pdf",
          "target_page": 158,
          "pages": [
            156,
            157,
            158,
            159,
            160
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 60387,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 15327,
        "completion_tokens": 289,
        "total_tokens": 15616
      }
    },
    {
      "question_id": 45,
      "question": "How did Comcast's financial commitments and governance arrangements with Atairos Group evolve between 2023 and 2024, particularly regarding capital obligations and control structures?",
      "original_answer": "In 2023, Comcast had a Fourth Amended and Restated Shareholders Agreement with Atairos Group, Inc., which was further amended in June 2023. This agreement outlined Comcast's role as the sole third-party investor and included governance terms among Atairos-related entities. By 2024, the relationship evolved into a more formalized investment framework under the equity method accounting. In this framework, Comcast reduced its capital commitment from up to $5 billion to $4.5 billion, limited annual capital calls to $400 million, and agreed to separately fund $40 million annually for management fees. Additionally, the 2024 filing clarified that Comcast absorbs approximately 99% of Atairos’ losses and receives approximately 86% of residual returns, while Atairos’ management companies (led by Comcast’s former CFO) retained all voting rights. These changes reflect a recalibration of financial exposure and a clearer delineation of control.",
      "llm_answer": "Between 2023 and 2024, Comcast’s financial commitments to Atairos evolved through an extension of its capital term to 16.5 years, a reduction of its aggregate funding commitment to $4.5 billion (with a $1.4 billion unfunded balance as of Dec 31 2024), and annual $40 million management‑fee obligations, while maintaining a residual‑return share of roughly 86 % and loss‑absorption of about 99 %. Governance remains overseen by former CFO‑led management companies that hold all voting rights; Comcast has only consent rights and no direct control, so it does not consolidate Atairos and accounts for the investment using the equity method. The 2024 10‑K notes that distributions retained by Atairos are treated as advances and that there are no additional liquidity or guarantee arrangements between the parties.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CMCSA_10k_2023.pdf",
          "target_page": 100,
          "pages": [
            97,
            98,
            99,
            100,
            101
          ]
        },
        "hop_2_rel": {
          "source_file": "CMCSA_10k_2024.pdf",
          "target_page": 84,
          "pages": [
            82,
            83,
            84,
            85,
            86
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 57363,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 14572,
        "completion_tokens": 202,
        "total_tokens": 14774
      }
    },
    {
      "question_id": 45,
      "question": "How did FedEx's projected utilization of the Cessna SkyCourier 408 change between 2022 and 2023 filings, and what does this indicate about its strategic role in the fleet compared to other aircraft?",
      "original_answer": "In the 2022 filing, FedEx projected a total of 49 Cessna SkyCourier 408 aircraft to be in service through 2027. By the 2023 filing, this projection dropped significantly to only 31 Cessna SkyCourier 408 aircraft through 2029. This indicates a strategic reduction in the planned reliance on the Cessna SkyCourier 408, especially when compared to other aircraft types like the B767F and B777F, which saw more stable or less reduced projections. This shift suggests FedEx may have reassessed the aircraft's role in its long-term fleet strategy.",
      "llm_answer": "Based on the 2022 and 2023 10-K filings, FedEx's projected utilization of the Cessna SkyCourier 408 increased significantly—from 1 aircraft committed for delivery in 2023 (as noted in the 2022 filing's purchase commitment table) to 17 aircraft scheduled for delivery in 2025 (as detailed in the 2023 filing's updated purchase commitments). This indicates a strategic shift toward greater reliance on the SkyCourier for regional and last-mile delivery, positioning it as a key component of the fleet alongside larger aircraft like the B777F and ATR 72-600F, while replacing older, less efficient models.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "FDX_10k_2022.pdf",
          "target_page": 40,
          "pages": [
            38,
            39,
            40,
            41,
            42
          ]
        },
        "hop_2_rel": {
          "source_file": "FDX_10k_2023.pdf",
          "target_page": 117,
          "pages": [
            115,
            116,
            117,
            118,
            119
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 9,
        "total_chars": 40006,
        "num_window_pages": 9,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 10236,
        "completion_tokens": 150,
        "total_tokens": 10386
      }
    },
    {
      "question_id": 45,
      "question": "How has Nike's approach to the Air Max product line evolved from 2022 to 2024, particularly in terms of revenue transparency and technological innovation emphasis?",
      "original_answer": "In 2022, Nike included Air Max in a general list of technologies within the revenue disaggregation table, indicating its presence in the product portfolio but without specific revenue figures. By 2024, while no direct revenue numbers were disclosed, Nike emphasized Air Max as a central example of its innovation strategy, highlighting its integration into broader product categories and consumer applications. This shift reflects a strategic move from passive acknowledgment to positioning Air Max as a key innovation driver, despite the continued lack of standalone financial metrics for the product line.",
      "llm_answer": "From 2022 to 2024, Nike’s financial disclosures show a shift toward greater transparency in revenue reporting, particularly through detailed segment breakdowns in the 2024 Form 10-K (pages 86–90), which disaggregates revenues by geography, product line, and distribution channel (e.g., wholesale vs. direct-to-consumer). While the 2022 filing (page 86) also provided segment revenue data, the 2024 version includes more granular metrics, such as specific figures for North America, EMEA, Greater China, and APLA, alongside clearer distinctions between Nike Brand and Converse revenues. Technologically, Nike continues to emphasize innovation in its Air Max line, with references to Air Sole manufacturing advancements (page 8) and R&D investments in technologies like Air Max, Zoom, and Flyknit (page 88), though revenue transparency around specific product lines like Air Max is not explicitly detailed. The company maintains a strong focus on technological differentiation as a competitive strategy, but revenue data does not isolate Air Max performance—only broader category trends (e.g., footwear, apparel) are reported. Overall, Nike’s approach to revenue transparency has evolved to include more structured, global segment reporting, while technological innovation remains central to its brand strategy, though not directly tied to revenue disclosures for specific products like Air Max.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "NKE_10k_2022.pdf",
          "target_page": 88,
          "pages": [
            86,
            87,
            88,
            89,
            90
          ]
        },
        "hop_2_rel": {
          "source_file": "NKE_10k_2024.pdf",
          "target_page": 6,
          "pages": [
            4,
            5,
            6,
            7,
            8
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 56662,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 14389,
        "completion_tokens": 348,
        "total_tokens": 14737
      }
    },
    {
      "question_id": 46,
      "question": "How did Comcast's capital expenditure strategy regarding Epic Universe evolve from 2023 to 2024, particularly in terms of specific investment amounts and thematic park development priorities?",
      "original_answer": "In 2023, Comcast specifically noted an increase in capital expenditures directly related to the development of Epic Universe in Orlando, with a total of $8.2 billion allocated to Connectivity & Platforms, which included investments in scalable infrastructure and line extensions. By 2024, the company continued to emphasize investment in existing and new attractions at Universal theme parks, including Epic Universe, as part of its broader capital expenditure plan for 2025. While specific figures for Epic Universe alone were not disclosed in 2024, the company indicated an ongoing commitment to theme park development, particularly in expanding attractions and enhancing capacity. The evolution shows a shift from initial infrastructure and development focus in 2023 to a more sustained investment strategy in 2024 that includes both infrastructure and guest experience enhancements.",
      "llm_answer": "Comcast's capital expenditure strategy shifted from 2023 to 2024 with a clear thematic park focus: in 2023, capital spending specifically included development of Epic Universe in Orlando ($8.2 billion total capex, with theme parks cited as a key driver), while 2024 saw increased investment in theme park attractions including Epic Universe construction, alongside continued network infrastructure spending. The company maintained its overall capex level ($8.286 billion in 2024 vs. $8.2 billion in 2023) but redirected emphasis toward theme park development, particularly Universal's Epic Universe, as a strategic priority for future growth.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CMCSA_10k_2023.pdf",
          "target_page": 37,
          "pages": [
            35,
            36,
            37,
            38,
            39
          ]
        },
        "hop_2_rel": {
          "source_file": "CMCSA_10k_2024.pdf",
          "target_page": 51,
          "pages": [
            49,
            50,
            51,
            52,
            53
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 41643,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 10643,
        "completion_tokens": 160,
        "total_tokens": 10804
      }
    },
    {
      "question_id": 47,
      "question": "How did FedEx's utilization of the ATR 72-600F aircraft evolve between 2022 and 2023 as reflected in their fleet projections for the same planning periods?",
      "original_answer": "In 2022, FedEx projected operating 11 ATR 72-600F aircraft in 2023, 6 in 2024, 6 in 2025, and only 1 in 2026. By 2023, the projections for the same time periods changed significantly, with 7 ATR 72-600F aircraft planned for 2025 and only 3 for 2026. This indicates a notable reduction in planned usage of the ATR 72-600F by FedEx over time.",
      "llm_answer": "Based on the provided 10-K filings, FedEx's utilization of the ATR 72‑600F aircraft declined between 2022 and 2023. In the 2022 fleet table (page 40), the company reported 6 ATR‑72‑600F aircraft on order with expected deliveries through 2026, and a total of 19 ATR‑72 aircraft (including the 6 ‑600Fs). By the 2023 projection (page 117), only 3 ATR‑72‑600F aircraft remained on the purchase commitment schedule for 2026, and the overall ATR‑72 fleet commitment dropped to 10 aircraft total, indicating a reduced reliance on the ATR 72‑600F model. Consequently, the airline’s planned utilization of the ATR 72‑600F decreased markedly from six aircraft slated for delivery in 2022‑2023 to just three slated for 2026, reflecting a strategic shift away from that type.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "FDX_10k_2022.pdf",
          "target_page": 40,
          "pages": [
            38,
            39,
            40,
            41,
            42
          ]
        },
        "hop_2_rel": {
          "source_file": "FDX_10k_2023.pdf",
          "target_page": 117,
          "pages": [
            115,
            116,
            117,
            118,
            119
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 9,
        "total_chars": 40006,
        "num_window_pages": 9,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 10225,
        "completion_tokens": 191,
        "total_tokens": 10416
      }
    },
    {
      "question_id": 47,
      "question": "How did Nike's approach to estimating product return reserves evolve between fiscal 2022 and fiscal 2024, and what does this indicate about changes in their revenue recognition methodology?",
      "original_answer": "In fiscal 2022, Nike disclosed that the estimated cost of inventory for expected product returns was $269 million, and these reserves were recorded in Prepaid expenses and other current assets. By fiscal 2024, while the specific dollar amount of the product return reserve was not disclosed, Nike described a more formalized estimation process, stating that it calculates anticipated reductions in revenue—such as sales returns—by determining the 'most likely amount' it will be entitled to receive. This indicates a shift toward a more probabilistic and forward-looking revenue estimation methodology, aligning with the broader revenue recognition framework where variable consideration is estimated at the time revenues are recognized.",
      "llm_answer": "Nike’s approach to estimating product return reserves evolved from a $269 million estimated cost of inventory for expected returns as of May 31 2021 to $194 million as of May 31 2022, reflecting a reduction in the reserve balance. This decline indicates that the company is adjusting its revenue‑recognition methodology to more conservatively estimate returns, likely due to changing market conditions or updated historical return patterns. Consequently, the lower reserve suggests a shift toward recognizing revenue with less anticipated return risk, which can affect the timing and amount of revenue recognized in each reporting period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "NKE_10k_2022.pdf",
          "target_page": 89,
          "pages": [
            87,
            88,
            89,
            90,
            91
          ]
        },
        "hop_2_rel": {
          "source_file": "NKE_10k_2024.pdf",
          "target_page": 66,
          "pages": [
            64,
            65,
            66,
            67,
            68
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 53809,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 13683,
        "completion_tokens": 159,
        "total_tokens": 13843
      }
    },
    {
      "question_id": 48,
      "question": "How did the planned fleet composition of the Cessna SkyCourier 408 change between 2022 and 2023 for the years 2025 and beyond, and what does this indicate about the company's strategic reliance on this aircraft model?",
      "original_answer": "In 2022, FDX projected a total of 12 Cessna SkyCourier 408 aircraft to be in operation by 2025 and planned to maintain that number through 2026. By 2023, the company increased its planned fleet count for 2025 to 17 but reduced it to 14 for 2026. This indicates a short-term increase in strategic reliance on the Cessna SkyCourier 408, followed by a moderate decline in planned usage by 2026, suggesting a recalibration of fleet strategy.",
      "llm_answer": "The planned fleet composition for the Cessna SkyCourier 408 was reduced from 17 aircraft scheduled for delivery in 2025 (as shown on page 117 of the 2024 filing) to 12 aircraft for 2025 and no deliveries thereafter in the 2024 filing, indicating that FedEx is scaling back its reliance on the SkyCourier model and shifting focus to other aircraft types such as the B767F and B777F for its future capacity needs. This reduction suggests a strategic pivot away from depending heavily on the Cessna 408 for long‑term growth.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "FDX_10k_2022.pdf",
          "target_page": 114,
          "pages": [
            112,
            113,
            114,
            115,
            116
          ]
        },
        "hop_2_rel": {
          "source_file": "FDX_10k_2023.pdf",
          "target_page": 117,
          "pages": [
            115,
            116,
            117,
            118,
            119
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 39546,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 10127,
        "completion_tokens": 130,
        "total_tokens": 10257
      }
    },
    {
      "question_id": 48,
      "question": "How has Mastercard's real-time account-based payments infrastructure evolved from 2023 to 2024, particularly in terms of operational scale and integrated security capabilities?",
      "original_answer": "In 2023, Mastercard operated or was implementing real-time payments infrastructure in 13 markets globally, offering instant payments with enhanced data and messaging capabilities. The company emphasized a distributed network architecture that enabled intelligent routing and applied value-added services like fraud scoring and tokenization in real time. By 2024, Mastercard expanded its capabilities by enhancing its ACH and real-time account-based payment systems to provide more secure, simple, and smart payment solutions across its global network. The company also reinforced its multi-layered security approach, integrating additional protections and partnerships to safeguard the payments ecosystem. These developments indicate a strategic shift toward strengthening both the scale and security of its real-time payments infrastructure.",
      "llm_answer": "Mastercard’s real‑time account‑based payments infrastructure continued to expand its operational footprint in 2024, extending coverage to 13 markets and supporting a broader set of use cases—including new B2B solutions such as Virtual Card Numbers, InControl™ controls, and the Mastercard Send™ platform that now reaches over 95 % of the world’s banked population.  The company also deepened its security capabilities, embedding multi‑layered cyber‑resilience, AI‑driven fraud scoring, and tokenization into the real‑time clearing and settlement layer, while maintaining a robust governance framework to protect the network and its participants.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MA_10k_2023.pdf",
          "target_page": 11,
          "pages": [
            9,
            10,
            11,
            12,
            13
          ]
        },
        "hop_2_rel": {
          "source_file": "MA_10k_2024.pdf",
          "target_page": 72,
          "pages": [
            70,
            71,
            72,
            73,
            74
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 54533,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 13860,
        "completion_tokens": 161,
        "total_tokens": 14021
      }
    },
    {
      "question_id": 48,
      "question": "How did Nike's use of foreign exchange forwards and options evolve between 2022 and 2024, particularly in terms of their impact on financial liabilities and hedging strategy?",
      "original_answer": "In 2022, foreign exchange forwards and options had a net gain of $8 million after tax, impacting various income categories such as revenues, cost of sales, and other (income) expense, net. By 2024, the liabilities associated with these instruments increased to $110 million under accrued liabilities and $5 million under deferred income taxes and other liabilities, indicating a shift in how these derivatives were managed or reported. This reflects a strategic evolution in Nike's hedging activities and financial exposure management.",
      "llm_answer": "Nike's use of foreign exchange forwards and options as cash flow hedges evolved from a $1.336 billion notional amount in 2022 to $16.2 billion in 2024, with the portion of deferred net gains in accumulated other comprehensive income expected to be reclassified to earnings falling from $607 million (2022) to $231 million (2024). Effective hedge results are recorded in revenues, cost of sales, demand‑creation expense or other income/expense, and gains/losses are re‑classified from accumulated OCI into those line items when the underlying hedged transactions occur. Discontinuation of hedge accounting occurs when forecasted transactions are no longer probable, at which point the derivative is treated as undesignated and any resulting gains/losses are recognized immediately in other (income) expense, net.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "NKE_10k_2022.pdf",
          "target_page": 87,
          "pages": [
            85,
            86,
            87,
            88,
            89
          ]
        },
        "hop_2_rel": {
          "source_file": "NKE_10k_2024.pdf",
          "target_page": 83,
          "pages": [
            81,
            82,
            83,
            84,
            85
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 65372,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 16570,
        "completion_tokens": 202,
        "total_tokens": 16773
      }
    },
    {
      "question_id": 48,
      "question": "How has the product category classification of Puffs within the Baby, Feminine & Family Care segment evolved between 2022 and 2023?",
      "original_answer": "In 2022, Puffs was categorized under the Family Care sub-category, which included Paper Towels, Tissues, and Toilet Paper. By 2023, Puffs remained in the Family Care category, but the specific mention of 'Tissues' replaced 'Tissues' with a more general listing without sub-category breakdowns, indicating a simplification or consolidation of how the segment details were reported.",
      "llm_answer": "Between 2022 and 2023, Puffs remained within the Baby, Feminine & Family Care segment, but its classification shifted from being grouped under \"Baby Care\" to being included under \"Feminine Care\" in the segment's product category breakdown. In 2023, Puffs was explicitly listed under \"Feminine Care (Adult Incontinence, Feminine Care)\" alongside brands like Always and Tampax, reflecting a reclassification within the segment's structure. This change was part of the segment's product category organization, though the segment itself (Baby, Feminine & Family Care) maintained its 24% share of net sales and 25% share of net earnings.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "PG_10k_2022.pdf",
          "target_page": 19,
          "pages": [
            17,
            18,
            19,
            20,
            21
          ]
        },
        "hop_2_rel": {
          "source_file": "PG_10k_2023.pdf",
          "target_page": 18,
          "pages": [
            16,
            17,
            18,
            19,
            20
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 9,
        "total_chars": 51030,
        "num_window_pages": 9,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 12973,
        "completion_tokens": 158,
        "total_tokens": 13131
      }
    },
    {
      "question_id": 49,
      "question": "How has the positioning of Tampax within P&G's product portfolio evolved between 2022 and 2023, particularly in terms of its categorization and associated product lines?",
      "original_answer": "In 2022, Tampax was categorized under 'Feminine Care' within the 'Baby, Feminine & Family Care' segment, which also included 'Baby Care' and 'Family Care' sub-categories. By 2023, the product category was refined, and Tampax was associated solely with 'Menstrual Care' under the same broader segment. This reflects a more focused positioning of Tampax, separating it from general 'Family Care' items and aligning it more specifically with menstrual health needs.",
      "llm_answer": "Between 2022 and 2023, Tampax remained within the Baby, Feminine & Family Care segment, which accounted for 25% of net sales and 23% of net earnings in 2023 (down slightly from 25% and 23% in 2022). The segment's product categories, including Feminine Care (with Tampax as a key brand), were part of P&G's strategic focus on daily-use products with leadership market positions. Tampax continued to be positioned as a core brand within the Feminine Care sub-category, which held over 20% global market share, consistent with P&G's broader strategy of maintaining leadership in high-growth categories. No structural changes to its categorization or product line associations were noted in the provided disclosures.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "PG_10k_2022.pdf",
          "target_page": 19,
          "pages": [
            17,
            18,
            19,
            20,
            21
          ]
        },
        "hop_2_rel": {
          "source_file": "PG_10k_2023.pdf",
          "target_page": 18,
          "pages": [
            16,
            17,
            18,
            19,
            20
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 9,
        "total_chars": 51030,
        "num_window_pages": 9,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 12983,
        "completion_tokens": 178,
        "total_tokens": 13161
      }
    },
    {
      "question_id": 49,
      "question": "How has Oracle's strategy and positioning of Oracle Engineered Systems evolved between fiscal 2022 and fiscal 2023, particularly in terms of revenue contribution and research investment expectations?",
      "original_answer": "In fiscal 2022, Oracle highlighted that its hardware business, which includes Oracle Engineered Systems, involved point-of-sale revenue recognition for hardware and related software, with the majority of products sold through indirect channels. By fiscal 2023, Oracle introduced a more forward-looking strategy, explicitly stating plans to continue investing in research and development to improve existing hardware products and develop new offerings. Additionally, in fiscal 2023, Oracle noted that hardware represented 6% of total revenues, a figure not specified in 2022, indicating a clearer emphasis on the segment's strategic positioning.",
      "llm_answer": "Oracle’s strategy shifted toward cloud‑centric growth, with cloud services and license support revenues rising from 25% of total revenue in fiscal 2022 to 37% in fiscal 2024, reflecting a deliberate emphasis on cloud and license offerings. Consequently, the company expects continued revenue expansion in this segment and plans to allocate additional research and development investment to sustain and enhance its cloud and license products and services.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "ORCL_10k_2022.pdf",
          "target_page": 51,
          "pages": [
            49,
            50,
            51,
            52,
            53
          ]
        },
        "hop_2_rel": {
          "source_file": "ORCL_10k_2023.pdf",
          "target_page": 43,
          "pages": [
            41,
            42,
            43,
            44,
            45
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 53642,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 13644,
        "completion_tokens": 113,
        "total_tokens": 13758
      }
    },
    {
      "question_id": 50,
      "question": "How did Honeywell's investment in private funds for its Non-U.S. pension plans evolve between 2022 and 2023, particularly in terms of allocation and classification across fair value hierarchy levels?",
      "original_answer": "In 2022, Honeywell reported $1,105 million invested in private funds for its U.S. pension plans, with the amount classified under Level 3 of the fair value hierarchy. By 2023, the company reported $115 million in private fund investments for its Non-U.S. pension plans, with $41 million classified under Level 2 and $74 million under Level 3 of the fair value hierarchy. This represents a significant decrease in overall private fund allocation, particularly in U.S. plans, and a shift in classification for the remaining private fund investments under the Non-U.S. plans.",
      "llm_answer": "Between 2022 and 2023, Honeywell's non-U.S. pension plan investments in private funds increased from $36 million (Level 3) to $74 million (Level 3), reflecting purchases of $39 million and a $3 million gain, while the overall allocation across the fair‑value hierarchy shifted toward higher Level 3 classification, especially within private funds and insurance buy‑in contracts.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "HON_10k_2022.pdf",
          "target_page": 111,
          "pages": [
            109,
            110,
            111,
            112,
            113
          ]
        },
        "hop_2_rel": {
          "source_file": "HON_10k_2023.pdf",
          "target_page": 110,
          "pages": [
            108,
            109,
            110,
            111,
            112
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 57819,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 14691,
        "completion_tokens": 94,
        "total_tokens": 14785
      }
    },
    {
      "question_id": 50,
      "question": "How did the status and management of the 2014 USD Notes evolve between 2023 and 2024, and what specific actions were taken regarding this debt in 2024?",
      "original_answer": "In 2023, the 2014 USD Notes were classified as short-term debt, net of unamortized discount and debt issuance costs, with a maturity date of April 2024. By 2024, the company reported that in April 2024, $1 billion of principal related to the 2014 USD Notes matured and was paid in full. This indicates that the company transitioned the obligation from a near-term liability in 2023 to a fully settled debt instrument in 2024.",
      "llm_answer": "Between 2023 and 2024 the Company retired the $1 billion of 2014 USD Notes that had been outstanding (they matured in April 2024) and replaced them with new 2024 USD Notes totaling $4 billion of issuances (including $1 billion due May 2034, $750 million due Jan 2028 and $1.15 billion due Jan 2032, $1.1 billion due Jan 2035).  In July 2024 the INR‑denominated term loan (originally due July 2023) was rolled into a larger INR 28.1 billion facility that matures in July 2024 and was fully repaid at that time.  These actions reduced short‑term debt and reshaped the Company’s debt profile, leaving $18.2 billion of total debt outstanding at year‑end 2024 with the next principal maturity scheduled for March 2025.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MA_10k_2023.pdf",
          "target_page": 97,
          "pages": [
            95,
            96,
            97,
            98,
            99
          ]
        },
        "hop_2_rel": {
          "source_file": "MA_10k_2024.pdf",
          "target_page": 58,
          "pages": [
            56,
            57,
            58,
            59,
            60
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 51141,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 13006,
        "completion_tokens": 178,
        "total_tokens": 13184
      }
    },
    {
      "question_id": 50,
      "question": "How has the treatment and documentation of Lowe's Officer Indemnification Agreements evolved between 2022 and 2024, and what does this indicate about the company's executive risk management and governance continuity?",
      "original_answer": "Between 2022 and 2024, Lowe's maintained the same form of Officer Indemnification Agreement, first filed as Exhibit 10.43 on April 2, 2019, and refiled without amendment in both the 2022 and 2024 10-K filings. This indicates that the company did not modify the terms or structure of these agreements over this period, suggesting consistent governance practices and a stable approach to executive risk management and retention. Investors can interpret this continuity as a sign of predictable leadership protections and aligned corporate governance priorities.",
      "llm_answer": "Based on the provided SEC filings, Lowe's updated its executive indemnification agreements between 2022 and 2024, with the most recent revisions appearing in 2024 filings (e.g., 10-K filed March 25, 2024, exhibits 10.23 and 10.24). These updates reflect a formalized, standardized approach to officer indemnification, aligning with evolving corporate governance practices and legal expectations. The consistent inclusion of these agreements in annual reports (10-K) and quarterly filings (10-Q) since 2018 indicates a stable, ongoing commitment to executive risk management and governance continuity, ensuring clarity in fiduciary protections for senior leadership amid regulatory and operational changes.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "LOW_10k_2022.pdf",
          "target_page": 90,
          "pages": [
            79,
            80,
            81,
            82,
            83
          ]
        },
        "hop_2_rel": {
          "source_file": "LOW_10k_2024.pdf",
          "target_page": 79,
          "pages": [
            77,
            78,
            79,
            80,
            81
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 8,
        "total_chars": 36727,
        "num_window_pages": 8,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 9419,
        "completion_tokens": 176,
        "total_tokens": 9596
      }
    },
    {
      "question_id": 50,
      "question": "How did the market share and category positioning of Always Discreet in the adult incontinence market change between the 2022 and 2023 Procter & Gamble 10-K filings?",
      "original_answer": "In the 2022 filing, Always Discreet was explicitly stated to have over 10% market share in the key adult incontinence markets where Procter & Gamble competes. However, in the 2023 filing, while Always Discreet is still listed as a major brand in the Feminine Care category under the Baby, Feminine & Family Care segment, no specific market share figure is provided for the brand. This suggests a shift in how the brand's performance is communicated, moving away from a quantified market share disclosure to a more general category association.",
      "llm_answer": "Based on the 2022 and 2023 10-K filings, Always Discreet’s market share and category positioning remained stable, with no significant changes reported. The company continued to hold a leadership position in the adult incontinence category, particularly in key markets where it maintained over 10% market share, consistent with its historical standing as a global market leader in feminine care and adult incontinence products. The filings do not indicate any notable shifts in market share or category strategy between the two years.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "PG_10k_2022.pdf",
          "target_page": 19,
          "pages": [
            17,
            18,
            19,
            20,
            21
          ]
        },
        "hop_2_rel": {
          "source_file": "PG_10k_2023.pdf",
          "target_page": 18,
          "pages": [
            16,
            17,
            18,
            19,
            20
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 9,
        "total_chars": 51030,
        "num_window_pages": 9,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 12982,
        "completion_tokens": 133,
        "total_tokens": 13115
      }
    },
    {
      "question_id": 50,
      "question": "How has Oracle's strategic positioning of Engineered Systems evolved between 2022 and 2023, particularly in terms of their role within the hardware business and implications for Oracle's cloud transformation narrative?",
      "original_answer": "In 2022, Oracle Engineered Systems were described as pre-integrated products central to both cloud and on-premise data center infrastructure, emphasizing their technical advantages such as improved performance, scalability, and simplified maintenance. However, by 2023, Oracle elevated the strategic importance of Engineered Systems by positioning them as part of a broader hardware business that now includes servers, storage, and operating systems, all tightly integrated and accounted for as combined performance obligations. The 2023 filing also highlighted that hardware revenues, including Engineered Systems, represented 6% of total revenues in both fiscal 2023 and 2024, and underscored ongoing R&D investments to enhance these offerings. This evolution suggests that Oracle is leveraging Engineered Systems not just as technical solutions but as foundational components in its hybrid cloud and on-premise strategies, aligning them more closely with its cloud transformation narrative while acknowledging the lower-margin nature of the hardware business.",
      "llm_answer": "Between 2022 and 2023 Oracle’s Engineered Systems shifted from being a distinct hardware profit center to a strategic enabler of its cloud transformation, with the hardware business now explicitly positioned as a support layer for Oracle Cloud (OCI) and engineered systems are marketed as integrated platforms (e.g., Exadata Cloud Service, Cloud@Customer) that drive cloud adoption and generate recurring support revenue. This evolution reflects a deliberate move to embed hardware within Oracle’s broader cloud narrative—emphasizing recurring support contracts, cloud migration pathways, and integrated hardware‑software offerings—rather than treating hardware as a standalone, lower‑margin segment.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "ORCL_10k_2022.pdf",
          "target_page": 13,
          "pages": [
            11,
            12,
            13,
            14,
            15
          ]
        },
        "hop_2_rel": {
          "source_file": "ORCL_10k_2023.pdf",
          "target_page": 43,
          "pages": [
            41,
            42,
            43,
            44,
            45
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 47637,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 12148,
        "completion_tokens": 175,
        "total_tokens": 12323
      }
    },
    {
      "question_id": 51,
      "question": "How did the disclosure regarding the 2020 Stock Plan's relationship with the 2011 Stock Plan evolve between the 2022 and 2023 10-K filings?",
      "original_answer": "In the 2022 10-K filing, the 2020 Stock Plan disclosure included the detail that 5,530,106 shares previously available under the 2011 Stock Plan were carried forward and made available for award grants under the 2020 Stock Plan. However, in the 2023 10-K filing, this specific reference to the 2011 Stock Plan and the carry-forward of shares was omitted. This indicates a shift in how the company chose to present the lineage and transition between the two stock plans, focusing only on the 2020 Stock Plan without linking it to its predecessor in the disclosed text.",
      "llm_answer": "The disclosure regarding the 2020 Stock Plan’s relationship with the 2011 Stock Plan was updated in the 2023 10‑K to clarify that the 2020 Stock Plan succeeded the 2011 Stock Plan and that shares previously available under the 2011 plan were now available for grant under the 2020 plan. Earlier filings (2022) presented the two plans separately without emphasizing this succession, but the 2023 filing explicitly states that the 2020 Stock Plan is the successor and that its shares include those previously reserved under the 2011 plan. This evolution reflects a consolidation of the equity‑incentive framework into a single, unified plan.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "NFLX_10k_2022.pdf",
          "target_page": 59,
          "pages": [
            57,
            58,
            59,
            60,
            61
          ]
        },
        "hop_2_rel": {
          "source_file": "NFLX_10k_2023.pdf",
          "target_page": 61,
          "pages": [
            59,
            60,
            61,
            62,
            63
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 45262,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 11534,
        "completion_tokens": 159,
        "total_tokens": 11694
      }
    },
    {
      "question_id": 51,
      "question": "How has Honeywell's allocation strategy toward private funds evolved between 2022 and 2023, and what might this indicate about the company's capital deployment priorities?",
      "original_answer": "In 2022, Honeywell reported $1,244 million invested in private funds, as disclosed in the 2022 10-K filing. By 2023, this amount increased slightly to $1,265 million, as noted in the 2023 10-K filing. This represents a modest increase of approximately 1.7%, suggesting that Honeywell maintained a relatively stable allocation strategy toward private funds despite broader reductions in total assets under the U.S. plans. This slight upward trend may indicate a strategic decision to preserve or slightly expand exposure to alternative investments, potentially to capitalize on expected higher returns or diversification benefits from private fund investments.",
      "llm_answer": "Honeywell’s allocation to private funds in its pension portfolio remained relatively stable, with direct private investments held at $1,284 million in 2022 and $1,293 million in 2023, and private‑fund assets measured at NAV slightly increasing from $1,258 million to $1,265 million over the same period. This modest growth suggests the company is maintaining a steady exposure to private‑equity and real‑estate investments, reflecting a continued focus on long‑term, higher‑return assets while keeping overall capital deployment priorities aligned with its target asset‑allocation ranges (e.g., 10‑20 % “other” investments).",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "HON_10k_2022.pdf",
          "target_page": 111,
          "pages": [
            109,
            110,
            111,
            112,
            113
          ]
        },
        "hop_2_rel": {
          "source_file": "HON_10k_2023.pdf",
          "target_page": 109,
          "pages": [
            107,
            108,
            109,
            110,
            111
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 62477,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 15848,
        "completion_tokens": 156,
        "total_tokens": 16004
      }
    },
    {
      "question_id": 51,
      "question": "How did the status and disclosure of Class B-2 Common Stock evolve between 2023 and 2024, particularly regarding its outstanding status and relationship to other stock classes?",
      "original_answer": "In 2023, Class B-2 Common Stock was subject to conversion rate adjustments tied to the U.S. litigation escrow account under the U.S. retrospective responsibility plan, which caused dilution in as-converted shares. Additionally, it was noted that no shares of Class B-2 were outstanding prior to the Class B-1 exchange offer. By 2024, the 10-K filing only referenced Class B-2 Common Stock in relation to its lack of outstanding shares prior to the Class B-1 exchange offer, with no further updates or disclosures regarding its conversion mechanics or dilution impacts, suggesting a reduced emphasis or potential discontinuation of its active role in the capital structure.",
      "llm_answer": "Between 2023 and 2024, Class B‑2 common stock transitioned from having no outstanding shares to 120 million shares issued and outstanding (as shown on page 85 of the 2024 filing). This issuance occurred as part of the class B‑1 common‑stock exchange offer completed on May 8 2024, where each exchanged B‑1 share was converted into one share of newly created Class B‑2 stock. The conversion rates for B‑2 shares are rounded to the tenth decimal (e.g., 1.5430) and are subject to adjustments tied to the U.S. litigation escrow account and the resolution of covered litigation, which can affect the as‑converted share count and conversion rates for all B‑stock classes.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "V_10k_2023.pdf",
          "target_page": 87,
          "pages": [
            85,
            86,
            87,
            88,
            89
          ]
        },
        "hop_2_rel": {
          "source_file": "V_10k_2024.pdf",
          "target_page": 59,
          "pages": [
            57,
            58,
            59,
            60,
            61
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 65546,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 16613,
        "completion_tokens": 166,
        "total_tokens": 16780
      }
    },
    {
      "question_id": 51,
      "question": "How did the financial obligations related to the Target Circle program change between 2022 and 2024, and what does this indicate about the program's evolution?",
      "original_answer": "In 2022, the deferred revenue related to the Target Circle program was $89 million as of January 29, 2022, while in 2024, the deferred revenue related to the program was $117 million as of February 3, 2024. This indicates a significant increase in the company's liability tied to unredeemed rewards, suggesting growth in program participation or changes in redemption patterns. However, by February 1, 2025, the deferred revenue had dropped to $19 million, signaling a sharp decline, which may reflect either a surge in reward redemptions or a strategic change in how the program's liabilities are recognized or managed.",
      "llm_answer": "Between 2022 and 2024, the Target Circle program’s deferred revenue liability declined sharply from $117 million (as of February 3, 2024) to $19 million (as of February 1, 2025), reflecting a major reduction in the program’s financial obligations. This decrease signals that Target has scaled back or restructured its Circle rewards and related revenue‑recognition practices, indicating an evolution toward a leaner, possibly more performance‑based loyalty model.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "TGT_10k_2022.pdf",
          "target_page": 46,
          "pages": [
            44,
            45,
            46,
            47,
            48
          ]
        },
        "hop_2_rel": {
          "source_file": "TGT_10k_2024.pdf",
          "target_page": 50,
          "pages": [
            48,
            49,
            50,
            51,
            52
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 41980,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 10718,
        "completion_tokens": 115,
        "total_tokens": 10834
      }
    },
    {
      "question_id": 52,
      "question": "How did the fair value of Netflix's 4.375% Senior Notes change between December 31, 2022, and December 31, 2023, and what does this indicate about investor perception or market conditions?",
      "original_answer": "The fair value of Netflix's 4.375% Senior Notes decreased from $980 million on December 31, 2022, to $996 million on December 31, 2023. This indicates a shift in investor perception or market conditions, as the fair value moved closer to the principal amount at par, suggesting a stabilization or improved outlook for the company's debt.",
      "llm_answer": "The fair value of Netflix's 4.375% Senior Notes was $996 million on December 31 2023 versus $980 million on December 31 2022, reflecting a modest increase in market value. This slight rise suggests that investor perception of the notes remained relatively stable, with market conditions supporting only a marginal premium over par.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "NFLX_10k_2022.pdf",
          "target_page": 56,
          "pages": [
            54,
            55,
            56,
            57,
            58
          ]
        },
        "hop_2_rel": {
          "source_file": "NFLX_10k_2023.pdf",
          "target_page": 56,
          "pages": [
            54,
            55,
            56,
            57,
            58
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 44329,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 11313,
        "completion_tokens": 82,
        "total_tokens": 11396
      }
    },
    {
      "question_id": 52,
      "question": "How did the equity structure related to Class C Common Stock evolve between 2023 and 2024, particularly in terms of share issuance and equity classification?",
      "original_answer": "In 2023, Visa conducted an exchange offer where 241 million shares of Class B-1 common stock were tendered, and in exchange, approximately 48 million shares of Class C common stock were issued. This indicates active restructuring of stock classes tied to the Visa Europe retrospective responsibility plans. By 2024, the balance of Class C common stock remained at 10 shares issued and outstanding, as stated in the equity section of the balance sheet. This suggests that while there was active movement and restructuring involving Class C shares in 2023, the 2024 disclosures indicate a stabilization or conclusion of that phase of equity restructuring.",
      "llm_answer": "Between 2023 and 2024, Visa issued approximately 120 million shares of Class B‑2 common stock and 48 million shares of Class C common stock as part of the May 2024 Class B‑1 common stock exchange offer, while also releasing $2.7 billion of as‑converted value from its Series B and C preferred stock in July 2024. The company continued to repurchase Class A shares (64 million shares for $17 billion in fiscal 2024) and maintained a substantial share‑repurchase authorization, but no new Class B‑1 shares were outstanding after the exchange. These actions reflect a shift in equity composition toward more Class B‑2 and Class C shares and a continued focus on capital returns through buybacks and dividend payments.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "V_10k_2023.pdf",
          "target_page": 40,
          "pages": [
            38,
            39,
            40,
            41,
            42
          ]
        },
        "hop_2_rel": {
          "source_file": "V_10k_2024.pdf",
          "target_page": 58,
          "pages": [
            56,
            57,
            58,
            59,
            60
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 58795,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 14921,
        "completion_tokens": 178,
        "total_tokens": 15099
      }
    },
    {
      "question_id": 52,
      "question": "How has Lowe's engagement with Rough Plumbing evolved from 2022 to 2024, particularly in terms of its business classification and service offerings?",
      "original_answer": "In 2022, Rough Plumbing was classified under the 'Building Products' category, indicating it was primarily offered as a product within Lowe's merchandise divisions. By 2024, Lowe's had expanded its engagement with Rough Plumbing by integrating it into both installation services and protection plans, signaling a shift from a pure product offering to a more service-oriented approach. This evolution reflects a strategic move to bundle Rough Plumbing with labor and extended protection, contributing to the approximately 5% of total sales attributed to installed sales in 2024.",
      "llm_answer": "From 2022 to 2024, Lowe's has shifted its Rough Plumbing business from being grouped under the broader \"Building Products\" category (which included Rough Plumbing among other subcategories) to being explicitly highlighted as a distinct service offering within its installed sales model. In the 2024 10-K, Lowe's specifically lists \"Rough Plumbing\" alongside Kitchen & Bath, Flooring, Appliances, and Millwork as a key category accounting for the majority of installed sales, emphasizing its standalone importance. Additionally, Lowe's expanded its service model to include dedicated installation services through independent contractors for Rough Plumbing, integrating it into its omnichannel approach where customers can now finalize installation contracts and checkout online via lowes.com or the mobile app, reducing the need for in-store returns. This evolution reflects a strategic focus on streamlining Rough Plumbing as a core, standalone service within its installed sales business, which represented approximately 5% of total sales in fiscal 2024.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "LOW_10k_2022.pdf",
          "target_page": 55,
          "pages": [
            53,
            54,
            55,
            56,
            57
          ]
        },
        "hop_2_rel": {
          "source_file": "LOW_10k_2024.pdf",
          "target_page": 7,
          "pages": [
            5,
            6,
            7,
            8,
            9
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 46115,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 11748,
        "completion_tokens": 264,
        "total_tokens": 12012
      }
    },
    {
      "question_id": 53,
      "question": "How did the introduction and subsequent status of Class B-2 common stock evolve between 2023 and 2024, and what does this indicate about its role in the company's capital structure?",
      "original_answer": "In 2023, Class B-2 common stock was newly introduced with 77 million shares outstanding, indicating its initial incorporation into the company's equity structure. By 2024, the company disclosed that no shares of Class B-2 common stock were outstanding prior to the Class B-1 common stock exchange offer, suggesting a strategic shift where Class B-2 shares may have been replaced or restructured as part of a broader capital realignment. This indicates a transformation in the role of Class B-2 common stock within the company’s capital structure.",
      "llm_answer": "The Class B‑2 common stock was created in May 2024 when Visa’s exchange offer retired the newly‑renamed Class B‑1 shares and issued approximately 120 million Class B‑2 shares (and 48 million Class C shares).  Prior to this exchange, no Class B‑2 shares were outstanding, and the newly issued Class B‑2 shares carry the same conversion‑rate adjustment mechanism that governs the Class B‑1 stock, effectively expanding the company’s equity base and altering the capital‑structure weighting among its multiple common‑stock classes.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "V_10k_2023.pdf",
          "target_page": 91,
          "pages": [
            89,
            90,
            91,
            92,
            93
          ]
        },
        "hop_2_rel": {
          "source_file": "V_10k_2024.pdf",
          "target_page": 59,
          "pages": [
            57,
            58,
            59,
            60,
            61
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 68082,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 17248,
        "completion_tokens": 132,
        "total_tokens": 17380
      }
    },
    {
      "question_id": 53,
      "question": "How has the financial liability associated with the Target Circle program changed between 2022 and 2024, and what does this indicate about the program's growth or evolution?",
      "original_answer": "In 2022, the Target Circle program was described primarily in terms of its benefits to customers, such as earning 1% rewards on non-RedCard purchases, but no specific liability figure was disclosed. By 2024, the deferred revenue related to the Target Circle program had grown to $117 million as of February 3, 2024, indicating a significant increase in the program's financial liability and suggesting substantial growth or expansion of the program. This increase reflects a greater number of participants or increased transactional activity within the program.",
      "llm_answer": "The financial liability associated with the Target Circle program, as reflected in the gift card liability and deferred revenue figures, remained relatively stable between 2023 and 2024. As of February 1, 2025, the Target Circle liability was $19 million, compared to $117 million as of February 3, 2024, indicating a significant decrease in deferred revenue related to the program. This reduction suggests a decline in the program's growth or evolution, potentially reflecting changes in redemption patterns or program adjustments, though the core program structure remains part of Target's broader customer loyalty strategy.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "TGT_10k_2022.pdf",
          "target_page": 5,
          "pages": [
            3,
            4,
            5,
            6,
            7
          ]
        },
        "hop_2_rel": {
          "source_file": "TGT_10k_2024.pdf",
          "target_page": 50,
          "pages": [
            48,
            49,
            50,
            51,
            52
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 34503,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 8851,
        "completion_tokens": 156,
        "total_tokens": 9008
      }
    },
    {
      "question_id": 54,
      "question": "How has NVDA's exposure to and concern about pollution limits evolved between 2023 and 2024, particularly in terms of regulatory impact on operations and customer data center expansion?",
      "original_answer": "In 2023, NVDA highlighted that pollution limits and related climate regulations could increase direct and indirect costs, including compliance, energy, and capital expenditures, and could require changes to manufacturing processes and supply chain operations. By 2024, the company expanded its concern to include not only cost increases but also the potential for land and permitting constraints tied to pollution limits, which could impair customers' ability to expand data center capacity—an essential market for NVDA's products. This indicates a growing concern that regulatory tightening around pollution could directly affect demand for NVDA's offerings.",
      "llm_answer": "NVIDIA’s 2024 10‑K shows that concerns about pollution limits and related regulatory constraints have shifted from a general risk discussion in 2023 to a more specific focus on how environmental rules could affect its data‑center supply chain and customer expansion.  In the 2023 filing the company warned that “pollution limits” could constrain operations and that trade restrictions might limit sales to certain markets.  By 2024 the language is tighter: the filing notes that “water and energy availability and reliability … are critical, and extreme heat or water shortages could impair the ability of our customers to expand their data‑center capacity and consume our products,” and that “new or proposed regulations relating to carbon taxes, fuel or energy taxes, pollution limits … could result in greater direct costs … and require us to alter our operations and product design activities.”  This indicates that regulatory pressure on energy‑intensive data‑center growth and emissions is now a concrete operational and strategic concern for NVIDIA.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "NVDA_10k_2023.pdf",
          "target_page": 22,
          "pages": [
            20,
            21,
            22,
            23,
            24
          ]
        },
        "hop_2_rel": {
          "source_file": "NVDA_10k_2024.pdf",
          "target_page": 22,
          "pages": [
            20,
            21,
            22,
            23,
            24
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 65042,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 16491,
        "completion_tokens": 264,
        "total_tokens": 16755
      }
    },
    {
      "question_id": 55,
      "question": "How did the composition and valuation of the company's Guaranteed Senior Notes evolve between 2023 and 2024, particularly in terms of issuance, repayment, and fair value inputs?",
      "original_answer": "In 2023, the company's Japanese subsidiary issued four Guaranteed Senior Notes totaling approximately $500 at fixed interest rates ranging from 1.400% to 2.120%. These notes were valued using Level 3 inputs. In 2024, the Japanese subsidiary repaid $77 of these Guaranteed Senior Notes. The fair value of long-term debt, including Guaranteed Senior Notes, was approximately $5,412 at the end of 2024, compared to $5,738 at the end of 2023. This indicates a reduction in the overall fair value of long-term debt, partially driven by repayments on the Guaranteed Senior Notes.",
      "llm_answer": "The company's Guaranteed Senior Notes issued by its Japanese subsidiary were valued using Level 3 inputs, and in July 2024 the subsidiary repaid $77 of these notes. Meanwhile, the Company retired $1,000 of its 2.750% Senior Notes on May 18, 2024, reducing the carrying amount of long‑term debt and resulting in a fair‑value estimate of the remaining long‑term debt of approximately $5,412 at the end of 2024.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "COST_10k_2023.pdf",
          "target_page": 52,
          "pages": [
            50,
            51,
            52,
            53,
            54
          ]
        },
        "hop_2_rel": {
          "source_file": "COST_10k_2024.pdf",
          "target_page": 52,
          "pages": [
            50,
            51,
            52,
            53,
            54
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 31704,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 8154,
        "completion_tokens": 102,
        "total_tokens": 8256
      }
    },
    {
      "question_id": 56,
      "question": "How did Netflix's investment in streaming service improvements and associated risk exposure evolve from 2022 to 2024, based on the specific personnel and cybersecurity-related changes disclosed in those years?",
      "original_answer": "In 2022, Netflix disclosed a $384 million increase in personnel-related costs driven by headcount growth to support production activity and improve the streaming service. By 2024, the focus had evolved to include significant emphasis on cybersecurity, with detailed descriptions of enterprise-wide security programs, third-party risk management, and the potential financial impact of cyber incidents. The company highlighted the risk of unauthorized data releases and digital content theft, noting that such events could adversely affect business operations and financial results. This represents a shift from purely growth-oriented investment in streaming to a more risk-aware posture as the service matured.",
      "llm_answer": "From 2022 to 2024, Netflix’s risk exposure related to streaming‑service investments shifted from a focus on personnel‑driven technology and development spending to heightened cybersecurity and regulatory scrutiny. In the 2022 filing, the company highlighted the need for skilled staff to maintain and improve its streaming platform, noting that “technology and development” expenses grew 24 % year‑over‑year, driven largely by headcount increases supporting streaming enhancements. By 2024, the same disclosures emphasized that cybersecurity risks—such as potential data breaches, unauthorized access to content, and the costs of maintaining a robust security program—had become a central concern, with the company describing its enterprise‑wide information‑security program, bug‑bounty initiatives, and regular third‑party audits as critical to protecting its streaming infrastructure. This evolution reflects a transition from expanding technical staff to managing the heightened risk exposure associated with protecting that expanded platform and its massive global user base.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "NFLX_10k_2022.pdf",
          "target_page": 26,
          "pages": [
            24,
            25,
            26,
            27,
            28
          ]
        },
        "hop_2_rel": {
          "source_file": "NFLX_10k_2024.pdf",
          "target_page": 17,
          "pages": [
            15,
            16,
            17,
            18,
            19
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 58633,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 14895,
        "completion_tokens": 269,
        "total_tokens": 15164
      }
    },
    {
      "question_id": 56,
      "question": "How did The Bank of New York Mellon Corporation's approach to restricted stock unit agreements evolve between the 2023 and 2024 filings, particularly in terms of the lifecycle management of these equity instruments and their implications for executive compensation strategy?",
      "original_answer": "In the 2023 filing, the '2024 Form of Restricted Stock Unit Agreement' was newly introduced and explicitly stated as 'Filed herewith,' indicating it was a current and newly adopted form for that year. This suggests the company was actively updating its equity compensation framework to align with strategic goals for executive retention and incentives. By the 2024 filing, this '2024 Form' was no longer newly filed but instead was referenced as 'Previously filed,' signaling it had become an established part of the company's compensation structure. Additionally, in 2024, the company introduced the '2025 Form of Restricted Stock Unit Agreement,' which was marked as 'Filed herewith,' showing a forward-looking update to the equity compensation strategy. This evolution indicates a consistent, proactive approach to managing executive compensation frameworks, with new forms being introduced annually and the prior year’s forms transitioning into reference documents. This reflects a mature, iterative process in shaping executive incentives and aligning them with long-term corporate objectives.",
      "llm_answer": "Based on the provided SEC filings, BNY Mellon's approach to restricted stock unit (RSU) agreements has evolved through incremental updates to its equity compensation framework rather than a fundamental shift. The 2024 filing (Exhibit 10.29) introduces a new form of RSU agreement, continuing a pattern of annual updates seen in prior years (e.g., 2021, 2022, 2023 forms filed as Exhibits 10.2, 10.22, and 10.24). These updates reflect ongoing refinement of lifecycle management for equity instruments, particularly in alignment with executive compensation strategy, as evidenced by the consistent incorporation of new RSU and performance share unit agreements (e.g., 2024 Performance Share Unit Agreement, Exhibit 10.25) into the company's compensation structure. The evolution underscores a systematic approach to adapting equity awards to regulatory and strategic needs, with no indication of structural changes to the core compensation philosophy.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "BK_10k_2023.pdf",
          "target_page": 20,
          "pages": [
            18,
            19,
            20,
            21,
            22
          ]
        },
        "hop_2_rel": {
          "source_file": "BK_10k_2024.pdf",
          "target_page": 19,
          "pages": [
            17,
            18,
            19,
            20,
            21
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 44969,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 11494,
        "completion_tokens": 237,
        "total_tokens": 11731
      }
    },
    {
      "question_id": 56,
      "question": "How has the status and structure of the 4.90% Senior Notes evolved from 2023 to 2024, particularly in terms of their carrying amount and maturity timeline?",
      "original_answer": "In 2023, the 4.90% Senior Notes were newly issued in November 2023, with a principal amount of $750 million, a discount of $3.4 million, and a maturity date of April 15, 2029. Interest payments were scheduled semi-annually starting April 15, 2024. By 2024, these notes remained outstanding, with a carrying amount of $743 million as of January 28, 2024. The maturity date remained unchanged at April 2029, and the notes continued to be listed among the company’s long-term debt obligations. The carrying amount slightly decreased, reflecting the initial discount and amortization progress over the year.",
      "llm_answer": "The 4.90% Senior Notes issued in 2029 remain outstanding through their maturity in 2029, with their carrying amount declining slightly from $743 million as of January 28, 2024 to $743 million as of February 2, 2025 (reflecting amortization of any discount and normal principal repayments). No redemption or refinancing of these specific notes was noted in the 2024 filings, so their maturity timeline stays unchanged, and their carrying amount reflects the ongoing accretion of the discount over the remaining term.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "HD_10k_2023.pdf",
          "target_page": 60,
          "pages": [
            58,
            59,
            60,
            61,
            62
          ]
        },
        "hop_2_rel": {
          "source_file": "HD_10k_2024.pdf",
          "target_page": 62,
          "pages": [
            60,
            61,
            62,
            63,
            64
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 52423,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 13328,
        "completion_tokens": 128,
        "total_tokens": 13456
      }
    },
    {
      "question_id": 56,
      "question": "How did the issuance and repayment of Guaranteed Senior Notes by Costco's Japanese subsidiary evolve between 2023 and 2024?",
      "original_answer": "In 2023, Costco's Japanese subsidiary issued four Guaranteed Senior Notes totaling approximately $500 at fixed interest rates ranging from 1.400% to 2.120%. In 2024, the subsidiary repaid $77 of these Guaranteed Senior Notes. Additionally, the proceeds from the issuance of these notes were referenced in the 2024 filing as a source of financing activity, indicating continued financial engagement with this instrument.",
      "llm_answer": "The Company’s Japanese subsidiary issued $500 million of Guaranteed Senior Notes in November 2023 at fixed rates of 1.400%–2.120% (maturing 2033‑2043) and subsequently repaid $77 million of those notes in July 2024.  In May 2024 the subsidiary also settled the $1,000 principal balance on the parent’s 2.750% Senior Notes, using cash and short‑term investments.  Overall, the issuance increased long‑term debt by roughly $500 million, while the July 2024 repayment reduced it by $77 million, leaving the net balance of the Japanese‑subsidiary debt at $919 million (including other long‑term debt) as of September 1, 2024.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "COST_10k_2023.pdf",
          "target_page": 52,
          "pages": [
            50,
            51,
            52,
            53,
            54
          ]
        },
        "hop_2_rel": {
          "source_file": "COST_10k_2024.pdf",
          "target_page": 30,
          "pages": [
            28,
            29,
            30,
            31,
            32
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 33469,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 8582,
        "completion_tokens": 155,
        "total_tokens": 8737
      }
    },
    {
      "question_id": 56,
      "question": "How has the risk associated with competitors developing after-market parts for DHR's products evolved from 2022 to 2023, particularly in terms of its impact on the company's business and financial statements?",
      "original_answer": "In 2022, the risk of competitors developing after-market parts was described as a direct threat that could 'detract from our sales,' with an emphasis on how commoditization and private-label offerings could reduce market prices and erode DHR's competitive position. By 2023, the framing of this risk shifted to being 'Impacted By' such competition, with a broader contextualization within cost containment trends in the healthcare industry and pricing pressures from managed care and government reimbursement policies. While the core risk remained, it was presented as one of several external pressures rather than a primary threat, suggesting a relative de-emphasis in severity or a strategic recalibration in how the company perceives this risk.",
      "llm_answer": "The risk from competitors developing after‑market parts has grown from 2022 to 2023, as reflected in the 2023 filing’s explicit discussion of “Competitors’ products can capture significant market share or lead to a decrease in market prices overall, resulting in an adverse effect on the Company’s business and financial statements,” and the earlier 2022 text that warned that “Competitors may also develop after‑market services and parts for our products which may detract from our sales.” This heightened risk is linked to intensified competition, pricing pressure and the potential for reduced sales of the Company’s own products, which can negatively impact revenue and profitability as disclosed in both years’ risk‑factor sections.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "DHR_10k_2022.pdf",
          "target_page": 23,
          "pages": [
            21,
            22,
            23,
            24,
            25
          ]
        },
        "hop_2_rel": {
          "source_file": "DHR_10k_2023.pdf",
          "target_page": 20,
          "pages": [
            18,
            19,
            20,
            21,
            22
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 9,
        "total_chars": 45502,
        "num_window_pages": 9,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 11611,
        "completion_tokens": 184,
        "total_tokens": 11795
      }
    },
    {
      "question_id": 57,
      "question": "How has Netflix's approach to membership plans evolved from 2022 to 2024, particularly in terms of pricing strategy and service features, and what business challenges were these changes intended to address?",
      "original_answer": "In 2022, Netflix experienced a 19% revenue increase driven by an 11% growth in average paying memberships and a 7% rise in average monthly revenue per membership, partly due to price increases and favorable foreign exchange rates. However, paid net membership additions dropped by 50% compared to the prior year, signaling early signs of member acquisition challenges. By 2024, Netflix responded by introducing a lower-priced ad-supported subscription plan and enforcing terms of use to limit multi-household usage. These changes were aimed at addressing fluctuating member acquisition, retention pressures, and increasing competition in the streaming and broader entertainment market. The company acknowledged that macroeconomic conditions, content competition, and consumer sensitivity to pricing adjustments could negatively impact membership growth and profitability.",
      "llm_answer": "From 2022 to 2024, Netflix refined its membership strategy by introducing lower‑priced, ad‑supported tiers and by testing modest price increases across regions to boost average revenue per user. These moves were designed to offset slower paid‑membership growth, sustain revenue expansion amid rising content costs, and counteract macro‑economic pressures such as inflation. The changes aimed to preserve profitability while maintaining a broad, globally diversified subscriber base.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "NFLX_10k_2022.pdf",
          "target_page": 23,
          "pages": [
            21,
            22,
            23,
            24,
            25
          ]
        },
        "hop_2_rel": {
          "source_file": "NFLX_10k_2024.pdf",
          "target_page": 6,
          "pages": [
            4,
            5,
            6,
            7,
            8
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 58566,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 14876,
        "completion_tokens": 120,
        "total_tokens": 14996
      }
    },
    {
      "question_id": 57,
      "question": "How has Boeing's approach to in-orbit incentive payments evolved between 2022 and 2023, particularly in terms of risk exposure and financial recognition?",
      "original_answer": "In 2022, Boeing highlighted the financial risks associated with in-orbit incentive payments, particularly in the context of potential program cancellations or failure to meet performance criteria, which could trigger termination provisions or loss of payments. The company noted that these risks were part of ongoing fixed-price development programs like Commercial Crew, KC-46A Tanker, and VC-25B. By 2023, Boeing had recorded $1,585 million in additional losses on its five most significant fixed-price development programs, which included those mentioned in 2022, and explicitly stated that in-orbit incentive payments were at risk if satellites failed to meet performance criteria over up to 15 years post-acceptance. The company also emphasized that the net present value of these fees was recognized as revenue during the construction period, increasing financial exposure if performance issues arose. This represents a shift from general risk acknowledgment in 2022 to a more specific quantification of losses and a detailed explanation of revenue recognition practices tied to in-orbit performance in 2023.",
      "llm_answer": "Between 2022 and 2023 Boeing’s approach to in‑orbit incentive payments remained tied to performance‑based risk, but the financial exposure and accounting treatment intensified.  In 2023 the company recorded $1.585 billion of additional reach‑forward losses on its five largest fixed‑price development programs—including Commercial Crew, KC‑46A, MQ‑25, T‑7A and VC‑25B—driven by production disruptions, supplier issues and technical challenges, which directly heightens the risk that in‑orbit incentive fees may be withheld or require refunds if satellites fail to meet contractual performance criteria.  Consequently, while revenue from in‑orbit payments is still recognized during construction, the increased reach‑forward loss recognition reflects a greater financial risk and a more conservative estimation of recoverable incentive fees in the 2023 reporting period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "BA_10k_2022.pdf",
          "target_page": 45,
          "pages": [
            43,
            44,
            45,
            46,
            47
          ]
        },
        "hop_2_rel": {
          "source_file": "BA_10k_2023.pdf",
          "target_page": 15,
          "pages": [
            13,
            14,
            15,
            16,
            17
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 8,
        "total_chars": 32036,
        "num_window_pages": 8,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 8230,
        "completion_tokens": 217,
        "total_tokens": 8448
      }
    },
    {
      "question_id": 57,
      "question": "How has the disclosure and accessibility of the Directors' Code of Conduct evolved between 2023 and 2024?",
      "original_answer": "In 2023, the Directors' Code of Conduct was explicitly described as being posted on the company's website at a specific URL: https://www.bnymellon.com/content/dam/bnymellon/documents/pdf/invrelations/directors-code-of-conduct.pdf, and the company stated its intention to disclose amendments or waivers on the website. In 2024, while the Code remained accessible, it was referenced more generally as part of a broader list of governance materials available on the company’s website, including committee charters and governance guidelines, without repeating the direct URL. The change indicates a shift from detailed disclosure of access to a more consolidated and implicit reference, suggesting a streamlined but less direct approach to public access in 2024.",
      "llm_answer": "Between 2023 and 2024, the disclosure of BNY Mellon’s Directors’ Code of Conduct remained consistent in its availability—referenced in both the 2023 and 2024 Form 10‑K filings as being posted on the company’s website (e.g., https://www.bnymellon.com/.../directors‑code‑of‑conduct.pdf)—but the 2024 filing explicitly notes that any amendments or waivers to the Code will be disclosed on the website, whereas the 2023 filing did not emphasize this disclosure mechanism. Thus, while the Code itself was still publicly accessible, the 2024 version added a clearer statement of intent to publish future changes or waivers, reflecting a modest evolution in transparency.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "BK_10k_2023.pdf",
          "target_page": 13,
          "pages": [
            11,
            12,
            13,
            14,
            15
          ]
        },
        "hop_2_rel": {
          "source_file": "BK_10k_2024.pdf",
          "target_page": 3,
          "pages": [
            1,
            2,
            3,
            4,
            5
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 35385,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 9054,
        "completion_tokens": 166,
        "total_tokens": 9220
      }
    },
    {
      "question_id": 57,
      "question": "How has the role and deployment strategy of Mobileye Drive™ evolved between 2022 and 2023?",
      "original_answer": "In 2022, Mobileye launched the SAE L4 Self-Driving System (SDS), Mobileye Drive™, and secured multiple collaborations for commercial use, including with Udelv for autonomous cargo delivery and with Transdev for self-driving mobility services. Additionally, Mobileye achieved its first consumer L4 design win with Geely. By 2023, Mobileye’s strategy had evolved to focus on supplying the Mobileye Drive™ self-driving system to transportation network companies, public transit operators, and suppliers of AV-ready vehicle platforms, with plans to bundle it with Moovit’s urban mobility and transit intelligence application. This shift indicates a more defined go-to-market strategy targeting fleet deployment and mobility-as-a-Service (MaaS) ecosystems.",
      "llm_answer": "Between 2022 and 2023, Mobileye Drive™ evolved from a concept to a production-ready L4 autonomous driving system designed for fleet deployment, primarily targeting transportation network companies, public transit operators, and mobility service providers. The strategy shifted toward bundling Mobileye Drive with Moovit’s MaaS platform and expanding design wins with OEMs like Polestar and Geely, while regulatory progress in countries like Germany enabled broader deployment of robotaxi services starting in 2022. This marked a transition from ADAS-focused volume growth to scaling autonomous driving solutions for commercial robotaxi and shared mobility markets.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "INTC_10k_2022.pdf",
          "target_page": 30,
          "pages": [
            28,
            29,
            30,
            31,
            32
          ]
        },
        "hop_2_rel": {
          "source_file": "INTC_10k_2023.pdf",
          "target_page": 34,
          "pages": [
            32,
            33,
            34,
            35,
            36
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 31976,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 8201,
        "completion_tokens": 166,
        "total_tokens": 8367
      }
    },
    {
      "question_id": 58,
      "question": "How has the structure and distribution rate of the Tower Preferred Interests evolved from 2022 to 2024?",
      "original_answer": "In 2022, the Tower Preferred Interests were divided into two series: the September series (Class A-1) totaling $1,500 with a 5.0% initial preferred distribution, and the December series (Class A-2) totaling $4,500 with a 4.75% initial preferred distribution. These distributions reset every five years. By 2024, the structure was amended in August 2024 to reclassify all 2019 Tower preferred interests into Fixed Rate Class A Limited Membership Interests (Tower Fixed Rate Interests) paying a 5.90% preferred distribution. Additionally, a portion of these fixed-rate interests will transition annually into Floating Rate Class A Limited Membership Interests (Tower Floating Rate Interests), which will pay a distribution equal to SOFR plus 250 basis points. This represents both a structural and rate evolution in the Tower Preferred Interests.",
      "llm_answer": "From 2022 through 2024 the structure of AT&T’s Tower preferred interests was reshaped.  \n- In 2019 AT&T issued two series of cumulative preferred interests in Tower Holdings – a $1,500 September series (Class A‑1) at a 5.0% initial distribution and a $4,500 December series (Class A‑2) at 4.75% – both reset every five years.  \n- In August 2024 the 2019 Tower preferred interests were amended and recast as Fixed‑Rate Class A Limited Membership Interests (paying a 5.90% distribution) and Floating‑Rate Class A Limited Membership Interests (paying SOFR + 250 bps), with the reset schedule extending to 2029 and the ability to call the floating tranche at any time.  \n- The amendment also changed the redemption trigger and added a five‑year call period beginning November 2029, while preserving the contingent‑redemption rights that allow holders to force redemption if distributions are missed or credit‑rating requirements are not met.  \n\nThus, between 2022 and 2024 the original 2019 Tower preferred interests remained in place but were restructured in 2024 into a mixed fixed‑ and floating‑rate regime with a later call date and updated reset mechanics.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "T_10k_2022.pdf",
          "target_page": 130,
          "pages": [
            128,
            129,
            130,
            131,
            132
          ]
        },
        "hop_2_rel": {
          "source_file": "T_10k_2024.pdf",
          "target_page": 87,
          "pages": [
            85,
            86,
            87,
            88,
            89
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 50171,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 12752,
        "completion_tokens": 289,
        "total_tokens": 13042
      }
    },
    {
      "question_id": 58,
      "question": "How did the investment approach and unrealized gains/(losses) for Level 3 assets related to the Balanced Index Fund evolve from 2022 to 2023?",
      "original_answer": "In 2022, the company disclosed unrealized losses for Level 3 assets still held at year-end, including ($16) million for corporate fixed income securities and ($11) million for mortgage-backed and asset-backed fixed income securities. By 2023, these values shifted to unrealized gains of $2 million for corporate fixed income securities and $6 million for mortgage-backed and asset-backed fixed income securities. This indicates a significant turnaround in the performance of these assets. Additionally, while the Balanced Index Fund's composition remained at approximately 60% equities and 40% debt securities in both years, the valuation methodology in 2023 explicitly referenced a market approach based on quoted market prices (Level 1), suggesting a more transparent and standardized valuation process.",
      "llm_answer": "The investment approach for Level 3 assets in the Balanced Index Fund remained consistent, with the fund being composed of approximately 60% equities and 40% debt securities, valued using a market approach based on quoted market prices of identical instruments (Level 1). Unrealized gains/(losses) for Level 3 assets in the Balanced Index Fund evolved as follows: for 2023, changes were $2 for corporate fixed income securities, $6 for mortgage-backed and asset-backed fixed income securities, and $3 for other fixed income securities; for 2022, changes were ($16) for corporate fixed income securities, ($11) for mortgage-backed and asset-backed fixed income securities, ($14) for municipal fixed income securities, and ($1) for real asset securities. This indicates a shift from net unrealized losses in 2022 to net unrealized gains in 2023 across key Level 3 asset classes within the fund.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "BA_10k_2022.pdf",
          "target_page": 115,
          "pages": [
            113,
            114,
            115,
            116,
            117
          ]
        },
        "hop_2_rel": {
          "source_file": "BA_10k_2023.pdf",
          "target_page": 96,
          "pages": [
            94,
            95,
            96,
            97,
            98
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 9,
        "total_chars": 44369,
        "num_window_pages": 9,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 11312,
        "completion_tokens": 223,
        "total_tokens": 11535
      }
    },
    {
      "question_id": 58,
      "question": "How has BNY Mellon's emphasis on accounting developments in its forward-looking statements evolved between 2023 and 2024, and what does this reveal about the changing influence of accounting standards on its strategic priorities?",
      "original_answer": "In 2023, BNY Mellon included accounting developments among a broader list of potential influences on forward-looking statements, noting they 'may impact our businesses' without specific elaboration. By 2024, the company expanded this language, explicitly stating that accounting developments 'may impact our businesses, regulatory, technology, market, economic or accounting developments and the impacts of such developments on our businesses.' This shift indicates a more integrated view of accounting changes as part of strategic risk and planning considerations. The inclusion of terms like 'capital plans including dividends and repurchases' and 'efficiency savings' in 2024 further suggests that accounting developments are increasingly tied to concrete business decisions and performance metrics.",
      "llm_answer": "Between 2023 and 2024, BNY Mellon’s forward-looking statements shifted from a broader focus on market, operational, and strategic risks to a more pronounced emphasis on accounting standards and regulatory compliance. In the 2023 filing, accounting developments were mentioned only as part of general risk factors, whereas the 2024 filing explicitly highlights changes in accounting standards as a distinct risk that could materially impact reported financial condition, results of operations, cash flows, and other financial data. This evolution reveals that accounting standards are increasingly shaping the company’s strategic priorities, compelling BNY Mellon to adjust its reporting, capital management, and business practices to align with evolving regulatory requirements.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "BK_10k_2023.pdf",
          "target_page": 3,
          "pages": [
            1,
            2,
            3,
            4,
            5
          ]
        },
        "hop_2_rel": {
          "source_file": "BK_10k_2024.pdf",
          "target_page": 3,
          "pages": [
            1,
            2,
            3,
            4,
            5
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 34970,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 8980,
        "completion_tokens": 194,
        "total_tokens": 9175
      }
    },
    {
      "question_id": 58,
      "question": "How did the evolution of risks related to store safety and cybersecurity in 2023 potentially impact the associate experience, as compared to the engagement-focused initiatives highlighted in 2022?",
      "original_answer": "In 2022, HD emphasized internal initiatives to improve the associate experience through engagement surveys, a digital engagement platform, and recognition programs, which historically showed that four out of five associates were emotionally committed. However, in 2023, the company highlighted external risks such as increased store shrink, particularly from organized retail crime, and cybersecurity threats that could compromise associate data and store safety. These risks were noted to potentially erode trust, impact associate morale and retention, and damage the company's reputation. This shift indicates that while HD was actively fostering associate engagement in 2022, the emergence or escalation of external risks in 2023 introduced new challenges that could undermine those earlier gains in associate experience.",
      "llm_answer": "The 2023 disclosures highlight heightened risks around store safety and cybersecurity that could directly undermine the associate experience—through concerns about personal safety, increased operational pressures, and potential disruptions to work environments—contrasting with the 2022 focus on engagement‑driven initiatives such as culture‑centric development, recognition programs, and enhanced benefits. Consequently, while 2022 emphasized building emotional commitment and inclusive growth, 2023’s risk narrative suggests that safety and cyber threats may erode morale, retention, and the overall associate experience.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "HD_10k_2022.pdf",
          "target_page": 13,
          "pages": [
            11,
            12,
            13,
            14,
            15
          ]
        },
        "hop_2_rel": {
          "source_file": "HD_10k_2023.pdf",
          "target_page": 20,
          "pages": [
            18,
            19,
            20,
            21,
            22
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 53705,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 13658,
        "completion_tokens": 155,
        "total_tokens": 13814
      }
    },
    {
      "question_id": 59,
      "question": "How has the role of the 'learning curve' in influencing cost and production estimates evolved between 2022 and 2023, particularly in relation to program profitability and risk management?",
      "original_answer": "In 2022, the 'learning curve' was identified as a risk factor that could negatively impact program profitability due to production complexities, rework, and delays—especially in programs like the 787—potentially leading to additional losses and abnormal production costs. By 2023, the 'learning curve' was no longer framed solely as a risk but was integrated into the company's cost estimation process, factored into production rate assumptions, supplier performance trends, and internal labor efficiency projections. This shift indicates that Boeing began treating the learning curve as a predictable and manageable component of production planning rather than an unpredictable risk.",
      "llm_answer": "The learning curve’s impact on cost and production estimates was explicitly highlighted in the 2023 disclosures as a key driver of program profitability and risk. Specifically, the company noted that changes in underlying assumptions—including the learning curve—could materially affect gross margins on commercial airplane programs, with a 1% shift in estimated gross margin translating to approximately $300 million (or $330 million for commercial programs) of pre‑tax income impact in 2023. This risk is tied to ongoing challenges on programs such as the VC‑25B, KC‑46A, Commercial Crew, T‑7A, MQ‑25, 777X, and 787, where learning‑curve‑related cost overruns or margin compression have led to cumulative catch‑up adjustments, reach‑forward losses, and the need for valuation allowances. Consequently, the role of the learning curve has evolved from a background factor to a central, quantifiable element in both cost estimation and risk management for 2023.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "BA_10k_2022.pdf",
          "target_page": 42,
          "pages": [
            40,
            41,
            42,
            43,
            44
          ]
        },
        "hop_2_rel": {
          "source_file": "BA_10k_2023.pdf",
          "target_page": 49,
          "pages": [
            47,
            48,
            49,
            50,
            51
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 38801,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 9930,
        "completion_tokens": 240,
        "total_tokens": 10170
      }
    },
    {
      "question_id": 59,
      "question": "How has the treatment or disclosure of the Dividend Reinvestment Plan evolved between the 2023 and 2024 SEC filings, particularly in relation to officer or director participation and associated trading arrangements?",
      "original_answer": "In the 2023 filing, the Dividend Reinvestment Plan was mentioned in the context of officer or director participation alongside the employee stock purchase plan and 401(k) plan, with specific reference to elections to have shares withheld for tax purposes or to pay the exercise price of stock awards. The disclosure also included a detailed description of how these elections may be structured under Rule 10b5-1 or non-Rule 10b5-1 trading arrangements as defined in Item 408(c) of Regulation S-K. In the 2024 filing, the Dividend Reinvestment Plan was again referenced in the context of officer or director participation, but the detailed explanation of Rule 10b5-1 and non-Rule 10b5-1 trading arrangements was omitted, indicating a simplification or standardization of the disclosure without the earlier level of specificity regarding trading frameworks.",
      "llm_answer": "The Dividend Reinvestment Plan (DRP) disclosure was updated in the 2024 filing to specifically note that certain officers and directors participate in the DRP and that they may elect to have shares withheld to cover taxes or exercise prices, which may involve non‑Rule 10b5‑1 trading arrangements. This language appears in Item 9B of the 2024 filing, whereas the 2023 filing only mentioned that officers or directors could participate in the DRP, employee stock purchase plan and 401(k) plan without detailing the withholding elections or the potential non‑Rule 10b5‑1 trading aspect.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "BK_10k_2023.pdf",
          "target_page": 12,
          "pages": [
            10,
            11,
            12,
            13,
            14
          ]
        },
        "hop_2_rel": {
          "source_file": "BK_10k_2024.pdf",
          "target_page": 12,
          "pages": [
            10,
            11,
            12,
            13,
            14
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 35796,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 9186,
        "completion_tokens": 146,
        "total_tokens": 9332
      }
    },
    {
      "question_id": 59,
      "question": "How has The Home Depot's investment in creating an interconnected shopping experience evolved from fiscal 2021 to fiscal 2023, and what specific changes were made in the way this experience is tailored to customers?",
      "original_answer": "In fiscal 2021, The Home Depot invested $2.6 billion in capital expenditures focused on supporting an interconnected customer experience. By fiscal 2023, the company had advanced this strategy by leveraging enhanced merchandising information technology tools to build an interconnected shopping experience tailored to customers' shopping intent and location. This represents a shift from general investment in interconnectedness to a more refined, data-driven personalization strategy.",
      "llm_answer": "From fiscal 2021 through fiscal 2023, The Home Depot’s investment in an interconnected shopping experience shifted from building the foundational omnichannel capabilities (e.g., BOPIS, BORIS, BOSS, BODFS, digital “hdPhone” tools, and computer‑vision inventory visibility) to actively tailoring that experience for customers.  In fiscal 2023 the company emphasized using data‑driven tools to personalize marketing, improve store navigation (e.g., mobile maps, self‑service lockers, curb‑side pickup) and enhance product assortment and availability based on location and shopping intent, creating a more frictionless, customized journey across stores, online and in‑home services.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "HD_10k_2022.pdf",
          "target_page": 6,
          "pages": [
            4,
            5,
            6,
            7,
            8
          ]
        },
        "hop_2_rel": {
          "source_file": "HD_10k_2023.pdf",
          "target_page": 7,
          "pages": [
            5,
            6,
            7,
            8,
            9
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 9,
        "total_chars": 44475,
        "num_window_pages": 9,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 11353,
        "completion_tokens": 169,
        "total_tokens": 11523
      }
    },
    {
      "question_id": 59,
      "question": "How has the financial relationship between DHR and Aldevron evolved between 2022 and 2023, particularly in terms of capital investment and acquisition-related expenditures?",
      "original_answer": "In 2022, DHR anticipated capital expenditures of approximately $1.5 billion, with a portion of this spending attributed to increased manufacturing capacity for products related to the Aldevron Acquisition, among others. This reflects a growing capital commitment tied to Aldevron. By 2023, the financial relationship had evolved significantly, as evidenced by the net cash consideration paid to Aldevron amounting to $9,561 million, indicating that Aldevron had transitioned from being primarily a capital investment target to a core component of DHR's consolidated assets. This represents a substantial shift in the nature of their relationship from a dependency to a stakeholding and integration model.",
      "llm_answer": "Between 2022 and 2023, the financial relationship between DHR and Aldevron evolved through increased capital investment and acquisition-related expenditures. In 2021, DHR acquired Aldevron for approximately $9.6 billion in cash, financed partly through commercial paper, and recorded $6.1 billion of goodwill. By 2023, DHR's capital expenditures rose to $1.5 billion (up from $1.3 billion in 2021), driven in part by investments to expand manufacturing capacity for biopharma products and diagnostics, partly funded by U.S. government grants. While specific 2023 acquisition-related expenditures for Aldevron are not detailed beyond routine integration costs, the company continued to invest in expanding Aldevron's role within its Life Sciences segment, including post-acquisition fair value adjustments and non-recurring items impacting earnings. Government assistance and strategic financing remained key to supporting these investments.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "DHR_10k_2022.pdf",
          "target_page": 59,
          "pages": [
            57,
            58,
            59,
            60,
            61
          ]
        },
        "hop_2_rel": {
          "source_file": "DHR_10k_2023.pdf",
          "target_page": 74,
          "pages": [
            72,
            73,
            74,
            75,
            76
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 9,
        "total_chars": 47138,
        "num_window_pages": 9,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 12011,
        "completion_tokens": 235,
        "total_tokens": 12246
      }
    },
    {
      "question_id": 60,
      "question": "How has the structure and total value of Telco LLC's preferred interests evolved from 2022 to 2024, and what changes were made to the distribution rates and reset schedules during this period?",
      "original_answer": "In 2022, Telco LLC had $2,000 in nonconvertible cumulative preferred interests (Telco Class A-1) with an initial preferred distribution rate of 4.25% annually, subject to reset every seven years. By 2024, Telco LLC expanded its preferred interests with the issuance of an additional $5,250 in preferred interests (Telco Class A-2 and A-3) in April 2023, bringing the total cumulative preferred interests to $7,250. The new preferred interests (Class A-2 and A-3) carried a significantly higher initial preferred distribution rate of 6.85% annually, with the first reset scheduled for November 1, 2027, and every seven years thereafter. This represents both a structural expansion in the capital stack and a strategic shift toward higher-yielding preferred instruments.",
      "llm_answer": "From 2022 to 2024, Telco LLC’s preferred interests grew from an initial $2,000 issuance of Telco Class A-1 in September 2020 to $7,250 in cumulative preferred interests by December 2024, following an April 2023 expansion that added $5,250 through Telco Class A-2 and A-3. The distribution rates were 4.25% annually for Class A-1 (subject to reset every seven years) and 6.85% annually for Classes A-2 and A-3 (subject to reset on November 1, 2027, and every seven years thereafter). In October 2024, an additional $2,250 of Telco Class A-4 preferred interests were authorized for issuance in Q1 2025, which will pay an initial 5.94% distribution (subject to reset on November 1, 2028, and every four years thereafter). Distribution rates for all Telco preferred interests remain subject to declaration, with no limitations on cash movements or dividend repurchases upon timely payment.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "T_10k_2022.pdf",
          "target_page": 130,
          "pages": [
            128,
            129,
            130,
            131,
            132
          ]
        },
        "hop_2_rel": {
          "source_file": "T_10k_2024.pdf",
          "target_page": 87,
          "pages": [
            85,
            86,
            87,
            88,
            89
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 50171,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 12775,
        "completion_tokens": 221,
        "total_tokens": 12996
      }
    },
    {
      "question_id": 60,
      "question": "How has AIG's use of Expected Loss Ratio Methods evolved between 2022 and 2024, particularly in terms of the types of insurance lines and the rationale for their application?",
      "original_answer": "In 2022, AIG used Expected Loss Ratio Methods primarily for the latest accident year and in combination with other methods like loss development for aviation exposures, due to their high-severity nature. By 2024, AIG expanded the use of Expected Loss Ratio Methods to include U.S. Workers' Compensation, a long-tail line of business, where it was used in combination with loss development and frequency/severity methods. This reflects a broader application of the method across different insurance lines with varying claim characteristics.",
      "llm_answer": "Between 2022 and 2024, AIG’s use of Expected Loss Ratio Methods shifted toward applying them primarily to newer, higher‑attachment‑point layers of U.S. Excess Casualty and program‑business lines where loss development is limited and severity is highly variable. The rationale for this focus is that these lines exhibit long‑tail, high‑severity claims with limited historical development data, making expected loss ratios a more reliable reserve driver than pure development methods. Consequently, AIG increasingly relies on expected loss ratios for the latest accident years in these segments, while still combining them with development‑based approaches for older years.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AIG_10k_2022.pdf",
          "target_page": 273,
          "pages": [
            271,
            272,
            273,
            274,
            275
          ]
        },
        "hop_2_rel": {
          "source_file": "AIG_10k_2024.pdf",
          "target_page": 151,
          "pages": [
            149,
            150,
            151,
            152,
            153
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 9,
        "total_chars": 289160,
        "num_window_pages": 9,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 72520,
        "completion_tokens": 167,
        "total_tokens": 72687
      }
    },
    {
      "question_id": 60,
      "question": "How has Target's approach to its owned brands evolved from 2023 to 2024, particularly in terms of strategic emphasis and product portfolio development?",
      "original_answer": "In 2023, Target emphasized expanding its owned brands portfolio as a core strategic element to drive relevancy and market share growth. By 2024, the company shifted focus to producing a broad range of owned and exclusive brands, listing over 40 distinct brands across various categories, indicating a more concrete execution phase of brand development and diversification.",
      "llm_answer": "Target’s owned‑brand strategy has shifted from a broad, diversified portfolio of value‑oriented labels in 2023 to a more curated, high‑margin mix in 2024, emphasizing exclusive, design‑focused brands (e.g., Opalhouse, Threshold, Universal Thread, and specialty beverage lines) and expanding limited‑edition collaborations. The company is deepening its “signature partnership” model—leveraging exclusive design deals with brands such as Apple, Disney, Levi’s and Ulta—while using its owned brands to drive higher gross margins and support its “delivering value” agenda through everyday low pricing and the Target Circle loyalty program. This evolution reflects a strategic emphasis on premium‑ish, trend‑forward products that differentiate Target’s assortment and fuel growth across both physical stores and digital channels.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "TGT_10k_2023.pdf",
          "target_page": 3,
          "pages": [
            1,
            2,
            3,
            4,
            5
          ]
        },
        "hop_2_rel": {
          "source_file": "TGT_10k_2024.pdf",
          "target_page": 6,
          "pages": [
            4,
            5,
            6,
            7,
            8
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 9,
        "total_chars": 25426,
        "num_window_pages": 9,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 6575,
        "completion_tokens": 206,
        "total_tokens": 6781
      }
    },
    {
      "question_id": 60,
      "question": "What does IBM's continued listing of the 0.875% Notes due 2030 in 2024 alongside the new 2.900% Notes due 2030 suggest about its debt financing strategy and the market conditions for long-term borrowing?",
      "original_answer": "In 2023, IBM listed the 0.875% Notes due 2030 (trading symbol IBM30A) among its registered securities, indicating its initial issuance of this long-term debt instrument. By 2024, IBM not only maintained the 0.875% Notes due 2030 in its capital structure but also introduced a new 2.900% Notes due 2030 (trading symbol IBM30C). The significant increase in the interest rate—from 0.875% to 2.900%—for the same maturity year suggests that IBM may have pursued additional financing in 2024 under less favorable interest rate conditions, or it may be targeting different investor segments with varied risk-return profiles. This dual listing could also indicate a strategic effort to diversify its debt portfolio and manage refinancing risks by having multiple instruments maturing in the same year but with different coupon rates.",
      "llm_answer": "IBM's continued listing of the 0.875% Notes due 2030 alongside the new 2.900% Notes due 2030 in its 2024 SEC filing indicates a strategic shift toward lower-cost long-term borrowing amid favorable market conditions. The lower coupon rate on the 0.875% notes reflects improved investor demand for IBM debt, allowing the company to refinance existing obligations at more attractive terms. This suggests IBM is capitalizing on strong market appetite for investment-grade corporate bonds, particularly for long-duration instruments, to optimize its capital structure and reduce financing costs without significantly diluting equity.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "IBM_10k_2023.pdf",
          "target_page": 1,
          "pages": [
            1,
            2,
            3,
            4,
            5
          ]
        },
        "hop_2_rel": {
          "source_file": "IBM_10k_2024.pdf",
          "target_page": 1,
          "pages": [
            1,
            2,
            3,
            4,
            5
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 53151,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 13520,
        "completion_tokens": 157,
        "total_tokens": 13677
      }
    },
    {
      "question_id": 61,
      "question": "How did the composition of AT&T's long-term debt instruments evolve between 2022 and 2024, particularly regarding the 4.000% Global Notes due June 1, 2049 and the addition of new long-term notes?",
      "original_answer": "In 2022, AT&T listed the 4.000% Global Notes due June 1, 2049 (T 49A) among other long-term debt instruments, but did not include the 4.300% Global Notes due November 18, 2034. By 2024, the 4.000% Global Notes due 2049 remained registered under the same symbol (T 49A), and the company added the 4.300% Global Notes due 2034 (T 34C). This indicates that AT&T expanded its long-term debt portfolio by introducing new maturities while maintaining existing long-dated obligations like the 2049 notes.",
      "llm_answer": "Between 2022 and 2024, AT&T retired its $4.375 billion 4.375% Global Notes due September 14, 2029 (T 29B) and added new long-term debt instruments, including the $1.8 billion 4.000% Global Notes due June 1, 2049 (T 49A), as evidenced by the 2024 debt table listing both the 2049 notes and newer maturities like the 2050 and 2066 tranches. The company continued issuing long-term debt with staggered maturities, maintaining a strategy of replacing maturing obligations with new long-term notes to manage its capital structure.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "T_10k_2022.pdf",
          "target_page": 2,
          "pages": [
            1,
            2,
            3,
            4,
            5
          ]
        },
        "hop_2_rel": {
          "source_file": "T_10k_2024.pdf",
          "target_page": 2,
          "pages": [
            1,
            2,
            3,
            4,
            5
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 42322,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 10809,
        "completion_tokens": 131,
        "total_tokens": 10941
      }
    },
    {
      "question_id": 61,
      "question": "How did the financial impact of the Heritage AspenTech acquisition evolve between 2023 and 2024, particularly in terms of intangibles amortization and restructuring costs?",
      "original_answer": "In 2023, the intangibles amortization related to the Heritage AspenTech acquisition was $258, while in 2024, this figure decreased to $97. Additionally, restructuring costs were $72 in 2023 and increased to $228 in 2024. This indicates a reduction in the amortization burden but a significant rise in restructuring expenses over the two years.",
      "llm_answer": "The Heritage AspenTech acquisition’s financial impact evolved from 2022 through 2024, with intangible amortization rising sharply as the acquired customer relationships and developed technology were amortized—$258 million in 2023 and $560 million in 2024—while restructuring costs associated with the integration also increased, totaling $228 million in 2024 versus $72 million in 2023. This reflects the ongoing absorption of acquisition‑related expenses as the combined entity scaled its operations.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "EMR_10k_2023.pdf",
          "target_page": 51,
          "pages": [
            49,
            50,
            51,
            52,
            53
          ]
        },
        "hop_2_rel": {
          "source_file": "EMR_10k_2024.pdf",
          "target_page": 55,
          "pages": [
            53,
            54,
            55,
            56,
            57
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 37481,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 9597,
        "completion_tokens": 125,
        "total_tokens": 9722
      }
    },
    {
      "question_id": 61,
      "question": "How has AIG's use of expected loss ratio methods for workers' compensation evolved between 2022 and 2024, particularly in relation to the segmentation of business types and the impact of large deductible accounts?",
      "original_answer": "In 2022, AIG applied expected loss ratio methods primarily to guaranteed cost business in the most recent accident year, while for excess of deductible business, these methods were given significant weight in the most recent five accident years. The company also noted that the proportion of large deductible business had increased, slowing the reporting pattern of claims. By 2024, AIG continued to use expected loss ratio methods but placed greater emphasis on segmentation by deductible size and claim handling (AIG vs. third-party administrators), and explicitly highlighted the increasing influence of large deductible accounts on slowing claim emergence. Additionally, 2024 disclosures emphasized limitations in claim count data due to aggregation and reinsurance exclusions, which were not as prominently noted in 2022.",
      "llm_answer": "AIG’s workers‑compensation reserving has shifted from a pure development‑factor approach toward a more segmented, risk‑share‑aware framework.  In recent years the company has increasingly grouped “large‑deductible” and “excess‑of‑deductible” business by deductible size, state and industry, and it now applies expected‑loss‑ratio methods to the most recent five accident years while still using development factors for older years.  This segmentation—especially the growing share of large‑deductible accounts—has slowed claim‑reporting patterns and prompted the use of separate development diagonals for those subsets, leading to a more nuanced loss‑development pattern between 2022 and 2024.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AIG_10k_2022.pdf",
          "target_page": 260,
          "pages": [
            258,
            259,
            260,
            261,
            262
          ]
        },
        "hop_2_rel": {
          "source_file": "AIG_10k_2024.pdf",
          "target_page": 151,
          "pages": [
            149,
            150,
            151,
            152,
            153
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 9,
        "total_chars": 259551,
        "num_window_pages": 9,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 65127,
        "completion_tokens": 173,
        "total_tokens": 65300
      }
    },
    {
      "question_id": 61,
      "question": "How has Target's approach to cybersecurity threat investigation and response evolved from 2023 to 2024, particularly in terms of its Cyber Fusion Center operations and collaboration with external organizations?",
      "original_answer": "In 2023, Target operated its Cyber Fusion Center as part of its threat investigation and response capabilities, and emphasized collaboration with organizations across industries to share threat intelligence and best practices. By 2024, Target not only maintained its Cyber Fusion Center but also introduced a more structured incident response program with a coordinated escalation model to inform management and the Board of Directors during security incidents. Additionally, in 2024, Target expanded its external engagement by incorporating regular training and compliance activities for team members, and by leveraging third-party vendors to assess and test its cybersecurity program. This represents a more comprehensive and mature approach to cybersecurity threat response and collaboration.",
      "llm_answer": "Target’s cybersecurity function has matured from a primarily internal risk‑management program in 2023 to a more coordinated, cross‑industry effort in 2024.  The 2024 filing notes that the company now runs a dedicated **cyber fusion center** to investigate and respond to threats, and it emphasizes formal collaboration with external organizations to share threat intelligence and best practices.  By contrast, the 2023 filing describes the fusion center only in passing and does not highlight such external partnerships.  Thus, from 2023 to 2024 Target has expanded both the operational scope of its Cyber Fusion Center and its collaborative ties with outside groups.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "TGT_10k_2023.pdf",
          "target_page": 17,
          "pages": [
            15,
            16,
            17,
            18,
            19
          ]
        },
        "hop_2_rel": {
          "source_file": "TGT_10k_2024.pdf",
          "target_page": 21,
          "pages": [
            19,
            20,
            21,
            22,
            23
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 43494,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 11110,
        "completion_tokens": 166,
        "total_tokens": 11276
      }
    },
    {
      "question_id": 61,
      "question": "How did Eli Lilly's financial relationship with Baqsimi evolve between 2023 and 2024, particularly in terms of revenue recognition and contractual arrangements?",
      "original_answer": "In 2023, Eli Lilly reported $579.0 million in revenue specifically attributed to the sale of the rights for Baqsimi. By 2024, Baqsimi was included within broader collaboration and other revenue disclosures, reflecting its integration into revenue from collaborations and other arrangements, which included the 2023 sales of rights for both the olanzapine portfolio and Baqsimi. This shift indicates a move from direct product revenue to a more complex revenue recognition model under collaborative arrangements, suggesting a strategic evolution in how the company accounts for and manages its financial relationship with Baqsimi.",
      "llm_answer": "Between 2023 and 2024, Eli Lilly’s revenue from Baqsimi was recognized as part of its collaboration and other revenue, reflecting the sale of the Baqsimi rights in 2023. The 2023 10‑K notes that the company received $645.7 million in U.S. revenue and $31.9 million outside the U.S. from Baqsimi, contributing to the overall $677.6 million recognized in 2023. Subsequent filings show no further specific revenue from Baqsimi in 2024, indicating that the transaction was a one‑time sale of rights rather than an ongoing revenue stream. Consequently, revenue recognition for Baqsimi ceased after the 2023 sale, with any future financial impact limited to the initial upfront payment and related accounting treatment.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "LLY_10k_2023.pdf",
          "target_page": 47,
          "pages": [
            45,
            46,
            47,
            48,
            49
          ]
        },
        "hop_2_rel": {
          "source_file": "LLY_10k_2024.pdf",
          "target_page": 64,
          "pages": [
            62,
            63,
            64,
            65,
            66
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 48167,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 12265,
        "completion_tokens": 178,
        "total_tokens": 12444
      }
    },
    {
      "question_id": 62,
      "question": "How did AT&T's approach to managing its capital structure through preferred interests evolve from 2023 to 2024, particularly regarding the repurchase of Mobility Preferred Interests and the expansion of Tower Holdings and Telco LLC preferred interests?",
      "original_answer": "In 2023, AT&T repurchased the remaining 213 million Mobility Preferred Interests for $5,414, removing $2,650 from 'Accounts payable and accrued liabilities' and $2,670 from 'Other noncurrent liabilities.' This repurchase was primarily funded by the issuance of $5,250 in new Telco LLC preferred interests, which carried a 6.85% annual distribution rate. By 2024, AT&T had shifted focus toward expanding its Tower Holdings preferred interests, where $6,000 in 2019 Tower preferred interests were restructured into fixed and floating rate classes with a 5.90% base rate and SOFR + 250 bps, respectively. Additionally, the total Telco LLC preferred interests increased to $7,250, including the original $2,000 (Telco Class A-1) and the 2023 additions. This reflects a strategic pivot from repurchasing legacy preferred interests to leveraging new preferred structures with more flexible redemption and distribution terms to manage capital and liquidity.",
      "llm_answer": "From 2023 to 2024, AT&T fully retired its legacy Mobility preferred interests—repurchasing the remaining 213 million shares for $5.414 billion in April 2023—and shifted its capital‑structure focus to expanding preferred equity in its subsidiaries. In 2024 it issued an additional $2.25 billion of non‑convertible cumulative preferred interests in Telco LLC (Telco Class A‑4) and continued to manage the Tower Holdings preferred interests, which were reset in November 2024 to a mixed fixed‑ and floating‑rate structure with distribution rates of 5.90 % (fixed) and SOFR + 250 bps (floating). These moves reflect a strategic transition from the now‑eliminated Mobility preferred equity to newer, subsidiary‑level preferred issuances that support capital needs while maintaining flexibility for dividends and share repurchases.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "T_10k_2023.pdf",
          "target_page": 38,
          "pages": [
            36,
            37,
            38,
            39,
            40
          ]
        },
        "hop_2_rel": {
          "source_file": "T_10k_2024.pdf",
          "target_page": 87,
          "pages": [
            85,
            86,
            87,
            88,
            89
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 56243,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 14306,
        "completion_tokens": 206,
        "total_tokens": 14513
      }
    },
    {
      "question_id": 62,
      "question": "How did Emerson's relationship with AspenTech evolve from 2023 to 2024, and what financial impacts did this transformation have on Emerson's gross margin and ownership structure?",
      "original_answer": "In 2023, Emerson had a business relationship with AspenTech as part of its Software and Control offerings. By 2024, this relationship transformed into a more significant strategic position, as Emerson acquired a 55% ownership stake in 'New AspenTech' (formerly Heritage AspenTech) following a transaction that included approximately $6.0 billion in cash. This change in relationship had a measurable financial impact: the AspenTech acquisition contributed to a 3.3 percentage point increase in gross margin in 2023 and was part of broader changes that led to a 1.8 percentage point increase in gross margin in 2024. Additionally, the ownership stake marked a structural shift in Emerson’s involvement with AspenTech, moving from a partner to a majority shareholder.",
      "llm_answer": "From 2023 to 2024 Emerson’s relationship with AspenTech shifted from a 55 % equity stake (as noted in the 2023 filing) to a full acquisition proposal announced in November 2024, under which Emerson would own the remaining shares at $240 per share, valuing AspenTech at roughly $15.3 billion. This transformation drove a $869 rise in cost of sales and added $231 of acquisition‑related inventory step‑up amortization, which together reduced gross margin by about 1.3 percentage points but still lifted gross margin to 50.8 % (up 1.8 pts). The deal also reshaped Emerson’s ownership structure, moving from a partial equity holding to seeking 100 % ownership, while the sale of its Copeland equity and note generated a $539 after‑tax gain that boosted overall earnings despite the margin pressure.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "EMR_10k_2023.pdf",
          "target_page": 73,
          "pages": [
            71,
            72,
            73,
            74,
            75
          ]
        },
        "hop_2_rel": {
          "source_file": "EMR_10k_2024.pdf",
          "target_page": 26,
          "pages": [
            24,
            25,
            26,
            27,
            28
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 46981,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 11973,
        "completion_tokens": 198,
        "total_tokens": 12172
      }
    },
    {
      "question_id": 62,
      "question": "How has AIG's Japan pension plans' contribution to non-U.S. pension obligations evolved between 2022 and 2024, and what change occurred in the weighted average discount rate applied to these plans during this period?",
      "original_answer": "In 2022, AIG's Japan pension plans accounted for 61% of total non-U.S. pension assets, with an expected long-term rate of return of 1.85%. By 2024, the Japan pension plans' share of non-U.S. projected benefit obligations decreased to 50% as of December 31, 2024, from 54% in 2023, and the weighted average discount rate increased to 1.81% in 2024 from 1.48% in 2023. This indicates a relative decline in the size of the Japan pension plans within AIG's non-U.S. pension structure, accompanied by a notable increase in the discount rate applied, likely reflecting changes in market conditions or investment strategy.",
      "llm_answer": "Between 2022 and 2024, AIG's Japan pension plans saw their weighted average discount rate increase from **0.52% (2021)** to **1.81% (2024)**, reflecting a significant rise in the rate applied to these obligations. Additionally, the expected future benefit payments for Japan pension plans rose from **$40 million (2022)** to **$48 million (2024)**, indicating growth in projected benefit outflows over this period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AIG_10k_2022.pdf",
          "target_page": 311,
          "pages": [
            309,
            310,
            311,
            312,
            313
          ]
        },
        "hop_2_rel": {
          "source_file": "AIG_10k_2024.pdf",
          "target_page": 183,
          "pages": [
            181,
            182,
            183,
            184,
            185
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 70966,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 17982,
        "completion_tokens": 103,
        "total_tokens": 18085
      }
    },
    {
      "question_id": 62,
      "question": "How did Amazon's disclosure about the impact of competitive stores on its business evolve between the 2022 and 2023 10-K filings, particularly in terms of the framing of external market conditions?",
      "original_answer": "In the 2022 10-K filing, Amazon described competitive stores as a general factor among many that could impact sales and operating results, listing them alongside internal capabilities such as inventory management and customer satisfaction. The 2022 filing included the phrase: 'the introduction of competitive stores, websites, products, services, price decreases, or improvements' as a potential cause of sales fluctuations. In contrast, the 2023 filing retained the same core language but embedded it within a broader context that emphasized external economic and geopolitical conditions, stating that revenue and operating profit growth 'depends on the continued growth of demand for the products and services offered by us or our sellers, and our business is affected by, among other things, general economic, business, and geopolitical conditions worldwide.' This indicates a shift toward framing competitive pressures as part of a larger set of external risks rather than a standalone concern.",
      "llm_answer": "The 2023 10‑K filing continues to discuss the competitive retail environment, but it frames the risk more broadly as “the introduction of competitive stores, websites, products, services, price decreases, or improvements” that could erode Amazon’s market share and margins, whereas the 2022 filing more specifically highlighted “the competitive nature of the e‑commerce and cloud services markets” and the threat posed by “new entrants and existing competitors” that could “adversely affect our business.” In both years the language underscores external market pressures, but the 2023 version places greater emphasis on competitive pricing and new entrants as direct drivers of potential harm, while the 2022 version stresses the general competitive landscape and the difficulty of maintaining market leadership.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AMZN_10k_2022.pdf",
          "target_page": 9,
          "pages": [
            7,
            8,
            9,
            10,
            11
          ]
        },
        "hop_2_rel": {
          "source_file": "AMZN_10k_2023.pdf",
          "target_page": 9,
          "pages": [
            7,
            8,
            9,
            10,
            11
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 9,
        "total_chars": 50015,
        "num_window_pages": 9,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 12736,
        "completion_tokens": 203,
        "total_tokens": 12939
      }
    },
    {
      "question_id": 62,
      "question": "How has Target's exposure to port security risks evolved between 2023 and 2024, particularly in terms of geographic focus and operational impact?",
      "original_answer": "In 2023, Target specifically highlighted California ports as a key area affected by port security issues, mentioning that these ports were where the company received a significant portion of its imported merchandise. By 2024, Target broadened its focus, referring to 'major U.S. ports' without specifically naming California, indicating a more generalized concern across multiple locations. Additionally, in 2023, the company noted it had made alternative arrangements due to past disruptions, while in 2024, the emphasis shifted to potential future impacts, including increased costs and inventory supply issues, due to ongoing global conflicts and labor disputes.",
      "llm_answer": "Target's exposure to port security risks has increased in 2024 relative to 2023, with a more pronounced geographic focus on U.S. ports that handle imports from China and other key sourcing countries. The 2024 filing explicitly highlights heightened vulnerability to disruptions at major U.S. ports—particularly those in California—due to factors such as congestion, labor disputes, and geopolitical tensions, which directly threaten the timely flow of imported merchandise that underpins its supply chain. This represents a shift from the 2023 discussion, which broadly referenced port-related risks as part of broader supply chain and third-party threats, to a 2024 emphasis on how port-specific events (e.g., diversions, labor unrest, and infrastructure bottlenecks) now constitute a distinct and material operational risk that can elevate costs and impair inventory availability. Consequently, the operational impact of port security risks has evolved from a generalized supply chain concern to a concentrated exposure centered on critical U.S. maritime entry points, potentially leading to higher costs, stockouts, and reputational damage if disruptions recur.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "TGT_10k_2023.pdf",
          "target_page": 13,
          "pages": [
            11,
            12,
            13,
            14,
            15
          ]
        },
        "hop_2_rel": {
          "source_file": "TGT_10k_2024.pdf",
          "target_page": 15,
          "pages": [
            13,
            14,
            15,
            16,
            17
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 51387,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 13067,
        "completion_tokens": 291,
        "total_tokens": 13358
      }
    },
    {
      "question_id": 63,
      "question": "How did Emerson's financial relationship with Heritage AspenTech evolve between 2023 and 2024, particularly in terms of acquisition-related amortization and restructuring costs?",
      "original_answer": "In 2023, Emerson reported $258 million in intangibles amortization related to the Heritage AspenTech acquisition. By 2024, this specific amortization was no longer reported, indicating that the focus had shifted away from AspenTech as a newly acquired entity. Additionally, restructuring costs increased significantly from $72 million in 2023 to $228 million in 2024, suggesting that Emerson undertook more extensive restructuring activities in 2024, potentially reflecting integration efforts or strategic realignments following the AspenTech acquisition.",
      "llm_answer": "Between 2023 and 2024, Emerson's financial relationship with Heritage AspenTech evolved through the sale of its 40% non-controlling equity interest in Copeland (a joint venture formed from the 2022 acquisition) and the related note receivable. In 2024, Emerson recognized a $539 gain ($435 after-tax) from selling its equity stake and $1.9 billion from selling the note receivable, while 2023 included a $10.6 billion pretax gain from the initial Copeland stake sale and $2.2 billion in income taxes related to that transaction. Restructuring costs related to the acquisition integration (including $43 of integration-related stock compensation) totaled $228 in 2024, reflecting ongoing integration efforts. Additionally, 2024 included $96 of acquisition/divestiture costs and $105 of restructuring expenses tied to the AspenTech integration, with $560 of intangible amortization (including $560 from the NI acquisition) impacting results.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "EMR_10k_2023.pdf",
          "target_page": 52,
          "pages": [
            50,
            51,
            52,
            53,
            54
          ]
        },
        "hop_2_rel": {
          "source_file": "EMR_10k_2024.pdf",
          "target_page": 55,
          "pages": [
            53,
            54,
            55,
            56,
            57
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 39265,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 10044,
        "completion_tokens": 234,
        "total_tokens": 10279
      }
    },
    {
      "question_id": 63,
      "question": "How has AIG's use of Expected Loss Ratio methods evolved between 2022 and 2024, particularly in terms of the weight given to this method across different lines of business and accident years?",
      "original_answer": "In 2022, AIG applied Expected Loss Ratio methods primarily for more recent accident years in lines such as D&O, E&O, EPLI, and professional liability, where losses are low frequency and high severity. The method was also used in conjunction with IBNR factor methods for low frequency/high severity losses, with factors continually reevaluated based on emerging claim experience and market factors. By 2024, AIG continued to use Expected Loss Ratio methods but expanded their application to include U.S. Workers' Compensation, a long-tail line of business, where they were used in combination with loss development and frequency/severity methods. This reflects a broader application of the method across different risk profiles and a more integrated approach to reserving in complex portfolios.",
      "llm_answer": "Between 2022 and 2024, AIG’s use of Expected Loss Ratio methods shifted toward greater weighting for more recent accident years, particularly in U.S. Excess Casualty and Financial Lines where recent years show higher weight on expected loss ratios due to evolving loss emergence patterns and market conditions. This reflects the methodology described in the 2024 Form 10-K, where Expected Loss Ratio methods are explicitly given more weight for newer accident years, while loss development methods are applied to more mature years. The shift is evident in the increasing use of Expected Loss Ratio estimates for accident years 2022–2024 across lines like U.S. Excess Casualty, with the methodology emphasizing recent accident years for IBNR projections.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AIG_10k_2022.pdf",
          "target_page": 270,
          "pages": [
            268,
            269,
            270,
            271,
            272
          ]
        },
        "hop_2_rel": {
          "source_file": "AIG_10k_2024.pdf",
          "target_page": 151,
          "pages": [
            149,
            150,
            151,
            152,
            153
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 9,
        "total_chars": 273896,
        "num_window_pages": 9,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 68708,
        "completion_tokens": 188,
        "total_tokens": 68896
      }
    },
    {
      "question_id": 63,
      "question": "How has the monetization strategy for Amazon's film groups evolved between 2022 and 2023, based on changes in capitalized video and music content costs and associated expenses?",
      "original_answer": "Amazon's monetization strategy for film groups evolved between 2022 and 2023, as evidenced by an increase in both the capitalized video and music content costs and the associated expenses. In 2022, the capitalized costs were $16.7 billion with total video and music expenses of $16.6 billion, while in 2023, these figures increased to $17.4 billion and $18.9 billion, respectively. This indicates a more aggressive investment in content and a corresponding rise in monetization efforts.",
      "llm_answer": "Based on the 10-K disclosures, Amazon's film group monetization strategy shifted significantly between 2022 and 2023, primarily driven by changes in capitalized content costs and expense recognition. In 2022, total capitalized video and music content costs were $16.7 billion, with total video and music expense at $16.6 billion. By 2023, capitalized costs increased to $17.4 billion, and total video and music expense rose to $18.9 billion. This reflects a strategic shift toward greater investment in original content (with capitalized production costs amortized on an accelerated basis) and expanded licensing, leading to higher amortization expenses in cost of sales. The weighted average remaining life of capitalized video content also increased slightly from 2.6 years (2022) to 3.5 years (2023), indicating longer monetization horizons for content assets.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AMZN_10k_2022.pdf",
          "target_page": 47,
          "pages": [
            45,
            46,
            47,
            48,
            49
          ]
        },
        "hop_2_rel": {
          "source_file": "AMZN_10k_2023.pdf",
          "target_page": 49,
          "pages": [
            47,
            48,
            49,
            50,
            51
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 48826,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 12435,
        "completion_tokens": 215,
        "total_tokens": 12650
      }
    },
    {
      "question_id": 63,
      "question": "How has Philip Morris International's financial relationship with RBH evolved between 2022 and 2024, particularly in terms of its stake and associated impairment?",
      "original_answer": "In 2022, Philip Morris maintained a trademark relationship with RBH, continuing to report volume of brands sold by RBH such as HEETS and other heated tobacco units. By 2024, PMI held an equity investment in RBH, which became subject to a significant impairment charge of $2,316 million due to unresolved allocation of a $32.5 billion Canadian tobacco litigation settlement among RBH, ITL, and JTIM. This reflects a shift from a trademark and brand licensing relationship to a more direct equity investment facing financial impairment.",
      "llm_answer": "Between 2022 and 2024, PMI's stake in RBH was impaired, resulting in a $2,316 million non-cash impairment charge recorded in 2024 (reflected in the diluted EPS impact of $1.49). This impairment arose from uncertainty around the allocation of a proposed CAD 32.5 billion settlement in the Canadian tobacco litigation, which signaled potential downside to the fair value of PMI's investment. The charge is explicitly detailed in the 2024 items affecting diluted EPS on page 32, where \"Impairment related to RBH equity investment\" shows a $(1.49) per share impact. While the provided documents do not specify changes in PMI's ownership stake over time, the impairment reflects a significant deterioration in the investment's value, driven by external legal and regulatory developments affecting RBH. No other changes in stake or associated financial adjustments are indicated in the provided pages.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "PM_10k_2022.pdf",
          "target_page": 34,
          "pages": [
            32,
            33,
            34,
            35,
            36
          ]
        },
        "hop_2_rel": {
          "source_file": "PM_10k_2024.pdf",
          "target_page": 30,
          "pages": [
            28,
            29,
            30,
            31,
            32
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 9,
        "total_chars": 30023,
        "num_window_pages": 9,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 7729,
        "completion_tokens": 223,
        "total_tokens": 7953
      }
    },
    {
      "question_id": 63,
      "question": "How did the sensitivity of LLY's net product revenue to changes in sales return, rebate, and discount liabilities evolve between 2023 and 2024, based on the disclosures in the respective 10-K filings?",
      "original_answer": "In 2023, LLY disclosed that a 5% change in its consolidated sales return, rebate, and discount liability would result in a $615 million change in revenue. In 2024, while the company continued to describe the accounting policy for revenue recognition and accruals for rebates and discounts, it did not provide an updated sensitivity figure. This omission suggests that the company did not disclose a revised estimate for the impact of liability changes on revenue in 2024, indicating a lack of updated quantitative disclosure compared to 2023.",
      "llm_answer": "The sensitivity of LLY’s net product revenue to changes in sales‑return, rebate and discount liabilities remained essentially unchanged between 2023 and 2024.  In both years the company disclosed that a 5 % change in the consolidated sales‑return/rebate/discount liability would affect revenue by roughly $600 million (2024) versus $615 million (2023), indicating only a modest shift in the magnitude of that sensitivity.  Consequently, the evolution of sensitivity shows no material change—it stays at a comparable level across the two periods.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "LLY_10k_2023.pdf",
          "target_page": 53,
          "pages": [
            51,
            52,
            53,
            54,
            55
          ]
        },
        "hop_2_rel": {
          "source_file": "LLY_10k_2024.pdf",
          "target_page": 53,
          "pages": [
            51,
            52,
            53,
            54,
            55
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 43899,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 11208,
        "completion_tokens": 136,
        "total_tokens": 11345
      }
    },
    {
      "question_id": 64,
      "question": "How has the role and revenue contribution of Bulk shipments evolved from 2022 to 2024, based on Union Pacific's disclosures?",
      "original_answer": "In 2022, Bulk shipments had an average revenue per car of $3,305 in 2021 (referenced in the 2022 filing), showing a 6% increase from 2020. By 2024, Bulk shipments had grown in strategic importance, contributing 32% of total freight revenues, with detailed operations covering grain, fertilizer, and coal markets, including international connections to Mexico and access to Canadian interline routes. This indicates a transformation in the Bulk segment's role from a revenue-per-unit perspective to a more strategically embedded and revenue-significant component of Union Pacific's operations.",
      "llm_answer": "Based on the provided disclosures, Bulk shipments' revenue contribution increased from $5,960 million in 2020 to $6,656 million in 2021, reflecting a 12% year‑over‑year rise driven by a 5% volume increase, core pricing gains, higher fuel surcharge revenue, and a more favorable traffic mix. This growth lifted Bulk’s share of total freight revenues, although it remained below the 2019 peak of $6,529 million, indicating a modest recovery but not yet a full rebound to pre‑pandemic levels.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "UNP_10k_2022.pdf",
          "target_page": 35,
          "pages": [
            33,
            34,
            35,
            36,
            37
          ]
        },
        "hop_2_rel": {
          "source_file": "UNP_10k_2024.pdf",
          "target_page": 6,
          "pages": [
            4,
            5,
            6,
            7,
            8
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 43385,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 11060,
        "completion_tokens": 122,
        "total_tokens": 11182
      }
    },
    {
      "question_id": 64,
      "question": "How did the interest rate of IBM's Notes due 2028 evolve between 2023 and 2024, and what does this indicate about IBM's debt strategy?",
      "original_answer": "In 2023, IBM had 1.750% Notes due 2028 (IBM 28A) listed, and in 2024, the same 1.750% Notes due 2028 (IBM 28A) were still present in the disclosures. This indicates that the interest rate for this specific issuance remained unchanged over the two years. However, IBM introduced new notes with different interest rates in 2024, such as the 2.900% Notes due 2030 and the 3.150% Notes due 2033, suggesting a broader strategy to issue debt at higher rates for longer maturities.",
      "llm_answer": "IBM's 2028 notes carry a fixed 0.300% interest rate in both the 2023 and 2024 filings, indicating no change in the coupon rate between those years. This stable, low-rate structure reflects IBM's strategy of maintaining a conservative debt profile with predictable financing costs, supporting its focus on long-term investments in hybrid cloud and AI rather than aggressive debt restructuring.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "IBM_10k_2023.pdf",
          "target_page": 1,
          "pages": [
            1,
            2,
            3,
            4,
            5
          ]
        },
        "hop_2_rel": {
          "source_file": "IBM_10k_2024.pdf",
          "target_page": 1,
          "pages": [
            1,
            2,
            3,
            4,
            5
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 53151,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 13502,
        "completion_tokens": 98,
        "total_tokens": 13600
      }
    },
    {
      "question_id": 65,
      "question": "How did AT&T's capital structure strategy regarding preferred interests evolve from 2023 to 2024, particularly in relation to the Mobility Preferred Interests and the introduction of new preferred instruments?",
      "original_answer": "In 2023, AT&T repurchased all of its Mobility Preferred Interests, which had a redemption value of approximately $5,340 million and paid annual cash distributions of $373 million. This marked a significant shift in strategy, as the company eliminated this class of preferred interests. In 2024, AT&T introduced structural modifications to other preferred instruments, including the restructuring of its Tower Holdings preferred interests to include both fixed and floating rate components, and the expansion of Telco LLC preferred interests to a total of $7,250 million. This evolution indicates a strategic pivot from Mobility-based preferred capital to more diversified and strategically tailored preferred instruments tied to infrastructure and telecommunications assets.",
      "llm_answer": "From 2023 to 2024 AT&T’s preferred‑interest strategy shifted from eliminating legacy structures to issuing new, higher‑yielding instruments. The 2018‑issued Mobility II preferred interests were fully repurchased by April 2023, ending the 7% perpetual preferred equity that had previously been re‑classified as a liability. In late 2024 AT&T announced plans to issue $2.25 billion of new non‑convertible cumulative preferred interests in Telco LLC (Telco Class A‑4) with a 5.94% initial distribution and reset provisions, and it also amended the 2019 Tower preferred interests to a mixed fixed‑rate/floating‑rate structure with distribution rates of 5.90% (fixed) and SOFR + 250 bps (floating). These moves reflect a strategy of replacing older, lower‑cost preferred equity with newer, more flexible preferred instruments that can be called or redeemed on staggered schedules and that carry higher, reset‑able dividend rates.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "T_10k_2023.pdf",
          "target_page": 55,
          "pages": [
            53,
            54,
            55,
            56,
            57
          ]
        },
        "hop_2_rel": {
          "source_file": "T_10k_2024.pdf",
          "target_page": 87,
          "pages": [
            85,
            86,
            87,
            88,
            89
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 62011,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 15738,
        "completion_tokens": 231,
        "total_tokens": 15969
      }
    },
    {
      "question_id": 65,
      "question": "How has Amazon's characterization of the competitive threat from websites evolved between 2022 and 2023, and what specific changes in language indicate a shift in the nature of this competition?",
      "original_answer": "In 2022, Amazon described competitive websites as part of a broader list of fluctuating business factors, indicating a general awareness of competitive pressures. By 2023, Amazon's language evolved to reflect a more direct and strategic competitive stance, specifically highlighting the introduction of 'competitive stores, websites, products, services, price decreases, or improvements' as a central concern. This shift indicates a more focused and intensified competitive threat from digital platforms, suggesting an evolution from a general operational risk to a more strategic and dynamic competitive challenge.",
      "llm_answer": "Between 2022 and 2023, Amazon’s language around the competitive threat from other websites shifted from a general warning about “the introduction of competitive stores, websites, products, services, price decreases, or improvements” in 2022 to a more specific focus on “the extent to which use of our services is affected by spyware, viruses, phishing and other spam emails, denial of service attacks, data theft, computer intrusions, outages, and similar events” in 2023. This change reflects a shift from viewing competition mainly as price or product‑offering pressure to emphasizing how cyber‑security threats and service‑disruption risks can erode the attractiveness and reliability of Amazon’s own platform.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AMZN_10k_2022.pdf",
          "target_page": 9,
          "pages": [
            7,
            8,
            9,
            10,
            11
          ]
        },
        "hop_2_rel": {
          "source_file": "AMZN_10k_2023.pdf",
          "target_page": 9,
          "pages": [
            7,
            8,
            9,
            10,
            11
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 9,
        "total_chars": 50015,
        "num_window_pages": 9,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 12735,
        "completion_tokens": 178,
        "total_tokens": 12913
      }
    },
    {
      "question_id": 65,
      "question": "How has PM's relationship with KT&G evolved from 2022 to 2024, particularly in terms of its strategic reliance on KT&G's heat-not-burn products within PMI's smoke-free product portfolio?",
      "original_answer": "In 2022, PM had a global collaboration agreement with KT&G that allowed PMI to exclusively distribute KT&G's smoke-free products, including heat-not-burn products like LIL Mini and LIL Plus, outside of South Korea. This agreement was initially for three years, indicating a strategic partnership aimed at expanding KT&G's products globally. By 2024, this relationship had evolved such that KT&G's heat-not-burn products were no longer just distributed by PMI but were integrated into PMI's broader smoke-free product portfolio, specifically being listed among PMI's own heat-not-burn offerings. This indicates a deeper strategic reliance on KT&G's product line within PMI's own commercialization efforts, suggesting a shift from a distribution partnership to a more embedded supplier or technology partner role for KT&G.",
      "llm_answer": "From 2022 to 2024, PMI’s strategic reliance on KT&G’s heat‑not‑burn products grew markedly.  In 2022 the collaboration was just beginning, but by 2024 KT&G’s licensed heated‑tobacco units (HTUs) accounted for a significant share of PMI’s smoke‑free volume – HTU shipments rose 11.6% and represented a key driver of the 2.5% overall shipment‑volume increase, while overall smoke‑free net revenues jumped from $10.19 bn in 2022 to $14.66 bn in 2024.  This reflects PMI’s deepening dependence on KT&G’s products as a core component of its smoke‑free portfolio.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "PM_10k_2022.pdf",
          "target_page": 51,
          "pages": [
            49,
            50,
            51,
            52,
            53
          ]
        },
        "hop_2_rel": {
          "source_file": "PM_10k_2024.pdf",
          "target_page": 40,
          "pages": [
            38,
            39,
            40,
            41,
            42
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 43765,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 11171,
        "completion_tokens": 139,
        "total_tokens": 11310
      }
    },
    {
      "question_id": 65,
      "question": "How did IBM's use of the PWCC Plan for funding employee awards evolve between 2022 and 2024, particularly in terms of its administration and scope?",
      "original_answer": "In 2022, the PWCC Plan was described as being used solely to fund awards for employees of PwCC who joined IBM after the acquisition, and it was stated that the plan would continue to be used for this purpose. By 2024, while the plan's administration and terms remained substantively identical to the 2001 Plan, IBM emphasized that the PWCC Plan 'has been and will continue to be used solely' for funding awards for former PwCC employees, indicating a reaffirmation rather than a change in scope. However, the shift in language from 'has been and will continue to be' in 2022 to a more definitive tone in 2024 suggests a stronger commitment to maintaining the plan’s current usage without expansion.",
      "llm_answer": "Based on the provided SEC filing excerpts, IBM's PWCC Plan (established for PricewaterhouseCoopers Consulting employees post-acquisition) has maintained its original scope and administration since its 2002 adoption. The plan continues to fund awards exclusively for PwCC employees who joined IBM through the acquisition, with no changes to its structure or eligibility criteria noted between 2022 and 2024. The 2024 filing confirms the PWCC Plan remains administratively identical to the 2001 Plan, with awards for senior executives explicitly excluded, and its terms remain unchanged from the original adoption.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "IBM_10k_2022.pdf",
          "target_page": 28,
          "pages": [
            26,
            27,
            28,
            29,
            30
          ]
        },
        "hop_2_rel": {
          "source_file": "IBM_10k_2024.pdf",
          "target_page": 18,
          "pages": [
            16,
            17,
            18,
            19,
            20
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 8,
        "total_chars": 36175,
        "num_window_pages": 8,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 9264,
        "completion_tokens": 153,
        "total_tokens": 9417
      }
    },
    {
      "question_id": 66,
      "question": "How did AT&T's financial obligations and strategic approach to Mobility Preferred Interests evolve between 2023 and 2024, and what does this shift indicate about its broader capital structure management?",
      "original_answer": "In 2023, AT&T repurchased all remaining Mobility Preferred Interests for a total of $5,414 million, which included accrued and unpaid distributions, effectively eliminating this financial obligation. By 2024, there was no mention of Mobility Preferred Interests in the disclosures, indicating a complete exit from this instrument. This contrasts with AT&T's treatment of other preferred interests, such as the Tower Holdings and Telco LLC preferred interests, which remained outstanding and were even expanded or restructured in 2024. This shift indicates a strategic move to reduce certain long-term liabilities while maintaining or adjusting other capital instruments for flexibility, suggesting a selective approach to managing its capital structure.",
      "llm_answer": "Between 2023 and 2024, AT&T’s strategic shift away from the legacy Mobility II Preferred Interests—culminating in their full repurchase in April 2023 and the termination of all related distributions—signaled a deliberate move to streamline its capital structure and eliminate legacy equity-like obligations. This was reinforced by the 2024 amendment of the Tower Holdings preferred interests, which reset rates, introduced floating‑rate components, and added new issuances (e.g., Telco Class A‑4) to fund future redemptions, while also expanding the company’s ability to call and restructure these securities. Collectively, these actions reflect AT&T’s broader strategy of tightening its balance sheet, reducing reliance on complex non‑controlling equity arrangements, and focusing capital on core growth initiatives such as 5G, fiber, and Open RAN deployments.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "T_10k_2023.pdf",
          "target_page": 25,
          "pages": [
            23,
            24,
            25,
            26,
            27
          ]
        },
        "hop_2_rel": {
          "source_file": "T_10k_2024.pdf",
          "target_page": 87,
          "pages": [
            85,
            86,
            87,
            88,
            89
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 51480,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 13103,
        "completion_tokens": 215,
        "total_tokens": 13319
      }
    },
    {
      "question_id": 66,
      "question": "How has IBM's relationship with stock exchange regulations evolved in terms of regulatory exposure for its debt securities between 2022 and 2024?",
      "original_answer": "In 2022, IBM described stock exchange regulations as one of several factors influencing the value of its debt securities, placing it among other external variables beyond the company's control. By 2024, IBM's language shifted to indicate a more direct regulatory exposure, stating it is 'subject to' stock exchange regulations, which implies a heightened recognition of their binding impact on the company's financing activities. This evolution reflects a stronger acknowledgment of regulatory influence in 2024 compared to the more general mention in 2022.",
      "llm_answer": "IBM's debt securities remain subject to market‑driven regulatory and exchange‑listing requirements that can affect their value and liquidity. The company’s 2022 filing notes that fluctuations in interest rates, exchange controls, and stock‑exchange regulations can impact debt‑security pricing, while the 2024 filing emphasizes that changes in market‑liquidity conditions and customer‑credit risk could further influence the company’s financing costs and access to capital. Thus, regulatory exposure for IBM’s debt securities has evolved from a focus on general market‑risk factors in 2022 to a more explicit concern about liquidity and credit‑risk impacts on financing conditions by 2024.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "IBM_10k_2022.pdf",
          "target_page": 22,
          "pages": [
            20,
            21,
            22,
            23,
            24
          ]
        },
        "hop_2_rel": {
          "source_file": "IBM_10k_2024.pdf",
          "target_page": 11,
          "pages": [
            9,
            10,
            11,
            12,
            13
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 8,
        "total_chars": 38003,
        "num_window_pages": 8,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 9720,
        "completion_tokens": 172,
        "total_tokens": 9893
      }
    },
    {
      "question_id": 67,
      "question": "How did Disney's financial relationship with A&E evolve from 2022 to 2024, particularly in terms of equity income contribution?",
      "original_answer": "In 2022, Disney's equity investment in A&E was a significant component of its equity income, with A&E being one of the most notable equity method investees alongside CTV Specialty Television. By 2024, Disney's equity in the income of investees had decreased by $207 million, specifically due to lower income generated from A+E. This indicates a material decline in the financial contribution from A&E to Disney over the two-year period.",
      "llm_answer": "From 2022 to 2024, Disney's equity income contribution from A+E Networks declined significantly, as reflected in the 2024 financial statements where equity in the income of investees decreased by $207 million to $575 million due to lower income from A+E. This reduction aligns with the broader trend of Disney shifting focus toward direct-to-consumer (DTC) distribution, which negatively impacted its international channels business, including A+E's international operations. Consequently, the equity income contribution from A+E, which had previously been a notable component of Disney's revenue streams, diminished substantially by 2024.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "DIS_10k_2022.pdf",
          "target_page": 12,
          "pages": [
            10,
            11,
            12,
            13,
            14
          ]
        },
        "hop_2_rel": {
          "source_file": "DIS_10k_2024.pdf",
          "target_page": 35,
          "pages": [
            33,
            34,
            35,
            36,
            37
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 9,
        "total_chars": 32800,
        "num_window_pages": 9,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 8415,
        "completion_tokens": 159,
        "total_tokens": 8575
      }
    },
    {
      "question_id": 67,
      "question": "How did the carrying value of securitized debt obligations change from 2022 to 2023, and what does this indicate about the company's long-term funding strategy?",
      "original_answer": "In 2022, the long-term funding, which primarily consists of securitized debt obligations and senior and subordinated notes, stood at $42.3 billion as of December 31, 2021, with a significant portion driven by securitized debt obligations. By December 31, 2023, the carrying value of securitized debt obligations alone decreased to $18.043 billion. This indicates a strategic shift or reduction in reliance on securitized debt obligations as part of the company's long-term funding structure over this period.",
      "llm_answer": "The carrying value of securitized debt obligations rose from $16,973 million at the end of 2022 to $18,043 million at the end of 2023, reflecting an increase of roughly $1.07 billion. This growth signals that Capital One is expanding its reliance on securitization as a source of long‑term funding, complementing its deposit base and other wholesale financing to support continued loan‑portfolio growth and diversify its funding profile.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "COF_10k_2022.pdf",
          "target_page": 114,
          "pages": [
            112,
            113,
            114,
            115,
            116
          ]
        },
        "hop_2_rel": {
          "source_file": "COF_10k_2023.pdf",
          "target_page": 210,
          "pages": [
            208,
            209,
            210,
            211,
            212
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 48210,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 12279,
        "completion_tokens": 109,
        "total_tokens": 12388
      }
    },
    {
      "question_id": 68,
      "question": "How has Disney's approach to scripted programming evolved between 2022 and 2024, particularly in terms of its international general entertainment channels and its strategic shift toward DTC platforms?",
      "original_answer": "In 2022, Disney operated approximately 220 General Entertainment channels outside the U.S., primarily under the Fox, National Geographic, and Star brands, featuring a mix of scripted, reality, and documentary programming across multiple languages and regions. By 2024, there was a notable strategic shift, with increased emphasis on DTC platforms and less focus on traditional linear channels. The 2024 report highlights that Disney, along with Fox Corporation and Warner Bros. Discovery, planned a joint venture (Venu Sports) to distribute sports content via a DTC platform, signaling a broader move toward streaming. Additionally, Disney announced plans to launch a new DTC offering in early fall 2025 that would include live linear streams of ESPN channels and ESPN+. This reflects a strategic pivot from scripted linear content toward live and sports-driven DTC offerings, indicating a transformation in Disney’s programming and distribution priorities.",
      "llm_answer": "Between 2022 and 2024, Disney dramatically reduced its reliance on traditional international linear channels—especially its General Entertainment and Sports networks—by shifting the bulk of their content and revenue to direct‑to‑consumer (DTC) platforms.  The company’s international General Entertainment channels (e.g., Fox, National Geographic, Star) and sports channels (e.g., ESPN, Star sports) now serve mainly as feeders that drive subscribers to Disney+, Disney+ Hotstar, Star+, and the upcoming ESPN‑branded tile on Disney+, while the firm simultaneously launched and expanded DTC offerings (Disney+, Disney+ Hotstar, ESPN+, Hulu) and pursued joint‑venture sports DTC initiatives such as Venu Sports.  Consequently, the international channels’ subscriber base is being deliberately run down as the company pivots to monetize its library through subscription fees, advertising, and premium‑access models rather than traditional licensing and affiliate revenue.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "DIS_10k_2022.pdf",
          "target_page": 11,
          "pages": [
            9,
            10,
            11,
            12,
            13
          ]
        },
        "hop_2_rel": {
          "source_file": "DIS_10k_2024.pdf",
          "target_page": 9,
          "pages": [
            7,
            8,
            9,
            10,
            11
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 39439,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 10092,
        "completion_tokens": 242,
        "total_tokens": 10334
      }
    },
    {
      "question_id": 68,
      "question": "How did Tesla's financial and operational challenges related to energy storage products evolve from 2022 to 2023, particularly in terms of accounts receivable and production scaling dependencies?",
      "original_answer": "In 2022, Tesla disclosed significant long-term government rebates receivable related to its energy storage products, with a balance of $627 million as of December 31, 2021, indicating extended collection periods of up to a year or more. By 2023, the focus shifted from financial implications of receivables to operational dependencies, as Tesla highlighted production scaling risks for energy storage products, including bottlenecks, supplier constraints, and facility ramp delays at factories in Nevada, Texas, and other locations. These changes reflect a shift from financial exposure tied to receivables to broader production and supply chain dependencies affecting the company's ability to meet cost and profitability targets.",
      "llm_answer": "From 2022 to 2023, Tesla’s accounts receivable remained heavily dependent on timing of customer and financing partner payments, with balances fluctuating due to factors like regulatory credit sales near quarter-end and government rebate collection delays (up to a year). This volatility directly impacted receivable levels, as seen in the $627 million long-term rebates receivable reported as of 2021. Concurrently, scaling production of energy storage products faced significant hurdles, including supply chain constraints (e.g., battery cell shortages), manufacturing ramp delays, and the need to establish new facilities (like Mexico), all of which created dependencies on accurate component forecasting and supplier reliability to meet growth targets without disrupting output or increasing costs.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "TSLA_10k_2022.pdf",
          "target_page": 64,
          "pages": [
            62,
            63,
            64,
            65,
            66
          ]
        },
        "hop_2_rel": {
          "source_file": "TSLA_10k_2023.pdf",
          "target_page": 16,
          "pages": [
            14,
            15,
            16,
            17,
            18
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 9,
        "total_chars": 49458,
        "num_window_pages": 9,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 12597,
        "completion_tokens": 200,
        "total_tokens": 12798
      }
    },
    {
      "question_id": 68,
      "question": "How has the role of syrups in Coca-Cola's business model evolved between 2022 and 2023, particularly in relation to its bottling partners and fountain retailers?",
      "original_answer": "In 2022, Coca-Cola's relationship with syrups was primarily defined by its sales to both consolidated and unconsolidated bottling partners, with revenue and volume recognition dependent on the ownership structure of those partners. Specifically, concentrate and syrup sales were not recognized until finished products were sold to third parties in the case of consolidated bottlers, while recognition occurred immediately for unconsolidated bottlers. By 2023, the company's description of syrups shifted to emphasize their role as a dependency within a broader operational framework, particularly in relation to fountain retailers. In 2023, the company clarified that it manufactures fountain syrups and sells them directly to fountain retailers or authorized wholesalers and bottlers, highlighting a more integrated and strategic role for syrups in its finished beverage delivery system. This represents a shift from a primarily volume-driven metric to a more operationally embedded component of the business model.",
      "llm_answer": "Between 2022 and 2023, Coca-Cola’s syrups shifted from being sold primarily to bottling partners for use in retail packaging to a greater focus on fountain‑retailer sales, especially in North America where the company manufactures and sells fountain syrups directly to retailers and authorized wholesalers. This change is highlighted by the 2023 MD&A discussion of “finished product operations” and “concentrate operations,” noting that finished‑product (including fountain syrup) revenues now represent a larger share of the business (42 % of net operating revenue in 2023 versus 44 % in 2022) while concentrate operations hold steady around 58 %–56 %. The company also emphasizes expanding its “incidence‑based concentrate pricing model” and supporting “e‑commerce” and “digital marketplace” channels, which increasingly involve selling syrups to fountain accounts rather than traditional bottling partners. Consequently, syrups are now a more strategic, higher‑margin conduit for reaching consumers through fountain venues and digital sales, while still maintaining the core concentrate‑to‑bottler model for retail distribution.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "KO_10k_2022.pdf",
          "target_page": 44,
          "pages": [
            42,
            43,
            44,
            45,
            46
          ]
        },
        "hop_2_rel": {
          "source_file": "KO_10k_2023.pdf",
          "target_page": 37,
          "pages": [
            35,
            36,
            37,
            38,
            39
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 48649,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 12386,
        "completion_tokens": 282,
        "total_tokens": 12668
      }
    },
    {
      "question_id": 69,
      "question": "How did Disney's investment in Other Mortgage- and Asset-Backed Securities (MBS & ABS) evolve from fiscal year 2022 to fiscal year 2024, and what was the trend in its proportion relative to the overall fair value hierarchy?",
      "original_answer": "In fiscal year 2022, Disney's investment in Other MBS & ABS was valued at $96 million, representing 1% of the total plan asset mix. By fiscal year 2024, this investment increased to $120 million, maintaining a 1% share of the total plan asset mix. While the absolute value of the investment grew moderately, its proportional representation within the portfolio remained stable.",
      "llm_answer": "From fiscal 2022 to fiscal 2024, Disney’s investment in Other Mortgage- and Asset-Backed Securities (MBS & ABS) declined from $166 million to $120 million, reflecting a downward trend in both absolute dollar amounts and its share of the overall fair‑value hierarchy. In the 2024 disclosures, Other MBS & ABS represented only about 1 % of total plan assets (Level 2 + Level 3), down from roughly 1 %–2 % in prior years, indicating a continued reduction in the relative proportion of these securities within Disney’s broader investment portfolio.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "DIS_10k_2022.pdf",
          "target_page": 104,
          "pages": [
            102,
            103,
            104,
            105,
            106
          ]
        },
        "hop_2_rel": {
          "source_file": "DIS_10k_2024.pdf",
          "target_page": 107,
          "pages": [
            105,
            106,
            107,
            108,
            109
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 55006,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 13993,
        "completion_tokens": 136,
        "total_tokens": 14129
      }
    },
    {
      "question_id": 69,
      "question": "How did the focus areas of Skunk Works' advanced development programs evolve between 2022 and 2023 in relation to next-generation military aircraft capabilities?",
      "original_answer": "In 2022, Skunk Works' Advanced Development Programs focused on future systems including unmanned and manned aerial systems and next-generation capabilities for hypersonics, intelligence, surveillance, reconnaissance, situational awareness, and air mobility. By 2023, the focus had evolved to emphasize air dominance, hypersonics, intelligence, surveillance, reconnaissance, situational awareness, and air mobility. The shift highlights an increased emphasis on air dominance as a core next-generation capability while maintaining focus on hypersonics and ISR. This represents a refinement of priorities rather than a complete overhaul of focus areas.",
      "llm_answer": "Between 2022 and 2023, the Skunk Works’ advanced development focus shifted from a broader portfolio of next‑generation platforms to a tighter concentration on hypersonic strike weapons and related air‑dominance technologies.  The 2022 disclosures highlighted ongoing work on hypersonics, unmanned and manned aerial systems, and air‑mobility concepts, while the 2023 filing emphasizes that hypersonic programs with the U.S. Army and Navy are entering early‑production phases and that these systems are a primary growth driver for the company’s future capabilities.  Consequently, the evolution of the focus areas reflects a strategic pivot toward maturing hypersonic weapons as the flagship next‑generation military aircraft capability.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "LMT_10k_2022.pdf",
          "target_page": 6,
          "pages": [
            4,
            5,
            6,
            7,
            8
          ]
        },
        "hop_2_rel": {
          "source_file": "LMT_10k_2023.pdf",
          "target_page": 4,
          "pages": [
            2,
            3,
            4,
            5,
            6
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 9,
        "total_chars": 48582,
        "num_window_pages": 9,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 12367,
        "completion_tokens": 183,
        "total_tokens": 12551
      }
    },
    {
      "question_id": 69,
      "question": "How has Tesla's approach to the Powerwall product evolved from 2022 to 2023, particularly in terms of integration strategy and production emphasis?",
      "original_answer": "In 2022, Tesla emphasized cross-selling Powerwall with residential solar energy products due to better availability and growing grid stability concerns. The company was also focused on improving installation capabilities and price efficiencies for Solar Roof, which is closely related to Powerwall integration. By 2023, Tesla had advanced its integration strategy by designing both Solar Roof and solar energy systems to specifically integrate with Powerwall, indicating a more deliberate and engineered approach to product synergy. This evolution reflects a shift from a sales and availability focus to a deeper technical and strategic integration within Tesla's energy ecosystem.",
      "llm_answer": "From 2022 to 2023, Tesla shifted from a modular, vehicle-derived design approach toward a more integrated, software-driven strategy for Powerwall, emphasizing remote control and dispatch capabilities while maintaining its focus on modular battery system design to optimize manufacturing capacity. Production emphasis remained on scaling energy storage output—particularly through Megapack and Powerwall—while leveraging in-house expertise in power electronics and battery cell development to support global deployment, though specific production capacity details for Powerwall are not explicitly detailed in the 2023 disclosures.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "TSLA_10k_2022.pdf",
          "target_page": 34,
          "pages": [
            32,
            33,
            34,
            35,
            36
          ]
        },
        "hop_2_rel": {
          "source_file": "TSLA_10k_2023.pdf",
          "target_page": 7,
          "pages": [
            5,
            6,
            7,
            8,
            9
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 9,
        "total_chars": 42301,
        "num_window_pages": 9,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 10795,
        "completion_tokens": 157,
        "total_tokens": 10952
      }
    },
    {
      "question_id": 69,
      "question": "How has Gilead's strategic positioning around Biktarvy evolved between 2022 and 2024, particularly in terms of its role within the company's HIV portfolio and associated commercial risks?",
      "original_answer": "In 2022, Biktarvy was prominently positioned as a key revenue-generating product within Gilead’s HIV portfolio, highlighted as a single-tablet regimen combining bictegravir, emtricitabine, and tenofovir alafenamide (TAF), emphasizing its convenience and efficacy. By 2024, while Biktarvy remained a core product, the company faced heightened commercial risk as it became more dependent on HIV products containing TAF. A shift in treatment paradigms or reduced preference for nucleoside-based therapies could significantly impact Biktarvy’s sales and, by extension, Gilead’s financial stability. This reflects a transition from a focus on product innovation to increased vulnerability due to overreliance on a narrow therapeutic class.",
      "llm_answer": "Between 2022 and 2024, Gilead's strategic positioning around Biktarvy evolved from being a core HIV product within a broader portfolio that included Genvoya, Descovy, Odefsey, Truvada, Complera, and Stribild, to a more focused anchor in its HIV segment amid rising competitive and commercialization risks. The 2024 10-K highlights that HIV products, particularly those containing TAF like Biktarvy, face threats from shifting treatment paradigms, generic competition, and the need for continual innovation to maintain market share, while also being exposed to broader commercial pressures such as reimbursement constraints and forecasting volatility due to reliance on a few U.S. wholesalers. This underscores a strategic shift toward protecting and optimizing Biktarvy’s position, even as Gilead navigates risks tied to product lifecycle management and external pricing reforms like the Inflation Reduction Act.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "GILD_10k_2022.pdf",
          "target_page": 5,
          "pages": [
            3,
            4,
            5,
            6,
            7
          ]
        },
        "hop_2_rel": {
          "source_file": "GILD_10k_2024.pdf",
          "target_page": 18,
          "pages": [
            16,
            17,
            18,
            19,
            20
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 47959,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 12219,
        "completion_tokens": 228,
        "total_tokens": 12447
      }
    },
    {
      "question_id": 70,
      "question": "How did the composition of the U.S. Retrospective Responsibility Plan change between 2022 and 2023, particularly regarding the mechanisms referenced in relation to the U.S. Litigation Escrow Agreement?",
      "original_answer": "In 2022, the U.S. Retrospective Responsibility Plan included mechanisms such as the U.S. Litigation Escrow Agreement, the conversion feature of Class B common stock, indemnification obligations of Visa U.S.A. members, an interchange judgment sharing agreement, a loss sharing agreement, and an omnibus agreement. By 2023, the composition evolved to include a new element — 'makewhole agreements relating to the Class B-1 common stock exchange offer' — while retaining the U.S. Litigation Escrow Agreement and other previously listed mechanisms. This indicates an expansion of the plan to incorporate additional financial safeguards or compensatory measures.",
      "llm_answer": "The U.S. Retrospective Responsibility Plan remained unchanged between 2022 and 2023, continuing to rely on the same mechanisms—including the U.S. litigation escrow agreement, conversion feature of class B common stock, indemnification obligations, interchange judgment sharing agreement, loss sharing agreement, and omnibus agreement—to address potential liability from U.S. covered litigation. No structural changes to these mechanisms were disclosed in the 2023 filing compared to 2022.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "V_10k_2022.pdf",
          "target_page": 71,
          "pages": [
            69,
            70,
            71,
            72,
            73
          ]
        },
        "hop_2_rel": {
          "source_file": "V_10k_2023.pdf",
          "target_page": 72,
          "pages": [
            70,
            71,
            72,
            73,
            74
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 52426,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 13339,
        "completion_tokens": 122,
        "total_tokens": 13461
      }
    },
    {
      "question_id": 70,
      "question": "How has the strategic importance of Biktarvy evolved for GILD from 2022 to 2024, based on its patent protection timeline and the company's risk disclosures around HIV product dependency?",
      "original_answer": "In 2022, Biktarvy was listed with a U.S. patent expiration in 2033 and no expiration listed in the E.U., indicating strong long-term protection and likely a key revenue driver. By 2024, although patent details were not explicitly mentioned, the company highlighted heightened risk around its HIV products, including Biktarvy, due to market competition and potential shifts in treatment paradigms. This suggests that despite long-term patent protection, Biktarvy's strategic position has become more vulnerable due to external market and regulatory pressures.",
      "llm_answer": "From 2022 through 2024, GILD’s patent protection for Biktarvy was extended to 2033, providing continued exclusivity for the product, while the company’s risk disclosures increasingly highlighted its reliance on HIV product sales and the broader challenges of maintaining market share amid patent expirations and competitive pressures.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "GILD_10k_2022.pdf",
          "target_page": 11,
          "pages": [
            9,
            10,
            11,
            12,
            13
          ]
        },
        "hop_2_rel": {
          "source_file": "GILD_10k_2024.pdf",
          "target_page": 18,
          "pages": [
            16,
            17,
            18,
            19,
            20
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 8,
        "total_chars": 41956,
        "num_window_pages": 8,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 10719,
        "completion_tokens": 83,
        "total_tokens": 10803
      }
    },
    {
      "question_id": 71,
      "question": "Have there been any modifications to the financial guarantees provided by AT&T for Illinois Bell Telephone Company between 2022 and 2023, particularly in terms of guarantee structure or referenced documentation?",
      "original_answer": "The financial guarantee relationship between AT&T and Illinois Bell Telephone Company remained structurally unchanged between 2022 and 2023. In 2022, AT&T's guarantee for Illinois Bell Telephone Company was referenced under Exhibit 4-d to Form 10-K for the period ending December 31, 2011. In 2023, the same guarantee was still in place and referenced under the identical exhibit number (Exhibit 4-d) and filing history (Form 10-K for the period ending December 31, 2011). There is no indication of modifications to the guarantee structure, terms, or documentation between the two years.",
      "llm_answer": "Based on the provided SEC 10-K filings, there have been no modifications to the financial guarantees provided by AT&T for Illinois Bell Telephone Company between 2022 and 2023. The documents confirm that the relevant guarantees are referenced in the \"Guaranty of certain obligations\" exhibits (specifically 4-c in T_10k_2022.pdf and 4-d in T_10k_2023.pdf), but no changes to the guarantee structure or referenced documentation are indicated in the provided pages. The 2023 filing (T_10k_2023.pdf, page 104) continues to reference the same legacy guarantees without any noted amendments or structural changes.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "T_10k_2022.pdf",
          "target_page": 141,
          "pages": [
            133,
            134,
            135,
            136,
            137
          ]
        },
        "hop_2_rel": {
          "source_file": "T_10k_2023.pdf",
          "target_page": 103,
          "pages": [
            101,
            102,
            103,
            104,
            105
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 41260,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 10553,
        "completion_tokens": 152,
        "total_tokens": 10705
      }
    },
    {
      "question_id": 71,
      "question": "What does the consistent Class C to Class A common stock conversion rate between 2022 and 2023 suggest about the potential impact on Class A common stockholders' voting power in significant corporate transactions?",
      "original_answer": "In 2022, the Class C common stock had a conversion rate of 4.0000 into Class A common stock, and this rate remained unchanged in 2023. Despite the as-converted Class A common stock value increasing slightly from 38 million in 2022 to 39 million in 2023, the unchanged conversion rate suggests that the relative voting power dilution for Class A common stockholders remained stable. This stability implies that there was no structural change in how Class C stockholders could influence significant corporate decisions through their voting rights tied to Class A equivalents.",
      "llm_answer": "The consistent Class C‑to‑Class A conversion rate between 2022 and 2023 indicates that the dilution effect on Class A common‑stock voting power remains unchanged, so any future conversion of Class C (or related preferred) securities will continue to reduce the voting influence of existing Class A shareholders in major corporate actions.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "V_10k_2022.pdf",
          "target_page": 32,
          "pages": [
            30,
            31,
            32,
            33,
            34
          ]
        },
        "hop_2_rel": {
          "source_file": "V_10k_2023.pdf",
          "target_page": 87,
          "pages": [
            85,
            86,
            87,
            88,
            89
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 9,
        "total_chars": 44619,
        "num_window_pages": 9,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 11391,
        "completion_tokens": 84,
        "total_tokens": 11475
      }
    },
    {
      "question_id": 71,
      "question": "How did Tesla's relationship with the Solar Roof evolve from 2022 to 2023 in terms of production focus and strategic dependencies?",
      "original_answer": "In 2022, Tesla directly produced the Solar Roof at Gigafactory New York, indicating active involvement in its manufacturing. However, by 2023, Tesla's disclosures shifted to emphasizing dependencies and risks associated with scaling production, including potential delays, supply chain constraints, and challenges in launching and ramping products like the Solar Roof. This reflects a transition from a production-centric view to a more cautionary outlook on strategic execution risks.",
      "llm_answer": "From 2022 to 2023, Tesla shifted its Solar Roof production focus from a high-volume, cost-intensive approach to a more controlled ramp, emphasizing quality and supply chain stability amid raw material constraints and supplier dependencies. The company increasingly relied on in-house battery cell production and localized manufacturing (e.g., Gigafactory Shanghai) to mitigate external risks, while maintaining strategic partnerships for key components to sustain growth.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "TSLA_10k_2022.pdf",
          "target_page": 9,
          "pages": [
            7,
            8,
            9,
            10,
            11
          ]
        },
        "hop_2_rel": {
          "source_file": "TSLA_10k_2023.pdf",
          "target_page": 16,
          "pages": [
            14,
            15,
            16,
            17,
            18
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 9,
        "total_chars": 45773,
        "num_window_pages": 9,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 11659,
        "completion_tokens": 117,
        "total_tokens": 11777
      }
    },
    {
      "question_id": 71,
      "question": "How has the role of syrups in Coca-Cola's business model evolved between 2022 and 2023, particularly in terms of their relationship to finished beverage production and distribution channels?",
      "original_answer": "In 2022, Coca-Cola described syrups as intermediate products used primarily in fountain beverage production, where bottling partners or fountain retailers mix them with water and sweeteners to create finished beverages for immediate consumption. The company emphasized that syrups were a key part of the concentrate operations, which generally yield lower net operating revenues but higher gross profit margins compared to finished product operations. By 2023, the company expanded its description to emphasize that fountain syrup sales in the U.S. were directly managed by Coca-Cola and sold to both fountain retailers and authorized wholesalers or bottling partners. Additionally, the 2023 filing highlighted that fountain syrup operations were specifically included in the North America operating segment, indicating a more structured and regionally focused approach to syrup distribution. This evolution reflects a strategic shift toward tighter control and segmentation of syrup-related revenue streams within the broader beverage production ecosystem.",
      "llm_answer": "Between 2022 and 2023, the role of syrups in Coca-Cola’s business model shifted further toward finished beverage production and distribution. While concentrate operations still generated 58 % of net operating revenue in 2023 (up from 56 % in 2022), syrup sales—especially fountain syrups sold to retailers and bottling partners—are increasingly integrated into the Company’s bottling and distribution network, supporting both its consolidated bottling operations and its Global Ventures segment. This reflects a continued evolution where syrups are no longer just a stand‑alone concentrate business but a key input for the Company’s finished‑product operations and its extensive distribution system.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "KO_10k_2022.pdf",
          "target_page": 5,
          "pages": [
            3,
            4,
            5,
            6,
            7
          ]
        },
        "hop_2_rel": {
          "source_file": "KO_10k_2023.pdf",
          "target_page": 37,
          "pages": [
            35,
            36,
            37,
            38,
            39
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 44791,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 11427,
        "completion_tokens": 174,
        "total_tokens": 11602
      }
    },
    {
      "question_id": 72,
      "question": "How has the company's operational focus on Africa/Eurasia evolved between 2022 and 2024, particularly in terms of its geographic reporting structure and financial contribution?",
      "original_answer": "In 2022, Africa/Eurasia was reported as part of the Oral, Personal and Home Care segment with an operating profit of $203 million, indicating a relatively minor financial contribution compared to other regions. By 2024, the company maintained Africa/Eurasia as a distinct reportable operating segment within the Oral, Personal and Home Care geographic structure. Additionally, in 2024, the company realigned its skin health business, shifting it from Europe to North America, signaling a strategic refinement in geographic reporting. This change suggests a more nuanced operational focus in how the company organizes and evaluates its regional performance, including in Africa/Eurasia.",
      "llm_answer": "Between 2022 and 2024, the company's operational focus on Africa/Eurasia remained limited in scale relative to its global footprint. Africa/Eurasia contributed $228 million to operating profit in 2022 (as reported in the 2022 segment data on page 116), $253 million in 2023 (page 115), and $253 million in 2024 (page 115), reflecting modest growth. Capital expenditures in Africa/Eurasia declined from $30 million in 2022 to $12 million in 2024 (page 116), indicating reduced investment in the region. The company's geographic reporting structure was realigned in 2024, moving skin health businesses from Europe to North America, but Africa/Eurasia remained a distinct reportable segment with consistent operating profit contributions. The company's strategic focus outside Africa/Eurasia appears to be on emerging markets like Latin America and Asia Pacific, which received significantly higher capital investments.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CL_10k_2022.pdf",
          "target_page": 117,
          "pages": [
            115,
            116,
            117,
            118,
            119
          ]
        },
        "hop_2_rel": {
          "source_file": "CL_10k_2024.pdf",
          "target_page": 114,
          "pages": [
            112,
            113,
            114,
            115,
            116
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 36181,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 9275,
        "completion_tokens": 229,
        "total_tokens": 9504
      }
    },
    {
      "question_id": 72,
      "question": "How has Johnson & Johnson's strategic presentation of its Orthopaedics business evolved between 2023 and 2024, particularly in terms of global sales performance and emphasis on enabling technologies?",
      "original_answer": "In 2023, JNJ's Orthopaedics segment was presented primarily through quantifiable sales figures, with global revenue reaching $8,942 million, showing a 4.1% increase from the prior year. The 2023 data emphasized steady growth, particularly in the U.S. ($5,525 million, up 3.8%) and modest international growth ($3,417 million, up 4.6%). By 2024, the strategic framing of Orthopaedics shifted from financial metrics to a qualitative emphasis on innovation and enabling technologies. The 2024 filing described Orthopaedics as a portfolio 'supported by products and enabling technologies' across hips, knees, trauma, spine, and sports medicine, without revisiting specific revenue figures. This reflects a strategic pivot from highlighting quantitative performance to underscoring technological leadership and product diversification within the segment.",
      "llm_answer": "Johnson & Johnson’s Orthopaedics business remained a stable, high‑volume component of its MedTech segment, with worldwide sales of $8.94 billion in 2023—up 4.1 % from 2022—and modest growth in both U.S. (3.8 %) and international (4.6 %) markets.  The segment’s focus on “enabling technologies” is evident in its expanding portfolio of hip, knee, trauma, spine, sports and surgical products, which together accounted for roughly 30 % of total MedTech sales and showed consistent double‑digit gains in advanced and surgical offerings (e.g., a 27.5 % rise in Interventional Solutions worldwide).  While overall Orthopaedics growth slowed slightly compared with the prior year, the company continues to emphasize innovation and technology‑driven solutions to sustain its market position.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "JNJ_10k_2023.pdf",
          "target_page": 90,
          "pages": [
            88,
            89,
            90,
            91,
            92
          ]
        },
        "hop_2_rel": {
          "source_file": "JNJ_10k_2024.pdf",
          "target_page": 8,
          "pages": [
            6,
            7,
            8,
            9,
            10
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 50571,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 12875,
        "completion_tokens": 195,
        "total_tokens": 13071
      }
    },
    {
      "question_id": 73,
      "question": "How has Visa's approach to managing litigation liabilities through loss sharing agreements evolved between 2022 and 2023, particularly in terms of the scope of U.S. covered litigation and liability allocation?",
      "original_answer": "In 2022, Visa detailed specific amendments to its loss sharing agreement, including the October 2015 amendment that expanded the scope of U.S. covered litigation to include opt-out actions from the Rule 23(b)(3) Settlement Class in MDL 1720 that arose out of similar facts or circumstances. This amendment was part of a broader framework involving the omnibus agreement, under which Visa assumed 66.6667% of any monetary liability in covered settlements or judgments, with Mastercard assuming 33.3333%. In 2023, Visa consolidated its approach under the U.S. Retrospective Responsibility Plan, which now encompasses the loss sharing agreement as part of a broader set of mechanisms designed to address potential liabilities from U.S. covered litigation. Notably, the 2023 filing emphasizes that U.S. covered litigation now includes matters that have been 'settled or otherwise fully or substantially resolved,' indicating a shift toward resolution and consolidation of past liabilities. The evolution from a focus on specific amendments and liability sharing with Mastercard in 2022 to a more comprehensive and retrospective liability framework in 2023 suggests a strategic pivot toward finalizing and managing legacy litigation exposure.",
      "llm_answer": "Between 2022 and 2023, Visa's approach to managing litigation liabilities through loss-sharing agreements remained consistent in structure but showed incremental expansion in scope and procedural refinement. In 2022, the company continued to allocate liability for U.S. covered litigation—encompassing the Interchange Multidistrict Litigation and opt-out cases under MDL 1720—among Visa U.S.A., Visa International, and participating members via the loss-sharing agreement, indemnification obligations, and the omnibus agreement, which formalized a 66.6667% Visa / 33.3333% Mastercard split for settlements and judgments. The 2023 updates, particularly through amendments to the omnibus agreement, extended coverage to include certain post-amendment opt-out actions arising from facts similar to MDL 1720, ensuring these were treated as covered litigation under the same liability-allocation framework. While the core mechanisms persisted, the 2023 changes emphasized broader inclusion of newly emerged cases within the U.S. covered litigation scope, reflecting a strategic evolution to preemptively manage emerging legal risks without altering the fundamental loss-sharing calculus. This expansion was operationalized through updated escrow account protocols and indemnification enforcement mechanisms, maintaining the 66.6667% liability allocation for Visa while reinforcing procedural safeguards for liability recovery via the Europe retrospective responsibility plan’s conversion rate adjustments.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "V_10k_2022.pdf",
          "target_page": 73,
          "pages": [
            71,
            72,
            73,
            74,
            75
          ]
        },
        "hop_2_rel": {
          "source_file": "V_10k_2023.pdf",
          "target_page": 72,
          "pages": [
            70,
            71,
            72,
            73,
            74
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 53500,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 13610,
        "completion_tokens": 375,
        "total_tokens": 13985
      }
    },
    {
      "question_id": 73,
      "question": "How did CL's investment in Guaranteed Investment Contracts evolve between 2022 and 2024, and what does this shift indicate about the company's pension plan asset strategy?",
      "original_answer": "In 2022, CL held $1 million in Guaranteed Investment Contracts under its United States Pension Plans and $55 million under its International Pension Plans. By 2024, the company had completely phased out Guaranteed Investment Contracts from its United States Pension Plans, reducing the International allocation to $34 million. This represents a significant shift away from Guaranteed Investment Contracts in the U.S. and a moderate decrease internationally, indicating a strategic reallocation of pension plan assets.",
      "llm_answer": "Between 2022 and 2024, Colgate-Palmolive’s allocation to Guaranteed Investment Contracts (GICs) declined sharply—from $55 million in 2022 (Level 2, International) to $34 million in 2023 and $30 million in 2024 (Level 2, International)—reflecting a strategic shift away from low‑yielding, fixed‑return assets. This reduction coincides with a broader rebalancing toward higher‑return pooled funds, fixed‑income securities, and equity investments, indicating that the company is moving its pension‑plan assets toward a more diversified, growth‑oriented portfolio and away from reliance on traditional GICs.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CL_10k_2022.pdf",
          "target_page": 101,
          "pages": [
            99,
            100,
            101,
            102,
            103
          ]
        },
        "hop_2_rel": {
          "source_file": "CL_10k_2024.pdf",
          "target_page": 100,
          "pages": [
            98,
            99,
            100,
            101,
            102
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 39712,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 10156,
        "completion_tokens": 150,
        "total_tokens": 10306
      }
    },
    {
      "question_id": 74,
      "question": "How has the strategic positioning and functionality of the Mastercard Developer Platform evolved between 2022 and 2024, particularly in terms of its role in enabling integration of digital assets and new technologies?",
      "original_answer": "In 2022, the Mastercard Developer Platform was described as a single access point that enables customers and partners to leverage Mastercard's digital assets and services, with an emphasis on ease of integration into new and existing solutions. By 2024, the platform continued to serve this role but expanded its strategic positioning by explicitly aligning with emerging technologies such as blockchain and digital currencies. In 2024, the platform was referenced in the context of enabling integration with the Mastercard Multi-Token Network™, which supports programmable payments and facilitates secure, scalable, and interoperable blockchain-based transactions. This evolution shows a shift from a general digital integration platform to one that specifically supports next-generation financial technologies and programmable commerce solutions.",
      "llm_answer": "Between 2022 and 2024, the Mastercard Developer Platform evolved from a general API gateway into a strategic hub for integrating digital assets and emerging technologies. It expanded its focus on blockchain and crypto by enabling programmable payments through the Mastercard Multi-Token Network™, supporting tokenized transactions, and facilitating the buying/spending of cryptocurrencies via card-linked solutions. Simultaneously, it strengthened its role in new payment flows—such as disbursements, remittances, and B2B payments—by offering APIs for Mastercard Send, Track BPS, and Alias-Based Remittances, while also enhancing integration capabilities for virtual cards, digital wallets, and AI-driven fraud prevention. This evolution positioned the platform as a critical enabler for secure, scalable, and innovative payment experiences across diverse commerce use cases.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MA_10k_2022.pdf",
          "target_page": 14,
          "pages": [
            12,
            13,
            14,
            15,
            16
          ]
        },
        "hop_2_rel": {
          "source_file": "MA_10k_2024.pdf",
          "target_page": 14,
          "pages": [
            12,
            13,
            14,
            15,
            16
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 46049,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 11750,
        "completion_tokens": 218,
        "total_tokens": 11968
      }
    },
    {
      "question_id": 74,
      "question": "How has the company's investment in U.S. common stocks within its pension plans evolved between 2022 and 2024, and what does this indicate about its strategic asset allocation?",
      "original_answer": "In 2022, the company reported no investments in U.S. common stocks within its pension plans, while by 2024, there was still no allocation to U.S. common stocks in the U.S. pension plan. However, the international pension plan maintained a $2 million investment in U.S. common stocks in both years. This indicates a continued strategic decision to avoid direct exposure to U.S. common stocks in the domestic pension portfolio while maintaining a minimal presence in the international portfolio.",
      "llm_answer": "Between 2022 and 2024, the company maintained **zero investment in U.S. common stock within its pension plans**, with no purchases, holdings, or dividends received from its own shares in either year. This consistent divestment reflects a deliberate strategic shift toward a more diversified and risk-averse asset allocation, emphasizing fixed income, pooled funds, and external equities rather than internal stock holdings. The absence of equity exposure to its own stock underscores a focus on reducing concentration risk and aligning with broader institutional investment best practices.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CL_10k_2022.pdf",
          "target_page": 100,
          "pages": [
            98,
            99,
            100,
            101,
            102
          ]
        },
        "hop_2_rel": {
          "source_file": "CL_10k_2024.pdf",
          "target_page": 100,
          "pages": [
            98,
            99,
            100,
            101,
            102
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 33481,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 8599,
        "completion_tokens": 147,
        "total_tokens": 8746
      }
    },
    {
      "question_id": 75,
      "question": "How did Disney's strategic focus on cruise ships evolve between 2022 and 2023, particularly in terms of capital investment plans and operational risk considerations?",
      "original_answer": "In 2022, Disney highlighted cruise ships as a key part of its capital investment strategy within the Parks & Experiences segment, noting that a majority of its capital spending was directed toward theme parks, resorts, and cruise ships. This indicated a growth-oriented approach focused on expanding physical assets. By 2023, the emphasis had shifted toward operational risks associated with cruise ships, particularly in the context of external disruptions like hurricanes and global events (e.g., the impact of Hurricane Milton on Walt Disney World operations). The 2023 filing framed cruise ships more as an operational exposure rather than a growth engine, signaling a shift from investment to risk mitigation. This evolution reflects a recalibration of strategic focus from asset expansion to managing volatility and external threats.",
      "llm_answer": "Between 2022 and 2023, Disney increased capital investment in its cruise line and broader Experiences segment, announcing plans to expand its fleet of cruise ships and boost spending on theme‑park and resort enhancements. At the same time, the company highlighted operational‑risk concerns tied to these investments—including higher borrowing costs from elevated interest rates, exposure to foreign‑exchange volatility, and the uncertainty of consumer demand for out‑of‑home entertainment—factors that could affect the profitability and timing of its cruise‑ship expansion and related capital projects.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "DIS_10k_2022.pdf",
          "target_page": 17,
          "pages": [
            15,
            16,
            17,
            18,
            19
          ]
        },
        "hop_2_rel": {
          "source_file": "DIS_10k_2023.pdf",
          "target_page": 21,
          "pages": [
            19,
            20,
            21,
            22,
            23
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 9,
        "total_chars": 51437,
        "num_window_pages": 9,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 13084,
        "completion_tokens": 150,
        "total_tokens": 13235
      }
    },
    {
      "question_id": 75,
      "question": "How has Mastercard's use of short duration foreign exchange derivative contracts evolved between 2022 and 2024, particularly in terms of their role in managing foreign exchange risk during daily settlement activities?",
      "original_answer": "In 2022, Mastercard used short duration foreign exchange derivative contracts to manage foreign exchange risk associated with daily settlement activities, aiming to reduce exposure to volatility from currency fluctuations on anticipated receipts and disbursements. By 2024, the company continued this practice, maintaining the same stated objective of minimizing volatility in gains and losses due to foreign exchange fluctuations. However, the context changed as the company actively adjusted its hedging strategies involving euro-denominated debt, de-designating and re-designating portions of it in 2023 and 2024, which indicates a more dynamic approach to managing foreign exchange exposure across the period. The continuity in the use of short duration contracts contrasts with the evolving structure of the company’s broader foreign exchange risk management strategy.",
      "llm_answer": "Mastercard has expanded its use of short‑duration foreign‑exchange derivatives to hedge the foreign‑currency exposure that arises during its daily settlement activities, moving from primarily cash‑flow hedges of anticipated revenues and expenses in 2022 toward a broader mix that includes net‑investment hedges and forward contracts tied to anticipated receipts and disbursements, with the notional amount of such short‑term contracts growing from roughly $1 billion in 2022 to over $2.7 billion in 2024.  These derivatives are now recorded in general and administrative expense when marked‑to‑market, and the company expects the associated gains or losses to be reclassified into earnings only when the underlying settlement transactions occur, typically within a few days of the transaction date.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MA_10k_2022.pdf",
          "target_page": 111,
          "pages": [
            109,
            110,
            111,
            112,
            113
          ]
        },
        "hop_2_rel": {
          "source_file": "MA_10k_2024.pdf",
          "target_page": 106,
          "pages": [
            104,
            105,
            106,
            107,
            108
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 61587,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 15637,
        "completion_tokens": 199,
        "total_tokens": 15836
      }
    },
    {
      "question_id": 75,
      "question": "How has Salesforce's strategic relationship with enterprise cloud companies evolved from 2023 to 2024, particularly in terms of investment focus and ecosystem integration?",
      "original_answer": "In 2023, Salesforce maintained a portfolio of strategic investments in enterprise cloud companies, technology startups, and system integrators, with a focus on digitally transforming industries and expanding its solution ecosystem. These investments were described as ranging from early to late-stage companies, including those concurrent with initial public offerings. By 2024, Salesforce's relationship with enterprise cloud companies shifted from primarily investing to a broader strategic dependency, leveraging these partners as part of its ecosystem to accelerate reach into new markets and industries. The 2024 filing emphasized the Salesforce Platform's role in enabling third-party developers and ISVs to create and deliver cloud-based applications through the AppExchange, indicating a deepened integration and dependency on enterprise cloud partners beyond mere financial investment.",
      "llm_answer": "From 2023 to 2024, Salesforce’s strategic relationship with enterprise cloud companies has deepened through tighter ecosystem integration and expanded investment focus on AI-driven platforms. The company has increasingly embedded AI agents (via Agentforce) across its core offerings—including Marketing, Commerce, Service, and Slack—leveraging Data Cloud and MuleSoft to unify data and automate workflows, while also broadening its strategic investments in enterprise cloud startups to accelerate platform adoption and industry-specific AI capabilities.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CRM_10k_2023.pdf",
          "target_page": 23,
          "pages": [
            21,
            22,
            23,
            24,
            25
          ]
        },
        "hop_2_rel": {
          "source_file": "CRM_10k_2024.pdf",
          "target_page": 8,
          "pages": [
            6,
            7,
            8,
            9,
            10
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 60057,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 15240,
        "completion_tokens": 138,
        "total_tokens": 15378
      }
    },
    {
      "question_id": 76,
      "question": "How did the company's approach to accrual rates for vendor funding programs evolve between fiscal 2023 and fiscal 2024, particularly in terms of sensitivity to projected purchase volumes?",
      "original_answer": "The company's approach to accrual rates for vendor funding programs remained methodologically consistent between fiscal 2023 and fiscal 2024, with no material changes in the recognition methodology over the past three fiscal years. However, in fiscal 2023, the company specifically highlighted sensitivity to 'graduated purchase volumes' that could impact accrued amounts, emphasizing the importance of projected volumes in determining accrual rates. In fiscal 2024, this explicit reference to 'graduated purchase volumes' was omitted, suggesting a potential simplification or stabilization in how accrual rates were adjusted throughout the year, despite continued monitoring of historical purchase trends and vendor confirmations.",
      "llm_answer": "The company’s accrual rates for vendor funding programs were adjusted to reflect higher projected purchase volumes, resulting in a more sensitive linkage between funding levels and anticipated purchase growth between fiscal 2023 and fiscal 2024. This increased sensitivity is evident in the updated vendor‑fund accrual methodology discussed in the “Merchandise Inventory” and “Critical Accounting Policies and Estimates” sections of the 2024 filing.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "LOW_10k_2023.pdf",
          "target_page": 33,
          "pages": [
            31,
            32,
            33,
            34,
            35
          ]
        },
        "hop_2_rel": {
          "source_file": "LOW_10k_2024.pdf",
          "target_page": 34,
          "pages": [
            32,
            33,
            34,
            35,
            36
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 41380,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 10575,
        "completion_tokens": 112,
        "total_tokens": 10688
      }
    },
    {
      "question_id": 76,
      "question": "How has the strategic relationship between LLY and Boehringer Ingelheim evolved from 2022 to 2024, particularly in terms of legal involvement and collaborative dependency on the Jardiance product?",
      "original_answer": "In 2022, LLY was not a direct party to the Jardiance patent litigation initiated by Boehringer Ingelheim (BI) against generic drug manufacturers under the Hatch-Waxman Act, indicating a more arms-length relationship in legal matters. By 2024, LLY's business became significantly dependent on the Jardiance collaboration, as the product was selected under the Inflation Reduction Act (IRA) for government-set pricing with a 66% discount compared to the 2023 list price, directly impacting LLY's revenue projections and business strategy. This shift reflects a deeper strategic entanglement and dependency on BI's partnership for navigating regulatory and pricing pressures.",
      "llm_answer": "From 2022 to 2024 the LLY–Boehringer Ingelheim partnership remained legally intertwined but grew more independent.  In 2022 BI sued generic firms over Jardiance patents, and the case was stayed, while LLY continued to receive BI‑driven indemnification for any product‑liability claims tied to Jardiance.  By 2024 the U.S. government had selected Jardiance for price‑setting under the IRA, signaling a shift toward regulatory exposure that now directly involves LLY, and the partnership’s collaborative dependency on the product had begun to erode as pricing pressure intensified.  Consequently, while the legal ties persisted, the strategic reliance on Jardiance as a shared revenue driver was diminishing.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "LLY_10k_2022.pdf",
          "target_page": 102,
          "pages": [
            100,
            101,
            102,
            103,
            104
          ]
        },
        "hop_2_rel": {
          "source_file": "LLY_10k_2024.pdf",
          "target_page": 45,
          "pages": [
            43,
            44,
            45,
            46,
            47
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 48292,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 12307,
        "completion_tokens": 176,
        "total_tokens": 12483
      }
    },
    {
      "question_id": 77,
      "question": "How did Disney's capital investment strategy toward cruise ships evolve from 2022 to 2023, particularly in relation to its broader Parks & Experiences business?",
      "original_answer": "In 2022, Disney's 10-K filing highlighted cruise ships as part of its broader Experiences segment but did not specifically emphasize capital investment in them, instead noting general risks from macroeconomic conditions such as inflation, supply chain delays, and currency fluctuations that could impact the implementation of business plans, including those for parks and resorts. By 2023, Disney explicitly listed cruise ships as part of its significant capital investments, indicating a strategic elevation in focus. The 2023 filing stated that the majority of the company’s capital spend was directed toward parks and experiences, including 'new attractions, cruise ships, capital improvements and systems infrastructure.' This shift demonstrates a clear prioritization of cruise ships as a key growth area within the broader Experiences segment.",
      "llm_answer": "From 2022 to 2023 Disney’s capital‑investment strategy shifted from a broad focus on parks‑and‑resorts expansion to a more targeted emphasis on cruise‑ship development and related Experiences, while still supporting overall Parks & Experiences growth. In 2022 the company highlighted cruise‑ship projects (e.g., Lighthouse Point) and capital spend on new attractions and resort upgrades, and by 2023 the narrative emphasized “majority of capital spend” still at Parks & Experiences but specifically called out cruise‑ship investments as part of that portfolio, reflecting a continued but refined allocation of capital toward expanding the Disney Cruise Line fleet and related vacation‑club and resort experiences.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "DIS_10k_2022.pdf",
          "target_page": 24,
          "pages": [
            22,
            23,
            24,
            25,
            26
          ]
        },
        "hop_2_rel": {
          "source_file": "DIS_10k_2023.pdf",
          "target_page": 12,
          "pages": [
            10,
            11,
            12,
            13,
            14
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 9,
        "total_chars": 48080,
        "num_window_pages": 9,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 12244,
        "completion_tokens": 178,
        "total_tokens": 12422
      }
    },
    {
      "question_id": 77,
      "question": "How has Mastercard Foundry's role in fostering innovation evolved between 2022 and 2024, particularly in relation to its engagement with emerging technologies and fintech partnerships?",
      "original_answer": "In 2022, Mastercard Foundry (formerly known as Mastercard Labs) was primarily described as a vehicle for bringing customers and partners access to thought leadership, innovation methodologies, new technologies, and early-stage fintech players. By 2024, its role had evolved into a more active innovation engine, with continued emphasis on identifying and experimenting with future technologies, start-ups, and trends. Specifically, in 2024, Foundry was positioned as a key enabler of blockchain-based business models and programmable payments through the Mastercard Multi-Token Network™, indicating a strategic shift toward deeper integration with next-generation financial technologies.",
      "llm_answer": "Mastercard Foundry’s role in fostering innovation has expanded significantly between 2022 and 2024, shifting from a primarily experimental innovation lab to a more integrated driver of strategic growth through technology adoption and fintech collaboration. In 2024, it launched targeted programs like Launchpad (a five-day app prototyping workshop) and expanded its innovation toolkit to include AI-powered solutions such as Decision Intelligence Pro, which leverages generative AI for enhanced fraud detection and transaction security. Concurrently, Foundry deepened partnerships with fintechs and financial institutions by integrating its open banking platform, enabling seamless data access and integration via APIs, while also supporting blockchain-based payment models through its Multi-Token Network. This evolution reflects a move toward embedding innovation directly into Mastercard’s core ecosystem—accelerating product development, enhancing security, and enabling scalable solutions like Click to Pay and tokenized payments that now represent 30% of all transactions.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MA_10k_2022.pdf",
          "target_page": 14,
          "pages": [
            12,
            13,
            14,
            15,
            16
          ]
        },
        "hop_2_rel": {
          "source_file": "MA_10k_2024.pdf",
          "target_page": 14,
          "pages": [
            12,
            13,
            14,
            15,
            16
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 46049,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 11741,
        "completion_tokens": 269,
        "total_tokens": 12011
      }
    },
    {
      "question_id": 77,
      "question": "How has the financial and strategic nature of the collaboration with Boehringer Ingelheim evolved between 2022 and 2024, particularly in terms of regulatory designations and pricing pressures?",
      "original_answer": "In 2022, the collaboration with Boehringer Ingelheim included the development of a therapy that had received Breakthrough Therapy and Fast Track designations from the FDA, indicating early-stage regulatory support and potential expedited development. By 2024, the collaboration faced significant pricing pressures under the Inflation Reduction Act, with Jardiance—part of the LLY-Boehringer Ingelheim partnership—selected for government-set pricing effective in 2026, subject to a 66% discount compared to the 2023 U.S. list price. This marks a shift from regulatory facilitation to regulatory-driven financial constraints.",
      "llm_answer": "Between 2022 and 2024, Lilly’s collaboration with Boehringer Ingelheim remained strategically focused on advancing key cardiometabolic and immunology assets, including empagliflozin (Jardiance) for heart failure and chronic kidney disease, and baricitinib for autoimmune conditions. However, regulatory designations such as FDA Breakthrough Therapy and Fast Track were granted earlier (e.g., empagliflozin in 2021), and by 2024, the partnership faced significant pricing pressures due to U.S. Inflation Reduction Act (IRA) provisions. Specifically, Jardiance was selected among the first ten drugs subject to Medicare price negotiation, with HHS setting a 66% discount off 2023 list prices effective in 2026, signaling accelerating revenue erosion for the collaboration’s flagship products. This regulatory shift, combined with ongoing global cost-containment efforts and payer consolidation, intensified pricing pressures on their joint portfolio.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "LLY_10k_2022.pdf",
          "target_page": 39,
          "pages": [
            37,
            38,
            39,
            40,
            41
          ]
        },
        "hop_2_rel": {
          "source_file": "LLY_10k_2024.pdf",
          "target_page": 45,
          "pages": [
            43,
            44,
            45,
            46,
            47
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 51463,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 13097,
        "completion_tokens": 237,
        "total_tokens": 13334
      }
    },
    {
      "question_id": 78,
      "question": "How has the strategic positioning of the CH-53K King Stallion heavy lift helicopter evolved within Lockheed Martin's Rotary and Mission Systems segment from 2023 to 2024?",
      "original_answer": "In 2023, the CH-53K King Stallion heavy lift helicopter was described as part of Lockheed Martin's near-to-mid-term growth elements, specifically under the Rotary and Mission Systems (RMS) segment, alongside radar surveillance systems. By 2024, the CH-53K remained a highlighted program within RMS, but the emphasis shifted to framing it within a broader context of advancing all-domain mission solutions and digital technologies such as AI/ML and autonomy. While no specific revenue figures are provided, the helicopter's positioning evolved from being a growth driver among several others to being part of a more integrated, technologically advanced portfolio aimed at improving interoperability and supporting multi-domain solutions.",
      "llm_answer": "From 2023 to 2024, the CH-53K King Stallion heavy‑lift helicopter transitioned from being highlighted as an ongoing program within RMS’s portfolio to a concrete, funded effort that reached key milestones—including the first four aircraft awarded in 2022 and the remaining orders completed in 2023, with international interest reinforced by a 2021 Letter of Offer and Acceptance from Israel for 12 units. The 2024 10‑K underscores that RMS continues to expand its CH‑53K production capacity to meet anticipated demand, positioning the platform as a strategic growth pillar alongside other mature programs such as the F‑35 and missile‑defense systems.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "LMT_10k_2023.pdf",
          "target_page": 29,
          "pages": [
            27,
            28,
            29,
            30,
            31
          ]
        },
        "hop_2_rel": {
          "source_file": "LMT_10k_2024.pdf",
          "target_page": 3,
          "pages": [
            1,
            2,
            3,
            4,
            5
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 48209,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 12277,
        "completion_tokens": 162,
        "total_tokens": 12439
      }
    },
    {
      "question_id": 78,
      "question": "What does the change in LLY's diabetes product portfolio co-commercialized with Boehringer Ingelheim between 2022 and 2024 indicate about the companies' shifting strategic priorities or market focus?",
      "original_answer": "In 2022, LLY and Boehringer Ingelheim were jointly developing and commercializing a broader portfolio of diabetes products, including Trajenta, Jentadueto, Jardiance, Glyxambi, Synjardy, Trijardy XR, and Basaglar. By 2024, the portfolio had narrowed to include only Jardiance, Glyxambi, Synjardy, and Trijardy XR. This indicates a strategic refocusing, potentially driven by lifecycle management, shifting market demand, or prioritization of products with stronger commercial performance or longer patent protection. The removal of Trajenta, Jentadueto, and Basaglar may reflect declining market relevance, generic competition, or a strategic decision to streamline the collaboration around products with greater growth potential or therapeutic differentiation.",
      "llm_answer": "The shift in Lilly’s diabetes portfolio—highlighted by the 2022‑2024 10‑K disclosures—shows a strategic pivot toward broader cardiovascular and obesity‑related indications (e.g., Jardiance’s cardiovascular death and heart‑failure benefits, Trulicity’s CV risk reduction, and the expansion of anti‑obesity pipelines) rather than focusing solely on glucose‑lowering. This reflects a market‑focused strategy to capture higher‑value therapeutic niches and counteract revenue pressure from generic/biosimilar competition, signaling that Lilly is prioritizing products with stronger payer justification and longer‑term growth potential.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "LLY_10k_2022.pdf",
          "target_page": 7,
          "pages": [
            5,
            6,
            7,
            8,
            9
          ]
        },
        "hop_2_rel": {
          "source_file": "LLY_10k_2024.pdf",
          "target_page": 8,
          "pages": [
            6,
            7,
            8,
            9,
            10
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 50926,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 12963,
        "completion_tokens": 157,
        "total_tokens": 13120
      }
    },
    {
      "question_id": 79,
      "question": "How did the financial performance and strategic importance of the JASSM program evolve between 2023 and 2024, particularly in terms of production activity and its contribution to backlog?",
      "original_answer": "In 2023, JASSM was a product under the Missiles and Fire Control (MFC) segment, contributing to the company's portfolio of tactical missiles, but there was no specific mention of significant changes in its production volume or backlog contribution. By 2024, JASSM experienced a production ramp-up, contributing to a $1.2 billion increase in tactical and strike missile programs within MFC. Additionally, JASSM was specifically cited as a key contributor to the increase in backlog alongside PAC-3 and GMLRS. This indicates a notable rise in both production activity and strategic importance for JASSM in 2024.",
      "llm_answer": "The JASSM program’s financial impact shifted markedly between 2023 and 2024. In 2023, the program contributed to a $1.6 billion increase in segment operating profit driven by favorable profit‑booking adjustments, but in 2024 operating profit fell 11% as profit‑booking rates declined—primarily because $555 million of losses were recorded on a classified contract and overall profit‑booking adjustments dropped by $375 million. Backlog grew in both years, expanding to $38.8 billion by year‑end 2024, reflecting higher orders on JASSM‑related platforms such as PAC‑3, LRASM and GMLRS. Consequently, while JASSM remained a key contributor to backlog growth, its direct contribution to operating profit weakened in 2024.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "LMT_10k_2023.pdf",
          "target_page": 40,
          "pages": [
            38,
            39,
            40,
            41,
            42
          ]
        },
        "hop_2_rel": {
          "source_file": "LMT_10k_2024.pdf",
          "target_page": 40,
          "pages": [
            38,
            39,
            40,
            41,
            42
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 46338,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 11815,
        "completion_tokens": 179,
        "total_tokens": 11994
      }
    },
    {
      "question_id": 79,
      "question": "How has JPM's focus in evaluating credit risk for Business Banking Loans evolved between 2023 and 2024, and what implications does this shift have for identifying early signs of borrower distress?",
      "original_answer": "In 2023, JPM focused on Business Banking Loans as part of its broader prime consumer credit strategy, emphasizing loan performance and scoring models within the 'Consumer, excluding credit card loan portfolio' segment. By 2024, the focus shifted toward delinquency rates as the primary credit quality indicator, particularly noting that loans more than 30 days past due serve as early warnings of financial difficulty. This evolution suggests a more proactive stance in identifying early signs of borrower distress, aligning Business Banking Loans with broader consumer loan risk frameworks where early delinquency tracking enhances risk mitigation. The shift indicates a strategic move toward earlier intervention and more granular performance monitoring.",
      "llm_answer": "JPMorgan's credit risk evaluation for Business Banking Loans has shifted from a focus on **delinquency rates and loan-to-value (LTV) ratios** in 2023 to a greater emphasis on **refreshed FICO scores and geographic risk concentrations** in 2024, as reflected in updated monitoring frameworks and portfolio segmentation disclosures. This evolution enhances early distress identification by prioritizing borrower creditworthiness trends (e.g., declining FICO scores) and regional economic vulnerabilities, which are more responsive to emerging stress signals than traditional delinquency metrics alone.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "JPM_10k_2023.pdf",
          "target_page": 242,
          "pages": [
            240,
            241,
            242,
            243,
            244
          ]
        },
        "hop_2_rel": {
          "source_file": "JPM_10k_2024.pdf",
          "target_page": 250,
          "pages": [
            248,
            249,
            250,
            251,
            252
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 47914,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 12214,
        "completion_tokens": 149,
        "total_tokens": 12363
      }
    },
    {
      "question_id": 79,
      "question": "How did Target Corporation's SPP II plan terms evolve between the 2022 and 2023 filings, and what does this suggest about the company's executive compensation framework?",
      "original_answer": "In the 2022 filing, the SPP II plan was described under the 2016 Plan Statement, as amended and restated effective April 3, 2016. However, in the 2023 filing, the SPP II plan was updated to the 2022 Plan Statement, as amended and restated effective May 1, 2022. This indicates that Target Corporation revised the SPP II plan within this timeframe, reflecting a shift in the structure or terms of the plan. Such changes could signal adjustments in the company's executive compensation strategy, potentially aligning incentives more closely with updated business objectives or governance standards.",
      "llm_answer": "Based on the provided SEC 10-K filing excerpts, Target Corporation's executive compensation framework shows evolution in its long-term incentive plans between 2022 and 2023 filings. Specifically, the company maintains multiple shareholder-approved plans (SPP I, SPP II, SPP III) with SPP II (2016 Plan Statement, as amended April 3, 2016) serving as a key component referenced in both years' filings. The 2023 filing (page 68) explicitly lists SPP II alongside other compensation plans like the 2020 Long-Term Incentive Plan and Officer Deferred Compensation Plan, indicating continuity in its executive pay structure. This consistency suggests Target's compensation framework emphasizes structured, long-term equity-based incentives (including performance shares and restricted stock units) rather than significant structural changes to its executive reward system between these filings.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "TGT_10k_2022.pdf",
          "target_page": 68,
          "pages": [
            65,
            66,
            67,
            68,
            69
          ]
        },
        "hop_2_rel": {
          "source_file": "TGT_10k_2023.pdf",
          "target_page": 70,
          "pages": [
            65,
            66,
            67,
            68,
            69
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 7,
        "total_chars": 26880,
        "num_window_pages": 7,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 6946,
        "completion_tokens": 222,
        "total_tokens": 7168
      }
    },
    {
      "question_id": 79,
      "question": "How did the financial obligations related to Incyte under the Olumiant collaboration evolve from 2022 to 2024, particularly regarding potential future milestone payments?",
      "original_answer": "In 2022, Incyte was eligible to receive up to $100.0 million in additional development-related regulatory milestones and another $100.0 million in sales-based milestones under the Olumiant agreement. By 2024, there is no mention of remaining regulatory milestones, suggesting they were either paid out or no longer applicable, and only ongoing royalty payments based on sales tiers (up to 20%) and a low teens royalty for sales exceeding a threshold in the context of COVID-19 treatment are explicitly referenced. This indicates a shift from a structure with both regulatory and sales milestones to one focused primarily on sales-based compensation.",
      "llm_answer": "The financial obligations under the Olumiant collaboration with Incyte have evolved such that milestone payments tied to regulatory and sales-based triggers have been capitalized as intangible assets and are being amortized to cost of sales, with Incyte eligible to receive up to $100 million in additional regulatory milestones and $100 million in sales milestones through 2024; future milestone payments remain contingent on achieving specified development and commercialization events, but no material contingent payments are expected beyond those already accrued.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "LLY_10k_2022.pdf",
          "target_page": 72,
          "pages": [
            70,
            71,
            72,
            73,
            74
          ]
        },
        "hop_2_rel": {
          "source_file": "LLY_10k_2024.pdf",
          "target_page": 73,
          "pages": [
            71,
            72,
            73,
            74,
            75
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 40221,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 10281,
        "completion_tokens": 141,
        "total_tokens": 10423
      }
    },
    {
      "question_id": 80,
      "question": "How has Cisco's financial exposure in the APJC region evolved between fiscal 2022 and fiscal 2023, based on its segment reporting and asset balances?",
      "original_answer": "In fiscal 2022, Cisco reported its business performance across geographic segments including APJC, though specific financial figures for APJC were not disclosed in the provided data. By fiscal 2023, Cisco's balance sheet showed that its assets in the APJC region stood at $5,382 million as of July 29, 2023, following additions from acquisitions and foreign currency translation adjustments. This indicates a more detailed financial disclosure regarding APJC in 2023 compared to 2022, where segment-level asset values were not explicitly itemized.",
      "llm_answer": "Cisco’s financial exposure in the APJC region grew modestly from fiscal 2022 to fiscal 2023, with APJC revenue rising from $8.0 billion to $8.027 billion and the segment’s gross margin increasing from $5.241 billion to $5.241 billion (essentially flat), while the company’s overall net deferred tax assets rose to $4.394 billion, reflecting a broader global tax position that includes the APJC footprint.  The segment’s asset balances (e.g., purchased intangibles and goodwill) also expanded, indicating a continued investment in the region, but the exposure remains limited to the typical revenue and margin levels reported for APJC in the 2022‑2023 fiscal years.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CSCO_10k_2022.pdf",
          "target_page": 105,
          "pages": [
            103,
            104,
            105,
            106,
            107
          ]
        },
        "hop_2_rel": {
          "source_file": "CSCO_10k_2023.pdf",
          "target_page": 76,
          "pages": [
            74,
            75,
            76,
            77,
            78
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 41020,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 10478,
        "completion_tokens": 166,
        "total_tokens": 10644
      }
    },
    {
      "question_id": 80,
      "question": "How has the strategic collaboration between LLY and Boehringer Ingelheim, specifically regarding Jardiance, evolved from 2022 to 2024 in response to regulatory changes?",
      "original_answer": "In 2022, Jardiance revenue was growing significantly, with a 30% increase in the U.S. and 28% outside the U.S., driven by increased demand and volume respectively. By 2024, the collaboration was significantly impacted by the Inflation Reduction Act (IRA), which introduced government-set pricing for certain drugs, including Jardiance. In August 2023, Jardiance was selected as one of the first ten medicines subject to government-set prices, and in August 2024, a 66% discount was applied compared to the 2023 U.S. list price, significantly affecting revenue projections and business strategy.",
      "llm_answer": "From 2022 to 2024, the strategic collaboration between LLY and Boehringer Ingelheim regarding Jardiance evolved in response to regulatory changes, particularly the Inflation Reduction Act (IRA). The IRA mandated government price-setting for certain drugs, and in August 2023, HHS selected Jardiance as one of the first ten medicines subject to price negotiation, with a 66% discount off the 2023 U.S. list price effective in 2026. This regulatory shift, along with the broader impact of IRA provisions on pricing and reimbursement, necessitated adjustments to LLY's business strategies, including potential impacts on revenue streams and investment in research and development. The collaboration now operates within a framework of significantly reduced pricing expectations for Jardiance and other selected products, accelerating revenue erosion prior to exclusivity expiration.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "LLY_10k_2022.pdf",
          "target_page": 45,
          "pages": [
            43,
            44,
            45,
            46,
            47
          ]
        },
        "hop_2_rel": {
          "source_file": "LLY_10k_2024.pdf",
          "target_page": 45,
          "pages": [
            43,
            44,
            45,
            46,
            47
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 41282,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 10546,
        "completion_tokens": 219,
        "total_tokens": 10766
      }
    },
    {
      "question_id": 81,
      "question": "How did GM's emphasis on the financial and reputational risks of product safety recalls evolve between 2022 and 2023, particularly concerning global platforms like the Chevrolet Bolt EV and the company's positioning in EV/AV technologies?",
      "original_answer": "In 2022, GM specifically highlighted the Chevrolet Bolt EV recall as an example of how global platform-related recalls could significantly increase costs due to their scale. The focus was on the financial burden and logistical complexity tied to such large-scale campaigns. By 2023, while the concern around global platforms remained, GM expanded its risk disclosure to emphasize the reputational damage to brand image and equity, particularly in relation to its leadership aspirations in EV and AV technologies. This evolution suggests a shift from a primarily cost-centric concern to a broader strategic risk tied to innovation and market positioning.",
      "llm_answer": "The 2023 10‑K shows GM’s cybersecurity risk discussion has been expanded to explicitly address safety‑critical vehicle systems and the reputational fallout from large‑scale recalls—e.g., the Bolt EV safety recall—highlighting that unauthorized access to in‑vehicle software could compromise safety, trigger costly recalls, and damage brand trust. While prior years emphasized general cyber‑risk and data‑privacy, the 2023 filing adds a dedicated focus on how cyber threats to connected‑vehicle platforms affect product safety, regulatory compliance and GM’s positioning in EV/AV technologies.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "GM_10k_2022.pdf",
          "target_page": 24,
          "pages": [
            22,
            23,
            24,
            25,
            26
          ]
        },
        "hop_2_rel": {
          "source_file": "GM_10k_2023.pdf",
          "target_page": 25,
          "pages": [
            23,
            24,
            25,
            26,
            27
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 56670,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 14410,
        "completion_tokens": 148,
        "total_tokens": 14558
      }
    },
    {
      "question_id": 81,
      "question": "How did the Guaranteed Senior Notes issued by Costco's Japanese subsidiary evolve between 2022 and 2024, and what does this indicate about the company's long-term financing strategy?",
      "original_answer": "In 2022, the Guaranteed Senior Notes issued by Costco's Japanese subsidiary were described in general terms, indicating only their existence and that they were valued using Level 3 inputs. By 2024, the company provided significantly more detailed information, disclosing that in November 2023, the subsidiary issued four new Guaranteed Senior Notes totaling approximately $500 at fixed interest rates ranging from 1.400% to 2.120%, with maturities extending from 2033 to 2043. Additionally, in July 2024, the subsidiary repaid $77 of these notes. This evolution indicates a more transparent and strategic approach to long-term financing, with a focus on fixed-rate debt and extended maturities to manage future liquidity needs.",
      "llm_answer": "The Guaranteed Senior Notes issued by Costco's Japanese subsidiary, totaling approximately $500 in November 2023 with maturities from 2033 to 2043, saw a $77 repayment in July 2024, reflecting ongoing reduction of this debt. This repayment, alongside the $1,000 repayment of the 2.750% Senior Notes in May 2024, demonstrates Costco's strategy of actively managing and reducing long‑term debt through targeted repayments and refinancing, supporting a long‑term financing approach focused on maintaining a strong balance sheet and lowering leverage.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "COST_10k_2022.pdf",
          "target_page": 51,
          "pages": [
            49,
            50,
            51,
            52,
            53
          ]
        },
        "hop_2_rel": {
          "source_file": "COST_10k_2024.pdf",
          "target_page": 52,
          "pages": [
            50,
            51,
            52,
            53,
            54
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 29993,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 7728,
        "completion_tokens": 136,
        "total_tokens": 7865
      }
    },
    {
      "question_id": 81,
      "question": "How did the value of Cisco's available-for-sale debt investments change between 2022 and 2023, and what does this indicate about the company's investment strategy?",
      "original_answer": "In 2022, Cisco reported gains from available-for-sale debt investments at $9 million, indicating a relatively minor role in their investment portfolio. By 2023, the total value of these investments dropped significantly from $15,592 million to $9,865 million, a decrease of $5,727 million. This indicates a strategic reduction in the company's holdings of available-for-sale debt instruments, suggesting a shift in investment focus or risk management approach.",
      "llm_answer": "The value of Cisco’s available‑for‑sale debt investments fell sharply from $15,592 million at the end of fiscal 2023 to $9,865 million at the end of fiscal 2024—a decline of about $5.7 billion (≈37%). This reduction reflects the company’s decision to sell or otherwise dispose of a portion of its high‑quality, investment‑grade securities, likely to free up cash for strategic initiatives such as the Splunk acquisition, dividend payments, share‑repurchase programs, and other capital‑allocation priorities. Consequently, the decrease signals a more aggressive deployment of cash toward growth investments and shareholder returns rather than holding a large portfolio of debt securities.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CSCO_10k_2022.pdf",
          "target_page": 49,
          "pages": [
            47,
            48,
            49,
            50,
            51
          ]
        },
        "hop_2_rel": {
          "source_file": "CSCO_10k_2023.pdf",
          "target_page": 47,
          "pages": [
            45,
            46,
            47,
            48,
            49
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 49381,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 12570,
        "completion_tokens": 171,
        "total_tokens": 12742
      }
    },
    {
      "question_id": 82,
      "question": "How has JPMorgan Chase's exposure to system damage risks evolved from 2023 to 2024, particularly in relation to third-party vendor attacks and data recovery challenges?",
      "original_answer": "In 2023, JPMorgan Chase highlighted risks related to system damage primarily through unauthorized access, zero-day vulnerabilities, and disruptions from distributed denial-of-service attacks. The company emphasized the risk of undetected vulnerabilities due to incomplete system enhancements and the potential for data loss or manipulation. By 2024, the exposure evolved to include more specific emphasis on ransomware attacks targeting third-party vendors and the risk of losses exceeding cyber insurance coverage. Additionally, JPMorgan Chase noted increased complexity in recovering from data theft or destruction, with a new concern around the inability to prevent systems from processing fraudulent transactions. These changes indicate a growing awareness of external cyber threats and their financial implications.",
      "llm_answer": "From 2023 to 2024, JPMorgan Chase’s exposure to system‑damage risks remained high, but the firm highlighted a continued escalation in third‑party vendor attacks and more complex data‑recovery challenges.  The 2024 filing stresses that breaches involving vendors—especially ransomware and attacks on open‑source components—can cause prolonged service outages, extended data‑restoration delays, and greater financial losses that may exceed cyber‑insurance coverage, while also amplifying reputational and regulatory fallout.  Consequently, the company’s risk profile has not diminished; instead, it has evolved toward heightened reliance on often‑inadequately secured external providers and the need for more robust, rapid recovery capabilities.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "JPM_10k_2023.pdf",
          "target_page": 25,
          "pages": [
            23,
            24,
            25,
            26,
            27
          ]
        },
        "hop_2_rel": {
          "source_file": "JPM_10k_2024.pdf",
          "target_page": 27,
          "pages": [
            25,
            26,
            27,
            28,
            29
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 52318,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 13305,
        "completion_tokens": 185,
        "total_tokens": 13491
      }
    },
    {
      "question_id": 82,
      "question": "What operational investments has Costco made by 2024 to support the private-label growth strategy mentioned in its 2022 filing?",
      "original_answer": "In 2022, Costco emphasized increasing the penetration of its private-label items as a merchandising strategy to manage inflationary pressures and maintain competitive pricing. By 2024, Costco had made tangible operational investments to support this strategy, including the operation of various processing, packaging, and manufacturing facilities dedicated to the production of private-label items. These facilities, referenced in the 2024 filing, represent a significant evolution from the earlier strategic focus, demonstrating a shift from sourcing private-label products externally to building internal production capabilities to scale the initiative.",
      "llm_answer": "Costco has invested in expanding its private‑label portfolio and supporting infrastructure to drive its private‑label growth strategy.  By 2024 the company had opened 26 new warehouses (including relocations) and added new distribution and logistics facilities that provide the space needed to stock and promote private‑label items, while also upgrading its supply‑chain and e‑commerce capabilities to increase the availability of private‑label products across its U.S., Canadian and international operations.  These operational investments underpin the company’s effort to grow private‑label sales and improve margins.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "COST_10k_2022.pdf",
          "target_page": 22,
          "pages": [
            20,
            21,
            22,
            23,
            24
          ]
        },
        "hop_2_rel": {
          "source_file": "COST_10k_2024.pdf",
          "target_page": 20,
          "pages": [
            18,
            19,
            20,
            21,
            22
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 80579,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 20361,
        "completion_tokens": 154,
        "total_tokens": 20515
      }
    },
    {
      "question_id": 82,
      "question": "How did UnitedHealth Group's approach to Medicaid managed care contract bidding evolve between 2022 and 2023, particularly in terms of assumptions and risks associated with bid accuracy?",
      "original_answer": "In 2022, UnitedHealth Group emphasized the risk of losing Medicaid members if it failed to renew state Medicaid managed care contracts, highlighting the importance of contract renewals to retain enrolled members. By 2023, the company placed greater emphasis on the assumptions behind its bids, noting that if these assumptions—such as enrollment, utilization, and medical costs—were materially incorrect due to unforeseen program changes or competitor pricing, it could materially affect results of operations and cash flows. This reflects an evolution from a focus on contract renewal risk to a more detailed discussion of the assumptions and competitive dynamics involved in the bidding process itself.",
      "llm_answer": "Between 2022 and 2023, UnitedHealth Group’s approach to Medicaid managed‑care bidding remained focused on submitting bids based on assumptions about enrollment, utilization and medical costs, but the risk of inaccurate assumptions grew as external factors—such as CMS payment adjustments, benchmark changes and competitive bidding environments—became more volatile. The company explicitly highlighted that any material mis‑estimation of these factors could adversely affect its results of operations, financial position and cash flows, underscoring heightened awareness of bid‑accuracy risk in both years.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "UNH_10k_2022.pdf",
          "target_page": 25,
          "pages": [
            23,
            24,
            25,
            26,
            27
          ]
        },
        "hop_2_rel": {
          "source_file": "UNH_10k_2023.pdf",
          "target_page": 20,
          "pages": [
            18,
            19,
            20,
            21,
            22
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 59571,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 15123,
        "completion_tokens": 151,
        "total_tokens": 15274
      }
    },
    {
      "question_id": 84,
      "question": "How did MET's investment in Municipals evolve from 2022 to 2023, particularly in terms of its valuation hierarchy classification?",
      "original_answer": "In 2022, MET's investment in Municipals was valued at $14,212 million and primarily categorized under 'Estimated Fair Value' without a detailed breakdown of valuation hierarchy levels. By 2023, the investment in Municipals decreased to $159 million and was explicitly classified under 'Level 2' of the fair value hierarchy. This indicates a significant reduction in the size of the Municipals investment and a more transparent categorization within the fair value hierarchy in 2023.",
      "llm_answer": "From 2022 to 2023, MetLife’s investment in Municipals within its Fixed Maturity Securities AFS portfolio remained classified at Level 2 of the fair‑value hierarchy. In the 2023 table, the Municipals line shows $147 million reported under Level 2 (with no Level 1 or Level 3 amounts), compared with $159 million reported at Level 2 in 2022. Thus, the valuation hierarchy classification did not change—Municipals continued to be categorized as Level 2 assets.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MET_10k_2022.pdf",
          "target_page": 102,
          "pages": [
            100,
            101,
            102,
            103,
            104
          ]
        },
        "hop_2_rel": {
          "source_file": "MET_10k_2023.pdf",
          "target_page": 308,
          "pages": [
            306,
            307,
            308,
            309,
            310
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 70876,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 17937,
        "completion_tokens": 114,
        "total_tokens": 18052
      }
    },
    {
      "question_id": 84,
      "question": "How has Microsoft's approach to Office 365 subscriptions evolved in terms of licensing flexibility and customer agreement models from fiscal year 2022 to 2024?",
      "original_answer": "In fiscal year 2022, Office 365 subscriptions were primarily managed under volume licensing programs and were recognized as part of unearned revenue, invoiced annually at the beginning of each contract period and recognized ratably over the coverage period. By fiscal year 2024, Microsoft introduced more structured and flexible customer agreement models, including the Microsoft Customer Agreement, Microsoft Online Subscription Agreement, and Microsoft Products and Services Agreement, which allowed customers to subscribe to cloud services seamlessly and directly, with options for monthly or annual subscriptions and no organization-wide commitment. This represents a shift toward enhanced customer-centric licensing flexibility.",
      "llm_answer": "From fiscal 2022 to 2024 Microsoft’s licensing model for Office 365 shifted from a primarily volume‑licensing approach—using agreements such as Enterprise Agreements, Microsoft Products and Services Agreements, and Open Value that required organization‑wide commitments and often bundled Software Assurance—to a broader suite of subscription‑focused contracts that emphasize flexibility and direct, non‑expiring agreements.  The newer Microsoft Customer Agreement and Microsoft Online Subscription Agreement let customers subscribe monthly or annually, purchase perpetual licenses with optional SA, and scale usage up or down without the long‑term, three‑year commitments typical of earlier Enterprise Agreements.  This evolution gives customers—especially small‑to‑medium businesses and government/academic entities—greater choice to mix perpetual and subscription rights, opt‑in to SA only when desired, and transact directly through simplified digital experiences rather than through traditional reseller or volume‑licensing channels.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MSFT_10k_2022.pdf",
          "target_page": 64,
          "pages": [
            62,
            63,
            64,
            65,
            66
          ]
        },
        "hop_2_rel": {
          "source_file": "MSFT_10k_2024.pdf",
          "target_page": 17,
          "pages": [
            15,
            16,
            17,
            18,
            19
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 9,
        "total_chars": 33643,
        "num_window_pages": 9,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 8635,
        "completion_tokens": 259,
        "total_tokens": 8894
      }
    },
    {
      "question_id": 85,
      "question": "How did the composition of MET's Level 3 Fixed Maturity Securities AFS change between 2022 and 2023, and what does this indicate about the company's investment strategy?",
      "original_answer": "In 2022, MET's Level 3 Fixed Maturity Securities AFS included $1 million in Corporate bonds, $1 million in Foreign Bonds, and $11 million in Equity Securities. By 2023, the Level 3 composition shifted significantly, with $54 million in Corporate bonds, $2 million in Foreign Bonds, and $828 million in Other Investments. This indicates a strategic shift toward increasing exposure in Other Investments while maintaining a relatively small position in Level 3 fixed maturity securities overall. The significant increase in Other Investments within Level 3 suggests a more aggressive approach to portfolio diversification or risk management.",
      "llm_answer": "Between 2022 and 2023, the composition of MET's Level 3 Fixed Maturity Securities AFS shifted significantly: the proportion of Level 3 holdings decreased from 2% to 0.1% of total fixed maturity securities AFS, while Level 2 holdings increased from 74% to 59% of the total. This indicates a strategic move toward more liquid, observable investments, reducing reliance on illiquid assets and aligning with a focus on managing risk and volatility in the investment portfolio.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MET_10k_2022.pdf",
          "target_page": 307,
          "pages": [
            305,
            306,
            307,
            308,
            309
          ]
        },
        "hop_2_rel": {
          "source_file": "MET_10k_2023.pdf",
          "target_page": 308,
          "pages": [
            306,
            307,
            308,
            309,
            310
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 63970,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 16221,
        "completion_tokens": 118,
        "total_tokens": 16339
      }
    },
    {
      "question_id": 85,
      "question": "How has Microsoft's strategic positioning of Office 365 evolved between 2022 and 2024, particularly in terms of its role within the broader cloud services portfolio and its response to competitive pressures from AI-driven offerings?",
      "original_answer": "In 2022, Office 365 was explicitly listed as a key component of Microsoft's service and other revenue, positioned alongside Azure, Dynamics 365, and Xbox as a core cloud-based solution. By 2024, Office 365 had evolved into a more integrated part of Microsoft’s broader AI-infused cloud services portfolio, reflecting the company's strategic shift to infuse generative AI capabilities into commercial offerings. The 2024 filing notes that Microsoft is devoting significant resources to develop and deploy AI models, platforms, and infrastructure to meet customer needs, indicating that Office 365 is now part of this AI-enhanced competitive strategy. This shift was driven by increasing competitive pressures from companies entering the AI market and offering alternative models such as free applications funded by advertising or open-source AI models, which Microsoft must counter with enhanced, integrated cloud experiences.",
      "llm_answer": "Microsoft's strategic positioning of Office 365 has evolved from a standalone on-premises productivity suite to a core component of its integrated cloud services portfolio, increasingly bundled with Azure and other cloud offerings. This shift reflects a response to competitive pressures from AI-driven platforms, as Office 365 now serves as a primary vehicle for delivering AI-enhanced capabilities (e.g., Copilot integrations) within Microsoft's broader cloud ecosystem, aiming to maintain market relevance against rivals like Google Workspace and Amazon Web Services. The company emphasizes seamless integration across its cloud services to drive subscription retention and monetize AI investments, positioning Office 365 as a strategic differentiator in a crowded market.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MSFT_10k_2022.pdf",
          "target_page": 62,
          "pages": [
            60,
            61,
            62,
            63,
            64
          ]
        },
        "hop_2_rel": {
          "source_file": "MSFT_10k_2024.pdf",
          "target_page": 21,
          "pages": [
            19,
            20,
            21,
            22,
            23
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 45703,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 11668,
        "completion_tokens": 193,
        "total_tokens": 11862
      }
    },
    {
      "question_id": 85,
      "question": "How did UnitedHealth Group's recognition and handling of credit-related impairments evolve between 2022 and 2023, particularly in terms of their evaluation methodology and financial impact?",
      "original_answer": "In 2022, UnitedHealth Group evaluated available-for-sale debt securities for credit-related impairments by analyzing expected cash flows, underlying credit quality, and credit ratings of issuers, concluding that there was no significant credit deterioration since purchase and that unrealized losses were primarily due to interest rate increases. The allowance for credit losses was not material. By 2023, the company formalized its impairment recognition process by distinguishing between credit-related and non-credit-related impairments, recording credit-related impairments as an allowance against investment income and non-credit-related impairments through other comprehensive income. Additionally, the company emphasized a more structured evaluation framework that includes present value of expected cash flows, the extent of fair value decline relative to amortized cost, and issuer-specific financial conditions. This reflects a more detailed and segmented approach to impairment recognition and financial reporting.",
      "llm_answer": "Between 2022 and 2023, UnitedHealth Group's handling of credit-related impairments remained consistent in methodology but showed improved financial transparency. The company continued to evaluate credit-related impairments on available-for-sale debt securities by comparing fair value to amortized cost, using observable inputs (Level 2) and only rarely relying on unobservable inputs (Level 3). While no material impairments were recorded in either year, the 2023 disclosures emphasized more detailed tracking of unrealized losses across security types and highlighted that losses were primarily driven by interest rate changes rather than credit deterioration. This refined disclosure approach enhanced transparency around the valuation of its $40+ billion investment portfolio, though the core impairment assessment methodology remained unchanged.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "UNH_10k_2022.pdf",
          "target_page": 57,
          "pages": [
            55,
            56,
            57,
            58,
            59
          ]
        },
        "hop_2_rel": {
          "source_file": "UNH_10k_2023.pdf",
          "target_page": 47,
          "pages": [
            45,
            46,
            47,
            48,
            49
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 54785,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 13927,
        "completion_tokens": 212,
        "total_tokens": 14140
      }
    },
    {
      "question_id": 86,
      "question": "How did the allocation and valuation of Fixed Maturity Securities AFS in MET's pension and other postretirement benefit plans evolve from 2022 to 2023?",
      "original_answer": "In 2022, Fixed Maturity Securities AFS accounted for 84% of U.S. Pension Benefits and 95% of U.S. Other Postretirement Benefits. By 2023, the total estimated fair value of Fixed Maturity Securities AFS was $6,714 million for Pension Benefits and $1,274 million for Other Postretirement Benefits. This indicates a shift from a primarily percentage-based allocation in 2022 to a more detailed valuation breakdown in 2023, showing both the scale and composition of MET's holdings.",
      "llm_answer": "From 2022 to 2023, the allocation of Fixed Maturity Securities AFS in MET's pension and other postretirement benefit plans shifted toward higher exposure to corporate bonds and foreign bonds within Level 2, while the Level 3 balance grew modestly (from $55 million in 2022 to $54 million in 2023) and the overall fair‑value hierarchy showed increased weighting of Level 2 assets (e.g., corporate bonds rising to $3.029 billion and foreign bonds to $808 million in 2023). Additionally, the target allocation for Fixed Maturity Securities AFS remained around 85‑95 % of plan assets, but the actual 2023 allocation was slightly lower at approximately 82 % for U.S. pension benefits.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MET_10k_2022.pdf",
          "target_page": 305,
          "pages": [
            303,
            304,
            305,
            306,
            307
          ]
        },
        "hop_2_rel": {
          "source_file": "MET_10k_2023.pdf",
          "target_page": 308,
          "pages": [
            306,
            307,
            308,
            309,
            310
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 66268,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 16791,
        "completion_tokens": 169,
        "total_tokens": 16961
      }
    },
    {
      "question_id": 86,
      "question": "How did Lowe's strategic positioning of the Kitchens & Bath product category evolve between 2022 and 2023, and what does this suggest about its relative importance in the company's product portfolio?",
      "original_answer": "In 2022, Kitchens & Bath was grouped under the Home Décor division alongside categories like Appliances, Décor, Flooring, and Paint, suggesting a more design-focused positioning. By 2023, Kitchens & Bath was listed among core construction and renovation categories such as Lumber, Building Materials, and Rough Plumbing, indicating a strategic repositioning toward home improvement and remodeling. This shift suggests that Lowe's placed greater strategic emphasis on Kitchens & Bath as a key growth area tied to higher-value home projects, aligning with its broader 'Total Home' strategy.",
      "llm_answer": "Between 2022 and 2023, Lowe's strategic positioning of the Kitchens & Bath product category evolved from being a relatively small segment (accounting for 2.6% of total sales in 2022) to a more prominent component within its broader product portfolio, though still representing a modest share of overall revenue. This growth aligns with the company's \"Elevate Assortment\" pillar under its Total Home strategy, which emphasizes expanding product offerings to meet customer needs across categories like Kitchens & Bath, Building Products, and Hardlines. The category's inclusion in the company's strategic pillars and its contribution to total sales (35.3% in 2023, up from 2.6% in 2022) suggests it has gained relative importance as part of Lowe's effort to broaden its core product mix beyond traditional hardware and lumber, though it remains a smaller portion of the overall portfolio compared to dominant categories like Building Products (32.4% in 2023) and Home Décor (35.3% in 2023). This evolution reflects a deliberate shift toward offering more integrated, high-margin solutions for home improvement projects, reinforcing its role as a strategic growth area within the company's omnichannel and Total Home strategy.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "LOW_10k_2022.pdf",
          "target_page": 55,
          "pages": [
            53,
            54,
            55,
            56,
            57
          ]
        },
        "hop_2_rel": {
          "source_file": "LOW_10k_2023.pdf",
          "target_page": 6,
          "pages": [
            4,
            5,
            6,
            7,
            8
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 43743,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 11168,
        "completion_tokens": 305,
        "total_tokens": 11474
      }
    },
    {
      "question_id": 86,
      "question": "How has Mondelez International's strategic focus on Cheese & Grocery evolved between 2022 and 2024, and what does this suggest about its prioritization of snack categories for long-term growth?",
      "original_answer": "In 2022, Mondelez directly produced Cheese & Grocery products, generating $1,990 million in total net revenues from this category. By 2024, the company no longer reported direct production in this category and instead indicated only a strategic stake in Cheese & Grocery, positioning it as an adjacent category within its broader snacking portfolio. This shift suggests a refocusing on core snack categories like biscuits and chocolate, while maintaining a presence in Cheese & Grocery through a lighter footprint. The change aligns with Mondelez's stated strategy of prioritizing long-term growth in core snacking segments and managing costs amid inflationary pressures.",
      "llm_answer": "Mondelez International has progressively shifted its strategic focus toward cheese and grocery categories, particularly through targeted acquisitions like Evirh in China (2024) and the expansion of its cheese & grocery portfolio within its broader snacking strategy. This evolution reflects a deliberate prioritization of cheese and grocery as high-growth, complementary segments to its core snacking business, aligning with its long-term growth agenda to drive sustainable revenue expansion beyond traditional snack categories. The company's investments and strategic emphasis on these categories underscore their role as key growth engines within its global snacking leadership vision.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MDLZ_10k_2022.pdf",
          "target_page": 136,
          "pages": [
            127,
            128,
            129,
            130,
            131
          ]
        },
        "hop_2_rel": {
          "source_file": "MDLZ_10k_2024.pdf",
          "target_page": 34,
          "pages": [
            32,
            33,
            34,
            35,
            36
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 46933,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 11967,
        "completion_tokens": 171,
        "total_tokens": 12139
      }
    },
    {
      "question_id": 86,
      "question": "How did Abbott's presentation of its enteral feeding product lineup, specifically the positioning of Jevity relative to Freego™ products, change between the 2022 and 2023 10-K filings?",
      "original_answer": "In the 2022 10-K filing, Jevity was listed first among enteral feeding products, followed by Glucerna 1.2 Cal, Glucerna 1.5 Cal, Osmolite®, Oxepa®, Freego™ (Enteral Pump), and Freego™ sets. In the 2023 filing, Jevity remained listed first, but the Freego™ (Enteral Pump) and Freego™ sets were now mentioned immediately after Jevity, before the Glucerna and Osmolite® product lines. This change in listing order suggests a shift in product emphasis within the enteral feeding category, with Freego™ products receiving more prominent placement alongside Jevity in 2023 compared to 2022.",
      "llm_answer": "Abbott's presentation of its enteral feeding product lineup shows a clear shift in how it positions Jevity relative to Freego™ products between the 2022 and 2023 10-K filings. In the 2022 filing (page 4 of ABT_10k_2022.pdf), Jevity is listed alongside other enteral products like Glucerna 1.2 Cal and Osmolite under the Nutritional Products segment, but Freego™ is not mentioned at all. By contrast, the 2023 filing (page 4 of ABT_10k_2023.pdf) explicitly groups Jevity with Freego™ (1.2 Cal and 1.5 Cal) as part of the \"nutritional products used in enteral feeding,\" indicating a more integrated presentation of these products. This change reflects Abbott's effort to position Freego™ as a complementary product line within its enteral feeding portfolio, moving it from an omitted reference to a defined component alongside Jevity.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "ABT_10k_2022.pdf",
          "target_page": 3,
          "pages": [
            1,
            2,
            3,
            4,
            5
          ]
        },
        "hop_2_rel": {
          "source_file": "ABT_10k_2023.pdf",
          "target_page": 4,
          "pages": [
            2,
            3,
            4,
            5,
            6
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 45040,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 11487,
        "completion_tokens": 208,
        "total_tokens": 11695
      }
    },
    {
      "question_id": 87,
      "question": "How did MET's investment in municipals evolve from 2022 to 2023 in terms of fair value and classification, and what does this suggest about the company's credit risk management strategy?",
      "original_answer": "In 2022, MET held $14,212 million in municipals, classified under the 'fixed maturity securities AFS' category, with a fair value that included $2,464 million in gross unrealized gains and only $13 million in gross unrealized losses. By 2023, this investment had significantly declined to just $159 million, now categorized under the 'fixed maturity securities AFS' and classified entirely within Level 2 of the fair value hierarchy, indicating a shift in MET's positioning. This dramatic reduction suggests a strategic move to reduce credit exposure to municipals, likely as part of a broader risk management adjustment to limit potential losses in this asset class.",
      "llm_answer": "From 2022 to 2023, MetLife’s municipal bond holdings declined in fair value from $524 million to $10 million (a reduction of roughly $514 million), and the classification of these securities shifted from “Municipals” within the Fixed Maturity Securities AFS portfolio to essentially zero exposure in the 2023 tables. This reduction reflects a deliberate de‑risking of the municipal segment, as the company recognized credit‑loss allowances and wrote down the securities, indicating a proactive strategy to limit exposure to potentially underperforming municipal credits and to manage overall credit‑risk concentrations within its investment portfolio.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MET_10k_2022.pdf",
          "target_page": 219,
          "pages": [
            217,
            218,
            219,
            220,
            221
          ]
        },
        "hop_2_rel": {
          "source_file": "MET_10k_2023.pdf",
          "target_page": 308,
          "pages": [
            306,
            307,
            308,
            309,
            310
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 67111,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 17010,
        "completion_tokens": 162,
        "total_tokens": 17173
      }
    },
    {
      "question_id": 87,
      "question": "How did Abbott's use of interest rate hedge contracts evolve between 2022 and 2023, particularly in terms of their notional value and the impact on fixed-rate debt management?",
      "original_answer": "In 2022, Abbott had interest rate hedge contracts totaling approximately $2.2 billion, which were used to manage exposure to changes in the fair value of fixed-rate debt by converting fixed-rate obligations into variable-rate obligations. By 2023, Abbott continued to use these contracts for the same purpose, and the notional value remained consistent at approximately $2.2 billion. However, in 2023, the company provided more detailed disclosures about the impact of these contracts on the carrying value of fixed-rate debt, indicating a more refined approach to interest rate risk management.",
      "llm_answer": "Abbott’s interest rate hedge contracts decreased from approximately $2.9 billion at December 31 2022 to $2.2 billion at December 31 2023, a reduction driven by the maturity of $700 million of hedges in 2023. The hedges, which convert portions of fixed‑rate debt to variable‑rate exposure, are marked‑to‑market and offset the fair‑value changes of the underlying fixed‑rate obligations, allowing Abbott to manage its fixed‑rate debt more flexibly.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "ABT_10k_2022.pdf",
          "target_page": 65,
          "pages": [
            63,
            64,
            65,
            66,
            67
          ]
        },
        "hop_2_rel": {
          "source_file": "ABT_10k_2023.pdf",
          "target_page": 64,
          "pages": [
            62,
            63,
            64,
            65,
            66
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 56485,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 14349,
        "completion_tokens": 111,
        "total_tokens": 14460
      }
    },
    {
      "question_id": 89,
      "question": "How did 3M's issuance and management of fixed rate registered notes evolve between 2022 and 2024, particularly in terms of repayment activity and interest rate strategies?",
      "original_answer": "In 2022, 3M had a significant amount of fixed rate registered notes, including $600 million of 10-year notes due 2030 with a coupon rate of 3.05%, and $650 million of 30-year notes due 2050 with a coupon rate of 3.70%. The company also issued $3.25 billion in fixed rate registered notes in August 2019, including $1.0 billion of 10-year notes due 2029 and $1.0 billion of 30-year notes due 2049. In 2024, 3M repaid $1.1 billion in medium-term notes that matured, and in 2023, it repaid $500 million in fixed-rate registered notes. Additionally, interest rate swaps initiated in 2021 converted portions of the fixed-rate notes due 2049 and 2050 into floating-rate debt through mid-2028, indicating a strategic shift toward managing interest rate exposure. This shows a decrease in the amount of fixed-rate debt outstanding and a shift toward floating-rate instruments through swaps.",
      "llm_answer": "Between 2022 and 2024, 3M’s fixed‑rate registered notes were systematically retired and replaced with new fixed‑rate issuances at progressively higher rates. In 2022 the company repaid €500 million of fixed‑rate medium‑term notes and $600 million of fixed‑rate medium‑term notes that matured, and in 2023 it retired $500 million of fixed‑rate registered notes and €650 million of fixed‑rate medium‑term notes as they reached maturity. By 2024 the remaining fixed‑rate registered notes outstanding carried rates of 2.41 % (2029 maturity) and 3.08 % (2030 maturity), while new issuances such as the $1 billion 2029 note at 2.41 % and the $600 million 2030 note at 3.08 % reflected a higher interest‑rate environment. Consequently, repayment activity shifted from maturing older, lower‑coupon notes to the issuance of newer fixed‑rate debt at higher effective rates, and the company began converting portions of its long‑term fixed‑rate exposure to floating‑rate exposure via interest‑rate swaps.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MMM_10k_2022.pdf",
          "target_page": 89,
          "pages": [
            87,
            88,
            89,
            90,
            91
          ]
        },
        "hop_2_rel": {
          "source_file": "MMM_10k_2024.pdf",
          "target_page": 69,
          "pages": [
            67,
            68,
            69,
            70,
            71
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 9,
        "total_chars": 58144,
        "num_window_pages": 9,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 14762,
        "completion_tokens": 248,
        "total_tokens": 15011
      }
    },
    {
      "question_id": 89,
      "question": "How has the role of securities issuances in Schwab's capital structure evolved between 2023 and 2024, particularly in relation to its overall funding sources and capital management strategy?",
      "original_answer": "In 2023, securities issuances by CSC were identified as a primary source of capital, directly supporting the company's capital management strategy, which included balance sheet growth and financial support to subsidiaries. By 2024, while still listed as one of several funding sources, securities issuances were positioned among a broader set of liquidity tools, including FHLB borrowings, repurchase agreements, and CDs, indicating a more diversified funding approach. This shift suggests a strategic evolution where securities issuances remain important but are more integrated within a wider capital structure framework.",
      "llm_answer": "Between 2023 and 2024, Schwab’s capital structure strategy shifted toward greater reliance on debt issuances—particularly senior unsecured notes and brokered CDs—to fund its banking subsidiaries and support brokerage client deposits, while reducing net interest revenue sensitivity through hedging of fixed‑to‑floating rate Senior Notes and a more stable asset‑liability duration profile. This evolution reflects a continued focus on maintaining strong regulatory capital ratios (e.g., Tier 1 Leverage ≈ 8.5 % in 2023) while managing funding costs in a higher‑rate environment, using both market‑issued securities and short‑term borrowings to supplement cash generated by client activity.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "SCHW_10k_2023.pdf",
          "target_page": 59,
          "pages": [
            57,
            58,
            59,
            60,
            61
          ]
        },
        "hop_2_rel": {
          "source_file": "SCHW_10k_2024.pdf",
          "target_page": 52,
          "pages": [
            50,
            51,
            52,
            53,
            54
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 52226,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 13288,
        "completion_tokens": 172,
        "total_tokens": 13460
      }
    },
    {
      "question_id": 89,
      "question": "How did Coca-Cola's contingent payment obligations related to fairlife evolve from 2022 to 2024, and what does this indicate about fairlife's performance against its financial targets?",
      "original_answer": "In 2022, Coca-Cola disclosed that it had a $270 million liability for contingent milestone payments related to its acquisition of fairlife, based on fairlife achieving certain financial targets through 2024. The company also noted that the first milestone payment of $100 million was made in 2021 after fairlife met its 2020 targets. By 2024, the remaining contingent payment was described as a milestone payment contingent on fairlife achieving certain financial targets through 2024 and was payable in 2025. This indicates that fairlife had met at least one set of financial targets (2020), triggering the initial $100 million payment, and that the company remained on track to potentially meet the remaining targets through 2024, as the obligation was still active and had not been rescinded or adjusted downward.",
      "llm_answer": "Coca-Cola's contingent payment obligations related to fairlife decreased from $270 million (recorded as a liability for the contingent consideration as of the acquisition date) to $3,017 million reflected in the liability column for 2023 and then to $6,126 million in the 2024 fair‑value table, indicating that the liability has grown as the company re‑measures it upward each quarter; however, the milestone payment of $275 million was made in 2023, showing that fairlife achieved the required financial targets and the remaining contingent consideration is now largely tied to future 2024‑2025 payouts. This evolution demonstrates that fairlife’s performance against its financial targets has been sufficient to trigger milestone payments, but the increasing fair‑value liability suggests ongoing uncertainty and the potential for additional payments if future targets are met.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "KO_10k_2022.pdf",
          "target_page": 75,
          "pages": [
            73,
            74,
            75,
            76,
            77
          ]
        },
        "hop_2_rel": {
          "source_file": "KO_10k_2024.pdf",
          "target_page": 111,
          "pages": [
            109,
            110,
            111,
            112,
            113
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 53383,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 13576,
        "completion_tokens": 219,
        "total_tokens": 13796
      }
    },
    {
      "question_id": 89,
      "question": "How has Oracle's strategic emphasis on Oracle Cloud Infrastructure (OCI) evolved between 2022 and 2024, particularly in terms of its global market positioning and integration with enterprise IT solutions?",
      "original_answer": "In 2022, Oracle's financial disclosures emphasized revenue contributions from cloud and license businesses, which generated $36.052 billion, representing 85% of total revenues, with no explicit strategic language about Oracle Cloud Infrastructure's positioning. By 2024, Oracle significantly elevated OCI's role, describing it as a core component of Oracle Cloud Services alongside SaaS, and emphasizing its ability to provide 'comprehensive and integrated applications and infrastructure services' that enable customers to choose deployment models best suited to their needs. This reflects a clear strategic shift toward positioning OCI as a central pillar in Oracle’s enterprise IT offerings, not just a contributor to cloud revenue.",
      "llm_answer": "Oracle's strategic emphasis on Oracle Cloud Infrastructure (OCI) has evolved from a complementary offering within its broader cloud and license business to a central pillar of its global growth strategy between 2022 and 2024. The company has increasingly prioritized OCI as a standalone, high-growth engine, emphasizing its integration with enterprise IT solutions through hybrid and multi-cloud deployment models that align with customer migration patterns. This shift is underscored by significant investments in infrastructure (e.g., $6.866B capital expenditures in 2024), expanded global data center footprints, and a strategic pivot away from non-core hardware toward cloud-based infrastructure technologies, as noted in the 2022 fiscal year discussion where hardware revenue declined due to \"de-emphasis of sales and marketing efforts for certain non-strategic hardware products.\" Financially, OCI's growth is reflected in the 6% constant-currency revenue increase in the cloud and license business (reaching $36.052B in 2022), driven by cloud services and license support adoption, while the company explicitly positions OCI as a key differentiator in its global market positioning, targeting enterprise IT modernization and integration with existing Oracle applications and infrastructure.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "ORCL_10k_2022.pdf",
          "target_page": 47,
          "pages": [
            45,
            46,
            47,
            48,
            49
          ]
        },
        "hop_2_rel": {
          "source_file": "ORCL_10k_2024.pdf",
          "target_page": 72,
          "pages": [
            70,
            71,
            72,
            73,
            74
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 52539,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 13370,
        "completion_tokens": 324,
        "total_tokens": 13694
      }
    },
    {
      "question_id": 90,
      "question": "How has the treatment and risk profile of PALs evolved between 2023 and 2024, particularly in terms of credit loss allowance and collateralization?",
      "original_answer": "In 2023, there was a slight decrease in PALs, and the allowance for credit losses was influenced by improved credit quality metrics and lower projected loss rates. By 2024, all PALs were fully collateralized by securities with fair values exceeding borrowings, and no allowance for credit losses for PALs was required as they were all subject to the collateral maintenance practical expedient under ASC 326. This indicates a strengthening in the risk profile and treatment of PALs over the period.",
      "llm_answer": "Between 2023 and 2024, the allowance for credit losses on Schwab's residential real estate loans (including First Mortgages and HELOCs) declined significantly, from $34 million to $15 million, reflecting a decrease in projected loss rates and improved credit quality. The allowance as a percentage of total year‑end loans fell from 0.18 % to 0.09 %, and the allowance relative to nonaccrual loans dropped from 317 % to 253 %, indicating a more favorable risk profile and reduced credit‑loss expectations for the portfolio.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "SCHW_10k_2023.pdf",
          "target_page": 146,
          "pages": [
            143,
            144,
            145,
            146,
            147
          ]
        },
        "hop_2_rel": {
          "source_file": "SCHW_10k_2024.pdf",
          "target_page": 88,
          "pages": [
            86,
            87,
            88,
            89,
            90
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 59496,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 15096,
        "completion_tokens": 130,
        "total_tokens": 15227
      }
    },
    {
      "question_id": 90,
      "question": "How has Nike's relationship with the Asia Pacific & Latin America (APLA) region evolved between fiscal years 2023 and 2024, particularly in terms of operational structure and strategic emphasis?",
      "original_answer": "In fiscal year 2023, Nike's relationship with APLA was characterized by direct operational involvement, with the region being one of the geographies where certain employees were represented by trade unions, indicating a more localized and embedded workforce structure. By fiscal year 2024, Nike transitioned parts of its APLA operations to third-party distributors, signaling a strategic shift away from direct control toward a more outsourced model. This evolution reflects a broader restructuring effort to optimize the business model and reduce operational complexity in certain international markets.",
      "llm_answer": "Nike’s operational structure and strategic emphasis in the Asia Pacific & Latin America (APLA) region have evolved significantly between fiscal years 2023 and 2024. In FY2024, the company reorganized its geographic reporting to explicitly highlight APLA as a distinct operating segment, reflecting a strategic focus on accelerating growth in this high-potential region. This shift aligns with leadership changes, including the appointment of Heidi O’Neill as President of Consumer, Product & Brand and Craig Williams as President of Geographies & Marketplace, both of whom have deep APLA experience. The company also intensified investments in localized product innovation, digital commerce expansion, and sustainable manufacturing partnerships across APLA, particularly in Vietnam and Indonesia, to capture rising consumer demand and mitigate supply chain risks. These moves underscore a deliberate pivot to position APLA as a core growth engine, moving beyond its historical role as a manufacturing hub to a strategic market and innovation center.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "NKE_10k_2023.pdf",
          "target_page": 9,
          "pages": [
            7,
            8,
            9,
            10,
            11
          ]
        },
        "hop_2_rel": {
          "source_file": "NKE_10k_2024.pdf",
          "target_page": 89,
          "pages": [
            87,
            88,
            89,
            90,
            91
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 54589,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 13879,
        "completion_tokens": 262,
        "total_tokens": 14141
      }
    },
    {
      "question_id": 90,
      "question": "How did Abbott's positioning and strategic emphasis on Pedialyte evolve between 2022 and 2023, particularly in relation to its U.S. Pediatric Nutritional business and product portfolio expansion?",
      "original_answer": "In 2022, Pedialyte was highlighted as a key growth driver within Abbott's U.S. Pediatric Nutritional business, with sales increasing 10.3% for the year, alongside Similac and PediaSure. By 2023, Pedialyte was formally included in Abbott's product portfolio under the Nutritional Products segment, listed among major brands such as Ensure, Glucerna, and PediaSure, signaling a more structured integration into Abbott's broader nutritional offerings. This reflects a strategic evolution from being a contributor to growth in 2022 to being a formally recognized and embedded part of the company's core U.S. Pediatric Nutritional product lineup in 2023.",
      "llm_answer": "Abbott’s 2022 10‑K shows that the U.S. Pediatric Nutritional business was a key growth driver within the Nutritionals segment, with U.S. Pediatric Nutritionals sales rising 10 % in 2021 (and 6 % in 2020) after a 10 % increase in 2020, reflecting strong demand for Pedialyte and other pediatric formulas.  In 2023 the company expanded the Pedialyte portfolio—adding new flavors and packaging formats—and intensified marketing spend to capture additional market share, positioning Pedialyte as the flagship product for growth in the U.S. pediatric nutrition space.  This strategic emphasis on product‑portfolio expansion and heightened focus on the U.S. pediatric segment carried through 2023, supporting overall sales growth in the Nutritionals segment.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "ABT_10k_2022.pdf",
          "target_page": 31,
          "pages": [
            29,
            30,
            31,
            32,
            33
          ]
        },
        "hop_2_rel": {
          "source_file": "ABT_10k_2023.pdf",
          "target_page": 4,
          "pages": [
            2,
            3,
            4,
            5,
            6
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 48187,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 12278,
        "completion_tokens": 188,
        "total_tokens": 12466
      }
    },
    {
      "question_id": 91,
      "question": "How did RTX's financial position regarding its 7.100% notes due 2027 evolve from 2022 to 2023, and what does this indicate about its debt management strategy?",
      "original_answer": "In 2022, RTX disclosed an aggregate principal balance of $6 million for its 7.100% notes due 2027. By 2023, RTX had a stake in the same notes with an aggregate principal balance of $135 million. This indicates a significant increase in RTX's exposure to this particular debt instrument, suggesting a shift in its debt management strategy, possibly involving refinancing or restructuring.",
      "llm_answer": "From 2022 to 2023, RTX's long-term debt increased significantly from $31,351 million to $43,638 million, driven by new issuances of $5.750% notes due 2026–2034 and term loans totaling $7 billion, while repayments of older notes (e.g., 3.700% and 3.650% notes due 2023) reduced only a modest portion of the principal. This expansion reflects a strategic shift toward longer‑dated, higher‑yielding debt to fund share repurchases and refinance maturing obligations, indicating that RTX is actively managing its debt profile by extending maturities and leveraging capital markets to support shareholder returns.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "RTX_10k_2022.pdf",
          "target_page": 94,
          "pages": [
            92,
            93,
            94,
            95,
            96
          ]
        },
        "hop_2_rel": {
          "source_file": "RTX_10k_2023.pdf",
          "target_page": 84,
          "pages": [
            82,
            83,
            84,
            85,
            86
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 43217,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 11027,
        "completion_tokens": 151,
        "total_tokens": 11179
      }
    },
    {
      "question_id": 91,
      "question": "How has Nike's relationship with Converse evolved in terms of revenue performance and strategic positioning between fiscal 2023 and fiscal 2024?",
      "original_answer": "In fiscal 2023, Converse revenues decreased by 15% on a currency-neutral basis, driven by declines in North America and Western Europe, with both wholesale and direct-to-consumer channels experiencing drops in unit sales and average selling price. By fiscal 2024, Converse was described as a wholly-owned subsidiary that operates on a stand-alone basis, indicating a strategic shift toward maintaining it as a distinct brand within Nike’s portfolio. This evolution reflects a move from a financially struggling entity in 2023 to a more strategically positioned brand in 2024, despite the earlier revenue contraction.",
      "llm_answer": "Between fiscal 2023 and fiscal 2024, Nike’s Converse segment experienced a sharp revenue decline—down roughly 14‑15% on a reported basis and about 15% on a currency‑neutral basis—driven by weaker sales in North America and Western Europe and reduced wholesale and direct‑to‑consumer volumes.  In contrast, Nike’s overall brand revenues grew modestly (about 4% reported, 8% constant‑currency), with footwear and apparel up 2‑10% and 10‑14% respectively, reflecting stronger demand in Men’s, Women’s, Jordan and Kids categories and strategic pricing actions.  Strategically, Converse is being treated as a distinct, stand‑alone operating segment that now contributes only a small share of total sales (≈58% of non‑U.S. revenue), allowing Nike to focus its growth initiatives on the core Nike Brand while continuing to manage Converse’s under‑performance separately.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "NKE_10k_2023.pdf",
          "target_page": 46,
          "pages": [
            44,
            45,
            46,
            47,
            48
          ]
        },
        "hop_2_rel": {
          "source_file": "NKE_10k_2024.pdf",
          "target_page": 4,
          "pages": [
            2,
            3,
            4,
            5,
            6
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 50293,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 12792,
        "completion_tokens": 215,
        "total_tokens": 13007
      }
    },
    {
      "question_id": 91,
      "question": "How has Coca-Cola's financial risk assessment regarding digital evolution changed from 2022 to 2024, particularly in terms of its impact on sales growth and margin improvement?",
      "original_answer": "In 2022, Coca-Cola viewed digital evolution as a risk factor that could negatively impact its business if it failed to implement digital transformation initiatives effectively, potentially leading to a loss in sales and brand relevance. By 2024, the company shifted its stance, identifying digital evolution as a strategic dependency, emphasizing that its future success would rely on expanding digital capabilities to increase sales and improve margins. The 2024 filing explicitly states that failure to digitalize operations could adversely impact financial performance, indicating a stronger financial linkage to digital initiatives than in 2022.",
      "llm_answer": "From 2022 to 2024, Coca‑Cola’s risk assessment shifted from a focus on traditional cost‑inflation and supply‑chain pressures to an explicit emphasis on digital transformation as a driver of sales growth and margin improvement.  In the 2022 filing the company highlighted digital evolution only as a “shopping‑pattern” change that could affect sales if not addressed, whereas the 2024 filing elevates digitization to a “top priority,” stating that successful digitization is essential to “increase sales and improve margins” and that failure to digitize could “adversely impact our financial performance.”  Consequently, the 2024 risk discussion ties digital initiatives directly to both revenue growth and margin expansion, reflecting a strategic evolution in how the company views the digital economy’s impact on its financial results.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "KO_10k_2022.pdf",
          "target_page": 17,
          "pages": [
            15,
            16,
            17,
            18,
            19
          ]
        },
        "hop_2_rel": {
          "source_file": "KO_10k_2024.pdf",
          "target_page": 19,
          "pages": [
            17,
            18,
            19,
            20,
            21
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 9,
        "total_chars": 58442,
        "num_window_pages": 9,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 14838,
        "completion_tokens": 209,
        "total_tokens": 15047
      }
    },
    {
      "question_id": 91,
      "question": "How has Oracle's strategic emphasis on Oracle Cloud Services evolved from fiscal year 2022 to 2024, particularly in terms of research and development investment and the positioning of cloud offerings relative to on-premise solutions?",
      "original_answer": "In fiscal year 2022, Oracle invested $7.2 billion in research and development, highlighting its commitment to enhancing Oracle Cloud Services, including Oracle SaaS and OCI, as part of a broader strategy to offer flexible and interoperable deployment models. Oracle positioned cloud services as a key differentiator against competitors by emphasizing rapid deployment, security, and integration. By fiscal year 2024, Oracle continued to emphasize cloud services but restructured its messaging to position Oracle Cloud Software-as-a-Service and Oracle Cloud Infrastructure as central to enabling customers to 'choose the best option that meets their specific business needs.' While the 2024 report does not specify the R&D investment amount, the increased focus on cloud-first positioning and integration with customer-specific needs indicates a strategic deepening of Oracle's commitment to cloud services over on-premise offerings.",
      "llm_answer": "From fiscal 2022 through 2024 Oracle’s R&D spending has risen steadily—$7.2 billion in FY22, $7.9 billion in FY23 and $8.5 billion in FY24—reflecting its push to expand cloud‑focused innovation.  This increased investment underpins a strategic shift that positions Oracle Cloud Services (SaaS and OCI) as the primary growth engine, while cloud license and support revenues now represent roughly 70‑71 % of total sales and are growing faster than traditional on‑premise license and hardware revenues.  Consequently, Oracle is emphasizing cloud subscriptions and migration programs to move customers from on‑premise deployments to its cloud offerings, even as it continues to support on‑premise licenses through renewal of support contracts.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "ORCL_10k_2022.pdf",
          "target_page": 6,
          "pages": [
            4,
            5,
            6,
            7,
            8
          ]
        },
        "hop_2_rel": {
          "source_file": "ORCL_10k_2024.pdf",
          "target_page": 72,
          "pages": [
            70,
            71,
            72,
            73,
            74
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 48939,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 12476,
        "completion_tokens": 184,
        "total_tokens": 12661
      }
    },
    {
      "question_id": 92,
      "question": "How has the status and availability of shares under the Norwest Corporation Directors' Formula Stock Award Plan evolved between 2023 and 2024?",
      "original_answer": "In 2023, the Norwest Corporation Directors' Formula Stock Award Plan was described as a plan under which shares of common stock were awarded to non-employee directors, with the ability to defer receipt of awards until a future year. However, it was noted that no future stock awards or deferrals could be made under this plan. In 2024, the 10-K filing further clarified that no future awards or deferrals would be made under the plan and that column (a) of the equity compensation table reflected all shares issuable under the plan upon distribution of outstanding awards or deferred compensation benefits. This indicates that by 2024, the plan was fully closed to any new activity and only existing obligations remained. The number of shares issuable in 2024 related to this plan was minimal (only 391 shares), showing that the plan had effectively concluded its active phase.",
      "llm_answer": "The Norwest Corporation Directors' Formula Stock Award Plan, which was used to award shares to non-employee directors, no longer permits new stock awards or deferrals—effective after its termination, no future awards or deferrals can be made under this plan. This means that the plan’s share pool (1,993,916 shares remaining as of 2023) is now closed for new issuances, and all outstanding awards are fully vested and distributed according to prior deferral elections.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "WFC_10k_2023.pdf",
          "target_page": 12,
          "pages": [
            10,
            11,
            12,
            13,
            14
          ]
        },
        "hop_2_rel": {
          "source_file": "WFC_10k_2024.pdf",
          "target_page": 14,
          "pages": [
            12,
            13,
            14,
            15,
            16
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 59649,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 15131,
        "completion_tokens": 117,
        "total_tokens": 15248
      }
    },
    {
      "question_id": 92,
      "question": "How has McDonald's disclosure around food safety concerns evolved between 2022 and 2023, particularly in relation to supply chain risks and cost volatility?",
      "original_answer": "In 2022, McDonald's characterized food safety concerns primarily as reputational risks that could impact brand perception and financial results due to incidents like food-borne illness or contamination. The focus was on the potential damage to consumer trust and the company's image. By 2023, the framing had evolved to emphasize food safety concerns as contributors to supply chain volatility, specifically in relation to commodity cost fluctuations. The 2023 filing noted that food safety issues, along with other macroeconomic and regulatory factors, could exacerbate volatility in the prices of key ingredients like beef, chicken, and pork, thereby affecting profitability. This indicates a shift in emphasis from reputational impact to financial exposure through supply chain disruption and cost pressures.",
      "llm_answer": "Between 2022 and 2023, McDonald’s disclosure around food safety concerns remained consistent in emphasizing supply chain risks and cost volatility, with no major shift in focus. The 2023 filing (page 31) reiterates that food safety events—including supply chain disruptions, contamination, or food-borne illness incidents—could adversely affect the brand, reputation, and financial results, similar to prior years. While the company highlights ongoing efforts to manage supply chain interruptions and commodity cost volatility (page 30), it does not indicate a new or evolved disclosure strategy; instead, it maintains the same risk framework as in 2022, particularly regarding supply chain reliability and the potential for cost increases impacting profitability. The emphasis on supply chain risks and cost volatility persists as a core component of its risk factors, without significant evolution in wording or scope.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MCD_10k_2022.pdf",
          "target_page": 31,
          "pages": [
            29,
            30,
            31,
            32,
            33
          ]
        },
        "hop_2_rel": {
          "source_file": "MCD_10k_2023.pdf",
          "target_page": 33,
          "pages": [
            31,
            32,
            33,
            34,
            35
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 66162,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 16763,
        "completion_tokens": 230,
        "total_tokens": 16993
      }
    },
    {
      "question_id": 92,
      "question": "How has the carrying value and interest rate of TMO's 1.750% 7-Year Senior Notes evolved between 2023 and 2024?",
      "original_answer": "In 2023, TMO's 1.750% 7-Year Senior Notes, due on October 15, 2028, had a carrying value of $700 million and an effective interest rate of 1.89%. In 2024, both the carrying value and effective interest rate remained unchanged at $700 million and 1.89% respectively. This indicates that there was no change in the financial structure or valuation of this particular debt instrument over the period.",
      "llm_answer": "Based on the provided pages, the carrying value of TMO's 1.750% 7-Year Senior Notes was $621 million at December 31 2024 and $662 million at December 31 2023, with an effective interest rate of 1.96 % for 2024 versus 1.89 % for 2023. This reflects a modest increase in carrying value and a slight rise in the effective interest rate over the one‑year period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "TMO_10k_2023.pdf",
          "target_page": 62,
          "pages": [
            60,
            61,
            62,
            63,
            64
          ]
        },
        "hop_2_rel": {
          "source_file": "TMO_10k_2024.pdf",
          "target_page": 47,
          "pages": [
            45,
            46,
            47,
            48,
            49
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 56701,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 14387,
        "completion_tokens": 89,
        "total_tokens": 14476
      }
    },
    {
      "question_id": 93,
      "question": "How did RTX's exposure to its 7.000% notes due 2038 change between 2022 and 2023, and what does this suggest about its approach to managing long-term debt maturities?",
      "original_answer": "In 2022, RTX disclosed an aggregate principal balance of $11 million for its 7.000% notes due 2038. By 2023, this amount had increased significantly to $148 million. This suggests that RTX either issued additional tranches of this note or restructured its debt to extend maturities, indicating a strategic shift toward increasing exposure to this particular long-term debt instrument.",
      "llm_answer": "RTX's exposure to its 7.000% notes due 2038 remained unchanged at $148 million in both 2022 and 2023, indicating that the company did not increase or decrease its holdings of this specific long‑term debt issue during the period. This stability suggests that RTX is maintaining a relatively steady long‑term debt maturity profile rather than actively adjusting the mix of maturing obligations.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "RTX_10k_2022.pdf",
          "target_page": 94,
          "pages": [
            92,
            93,
            94,
            95,
            96
          ]
        },
        "hop_2_rel": {
          "source_file": "RTX_10k_2023.pdf",
          "target_page": 85,
          "pages": [
            83,
            84,
            85,
            86,
            87
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 44968,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 11467,
        "completion_tokens": 98,
        "total_tokens": 11565
      }
    },
    {
      "question_id": 93,
      "question": "How did McDonald's financial relationship with its franchisees evolve between 2022 and 2023, particularly regarding the collection of rent and royalties?",
      "original_answer": "In 2022, McDonald's disclosed that it had deferred approximately $1 billion in rent and royalties from franchisees, primarily during the first half of 2020, due to the impact of government restrictions related to COVID-19. By the end of 2021, the company had collected substantially all of these deferred amounts. In contrast, the 2023 filing reflects a return to standard operations, with no mention of ongoing deferrals or pandemic-related financial accommodations. Instead, the 2023 report outlines the normalization of franchise operations, including a detailed breakdown of restaurant ownership types, which indicates that franchisees were operating under regular financial obligations without pandemic-era relief measures.",
      "llm_answer": "Between 2022 and 2023, McDonald's financial relationship with its franchisees regarding rent and royalties evolved in two key ways: First, while total franchise revenue grew to $13.085 billion in 2021 (up from $10.726 billion in 2020), the company continued to collect both minimum rent payments (based on underlying lease investments) and variable royalties tied to sales, with future minimum payments due under franchise arrangements totaling $33.78 billion over the life of agreements. Second, the company maintained its practice of allocating franchise revenue between lease (rental income) and non-lease components (royalties and initial fees), and although pandemic-related disruptions caused temporary deferrals of approximately $1 billion in cash collections from franchisees in 2020, by December 31, 2021, substantially all of these deferrals had been collected, indicating a return to normal collection patterns.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MCD_10k_2022.pdf",
          "target_page": 51,
          "pages": [
            49,
            50,
            51,
            52,
            53
          ]
        },
        "hop_2_rel": {
          "source_file": "MCD_10k_2023.pdf",
          "target_page": 43,
          "pages": [
            41,
            42,
            43,
            44,
            45
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 50548,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 12859,
        "completion_tokens": 230,
        "total_tokens": 13089
      }
    },
    {
      "question_id": 93,
      "question": "How has The Coca-Cola Company's financial stake in Embotelladora Andina S.A. evolved from 2022 to 2024, and what does this indicate about the company's strategic positioning with respect to this equity investment?",
      "original_answer": "In 2022, Coca-Cola recognized a gain of $39 million from the partial sale of its ownership interest in Embotelladora Andina S.A., indicating a strategic refranchising or divestiture move while retaining an equity stake. By 2024, Coca-Cola still held a financial stake in Andina, with a carrying value of $90 million and a fair value of $168 million, showing that the company maintained its involvement but with a relatively modest valuation compared to other equity investments. This indicates a partial exit strategy rather than a complete divestiture, with ongoing but reduced exposure.",
      "llm_answer": "The Coca‑Cola Company’s stake in Embotelladora Andina S.A. has been treated as an equity‑method investment that remains on the books through 2024.  In the 2022 10‑K (pages 74‑78) the company notes that it continues to account for its remaining ownership interest in Andina as an equity‑method investment, and the 2024 10‑K (pages 85‑89) shows that the carrying value of that investment ($90 million) is far below its fair value ($168 million), leaving a $78 million unrealized gain.  This evolution—maintaining a modest equity stake while the fair‑value‑to‑carrying‑value gap persists—signals that Coca‑Cola is using the investment as a strategic foothold in the Andean bottling market rather than seeking a full exit or refranchising, positioning the holding as a long‑term partnership that complements its broader bottling‑investments portfolio.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "KO_10k_2022.pdf",
          "target_page": 76,
          "pages": [
            74,
            75,
            76,
            77,
            78
          ]
        },
        "hop_2_rel": {
          "source_file": "KO_10k_2024.pdf",
          "target_page": 87,
          "pages": [
            85,
            86,
            87,
            88,
            89
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 53813,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 13690,
        "completion_tokens": 211,
        "total_tokens": 13901
      }
    },
    {
      "question_id": 93,
      "question": "How has Oracle's strategic investment in cloud infrastructure evolved from 2022 to 2024, particularly regarding internal development efforts and the positioning of Oracle Cloud Infrastructure in its product portfolio?",
      "original_answer": "In 2022, Oracle emphasized internal development as a core strategy, dedicating significant resources to research and development to maintain and improve its existing product suite, including cloud technologies. The company highlighted its global R&D workforce and the importance of innovation in response to evolving market demands. By 2024, this focus had evolved into a more product-specific strategy with the explicit introduction of Oracle Cloud Infrastructure (OCI) as a central offering within Oracle Cloud Services. OCI was positioned as a comprehensive and integrated infrastructure solution, indicating a shift from general cloud development to a structured, customer-facing product portfolio. This evolution demonstrates a strategic deepening of Oracle's cloud infrastructure commitment, aligning internal R&D with the delivery of a defined, market-ready suite of cloud services.",
      "llm_answer": "From 2022 to 2024, Oracle’s strategic investment in cloud infrastructure evolved from a focus on foundational hardware and platform capabilities toward a more integrated, enterprise-grade cloud services model anchored by Oracle Cloud Infrastructure (OCI). Early investments emphasized server and storage hardware, operating systems, and virtualization technologies to support both on-premise and cloud deployments. By 2024, Oracle had significantly expanded its cloud platform, investing in data center capacity, global expansion, and automated service delivery through Oracle Cloud Operations, enabling rapid deployment of cloud updates on a quarterly cadence. This evolution positioned OCI not just as an infrastructure layer but as a strategic differentiator within Oracle’s broader product portfolio, supporting cloud license and SaaS offerings with integrated services, support, and hybrid deployment flexibility. The company’s internal development efforts intensified to enhance scalability, security, and compatibility—particularly around Java and enterprise workloads—reinforcing OCI’s role as a differentiated alternative to competitors like AWS and Microsoft Azure.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "ORCL_10k_2022.pdf",
          "target_page": 16,
          "pages": [
            14,
            15,
            16,
            17,
            18
          ]
        },
        "hop_2_rel": {
          "source_file": "ORCL_10k_2024.pdf",
          "target_page": 72,
          "pages": [
            70,
            71,
            72,
            73,
            74
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 49374,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 12582,
        "completion_tokens": 293,
        "total_tokens": 12876
      }
    },
    {
      "question_id": 93,
      "question": "How did TMO's involvement with The Binding Site Group evolve between 2023 and 2024, and what does this indicate about the company's integration and strategic focus post-acquisition?",
      "original_answer": "In 2023, TMO acquired The Binding Site Group for $2.70 billion as part of its Specialty Diagnostics segment, expanding its portfolio in diagnostics for blood cancers and immune disorders. By 2024, the company had integrated the acquisition into its asset base, with The Binding Site Group contributing to the 19-year weighted-average amortization period for customer relationships among definite-lived intangible assets. This evolution indicates a strategic focus on long-term value creation through integration of acquired innovation into its core diagnostics offerings.",
      "llm_answer": "TMO's integration of The Binding Site Group, acquired in January 2023, is evident in its contribution to the Specialty Diagnostics segment’s revenue and income growth, and its later acquisition of Olink Holding AB in July 2024 further expands the Life Sciences Solutions segment’s proteomics capabilities. These moves underscore a strategic focus on broadening high‑growth diagnostic and proteomics offerings while leveraging synergies and cash‑flow generation to fund ongoing acquisitions and shareholder returns.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "TMO_10k_2023.pdf",
          "target_page": 24,
          "pages": [
            22,
            23,
            24,
            25,
            26
          ]
        },
        "hop_2_rel": {
          "source_file": "TMO_10k_2024.pdf",
          "target_page": 65,
          "pages": [
            63,
            64,
            65,
            66,
            67
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 51724,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 13160,
        "completion_tokens": 128,
        "total_tokens": 13288
      }
    },
    {
      "question_id": 94,
      "question": "How has the disclosure and accessibility of the Directors' Code of Conduct evolved between 2022 and 2024, particularly in terms of website links and scope of application?",
      "original_answer": "In 2022, the Directors' Code of Conduct was posted on BNY Mellon's website at a specific URL: https://www.bnymellon.com/content/dam/bnymellon/documents/pdf/investor-relations/directors-code-of-conduct.pdf, and it applied to all directors. By 2024, while the scope of application remained the same—applying to all directors—the URL for the Directors' Code of Conduct had changed to https://www.bny.com/content/dam/bnymellon/documents/pdf/investor-relations/directors-code-ofconduct.pdf. This indicates a change in the website structure or domain branding, likely reflecting a broader rebranding from 'BNY Mellon' to 'BNY', while maintaining the same governance policy content and disclosure intent.",
      "llm_answer": "Between 2022 and 2024, the disclosure of BNY Mellon’s Directors’ Code of Conduct evolved from a standalone document referenced only in the 2022 filing (with a link to a PDF hosted at `https://www.bnymellon.com/content/dam/bnymellon/documents/pdf/in relations/directors-code-of-conduct.pdf`) to a more clearly defined, website-hosted policy in the 2024 filing, which explicitly states that the Directors’ Code of Conduct is posted at `https://www.bnymellon.com/content/dam/bnymellon/documents/pdf/in relations/directors-code-of-conduct.pdf` and commits to disclosing amendments or waivers on the website. The scope of application remained consistent—applying to all directors of BNY Mellon—but the 2024 version strengthened the commitment to transparency by specifying that changes to the Directors’ Code of Conduct will be disclosed on the website, whereas the 2022 version only mentioned the intention to disclose such changes without detailing the platform. Additionally, the 2024 filing refined the website URL structure (removing \"www\" and standardizing the path), reflecting a more deliberate and accessible disclosure practice.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "BK_10k_2022.pdf",
          "target_page": 11,
          "pages": [
            9,
            10,
            11,
            12,
            13
          ]
        },
        "hop_2_rel": {
          "source_file": "BK_10k_2024.pdf",
          "target_page": 13,
          "pages": [
            11,
            12,
            13,
            14,
            15
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 36067,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 9242,
        "completion_tokens": 283,
        "total_tokens": 9525
      }
    },
    {
      "question_id": 94,
      "question": "How has McDonald's relationship with franchisees evolved in terms of financial reporting and strategic emphasis between 2022 and 2023?",
      "original_answer": "In 2022, McDonald's noted that the results of operations from restaurant businesses purchased and sold in transactions with franchisees were not material to the consolidated financial statements, indicating a limited financial impact from such transactions. By 2023, the company explicitly included franchisees and licensees as key stakeholders in its business model, emphasizing their role alongside company-operated restaurants in a detailed breakdown of restaurant ownership types. This shift reflects a more strategic and transparent focus on franchisees as integral to McDonald's global business structure.",
      "llm_answer": "Between 2022 and 2023, McDonald's financial reporting and strategic emphasis regarding franchisees evolved in several key ways. The company continued to emphasize its role as the principal in franchise-related revenue streams, particularly for technology platforms and brand licensing, recognizing revenue on a gross basis as goods/services are transferred to franchisees. Additionally, the company refined its goodwill reporting, with a 2023 table showing increased goodwill balances ($2.9B to $3.04B) and ongoing qualitative impairment testing, while maintaining historical practices of writing off goodwill on restaurant sales within 24 months. The company also refined its capitalized software amortization policies (3-10 year lives) and maintained its approach to reviewing long-lived assets for impairment at the market level, ensuring franchisee-related cash flow dependencies were considered in impairment assessments. These adjustments reflect a continued focus on aligning financial reporting with the operational realities of its franchise-heavy business model.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MCD_10k_2022.pdf",
          "target_page": 43,
          "pages": [
            41,
            42,
            43,
            44,
            45
          ]
        },
        "hop_2_rel": {
          "source_file": "MCD_10k_2023.pdf",
          "target_page": 43,
          "pages": [
            41,
            42,
            43,
            44,
            45
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 67922,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 17198,
        "completion_tokens": 268,
        "total_tokens": 17466
      }
    },
    {
      "question_id": 94,
      "question": "How did the accounting treatment or status of the contingent consideration liabilities related to the Clif Bar acquisition evolve between 2023 and 2024, particularly in terms of fair value measurement and purchase price allocation adjustments?",
      "original_answer": "In 2023, the contingent consideration liabilities related to the Clif Bar acquisition were actively measured at fair value using a Monte Carlo simulation, with $548 million classified as long-term liabilities at December 31, 2023. These liabilities were tied to performance targets in 2025 and 2026 and were subject to fair value adjustments recorded in selling, general, and administrative expenses. By 2024, there is no direct mention of the contingent consideration liabilities; instead, the 2024 filing references purchase price allocation adjustments for Clif Bar during 2023. This indicates that the contingent consideration may have been finalized or reclassified as part of the purchase price allocation process, though the 2024 disclosure does not provide updated figures or valuation methods for these liabilities.",
      "llm_answer": "The contingent consideration liability related to the Clif Bar acquisition was initially recorded at fair value of $548 million (Level 3) as of December 31 2023 and $452 million as of December 31 2022. Subsequent fair‑value adjustments of $128 million in 2023 and $44 million in 2022 were recorded in selling, general and administrative expenses, and the liability balance increased to $680 million by the end of 2023 before any further changes in 2024. These adjustments reflect the ongoing re‑measurement of the contingent consideration under the purchase price allocation.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MDLZ_10k_2023.pdf",
          "target_page": 99,
          "pages": [
            97,
            98,
            99,
            100,
            101
          ]
        },
        "hop_2_rel": {
          "source_file": "MDLZ_10k_2024.pdf",
          "target_page": 87,
          "pages": [
            85,
            86,
            87,
            88,
            89
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 47068,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 12012,
        "completion_tokens": 143,
        "total_tokens": 12156
      }
    },
    {
      "question_id": 94,
      "question": "How has AMD's strategic emphasis on Vulkan API support evolved between 2022 and 2024, and what does this reveal about its approach to maintaining competitiveness in the discrete GPU market?",
      "original_answer": "In 2022, AMD highlighted its support for Vulkan as part of its Radeon™ series discrete GPUs, which were built on the RDNA 2 architecture and aimed at delivering high-performance gaming and creation workloads. By 2024, AMD continued to support Vulkan but shifted its focus toward the newer RDNA 3 architecture, which underpins the Radeon RX 7000 Series GPUs. This evolution suggests AMD is maintaining its commitment to Vulkan while advancing its GPU capabilities to meet the growing demands of immersive gaming and AI/ML computing. This strategic continuity in API support combined with architectural innovation indicates AMD’s effort to stay competitive by offering both backward compatibility and cutting-edge performance enhancements.",
      "llm_answer": "AMD’s strategic focus on Vulkan API support has evolved from a foundational emphasis in 2022—highlighted by its promotion of open standards like Vulkan and ROCm for cross-platform graphics and compute—to a more integrated, performance-driven approach by 2024, where Vulkan is positioned alongside ROCm optimizations to enhance AI/ML workloads and heterogeneous computing in data centers and gaming. This shift reflects AMD’s broader strategy to maintain competitiveness in the discrete GPU market by leveraging open ecosystems to challenge NVIDIA’s dominance, particularly through initiatives like FSR (FidelityFX Super Resolution) and tighter integration of Vulkan with AI acceleration, ensuring its GPUs remain relevant in emerging workloads while reducing reliance on proprietary APIs like DirectX 12 Ultimate.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AMD_10k_2022.pdf",
          "target_page": 8,
          "pages": [
            6,
            7,
            8,
            9,
            10
          ]
        },
        "hop_2_rel": {
          "source_file": "AMD_10k_2024.pdf",
          "target_page": 8,
          "pages": [
            6,
            7,
            8,
            9,
            10
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 47469,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 12096,
        "completion_tokens": 203,
        "total_tokens": 12299
      }
    },
    {
      "question_id": 95,
      "question": "How did RTX's integration-related charges impact its operating profit trends between 2022 and 2023, particularly with the introduction of the Powder Metal Matter charge in 2023?",
      "original_answer": "In 2022, RTX reported a decrease in Acquisition Accounting Adjustments, which contributed positively to its operating profit. However, in 2023, there was a significant $2.9 billion charge associated with the Powder Metal Matter, which became a major driver of the $1.9 billion decrease in Operating Profit compared to 2022. This reflects a notable shift from a declining trend in integration-related charges in 2022 to a significant new expense in 2023 that directly impacted profitability.",
      "llm_answer": "The Powder Metal Matter charge recorded in 2023 reduced RTX’s operating profit by $2.9 billion, driving a $1.9 billion decline in operating profit from 2022 to 2023. This charge, along with related acquisition‑accounting adjustments, was the primary factor behind the steep drop in operating profit margin (from 8.2 % in 2022 to 5.2 % in 2023).",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "RTX_10k_2022.pdf",
          "target_page": 51,
          "pages": [
            49,
            50,
            51,
            52,
            53
          ]
        },
        "hop_2_rel": {
          "source_file": "RTX_10k_2023.pdf",
          "target_page": 39,
          "pages": [
            37,
            38,
            39,
            40,
            41
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 54965,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 13969,
        "completion_tokens": 86,
        "total_tokens": 14055
      }
    },
    {
      "question_id": 95,
      "question": "How has MDLZ's relationship with Clif Bar evolved between 2023 and 2024, particularly in terms of acquisition-related financial activities?",
      "original_answer": "In 2023, MDLZ acquired Clif Bar, as noted in the 2023 10-K filing, with specific reference to the August 1, 2022 acquisition and related financial impacts such as integration costs and contingent consideration adjustments. By 2024, the relationship had evolved to include purchase price allocation adjustments for Clif Bar during the prior year, as detailed in the 2024 10-K filing. This indicates that the company had moved beyond the initial acquisition phase into a period of financial recalibration and consolidation of the Clif Bar acquisition.",
      "llm_answer": "Between 2023 and 2024 the relationship with Clif Bar shifted from an acquisition‑related integration cost to a divestiture‑related cost. In 2023 the company recorded $11 million of acquisition‑related costs tied to the Clif Bar purchase, but by 2024 those costs disappeared and were replaced by $25 million of divestiture‑related costs associated with the sale of its stake in JDE Peet’s (which included the Clif Bar equity‑method investment). Thus, the financial activity moved from acquisition‑integration expense in 2023 to a gain/loss on equity‑method investment and divestiture costs in 2024.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MDLZ_10k_2023.pdf",
          "target_page": 41,
          "pages": [
            39,
            40,
            41,
            42,
            43
          ]
        },
        "hop_2_rel": {
          "source_file": "MDLZ_10k_2024.pdf",
          "target_page": 87,
          "pages": [
            85,
            86,
            87,
            88,
            89
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 48436,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 12328,
        "completion_tokens": 149,
        "total_tokens": 12477
      }
    },
    {
      "question_id": 96,
      "question": "How has Gulfstream's approach to energy efficient engines evolved from 2023 to 2024, and what specific aircraft developments reflect this shift?",
      "original_answer": "In 2023, Gulfstream emphasized its leadership in the use of sustainable aviation fuel (SAF) and energy efficient engines, focusing on continuous R&D investment to develop technologically advanced business jets. However, no new aircraft model powered by energy efficient engines was introduced that year. By 2024, Gulfstream had transitioned from announcement and development phases to actual production of energy efficient engines, as evidenced by the introduction of the G700, which features 'all-new engines' designed for high-speed performance and efficiency. This marks a tangible evolution from strategic positioning in 2023 to operational realization in 2024.",
      "llm_answer": "From 2023 to 2024 Gulfstream’s energy‑efficient engine strategy shifted from incremental upgrades to a broader sustainability focus, highlighted by expanded use of sustainable aviation fuel (SAF) and the launch of the ultra‑long‑range, ultra‑large‑cabin G700. The G700, certified by the FAA in early 2024, incorporates new, more efficient engines and aerodynamic refinements that improve fuel efficiency and reduce emissions, reflecting the company’s move toward higher‑performance, lower‑carbon aircraft. This evolution is also evident in the continued deployment of SAF‑capable service and test aircraft, with Gulfstream having flown over two million nautical miles on SAF since 2016 and conducting the world’s first 100 % SAF transatlantic flight in November 2023.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "GD_10k_2023.pdf",
          "target_page": 4,
          "pages": [
            2,
            3,
            4,
            5,
            6
          ]
        },
        "hop_2_rel": {
          "source_file": "GD_10k_2024.pdf",
          "target_page": 4,
          "pages": [
            2,
            3,
            4,
            5,
            6
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 32123,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 8247,
        "completion_tokens": 191,
        "total_tokens": 8439
      }
    },
    {
      "question_id": 96,
      "question": "How has AMD's relationship with semi-custom SoC products evolved from 2022 to 2024, particularly in terms of revenue structure and strategic positioning?",
      "original_answer": "In 2022, AMD's relationship with semi-custom SoC products was characterized by dependency, with revenue derived from both non-recurring engineering fees and sales of the products themselves, and success was directly tied to third-party product performance. By 2024, AMD's relationship evolved to one of active production and broader strategic integration, as semi-custom SoC products became part of a more diversified product portfolio that includes AI accelerators, GPUs, APUs, and DPUs. This shift indicates a more central and controlled role for AMD in the development and commercialization of these products, aligning them more closely with long-term industry trends and internal innovation strategies.",
      "llm_answer": "From 2022 through 2024 AMD’s semi‑custom SoC business moved from a model that relied on long‑term wafer‑purchase commitments and exclusivity with a single foundry (the 2021 amendment to the GF wafer‑supply agreement) to a more flexible, multi‑foundry strategy that emphasizes design‑services revenue and custom‑product sales rather than volume wafer purchases.  The company now derives semi‑custom revenue from design‑services fees and sales of its custom SoCs to OEMs, while its wafer‑purchase targets under the GF agreement are limited to 2022‑2025 with penalties only for missing purchase targets, and AMD has removed any exclusivity constraints, allowing it to shift capacity to other foundries as needed.  Consequently, the revenue contribution of semi‑custom SoCs has become a smaller, more project‑based component of AMD’s overall product mix, with growth tied to the success of the specific customer programs that incorporate those chips rather than to broad, long‑term volume commitments.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AMD_10k_2022.pdf",
          "target_page": 25,
          "pages": [
            23,
            24,
            25,
            26,
            27
          ]
        },
        "hop_2_rel": {
          "source_file": "AMD_10k_2024.pdf",
          "target_page": 62,
          "pages": [
            60,
            61,
            62,
            63,
            64
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 43101,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 10997,
        "completion_tokens": 249,
        "total_tokens": 11246
      }
    },
    {
      "question_id": 96,
      "question": "How has the company's structure of preferred share authorization evolved between fiscal years 2023 and 2024, and what does this indicate about its capital strategy?",
      "original_answer": "The company's preferred share authorization structure remained unchanged between fiscal years 2023 and 2024, with 127.5 million Preferred Shares at $0.20 par value and 500 thousand A Preferred Shares at $1.00 par value authorized in both years. Additionally, no Preferred Shares or A Preferred Shares were issued or outstanding in either year. This indicates that the company has not utilized or pursued any changes in its preferred share structure as part of its capital strategy during this period.",
      "llm_answer": "Between fiscal years 2023 and 2024, Medtronic increased its authorized preferred share capacity from 127.5 million to 500,000 shares (though no shares were outstanding), reflecting a strategic expansion of its capital structure options. This evolution indicates a proactive approach to capital management, providing greater flexibility for future financing or equity-based initiatives while maintaining a focus on shareholder returns through dividends and repurchases.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MDT_10k_2023.pdf",
          "target_page": 81,
          "pages": [
            79,
            80,
            81,
            82,
            83
          ]
        },
        "hop_2_rel": {
          "source_file": "MDT_10k_2024.pdf",
          "target_page": 81,
          "pages": [
            79,
            80,
            81,
            82,
            83
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 46293,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 11798,
        "completion_tokens": 117,
        "total_tokens": 11915
      }
    },
    {
      "question_id": 97,
      "question": "How has the framing of reputational risk related to adverse publicity evolved between 2022 and 2024 in BK's risk disclosures, particularly in terms of associated impacts or linked concerns?",
      "original_answer": "In 2022, BK identified adverse publicity as a risk that could negatively affect its business, financial condition, and results of operations, and linked it with government scrutiny and other reputational harm. By 2024, the framing of this risk remained present but was expanded to include broader reputational impacts from sustainability concerns such as climate change and diversity, in addition to being tied to new operational models like the platforms operating model transition. This indicates a broadening of the contexts in which adverse publicity could negatively impact BK's reputation and business outcomes.",
      "llm_answer": "The framing of reputational risk related to adverse publicity has shifted from a general mention of reputational harm tied to business disruptions and regulatory scrutiny in 2022 to a more explicit linkage with sustainability concerns, climate change, and geopolitical events in 2024, reflecting heightened focus on environmental and societal impacts as drivers of reputational damage. In both years, adverse publicity was connected to operational failures, cybersecurity incidents, and regulatory actions, but the 2024 disclosures broaden the scope to include climate-related risks and sustainability-focused reputational threats as key concerns.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "BK_10k_2022.pdf",
          "target_page": 4,
          "pages": [
            2,
            3,
            4,
            5,
            6
          ]
        },
        "hop_2_rel": {
          "source_file": "BK_10k_2024.pdf",
          "target_page": 5,
          "pages": [
            3,
            4,
            5,
            6,
            7
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 41015,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 10482,
        "completion_tokens": 161,
        "total_tokens": 10643
      }
    },
    {
      "question_id": 97,
      "question": "How did Amazon's financial investment and valuation approach toward Anthropic, PBC evolve from 2023 to 2024, particularly in terms of investment classification and the factors affecting its valuation?",
      "original_answer": "In 2023, Amazon disclosed a $1.25 billion convertible note investment in Anthropic, PBC, classified as available-for-sale and reported at fair value with unrealized gains and losses included in 'Accumulated other comprehensive income (loss).' The note was categorized as a Level 3 asset, and Amazon had an agreement to invest an additional $2.75 billion in a second convertible note by Q1 2024. By 2024, the investment was still classified as available-for-sale but was noted to be part of a broader portfolio of convertible debt investments in private companies, primarily referencing Anthropic, PBC. The 2024 filing emphasized increased complexity in valuing private company investments due to the lack of readily available market data and global economic uncertainty, indicating a shift toward acknowledging heightened valuation risk. While the classification remained consistent, the 2024 disclosure placed more emphasis on the challenges of valuation rather than the mechanics of the investment itself.",
      "llm_answer": "From 2023 to 2024, Amazon’s accounting treatment of its $1.25 billion convertible note investment in Anthropic, PBC remained classified as an available‑for‑sale security measured at fair value with unrealized gains and losses recorded in “Accumulated other comprehensive income (loss).” The note was initially recorded at cost and later adjusted to fair value; any impairment would have been recognized in “Other income (expense), net.” By 2024 the investment was still held as a Level 3 asset, but the company’s disclosures on market‑risk and equity‑investment risk indicate that its fair‑value measurement is highly uncertain due to the lack of market data for private‑company investments and the impact of broader economic conditions. Consequently, while the classification (available‑for‑sale) did not change, the valuation approach became more dependent on qualitative assessments of impairment and on observable price changes, reflecting heightened risk and uncertainty in Anthropic’s valuation.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AMZN_10k_2023.pdf",
          "target_page": 50,
          "pages": [
            48,
            49,
            50,
            51,
            52
          ]
        },
        "hop_2_rel": {
          "source_file": "AMZN_10k_2024.pdf",
          "target_page": 32,
          "pages": [
            30,
            31,
            32,
            33,
            34
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 37626,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 9641,
        "completion_tokens": 250,
        "total_tokens": 9891
      }
    },
    {
      "question_id": 97,
      "question": "How has the nature of the risks related to the protection of MDLZ's intellectual property, including know-how, evolved between 2023 and 2024?",
      "original_answer": "In 2023, MDLZ emphasized the importance of protecting its intellectual property rights, particularly trademarks, patents, copyrights, and know-how, through a combination of legal mechanisms such as patent and trademark laws, licensing agreements, and third-party nondisclosure agreements. The company expressed concern that failure to protect these rights or any legal changes reducing intellectual property protections—especially in response to developments in artificial intelligence technologies—could significantly harm its competitiveness and financial condition. In 2024, while the company maintained its emphasis on the significance of intellectual property rights, it did not specifically mention artificial intelligence as a factor affecting protection. Instead, the 2024 disclosure focused on the broader risks of legal or regulatory non-compliance and the potential for civil or criminal penalties, reputational damage, and financial loss due to litigation or enforcement actions. This shift indicates a broadening of the risk context without the specific emphasis on AI-related threats present in 2023.",
      "llm_answer": "Between 2023 and 2024, the risks to MDLZ’s intellectual property protection shifted from a general focus on maintaining trademark, patent, copyright and trade‑secret rights through traditional legal mechanisms and third‑party agreements to an added concern about emerging threats such as artificial‑intelligence‑related developments that could undermine those protections. The company now explicitly warns that any failure to obtain or adequately safeguard its IP—especially in light of evolving AI technologies—could diminish its competitiveness and materially harm its business, financial condition and stock price. This evolution reflects a heightened awareness of both legal changes and technological disruptions that could weaken MDLZ’s IP shield.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MDLZ_10k_2023.pdf",
          "target_page": 26,
          "pages": [
            24,
            25,
            26,
            27,
            28
          ]
        },
        "hop_2_rel": {
          "source_file": "MDLZ_10k_2024.pdf",
          "target_page": 26,
          "pages": [
            24,
            25,
            26,
            27,
            28
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 56078,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 14239,
        "completion_tokens": 188,
        "total_tokens": 14427
      }
    },
    {
      "question_id": 98,
      "question": "How has Goldman Sachs' treatment of Non-Employee Director Equity Award Agreements evolved between the 2023 and 2024 SEC filings, particularly in terms of referenced agreements and their timelines?",
      "original_answer": "In 2023, Goldman Sachs referenced Non-Employee Director Equity Award Agreements through Exhibit 10.17, which pointed to an amendment dated November 28, 2008. By 2024, the company continued to disclose these agreements under the same exhibit number (10.18), but the referenced source shifted to Exhibit 10.69 from the 2008 Annual Report, indicating a formalization or consolidation of prior amendments. This evolution shows a continuation of the policy with deeper historical documentation being emphasized in the later filing.",
      "llm_answer": "Based on the provided SEC filing excerpts, Goldman Sachs' treatment of Non-Employee Director Equity Award Agreements shows a clear evolution between the 2023 and 2024 filings. In the 2023 filing (page 10.32), the company referenced \"Form of Non-Employee Director RSU Award Agreement\" and \"Form of Non-Employee Director RSU Award Agreement (Cash-Settled)\" as part of its standard equity compensation documentation. However, in the 2024 filing (page 247), these specific forms are no longer referenced in the exhibit list; instead, the 2024 filing includes updated language about \"Form of One-Time/Year-End RSU Award Agreement\" (pages 244-245) and references amendments to director equity agreements (page 246), indicating a formal revision to the award structure and terms for non-employee directors, moving away from the prior pre-2015 agreement formats.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "GS_10k_2023.pdf",
          "target_page": 6,
          "pages": [
            3,
            4,
            5,
            6,
            7
          ]
        },
        "hop_2_rel": {
          "source_file": "GS_10k_2024.pdf",
          "target_page": 246,
          "pages": [
            243,
            244,
            245,
            246,
            247
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 9,
        "total_chars": 41486,
        "num_window_pages": 9,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 10604,
        "completion_tokens": 213,
        "total_tokens": 10817
      }
    },
    {
      "question_id": 98,
      "question": "How has BKNG's relationship with travel service providers evolved between 2022 and 2023 in terms of revenue recognition and contractual responsibilities?",
      "original_answer": "In 2022, BKNG described its relationship with travel service providers as one where it connects consumers to providers through its platforms, emphasizing its role as an intermediary without taking responsibility for delivering the travel services. The company highlighted that it earns revenues primarily from facilitating reservations and also mentioned the impact of cancellations during the pandemic recovery phase. By 2023, BKNG provided more detailed accounting treatment around its contracts with travel service providers, specifying that it recognizes revenue on a net basis due to its role as an agent, and further clarified its revenue recognition timing as occurring at the point when travelers begin using the arranged services. This reflects a shift from a general description of the relationship to a more structured and accounting-driven dependency on travel service providers, particularly in how it recognizes commissions and transaction revenues.",
      "llm_answer": "Between 2022 and 2023, BKNG's relationship with travel service providers shifted toward greater merchant-based transactions, increasing its contractual responsibilities for payment processing, refunds, and revenue recognition. This evolution resulted in higher merchant-related expenses (e.g., payment processing, chargebacks) that negatively impacted operating margins, while also generating incremental revenues like credit card rebates. Revenue recognition now primarily reflects commissions or margins on transactions where BKNG facilitates payments from travelers, with revenue measured based on expected consideration from contracts with travel providers, including discounts and sales incentives.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "BKNG_10k_2022.pdf",
          "target_page": 48,
          "pages": [
            46,
            47,
            48,
            49,
            50
          ]
        },
        "hop_2_rel": {
          "source_file": "BKNG_10k_2023.pdf",
          "target_page": 83,
          "pages": [
            81,
            82,
            83,
            84,
            85
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 44290,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 11295,
        "completion_tokens": 175,
        "total_tokens": 11471
      }
    },
    {
      "question_id": 99,
      "question": "What specific changes occurred in the structure of Goldman Sachs' executive life insurance policy disclosures between the 2023 and 2024 10-K filings?",
      "original_answer": "In the 2023 10-K filing, Goldman Sachs included the Goldman Sachs & Co. LLC Executive Life Insurance Policy and Certificate with Metropolitan Life Insurance Company (Exhibit 10.11) and a form of the policy with Pacific Life & Annuity Company (Exhibit 10.12). In the 2024 10-K filing, these exhibits were not only retained but renumbered to 10.12 and 10.13 respectively, indicating a reorganization of exhibit numbering. This renumbering and retention of the policies in the 2024 filing demonstrates a structural update in how the policies are presented within the filing, rather than a substantive change in the policies themselves.",
      "llm_answer": "The executive life insurance policy disclosures remained unchanged between the 2023 and 2024 10-K filings, with no new policy language or structural modifications appearing in the 2024 filing. The 2024 filing (page 246) continues to reference the same historical policy documents (pages 10.12 and 10.13) first disclosed in 2006, with no updates or revisions to the policy terms or disclosure format.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "GS_10k_2023.pdf",
          "target_page": 5,
          "pages": [
            3,
            4,
            5,
            6,
            7
          ]
        },
        "hop_2_rel": {
          "source_file": "GS_10k_2024.pdf",
          "target_page": 246,
          "pages": [
            243,
            244,
            245,
            246,
            247
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 9,
        "total_chars": 41486,
        "num_window_pages": 9,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 10592,
        "completion_tokens": 99,
        "total_tokens": 10692
      }
    },
    {
      "question_id": 99,
      "question": "How has the strategic importance and manufacturing approach for FBAR filters evolved between 2022 and 2024, particularly in terms of internal fabrication and competitive positioning?",
      "original_answer": "In 2022, FBAR filters were highlighted as a key product utilizing Broadcom’s proprietary processes, fabricated internally to protect IP and accelerate time to market, alongside vertical-cavity surface emitting lasers and side emitting lasers. The internal fabrication was specifically emphasized as a means to maintain competitive advantage by safeguarding innovation. By 2024, FBAR filters remained part of the internal fabrication strategy, but the context expanded to include a more comprehensive list of competitors in the semiconductor space, such as Qorvo, Qualcomm, and Skyworks, indicating a more intense competitive environment. This suggests that while the internal manufacturing strategy for FBAR filters remained consistent, the competitive pressure in wireless communications increased significantly, requiring Broadcom to reinforce its IP protections and innovation cycle.",
      "llm_answer": "Between 2022 and 2024, Broadcom’s strategic focus on FBAR filters shifted from external reliance to greater internal control and differentiation. In 2022, the company emphasized outsourcing most manufacturing but retained internal fabrication for proprietary processes like FBAR filters to protect IP and accelerate time-to-market. By 2024, this approach was reinforced as part of a broader strategy to leverage internal capabilities for high-value products, ensuring competitive positioning through proprietary technology, system-level expertise, and tailored solutions for key customers, while maintaining a variable, low-cost model through selective outsourcing.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AVGO_10k_2022.pdf",
          "target_page": 15,
          "pages": [
            13,
            14,
            15,
            16,
            17
          ]
        },
        "hop_2_rel": {
          "source_file": "AVGO_10k_2024.pdf",
          "target_page": 13,
          "pages": [
            11,
            12,
            13,
            14,
            15
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 8,
        "total_chars": 45918,
        "num_window_pages": 8,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 11709,
        "completion_tokens": 166,
        "total_tokens": 11875
      }
    },
    {
      "question_id": 99,
      "question": "How has BMY's strategic positioning of Krazati evolved between 2023 and 2024, particularly in terms of clinical development focus and financial valuation?",
      "original_answer": "In 2023, Krazati was positioned as part of BMY’s oncology portfolio with specific clinical trials listed: KRYSTAL-17 for 1L NSCLC TPS<50%, KRYSTAL-10 for 2L CRC, and KRYSTAL-12* for 2L+ Mutated NSCLC. By 2024, BMY had acquired Mirati for $4.8 billion, securing full rights to Krazati, which had already received FDA and EMA approvals for second-line NSCLC and FDA approval for advanced KRAS-mutated colorectal cancer. Additionally, Krazati was now being developed in combination with a PD-1 inhibitor for first-line NSCLC, indicating a significant expansion in its clinical and commercial strategy.",
      "llm_answer": "BMY's strategic positioning of Krazati evolved significantly between 2023 and 2024 through its acquisition of Mirati Therapeutics in January 2024, which granted BMS exclusive rights to commercialize Krazati (a KRAS inhibitor) for second-line NSCLC and other indications, while also advancing its PRMT5 inhibitor in clinical development. Financially, the acquisition was valued at approximately $4.8 billion (including $4.5 billion in cash for shares and $1.0 billion in contingent value rights), with $640 million allocated to definite-lived acquired product rights (including Krazati) and $3.5 billion to indefinite-lived IPRD assets, reflecting a strategic shift toward oncology-focused growth with high-value pipeline assets. This move strengthened BMS's oncology portfolio and contributed to the company's overall financial strategy, though specific valuation impacts are tied to the broader acquisition accounting rather than Krazati's standalone performance.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "BMY_10k_2023.pdf",
          "target_page": 14,
          "pages": [
            12,
            13,
            14,
            15,
            16
          ]
        },
        "hop_2_rel": {
          "source_file": "BMY_10k_2024.pdf",
          "target_page": 93,
          "pages": [
            91,
            92,
            93,
            94,
            95
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 91683,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 23143,
        "completion_tokens": 241,
        "total_tokens": 23384
      }
    },
    {
      "question_id": 100,
      "question": "How has the relationship between BKNG and travel service providers evolved between 2022 and 2023, particularly in terms of how BKNG manages financial obligations and incentives related to these providers?",
      "original_answer": "In 2022, BKNG primarily competed with travel service providers, highlighting the intense and evolving nature of the competitive landscape in the online travel market. By 2023, BKNG's relationship with travel service providers shifted to a more dependent model, as evidenced by the increase in the 'Deferred merchant bookings' liability on its balance sheet, which reflects amounts estimated to be payable to travel service providers. Additionally, BKNG introduced more incentive programs, such as referral bonuses, rebates, and loyalty points, which are recognized as a reduction of revenue, indicating a strategic shift toward enhancing partnerships and incentivizing collaboration with travel service providers rather than solely competing with them.",
      "llm_answer": "Between 2022 and 2023, BKNG’s relationship with travel service providers shifted toward deeper integration and more structured financial arrangements, particularly around incentive programs and deferred merchant bookings. The company increasingly uses incentive-based compensation (e.g., referral bonuses, rebates, loyalty points) as a reduction of revenue at grant time, while also managing financial obligations through deferred revenue from merchant bookings—liabilities held until travel services are delivered. This reflects a more mature, mutually dependent ecosystem where BKNG balances marketing spend, incentive costs, and revenue recognition with provider partners, especially as it expands connected trip offerings and payment solutions.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "BKNG_10k_2022.pdf",
          "target_page": 8,
          "pages": [
            6,
            7,
            8,
            9,
            10
          ]
        },
        "hop_2_rel": {
          "source_file": "BKNG_10k_2023.pdf",
          "target_page": 84,
          "pages": [
            82,
            83,
            84,
            85,
            86
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 50184,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 12780,
        "completion_tokens": 187,
        "total_tokens": 12967
      }
    },
    {
      "question_id": 100,
      "question": "How has Broadcom's involvement in the development of Custom Touch Controllers evolved from 2022 to 2024, particularly in terms of their role in the product lifecycle?",
      "original_answer": "In 2022, Broadcom was described as supplying Custom Touch Controllers as part of its semiconductor solutions for the wireless market. By 2024, the company's role had evolved to include producing these controllers as part of its broader custom silicon solutions, reflecting a deeper engagement in their development. This shift indicates a strategic move from being a component supplier to an active producer involved in the design and creation process.",
      "llm_answer": "From 2022 to 2024, Broadcom’s involvement in custom touch controllers evolved from being highlighted as a key component within its wireless product portfolio—specifically noted for processing signals from touch screens in mobile devices—through 2023 and into 2024, where it remained part of its broader semiconductor offerings for mobile device connectivity. While the 2022 document lists custom touch controllers under wireless applications, later filings continue to reference them within the wireless and mobile device markets, indicating sustained development and integration into mobile platforms. However, there is no explicit mention of a shift in role or lifecycle stage (such as maturity or phase-out) in the provided materials, suggesting that Broadcom maintained its involvement in custom touch controllers as part of its ongoing product portfolio, particularly within wireless and mobile device semiconductor solutions.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AVGO_10k_2022.pdf",
          "target_page": 5,
          "pages": [
            3,
            4,
            5,
            6,
            7
          ]
        },
        "hop_2_rel": {
          "source_file": "AVGO_10k_2024.pdf",
          "target_page": 5,
          "pages": [
            3,
            4,
            5,
            6,
            7
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 9,
        "total_chars": 41795,
        "num_window_pages": 9,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 10672,
        "completion_tokens": 232,
        "total_tokens": 10905
      }
    },
    {
      "question_id": 101,
      "question": "How has Union Pacific's approach to freight cars evolved from 2023 to 2024, particularly in terms of asset acquisition strategy?",
      "original_answer": "In 2023, Union Pacific primarily leased freight cars as part of its operational strategy, reflecting a reliance on leased assets for rail operations. By 2024, the company's strategy shifted toward acquiring freight cars, including lease buyouts of $143 million in 2024 compared to $57 million in 2023, indicating a more aggressive stance on asset ownership to support replacement and growth opportunities.",
      "llm_answer": "Union Pacific's freight car asset acquisition strategy shifted from aggressive purchase commitments in 2023 to a more restrained approach in 2024, as evidenced by reduced purchase obligations ($999 million due in 2025 versus $590 million in 2026) and lower capital investment in freight cars ($788 million in 2024 versus $800 million in 2022), while maintaining focus on modernizing the fleet through lease buyouts and targeted acquisitions rather than large-scale new purchases.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "UNP_10k_2023.pdf",
          "target_page": 68,
          "pages": [
            66,
            67,
            68,
            69,
            70
          ]
        },
        "hop_2_rel": {
          "source_file": "UNP_10k_2024.pdf",
          "target_page": 33,
          "pages": [
            31,
            32,
            33,
            34,
            35
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 45553,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 11604,
        "completion_tokens": 119,
        "total_tokens": 11724
      }
    },
    {
      "question_id": 101,
      "question": "What were the financial and operational impacts of Nike's structural changes in APLA between FY2022 and FY2023, particularly regarding the transition of certain businesses to third-party distributors?",
      "original_answer": "In FY2022, Nike directly operated within APLA as part of its geographic operating segments, which included associated costs and foreign currency impacts such as non-recurring impairment charges due to the anticipated release of non-cash cumulative foreign currency translation losses from transitioning certain businesses to third-party distributors. By FY2023, Nike had shifted its relationship with APLA from direct operations to a strategic stake, where the company now oversees results through third-party distributors. This transition is reflected in the 2023 filing noting that APLA includes results for the NIKE and Jordan brands and referencing Note 18 on divestitures related to the transition. Operationally, this change represents a strategic shift to reduce direct operational overhead in APLA, likely aiming to improve financial efficiency and focus on brand management rather than local execution.",
      "llm_answer": "Nike's structural changes in APLA, specifically the transition of certain NIKE Brand businesses to third-party distributors, resulted in a significant reduction in direct operations and inventory holdings within the region. This shift, highlighted in Note 18 (Divestitures) and referenced in Note 15 (Operating Segments), led to a decrease in Asia Pacific & Latin America revenues from $5,955 million in FY2022 to $6,431 million in FY2023 (though the document shows FY2023 as $6,431M and FY2022 as $5,955M), while also reducing inventory levels in APLA from $894 million (FY2022) to $810 million (FY2023) and decreasing additions to property, plant, and equipment in the region from $56 million (FY2022) to $64 million (FY2023). The move aimed to streamline operations but impacted revenue growth and asset utilization in the APLA segment.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "NKE_10k_2022.pdf",
          "target_page": 90,
          "pages": [
            88,
            89,
            90,
            91,
            92
          ]
        },
        "hop_2_rel": {
          "source_file": "NKE_10k_2023.pdf",
          "target_page": 89,
          "pages": [
            87,
            88,
            89,
            90,
            91
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 51857,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 13198,
        "completion_tokens": 209,
        "total_tokens": 13408
      }
    },
    {
      "question_id": 101,
      "question": "How has Broadcom's involvement with InP lasers evolved from 2022 to 2024, particularly in terms of their internal fabrication strategy and competitive positioning?",
      "original_answer": "In 2022, Broadcom disclosed using internal fabrication facilities for products based on proprietary processes, including vertical-cavity surface emitting lasers and side emitting lasers using GaAs and InP lasers for fiber optic communications. By 2024, Broadcom continued this strategy but began emphasizing the competitive landscape more explicitly, listing companies like Coherent Corp., Lumentum Holdings Inc., and others as competitors in semiconductor solutions. This indicates a strategic shift toward highlighting InP laser capabilities as part of its competitive differentiation in the market.",
      "llm_answer": "From 2022 to 2024, Broadcom’s involvement with InP lasers evolved from a focus on leveraging its internal III-V fabrication capabilities—particularly for high-value components like FBAR filters and InP-based lasers used in optical transceivers—to a more pronounced strategic emphasis on vertical integration and IP protection. By 2024, the company reinforced its internal fabrication strategy for InP lasers, citing it as a key differentiator that enables faster time-to-market, IP safeguarding, and performance leadership in fiber-optic communications, while maintaining reliance on external foundries for commodity CMOS processes. This shift solidified Broadcom’s competitive positioning in high-speed optical modules, where proprietary InP laser design and integration became central to its value proposition against peers like Coherent and Lumentum.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AVGO_10k_2022.pdf",
          "target_page": 15,
          "pages": [
            13,
            14,
            15,
            16,
            17
          ]
        },
        "hop_2_rel": {
          "source_file": "AVGO_10k_2024.pdf",
          "target_page": 13,
          "pages": [
            11,
            12,
            13,
            14,
            15
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 8,
        "total_chars": 45918,
        "num_window_pages": 8,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 11704,
        "completion_tokens": 213,
        "total_tokens": 11918
      }
    },
    {
      "question_id": 102,
      "question": "How has the ownership structure of Swoosh, LLC in relation to NIKE's Class A and Class B Common Stock evolved between 2022 and 2023, and what implications does this have for shareholder influence?",
      "original_answer": "In 2022, Swoosh, LLC beneficially owned approximately 77% of NIKE's Class A Common Stock, which would translate to approximately 16% ownership of Class B Common Stock if all shares were converted. In 2023, the ownership structure remained consistent with Swoosh, LLC still beneficially owning approximately 77% of Class A Common Stock, with a commensurate ownership percentage of approximately 16% in Class B Common Stock if all shares were converted. Despite the consistency in ownership percentages, the continued concentration of ownership in Swoosh, LLC implies sustained influence by Travis Knight, who has a significant role in managing the Class A Common Stock owned by Swoosh, LLC, potentially affecting shareholder decisions and market dynamics.",
      "llm_answer": "Between 2022 and 2023, the ownership structure of Swoosh, LLC relative to NIKE’s Class A and Class B Common Stock remained essentially unchanged: Swoosh, LLC continued to beneficially own roughly 77 % of the Class A shares, which would convert to about 16 % of the Class B shares if fully converted. This concentration means that a single entity controls the vast majority of voting power despite the lower percentage of Class B ownership, limiting the influence of other shareholders in corporate governance matters.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "NKE_10k_2022.pdf",
          "target_page": 25,
          "pages": [
            23,
            24,
            25,
            26,
            27
          ]
        },
        "hop_2_rel": {
          "source_file": "NKE_10k_2023.pdf",
          "target_page": 26,
          "pages": [
            24,
            25,
            26,
            27,
            28
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 51149,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 13020,
        "completion_tokens": 129,
        "total_tokens": 13149
      }
    },
    {
      "question_id": 102,
      "question": "How did PMI's strategic positioning of Reduced-Risk Products evolve from 2022 to 2023, particularly in terms of portfolio integration and market availability?",
      "original_answer": "In 2022, PMI classified Reduced-Risk Products (RRPs) as a distinct category, including heated tobacco units, heat-not-burn devices, e-vapor, and oral nicotine products, with separate net revenue reporting. By 2023, RRPs were integrated into a broader category called Smoke-Free Products (SFPs), which now also included wellness and healthcare offerings. Additionally, PMI reported that its smoke-free products were available in 84 markets by the end of 2023, a notable expansion from the unspecified market availability in 2022. This evolution reflects a strategic shift toward consolidating RRPs under a unified smoke-free vision and expanding their global footprint.",
      "llm_answer": "From 2022 to 2023, PMI integrated its Reduced‑Risk Products (RRPs) more tightly into the core commercial structure: the Swedish Match acquisition (completed in 2022) gave PMI a leading oral‑nicotine portfolio (ZYN) that was folded into the existing geographical segments, and by early 2024 the company planned to report RRP performance within its four main regional segments rather than as a separate category.  Market availability expanded as PMI continued to roll out IQOS and other RRPs in 84 markets, while also investing $30 million in a new production facility in Lviv, Ukraine, to support supply.  This integration and geographic expansion drove the 10.7 % rise in net revenues to $35.2 billion in 2023, with RRPs contributing $9.1 billion of net revenue.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "PM_10k_2022.pdf",
          "target_page": 97,
          "pages": [
            95,
            96,
            97,
            98,
            99
          ]
        },
        "hop_2_rel": {
          "source_file": "PM_10k_2023.pdf",
          "target_page": 28,
          "pages": [
            26,
            27,
            28,
            29,
            30
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 42650,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 10885,
        "completion_tokens": 190,
        "total_tokens": 11076
      }
    },
    {
      "question_id": 103,
      "question": "How has Caterpillar's strategic role in the reciprocating engines business evolved from 2022 to 2024, and what impact has this had on its revenue composition and gross margin potential?",
      "original_answer": "In 2022, Caterpillar primarily sold reciprocating engines through its global dealer network and through subsidiary Perkins Engines Company Limited, which operated 90 distributors across 171 countries. By 2024, Caterpillar expanded its involvement by including the remanufacturing of Caterpillar reciprocating engines and components, as well as offering remanufacturing services for other companies. This evolution from a seller to a full lifecycle service provider likely improved gross margin potential, as remanufacturing typically involves lower material costs compared to new engine production and leverages existing asset value. The shift also diversified revenue composition by incorporating service-based income streams alongside traditional product sales.",
      "llm_answer": "From 2022 to 2024, Caterpillar’s strategic role in the reciprocating engines business shifted from a primary engine supplier to a broader power‑generation and engine‑system integrator.  In 2022 the company highlighted its engine portfolio and dealer network as the main channel for reciprocating engines, but by 2024 it was emphasizing “Power Generation” and “Industrial” applications, noting that sales of large reciprocating engines for data‑center and gas‑compression uses had grown sharply while industrial engine sales declined.  This repositioning has expanded the revenue base of the Energy & Transportation segment—total sales rose 3 % to $28.85 bn in 2024, with profit margin improving from 17.6 % to 19.9 %—and has lifted the contribution of engine‑related sales to overall gross margin, as higher‑margin power‑generation products now represent a larger share of the mix.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CAT_10k_2022.pdf",
          "target_page": 9,
          "pages": [
            7,
            8,
            9,
            10,
            11
          ]
        },
        "hop_2_rel": {
          "source_file": "CAT_10k_2024.pdf",
          "target_page": 39,
          "pages": [
            37,
            38,
            39,
            40,
            41
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 9,
        "total_chars": 44157,
        "num_window_pages": 9,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 11268,
        "completion_tokens": 220,
        "total_tokens": 11489
      }
    },
    {
      "question_id": 103,
      "question": "How did BNY Mellon's approach to disclosing amendments to the Directors' Code of Conduct evolve between 2022 and 2023, particularly in terms of the mechanisms and transparency commitments outlined for informing stakeholders of changes?",
      "original_answer": "BNY Mellon's approach to disclosing amendments to the Directors' Code of Conduct remained consistent between 2022 and 2023, with the company reaffirming its commitment to post any amendments or waivers on its website in both years. There was no change in the specific mechanism or transparency commitment described across the two years, indicating a stable governance communication strategy.",
      "llm_answer": "Based on the provided SEC 10-K filings, BNY Mellon's approach to disclosing amendments to the Directors' Code of Conduct evolved in terms of transparency and mechanisms between 2022 and 2023. In the 2022 filing (page 11), the company stated its intent to disclose amendments to the Code of Conduct for executive officers and the Directors' Code of Conduct on its website, but did not specify a formal mechanism for stakeholder notification. By the 2023 filing (page 11), the language remained consistent regarding disclosure on the website, but the context shifted to include updated governance details under \"ITEM 10. DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE,\" with no explicit new commitment beyond the prior year's approach. Notably, the 2023 filing (page 12) referenced a specific amendment to the Executive Severance Plan (effective March 1, 2024) as part of governance updates, but this pertained to severance terms rather than the Directors' Code of Conduct itself. Crucially, neither filing detailed a new mechanism for informing stakeholders of changes to the Directors' Code of Conduct beyond the general website disclosure commitment, indicating no significant evolution in transparency practices between the years. The core commitment to website disclosure remained unchanged, with no additional transparency measures (e.g., dedicated governance reports or stakeholder notifications) introduced in 2023.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "BK_10k_2022.pdf",
          "target_page": 11,
          "pages": [
            9,
            10,
            11,
            12,
            13
          ]
        },
        "hop_2_rel": {
          "source_file": "BK_10k_2023.pdf",
          "target_page": 13,
          "pages": [
            11,
            12,
            13,
            14,
            15
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 36568,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 9384,
        "completion_tokens": 357,
        "total_tokens": 9741
      }
    },
    {
      "question_id": 103,
      "question": "How has Nike's strategic approach to the APLA market evolved between FY22 and FY23, particularly in terms of operational structure and market participation?",
      "original_answer": "In FY22, Nike operated directly in APLA, maintaining a significant presence through its NIKE Direct operations and wholesale distribution, with APLA contributing to the 14% growth in the NIKE Direct business. By FY23, Nike began transitioning certain businesses within APLA to third-party distributors, signaling a strategic shift away from direct market participation in some parts of the region. This change indicates a move toward a more distributed, partner-driven model in APLA, altering the way Nike engages with that market.",
      "llm_answer": "Between FY22 and FY23, Nike shifted from a wholesale‑centric operating model in APLA to a distributor‑driven model, reducing its direct sales presence in the region. This strategic change is reflected in the FY23 filing where APLA revenues are now reported under “Asia Pacific & Latin America” and show growth driven by distributor partnerships rather than NIKE‑owned channels, while corporate overhead and restructuring costs were adjusted to support the new model. Consequently, Nike’s operational structure in APLA moved toward greater reliance on third‑party distributors, altering its market participation and reducing direct revenue exposure in that geography.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "NKE_10k_2022.pdf",
          "target_page": 31,
          "pages": [
            29,
            30,
            31,
            32,
            33
          ]
        },
        "hop_2_rel": {
          "source_file": "NKE_10k_2023.pdf",
          "target_page": 89,
          "pages": [
            87,
            88,
            89,
            90,
            91
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 9,
        "total_chars": 44697,
        "num_window_pages": 9,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 11397,
        "completion_tokens": 166,
        "total_tokens": 11563
      }
    },
    {
      "question_id": 104,
      "question": "How has the impact of Favorable Price Realization on Caterpillar's sales and profitability evolved from 2022 to 2024?",
      "original_answer": "In 2022, favorable price realization contributed to a $9.223 billion increase in total sales and revenues, driven by higher end-user demand and changes in dealer inventories. By 2024, favorable price realization continued to play a key role, partially offsetting a $2.251 billion decrease in sales volume and contributing to an increase in profit from $10.335 billion in 2023 to $10.792 billion in 2024. This indicates that while Caterpillar faced declining sales volume in 2024, the company leveraged pricing strategies more effectively to maintain profitability.",
      "llm_answer": "From 2022 to 2024, the impact of favorable price realization on Caterpillar’s sales and profitability evolved significantly. In 2021, favorable price realization contributed to a 22% increase in consolidated sales and revenues to $50.971 billion, driven by higher end-user demand and dealer inventory adjustments, while operating profit rose 51% to $6.878 billion, supported by higher sales volume and favorable price realization offsetting unfavorable manufacturing costs. By 2024, sales and revenues declined 3% to $64.809 billion due to lower sales volume, but operating profit margin expanded to 20.2% (from 19.3% in 2023), with adjusted profit per share reaching $21.90, indicating that favorable price realization partially offset volume declines and contributed to improved profitability despite reduced revenue. The document notes that in 2025, the company expects favorable price realization in Energy & Transportation to offset lower volume impacts in Construction and Resource Industries.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CAT_10k_2022.pdf",
          "target_page": 34,
          "pages": [
            32,
            33,
            34,
            35,
            36
          ]
        },
        "hop_2_rel": {
          "source_file": "CAT_10k_2024.pdf",
          "target_page": 30,
          "pages": [
            28,
            29,
            30,
            31,
            32
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 8,
        "total_chars": 74051,
        "num_window_pages": 8,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 18726,
        "completion_tokens": 249,
        "total_tokens": 18975
      }
    },
    {
      "question_id": 104,
      "question": "How has General Motors' approach to EV manufacturing capacity evolved between 2023 and 2024, particularly in terms of strategic focus and supply chain development?",
      "original_answer": "In 2023, General Motors emphasized significant investments in EV manufacturing capacity based on expectations for future EV demand, acknowledging the risks and uncertainties associated with such investments, including high fixed costs and limitations on closing facilities. By 2024, GM's strategy had evolved to include a stronger emphasis on developing a resilient, scalable, and sustainable North American-focused EV supply chain. This included advancing strategic sourcing initiatives to secure supply through investments in raw materials suppliers and the execution of multi-year supply agreements. The shift indicates a more structured and regionally focused approach to EV manufacturing, aiming to mitigate supply chain risks and ensure long-term scalability.",
      "llm_answer": "Between 2023 and 2024 GM’s EV manufacturing strategy shifted from a broad, capital‑intensive rollout toward a more focused, financially disciplined approach.  In the 2023 filing the company emphasized scaling EV production, building a North‑American‑centric battery supply chain and monetising its EV platforms, while warning that high fixed costs and uncertain demand could force inventory losses.  By the 2024 filing the narrative tightens around “profitable delivery of a strategic EV portfolio,” stressing that near‑term earnings still rely on high‑margin ICE trucks and SUVs to fund EV development, and highlighting tighter cost controls, targeted raw‑material sourcing agreements, and a refocused autonomous‑driving effort that reduces capital outlays.  This evolution reflects a strategic pivot to preserve cash, mitigate risk, and align EV capacity growth with realistic demand and supply‑chain constraints.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "GM_10k_2023.pdf",
          "target_page": 18,
          "pages": [
            16,
            17,
            18,
            19,
            20
          ]
        },
        "hop_2_rel": {
          "source_file": "GM_10k_2024.pdf",
          "target_page": 16,
          "pages": [
            14,
            15,
            16,
            17,
            18
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 62280,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 15794,
        "completion_tokens": 228,
        "total_tokens": 16023
      }
    },
    {
      "question_id": 104,
      "question": "How has Pfizer's financial commitment to Paxlovid evolved from 2022 to 2024, based on remaining performance obligations disclosed in the 10-K filings?",
      "original_answer": "In 2022, Pfizer's 10-K filing did not disclose specific remaining performance obligations related to Paxlovid. However, by 2024, Pfizer reported that remaining performance obligations for Paxlovid totaled approximately $1 billion as of December 31, 2024, indicating a significant ongoing financial commitment tied to future delivery of the product. This shows a clear evolution from an undefined obligation in 2022 to a quantified $1 billion commitment in 2024.",
      "llm_answer": "Pfizer's financial commitment to Paxlovid has significantly declined from 2022 to 2024, as evidenced by the remaining performance obligations disclosed in the 10-K filings. In 2022, Paxlovid generated $18.9 billion in revenue, but by 2024, its revenue had dropped to $5.7 billion, with only $1 billion in contracted revenue expected to be recognized from remaining performance obligations through 2028. This reflects the transition from government procurement to commercial markets and the diminishing demand for Paxlovid as the pandemic recedes.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "PFE_10k_2022.pdf",
          "target_page": 8,
          "pages": [
            6,
            7,
            8,
            9,
            10
          ]
        },
        "hop_2_rel": {
          "source_file": "PFE_10k_2024.pdf",
          "target_page": 109,
          "pages": [
            107,
            108,
            109,
            110,
            111
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 9,
        "total_chars": 79175,
        "num_window_pages": 9,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 20015,
        "completion_tokens": 136,
        "total_tokens": 20152
      }
    },
    {
      "question_id": 105,
      "question": "How has Caterpillar's approach to monitoring supplier financial viability evolved between 2022 and 2023, particularly in terms of risk mitigation strategies and contractual agreements?",
      "original_answer": "In 2022, Caterpillar indicated that it uses 'a variety of agreements with suppliers to protect our intellectual property and processes to monitor and mitigate risks of the supply base causing a business disruption,' including monitoring supplier financial viability. By 2023, Caterpillar maintained the same monitoring approach but placed a more explicit emphasis on 'supplier financial viability' as a key risk factor, listing it as the first risk under its supply chain disclosures. Additionally, in 2023, Caterpillar reinforced its global strategic sourcing models to build long-term supplier relationships and leverage enterprise spend, suggesting a potentially more structured or prioritized focus on supplier financial health compared to 2022.",
      "llm_answer": "Caterpillar's approach to monitoring supplier financial viability has remained consistent between 2022 and 2023, with no significant evolution in risk mitigation strategies or contractual agreements. The company continues to require suppliers to maintain industry-leading quality and delivery capabilities, monitor supplier financial viability as part of its risk management, and use agreements to protect intellectual property and mitigate supply chain disruptions. However, the core contractual framework for supplier relationships—particularly the standard sales and service agreements governing dealer interactions—has not changed materially, remaining terminable at will with 90 days' notice and requiring dealers to maintain detailed financial records available for review. (Based on consistent references to supplier risk monitoring in raw materials sections across both years and unchanged dealer agreement terms in pages 7, 8, 9, 10, 11 of both 2022 and 2023 filings.)",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CAT_10k_2022.pdf",
          "target_page": 9,
          "pages": [
            7,
            8,
            9,
            10,
            11
          ]
        },
        "hop_2_rel": {
          "source_file": "CAT_10k_2023.pdf",
          "target_page": 9,
          "pages": [
            7,
            8,
            9,
            10,
            11
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 9,
        "total_chars": 43735,
        "num_window_pages": 9,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 11162,
        "completion_tokens": 244,
        "total_tokens": 11406
      }
    },
    {
      "question_id": 105,
      "question": "How has Visa's approach to Risk and Identity Solutions evolved between 2022 and 2024, particularly in terms of its strategic positioning and integration within its value-added services?",
      "original_answer": "In 2022, Visa positioned Risk and Identity Solutions as part of a broader set of value-added services aimed at supporting clients, but without detailed elaboration on specific capabilities or strategic direction. By 2024, Risk and Identity Solutions were embedded within a more structured value-added services framework, with a clear three-pillar strategy: (1) services for Visa transactions, (2) network-agnostic services for non-Visa transactions, and (3) services beyond payments. This evolution reflects a more strategic and comprehensive integration of Risk and Identity Solutions into Visa's broader service portfolio, with an emphasis on scalability and business outcomes.",
      "llm_answer": "Visa has strategically expanded its Risk and Identity Solutions within Value-Added Services by integrating AI-driven fraud prevention tools like Visa Protect Authentication Intelligence, Visa Deep Authorization, and Visa Risk Manager into its Visa Protect suite, while simultaneously enhancing its identity verification capabilities through open banking initiatives and acquisitions such as Pismo. This evolution reflects a deliberate shift toward embedding advanced, network-agnostic security and authentication solutions across both card-based and emerging payment flows (e.g., A2A, P2P), positioning these services as critical differentiators within its broader \"network of networks\" strategy to capture new transaction opportunities in B2B, cross-border, and real-time payments ecosystems.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "V_10k_2022.pdf",
          "target_page": 5,
          "pages": [
            3,
            4,
            5,
            6,
            7
          ]
        },
        "hop_2_rel": {
          "source_file": "V_10k_2024.pdf",
          "target_page": 11,
          "pages": [
            9,
            10,
            11,
            12,
            13
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 9,
        "total_chars": 35289,
        "num_window_pages": 9,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 9050,
        "completion_tokens": 198,
        "total_tokens": 9248
      }
    },
    {
      "question_id": 105,
      "question": "How has the company's exposure to shelf space limitations as a risk factor evolved between 2022 and 2023, particularly in relation to changes in retail customer policies and the expansion of alternative retail channels?",
      "original_answer": "In 2022, the company noted that it had been and could continue to be negatively affected by changes in retail customer policies such as limitations on access to shelf space and delisting of products. By 2023, the company was actively impacted by these limitations and described them as part of a broader set of evolving retail dynamics, including the growth of eCommerce and alternative retail channels such as subscription services and direct-to-consumer businesses. This evolution indicates a shift from potential risk to an actively experienced challenge, with the company planning to invest more in digital and analytics capabilities to adapt.",
      "llm_answer": "The company's exposure to shelf space limitations has not been explicitly detailed as a separate risk factor in the 2023 filing, but the 2022 filing (page 12) notes that “changes in the policies or practices of our retail trade customers, such as inventory de‑stocking, fulfillment requirements, limitations on access to shelf space, delisting of our products, or environmental, sustainability, supply chain and packaging standards or initiatives” can adversely affect the business. The 2023 outlook (page 31) reiterates that “the retail landscape … continues to evolve … as a result of the continued growth of eCommerce, changing consumer preferences … and the increased presence of alternative retail channels, such as subscription services and direct‑to‑consumer businesses,” which further underscores that shelf‑space constraints and related retail‑customer policy shifts remain an ongoing risk. Consequently, while the 2023 filing does not quantify a change in exposure, it confirms that the risk associated with limited shelf space and evolving retail policies persists and is still being managed through investments in data, digital, and alternative channels.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CL_10k_2022.pdf",
          "target_page": 11,
          "pages": [
            9,
            10,
            11,
            12,
            13
          ]
        },
        "hop_2_rel": {
          "source_file": "CL_10k_2023.pdf",
          "target_page": 31,
          "pages": [
            29,
            30,
            31,
            32,
            33
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 9,
        "total_chars": 35829,
        "num_window_pages": 9,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 9195,
        "completion_tokens": 291,
        "total_tokens": 9486
      }
    },
    {
      "question_id": 105,
      "question": "How has Oracle's approach to hybrid deployments evolved between fiscal years 2023 and 2024, particularly in terms of product offerings and strategic emphasis?",
      "original_answer": "In fiscal 2023, Oracle emphasized hybrid deployments as part of its broader deployment models, including on-premise, cloud-based, and hybrid options such as Oracle Exadata Cloud@Customer and Dedicated Region offerings. The company highlighted its commitment to providing customers with choice and flexibility in how they deploy Oracle technologies. By fiscal 2024, Oracle continued to support hybrid deployments but introduced more specific product integrations and services tailored for hybrid environments, indicating a strategic shift toward deeper integration and support for customer-managed cloud and on-premise IT environments. This evolution reflects Oracle's ongoing investment in making hybrid deployments more interoperable and extensible with other IT and cloud environments.",
      "llm_answer": "Oracle's hybrid deployment strategy has evolved to emphasize greater integration and flexibility across on-premise, cloud, and hybrid environments, particularly through expanded offerings like Oracle Cloud@Customer and dedicated region instances that enable seamless workload migration and interoperability. The company has increasingly positioned its cloud services (including SaaS and OCI) as a core component of its strategy, with cloud services revenue growing from 25% to 37% of total revenue between fiscal 2022 and 2024, reflecting a strategic shift toward cloud-first deployment models while maintaining support for hybrid and on-premise solutions through complementary license, hardware, and services offerings. This evolution is underscored by investments in cloud infrastructure, expanded SaaS portfolio (e.g., Fusion Cloud applications), and initiatives to facilitate customer migration to Oracle Cloud, as highlighted in the 2024 10-K's discussion of deployment models and revenue trends.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "ORCL_10k_2023.pdf",
          "target_page": 6,
          "pages": [
            4,
            5,
            6,
            7,
            8
          ]
        },
        "hop_2_rel": {
          "source_file": "ORCL_10k_2024.pdf",
          "target_page": 72,
          "pages": [
            70,
            71,
            72,
            73,
            74
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 9,
        "total_chars": 47034,
        "num_window_pages": 9,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 11981,
        "completion_tokens": 250,
        "total_tokens": 12231
      }
    },
    {
      "question_id": 105,
      "question": "How has Pfizer's financial commitment to Paxlovid evolved between 2022 and 2024, based on remaining performance obligations and contracted revenue expectations?",
      "original_answer": "In 2022, Pfizer indicated that Paxlovid had the potential to provide ongoing revenue streams, though it acknowledged that post-pandemic revenues might not match the levels seen during the pandemic. By 2024, Pfizer reported that remaining performance obligations for Paxlovid totaled approximately $1 billion as of December 31, 2024, with contracted revenue expected to be recognized from 2025 through 2028. This reflects a continued but reduced financial commitment compared to the pandemic period, as the company anticipates delivery and revenue recognition over a multi-year horizon rather than immediate high-volume sales.",
      "llm_answer": "Based on the provided 10-K excerpts, Pfizer's financial commitment to Paxlovid has significantly evolved between 2022 and 2024. In 2022, Paxlovid generated $18.9 billion in revenue (as noted in the 2022 Form 10-K), but by 2024, its revenue declined sharply to $5.7 billion, reflecting the transition from government procurement to commercial markets and the impact of U.S. government inventory returns. The company now expects only $1 billion in contracted revenue from remaining Paxlovid performance obligations as of December 31, 2024, with $4 billion expected from Comirnaty, indicating a strategic shift away from pandemic-driven revenue toward long-term commercial sustainability.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "PFE_10k_2022.pdf",
          "target_page": 23,
          "pages": [
            21,
            22,
            23,
            24,
            25
          ]
        },
        "hop_2_rel": {
          "source_file": "PFE_10k_2024.pdf",
          "target_page": 109,
          "pages": [
            107,
            108,
            109,
            110,
            111
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 82254,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 20788,
        "completion_tokens": 171,
        "total_tokens": 20960
      }
    },
    {
      "question_id": 106,
      "question": "How has Caterpillar's relationship with its independent dealers evolved between 2022 and 2023, particularly in terms of contractual obligations and strategic emphasis?",
      "original_answer": "In 2022, Caterpillar described its relationship with independent dealers in general terms as part of its global sales and marketing strategy. By 2023, the company formalized and detailed these relationships through standardized sales and service agreements, granting dealers the right to purchase, sell, and service Caterpillar products within specified territories. In exchange, dealers were obligated to develop and promote Caterpillar products, maintain adequate sales and support personnel, and keep detailed financial records accessible to Caterpillar. This represents a shift from a general partnership model to a more structured contractual framework, indicating a strategic emphasis on formalizing dealer relationships to enhance control and accountability.",
      "llm_answer": "Caterpillar’s relationship with its independent dealers remained unchanged in structure—dealers continue to operate under standard sales and service agreements that grant them rights to purchase, sell and service Caterpillar products within defined territories, while obligating them to promote the brand, maintain adequate staffing, and provide detailed financial records. However, the strategic emphasis shifted: in 2023 the company highlighted tighter integration of dealer‑financed financing programs (via Cat Financial) and reinforced dealer support for warranty, technical assistance, and intellectual‑property protection, while still allowing termination on 90‑day notice. The 2023 disclosures also underscored the company’s focus on dealer‑driven market expansion and the use of dealer networks for financing and insurance services, reflecting a continued but more strategically coordinated partnership.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CAT_10k_2022.pdf",
          "target_page": 4,
          "pages": [
            2,
            3,
            4,
            5,
            6
          ]
        },
        "hop_2_rel": {
          "source_file": "CAT_10k_2023.pdf",
          "target_page": 10,
          "pages": [
            8,
            9,
            10,
            11,
            12
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 43200,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 11024,
        "completion_tokens": 227,
        "total_tokens": 11251
      }
    },
    {
      "question_id": 106,
      "question": "How did the company's financial allocation or operational focus related to Africa/Eurasia evolve from 2022 to 2023, based on capital expenditures and restructuring charges?",
      "original_answer": "In 2022, the company reported capital expenditures for Africa/Eurasia at $33 million, showing a steady increase from $13 million in 2021 and $8 million in 2020. However, in 2023, the company indicated that approximately 10% of the cumulative pretax charges from the 2022 Global Productivity Initiative would relate to initiatives undertaken in Africa/Eurasia, signaling a shift in focus toward restructuring and cost optimization in the region rather than continued capital investment. This reflects a strategic evolution from growth-oriented capital allocation to operational restructuring within Africa/Eurasia.",
      "llm_answer": "From 2022 to 2023, the company’s operational focus in Africa/Eurasia shifted toward higher capital investment and restructuring activity. Africa/Eurasia’s share of the 2022 Global Productivity Initiative charges dropped from 11% in 2022 to 5% in 2023, reflecting reduced restructuring spending in the region, while capital expenditures in Africa/Eurasia rose modestly from $13 million in 2022 to $33 million in 2023. This indicates a strategic reallocation of resources away from broad productivity initiatives toward targeted growth and efficiency projects in other segments.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CL_10k_2022.pdf",
          "target_page": 117,
          "pages": [
            115,
            116,
            117,
            118,
            119
          ]
        },
        "hop_2_rel": {
          "source_file": "CL_10k_2023.pdf",
          "target_page": 47,
          "pages": [
            45,
            46,
            47,
            48,
            49
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 26631,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 6885,
        "completion_tokens": 144,
        "total_tokens": 7029
      }
    },
    {
      "question_id": 106,
      "question": "How has Qualcomm's strategic focus on 5G technologies evolved from 2022 to 2024, particularly in terms of investment emphasis and commercialization outcomes?",
      "original_answer": "In 2022, Qualcomm was heavily investing in 5G technologies as part of its broader strategy to expand beyond mobile handsets into areas like automotive and IoT, with an emphasis on developing leading and cost-effective 5G-based technologies and products. The company acknowledged significant risks around the success of these investments due to potential regulatory hurdles, competition, and the long design-in cycles typical of new industries like automotive. By 2024, Qualcomm had transitioned from a primarily investment phase to a more mature stage where it had developed a leading patent portfolio in 5G NR and was actively licensing these technologies. The company reported generating the majority of its QTL revenues from OFDMA-based products, including multimode 3G/4G/5G devices such as smartphones, indicating a successful commercialization phase. This shift shows that Qualcomm moved from strategic investment and development in 5G across multiple industries to a position of market leadership and monetization in 5G technologies.",
      "llm_answer": "From 2022 to 2024, Qualcomm’s strategic focus on 5G evolved from a period of risk mitigation and supply chain resilience (highlighted by 2022 concerns over strategic investment failures, supply disruptions, and customer vertical integration threats) to a more mature commercialization phase by 2024, marked by expanded RFFE and modem-RF integrations (e.g., Snapdragon 5G modem-RF platforms), broader adoption in automotive/IoT beyond handsets, and sustained investment in 5G Advanced/6G research. While 2022 emphasized safeguarding against investment losses and supply vulnerabilities, 2024 reflects successful scaling of 5G technologies into new markets—evidenced by QCT’s diversification into automotive and IoT, long-term supplier partnerships (despite ongoing geopolitical risks), and continued leadership in 5G patent licensing (with 200+ 5G license agreements), though challenges like customer vertical integration (e.g., Apple, Samsung) and China-related tensions persist. Investment emphasis shifted from defensive risk management to strategic growth in adjacent sectors, with commercialization outcomes showing increased revenue from non-handset applications, albeit amid intense competition and supply chain constraints.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "QCOM_10k_2022.pdf",
          "target_page": 21,
          "pages": [
            19,
            20,
            21,
            22,
            23
          ]
        },
        "hop_2_rel": {
          "source_file": "QCOM_10k_2024.pdf",
          "target_page": 13,
          "pages": [
            11,
            12,
            13,
            14,
            15
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 64478,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 16343,
        "completion_tokens": 307,
        "total_tokens": 16650
      }
    },
    {
      "question_id": 106,
      "question": "How has Pfizer's financial and strategic positioning of Paxlovid evolved between 2022 and 2024, particularly in terms of revenue contribution and contractual commitments?",
      "original_answer": "In 2022, Paxlovid generated $76 million in revenue, marking its initial contribution as a newly launched product targeting high-risk COVID-19 patients. By 2024, while direct revenue figures for Paxlovid are not explicitly stated, Pfizer disclosed approximately $1 billion in remaining performance obligations tied to future Paxlovid deliveries under existing contracts. This indicates a strategic shift from initial market entry to securing longer-term contractual commitments, despite potential market or regulatory challenges reflected in the context of government returns and adjustments in 2024.",
      "llm_answer": "Between 2022 and 2024, Paxlovid’s revenue contribution declined sharply as the U.S. government’s procurement transitioned to commercial markets. In 2022, Paxlovid generated $18.9 billion in revenue, accounting for a large share of total sales, but by 2023 this fell to $1.279 billion, and in 2024 it was $5.716 billion, reflecting the shift to commercial pricing and the impact of revenue reversals tied to government inventory returns. Contractual commitments included advance purchases under EUAs that were later reversed—$3.5 billion was reversed in Q4 2023, with a $771 million favorable adjustment in Q1 2024 for returned courses—while new agreements now provide for future deliveries through 2028, with remaining performance obligations totaling roughly $1 billion as of December 31, 2024.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "PFE_10k_2022.pdf",
          "target_page": 113,
          "pages": [
            111,
            112,
            113,
            114,
            115
          ]
        },
        "hop_2_rel": {
          "source_file": "PFE_10k_2024.pdf",
          "target_page": 109,
          "pages": [
            107,
            108,
            109,
            110,
            111
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 90758,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 22918,
        "completion_tokens": 198,
        "total_tokens": 23117
      }
    },
    {
      "question_id": 107,
      "question": "How has the company's exposure to credit market tightness as a supply chain risk evolved between 2022 and 2023, and what does this indicate about its changing vulnerability to external financial conditions?",
      "original_answer": "In 2022, tighter credit or capital markets were described as a risk that 'negatively impacts' suppliers, with a direct concern that this could disrupt the supply of raw and packaging materials. By 2023, the framing shifted to indicate that the company's operations are 'impacted by' these conditions, suggesting a broader recognition of ongoing vulnerability. This evolution reflects a continuation of concern over credit market conditions but with a more integrated perspective on how such financial constraints affect not just suppliers, but the company's overall supply chain resilience.",
      "llm_answer": "Between 2022 and 2023, the company’s exposure to credit market tightness as a supply chain risk shifted from a general mention of “the impact on our suppliers of tighter credit or capital markets” in the 2022 filing to a more explicit warning that “tighter credit or capital markets” could directly disrupt supply‑chain operations and that such disruptions could “adversely affect our business, results of operations, cash flows and financial condition” if not remedied. This evolution indicates that the firm’s vulnerability to external financial conditions has increased: it now anticipates that restricted credit and tighter capital markets could impair its ability to secure raw and packaging materials, maintain supplier relationships, and sustain production, making the business more sensitive to macro‑financial stress.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CL_10k_2022.pdf",
          "target_page": 16,
          "pages": [
            14,
            15,
            16,
            17,
            18
          ]
        },
        "hop_2_rel": {
          "source_file": "CL_10k_2023.pdf",
          "target_page": 15,
          "pages": [
            13,
            14,
            15,
            16,
            17
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 42500,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 10860,
        "completion_tokens": 206,
        "total_tokens": 11066
      }
    },
    {
      "question_id": 107,
      "question": "How has Pfizer's financial commitment and contractual obligations related to Paxlovid evolved from 2022 to 2024, based on disclosed figures and agreements?",
      "original_answer": "In 2022, Paxlovid was under Emergency Use Authorization (EUA) in the U.S. and had received conditional marketing authorization (CMA) in the EU and full approval in Japan, indicating early-stage regulatory and commercial momentum. By 2024, Pfizer disclosed that remaining performance obligations for Paxlovid totaled approximately $1 billion as of December 31, 2024, reflecting firm orders from long-term contracts with customers. This shows a significant financial commitment to Paxlovid, with delivery expected from 2025 through 2028, subject to renegotiation. Additionally, 2024 included a $771 million favorable final adjustment related to a prior revenue reversal tied to Paxlovid EUA-labeled treatment courses returned by the U.S. government, indicating ongoing financial adjustments and evolving contractual dynamics.",
      "llm_answer": "From 2022 to 2024 Pfizer’s contractual and financial commitments tied to Paxlovid shifted dramatically. In 2022, Paxlovid generated $18.9 billion of revenue and was supplied under multiple government purchase agreements, with deferred revenue balances of about $5.1 billion. By 2023, revenues fell to $1.28 billion as U.S. government contracts wound down and a $3.5 billion non‑cash revenue reversal was recorded; remaining performance obligations were roughly $1 billion. In 2024, Paxlovid revenue rebounded modestly to $5.7 billion, driven by commercial sales and a $771 million favorable adjustment to prior returns, while remaining performance obligations are now projected at about $1 billion to be recognized through 2028. Thus, Pfizer’s fiscal exposure to Paxlovid contracted sharply after 2022, transitioning from large government‑backed supply commitments to a smaller, commercially‑focused revenue stream with limited future contractual obligations.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "PFE_10k_2022.pdf",
          "target_page": 47,
          "pages": [
            45,
            46,
            47,
            48,
            49
          ]
        },
        "hop_2_rel": {
          "source_file": "PFE_10k_2024.pdf",
          "target_page": 109,
          "pages": [
            107,
            108,
            109,
            110,
            111
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 78243,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 19784,
        "completion_tokens": 239,
        "total_tokens": 20024
      }
    },
    {
      "question_id": 108,
      "question": "How has the financial liability and risk exposure related to Aearo Technologies' respirator mask/asbestos litigation evolved from 2023 to 2024?",
      "original_answer": "In 2023, MMM had an accrual of $574 million for respirator mask/asbestos liabilities excluding Aearo, and Aearo was in bankruptcy proceedings, which resulted in a stay of litigation. By 2024, MMM, through Aearo, had accruals of $51 million specifically for Aearo-related asbestos, silica-related, and coal mine dust claims. Additionally, Aearo’s liability was limited by its agreement with Cabot, where Cabot assumed responsibility for claims involving exposure prior to January 1, 1997, as long as Aearo continued to pay a quarterly fee of $100,000. This represents a shift from a broader liability exposure under bankruptcy protection in 2023 to a more defined and limited liability framework in 2024, with Aearo actively managing its share of liability through contractual arrangements and cost-sharing with other co-defendants.",
      "llm_answer": "From 2023 to 2024 the estimated financial liability for Aearo‑related respirator‑mask/asbestos claims fell from **$62 million (accrued as of Dec 31 2023)** to **$51 million (accrued as of Dec 31 2024)**, reflecting a $11 million reduction in the accrual.  The company notes that the liability is shared among Aearo, Cabot, American Optical and a Warner‑Lambert subsidiary (the “Payor Group”), and that the amount can change if future claim volume, cost trends, settlement outcomes, or interpretations of the indemnity agreements shift.  Consequently, while the accrued liability decreased, the company cannot precisely predict how much the ultimate liability may exceed the recorded amount.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MMM_10k_2023.pdf",
          "target_page": 82,
          "pages": [
            80,
            81,
            82,
            83,
            84
          ]
        },
        "hop_2_rel": {
          "source_file": "MMM_10k_2024.pdf",
          "target_page": 87,
          "pages": [
            85,
            86,
            87,
            88,
            89
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 61725,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 15651,
        "completion_tokens": 172,
        "total_tokens": 15823
      }
    },
    {
      "question_id": 108,
      "question": "How did the retail share of Skoal, a product of MO, change between 2023 and 2024, and how does this compare to its shipment volume trend between 2020 and 2021?",
      "original_answer": "The retail share of Skoal decreased from 9.3% in 2023 to 7.6% in 2024, indicating a decline in market presence. In contrast, Skoal's shipment volume was also declining between 2020 and 2021, dropping from 208.5 million packs/cans in 2020 to 197.4 million packs/cans in 2021. Both metrics show a consistent downward trend, suggesting a potential long-term challenge for the product's performance in the market.",
      "llm_answer": "The retail share of Skoal declined from 7.6% in 2023 to 7.6% → 7.6%? Actually 2024 share is 7.6% (down from 9.3% in 2023), a drop of about 1.7 percentage points. This share decline occurred alongside a modest decrease in shipment volume (down ~1% in 2024 vs. 2023), whereas between 2020 and 2021 the segment’s shipment volume was essentially flat (820.3 million cans in 2021 vs. 819.6 million in 2020) with only a slight share loss. Thus, Skoal’s retail‑share trend fell sharply from 2023 to 2024, contrasting with the near‑steady shipment volumes seen from 2020 to 2021.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MO_10k_2022.pdf",
          "target_page": 46,
          "pages": [
            44,
            45,
            46,
            47,
            48
          ]
        },
        "hop_2_rel": {
          "source_file": "MO_10k_2024.pdf",
          "target_page": 48,
          "pages": [
            46,
            47,
            48,
            49,
            50
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 54361,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 13813,
        "completion_tokens": 142,
        "total_tokens": 13956
      }
    },
    {
      "question_id": 108,
      "question": "How has Qualcomm's approach to multimedia technologies evolved from 2022 to 2024, particularly in terms of engineering focus areas and integration into product offerings?",
      "original_answer": "In 2022, Qualcomm emphasized engineering expertise in multimedia technologies such as camera, video, display, and computer vision as part of a broader set of capabilities including modem, RF, and sensor perception technologies. The focus was on enhancing existing products and developing new technologies for industries beyond mobile handsets, such as automotive and IoT. By 2024, the company's description of its multimedia technology efforts remained consistent, but there was a notable expansion in the integration of AI, particularly generative AI, into its research and development strategy. Additionally, in 2024, Qualcomm placed greater emphasis on enabling developers to design and deploy applications across multiple device categories and industries, signaling a more deliberate diversification strategy. This evolution reflects a shift from primarily hardware-centric multimedia innovation in 2022 to a more platform-oriented, AI-enhanced approach by 2024.",
      "llm_answer": "From 2022 to 2024, Qualcomm’s engineering focus shifted from primarily advancing 4G/LTE and multimode RF technologies toward deeper integration of AI, multimedia (camera, video, display, computer vision), and on-device generative AI capabilities, while expanding its R&D into automotive (ADAS/AD), XR, and broader IoT applications. This evolution is reflected in its 2024 disclosures emphasizing AI research (including power-efficient, personalized on-device AI), multimedia SoC innovations, and strategic investments in AI and automotive sectors, moving beyond mobile handsets to target industries like automotive and industrial IoT, as detailed in the \"Research and Development\" sections of both 2022 and 2024 filings.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "QCOM_10k_2022.pdf",
          "target_page": 14,
          "pages": [
            12,
            13,
            14,
            15,
            16
          ]
        },
        "hop_2_rel": {
          "source_file": "QCOM_10k_2024.pdf",
          "target_page": 14,
          "pages": [
            12,
            13,
            14,
            15,
            16
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 62531,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 15859,
        "completion_tokens": 180,
        "total_tokens": 16039
      }
    },
    {
      "question_id": 109,
      "question": "How did 3M's financial relationship with the Aearo Entities evolve between 2023 and 2024, particularly in terms of equity investment and intercompany balances?",
      "original_answer": "In 2023, 3M reconsolidated the Aearo Entities, which resulted in the removal of a $0.7 billion asset balance in equity and other investments and a $0.6 billion net liability for former intercompany amounts from its consolidated balance sheet as of December 31, 2023. By 2024, the Aearo Entities were no longer consolidated, and instead, 3M now 'has a stake in' them, indicating a shift from full consolidation to a retained equity interest. This reflects a significant change in the financial structure and relationship between 3M and the Aearo Entities.",
      "llm_answer": "Between 2023 and 2024, 3M’s financial relationship with the Aearo Entities evolved from deconsolidation in late 2022 to full reconsolidation in Q2 2023 after the bankruptcy dismissal of the Aearo entities. Following reconsolidation, 3M recorded a $4.2 billion pre‑tax charge in Q3 2023 related to the CAE Settlement, reflecting a $5.3 billion present‑value contribution (cash and stock) to fund the settlement and associated legal costs. By year‑end 2023, 3M had accrued $5.0 billion for Combat‑Arms earplug liabilities and, in 2024, continued to fund the settlement—paying $10 million in September 2023, $250 million in December 2023, and $253 million on Jan 31 2024—while the $1 billion equity portion of the settlement was converted to cash. Intercompany balances tied to the former deconsolidated entities were eliminated, resulting in a net liability of about $0.6 billion that was removed from the consolidated balance sheet. Thus, the relationship shifted from a largely off‑balance‑sheet, contingent exposure to an actively funded, settled liability with the Aearo entities now fully re‑included in 3M’s consolidated financial statements.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MMM_10k_2023.pdf",
          "target_page": 101,
          "pages": [
            99,
            100,
            101,
            102,
            103
          ]
        },
        "hop_2_rel": {
          "source_file": "MMM_10k_2024.pdf",
          "target_page": 50,
          "pages": [
            48,
            49,
            50,
            51,
            52
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 62688,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 15896,
        "completion_tokens": 286,
        "total_tokens": 16183
      }
    },
    {
      "question_id": 109,
      "question": "How has Visa's Risk and Identity Solutions evolved between 2022 and 2024, particularly in terms of their strategic positioning within the company's broader value-added services portfolio?",
      "original_answer": "In 2022, Visa's Risk and Identity Solutions were described as tools that 'transform data into insights for near real-time decisions' and included named products like Visa Advanced Authorization and Visa Secure. These solutions were positioned primarily around fraud prevention and payment security, with an emphasis on helping clients protect account holder data and prevent fraud in the context of omnichannel commerce. By 2024, Risk and Identity Solutions had been elevated as one of five core categories within a more expansive value-added services portfolio that now includes Open Banking Solutions and Advisory Services. The 2024 report highlights that Visa offered more than 200 products and services as of September 30, 2024, many designed to work together for 'high impact business outcomes,' indicating a broader strategic integration of Risk and Identity Solutions within a more diversified services ecosystem.",
      "llm_answer": "Between 2022 and 2024, Visa’s Risk and Identity Solutions evolved from a primarily fraud‑prevention toolkit into a broader, AI‑driven suite that underpins its “network of networks” strategy. The portfolio now includes real‑time authorization scoring (Visa Deep Authorization), A2A‑specific fraud protection (Visa Protect for A2A), and expanded token‑based authentication (Visa Consumer Authentication Service), positioning these capabilities as core value‑added services that support Visa’s expanded B2B, cross‑border and open‑banking flows. This strategic shift reinforces Risk and Identity Solutions as a differentiator within Visa’s overall value‑added services portfolio, driving deeper client engagement and new revenue streams.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "V_10k_2022.pdf",
          "target_page": 12,
          "pages": [
            10,
            11,
            12,
            13,
            14
          ]
        },
        "hop_2_rel": {
          "source_file": "V_10k_2024.pdf",
          "target_page": 11,
          "pages": [
            9,
            10,
            11,
            12,
            13
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 42330,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 10812,
        "completion_tokens": 183,
        "total_tokens": 10995
      }
    },
    {
      "question_id": 110,
      "question": "How did RTX's disclosure and quantification of Acquisition Accounting Adjustments' impact on operating profit evolve between 2023 and 2024?",
      "original_answer": "In 2023, RTX provided specific quantified impacts of Acquisition Accounting Adjustments on operating profit, showing a negative impact of $1,998 million in 2023, compared to $1,893 million in 2022 and $2,203 million in 2021. By 2024, RTX shifted its disclosure approach by providing qualitative policy context about the components of these adjustments, but did not include updated quantitative figures for the current year's impact on operating profit. This represents a move from concrete numerical disclosure to a more conceptual explanation of acquisition accounting practices without continuing the year-over-year quantification.",
      "llm_answer": "Between 2023 and 2024, RTX's disclosure of Acquisition Accounting Adjustments shifted from a $1.998 billion net adjustment in 2023 to a $2.058 billion net adjustment in 2024, reflecting a modest increase driven primarily by higher amortization of acquired intangibles and property‑plant‑equipment fair‑value adjustments, partially offset by slightly lower amortization of customer contractual obligations. This evolution indicates that while the overall magnitude of acquisition‑related adjustments remained relatively stable, the 2024 figure shows a small upward trend compared with the prior year.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "RTX_10k_2023.pdf",
          "target_page": 109,
          "pages": [
            107,
            108,
            109,
            110,
            111
          ]
        },
        "hop_2_rel": {
          "source_file": "RTX_10k_2024.pdf",
          "target_page": 54,
          "pages": [
            52,
            53,
            54,
            55,
            56
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 56577,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 14364,
        "completion_tokens": 149,
        "total_tokens": 14514
      }
    },
    {
      "question_id": 111,
      "question": "How has Microsoft's Office 365 Commercial revenue contribution to the Microsoft Cloud evolved between fiscal years 2022 and 2023, and what does this indicate about its growth trajectory within the broader cloud ecosystem?",
      "original_answer": "In fiscal year 2022, Office 365 Commercial was explicitly cited as a key growth driver within the Productivity and Business Processes segment, contributing to an 18% overall revenue increase for the company. By fiscal year 2023, Office 365 Commercial was included in a newly disclosed consolidated Microsoft Cloud revenue figure, which reached $111.6 billion in FY2023, up from $91.4 billion in FY2022. This indicates that Office 365 Commercial continued to grow as part of a broader, increasingly transparent cloud revenue portfolio that now includes Azure, LinkedIn (commercial portion), Dynamics 365, and other cloud services.",
      "llm_answer": "Microsoft's Office 365 Commercial revenue grew from $44.97 billion in fiscal 2022 to $48.85 billion in fiscal 2023, reflecting a strong upward trajectory within the Microsoft Cloud portfolio. This growth contributed to the overall Microsoft Cloud revenue increasing from $91.4 billion in 2022 to $111.6 billion in 2023, underscoring Office 365 Commercial's expanding share and importance in the broader cloud ecosystem.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MSFT_10k_2022.pdf",
          "target_page": 43,
          "pages": [
            41,
            42,
            43,
            44,
            45
          ]
        },
        "hop_2_rel": {
          "source_file": "MSFT_10k_2023.pdf",
          "target_page": 93,
          "pages": [
            91,
            92,
            93,
            94,
            95
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 37939,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 9724,
        "completion_tokens": 104,
        "total_tokens": 9829
      }
    },
    {
      "question_id": 111,
      "question": "How did Merck's alliance revenue related to Lynparza evolve between 2023 and 2024, and what factors contributed to the change?",
      "original_answer": "In 2023, alliance revenue for Lynparza was part of Merck's broader alliance revenue reporting, which included profits based on product sales net of cost of sales and commercialization costs. By 2024, alliance revenue related to Lynparza specifically grew by 9%, driven by higher demand in most international markets. This growth indicates a positive shift in Lynparza's market performance during the period.",
      "llm_answer": "Alliance revenue related to Lynparza increased from $1,199 million in 2023 to $1,311 million in 2024, reflecting a 9% rise (11% excluding foreign‑exchange effects). This growth was driven by higher demand for Lynparza in most international markets, including the January 2025 Chinese approval for its use as an adjuvant treatment for germline‑BRCA‑mutated, HER2‑negative high‑risk early breast cancer. The expansion of its indication and continued uptake abroad were the primary factors behind the revenue uplift.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MRK_10k_2023.pdf",
          "target_page": 126,
          "pages": [
            108,
            109,
            110,
            111,
            112
          ]
        },
        "hop_2_rel": {
          "source_file": "MRK_10k_2024.pdf",
          "target_page": 55,
          "pages": [
            53,
            54,
            55,
            56,
            57
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 57741,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 14652,
        "completion_tokens": 128,
        "total_tokens": 14780
      }
    },
    {
      "question_id": 112,
      "question": "How has the treatment and disclosure of the Procter & Gamble 2014 Stock and Incentive Compensation Plan evolved between 2023 and 2024, particularly in terms of its regulatory context and inclusion in equity compensation reporting?",
      "original_answer": "In 2023, the 2014 Stock and Incentive Compensation Plan was disclosed in the context of regulatory documentation and was referenced alongside other compensation plans and agreements, such as the 2009 and 2019 plans, indicating its active role in executive compensation. By 2024, the plan was included in a broader list of equity compensation plans for reporting on stock issuances upon exercise of options, suggesting a shift from regulatory disclosure to a focus on ownership structure and equity compensation transparency. This evolution indicates a more integrated view of the 2014 plan within the company’s overall equity compensation framework.",
      "llm_answer": "The treatment and disclosure of the Procter & Gamble 2014 Stock and Incentive Compensation Plan in the 2024 Form 10-K reflects its continued inclusion within the company’s broader equity compensation framework, now operating alongside newer plans such as the 2019 Stock and Incentive Compensation Plan. While the 2014 Plan is referenced in the exhibit list and related governance materials, it is no longer the primary vehicle for future equity grants, with the 2019 Plan now serving as the main plan permitting future issuances. Disclosure of the 2014 Plan’s terms and conditions is incorporated by reference from prior filings, consistent with SEC requirements, but its role has diminished in current compensation reporting, particularly in the summary of equity awards and future available shares presented in Item 12.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "PG_10k_2023.pdf",
          "target_page": 70,
          "pages": [
            68,
            69,
            70,
            71,
            72
          ]
        },
        "hop_2_rel": {
          "source_file": "PG_10k_2024.pdf",
          "target_page": 68,
          "pages": [
            66,
            67,
            68,
            69,
            70
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 70694,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 17914,
        "completion_tokens": 205,
        "total_tokens": 18119
      }
    },
    {
      "question_id": 113,
      "question": "How has the treatment of the 1992 Stock Plan evolved between the 2023 and 2024 10-K filings, particularly in terms of its role within the company's equity compensation structure?",
      "original_answer": "In the 2023 10-K filing, the 1992 Stock Plan was referenced as an adopted plan with specific terms and conditions incorporated by reference to prior filings. However, in the 2024 10-K filing, the 1992 Stock Plan is listed among other equity compensation plans in a consolidated table that outlines shares authorized for issuance upon the exercise of options, warrants, and rights. This indicates a shift from a standalone referenced plan to one being tracked alongside newer plans, suggesting its role has transitioned from active adoption to a more passive stake within the broader equity compensation framework.",
      "llm_answer": "The 1992 Stock Plan remains part of P&G’s legacy equity framework but is no longer a primary vehicle for new grants; its role has been superseded by the 2019 Stock and Incentive Compensation Plan, which now serves as the principal plan for future equity awards within the company’s compensation structure.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "PG_10k_2023.pdf",
          "target_page": 69,
          "pages": [
            67,
            68,
            69,
            70,
            71
          ]
        },
        "hop_2_rel": {
          "source_file": "PG_10k_2024.pdf",
          "target_page": 68,
          "pages": [
            66,
            67,
            68,
            69,
            70
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 71108,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 18005,
        "completion_tokens": 76,
        "total_tokens": 18081
      }
    },
    {
      "question_id": 113,
      "question": "How has the company's emphasis on large-scale transformations evolved between 2023 and 2024, particularly in terms of client spending patterns and revenue conversion timelines?",
      "original_answer": "In 2023, the filing noted that clients were reducing or deferring spending on smaller contracts with shorter durations and that there was a slowdown in client spending, especially for consulting services. However, clients were still prioritizing large-scale transformations, which convert to revenue over a longer period. In 2024, the filing reiterated that clients continued to prioritize large-scale transformations, emphasizing the ongoing shift toward longer-duration contracts. While there was no explicit quantitative metric provided in either year, the repeated emphasis in both filings on the extended revenue conversion timeline for large-scale transformations indicates a strategic reinforcement of this focus, especially amid ongoing economic volatility.",
      "llm_answer": "The company’s focus on large‑scale transformations has remained consistent, but the 2024 filing notes that client spending is now more closely tied to these long‑term transformation projects, with revenue recognition spread over a longer horizon. Consequently, while the strategic emphasis on transformations has not changed, the timing of revenue conversion has slowed, reflecting a shift toward more extended, value‑driven engagements.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "ACN_10k_2023.pdf",
          "target_page": 21,
          "pages": [
            19,
            20,
            21,
            22,
            23
          ]
        },
        "hop_2_rel": {
          "source_file": "ACN_10k_2024.pdf",
          "target_page": 21,
          "pages": [
            19,
            20,
            21,
            22,
            23
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 8,
        "total_chars": 42463,
        "num_window_pages": 8,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 10843,
        "completion_tokens": 109,
        "total_tokens": 10953
      }
    },
    {
      "question_id": 114,
      "question": "How did Accenture's issuance of Class A Ordinary Shares for employee compensation change from fiscal 2023 to 2024, and what was the impact on the company's equity structure?",
      "original_answer": "In fiscal 2023, Accenture acquired Class A Ordinary Shares primarily through share withholding for payroll tax obligations related to employee equity awards. In fiscal 2024, the company issued 7,970 Class A Ordinary Shares specifically for employee share programs, while also purchasing 12,181 treasury shares. This shift reflects a more active use of Class A Ordinary Shares for compensation purposes in 2024. The equity structure was impacted as Class A Ordinary Shares increased from 15,656,591 in 2023 to 15,664,561 in 2024, while treasury shares decreased in value from $(3,408,491) million to $(6,678,037) million, indicating a significant reallocation of shares for employee programs.",
      "llm_answer": "From fiscal 2023 to 2024, Accenture issued 7.9 million Class A ordinary shares for employee share programs, increasing the total Class A share count from 15,664,616 to 15,672,485. This issuance contributed $1.42 billion to shareholders’ equity and modestly diluted the share count, but did not fundamentally alter the overall equity structure beyond the addition of new Class A shares and related paid‑in capital.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "ACN_10k_2023.pdf",
          "target_page": 101,
          "pages": [
            81,
            82,
            83,
            84,
            85
          ]
        },
        "hop_2_rel": {
          "source_file": "ACN_10k_2024.pdf",
          "target_page": 70,
          "pages": [
            68,
            69,
            70,
            71,
            72
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 35266,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 9043,
        "completion_tokens": 103,
        "total_tokens": 9147
      }
    },
    {
      "question_id": 115,
      "question": "How did MDLZ's exposure to Canadian-denominated debt instruments change between 2022 and 2023, and how does this shift compare to the company's overall trend in managing foreign currency-denominated debt during this period?",
      "original_answer": "In 2022, MDLZ reported a decrease in Canadian notes of $3 million, continuing a trend of declining balances from $17 million in 2019 to $7 million in 2020 and $3 million in 2021. However, in 2023, the company experienced an increase in Canadian notes by $8 million, reversing the previous downward trajectory. This shift contrasts with the broader pattern of fluctuating foreign currency exposure, where Euro notes decreased significantly from $211 million in 2021 to $81 million in 2023, while Swiss franc notes also showed volatility. The reversal in Canadian notes indicates a notable deviation from the prior year's trend of reducing exposure to this currency denomination.",
      "llm_answer": "MDLZ reduced its exposure to Canadian‑denominated debt designated as net‑investment hedges from $443 million at the end of 2022 to $453 million at the end of 2023 (a modest increase in notional amount, but the related after‑tax gain/loss shifted from a $25 million gain in 2022 to an $8 million loss in 2023). This change reflects a broader trend of actively managing foreign‑currency‑denominated debt, as the company also adjusted its net‑investment hedge program and overall foreign‑currency hedge coverage across other currencies, indicating a strategic shift in how it hedges international debt exposures.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MDLZ_10k_2022.pdf",
          "target_page": 114,
          "pages": [
            112,
            113,
            114,
            115,
            116
          ]
        },
        "hop_2_rel": {
          "source_file": "MDLZ_10k_2023.pdf",
          "target_page": 98,
          "pages": [
            96,
            97,
            98,
            99,
            100
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 52649,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 13404,
        "completion_tokens": 152,
        "total_tokens": 13556
      }
    },
    {
      "question_id": 115,
      "question": "How has Accenture's approach to engaging with growth-stage companies evolved from 2023 to 2024, particularly in terms of strategic involvement and investment activity?",
      "original_answer": "In 2023, Accenture Ventures was described as primarily partnering with growth-stage companies that create innovative enterprise technologies. By 2024, the relationship evolved from a partnership model to a more direct investment approach, indicating a deeper financial and strategic commitment. This shift from 'partners with' to 'invests in' growth-stage firms suggests Accenture is taking a more active role in shaping innovation ecosystems through capital allocation, aligning with its broader innovation strategy supported by $1.3 billion in R&D spending in fiscal 2023 and $1.2 billion in fiscal 2024.",
      "llm_answer": "Accenture's approach to growth-stage companies has evolved significantly from 2023 to 2024, particularly through its Accenture Ventures unit, which now actively partners with and invests in growth-stage technology companies to accelerate innovation. This strategic involvement is underscored by the firm's increased focus on emerging technologies like AI and generative AI, as well as its broader ecosystem engagement to scale solutions for clients. While specific investment figures are not detailed in the provided pages, the emphasis on growth-stage companies reflects a deliberate shift toward deeper, more strategic collaboration to drive client value and market leadership.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "ACN_10k_2023.pdf",
          "target_page": 17,
          "pages": [
            15,
            16,
            17,
            18,
            19
          ]
        },
        "hop_2_rel": {
          "source_file": "ACN_10k_2024.pdf",
          "target_page": 17,
          "pages": [
            15,
            16,
            17,
            18,
            19
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 7,
        "total_chars": 23233,
        "num_window_pages": 7,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 6034,
        "completion_tokens": 169,
        "total_tokens": 6203
      }
    },
    {
      "question_id": 115,
      "question": "How has Merck's financial and strategic involvement in the Lynparza collaboration with AstraZeneca evolved from 2022 to 2024, particularly in terms of asset amortization and alliance revenue growth?",
      "original_answer": "In 2022, Merck was amortizing an intangible asset balance of $1.1 billion related to Lynparza, which included capitalized milestone payments, and was expected to be amortized through 2028. By 2024, the focus shifted from asset amortization to revenue growth, with alliance revenue from Lynparza increasing by 9% due to higher demand in international markets. Additionally, in early 2025, Lynparza received a new approval in China for adjuvant treatment in early breast cancer, indicating an expansion in its therapeutic footprint and strategic importance to Merck.",
      "llm_answer": "From 2022 through 2024 Merck’s Lynparza collaboration with AstraZeneca has moved from a milestone‑driven, catch‑up amortization model to a growth‑focused revenue stream.  The 2021 intangible‑asset balance for Lynparza ($1.1 bn) is being amortized through 2028, and by 2024 alliance revenue from Lynparza had risen 9% year‑over‑year to $1.311 bn, reflecting higher international demand and the absence of further catch‑up amortization.  Consequently, the earlier $153 m cumulative amortization catch‑up recorded in 2021 is no longer a driver; instead, Lynparza’s contribution to overall alliance revenue is expanding organically as the drug gains new regulatory approvals (e.g., China’s 2025 adjuvant indication).",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MRK_10k_2022.pdf",
          "target_page": 102,
          "pages": [
            100,
            101,
            102,
            103,
            104
          ]
        },
        "hop_2_rel": {
          "source_file": "MRK_10k_2024.pdf",
          "target_page": 55,
          "pages": [
            53,
            54,
            55,
            56,
            57
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 53630,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 13642,
        "completion_tokens": 178,
        "total_tokens": 13820
      }
    },
    {
      "question_id": 116,
      "question": "How has AVGO's strategic emphasis on ValueOps changed between 2023 and 2024, and what does this indicate about its evolving role in the Distributed Software portfolio?",
      "original_answer": "In 2023, ValueOps was listed as one of several key offerings under AVGO's Distributed Software portfolio, positioned alongside other solutions like DevOps and AIOps without specific elaboration on its strategic role. By 2024, ValueOps was elevated to be one of the three core domains—alongside DevOps and AIOps—that AVGO's distributed software solutions are 'organized in the domains of,' with an explicit emphasis on delivering 'end-to-end visibility across all stages of the digital lifecycle.' This indicates a strategic shift where ValueOps became more central to AVGO's value proposition, aligning it more deeply with business outcomes and customer experiences. The change reflects a broader evolution from being a feature in the portfolio to a foundational pillar supporting enterprise digital transformation.",
      "llm_answer": "Between 2023 and 2024, Broadcom’s strategic emphasis on **ValueOps** within its Distributed Software portfolio shifted from a general capability for streamlining software planning, development and delivery (highlighted in 2023 as part of its broader distributed‑software offering) to a more pronounced, dedicated focus in 2024, where ValueOps is explicitly positioned alongside DevOps and AIOps as a core pillar of the Distributed Software portfolio and is featured prominently in the “Distributed Software Portfolio” table and accompanying descriptions. This evolution indicates that Broadcom is treating ValueOps as a strategic growth driver—integrating it more deeply into its broader private‑cloud and enterprise‑software strategy and aligning it with its broader infrastructure‑software and security initiatives—to strengthen its end‑to‑end visibility and business‑outcome focus across the software lifecycle.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AVGO_10k_2023.pdf",
          "target_page": 8,
          "pages": [
            6,
            7,
            8,
            9,
            10
          ]
        },
        "hop_2_rel": {
          "source_file": "AVGO_10k_2024.pdf",
          "target_page": 10,
          "pages": [
            8,
            9,
            10,
            11,
            12
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 60089,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 15247,
        "completion_tokens": 228,
        "total_tokens": 15475
      }
    },
    {
      "question_id": 117,
      "question": "How did FedEx's strategic approach to Network 2.0 within the DRIVE transformation evolve between 2023 and 2024, particularly in terms of expected cost savings and implementation risks?",
      "original_answer": "In 2023, FedEx emphasized the strategic importance of Network 2.0 as part of its DRIVE transformation, noting that significant investments were being made with the expectation of achieving operational efficiencies, network flexibility, and alignment of the cost base with demand. However, the filing acknowledged that the failure to successfully execute Network 2.0 within the expected time frame and cost could adversely affect future results. By 2024, FedEx shifted focus to the integration complexities of Network 2.0, including risks related to harmonizing operating practices, maintaining customer and service provider agreements, addressing labor and cultural differences, and managing unforeseen expenses. The 2024 filing also noted that the actual amount and timing of cost savings and permanent cost reductions might differ from expectations, and that asset impairment charges, tax impacts, and litigation risks could arise. This reflects a transition from strategic planning and investment justification in 2023 to operational integration and financial risk mitigation in 2024.",
      "llm_answer": "Between 2023 and 2024, FedEx’s DRIVE transformation—specifically Network 2.0—moved from planning to execution, with the new legal structure finalized in June 2024 and integration of legacy FedEx Ground and FedEx Services underway. The company expects the transformation to generate cost savings and a more flexible, aligned cost base, but acknowledges that actual savings, timing and the magnitude of those benefits may differ from expectations due to integration complexities, labor‑relation issues, regulatory hurdles and potential asset impairments. Consequently, while Network 2.0 is projected to deliver operational efficiencies and permanent cost reductions, it also carries implementation risks that could increase costs, delay benefits or adversely affect financial results if not successfully executed.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "FDX_10k_2023.pdf",
          "target_page": 32,
          "pages": [
            30,
            31,
            32,
            33,
            34
          ]
        },
        "hop_2_rel": {
          "source_file": "FDX_10k_2024.pdf",
          "target_page": 29,
          "pages": [
            27,
            28,
            29,
            30,
            31
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 63825,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 16186,
        "completion_tokens": 202,
        "total_tokens": 16389
      }
    },
    {
      "question_id": 117,
      "question": "How did the financial impact from equity method investment contracts evolve between 2022 and 2023, and what does this indicate about MDLZ's engagement with these investments?",
      "original_answer": "In 2022, MDLZ reported a net liability of $3 million related to equity method investment contracts. By 2023, this position had shifted to a gain of $7 million from equity method investment contracts, indicating a reversal in financial impact and potentially more active or favorable engagement with these investments. This evolution highlights a strategic or operational shift in how MDLZ managed these equity method investments over the two years.",
      "llm_answer": "The financial impact from equity method investment contracts remained minimal and essentially unchanged between 2022 and 2023, with the fair value of the embedded derivative consistently recorded as a $3 liability in both years. This stability indicates that Mondelez International's engagement with these specific investment contracts did not result in significant financial fluctuations during this period, suggesting a relatively static position in their equity method investment strategy.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MDLZ_10k_2022.pdf",
          "target_page": 111,
          "pages": [
            109,
            110,
            111,
            112,
            113
          ]
        },
        "hop_2_rel": {
          "source_file": "MDLZ_10k_2023.pdf",
          "target_page": 98,
          "pages": [
            96,
            97,
            98,
            99,
            100
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 51486,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 13101,
        "completion_tokens": 123,
        "total_tokens": 13224
      }
    },
    {
      "question_id": 117,
      "question": "How did Broadcom's (AVGO) estimated cost to complete for the VMware Cloud Foundation July 2024 releases evolve from fiscal year 2023 to fiscal year 2024, and what does this indicate about the development progress relative to expectations?",
      "original_answer": "The estimated cost to complete for the VMware Cloud Foundation July 2024 releases remained unchanged at $38 million from fiscal year 2023 to fiscal year 2024. This consistency in the cost estimate indicates that the development progress for this product was proceeding largely as planned, with actual expenditures aligning with earlier projections. The lack of an increase or decrease in the estimated cost to complete suggests that Broadcom (AVGO) did not encounter significant unexpected expenses or delays in the development timeline for this specific release.",
      "llm_answer": "Based on the document, the estimated cost to complete the VMware Cloud Foundation July 2024 releases was $38 million at the end of fiscal 2023 and increased to $38 million (the same absolute amount) by fiscal 2024, but the percentage of completion rose from 67 % to 67 % – effectively indicating that the remaining work stayed constant while the overall project remained on schedule. The modest increase in absolute cost to complete, together with the high completion rate, shows that development is progressing close to expectations, with only a small amount of work left to finish the July 2024 releases.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AVGO_10k_2023.pdf",
          "target_page": 69,
          "pages": [
            67,
            68,
            69,
            70,
            71
          ]
        },
        "hop_2_rel": {
          "source_file": "AVGO_10k_2024.pdf",
          "target_page": 69,
          "pages": [
            67,
            68,
            69,
            70,
            71
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 36752,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 9432,
        "completion_tokens": 151,
        "total_tokens": 9583
      }
    },
    {
      "question_id": 118,
      "question": "How has the strategic positioning of FedEx Office's Ship and Go kiosk evolved between 2023 and 2024, and what does this indicate about the company's approach to e-commerce logistics and returns management?",
      "original_answer": "In 2023, the Ship and Go kiosk was described primarily as a self-serve shipping solution available in approximately 1,300 locations, allowing customers to generate labels via mobile or QR code and drop off packages securely. While it mentioned facilitating e-commerce returns, the integration was not emphasized. By 2024, the description of Ship and Go remained consistent in terms of presence (still in approximately 1,300 locations) and core functionality, but there was a notable shift in emphasis: it was now more explicitly tied to FedEx Returns Technology and Consolidated Returns, highlighting its role in in-store printing of return labels and enabling customers to drop off returns without a box or label. This evolution indicates a strategic shift toward positioning Ship and Go not just as a shipping tool, but as a key node in FedEx's broader e-commerce returns infrastructure.",
      "llm_answer": "The strategic positioning of FedEx Office's Ship and Go kiosk has evolved from a niche self-service shipping option to a core component of an integrated e-commerce and returns ecosystem between 2023 and 2024. This evolution reflects FedEx's broader approach to unifying logistics and returns management—leveraging kiosks for seamless label generation and drop-offs, integrating with FedEx Returns Technology for in-store return label printing, and expanding capabilities like Consolidated Returns to enable boxless, label-less returns—demonstrating a strategic shift toward frictionless, customer-centric omnichannel fulfillment that aligns with the growth of e-commerce.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "FDX_10k_2023.pdf",
          "target_page": 15,
          "pages": [
            13,
            14,
            15,
            16,
            17
          ]
        },
        "hop_2_rel": {
          "source_file": "FDX_10k_2024.pdf",
          "target_page": 15,
          "pages": [
            13,
            14,
            15,
            16,
            17
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 51878,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 13204,
        "completion_tokens": 167,
        "total_tokens": 13372
      }
    }
  ]
}